{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
      "[nltk_data]     C:\\Users\\amoha\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package averaged_perceptron_tagger is already up-to-\n",
      "[nltk_data]       date!\n",
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\amoha\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "from utilities.utils_clean import *\n",
    "from utilities.test_dataset_utils import *\n",
    "from utilities.nlp_processing import *"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 25081 patents from ../data/test_dataset_2015.pkl\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>patentnumber</th>\n",
       "      <th>appyear</th>\n",
       "      <th>issueyear</th>\n",
       "      <th>inventorcountry</th>\n",
       "      <th>divisional</th>\n",
       "      <th>continuation</th>\n",
       "      <th>prioritydate</th>\n",
       "      <th>priority.formatted</th>\n",
       "      <th>priorityyear</th>\n",
       "      <th>...</th>\n",
       "      <th>yr4</th>\n",
       "      <th>yr8</th>\n",
       "      <th>yr11</th>\n",
       "      <th>claims</th>\n",
       "      <th>wordaverage</th>\n",
       "      <th>litigated</th>\n",
       "      <th>orangebook</th>\n",
       "      <th>forward.cites</th>\n",
       "      <th>industry</th>\n",
       "      <th>subindustry</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>497653</td>\n",
       "      <td>8969641</td>\n",
       "      <td>1976.0</td>\n",
       "      <td>2015.0</td>\n",
       "      <td>US</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>19760903.0</td>\n",
       "      <td>28006.0</td>\n",
       "      <td>1976.0</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>497654</td>\n",
       "      <td>9134302</td>\n",
       "      <td>1995.0</td>\n",
       "      <td>2015.0</td>\n",
       "      <td>US</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19830505.0</td>\n",
       "      <td>30441.0</td>\n",
       "      <td>1983.0</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>497655</td>\n",
       "      <td>8926966</td>\n",
       "      <td>1995.0</td>\n",
       "      <td>2015.0</td>\n",
       "      <td>US</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19900921.0</td>\n",
       "      <td>33137.0</td>\n",
       "      <td>1990.0</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>31.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>497656</td>\n",
       "      <td>9181140</td>\n",
       "      <td>1993.0</td>\n",
       "      <td>2015.0</td>\n",
       "      <td>US</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19920916.0</td>\n",
       "      <td>33863.0</td>\n",
       "      <td>1992.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>497657</td>\n",
       "      <td>9199886</td>\n",
       "      <td>2009.0</td>\n",
       "      <td>2015.0</td>\n",
       "      <td>US</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19940119.0</td>\n",
       "      <td>34353.0</td>\n",
       "      <td>1994.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 32 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0 patentnumber  appyear  issueyear inventorcountry  divisional  \\\n",
       "0      497653      8969641   1976.0     2015.0              US         0.0   \n",
       "1      497654      9134302   1995.0     2015.0              US         1.0   \n",
       "2      497655      8926966   1995.0     2015.0              US         1.0   \n",
       "3      497656      9181140   1993.0     2015.0              US         0.0   \n",
       "4      497657      9199886   2009.0     2015.0              US         0.0   \n",
       "\n",
       "   continuation  prioritydate  priority.formatted  priorityyear  ...  yr4  \\\n",
       "0           0.0    19760903.0             28006.0        1976.0  ...  NaN   \n",
       "1           1.0    19830505.0             30441.0        1983.0  ...  NaN   \n",
       "2           1.0    19900921.0             33137.0        1990.0  ...  NaN   \n",
       "3           1.0    19920916.0             33863.0        1992.0  ...  0.0   \n",
       "4           1.0    19940119.0             34353.0        1994.0  ...  0.0   \n",
       "\n",
       "   yr8  yr11  claims wordaverage  litigated  orangebook  forward.cites  \\\n",
       "0  NaN   NaN     NaN         NaN        0.0         0.0            0.0   \n",
       "1  NaN   NaN     NaN         NaN        0.0         0.0            0.0   \n",
       "2  NaN   NaN     NaN         NaN        0.0         0.0            0.0   \n",
       "3  0.0   0.0     NaN         NaN        0.0         0.0            0.0   \n",
       "4  0.0   0.0     NaN         NaN        0.0         0.0            0.0   \n",
       "\n",
       "   industry  subindustry  \n",
       "0       1.0         19.0  \n",
       "1       NaN          NaN  \n",
       "2       3.0         31.0  \n",
       "3       NaN          NaN  \n",
       "4       NaN          NaN  \n",
       "\n",
       "[5 rows x 32 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_data = load_from_pickle(\"../data/test_dataset_2015.pkl\")\n",
    "\n",
    "df_test_data = pd.DataFrame(test_data,index=[\"xml\"],).T.reset_index()\n",
    "df_test_data.columns = [\"patentnumber\",\"xml\"] \n",
    "\n",
    "\n",
    "# df = read_xlsb_file()\n",
    "# df[(df.issueyear == 2015) | (df.prophetic !=0)][[\"patentnumber\",\"prophetic\",\"nonprophetic\",\"issueyear\"]]\n",
    "# df[df.issueyear == 2015].to_csv(\"freilichdataet_2015.csv\")\n",
    "df = pd.read_csv(\"../data/freilichdataet_2015.csv\")\n",
    "df[\"patentnumber\"] = df[\"patentnumber\"].astype(str).transform(lambda x: x.replace(\".0\", \"\"))\n",
    "df[\"patentnumber\"] = df[\"patentnumber\"].apply(remove_leadiong_zeros)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "25081\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patentnumber</th>\n",
       "      <th>xml</th>\n",
       "      <th>prophetic</th>\n",
       "      <th>nonprophetic</th>\n",
       "      <th>allprophetic</th>\n",
       "      <th>someprophetic</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>RE045323</td>\n",
       "      <td>&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;\\n&lt;!DOCT...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>RE045324</td>\n",
       "      <td>&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;\\n&lt;!DOCT...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RE045325</td>\n",
       "      <td>&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;\\n&lt;!DOCT...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>8925349</td>\n",
       "      <td>&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;\\n&lt;!DOCT...</td>\n",
       "      <td>26.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8925551</td>\n",
       "      <td>&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;\\n&lt;!DOCT...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  patentnumber                                                xml  prophetic  \\\n",
       "0     RE045323  <?xml version=\"1.0\" encoding=\"UTF-8\"?>\\n<!DOCT...        1.0   \n",
       "1     RE045324  <?xml version=\"1.0\" encoding=\"UTF-8\"?>\\n<!DOCT...        0.0   \n",
       "2     RE045325  <?xml version=\"1.0\" encoding=\"UTF-8\"?>\\n<!DOCT...        0.0   \n",
       "3      8925349  <?xml version=\"1.0\" encoding=\"UTF-8\"?>\\n<!DOCT...       26.0   \n",
       "4      8925551  <?xml version=\"1.0\" encoding=\"UTF-8\"?>\\n<!DOCT...        6.0   \n",
       "\n",
       "   nonprophetic  allprophetic  someprophetic  \n",
       "0          12.0           0.0            1.0  \n",
       "1           8.0           0.0            0.0  \n",
       "2           8.0           0.0            0.0  \n",
       "3           0.0           1.0            0.0  \n",
       "4           5.0           0.0            1.0  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged = df_test_data.merge(df, on=\"patentnumber\", how=\"left\")\n",
    "print(len(merged))\n",
    "cols = [\"patentnumber\",\"xml\",\"prophetic\",\"nonprophetic\",\"allprophetic\",\"someprophetic\"]\n",
    "merged[cols].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_examples_start_w_word_test(xml_siblings):\n",
    "    examples = []\n",
    "    current_example = None\n",
    "    in_example = False\n",
    "\n",
    "    for tag in xml_siblings:\n",
    "        if tag.name == \"heading\":\n",
    "            if (\n",
    "                tag.text.strip().lower().startswith(\"example\")\n",
    "                or tag.text.strip().lower().startswith(\"experiment\")\n",
    "                or tag.text.strip().lower().startswith(\"test\")\n",
    "            ):\n",
    "                in_example = True\n",
    "                current_example = {\n",
    "                    \"number\": tag.text.strip(),\n",
    "                    \"title\": xml_siblings[xml_siblings.index(tag) + 1].text.strip(),\n",
    "                    \"content\": [],\n",
    "                }\n",
    "                examples.append(current_example)\n",
    "        elif tag.name == \"heading\" and (tag.text.strip().lower().startswith(\"example\")\n",
    "                or tag.text.strip().lower().startswith(\"experiment\")\n",
    "                or tag.text.strip().lower().startswith(\"test\")):\n",
    "                in_example = False\n",
    "            # else:\n",
    "            #     # If we hit any other heading, stop collecting content\n",
    "            #     in_example = False\n",
    "        elif in_example and current_example is not None:\n",
    "            current_example[\"content\"].append(tag.text.strip())\n",
    "\n",
    "    return examples\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "found_heading: 528, not_found_heading: 272, gibberish: 176, too_short: 24\n",
      "Num good xmls: 800, out of 1000\n",
      "Extracted patents with content 0.99875 patents MAE: 0.3375, total_error: 270.0, highest_difference: 56.0, highest_difference_patent: 8933072\n"
     ]
    }
   ],
   "source": [
    "def extract_examples(merged, num_of_patents=1000):\n",
    "    \"\"\"\n",
    "    Analyze patents to extract and compare example counts\n",
    "    \n",
    "    Args:\n",
    "        merged: DataFrame containing patent data\n",
    "        cols: Columns to use from the DataFrame\n",
    "        num_of_patents: Number of patents to analyze (default=1000)\n",
    "    \n",
    "    Returns:\n",
    "        dict: Statistics about the analysis results\n",
    "    \"\"\"\n",
    "    mae = 0\n",
    "    highest_difference = 0\n",
    "    found_heading = 0\n",
    "    not_found_heading = 0\n",
    "    gib = 0\n",
    "    short = 0\n",
    "    mostdifss = []\n",
    "    doc_w_exp = {}\n",
    "    highest_difference_patent = None\n",
    "    xmls = []\n",
    "    for row in merged[:num_of_patents].iterrows():\n",
    "        xml = row[1][\"xml\"]\n",
    "        if len(xml) <= 2000:\n",
    "\n",
    "            short += 1\n",
    "            continue  \n",
    "        s_tags = re.findall(r'<s\\d+>.*?</s\\d+>', xml)\n",
    "        if len(s_tags) > 0 or '<sequence-cwu id=\"SEQLST-0\">' in xml:\n",
    "            gib += 1\n",
    "            xmls.append(xml)\n",
    "            continue\n",
    "            \n",
    "        heading = extract_experiments_w_heading(xml)\n",
    "        janetsnumexamples = row[1][\"prophetic\"] + row[1][\"nonprophetic\"]\n",
    "\n",
    "        # Process examples based on heading presence\n",
    "        if heading and len(heading) == 1:\n",
    "            found_heading += 1\n",
    "            examples = extract_examples_start_w_word_test(heading[0].find_next_siblings())\n",
    "            if len(examples) == 0:\n",
    "                soup = BeautifulSoup(xml, 'xml')\n",
    "                siblings = soup.find_all(['heading', 'p'])\n",
    "                examples = extract_examples_start_w_word_test(siblings)\n",
    "        else:\n",
    "            not_found_heading += 1\n",
    "            soup = BeautifulSoup(xml, 'xml')\n",
    "            siblings = soup.find_all(['heading', 'p'])\n",
    "            examples = extract_examples_start_w_word_test(siblings)\n",
    "        numexamples = len(examples)\n",
    "        difference = abs(numexamples - janetsnumexamples)\n",
    "        mae += difference\n",
    "        \n",
    "        # if difference > 0:\n",
    "        #     mostdifss.append([difference, row[1][\"patentnumber\"]])\n",
    "        # if difference > highest_difference:\n",
    "        #     highest_difference = difference\n",
    "        #     highest_difference_patent = row[1][\"patentnumber\"]\n",
    "        # if isinstance(examples, list) and len(examples) > 0:\n",
    "        #     exs = []\n",
    "        #     for ex in examples:\n",
    "        #         if len(ex[\"content\"])>0:\n",
    "        #             exs.append(ex[\"content\"])\n",
    "        #     examples = exs\n",
    "        # elif len(examples) > 0:\n",
    "        #         doc_w_exp[row[1][\"patentnumber\"]] = examples\n",
    "        if difference > 0:\n",
    "            mostdifss.append([difference, row[1][\"patentnumber\"]])\n",
    "        if difference > highest_difference:\n",
    "            highest_difference = difference\n",
    "            highest_difference_patent = row[1][\"patentnumber\"]\n",
    "        if len(examples) > 0:\n",
    "            doc_w_exp[row[1][\"patentnumber\"]] = examples\n",
    "\n",
    "    results = {\n",
    "        \"found_heading\": found_heading,\n",
    "        \"not_found_heading\": not_found_heading,\n",
    "        \"gibberish\": gib,\n",
    "        \"too_short\": short,\n",
    "        \"mae\": mae/(found_heading + not_found_heading),\n",
    "        \"total_error\": mae,\n",
    "        \"highest_difference\": highest_difference,\n",
    "        \"highest_difference_patent\": highest_difference_patent,\n",
    "        \"most_differences\": mostdifss,\n",
    "        \"documents_with_examples\": doc_w_exp,\n",
    "        \"gibs\": xmls\n",
    "    }\n",
    "    \n",
    "    return results\n",
    "\n",
    "\n",
    "num_of_patents = 1000\n",
    "stats = extract_examples(merged, num_of_patents=num_of_patents)\n",
    "print(f\"found_heading: {stats['found_heading']}, not_found_heading: {stats['not_found_heading']}, gibberish: {stats['gibberish']}, too_short: {stats['too_short']}\")\n",
    "print(f\"Num good xmls: {stats['found_heading'] + stats['not_found_heading']}, out of {num_of_patents}\")\n",
    "print(f\"Extracted patents with content {len(stats['documents_with_examples'].keys())/(stats['found_heading'] + stats['not_found_heading'])} patents MAE: {stats['mae']}, total_error: {stats['total_error']}, highest_difference: {stats['highest_difference']}, highest_difference_patent: {stats['highest_difference_patent']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'number': 'Example 1',\n",
       "  'title': 'General Synthetic Methods',\n",
       "  'content': ['']},\n",
       " {'number': 'Example 1.1.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of 4′-Bromo-(1,1′-biphenyl)-4-ol (10.0 g, 40.1 mmol), 4-iodoanisole (18.72 g, 80.0 mmol), cesium carbonate (26.1 g, 80.2 mmol), copper iodide (760 mg, 4.0 mmol), dimethylglycine hydrochloride (1.68 g, 12.0 mmol), and anhydrous 1,4-dioxane (50 mL) was purged via freeze-pump-thaw method. The resulting mixture was heated to 110° C. overnight. After cooling, the resulting mixture was poured into ethyl acetate (300 mL), and stirred at 40° C. for 30 min; and the resulting solids were filtered off. The filtrate was dried under vacuum to give ivory solids. The ivory solids were washed with a mixture of ethyl acetate and methanol to give pure product (Compound 1); 6.5 g, 46% yield; confirmed by HNMR']},\n",
       " {'number': 'Example 1.1.2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 1 (2 g, 5.63 mmol) was dissolved in anhydrous tetrahydrofuran (30 mL), and the resulting solution was cooled to −78° C. Butyllithium (3.43 mL of a 1.6 M solution, 5.5 mmol) was added dropwise and the solution was stirred at −78° C. for three hours. Trimethyl borate (0.572 mL, 5.5 mmol) was added slowly, and the resulting mixture was stirred for three hours at room temperature. Saturated ammonium chloride solution (45 mL) (alternatively, 10% HCl solution used) was added and the mixture was stirred overnight at room temperature. The desired product extracted with ethyl acetate (2×100 mL). The organic layer from the extraction was dried under vacuum. Precipitation in DCM/methanol gave white solids. The white solids were filtered and washed with methanol. The filtrate was dried to give relatively pure product (Compound 2); 1.2 g, 53% yield; relatively pure by HNMR.']},\n",
       " {'number': 'Example 1.1.3',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of Compound 2 (100 mg, 0.31 mmol), 2-chlorobenzoxazole (50 mg, 0.33 mmol), Pd(OAc)2 (3.5 mg, 0.015 mmol), di-t-butyl-biphenylphosphine (9 mg, 0.03 mmol) and KF (54 mg, 0.93 mmol) in 1,4-dioxane (5 mL) was degassed then heated at 110° C. for 36 hours under argon. After cooling to room temperature, the mixture was poured into dichloromethane (100 mL). After filtration, the filtrate was loaded on silica gel column and purified by flash chromatography (heaxanes/ethyl acetate 10:1 to 5:1). A white solid was obtained (40 mg, 40%) as the desired product (Compound 3), which was confirmed by LCMS (calculated for C26H20NO3 (M+H): 394; found m/e=394) and HNMR.']},\n",
       " {'number': 'Example 1.2', 'title': '', 'content': ['']},\n",
       " {'number': 'Example 1.2.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of 4-hydroxylbiphenyl-1-carboxylic acid (2.14 g, 10 mmol) and N-phenyl-1,2-diaminobenzene (1.84 g, 10 mmol) in polyphosphoric acid (10 ml) was degassed by vacuum then heated at 180° C. at 10 torr overnight. After cooling to room temperature, the mixture was poured into water. Filtration and washing with water gave a dark solid (6.8 g, 84%) as the desired product (Compound 4), which was confirmed by LCMS (calculated for C25H18N2O4P (M−H): 441, found m/e: 441).']},\n",
       " {'number': 'Example 1.2.2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a solution of Compound 4 (3.6 g, 8 mmol) in DMSO (20 mL), was added tetrabutylammonium fluoride (1 M in THF, 18 mL). The mixture was heated at 85° C. for 6 hours. Water (50 mL) was added to the hot solution, followed by 5 mL concentrated HCl. The mixture was stirred for 5 min and allowed to cool down to room temperature. Filtration and drying under vacuum at 110° C. overnight afford a black solid (1.6 g, 55%) as desired product (Compound 5), which was confirmed by LCMS (calculated for C25H17N20 (M−H): 361; found m/e=361).']},\n",
       " {'number': 'Example 1.2.3',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of carbazole (7.0 g, 42.2 mmol), 4-bromo-iodobenzene (17.9 g, 63.3 mmol), copper (13.6 g, 214 mmol), 18-crown-6 (4.36 g, 16.48 mmol), potassium carbonate (29.5 g, 214 mmol), and anhydrous N,N-dimethylformamide (50 mL) was degassed for 30 minutes. The mixture was heated to 150° C. overnight under argon. After cooling, the mixture was poured into DCM (400 mL) and the subsequent mixture was filtered. The filtrate was concentrated under vacuum, and hexane was added to precipitate out 18-crown-6, which was filtered off. The filtrate was loaded on silica gel. A flash column (silica, 100% hexane) and reprecipitation in DCM/hexanes yielded 9.44 g of relatively pure product (Compound 6) (white crystals) in 70% yield; confirmed by HNMR.']},\n",
       " {'number': 'Example 1.2.4',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of Compound 6 (1.09 g, 3.40 mmol), Compound 5 (1.24 g, 3.42 mmol), cesium carbonate (2.23 g, 6.84 mmol), copper iodide (65 mg, 0.342 mmol), dimethylglycine hydrochloride (95 mg, 0.684 mmol) and anhydrous 1,4-dioxane (30 mL) was degassed for 30 minutes. The mixture was heated to 120° C. overnight under argon. After cooling, the resulting mixture was poured into DCM (250 mL) and filtered. The resulting filtrate was loaded onto silica gel. The resulting effluent from the flash column (silica, 5% to 50% ethyl acetate in hexanes gradient) gave an orange solid. Precipitation of the orange impurity was accomplished using DCM and methanol. The impurity was filtered off, and the filtrate containing the product was dried under vacuum. After drying, 270 mg of product (Compound 7) (pale orange powder, 13% yield) was isolated; pure by HNMR.']},\n",
       " {'number': 'Example 1.3', 'title': '', 'content': ['']},\n",
       " {'number': 'Example 1.3.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a solution of 4-bromo-benzoyl chloride (11 g, 50 mmol) in anhydrous dichloromethane (DCM) (100 ml), was added N-phenylbenzene-1,2-diamine (10.2 g, 55 mmol), then triethylamine (17 ml, 122 mmol) slowly. The whole mixture was then stirred at room temperature (r.t.) overnight. Subsequent filtration gave a white solid (Compound 8) (6.5 g). The filtrate was worked up with water (300 ml), and then extracted with DCM (300 ml) three times. The resulting organic phase was collected and dried over MgSO4, concentrated and recrystallized in DCM/hexanes to give another portion of white solid (Compound 8) (10.6 g). The total amount of product (Compound 8) was 17.1 g, in 93% yield.']},\n",
       " {'number': 'Example 1.3.2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a suspension of amide 1 (9.6 g, 26 mmol) in anhydrous 1,4-dioxane (100 mL) was added phosphorous oxychloride (POCl3) (9.2 mL, 100 mmol) slowly. The whole was then heated at 100° C. overnight. After cooling to r.t., the mixture was poured into ice (200 g) with stirring. Filtration, followed by recrystallization in DCM/hexanes gave a pale grey solid (Compound 9) (8.2 g, in 90% yield).']},\n",
       " {'number': 'Example 1.3.3',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of Compound 9 (0.70 g, 2 mmol), bis(pinacolate)diborane (0.533 g, 2.1 mmol), 1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium (Pd(dppf)Cl2) (0.060 g, 0.08 mmol) and anhydrous potassium acetate (0.393 g, 4 mmol) in 1,4-dioxane (20 mL) was heated at 80° C. under argon overnight. After cooling to r.t., the whole mixture was diluted with ethyl acetate (80 mL) then filtered. The solution was absorbed on silica gel, then purified by column chromatography (hexanes/ethyl acetate 5:1 to 3:1) to give a white solid (Compound 10) (0.64 g, in 81% yield).']},\n",
       " {'number': 'Example 1.3.4',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of Compound 10 (1.41 g, 3.56 mmol), 9-(4-bromophenyl)-9H-carbazole (1.15 g, 3.56 mmol), Pd(dppf)Cl2 (100 mg, 0.14 mmol) and KF (0.619 g, 10.7 mmol) in anhydrous DMF (20 mL) was heated at 120° C. under argon overnight. After cooling to r.t., ethyl acetate (200 mL) was added and the whole was stirred for 15 min. The resulting mixture was filtered. The solid was collected and dissolved in DCM (200 mL), which was filtered, concentrated and recrystallized to give a white solid (Compound 11) (550 mg).',\n",
       "   'The filtrate from the first separation was absorbed on silica gel, then purified by column chromatography (hexanes/ethyl acetate 7:1 to 3:1) to give a pale yellow solid (Compound 11) (300 mg). NMR shows both of the two solids are desired product (Compound 11), with total amount of 850 mg, in 47% yield.']},\n",
       " {'number': 'Example 1.4', 'title': '', 'content': ['']},\n",
       " {'number': 'Example 1.4.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of carbazole (10.0 g, 60.2 mmol), 4-iodoanisole (21.1 g, 90.4 mmol), copper powder (28.58 g, 450 mmol), 18-crown-6 (9.33 g, 35.3 mmol), and potassium carbonate (62.1 g, 450 mmol) was degassed in dimethylformamide (anhydrous, 100 mL) for 45 minutes. The resulting mixture was heated to 150° C. overnight under argon. After cooling, the mixture was poured into DCM (500 mL). Then, the remaining copper and salts were filtered off. The resulting filtrate washed with water (2×200 mL). The organic layer was collected, dried over sodium sulfate, and then loaded onto silica gel. A flash column (gradient of 3-5% ethyl acetate in hexanes) and reprecipitation from DCM/hexanes gave 11.71 g (71% yield) of product (Compound 12); confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.4.2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 12 (11.63 g, 42.6 mmol) was dissolved in DCM and the solution was cooled to −77° C. Boron tribromide (45 mL of a 1M solution) was added dropwise to the cold solution. The solution was stirred overnight under argon while slowly warming to room temperature. LCMS showed a single peak with desired mass (M−=528). Methanol (100 mL) was added to reaction mixture; and stirred for 30 minutes. The whole was loaded onto silica gel. A flash column (gradient of 10-20% ethyl acetate in hexanes) gave 10.94 g of product (Compound 13) (99% yield), confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.4.3',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of the Compound 13 (10.0 g, 8.3 mmol), 4,4′-dibromobiphenyl (24.1 g, 77.2 mmol), cesium carbonate (25.2 g, 77.2 mmol), copper iodide (700 mg, 3.86 mmol), and dimethylglycine hydrochloride (1.62 g, 11.6 mmol) was degassed in 1,4-dioxane (anhydrous, 100 mL) for 45 minutes. The mixture was heated to 120° C. overnight under argon. After cooling, the mixture was poured into DCM (300 mL) the subsequent mixture was washed with water and brine. The organic layer was collected, dried over sodium sulfate, and loaded onto silica gel. A plug using 10% ethyl acetate in hexanes was used to remove baseline impurities. A subsequent flash column (5% toluene in hexanes), and precipitation from DCM/methanol gave 11.17 g of product (Compound 14) (59% yield), confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.4.4',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of the Compound 14 (1.85 g, 3.79 mmol), 1-phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-benzo[d]imidazole (1.5 g, 3.79 mmol), 1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium (139 mg, 0.190 mmol), and potassium fluoride (661 mg, 11.4 mmol) was degassed in dimethylformamide (anhydrous, 30 mL) for 30 minutes. The mixture was heated to 80° C. overnight under argon. After cooling, the mixture was poured into DCM (200 mL) and washed with water and brine. The organic layer was collected, dried over sodium sulfate, and loaded onto silica gel. A flash column (20% ethyl acetate in hexanes) and recrystallization from DCM/methanol gave 1.83 g (71% yield) of product (Compound 15); confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.5', 'title': '', 'content': ['']},\n",
       " {'number': 'Example 1.5.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of carbazole (300 mg, 1.81 mmol), 4,4′-dibromobiphenyl (846 mg, 2.71 mmol), copper (344 mg, 5.43 mmol), 18-crown-6 (187 mg, 0.71 mmol), potassium carbonate (750 mg, 5.43 mmol), and anhydrous N,N-dimethylformamide (10 mL) was degassed for 30 minutes. The mixture was heated to 155° C. for 66 hours under argon. After cooling, the mixture was poured into DCM (400 mL) and the subsequent mixture was filtered. The filtrate was loaded on silica gel. A flash column (silica, 10% DCM in hexane) and reprecipitation in DCM/hexanes yielded 304 mg (42% yield) of pure product; confirmed by HNMR.']},\n",
       " {'number': 'Example 1.5.2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of Compound 16 (250 mg, 0.63 mmol), 1-phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-benzo[d]imidazole (Compound 10) (250 mg, 0.63 mmol), [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (23 mg, 0.03 mmol), potassium fluoride (110 mg, 1.89 mmol), and dimethylformamide (anhydrous, 15 mL) was degassed for 20 minutes. The mixture was then heated to 80° C. overnight under argon. After cooling, the mixture was poured into DCM (200 mL), and solids were filtered off. The resulting filtrate was washed with water (2×100 mL), dried over sodium sulfate, and then loaded onto silica gel. A flash column (gradient of 3-10% ethyl acetate in DCM) and recrystallization using DCM/hexanes gave 170 mg (46% yield) of material (Compound 17); confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.6', 'title': '', 'content': ['']},\n",
       " {'number': 'Example 1.6.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of tris(dibenzylideneacetone)dipalladium (60 mg, catalytic), and tri-tert-butyl phosphine (5 ml of a 10% solution in hexanes) was degassed in toluene (anhydrous, 60 mL) for 20 minutes. Di-p-tolylamine (4.0 g, 20.3 mmol), and 4-iodoanisole (11.88 g, 50.8 mmol) were added and degassing continued 15 minutes. Sodium tert-butoxide (2.4 g, 25 mmol) was added, and mixture was further degassed for 10 minutes. The whole mixture was heated overnight at 120° C. under argon. After cooling, the mixture was poured into ethyl acetate and washed with water (2×200 mL). The organic layer was collected and dried over sodium sulfate, then loaded onto silica gel. A flash column (gradient of 2-3% ethyl acetate in hexanes) gave 3.26 g of material (Compound 18) (53% yield); confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.6.2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 18 (3.05 g, 10.1 mmol) was dissolved in DCM (anhydrous, 50 mL) and the solution was cooled to −77° C. Boron tribromide (12 mL of a 1 M solution) was added dropwise to the cold solution. The whole mixture was stirred and slowly warmed to room temperature overnight under argon. LCMS showed a single desired mass of 288 (M−). The mixture was poured into methanol (200 mL) and stirred for 45 minutes. The mixture was then concentrated under vacuum, then DCM (100 mL) was added. The solution was washed with water (2×200 mL). The organic layer was collected, dried over sodium sulfate, and concentrated under vacuum. Precipitation of the organic layer using hexanes gave 2.44 g of material (Compound 19) (84% yield); confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.6.3',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of the Compound 19 (2.4 g, 8.3 mmol), 4,4′-dibromobiphenyl (1.25 g, 4.0 mmol), cesium carbonate (5.41 g, 16.6 mmol), copper iodide (158 mg, 0.83 mmol), and dimethylglycine hydrochloride (348 mg, 2.49 mmol) was degassed in 1,4-dioxane (anhydrous, 40 mL) for 45 minutes. The mixture was heated to 120° C. overnight under argon. After cooling, the mixture was poured into DCM (300 mL), and the subsequent mixture was washed with water and brine. The organic layer was collected, dried over sodium sulfate, and loaded onto silica gel. A flash column (gradient of 5-20% DCM in hexanes), and reprecipitation from DCM/hexanes gave 760 mg of product (Compound 20) (37% yield), confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.6.4',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of Compound 20 (656 mg, 1.26 mmol), 1-phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-benzo[d]imidazole (500 mg, 1.26 mmol), 1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium (100 mg, catalytic), and potassium fluoride (220 mg, 3.8 mmol) was degassed in dimethylformamide (anhydrous, 8 mL) for 30 minutes. Mixture was heated to 80° C. overnight under argon. After cooling, the mixture was poured into water (200 mL). Product was extracted with DCM (2×150 mL). The organic layer collected, dried over sodium sulfate, and loaded onto silica gel. A flash column (gradient of 15-45% ethyl acetate in hexanes) and reprecipitation from DCM/methanol gave 400 mg (45% yield) of product; confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.7', 'title': '', 'content': ['']},\n",
       " {'number': 'Example 1.7.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of tris(dibenzylideneacetone)dipalladium (353 mg, 0.385 mmol), and tri-tert-butyl phosphine (3.11 g of a 10% solution in hexanes) was degassed in toluene (anhydrous, 50 mL) for 20 minutes. Di-p-tolylamine (3.00 g, 15.2 mmol), and 4,4′-dibromobiphenyl (4.80 g, 15.4 mmol) were added and the mixture was further degassed for 15 minutes. Sodium tert-butoxide (2.4 g, 25 mmol) was added, and mixture was further degassed for 10 minutes. The whole was heated overnight at 120° C. under argon. After cooling, the mixture was poured into DCM, and solids were filtered off. Filtrate was washed with water and brine. The organic layer was collected and dried over sodium sulfate, then loaded onto silica gel. A flash column (gradient of 2-20% ethyl acetate in hexanes) gave 190 mg of material (3% yield); confirmed pure by HNMR.']},\n",
       " {'number': 'Example 1.7.2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of Compound 22 (170 mg, 0.397 mmol), 1-phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-benzo[d]imidazole (173 mg, 0.436 mmol), 1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium (15 mg, 0.02 mmol), and potassium fluoride (70 mg, 1.2 mmol) was degassed in dimethylformamide (anhydrous, 15 mL) for 30 minutes. Mixture was heated to 90° C. overnight under argon. After cooling, the mixture was poured into water and filtered. The solids were dissolved in DCM (50 mL) and solution was washed with water and brine. To filtrate from first filtration: filtrate was extracted with DCM (2×100 mL). All organic phases were combined, dried over sodium sulfate, and loaded onto silica gel. A flash column (gradient of 10-20% ethyl acetate in hexanes) and reprecipitation in DCM/methanol gave 146 mg (59% yield) of product (Compound 23); confirmed by HNMR.']},\n",
       " {'number': 'Example 1.8.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of 4-bromophenyl-ditolyamine (2.80 g, 8.0 mmol), Compound 10 (3.15 g, 8.0 mmol), Pd(PPh3)4 (0.90 g, 0.8 mmol) and K2CO3 (2.76 g, 20 mmol) in 1,4-dioxane/H2O (30 mL/5 mL) was degassed and the resulting mixture was heated at about 100° C. overnight. After cooling to room temperature, the resulting mixture was worked up with 10% NaCl aqueous solution, then extracted with ethyl acetate (150 mL×2). The organic phase was collected and dried over Na2SO4, then absorbed on silica gel and purified by flash chromatography (hexanes/ethyl acetate 6:1 to 4:1) to give a yellow solid, which was recrystallized in dichloromethane/methanol 3 times to afford a white solid (Compound 24) (1.55 g, 36% yield).']},\n",
       " {'number': 'Example 1.9.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a solution of 4-bromo-N,N-diphenylaniline (22 g, 68 mmol) in anhydrous THF (170 mL) was added n-BuLi solution (2.5 M in hexanes, 20 mL, 75 mmol) at −78° C. slowly. The resulting mixture was then stirred at −78° C. for about 5 hours, then freshly distilled trimethylborate (8.8 mL, 80 mmol) was added. The resulting mixture was stirred at room temperature over weekend. To the solution, 5% HCl solution (150 mL) was added and stirred overnight, then extracted with ethyl acetate (200 mL×2). The organic phase was collected and dried over Na2SO4. After removal of solvent, the remaining solid was recrystallized in dichloromethane/hexanes to give a white solid (11.0 g). The filtrate solution was purified by flash chromatography (silica gel, hexnaes/ethyl acetate, 9:1 to 2:1) to give additional white solid (2.0 g). The total amount of product (Compound 25) was 13 gram, in 66% yield.',\n",
       "   'A mixture of Compound 25 (4-(diphenylamino)phenyl)boronic acid (900 mg, 3.1 mmol), Compound 9 (1.09 g, 3.1 mmol), Pd(PPh3)4 (180 mg, 0.16 mmol) and K2CO3 (1.38 g, 10 mmol) in 1,4-dioxane/H2O (25 mL/5 mL) was degassed and the resulting mixture was heated at about 100° C. overnight under an argon atmosphere. After cooling to room temperature, the resulting mixture was poured into water, extracted with ethyl acetate (100 mL×2). The organic phase was dried over Na2SO4 and filtered. After addition of hexanes (100 mL), a yellow precipitate formed after about one hour. Filtration gave a yellow solid (760 mg) and the filtrate was absorbed on silica gel and purified by flash chromatography to give a yellow solid (200 mg). The total amount of product (Compound 26) was 960 mg in 62% yield.']},\n",
       " {'number': 'Example 1.10.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '2-(4-bromophenyl)benzo[d]oxazole (Compound 27): A mixture of 4-bromobenzoylchloride (4.84 g, 22 mmol), 2-bromoaniline (3.8 g, 22 mmol), CuI (0.21 g, 1.1 mmol), Cs2CO3 (14.3 g, 44 mmol) and 1,10-phenathroline (0.398 g, 2.2 mmol) in anhydrous 1,4-dioxane (80 mL) was degassed and the resulting mixture was heated at about 125° C. under argon overnight. The resulting mixture was cooled and poured into ethyl acetate (˜200 mL) and filtered. The filtrate was absorbed on silica gel, purified by column chromatography (hexanes/ethyl acetate 4:1), and precipitated by hexanes to give a white solid (Compound 27) (5.2 g, in 87% yield).',\n",
       "   '',\n",
       "   'A mixture of 10 (4.45 g, 16 mmol), bis(pinacolate)diborane (4.09 g, 16.1 mmol), anhydrous potassium acetate (3.14 g, 32 mmol) and Pd(dppf)Cl2 (0.48 g, 0.66 mmol) in anhydrous 1,4-dioxane (80 mL) was degassed and the resulting mixture was heated at about 85° C. for about 48 hours under argon. After cooling to room temperature, the mixture was poured into ethyl acetate (˜200 mL) and filtered. The filtrate was absorbed on silica gel and purified by column chromatography (hexanes/ethyl acetate, 4:1) to give a white solid (Compound 28) (4.15 g, in 81% yield).',\n",
       "   '',\n",
       "   'A mixture of Compound 28 (0.66 g, 2.05 mmol), Compound 22 (0.80 g, 1.87 mmol), Na2CO3 (0.708 g, 6.68 mmol) and Pd(PPh3)4 (0.065 g, 56.1 mmol) in THF/H2O (10 mL/6 mL) was degassed and the resulting mixture was heated at about 80° C. overnight under argon atmosphere. After cooling, the resulting mixture was poured into dichloromethane (100 mL) and washed with water (2×200 mL) and brine (100 mL). The organic phase was collected, dried over Na2SO4, then purified by flash chromatography (silica gel, hexanes/ethyl acetate 40:1 to 9:1) to give a solid (Compound 29) (0.936 g, in 93% yield).']},\n",
       " {'number': 'Example 1.11.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of carbazole (300 mg, 1.81 mmol), 4,4′-dibromobiphenyl (846 mg, 2.71 mmol), copper (344 mg, 5.43 mmol), 18-crown-6 (187 mg, 0.71 mmol), potassium carbonate (750 mg, 5.43 mmol), and anhydrous N,N-dimethylformamide (10 mL) was degassed for 30 minutes. The resulting mixture was then heated to about 155° C. for 66 hours under argon. After cooling, the resulting mixture was poured into methylene chloride (400 mL) and the subsequent mixture was filtered. The filtrate was loaded on silica gel. A flash column (silica, 10% methylene chloride in hexane) and reprecipitation in methylene chloride/hexanes yielded 304 mg (42% yield) of pure product; confirmed by HNMR.',\n",
       "   '',\n",
       "   'A mixture of 9-(4′-bromobiphenyl-4-yl)-9H-carbazole (Compound 30) (1.6 g, 4.03 mmol), Compound 28 (1.42 g, 4.43 mmol), Na2CO3 (1.53 g, 14.39 mmol) and Pd(PPh3)4 (0.14 g, 0.121 mmol) in THF/H2O (24 mL/14 mL) was degassed and the resulting mixture was heated to about 85° C. overnight under argon atmosphere. After cooling, the resulting mixture was poured into dichloromethane (200 mL), and washed with water (2×150 mL) and brine (150 mL). The organic phase was collected and dried over Na2SO4, and concentrated to form a grey precipitate. Filtration gave a filtrate (A) and solid, which was redissolved in chloroform (550 mL) and filter off suspended particles, the clear filtrate (B) was kept at −15 C.° overnight to form a white solid (1.19 g). The filtrate (C) was combined with the Filtrate A and absorbed on silica gel, purified by flash chromatography (dichloromethane) give an additional 0.52 g solid. Both solids were combined and washed with hot ethyl acetate, and filtered to yield the product (Compound 31)(1.66 g, 81% yield).']},\n",
       " {'number': 'Example 1.12.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of 2-aminobenzenethiol (2.0 g, 15.97 mmol), 4-bromobenzaldehyde (2.95 g, 15.97 mmol) and 50 mg of 10% Pd on carbon in ethanol (50 mL) was bubbled with air for about 20 min and then heated to reflux for about 6 days. After cooling, the mixture was poured into dichloromethane (100 mL), the catalyst was filtered off. The filtrated was washed with water (100 mL) and brine (100 mL), then dried over Na2SO4, followed by flash chromatography (silica gel, hexanes/ethyl acetate 20:1) and recrystallized in dichloromethane/methanol to give a white solid (Compound 32) (2.90 g, in 63% yield).',\n",
       "   '',\n",
       "   'A mixture of 32 (2.32 g, 7.99 mmol), bis(pinacolate)diborane (2.25 g, 8.79 mmol), anhydrous potassium acetate (2.35 g, 23.97 mmol) and Pd(dppf)Cl2 (0.292 g, 0.399 mmol) in anhydrous 1,4-dioxane (40 mL) was degassed and the resulting mixture heated at about 85° C. for about 20 hours under argon. After cooling, mixture was poured into dichloromethane, and the salts were filtered off. The filtrate was dried under vacuum to remove dioxane, then redissolved in dichloromethane. After washing with water and then brine, the resulting mixture was loaded on silica gel and purified by flash chromatography (hexanes/dichloromethane 2:1 to 1:1) to give a white solid (Compound 33) (1.89 g, 90% yield).',\n",
       "   '',\n",
       "   'A mixture of 33 (1.48 g, 4.39 mmol), Compound 22 (1.71 g, 4.0 mmol), Na2CO3 (1.51 g, 14.28 mmol) and Pd(PPh3)4 (0.139 g, 0.12 mmol) in THF/water (24 mL/14 mL) was degassed for 45 min, then the resulting mixture was heated to reflux overnight under argon atmosphere. After cooling, the resulting mixture was poured into chloroform (300 mL) and heated to dissolve the product. The solution was washed with water (2×200 mL) and brine (200 mL). The organic phased was dried over Na2SO4 and concentrated to precipitate out solid, which was filtered and washed with methanol to give a solid (Compound 34) (1.24 g, 53% yield).']},\n",
       " {'number': 'Example 1.13.1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A mixture of (4-(diphenylamino)phenyl)boronic acid (1.5 g, 5.19 mmol), 4-iodo-1-bromobenzene (1.33 g, 4.71 mmol), Na2CO3 (1.78 g, 16.8 mmol) and Pd(PPh3)4 (0.163 g, 0.141 mmol) in THF/H2O (28 mL/17 mL) was degassed and the resulting mixture was heated at reflux overnight under an argon atmosphere. After cooling, the mixture was poured into dichloromethane (150 mL), then washed with water (2×150 mL) and brine (100 mL). The organic phase was dried over Na2SO4, purified with flash column chromatography (silica gel, hexanes/ethyl acetate 50:1) then recrystallized in dichloromethane/methanol to afford a white solid (Compound 35)(1.64 g, in 87% yield).',\n",
       "   '',\n",
       "   'A mixture of 35 (1.40 g, 3.5 mmol), Compound 28 (1.52 g, 3.85 mmol), Na2CO3 (1.32 g, 12.5 mmol) and Pd(PPh3)4 (121 mg, 0.105 mmol) in THF/H2O (21 mL/12.5 mL) was degassed and the resulting mixture was heated at reflux overnight under argon atmosphere. After cooling to room temperature, the resulting mixture was poured into dichloromethane (150 mL), then washed with water (150 mL) and brine (150 mL). The organic phase was dried over Na2SO4, absorbed on silica gel, and purified with flash column chromatography (hexane/ethyl acetate 5:1 to 2:1, then dichoromethane as eluent). The product was collected and recrystallized from acetone/hexanes to give a solid (1.69 g). It was recrystallized again in dichoromethane/ethyl acetate to give a solid (Compound 36) (1.4 g, 68% yield).']},\n",
       " {'number': 'Example 2',\n",
       "  'title': 'OLED Device Configuration and Performance',\n",
       "  'content': []},\n",
       " {'number': 'Example 2.1',\n",
       "  'title': 'Fabrication of light-emitting device: the ITO coated glass substrates were cleaned by ultrasound in acetone, and consecutively in 2-propanol, baked at 110° C. for 3 hours, followed by treatment with oxygen plasma for 5 min. A layer of PEDOT: PSS (Baytron P purchased from H.C. Starck) was spin-coated at 3000 rpm onto the pre-cleaned and O2-plasma treated (ITO)-substrate and annealed at 180° C. for 10 min, yielding a thickness of around 40 nm. In a glove-box hosted vacuum deposition system at a pressure of 10−7 torr (1 torr=133.322 Pa), 4,4′4″-tri(N-carbazolyl)triphenylamine (TCTA) was first deposited on top of PEDOT/PSS layer at deposition rate of 0.06 nm/s, yielding a 30 nm thick film. Then the deep blue emitter Compound 17 was deposited on top of TCTA to form a 30 nm thick film, followed by deposition of a 40 nm thick layer of 1,3,5-tris(N-phenylbenzimidizol-2-yl)benzene (TPBI), all at deposition rate around 0.06 nm/s. CsF and Al were then deposited successively at deposition rates of 0.005 and 0.2 nm/s, respectively. Each individual device has areas of 0.14 cm2. Spectra is measured with an ocean optics HR4000 spectrometer and I-V light output measurements is taken with a Keithley 2400 SourceMeter and Newport 2832-C power meter and 818 UV detector. All device operation is carried out inside a nitrogen-filled glove-box.',\n",
       "  'content': ['Fabrication of light-emitting device: the ITO coated glass substrates were cleaned by ultrasound in acetone, and consecutively in 2-propanol, baked at 110° C. for 3 hours, followed by treatment with oxygen plasma for 5 min. A layer of PEDOT: PSS (Baytron P purchased from H.C. Starck) was spin-coated at 3000 rpm onto the pre-cleaned and O2-plasma treated (ITO)-substrate and annealed at 180° C. for 10 min, yielding a thickness of around 40 nm. In a glove-box hosted vacuum deposition system at a pressure of 10−7 torr (1 torr=133.322 Pa), 4,4′4″-tri(N-carbazolyl)triphenylamine (TCTA) was first deposited on top of PEDOT/PSS layer at deposition rate of 0.06 nm/s, yielding a 30 nm thick film. Then the deep blue emitter Compound 17 was deposited on top of TCTA to form a 30 nm thick film, followed by deposition of a 40 nm thick layer of 1,3,5-tris(N-phenylbenzimidizol-2-yl)benzene (TPBI), all at deposition rate around 0.06 nm/s. CsF and Al were then deposited successively at deposition rates of 0.005 and 0.2 nm/s, respectively. Each individual device has areas of 0.14 cm2. Spectra is measured with an ocean optics HR4000 spectrometer and I-V light output measurements is taken with a Keithley 2400 SourceMeter and Newport 2832-C power meter and 818 UV detector. All device operation is carried out inside a nitrogen-filled glove-box.']},\n",
       " {'number': 'Example 2.2',\n",
       "  'title': 'Another device (Device B) was constructed in accordance to Example 2.1, except that instead of neat Compound 17 layer being deposited on top of the TCTA, a mixture of Compound 17 (99.35%), tris(2-phenylpyridine anion) iridium (III) complex (Ir(ppy)3)(0.5%) and bis(2-phenyl quinolyl-N,C2′)acetylacetonate iridium(III) (PQIr) (0.15%) was codeposited on top of TCTA to form a 15 nm thick film.',\n",
       "  'content': ['Another device (Device B) was constructed in accordance to Example 2.1, except that instead of neat Compound 17 layer being deposited on top of the TCTA, a mixture of Compound 17 (99.35%), tris(2-phenylpyridine anion) iridium (III) complex (Ir(ppy)3)(0.5%) and bis(2-phenyl quinolyl-N,C2′)acetylacetonate iridium(III) (PQIr) (0.15%) was codeposited on top of TCTA to form a 15 nm thick film.']},\n",
       " {'number': 'Example 2.3',\n",
       "  'title': 'Device C was fabricated as follows: the ITO coated glass substrates were cleaned by ultrasound in acetone, and consecutively in 2-propanol, baked at 110° C. for 3 hours, followed by treatment with oxygen plasma for 5 min. A layer of PEDOT: PSS (Baytron P purchased from H.C. Starck) was spin-coated at 3000 rpm onto the pre-cleaned and O2-plasma treated (ITO)-substrate and annealed at 180° C. for 10 min, yielding a thickness of around 40 nm. In a glove-box hosted vacuum deposition system at a pressure of 10−7 torr (1 torr=133.322 Pa), 4,4′-bis[N-(naphthyl)-N-phenyl-amino]biphenyl (α-NPD) was first deposited on top of PEDOT/PSS layer at deposition rate of 0.06 nm/s, yielding a 30 nm thick film. Then the deep blue emitter Compound 23 was deposited on top of α-NPD to form a 30 nm thick film, followed by deposition of a 40 nm thick layer of 1,3,5-tris(N-phenylbenzimidizol-2-yl)benzene (TPBI), all at deposition rate around 0.06 nm/s. CsF and Al were then deposited successively at deposition rates of 0.005 and 0.2 nm/s, respectively. Each individual device has areas of 0.14 cm2. Spectra is measured with an ocean optics HR4000 spectrometer and I-V light output measurements is taken with a Keithley 2400 SourceMeter and Newport 2832-C power meter and 818 UV detector. All device operation is carried out inside a nitrogen-filled glove-box.',\n",
       "  'content': ['Device C was fabricated as follows: the ITO coated glass substrates were cleaned by ultrasound in acetone, and consecutively in 2-propanol, baked at 110° C. for 3 hours, followed by treatment with oxygen plasma for 5 min. A layer of PEDOT: PSS (Baytron P purchased from H.C. Starck) was spin-coated at 3000 rpm onto the pre-cleaned and O2-plasma treated (ITO)-substrate and annealed at 180° C. for 10 min, yielding a thickness of around 40 nm. In a glove-box hosted vacuum deposition system at a pressure of 10−7 torr (1 torr=133.322 Pa), 4,4′-bis[N-(naphthyl)-N-phenyl-amino]biphenyl (α-NPD) was first deposited on top of PEDOT/PSS layer at deposition rate of 0.06 nm/s, yielding a 30 nm thick film. Then the deep blue emitter Compound 23 was deposited on top of α-NPD to form a 30 nm thick film, followed by deposition of a 40 nm thick layer of 1,3,5-tris(N-phenylbenzimidizol-2-yl)benzene (TPBI), all at deposition rate around 0.06 nm/s. CsF and Al were then deposited successively at deposition rates of 0.005 and 0.2 nm/s, respectively. Each individual device has areas of 0.14 cm2. Spectra is measured with an ocean optics HR4000 spectrometer and I-V light output measurements is taken with a Keithley 2400 SourceMeter and Newport 2832-C power meter and 818 UV detector. All device operation is carried out inside a nitrogen-filled glove-box.']},\n",
       " {'number': 'Example 2.4',\n",
       "  'title': 'Another device (Comparative Device A) was constructed in accordance to Example 2.3, except that instead of neat Compound 23 layer being deposited on top of the α-NPD, neat:',\n",
       "  'content': ['Another device (Comparative Device A) was constructed in accordance to Example 2.3, except that instead of neat Compound 23 layer being deposited on top of the α-NPD, neat:',\n",
       "   'was deposited on top of α-NPD to form a 30 nm thick film.']},\n",
       " {'number': 'Example 3', 'title': 'Device Performance', 'content': []},\n",
       " {'number': 'Example 3.1',\n",
       "  'title': 'Device A, a blue light emitting device, comprising Compound 21 and fabricated in accordance with Examples 1 and 2, was tested to determine the emissive qualities of the device by examining the (1) emissive intensity of Device A (intensity of the device [a.u.] as a function of wavelength; (2) determining the CIE coordinates of Device A; (3) determining the efficiency of Device A (current density and brightness as a function of the voltage applied to the device; and external quantum efficiency, power efficiency and brightness as a function of current density). All spectra were measured with an Ocean Optics HR 4000 spectrometer (Ocean Optics, Dunedin, Fla., USA) and I-V-L characteristics were taken with a Keithley 2400 SourceMeter (Keithley Instruments, Inc., Cleveland, Ohio, USA) and Newport 2832-C power meter and 818 UV detector (Newport, Corp., Irvine, Calif., USA). All device operation was performed inside a nitrogen-filled glove-box. An exemplary configuration of the device (Device A) is shown in FIG. 1 (Device structure: PEDOT:PSS/TCTA (30 nm)/Compound 17 (30 nm)/TPBi (40 nm)/CsF/Al). FIG. 2 shows electroluminescence spectrum of Device A, plus the CIE coordinate. The spectrum shows significant emission between 400 and 500 nm. The purity of the deep blue emitted radiation is demonstrated by the CIE coordinates (X=0.16; Y=0.05). In addition, as shown in FIGS. 3, 4 and 5, Device A demonstrates efficacy in conventional organic light emitting device parameters. Thus Compound 21 has demonstrated its effectiveness as a blue emitting compound in organic light emitting devices.',\n",
       "  'content': ['Device A, a blue light emitting device, comprising Compound 21 and fabricated in accordance with Examples 1 and 2, was tested to determine the emissive qualities of the device by examining the (1) emissive intensity of Device A (intensity of the device [a.u.] as a function of wavelength; (2) determining the CIE coordinates of Device A; (3) determining the efficiency of Device A (current density and brightness as a function of the voltage applied to the device; and external quantum efficiency, power efficiency and brightness as a function of current density). All spectra were measured with an Ocean Optics HR 4000 spectrometer (Ocean Optics, Dunedin, Fla., USA) and I-V-L characteristics were taken with a Keithley 2400 SourceMeter (Keithley Instruments, Inc., Cleveland, Ohio, USA) and Newport 2832-C power meter and 818 UV detector (Newport, Corp., Irvine, Calif., USA). All device operation was performed inside a nitrogen-filled glove-box. An exemplary configuration of the device (Device A) is shown in FIG. 1 (Device structure: PEDOT:PSS/TCTA (30 nm)/Compound 17 (30 nm)/TPBi (40 nm)/CsF/Al). FIG. 2 shows electroluminescence spectrum of Device A, plus the CIE coordinate. The spectrum shows significant emission between 400 and 500 nm. The purity of the deep blue emitted radiation is demonstrated by the CIE coordinates (X=0.16; Y=0.05). In addition, as shown in FIGS. 3, 4 and 5, Device A demonstrates efficacy in conventional organic light emitting device parameters. Thus Compound 21 has demonstrated its effectiveness as a blue emitting compound in organic light emitting devices.']},\n",
       " {'number': 'Example 3.2',\n",
       "  'title': 'Device B, a white light emitting device, comprising Compound 17, tris(2-phenylpyridine)iridium (Ir(ppy)3), and PQIr; and fabricated in accordance with Examples 1 and 2, was tested to determine the emissive qualities of the device by examining the (1) emissive intensity of Device B (intensity of the device [a.u.] as a function of wavelength; (2) determining the CIE coordinates of Device B; (3) determining the efficiency of Device B (current density and brightness as a function of the voltage applied to the device; and external quantum efficiency, power efficiency and brightness as a function of current density). All spectra were measured with an Ocean Optics HR 4000 spectrometer (Ocean Optics, Dunedin, Fla., USA) and I-V-L characteristics were taken with a Keithley 2400 SourceMeter (Keithley Instruments, Inc., Cleveland, Ohio, USA) and Newport 2832-C power meter and 818 UV detector (Newport, Corp., Irvine, Calif., USA). All device operation was performed inside a nitrogen-filled glove-box. An exemplary configuration of the device (Device B) is shown in FIG. 6 (Device structure: PEDOT:PSS/TCTA (30 nm)/Cmd 17:Ir(ppy)3 (0.5%):Ir(pq)2acac (PQIr) (0.15%) (15 nm)/TPBi (40 nm)/CsF/Al). FIG. 7 shows electroluminescence spectrum of Device B, plus the CIE coordinate and CRI value. The spectrum shows significant emission between 400 and 450; 500 and 525 and 575 and 625 nm. The purity of the white emitted radiation is demonstrated by the CIE coordinates (X=0.37; Y=0.37) and a color rendering index of 77. In addition, as shown in FIGS. 8, 9 and 10, Device B demonstrates efficacy in conventional organic light emitting device parameters. Thus Compound 17 has demonstrated its effectiveness as a blue emitting compound in white light emitting organic light emitting devices.',\n",
       "  'content': ['Device B, a white light emitting device, comprising Compound 17, tris(2-phenylpyridine)iridium (Ir(ppy)3), and PQIr; and fabricated in accordance with Examples 1 and 2, was tested to determine the emissive qualities of the device by examining the (1) emissive intensity of Device B (intensity of the device [a.u.] as a function of wavelength; (2) determining the CIE coordinates of Device B; (3) determining the efficiency of Device B (current density and brightness as a function of the voltage applied to the device; and external quantum efficiency, power efficiency and brightness as a function of current density). All spectra were measured with an Ocean Optics HR 4000 spectrometer (Ocean Optics, Dunedin, Fla., USA) and I-V-L characteristics were taken with a Keithley 2400 SourceMeter (Keithley Instruments, Inc., Cleveland, Ohio, USA) and Newport 2832-C power meter and 818 UV detector (Newport, Corp., Irvine, Calif., USA). All device operation was performed inside a nitrogen-filled glove-box. An exemplary configuration of the device (Device B) is shown in FIG. 6 (Device structure: PEDOT:PSS/TCTA (30 nm)/Cmd 17:Ir(ppy)3 (0.5%):Ir(pq)2acac (PQIr) (0.15%) (15 nm)/TPBi (40 nm)/CsF/Al). FIG. 7 shows electroluminescence spectrum of Device B, plus the CIE coordinate and CRI value. The spectrum shows significant emission between 400 and 450; 500 and 525 and 575 and 625 nm. The purity of the white emitted radiation is demonstrated by the CIE coordinates (X=0.37; Y=0.37) and a color rendering index of 77. In addition, as shown in FIGS. 8, 9 and 10, Device B demonstrates efficacy in conventional organic light emitting device parameters. Thus Compound 17 has demonstrated its effectiveness as a blue emitting compound in white light emitting organic light emitting devices.']},\n",
       " {'number': 'Example 3.3',\n",
       "  'title': 'Devices C and Comparative Device D, both blue light emitting devices, comprising Compound 23 and Comparative Compound A, respectively; and fabricated in accordance with Examples 2.3 and 2.4, were tested to determine the emissive qualities of the device by at least examining the (1) emissive intensity of Devices C and D (intensity of the device [a.u.] as a function of wavelength; (2) determining the efficiency of Devices C and D (current density and brightness as a function of the voltage applied to the device; and external quantum efficiency, power efficiency and brightness as a function of current density). All spectra were measured with an Ocean Optics HR 4000 spectrometer (Ocean Optics, Dunedin, Fla., USA) and I-V-L characteristics were taken with a Keithley 2400 SourceMeter (Keithley Instruments, Inc., Cleveland, Ohio, USA) and Newport 2832-C power meter and 818 UV detector (Newport, Corp., Irvine, Calif., USA). All device operation was performed inside a nitrogen-filled glove-box. An exemplary configuration of the devices (Devices C and D) are shown in FIG. 6 (Device C structure: PEDOT:PSS/α-NPD (30 nm)/Cmd 23 (30 nm)/TPBi (40 nm)/CsF/Al); Device D structure: PEDOT:PSS/α-NPD (30 nm)/ComparativeCmd A (30 nm)/TPBi (40 nm)/CsF/Al). The results are provided in Table 1.',\n",
       "  'content': ['Devices C and Comparative Device D, both blue light emitting devices, comprising Compound 23 and Comparative Compound A, respectively; and fabricated in accordance with Examples 2.3 and 2.4, were tested to determine the emissive qualities of the device by at least examining the (1) emissive intensity of Devices C and D (intensity of the device [a.u.] as a function of wavelength; (2) determining the efficiency of Devices C and D (current density and brightness as a function of the voltage applied to the device; and external quantum efficiency, power efficiency and brightness as a function of current density). All spectra were measured with an Ocean Optics HR 4000 spectrometer (Ocean Optics, Dunedin, Fla., USA) and I-V-L characteristics were taken with a Keithley 2400 SourceMeter (Keithley Instruments, Inc., Cleveland, Ohio, USA) and Newport 2832-C power meter and 818 UV detector (Newport, Corp., Irvine, Calif., USA). All device operation was performed inside a nitrogen-filled glove-box. An exemplary configuration of the devices (Devices C and D) are shown in FIG. 6 (Device C structure: PEDOT:PSS/α-NPD (30 nm)/Cmd 23 (30 nm)/TPBi (40 nm)/CsF/Al); Device D structure: PEDOT:PSS/α-NPD (30 nm)/ComparativeCmd A (30 nm)/TPBi (40 nm)/CsF/Al). The results are provided in Table 1.',\n",
       "   'TABLE 1\\n\\n\\n\\n\\n\\n\\n\\nλem\\nV\\nI\\nLE\\nPE\\n\\nLT50\\n\\n\\n\\n(nm)\\n(V)\\n(mA)\\n(cd/A)\\n(lm/W)\\nEQE\\n(h)\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nComparative\\n457\\n3.73\\n1.55\\n5.16\\n4.34\\n3.68%\\n8.3\\n\\n\\nCmd A\\n\\n\\nCompound\\n470\\n3.76\\n0.95\\n9.28\\n7.75\\n6.80%\\n10\\n\\n\\n23',\n",
       "   'As shown in Table 1, Device C demonstrates almost twice the luminescent efficiency (9.28 cd/A [Device C], 5.16 cd/A [Device D]), almost twice the power efficiency (7.75 lm/W [Device C], 4.34 lm/W [Device D]), and almost twice the EQE (6.80% [Device C], 3.68% [Device D]), conventional organic light emitting device parameters. Thus Compound 23 has demonstrated its effectiveness as a blue emitting compound as compared to Comparative Example A in blue light emitting organic light emitting devices.',\n",
       "   'It will be understood by those of skill in the art that numerous and various modifications can be made without departing from the spirit of the present invention. Therefore, it should be clearly understood that the forms of the present invention are illustrative only and are not intended to limit the scope of the present invention.']}]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stats[\"documents_with_examples\"][\"8927121\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
      "[nltk_data]     C:\\Users\\amoha\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package averaged_perceptron_tagger is already up-to-\n",
      "[nltk_data]       date!\n",
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\amoha\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "# import nltk\n",
    "# from nltk import pos_tag, word_tokenize\n",
    "# from bs4 import BeautifulSoup\n",
    "# import re\n",
    "\n",
    "\n",
    "# nltk.download(\"averaged_perceptron_tagger\")\n",
    "# nltk.download(\"punkt\")\n",
    "\n",
    "\n",
    "# # region tense analysis\n",
    "# def check_tense_nltk(sentence):\n",
    "#     words = word_tokenize(sentence)\n",
    "#     tagged = pos_tag(words)\n",
    "\n",
    "#     past = [\"VBD\", \"VBN\"]\n",
    "#     present = [\"VB\", \"VBG\", \"VBP\", \"VBZ\", \"MD\"]\n",
    "\n",
    "#     tenses = {\"past\": 0, \"present\": 0}\n",
    "\n",
    "#     for word, tag in tagged:\n",
    "#         if tag in past:\n",
    "#             tenses[\"past\"] += 1\n",
    "#         elif tag in present:\n",
    "#             tenses[\"present\"] += 1\n",
    "#         elif word.lower() in [\"will\", \"shall\"]:\n",
    "#             tenses[\"present\"] += 1\n",
    "\n",
    "#     return max(tenses, key=tenses.get) if max(tenses.values()) > 0 else \"Unknown\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Primary tense: present\n"
     ]
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'TiO2 particles were first coated with Gantrez S-97BF polymer and then with KF9909 silicone fluid under sonication, and the coated particles were then mixed with more KF9909 silicone fluid in a main beaker and mixed together using a pro mixer manufactured by Caframo in Ontario, Canada (Model # BDC 1850) at digital reading of 105 until a homogenous mixture was formed. Stannous octoate, which was commercially available from Arkema as Fascat® 2003 catalyst, was added into the main beaker at room temperature, and mixing was resumed for about 1 minute. The resulting mixture was immediate poured onto a flat surface and allowed to sit for 30 minutes, thereby forming a cross-linked flat sheet. The flat sheet was subsequently reduced to particles by mortar pestle. The resulting treated particles had an average particle size ranging from about 1 micron to 10 microns, as measured under microscope. Such treated particles contained about 85.31 wt % of TiO2, 3.52% Gantrez S-97BF, 0.41% stannous octoate, and about 12.57 wt % of KF-9909 silicone fluid.While the present invention has been described hereinabove with reference to specific embodiments, features and aspects, it will be recognized that the invention is not thus limited, but rather extends in utility to other modifications, variations, applications, and embodiments, and accordingly all such other modifications, variations, applications, and embodiments are to be regarded as being within the spirit and scope of the present invention.'"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"\".join((ex[0][\"content\"]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['NNP', 'NN', '(', 'CD', ':', 'CC', 'IN', ')', 'VBZ', 'VBN', 'JJ',\n",
       "       '.', 'DT', 'RB', 'NNS', 'VBD', 'TO', 'VBG', ',', 'VB'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokens = word_tokenize(\"\".join((ex[125][\"content\"])))\n",
    "tagged = pos_tag(tokens)\n",
    "d = pd.DataFrame(tagged)\n",
    "d.columns = [\"word\",\"tag\"]\n",
    "d.tag.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    RE045323\n",
       "1    RE045324\n",
       "2    RE045325\n",
       "3     8925349\n",
       "4     8925551\n",
       "Name: patentnumber, dtype: object"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged.patentnumber.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('<?xml version=\"1.0\" encoding=\"UTF-8\"?>\\n'\n",
      " '<!DOCTYPE us-patent-grant SYSTEM \"us-patent-grant-v45-2014-04-03.dtd\" [ ]>\\n'\n",
      " '<us-patent-grant lang=\"EN\" dtd-version=\"v4.5 2014-04-03\" '\n",
      " 'file=\"US08927557-20150106.XML\" status=\"PRODUCTION\" id=\"us-patent-grant\" '\n",
      " 'country=\"US\" date-produced=\"20141219\" date-publ=\"20150106\">\\n'\n",
      " '<us-bibliographic-data-grant>\\n'\n",
      " '<publication-reference>\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<doc-number>08927557</doc-number>\\n'\n",
      " '<kind>B2</kind>\\n'\n",
      " '<date>20150106</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</publication-reference>\\n'\n",
      " '<application-reference appl-type=\"utility\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<doc-number>13390940</doc-number>\\n'\n",
      " '<date>20100824</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</application-reference>\\n'\n",
      " '<us-application-series-code>13</us-application-series-code>\\n'\n",
      " '<priority-claims>\\n'\n",
      " '<priority-claim sequence=\"01\" kind=\"regional\">\\n'\n",
      " '<country>EP</country>\\n'\n",
      " '<doc-number>09168685</doc-number>\\n'\n",
      " '<date>20090826</date>\\n'\n",
      " '</priority-claim>\\n'\n",
      " '</priority-claims>\\n'\n",
      " '<us-term-of-grant>\\n'\n",
      " '<us-term-extension>74</us-term-extension>\\n'\n",
      " '</us-term-of-grant>\\n'\n",
      " '<classifications-ipcr>\\n'\n",
      " '<classification-ipcr>\\n'\n",
      " '<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\\n'\n",
      " '<classification-level>A</classification-level>\\n'\n",
      " '<section>C</section>\\n'\n",
      " '<class>07</class>\\n'\n",
      " '<subclass>D</subclass>\\n'\n",
      " '<main-group>487</main-group>\\n'\n",
      " '<subgroup>04</subgroup>\\n'\n",
      " '<symbol-position>F</symbol-position>\\n'\n",
      " '<classification-value>I</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '</classification-ipcr>\\n'\n",
      " '<classification-ipcr>\\n'\n",
      " '<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\\n'\n",
      " '<classification-level>A</classification-level>\\n'\n",
      " '<section>A</section>\\n'\n",
      " '<class>61</class>\\n'\n",
      " '<subclass>K</subclass>\\n'\n",
      " '<main-group>31</main-group>\\n'\n",
      " '<subgroup>519</subgroup>\\n'\n",
      " '<symbol-position>L</symbol-position>\\n'\n",
      " '<classification-value>I</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '</classification-ipcr>\\n'\n",
      " '<classification-ipcr>\\n'\n",
      " '<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\\n'\n",
      " '<classification-level>A</classification-level>\\n'\n",
      " '<section>A</section>\\n'\n",
      " '<class>61</class>\\n'\n",
      " '<subclass>P</subclass>\\n'\n",
      " '<main-group>9</main-group>\\n'\n",
      " '<subgroup>08</subgroup>\\n'\n",
      " '<symbol-position>L</symbol-position>\\n'\n",
      " '<classification-value>I</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '</classification-ipcr>\\n'\n",
      " '<classification-ipcr>\\n'\n",
      " '<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\\n'\n",
      " '<classification-level>A</classification-level>\\n'\n",
      " '<section>A</section>\\n'\n",
      " '<class>61</class>\\n'\n",
      " '<subclass>P</subclass>\\n'\n",
      " '<main-group>1</main-group>\\n'\n",
      " '<subgroup>16</subgroup>\\n'\n",
      " '<symbol-position>L</symbol-position>\\n'\n",
      " '<classification-value>I</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '</classification-ipcr>\\n'\n",
      " '<classification-ipcr>\\n'\n",
      " '<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\\n'\n",
      " '<classification-level>A</classification-level>\\n'\n",
      " '<section>A</section>\\n'\n",
      " '<class>61</class>\\n'\n",
      " '<subclass>P</subclass>\\n'\n",
      " '<main-group>9</main-group>\\n'\n",
      " '<subgroup>12</subgroup>\\n'\n",
      " '<symbol-position>L</symbol-position>\\n'\n",
      " '<classification-value>I</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '</classification-ipcr>\\n'\n",
      " '</classifications-ipcr>\\n'\n",
      " '<classifications-cpc>\\n'\n",
      " '<main-cpc>\\n'\n",
      " '<classification-cpc>\\n'\n",
      " '<cpc-version-indicator><date>20130101</date></cpc-version-indicator>\\n'\n",
      " '<section>C</section>\\n'\n",
      " '<class>07</class>\\n'\n",
      " '<subclass>D</subclass>\\n'\n",
      " '<main-group>487</main-group>\\n'\n",
      " '<subgroup>04</subgroup>\\n'\n",
      " '<symbol-position>F</symbol-position>\\n'\n",
      " '<classification-value>I</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '<scheme-origination-code>C</scheme-origination-code>\\n'\n",
      " '</classification-cpc>\\n'\n",
      " '</main-cpc>\\n'\n",
      " '<further-cpc>\\n'\n",
      " '<combination-set>\\n'\n",
      " '<group-number>1</group-number>\\n'\n",
      " '<combination-rank>\\n'\n",
      " '<rank-number>2</rank-number>\\n'\n",
      " '<classification-cpc>\\n'\n",
      " '<cpc-version-indicator><date>20130101</date></cpc-version-indicator>\\n'\n",
      " '<section>A</section>\\n'\n",
      " '<class>61</class>\\n'\n",
      " '<subclass>K</subclass>\\n'\n",
      " '<main-group>2300</main-group>\\n'\n",
      " '<subgroup>00</subgroup>\\n'\n",
      " '<symbol-position>L</symbol-position>\\n'\n",
      " '<classification-value>A</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '<scheme-origination-code>C</scheme-origination-code>\\n'\n",
      " '</classification-cpc>\\n'\n",
      " '</combination-rank>\\n'\n",
      " '<combination-rank>\\n'\n",
      " '<rank-number>1</rank-number>\\n'\n",
      " '<classification-cpc>\\n'\n",
      " '<cpc-version-indicator><date>20130101</date></cpc-version-indicator>\\n'\n",
      " '<section>C</section>\\n'\n",
      " '<class>07</class>\\n'\n",
      " '<subclass>D</subclass>\\n'\n",
      " '<main-group>487</main-group>\\n'\n",
      " '<subgroup>04</subgroup>\\n'\n",
      " '<symbol-position>L</symbol-position>\\n'\n",
      " '<classification-value>I</classification-value>\\n'\n",
      " '<action-date><date>20150106</date></action-date>\\n'\n",
      " '<generating-office><country>US</country></generating-office>\\n'\n",
      " '<classification-status>B</classification-status>\\n'\n",
      " '<classification-data-source>H</classification-data-source>\\n'\n",
      " '<scheme-origination-code>C</scheme-origination-code>\\n'\n",
      " '</classification-cpc>\\n'\n",
      " '</combination-rank>\\n'\n",
      " '</combination-set>\\n'\n",
      " '</further-cpc>\\n'\n",
      " '</classifications-cpc>\\n'\n",
      " '<classification-national>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<main-classification>5142651</main-classification>\\n'\n",
      " '<further-classification>544280</further-classification>\\n'\n",
      " '<further-classification>544229</further-classification>\\n'\n",
      " '<further-classification>548533</further-classification>\\n'\n",
      " '<further-classification>558442</further-classification>\\n'\n",
      " '<further-classification>558443</further-classification>\\n'\n",
      " '<further-classification>546242</further-classification>\\n'\n",
      " '<further-classification>546115</further-classification>\\n'\n",
      " '</classification-national>\\n'\n",
      " '<invention-title '\n",
      " 'id=\"d2e71\">Methylpyrrolopyrimidinecarboxamides</invention-title>\\n'\n",
      " '<us-references-cited>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00001\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<doc-number>5877190</doc-number>\\n'\n",
      " '<kind>A</kind>\\n'\n",
      " '<name>Dhainaut et al.</name>\\n'\n",
      " '<date>19990300</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00002\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<doc-number>2003/0004172</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<name>Harter et al.</name>\\n'\n",
      " '<date>20030100</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00003\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<doc-number>2005/0124623</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<name>Bender et al.</name>\\n'\n",
      " '<date>20050600</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00004\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>EP</country>\\n'\n",
      " '<doc-number>1 634 883</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<date>20060300</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00005\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>WO</country>\\n'\n",
      " '<doc-number>01/94350</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<date>20011200</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00006\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>WO</country>\\n'\n",
      " '<doc-number>2006/049952</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<date>20060500</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00007\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>WO</country>\\n'\n",
      " '<doc-number>2008/030119</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<date>20080300</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<patcit num=\"00008\">\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>WO</country>\\n'\n",
      " '<doc-number>2009/106531</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<date>20090900</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</patcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00009\">\\n'\n",
      " '<othercit>Esper et. al. (Expert. Opin. Investig. Drugs, 2005, 14(5), '\n",
      " '633-645).</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by examiner</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00010\">\\n'\n",
      " '<othercit>MedicineNet.com (Cirrohosis, '\n",
      " '&#x3c;http://www.medicinenet.com/cirrhosis/article.htm&#x3e;, downloaded '\n",
      " 'Aug. 26, 2012).</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by examiner</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00011\">\\n'\n",
      " '<othercit>Mayo Clinic '\n",
      " '(&#x3c;http://www.mayoclinic.com/health/pulmonary-fibrosis/DS00927/DSECTION=treatments-and-drugs '\n",
      " '&#x3e;downloaded Aug. 26, 2012).</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by examiner</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00012\">\\n'\n",
      " '<othercit>P.C. Belanger, et al., &#x201c;Facile Preparations of '\n",
      " '4-Fluororesorcinol&#x201d;, Canadian Journal of Chemistry, 1988, vol. 66, '\n",
      " 'pp. 1479-1482.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00013\">\\n'\n",
      " '<othercit>H.R. Collard, et al., &#x201c;Sildenafil Improves Walk Distance in '\n",
      " 'Idiopathic Pulmonary Fibrosis&#x201d;, Chest, 2007, vol. 131, pp. '\n",
      " '897-899.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00014\">\\n'\n",
      " '<othercit>E.J. Corey, et al., &#x201c;New Methods for the Oxidation of '\n",
      " 'Aldehydes to Carboxylic Acids and Esters&#x201d;, Journal of the American '\n",
      " 'Chemical Society, 1968, vol. 90, pp. 5616-5617.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00015\">\\n'\n",
      " '<othercit>J. Cortijo, et al., &#x201c;Roflumilast, a phosphodiesterase 4 '\n",
      " 'inhibitor, alleviates bleomycin-induced lung injury&#x201d;, British Journal '\n",
      " 'of Pharmacology, 2009, vol. 156, pp. 534-544.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00016\">\\n'\n",
      " '<othercit>T.R. Dunkern, et al., &#x201c;Inhibition of TGF-&#x3b2; induced '\n",
      " 'lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting '\n",
      " 'drugs and activators of soluble guanylyl cyclase&#x201d;, European Journal '\n",
      " 'of Pharmacology, 2007, vol. 572, pp. 12-22.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00017\">\\n'\n",
      " '<othercit>S.D. Erickson, et al., &#x201c;Potent, selective MCH-1 receptor '\n",
      " 'antagonists&#x201d;, Bioorganic &#x26; Medicinal Chemistry Letters, 2008, '\n",
      " 'vol. 18, pp. 1402-1406.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00018\">\\n'\n",
      " '<othercit>J. Freedman, et al., &#x201c;The Preparation of '\n",
      " '3,4-Dihydro-1-benzoxepin-5(2H)-ones&#x201d;, J. Heterocycl. Chem., 1989, '\n",
      " 'vol. 26, pp. 1547-1554.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00019\">\\n'\n",
      " '<othercit>A. Gangjee, et al., &#x201c;Design, Synthesis, and Biological '\n",
      " 'Evaluation of Classical and Nonclassical '\n",
      " '2-Amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as Dual '\n",
      " 'Thymidylate Synthase and Dihydrofolate Reductase Inhibitors&#x201d;, J. Med. '\n",
      " 'Chem., 2008, vol. 51, pp. 68-76.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00020\">\\n'\n",
      " '<othercit>P.G. Gassman, et al., &#x201c;A General Procedure for the '\n",
      " 'Base-Promoted Hydrolysis of Hindered Esters at Ambient Temperatures&#x201d;, '\n",
      " 'J. Org. Chem., 1977, vol. 42, pp. 918-920.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00021\">\\n'\n",
      " '<othercit>H.A. Ghofrani, et al., &#x201c;Sildenafil for Treatment of Lung '\n",
      " 'Fibrosis and Pulmonary Hypertension: a Randomised Controlled Trial&#x201d;, '\n",
      " 'The Lancet, Sep. 2002, vol. 360, pp. 895-900.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00022\">\\n'\n",
      " '<othercit>A.R. Hemnes, et al., &#x201c;PDE5A inhibition attenuates '\n",
      " 'bleomycin-induced pulmonary fibrosis and pulmonary hypertension through '\n",
      " 'inhibition of ROS generation and RhoA/Rho kinase activation&#x201d;, Am. '\n",
      " 'Physiol. Lung Cell Mol. Physiol., 2008, vol. 294, pp. 24-33.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00023\">\\n'\n",
      " '<othercit>J.R. Hwu, et al, &#x201c;The Trimethylsilyl Cationic Species as a '\n",
      " 'Bulky Proton. Application to Chemoselective Dioxolanation&#x201d;, J. Org. '\n",
      " 'Chem., 1985, vol. 50, pp. 3946-3948.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00024\">\\n'\n",
      " '<othercit>T. Kohyama, et al. &#x201c;PDE4 Inhibitors Attenuate Fibroblast '\n",
      " 'Chemotaxis and Contraction of Native Collagen Gels&#x201d;, Am. J. Respir. '\n",
      " 'Cell Mol. Biol., 2002, vol. 26, pp. 694-701.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00025\">\\n'\n",
      " '<othercit>C. Martin-Chouly, et al., &#x201c;Modulation of matrix '\n",
      " 'metalloproteinase production from human lung fibroblasts by type 4 '\n",
      " 'phosphodiesterase inhibitors&#x201d;, Life Sciences, 2004, vol. 75, pp. '\n",
      " '823-840.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00026\">\\n'\n",
      " '<othercit>D. Milne, et al., &#x201c;Dilithiated Aminoalcohols as Homochiral '\n",
      " 'Bases&#x201d;, J. Chem. Soc., Chem. Commun., 1993, pp. 884-886.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00027\">\\n'\n",
      " '<othercit>J.M. Muchowski, et al., &#x201c;Protecting Groups for the Pyrrole '\n",
      " 'and Indole Nitrogen Atom. The [2-(Trimethylsilyl)ethoxy] methyl Moiety. '\n",
      " 'Lithiation of 1-[ [ 2-(Trimethylsilypethoxy]methyl]pyrrole&#x201d;, J. Org. '\n",
      " 'Chem., 1984, vol. 49, pp. 203-205.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00028\">\\n'\n",
      " '<othercit>M. Murata, et al., &#x201c;Palladium-Catalyzed Borylation of Aryl '\n",
      " 'Halides or Triflates with Dialkoxyborane: A Novel and Facile Synthetic Route '\n",
      " 'to Arylboronates&#x201d;, J. Org. Chem., 2000, vol. 65, pp. '\n",
      " '164-168.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00029\">\\n'\n",
      " '<othercit>M. Murata, et al., &#x201c;Novel Palladium(0)-Catalyzed Coupling '\n",
      " 'Reaction of Dialkoxyborane with Aryl Halides: Convenient Synthetic Route to '\n",
      " 'Arylboronates&#x201d;, J. Organic Chemistry, 1997, vol. 62, pp. '\n",
      " '6458-6459.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00030\">\\n'\n",
      " '<othercit>W.H. Okamura, et al., &#x201c;Thermal [1,7]-Sigmatropic Shift of '\n",
      " 'Previtamin D3 to Vitamin D3: Synthesis and Study of Pentadeuterio '\n",
      " 'Derivatives&#x201d;, J. Org. Chem., 1993, vol. 58, pp. 600-610.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00031\">\\n'\n",
      " '<othercit>B.B. Snider, et al., &#x201c;Total Synthesis of '\n",
      " '(&#xb1;)-Deoxypenostatin A. Approaches to the Syntheses of Penostatins A and '\n",
      " 'B&#x201d;, J. Org. Chem., 2000, vol. 65, pp. 8490-8498.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00032\">\\n'\n",
      " '<othercit>B. Venugopalan, et al., &#x201c;Synthesis of '\n",
      " '6,7-Dimethoxypyrimido[4,5-b]-indoles as Potential Antihypertensive '\n",
      " 'Agents&#x201d;, J. Heterocyclic. Chem., 1988, vol. 25, pp. '\n",
      " '1633-1639.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00033\">\\n'\n",
      " '<othercit>Y. Yamamoto, et al., &#x201c;Synthesis of arylboronates via '\n",
      " 'Cp*RuCl-catalyzed cycloaddition of alkynylboronates&#x201d;, Tetrahedron, '\n",
      " '2006, vol. 62, pp. 4294-4305.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00034\">\\n'\n",
      " '<othercit>S. Zhao, et al., &#x201c;Synthetic Studies Towards A trans-3, '\n",
      " '4-Diamine Derivative of Piperidine Mimicking Buspironea&#x201d;, '\n",
      " 'Heterocycles, 1994, vol. 39, No. 1, pp. 163-170.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '<us-citation>\\n'\n",
      " '<nplcit num=\"00035\">\\n'\n",
      " '<othercit>Mezentseva, M.V., et al.,&#x201c;Synthesis and Antitumor Activity '\n",
      " 'of Pyrrolo [3,2-d]Pyrimidines&#x201d; Khimiko-Farmatsevticheskii Zhurnal '\n",
      " '(Pharmaceutical Chemistry Journal), vol. 25, No. 12, 1991, pp. 19-23, '\n",
      " 'English translation.</othercit>\\n'\n",
      " '</nplcit>\\n'\n",
      " '<category>cited by applicant</category>\\n'\n",
      " '</us-citation>\\n'\n",
      " '</us-references-cited>\\n'\n",
      " '<number-of-claims>27</number-of-claims>\\n'\n",
      " '<us-exemplary-claim>1</us-exemplary-claim>\\n'\n",
      " '<us-field-of-classification-search>\\n'\n",
      " '<classification-national>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<main-classification>544280</main-classification>\\n'\n",
      " '</classification-national>\\n'\n",
      " '<classification-national>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<main-classification>5142651</main-classification>\\n'\n",
      " '</classification-national>\\n'\n",
      " '<classification-cpc-text>C07D 487/04</classification-cpc-text>\\n'\n",
      " '</us-field-of-classification-search>\\n'\n",
      " '<us-related-documents>\\n'\n",
      " '<related-publication>\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>US</country>\\n'\n",
      " '<doc-number>20120149721</doc-number>\\n'\n",
      " '<kind>A1</kind>\\n'\n",
      " '<date>20120614</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</related-publication>\\n'\n",
      " '</us-related-documents>\\n'\n",
      " '<us-parties>\\n'\n",
      " '<us-applicants>\\n'\n",
      " '<us-applicant sequence=\"001\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Stadlwieser</last-name>\\n'\n",
      " '<first-name>Josef</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"002\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Schmidt</last-name>\\n'\n",
      " '<first-name>Beate</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Allensbach</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"003\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Bernsmann</last-name>\\n'\n",
      " '<first-name>Heiko</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Frankfurt</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"004\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Dunkern</last-name>\\n'\n",
      " '<first-name>Torsten</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Juechen Gierath</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"005\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Benediktus</last-name>\\n'\n",
      " '<first-name>Ewald</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Biberach</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"006\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Pahl</last-name>\\n'\n",
      " '<first-name>Andreas</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Ahrensburg</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"007\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Hussong</last-name>\\n'\n",
      " '<first-name>Ragna</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Deisslingen</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"008\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Nimz</last-name>\\n'\n",
      " '<first-name>Olaf</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"009\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Mueller</last-name>\\n'\n",
      " '<first-name>Matthias</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '<us-applicant sequence=\"010\" app-type=\"applicant\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Viertelhaus</last-name>\\n'\n",
      " '<first-name>Martin</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '<residence>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</residence>\\n'\n",
      " '</us-applicant>\\n'\n",
      " '</us-applicants>\\n'\n",
      " '<inventors>\\n'\n",
      " '<inventor sequence=\"001\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Stadlwieser</last-name>\\n'\n",
      " '<first-name>Josef</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"002\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Schmidt</last-name>\\n'\n",
      " '<first-name>Beate</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Allensbach</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"003\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Bernsmann</last-name>\\n'\n",
      " '<first-name>Heiko</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Frankfurt</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"004\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Dunkern</last-name>\\n'\n",
      " '<first-name>Torsten</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Juechen Gierath</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"005\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Benediktus</last-name>\\n'\n",
      " '<first-name>Ewald</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Biberach</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"006\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Pahl</last-name>\\n'\n",
      " '<first-name>Andreas</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Ahrensburg</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"007\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Hussong</last-name>\\n'\n",
      " '<first-name>Ragna</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Deisslingen</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"008\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Nimz</last-name>\\n'\n",
      " '<first-name>Olaf</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"009\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Mueller</last-name>\\n'\n",
      " '<first-name>Matthias</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '<inventor sequence=\"010\" designation=\"us-only\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>Viertelhaus</last-name>\\n'\n",
      " '<first-name>Martin</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</inventor>\\n'\n",
      " '</inventors>\\n'\n",
      " '<agents>\\n'\n",
      " '<agent sequence=\"01\" rep-type=\"attorney\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<orgname>Nath, Goldberg And Meyer</orgname>\\n'\n",
      " '<address>\\n'\n",
      " '<country>unknown</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</agent>\\n'\n",
      " '<agent sequence=\"02\" rep-type=\"attorney\">\\n'\n",
      " '<addressbook>\\n'\n",
      " '<last-name>McGee</last-name>\\n'\n",
      " '<first-name>Sheldon M.</first-name>\\n'\n",
      " '<address>\\n'\n",
      " '<country>unknown</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</agent>\\n'\n",
      " '</agents>\\n'\n",
      " '</us-parties>\\n'\n",
      " '<assignees>\\n'\n",
      " '<assignee>\\n'\n",
      " '<addressbook>\\n'\n",
      " '<orgname>Takeda GmbH</orgname>\\n'\n",
      " '<role>03</role>\\n'\n",
      " '<address>\\n'\n",
      " '<city>Konstanz</city>\\n'\n",
      " '<country>DE</country>\\n'\n",
      " '</address>\\n'\n",
      " '</addressbook>\\n'\n",
      " '</assignee>\\n'\n",
      " '</assignees>\\n'\n",
      " '<examiners>\\n'\n",
      " '<primary-examiner>\\n'\n",
      " '<last-name>Moore</last-name>\\n'\n",
      " '<first-name>Susanna</first-name>\\n'\n",
      " '<department>1624</department>\\n'\n",
      " '</primary-examiner>\\n'\n",
      " '</examiners>\\n'\n",
      " '<pct-or-regional-filing-data>\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>WO</country>\\n'\n",
      " '<doc-number>PCT/EP2010/062329</doc-number>\\n'\n",
      " '<kind>00</kind>\\n'\n",
      " '<date>20100824</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '<us-371c124-date>\\n'\n",
      " '<date>20120217</date>\\n'\n",
      " '</us-371c124-date>\\n'\n",
      " '</pct-or-regional-filing-data>\\n'\n",
      " '<pct-or-regional-publishing-data>\\n'\n",
      " '<document-id>\\n'\n",
      " '<country>WO</country>\\n'\n",
      " '<doc-number>WO2011/023693</doc-number>\\n'\n",
      " '<kind>A </kind>\\n'\n",
      " '<date>20110303</date>\\n'\n",
      " '</document-id>\\n'\n",
      " '</pct-or-regional-publishing-data>\\n'\n",
      " '</us-bibliographic-data-grant>\\n'\n",
      " '<abstract id=\"abstract\">\\n'\n",
      " '<p id=\"p-0001\" num=\"0000\">The compounds of Formula (I),</p>\\n'\n",
      " '<p id=\"p-0002\" num=\"0000\"><chemistry id=\"CHEM-US-00001\" num=\"00001\">\\n'\n",
      " '<img id=\"EMI-C00001\" he=\"49.28mm\" wi=\"61.72mm\" '\n",
      " 'file=\"US08927557-20150106-C00001.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<br/>\\n'\n",
      " 'wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in '\n",
      " 'the description, the salts thereof, the stereoisomers of the compounds and '\n",
      " 'the salts thereof are effective inhibitors of the type 5 phosphodiesterase.\\n'\n",
      " '</p>\\n'\n",
      " '</abstract>\\n'\n",
      " '<description id=\"description\">\\n'\n",
      " '<?BRFSUM description=\"Brief Summary\" end=\"lead\"?>\\n'\n",
      " '<p id=\"p-0003\" num=\"0001\">This application is filed under 35 U.S.C. 371 as '\n",
      " 'the national stage of PCT/EP2010/062329, filed Aug. 24, 2010, which claims '\n",
      " 'priority to EP 09168685.7, filed Aug. 26, 2009.</p>\\n'\n",
      " '<heading id=\"h-0001\" level=\"1\">FIELD OF APPLICATION OF THE PRESENT SUBJECT '\n",
      " 'MATTER</heading>\\n'\n",
      " '<p id=\"p-0004\" num=\"0002\">The present subject matter relates to '\n",
      " 'methylpyrrolopyrimidinecarboxamide compounds, processes for their '\n",
      " 'preparation, pharmaceutical compositions comprising said compounds and the '\n",
      " 'use thereof in the treatment or prophylaxis of diseases.</p>\\n'\n",
      " '<heading id=\"h-0002\" level=\"1\">BACKGROUND OF THE INVENTION</heading>\\n'\n",
      " '<p id=\"p-0005\" num=\"0003\">Pyrrolopyrimidinecarboxamides are described in '\n",
      " 'WO2009/106531. EP1634883 disclose 2-substituted '\n",
      " 'phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one '\n",
      " 'derivatives and their use for treatment and/or prevention of sexual '\n",
      " 'dysfunction and other diseases related to phospholipase 5. WO01/94350 '\n",
      " 'disclose 6-phenylpyrrolopyrimidine derivatives as selective cyclic GMP '\n",
      " 'specific phosphodiesterase (PDE 5) inhibitors.</p>\\n'\n",
      " '<?BRFSUM description=\"Brief Summary\" end=\"tail\"?>\\n'\n",
      " '<?DETDESC description=\"Detailed Description\" end=\"lead\"?>\\n'\n",
      " '<heading id=\"h-0003\" level=\"1\">DESCRIPTION OF THE PRESENT SUBJECT '\n",
      " 'MATTER</heading>\\n'\n",
      " '<p id=\"p-0006\" num=\"0004\">It has now been found that the '\n",
      " 'methylpyrrolopyrimidinecarboxamide compounds, which are described in detail '\n",
      " 'below, have surprising and advantageous properties.</p>\\n'\n",
      " '<p id=\"p-0007\" num=\"0005\">The present subject matter relates to compounds of '\n",
      " 'formula (I)</p>\\n'\n",
      " '<p id=\"p-0008\" num=\"0006\"><chemistry id=\"CHEM-US-00002\" num=\"00002\">\\n'\n",
      " '<img id=\"EMI-C00002\" he=\"49.28mm\" wi=\"61.72mm\" '\n",
      " 'file=\"US08927557-20150106-C00002.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<br/>\\n'\n",
      " 'wherein\\n'\n",
      " '<ul id=\"ul0001\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0001-0001\" num=\"0007\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0001-0002\" num=\"0008\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0003\" num=\"0009\">R2 is hydrogen or 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0001-0004\" num=\"0010\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0001-0005\" num=\"0011\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0001-0006\" num=\"0012\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0001-0007\" num=\"0013\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0008\" num=\"0014\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0001-0009\" num=\"0015\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0001-0010\" num=\"0016\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0001-0011\" num=\"0017\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0001-0012\" num=\"0018\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0001-0013\" num=\"0019\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0001-0014\" num=\"0020\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0015\" num=\"0021\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0016\" num=\"0022\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0001-0017\" num=\"0023\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0001-0018\" num=\"0024\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0001-0019\" num=\"0025\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0020\" num=\"0026\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0001-0021\" num=\"0027\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0022\" num=\"0028\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0023\" num=\"0029\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0024\" num=\"0030\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0001-0025\" num=\"0031\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0001-0026\" num=\"0032\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0001-0027\" num=\"0033\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0009\" num=\"0034\">1-4C-Alkyl is a straight-chain or branched alkyl '\n",
      " 'group having 1 to 4 carbon atoms. Examples are methyl, ethyl, n-propyl, '\n",
      " 'iso-propyl, n-butyl, iso-butyl, sec-butyl and tert-butyl.</p>\\n'\n",
      " '<p id=\"p-0010\" num=\"0035\">2-4C-Alkyl is a straight-chain or branched alkyl '\n",
      " 'group having 2 to 4 carbon atoms. Examples are ethyl, n-propyl, iso-propyl, '\n",
      " 'n-butyl, iso-butyl, sec-butyl and tert-butyl.</p>\\n'\n",
      " '<p id=\"p-0011\" num=\"0036\">1-4C-Fluoroalkyl is a straight-chain or branched '\n",
      " 'alkyl moiety having 1 to 4 carbon atoms, wherein one or more of the hydrogen '\n",
      " 'atoms of the alkyl moiety are replaced by fluorine. Examples include, but '\n",
      " 'are not limited to, a trifluoromethyl, difluoromethyl, fluoromethyl, '\n",
      " 'perfluoroethyl, 1,1,1-trifluoro-2-fluoroethyl, 1,1,1-trifluoroethyl, '\n",
      " '1,1-difluoro-2,2-difluoroethyl, 1,1-difluoro-2-fluoroethyl, '\n",
      " '1,1-difluoroethyl, 1-fluoro-2,2-difluoroethyl, 1-fluoro-2-fluoroethyl, '\n",
      " '1-fluoroethyl, 2,2-difluoroethyl, 2-fluoroethyl, n-perfluoropropyl, and '\n",
      " 'n-perfluorobutyl group.</p>\\n'\n",
      " '<p id=\"p-0012\" num=\"0037\">1-2C-Fluoroalkyl is a straight-chain or branched '\n",
      " 'alkyl moiety having 1 to 2 carbon atoms, wherein one or more of the hydrogen '\n",
      " 'atoms of the alkyl moiety are replaced by fluorine. Examples include, but '\n",
      " 'are not limited to, a trifluoromethyl, difluoromethyl, fluoromethyl, '\n",
      " 'perfluoroethyl, 1,1,1-trifluoro-2-fluoroethyl, 1,1,1-trifluoroethyl, '\n",
      " '1,1-difluoro-2,2-difluoroethyl, 1,1-difluoro-2-fluoroethyl, '\n",
      " '1,1-difluoroethyl, 1-fluoro-2,2-difluoroethyl, 1-fluoro-2-fluoroethyl, '\n",
      " '1-fluoroethyl, 2,2-difluoroethyl and 2-fluoroethyl group.</p>\\n'\n",
      " '<p id=\"p-0013\" num=\"0038\">Halogen includes fluorine, chlorine, bromine and '\n",
      " 'iodine. In case of R22 and/or R23 and/or R5 and/or R6 and/or R61 being '\n",
      " 'halogen, fluorine is preferred.</p>\\n'\n",
      " '<p id=\"p-0014\" num=\"0039\">3-6C-Cycloalkyl is a cycloalkyl group having 3 to '\n",
      " '6 carbon atoms, examples of which include the cyclopropyl, cyclobutyl, '\n",
      " 'cyclopentyl and cyclohexyl group. In case of R3 being 3-6C-cycloalkyl, '\n",
      " 'cyclohexyl and cyclopentyl are preferred.</p>\\n'\n",
      " '<p id=\"p-0015\" num=\"0040\">3-4C-Cycloalkyl is a cycloalkyl group having 3 to '\n",
      " '4 carbon atoms, examples of which include the cyclopropyl and cyclobutyl '\n",
      " 'group.</p>\\n'\n",
      " '<p id=\"p-0016\" num=\"0041\">5-6C-Cycloalkyl is a cycloalkyl group having 5 to '\n",
      " '6 carbon atoms, examples of which include the cyclopentyl and cyclohexyl '\n",
      " 'group.</p>\\n'\n",
      " '<p id=\"p-0017\" num=\"0042\">1-4C-Alkoxy represents a group which, in addition '\n",
      " 'to the oxygen atom, contains a straight-chain or branched alkyl moiety '\n",
      " 'having 1 to 4 carbon atoms. Examples are methoxy, ethoxy, n-propoxy, '\n",
      " 'iso-propoxy, n-butoxy, iso-butoxy, sec-butoxy and tert-butoxy.</p>\\n'\n",
      " '<p id=\"p-0018\" num=\"0043\">1-2C-Alkoxy represents a group which, in addition '\n",
      " 'to the oxygen atom, contains a straight-chain alkyl moiety having 1 to 2 '\n",
      " 'carbon atoms. Examples are methoxy and ethoxy,</p>\\n'\n",
      " '<p id=\"p-0019\" num=\"0044\">1-4C-Fluoroalkoxy represents a group which, in '\n",
      " 'addition to the oxygen atom, contains a straight-chain or branched alkyl '\n",
      " 'moiety having 1 to 4 carbon atoms, wherein one or more of the hydrogen atoms '\n",
      " 'of the alkyl moiety are replaced by fluorine. Examples include, but are not '\n",
      " 'limited to, a trifluoromethoxy, difluoromethoxy, fluoromethoxy, '\n",
      " 'perfluoroethoxy, 1,1,1-trifluoro-2-fluoroethoxy, 1,1,1-trifluoroethoxy, '\n",
      " '1,1-difluoro-2,2-difluoroethoxy, 1,1-difluoro-2-fluoroethoxy, '\n",
      " '1,1-difluoroethoxy, 1-fluoro-2,2-difluoroethoxy, 1-fluoro-2-fluoroethoxy, '\n",
      " '1-fluoroethoxy, 2,2-difluoroethoxy, 2-fluoroethoxy, n-perfluoropropoxy, and '\n",
      " 'n-perfluorobutoxy group.</p>\\n'\n",
      " '<p id=\"p-0020\" num=\"0045\">The group &#x2014;C(O)-1-4C-alkyl represents a '\n",
      " 'group which, in addition to the carbonyl group &#x2014;C(O)&#x2014;, '\n",
      " 'contains a straight-chain or branched alkyl moiety having 1 to 4 carbon '\n",
      " 'atoms. Examples are methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, '\n",
      " 'iso-propylcarbonyl, n-butylcarbonyl, iso-butylcarbonyl, sec-butylcarbonyl '\n",
      " 'and tert-butylcarbonyl.</p>\\n'\n",
      " '<p id=\"p-0021\" num=\"0046\">The group &#x2014;C(O)-1-2C-alkyl represents a '\n",
      " 'group which, in addition to the carbonyl group &#x2014;C(O)&#x2014;, '\n",
      " 'contains a straight-chain or branched alkyl moiety having 1 to 2 carbon '\n",
      " 'atoms. Examples are methylcarbonyl and ethylcarbonyl.</p>\\n'\n",
      " '<p id=\"p-0022\" num=\"0047\">The group &#x2014;C(O)-3-6C-cycloalkyl represents '\n",
      " 'a group which, in addition to the carbonyl group &#x2014;C(O)&#x2014;, '\n",
      " 'contains a cycloalkyl group having 3 to 6 carbon atoms. Examples are '\n",
      " 'cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl and '\n",
      " 'cyclohexylcarbonyl.</p>\\n'\n",
      " '<p id=\"p-0023\" num=\"0048\">The group &#x2014;C(O)&#x2014;O-1-4C-alkyl '\n",
      " 'represents a group which, in addition to the oxycarbonyl group '\n",
      " '&#x2014;C(O)&#x2014;O&#x2014;, contains a straight-chain or branched alkyl '\n",
      " 'moiety having 1 to 4 carbon atoms. Examples are methyloxycarbonyl, '\n",
      " 'ethyloxycarbonyl, n-propyloxycarbonyl, iso-propyloxycarbonyl, '\n",
      " 'n-butyloxycarbonyl, iso-butyloxycarbonyl, sec-butyloxycarbonyl and '\n",
      " 'tert-butyloxycarbonyl.</p>\\n'\n",
      " '<p id=\"p-0024\" num=\"0049\">The 4- to 7-membered saturated heterocyclic ring '\n",
      " 'containing one nitrogen atom and optionally one oxygen atom includes, but is '\n",
      " 'not limited to, azetidinyl, oxazetidinyl, pyrrolidinyl, oxazolidinyl, '\n",
      " 'piperidinyl, morpholinyl, azepanyl and oxazepanyl, in particular azetidinyl, '\n",
      " '1,3-oxazetidinyl, pyrrolidinyl, 1,3-oxazolidinyl, piperidinyl, morpholinyl, '\n",
      " 'azepanyl and 1,3-oxazepanyl, preferably azetidin-3-yl, pyrrolidin-3-yl, '\n",
      " 'morpholin-2-yl, piperidin-3-yl and piperidin-4-yl.</p>\\n'\n",
      " '<p id=\"p-0025\" num=\"0050\">The 4- to 6-membered saturated heterocyclic ring '\n",
      " 'containing one nitrogen atom and optionally one oxygen atom includes, but is '\n",
      " 'not limited to, azetidinyl, oxazetidinyl, pyrrolidinyl, oxazolidinyl, '\n",
      " 'piperidinyl and morpholinyl, in particular azetidinyl, 1,3-oxazetidinyl, '\n",
      " 'pyrrolidinyl, 1,3-oxazolidinyl, piperidinyl, morpholinyl, preferably '\n",
      " 'azetidin-3-yl, pyrrolidin-3-yl, morpholin-2-yl, piperidin-3-yl and '\n",
      " 'piperidin-4-yl.</p>\\n'\n",
      " '<p id=\"p-0026\" num=\"0051\">The 5- to 6-membered saturated heterocyclic ring '\n",
      " 'containing one nitrogen atom and optionally one oxygen atom includes, but is '\n",
      " 'not limited to, pyrrolidinyl, oxazolidinyl, piperidinyl and morpholinyl, in '\n",
      " 'particular pyrrolidinyl, 1,3-oxazolidinyl, piperidinyl, morpholinyl, '\n",
      " 'preferably pyrrolidin-3-yl, morpholin-2-yl, piperidin-3-yl and '\n",
      " 'piperidin-4-yl.</p>\\n'\n",
      " '<p id=\"p-0027\" num=\"0052\">In one embodiment, the present subject matter '\n",
      " 'relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0002\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0002-0001\" num=\"0053\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0002-0002\" num=\"0054\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0003\" num=\"0055\">R2 is hydrogen or 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0002-0004\" num=\"0056\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0002-0005\" num=\"0057\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0002-0006\" num=\"0058\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0002-0007\" num=\"0059\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0008\" num=\"0060\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0002-0009\" num=\"0061\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0002-0010\" num=\"0062\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0002-0011\" num=\"0063\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0002-0012\" num=\"0064\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0002-0013\" num=\"0065\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0002-0014\" num=\"0066\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0015\" num=\"0067\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0016\" num=\"0068\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0017\" num=\"0069\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0018\" num=\"0070\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0002-0019\" num=\"0071\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0002-0020\" num=\"0072\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0021\" num=\"0073\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0022\" num=\"0074\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0023\" num=\"0075\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0002-0024\" num=\"0076\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0002-0025\" num=\"0077\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0002-0026\" num=\"0078\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0028\" num=\"0079\">In one embodiment, the present subject matter '\n",
      " 'relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0003\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0003-0001\" num=\"0080\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl or 2-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0003-0002\" num=\"0081\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0003-0003\" num=\"0082\">R2 is hydrogen or 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0003-0004\" num=\"0083\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0003-0005\" num=\"0084\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0003-0006\" num=\"0085\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0003-0007\" num=\"0086\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0003-0008\" num=\"0087\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0003-0009\" num=\"0088\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0003-0010\" num=\"0089\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0003-0011\" num=\"0090\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0003-0012\" num=\"0091\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0003-0013\" num=\"0092\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0003-0014\" num=\"0093\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0003-0015\" num=\"0094\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0003-0016\" num=\"0095\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0003-0017\" num=\"0096\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0003-0018\" num=\"0097\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0003-0019\" num=\"0098\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0003-0020\" num=\"0099\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0003-0021\" num=\"0100\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0003-0022\" num=\"0101\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0003-0023\" num=\"0102\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0029\" num=\"0103\">In one embodiment, the present subject matter '\n",
      " 'relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0004\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0004-0001\" num=\"0104\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl or 2-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0004-0002\" num=\"0105\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0003\" num=\"0106\">R2 is hydrogen or 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0004-0004\" num=\"0107\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0004-0005\" num=\"0108\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0004-0006\" num=\"0109\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0004-0007\" num=\"0110\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0008\" num=\"0111\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0004-0009\" num=\"0112\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0004-0010\" num=\"0113\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0004-0011\" num=\"0114\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0004-0012\" num=\"0115\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0004-0013\" num=\"0116\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0004-0014\" num=\"0117\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0015\" num=\"0118\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0016\" num=\"0119\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0017\" num=\"0120\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0018\" num=\"0121\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0004-0019\" num=\"0122\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0004-0020\" num=\"0123\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0021\" num=\"0124\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0004-0022\" num=\"0125\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0030\" num=\"0126\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0005\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0005-0001\" num=\"0127\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl or 2-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0005-0002\" num=\"0128\">R2 is hydrogen or 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0005-0003\" num=\"0129\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0005-0004\" num=\"0130\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0005-0005\" num=\"0131\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0005-0006\" num=\"0132\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0005-0007\" num=\"0133\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0005-0008\" num=\"0134\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0005-0009\" num=\"0135\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0005-0010\" num=\"0136\">R3 is a 4- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5,</li>\\n'\n",
      " '    <li id=\"ul0005-0011\" num=\"0137\">or a 3-6C-cycloalkyl group substituted '\n",
      " 'by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0005-0012\" num=\"0138\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0005-0013\" num=\"0139\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0005-0014\" num=\"0140\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0005-0015\" num=\"0141\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0005-0016\" num=\"0142\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0005-0017\" num=\"0143\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0005-0018\" num=\"0144\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0005-0019\" num=\"0145\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0005-0020\" num=\"0146\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0031\" num=\"0147\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0006\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0006-0001\" num=\"0148\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl or 2-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0006-0002\" num=\"0149\">R2 is hydrogen or 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0006-0003\" num=\"0150\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0006-0004\" num=\"0151\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0006-0005\" num=\"0152\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0006-0006\" num=\"0153\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0006-0007\" num=\"0154\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0006-0008\" num=\"0155\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0006-0009\" num=\"0156\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0006-0010\" num=\"0157\">R3 is a 4- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0006-0011\" num=\"0158\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0006-0012\" num=\"0159\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0006-0013\" num=\"0160\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0006-0014\" num=\"0161\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0006-0015\" num=\"0162\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0006-0016\" num=\"0163\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0006-0017\" num=\"0164\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0006-0018\" num=\"0165\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0032\" num=\"0166\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0007\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0007-0001\" num=\"0167\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl or 2-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0007-0002\" num=\"0168\">R2 is hydrogen or 1-4C-alkyl R21 is '\n",
      " 'hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0007-0003\" num=\"0169\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0007-0004\" num=\"0170\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0007-0005\" num=\"0171\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0007-0006\" num=\"0172\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0007-0007\" num=\"0173\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0007-0008\" num=\"0174\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0007-0009\" num=\"0175\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0007-0010\" num=\"0176\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0007-0011\" num=\"0177\">R41 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0007-0012\" num=\"0178\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0007-0013\" num=\"0179\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0007-0014\" num=\"0180\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0007-0015\" num=\"0181\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0007-0016\" num=\"0182\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0033\" num=\"0183\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0008\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0008-0001\" num=\"0184\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl or 2-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0008-0002\" num=\"0185\">R2 is hydrogen or 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0008-0003\" num=\"0186\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0008-0004\" num=\"0187\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0008-0005\" num=\"0188\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0008-0006\" num=\"0189\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0008-0007\" num=\"0190\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0008-0008\" num=\"0191\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0008-0009\" num=\"0192\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0008-0010\" num=\"0193\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0008-0011\" num=\"0194\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0008-0012\" num=\"0195\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0008-0013\" num=\"0196\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0008-0014\" num=\"0197\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy, halogen or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0008-0015\" num=\"0198\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0008-0016\" num=\"0199\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0034\" num=\"0200\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0009\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0009-0001\" num=\"0201\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0009-0002\" num=\"0202\">R2 is hydrogen or methyl</li>\\n'\n",
      " '    <li id=\"ul0009-0003\" num=\"0203\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0009-0004\" num=\"0204\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-2C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-2C-alkyl or '\n",
      " '1-2C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0009-0005\" num=\"0205\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0009-0006\" num=\"0206\">R23 is hydrogen, halogen, '\n",
      " '1-2C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0009-0007\" num=\"0207\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0009-0008\" num=\"0208\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0009-0009\" num=\"0209\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0009-0010\" num=\"0210\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one or '\n",
      " 'two substituents R5 at said heterocyclic ring, or a cyclohexyl or '\n",
      " 'cyclopentyl group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0009-0011\" num=\"0211\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0009-0012\" num=\"0212\">R41 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0009-0013\" num=\"0213\">R5 is fluoro, methyl, or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from fluoro or methyl or together with the '\n",
      " 'carbon atom, to which they are bonded, form a spiro-linked cyclopropane '\n",
      " 'ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0009-0014\" num=\"0214\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0009-0015\" num=\"0215\">R61 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0009-0016\" num=\"0216\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0009-0017\" num=\"0217\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0035\" num=\"0218\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0010\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0010-0001\" num=\"0219\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0010-0002\" num=\"0220\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0010-0003\" num=\"0221\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0010-0004\" num=\"0222\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-2C-alkoxy 1-4C-fluoroalkoxy, &#x2014;C(O)-1-2C-alkyl or '\n",
      " '1-2C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0010-0005\" num=\"0223\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0010-0006\" num=\"0224\">R23 is hydrogen, halogen, '\n",
      " '1-2C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0010-0007\" num=\"0225\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0010-0008\" num=\"0226\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0010-0009\" num=\"0227\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0010-0010\" num=\"0228\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0010-0011\" num=\"0229\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0010-0012\" num=\"0230\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0010-0013\" num=\"0231\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0010-0014\" num=\"0232\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0010-0015\" num=\"0233\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0036\" num=\"0234\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0011\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0011-0001\" num=\"0235\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0011-0002\" num=\"0236\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0011-0003\" num=\"0237\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0011-0004\" num=\"0238\">R22 is hydrogen, fluoro, methy, ethyl, '\n",
      " 'isopropyl, methoxy, &#x2014;C(O)-methyl, fluoromethyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0011-0005\" num=\"0239\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0011-0006\" num=\"0240\">R23 is hydrogen, fluoro, or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0011-0007\" num=\"0241\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0011-0008\" num=\"0242\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0011-0009\" num=\"0243\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0011-0010\" num=\"0244\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0011-0011\" num=\"0245\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0011-0012\" num=\"0246\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0011-0013\" num=\"0247\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0011-0014\" num=\"0248\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0011-0015\" num=\"0249\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0037\" num=\"0250\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I),\\n'\n",
      " '<ul id=\"ul0012\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0012-0001\" num=\"0000\">\\n'\n",
      " '    <ul id=\"ul0013\" list-style=\"none\">\\n'\n",
      " '        <li id=\"ul0013-0001\" num=\"0251\">wherein</li>\\n'\n",
      " '    </ul>\\n'\n",
      " '    </li>\\n'\n",
      " '    <li id=\"ul0012-0002\" num=\"0252\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0012-0003\" num=\"0253\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0012-0004\" num=\"0254\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0012-0005\" num=\"0255\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0012-0006\" num=\"0256\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0012-0007\" num=\"0257\">R23 is hydrogen, halogen, 1-4C-alkyl or '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0012-0008\" num=\"0258\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0012-0009\" num=\"0259\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0012-0010\" num=\"0260\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0012-0011\" num=\"0261\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one substituent R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0012-0012\" num=\"0262\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0012-0013\" num=\"0263\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0012-0014\" num=\"0264\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0012-0015\" num=\"0265\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0012-0016\" num=\"0266\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0012-0017\" num=\"0267\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0012-0018\" num=\"0268\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0012-0019\" num=\"0269\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0012-0020\" num=\"0270\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0038\" num=\"0271\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I),\\n'\n",
      " '<ul id=\"ul0014\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0014-0001\" num=\"0000\">\\n'\n",
      " '    <ul id=\"ul0015\" list-style=\"none\">\\n'\n",
      " '        <li id=\"ul0015-0001\" num=\"0272\">wherein</li>\\n'\n",
      " '    </ul>\\n'\n",
      " '    </li>\\n'\n",
      " '    <li id=\"ul0014-0002\" num=\"0273\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0014-0003\" num=\"0274\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0014-0004\" num=\"0275\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0014-0005\" num=\"0276\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0014-0006\" num=\"0277\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0014-0007\" num=\"0278\">R23 is hydrogen, halogen or '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0014-0008\" num=\"0279\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0014-0009\" num=\"0280\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0014-0010\" num=\"0281\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0014-0011\" num=\"0282\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one substituent R5, or a '\n",
      " '5-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0014-0012\" num=\"0283\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0014-0013\" num=\"0284\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0014-0014\" num=\"0285\">R5 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0014-0015\" num=\"0286\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0014-0016\" num=\"0287\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0014-0017\" num=\"0288\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0014-0018\" num=\"0289\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0039\" num=\"0290\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I),\\n'\n",
      " '<ul id=\"ul0016\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0016-0001\" num=\"0000\">\\n'\n",
      " '    <ul id=\"ul0017\" list-style=\"none\">\\n'\n",
      " '        <li id=\"ul0017-0001\" num=\"0291\">wherein</li>\\n'\n",
      " '    </ul>\\n'\n",
      " '    </li>\\n'\n",
      " '    <li id=\"ul0016-0002\" num=\"0292\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0016-0003\" num=\"0293\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0016-0004\" num=\"0294\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0016-0005\" num=\"0295\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0016-0006\" num=\"0296\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O-Oft-O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0016-0007\" num=\"0297\">R23 is hydrogen, halogen or '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0016-0008\" num=\"0298\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0016-0009\" num=\"0299\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0016-0010\" num=\"0300\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0016-0011\" num=\"0301\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one substituent R5, or a '\n",
      " '5-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0016-0012\" num=\"0302\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0016-0013\" num=\"0303\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0016-0014\" num=\"0304\">R5 is halogen, hydroxy or '\n",
      " '1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0016-0015\" num=\"0305\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0016-0016\" num=\"0306\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0016-0017\" num=\"0307\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0016-0018\" num=\"0308\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0040\" num=\"0309\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0018\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0018-0001\" num=\"0310\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0018-0002\" num=\"0311\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0018-0003\" num=\"0312\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0018-0004\" num=\"0313\">R22 is hydrogen, fluoro, methyl, '\n",
      " 'methoxy, &#x2014;C(O)-methyl, difluoromethyl or trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0018-0005\" num=\"0314\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0018-0006\" num=\"0315\">R23 is hydrogen, fluoro or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0018-0007\" num=\"0316\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0018-0008\" num=\"0317\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0018-0009\" num=\"0318\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0018-0010\" num=\"0319\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one '\n",
      " 'substituent R5 at said heterocyclic ring, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0018-0011\" num=\"0320\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0018-0012\" num=\"0321\">R5 is fluoro, hydroxy or methyl,</li>\\n'\n",
      " '    <li id=\"ul0018-0013\" num=\"0322\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0018-0014\" num=\"0323\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0018-0015\" num=\"0324\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0018-0016\" num=\"0325\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0041\" num=\"0326\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I),\\n'\n",
      " '<ul id=\"ul0019\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0019-0001\" num=\"0000\">\\n'\n",
      " '    <ul id=\"ul0020\" list-style=\"none\">\\n'\n",
      " '        <li id=\"ul0020-0001\" num=\"0327\">wherein</li>\\n'\n",
      " '    </ul>\\n'\n",
      " '    </li>\\n'\n",
      " '    <li id=\"ul0019-0002\" num=\"0328\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0019-0003\" num=\"0329\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0019-0004\" num=\"0330\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0019-0005\" num=\"0331\">R22 is hydrogen, fluoro, methyl, '\n",
      " 'methoxy, &#x2014;C(O)-methyl, difluoromethyl or trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0019-0006\" num=\"0332\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0019-0007\" num=\"0333\">R23 is hydrogen, fluoro or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0019-0008\" num=\"0334\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0019-0009\" num=\"0335\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0019-0010\" num=\"0336\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0019-0011\" num=\"0337\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one '\n",
      " 'substituent R5 at said heterocyclic ring, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0019-0012\" num=\"0338\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0019-0013\" num=\"0339\">R41 is methoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0019-0014\" num=\"0340\">R5 is fluoro, hydroxy or methyl,</li>\\n'\n",
      " '    <li id=\"ul0019-0015\" num=\"0341\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0019-0016\" num=\"0342\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0019-0017\" num=\"0343\">R7 is methyl or ethyl, which are '\n",
      " 'optionally substituted by R71, or ethoxy,</li>\\n'\n",
      " '    <li id=\"ul0019-0018\" num=\"0344\">R71 is methoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0042\" num=\"0345\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0021\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0021-0001\" num=\"0346\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0021-0002\" num=\"0347\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0021-0003\" num=\"0348\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0021-0004\" num=\"0349\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0021-0005\" num=\"0350\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0021-0006\" num=\"0351\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0021-0007\" num=\"0352\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0021-0008\" num=\"0353\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0021-0009\" num=\"0354\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0021-0010\" num=\"0355\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0021-0011\" num=\"0356\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0021-0012\" num=\"0357\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0021-0013\" num=\"0358\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0021-0014\" num=\"0359\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0021-0015\" num=\"0360\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0021-0016\" num=\"0361\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0021-0017\" num=\"0362\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0021-0018\" num=\"0363\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0021-0019\" num=\"0364\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0021-0020\" num=\"0365\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0021-0021\" num=\"0366\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0021-0022\" num=\"0367\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0021-0023\" num=\"0368\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0021-0024\" num=\"0369\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0021-0025\" num=\"0370\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0043\" num=\"0371\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0022\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0022-0001\" num=\"0372\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0022-0002\" num=\"0373\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0022-0003\" num=\"0374\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0022-0004\" num=\"0375\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0022-0005\" num=\"0376\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0022-0006\" num=\"0377\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0022-0007\" num=\"0378\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0022-0008\" num=\"0379\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0022-0009\" num=\"0380\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0022-0010\" num=\"0381\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0022-0011\" num=\"0382\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0022-0012\" num=\"0383\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0022-0013\" num=\"0384\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0022-0014\" num=\"0385\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0022-0015\" num=\"0386\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0022-0016\" num=\"0387\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0022-0017\" num=\"0388\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0022-0018\" num=\"0389\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0022-0019\" num=\"0390\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0022-0020\" num=\"0391\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0044\" num=\"0392\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0023\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0023-0001\" num=\"0393\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0023-0002\" num=\"0394\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0023-0003\" num=\"0395\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0023-0004\" num=\"0396\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0023-0005\" num=\"0397\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0023-0006\" num=\"0398\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0023-0007\" num=\"0399\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0023-0008\" num=\"0400\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0023-0009\" num=\"0401\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0023-0010\" num=\"0402\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0023-0011\" num=\"0403\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0023-0012\" num=\"0404\">or &#x2014;C(O)&#x2014;O-1-4C-alkyl, '\n",
      " 'wherein the 1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0023-0013\" num=\"0405\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0023-0014\" num=\"0406\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0023-0015\" num=\"0407\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0023-0016\" num=\"0408\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0023-0017\" num=\"0409\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0023-0018\" num=\"0410\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0023-0019\" num=\"0411\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0023-0020\" num=\"0412\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0045\" num=\"0413\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0024\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0024-0001\" num=\"0414\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0024-0002\" num=\"0415\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0024-0003\" num=\"0416\">R21 is hydrogen or halogen,</li>\\n'\n",
      " '    <li id=\"ul0024-0004\" num=\"0417\">R22 is hydrogen, halogen, 1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0024-0005\" num=\"0418\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0024-0006\" num=\"0419\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0024-0007\" num=\"0420\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0024-0008\" num=\"0421\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0024-0009\" num=\"0422\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0024-0010\" num=\"0423\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0024-0011\" num=\"0424\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0024-0012\" num=\"0425\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0024-0013\" num=\"0426\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0024-0014\" num=\"0427\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0024-0015\" num=\"0428\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0024-0016\" num=\"0429\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0024-0017\" num=\"0430\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0024-0018\" num=\"0431\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0046\" num=\"0432\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0025\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0025-0001\" num=\"0433\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0025-0002\" num=\"0434\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0025-0003\" num=\"0435\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0025-0004\" num=\"0436\">R22 is hydrogen, halogen, 1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0025-0005\" num=\"0437\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0025-0006\" num=\"0438\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0025-0007\" num=\"0439\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0025-0008\" num=\"0440\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0025-0009\" num=\"0441\">R3 is a 4- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0025-0010\" num=\"0442\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0025-0011\" num=\"0443\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0025-0012\" num=\"0444\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0025-0013\" num=\"0445\">R5 is methoxy, fluoro, methyl or '\n",
      " 'hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from fluoro or methyl or together with the '\n",
      " 'carbon atom, to which they are bonded, form a spiro-linked cyclopropane '\n",
      " 'ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0025-0014\" num=\"0446\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0025-0015\" num=\"0447\">R61 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0025-0016\" num=\"0448\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0025-0017\" num=\"0449\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0025-0018\" num=\"0450\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0047\" num=\"0451\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0026\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0026-0001\" num=\"0452\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0026-0002\" num=\"0453\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0026-0003\" num=\"0454\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0026-0004\" num=\"0455\">R22 is hydrogen, halogen, 1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0026-0005\" num=\"0456\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0026-0006\" num=\"0457\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0026-0007\" num=\"0458\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0026-0008\" num=\"0459\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0026-0009\" num=\"0460\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " 'cyclohexyl or cyclopentyl group substituted by R6 and optionally substituted '\n",
      " 'by R61,</li>\\n'\n",
      " '    <li id=\"ul0026-0010\" num=\"0461\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0026-0011\" num=\"0462\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0026-0012\" num=\"0463\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0026-0013\" num=\"0464\">R5 is methoxy, fluoro, methyl or '\n",
      " 'hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from fluoro or methyl or together with the '\n",
      " 'carbon atom, to which they are bonded, form a spiro-linked cyclopropane '\n",
      " 'ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0026-0014\" num=\"0465\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0026-0015\" num=\"0466\">R61 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0026-0016\" num=\"0467\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0026-0017\" num=\"0468\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0026-0018\" num=\"0469\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0048\" num=\"0470\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0027\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0027-0001\" num=\"0471\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0027-0002\" num=\"0472\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0027-0003\" num=\"0473\">R21 is hydrogen or fluoro,</li>\\n'\n",
      " '    <li id=\"ul0027-0004\" num=\"0474\">R22 is hydrogen, halogen, 1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0027-0005\" num=\"0475\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0027-0006\" num=\"0476\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0027-0007\" num=\"0477\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0027-0008\" num=\"0478\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0027-0009\" num=\"0479\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0027-0010\" num=\"0480\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0027-0011\" num=\"0481\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0027-0012\" num=\"0482\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0027-0013\" num=\"0483\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0027-0014\" num=\"0484\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0027-0015\" num=\"0485\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0027-0016\" num=\"0486\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0049\" num=\"0487\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0028\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0028-0001\" num=\"0488\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0028-0002\" num=\"0489\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0028-0003\" num=\"0490\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0028-0004\" num=\"0491\">R22 is hydrogen, fluoro, methyl, ethyl, '\n",
      " 'isopropyl, fluoromethyl, difluoromethyl or trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0028-0005\" num=\"0492\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0028-0006\" num=\"0493\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0028-0007\" num=\"0494\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0028-0008\" num=\"0495\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0028-0009\" num=\"0496\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one or '\n",
      " 'two substituents R5 at said heterocyclic ring, or a cyclohexyl or '\n",
      " 'cyclopentyl group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0028-0010\" num=\"0497\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0028-0011\" num=\"0498\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0028-0012\" num=\"0499\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0028-0013\" num=\"0500\">R5 is methoxy, fluoro, methyl or '\n",
      " 'hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from fluoro or methyl or together with the '\n",
      " 'carbon atom, to which they are bonded, form a spiro-linked cyclopropane '\n",
      " 'ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0028-0014\" num=\"0501\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0028-0015\" num=\"0502\">R61 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0028-0016\" num=\"0503\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0028-0017\" num=\"0504\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0028-0018\" num=\"0505\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0050\" num=\"0506\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0029\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0029-0001\" num=\"0507\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0029-0002\" num=\"0508\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0029-0003\" num=\"0509\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0029-0004\" num=\"0510\">R22 is halogen, 1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0029-0005\" num=\"0511\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0029-0006\" num=\"0512\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0029-0007\" num=\"0513\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0029-0008\" num=\"0514\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0029-0009\" num=\"0515\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one substituent R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0029-0010\" num=\"0516\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0029-0011\" num=\"0517\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0029-0012\" num=\"0518\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0029-0013\" num=\"0519\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0029-0014\" num=\"0520\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0029-0015\" num=\"0521\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0029-0016\" num=\"0522\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0029-0017\" num=\"0523\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0029-0018\" num=\"0524\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0029-0019\" num=\"0525\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0029-0020\" num=\"0526\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0051\" num=\"0527\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0030\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0030-0001\" num=\"0528\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0030-0002\" num=\"0529\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0030-0003\" num=\"0530\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0030-0004\" num=\"0531\">R22 is halogen, 1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0030-0005\" num=\"0532\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0030-0006\" num=\"0533\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0030-0007\" num=\"0534\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0030-0008\" num=\"0535\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0030-0009\" num=\"0536\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one substituent R5, or a '\n",
      " '5-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0030-0010\" num=\"0537\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0030-0011\" num=\"0538\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0030-0012\" num=\"0539\">R5 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0030-0013\" num=\"0540\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0030-0014\" num=\"0541\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0030-0015\" num=\"0542\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0030-0016\" num=\"0543\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0052\" num=\"0544\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0031\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0031-0001\" num=\"0545\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0031-0002\" num=\"0546\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0031-0003\" num=\"0547\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0031-0004\" num=\"0548\">R22 is halogen, 1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0031-0005\" num=\"0549\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0031-0006\" num=\"0550\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0031-0007\" num=\"0551\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0031-0008\" num=\"0552\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0031-0009\" num=\"0553\">R3 is a 5-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0031-0010\" num=\"0554\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0031-0011\" num=\"0555\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0031-0012\" num=\"0556\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0031-0013\" num=\"0557\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0053\" num=\"0558\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0032\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0032-0001\" num=\"0559\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0032-0002\" num=\"0560\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0032-0003\" num=\"0561\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0032-0004\" num=\"0562\">R22 is fluoro, methyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0032-0005\" num=\"0563\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0032-0006\" num=\"0564\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0032-0007\" num=\"0565\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0032-0008\" num=\"0566\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0032-0009\" num=\"0567\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one '\n",
      " 'substituent R5 at said heterocyclic ring, or a 5-6C-cycloalkyl group '\n",
      " 'substituted by</li>\\n'\n",
      " '    <li id=\"ul0032-0010\" num=\"0568\">R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0032-0011\" num=\"0569\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0032-0012\" num=\"0570\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0032-0013\" num=\"0571\">R5 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0032-0014\" num=\"0572\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0032-0015\" num=\"0573\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0032-0016\" num=\"0574\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0032-0017\" num=\"0575\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0054\" num=\"0576\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0033\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0033-0001\" num=\"0577\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0033-0002\" num=\"0578\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0033-0003\" num=\"0579\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0033-0004\" num=\"0580\">R22 is fluoro, methyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0033-0005\" num=\"0581\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0033-0006\" num=\"0582\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0033-0007\" num=\"0583\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0033-0008\" num=\"0584\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0033-0009\" num=\"0585\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one '\n",
      " 'substituent R5 at said heterocyclic ring, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0033-0010\" num=\"0586\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0033-0011\" num=\"0587\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0033-0012\" num=\"0588\">R5 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0033-0013\" num=\"0589\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0033-0014\" num=\"0590\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0033-0015\" num=\"0591\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0033-0016\" num=\"0592\">R71 is 1-4C-alkoxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0055\" num=\"0593\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0034\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0034-0001\" num=\"0594\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0034-0002\" num=\"0595\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0034-0003\" num=\"0596\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0034-0004\" num=\"0597\">R22 is fluoro, methyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0034-0005\" num=\"0598\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0034-0006\" num=\"0599\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0034-0007\" num=\"0600\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0034-0008\" num=\"0601\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0034-0009\" num=\"0602\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one '\n",
      " 'substituent R5 at said heterocyclic ring, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0034-0010\" num=\"0603\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0034-0011\" num=\"0604\">R41 is 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0034-0012\" num=\"0605\">R5 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0034-0013\" num=\"0606\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0034-0014\" num=\"0607\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0034-0015\" num=\"0608\">R7 is methyl or ethyl, which are '\n",
      " 'optionally substituted by R71, or ethoxy,</li>\\n'\n",
      " '    <li id=\"ul0034-0016\" num=\"0609\">R71 is methoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0056\" num=\"0610\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0035\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0035-0001\" num=\"0611\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0035-0002\" num=\"0612\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0035-0003\" num=\"0613\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0035-0004\" num=\"0614\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0035-0005\" num=\"0615\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0035-0006\" num=\"0616\">R23 is hydrogen, halogen, 1-4C-alkoxy, '\n",
      " 'hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0035-0007\" num=\"0617\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0035-0008\" num=\"0618\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0035-0009\" num=\"0619\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0035-0010\" num=\"0620\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0035-0011\" num=\"0621\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0035-0012\" num=\"0622\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0035-0013\" num=\"0623\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0035-0014\" num=\"0624\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0035-0015\" num=\"0625\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0035-0016\" num=\"0626\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0035-0017\" num=\"0627\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0035-0018\" num=\"0628\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0035-0019\" num=\"0629\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0035-0020\" num=\"0630\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0035-0021\" num=\"0631\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0035-0022\" num=\"0632\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0035-0023\" num=\"0633\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0035-0024\" num=\"0634\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0057\" num=\"0635\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0036\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0036-0001\" num=\"0636\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0036-0002\" num=\"0637\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0036-0003\" num=\"0638\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0036-0004\" num=\"0639\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0036-0005\" num=\"0640\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0036-0006\" num=\"0641\">R23 is hydrogen, halogen, 1-4C-alkoxy, '\n",
      " 'hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0036-0007\" num=\"0642\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0036-0008\" num=\"0643\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0036-0009\" num=\"0644\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0036-0010\" num=\"0645\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0036-0011\" num=\"0646\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0036-0012\" num=\"0647\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0036-0013\" num=\"0648\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0036-0014\" num=\"0649\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0036-0015\" num=\"0650\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0036-0016\" num=\"0651\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0036-0017\" num=\"0652\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0036-0018\" num=\"0653\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0036-0019\" num=\"0654\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0058\" num=\"0655\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0037\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0037-0001\" num=\"0656\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0037-0002\" num=\"0657\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0037-0003\" num=\"0658\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0037-0004\" num=\"0659\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0037-0005\" num=\"0660\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0037-0006\" num=\"0661\">R23 is hydrogen, halogen, 1-4C-alkoxy, '\n",
      " 'hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0037-0007\" num=\"0662\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0037-0008\" num=\"0663\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0037-0009\" num=\"0664\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0037-0010\" num=\"0665\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0037-0011\" num=\"0666\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0037-0012\" num=\"0667\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0037-0013\" num=\"0668\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0037-0014\" num=\"0669\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0037-0015\" num=\"0670\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0037-0016\" num=\"0671\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0037-0017\" num=\"0672\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0037-0018\" num=\"0673\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0059\" num=\"0674\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0038\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0038-0001\" num=\"0675\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0038-0002\" num=\"0676\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0038-0003\" num=\"0677\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0038-0004\" num=\"0678\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0038-0005\" num=\"0679\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0038-0006\" num=\"0680\">R23 is hydrogen, halogen or '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0038-0007\" num=\"0681\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0038-0008\" num=\"0682\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0038-0009\" num=\"0683\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0038-0010\" num=\"0684\">R3 is a 4- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0038-0011\" num=\"0685\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0038-0012\" num=\"0686\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0038-0013\" num=\"0687\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0038-0014\" num=\"0688\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0038-0015\" num=\"0689\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0038-0016\" num=\"0690\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0038-0017\" num=\"0691\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0060\" num=\"0692\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0039\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0039-0001\" num=\"0693\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0039-0002\" num=\"0694\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0039-0003\" num=\"0695\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0039-0004\" num=\"0696\">R22 is hydrogen, fluoro, methyl, ethyl, '\n",
      " 'isopropyl, methoxy, ethoxy, &#x2014;C(O)-1-2C-alkyl, fluoromethyl, '\n",
      " 'difluoromethyl or trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0039-0005\" num=\"0697\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0039-0006\" num=\"0698\">R23 is hydrogen, fluoro or methoxy</li>\\n'\n",
      " '    <li id=\"ul0039-0007\" num=\"0699\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0039-0008\" num=\"0700\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0039-0009\" num=\"0701\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0039-0010\" num=\"0702\">R3 is a 4- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0039-0011\" num=\"0703\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0039-0012\" num=\"0704\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0039-0013\" num=\"0705\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0039-0014\" num=\"0706\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0039-0015\" num=\"0707\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0039-0016\" num=\"0708\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0039-0017\" num=\"0709\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0061\" num=\"0710\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0040\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0040-0001\" num=\"0711\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0040-0002\" num=\"0712\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0040-0003\" num=\"0713\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0040-0004\" num=\"0714\">R22 is hydrogen, fluoro, methyl or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0005\" num=\"0715\">R23 is hydrogen, fluoro or methoxy</li>\\n'\n",
      " '    <li id=\"ul0040-0006\" num=\"0716\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0040-0007\" num=\"0717\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0040-0008\" num=\"0718\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0040-0009\" num=\"0719\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0040-0010\" num=\"0720\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0040-0011\" num=\"0721\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0012\" num=\"0722\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0013\" num=\"0723\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0014\" num=\"0724\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0040-0015\" num=\"0725\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0040-0016\" num=\"0726\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0017\" num=\"0727\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0018\" num=\"0728\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0019\" num=\"0729\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0040-0020\" num=\"0730\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0040-0021\" num=\"0731\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0040-0022\" num=\"0732\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0062\" num=\"0733\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0041\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0041-0001\" num=\"0734\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0041-0002\" num=\"0735\">R2 is hydrogen or methyl,</li>\\n'\n",
      " '    <li id=\"ul0041-0003\" num=\"0736\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0041-0004\" num=\"0737\">R22 is hydrogen, fluoro, methyl or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0041-0005\" num=\"0738\">R23 is hydrogen, fluoro or methoxy</li>\\n'\n",
      " '    <li id=\"ul0041-0006\" num=\"0739\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0041-0007\" num=\"0740\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0041-0008\" num=\"0741\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0041-0009\" num=\"0742\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0041-0010\" num=\"0743\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0041-0011\" num=\"0744\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0041-0012\" num=\"0745\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0041-0013\" num=\"0746\">R5 is methoxy, fluoro, methyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0041-0014\" num=\"0747\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0041-0015\" num=\"0748\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0041-0016\" num=\"0749\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0041-0017\" num=\"0750\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0063\" num=\"0751\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0042\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0042-0001\" num=\"0752\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0042-0002\" num=\"0753\">R2 is hydrogen or methyl,</li>\\n'\n",
      " '    <li id=\"ul0042-0003\" num=\"0754\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0042-0004\" num=\"0755\">R22 is hydrogen, fluoro, methyl or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0042-0005\" num=\"0756\">R23 is hydrogen, fluoro or methoxy</li>\\n'\n",
      " '    <li id=\"ul0042-0006\" num=\"0757\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0042-0007\" num=\"0758\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0042-0008\" num=\"0759\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0042-0009\" num=\"0760\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0042-0010\" num=\"0761\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0042-0011\" num=\"0762\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0042-0012\" num=\"0763\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0042-0013\" num=\"0764\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0042-0014\" num=\"0765\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0042-0015\" num=\"0766\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0042-0016\" num=\"0767\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0064\" num=\"0768\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0043\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0043-0001\" num=\"0769\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0043-0002\" num=\"0770\">R2 is hydrogen</li>\\n'\n",
      " '    <li id=\"ul0043-0003\" num=\"0771\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0043-0004\" num=\"0772\">R22 is hydrogen, fluoro, methyl or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0043-0005\" num=\"0773\">R23 is hydrogen, fluoro or methoxy</li>\\n'\n",
      " '    <li id=\"ul0043-0006\" num=\"0774\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0043-0007\" num=\"0775\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0043-0008\" num=\"0776\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0043-0009\" num=\"0777\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one or '\n",
      " 'two substituents R5 at said heterocyclic ring, or a cyclohexyl or '\n",
      " 'cyclopentyl group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0043-0010\" num=\"0778\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0043-0011\" num=\"0779\">R41 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0043-0012\" num=\"0780\">R5 is fluoro, methyl or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from fluoro or methyl or together with the '\n",
      " 'carbon atom, to which they are bonded, form a spiro-linked cyclopropane '\n",
      " 'ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0043-0013\" num=\"0781\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0043-0014\" num=\"0782\">R61 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0043-0015\" num=\"0783\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0043-0016\" num=\"0784\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0065\" num=\"0785\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0044\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0044-0001\" num=\"0786\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0044-0002\" num=\"0787\">R2 is hydrogen</li>\\n'\n",
      " '    <li id=\"ul0044-0003\" num=\"0788\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0044-0004\" num=\"0789\">R22 is hydrogen, fluoro, methyl or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0044-0005\" num=\"0790\">R23 is hydrogen, fluoro or methoxy</li>\\n'\n",
      " '    <li id=\"ul0044-0006\" num=\"0791\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0044-0007\" num=\"0792\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0044-0008\" num=\"0793\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0044-0009\" num=\"0794\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one '\n",
      " 'substituent R5 at said heterocyclic ring, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0044-0010\" num=\"0795\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0044-0011\" num=\"0796\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0044-0012\" num=\"0797\">R5 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0044-0013\" num=\"0798\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0044-0014\" num=\"0799\">R61 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0044-0015\" num=\"0800\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0044-0016\" num=\"0801\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0066\" num=\"0802\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0045\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0045-0001\" num=\"0803\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0045-0002\" num=\"0804\">R2 is hydrogen</li>\\n'\n",
      " '    <li id=\"ul0045-0003\" num=\"0805\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0045-0004\" num=\"0806\">R22 is hydrogen, fluoro, methyl or '\n",
      " 'methoxy,</li>\\n'\n",
      " '    <li id=\"ul0045-0005\" num=\"0807\">R23 is hydrogen, fluoro or methoxy</li>\\n'\n",
      " '    <li id=\"ul0045-0006\" num=\"0808\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0045-0007\" num=\"0809\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0045-0008\" num=\"0810\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0045-0009\" num=\"0811\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and optionally substituted by one '\n",
      " 'substituent R5 at said heterocyclic ring, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0045-0010\" num=\"0812\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0045-0011\" num=\"0813\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0045-0012\" num=\"0814\">R5 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0045-0013\" num=\"0815\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0045-0014\" num=\"0816\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0045-0015\" num=\"0817\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0045-0016\" num=\"0818\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0067\" num=\"0819\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0046\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0046-0001\" num=\"0820\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0046-0002\" num=\"0821\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0046-0003\" num=\"0822\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0046-0004\" num=\"0823\">R22 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0046-0005\" num=\"0824\">R23 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0046-0006\" num=\"0825\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0046-0007\" num=\"0826\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0046-0008\" num=\"0827\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0046-0009\" num=\"0828\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0046-0010\" num=\"0829\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0046-0011\" num=\"0830\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0012\" num=\"0831\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0013\" num=\"0832\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0014\" num=\"0833\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0015\" num=\"0834\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0046-0016\" num=\"0835\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0046-0017\" num=\"0836\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0018\" num=\"0837\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0019\" num=\"0838\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0020\" num=\"0839\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0046-0021\" num=\"0840\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0046-0022\" num=\"0841\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0046-0023\" num=\"0842\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0068\" num=\"0843\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0047\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0047-0001\" num=\"0844\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0047-0002\" num=\"0845\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0047-0003\" num=\"0846\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0047-0004\" num=\"0847\">R22 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0047-0005\" num=\"0848\">R23 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0047-0006\" num=\"0849\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0047-0007\" num=\"0850\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0047-0008\" num=\"0851\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0047-0009\" num=\"0852\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0047-0010\" num=\"0853\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0047-0011\" num=\"0854\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0047-0012\" num=\"0855\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0047-0013\" num=\"0856\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0047-0014\" num=\"0857\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0047-0015\" num=\"0858\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0047-0016\" num=\"0859\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0047-0017\" num=\"0860\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0069\" num=\"0861\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0048\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0048-0001\" num=\"0862\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0048-0002\" num=\"0863\">R2 is hydrogen or methyl,</li>\\n'\n",
      " '    <li id=\"ul0048-0003\" num=\"0864\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0048-0004\" num=\"0865\">R22 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0048-0005\" num=\"0866\">R23 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0048-0006\" num=\"0867\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0048-0007\" num=\"0868\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0048-0008\" num=\"0869\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0048-0009\" num=\"0870\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0048-0010\" num=\"0871\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0048-0011\" num=\"0872\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0048-0012\" num=\"0873\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0048-0013\" num=\"0874\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0048-0014\" num=\"0875\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0048-0015\" num=\"0876\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0048-0016\" num=\"0877\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0070\" num=\"0878\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0049\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0049-0001\" num=\"0879\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0049-0002\" num=\"0880\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0049-0003\" num=\"0881\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0049-0004\" num=\"0882\">R22 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0049-0005\" num=\"0883\">R23 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0049-0006\" num=\"0884\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0049-0007\" num=\"0885\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0049-0008\" num=\"0886\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0049-0009\" num=\"0887\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0049-0010\" num=\"0888\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0049-0011\" num=\"0889\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0049-0012\" num=\"0890\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0049-0013\" num=\"0891\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'fluoro, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0049-0014\" num=\"0892\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0049-0015\" num=\"0893\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0049-0016\" num=\"0894\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0071\" num=\"0895\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0050\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0050-0001\" num=\"0896\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0050-0002\" num=\"0897\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0050-0003\" num=\"0898\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0050-0004\" num=\"0899\">R22 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0050-0005\" num=\"0900\">R23 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0050-0006\" num=\"0901\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0050-0007\" num=\"0902\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0050-0008\" num=\"0903\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0050-0009\" num=\"0904\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0050-0010\" num=\"0905\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0050-0011\" num=\"0906\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0050-0012\" num=\"0907\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0050-0013\" num=\"0908\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71,</li>\\n'\n",
      " '    <li id=\"ul0050-0014\" num=\"0909\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0072\" num=\"0910\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0051\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0051-0001\" num=\"0911\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0051-0002\" num=\"0912\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0051-0003\" num=\"0913\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0051-0004\" num=\"0914\">R22 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0051-0005\" num=\"0915\">R23 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0051-0006\" num=\"0916\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0051-0007\" num=\"0917\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0051-0008\" num=\"0918\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0051-0009\" num=\"0919\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0051-0010\" num=\"0920\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0051-0011\" num=\"0921\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0051-0012\" num=\"0922\">R5 is hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0051-0013\" num=\"0923\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0051-0014\" num=\"0924\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71,</li>\\n'\n",
      " '    <li id=\"ul0051-0015\" num=\"0925\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0073\" num=\"0926\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0052\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0052-0001\" num=\"0927\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0052-0002\" num=\"0928\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0052-0003\" num=\"0929\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0052-0004\" num=\"0930\">R22 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0052-0005\" num=\"0931\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0052-0006\" num=\"0932\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0052-0007\" num=\"0933\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0052-0008\" num=\"0934\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0052-0009\" num=\"0935\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0052-0010\" num=\"0936\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0052-0011\" num=\"0937\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0052-0012\" num=\"0938\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0052-0013\" num=\"0939\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0052-0014\" num=\"0940\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0052-0015\" num=\"0941\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0052-0016\" num=\"0942\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0052-0017\" num=\"0943\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0052-0018\" num=\"0944\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0052-0019\" num=\"0945\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0052-0020\" num=\"0946\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0052-0021\" num=\"0947\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0052-0022\" num=\"0948\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0052-0023\" num=\"0949\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0052-0024\" num=\"0950\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0074\" num=\"0951\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0053\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0053-0001\" num=\"0952\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0053-0002\" num=\"0953\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0053-0003\" num=\"0954\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0053-0004\" num=\"0955\">R22 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0053-0005\" num=\"0956\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0053-0006\" num=\"0957\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0053-0007\" num=\"0958\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0053-0008\" num=\"0959\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0053-0009\" num=\"0960\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0053-0010\" num=\"0961\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0053-0011\" num=\"0962\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0053-0012\" num=\"0963\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0053-0013\" num=\"0964\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0053-0014\" num=\"0965\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0053-0015\" num=\"0966\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0053-0016\" num=\"0967\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0053-0017\" num=\"0968\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0053-0018\" num=\"0969\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0075\" num=\"0970\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0054\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0054-0001\" num=\"0971\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0054-0002\" num=\"0972\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0054-0003\" num=\"0973\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0054-0004\" num=\"0974\">R22 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0054-0005\" num=\"0975\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0054-0006\" num=\"0976\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0054-0007\" num=\"0977\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0054-0008\" num=\"0978\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0054-0009\" num=\"0979\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0054-0010\" num=\"0980\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0054-0011\" num=\"0981\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0054-0012\" num=\"0982\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0054-0013\" num=\"0983\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0054-0014\" num=\"0984\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0054-0015\" num=\"0985\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0054-0016\" num=\"0986\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0076\" num=\"0987\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0055\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0055-0001\" num=\"0988\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0055-0002\" num=\"0989\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0055-0003\" num=\"0990\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0055-0004\" num=\"0991\">R22 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0055-0005\" num=\"0992\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0055-0006\" num=\"0993\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0055-0007\" num=\"0994\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0055-0008\" num=\"0995\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0055-0009\" num=\"0996\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0055-0010\" num=\"0997\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0055-0011\" num=\"0998\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0055-0012\" num=\"0999\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0055-0013\" num=\"1000\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0077\" num=\"1001\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0056\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0056-0001\" num=\"1002\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0056-0002\" num=\"1003\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0056-0003\" num=\"1004\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0056-0004\" num=\"1005\">R22 is fluoro</li>\\n'\n",
      " '    <li id=\"ul0056-0005\" num=\"1006\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0056-0006\" num=\"1007\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0056-0007\" num=\"1008\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0056-0008\" num=\"1009\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0056-0009\" num=\"1010\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0056-0010\" num=\"1011\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0056-0011\" num=\"1012\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0056-0012\" num=\"1013\">R5 is hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0056-0013\" num=\"1014\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0056-0014\" num=\"1015\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy</li>\\n'\n",
      " '    <li id=\"ul0056-0015\" num=\"1016\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0078\" num=\"1017\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0057\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0057-0001\" num=\"1018\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0057-0002\" num=\"1019\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0057-0003\" num=\"1020\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0057-0004\" num=\"1021\">R22 is methoxy</li>\\n'\n",
      " '    <li id=\"ul0057-0005\" num=\"1022\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0057-0006\" num=\"1023\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0057-0007\" num=\"1024\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0057-0008\" num=\"1025\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0057-0009\" num=\"1026\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0057-0010\" num=\"1027\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0057-0011\" num=\"1028\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0012\" num=\"1029\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0013\" num=\"1030\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0014\" num=\"1031\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0015\" num=\"1032\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0057-0016\" num=\"1033\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0057-0017\" num=\"1034\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0018\" num=\"1035\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0019\" num=\"1036\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0020\" num=\"1037\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0057-0021\" num=\"1038\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0057-0022\" num=\"1039\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0057-0023\" num=\"1040\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0079\" num=\"1041\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0058\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0058-0001\" num=\"1042\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0058-0002\" num=\"1043\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0058-0003\" num=\"1044\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0058-0004\" num=\"1045\">R22 is methoxy</li>\\n'\n",
      " '    <li id=\"ul0058-0005\" num=\"1046\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0058-0006\" num=\"1047\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0058-0007\" num=\"1048\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0058-0008\" num=\"1049\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0058-0009\" num=\"1050\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0058-0010\" num=\"1051\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0058-0011\" num=\"1052\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0058-0012\" num=\"1053\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0058-0013\" num=\"1054\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0058-0014\" num=\"1055\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0058-0015\" num=\"1056\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0058-0016\" num=\"1057\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0058-0017\" num=\"1058\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0080\" num=\"1059\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0059\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0059-0001\" num=\"1060\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0059-0002\" num=\"1061\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0059-0003\" num=\"1062\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0059-0004\" num=\"1063\">R22 is methoxy</li>\\n'\n",
      " '    <li id=\"ul0059-0005\" num=\"1064\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0059-0006\" num=\"1065\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0059-0007\" num=\"1066\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0059-0008\" num=\"1067\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0059-0009\" num=\"1068\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0059-0010\" num=\"1069\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0059-0011\" num=\"1070\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0059-0012\" num=\"1071\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0059-0013\" num=\"1072\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0059-0014\" num=\"1073\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0059-0015\" num=\"1074\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0059-0016\" num=\"1075\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0059-0017\" num=\"1076\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0081\" num=\"1077\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0060\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0060-0001\" num=\"1078\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0060-0002\" num=\"1079\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0060-0003\" num=\"1080\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0060-0004\" num=\"1081\">R22 is methoxy</li>\\n'\n",
      " '    <li id=\"ul0060-0005\" num=\"1082\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0060-0006\" num=\"1083\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0060-0007\" num=\"1084\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0060-0008\" num=\"1085\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0060-0009\" num=\"1086\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0060-0010\" num=\"1087\">R3 is a 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0060-0011\" num=\"1088\">R4 is &#x2014;C(O)-1-4C-alkyl, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0060-0012\" num=\"1089\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0060-0013\" num=\"1090\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0060-0014\" num=\"1091\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0082\" num=\"1092\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0061\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0061-0001\" num=\"1093\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0061-0002\" num=\"1094\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0061-0003\" num=\"1095\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0061-0004\" num=\"1096\">R22 is methyl,</li>\\n'\n",
      " '    <li id=\"ul0061-0005\" num=\"1097\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0061-0006\" num=\"1098\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0061-0007\" num=\"1099\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0061-0008\" num=\"1100\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0061-0009\" num=\"1101\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0061-0010\" num=\"1102\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0061-0011\" num=\"1103\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0012\" num=\"1104\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0013\" num=\"1105\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0014\" num=\"1106\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0015\" num=\"1107\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0061-0016\" num=\"1108\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0061-0017\" num=\"1109\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0018\" num=\"1110\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0019\" num=\"1111\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0020\" num=\"1112\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0061-0021\" num=\"1113\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0061-0022\" num=\"1114\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0061-0023\" num=\"1115\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0083\" num=\"1116\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0062\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0062-0001\" num=\"1117\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0062-0002\" num=\"1118\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0062-0003\" num=\"1119\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0062-0004\" num=\"1120\">R22 is methyl,</li>\\n'\n",
      " '    <li id=\"ul0062-0005\" num=\"1121\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0062-0006\" num=\"1122\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0062-0007\" num=\"1123\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0062-0008\" num=\"1124\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0062-0009\" num=\"1125\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0062-0010\" num=\"1126\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0062-0011\" num=\"1127\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0062-0012\" num=\"1128\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0062-0013\" num=\"1129\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0062-0014\" num=\"1130\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0062-0015\" num=\"1131\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0062-0016\" num=\"1132\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0062-0017\" num=\"1133\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0084\" num=\"1134\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0063\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0063-0001\" num=\"1135\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0063-0002\" num=\"1136\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0063-0003\" num=\"1137\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0063-0004\" num=\"1138\">R22 is methyl,</li>\\n'\n",
      " '    <li id=\"ul0063-0005\" num=\"1139\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0063-0006\" num=\"1140\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0063-0007\" num=\"1141\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0063-0008\" num=\"1142\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0063-0009\" num=\"1143\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0063-0010\" num=\"1144\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0063-0011\" num=\"1145\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0063-0012\" num=\"1146\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0063-0013\" num=\"1147\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0063-0014\" num=\"1148\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0063-0015\" num=\"1149\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0063-0016\" num=\"1150\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0063-0017\" num=\"1151\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0085\" num=\"1152\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0064\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0064-0001\" num=\"1153\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0064-0002\" num=\"1154\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0064-0003\" num=\"1155\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0064-0004\" num=\"1156\">R22 is methyl,</li>\\n'\n",
      " '    <li id=\"ul0064-0005\" num=\"1157\">R23 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0064-0006\" num=\"1158\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0064-0007\" num=\"1159\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0064-0008\" num=\"1160\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0064-0009\" num=\"1161\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0064-0010\" num=\"1162\">R3 is a 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0064-0011\" num=\"1163\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0064-0012\" num=\"1164\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0064-0013\" num=\"1165\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0064-0014\" num=\"1166\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71,</li>\\n'\n",
      " '    <li id=\"ul0064-0015\" num=\"1167\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0086\" num=\"1168\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0065\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0065-0001\" num=\"1169\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0065-0002\" num=\"1170\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0065-0003\" num=\"1171\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0065-0004\" num=\"1172\">R22 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0065-0005\" num=\"1173\">R23 is methoxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0006\" num=\"1174\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0065-0007\" num=\"1175\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0065-0008\" num=\"1176\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0065-0009\" num=\"1177\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or R5, '\n",
      " 'or a 3-6C-cycloalkyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0065-0010\" num=\"1178\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0065-0011\" num=\"1179\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0012\" num=\"1180\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0013\" num=\"1181\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0014\" num=\"1182\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0015\" num=\"1183\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0065-0016\" num=\"1184\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0065-0017\" num=\"1185\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0018\" num=\"1186\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0019\" num=\"1187\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0020\" num=\"1188\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0065-0021\" num=\"1189\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0065-0022\" num=\"1190\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0065-0023\" num=\"1191\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0087\" num=\"1192\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0066\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0066-0001\" num=\"1193\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0066-0002\" num=\"1194\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0066-0003\" num=\"1195\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0066-0004\" num=\"1196\">R22 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0066-0005\" num=\"1197\">R23 is methoxy,</li>\\n'\n",
      " '    <li id=\"ul0066-0006\" num=\"1198\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0066-0007\" num=\"1199\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0066-0008\" num=\"1200\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0066-0009\" num=\"1201\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0066-0010\" num=\"1202\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0066-0011\" num=\"1203\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0066-0012\" num=\"1204\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0066-0013\" num=\"1205\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0066-0014\" num=\"1206\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0066-0015\" num=\"1207\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0066-0016\" num=\"1208\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0066-0017\" num=\"1209\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0088\" num=\"1210\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0067\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0067-0001\" num=\"1211\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0067-0002\" num=\"1212\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0067-0003\" num=\"1213\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0067-0004\" num=\"1214\">R22 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0067-0005\" num=\"1215\">R23 is methoxy,</li>\\n'\n",
      " '    <li id=\"ul0067-0006\" num=\"1216\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0067-0007\" num=\"1217\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0067-0008\" num=\"1218\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0067-0009\" num=\"1219\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0067-0010\" num=\"1220\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0067-0011\" num=\"1221\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0067-0012\" num=\"1222\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0067-0013\" num=\"1223\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0067-0014\" num=\"1224\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0067-0015\" num=\"1225\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0067-0016\" num=\"1226\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0067-0017\" num=\"1227\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0089\" num=\"1228\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0068\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0068-0001\" num=\"1229\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0068-0002\" num=\"1230\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0068-0003\" num=\"1231\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0068-0004\" num=\"1232\">R22 is fluoro,</li>\\n'\n",
      " '    <li id=\"ul0068-0005\" num=\"1233\">R23 is methoxy,</li>\\n'\n",
      " '    <li id=\"ul0068-0006\" num=\"1234\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0068-0007\" num=\"1235\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0068-0008\" num=\"1236\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0068-0009\" num=\"1237\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0068-0010\" num=\"1238\">R3 is a 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0068-0011\" num=\"1239\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0068-0012\" num=\"1240\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0068-0013\" num=\"1241\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0068-0014\" num=\"1242\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0068-0015\" num=\"1243\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0090\" num=\"1244\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0069\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0069-0001\" num=\"1245\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0069-0002\" num=\"1246\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0069-0003\" num=\"1247\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0069-0004\" num=\"1248\">R22 is 1-4C-alkyl</li>\\n'\n",
      " '    <li id=\"ul0069-0005\" num=\"1249\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0069-0006\" num=\"1250\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0069-0007\" num=\"1251\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0069-0008\" num=\"1252\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0069-0009\" num=\"1253\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0069-0010\" num=\"1254\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0069-0011\" num=\"1255\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0069-0012\" num=\"1256\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0069-0013\" num=\"1257\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0069-0014\" num=\"1258\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0069-0015\" num=\"1259\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0069-0016\" num=\"1260\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0069-0017\" num=\"1261\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0069-0018\" num=\"1262\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0069-0019\" num=\"1263\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0069-0020\" num=\"1264\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0069-0021\" num=\"1265\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0069-0022\" num=\"1266\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0069-0023\" num=\"1267\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0069-0024\" num=\"1268\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0091\" num=\"1269\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0070\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0070-0001\" num=\"1270\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0070-0002\" num=\"1271\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0070-0003\" num=\"1272\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0070-0004\" num=\"1273\">R22 is methyl, ethyl or isopropyl,</li>\\n'\n",
      " '    <li id=\"ul0070-0005\" num=\"1274\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0070-0006\" num=\"1275\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0070-0007\" num=\"1276\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0070-0008\" num=\"1277\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0070-0009\" num=\"1278\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0070-0010\" num=\"1279\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0070-0011\" num=\"1280\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0070-0012\" num=\"1281\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0070-0013\" num=\"1282\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0070-0014\" num=\"1283\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0070-0015\" num=\"1284\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0070-0016\" num=\"1285\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0070-0017\" num=\"1286\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0070-0018\" num=\"1287\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0092\" num=\"1288\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0071\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0071-0001\" num=\"1289\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0071-0002\" num=\"1290\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0071-0003\" num=\"1291\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0071-0004\" num=\"1292\">R22 is methyl, ethyl or isopropyl,</li>\\n'\n",
      " '    <li id=\"ul0071-0005\" num=\"1293\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0071-0006\" num=\"1294\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0071-0007\" num=\"1295\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0071-0008\" num=\"1296\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0071-0009\" num=\"1297\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0071-0010\" num=\"1298\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0071-0011\" num=\"1299\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0071-0012\" num=\"1300\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0071-0013\" num=\"1301\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0071-0014\" num=\"1302\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0071-0015\" num=\"1303\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0071-0016\" num=\"1304\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0071-0017\" num=\"1305\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0093\" num=\"1306\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0072\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0072-0001\" num=\"1307\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0072-0002\" num=\"1308\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0072-0003\" num=\"1309\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0072-0004\" num=\"1310\">R22 is methyl, ethyl or isopropyl,</li>\\n'\n",
      " '    <li id=\"ul0072-0005\" num=\"1311\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0072-0006\" num=\"1312\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0072-0007\" num=\"1313\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0072-0008\" num=\"1314\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0072-0009\" num=\"1315\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0072-0010\" num=\"1316\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 and/or R5 at said nitrogen atom, or a cyclohexyl or '\n",
      " 'cyclopentyl group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0072-0011\" num=\"1317\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0072-0012\" num=\"1318\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0072-0013\" num=\"1319\">R5 is methoxy, fluoro, methyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0072-0014\" num=\"1320\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0072-0015\" num=\"1321\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0072-0016\" num=\"1322\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0094\" num=\"1323\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0073\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0073-0001\" num=\"1324\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0073-0002\" num=\"1325\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0073-0003\" num=\"1326\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0073-0004\" num=\"1327\">R22 is 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0073-0005\" num=\"1328\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0073-0006\" num=\"1329\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0073-0007\" num=\"1330\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0073-0008\" num=\"1331\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0073-0009\" num=\"1332\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0073-0010\" num=\"1333\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0073-0011\" num=\"1334\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0073-0012\" num=\"1335\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0073-0013\" num=\"1336\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0073-0014\" num=\"1337\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0073-0015\" num=\"1338\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0073-0016\" num=\"1339\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0073-0017\" num=\"1340\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0095\" num=\"1341\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0074\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0074-0001\" num=\"1342\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0074-0002\" num=\"1343\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0074-0003\" num=\"1344\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0074-0004\" num=\"1345\">R22 is methyl, ethyl or isopropyl,</li>\\n'\n",
      " '    <li id=\"ul0074-0005\" num=\"1346\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0074-0006\" num=\"1347\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0074-0007\" num=\"1348\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0074-0008\" num=\"1349\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0074-0009\" num=\"1350\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0074-0010\" num=\"1351\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0074-0011\" num=\"1352\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0074-0012\" num=\"1353\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0074-0013\" num=\"1354\">R5 is hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0074-0014\" num=\"1355\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0074-0015\" num=\"1356\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0074-0016\" num=\"1357\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0096\" num=\"1358\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0075\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0075-0001\" num=\"1359\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0075-0002\" num=\"1360\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0075-0003\" num=\"1361\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0075-0004\" num=\"1362\">R22 is methyl,</li>\\n'\n",
      " '    <li id=\"ul0075-0005\" num=\"1363\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0075-0006\" num=\"1364\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0075-0007\" num=\"1365\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0075-0008\" num=\"1366\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0075-0009\" num=\"1367\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0075-0010\" num=\"1368\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0075-0011\" num=\"1369\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0075-0012\" num=\"1370\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0075-0013\" num=\"1371\">R5 is hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0075-0014\" num=\"1372\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0075-0015\" num=\"1373\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0075-0016\" num=\"1374\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0097\" num=\"1375\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0076\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0076-0001\" num=\"1376\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0076-0002\" num=\"1377\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0076-0003\" num=\"1378\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0076-0004\" num=\"1379\">R22 is 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0076-0005\" num=\"1380\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0076-0006\" num=\"1381\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0076-0007\" num=\"1382\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0076-0008\" num=\"1383\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0076-0009\" num=\"1384\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0076-0010\" num=\"1385\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0076-0011\" num=\"1386\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0076-0012\" num=\"1387\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0076-0013\" num=\"1388\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0076-0014\" num=\"1389\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0076-0015\" num=\"1390\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0076-0016\" num=\"1391\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0076-0017\" num=\"1392\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0076-0018\" num=\"1393\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0076-0019\" num=\"1394\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0076-0020\" num=\"1395\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0076-0021\" num=\"1396\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0076-0022\" num=\"1397\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0076-0023\" num=\"1398\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0076-0024\" num=\"1399\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0098\" num=\"1400\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0077\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0077-0001\" num=\"1401\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0077-0002\" num=\"1402\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0077-0003\" num=\"1403\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0077-0004\" num=\"1404\">R22 is fluoromethyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0077-0005\" num=\"1405\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0077-0006\" num=\"1406\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0077-0007\" num=\"1407\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0077-0008\" num=\"1408\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0077-0009\" num=\"1409\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0077-0010\" num=\"1410\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0077-0011\" num=\"1411\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0077-0012\" num=\"1412\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0077-0013\" num=\"1413\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0077-0014\" num=\"1414\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0077-0015\" num=\"1415\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0077-0016\" num=\"1416\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0077-0017\" num=\"1417\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0077-0018\" num=\"1418\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0077-0019\" num=\"1419\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0077-0020\" num=\"1420\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0077-0021\" num=\"1421\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0077-0022\" num=\"1422\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0077-0023\" num=\"1423\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0077-0024\" num=\"1424\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0099\" num=\"1425\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0078\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0078-0001\" num=\"1426\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0078-0002\" num=\"1427\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0078-0003\" num=\"1428\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0078-0004\" num=\"1429\">R22 is fluoromethyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0078-0005\" num=\"1430\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0078-0006\" num=\"1431\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0078-0007\" num=\"1432\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0078-0008\" num=\"1433\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0078-0009\" num=\"1434\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5, or a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0078-0010\" num=\"1435\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0078-0011\" num=\"1436\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0078-0012\" num=\"1437\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0078-0013\" num=\"1438\">R5 is methoxy, fluoro, methyl or '\n",
      " 'hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0078-0014\" num=\"1439\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0078-0015\" num=\"1440\">R61 is fluoro, methyl or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0078-0016\" num=\"1441\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0078-0017\" num=\"1442\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0078-0018\" num=\"1443\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0100\" num=\"1444\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0079\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0079-0001\" num=\"1445\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0079-0002\" num=\"1446\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0079-0003\" num=\"1447\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0079-0004\" num=\"1448\">R22 is fluoromethyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0079-0005\" num=\"1449\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0079-0006\" num=\"1450\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0079-0007\" num=\"1451\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0079-0008\" num=\"1452\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0079-0009\" num=\"1453\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0079-0010\" num=\"1454\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0079-0011\" num=\"1455\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0079-0012\" num=\"1456\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0079-0013\" num=\"1457\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0079-0014\" num=\"1458\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0079-0015\" num=\"1459\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0079-0016\" num=\"1460\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0079-0017\" num=\"1461\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0101\" num=\"1462\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0080\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0080-0001\" num=\"1463\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0080-0002\" num=\"1464\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0080-0003\" num=\"1465\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0080-0004\" num=\"1466\">R22 trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0080-0005\" num=\"1467\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0080-0006\" num=\"1468\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0080-0007\" num=\"1469\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0080-0008\" num=\"1470\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0080-0009\" num=\"1471\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0080-0010\" num=\"1472\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0080-0011\" num=\"1473\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0080-0012\" num=\"1474\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0080-0013\" num=\"1475\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0080-0014\" num=\"1476\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0080-0015\" num=\"1477\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0102\" num=\"1478\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0081\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0081-0001\" num=\"1479\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0081-0002\" num=\"1480\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0081-0003\" num=\"1481\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0081-0004\" num=\"1482\">R22 is 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0081-0005\" num=\"1483\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0081-0006\" num=\"1484\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0081-0007\" num=\"1485\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0081-0008\" num=\"1486\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0081-0009\" num=\"1487\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one substituent R5, or a '\n",
      " '5-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0081-0010\" num=\"1488\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0081-0011\" num=\"1489\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0081-0012\" num=\"1490\">R5 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0081-0013\" num=\"1491\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0081-0014\" num=\"1492\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0081-0015\" num=\"1493\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0081-0016\" num=\"1494\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0103\" num=\"1495\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0082\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0082-0001\" num=\"1496\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0082-0002\" num=\"1497\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0082-0003\" num=\"1498\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0082-0004\" num=\"1499\">R22 is fluoromethyl, difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0082-0005\" num=\"1500\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0082-0006\" num=\"1501\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0082-0007\" num=\"1502\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0082-0008\" num=\"1503\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0082-0009\" num=\"1504\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one substituent R5, or a '\n",
      " '5-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0082-0010\" num=\"1505\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0082-0011\" num=\"1506\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0082-0012\" num=\"1507\">R5 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0082-0013\" num=\"1508\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0082-0014\" num=\"1509\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0082-0015\" num=\"1510\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0082-0016\" num=\"1511\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0104\" num=\"1512\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0083\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0083-0001\" num=\"1513\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0083-0002\" num=\"1514\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0083-0003\" num=\"1515\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0083-0004\" num=\"1516\">R22 is difluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0083-0005\" num=\"1517\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0083-0006\" num=\"1518\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0083-0007\" num=\"1519\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0083-0008\" num=\"1520\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0083-0009\" num=\"1521\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one substituent R5, or a '\n",
      " '5-6C-cycloalkyl group substituted by R6 and optionally substituted by '\n",
      " 'R61,</li>\\n'\n",
      " '    <li id=\"ul0083-0010\" num=\"1522\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0083-0011\" num=\"1523\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0083-0012\" num=\"1524\">R5 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0083-0013\" num=\"1525\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0083-0014\" num=\"1526\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0083-0015\" num=\"1527\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0083-0016\" num=\"1528\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0105\" num=\"1529\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0084\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0084-0001\" num=\"1530\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0084-0002\" num=\"1531\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0084-0003\" num=\"1532\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0084-0004\" num=\"1533\">R22 is difluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0084-0005\" num=\"1534\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0084-0006\" num=\"1535\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0084-0007\" num=\"1536\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0084-0008\" num=\"1537\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0084-0009\" num=\"1538\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0084-0010\" num=\"1539\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0084-0011\" num=\"1540\">R41 is 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0084-0012\" num=\"1541\">R5 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0084-0013\" num=\"1542\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0084-0014\" num=\"1543\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0084-0015\" num=\"1544\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0084-0016\" num=\"1545\">R71 is 1-4C-alkoxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0106\" num=\"1546\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0085\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0085-0001\" num=\"1547\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0085-0002\" num=\"1548\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0085-0003\" num=\"1549\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0085-0004\" num=\"1550\">R22 is difluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0085-0005\" num=\"1551\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0085-0006\" num=\"1552\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0085-0007\" num=\"1553\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0085-0008\" num=\"1554\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0085-0009\" num=\"1555\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0085-0010\" num=\"1556\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0085-0011\" num=\"1557\">R41 is 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0085-0012\" num=\"1558\">R5 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0085-0013\" num=\"1559\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0085-0014\" num=\"1560\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0085-0015\" num=\"1561\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0085-0016\" num=\"1562\">R71 is 1-4C-alkoxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0107\" num=\"1563\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0086\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0086-0001\" num=\"1564\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0086-0002\" num=\"1565\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0086-0003\" num=\"1566\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0086-0004\" num=\"1567\">R22 is difluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0086-0005\" num=\"1568\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0086-0006\" num=\"1569\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0086-0007\" num=\"1570\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0086-0008\" num=\"1571\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0086-0009\" num=\"1572\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and said heterocyclic ring being '\n",
      " 'optionally substituted by R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0086-0010\" num=\"1573\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0086-0011\" num=\"1574\">R41 is 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0086-0012\" num=\"1575\">R5 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0086-0013\" num=\"1576\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0086-0014\" num=\"1577\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0086-0015\" num=\"1578\">R7 is methyl or ethyl, which are '\n",
      " 'optionally substituted by R71, or ethoxy,</li>\\n'\n",
      " '    <li id=\"ul0086-0016\" num=\"1579\">R71 is methoxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0108\" num=\"1580\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0087\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0087-0001\" num=\"1581\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0087-0002\" num=\"1582\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0087-0003\" num=\"1583\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0087-0004\" num=\"1584\">R22 is 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0087-0005\" num=\"1585\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0087-0006\" num=\"1586\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0087-0007\" num=\"1587\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0087-0008\" num=\"1588\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0087-0009\" num=\"1589\">R3 is a 5-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0087-0010\" num=\"1590\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0087-0011\" num=\"1591\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0087-0012\" num=\"1592\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71,</li>\\n'\n",
      " '    <li id=\"ul0087-0013\" num=\"1593\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0109\" num=\"1594\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0088\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0088-0001\" num=\"1595\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0088-0002\" num=\"1596\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0088-0003\" num=\"1597\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0088-0004\" num=\"1598\">R22 is difluoromethyl or '\n",
      " 'trifluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0088-0005\" num=\"1599\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0088-0006\" num=\"1600\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0088-0007\" num=\"1601\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0088-0008\" num=\"1602\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0088-0009\" num=\"1603\">R3 is a cyclohexyl group substituted by '\n",
      " 'R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0088-0010\" num=\"1604\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0088-0011\" num=\"1605\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0088-0012\" num=\"1606\">R7 is methyl or ethyl, which are '\n",
      " 'optionally substituted by R71,</li>\\n'\n",
      " '    <li id=\"ul0088-0013\" num=\"1607\">R71 is methoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0110\" num=\"1608\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0089\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0089-0001\" num=\"1609\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0089-0002\" num=\"1610\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0089-0003\" num=\"1611\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0089-0004\" num=\"1612\">R22 is difluoromethyl,</li>\\n'\n",
      " '    <li id=\"ul0089-0005\" num=\"1613\">R23 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0089-0006\" num=\"1614\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0089-0007\" num=\"1615\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0089-0008\" num=\"1616\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0089-0009\" num=\"1617\">R3 is a cyclohexyl group substituted by '\n",
      " 'R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0089-0010\" num=\"1618\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0089-0011\" num=\"1619\">R61 is fluoro or methyl,</li>\\n'\n",
      " '    <li id=\"ul0089-0012\" num=\"1620\">R7 is methyl or ethyl, which are '\n",
      " 'optionally substituted by R71,</li>\\n'\n",
      " '    <li id=\"ul0089-0013\" num=\"1621\">R71 is methoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0111\" num=\"1622\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0090\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0090-0001\" num=\"1623\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0090-0002\" num=\"1624\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0090-0003\" num=\"1625\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0090-0004\" num=\"1626\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0090-0005\" num=\"1627\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0090-0006\" num=\"1628\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0090-0007\" num=\"1629\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0090-0008\" num=\"1630\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0090-0009\" num=\"1631\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0090-0010\" num=\"1632\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0090-0011\" num=\"1633\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0090-0012\" num=\"1634\">R3 is a 4- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5,</li>\\n'\n",
      " '    <li id=\"ul0090-0013\" num=\"1635\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0090-0014\" num=\"1636\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0090-0015\" num=\"1637\">R42 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0090-0016\" num=\"1638\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0090-0017\" num=\"1639\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0112\" num=\"1640\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0091\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0091-0001\" num=\"1641\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0091-0002\" num=\"1642\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0091-0003\" num=\"1643\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0091-0004\" num=\"1644\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0091-0005\" num=\"1645\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0091-0006\" num=\"1646\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0091-0007\" num=\"1647\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0091-0008\" num=\"1648\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0091-0009\" num=\"1649\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0091-0010\" num=\"1650\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0091-0011\" num=\"1651\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or by one or two substituents R5,</li>\\n'\n",
      " '    <li id=\"ul0091-0012\" num=\"1652\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0091-0013\" num=\"1653\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0091-0014\" num=\"1654\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0091-0015\" num=\"1655\">R5 is methoxy, fluoro, 1-4C-alkyl or '\n",
      " 'hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0113\" num=\"1656\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0092\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0092-0001\" num=\"1657\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0092-0002\" num=\"1658\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0092-0003\" num=\"1659\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0092-0004\" num=\"1660\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0092-0005\" num=\"1661\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0092-0006\" num=\"1662\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0092-0007\" num=\"1663\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0092-0008\" num=\"1664\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0092-0009\" num=\"1665\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0092-0010\" num=\"1666\">R3 is a 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom,</li>\\n'\n",
      " '    <li id=\"ul0092-0011\" num=\"1667\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0092-0012\" num=\"1668\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0092-0013\" num=\"1669\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0114\" num=\"1670\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0093\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0093-0001\" num=\"1671\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0093-0002\" num=\"1672\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0093-0003\" num=\"1673\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0093-0004\" num=\"1674\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0093-0005\" num=\"1675\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0093-0006\" num=\"1676\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0093-0007\" num=\"1677\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0093-0008\" num=\"1678\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0093-0009\" num=\"1679\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0093-0010\" num=\"1680\">R3 is a 5-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom,</li>\\n'\n",
      " '    <li id=\"ul0093-0011\" num=\"1681\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0093-0012\" num=\"1682\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0093-0013\" num=\"1683\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0115\" num=\"1684\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0094\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0094-0001\" num=\"1685\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0094-0002\" num=\"1686\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0094-0003\" num=\"1687\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0094-0004\" num=\"1688\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0094-0005\" num=\"1689\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0094-0006\" num=\"1690\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0094-0007\" num=\"1691\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0094-0008\" num=\"1692\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0094-0009\" num=\"1693\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0094-0010\" num=\"1694\">R3 is a 5-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and/or R5,</li>\\n'\n",
      " '    <li id=\"ul0094-0011\" num=\"1695\">R4 is &#x2014;C(O)&#x2014;H, '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, or &#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the '\n",
      " '1-4C-alkyl group is optionally substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0094-0012\" num=\"1696\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0094-0013\" num=\"1697\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0094-0014\" num=\"1698\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0116\" num=\"1699\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0095\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0095-0001\" num=\"1700\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0095-0002\" num=\"1701\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0095-0003\" num=\"1702\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0095-0004\" num=\"1703\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0095-0005\" num=\"1704\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0095-0006\" num=\"1705\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0095-0007\" num=\"1706\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0095-0008\" num=\"1707\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0095-0009\" num=\"1708\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0095-0010\" num=\"1709\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom,</li>\\n'\n",
      " '    <li id=\"ul0095-0011\" num=\"1710\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0095-0012\" num=\"1711\">R41 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0117\" num=\"1712\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0096\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0096-0001\" num=\"1713\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0096-0002\" num=\"1714\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0096-0003\" num=\"1715\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0096-0004\" num=\"1716\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0096-0005\" num=\"1717\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0096-0006\" num=\"1718\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0096-0007\" num=\"1719\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0096-0008\" num=\"1720\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0096-0009\" num=\"1721\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0096-0010\" num=\"1722\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and/or said heterocyclic ring being '\n",
      " 'optionally substituted by R5,</li>\\n'\n",
      " '    <li id=\"ul0096-0011\" num=\"1723\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0096-0012\" num=\"1724\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0096-0013\" num=\"1725\">R43 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0096-0014\" num=\"1726\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0118\" num=\"1727\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0097\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0097-0001\" num=\"1728\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0097-0002\" num=\"1729\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0097-0003\" num=\"1730\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0097-0004\" num=\"1731\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0097-0005\" num=\"1732\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0097-0006\" num=\"1733\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0097-0007\" num=\"1734\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0097-0008\" num=\"1735\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0097-0009\" num=\"1736\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0097-0010\" num=\"1737\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and/or said heterocyclic ring being '\n",
      " 'optionally substituted by R5,</li>\\n'\n",
      " '    <li id=\"ul0097-0011\" num=\"1738\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0097-0012\" num=\"1739\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0097-0013\" num=\"1740\">R5 is halogen or 1-4C-alkyl,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0119\" num=\"1741\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0098\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0098-0001\" num=\"1742\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0098-0002\" num=\"1743\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0098-0003\" num=\"1744\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0098-0004\" num=\"1745\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0098-0005\" num=\"1746\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0098-0006\" num=\"1747\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0098-0007\" num=\"1748\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0098-0008\" num=\"1749\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0098-0009\" num=\"1750\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0098-0010\" num=\"1751\">R3 is a 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom and/or said heterocyclic ring being '\n",
      " 'optionally substituted by R5,</li>\\n'\n",
      " '    <li id=\"ul0098-0011\" num=\"1752\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0098-0012\" num=\"1753\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0098-0013\" num=\"1754\">R5 is halogen or 1-4C-alkyl,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0120\" num=\"1755\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0099\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0099-0001\" num=\"1756\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0099-0002\" num=\"1757\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0099-0003\" num=\"1758\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0099-0004\" num=\"1759\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0099-0005\" num=\"1760\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy or &#x2014;C(O)-1-4C-alkyl, '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0099-0006\" num=\"1761\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0099-0007\" num=\"1762\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0099-0008\" num=\"1763\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0099-0009\" num=\"1764\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0099-0010\" num=\"1765\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0099-0011\" num=\"1766\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0099-0012\" num=\"1767\">R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0099-0013\" num=\"1768\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0099-0014\" num=\"1769\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0099-0015\" num=\"1770\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0099-0016\" num=\"1771\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0099-0017\" num=\"1772\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0099-0018\" num=\"1773\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0099-0019\" num=\"1774\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0099-0020\" num=\"1775\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0099-0021\" num=\"1776\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0099-0022\" num=\"1777\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0121\" num=\"1778\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0100\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0100-0001\" num=\"1779\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0100-0002\" num=\"1780\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0100-0003\" num=\"1781\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0100-0004\" num=\"1782\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0100-0005\" num=\"1783\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy or &#x2014;C(O)-1-4C-alkyl, '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0100-0006\" num=\"1784\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0100-0007\" num=\"1785\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0100-0008\" num=\"1786\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0100-0009\" num=\"1787\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0100-0010\" num=\"1788\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0100-0011\" num=\"1789\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0100-0012\" num=\"1790\">R3 is a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0100-0013\" num=\"1791\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " '&#x2014;C(O)&#x2014;NR8R9, halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0100-0014\" num=\"1792\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0100-0015\" num=\"1793\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by '\n",
      " 'R73,</li>\\n'\n",
      " '    <li id=\"ul0100-0016\" num=\"1794\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0100-0017\" num=\"1795\">R72 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0100-0018\" num=\"1796\">R73 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0100-0019\" num=\"1797\">R8 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0100-0020\" num=\"1798\">R9 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R91, or 3-6C-cycloalkyl, which is optionally substituted by '\n",
      " 'R92,</li>\\n'\n",
      " '    <li id=\"ul0100-0021\" num=\"1799\">R91 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0100-0022\" num=\"1800\">R92 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0122\" num=\"1801\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0101\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0101-0001\" num=\"1802\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0101-0002\" num=\"1803\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0101-0003\" num=\"1804\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0101-0004\" num=\"1805\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy or &#x2014;C(O)-1-4C-alkyl, '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0101-0005\" num=\"1806\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0101-0006\" num=\"1807\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0101-0007\" num=\"1808\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0101-0008\" num=\"1809\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0101-0009\" num=\"1810\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0101-0010\" num=\"1811\">R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0101-0011\" num=\"1812\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0101-0012\" num=\"1813\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0101-0013\" num=\"1814\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0101-0014\" num=\"1815\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0101-0015\" num=\"1816\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0123\" num=\"1817\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0102\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0102-0001\" num=\"1818\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0102-0002\" num=\"1819\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0102-0003\" num=\"1820\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0102-0004\" num=\"1821\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0102-0005\" num=\"1822\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0102-0006\" num=\"1823\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0102-0007\" num=\"1824\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0102-0008\" num=\"1825\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0102-0009\" num=\"1826\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0102-0010\" num=\"1827\">R3 is a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6 and optionally substituted by R61, R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0102-0011\" num=\"1828\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0102-0012\" num=\"1829\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0102-0013\" num=\"1830\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0102-0014\" num=\"1831\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0124\" num=\"1832\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0103\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0103-0001\" num=\"1833\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0103-0002\" num=\"1834\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0103-0003\" num=\"1835\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0103-0004\" num=\"1836\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0103-0005\" num=\"1837\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0103-0006\" num=\"1838\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0103-0007\" num=\"1839\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0103-0008\" num=\"1840\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0103-0009\" num=\"1841\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0103-0010\" num=\"1842\">R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0103-0011\" num=\"1843\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0103-0012\" num=\"1844\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0103-0013\" num=\"1845\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0103-0014\" num=\"1846\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0125\" num=\"1847\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0104\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0104-0001\" num=\"1848\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0104-0002\" num=\"1849\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0104-0003\" num=\"1850\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0104-0004\" num=\"1851\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0104-0005\" num=\"1852\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0104-0006\" num=\"1853\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0104-0007\" num=\"1854\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0104-0008\" num=\"1855\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0104-0009\" num=\"1856\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0104-0010\" num=\"1857\">R3 is a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0104-0011\" num=\"1858\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0104-0012\" num=\"1859\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0104-0013\" num=\"1860\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0104-0014\" num=\"1861\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0126\" num=\"1862\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0105\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0105-0001\" num=\"1863\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</li>\\n'\n",
      " '    <li id=\"ul0105-0002\" num=\"1864\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0105-0003\" num=\"1865\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0105-0004\" num=\"1866\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0105-0005\" num=\"1867\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0105-0006\" num=\"1868\">R23 is hydrogen, halogen, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0105-0007\" num=\"1869\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0105-0008\" num=\"1870\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0105-0009\" num=\"1871\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0105-0010\" num=\"1872\">R3 is a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6 and optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0105-0011\" num=\"1873\">R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7,</li>\\n'\n",
      " '    <li id=\"ul0105-0012\" num=\"1874\">R61 is halogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0105-0013\" num=\"1875\">R7 is 1-4C-alkyl, which is optionally '\n",
      " 'substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0105-0014\" num=\"1876\">R71 is 1-4C-alkoxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0127\" num=\"1877\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I),\\n'\n",
      " '<ul id=\"ul0106\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0106-0001\" num=\"0000\">\\n'\n",
      " '    <ul id=\"ul0107\" list-style=\"none\">\\n'\n",
      " '        <li id=\"ul0107-0001\" num=\"1878\">wherein</li>\\n'\n",
      " '    </ul>\\n'\n",
      " '    </li>\\n'\n",
      " '    <li id=\"ul0106-0002\" num=\"1879\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0106-0003\" num=\"1880\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0106-0004\" num=\"1881\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0106-0005\" num=\"1882\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0106-0006\" num=\"1883\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy, 1-4C-fluoroalkoxy or &#x2014;C(O)-1-4C-alkyl, '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0106-0007\" num=\"1884\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0106-0008\" num=\"1885\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, hydroxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0106-0009\" num=\"1886\">or R22 and R23 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0106-0010\" num=\"1887\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0106-0011\" num=\"1888\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0106-0012\" num=\"1889\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0106-0013\" num=\"1890\">R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by R4 and/or by '\n",
      " 'one or two substituents R5, or a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</li>\\n'\n",
      " '    <li id=\"ul0106-0014\" num=\"1891\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43,</li>\\n'\n",
      " '    <li id=\"ul0106-0015\" num=\"1892\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0106-0016\" num=\"1893\">R43 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if only one substituent R5 is present then\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0106-0017\" num=\"1894\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'if two substituents R5 are present, these are identical and binding at the '\n",
      " 'same carbon atom and are selected from halogen or 1-4C-alkyl or together '\n",
      " 'with the carbon atom, to which they are bonded, form a spiro-linked '\n",
      " 'cyclopropane ring,\\n'\n",
      " '</li>\\n'\n",
      " '    <li id=\"ul0106-0018\" num=\"1895\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, '\n",
      " 'halogen, hydroxy or NH<sub>2</sub>,</li>\\n'\n",
      " '    <li id=\"ul0106-0019\" num=\"1896\">R61 is halogen, 1-4C-alkyl or '\n",
      " 'hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0106-0020\" num=\"1897\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, which is optionally '\n",
      " 'substituted by R73,</li>\\n'\n",
      " '    <li id=\"ul0106-0021\" num=\"1898\">R71 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0106-0022\" num=\"1899\">R73 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0128\" num=\"1900\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0108\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0108-0001\" num=\"1901\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl which is optionally '\n",
      " 'substituted by R11,</li>\\n'\n",
      " '    <li id=\"ul0108-0002\" num=\"1902\">R11 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0108-0003\" num=\"1903\">R2 is hydrogen or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0108-0004\" num=\"1904\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0108-0005\" num=\"1905\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0108-0006\" num=\"1906\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0108-0007\" num=\"1907\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy or 1-4C-fluoroalkoxy,</li>\\n'\n",
      " '    <li id=\"ul0108-0008\" num=\"1908\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0108-0009\" num=\"1909\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0108-0010\" num=\"1910\">n is 0 or 1,</li>\\n'\n",
      " '    <li id=\"ul0108-0011\" num=\"1911\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'optionally substituted by R4 and/or R5, or a cyclohexyl or cyclopentyl group '\n",
      " 'substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0108-0012\" num=\"1912\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0108-0013\" num=\"1913\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0108-0014\" num=\"1914\">R5 is 1-4C-alkoxy, halogen, 1-4C-alkyl '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0108-0015\" num=\"1915\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0108-0016\" num=\"1916\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0108-0017\" num=\"1917\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0129\" num=\"1918\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), wherein\\n'\n",
      " '<ul id=\"ul0109\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0109-0001\" num=\"1919\">R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl,</li>\\n'\n",
      " '    <li id=\"ul0109-0002\" num=\"1920\">R2 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0109-0003\" num=\"1921\">R21 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0109-0004\" num=\"1922\">R22 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy, 1-4C-fluoroalkoxy, &#x2014;C(O)-1-4C-alkyl or '\n",
      " '1-4C-fluoroalkyl,</li>\\n'\n",
      " '    <li id=\"ul0109-0005\" num=\"1923\">or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0109-0006\" num=\"1924\">R23 is hydrogen, halogen, 1-4C-alkyl, '\n",
      " '1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0109-0007\" num=\"1925\">R24 is hydrogen,</li>\\n'\n",
      " '    <li id=\"ul0109-0008\" num=\"1926\">Y is '\n",
      " '&#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</li>\\n'\n",
      " '    <li id=\"ul0109-0009\" num=\"1927\">n is 0,</li>\\n'\n",
      " '    <li id=\"ul0109-0010\" num=\"1928\">R3 is a 5- to 6-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom, said heterocyclic ring being '\n",
      " 'substituted by R4 at said nitrogen atom, or a cyclohexyl or cyclopentyl '\n",
      " 'group substituted by R6,</li>\\n'\n",
      " '    <li id=\"ul0109-0011\" num=\"1929\">R4 is &#x2014;C(O)-1-4C-alkyl, wherein '\n",
      " 'the 1-4C-alkyl group is optionally substituted by R41,</li>\\n'\n",
      " '    <li id=\"ul0109-0012\" num=\"1930\">R41 is 1-4C-alkoxy or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0109-0013\" num=\"1931\">R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'or hydroxy,</li>\\n'\n",
      " '    <li id=\"ul0109-0014\" num=\"1932\">R7 is hydrogen, 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy,</li>\\n'\n",
      " '    <li id=\"ul0109-0015\" num=\"1933\">R71 is 1-4C-alkoxy or hydroxy,\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0130\" num=\"1934\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl or 1-4C-alkyl, R2, R21, R22, R23, '\n",
      " 'R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, '\n",
      " 'R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0131\" num=\"1935\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-6C-cycloalkyl, R2, R21, R22, R23, R24, Y, n, R3, '\n",
      " 'R4, R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are '\n",
      " 'as described above or below.</p>\\n'\n",
      " '<p id=\"p-0132\" num=\"1936\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl, R2, R21, R22, R23, R24, Y, n, R3, '\n",
      " 'R4, R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are '\n",
      " 'as described above or below.</p>\\n'\n",
      " '<p id=\"p-0133\" num=\"1937\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R2 is '\n",
      " 'hydrogen, R1, R21, R22, R23, R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0134\" num=\"1938\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R2 is '\n",
      " 'methyl, R1, R21, R22, R23, R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0135\" num=\"1939\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R21 is '\n",
      " 'hydrogen, R1, R2, R22, R23, R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0136\" num=\"1940\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R21 is '\n",
      " 'fluoro, R1, R2, R22, R23, R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, R7, '\n",
      " 'R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0137\" num=\"1941\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R22 is '\n",
      " 'hydrogen, halogen, 1-4C-alkyl, 1-4C-alkoxy, &#x2014;C(O)-1-4C-alkyl, '\n",
      " '1-4C-fluoroalkyl, or R21 and R22 combine to form a group '\n",
      " '&#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;, R1, R11, R2, R21, R23, '\n",
      " 'R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, '\n",
      " 'R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0138\" num=\"1942\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R22 is '\n",
      " 'hydrogen, fluoro, methy, ethyl, isopropyl, methoxy, &#x2014;C(O)-methyl, '\n",
      " 'fluoromethyl, difluoromethyl, trifluoromethyl, or R21 and R22 combine to '\n",
      " 'form a group &#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;, R1, R11, R2, '\n",
      " 'R21, R23, R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, '\n",
      " 'R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0139\" num=\"1943\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R22 is '\n",
      " 'fluoro, methyl, difluoromethyl or trifluoromethyl, R1, R11, R2, R21, R23, '\n",
      " 'R24, Y, n, R3, R4, R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, '\n",
      " 'R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0140\" num=\"1944\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R23 is '\n",
      " 'hydrogen, halogen, or 1-4C-alkoxy, R1, R11, R2, R21, R22, R24, Y, n, R3, R4, '\n",
      " 'R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as '\n",
      " 'described above or below.</p>\\n'\n",
      " '<p id=\"p-0141\" num=\"1945\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R23 is '\n",
      " 'hydrogen, fluoro, or methoxy, R1, R11, R2, R21, R22, R24, Y, n, R3, R4, R41, '\n",
      " 'R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as '\n",
      " 'described above or below.</p>\\n'\n",
      " '<p id=\"p-0142\" num=\"1946\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein n is 0, '\n",
      " 'R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, R6, R61, R7, '\n",
      " 'R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0143\" num=\"1947\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R3 is a '\n",
      " '5- to 6-membered saturated heterocyclic ring containing one nitrogen atom, '\n",
      " 'said heterocyclic ring being substituted by R4 at said nitrogen atom and '\n",
      " 'optionally substituted by one or two substituents R5 at said heterocyclic '\n",
      " 'ring, or a cyclohexyl or cyclopentyl group substituted by R6 and optionally '\n",
      " 'substituted by R61, R1, R11, R2, R21, R22, R23, R24, Y, R4, R41, R42, R43, '\n",
      " 'R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above '\n",
      " 'or below.</p>\\n'\n",
      " '<p id=\"p-0144\" num=\"1948\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R3 is a '\n",
      " '5- to 6-membered saturated heterocyclic ring containing one nitrogen atom, '\n",
      " 'said heterocyclic ring being substituted by R4 at said nitrogen atom and '\n",
      " 'optionally substituted by one substituent R5 at said heterocyclic ring, or a '\n",
      " 'cyclohexyl or cyclopentyl group substituted by R6 and optionally substituted '\n",
      " 'by R61, R1, R11, R2, R21, R22, R23, R24, Y, R4, R41, R42, R43, R5, R6, R61, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0145\" num=\"1949\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R3 is a '\n",
      " '5- to 6-membered saturated heterocyclic ring containing one nitrogen atom, '\n",
      " 'said heterocyclic ring being substituted by R4 at said nitrogen atom, or a '\n",
      " 'cyclohexyl or cyclopentyl group substituted by R6, R1, R11, R2, R21, R22, '\n",
      " 'R23, R24, Y, R4, R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 '\n",
      " 'and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0146\" num=\"1950\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R3 is '\n",
      " 'piperidine substituted by R4 at the nitrogen atom and optionally substituted '\n",
      " 'by one or two substituents R5 at said piperidine ring, or a cyclohexyl or '\n",
      " 'cyclopentyl group substituted by R6 and optionally substituted by R61, R1, '\n",
      " 'R11, R2, R21, R22, R23, R24, Y, R4, R41, R42, R43, R5, R6, R61, R7, R71, '\n",
      " 'R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0147\" num=\"1951\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R3 is '\n",
      " 'piperidine substituted by R4 at the nitrogen atom, or a cyclohexyl or '\n",
      " 'cyclopentyl group substituted by R6, R1, R11, R2, R21, R22, R23, R24, Y, R4, '\n",
      " 'R41, R42, R43, R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as '\n",
      " 'described above or below.</p>\\n'\n",
      " '<p id=\"p-0148\" num=\"1952\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R4 is '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, R1, R11, R2, R21, R22, R23, R24, Y, R3, R41, R42, R43, '\n",
      " 'R5, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above '\n",
      " 'or below.</p>\\n'\n",
      " '<p id=\"p-0149\" num=\"1953\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R5 is '\n",
      " 'hydroxy, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, R42, R43, R6, R61, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0150\" num=\"1954\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R5 is '\n",
      " 'fluoro, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, R42, R43, R6, R61, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0151\" num=\"1955\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R5 is '\n",
      " 'hydroxy or fluoro, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, R42, '\n",
      " 'R43, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above '\n",
      " 'or below.</p>\\n'\n",
      " '<p id=\"p-0152\" num=\"1956\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R5 is '\n",
      " 'methyl, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, R42, R43, R6, R61, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0153\" num=\"1957\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein two '\n",
      " 'substituents R5 are present, these are identical and binding at the same '\n",
      " 'carbon atom and are fluoro, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, '\n",
      " 'R42, R43, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as described '\n",
      " 'above or below.</p>\\n'\n",
      " '<p id=\"p-0154\" num=\"1958\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein two '\n",
      " 'substituents R5 are present, these are identical and binding at the same '\n",
      " 'carbon atom and are methyl, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, '\n",
      " 'R42, R43, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as described '\n",
      " 'above or below.</p>\\n'\n",
      " '<p id=\"p-0155\" num=\"1959\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein two '\n",
      " 'substituents R5 are present and together with the carbon atom, to which they '\n",
      " 'are bonded, form a spiro-linked cyclopropane ring, R1, R11, R21, R2, R22, '\n",
      " 'R23, R24, Y, R3, R4, R41, R42, R43, R6, R61, R7, R71, R72, R73, R8, R9, R91 '\n",
      " 'and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0156\" num=\"1960\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R5 is '\n",
      " 'halogen or 1-4C-alkyl, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, R42, '\n",
      " 'R43, R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above '\n",
      " 'or below.</p>\\n'\n",
      " '<p id=\"p-0157\" num=\"1961\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R5 is '\n",
      " 'fluoro or methyl, R1, R11, R21, R2, R22, R23, R24, Y, R3, R4, R41, R42, R43, '\n",
      " 'R6, R61, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or '\n",
      " 'below.</p>\\n'\n",
      " '<p id=\"p-0158\" num=\"1962\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7, halogen, hydroxy or NH<sub>2</sub>, R1, '\n",
      " 'R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, R61, R7, R71, R72 '\n",
      " 'and R73 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0159\" num=\"1963\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7, hydroxy or NH<sub>2</sub>, R1, R11, R2, '\n",
      " 'R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, R61, R7, R71, R72 and R73 '\n",
      " 'are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0160\" num=\"1964\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7 or NH<sub>2</sub>, R1, R11, R2, R21, R22, '\n",
      " 'R23, R24, Y, R3, R4, R41, R42, R43, R5, R61, R7, R71, R72 and R73 are as '\n",
      " 'described above or below.</p>\\n'\n",
      " '<p id=\"p-0161\" num=\"1965\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7 or hydroxy, R1, R11, R2, R21, R22, R23, '\n",
      " 'R24, Y, R3, R4, R41, R42, R43, R5, R61, R7, R71, R72 and R73 are as '\n",
      " 'described above or below.</p>\\n'\n",
      " '<p id=\"p-0162\" num=\"1966\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7, R1, R11, R2, R21, R22, R23, R24, Y, R3, '\n",
      " 'R4, R41, R42, R43, R5, R61, R7, R71, R72 and R73 are as described above or '\n",
      " 'below.</p>\\n'\n",
      " '<p id=\"p-0163\" num=\"1967\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R6 is '\n",
      " 'hydroxy, R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5 and '\n",
      " 'R61 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0164\" num=\"1968\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R6 is '\n",
      " 'halogen R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, and '\n",
      " 'R61 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0165\" num=\"1969\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R61 is '\n",
      " 'halogen R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, R6, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0166\" num=\"1970\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R61 is '\n",
      " 'fluoro R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, R6, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0167\" num=\"1971\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R61 is '\n",
      " '1-4C-alkyl R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, '\n",
      " 'R6, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or '\n",
      " 'below.</p>\\n'\n",
      " '<p id=\"p-0168\" num=\"1972\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R61 is '\n",
      " 'methyl R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, R6, '\n",
      " 'R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0169\" num=\"1973\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R61 is '\n",
      " 'halogen or 1-4C-alkyl, R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, '\n",
      " 'R43, R5, R6, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above '\n",
      " 'or below.</p>\\n'\n",
      " '<p id=\"p-0170\" num=\"1974\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R61 is '\n",
      " 'fluoro or methyl, R1, R11, R2, R21, R22, R23, R24, Y, R3, R4, R41, R42, R43, '\n",
      " 'R5, R6, R7, R71, R72, R73, R8, R9, R91 and R92 are as described above or '\n",
      " 'below.</p>\\n'\n",
      " '<p id=\"p-0171\" num=\"1975\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R7 is '\n",
      " '1-4C-alkyl, which is optionally substituted by R71, or 1-4C-alkoxy, R1, R11, '\n",
      " 'R21, R2, R22, R23, R24, Y, R3, R4, R41, R42, R43, R5, R6, R61, R71, R8, R9, '\n",
      " 'R91 and R92 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0172\" num=\"1976\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl, n is 0, R2 is hydrogen, R3 is a 5- '\n",
      " 'to 6-membered saturated heterocyclic ring containing one nitrogen atom, said '\n",
      " 'heterocyclic ring being substituted by R4 at said nitrogen atom and '\n",
      " 'optionally substituted by one or two substituents R5 at said heterocyclic '\n",
      " 'ring, or a cyclohexyl or cyclopentyl group substituted by R6 and optionally '\n",
      " 'substituted by R61, R4 is &#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl '\n",
      " 'group is optionally substituted by R41, R6 is '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7 or hydroxy, R7 is 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, or 1-4C-alkoxy, R21, R22, R23, R24, Y, R41 '\n",
      " 'R5, R61 and R71 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0173\" num=\"1977\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl, n is 0, R2 is hydrogen, R3 is a 5- '\n",
      " 'to 6-membered saturated heterocyclic ring containing one nitrogen atom, said '\n",
      " 'heterocyclic ring being substituted by R4 at said nitrogen atom and '\n",
      " 'optionally substituted by one substituent R5 at said heterocyclic ring, or a '\n",
      " 'cyclohexyl or cyclopentyl group substituted by R6 and optionally substituted '\n",
      " 'by R61, R4 is &#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is '\n",
      " 'optionally substituted by R41, R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, R7 is '\n",
      " '1-4C-alkyl, which is optionally substituted by R71, or 1-4C-alkoxy, R21, '\n",
      " 'R22, R23, R24, Y, R41 R5, R61 and R71 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0174\" num=\"1978\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl, n is 0, R2 is hydrogen, R3 is a 5- '\n",
      " 'to 6-membered saturated heterocyclic ring containing one nitrogen atom, said '\n",
      " 'heterocyclic ring being substituted by R4 at said nitrogen atom, or a '\n",
      " 'cyclohexyl or cyclopentyl group substituted by R6, R4 is '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7 or hydroxy, R7 is '\n",
      " '1-4C-alkyl, which is optionally substituted by R71, or 1-4C-alkoxy, R21, '\n",
      " 'R22, R23, R24, Y, R41 and R71 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0175\" num=\"1979\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I) or salts thereof, wherein R1 is '\n",
      " '&#x2014;CH<sub>2</sub>-3-4C-cycloalkyl, n is 0, R2 is hydrogen, R3 is a 5- '\n",
      " 'to 6-membered saturated heterocyclic ring containing one nitrogen atom, said '\n",
      " 'heterocyclic ring being substituted by R4 at said nitrogen atom, or a '\n",
      " 'cyclohexyl or cyclopentyl group substituted by R6, R4 is '\n",
      " '&#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R41, R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7, R7 is '\n",
      " '1-4C-alkyl, which is optionally substituted by R71, or 1-4C-alkoxy, R21, '\n",
      " 'R22, R23, R24, Y, R41 and R71 are as described above or below.</p>\\n'\n",
      " '<p id=\"p-0176\" num=\"1980\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), selected from '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3S*,4S*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (1-acetyl-piperidin-4-yl)-amide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-(2-methoxy-acetyl)-piperidin-4-yl]-amide; Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propionylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3S*,4S*)-1-Acetyl-4-hydroxypiperidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxy-1-propionylpiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxy-1-(methoxyacetyl)piperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-(1-acetylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-Acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-Acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R)-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-(2-hydroxy-acetyl)-piperidin-4-yl]-amide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-((S)-2-hydroxy-propionyl)-piperidin-4-yl]-amide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R)-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-1-glycoloyl-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methyl '\n",
      " 'phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methyl '\n",
      " 'phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide-4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'Tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'Tert-butyl(3S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-({1-[4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl]-methanoyl}-amino)-piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-({[4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl]amino)piperidine-1-carboxylate; '\n",
      " 'tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '(3S*,4S*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate;</p>\\n'\n",
      " '<p id=\"h-0004\" num=\"0000\">a salt thereof, or a stereoisomer of the compound '\n",
      " 'or a salt thereof.</p>\\n'\n",
      " '<p id=\"p-0177\" num=\"1981\">In an alternative embodiment, the present subject '\n",
      " 'matter relates to compounds of formula (I), selected from '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3S*,4S*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (1-acetyl-piperidin-4-yl)-amide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-(2-methoxy-acetyl)-piperidin-4-yl]-amide; Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-acetylpiperidin-4-yl)-4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propionylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3S*,4S*)-1-Acetyl-4-hydroxypiperidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxy-1-propionylpiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxy-1-(methoxyacetyl)piperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-(1-acetylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-Acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R)-1-Acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy-5-fluoro-4-methoxyphenyl]-N-([3R*,4R*)-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R)-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-(2-hydroxy-acetyl)-piperidin-4-yl]-amide; '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-((S)-2-hydroxy-propionyl)-piperidin-4-yl]-amide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R)-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-(2-Ethoxy-5-fluorophenyl)-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-1-glycoloyl-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methyl '\n",
      " 'phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide-4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'Tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'Tert-butyl(3S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-({1-[4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl]-methanoyl}-amino)-piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-({[4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl]amino)piperidine-1-carboxylate; '\n",
      " 'tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '(3S*,4S*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate; '\n",
      " 'tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate; '\n",
      " 'N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5<sup>H</sup>-pyrrolo[3,2-<sup>d</sup>]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(3S,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S,5S)-5-methyl-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,5S)-1-(methoxyacetyl)-5-methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S,3S)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S,3S)-3-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S,3S)-3-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,2S*,4S*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,2S*,4S*)-2-methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2S*,4S*)-4-[(methoxyacetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,3S*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,3S*,4S*)-3-methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-4-[(methoxyacetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,3S*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3S*,4S*)-3-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-3-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,3S*,4S*)-3-(Acetylamino)-4-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,3S*,4S*)-3-methyl-4-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3S*,4S*)-3-[(methoxyacetyl)amino]-4-methylcyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-methyl-4-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-4-[(methoxyacetyl)amino]-2-methylcyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,3S*,4S*)-3-(Acetylamino)-4-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3S*,4S*)-3-fluoro-4-(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-3-fluoro-4-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide;</p>\\n'\n",
      " '<p id=\"h-0005\" num=\"0000\">a salt thereof, or a stereoisomer of the compound '\n",
      " 'or a salt thereof.</p>\\n'\n",
      " '<p id=\"p-0178\" num=\"1982\">It is to be understood that the present subject '\n",
      " 'matter covers all combinations of substituent groups referred to '\n",
      " 'hereinabove. In particular, the present subject matter covers all '\n",
      " 'combinations of alternative or preferred groups described hereinabove.</p>\\n'\n",
      " '<p id=\"p-0179\" num=\"1983\">Salts of the compounds according to the present '\n",
      " 'subject matter and the stereoisomers thereof include all inorganic and '\n",
      " 'organic acid addition salts and salts with bases, especially all '\n",
      " 'pharmaceutically acceptable inorganic and organic acid addition salts and '\n",
      " 'salts with bases, particularly all pharmaceutically acceptable inorganic and '\n",
      " 'organic acid addition salts and salts with bases customarily used in '\n",
      " 'pharmacy.</p>\\n'\n",
      " '<p id=\"p-0180\" num=\"1984\">Examples of acid addition salts include, but are '\n",
      " 'not limited to, hydrochlorides, hydrobromides, phosphates, nitrates, '\n",
      " 'sulfates, acetates, trifluoroacetates, citrates, gluconates including '\n",
      " 'D-gluconates and L-gluconates, glucuronates including D-glucuronates and '\n",
      " 'L-glucuronates, benzoates, 2-(4-hydroxybenzoyl)benzoates, butyrates, '\n",
      " 'salicylates, sulfosalicylates, maleates, laurates, malates including '\n",
      " 'L-malates and D-malates, lactates including L-lactates and D-lactates, '\n",
      " 'fumarates, succinates, oxalates, tartarates including L-tartarates, '\n",
      " 'D-tartarates and meso-tartarates, stearates, benzenesulfonates (besilates), '\n",
      " 'toluenesulfonates (tosilates), methanesulfonates (mesilates), '\n",
      " 'laurylsulfonates, 3-hydroxy-2-naphthoates, lactobionates (salts of '\n",
      " '4-O-beta-D-galactopyranosyl-D-gluconic acid), galactarates, embonates and '\n",
      " 'ascorbates.</p>\\n'\n",
      " '<p id=\"p-0181\" num=\"1985\">Examples of salts with bases include, but are not '\n",
      " 'limited to, lithium, sodium, potassium, calcium, aluminum, magnesium, '\n",
      " 'titanium, ammonium, meglumine and guanidinium salts.</p>\\n'\n",
      " '<p id=\"p-0182\" num=\"1986\">The salts include water-insoluble and, '\n",
      " 'particularly, water-soluble salts.</p>\\n'\n",
      " '<p id=\"p-0183\" num=\"1987\">The compounds according to the present subject '\n",
      " 'matter, the salts thereof, the stereoisomers of the compounds and the salts '\n",
      " 'thereof may contain, e.g. when isolated in crystalline form, varying amounts '\n",
      " 'of solvents. Included within the scope of the present subject matter are, '\n",
      " 'therefore, all solvates of the compounds of formula (I), the salts thereof, '\n",
      " 'the stereoisomers of the compounds and the salts thereof. Hydrates are a '\n",
      " 'preferred example of said solvates.</p>\\n'\n",
      " '<p id=\"p-0184\" num=\"1988\">Some of the compounds of formula 1, salts thereof, '\n",
      " 'stereoisomers thereof or salts of the latter may exist in different '\n",
      " 'crystalline forms (polymorphs), which are within the scope of the invention. '\n",
      " 'The obtained solids of the compounds of formula 1, salts thereof, '\n",
      " 'stereoisomers thereof or salts of the latter are re-crystalised in different '\n",
      " 'crystalline forms (polymorphs) with solvents or mixtures of the solvents '\n",
      " 'selected from water, methanol, ethanol, isopropanol, n-butanol, '\n",
      " 'dichloromethane, tert-butylmethylether, acetonitril, dioxan, '\n",
      " 'methylethylketon, aceton, glycole, ethylene glycol, '\n",
      " 'methylisobutylketon,</p>\\n'\n",
      " '<p id=\"p-0185\" num=\"1989\">The compounds according to the present subject '\n",
      " 'matter and the salts thereof include stereoisomers.</p>\\n'\n",
      " '<p id=\"p-0186\" num=\"1990\">Examples of stereoisomers include, but are not '\n",
      " 'limited to, compounds of formula (I) wherein R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6. Stereoisomers of one exemplified compound of formula (I) '\n",
      " 'wherein R3 is a 3-6C-cycloalkyl group substituted by R6 are shown below '\n",
      " '(cis/trans stereoisomers), wherein the trans stereoisomer (S1) is '\n",
      " 'preferred:</p>\\n'\n",
      " '<p id=\"p-0187\" num=\"1991\"><chemistry id=\"CHEM-US-00003\" num=\"00003\">\\n'\n",
      " '<img id=\"EMI-C00003\" he=\"151.05mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00003.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0188\" num=\"1992\">Furthermore the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0189\" num=\"1993\"><chemistry id=\"CHEM-US-00004\" num=\"00004\">\\n'\n",
      " '<img id=\"EMI-C00004\" he=\"224.20mm\" wi=\"63.92mm\" '\n",
      " 'file=\"US08927557-20150106-C00004.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00005\" num=\"00005\">\\n'\n",
      " '<img id=\"EMI-C00005\" he=\"231.65mm\" wi=\"63.92mm\" '\n",
      " 'file=\"US08927557-20150106-C00005.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00006\" num=\"00006\">\\n'\n",
      " '<img id=\"EMI-C00006\" he=\"159.94mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00006.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0190\" num=\"1994\">Examples of stereoisomers include, but are not '\n",
      " 'limited to, compounds of formula (I) wherein R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61. Stereoisomers of one '\n",
      " 'exemplified compound of formula (I) wherein R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61 includes the pure '\n",
      " '(S,S,S)-isomers, (S,S,R)-isomers, (S,R,S)-isomers and (S,R,R)-isomers, '\n",
      " '(R,R,R)-isomers, (R,R,S)-isomers, (R,S,S)-isomers and (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio, wherein the stereoisomers '\n",
      " '(S11), (S13), (S15) and (S18) and mixtures of two or more thereof in any '\n",
      " 'ratio are preferred. An example of said isomers is shown below:</p>\\n'\n",
      " '<p id=\"p-0191\" num=\"1995\"><chemistry id=\"CHEM-US-00007\" num=\"00007\">\\n'\n",
      " '<img id=\"EMI-C00007\" he=\"239.18mm\" wi=\"63.58mm\" '\n",
      " 'file=\"US08927557-20150106-C00007.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00008\" num=\"00008\">\\n'\n",
      " '<img id=\"EMI-C00008\" he=\"237.24mm\" wi=\"63.58mm\" '\n",
      " 'file=\"US08927557-20150106-C00008.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00009\" num=\"00009\">\\n'\n",
      " '<img id=\"EMI-C00009\" he=\"167.72mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00009.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0192\" num=\"1996\">Furthermore examples of stereoisomers include, but '\n",
      " 'are not limited to, compounds of formula (I) wherein R3 is a 3-6C-cycloalkyl '\n",
      " 'group substituted by R6 and optionally substituted by R61. Stereoisomers of '\n",
      " 'one exemplified compound of formula (I) wherein R3 is a 3-6C-cycloalkyl '\n",
      " 'group substituted by R6 and optionally substituted by R61 includes the pure '\n",
      " '(S,S,S)-isomers, (S,S,R)-isomers, (S,R,S)-isomers and (S,R,R)-isomers, '\n",
      " '(R,R,R)-isomers, (R,R,S)-isomers, (R,S,S)-isomers and (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio, wherein the stereoisomers '\n",
      " '(S19), (S21), (S23) and (S26) and mixtures of two or more thereof in any '\n",
      " 'ratio are preferred. An example of said isomers is shown below:</p>\\n'\n",
      " '<p id=\"p-0193\" num=\"1997\"><chemistry id=\"CHEM-US-00010\" num=\"00010\">\\n'\n",
      " '<img id=\"EMI-C00010\" he=\"239.27mm\" wi=\"63.58mm\" '\n",
      " 'file=\"US08927557-20150106-C00010.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00011\" num=\"00011\">\\n'\n",
      " '<img id=\"EMI-C00011\" he=\"244.52mm\" wi=\"63.58mm\" '\n",
      " 'file=\"US08927557-20150106-C00011.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00012\" num=\"00012\">\\n'\n",
      " '<img id=\"EMI-C00012\" he=\"170.26mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00012.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0194\" num=\"1998\">Further examples of stereoisomers include, but are '\n",
      " 'not limited to, compounds of formula (I) wherein R3 is a 4- to 7-membered '\n",
      " 'saturated heterocyclic ring containing one nitrogen atom and optionally one '\n",
      " 'oxygen atom, said heterocyclic ring being optionally substituted by R4 and '\n",
      " 'wherein said heterocyclic ring contains a stereogenic center. Stereoisomers '\n",
      " 'of an exemplified compound of formula (I) wherein R3 is a 4- to 7-membered '\n",
      " 'saturated heterocyclic ring containing one nitrogen atom, said heterocyclic '\n",
      " 'ring being optionally substituted by R4 and said heterocyclic ring '\n",
      " 'containing a stereogenic center are shown below:</p>\\n'\n",
      " '<p id=\"p-0195\" num=\"1999\"><chemistry id=\"CHEM-US-00013\" num=\"00013\">\\n'\n",
      " '<img id=\"EMI-C00013\" he=\"135.21mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00013.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0196\" num=\"2000\">Further examples of stereoisomers include, but are '\n",
      " 'not limited to, compounds of formula (I) wherein R3 is a 4- to 7-membered '\n",
      " 'saturated heterocyclic ring containing one nitrogen atom and optionally one '\n",
      " 'oxygen atom, said heterocyclic ring being optionally substituted by R4 '\n",
      " 'and/or by two substituents R5 and wherein said heterocyclic ring contains a '\n",
      " 'stereogenic center. Stereoisomers of an exemplified compound of formula (I) '\n",
      " 'wherein R3 is a 4- to 7-membered saturated heterocyclic ring containing one '\n",
      " 'nitrogen atom, said heterocyclic ring being optionally substituted by R4 '\n",
      " 'and/or by two substituents R5 and said heterocyclic ring containing a '\n",
      " 'stereogenic center are shown below:</p>\\n'\n",
      " '<p id=\"p-0197\" num=\"2001\"><chemistry id=\"CHEM-US-00014\" num=\"00014\">\\n'\n",
      " '<img id=\"EMI-C00014\" he=\"133.77mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00014.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0198\" num=\"2002\">Further examples of stereoisomers include, but are '\n",
      " 'not limited to, compounds of formula (I) wherein R3 is a 4- to 7-membered '\n",
      " 'saturated heterocyclic ring containing one nitrogen atom and optionally one '\n",
      " 'oxygen atom, said heterocyclic ring being optionally substituted by R4 '\n",
      " 'and/or R5 and wherein said heterocyclic ring contains stereogenic centers. '\n",
      " 'The present subject matter includes the pure (R,R)-isomers, (R,S)-isomers, '\n",
      " '(S,R)-isomers and (S,S)-isomers, and mixtures of two or more thereof in any '\n",
      " 'ratio. An example of said isomers is shown below:</p>\\n'\n",
      " '<p id=\"p-0199\" num=\"2003\"><chemistry id=\"CHEM-US-00015\" num=\"00015\">\\n'\n",
      " '<img id=\"EMI-C00015\" he=\"192.45mm\" wi=\"71.04mm\" '\n",
      " 'file=\"US08927557-20150106-C00015.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00016\" num=\"00016\">\\n'\n",
      " '<img id=\"EMI-C00016\" he=\"70.61mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00016.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0200\" num=\"2004\">Furthermore the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0201\" num=\"2005\"><chemistry id=\"CHEM-US-00017\" num=\"00017\">\\n'\n",
      " '<img id=\"EMI-C00017\" he=\"192.45mm\" wi=\"71.04mm\" '\n",
      " 'file=\"US08927557-20150106-C00017.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00018\" num=\"00018\">\\n'\n",
      " '<img id=\"EMI-C00018\" he=\"70.61mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00018.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0202\" num=\"2006\">Furthermore the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0203\" num=\"2007\"><chemistry id=\"CHEM-US-00019\" num=\"00019\">\\n'\n",
      " '<img id=\"EMI-C00019\" he=\"192.87mm\" wi=\"71.04mm\" '\n",
      " 'file=\"US08927557-20150106-C00019.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00020\" num=\"00020\">\\n'\n",
      " '<img id=\"EMI-C00020\" he=\"70.95mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00020.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0204\" num=\"2008\">Furthermore the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0205\" num=\"2009\"><chemistry id=\"CHEM-US-00021\" num=\"00021\">\\n'\n",
      " '<img id=\"EMI-C00021\" he=\"204.47mm\" wi=\"71.04mm\" '\n",
      " 'file=\"US08927557-20150106-C00021.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00022\" num=\"00022\">\\n'\n",
      " '<img id=\"EMI-C00022\" he=\"70.95mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00022.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0206\" num=\"2010\">Stereoisomers of a further exemplified compound of '\n",
      " 'formula (I) wherein R3 is a 4- to 7-membered saturated heterocyclic ring '\n",
      " 'containing one nitrogen atom, said heterocyclic ring being optionally '\n",
      " 'substituted by R4 and said heterocyclic ring containing a stereogenic center '\n",
      " 'are shown below:</p>\\n'\n",
      " '<p id=\"p-0207\" num=\"2011\"><chemistry id=\"CHEM-US-00023\" num=\"00023\">\\n'\n",
      " '<img id=\"EMI-C00023\" he=\"144.53mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00023.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0208\" num=\"2012\">Stereoisomers of a further exemplified compound of '\n",
      " 'formula (I) wherein R3 is a 4- to 7-membered saturated heterocyclic ring '\n",
      " 'containing one nitrogen atom, said heterocyclic ring being optionally '\n",
      " 'substituted by R4 and/or R5 and said heterocyclic ring containing '\n",
      " 'stereogenic centers. The present subject matter includes the pure '\n",
      " '(R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and mixtures '\n",
      " 'of two or more thereof in any ratio. An example of said isomers is shown '\n",
      " 'below:</p>\\n'\n",
      " '<p id=\"p-0209\" num=\"2013\"><chemistry id=\"CHEM-US-00024\" num=\"00024\">\\n'\n",
      " '<img id=\"EMI-C00024\" he=\"201.42mm\" wi=\"70.53mm\" '\n",
      " 'file=\"US08927557-20150106-C00024.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00025\" num=\"00025\">\\n'\n",
      " '<img id=\"EMI-C00025\" he=\"72.81mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00025.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0210\" num=\"2014\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0211\" num=\"2015\"><chemistry id=\"CHEM-US-00026\" num=\"00026\">\\n'\n",
      " '<img id=\"EMI-C00026\" he=\"211.16mm\" wi=\"70.53mm\" '\n",
      " 'file=\"US08927557-20150106-C00026.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00027\" num=\"00027\">\\n'\n",
      " '<img id=\"EMI-C00027\" he=\"217.85mm\" wi=\"70.53mm\" '\n",
      " 'file=\"US08927557-20150106-C00027.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00028\" num=\"00028\">\\n'\n",
      " '<img id=\"EMI-C00028\" he=\"152.32mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00028.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0212\" num=\"2016\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0213\" num=\"2017\"><chemistry id=\"CHEM-US-00029\" num=\"00029\">\\n'\n",
      " '<img id=\"EMI-C00029\" he=\"211.16mm\" wi=\"70.53mm\" '\n",
      " 'file=\"US08927557-20150106-C00029.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00030\" num=\"00030\">\\n'\n",
      " '<img id=\"EMI-C00030\" he=\"215.22mm\" wi=\"70.53mm\" '\n",
      " 'file=\"US08927557-20150106-C00030.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00031\" num=\"00031\">\\n'\n",
      " '<img id=\"EMI-C00031\" he=\"149.69mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00031.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0214\" num=\"2018\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0215\" num=\"2019\"><chemistry id=\"CHEM-US-00032\" num=\"00032\">\\n'\n",
      " '<img id=\"EMI-C00032\" he=\"201.51mm\" wi=\"68.92mm\" '\n",
      " 'file=\"US08927557-20150106-C00032.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00033\" num=\"00033\">\\n'\n",
      " '<img id=\"EMI-C00033\" he=\"72.81mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00033.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0216\" num=\"2020\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0217\" num=\"2021\"><chemistry id=\"CHEM-US-00034\" num=\"00034\">\\n'\n",
      " '<img id=\"EMI-C00034\" he=\"201.51mm\" wi=\"68.92mm\" '\n",
      " 'file=\"US08927557-20150106-C00034.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00035\" num=\"00035\">\\n'\n",
      " '<img id=\"EMI-C00035\" he=\"72.81mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00035.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0218\" num=\"2022\">Further examples of stereoisomers include, but are '\n",
      " 'not limited to, compounds of formula (I) wherein R4 is a group having a '\n",
      " 'stereogenic center, such as a group '\n",
      " '&#x2014;C(O)&#x2014;CH(CH<sub>3</sub>)&#x2014;OH. Further examples of '\n",
      " 'stereoisomers include, but are not limited to, compounds of formula (I) '\n",
      " 'wherein R6 is a group having a stereogenic center, such as a group '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;CH(CH<sub>3</sub>)&#x2014;OCH<sub>3</sub>.</p>\\n'\n",
      " '<p id=\"p-0219\" num=\"2023\">Each of said stereogenic centers may have the '\n",
      " 'absolute configuration R or the absolute configuration S (according to the '\n",
      " 'rules of Cahn, Ingold and Prelog).</p>\\n'\n",
      " '<p id=\"p-0220\" num=\"2024\">The present subject matter relates to the pure '\n",
      " 'stereoisomers and to mixtures of the stereoisomers independent of the ratio, '\n",
      " 'including the racemates. Accordingly, the present subject matter relates to '\n",
      " 'the pure (cis)-isomers, the pure (trans)-isomers, and mixtures thereof, the '\n",
      " 'pure (R)-isomers, the pure (S)-isomers, and mixtures thereof, the pure '\n",
      " '(RS)-isomers, the pure (SS)-isomers, the pure (SR)-isomers, the pure '\n",
      " '(RR)-isomers, and mixtures of two or more thereof in any ratio.</p>\\n'\n",
      " '<p id=\"p-0221\" num=\"2025\">Furthermore, the present subject matter includes '\n",
      " 'the pure (trans,R)-isomers, (trans,S)-isomers, (cis,R)-isomers and '\n",
      " '(cis,S)-isomers, and mixtures of two or more thereof in any ratio, wherein '\n",
      " 'the stereoisomers (S77) and (S78) and mixtures of two or more thereof in any '\n",
      " 'ratio are preferred. An example of said isomers is shown below:</p>\\n'\n",
      " '<p id=\"p-0222\" num=\"2026\"><chemistry id=\"CHEM-US-00036\" num=\"00036\">\\n'\n",
      " '<img id=\"EMI-C00036\" he=\"166.71mm\" wi=\"70.36mm\" '\n",
      " 'file=\"US08927557-20150106-C00036.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00037\" num=\"00037\">\\n'\n",
      " '<img id=\"EMI-C00037\" he=\"177.12mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00037.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0223\" num=\"2027\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0224\" num=\"2028\"><chemistry id=\"CHEM-US-00038\" num=\"00038\">\\n'\n",
      " '<img id=\"EMI-C00038\" he=\"210.48mm\" wi=\"72.98mm\" '\n",
      " 'file=\"US08927557-20150106-C00038.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00039\" num=\"00039\">\\n'\n",
      " '<img id=\"EMI-C00039\" he=\"82.13mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00039.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0225\" num=\"2029\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0226\" num=\"2030\"><chemistry id=\"CHEM-US-00040\" num=\"00040\">\\n'\n",
      " '<img id=\"EMI-C00040\" he=\"207.77mm\" wi=\"72.98mm\" '\n",
      " 'file=\"US08927557-20150106-C00040.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00041\" num=\"00041\">\\n'\n",
      " '<img id=\"EMI-C00041\" he=\"81.70mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00041.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0227\" num=\"2031\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0228\" num=\"2032\"><chemistry id=\"CHEM-US-00042\" num=\"00042\">\\n'\n",
      " '<img id=\"EMI-C00042\" he=\"203.28mm\" wi=\"73.49mm\" '\n",
      " 'file=\"US08927557-20150106-C00042.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00043\" num=\"00043\">\\n'\n",
      " '<img id=\"EMI-C00043\" he=\"85.26mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00043.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0229\" num=\"2033\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0230\" num=\"2034\"><chemistry id=\"CHEM-US-00044\" num=\"00044\">\\n'\n",
      " '<img id=\"EMI-C00044\" he=\"207.77mm\" wi=\"72.98mm\" '\n",
      " 'file=\"US08927557-20150106-C00044.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00045\" num=\"00045\">\\n'\n",
      " '<img id=\"EMI-C00045\" he=\"81.70mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00045.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0231\" num=\"2035\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0232\" num=\"2036\"><chemistry id=\"CHEM-US-00046\" num=\"00046\">\\n'\n",
      " '<img id=\"EMI-C00046\" he=\"243.16mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00046.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0233\" num=\"2037\">Furthermore, the present subject matter includes '\n",
      " 'the pure (R,R)-isomers, (R,S)-isomers, (S,R)-isomers and (S,S)-isomers, and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0234\" num=\"2038\"><chemistry id=\"CHEM-US-00047\" num=\"00047\">\\n'\n",
      " '<img id=\"EMI-C00047\" he=\"245.11mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00047.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0235\" num=\"2039\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,R,S)-isomers, (R,R,S)-isomers, (S,R,R)-isomers, (R,R,R)-isomers, '\n",
      " '(S,S,S)-isomers, (R,S,S)-isomers and (S,S,R)-isomers, (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0236\" num=\"2040\"><chemistry id=\"CHEM-US-00048\" num=\"00048\">\\n'\n",
      " '<img id=\"EMI-C00048\" he=\"252.05mm\" wi=\"74.34mm\" '\n",
      " 'file=\"US08927557-20150106-C00048.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00049\" num=\"00049\">\\n'\n",
      " '<img id=\"EMI-C00049\" he=\"252.98mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00049.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0237\" num=\"2041\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,R,S)-isomers, (R,R,S)-isomers, (S,R,R)-isomers, (R,R,R)-isomers, '\n",
      " '(S,S,S)-isomers, (R,S,S)-isomers and (S,S,R)-isomers, (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0238\" num=\"2042\"><chemistry id=\"CHEM-US-00050\" num=\"00050\">\\n'\n",
      " '<img id=\"EMI-C00050\" he=\"198.54mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00050.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00051\" num=\"00051\">\\n'\n",
      " '<img id=\"EMI-C00051\" he=\"192.19mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00051.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00052\" num=\"00052\">\\n'\n",
      " '<img id=\"EMI-C00052\" he=\"138.68mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00052.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0239\" num=\"2043\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,R,S)-isomers, (R,R,S)-isomers, (S,R,R)-isomers, (R,R,R)-isomers, '\n",
      " '(S,S,S)-isomers, (R,S,S)-isomers and (S,S,R)-isomers, (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0240\" num=\"2044\"><chemistry id=\"CHEM-US-00053\" num=\"00053\">\\n'\n",
      " '<img id=\"EMI-C00053\" he=\"194.06mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00053.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00054\" num=\"00054\">\\n'\n",
      " '<img id=\"EMI-C00054\" he=\"199.22mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00054.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00055\" num=\"00055\">\\n'\n",
      " '<img id=\"EMI-C00055\" he=\"147.07mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00055.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0241\" num=\"2045\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,R,S)-isomers, (R,R,S)-isomers, (S,R,R)-isomers, (R,R,R)-isomers, '\n",
      " '(S,S,S)-isomers, (R,S,S)-isomers and (S,S,R)-isomers, (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0242\" num=\"2046\"><chemistry id=\"CHEM-US-00056\" num=\"00056\">\\n'\n",
      " '<img id=\"EMI-C00056\" he=\"190.67mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00056.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00057\" num=\"00057\">\\n'\n",
      " '<img id=\"EMI-C00057\" he=\"192.28mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00057.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00058\" num=\"00058\">\\n'\n",
      " '<img id=\"EMI-C00058\" he=\"144.02mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00058.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0243\" num=\"2047\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,R,S)-isomers, (R,R,S)-isomers, (S,R,R)-isomers, (R,R,R)-isomers, '\n",
      " '(S,S,S)-isomers, (R,S,S)-isomers and (S,S,R)-isomers, (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0244\" num=\"2048\"><chemistry id=\"CHEM-US-00059\" num=\"00059\">\\n'\n",
      " '<img id=\"EMI-C00059\" he=\"197.02mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00059.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00060\" num=\"00060\">\\n'\n",
      " '<img id=\"EMI-C00060\" he=\"195.16mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00060.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00061\" num=\"00061\">\\n'\n",
      " '<img id=\"EMI-C00061\" he=\"139.78mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00061.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0245\" num=\"2049\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,R,S)-isomers, (R,R,S)-isomers, (S,R,R)-isomers, (R,R,R)-isomers, '\n",
      " '(S,S,S)-isomers, (R,S,S)-isomers and (S,S,R)-isomers, (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0246\" num=\"2050\"><chemistry id=\"CHEM-US-00062\" num=\"00062\">\\n'\n",
      " '<img id=\"EMI-C00062\" he=\"191.26mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00062.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00063\" num=\"00063\">\\n'\n",
      " '<img id=\"EMI-C00063\" he=\"190.42mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00063.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00064\" num=\"00064\">\\n'\n",
      " '<img id=\"EMI-C00064\" he=\"134.96mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00064.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0247\" num=\"2051\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,R,S)-isomers, (R,R,S)-isomers, (S,R,R)-isomers, (R,R,R)-isomers, '\n",
      " '(S,S,S)-isomers, (R,S,S)-isomers and (S,S,R)-isomers, (R,S,R)-isomers and '\n",
      " 'mixtures of two or more thereof in any ratio. An example of said isomers is '\n",
      " 'shown below:</p>\\n'\n",
      " '<p id=\"p-0248\" num=\"2052\"><chemistry id=\"CHEM-US-00065\" num=\"00065\">\\n'\n",
      " '<img id=\"EMI-C00065\" he=\"188.30mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00065.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00066\" num=\"00066\">\\n'\n",
      " '<img id=\"EMI-C00066\" he=\"198.29mm\" wi=\"75.78mm\" '\n",
      " 'file=\"US08927557-20150106-C00066.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00067\" num=\"00067\">\\n'\n",
      " '<img id=\"EMI-C00067\" he=\"140.97mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00067.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0249\" num=\"2053\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,S,S,S)-isomers, (S,S,S,R)-isomers, (R,S,S,S)-isomers and '\n",
      " '(R,S,S,R)-isomers, (S,R,S,S)-isomers, (S,R,S,R)-isomers, (R,R,S,S)-isomers, '\n",
      " '(R,R,S,R)-isomers, (S,S,R,S)-isomers, (S,S,R,R)-isomers, (R,S,R,S)-isomers, '\n",
      " '(R,S,R,R)-isomers, (S,R,R,S)-isomers, (S,R,R,R)-isomers, (R,R,R,S)-isomers '\n",
      " 'and (R,R,R,R)-isomers and mixtures of two or more thereof in any ratio, '\n",
      " 'wherein the stereoisomers (S161), (S162), (S165), (S166), (S171), (S172), '\n",
      " '(S175) and (S176) and mixtures of two or more thereof in any ratio are '\n",
      " 'preferred. An example of said isomers is shown below:</p>\\n'\n",
      " '<p id=\"p-0250\" num=\"2054\"><chemistry id=\"CHEM-US-00068\" num=\"00068\">\\n'\n",
      " '<img id=\"EMI-C00068\" he=\"172.72mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00068.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00069\" num=\"00069\">\\n'\n",
      " '<img id=\"EMI-C00069\" he=\"172.72mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00069.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00070\" num=\"00070\">\\n'\n",
      " '<img id=\"EMI-C00070\" he=\"172.72mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00070.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00071\" num=\"00071\">\\n'\n",
      " '<img id=\"EMI-C00071\" he=\"172.72mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00071.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00072\" num=\"00072\">\\n'\n",
      " '<img id=\"EMI-C00072\" he=\"172.72mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00072.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00073\" num=\"00073\">\\n'\n",
      " '<img id=\"EMI-C00073\" he=\"172.72mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00073.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00074\" num=\"00074\">\\n'\n",
      " '<img id=\"EMI-C00074\" he=\"172.72mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00074.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00075\" num=\"00075\">\\n'\n",
      " '<img id=\"EMI-C00075\" he=\"189.57mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00075.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0251\" num=\"2055\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,S,S,S)-isomers, (S,S,S,R)-isomers, (R,S,S,S)-isomers and '\n",
      " '(R,S,S,R)-isomers, (S,R,S,S)-isomers, (S,R,S,R)-isomers, (R,R,S,S)-isomers, '\n",
      " '(R,R,S,R)-isomers, (S,S,R,S)-isomers, (S,S,R,R)-isomers, (R,S,R,S)-isomers, '\n",
      " '(R,S,R,R)-isomers, (S,R,R,S)-isomers, (S,R,R,R)-isomers, (R,R,R,S)-isomers '\n",
      " 'and (R,R,R,R)-isomers and mixtures of two or more thereof in any ratio, '\n",
      " 'wherein the stereoisomers (S177), (S178), (S181), (S182), (S187), (S188), '\n",
      " '(S191) and (S192) and mixtures of two or more thereof in any ratio are '\n",
      " 'preferred. An example of said isomers is shown below:</p>\\n'\n",
      " '<p id=\"p-0252\" num=\"2056\"><chemistry id=\"CHEM-US-00076\" num=\"00076\">\\n'\n",
      " '<img id=\"EMI-C00076\" he=\"181.44mm\" wi=\"72.05mm\" '\n",
      " 'file=\"US08927557-20150106-C00076.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00077\" num=\"00077\">\\n'\n",
      " '<img id=\"EMI-C00077\" he=\"185.84mm\" wi=\"71.97mm\" '\n",
      " 'file=\"US08927557-20150106-C00077.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00078\" num=\"00078\">\\n'\n",
      " '<img id=\"EMI-C00078\" he=\"185.84mm\" wi=\"72.14mm\" '\n",
      " 'file=\"US08927557-20150106-C00078.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00079\" num=\"00079\">\\n'\n",
      " '<img id=\"EMI-C00079\" he=\"185.84mm\" wi=\"71.88mm\" '\n",
      " 'file=\"US08927557-20150106-C00079.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00080\" num=\"00080\">\\n'\n",
      " '<img id=\"EMI-C00080\" he=\"185.84mm\" wi=\"71.88mm\" '\n",
      " 'file=\"US08927557-20150106-C00080.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00081\" num=\"00081\">\\n'\n",
      " '<img id=\"EMI-C00081\" he=\"185.84mm\" wi=\"71.88mm\" '\n",
      " 'file=\"US08927557-20150106-C00081.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00082\" num=\"00082\">\\n'\n",
      " '<img id=\"EMI-C00082\" he=\"185.84mm\" wi=\"72.05mm\" '\n",
      " 'file=\"US08927557-20150106-C00082.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00083\" num=\"00083\">\\n'\n",
      " '<img id=\"EMI-C00083\" he=\"206.59mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00083.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0253\" num=\"2057\">Furthermore, the present subject matter includes '\n",
      " 'the pure (S,S,S,S)-isomers, (S,S,S,R)-isomers, (R,S,S,S)-isomers and '\n",
      " '(R,S,S,R)-isomers, (S,R,S,S)-isomers, (S,R,S,R)-isomers, (R,R,S,S)-isomers, '\n",
      " '(R,R,S,R)-isomers, (S,S,R,S)-isomers, (S,S,R,R)-isomers, (R,S,R,S)-isomers, '\n",
      " '(R,S,R,R)-isomers, (S,R,R,S)-isomers, (S,R,R,R)-isomers, (R,R,R,S)-isomers '\n",
      " 'and (R,R,R,R)-isomers and mixtures of two or more thereof in any ratio, '\n",
      " 'wherein the stereoisomers (S193), (S194), (S197), (S198), (S203), (S204), '\n",
      " '(S207) and (S208) and mixtures of two or more thereof in any ratio are '\n",
      " 'preferred. An example of said isomers is shown below:</p>\\n'\n",
      " '<p id=\"p-0254\" num=\"2058\"><chemistry id=\"CHEM-US-00084\" num=\"00084\">\\n'\n",
      " '<img id=\"EMI-C00084\" he=\"174.33mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00084.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00085\" num=\"00085\">\\n'\n",
      " '<img id=\"EMI-C00085\" he=\"174.41mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00085.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00086\" num=\"00086\">\\n'\n",
      " '<img id=\"EMI-C00086\" he=\"174.33mm\" wi=\"73.07mm\" '\n",
      " 'file=\"US08927557-20150106-C00086.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00087\" num=\"00087\">\\n'\n",
      " '<img id=\"EMI-C00087\" he=\"174.41mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00087.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00088\" num=\"00088\">\\n'\n",
      " '<img id=\"EMI-C00088\" he=\"174.33mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00088.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00089\" num=\"00089\">\\n'\n",
      " '<img id=\"EMI-C00089\" he=\"174.33mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00089.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00090\" num=\"00090\">\\n'\n",
      " '<img id=\"EMI-C00090\" he=\"174.33mm\" wi=\"72.73mm\" '\n",
      " 'file=\"US08927557-20150106-C00090.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00091\" num=\"00091\">\\n'\n",
      " '<img id=\"EMI-C00091\" he=\"192.70mm\" wi=\"76.20mm\" '\n",
      " 'file=\"US08927557-20150106-C00091.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0255\" num=\"2059\">Furthermore, derivatives of the compounds '\n",
      " 'according to the present subject matter, the salts thereof, the '\n",
      " 'stereoisomers of the compounds and the salts thereof which are converted '\n",
      " 'into compounds according to the present subject matter, the salts thereof, '\n",
      " 'the stereoisomers of the compounds or the salts thereof in a biological '\n",
      " 'system (bioprecursors or pro-drugs) are covered by the present subject '\n",
      " 'matter. Said biological system is e.g. a mammalian organism, particularly a '\n",
      " 'human subject. The bioprecursor is, for example, converted into the '\n",
      " 'compounds according to the present subject matter, the salts thereof, the '\n",
      " 'stereoisomers of the compounds or the salts thereof by metabolic '\n",
      " 'processes.</p>\\n'\n",
      " '<p id=\"p-0256\" num=\"2060\">The compounds according to the invention can be '\n",
      " 'prepared as follows.</p>\\n'\n",
      " '<p id=\"p-0257\" num=\"2061\"><chemistry id=\"CHEM-US-00092\" num=\"00092\">\\n'\n",
      " '<img id=\"EMI-C00092\" he=\"204.81mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00092.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0258\" num=\"2062\">The compound of formula (6) wherein R2 is hydrogen '\n",
      " 'can be obtained as shown in reaction scheme 1 according to the procedures '\n",
      " 'described in US 2005/0124623A1.</p>\\n'\n",
      " '<p id=\"p-0259\" num=\"2063\"><chemistry id=\"CHEM-US-00093\" num=\"00093\">\\n'\n",
      " '<img id=\"EMI-C00093\" he=\"218.02mm\" wi=\"63.75mm\" '\n",
      " 'file=\"US08927557-20150106-C00093.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '<chemistry id=\"CHEM-US-00094\" num=\"00094\">\\n'\n",
      " '<img id=\"EMI-C00094\" he=\"104.48mm\" wi=\"63.50mm\" '\n",
      " 'file=\"US08927557-20150106-C00094.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0260\" num=\"2064\">As shown in reaction scheme 2 synthesis of the '\n",
      " 'compound of formula (25), wherein R2 is methyl may start from the literature '\n",
      " 'known compound of formula (17) [Gangjee, A.; Li, W.; Yang, J.; Kisliuk, R. '\n",
      " 'L.; J. Med. Chem. 2008, 51, 68] by reaction with a nitril of formula (18) in '\n",
      " 'the presence of an acid (preferentially hydrochloric acid) under anhydrous '\n",
      " 'conditions and cyclization of the obtained compound of formula (19) or its '\n",
      " 'salt to the compound of formula (20) wherein R2 is methyl according to the '\n",
      " 'procedures as for example described in Venugopalan, B.; Desai, P. D.; Souza, '\n",
      " 'N. J.; J. Heterocyclic Chem. 1988, 25, 1633. Subsequent reaction of the '\n",
      " 'compound of formula (20) with either neat POCl<sub>3 </sub>or a solution of '\n",
      " 'POCl<sub>3 </sub>in an inert organic solvent (preferentially acetonitril) at '\n",
      " 'reflux temperature for 2 h to 24 h and reaction of the obtained compound of '\n",
      " 'formula (21) with for example bromine or N-bromosuccinimide in an organic '\n",
      " 'solvent such as dichloromethane (DCM) at a temperature of from &#x2212;40 to '\n",
      " '20&#xb0; C. for 0.5 to 4 h gives the compounds of formula (22). The compound '\n",
      " 'of formula (22) thus obtained can then be protected by reaction with a base '\n",
      " 'such as sodium hydride and (2-chloromethoxy-ethyl)-trimethyl-silane in a '\n",
      " 'organic solvent such as dimethoxyethane, dimethylformamide or '\n",
      " 'dimethylsulfoxide at a temperature of from 0&#xb0; C. to 25&#xb0; C. for 1 h '\n",
      " 'to 24 h as for example described in Muchowski, J. M.; Solas, D. R.; J. Org: '\n",
      " 'Chem. 1984, 49, 203 to a compound of formula (23).</p>\\n'\n",
      " '<p id=\"p-0261\" num=\"2065\">In an additional step a solution of the compound '\n",
      " 'of formula (23) in an organic solvent, such as tetrahydrofurane can be '\n",
      " 'reacted with n-BuLi (n-butyl lithium) in an organic solvent, such as hexane, '\n",
      " 'at a temperature of &#x2212;78&#xb0; C. for 0.5 to 3 h. Subsequently, '\n",
      " 'dimethylformamide (DMF) is added and the reaction is performed at a '\n",
      " 'temperature of from &#x2212;78 to 0&#xb0; C. for 0.5 to 3 h, as for example '\n",
      " 'described in WO2008/30119 to yield the compound of formula (24).</p>\\n'\n",
      " '<p id=\"p-0262\" num=\"2066\">Finally a solution of the compound of formula (24) '\n",
      " 'in methanol is treated with MnO<sub>2 </sub>in the presence of potassium '\n",
      " 'cyanide at ambient temperature for 4 h to 24 h as for example described in '\n",
      " 'Corey, E. J.; Gilman, N. W.; Ganem, B. E.; J. Am. Chem. Soc. 1968, 90, 5616 '\n",
      " 'to give the compound of formula (25).</p>\\n'\n",
      " '<p id=\"p-0263\" num=\"2067\"><chemistry id=\"CHEM-US-00095\" num=\"00095\">\\n'\n",
      " '<img id=\"EMI-C00095\" he=\"71.37mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00095.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0264\" num=\"2068\">As shown in reaction scheme 3, synthesis of a '\n",
      " 'boronic acid derivative of formula (9) may start from phenols of formula (7) '\n",
      " 'wherein R21, R22, R23 and R24 have the above defined meanings. The phenols '\n",
      " 'of formula (7) are commercially available or can be prepared by methods '\n",
      " 'known to a person skilled in the art. In a first step R1, which has the '\n",
      " 'above defined meaning, may be introduced by alkylation. The alkylation is '\n",
      " 'for example carried out by suspending sodium hydride in an organic solvent, '\n",
      " 'such as dimethylethane (DME) or dimethylsulfoxide (DMSO) or a mixture '\n",
      " 'thereof, adding a solution of compound (7) in an organic solvent, such as '\n",
      " 'DME, at a temperature in the range of from 0 to 40&#xb0; C., then adding a '\n",
      " 'compound R1-halogen, preferably R1-Br or R1-I, and reacting the mixture at a '\n",
      " 'temperature of from 20 to 80&#xb0; C. for 1 to 48 h to give a compound of '\n",
      " 'formula (8). In a second step, directed ortho-metalation followed by '\n",
      " 'reaction with a boron electrophile leads to the compounds of formula (9) '\n",
      " 'wherein R1, R21, R22, R23 and R24 have the above defined meanings, and Ra '\n",
      " 'and Rb represent 1-4C-alkyl or hydrogen, preferably Ra and Rb combine to '\n",
      " 'form a straight-chain or branched alkylene group having 2 to 8 carbon atoms, '\n",
      " 'for example without limitation '\n",
      " '&#x2014;C(CH<sub>3</sub>)<sub>2</sub>&#x2014;C(CH<sub>3</sub>)<sub>2</sub>&#x2014;. '\n",
      " 'In particular, a solution of compound (8) in an organic solvent, such as '\n",
      " 'tetrahydrofuran (THF), can be reacted with n-butyl lithium (n-BuLi) in an '\n",
      " 'organic solvent, such as hexane, at a temperature of from &#x2212;78 to '\n",
      " '0&#xb0; C. for 0.5 to 4 h. Subsequently, for example commercially available '\n",
      " '2-iso-propoxy-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is added and the '\n",
      " 'reaction is performed at a temperature of from &#x2212;78 to 0&#xb0; C. for '\n",
      " '0.5 to 3 h to yield a compound of formula (9).</p>\\n'\n",
      " '<p id=\"p-0265\" num=\"2069\"><chemistry id=\"CHEM-US-00096\" num=\"00096\">\\n'\n",
      " '<img id=\"EMI-C00096\" he=\"105.49mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00096.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0266\" num=\"2070\">An alternative preparation of compounds of formula '\n",
      " '(9) is shown in reaction scheme 4. The preparation may start from phenols of '\n",
      " 'formula (7), wherein R21, R22, R23 and R24 have the above or below defined '\n",
      " 'meanings and which are commercially available or can be prepared by methods '\n",
      " 'known to a person skilled in the art or as for example described in '\n",
      " 'Yamamoto, Y.; Hattori, K.; Ishii, J.-I.; Nishiyama, H. Tetrahedron, 2006, '\n",
      " '62, 4294. The phenols of formula (7) are for example reacted with bromine or '\n",
      " 'N-bromosuccinimide in an organic solvent such as dichloromethane (DCM) at a '\n",
      " 'temperature of from &#x2212;40 to 20&#xb0; C. for 0.5 to 4 h to give '\n",
      " 'compounds of formula (10). In a second step R1, which has the above defined '\n",
      " 'meaning, may be introduced by alkylation. The alkylation is for example '\n",
      " 'carried out by suspending sodium hydride in an organic solvent, such as '\n",
      " 'dimethylethane (DME) or dimethylsulfoxide (DMSO) or a mixture thereof, '\n",
      " 'adding a solution of compound (10) in an organic solvent, such as DME, at a '\n",
      " 'temperature in the range of from 0 to 40&#xb0; C., then adding a compound '\n",
      " 'R1-halogen, preferably R1-Br or R1-I, and reacting the mixture at a '\n",
      " 'temperature of from 20 to 80&#xb0; C. for 1 to 48 h leading to compounds of '\n",
      " 'formula (II). In case R22 is difluoromethyl a compound of formula II, '\n",
      " 'wherein R21, R23, R24 and R1 have the above defined meanings and R22 is '\n",
      " 'CH&#x2550;O is reacted in an additional step with a fluorinating agent, such '\n",
      " 'as tris(2-methoxyethyl)aminosulfurtrifluoride, in an organic solvent, such '\n",
      " 'as dichloromethane, at elevated temperatures preferably under microwave '\n",
      " 'heating. In a next step, halogen-lithium exchange followed by reaction with '\n",
      " 'a boron electrophile yields the compounds of formula (9), wherein R1, R21, '\n",
      " 'R22, R23 and R24 have the above defined meanings, and Ra and Rb represent '\n",
      " '1-4C-alkyl or hydrogen, preferably Ra and Rb combine to form a '\n",
      " 'straight-chain or branched alkylene group having 2 to 8 carbon atoms, for '\n",
      " 'example without limitation '\n",
      " '&#x2014;C(CH<sub>3</sub>)<sub>2</sub>&#x2014;C(CH<sub>3</sub>)<sub>2</sub>&#x2014;. '\n",
      " 'In particular, a solution of compound (II) in an organic solvent, such as '\n",
      " 'tert-butylmethylether, can be reacted with n-BuLi (n-butyl lithium) in an '\n",
      " 'organic solvent, such as hexane, at a temperature of from &#x2212;78 to '\n",
      " '0&#xb0; C. for 0.5 to 3 h. Subsequently, for example commercially available '\n",
      " '2-iso-propoxy-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is added and the '\n",
      " 'reaction is performed at a temperature of from &#x2212;78 to 0&#xb0; C. for '\n",
      " '0.5 to 3 h to yield a compound of formula (9). Compounds of formula (9), '\n",
      " 'wherein R22 is 1-4C-alkyl-1,3-dioxolane and R1, R21, R23, R24, Ra and Rb '\n",
      " 'have the above defined meanings can be also prepared starting from phenols '\n",
      " 'of formula (7), wherein R22 is &#x2014;C(O)-1-4C-alkyl and R1, R21, R23 and '\n",
      " 'R24 have the above defined meanings, by acetalisation of compound (II), '\n",
      " 'wherein R22 is &#x2014;C(O)-1-4C-alkyl and R1, R21, R23 and R24 have the '\n",
      " 'above defined meanings before the halogen-lithium exchange reaction as '\n",
      " 'described above is followed. The acetalisation can be performed by methods '\n",
      " 'known to a person skilled in the art for example by reacting compound (II) '\n",
      " 'in an organic solvent, such as dichloromethane with '\n",
      " '1,2-bis(trimethylsilyloxy)-ethane in the presence of a catalytic amount of '\n",
      " 'trimethylsilyl trifluoro-methane sulfonate at a temperature of from 0&#xb0; '\n",
      " 'C. to 25&#xb0; C. for 1 to 4 h as for example described in Hwu, J. R.; '\n",
      " 'Wetzel, J. M.; J. Org. Chem. 1985, 50, 3946.</p>\\n'\n",
      " '<p id=\"p-0267\" num=\"2071\"><chemistry id=\"CHEM-US-00097\" num=\"00097\">\\n'\n",
      " '<img id=\"EMI-C00097\" he=\"105.49mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00097.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0268\" num=\"2072\">According to a further alternative preparation '\n",
      " 'method shown in reaction scheme 5, synthesis of boronic acid derivatives of '\n",
      " 'formula (9) may start from phenols of formula (7) wherein R21, R22, R23 and '\n",
      " 'R24 have the above defined meanings and which are commercially available or '\n",
      " 'can be prepared by methods known to a person skilled in the art. In a first '\n",
      " 'step R1, which has the above defined meaning, is introduced by alkylation. '\n",
      " 'The alkylation is for example carried out by suspending sodium hydride in an '\n",
      " 'organic solvent, such as dimethylethane (DME) or dimethylsulfoxide (DMSO) or '\n",
      " 'a mixture thereof, adding a solution of compound (7) in an organic solvent, '\n",
      " 'such as DME, at a temperature in the range of from 0 to 40&#xb0; C., then '\n",
      " 'adding a compound R1-halogen, preferably R1-Br or R1-I, and reacting the '\n",
      " 'mixture at a temperature of from 20 to 80&#xb0; C. for 1 to 48 h to give a '\n",
      " 'compound of formula (12). In a second step, compound (II) may be prepared '\n",
      " 'for example from compound (12) by reaction with N-bromosuccinimide in an '\n",
      " 'organic solvent, such as dimethylformamide, at a temperature of from 0 to '\n",
      " '60&#xb0; C. for 0.5 to 5 h. In a third step, halogen-lithium exchange '\n",
      " 'followed by reaction with a boron electrophile yields the compounds of '\n",
      " 'formula (9), wherein R1, R21, R22, R23 and R24 have the above defined '\n",
      " 'meanings, and Ra and Rb represent 1-4C-alkyl or hydrogen, preferably Ra and '\n",
      " 'Rb combine to form a straight-chain or branched alkylene group having 2 to 8 '\n",
      " 'carbon atoms, for example without limitation '\n",
      " '&#x2014;C(CH<sub>3</sub>)<sub>2</sub>&#x2014;C(CH<sub>3</sub>)<sub>2</sub>&#x2014;. '\n",
      " 'In particular, a solution of compound (II) in an organic solvent, such as '\n",
      " 'tert-butylmethylether, can be reacted with n-BuLi (n-butyl lithium) in an '\n",
      " 'organic solvent, such as hexane, at a temperature of from &#x2212;78 to '\n",
      " '0&#xb0; C. for 0.5 to 3 h. Subsequently, for example commercially available '\n",
      " '2-iso-propoxy-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is added and the '\n",
      " 'reaction is performed at a temperature of from &#x2212;78 to 0&#xb0; C. for '\n",
      " '0.5 to 3 h to yield a compound of formula (9). Alternatively, compounds of '\n",
      " 'formula (9) may be synthesized from compounds of formula (II) and an '\n",
      " 'appropriate boron compound, such as bis(pinacolato)diboron, in the presence '\n",
      " 'of a Pd catalyst, such as 1,1&#x2032;-bis(diphenyl-phosphino)ferrocene '\n",
      " 'palladium-(II)-chloride, and a base, such as potassium acetate, in an '\n",
      " 'organic solvent, such as dioxane, at a temperature of from 20 to 100&#xb0; '\n",
      " 'C. for 1 to 24 h. The Pd catalyzed preparation of boronic acid derivatives '\n",
      " 'is, for example, described in Murata et al, J Org Chem 2000, 65, 164 and J '\n",
      " 'Org Chem 1997, 62, 6458.</p>\\n'\n",
      " '<p id=\"p-0269\" num=\"2073\"><chemistry id=\"CHEM-US-00098\" num=\"00098\">\\n'\n",
      " '<img id=\"EMI-C00098\" he=\"230.89mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00098.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0270\" num=\"2074\">Reaction scheme 6 illustrates the synthesis of '\n",
      " 'compounds of formula (15) wherein R2 is hydrogen and R1, R21, R22, R23 and '\n",
      " 'R24 have the above defined meanings. In a first step, compound (6) prepared '\n",
      " 'according to reaction scheme 1 can be reacted with a compound of formula (9) '\n",
      " 'prepared according to any of reaction schemes 3, 4 or 5, wherein R1, R21, '\n",
      " 'R22, R23, R24, Ra and Rb have the above defined meanings, to obtain a '\n",
      " 'compound of formula (13). In particular, the compound of formula (6), a '\n",
      " 'base, such as K<sub>2</sub>CO<sub>3</sub>, Cs<sub>2</sub>CO<sub>3 </sub>or '\n",
      " 'K<sub>3</sub>PO<sub>4</sub>, a solvent, such as dimethoxyethane, dioxane or '\n",
      " 'dimethylformamide, a compound of formula (9) and a Pd catalyst, such as '\n",
      " 'PdCl<sub>2</sub>(PCy<sub>3</sub>)<sub>2 </sub>(Cy=cyclohexyl), are '\n",
      " 'preferably heated at a temperature in the range of from 60 to 120&#xb0; C. '\n",
      " 'for 1 to 16 h. The compound of formula (13) thus obtained can then be '\n",
      " 'protected by reaction with a base such as sodium hydride and '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane in a organic solvent such as '\n",
      " 'dimethoxyethane, dimethylformamide or dimethylsulfoxide at a temperature of '\n",
      " 'from 0&#xb0; C. to 25&#xb0; C. for 1 h to 24 h as for example described in '\n",
      " 'Muchowski, J. M.; Solas, D. R.; J. Org: Chem. 1984, 49, 203 to a compound of '\n",
      " 'formula (14). The compound of formula (14) is reacted with an alkali '\n",
      " 'hydroxide, such as LiOH, in a solvent, preferably a mixture of an organic '\n",
      " 'solvent, such as dioxane, and water, at a temperature in the range of from '\n",
      " '20 to 100&#xb0; C. for 1 to 48 h to yield a compound of formula (15).</p>\\n'\n",
      " '<p id=\"p-0271\" num=\"2075\"><chemistry id=\"CHEM-US-00099\" num=\"00099\">\\n'\n",
      " '<img id=\"EMI-C00099\" he=\"220.47mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00099.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0272\" num=\"2076\">Reaction scheme 7 illustrates the synthesis of '\n",
      " 'compounds of formula (15) wherein R2 is methyl and R1, R2, R21, R22, R23 and '\n",
      " 'R24 have the above defined meanings. In a first step, compound (25) prepared '\n",
      " 'according to reaction scheme 2 can be reacted with a compound of formula (9) '\n",
      " 'prepared according to any of reaction schemes 3, 4 or 5, wherein R1, R21, '\n",
      " 'R22, R23, R24, Ra and Rb have the above defined meanings, to obtain a '\n",
      " 'compound of formula (26). In particular, the compound of formula (25), a '\n",
      " 'base, such as K<sub>2</sub>CO<sub>3</sub>, Cs<sub>2</sub>CO<sub>3 </sub>or '\n",
      " 'K<sub>3</sub>PO<sub>4</sub>, a solvent, such as dimethoxyethane, dioxane or '\n",
      " 'dimethylformamide, a compound of formula (9) and a Pd catalyst, such as '\n",
      " 'PdCl<sub>2</sub>(PCy<sub>3</sub>)<sub>2 </sub>(Cy=cyclohexyl), are '\n",
      " 'preferably heated at a temperature in the range of from 60 to 120&#xb0; C. '\n",
      " 'for 1 to 16 h. The compound of formula (26) thus obtained is reacted with an '\n",
      " 'alkali hydroxide, such as LiOH, in a solvent, preferably a mixture of an '\n",
      " 'organic solvent, such as dioxane, and water, at a temperature in the range '\n",
      " 'of from 20 to 100&#xb0; C. for 1 to 48 h to yield a compound of formula '\n",
      " '(15).</p>\\n'\n",
      " '<p id=\"p-0273\" num=\"2077\"><chemistry id=\"CHEM-US-00100\" num=\"00100\">\\n'\n",
      " '<img id=\"EMI-C00100\" he=\"103.89mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00100.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0274\" num=\"2078\">As shown in reaction scheme 8, starting from '\n",
      " 'compounds of formula (15) prepared according to any of reaction schemes 6 or '\n",
      " '7, compounds of formula (I-1), wherein R1, R2, R21, R22, R23, R24 and Y have '\n",
      " 'the above defined meanings and R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being substituted by R4 and optionally '\n",
      " 'substituted by one or two substituents R5, wherein R5 has the above defined '\n",
      " 'meaning and R4 being &#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group '\n",
      " 'is optionally substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43, with R41, R42 and R43 having the above defined meanings, '\n",
      " 'can be prepared by reaction with compounds of formula (16-1), wherein Y has '\n",
      " 'the above defined meaning and R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being substituted by R4 and optionally '\n",
      " 'substituted by one or two substituents R5, wherein R5 has the above defined '\n",
      " 'meaning and R4 being &#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group '\n",
      " 'is optionally substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43, with R41, R42 and R43 having the above defined meanings, '\n",
      " 'under standard amide bond forming conditions. The compounds of formula '\n",
      " '(16-1) are commercially available or can be prepared by methods known to a '\n",
      " 'person skilled in the art or as described in reaction scheme 16. In '\n",
      " 'particular, a dehydrating agent, such as '\n",
      " '1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, a base, such as '\n",
      " 'triethylamine, and a catalyst, such as 1-hydroxybenzotriazole, can be added '\n",
      " 'to a compound of formula (15) which is preferably dissolved or suspended in '\n",
      " 'an organic solvent, e.g. dichloromethane. After stirring the mixture e.g. '\n",
      " 'for 0.3 to 2 h, preferably at ambient temperature (e.g. 20 to 25&#xb0; C.), '\n",
      " 'a compound of formula (16-1) can be added and the reaction is preferably '\n",
      " 'performed at ambient temperature (e.g. 20 to 25&#xb0; C.) for 1 to 48 h to '\n",
      " 'yield the compound of formula (I-1).</p>\\n'\n",
      " '<p id=\"p-0275\" num=\"2079\"><chemistry id=\"CHEM-US-00101\" num=\"00101\">\\n'\n",
      " '<img id=\"EMI-C00101\" he=\"100.41mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00101.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0276\" num=\"2080\">As shown in reaction scheme 9, compounds of '\n",
      " 'formula (I-2), wherein R1, R2, R21, R22, R23, R24 and Y have the above '\n",
      " 'defined meanings and R3 is a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61, with R6 being '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7 and R7 being 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by R73, '\n",
      " 'with R61, R71, R72 and R73 having the above defined meanings can be '\n",
      " 'synthesized by reaction of compounds of formula (15) prepared according to '\n",
      " 'any of reaction schemes 6 or 7, with compounds of formula (16-2), wherein Y '\n",
      " 'has the above defined meaning and R3 is a 3-6C-cycloalkyl group substituted '\n",
      " 'by R6 and optionally substituted by R61, with R6 being '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7 and R7 being 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by R73, '\n",
      " 'with R61, R71, R72 and R73 having the above defined meanings. The compounds '\n",
      " 'of formula (16-2) are commercially available or can be prepared by methods '\n",
      " 'known to a person skilled in the art or can be prepared by methods described '\n",
      " 'in the experimental part (see C11, CC22, C33 and C44). In particular, a '\n",
      " 'dehydrating agent, such as 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide '\n",
      " 'hydrochloride, a base, such as triethylamine, and a catalyst, such as '\n",
      " '1-hydroxybenzotriazole, can be added to a compound of formula (15) which is '\n",
      " 'preferably dissolved or suspended in an organic solvent, such as '\n",
      " 'dichloromethane. After stirring the mixture e.g. for 0.3 to 2 h preferably '\n",
      " 'at ambient temperature (e.g. 20 to 25&#xb0; C.), a compound of formula '\n",
      " '(16-2) can be added and the reaction is preferably performed at ambient '\n",
      " 'temperature (e.g. 20 to 25&#xb0; C.) for 1 to 48 h to yield the compound of '\n",
      " 'formula (I-2).</p>\\n'\n",
      " '<p id=\"p-0277\" num=\"2081\"><chemistry id=\"CHEM-US-00102\" num=\"00102\">\\n'\n",
      " '<img id=\"EMI-C00102\" he=\"158.58mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00102.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0278\" num=\"2082\">Compounds of formula (I-1), wherein R1, R2, R21, '\n",
      " 'R22, R23, R24 and Y have the above defined meanings and R3 is a 4- to '\n",
      " '7-membered saturated heterocyclic ring containing one nitrogen atom and '\n",
      " 'optionally one oxygen atom, said heterocyclic ring being substituted by R4 '\n",
      " 'and optionally substituted by one or two substituents R5, wherein R5 has the '\n",
      " 'above defined meaning and R4 being '\n",
      " '&#x2014;C(O)&#x2014;O&#x2014;C(CH<sub>3</sub>)<sub>3</sub>, prepared '\n",
      " 'according to reaction scheme 8 can be deprotected and converted into '\n",
      " 'compounds of formula (I-4), wherein R1, R2, R21, R22, R23, R24 and Y have '\n",
      " 'the above defined meanings and R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by one or two '\n",
      " 'substituents R5, wherein R5 has the above defined meaning. In particular, '\n",
      " 'compounds of formula (I-1) are deprotected by methods known to a person '\n",
      " 'skilled in the art for example by reaction with tetrabutylammonium fluoride '\n",
      " 'and 1,2-diamino-ethane in an organic solvent like tetrahydrofurane as for '\n",
      " 'example described in Muchowski, J. M.; Solas, D. R.; J. Org: Chem. 1984, 49, '\n",
      " '203.</p>\\n'\n",
      " '<p id=\"p-0279\" num=\"2083\">In the following step HCl preferably dissolved in '\n",
      " 'an organic solvent, such as dioxane, can be added to the compound of formula '\n",
      " '(I-3) which is preferably dissolved in an organic solvent, such as an '\n",
      " 'alcohol, e.g. 2-propanol. The reaction mixture is then preferably heated at '\n",
      " '40 to 80&#xb0; C. for 1 to 4 h to yield the hydrochloride of the compound of '\n",
      " 'formula (I-4). The compound of formula (I-4) can be prepared from said '\n",
      " 'hydrochloride as known to a person skilled in the art, such as by treatment '\n",
      " 'with a base, e.g. aqueous potassium carbonate or aqueous ammonia.</p>\\n'\n",
      " '<p id=\"p-0280\" num=\"2084\"><chemistry id=\"CHEM-US-00103\" num=\"00103\">\\n'\n",
      " '<img id=\"EMI-C00103\" he=\"154.60mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00103.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0281\" num=\"2085\">Compounds of formula (I-2), wherein R1, R2, R21, '\n",
      " 'R22, R23, R24 and Y have the above defined meanings and R3 is a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by R61 '\n",
      " 'with R6 being &#x2014;NH&#x2014;C(O)&#x2014;R7 and R7 being '\n",
      " '&#x2014;O&#x2014;C(CH<sub>3</sub>)<sub>3 </sub>and R61 has the above defined '\n",
      " 'meaning prepared according to reaction scheme 9 can be deprotected and '\n",
      " 'converted into compounds of formula (I-6), wherein R1, R2, R21, R22, R23, '\n",
      " 'R24 and Y have the above defined meanings and R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61 with R6 being '\n",
      " '&#x2014;NH<sub>2 </sub>as shown in reaction scheme 11 and R61 has the above '\n",
      " 'defined meaning. In particular, compounds of formula (I-2) are deprotected '\n",
      " 'by methods known to a person skilled in the art for example by reaction with '\n",
      " 'tetrabutylammonium fluoride and 1,2-diamino-ethane in an organic solvent '\n",
      " 'like tetrahydrofurane as for example described in Muchowski, J. M.; Solas, '\n",
      " 'D. R.; J. Org: Chem. 1984, 49, 203.</p>\\n'\n",
      " '<p id=\"p-0282\" num=\"2086\">In the following step HCl preferably dissolved in '\n",
      " 'an organic solvent, such as dioxane, can be added to the compound of formula '\n",
      " '(I-5) which is preferably dissolved in an organic solvent, such as an '\n",
      " 'alcohol, e.g. 2-propanol. The reaction mixture is then preferably heated at '\n",
      " '40 to 80&#xb0; C. for 1 to 4 h to yield the hydrochloride of the compound of '\n",
      " 'formula (I-6). The compound of formula (I-6) can be prepared from said '\n",
      " 'hydrochloride as known to a person skilled in the art, such as by treatment '\n",
      " 'with a base, e.g. aqueous potassium carbonate or aqueous ammonia.</p>\\n'\n",
      " '<p id=\"p-0283\" num=\"2087\">Compounds of formula (I-2), wherein R1, R2, R21, '\n",
      " 'R22, R23, R24 and Y have the above defined meanings and R3 is a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by R61 '\n",
      " 'with R6 being hydroxy and R61 has the above defined meaning, prepared '\n",
      " 'according to reaction scheme 9 can be deprotected and converted into '\n",
      " 'compounds of formula (I-5), wherein R1, R2, R21, R22, R23, R24 and Y have '\n",
      " 'the above defined meanings and R3 is a 3-6C-cycloalkyl group substituted by '\n",
      " 'R6 and optionally substituted by R61 with R6 being hydroxy as shown in '\n",
      " 'reaction scheme 11 and R61 has the above defined meaning. In particular, '\n",
      " 'compounds of formula (I-2) are deprotected by methods known to a person '\n",
      " 'skilled in the art for example by reaction with tetrabutylammonium fluoride '\n",
      " 'and 1,2-diamino-ethane in an organic solvent like tetrahydrofurane as for '\n",
      " 'example described in Muchowski, J. M.; Solas, D. R.; J. Org: Chem. 1984, 49, '\n",
      " '203.</p>\\n'\n",
      " '<p id=\"p-0284\" num=\"2088\"><chemistry id=\"CHEM-US-00104\" num=\"00104\">\\n'\n",
      " '<img id=\"EMI-C00104\" he=\"142.07mm\" wi=\"219.29mm\" '\n",
      " 'file=\"US08927557-20150106-C00104.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0285\" num=\"2089\">An alternative synthesis of compounds of formula '\n",
      " '(I-3), wherein R1, R2, R21, R22, R23, R24 and Y have the above defined '\n",
      " 'meanings and R3 is a 4- to 7-membered saturated heterocyclic ring containing '\n",
      " 'one nitrogen atom and optionally one oxygen atom, said heterocyclic ring '\n",
      " 'being substituted by R4 and optionally substituted by one or two '\n",
      " 'substituents R5, wherein R5 has the above defined meaning and R4 being '\n",
      " '&#x2014;C(O)&#x2014;O&#x2014;C(CH<sub>3</sub>)<sub>3</sub>, and compounds of '\n",
      " 'formula (I-5), wherein R1, R2, R21, R22, R23, R24 and Y have the above '\n",
      " 'defined meanings and R3 is a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61 with R6 being &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'and R7 being &#x2014;O&#x2014;C(CH<sub>3</sub>)<sub>3 </sub>and R61 has the '\n",
      " 'above defined meaning, and compounds of formula (I-6), wherein R1, R2, R21, '\n",
      " 'R22, R23, R24 and Y have the above defined meanings and R3 is a '\n",
      " '3-6C-cycloalkyl group substituted by R6 and optionally substituted by R61 '\n",
      " 'with R6 being &#x2014;NH<sub>2 </sub>and R61 has the above defined meaning, '\n",
      " 'is shown in reaction scheme 11a.</p>\\n'\n",
      " '<p id=\"p-0286\" num=\"2090\">A compound of formula (13) prepared according to '\n",
      " 'reaction scheme 6, wherein R1, R2, R21, R22, R23 and R24 have the above '\n",
      " 'defined meanings is transformed into a compound of formula (13a) by reacting '\n",
      " 'with an alkali metal hydroxid preferably KOH (generated from potassium '\n",
      " 'tert-butoxyde and water) in an organic solvent preferably tert-BuOH. A '\n",
      " 'comparable reaction is, for example described in Gassman, P. G.; Schenk, W. '\n",
      " 'N. <i>J. Org. Chem. </i>1977, 42, 918.</p>\\n'\n",
      " '<p id=\"p-0287\" num=\"2091\">A compound of formula (13a) can be reacted with a '\n",
      " 'compound of formula (16-1), which are commercially available or can be '\n",
      " 'prepared by methods known to a person skilled in the art or as described in '\n",
      " 'reaction scheme 16, a compound of formula (16-2), which are commercially '\n",
      " 'available or can be prepared by methods known to a person skilled in the art '\n",
      " 'or can be prepared by methods described in the experimental part (see C11, '\n",
      " 'CC22, C33 and C44), or a compound of (16-3), which are commercially '\n",
      " 'available or can be prepared by methods known to a person skilled in the art '\n",
      " 'or can be prepared by methods described in the experimental part (see C12, '\n",
      " 'C23, C34 and C45). In particular, a dehydrating agent, such as '\n",
      " '1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, a base, such as '\n",
      " 'triethylamine, and a catalyst, such as 1-hydroxybenzotriazole, can be added '\n",
      " 'to a compound of formula (13) which is preferably dissolved or suspended in '\n",
      " 'an organic solvent, such as dichloromethane. After stirring the mixture e.g. '\n",
      " 'for 0.3 to 2 h preferably at ambient temperature (e.g. 20 to 25&#xb0; C.), a '\n",
      " 'compound of formula (16-1), a compound of formula (16-2) or a compound of '\n",
      " 'formula (16-3) can be added and the reaction is preferably performed at '\n",
      " 'ambient temperature (e.g. 20 to 25&#xb0; C.) for 1 to 48 h to yield a '\n",
      " 'corresponding compound of formula (I-3), a compound of formula (I-5) or a '\n",
      " 'compound of formula (13b). A compound of formula (I-6) can be obtained by '\n",
      " 'pressure hydrogenation, such as 10 to 30 bar, of a compound of formula (13b) '\n",
      " 'preferably at ambient temperature, such as 20 to 25&#xb0; C., in the '\n",
      " 'presence of a catalyst, such as Pd on carbon or Pd(OH)<sub>2 </sub>on '\n",
      " 'carbon, in an organic solvent such as methanol.</p>\\n'\n",
      " '<p id=\"p-0288\" num=\"2092\"><chemistry id=\"CHEM-US-00105\" num=\"00105\">\\n'\n",
      " '<img id=\"EMI-C00105\" he=\"107.36mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00105.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0289\" num=\"2093\">Alternatively, as shown in reaction scheme 12, '\n",
      " 'compounds of formula (I-1), wherein R1, R2, R21, R22, R23, R24 and Y have '\n",
      " 'the above defined meanings and R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being substituted by R4 and optionally '\n",
      " 'substituted by one or two substituents R5, wherein R5 has the above defined '\n",
      " 'meaning and R4 being &#x2014;C(O)-1-4C-alkyl, wherein the 1-4C-alkyl group '\n",
      " 'is optionally substituted by R41, &#x2014;C(O)-3-6C-cycloalkyl, wherein the '\n",
      " '3-6C-cycloalkyl group is optionally substituted by R42, or '\n",
      " '&#x2014;C(O)&#x2014;O-1-4C-alkyl, wherein the 1-4C-alkyl group is optionally '\n",
      " 'substituted by R43, and R41, R42 and R43 are as defined above, may be '\n",
      " 'prepared from compounds of formula (I-4), wherein R1, R21, R22, R23, R24 and '\n",
      " 'Y have the above defined meanings and R3 is a 4- to 7-membered saturated '\n",
      " 'heterocyclic ring containing one nitrogen atom and optionally one oxygen '\n",
      " 'atom, said heterocyclic ring being optionally substituted by one or two '\n",
      " 'substituents R5, wherein R5 has the above defined meaning, prepared '\n",
      " 'according to reaction scheme 10. In particular, a compound R4-Cl can be '\n",
      " 'added to the compound of formula (I-4) which is preferably dissolved in an '\n",
      " 'organic solvent, such as dichloromethane, in the presence of a base, such as '\n",
      " 'diazabicycloundecene (DBU). The compound of formula R4-Cl is commercially '\n",
      " 'available or can be prepared by methods known to a person skilled in the '\n",
      " 'art. The addition is preferably carried out at a temperature of from 0 to '\n",
      " '20&#xb0; C. After complete addition, the reaction is preferably continued at '\n",
      " 'ambient temperature (e.g. 20 to 25&#xb0; C.) for 1 to 24 h. In case R41, R42 '\n",
      " 'or R43 represent hydroxy, it is known to a person skilled in the art that '\n",
      " 'the hydroxy group is preferably to be protected by a suitable protecting '\n",
      " 'group, such as an acetate group or a silyl protective group, e.g. a '\n",
      " 'tert-butyl-dimethylsilyl group or a tert-butyl-diphenylsilyl group. Said '\n",
      " 'protective groups can be removed by methods known to a person skilled in the '\n",
      " 'art with or without prior isolation of the protected intermediate (i.e. the '\n",
      " 'compound of formula (I-1) in its protected form).</p>\\n'\n",
      " '<p id=\"p-0290\" num=\"2094\"><chemistry id=\"CHEM-US-00106\" num=\"00106\">\\n'\n",
      " '<img id=\"EMI-C00106\" he=\"113.20mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00106.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0291\" num=\"2095\">Alternatively, as shown in reaction scheme 13, '\n",
      " 'compounds of formula (I-2), wherein R1, R2, R21, R22, R23, R24 and Y have '\n",
      " 'the above defined meanings and R3 is a 3-6C-cycloalkyl group substituted by '\n",
      " 'R6 and optionally substituted by R61, with R6 being '\n",
      " '&#x2014;NH&#x2014;C(O)&#x2014;R7, with R7 being 1-4C-alkyl, which is '\n",
      " 'optionally substituted by R71, 3-6C-cycloalkyl, which is optionally '\n",
      " 'substituted by R72, or 1-4C-alkoxy, which is optionally substituted by R73, '\n",
      " 'and R61, R71, R72 and R73 are as defined above, may be prepared from '\n",
      " 'compounds of formula (I-6), wherein R1, R21, R22, R23, R24 and Y have the '\n",
      " 'above defined meanings and R3 is a 3-6C-cycloalkyl group substituted by R6 '\n",
      " 'and optionally substituted by R61 with R6 being NFI<sub>2 </sub>prepared '\n",
      " 'according to reaction scheme 11 and R61 has the above defined meanings. In '\n",
      " 'particular, a compound R7-C(O)&#x2014;Cl can be added to the compound of '\n",
      " 'formula (I-6) which is preferably dissolved in an organic solvent, such as '\n",
      " 'dichloromethane, in the presence of a base, such as diazabicycloundecene '\n",
      " '(DBU). The compound of formula R7-C(O)&#x2014;Cl is commercially available '\n",
      " 'or can be prepared by methods known to a person skilled in the art. The '\n",
      " 'addition is preferably carried out at a temperature of from 0 to 20&#xb0; C. '\n",
      " 'After complete addition, the reaction is preferably continued at ambient '\n",
      " 'temperature (e.g. 20 to 25&#xb0; C.) for 1 to 24 h to yield the compound of '\n",
      " 'formula (I-2). In case R71, R72 or R73 represent hydroxy, it is known to a '\n",
      " 'person skilled in the art that the hydroxy group is preferably to be '\n",
      " 'protected by a suitable protecting group, such as an acetate group or a '\n",
      " 'silyl protective group, e.g. a tert-butyl-dimethylsilyl group or '\n",
      " 'tert-butyl-diphenylsilyl group. Said protective groups can be removed by '\n",
      " 'methods known to a person skilled in the art with or without prior isolation '\n",
      " 'of the protected intermediate (i.e. the compound of formula (I-2) in its '\n",
      " 'protected form).</p>\\n'\n",
      " '<p id=\"p-0292\" num=\"2096\"><chemistry id=\"CHEM-US-00107\" num=\"00107\">\\n'\n",
      " '<img id=\"EMI-C00107\" he=\"113.20mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00107.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0293\" num=\"2097\">As shown in reaction scheme 14, compounds of '\n",
      " 'formula (I-1), wherein R1, R2, R21, R22, R23, R24 and Y have the above '\n",
      " 'defined meanings and R3 is a 4- to 7-membered saturated heterocyclic ring '\n",
      " 'containing one nitrogen atom and optionally one oxygen atom, said '\n",
      " 'heterocyclic ring being substituted by R4 and optionally substituted by one '\n",
      " 'or two substituents R5, wherein R5 has the above defined meaning and R4 '\n",
      " 'being &#x2014;C(O)&#x2014;H can be prepared from compounds of formula (I-4), '\n",
      " 'wherein R1, R2, R21, R22, R23, R24 and Y have the above defined meanings and '\n",
      " 'R3 is a 4- to 7-membered saturated heterocyclic ring containing one nitrogen '\n",
      " 'atom and optionally one oxygen atom, said heterocyclic ring being optionally '\n",
      " 'substituted by one or two substituents R5, wherein R5 has the above defined '\n",
      " 'meaning, prepared according to reaction scheme 10. In particular, the '\n",
      " 'compound R4-O&#x2014;C(O)&#x2014;CH<sub>3</sub>, which can be prepared by '\n",
      " 'methods known to a person skilled in the art, can be added to the compound '\n",
      " 'of formula (I-4) which is preferably dissolved in an organic solvent, such '\n",
      " 'as dichloromethane, in the presence of a base, such as diazabicycloundecene '\n",
      " '(DBU). The addition is preferably carried out at a temperature of from 0 to '\n",
      " '20&#xb0; C. After completion of addition, the reaction is preferably '\n",
      " 'continued at ambient temperature (e.g. 20 to 25&#xb0; C.) for 1 to 24 h to '\n",
      " 'yield the compound of formula (I-1).</p>\\n'\n",
      " '<p id=\"p-0294\" num=\"2098\"><chemistry id=\"CHEM-US-00108\" num=\"00108\">\\n'\n",
      " '<img id=\"EMI-C00108\" he=\"124.12mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00108.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0295\" num=\"2099\">As shown in reaction scheme 15, compounds of '\n",
      " 'formula (I-2), wherein R1, R2, R21, R22, R23, R24 and Y have the above '\n",
      " 'defined meanings and R3 is a 3-6C-cycloalkyl group substituted by R6 and '\n",
      " 'optionally substituted by R61 with R6 being &#x2014;NH&#x2014;C(O)&#x2014;R7 '\n",
      " 'with R7 being hydrogen and R61 has the above defined meaning can be prepared '\n",
      " 'from compounds of formula (I-6), wherein R1, R2, R21, R22, R23, R24 and Y '\n",
      " 'have the above defined meanings and R3 is a 3-6C-cycloalkyl group '\n",
      " 'substituted by R6 and optionally substituted by R61 with R6 being '\n",
      " '&#x2014;NH<sub>2</sub>, obtained according to reaction scheme 11. In '\n",
      " 'particular, the compound R7-C(O)&#x2014;O&#x2014;C(O)&#x2014;C<sub>3 '\n",
      " '</sub>with R7 being hydrogen, which can be prepared by methods known to a '\n",
      " 'person skilled in the art, can be added to the compound of formula (I-6) '\n",
      " 'which is preferably dissolved in an organic solvent, such as '\n",
      " 'dichloromethane, in the presence of a base, such as diazabicycloundecene '\n",
      " '(DBU). The addition is preferably carried out at a temperature of from 0 to '\n",
      " '20&#xb0; C. After completion of addition, the reaction is preferably '\n",
      " 'continued at ambient temperature (e.g. 20 to 25&#xb0; C.) for 1 to 24 h to '\n",
      " 'yield a compound of formula (I-2).</p>\\n'\n",
      " '<p id=\"p-0296\" num=\"2100\"><chemistry id=\"CHEM-US-00109\" num=\"00109\">\\n'\n",
      " '<img id=\"EMI-C00109\" he=\"99.31mm\" wi=\"75.86mm\" '\n",
      " 'file=\"US08927557-20150106-C00109.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-0297\" num=\"2101\">As shown in reaction scheme 16, compounds of '\n",
      " 'formula (16a) or (16b) can be prepared from known compounds (18a) or (18b) '\n",
      " \"[Zhao, S.; Ghosh, A.; D'Andrea, S. V.; Freeman, P.; VonVoigtlander, P. F.; \"\n",
      " 'Carter, D. B.; Smith, M. W.; Heterocycles, 1994, 39, 163 and Erickson, S. '\n",
      " 'D.; Banner, B.; Berthel, S.; Conde-Knape, K.; Falicioni, F.; Hakimi, I.; '\n",
      " 'Hennessy, B.; Kester, R. F.; Kim, K.; Ma, Ch.; McComas, W.; Mennona, F.; '\n",
      " 'Mischke, S.; Orzechowski, L.; Qian, Y.; Salari, H.; Tengi, J.; Thakkar, K.; '\n",
      " 'Taub, R.; Tilley, J. W.; Wang, H.; Bioorg. Med. Chem. Lett. 2008, 18, 1402] '\n",
      " 'by methods known to a person skilled in the art for example by catalytic '\n",
      " 'hydrogenation in an organic solvent like ethanol or methanol in the presence '\n",
      " 'of a precious metal catalyst like palladium on carbon or platinum oxide at a '\n",
      " 'temperature of from 20 to 50&#xb0; C. and at standard atmospheric pressure '\n",
      " '(101,325 kPa) to 1050 kPa for 1 h to 48 h.</p>\\n'\n",
      " '<p id=\"p-0298\" num=\"2102\">It is known to the person skilled in the art that, '\n",
      " 'if there are a number of reactive centers on a starting or intermediate '\n",
      " 'compound, it may be necessary to block one or more reactive centers '\n",
      " 'temporarily by protective groups in order to allow a reaction to proceed '\n",
      " 'specifically at the desired reaction center.</p>\\n'\n",
      " '<p id=\"p-0299\" num=\"2103\">The compounds according to the present subject '\n",
      " 'matter are isolated and purified in a manner known per se, e.g. by '\n",
      " 'distilling off the solvent in vacuo and recrystallizing the residue obtained '\n",
      " 'from a suitable solvent or subjecting them to one of the customary '\n",
      " 'purification methods, such as column chromatography on a suitable support '\n",
      " 'material.</p>\\n'\n",
      " '<p id=\"p-0300\" num=\"2104\">Salts of the compounds of formula (I) and the '\n",
      " 'stereoisomers thereof can be obtained by dissolving the free compound in a '\n",
      " 'suitable solvent (for example a ketone such as acetone, methylethylketone or '\n",
      " 'methylisobutylketone, an ether such as diethyl ether, tetrahydrofurane or '\n",
      " 'dioxane, a chlorinated hydrocarbon such as methylene chloride or chloroform, '\n",
      " 'a low molecular weight aliphatic alcohol such as methanol, ethanol or '\n",
      " 'isopropanol, a low molecular weight aliphatic ester such as ethyl acetate or '\n",
      " 'isopropyl acetate, or water) which contains the desired acid or base, or to '\n",
      " 'which the desired acid or base is then added. The acid or base can be '\n",
      " 'employed in salt preparation, depending on whether a mono- or polybasic acid '\n",
      " 'or base is concerned and depending on which salt is desired, in an equimolar '\n",
      " 'quantitative ratio or one differing therefrom. The salts are obtained by '\n",
      " 'filtering, reprecipitating, precipitating with a non-solvent for the salt or '\n",
      " 'by evaporating the solvent. Salts obtained can be converted into the free '\n",
      " 'compounds which, in turn, can be converted into salts. In this manner, '\n",
      " 'pharmaceutically unacceptable salts, which can be obtained, for example, as '\n",
      " 'process products in the manufacturing on an industrial scale, can be '\n",
      " 'converted into pharmaceutically acceptable salts by processes known to the '\n",
      " 'person skilled in the art.</p>\\n'\n",
      " '<p id=\"p-0301\" num=\"2105\">Pure diastereomers and pure enantiomers of the '\n",
      " 'compounds of formula (I) and the salts thereof can be obtained e.g. by '\n",
      " 'asymmetric synthesis, by using chiral starting compounds in synthesis and/or '\n",
      " 'by splitting up enantiomeric and diasteriomeric mixtures obtained in '\n",
      " 'synthesis. Preferably, the pure diastereomeric and pure enantiomeric '\n",
      " 'compounds of the present subject matter are obtainable by using chiral '\n",
      " 'starting compounds in synthesis and/or by splitting up enantiomeric and '\n",
      " 'diasteriomeric mixtures obtained in synthesis.</p>\\n'\n",
      " '<p id=\"p-0302\" num=\"2106\">Enantiomeric and diastereomeric mixtures can be '\n",
      " 'split up into the pure enantiomers and pure diastereomers by methods known '\n",
      " 'to a person skilled in the art. Preferably, diastereomeric mixtures are '\n",
      " 'separated by crystallization, in particular fractional crystallization, or '\n",
      " 'chromatography. Enantiomeric mixtures can be separated e.g. by forming '\n",
      " 'diastereomers with a chiral auxiliary agent, resolving the diastereomers '\n",
      " 'obtained and removing the chiral auxiliary agent. As chiral auxiliary '\n",
      " 'agents, for example, chiral acids can be used to separate enantiomeric bases '\n",
      " 'and chiral bases can be used to separate enantiomeric acids via formation of '\n",
      " 'diastereomeric salts. Furthermore, diastereomeric derivatives such as '\n",
      " 'diastereomeric esters can be formed from enantiomeric mixtures of alcohols '\n",
      " 'or enantiomeric mixtures of acids, respectively, using chiral acids or '\n",
      " 'chiral alcohols, respectively, as chiral auxiliary agents. Additionally, '\n",
      " 'diastereomeric complexes or diastereomeric clathrates may be used for '\n",
      " 'separating enantiomeric mixtures. Alternatively, enantiomeric mixtures can '\n",
      " 'be split up using chiral separating columns in chromatography. Another '\n",
      " 'suitable method for the isolation of enantiomers is the enzymatic '\n",
      " 'separation.</p>\\n'\n",
      " '<p id=\"p-0303\" num=\"2107\">All patents, patent applications, publications, '\n",
      " 'test methods and other materials cited herein are incorporated by reference '\n",
      " 'in their entireties.</p>\\n'\n",
      " '<p id=\"p-0304\" num=\"2108\">The following examples illustrate the present '\n",
      " 'subject matter in greater detail, without restricting it. Further compounds '\n",
      " 'according to the present subject matter, of which the preparation is not '\n",
      " 'explicitly described, can be prepared in an analogous way.</p>\\n'\n",
      " '<p id=\"p-0305\" num=\"2109\">The compounds, salts and stereoisomers which are '\n",
      " 'mentioned in the examples, and the salts of the compounds which are '\n",
      " 'mentioned in the examples, and the stereoisomers of the compounds mentioned '\n",
      " 'in the examples, the stereoisomers of the salts which are mentioned in the '\n",
      " 'examples and the stereoisomers of the salts of the compounds which are '\n",
      " 'mentioned in the examples represent preferred embodiments of the present '\n",
      " 'subject matter.</p>\\n'\n",
      " '<heading id=\"h-0006\" level=\"1\">EXAMPLES</heading>\\n'\n",
      " '<p id=\"p-0306\" num=\"2110\">The following abbreviations are used: min: '\n",
      " 'minutes, h: hour(s), DCM: dichloromethane, DCE: dichloroethane, THF: '\n",
      " 'tetrahydrofuran, EA: ethyl acetate, sesamol: 3,4-methylenedioxyphenol, '\n",
      " 'brine: saturated sodium chloride solution, DBU: '\n",
      " '1,8-diazabicyclo[5.4.0]undec-7-en, Huenigs base: N-ethyl-diisopropylamine, '\n",
      " 'mp.: melting point, bp: boiling point, RT: room temperature (20 to 25&#xb0; '\n",
      " 'C.), ambient temperature: 20 to 25&#xb0; C., TLC: thin layer chromatography, '\n",
      " 'GC-MS (EI): gas chromatography coupled to mass spectrometry with electron '\n",
      " 'impact ionization, MS (ESI): mass spectrometry with electron spray '\n",
      " 'ionization, HR-MM (ESI): high resolution mass spectrometry with electron '\n",
      " 'spray ionization, <sup>1</sup>H-NMR: <sup>1</sup>H nuclear magnetic '\n",
      " 'resonance spectroscopy (chemical shifts are reported as ppm against '\n",
      " 'tetramethylsilane as internal standard, coupling constants J are reported in '\n",
      " 'Hz). Epimers and/or racemates are marked herein with a &#x201c;*&#x201d; in '\n",
      " 'the chemical name at the corresponding stereogenic center.</p>\\n'\n",
      " '<heading id=\"h-0007\" level=\"1\">Example A1</heading>\\n'\n",
      " '<heading id=\"h-0008\" level=\"1\">(E/Z)-2-Cyano-3-ethoxy-but-2-enoic acid ethyl '\n",
      " 'ester</heading>\\n'\n",
      " '<p id=\"p-0307\" num=\"2111\">A round bottom flask equipped with a magnetic '\n",
      " 'stirring bar, a short Vigreux-Column and a condenser is charged with '\n",
      " 'commercially available triethyl ortho acetate (973.4 g; 6.0 mol), '\n",
      " 'commercially available cyano-acetic acid ethyl ester (452.5 g; 4.0 mol) and '\n",
      " 'commercially available acetic anhydride (816.7 g; 8.0 mol). The stirred '\n",
      " 'reaction mixture is heated to about 100&#xb0; C. and the formed ethyl '\n",
      " 'acetate is removed by distillation. As the reaction progressed the '\n",
      " 'temperature is gradually raised to 150&#xb0; C.</p>\\n'\n",
      " '<p id=\"p-0308\" num=\"2112\">The reaction mixture is cooled to ambient '\n",
      " 'temperature. The semisolid crude is distilled in high vacuum. The fraction '\n",
      " 'boiling between 110&#xb0; C. and 120&#xb0; C. (4&#xd7;10<sup>&#x2212;3 '\n",
      " '</sup>mbar) is collected and redistilled to yield the title compound as pale '\n",
      " 'yellow solid.</p>\\n'\n",
      " '<p id=\"p-0309\" num=\"2113\">GC-MS (EI): m/z=183 (M<sup>+</sup>); 127 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0310\" num=\"2114\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '4.35 (qu, J=7.0, 2H); 4.15 (qu, J=7.1, 2H); 2.63 (s, 3H); 1.29 (t, J=7.0, '\n",
      " '3H); 1.22 (t, J=7.1, 3H).</p>\\n'\n",
      " '<heading id=\"h-0009\" level=\"1\">Example A2</heading>\\n'\n",
      " '<heading id=\"h-0010\" level=\"1\">3-Amino-5-methyl-1H-pyrrole-2,4-dicarboxylic '\n",
      " 'acid diethyl ester</heading>\\n'\n",
      " '<p id=\"p-0311\" num=\"2115\">A reaction flask equipped with a mechanic stirrer, '\n",
      " 'a dropping funnel, a reflux condenser and a nitrogen bubbler is charged with '\n",
      " 'dry EtOH (700 mL), (E/Z)-2-cyano-3-ethoxy-but-2-enoic acid ethyl ester from '\n",
      " 'example 1 (128.25 g; 0.70 mol) and commercially available 2-amino-malonic '\n",
      " 'acid diethyl ester hydrochloride (148.15 g; 0.70 mol). To the well-stirred '\n",
      " 'reaction mixture NaOEt (&#x2dc;21% solution in EtOH; 1150 mL; &#x2dc;2.45 '\n",
      " 'mol) is added within 15 min (slightly exothermic). After complete addition '\n",
      " 'the reaction mixture is heated to gentle reflux under an atmosphere of '\n",
      " 'nitrogen and mechanical stirring for 18 hours.</p>\\n'\n",
      " '<p id=\"p-0312\" num=\"2116\">The reaction mixture is cooled to ambient '\n",
      " 'temperature and neutralized to pH=7 by slow addition of a sufficient amount '\n",
      " 'of 1M citric acid. EtOH is removed under reduced pressure at 50&#xb0; C. '\n",
      " '(rotava-pour). The residual solid is distributed between water (1500 mL) and '\n",
      " 'dichloromethane (500 mL). The organic layer is separated. The aqueous layer '\n",
      " 'is extracted with dichloromethane (2&#xd7;500 ml). The combined organic '\n",
      " 'layers are dried over MgSO<sub>4 </sub>in the presence of decolorizing '\n",
      " 'charcoal. The solution is filtered through a plug of neutral alumina (act. '\n",
      " '2-3) followed by filtration through a plug of silica. The solvent is removed '\n",
      " 'under reduced pressure until the product starts to precipitate. '\n",
      " 'Precipitation of the product is completed by addition of cyclohexane (1000 '\n",
      " 'ml) and cooling to 0&#xb0; C. for three hours. The solid is collected by '\n",
      " 'suction filtration, washed with several portions of hexane and dried in '\n",
      " 'vacuum at 50&#xb0; C. over night to yield the title compound as off-white '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-0313\" num=\"2117\">MS (ESI): m/z=241 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0314\" num=\"2118\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.26 (br.s, 1H, &#x2014;NH); 5.62 (br.s, 2H, &#x2014;NH<sub>2</sub>); 4.20 '\n",
      " '(qu, J=7.1, 2H); 4.18 (qu, J=7.1, 2H); 2.34 (s, 3H); 1.27 (t, J=7.1, 3H); '\n",
      " '1.26 (t, J=7.1, 3H).</p>\\n'\n",
      " '<heading id=\"h-0011\" level=\"1\">Example A3</heading>\\n'\n",
      " '<heading id=\"h-0012\" '\n",
      " 'level=\"1\">Ethyl-4-hydroxy-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0315\" num=\"2119\">A reaction flask equipped with a mechanical '\n",
      " 'stirrer, a reflux condenser and a nitrogen bubbler is charged with EtOH '\n",
      " '(5000 mL), 3-amino-5-methyl-1H-pyrrole-2,4-dicarboxylic acid diethyl ester '\n",
      " 'from example A2 (565.57 g; 2.50 mol) and formamidine acetate (1041.10 g; '\n",
      " '10.00 mol). The well-stirred reaction mixture is heated to gentle reflux for '\n",
      " 'five days under an atmosphere of nitrogen.</p>\\n'\n",
      " '<p id=\"p-0316\" num=\"2120\">The reaction mixture is cooled to ambient '\n",
      " 'temperature. The precipitated crude is collected by suction filtration, '\n",
      " 'washed with several small portions of EtOH and sucked dry for one hour. The '\n",
      " 'solid is suspended in water (2500 mL), stirred for two hours at ambient '\n",
      " 'temperature, collected by suction filtration, ished with several small '\n",
      " 'portions of water and sucked dry for one hour. The solid is again suspended '\n",
      " 'in EtOH (2500 mL). The suspension is stirred for three hours at ambient '\n",
      " 'temperature. The solid is collected by suction filtration, washed with '\n",
      " 'several small portions of EtOH, sucked dry for one hour and finally dried in '\n",
      " 'vacuum at 50&#xb0; C. over night to yield the title compound 7 containing 15 '\n",
      " 'mol % of isomer 8 as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0317\" num=\"2121\">The mixture of 7 and 8 (50.0 g, 0.23 mol) is '\n",
      " 'suspended in EtOH (1000 mL). The stirred suspension is refluxed for one '\n",
      " 'hour, filtered while still hot and washed with several small portions of '\n",
      " 'boiling EtOH. The remaining solid is resuspended in EtOH (500 mL). The '\n",
      " 'stirred suspension is refluxed for one hour, filtered while still hot, '\n",
      " 'washed with several small portions of boiling EtOH and dried in vacuum at '\n",
      " '50&#xb0; C. over night to deliver the title compound as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-0318\" num=\"2122\">MS (ESI): m/z=222 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0319\" num=\"2123\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.56 (s, 1H, &#x2014;NH); 12.04 (s, 1H, &#x2014;OH); 7.88 (s, 1H); 4.24 '\n",
      " '(qu, J=6.9, 2H); 2.55 (s, 3H); 1.28 (t, J=6.9, 3H).</p>\\n'\n",
      " '<p id=\"p-0320\" num=\"2124\">Pure isomer 8 is obtained as colorless solid from '\n",
      " 'the evaporated filtrates after crystallization from EtOH.</p>\\n'\n",
      " '<p id=\"p-0321\" num=\"2125\">MS (ESI): m/z=222 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0322\" num=\"2126\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.64 (s, 1H, &#x2014;NH); 11.41 (s, 1H, &#x2014;OH); 7.77 (s, 1H); 4.28 '\n",
      " '(qu, J=7.1, 2H); 2.56 (s, 3H); 1.30 (t, J=7.1, 3H).</p>\\n'\n",
      " '<heading id=\"h-0013\" level=\"1\">Example A4</heading>\\n'\n",
      " '<heading id=\"h-0014\" '\n",
      " 'level=\"1\">Ethyl-4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0323\" num=\"2127\">A reaction flask, equipped with a mechanic '\n",
      " 'stirrer, a reflux condenser and a nitrogen bubbler is charged with '\n",
      " 'POCl<sub>3 </sub>(1200 mL). Ethyl '\n",
      " '4-hydroxy-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate from example A3 '\n",
      " '(207.19 g; 1.00 mol) is added in several portions. The carefully stirred '\n",
      " 'suspension is heated to gentle reflux for five hours.</p>\\n'\n",
      " '<p id=\"p-0324\" num=\"2128\">The resulting dark solution is cooled to ambient '\n",
      " 'temperature. POCl<sub>3 </sub>is removed by distillation under reduced '\n",
      " 'pressure until the precipitated crude product prevented further stirring. '\n",
      " 'Remaining POCl<sub>3 </sub>is removed by repeated co-distillation with dry '\n",
      " 'toluene (3&#xd7;1000 mL). Finally the resulting solid is suspended in '\n",
      " 'toluene and stirred at ambient temperature under an atmosphere of nitrogen '\n",
      " 'over night. The dark precipitate is collected by suction filtration, ished '\n",
      " 'with several small portions of toluene and diethyl ether, and sucked dry '\n",
      " 'under an atmosphere of nitrogen.</p>\\n'\n",
      " '<p id=\"p-0325\" num=\"2129\">The dry solid is suspended in ice cold water (1000 '\n",
      " 'mL). The pH of the well-stirred suspension is adjusted to 8 by careful '\n",
      " 'addition of 2M KHCO<sub>3</sub>-solution. The suspension is stirred for '\n",
      " 'several hours until pH stayed at 8.0 (from time to time the pH has to be '\n",
      " 'readjusted to 8.0 by addition of 2M KHCO<sub>3</sub>-solution). The product '\n",
      " 'is isolated by suction filtration, washed with several small portions of '\n",
      " 'water and sucked dry for two hours.</p>\\n'\n",
      " '<p id=\"p-0326\" num=\"2130\">For further purification the product is suspended '\n",
      " 'in acetonitrile (1000 mL). The suspension is stirred at 60&#xb0; C. for one '\n",
      " 'hour and at ambient temperature for one additional hour. The product is '\n",
      " 'collected by suction filtration washed with several small portions of '\n",
      " 'acetonitril and sucked dry for one hour. A second crop of product is '\n",
      " 'obtained from the mother liquor after concentration under reduced pressure. '\n",
      " 'The solids are combined and dried in vacuum at 50&#xb0; C. over night to '\n",
      " 'yield the title compound as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0327\" num=\"2131\">MS (ESI): m/z=240 (MH<sup>+</sup>); 226 (100%); '\n",
      " '212.</p>\\n'\n",
      " '<p id=\"p-0328\" num=\"2132\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.76 (br.s, 1H, &#x2014;NH); 8.64 (s, 1H); 4.29 (qu, J=7.1, 2H); 1.32 (t, '\n",
      " 'J=7.1, 3H).</p>\\n'\n",
      " '<heading id=\"h-0015\" level=\"1\">Example A.5</heading>\\n'\n",
      " '<heading id=\"h-0016\" level=\"1\">Ethyl '\n",
      " '3-(ethanimidoylamino)-5-methyl-1H-pyrrole-2-carboxylate '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-0329\" num=\"2133\">Ethyl-3-amino-5-methyl-1H-pyrrole-2-carboxylate '\n",
      " '(58.87 g; 0.35 mol) prepared according to literature [Gangjee A.; Li W.; '\n",
      " 'Yang J.; Kisliuk R. L.; J. Med. Chem. 2008, 51, 68] is suspended in '\n",
      " 'acetonitrile (1750 mL). To the suspension is added dropwise 4M HCl in '\n",
      " 'dioxane (473 mL; 1.89 mol) within 15 minutes. After complete addition the '\n",
      " 'reaction mixture is heated to 50&#xb0; C. for 18 hours. The reaction mixture '\n",
      " 'is cooled to 10&#xb0; C., the solid is collected by suction filtration and '\n",
      " 'washed with cold acetonitrile (400 mL). A second crop of product is obtained '\n",
      " 'from the mother liquor after concentration under reduced pressure. The '\n",
      " 'residue is collected with t-butylmethyl-ether. After the suction filtration '\n",
      " 'the solids are combined and dried in vacuum at 50&#xb0; C. to yield the '\n",
      " 'title compound as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0330\" num=\"2134\">MS (ESI): m/z=210 (MH<sup>+</sup>)</p>\\n'\n",
      " '<p id=\"p-0331\" num=\"2135\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.96 (s, 1H, &#x2014;NH); 10.93 (s, 1H, &#x2014;NH); 9.45 (s, 1H, '\n",
      " '&#x2014;NH); 8.22 (s, 1H, &#x2014;NH); 5.92 (m, 1H); 4.19 (qu, J=7.1, 2H); '\n",
      " '2.29 (s, 3H); 2.23 (s, 3H); 1.26 (t, J=7.1, 3H).</p>\\n'\n",
      " '<heading id=\"h-0017\" level=\"1\">Example A.6</heading>\\n'\n",
      " '<heading id=\"h-0018\" '\n",
      " 'level=\"1\">2,6-Dimethyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one</heading>\\n'\n",
      " '<p id=\"p-0332\" num=\"2136\">A reaction flask equipped with a mechanical '\n",
      " 'stirrer and a reflux condenser is charged with EtOH (900 mL), '\n",
      " 'Ethyl-3-(ethanimidoylamino)-5-methyl-1H-pyrrole-2-carboxylate hydrochloride '\n",
      " 'from example A5 (82.79 g; 0.34 mol) and 6M NaOH (226 mL; 1.36 mol). The '\n",
      " 'well-stirred reaction mixture is heated to gentle reflux for 4 hours and is '\n",
      " 'cooled to ambient temperature. The resulting solution is diluted with water '\n",
      " '(1000 mL) and the pH is adjusted to 6.5 by carefully addition of 2M citric '\n",
      " 'acid. The precipitate is collected by suction filtration, washed with '\n",
      " 'several portions of water and dried in vacuum at 50&#xb0; C. to yield the '\n",
      " 'title compound as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0333\" num=\"2137\">MS (ESI): m/z=164 (MH<sup>+</sup>)</p>\\n'\n",
      " '<p id=\"p-0334\" num=\"2138\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.63 (s, 1H, &#x2014;NH); 11.58 (s, 1H, &#x2014;OH); 5.98 (m, 1H); 2.29 (s, '\n",
      " '3H); 2.26 (s, 3H).</p>\\n'\n",
      " '<heading id=\"h-0019\" level=\"1\">Example A.7</heading>\\n'\n",
      " '<heading id=\"h-0020\" '\n",
      " 'level=\"1\">4-Chloro-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine</heading>\\n'\n",
      " '<p id=\"p-0335\" '\n",
      " 'num=\"2139\">2,6-Dimethyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one from '\n",
      " 'example A6 (87.00 g; 0.53 mol) is suspended in dry acetonitrile (870 mL). '\n",
      " 'After addition of POCl<sub>3 </sub>(122 mL; 1.33 mol) the stirred reaction '\n",
      " 'mixture is heated to gentle reflux for 18 hours.</p>\\n'\n",
      " '<p id=\"p-0336\" num=\"2140\">The volatiles are removed by destillation under '\n",
      " 'reduced pressure. The residue is diluted with ice cold water (1500 mL) and '\n",
      " 'the well-stirred suspension is adjusted to pH=8 by addition of 5M KOH. The '\n",
      " 'suspension is stirred for several hours until pH stayed at 8.0. (from time '\n",
      " 'to time the pH has to be readjusted to 8.0 by addition of 5M KOH). The solid '\n",
      " 'is isolated by suction filtration, dissolved in dichloromethane, dried over '\n",
      " 'MgSO<sub>4 </sub>and filtered through a plug of neutral alumina (act. 2-3). '\n",
      " 'The solvent is removed under reduced pressure. The product is resuspended in '\n",
      " 'tert-butylmethylether, filtered and dried in vacuum at 50&#xb0; C. over '\n",
      " 'night to yield the title compound as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0337\" num=\"2141\">MS (ESI): m/z=182 (MH<sup>+</sup>)</p>\\n'\n",
      " '<p id=\"p-0338\" num=\"2142\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.99 (s, 1H, &#x2014;NH); 6.33 (m, 1H); 2.57 (s, 3H); 2.48 (s, 3H).</p>\\n'\n",
      " '<heading id=\"h-0021\" level=\"1\">Example A.8</heading>\\n'\n",
      " '<heading id=\"h-0022\" '\n",
      " 'level=\"1\">7-Bromo-4-chloro-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine</heading>\\n'\n",
      " '<p id=\"p-0339\" num=\"2143\">4-Chloro-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine '\n",
      " 'from example A7 (10.90 g; 60.00 mmol) is dissolved in dichloromethane (120 '\n",
      " 'mL). The stirred mixture is cooled to &#x2212;10&#xb0; C. Br<sub>2 '\n",
      " '</sub>(3.08 mL; 60.00 mmol) dissolved in dichloromethane (20 mL) is added '\n",
      " 'dropwise within 25 minutes. The re-suiting precipitate is collected by '\n",
      " 'suction filtration, suspended in Na<sub>2</sub>SO<sub>3 </sub>(5% solution) '\n",
      " '(100 mL) and is stirred for 30 minutes at ambient temperature. After '\n",
      " 'filtratrion the product is dissolved in acetonitrile (1000 mL), refluxed for '\n",
      " 'one hour and filtered while still hot. The solvent is removed under reduced '\n",
      " 'pressure until the product starts to precipitate. Precipitation of the '\n",
      " 'product is completed by addition of cyclohexane and cooling to 0&#xb0; C. '\n",
      " 'for several hours. The solid is collected by suction filtration, washed with '\n",
      " 'cyclohexane and dried in vacuum at 50&#xb0; C. over night to yield the title '\n",
      " 'compound as a white solid.</p>\\n'\n",
      " '<p id=\"p-0340\" num=\"2144\">MS (ESI): m/z=262 (MH<sup>+</sup>)</p>\\n'\n",
      " '<p id=\"p-0341\" num=\"2145\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.61 (s, 1H, &#x2014;NH); 2.62 (s, 3H); 2.48 (s, 3H).</p>\\n'\n",
      " '<heading id=\"h-0023\" level=\"1\">Example A.9</heading>\\n'\n",
      " '<heading id=\"h-0024\" '\n",
      " 'level=\"1\">7-Bromo-4-chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine</heading>\\n'\n",
      " '<p id=\"p-0342\" num=\"2146\">Sodium hydride (1.82 g; 45.60 mmol; 60% in oil, '\n",
      " 'washed with hexane), is suspended in dry DMF (125 mL) and dry DMSO (25 mL). '\n",
      " 'To the stirring suspension '\n",
      " '7-Bromo-4-chloro-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine from example A8 '\n",
      " '(10.00 g; 38.00 mmol) dissolved in dry DMF (125 mL) is added dropwise within '\n",
      " '30 minutes at ambient temperature. After complete addition the reaction '\n",
      " 'mixture is stirred for one hour at ambient temperature. To the resulting '\n",
      " 'solution 2-(trimethylsilyl)ethoxymethylchloride (8.74 mL; 49.40 mmol) is '\n",
      " 'added dropwise and the reaction mixture is stirred for one hour at ambient '\n",
      " 'temperature. After diluting with water/ice and dichloromethane, the organic '\n",
      " 'layer is separated and the aqueous layer is extracted with dichloromethane '\n",
      " '(2&#xd7;400 mL). The combined organic layers are dried over MgSO<sub>4 '\n",
      " '</sub>and filtered through a plug of neutral alumina (act. 2-3). The solvent '\n",
      " 'is removed under reduced pressure and the residue is purified by column '\n",
      " 'chromatography on silica gel (cyclohexane:ethylacetate/9:1) affording the '\n",
      " 'title compound as a white solid.</p>\\n'\n",
      " '<p id=\"p-0343\" num=\"2147\">MS (ESI): m/z=392 (MH<sup>+</sup>)</p>\\n'\n",
      " '<p id=\"p-0344\" num=\"2148\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '5.81 (s, 2H); 3.57 (t, J=7.9, 2H); 2.63 (s, 3H); 2.58 (s, 3H); 0.83 (m, 2H); '\n",
      " '&#x2212;0.09 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0025\" level=\"1\">Example A.10</heading>\\n'\n",
      " '<heading id=\"h-0026\" '\n",
      " 'level=\"1\">4-Chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carbaldehyde</heading>\\n'\n",
      " '<p id=\"p-0345\" '\n",
      " 'num=\"2149\">7-Bromo-4-chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine '\n",
      " 'from example A9 (12.41 g; 31.76 mmol) is dissolved in dry tetrahydrofurane '\n",
      " '(100 mL). At &#x2212;78&#xb0; C. n-butyllithium (12.7 mL; 31.76 mmol; 2.5M '\n",
      " 'solution in n-hexane) is syringed into the stirred reaction mixture. After '\n",
      " '30 min DMF (12.4 mL; 158.80 mmol) is added via syringe and the mixture is '\n",
      " 'stirred for additional 2 hours at &#x2212;78&#xb0; C. and for 30 minutes at '\n",
      " '0&#xb0; C. The reaction is quenched by addition of 1M citric acid (32 mL) '\n",
      " 'and brine (32 mL). After diluting with tert-butylmethylether the aqueous '\n",
      " 'layer is separated and extracted with tert-butylmethylether (3&#xd7;50 mL). '\n",
      " 'The combined organic layers are dried over MgSO<sub>4 </sub>and the solvent '\n",
      " 'is removed under reduced pressure. The residue is purified by column '\n",
      " 'chromatography on silica gel (cyclohexane:ethylacetate/7:3) affording the '\n",
      " 'title compound as a white solid.</p>\\n'\n",
      " '<p id=\"p-0346\" num=\"2150\">MS (ESI): m/z=340 (MH<sup>+</sup>)</p>\\n'\n",
      " '<p id=\"p-0347\" num=\"2151\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '10.35 (s, 1H); 5.85 (s, 1H); 3.61 (t. J=7.9, 2H); 2.87 (s, 3H); 2.67 (s, '\n",
      " '3H); 0.85 (m, 2H); &#x2212;0.08 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0027\" level=\"1\">Example A.11</heading>\\n'\n",
      " '<heading id=\"h-0028\" level=\"1\">Methyl '\n",
      " '4-chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0348\" num=\"2152\">To a well stirred mixture of '\n",
      " '4-chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carbaldehyde '\n",
      " 'from example A10 (9.49 g; 27.90 mmol), MeOH (50 mL), KCN (6.00 g; 92.10 '\n",
      " 'mmol) and MnO<sub>2 </sub>(35.60 g, 383.30 mmol) acetic acid (1.68 g; 27.90 '\n",
      " 'mmol) is added at ambient temperature. After 4 hours the dark mixture is '\n",
      " 'filtered through Celite and the solvent is removed under reduced pressure. '\n",
      " 'The residue is purified by column chromatography on silica gel '\n",
      " '(cyclohexane:ethylacetate/9:1) affording the title compound as an pale '\n",
      " 'yellow oil.</p>\\n'\n",
      " '<p id=\"p-0349\" num=\"2153\">MS (ESI): m/z=370 (MH<sup>+</sup>)</p>\\n'\n",
      " '<p id=\"p-0350\" num=\"2154\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '5.85 (s, 2H); 3.84 (s, 3H); 3.59 (t, J=7.9, 2H); 2.84 (s, 3H); 2.64 (s, 3H); '\n",
      " '0.84 (m, 2H); &#x2212;0.09 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0029\" level=\"1\">Example B.a1</heading>\\n'\n",
      " '<heading id=\"h-0030\" level=\"1\">2-Bromo-5-fluoro-4-methoxy-phenol</heading>\\n'\n",
      " '<p id=\"p-0351\" num=\"2155\">3-Fluoro-4-methoxy-phenol (21.32 g; 0.15 mol) '\n",
      " 'prepared according to literature [Freedman, J.; Stewart, K. T.; J. '\n",
      " 'Heterocycl. Chem. 1989, 26, 1547-1554] is dissolved in dry dichloromethane '\n",
      " '(300 mL). The well stirred reaction mixture is cooled to &#x2212;15&#xb0; C. '\n",
      " '(ice/salt). A solution of bromine (23.97 g; 0.15 mol) in dry dichloromethane '\n",
      " '(75 mL) is dropped into the reaction mixture. After complete addition '\n",
      " 'stirring is continued for one hour. Water (150 mL) containing sodium sulfite '\n",
      " '(3.0 g) is added to the reaction mixture. Stirring is continued at ambient '\n",
      " 'temperature for 30 min. The organic layer is separated, washed with water '\n",
      " '(100 mL) and dried over MgSO<sub>4 </sub>in the presence of decolorizing '\n",
      " 'charcoal. After filtration the solvent is completely removed under reduced '\n",
      " 'pressure. The residue is crystallized from tert-butylmethylether/hexane to '\n",
      " 'yield the title compound as a colorless solid.</p>\\n'\n",
      " '<p id=\"p-0352\" num=\"2156\">GC-MS (EI): m/z=222, 220 (M<sup>+</sup>); 207, 205 '\n",
      " '(M<sup>+</sup>-CH<sub>3</sub>, 100%); 179, 177.</p>\\n'\n",
      " '<p id=\"p-0353\" num=\"2157\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '10.06 (s, 1H, &#x2014;OH); 7.28 (d, J=9.2, 1H); 6.81 (d, J=12.6, 1H); 3.76 '\n",
      " '(s, 3H).</p>\\n'\n",
      " '<p id=\"p-0354\" num=\"2158\">The following compounds are obtained analogously '\n",
      " 'to the procedure described in above example B.a1.</p>\\n'\n",
      " '<heading id=\"h-0031\" level=\"1\">Example B.a2</heading>\\n'\n",
      " '<heading id=\"h-0032\" level=\"1\">2-Bromo-4-fluoro-5-methoxy-phenol</heading>\\n'\n",
      " '<p id=\"p-0355\" num=\"2159\">Starting from 4-fluoro-3-methoxy-phenol prepared '\n",
      " 'according to literature [Belanger, P. C.; Lau, C. K.; Williams, H. W. R.; '\n",
      " 'Dufresne, C.; Scheigetz, J. Can. J. Chem. 1988, 66, 1479-1482] the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0356\" num=\"2160\">GC-MS (EI): m/z=222, 220 (M<sup>+</sup>, 100%); '\n",
      " '207, 205 (M-CH<sub>3</sub><sup>+</sup>); 179, 177.</p>\\n'\n",
      " '<p id=\"p-0357\" num=\"2161\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.16 (d, J=10.2, 1H); 6.67 (d, J=7.7, 1H); 5.29 (s, 1H, &#x2014;OH); 3.85 '\n",
      " '(s, 3H)</p>\\n'\n",
      " '<heading id=\"h-0033\" level=\"1\">Example B.a3</heading>\\n'\n",
      " '<heading id=\"h-0034\" level=\"1\">2-Bromo-5-fluoro-4-methylphenol</heading>\\n'\n",
      " '<p id=\"p-0358\" num=\"2162\">Starting from commercially available '\n",
      " '3-fluoro-4-methylphenol the title compound is obtained as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-0359\" num=\"2163\">GC-MS (EI): m/z=206, 204 (M<sup>+</sup>); 125 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0360\" num=\"2164\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '10.38 (br.s, 1H, &#x2014;OH); 7.39 (d, J=8.2, 1H); 6.70 (d, J=11.1, 1H); '\n",
      " '2.11 (s, 3H).</p>\\n'\n",
      " '<heading id=\"h-0035\" level=\"1\">Example B.a4</heading>\\n'\n",
      " '<heading id=\"h-0036\" '\n",
      " 'level=\"1\">1-(3-Bromo-4-hydroxy-phenyl)-ethanone</heading>\\n'\n",
      " '<p id=\"p-0361\" num=\"2165\">Starting from commercially available '\n",
      " '1-(4-hydroxy-phenyl)-ethanone the title compound is obtained as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-0362\" num=\"2166\">GC-MS (EI): m/z=214, 212 (M<sup>+</sup>); 199,197 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0363\" num=\"2167\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.19 (s, 1H, &#x2014;OH); 8.06 (d, J=2.2, 1H); 7.82 (dd, J=8.4, 2.2, 1H); '\n",
      " '7.03 (d, J=8.4, 1H); 2.49 (s, 3H).</p>\\n'\n",
      " '<heading id=\"h-0037\" level=\"1\">Example B.a5</heading>\\n'\n",
      " '<heading id=\"h-0038\" level=\"1\">2-Bromo-4-ethyl-phenol</heading>\\n'\n",
      " '<p id=\"p-0364\" num=\"2168\">Starting from commercially available '\n",
      " '4-ethyl-phenol the title compound is obtained as colorless oil after short '\n",
      " 'path distillation at 10 mbar.</p>\\n'\n",
      " '<p id=\"p-0365\" num=\"2169\">GC-MS (EI): m/z=202, 200 (M<sup>+</sup>); 187,195 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0366\" num=\"2170\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.88 (s, 1H, &#x2014;OH); 7.29 (d, J=2.0, 1H); 7.00 (dd, J=8.2, 2.0, 1H); '\n",
      " '6.85 (d, J=8.2, 1H); 2.49 (qu, J=7.7, 2H); 1.12 (t, J=7.7, 3H).</p>\\n'\n",
      " '<heading id=\"h-0039\" level=\"1\">Example B.a6</heading>\\n'\n",
      " '<heading id=\"h-0040\" level=\"1\">2-bromo-4-isopropyl-phenol</heading>\\n'\n",
      " '<p id=\"p-0367\" num=\"2171\">Starting from commercially available '\n",
      " '4-isopropyl-phenol the title compound is obtained as colorless oil after '\n",
      " 'short path distillation at 10 mbar.</p>\\n'\n",
      " '<p id=\"p-0368\" num=\"2172\">GC-MS (EI): m/z=216, 214 (M<sup>+</sup>); 201, '\n",
      " '199; 120 (100%).</p>\\n'\n",
      " '<p id=\"p-0369\" num=\"2173\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.88 (s, 1H, &#x2014;OH); 7.30 (d, J=2.2, 1H); 7.04 (dd, J=8.4, 2.2, 1H); '\n",
      " '6.86 (d, J=8.4, 1H); 2.78 (sept, J=6.9, 1H); 1.14 (d, J=6.9, 6H).</p>\\n'\n",
      " '<heading id=\"h-0041\" level=\"1\">Example B.b1</heading>\\n'\n",
      " '<heading id=\"h-0042\" '\n",
      " 'level=\"1\">5-Cyclopropylmethoxy-benzo[1,3]dioxole</heading>\\n'\n",
      " '<p id=\"p-0370\" num=\"2174\">Sodium hydride (60 wt % dispersion in mineral oil; '\n",
      " '11.0 g; 275.0 mmol) is freed from oil by washing with hexane (2&#xd7;50 mL) '\n",
      " 'and suspended in dry DME (375 mL) and dry DMSO (37.5 mL).</p>\\n'\n",
      " '<p id=\"p-0371\" num=\"2175\">Under an atmosphere of nitrogen a solution of '\n",
      " 'commercially available sesamol (3,4-methylenedioxy-phenol) (34.53 g; 250.0 '\n",
      " 'mmol) in dry DME (250 mL) is dropped into the well-stirred suspension at a '\n",
      " 'rate to keep the internal temperature below 40&#xb0; C. After complete '\n",
      " 'addition stirring is continued at ambient temperature for one hour.</p>\\n'\n",
      " '<p id=\"p-0372\" num=\"2176\">Neat commercially available '\n",
      " 'bromomethyl-cyclopropane (37.13 g; 275.0 mmol) is added in one portion and '\n",
      " 'the reaction mixture is stirred at 80&#xb0; C. over night. Ice-cold water '\n",
      " '(125 mL) is drop wise added and the reaction mixture is stirred for 30 min '\n",
      " 'at ambient temperature. After addition of brine (125 mL) the organic layer '\n",
      " 'is separated and concentrated in vacuo. The aqueous layer is extracted with '\n",
      " 'tert-butylmethylether (3&#xd7;200 mL). All organic phases are combined, '\n",
      " 'washed with brine (200 mL), dried over MgSO<sub>4 </sub>and filtered through '\n",
      " 'a plug of neutral alumina containing 5 wt % of water. The product is '\n",
      " 'completely eluted with several portions of tert-butylmethylether. The '\n",
      " 'solvent is removed under reduced pressure. The remaining crude product is '\n",
      " 'purified by short path distillation at 3&#xd7;10<sup>&#x2212;3 </sup>mbar '\n",
      " '(117&#xb0; C.) to give the title compound as colorless oil that solidifies '\n",
      " 'at ambient temperature.</p>\\n'\n",
      " '<p id=\"p-0373\" num=\"2177\">GC-MS (EI): m/z=192 (M<sup>+</sup>); 138 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>, 100%).</p>\\n'\n",
      " '<p id=\"p-0374\" num=\"2178\"><sup>1</sup>H-NMR (200 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.77 (d, J=8.5, 1H); 6.59 (d, J=2.5, 1H); 6.32 (dd, J=8.5, 2.5, 1H); 5.93 '\n",
      " '(s, 2H); 3.71 (d, J=6.9, 2H); 1.15 (m, 1H); 0.53 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-0375\" num=\"2179\">The following compounds are obtained analogously '\n",
      " 'to the procedure described in above example B.b1.</p>\\n'\n",
      " '<heading id=\"h-0043\" level=\"1\">Example B.b2</heading>\\n'\n",
      " '<heading id=\"h-0044\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-4-fluoro-benzene</heading>\\n'\n",
      " '<p id=\"p-0376\" num=\"2180\">Starting from commercially available '\n",
      " '2-bromo-5-fluoro-phenol and commercially available bromo-methyl-cyclopropane '\n",
      " 'the title compound is obtained as colorless oil after distillation at '\n",
      " '5&#xd7;10<sup>3 </sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0377\" num=\"2181\">GC-MS (EI): m/z=244, 246 (M<sup>+</sup>); 190, 192 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 55 (100%).</p>\\n'\n",
      " '<p id=\"p-0378\" num=\"2182\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.58 (dd, J=8.7, 6.4, 1H); 7.02 (dd, J=11.2, 2.8, 1H); 6.75 (ddd, J=8.7, '\n",
      " '2.8, 1H); 3.93 (d, J=6.8, 2H); 1.24 (m, 1H); 0.56 (m, 2H); 0.38 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0045\" level=\"1\">Example B.b3</heading>\\n'\n",
      " '<heading id=\"h-0046\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-5-fluoro-benzene</heading>\\n'\n",
      " '<p id=\"p-0379\" num=\"2183\">Starting from commercially available '\n",
      " '2-bromo-4-fluoro-phenol and commercially available bromo-methyl-cyclopropane '\n",
      " 'the title compound is obtained as colorless oil after distillation at '\n",
      " '5&#xd7;10<sup>&#x2212;3 </sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0380\" num=\"2184\">GC-MS (EI): m/z=244, 246 (M<sup>+</sup>); 190, '\n",
      " '192; (M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 55 (100%).</p>\\n'\n",
      " '<p id=\"p-0381\" num=\"2185\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.52 (dd, J<sub>1</sub>=8.2, J<sub>2</sub>=3.1, 1H); 7.19 (ddd, '\n",
      " 'J<sub>1</sub>=9.1, J<sub>2</sub>=8.2, J<sub>3</sub>=3.1, 1H); 7.10 (dd, '\n",
      " 'J1=9.1, J2=5.0, 1H); 3.89 (d, J=6.8, 2H); 1.22 (m, 2H); 0.57 (m, 2H); 0.35 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0047\" level=\"1\">Example B.b5</heading>\\n'\n",
      " '<heading id=\"h-0048\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-4-methoxy-benzene</heading>\\n'\n",
      " '<p id=\"p-0382\" num=\"2186\">Starting from commercially available '\n",
      " '2-bromo-5-methoxy-phenol and bromomethyl-cyclopropane the title compound is '\n",
      " 'obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0383\" num=\"2187\">GC-MS (EI): m/z=258, 256 (M<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0384\" num=\"2188\"><sup>1</sup>H-NMR (200 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.41 (d, J=7.9, 1H); 6.48 (dd, J<sub>1</sub>=7.9, J<sub>2</sub>=2.2, 1H); '\n",
      " '6.45 (d, J=2.2, 1H); 3.87 (d, J=5.6, 2H); 3.76 (s, 3H); 1.26 (m, 1H); 0.63 '\n",
      " '(m, 2H); 0.36 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0049\" level=\"1\">Example B.b6</heading>\\n'\n",
      " '<heading id=\"h-0050\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-5-methoxy-benzene</heading>\\n'\n",
      " '<p id=\"p-0385\" num=\"2189\">Starting from commercially available '\n",
      " '2-bromo-4-methoxy-phenol and bromomethyl-cyclopropane the title compound is '\n",
      " 'obtained as colorless oil after distillation at 5&#xd7;10<sup>&#x2212;3 '\n",
      " '</sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0386\" num=\"2190\">GC-MS (EI): m/z=256, 258 (M<sup>+</sup>); 202, 204 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0387\" num=\"2191\"><sup>1</sup>H-NMR (200 MHz, CDCl<sub>3</sub>): '\n",
      " '7.11 (d, J=2.8, 1H); 6.86 (d, J=8.9, 1H); 6.78 (dd, J<sub>1</sub>=8.9, '\n",
      " 'J<sub>2</sub>=2.8, 1H); 3.82 (d, J=6.8, 2H); 3.75 (s, 3H); 1.16 (m, 1H); '\n",
      " '0.51 (m, 2H); 0.44 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0051\" level=\"1\">Example B.b7</heading>\\n'\n",
      " '<heading id=\"h-0052\" '\n",
      " 'level=\"1\">2-Bromo-1-cyclopropylmethoxy-4-methyl-benzene</heading>\\n'\n",
      " '<p id=\"p-0388\" num=\"2192\">Starting from commercially available '\n",
      " '2-bromo-4-methyl-phenol and bromomethyl-cyclopropane the title compound is '\n",
      " 'obtained as colorless oil after distillation at 5&#xd7;10<sup>&#x2212;3 '\n",
      " '</sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0389\" num=\"2193\">GC-MS (EI): m/z=242,240 (M<sup>+</sup>); 188,186 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 107; 80, 78; 55 (100%).</p>\\n'\n",
      " '<p id=\"p-0390\" num=\"2194\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.38 (dd, J=2.2, 0.7, 1H); 7.10 (ddd, J=8.4, 2.2, 0.7, 1H); 6.96 (d, J=8.4, '\n",
      " '1H); 3.86 (d, J=6.8, 2H); 2.22 (s, 3H); 1.21 (m, 1H); 0.56 (m, 2H); 0.33 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0053\" level=\"1\">Example B.b8</heading>\\n'\n",
      " '<heading id=\"h-0054\" '\n",
      " 'level=\"1\">2-Bromo-1-cyclopropylmethoxy-4-trifluoromethyl-benzene</heading>\\n'\n",
      " '<p id=\"p-0391\" num=\"2195\">Starting from commercially available '\n",
      " '2-bromo-4-trifluoromethyl-phenol and bromomethyl-cyclopropane the title '\n",
      " 'compound is obtained as colorless oil after distillation at '\n",
      " '5&#xd7;10<sup>&#x2212;3 </sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0392\" num=\"2196\">GC-MS (EI): m/z=296,294 (M<sup>+</sup>); 268, 266; '\n",
      " '242, 240 (M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 132; 55 (100%).</p>\\n'\n",
      " '<p id=\"p-0393\" num=\"2197\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.93 (dd, J=2.3, 0.5, 1H); 7.70 (ddd, J=8.8, 2.3, 0.5, 1H); 7.26 (d, J=8.8, '\n",
      " '1H); 4.03 (d, J=6.9, 2H); 1.27 (m, 1H); 0.60 (m, 2H); 0.38 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0055\" level=\"1\">Example B.b9</heading>\\n'\n",
      " '<heading id=\"h-0056\" '\n",
      " 'level=\"1\">2-Bromo-1-ethoxy-4-trifluoromethyl-benzene</heading>\\n'\n",
      " '<p id=\"p-0394\" num=\"2198\">Starting from commercially available '\n",
      " '2-bromo-4-trifluoromethyl-phenol and ethyliodide the title compound is '\n",
      " 'obtained as colorless oil after distillation at 5&#xd7;10<sup>&#x2212;3 '\n",
      " '</sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0395\" num=\"2199\">GC-MS (EI): m/z=270, 268 (M<sup>+</sup>); 242, 240 '\n",
      " '(M<sup>+</sup>-C<sub>2</sub>H<sub>4</sub>, 100%); 132.</p>\\n'\n",
      " '<p id=\"p-0396\" num=\"2200\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.93 (dd, J=2.3, 0.7, 1H); 7.71 (ddd, J=8.8, 2.3, 0.7, 1H); 7.27 (d, J=8.8, '\n",
      " '1H); 4.21 (qu, J=6.9, 2H); 1.38 (t, J=6.9, 3H).</p>\\n'\n",
      " '<heading id=\"h-0057\" level=\"1\">Example B.b10</heading>\\n'\n",
      " '<heading id=\"h-0058\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-4-fluoro-5-methoxy-benzene</heading>\\n'\n",
      " '<p id=\"p-0397\" num=\"2201\">Starting from 2-bromo-5-fluoro-4-methoxy-phenol '\n",
      " '(example B.a1) and commercially available bromomethyl-cyclopropane the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0398\" num=\"2202\">GC-MS (EI): m/z=276, 274 (M<sup>+</sup>); 222, 220 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>, 100%); 206, 204.</p>\\n'\n",
      " '<p id=\"p-0399\" num=\"2203\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.38 (d, J=9.2, 1H); 7.13 (d, J=13.1, 1H); 3.85 (d, J=6.9, 2H); 3.80 (s, '\n",
      " '3H); 1.20 (m, 1H); 0.57 (m, 2H); 0.33 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0059\" level=\"1\">Example B.b11</heading>\\n'\n",
      " '<heading id=\"h-0060\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-4-fluoro-5-methyl-benzene</heading>\\n'\n",
      " '<p id=\"p-0400\" num=\"2204\">Starting from 2-bromo-5-fluoro-4-methyl-phenol '\n",
      " '(example B.a3) and commercially available bromomethyl-cyclopropane the title '\n",
      " 'compound is obtained as colorless oil after distillation at '\n",
      " '5&#xd7;10<sup>&#x2212;3 </sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0401\" num=\"2205\">GC-MS (EI): m/z=260, 258 (M<sup>+</sup>); 206, 204 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 179; 125; 96; 55 (100%).</p>\\n'\n",
      " '<p id=\"p-0402\" num=\"2206\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.49 (d, J=8.2, 1H); 6.97 (d, J=11.7, 1H); 3.89 (d, J=6.9, 2H); 2.14 (d, '\n",
      " 'J=1.8, 3H); 1.22 (m, 1H); 0.57 (m, 2H); 0.34 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0061\" level=\"1\">Example B.b12</heading>\\n'\n",
      " '<heading id=\"h-0062\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-5-fluoro-4-methoxy-benzene</heading>\\n'\n",
      " '<p id=\"p-0403\" num=\"2207\">Starting from 2-bromo-4-fluoro-5-methoxy-phenol '\n",
      " '(example B.a2) and commercially available bromomethyl-cyclopropane the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0404\" num=\"2208\">GC-MS (EI): m/z=276, 274 (M<sup>+</sup>); 222, 220 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>, 100%).</p>\\n'\n",
      " '<p id=\"p-0405\" num=\"2209\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.48 (d, J=10.8, 1H); 6.90 (d, J=7.9, 1H); 3.93 (d, J=6.8, 2H); 3.85 (s, '\n",
      " '3H); 1.24 (m, 1H); 0.58 (m, 2H); 0.36 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0063\" level=\"1\">Example B.b13</heading>\\n'\n",
      " '<heading id=\"h-0064\" '\n",
      " 'level=\"1\">1-(3-Bromo-4-cyclopropylmethoxy-phenyl)-ethanone</heading>\\n'\n",
      " '<p id=\"p-0406\" num=\"2210\">Starting from '\n",
      " '1-(3-bromo-4-hydroxy-phenyl)-ethanone (example B.a4) and commercially '\n",
      " 'available bromomethyl-cyclopropane the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-0407\" num=\"2211\">GC-MS (EI): m/z=270, 268 (M<sup>+</sup>); 242, '\n",
      " '240; 216, 214 (M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 201, 199; 55 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0408\" num=\"2212\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.11 (d, J=2.1, 1H); 7.94 (dd, J=8.7, 2.1, 1H); 7.19 (d, J=8.7, 1H); 4.03 '\n",
      " '(d, J=6.9, 2H); 2.53 (s, 3H); 1.27 (m, 1H); 0.60 (m, 2H); 0.38 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0065\" level=\"1\">Example B.b14</heading>\\n'\n",
      " '<heading id=\"h-0066\" '\n",
      " 'level=\"1\">2-[3-Bromo-4-(cyclopropylmethoxy)phenyl]-2-methyl-1,3-dioxolane</heading>\\n'\n",
      " '<p id=\"p-0409\" num=\"2213\">A solution of '\n",
      " '1-(3-bromo-4-cyclopropylmethoxy-phenyl)-ethanone from example B.b13 (14.0 g; '\n",
      " '52.0 mmol) in dry dichloromethane (250 mL) was cooled in an ice-bath before '\n",
      " 'addition of trimethylsilyl trifluoro-methane sulfonate (0.23 g; 1.04 mmol) '\n",
      " 'and dropwise addition of 1,2-bis-(trimethylsilyloxy)-ethane (13.15 g; 62.4 '\n",
      " 'mmol). The reaction mixture was stirred for two hours, extracted with 1M '\n",
      " 'aqueous NaHCO<sub>3 </sub>(100 mL) and dried over MgSO<sub>4</sub>. The '\n",
      " 'crude is purified by column chromatography on silica gel (ethyl '\n",
      " 'acetate/cyclohexane&#x2014;9:1) to yield the title compound as pale yellow '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-0410\" num=\"2214\">GC-MS (EI): m/z=314, 314 (M<sup>+</sup>); 299, 297 '\n",
      " '(M<sup>+</sup>-CH<sub>3</sub>, 100%); 245, 243 '\n",
      " '(M<sup>+</sup>-CH<sub>3</sub>, &#x2014;C<sub>4</sub>H<sub>6</sub>); 201, '\n",
      " '199; 87; 55.</p>\\n'\n",
      " '<p id=\"p-0411\" num=\"2215\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.53 (d, J=2.2, 1H); 7.33 (dd, J=8.6, 2.2, 1H); 7.05 (d, J=8.6, 1H); 3.96 '\n",
      " '(m, 2H); 3.91 (d, J=6.9, 2H); 3.69 (m, 2H); 1.53 (s, 3H); 1.23 (m, 1H); 0.58 '\n",
      " '(m, 2H); 0.35 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0067\" level=\"1\">Example B.b15</heading>\\n'\n",
      " '<heading id=\"h-0068\" '\n",
      " 'level=\"1\">1-Bromo-2-cyclopropylmethoxy-5-ethyl-benzene</heading>\\n'\n",
      " '<p id=\"p-0412\" num=\"2216\">Starting from 2-bromo-4-ethyl-phenol (example '\n",
      " 'B.a5) and commercially available bromomethyl-cyclopropane the title compound '\n",
      " 'is obtained as colorless oil after distillation at 10 mbar.</p>\\n'\n",
      " '<p id=\"p-0413\" num=\"2217\">GC-MS (EI): m/z=256, 254 (M<sup>+</sup>); 228, 226 '\n",
      " '(M<sup>+</sup>-C<sub>2</sub>H<sub>4</sub>); 202, 200 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 187, 185 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>, &#x2014;CH<sub>3</sub>); 55 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0414\" num=\"2218\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.39 (d, J=2.0, 1H); 7.13 (dd, J=8.4, 2.0, 1H); 6.98 (d, J=8.4, 1H); 3.87 '\n",
      " '(d, J=6.8, 2H); 3.53 (qu, J=7.7, 2H); 1.22 (m, 1H); 1.13 (t, J=7.7, 3H); '\n",
      " '0.56 (m, 2H); 0.33 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0069\" level=\"1\">Example B.b16</heading>\\n'\n",
      " '<heading id=\"h-0070\" '\n",
      " 'level=\"1\">2-Bromo-1-cyclopropylmethoxy-4-(propan-2-yl)benzene</heading>\\n'\n",
      " '<p id=\"p-0415\" num=\"2219\">Starting from 2-bromo-4-isopropyl-phenol (example '\n",
      " 'B.a6) and commercially available bromomethyl-cyclopropane the title compound '\n",
      " 'is obtained as colorless solid after short path distillation at '\n",
      " '2&#xd7;10<sup>&#x2212;3 </sup>mbar.</p>\\n'\n",
      " '<p id=\"p-0416\" num=\"2220\">GC-MS (EI): m/z=270, 268 (M<sup>+</sup>); 201, '\n",
      " '199; 120; 91; 55 (100%).</p>\\n'\n",
      " '<p id=\"p-0417\" num=\"2221\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.41 (d, J=2.2, 1H); 7.17 (dd, J=8.4, 2.2, 1H); 6.99 (d, J=8.4, 1H); 3.87 '\n",
      " '(d, J=6.8, 2H); 2.38 (sept, J=6.9, 1H); 1.22 (m, 1H); 1.16 (d, J=6.9, 6H); '\n",
      " '0.56 (m, 2H); 0.34 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0071\" level=\"1\">Example B.b17</heading>\\n'\n",
      " '<heading id=\"h-0072\" '\n",
      " 'level=\"1\">3-Bromo-4-(cyclopropylmethoxy)benzaldehyde</heading>\\n'\n",
      " '<p id=\"p-0418\" num=\"2222\">A well stirred mixture of commercially available '\n",
      " '3-bromo-4-hydroxy-benzaldehyde (40.2 g; 220 mmol), anhydrous '\n",
      " 'K<sub>2</sub>CO<sub>3 </sub>(30.4 g; 220 mmol) and commercially available '\n",
      " 'bromomethyl-cyclopropane (32.4 g; 240 mmol) in dry DMF (200 mL) is heated to '\n",
      " '60&#xb0; C. over night. The reaction mixture is filtered, concentrated under '\n",
      " 'reduced pressure, diluted with water and extracted with tert. BuOMe. The '\n",
      " 'combined organic extracts are washed with brine, dried over '\n",
      " 'Mg<sub>2</sub>SO<sub>4 </sub>and concentrated under reduced pressure. The '\n",
      " 'residue is chomatographed on silica gel (cyclohexane/AcOEt 100:0 to 85:15) '\n",
      " 'to yield 47.5 g of the title compound as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0419\" num=\"2223\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.85 8 s, 1H); 8.10 (d, J=2.0, 1H); 7.89 (dd, J=8.6, 2.0, 1H); 7.28 (d, '\n",
      " 'J=8.6, 1H); 4.06 (d, J=6.9, 2H); 1.28 (m, 1H); 0.61 (m, 2H); 0.39 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0073\" level=\"1\">Example B.b18</heading>\\n'\n",
      " '<heading id=\"h-0074\" '\n",
      " 'level=\"1\">2-Bromo-1-(cyclopropylmethoxy)-4-(difluoromethyl)benzene</heading>\\n'\n",
      " '<p id=\"p-0420\" num=\"2224\">A pressure vial is charged with dichloromethane '\n",
      " '(10.0 mL), 3-bromo-4-cyclopropylmethoxy-benzaldehyde (example B.b17; 2.55 g; '\n",
      " '10.0 mmol) and commercially available '\n",
      " 'bis(2-methoxyethyl)aminosulfurtrifluoride (5.53 g; 25.0 mmol). After capping '\n",
      " 'the reaction mixture was heated in a microwave oven to 70&#xb0; C. for 15 '\n",
      " 'min. and slowly poured into a well stirred ice cold 2M NaHCO<sub>3 '\n",
      " '</sub>solution (50 mL.). After extraction with dichloromethane the combined '\n",
      " 'organic layers are dried over MgSO<sub>4 </sub>and concentrated under '\n",
      " 'reduced pressure. The residue is chromatographed on silica gel '\n",
      " '(hexane/AcOEt: 90:10 to 80:20) to yield 2.3 g of the title compound as pale '\n",
      " 'yellow oil.</p>\\n'\n",
      " '<p id=\"p-0421\" num=\"2225\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.77 (&#x2dc;t, J=0.9, 1H); 7.54 (&#x2dc;dt, J=8.6, 0.9, 1H); 7.20 (d, '\n",
      " 'J=8.6, 1H); 6.95 (t, J=55.9, 1H); 3.98 (d, J 0 6.9, 2H); 1.26 (m, 1H), 0.59 '\n",
      " '(m, 2H); 0.37 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0075\" level=\"1\">Example B.c1</heading>\\n'\n",
      " '<heading id=\"h-0076\" '\n",
      " 'level=\"1\">5-Cyclopropylmethoxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzo[1,3]dioxole</heading>\\n'\n",
      " '<p id=\"p-0422\" num=\"2226\">The reaction is performed in flame-dried glassware '\n",
      " 'under an atmosphere of argon. A stirred solution of '\n",
      " '5-cyclopropylmethoxy-benzo[1,3]dioxole from example B.b1 (38.44 g; 200.0 '\n",
      " 'mmol) in dry THF (500 mL) is cooled to &#x2212;40&#xb0; C. before n-butyl '\n",
      " 'lithium (138.0 mL; 1.6 M solution in hexane; 220 mmol) is slowly added via '\n",
      " 'syringe. After complete addition, stirring is continued at &#x2212;40&#xb0; '\n",
      " 'C. for two hours. At &#x2212;78&#xb0; C. neat '\n",
      " '2-iso-propoxy-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (40.95 g; 220.0 mmol) '\n",
      " 'is added via syringe and stirring is continued at &#x2212;78&#xb0; C. for '\n",
      " 'two hours.</p>\\n'\n",
      " '<p id=\"p-0423\" num=\"2227\">At &#x2212;15&#xb0; C. the reaction mixture is '\n",
      " 'quenched with saturated NH<sub>4</sub>Cl-solution (200 mL) and stirred at '\n",
      " 'ambient temperature for 30 min. The organic layer is separated and '\n",
      " 'concentrated under reduced pressure. The aqueous layer is extracted with '\n",
      " 'tert.-butylmethylether (3&#xd7;200 mL). All organic phases are combined, '\n",
      " 'washed with saturated NaCl-solution (200 mL), dried over MgSO<sub>4 '\n",
      " '</sub>and filtered through a plug of neutral alumina containing 5 wt % of '\n",
      " 'water. The product is completely eluted with several small portions of '\n",
      " 'tert.butylmethylether.</p>\\n'\n",
      " '<p id=\"p-0424\" num=\"2228\">The solvent is removed under reduced pressure. The '\n",
      " 'crude is treated with ice-cold methanol (50 mL) to deliver the title '\n",
      " 'compound as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0425\" num=\"2229\">GC-MS (EI): m/z=318 (M<sup>+</sup>); 264 '\n",
      " '(M<sup>+</sup>-C<sub>4</sub>H<sub>6</sub>); 207; 164 (100%).</p>\\n'\n",
      " '<p id=\"p-0426\" num=\"2230\"><sup>1</sup>H-NMR (200 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.78 (d, J=8.4, 1H); 6.29 (d, J=8.4; 1H); 5.92 (s, 2H); 3.71 (d, J=6.3, 2H); '\n",
      " '1.29 (s, 12H); 1.14 (m, 1H); 0.50 (m, 2H); 0.34 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0077\" level=\"1\">Example B.c2</heading>\\n'\n",
      " '<heading id=\"h-0078\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-4-fluoro-5-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0427\" num=\"2231\">The reaction is performed in flame-dried glassware '\n",
      " 'under an atmosphere of argon.</p>\\n'\n",
      " '<p id=\"p-0428\" num=\"2232\">A stirred solution of '\n",
      " '1-bromo-2-cyclopropylmethoxy-4-fluoro-5-methoxy-benzene from example B.b10 '\n",
      " '(27.51 g; 0.10 mol) in dry tert.butylmethylether (500 mL) is cooled to '\n",
      " '&#x2212;20&#xb0; C. before addition of n-butyl lithium (1.6 M in hexane; '\n",
      " '68.8 mL; 0.11 mol) via syringe. After complete addition stirring is '\n",
      " 'continued for one hour. Neat '\n",
      " '2-iso-propoxy-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is added via syringe '\n",
      " 'into the reaction mixture at &#x2212;40&#xb0; C. After 30 min the reaction '\n",
      " 'is quenched with 1M citric acid (200 mL) at 0&#xb0; C. and stirred for one '\n",
      " 'hour at ambient temperature. The organic layer is separated. The aqueous '\n",
      " 'layer is extracted with tert.-butylmethylether (100 mL). The combined '\n",
      " 'organic layers are washed with brine (200 mL) dried over MgSO<sub>4 '\n",
      " '</sub>and filtered through a plug of neutral alumina containing 5 wt % of '\n",
      " 'water. The product is completely eluted with several small portions of '\n",
      " 'tert.-butylmethylether. The solvent is removed under reduced pressure. The '\n",
      " 'crude is purified by short path distillation at 3&#xd7;10<sup>&#x2212;3 '\n",
      " '</sup>mbar (160&#xb0; C.) to give the title compound as a colorless oil that '\n",
      " 'solidifies at ambient temperature.</p>\\n'\n",
      " '<p id=\"p-0429\" num=\"2233\">GC-MS (EI): m/z=322 (M<sup>+</sup>, 100%); 211, '\n",
      " '168.</p>\\n'\n",
      " '<p id=\"p-0430\" num=\"2234\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.14 (d, J=10.5, 1H); 6.91 (d, J=13.6, 1H); 3.81 (d, J=6.0, 2H); 3.77 (s, '\n",
      " '3H); 1.28 (s, 12H); 1.16 (m, 1H); 0.48 (m, 2H); 0.38 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-0431\" num=\"2235\">The following compounds are obtained analogously '\n",
      " 'to the procedure described in above example B.c2.</p>\\n'\n",
      " '<heading id=\"h-0079\" level=\"1\">Example B.c3</heading>\\n'\n",
      " '<heading id=\"h-0080\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-4-fluoro-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0432\" num=\"2236\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-4-fluoro-benzene (example B.b2) the title '\n",
      " 'compound is obtained as colorless solid after short bath distillation at '\n",
      " '3&#xd7;10<sup>&#x2212;3 </sup>mbar (130&#xb0; C.).</p>\\n'\n",
      " '<p id=\"p-0433\" num=\"2237\">GC-MS (EI): m/z=292 (M<sup>+</sup>); 181, 55 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0434\" num=\"2238\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.48 (dd, J1=8.9, J2=8.0, 1H); 6.80 (dd, J1=12.0, J2=2.2, 1H); 6.71 (ddd, '\n",
      " 'J1=8.4, J2=8.0, J3=2.2, 1H); 3.89 (d, J=5.8, 2H); 1.27 (s, 12H); 1.17 (m, '\n",
      " '1H); 0.51 (m, 2H); 0.46 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0081\" level=\"1\">Example B.c4</heading>\\n'\n",
      " '<heading id=\"h-0082\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0435\" num=\"2239\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-5-fluoro-benzene (example B.b3) the title '\n",
      " 'compound is obtained as colorless solid after short bath distillation at '\n",
      " '3&#xd7;10<sup>&#x2212;3 </sup>mbar (100&#xb0; C.).</p>\\n'\n",
      " '<p id=\"p-0436\" num=\"2240\">GC-MS (EI): m/z=292 (M+); 181 (100%); 55.</p>\\n'\n",
      " '<p id=\"p-0437\" num=\"2241\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.22-7.13 (m, 2H); 6.95 (dd, J1=8.9, J2=4.2, 1H); 3.85 (d, J=6.4, 2H); 1.28 '\n",
      " '(s, 12H); 1.17 (m, 1H); 0.52 (m, 2H); 0.46 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0083\" level=\"1\">Example B.c6</heading>\\n'\n",
      " '<heading id=\"h-0084\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-4-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0438\" num=\"2242\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-4-methoxy-benzene (example B.b5) the title '\n",
      " 'compound is prepared as colorless solid after crystallization from '\n",
      " 'hexane.</p>\\n'\n",
      " '<p id=\"p-0439\" num=\"2243\">GC-MS (EI): m/z=304 (M<sup>+</sup>); 276; 250; '\n",
      " '193; 164 (100%); 150.</p>\\n'\n",
      " '<p id=\"p-0440\" num=\"2244\"><sup>1</sup>H-NMR (200 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.41 (d, J=7.9, 1H); 6.48 (dd, J<sub>1</sub>=7.9, J<sub>2</sub>=2.2, 1H); '\n",
      " '6.45 (d, J=2.2, 1H); 3.87 (d, J=5.6, 2H); 3.75 (s, 3H); 1.25 (s, 12H); 1.16 '\n",
      " '(m, 1H); 0.49 (m, 2H); 0.44 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0085\" level=\"1\">Example B.c7</heading>\\n'\n",
      " '<heading id=\"h-0086\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-5-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0441\" num=\"2245\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-5-methoxy-benzene (example B.b6) the title '\n",
      " 'compound is obtained as colorless oil after short bath distillation at '\n",
      " '3&#xd7;10<sup>&#x2212;3 </sup>mbar (160&#xb0; C.).</p>\\n'\n",
      " '<p id=\"p-0442\" num=\"2246\">GC-MS (EI): m/z=304 (M<sup>+</sup>); 276; 250; 193 '\n",
      " '(100%); 150.</p>\\n'\n",
      " '<p id=\"p-0443\" num=\"2247\"><sup>1</sup>H-NMR (200 MHz, CDCl<sub>3</sub>): '\n",
      " '7.15 (d, J=3.1, 1H); 6.90 (dd, J<sub>1</sub>=9.0, J<sub>2</sub>=3.1, 1H); '\n",
      " '6.81 (d, J=9.0, 1H); 3.80 (d, J=6.3, 2H); 3.78 (s, 3H); 1.35 (s, 12H); 1.17 '\n",
      " '(m, 1H); 0.55 (m, 2H); 0.38 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0087\" level=\"1\">Example B.c8</heading>\\n'\n",
      " '<heading id=\"h-0088\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-5-methyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0444\" num=\"2248\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-5-methyl-benzene (example B.b7) the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0445\" num=\"2249\">GC-MS (EI): m/z=288 (M<sup>+</sup>); 177 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0446\" num=\"2250\"><sup>1</sup>H-NMR 400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.26 (d, J=2.1, 1H); 7.16 (dd, J=8.3, 2.1, 1H); 6.81 (d, J=8.3, 1H); 3.81 '\n",
      " '(d, J=5.9, 2H); 2.21 (s, 3H); 1.27 (s, 12H); 1.15 (m, 1H); 0.47 (m, 2H); '\n",
      " '0.40 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0089\" level=\"1\">Example B.c9</heading>\\n'\n",
      " '<heading id=\"h-0090\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-5-trifluoromethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0447\" num=\"2251\">Starting from '\n",
      " '2-bromo-1-cyclopropylmethoxy-4-trifluoromethyl-benzene (example B.b8) the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0448\" num=\"2252\">GC-MS (EI): m/z=342 (M<sup>+</sup>); 231 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0449\" num=\"2253\"><sup>1</sup>H-NMR 300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.74 (ddd, J=8.8, 2.6, 0.7, 1H); 7.69 (d, J=2.6, 1H); 7.12 (d, J=8.8, 1H); '\n",
      " '3.98 (d, J=5.8, 2H); 1.30 (s, 12H); 1.20 (m, 1H); 0.59 (m, 2H); 0.43 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0091\" level=\"1\">Example B.c10</heading>\\n'\n",
      " '<heading id=\"h-0092\" '\n",
      " 'level=\"1\">2-(2-Ethoxy-5-trifluoromethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0450\" num=\"2254\">Starting from '\n",
      " '2-bromo-1-ethoxy-4-trifluoromethyl-benzene (example B.b9) the title compound '\n",
      " 'is obtained as colorless solid</p>\\n'\n",
      " '<p id=\"p-0451\" num=\"2255\">GC-MS (EI): m/z=316 (M<sup>+</sup>); 216 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0452\" num=\"2256\"><sup>1</sup>H-NMR 300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.75 (ddd, J=8.8, 2.4, 0.6, 1H); 7.70 (d, J=2.4, 1H); 7.13 (d, J=8.8, 1H); '\n",
      " '4.09 (qu, J=6.9, 2H); 1.33 (t, j=6.9, 3H); 1.29 (s, 12H).</p>\\n'\n",
      " '<heading id=\"h-0093\" level=\"1\">Example B.c11</heading>\\n'\n",
      " '<heading id=\"h-0094\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-4-fluoro-5-methyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0453\" num=\"2257\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-4-fluoro-5-methyl-benzene (example B.b11) the '\n",
      " 'title compound is obtained as colorless oil.</p>\\n'\n",
      " '<p id=\"p-0454\" num=\"2258\">GC-MS (EI): m/z=306 (M<sup>+</sup>); 195 (100%); '\n",
      " '55.</p>\\n'\n",
      " '<p id=\"p-0455\" num=\"2259\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.35 (dd, J=10.0, 0.5, 1H); 6.76 (d, J=12.4, 1H); 3.85 (d, J=5.8, 2H); 2.13 '\n",
      " '(d, J=0.5, 3H); 1.27 (s, 12H); 1.15 (m, 1H); 0.49 (m, 2H); 0.41 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0095\" level=\"1\">Example B.c12</heading>\\n'\n",
      " '<heading id=\"h-0096\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-5-fluoro-4-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0456\" num=\"2260\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-5-fluoro-4-methoxy-benzene (example B.b12) the '\n",
      " 'title compound is obtained as colorless solid after crystallization from '\n",
      " 'methanol.</p>\\n'\n",
      " '<p id=\"p-0457\" num=\"2261\">GC-MS (EI): m/z=322 (M<sup>+</sup>); 211; 182; 168 '\n",
      " '(100%); 55.</p>\\n'\n",
      " '<p id=\"p-0458\" num=\"2262\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.15 (d, J=11.7, 1H); 6.73 (d, J=7.0, 1H); 3.88 (d, J=6.0, 2H); 3.85 (s, '\n",
      " '3H); 1.26 (s, 12H); 1.16 (m, 1H); 0.50 (m, 2H); 0.30 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0097\" level=\"1\">Example B.c13</heading>\\n'\n",
      " '<heading id=\"h-0098\" '\n",
      " 'level=\"1\">2-[2-(Cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0459\" num=\"2263\">Starting from '\n",
      " '2-[3-bromo-4-(cyclopropylmethoxy)phenyl]-2-methyl-1,3-dioxolane (example '\n",
      " 'B.b14) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0460\" num=\"2264\">GC-MS (EI): m/z=360 (M<sup>+</sup>); 345 '\n",
      " '(100%).</p>\\n'\n",
      " '<p id=\"p-0461\" num=\"2265\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.49 (d, J=2.5, 1H); 7.40 (dd, J=8.6, 2.5, 1H); 6.89 (d, J=8.6, 1H); 3.95 '\n",
      " '(m, 2H); 3.86 (d, J=5.7, 2H); 3.67 (m, 2H); 1.50 (s, 3H); 1.28 (s, 12H); '\n",
      " '1.17 (m, 1H); 0.48 (m, 2H); 0.41 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0099\" level=\"1\">Example B.c14</heading>\\n'\n",
      " '<heading id=\"h-0100\" '\n",
      " 'level=\"1\">2-(2-Cyclopropylmethoxy-5-ethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0462\" num=\"2266\">Starting from '\n",
      " '1-bromo-2-cyclopropylmethoxy-5-ethyl-benzene (example B.b15) the title '\n",
      " 'compound is obtained as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0463\" num=\"2267\">GC-MS (EI): m/z=302 (M<sup>+</sup>); 274; 191 '\n",
      " '(100%); 55.</p>\\n'\n",
      " '<p id=\"p-0464\" num=\"2268\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.27 (d, J=2.0, 1H); 7.20 (dd, J=8.4, 2.0, 1H); 6.83 (d, J=8.4, 1H); 3.82 '\n",
      " '(d, J=5.8, 2H); 2.50 (qu, J=7.7, 2H); 1.28 (s, 12H); 1.13 (t, J=7.7, 3H); '\n",
      " '1.12 (m, 1H); 0.48 (m, 2H); 0.39 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0101\" level=\"1\">Example B.c15</heading>\\n'\n",
      " '<heading id=\"h-0102\" '\n",
      " 'level=\"1\">2-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0465\" num=\"2269\">Starting from '\n",
      " '2-bromo-1-cyclopropylmethoxy-4-(propan-2-yl)benzene (example B.b16) the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0466\" num=\"2270\">GC-MS (EI): m/z=316 (M<sup>+</sup>); 301; 288; '\n",
      " '247; 205; 147 (100%); 103; 83; 55.</p>\\n'\n",
      " '<p id=\"p-0467\" num=\"2271\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.29 (d, J=2.4, 1H); 7.23 (dd, J=8.4, 2.2, 1H); 6.84 (d, J=8.4, 1H); 3.82 '\n",
      " '(d, J=5.9, 2H); 2.81 (sept, J=6.9, 1H); 1.28 (s, 12H); 1.15 (d, J=6.9, 6H '\n",
      " '&#x26; m, 1H); 0.48 (m, 2H); 0.40 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0103\" level=\"1\">Example B.c16</heading>\\n'\n",
      " '<heading id=\"h-0104\" '\n",
      " 'level=\"1\">2-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane</heading>\\n'\n",
      " '<p id=\"p-0468\" '\n",
      " 'num=\"2272\">2-Bromo-1-cyclopropylmethoxy-4-difluoromethyl-benzene (example '\n",
      " 'B.b18; 24.35 g; 87.9 mmol) is dissolved in dry tert. BuOMe (440 mL). n-BuLi '\n",
      " '(1.6M in hexane; 60.0 mL; 96.0 mmol) is slowly syringed into the well '\n",
      " 'stirred reaction mixture at &#x2212;40&#xb0; C. After one hour commercially '\n",
      " 'available 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (17.86 g; '\n",
      " '96.0 mmol) is added at &#x2212;40&#xb0; C. followed by stirring at 0&#xb0; '\n",
      " 'C. for one additional hour. The reaction mixture is quenched by addition of '\n",
      " '2M aqueous citric acid (90.0 mL). The organic layer is separated, washed '\n",
      " 'with brine, dried over Mg<sub>2</sub>SO<sub>4 </sub>and filtered through a '\n",
      " 'pad of neutral alumina (act.2-3). The solvent is removed under reduced '\n",
      " 'pressure to yield 28.1 g of the title compound as pale yellow oil.</p>\\n'\n",
      " '<p id=\"h-0105\" num=\"0000\">Caution:</p>\\n'\n",
      " '<p id=\"p-0469\" num=\"2273\">THE COMPOUND TENDS TO VIGOROUSLY DECOMPOSE WHEN '\n",
      " 'HEATED ABOVE 80&#xb0; C.</p>\\n'\n",
      " '<p id=\"p-0470\" num=\"2274\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.63 (&#x2dc;t, J=1.1, 1H); 7.58 (&#x2dc;dt, J=8.4, 1.1, 1H); 7.05 (d, '\n",
      " 'J=8.4, 1H); 6.95 (t, J=56.2, 1H); 3.94 (d, J=5.8, 2H); 1.29 (s, 12H); 1.19 '\n",
      " '(m, 1H), 0.51 (m, 2H); 0.43 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0106\" level=\"1\">Example C1</heading>\\n'\n",
      " '<heading id=\"h-0107\" '\n",
      " 'level=\"1\">tert-Butyl-(3R*,4R*)-4-azido-3-hydroxy-piperidine-1-carboxylate '\n",
      " '(23f) and tert-butyl-(3S*,4S*)-3-azido-4-hydroxy-piperidine-1-carboxylate '\n",
      " '(23g)</heading>\\n'\n",
      " '<p id=\"p-0471\" num=\"2275\">A mixture of tert-butyl '\n",
      " '7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate (60 g, 0.30 mol), prepared '\n",
      " \"according to literature [Zhao, S.; Ghosh, A.; D'Andrea, S. V.; Freeman, P.; \"\n",
      " 'VonVoigtlander, P. F.; Carter, D. B.; Smith, M. W.; Heterocycles, 1994, 39, '\n",
      " '163], sodium azide (25.4 g, 0.39 mol) and ammonium chloride (21 g, 0.39 mol) '\n",
      " 'in ethanol (150 mL) and water (150 mL) is heated to gentle reflux overnight. '\n",
      " 'Ethanol is evaporated in vacuo. The residue is distributed between '\n",
      " 'dichloromethane and water. The aqueous layer is separated and extracted with '\n",
      " 'dichloromethane. The combined organic layer is washed with water and brine, '\n",
      " 'dried over Na<sub>2</sub>SO<sub>4 </sub>and concentrated in vacuo to obtain, '\n",
      " '67.3 g of the crude as a 4:1 mixture 23f and 23g according to '\n",
      " '<sup>1</sup>H-NMR in agreement with literature data [Erickson, S. D.; '\n",
      " 'Banner, B.; Berthel, S.; Conde-Knape, K.; Falicioni, F.; Hakimi, I.; '\n",
      " 'Hennessy, B.; Kester, R. F.; Kim, K.; Ma, Ch.; McComas, W.; Mennona, F.; '\n",
      " 'Mischke, S.; Orzechowski, L.; Qian, Y.; Salari, H.; Tengi, J.; Thakkar, K.; '\n",
      " 'Taub, R.; Tilley, J. W.; Wang, H.; Bio-org. Med. Chem. Lett. 2008, 18, '\n",
      " '1402].</p>\\n'\n",
      " '<p id=\"p-0472\" num=\"2276\">Separation by column chromatography on silica gel '\n",
      " '(heptane:ethyl acetate&#x2014;4:1) yields faster eluting 23f, slower eluting '\n",
      " '23g and un-separated 23f and 23g.</p>\\n'\n",
      " '<heading id=\"h-0108\" '\n",
      " 'level=\"1\">tert-Butyl-(3R*,4R*)-4-azido-3-hydroxy-piperidine-1-carboxylate '\n",
      " '(23f)</heading>\\n'\n",
      " '<p id=\"p-0473\" num=\"2277\">MS (ESI): m/z=217 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0474\" num=\"2278\"><sup>1</sup>H-NMR (400 MHz, CDCl<sub>3</sub>): '\n",
      " '4.12 (m, 1H); 3.95 (br. m, 1H); 3.50 (m, 1H); 3.38 (m, 1H); 2.89 (m, 1H); '\n",
      " '2.78 (m, 1H); 2.71-2.32 (m 1H); 2.00 (m, 1H); 1.52 (m, 1H); 1.44 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0109\" '\n",
      " 'level=\"1\">tert-Butyl-(3S*,4S*)-3-azido-4-hydroxy-piperidine-1-carboxylate '\n",
      " '(23g)</heading>\\n'\n",
      " '<p id=\"p-0475\" num=\"2279\">MS (ESI): m/z=217 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0476\" num=\"2280\"><sup>1</sup>H-NMR (400 MHz, CDCl<sub>3</sub>): '\n",
      " '4.23 (m, 1H); 4.00 (m, 1H); 3.54 (m, 1H); 3.30 (m, 1H); 2.82 (m, 1H); 2.66 '\n",
      " '(m, 1H); 2.24 (m, 1H); 1.97 (m, 1H); 1.59 (m, 1H); 1.46 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0110\" level=\"1\">Example C2</heading>\\n'\n",
      " '<heading id=\"h-0111\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-amino-3-hydroxy-piperidine-1-carboxylate '\n",
      " '(21f)</heading>\\n'\n",
      " '<p id=\"p-0477\" num=\"2281\">(3S*,4S*)-tert-butyl '\n",
      " '4-azido-3-hydroxypiperidine-1-carboxylate from example C1 (47 g, 194 mmol) '\n",
      " 'is dissolved in methanol (1200 mL) under nitrogen. Palladium hydroxide (20% '\n",
      " 'on carbon; 4.7 g) is added. The atmosphere is changed to hydrogen and the '\n",
      " 'stirred reaction mixture is hydrogenated at room temperature and 70 psi for '\n",
      " '72 hours. The mixture is filtered through celite. The filtrate is '\n",
      " 'evaporated. The residue is recrystallized from CH<sub>2</sub>Cl<sub>2 '\n",
      " '</sub>with a small amount of MeOH to obtain the title compound as a white '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-0478\" num=\"2282\">HR-MS (ESI): m/z=217.1539 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>10</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>, calc. '\n",
      " '217.1547).</p>\\n'\n",
      " '<heading id=\"h-0112\" level=\"1\">Example C3</heading>\\n'\n",
      " '<heading id=\"h-0113\" level=\"1\">tert-Butyl '\n",
      " '(3S*,4S*)-3-Amino-4-hydroxy-piperidine-1-carboxylate (21g)</heading>\\n'\n",
      " '<p id=\"p-0479\" num=\"2283\">Following the procedure outlined in above example '\n",
      " 'C2 starting from (3S*,4S*)-3-azido-4-hydroxy-piperidine-1-carboxylic acid '\n",
      " 'tert-butyl ester (example C1) the title compound is obtained as white '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-0480\" num=\"2284\">HR-MS (ESI): m/z=217.1541 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>10</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>, calc. '\n",
      " '217.1547).</p>\\n'\n",
      " '<heading id=\"h-0114\" level=\"1\">Example C4</heading>\\n'\n",
      " '<heading id=\"h-0115\" '\n",
      " 'level=\"1\">(1R,3S)-3-[(tert-Butoxycarbonyl)amino]cyclopentyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0481\" num=\"2285\">Methansulfonyl chloride (8.2 g; 72.0 mmol) is '\n",
      " 'slowly added to an ice cold solution of commercially available tert-butyl '\n",
      " '[(1S,3R)-3-hydroxycyclopentyl]carbamate (12.1 g; 60.0 mmol) and 2,6-lutidine '\n",
      " '(9.6 g; 90.0 mmol) in dry dichloromethane (300 mL). The stirred reaction '\n",
      " 'mixture is allowed to warm to ambient temperature over night. The reaction '\n",
      " 'mixture is extracted with water, ice cold 1N HCl, half saturated brine, and '\n",
      " 'dried over MgSO<sub>4</sub>. After filtration through a pad of neural '\n",
      " 'alumina (act. 2-3) the solvent is removed under reduced pressure to yield '\n",
      " 'the crude title compound as yellow oil that is processed without additional '\n",
      " 'purification.</p>\\n'\n",
      " '<heading id=\"h-0116\" level=\"1\">Example C5</heading>\\n'\n",
      " '<heading id=\"h-0117\" level=\"1\">tert-Butyl '\n",
      " '[(1S,3S)-3-azidocyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0482\" num=\"2286\">Crude product from example C4 is dissolved in dry '\n",
      " 'DMF (180 mL). After addition of sodium azide (11.7 g; 180.0 mmol) the '\n",
      " 'reaction mixture is stirred for three days at 60&#xb0; C. After filtration '\n",
      " 'the reaction mixture is concentrated under reduced pressure, diluted with '\n",
      " 'dichloromethane, extracted with water, half saturated brine and dried over '\n",
      " 'MgSO<sub>4</sub>. After column chromatography on silica gel '\n",
      " '(cyclohexane/AcOEt&#x2014;9:1) 11.8 g of the title compound is obtained as '\n",
      " 'pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0483\" num=\"2287\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.90 (d, J=6.2, 1H, &#x2014;NH); 4.11 (m, 1H); 3.88 (m, 1H); 2.08-1.77 (m, '\n",
      " '3H); 1.70 (m, 1H); 1.60-1.31 (m, 2H &#x26; s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0118\" level=\"1\">Example C6</heading>\\n'\n",
      " '<heading id=\"h-0119\" level=\"1\">tert-Butyl '\n",
      " '[(1S,3S)-3-aminocyclopentyl]carbamate hydrochloride</heading>\\n'\n",
      " '<p id=\"p-0484\" num=\"2288\">tert-Butyl [(1S,3S)-3-azidocyclopentyl]carbamate '\n",
      " '(example C5; 11.3 g; 50.0 mmol) is dissolved in MeOH (250 mL) and pressure '\n",
      " 'hydrogenated over Pd(OH)<sub>2 </sub>(20% on charcoal; 0.45 g) at 20 bar and '\n",
      " 'ambient temperature over night. After filtration through a pad of celite the '\n",
      " 'solvent is removed under reduced pressure. The residue is dissolved in '\n",
      " 'tert.-BuOMe (250 mL) cooled to 0&#xb0; C. and treated with HCl (4N in '\n",
      " 'dioxane; 13.5 mL). The precipitate is collected by suction filtration, '\n",
      " 'washed with several small portions of tert.-BuOMe and dried under reduced '\n",
      " 'pressure to yield 11.1 g of the title compound as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0485\" num=\"2289\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.26-7.08 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 6.95 (d, J=6.9, '\n",
      " '1H, &#x2014;NH); 3.95 (m, 1H); 3.52 (m, 1H); 1.98 (m, 2H); 1.77 (m, 2H); '\n",
      " '1.43 (m, 2H); 1.38 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0120\" level=\"1\">Example C7</heading>\\n'\n",
      " '<heading id=\"h-0121\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,3S*,4R*)-4-(benzyloxy)-3-methylcyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0486\" num=\"2290\">Known (1R*,2S*,4R*)-4-azido-2-methylcyclohexyl '\n",
      " 'benzyl ether (12.0 g; 48.9 mmol) [Aicher, T.; Chicarelli, M. J.; Hinklin, R. '\n",
      " 'J.; Tian, H.; Wallace, O. B.; Chen, Z.; Mabry, T. E.; McCowan, J. R.; '\n",
      " 'Snyder, N. J.; Winneroski, L. L.; Allen, J. G.; WO 2006/049952 (2009)] is '\n",
      " 'dissolved in MeOH (500.0 mL) and pressure hydrogenated over Pd (10% on '\n",
      " 'charcoal; 1.2 g) at 20 bar and ambient temperature for two hours. The '\n",
      " 'catalyst is removed by filtration through a pad of celite. The filtrate is '\n",
      " 'concentrated under reduced pressure. The residue is dissolved in dioxane '\n",
      " '(100 mL). After addition of 2N NaOH (25.0 mL; 50.0 mmol) and di tert-butyl '\n",
      " 'dicarbonate (11.4 g; 51.3 mmol) the mixture is stirred for one hour at '\n",
      " 'ambient temperature and concentrated under reduced pressure. After addition '\n",
      " 'of water and extraction with tert-BuOMe the organic layer is dried over '\n",
      " 'MgSO<sub>4</sub>. The solvent is removed under reduced pressure and the '\n",
      " 'residue is chromatographed on silica gel (cyclohexane/AcOEt&#x2014;9:1) to '\n",
      " 'yield 14.4 g of the title compound as colourless oil.</p>\\n'\n",
      " '<p id=\"p-0487\" num=\"2291\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.35-7.21 (m, 5H); 4.59 (d, J=12.1, 1H); 4.36 (d, J=12.1, 1H &#x26; br.s, '\n",
      " '1H, &#x2014;NH); 3.55-3.35 (m, 2H); 2.08 (m, 1H); 1.79-1.57 (m, 3H); 1.44 '\n",
      " '(s, 9H); 1.42-1.21 (m, 3H); 0.99 (d, J=6.6, 3H).</p>\\n'\n",
      " '<heading id=\"h-0122\" level=\"1\">Example C8</heading>\\n'\n",
      " '<heading id=\"h-0123\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,3R*,4S*)-4-hydroxy-3-methylcyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0488\" num=\"2292\">tert-Butyl '\n",
      " '[(1R*,3S*,4R*)-4-(benzyloxy)-3-methylcyclohexyl]carbamate (example C7; 14.0 '\n",
      " 'g; 43.8 mmol) dissolved in MeOH (440 mL) is pressure hydrogenated over Pd '\n",
      " '(10% on charcoal; 1.4 g) at 50 bar and ambient temperature for 72 hours. The '\n",
      " 'catalyst is removed by filtration through a pad of celite. The filtrate is '\n",
      " 'concentrated under reduced pressure. The residue is chromatographed on '\n",
      " 'silica gel (cyclohexane/AcOEt&#x2014;70:30 to 50:50) to yield 8.5 g of the '\n",
      " 'tile compound as colourless oil.</p>\\n'\n",
      " '<p id=\"p-0489\" num=\"2293\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '4.42 (br.s, 1H, &#x2014;NH); 3.76 (m, 1H); 3.46 (m, 1H); 1.89 (m, 1H); '\n",
      " '1.80-1.33 (m, 6H); 1.45 (s, 9H); 1.23 (m, 1H); 0.98 (d, J=6.8, 3H).</p>\\n'\n",
      " '<heading id=\"h-0124\" level=\"1\">Example C9</heading>\\n'\n",
      " '<heading id=\"h-0125\" '\n",
      " 'level=\"1\">(1S*,2R*,4R*)-4-[(tert-Butoxycarbonyl)amino]-2-methylcyclohexyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0490\" num=\"2294\">Starting from tert-butyl '\n",
      " '[(1R*,3R*,4S*)-4-hydroxy-3-methylcyclohexyl]carbamate (example C8; 10.2 g; '\n",
      " '44.3 mmol) and following the procedure as described in example C4 12.3 g of '\n",
      " 'the title compound is obtained as colourless oil after column chromatography '\n",
      " 'on silica gel (cyclohexane/AcOEt&#x2014;70:30).</p>\\n'\n",
      " '<p id=\"p-0491\" num=\"2295\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '4.74 (br.s, 1H); 4.42 (br.s, 1H, &#x2014;NH); 3.51 (m, 1H); 3.01 (s, 3H); '\n",
      " '2.24 (m, 1H); 1.93-1.56 (m, 4H); 1.44 (s, 9H &#x26; m, 1H); 1.20 (m, 1H); '\n",
      " '1.03 (d, J=6.6, 3H).</p>\\n'\n",
      " '<heading id=\"h-0126\" level=\"1\">Example C10</heading>\\n'\n",
      " '<heading id=\"h-0127\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,3R*,4R*)-4-azido-3-methylcyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0492\" num=\"2296\">Starting from '\n",
      " '(1S*,2R*,4R*)-4-[(tert-butoxycarbonyl)amino]-2-methylcyclohexyl '\n",
      " 'methanesulfonate (example C9; 2.4 g; 7.8 mmol) and following the procedure '\n",
      " 'as described in example C5 1.4 g of the title compound is obtained as '\n",
      " 'colourless solid after column chromatography on silica gel '\n",
      " '(cyclohexane/AcOEt &#x2014;95:05 to 85:15).</p>\\n'\n",
      " '<p id=\"p-0493\" num=\"2297\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '4.35 (br.s, 1H, &#x2014;NH); 3.46 (m, 1H); 2.78 2.78 (m, 1H); 2.18-1.95 (m, '\n",
      " '3H); 1.63-1.33 (s, 9H &#x26; m, 2H); 1.17 (m, 1H); 1.03 (d, J=6.6, 3H); 0.90 '\n",
      " '(m, 1H).</p>\\n'\n",
      " '<heading id=\"h-0128\" level=\"1\">Example C11</heading>\\n'\n",
      " '<heading id=\"h-0129\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,3R*,4R*)-4-amino-3-methylcyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0494\" num=\"2298\">tert-Butyl '\n",
      " '[(1R*,3R*,4R*)-4-azido-3-methylcyclohexyl]carbamate (example C10; 1.2 g; 4.7 '\n",
      " 'mmol) is dissolved in MeOH (20.0 mL) and pressure hydrogenated over Pd (10% '\n",
      " 'on charcoal; 0.1 g) at 20 bar and ambient temperature over night. After '\n",
      " 'filtration through a pad of celite the solvent is removed under reduced '\n",
      " 'pressure to yield 1.0 g of the title compound as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0495\" num=\"2299\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 3.41 (m, 1H); 2.20 (m, 1H); 2.03-1.81 (m, 3H); 1.44 (s, '\n",
      " '9H); 1.34-1.07 (m, 3H); 0.98 (d, J=6.6, 3H); 0.91 (m, 1H).</p>\\n'\n",
      " '<p id=\"p-0496\" num=\"2300\">HR-MS (ESI): m/z=229.1899 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>12</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub><sup>+</sup>, calc. '\n",
      " '229.1911).</p>\\n'\n",
      " '<heading id=\"h-0130\" level=\"1\">Example C12</heading>\\n'\n",
      " '<heading id=\"h-0131\" level=\"1\">(1R*,3R*,4R*)-4-Azido-3-methylcyclohexanamine '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-0497\" num=\"2301\">tert-Butyl '\n",
      " '[(1R*,3R*,4R*)-4-azido-3-methylcyclohexyl]carbamate (example C10; 2.5 g; '\n",
      " '10.0 mmol) is dissolved in THF (25.0 mL). After addition of HCl (4M solution '\n",
      " 'in dioxane; 10.0 mL; 40.0 mmol) the reaction mixture is stirred at ambient '\n",
      " 'temperature over night and gently refluxed for additional 6 hours. '\n",
      " 'tert-BuOMe is added at ambient temperature, the precipitated product is '\n",
      " 'collected by suction filtration, washed with several small portions of '\n",
      " 'tert-BuOMe and dried under reduced pressure to yield 1.8 g of the title '\n",
      " 'compound as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0498\" num=\"2302\"><sup>1</sup>H-NMR (400 MHz, MeOH-d<sub>4</sub>): '\n",
      " '3.16 (m, 1H); 2.95 (m, 1H); 2.19 (m, 1H); 2.11 (m, 1H); 2.03 (m, 1H); '\n",
      " '1.60-1.44 (m, 3H); 1.23 (m, 1H); 1.10 (d, J=6.5, 3H).</p>\\n'\n",
      " '<p id=\"p-0499\" num=\"2303\">HR-MS (ESI): m/z=155.1284 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>7</sub>H<sub>15</sub>N<sub>4</sub><sup>+</sup>, calc. 155.1291).</p>\\n'\n",
      " '<heading id=\"h-0132\" level=\"1\">Example C13</heading>\\n'\n",
      " '<heading id=\"h-0133\" '\n",
      " 'level=\"1\">tert-Butyl(diphenyl)({4-[(trimethylsilyl)oxy]cyclohex-3-en-1-yl}oxy)silane</heading>\\n'\n",
      " '<p id=\"p-0500\" num=\"2304\">Trimethylsilyl trifluoromethanesulfonate (45.0 g; '\n",
      " '198.8 mmol) is dropped into a solution of known '\n",
      " '4{[tert-butyl(diphenyl)silyl]oxy}cyclohexanone [Okamura, W. H.; Elnagar, H. '\n",
      " 'Y.; Ruther, M.; Dobreff, S. <i>J. Org. Chem. </i>1993, 58, 600] (58.4 g, '\n",
      " '165.5 mmol) and triethylamine (55.4 mL; 397.6 mmol) in dichloromethane (500 '\n",
      " 'mL) at &#x2212;78&#xb0; C. under an atmosphere of nitrogen. After one hour '\n",
      " 'the reaction mixture is allowed to warm to 0&#xb0; C. and quenched with '\n",
      " 'saturated NaHCO<sub>3</sub>-solution (120 mL). The organic layer is '\n",
      " 'separated, dried over MgSO<sub>4 </sub>and concentrated under reduced '\n",
      " 'pressure. A 1:1-mixture of tert-BuOMe and hexane is added to the biphasic '\n",
      " 'residue. The organic layer is separated, washed with saturated '\n",
      " 'NaHCO<sub>3</sub>-solution and dried over MgSO<sub>4</sub>. The solvent is '\n",
      " 'removed under reduced pressure to deliver 69.0 g of the title compound as '\n",
      " 'colourless oil.</p>\\n'\n",
      " '<p id=\"p-0501\" num=\"2305\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.64 (m, 4H); 7.45-7.32 (m, 6H); 4.64 (m, 1H); 3.93 (m, 1H); 2.23-2.05 (m, '\n",
      " '3H); 1.99-1.85 (m, 1H); 1.81-1.62 (m, 2H); 1.05 (s, 9H); 0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0134\" level=\"1\">Example C14</heading>\\n'\n",
      " '<heading id=\"h-0135\" '\n",
      " 'level=\"1\">(2S*,4R*)-4-{[tert-Butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanone '\n",
      " 'and '\n",
      " '(2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanone</heading>\\n'\n",
      " '<p id=\"p-0502\" num=\"2306\">To a stirred solution of '\n",
      " 'tert-butyl(diphenyl)({4-[(trimethylsilyl)oxy]cyclohex-3-en-1-yl}oxy)silane '\n",
      " '(example C13; 69.0 g; 162 mmol) in dry acetonitrile (750 mL) Selectfluor '\n",
      " '(68.6 g; 184 mmol) is added in small portions at 5&#xb0; C. After complete '\n",
      " 'addition the reaction mixture is stirred at ambient temperature over night. '\n",
      " 'Saturated NaHCO<sub>3</sub>-solution (200 mL) is added, the precipitate is '\n",
      " 'removed by filtration and the filtrate is concentrated under reduced '\n",
      " 'pressure. The residue is distributed between tert-BuOMe and saturated '\n",
      " 'NaHCO<sub>3</sub>-solution. The organic layer is separated, washed with '\n",
      " 'brine and dried over MgSO4. The solvent is removed under reduced pressure. '\n",
      " 'The residue is chromatographed on silica gel (cyclohexane/AcOEt&#x2014;10:0 '\n",
      " 'to 9:1) to deliver 44.9 g of '\n",
      " '(2S*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanone as white '\n",
      " 'solid</p>\\n'\n",
      " '<p id=\"p-0503\" num=\"2307\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.67 (m, 4H); 7.50-7.34 (m, 6H); 5.41 (ddd, J=48.7, 12.2, 6.8, 1H); 4.33 (m, '\n",
      " '1H); 2.93 (td, J=13.9, 6.0, 1H); 2.56-2.34 (m, 2H); 2.05-1.93 (m, 1H); 1.81 '\n",
      " '(m, 1H); 1.69 (tdd, J=13.9, 4.6, 2.4, 1H); 1.12 (s, 9H)</p>\\n'\n",
      " '<p id=\"p-0504\" num=\"2308\">and 9.3 g of '\n",
      " '(2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanone as white '\n",
      " 'solid</p>\\n'\n",
      " '<p id=\"p-0505\" num=\"2309\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.68 (m, 4H); 7.49-7.36 (m, 6H); 4.68 (ddd, J=48.0, 12.4, 7.3, 1H); 4.08 (m, '\n",
      " '1H); 2.54 (m, 1H); 2.40 (m, 1H); 2.16-1.96 (m, 3H); 1.89-1.73 (m, 1H); 1.06 '\n",
      " '(s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0136\" level=\"1\">Example C15</heading>\\n'\n",
      " '<heading id=\"h-0137\" '\n",
      " 'level=\"1\">(1R*,2S*,4R*)-4-{[tert-Butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanol</heading>\\n'\n",
      " '<p id=\"p-0506\" num=\"2310\">L-Selectride&#xae; (1M in THF; 69.0 mL; 69.0 mm01) '\n",
      " 'is dropped into a stirred solution of '\n",
      " '(2S*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanone (example '\n",
      " 'C14; 23.3 g; 62.8 mmol) in dry THF (230 mL) at &#x2212;15&#xb0; C. The '\n",
      " 'reaction mixture is stirred over night and cooled to 0&#xb0; C. before '\n",
      " 'careful addition of ice cold water (100 mL), followed by dropwise addition '\n",
      " 'of H<sub>2</sub>O<sub>2 </sub>(30% solution in water; 39.0 mL). After 30 '\n",
      " 'min. saturated Na<sub>2</sub>SO<sub>3</sub>-solution (80 mL) is dropwise '\n",
      " 'added at 0&#xb0; C. tert-BuOMe (300 mL) is added, the organic layer is '\n",
      " 'separated and concentrated under reduced pressure. The aqueous layer is '\n",
      " 'extracted with tert-BuOMe. All combined organic phases are washed with brine '\n",
      " 'and dried over MgSO<sub>4</sub>. The solvent is removed under reduced '\n",
      " 'pressure. The residue is chromatographed on silica gel '\n",
      " '(cyclohexane/AcOEt&#x2014;10:0 to 9:1) to yield 15.5 g of the title compound '\n",
      " 'as colourless liquid.</p>\\n'\n",
      " '<p id=\"p-0507\" num=\"2311\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.59 (m, 4H); 7.44 (m, 6H); 4.77 (d, J=4.7, 1H, &#x2014;OH); 4.70 (tdd, '\n",
      " 'J=49.5, 7.1, 2.7, 1H); 3.97 (m, 1H); 3.70 (m, 1H); 1.98 (m, 1H); 1.75-1.53 '\n",
      " '(m, 3H); 1.40 (m, 2H); 1.01 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0138\" level=\"1\">Example C16</heading>\\n'\n",
      " '<heading id=\"h-0139\" '\n",
      " 'level=\"1\">(1R*,2S*,4R*)-4-{[tert-Butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl '\n",
      " 'methane sulfonate</heading>\\n'\n",
      " '<p id=\"p-0508\" num=\"2312\">Starting from '\n",
      " '(1R*,2S*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanol '\n",
      " '(example C15; 10.4 g; 27.8 mmol) and following the procedure as described in '\n",
      " 'example C4 12.2 g of the title compound is obtained as pale yellow oil after '\n",
      " 'column chromatography on silica gel (cyclohexane/AcOEt &#x2014;90:10 to '\n",
      " '80:20).</p>\\n'\n",
      " '<p id=\"p-0509\" num=\"2313\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.62 (m, 4H); 7.43 (m, 6H); 5.16-4.91 (m, 2H); 4.20 (m, 1H); 3.02 (s, 3H); '\n",
      " '2.17-1.84 (m, 4H); 1.69 (m, 1H); 1.49 (m, 1H); 1.07 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0140\" level=\"1\">Example C17</heading>\\n'\n",
      " '<heading id=\"h-0141\" '\n",
      " 'level=\"1\">{[(1R*,3S*,4S*)-4-Azido-3-fluorocyclohexyl]oxy}(tert-butyl)diphenylsilane</heading>\\n'\n",
      " '<p id=\"p-0510\" num=\"2314\">Starting from '\n",
      " '(1R*,2S*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl '\n",
      " 'methanesulfonate (example C16; 12.1 g; 26.8 mmol) and following the '\n",
      " 'procedure as described in example C5, 9.4 g of the title compound is '\n",
      " 'obtained as colourless oil after column chromatography on silica gel '\n",
      " '(cyclohexane/AcOEt&#x2014;95:05).</p>\\n'\n",
      " '<p id=\"p-0511\" num=\"2315\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.63 (m, 4H); 7.39 (m, 6H); 4.84 (dm, J=50.3, 1H); 4.15 (m, 1H); 3.45 (m, '\n",
      " '1H); 2.16 (m, 1H); 1.99-1.75 (m, 2H); 1.65 (m, 1H); 1.49 (m, 1H); 1.33 (m, '\n",
      " '1H); 1.07 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0142\" level=\"1\">Example C18</heading>\\n'\n",
      " '<heading id=\"h-0143\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0512\" num=\"2316\">Starting from '\n",
      " '{[(1R*,3S*,4S*)-4-azido-3-fluorocyclohexyl]oxy}(tert-butyl)diphenylsilane '\n",
      " '(example C17; 9.4 g; 23.6 mmol) and following the procedure as described in '\n",
      " 'example C7, 8.7 g of the title compound is obtained as colourless solid '\n",
      " 'after column chromatography on silica gel '\n",
      " '(cyclohex-ane/AcOEt&#x2014;95:05).</p>\\n'\n",
      " '<p id=\"p-0513\" num=\"2317\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.60 (m, 4H); 7.46 (m, 6H); 7.11 (d, J=8.4, 1H, &#x2014;NH); 4.73 (tdd, '\n",
      " 'J=50.4, 10.4, 4.6, 1H); 4.09 (m, 1H); 3.44 (m, 1H); 1.98 (m, 1H); 1.76 (m, '\n",
      " '1H); 1.67-1.46 (m, 3H); 1.39 (s, 9H &#x26; m, 1H); 1.03 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0144\" level=\"1\">Example C19</heading>\\n'\n",
      " '<heading id=\"h-0145\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4R*)-2-fluoro-4-hydroxycyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0514\" num=\"2318\">Tetrabutylammoniumfluoride trihydrate (11.9 g; '\n",
      " '36.7 mmol) is added to a solution of tert-butyl '\n",
      " '[(1S*,2S*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl]carbamate '\n",
      " '(example C18; 8.7 g; 18.3 mmol). The reaction mixture is stirred over night '\n",
      " 'at ambient temperature. The solvent is removed under reduced pressure. The '\n",
      " 'residue is chromatographed on silica gel (cyclohexane/AcOEt&#x2014;60:40 to '\n",
      " '40:60) to yield 4.2 g of the title compound as colourless oil.</p>\\n'\n",
      " '<p id=\"p-0515\" num=\"2319\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.91 (d, J=8.0, 1H, &#x2014;NH); 4.57 (d, J=2.7, 1H, &#x2014;OH); 4.56 (dm, '\n",
      " 'J=50.4, 1H); 3.94 (m, 1H); 3.41 (m, 1H); 2.03 (m, 1H); 1.64-1.50 (m, 4H); '\n",
      " '1.50-1.32 (s, 9H &#x26; m, 1H).</p>\\n'\n",
      " '<heading id=\"h-0146\" level=\"1\">Example C20</heading>\\n'\n",
      " '<heading id=\"h-0147\" '\n",
      " 'level=\"1\">(1R*,3S*,4S*)-4-[(tert-Butoxycarbonyl)amino]-3-fluorocyclohexyl '\n",
      " 'methane sulfonate</heading>\\n'\n",
      " '<p id=\"p-0516\" num=\"2320\">Starting from tert-butyl '\n",
      " '[(1S*,2S*,4R*)-2-fluoro-4-hydroxycyclohexyl]carbamate (example C19; 5.9 g; '\n",
      " '25.5 mmol) and following the procedure as described in example C4, 6.6 g of '\n",
      " 'the title compound is obtained as colourless solid after chromatography on '\n",
      " 'silica gel (cyclohexane/AcOEt&#x2014;60:40 to 50:50)</p>\\n'\n",
      " '<p id=\"p-0517\" num=\"2321\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '5.05 (m, 1H); 4.61 (br.s, 1H, &#x2014;NH &#x26; dm, J=48.9, 1H); 3.72 (m, '\n",
      " '1H); 3.02 (s, 3H); 2.40 (m, 1H); 2.09 (m, 1H); 1.96 (m, 2H); 1.79 (m, 1H); '\n",
      " '1.64 (m, 1H); 1.45 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0148\" level=\"1\">Example C21</heading>\\n'\n",
      " '<heading id=\"h-0149\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4S*)-4-azido-2-fluorocyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0518\" num=\"2322\">Starting from '\n",
      " '(1R*,3S*,4S*)-4-[(tert-butoxycarbonyl)amino]-3-fluorocyclohexyl '\n",
      " 'methanesulfonate (example C20; 5.3 g; 17.0 mmol) and following the procedure '\n",
      " 'as described in example C5, 4.0 g of the title compound is obtained as '\n",
      " 'colourless solid after chromatography on silica gel '\n",
      " '(cyclohex-ane/AcOEt&#x2014;60:40).</p>\\n'\n",
      " '<p id=\"p-0519\" num=\"2323\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '4.45 (br.s, 1H, &#x2014;NH); 4.25 (dm, J=49.7, 1H); 3.55 (m, 1H); 3.35 (m, '\n",
      " '1H); 2.46 (m, 1H); 2.21 (m, 1H); 1.99 (m, 1H); 1.64 (m, 1H); 1.45 (s, 9H '\n",
      " '&#x26; m, 1H); 1.23 (m, 1H).</p>\\n'\n",
      " '<heading id=\"h-0150\" level=\"1\">Example C22</heading>\\n'\n",
      " '<heading id=\"h-0151\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4S*)-4-amino-2-fluorocyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0520\" num=\"2324\">Starting from tert-butyl '\n",
      " '[(1S*,2S*,4S*)-4-azido-2-fluorocyclohexyl]carbamate (example C21; 2.0 g; 7.7 '\n",
      " 'mmol) and following the procedure as described in example C11 yields 1.7 g '\n",
      " 'of the title compound as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0521\" num=\"2325\">HR-MS (ESI): m/z=233.1651 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>11</sub>H<sub>22</sub>FN<sub>2</sub>O<sub>2</sub><sup>+</sup>, calc. '\n",
      " '233.1659).</p>\\n'\n",
      " '<heading id=\"h-0152\" level=\"1\">Example C23</heading>\\n'\n",
      " '<heading id=\"h-0153\" level=\"1\">(1S*,2S*,4S*)-4-Azido-2-fluorocyclohexanamine '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-0522\" num=\"2326\">Starting from tert-butyl '\n",
      " '[(1S*,2S*,4S*)-4-azido-2-fluorocyclohexyl]carbamate (example C21; 1.9 g; 7.5 '\n",
      " 'mmol) and following the procedure as described in example C12 yields 1.4 g '\n",
      " 'of the title compound as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0523\" num=\"2327\">HR-MS (ESI): m/z=159.1038 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>6</sub>H<sub>13</sub>FN<sub>4</sub><sup>+</sup>, calc. 159.1040).</p>\\n'\n",
      " '<heading id=\"h-0154\" level=\"1\">Example C24</heading>\\n'\n",
      " '<heading id=\"h-0155\" '\n",
      " 'level=\"1\">(1S*,2S*,4S*)-4-(Benzyloxy)-2-methylcyclopentanol</heading>\\n'\n",
      " '<p id=\"p-0524\" num=\"2328\">A stirred suspension of CuCN (8.9 g; 100.0 mmol) '\n",
      " 'in dry THF (100.0 mL) is cooled to &#x2212;78&#xb0; C. before addition of '\n",
      " 'MeLi (1.6 M solution in Et<sub>2</sub>O; 125.0 mL; 200.0 mmol). The mixture '\n",
      " 'is allowed to warm to ambient temperature and re-cooled to &#x2212;78&#xb0; '\n",
      " 'C. before dropwise addition of a solution of known '\n",
      " 'cis-3-(benzyloxy)-6-oxabicyclo[3.1.0]hexane (9.5 g; 50.0 mmol) [Snider, B. '\n",
      " 'B.; Liu, T. J. Org. Chem. 2000, 65, 8490; Milne, D.; Murphy, P. J. <i>J. '\n",
      " 'Chem. Soc. Chemical Communication </i>1993, 884] in dry THF (100 mL) '\n",
      " 'followed by dropwise addition of BF<sub>3 </sub>etherate (6.8 mL; 55.0 '\n",
      " 'mmol). The cooled reaction mixture is stirred over night, allowed to warm to '\n",
      " '0&#xb0; C. and quenched with saturated NH<sub>4</sub>C1-solution containing '\n",
      " '10% (v/v) of 25% aqueous NH<sub>4</sub>OH-solution (250 mL). The organic '\n",
      " 'layer is separated and concentrated under reduced pressure. The aqueous '\n",
      " 'layer is extracted with tert-BuOMe. All organic phases are combined, washed '\n",
      " 'with brine, dried over MgSO<sub>4 </sub>and concentrated under reduced '\n",
      " 'pressure. The residue is chromatographed on silica gel '\n",
      " '(cyclohexane/tert-BuOMe&#x2014;80:20 to 50:50) to yield 7.6 g of the title '\n",
      " 'compound as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0525\" num=\"2329\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.31 (m, 5H); 4.62 (d, J=5.3, 1H, &#x2014;OH); 4.38 (s, 2H); 3.87 (m, 1H); '\n",
      " '3.39 (m, 1H); 2.26 (m, 1H); 1.84 (m, 2H); 1.47 (m, 1H); 1.30 (m, 1H); 0.93 '\n",
      " '(d, J=6.2, 3H).</p>\\n'\n",
      " '<heading id=\"h-0156\" level=\"1\">Example C25</heading>\\n'\n",
      " '<heading id=\"h-0157\" '\n",
      " 'level=\"1\">(1R*,2S*,4S*)-4-(Benzyloxy)-2-methylcyclopentyl '\n",
      " '3-nitrobenzoate</heading>\\n'\n",
      " '<p id=\"p-0526\" num=\"2330\">To an ice-cold stirred solution of '\n",
      " '(1S*,2S*,4S*)-4-(benzyloxy)-2-methylcyclopentanol (example C24; 7.5 g; 36.5 '\n",
      " 'mmol), 3-nirobenzoic acid (18.4 g; 110.0 mmol) and triphenylphoshine (23.0 '\n",
      " 'g; 87.6 mmol) diethyl azodicarboxylate (40% solution in toluene; 38.1 g; '\n",
      " '87.6 mmol) is dropwise added. The reaction mixture is stirred at ambient '\n",
      " 'temperature for two hours and concentrated under reduced pressure. The '\n",
      " 'residue is chromatographed on silica gel '\n",
      " '(cyclohexane/tert-BuOMe&#x2014;100:0 to 80:20) to yield 11.5 g of the title '\n",
      " 'compound as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0527\" num=\"2331\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.61 (&#x2dc;s, 1H); 8.49 (m, 1H); 8.37 (m, 1H); 7.84 (t, J=8.0, 1H); 7.33 '\n",
      " '(m, 5H); 5.41 (m, 1H); 4.44 (d, J=1.5, 2H); 4.20 (m, 1H); 2.43 (m, 1H); 2.18 '\n",
      " '(m, 2H); 2.00 (m, 1H); 1.73 (m, 1H); 1.00 (d, J=6.7, 3H).</p>\\n'\n",
      " '<heading id=\"h-0158\" level=\"1\">Example C26</heading>\\n'\n",
      " '<heading id=\"h-0159\" '\n",
      " 'level=\"1\">(1R*,2S*,4S*)-4-(Benzyloxy)-2-methylcyclopentanol</heading>\\n'\n",
      " '<p id=\"p-0528\" num=\"2332\">To a solution of '\n",
      " '(1R*,2S*,4S*)-4-(benzyloxy)-2-methylcyclopentyl 3-nitrobenzoate (example 25; '\n",
      " '11.5 g; 32.5 mmol) in THF (80.0 mL) and MeOH (40.0 mL) LiOH (1.17 g; 48.7 '\n",
      " 'mmol) dissolved in water (40.0 mL) is added. The reaction mixture is stirred '\n",
      " 'at ambient temperature for one hour and concentrated under reduced pressure. '\n",
      " 'The residue is diluted with water and extracted with dichloromethane. The '\n",
      " 'organic layer is dried over MgSO<sub>4</sub>, and concentrated under reduced '\n",
      " 'pressure. The residue is chromatographed on silica gel '\n",
      " '(cyclohexane/tert-BuOMe&#x2014;80:20 to 50:50) to yield 5.9 g of the title '\n",
      " 'compound as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0529\" num=\"2333\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.30 (m, 5H); 4.37 (s, 2H); 4.28 (d, J=4.2, 1H, &#x2014;OH); 4.07 (m, 1H); '\n",
      " '3.97 (m, 1H); 2.08-1.86 (m, 2H); 1.84-1.68 (m, 2H); 1.54 (m, 1H); 0.90 (d, '\n",
      " 'J=6.8, 3H).</p>\\n'\n",
      " '<heading id=\"h-0160\" level=\"1\">Example C27</heading>\\n'\n",
      " '<heading id=\"h-0161\" '\n",
      " 'level=\"1\">(1R*,2S*,4S*)-4-(Benzyloxy)-2-methylcyclopentyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0530\" num=\"2334\">Starting from '\n",
      " '(1R*,2S*,4S*)-4-(benzyloxy)-2-methylcyclopentanol (example C26; 5.9 g; 28.4 '\n",
      " 'mmol) and following the procedure as described in example C4, 7.5 g of the '\n",
      " 'title compound is obtained as pale yellow oil after column chromatography on '\n",
      " 'silica gel (cyclohexane/tert-BuOMe&#x2014;90:10 to 65:35).</p>\\n'\n",
      " '<p id=\"p-0531\" num=\"2335\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.32 (m, 5H); 5.02 (m, 1H); 4.40 (d, J=2.2, 2H); 4.14 (m, 1H); 3.14 (s, 3H); '\n",
      " '2.39-2.24 (m, 2H); 2.08 (m, 1H); 1.91 (m, 1H); 1.52 (m, 1H); 0.99 (d, J=6.7, '\n",
      " '3H).</p>\\n'\n",
      " '<heading id=\"h-0162\" level=\"1\">Example C28</heading>\\n'\n",
      " '<heading id=\"h-0163\" '\n",
      " 'level=\"1\">(1S*,2S*,4S*)-1-Azido-4-(benzyloxy)-2-methylcyclopentane</heading>\\n'\n",
      " '<p id=\"p-0532\" num=\"2336\">Starting from '\n",
      " '(1R*,2S*,4S*)-4-(benzyloxy)-2-methylcyclopentyl methanesulfonate (example '\n",
      " 'C27; 7.4 g; 26.5 mmol) and following the procedure as described in example '\n",
      " 'C5, 5.6 g of the title compound is obtained as pale yellow oil after column '\n",
      " 'chromatography on silica gel (cyclohexane/tert-BuOMe&#x2014;90:10 to '\n",
      " '65:35).</p>\\n'\n",
      " '<p id=\"p-0533\" num=\"2337\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.32 (m, 5H); 4.41 (s, 2H); 3.97 (m, 1H); 3.38 (m, 1H); 2.40 (m, 1H); '\n",
      " '2.11-1.90 (m, 2H); 1.65 (m, 1H); 1.39 (m, 1H); 1.02 (d, J=6.4, 3H).</p>\\n'\n",
      " '<heading id=\"h-0164\" level=\"1\">Example C29</heading>\\n'\n",
      " '<heading id=\"h-0165\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4S*)-4-(benzyloxy)-2-methylcyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0534\" num=\"2338\">Starting from '\n",
      " '(1S*,2S*,4S*)-1-azido-4-(benzyloxy)-2-methylcyclopentane (example C28; 4.9 '\n",
      " 'g; 24.0 mmol) and following the procedure as described in example C7, 5.5 g '\n",
      " 'of the title compound is obtained as pale yellow oil after column '\n",
      " 'chromatography on silica gel (cyclohexane/tert-BuOMe&#x2014;95:05 to '\n",
      " '70:30).</p>\\n'\n",
      " '<p id=\"p-0535\" num=\"2339\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.31 (m, 5H); 6.74 (d, J=8.2, 1H, &#x2014;NH); 4.37 (s, 2H); 3.90 (m, 1H); '\n",
      " '3.26 (m, 1H); 2.27 (m, 1H); 1.87 (m, 2H); 1.46 (m, 1H); 1.37 (s, 9H &#x26; '\n",
      " 'm, 1H); 0.90 (d, J=6.0, 3H).</p>\\n'\n",
      " '<heading id=\"h-0166\" level=\"1\">Example C30</heading>\\n'\n",
      " '<heading id=\"h-0167\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4S*)-4-hydroxy-2-methylcyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0536\" num=\"2340\">Starting from tert-butyl '\n",
      " '[(1S*,2S*,4S*)-4-(benzyloxy)-2-methylcyclopentyl]carbamate (example C29; 5.4 '\n",
      " 'g; 18.1 mmol) and following the procedure as described in example C8, 3.9 g '\n",
      " 'of the title compound is obtained as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0537\" num=\"2341\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.64 (d, J=8.0, 1H, &#x2014;NH); 4.47 (d, J=4.0, 1H, &#x2014;OH); 4.03 (m, '\n",
      " '1H); 3.21 (m, 1H); 2.15 (m, 1H); 1.89 (m, 1H); 1.64 (m, 1H); 1.37 (s, 9H); '\n",
      " '1.31 (m, 2H); 0.89 (d, J=6.6, 3H).</p>\\n'\n",
      " '<heading id=\"h-0168\" level=\"1\">Example C31</heading>\\n'\n",
      " '<heading id=\"h-0169\" '\n",
      " 'level=\"1\">(1S*,3S*,4S*)-3-[(tert-Butoxycarbonyl)amino]-4-methylcyclopentyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0538\" num=\"2342\">Starting from tert-butyl '\n",
      " '[(1S*,2S*,4S*)-4-hydroxy-2-methylcyclopentyl]carbamate (example C30; 3.9 g; '\n",
      " '18.0 mmol) and following the procedure as described in example C4, 4.8 g of '\n",
      " 'the title compound is obtained as colourless solid after column '\n",
      " 'chromatography on silica gel (cyclohexane/tert-BuOMe&#x2014;90:10 to '\n",
      " '60:40).</p>\\n'\n",
      " '<p id=\"p-0539\" num=\"2343\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.89 (d, J=7.9, 1H, &#x2014;NH); 4.99 (m, 1H); 3.29 (m, 1H); 3.12 (s, 3H); '\n",
      " '2.45 (m, 1H); 2.09-1.84 (m, 2H); 1.69-1.50 (m, 2H); 1.38 (s, 9H); 0.93 (d, '\n",
      " 'J=6.2, 3H).</p>\\n'\n",
      " '<heading id=\"h-0170\" level=\"1\">Example C32</heading>\\n'\n",
      " '<heading id=\"h-0171\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4R*)-4-azido-2-methylcyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0540\" num=\"2344\">Starting from '\n",
      " '(1S*,3S*,4S*)-3-[(tert-butoxycarbonyl)amino]-4-methylcyclopentyl '\n",
      " 'methanesulfonate (example C31; 4.8 g; 16.0 mmol) and following the procedure '\n",
      " 'as described in example C5, 3.7 g of the title compound is obtained as '\n",
      " 'colourless oil after column chromatography on silica gel '\n",
      " '(cyclo-hexane/tert-BuOMe&#x2014;90:10 to 80:20).</p>\\n'\n",
      " '<p id=\"p-0541\" num=\"2345\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.82 (d, J=8.0, 1H, &#x2014;NH); 4.03 (m, 1H); 3.42 (m, 1H); 2.22 (m, 1H); '\n",
      " '1.87 (m, 1H); 1.79-1.64 (m, 2H); 1.38 (s, 9H); 1.15 (m, 1H); 0.96 (d, J=6.2, '\n",
      " '3H).</p>\\n'\n",
      " '<heading id=\"h-0172\" level=\"1\">Example C33</heading>\\n'\n",
      " '<heading id=\"h-0173\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2S*,4R*)-4-amino-2-methylcyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0542\" num=\"2346\">Starting from tert-butyl '\n",
      " '[(1S*,2S*,4R*)-4-azido-2-methylcyclopentyl]carbamate (example C32; 1.6 g; '\n",
      " '6.8 mmol) and following the procedure as described in example C11, 1.4 g of '\n",
      " 'the title compound is obtained as colourless oil.</p>\\n'\n",
      " '<p id=\"p-0543\" num=\"2347\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.64 (d, J=7.7, 1H, &#x2014;NH); 3.45 (m, 1H); 3.29 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub>); 3.21 (m, 1H); 1.99 (m, 1H); 1.71-1.50 (m, 3H); 1.37 '\n",
      " '(s, 9H); 0.93 (d, J=6.6, 3H); 0.83 (m, 1H).</p>\\n'\n",
      " '<heading id=\"h-0174\" level=\"1\">Example C34</heading>\\n'\n",
      " '<heading id=\"h-0175\" '\n",
      " 'level=\"1\">(1S*,2S*,4R*)-4-Azido-2-methylcyclopentanamine '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-0544\" num=\"2348\">Starting from tert-butyl '\n",
      " '[(1S*,2S*,4R*)-4-azido-2-methylcyclopentyl]carbamate (example C32; 3.6 g; '\n",
      " '15.0 mmol) and following the procedure as described in example C12, 2.4 g of '\n",
      " 'the title compound is obtained as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0545\" num=\"2349\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.27 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 4.20 (m, 1H); 3.12 (m, '\n",
      " '1H); 2.29 (m, 1H); 2.13-1.94 (m, 3H); 1.26 (m, 1H); 1.10 (d, J=6.8, '\n",
      " '3H).</p>\\n'\n",
      " '<p id=\"p-0546\" num=\"2350\">HR-MS (ESI): m/z=141.1136 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>6</sub>H<sub>13</sub>N<sub>4</sub><sup>+</sup>, calc. 141.1135)</p>\\n'\n",
      " '<heading id=\"h-0176\" level=\"1\">Example C35</heading>\\n'\n",
      " '<heading id=\"h-0177\" '\n",
      " 'level=\"1\">(1S*,2S*,4R*)-4-(Benzyloxy)-2-fluorocyclopentanol</heading>\\n'\n",
      " '<p id=\"p-0547\" num=\"2351\">A stirred mixture of known '\n",
      " 'cis-3-(benzyloxy)-6-oxabicyclo[3.1.0]hexane (6.1 g; 32.1 mmol) [Snider, B. '\n",
      " 'B.; Liu, T. <i>J. Org. Chem. </i>2000, 65, 8490; Milne, D.; Murphy, P. J. '\n",
      " '<i>J. Chem. Soc. Chemical Communication </i>1993, 884] and '\n",
      " 'tetrabutylammonium dihydrogen trifluoride (16.3 g; 54.1 mmol) is heated to '\n",
      " '150&#xb0; C. over night. The mixture is diluted with AcOEt and extracted '\n",
      " 'with sat. NaHCO<sub>3</sub>-solution. The organic layer is dried over '\n",
      " 'MgSO<sub>4 </sub>and concentrated under reduced pressure. The residue is '\n",
      " 'chromatographed on silica gel (cyclohexane/AcOEt&#x2014;10:0 to 80:29) to '\n",
      " 'yield 5.5 g of the title compound as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0548\" num=\"2352\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.32 (m, 5H); 5.13 (d, J=4.6, 1H, &#x2014;OH); 4.81 (dm, J=53.1, 1H); 4.43 '\n",
      " '(s, 2H); 4.11-3.93 (m, 2H); 2.32 (m, 1H); 2.18-1.88 (m, 2H); 1.51 (m, '\n",
      " '1H).</p>\\n'\n",
      " '<heading id=\"h-0178\" level=\"1\">Example C36</heading>\\n'\n",
      " '<heading id=\"h-0179\" '\n",
      " 'level=\"1\">(1S*,2R*,4S*)-4-(Benzyloxy)-2-fluorocyclopentyl '\n",
      " '3-nitrobenzoate</heading>\\n'\n",
      " '<p id=\"p-0549\" num=\"2353\">Starting from '\n",
      " '(1S*,2S*,4R*)-4-(Benzyloxy)-2-fluorocyclopentanol (example C35; 6.5 g; 30.9 '\n",
      " 'mmol) and following the procedure as described in example C25, 7.3 g of the '\n",
      " 'title compound is obtained as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0550\" num=\"2354\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.63 (m, 1H); 8.52 (m, 1H); 8.39 (m, 1H); 7.86 (t, J=8.0, 1H); 7.40-7.24 (m, '\n",
      " '5H); 5.50-5.21 (m, 2H); 4.48 (s, 2H); 4.30 (m, 1H); 2.46-2.04 (m, 4H).</p>\\n'\n",
      " '<heading id=\"h-0180\" level=\"1\">Example C37</heading>\\n'\n",
      " '<heading id=\"h-0181\" '\n",
      " 'level=\"1\">(1S*,2R*,4S*)-4-(Benzyloxy)-2-fluorocyclopentanol</heading>\\n'\n",
      " '<p id=\"p-0551\" num=\"2355\">Starting from '\n",
      " '(1S*,2R*,4S*)-4-(Benzyloxy)-2-fluorocyclopentyl 3-nitrobenzoate (example '\n",
      " 'C36; 7.3 g; 20.0 mmol) and following the procedure as described in example '\n",
      " 'C26, 3.8 g of the title compound is obtained as colourless oil.</p>\\n'\n",
      " '<p id=\"p-0552\" num=\"2356\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.31 (m, 5H); 4.91 (d, J=5.8, 1H, &#x2014;OH); 4.83 (dm, J=54.7, 1H); 4.39 '\n",
      " '(s, 2H); 4.18-3.99 (m, 2H); 2.20 (m, 1H); 2.00-1.75 (m, 3H).</p>\\n'\n",
      " '<heading id=\"h-0182\" level=\"1\">Example C38</heading>\\n'\n",
      " '<heading id=\"h-0183\" '\n",
      " 'level=\"1\">(1S*,2R*,4S*)-4-(Benzyloxy)-2-fluorocyclopentyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0553\" num=\"2357\">Starting from '\n",
      " '(1S*,2R*,4S*)-4-(benzyloxy)-2-fluorocyclopentanol (example C37; 3.8 g; 17.9 '\n",
      " 'mmol) and following the procedure as described in example C4, 5.1 g of the '\n",
      " 'title compound is obtained as pale yellow oil.</p>\\n'\n",
      " '<p id=\"p-0554\" num=\"2358\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.33 (m, 5H); 5.32-5.01 (m, 2H); 4.43 (d, J=1.8, 2H); 4.22 (m, 1H); 3.24 (s, '\n",
      " '3H); 2.40-1.91 (m, 4H).</p>\\n'\n",
      " '<heading id=\"h-0184\" level=\"1\">Example C39</heading>\\n'\n",
      " '<heading id=\"h-0185\" level=\"1\">(1S*,3R*,4R*)-3-Azido-4-fluorocyclopentyl '\n",
      " 'benzyl ether</heading>\\n'\n",
      " '<p id=\"p-0555\" num=\"2359\">Starting from '\n",
      " '(1S*,2R*,4S*)-4-(Benzyloxy)-2-fluorocyclopentyl methanesulfonate (example '\n",
      " 'C38; 5.1 g; 17.7 mmol) and following the procedure as described in example '\n",
      " 'C5, 3.5 g of the title compound is obtained as colourless oil.</p>\\n'\n",
      " '<p id=\"p-0556\" num=\"2360\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.32 (m, 5H); 5.03 (dm, J=53.1, 1H); 4.44 (s, 2H); 4.22-4.07 (m, 2H); 2.44 '\n",
      " '(m, 1H); 2.16 (m, 1H); 2.08 (m, 1H); 1.72 (m, 1H).</p>\\n'\n",
      " '<heading id=\"h-0186\" level=\"1\">Example C40</heading>\\n'\n",
      " '<heading id=\"h-0187\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,2R*,4S*)-4-(benzyloxy)-2-fluorocyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0557\" num=\"2361\">Starting from '\n",
      " '(1S*,3R*,4R*)-3-azido-4-fluorocyclopentyl benzyl ether (example C39; 4.5 g; '\n",
      " '19.0 mmol) and following the procedure as described in example C7, 5.2 g of '\n",
      " 'the title compound is obtained as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0558\" num=\"2362\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.32 (m, 5H); 6.95 (br. d, J=6.8, 1H, &#x2014;NH); 4.87 (dm, J=53.3, 1H); '\n",
      " '4.43 (s, 2H); 4.05 (m, 1H); 3.83 (m, 1H); 2.32 (m, 1H); 2.18-1.89 (m, 2H); '\n",
      " '1.53 (m, 1H); 1.38 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0188\" level=\"1\">Example C41</heading>\\n'\n",
      " '<heading id=\"h-0189\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,2R*,4S*)-2-fluoro-4-hydroxycyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0559\" num=\"2363\">Starting from tert-butyl '\n",
      " '[(1R*,2R*,4S*)-4-(benzyloxy)-2-fluorocyclopentyl]carbamate (example C40; 5.2 '\n",
      " 'g; 16.9 mmol) and following the procedure as described in example C8, 3.5 g '\n",
      " 'of the title compound is obtained as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0560\" num=\"2364\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '6.86 (br. d, J=7.1, 1H, &#x2014;NH); 4.86 (d, J=3.7, 1H, &#x2014;OH); 4.84 '\n",
      " '(dm; J=53.1, 1H); 4.15 (m, 1H); 3.79 (m, 1H); 2.19 (m, 1H); 2.07-1.71 (m, '\n",
      " '2H); 1.38 (s, 9H &#x26; m, 1H).</p>\\n'\n",
      " '<heading id=\"h-0190\" level=\"1\">Example C42</heading>\\n'\n",
      " '<heading id=\"h-0191\" '\n",
      " 'level=\"1\">(1S*,3R*,4R*)-3-[(tert-Butoxycarbonyl)amino]-4-fluorocyclopentyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0561\" num=\"2365\">Starting from tert-butyl '\n",
      " '[(1R*,2R*,4S*)-2-fluoro-4-hydroxycyclopentyl]carbamate (example C41; 3.5 g; '\n",
      " '16.0 mmol) and following the procedure as described in example C4, 4.4 g of '\n",
      " 'the title compound is obtained as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0562\" num=\"2366\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.13 (br. d, J=6.6, 1H, &#x2014;NH); 5.09 (m, 1H); 4.93 (dm; J=52.8, 1H); '\n",
      " '3.87 (m, 1H); 3.18 (s, 3H); 2.52 (m, 1H); 2.38-2.10 (m, 2H); 1.74 (m, 1H); '\n",
      " '1.39 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0192\" level=\"1\">Example C43</heading>\\n'\n",
      " '<heading id=\"h-0193\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,2R*,4R*)-4-azido-2-fluorocyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0563\" num=\"2367\">Starting from '\n",
      " '(1S*,3R*,4R*)-3-[(tert-butoxycarbonyl)amino]-4-fluorocyclopentyl '\n",
      " 'methanesulfonate (example C42; 4.4 g; 14.8 mmol) and following the procedure '\n",
      " 'as described in example C5, 3.5 g of the title compound is obtained as '\n",
      " 'colourless solid.</p>\\n'\n",
      " '<p id=\"p-0564\" num=\"2368\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.07 (br. d, J=5.8, 1H, &#x2014;NH); 4.85 (dm; J=52.8, 1H); 4.20 (m, 1H); '\n",
      " '3.98 (m, 1H); 2.36 (m, 1H); 1.97 (m, 1H); 1.92-1.73 (m, 2H); 1.39 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0194\" level=\"1\">Example C44</heading>\\n'\n",
      " '<heading id=\"h-0195\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,2R*,4R*)-4-amino-2-fluorocyclopentyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0565\" num=\"2369\">Starting from tert-butyl '\n",
      " '[(1R*,2R*,4R*)-4-azido-2-fluorocyclopentyl]carbamate (example C43; 1.7 g; '\n",
      " '7.0 mmol) and following the procedure as described in example C11, 1.5 g of '\n",
      " 'the title compound is obtained as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0566\" num=\"2370\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 4.76 (dm; J=52.8, 1H); 4.04 (m, 1H); 3.31 (m, 1H); 2.23 '\n",
      " '(m, 1H); 1.67 (m, 2H); 1.48 (m, 1H); 1.39 (s, 9H).</p>\\n'\n",
      " '<p id=\"p-0567\" num=\"2371\">HR-MS (ESI): m/z=219.1495 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>10</sub>H<sub>20</sub>FN<sub>2</sub>O<sub>2</sub><sup>+</sup>, calc. '\n",
      " '219.1503).</p>\\n'\n",
      " '<heading id=\"h-0196\" level=\"1\">Example C45</heading>\\n'\n",
      " '<heading id=\"h-0197\" '\n",
      " 'level=\"1\">(1R*,2R*,4R*)-4-Azido-2-fluorocyclopentanamine '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-0568\" num=\"2372\">Starting from tert-butyl '\n",
      " '[(1R*,2R*,4R*)-4-azido-2-fluorocyclopentyl]carbamate (example C43; 1.8 g; '\n",
      " '7.5 mmol) and following the procedure as described in example C12, 1.3 g of '\n",
      " 'the title compound is obtained as colourless solid.</p>\\n'\n",
      " '<p id=\"p-0569\" num=\"2373\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.54 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 5.19 (dm; J=52.4, 1H); '\n",
      " '4.34 (m, 1H); 3.75 (m, 1H); 2.49 (m, 1H); 2.17 (m, 1H); 2.06-1.88 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<p id=\"p-0570\" num=\"2374\">HR-MS (ESI): m/z=145.0888 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>5</sub>H<sub>10</sub>FN<sub>4</sub><sup>+</sup>, calc. 145.0884).</p>\\n'\n",
      " '<heading id=\"h-0198\" level=\"1\">Example C46</heading>\\n'\n",
      " '<heading id=\"h-0199\" '\n",
      " 'level=\"1\">(1S*,2R*,4R*)-4-{[tert-Butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanol</heading>\\n'\n",
      " '<p id=\"p-0571\" num=\"2375\">Starting from '\n",
      " '((2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanone (example '\n",
      " 'C14; 18.7 g; 50.4 mmol) and following the procedure as described in example '\n",
      " 'C15 17.9 g of the title compound is obtained as colourless oil after column '\n",
      " 'chromatography on silica gel (cyclohex-ane/AcOEt&#x2014;100:0 to '\n",
      " '85:15).</p>\\n'\n",
      " '<p id=\"p-0572\" num=\"2376\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.67 (m, 4H); 7.38 (m, 6H); 4.31 (dddd, J=47.1, 10.7, 4.8, 2.9, 1H); 3.94 '\n",
      " '(m, 1H); 3.61 (m, 1H); 2.14-1.67 (m, 4H &#x26; 1H, &#x2014;OH); 2.92 (m, '\n",
      " '1H); 1.20 (m, 1H); 1.05 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0200\" level=\"1\">Example C47</heading>\\n'\n",
      " '<heading id=\"h-0201\" '\n",
      " 'level=\"1\">(1R*,2R*,4R*)-4-{[tert-Butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl '\n",
      " '3-nitrobenzoate</heading>\\n'\n",
      " '<p id=\"p-0573\" num=\"2377\">Starting from '\n",
      " '(1S*,2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanol '\n",
      " '(example C46; 17.8 g; 47.9 mmol) and following the procedure as described in '\n",
      " 'example C25 15.8 g of the title compound is obtained as pale yellow oil '\n",
      " 'after column chromatography on silica gel (cyclohex-ane/AcOEt&#x2014;100:0 '\n",
      " 'to 85:15).</p>\\n'\n",
      " '<p id=\"p-0574\" num=\"2378\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.60 (m, 1H); 8.49 (m, 1H); 8.34 (m, 1H); 7.83 (t, J=8.2, 1H); 7.64 (m, 4H); '\n",
      " '7.46 (m, 6H); 5.09 (m, 1H); 4.65 (dm, J=50.6, 1H); 3.87 (m, 1H); 2.24 (m, '\n",
      " '1H); 1.97 (m, 1H); 1.87-1.50 (m, 3H); 1.35 (m, 1H); 1.02 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0202\" level=\"1\">Example C48</heading>\\n'\n",
      " '<heading id=\"h-0203\" '\n",
      " 'level=\"1\">(1R*,2R*,4R*)-4-{[tert-Butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanol</heading>\\n'\n",
      " '<p id=\"p-0575\" num=\"2379\">Starting from '\n",
      " '(1R*,2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl '\n",
      " '3-nitrobenzoate (example C47; 15.8 g; 30.3 mmol) and following the procedure '\n",
      " 'as described in example C26 10.9 g of the title compound is obtained as '\n",
      " 'colourless oil after column chromatography on silica gel '\n",
      " '(cyclohexane/AcOEt&#x2014;100:0 to 85:15).</p>\\n'\n",
      " '<p id=\"p-0576\" num=\"2380\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.61 (m, 4H); 7.45 (m, 6H); 4.97 (d, J=4.7, 1H, &#x2014;OH); 4.01 (dm, '\n",
      " 'J=50.4, 1H); 3.71 (m, 1H); 3.40 (m, 1H); 2.09 (m, 1H); 1.67 (m, 2H); 1.53 '\n",
      " '(m, 1H); 1.37 (m, 1H); 1.00 (s, 9H &#x26; m, 1H).</p>\\n'\n",
      " '<heading id=\"h-0204\" level=\"1\">Example C49</heading>\\n'\n",
      " '<heading id=\"h-0205\" '\n",
      " 'level=\"1\">(1R*,2R*,4R*)-4-{[tert-Butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0577\" num=\"2381\">Starting from '\n",
      " '(1R*,2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexanol '\n",
      " '(example C48; 13.1 g; 35.2 mmol) and following the procedure as described in '\n",
      " 'example C4 14.8 g of the title compound is obtained as pale yellow oil after '\n",
      " 'column chromatography on silica gel (cyclohexane/AcOEt&#x2014;100:0 to '\n",
      " '80:20).</p>\\n'\n",
      " '<p id=\"p-0578\" num=\"2382\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.62 (m, 4H); 7.45 (m, 6H); 4.63 (m, 1H); 4.45 (dm, J=50.3, 1H); 3.83 (m, '\n",
      " '1H); 3.13 (s, 3H); 2.19 (m, 1H); 1.97 (m, 1H); 1.72 (m, 2H); 1.51 (m, 1H); '\n",
      " '1.35 (m, 1H); 1.00 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0206\" level=\"1\">Example C50</heading>\\n'\n",
      " '<heading id=\"h-0207\" '\n",
      " 'level=\"1\">{[(1R*,3R*,4S*)-4-Azido-3-fluorocyclohexyl]oxy}(tert-butyl)diphenylsilane</heading>\\n'\n",
      " '<p id=\"p-0579\" num=\"2383\">Starting from '\n",
      " '(1R*,2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl '\n",
      " 'methanesulfonate (example C49; 14.7 g; 32.7 mmol) and following the '\n",
      " 'procedure as described in example C5 10.2 g of the title compound is '\n",
      " 'obtained as colourless oil after column chromatography on silica gel '\n",
      " '(cyclohexane/AcOEt&#x2014;100:0 to 95:05).</p>\\n'\n",
      " '<p id=\"p-0580\" num=\"2384\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.66 (m, 4H); 7.39 (m, 6H); 4.41 (dm, J=46.4, 1H); 3.79 (m, 1H); 3.60 (m, '\n",
      " '1H); 2.13-1.81 (m, 3H); 1.71-1.46 (m, 2H); 1.22 (m, 1H); 1.05 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0208\" level=\"1\">Example C51</heading>\\n'\n",
      " '<heading id=\"h-0209\" level=\"1\">tert-Butyl '\n",
      " '[(1S*,2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0581\" num=\"2385\">Starting from '\n",
      " '{[(1R*,3R*,4S*)-4-azido-3-fluorocyclohexyl]oxy}(tert-butyl)diphenylsilane '\n",
      " '(example C50; 10.1 g; 25.6 mmol) and following the procedure as described in '\n",
      " 'example C7 10.5 g of the title compound is obtained as colourless solid '\n",
      " 'after column chromatography on silica gel (cyclohex-ane/AcOEt&#x2014;100:0 '\n",
      " 'to 95:05).</p>\\n'\n",
      " '<p id=\"p-0582\" num=\"2386\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '7.66 (m, 4H); 7.39 (m, 6H); 4.92 (br.s, 1H, &#x2014;NH); 4.64 (dm, J=46.7, 1 '\n",
      " 'H); 3.89 (m, 1H); 3.66 (m, 1H); 2.08 (m, 2H); 1.87-1.37 (m, 4H); 1.45 (s, '\n",
      " '9H); 1.06 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0210\" level=\"1\">Example C52</heading>\\n'\n",
      " '<heading id=\"h-0211\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,2S*,4S*)-2-fluoro-4-hydroxycyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0583\" num=\"2387\">Starting from tert-butyl '\n",
      " '[(1S*,2R*,4R*)-4-{[tert-butyl(diphenyl)silyl]oxy}-2-fluorocyclohexyl]carbamate '\n",
      " '(example C51; 10.4 g; 22.0 mmol) and following the procedure as described in '\n",
      " 'example C19 4.5 g of the title compound is obtained as colourless oil after '\n",
      " 'column chromatography on silica gel (cyclohexane/AcOEt&#x2014;50:50).</p>\\n'\n",
      " '<p id=\"p-0584\" num=\"2388\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '4.89 (dm, J=48.9, 1H); 4.87 (br.s, 1H, &#x2014;NH); 3.97 (m, 1H); 3.66 (m, '\n",
      " '1H); 2.31 (m, 1H); 2.19 (m, 1H); 2.01-1.80 (m, 2H); 1.78-1.54 (m, 2H &#x26; '\n",
      " '1H, &#x2014;OH); 1.45 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0212\" level=\"1\">Example C53</heading>\\n'\n",
      " '<heading id=\"h-0213\" '\n",
      " 'level=\"1\">(1S*,3S*,4R*)-4-[(tert-Butoxycarbonyl)amino]-3-fluorocyclohexyl '\n",
      " 'methanesulfonate</heading>\\n'\n",
      " '<p id=\"p-0585\" num=\"2389\">Starting from tert-butyl '\n",
      " '[(1R*,2S*,4S*)-2-fluoro-4-hydroxycyclohexyl]carbamate (example C52; 4.4 g; '\n",
      " '18.7 mmol) and following the procedure as described in example C4 5.1 g of '\n",
      " 'the title compound is obtained as pale yellow solid after column '\n",
      " 'chromatography on silica gel (cyclohexane/AcOEt&#x2014;50:50).</p>\\n'\n",
      " '<p id=\"p-0586\" num=\"2390\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '4.97 (m, 1H); 4.88 (br.s, 1H, &#x2014;NH); 4.80 (dm, J=48.9, 1H); 3.68 (m, '\n",
      " '1H); 3.03 (s, 3H); 2.56 (m, 1H); 2.19 (m, 1H); 2.01-1.63 (m, 4H); 1.45 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0214\" level=\"1\">Example C54</heading>\\n'\n",
      " '<heading id=\"h-0215\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,2S*,4R*)-4-azido-2-fluorocyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0587\" num=\"2391\">Starting from '\n",
      " '(1S*,3S*,4R*)-4-[(tert-butoxycarbonyl)amino]-3-fluorocyclohexyl '\n",
      " 'methanesulfonate (example C53; 5.0 g; 16.1 mmol) and following the procedure '\n",
      " 'as described in example C5 3.0 g of the title compound is obtained as '\n",
      " 'colourless solid after column chromatography on silica gel '\n",
      " '(cyclohexane/tert-BuOMe&#x2014;80:20).</p>\\n'\n",
      " '<p id=\"p-0588\" num=\"2392\"><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): '\n",
      " '4.86 (dm, J=49.5, 1H); 4.77 (br.s, 1H, &#x2014;NH); 3.75-3.51 (m, 2H); 2.38 '\n",
      " '(m, 1H); 2.08 (m, 1H); 1.90 (m, 1H); 1.70-1.37 (m, 3H); 1.44 (m, 9H).</p>\\n'\n",
      " '<heading id=\"h-0216\" level=\"1\">Example C55</heading>\\n'\n",
      " '<heading id=\"h-0217\" level=\"1\">tert-Butyl '\n",
      " '[(1R*,2S*,4R*)-4-amino-2-fluorocyclohexyl]carbamate</heading>\\n'\n",
      " '<p id=\"p-0589\" num=\"2393\">Starting from tert-butyl '\n",
      " '[(1R*,2S*,4R*)-4-azido-2-fluorocyclohexyl]carbamate (example C54; 0.72 g; '\n",
      " '2.8 mmol) and following the procedure as described in example C11 0.65 g of '\n",
      " 'the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0590\" num=\"2394\">HR-MS (ESI): m/z=233.1665 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>11</sub>H<sub>22</sub>FN<sub>2</sub>O<sub>2</sub><sup>+</sup>, calc. '\n",
      " '233.1660).</p>\\n'\n",
      " '<heading id=\"h-0218\" level=\"1\">Example C56</heading>\\n'\n",
      " '<heading id=\"h-0219\" level=\"1\">(1R*,2S*,4R*)-4-Azido-2-fluorocyclohexanamine '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-0591\" num=\"2395\">Starting from tert-butyl '\n",
      " '[(1R*,2S*,4R*)-4-azido-2-fluorocyclohexyl]carbamate (example C54; 1.29 g; '\n",
      " '5.0 mmol) and following the procedure as described in example C12 0.92 g of '\n",
      " 'the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0592\" num=\"2396\">HR-MS (ESI): m/z=159.1036 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>6</sub>H<sub>12</sub>FN<sub>4</sub><sup>+</sup>, calc. 159.1041).</p>\\n'\n",
      " '<heading id=\"h-0220\" level=\"1\">Example D.a1</heading>\\n'\n",
      " '<heading id=\"h-0221\" level=\"1\">Ethyl '\n",
      " '4-(5-cyclopropylmethoxy-benzo[1,3]dioxol-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0593\" '\n",
      " 'num=\"2397\">Ethyl-4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " 'from example A4 (11.98 g; 50.0 mmol), dioxane (200 mL) and '\n",
      " 'Cs<sub>2</sub>CO<sub>3 </sub>(2M aqueous solution; 75.0 mL; 150.0 mmol) is '\n",
      " 'heated to 80&#xb0; C. under nitrogen before addition of Pd(OAc)<sub>2 '\n",
      " '</sub>(247 mg; 1.1 mmol) and tricyclohexylphosphine (617 mg; 2.2 mmol). '\n",
      " 'After 30 min a solution of '\n",
      " '5-cyclopropylmethoxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzo[1,3]dioxole '\n",
      " 'from example B.c1 (17.50 g; 55.0 mmol) in dioxane (50.0 mL) is added and the '\n",
      " 'reaction mixture is heated to 100&#xb0; C. until the starting material is '\n",
      " 'consumed according to LC-MS.</p>\\n'\n",
      " '<p id=\"p-0594\" num=\"2398\">The cooled reaction mixture is diluted with water '\n",
      " '(250 mL) and acidified to pH=6 by careful addition of 2M aqueous citric '\n",
      " 'acid. The precipitated crude is filtered, dissolved in dioxane and filtered '\n",
      " 'through a short column of neutral alumina containing 5 wt % of water. The '\n",
      " 'column is rinsed with several portions of dioxane. The filtrate is '\n",
      " 'concentrated under reduced pressure and the product is collected with '\n",
      " 'tert-butyl methyl ether to yield the title compound as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0595\" num=\"2399\">MS (ESI): m/z=396 (MH<sup>+</sup>, 100%); '\n",
      " '382.</p>\\n'\n",
      " '<p id=\"p-0596\" num=\"2400\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.09 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 7.00 (d, J=8.6, 1H); 6.55 (d, '\n",
      " 'J=8.6, 1H); 5.99 (s, 2H); 4.31 (qu, J=7.1, 2H); 3.75 (d, J=6.7, 2H); 2.72 '\n",
      " '(s, 3H); 1.33 (t, J=7.1, 3H); 0.88 (m, 1H); 0.30 (m, 2H); 0.11 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-0597\" num=\"2401\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in above example D.a1.</p>\\n'\n",
      " '<heading id=\"h-0222\" level=\"1\">Example D.a2</heading>\\n'\n",
      " '<heading id=\"h-0223\" level=\"1\">Ethyl '\n",
      " '4-(2-cyclopropylmethoxy-4-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0598\" num=\"2402\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-4-fluoro-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c3) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0599\" num=\"2403\">MS (ESI): m/z=392 (MNa<sup>+</sup>); 370 '\n",
      " '(MH<sup>+</sup>); 356 (100%); 314; 302.</p>\\n'\n",
      " '<p id=\"p-0600\" num=\"2404\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.89 (br.s, 1H, &#x2014;NH); 9.19 (s, 1H); 7.64 (dd, J=8.4, 7.4, 1H); 7.08 '\n",
      " '(dd, J=11.6, 2.1, 1H); 6.95 (ddd; J=8.4, 8.4, 2.1, 1H); 4.31 (qu, J=6.9, '\n",
      " '2H); 3.90 (d, J=6.9, 2H); 2.74 (s, 3H); 1.34 (t, J=6.9, 3H); 0.94 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0224\" level=\"1\">Example D.a3</heading>\\n'\n",
      " '<heading id=\"h-0225\" level=\"1\">Ethyl '\n",
      " '4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0601\" num=\"2405\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-5-fluoro-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c4) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0602\" num=\"2406\">MS (ESI): m/z=424 (MH<sup>+</sup>, 100%); '\n",
      " '356.</p>\\n'\n",
      " '<p id=\"p-0603\" num=\"2407\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.92 (br.s, 1H, &#x2014;NH); 8.96 (s, 1H); 7.41 (dd, J=9.0, 3.2, 1H); 7.37 '\n",
      " '(ddd, J=9.1, 8.3, 3.2, 1H); 7.18 (dd, J=9.1, 4.4, 1H); 4.32 (qu, J=7.1, 2H); '\n",
      " '3.87 (d, J=6.9, 2H); 2.74 (s, 3H); 1.34 (t, J=7.1, 3H); 0.93 (m, 1H); 0.36 '\n",
      " '(m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0226\" level=\"1\">Example D.a4</heading>\\n'\n",
      " '<heading id=\"h-0227\" level=\"1\">Ethyl '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0604\" num=\"2408\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " 'commercially available 2-ethoxy-5-fluoro-phenyl-boronic acid the title '\n",
      " 'compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0605\" num=\"2409\">MS (ESI): m/z=344 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0606\" num=\"2410\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.95 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 7.41 (ddd, J=8.9, 8.9, 3.3, 1H); '\n",
      " '7.37 (dd, J=8.2, 3.3, 1H); 7.22 (dd, J=8.9, 4.4, 1H); 4.31 (qu, J=7.1, 2H); '\n",
      " '4.08 (qu, J=6.9, 2H); 2.74 (s, 3H); 1.34 (t, J=7.1, 3H); 1.10 (t, J=6.9, '\n",
      " '3H).</p>\\n'\n",
      " '<heading id=\"h-0228\" level=\"1\">Example D.a5</heading>\\n'\n",
      " '<heading id=\"h-0229\" level=\"1\">Ethyl '\n",
      " '4-(2-cyclopropylmethoxy-4-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0607\" num=\"2411\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-4-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c6) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0608\" num=\"2412\">MS (ESI): m/z=404 (MNa<sup>+</sup>); 382 '\n",
      " '(MH<sup>+</sup>, 100%); 368; 314.</p>\\n'\n",
      " '<p id=\"p-0609\" num=\"2413\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (br.s, 1H, &#x2014;NH); 8.90 (s, 1H); 7.56 (d, J=8.4, 1H); 6.71 (dd, '\n",
      " 'J=8.4, 2.2, 2H); 6.68 (d, J=2.2, 1H); 4.30 (qu, J=7.0, 2H); 3.90 (d, J=6.9, '\n",
      " '2H); 3.85 (s, 3H); 2.73 (s, 3H); 1.33 (t, J=7.1, 3H); 0.95 (m, 1H); 0.37 (m, '\n",
      " '2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0230\" level=\"1\">Example D.a6</heading>\\n'\n",
      " '<heading id=\"h-0231\" level=\"1\">Ethyl '\n",
      " '4-(2-cyclopropylmethoxy-5-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0610\" num=\"2414\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-5-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c7) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-0611\" num=\"2415\">MS (ESI): m/z=404 (MNa<sup>+</sup>); 382 '\n",
      " '(MH<sup>+</sup>, 100%); 368; 298.</p>\\n'\n",
      " '<p id=\"p-0612\" num=\"2416\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (br.s, 1H, &#x2014;NH); 8.94 (s, 1H); 7.15 (t, J=1.8, 1H); 7.09 (d, '\n",
      " 'J=1.8, 2H); 4.31 (qu, J=7.1, 2H); 3.81 (d, J=6.9, 2H); 3.76 (s, 3H); 2.73 '\n",
      " '(s, 3H); 1.34 (t, J=7.1, 3H); 0.91 (m, 1H); 0.34 (m, 2H); 0.18 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0232\" level=\"1\">Example D.a7</heading>\\n'\n",
      " '<heading id=\"h-0233\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0613\" num=\"2417\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-5-methyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c8) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0614\" num=\"2418\">MS (ESI): m/z=366 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0615\" num=\"2419\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.82 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 7.41 (d, J=2.1, 1H); 7.32 (dd, '\n",
      " 'J=8.4, 2.1, 1H); 7.05 (d, J=8.4, 1H); 4.31 (qu, J=7.1, 2H); 3.85 (d, J=6.8, '\n",
      " '2H); 2.72 (s, 3H); 2.33 (s, 3H); 1.34 (t, J=7.1, 3H); 0.93 (m, 1H); 0.35 (m, '\n",
      " '2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0234\" level=\"1\">Example D.a8</heading>\\n'\n",
      " '<heading id=\"h-0235\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0616\" num=\"2420\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-Cyclopropylmethoxy-5-trifluoromethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c9) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0617\" num=\"2421\">MS (ESI): m/z=420 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0618\" num=\"2422\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.98 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 7.93-7.85 (m, 2H); 7.37 (m, 1H); '\n",
      " '4.32 (qu, J=7.1, 2H); 3.99 (d, J=6.9, 2H); 2.74 (s, 3H); 1.34 (t, J=7.1, '\n",
      " '3H); 0.89 (m, 1H); 0.39 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0236\" level=\"1\">Example D.a9</heading>\\n'\n",
      " '<heading id=\"h-0237\" level=\"1\">Ethyl '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0619\" num=\"2423\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-Ethoxy-5-trifluoromethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c10) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0620\" num=\"2424\">MS (ESI): m/z=394 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0621\" num=\"2425\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.01 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 7.91 (dd, J=8.9, 2.1, 1H); 7.89 (d, '\n",
      " 'J=2.1, 1H); 7.41 (d, J=8.9, 1H); 4.32 (qu, J=7.1, 2H); 4.20 (qu, J=6.9, 2H); '\n",
      " '2.74 (s, 3H); 1.34 (t, J=7.1, 3H); 1.15 (t, J=6.9, 3H).</p>\\n'\n",
      " '<heading id=\"h-0238\" level=\"1\">Example D.a10</heading>\\n'\n",
      " '<heading id=\"h-0239\" level=\"1\">Ethyl '\n",
      " '4-(2-cyclopropylmethoxy-4-fluoro-5-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0622\" num=\"2426\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-Cyclopropylmethoxy-4-fluoro-5-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c2) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0623\" num=\"2427\">MS (ESI): m/z=422 (MNa<sup>+</sup>, 100%); 400 '\n",
      " '(MH<sup>+</sup>); 368; 316.</p>\\n'\n",
      " '<p id=\"p-0624\" num=\"2428\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (br.s, 1H, &#x2014;NH); 8.95 (s, 1H); 7.37 (d, J=9.8, 1H); 7.17 (d, '\n",
      " 'J=13.5, 1H); 4.31 (qu, J=7.1, 2H); 3.84 (s, 3H); 3.83 (d, J=6.9, 2H); 2.74 '\n",
      " '(s, 3H); 1.34 (t, J=7.1, 3H); 0.92 (m, 1H); 0.36 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0240\" level=\"1\">Example D.a11</heading>\\n'\n",
      " '<heading id=\"h-0241\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0625\" num=\"2429\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-4-fluoro-5-methyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c11) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0626\" num=\"2430\">MS (ESI): m/z=384 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0627\" num=\"2431\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 7.52 (d, J=9.7, 1H); 7.03 (d, '\n",
      " 'J=12.2, 1H); 4.31 (qu, J=7.1, 2H); 3.87 (d, J=6.9, 2H); 2.73 (s, 3H); 2.24 '\n",
      " '(d, J=1.3, 3H); 1.34 (t, J=7.1, 3H); 0.94 (m, 1H); 0.37 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0242\" level=\"1\">Example D.a12</heading>\\n'\n",
      " '<heading id=\"h-0243\" level=\"1\">Ethyl '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-4-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0628\" num=\"2432\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-5-fluoro-4-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c12) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0629\" num=\"2433\">MS (ESI): m/z=422 (MNa<sup>+</sup>); 400 '\n",
      " '(MH<sup>+</sup>, 100%); 386; 331.</p>\\n'\n",
      " '<p id=\"p-0630\" num=\"2434\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (br.s, 1H, &#x2014;NH); 8.91 (s, 1H); 7.45 (d, J=11.8, 1H); 6.92 (d, '\n",
      " 'J=7.3, 1H); 4.31 (qu, J=7.1, 2H); 3.96 (s, 3H); 3.93 (d, J=7.0, 2H); 2.74 '\n",
      " '(s, 3H); 1.33 (t, J=7.1, 3H); 0.94 (m, 1H); 0.38 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0244\" level=\"1\">Example D.a13</heading>\\n'\n",
      " '<heading id=\"h-0245\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0631\" num=\"2435\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane '\n",
      " '(example B.c13) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0632\" num=\"2436\">MS (ESI): m/z=438 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0633\" num=\"2437\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 7.63 (d, J=2.4, 1H); 7.54 (dd, '\n",
      " 'J=8.6, 2.4, 1H); 7.14 (d, J=8.6, 1H); 4.31 (qu, J=7.1, 2H); 3.99 (m, 2H); '\n",
      " '3.90 (d, J=6.9. 2H); 3.71 (m, 2H); 2.73 (s, 3H); 1.58 (s, 3H); 1.34 (t, '\n",
      " 'J=7.1, 3H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0246\" level=\"1\">Example D.a14</heading>\\n'\n",
      " '<heading id=\"h-0247\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0634\" num=\"2438\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-(2-cyclopropylmethoxy-5-ethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c14) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0635\" num=\"2439\">MS (ESI): m/z=380 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0636\" num=\"2440\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 7.43 (d, J=2.4, 1H); 7.35 (dd, '\n",
      " 'J=8.4, 2.4, 1H); 7.07 (d, J=8.4, 1H); 4.31 (qu, J=7.1, 2H); 3.86 (d, J=6.9, '\n",
      " '2H); 2.73 (s, 3H); 2.63 (qu, J=7.5, 2H); 1.34 (t, J=7.1, 3H); 1.18 (t, '\n",
      " 'J=7.5, 3H); 0.93 (m, 1H); 0.35 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0248\" level=\"1\">Example D.a15</heading>\\n'\n",
      " '<heading id=\"h-0249\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0637\" num=\"2441\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane '\n",
      " '(example B.c15) the title compound is obtained as off white solid.</p>\\n'\n",
      " '<p id=\"p-0638\" num=\"2442\">MS (ESI): m/z=394 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0639\" num=\"2443\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 7.45 (d, J=2.4, 1H); 7.39 (dd, '\n",
      " 'J=8.6, 2.4, 1H); 7.08 (d; J=8.6, 1H); 4.31 (qu, J=7.1, 2H); 3.86 (d, J=6.9, '\n",
      " '2H); 2.94 (sept, J=6.9, 1H); 2.73 (s, 3H); 1.34 (t, J=7.1, 3H); 1.22 (d, '\n",
      " 'J=6.9, 6H); 0.93 (m, 1H); 0.35 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0250\" level=\"1\">Example D.a16</heading>\\n'\n",
      " '<heading id=\"h-0251\" level=\"1\">Methyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0640\" num=\"2444\">Starting from methyl '\n",
      " '4-chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example A.11) and '\n",
      " '2-(2-cyclopropylmethoxy-5-methyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c8) the title compound is obtained as off white solid.</p>\\n'\n",
      " '<p id=\"p-0641\" num=\"2445\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-0642\" num=\"2446\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.31 (dd, J=8.4, 2.0, 1H); 7.23 (d, J=2-0, 1H); 7.03 (d, J=8.4, 1H); 5.38 '\n",
      " '(d, J=11.0, 1H); 4.98 (d, J=11.0, 1H); 3.85 (s, 3H); 3.79 (dd, J=10.4, 6.6, '\n",
      " '1H); 3.75 (dd, J=10.4, 6.9, 1H); 2.87 (m, 2H); 2.78 (s, 3H); 2.67 (s, 3H); '\n",
      " '2.31 (s, 3H); 0.87 (m, 1H); 0.52 (m, 2H); 0.30 (m, 2H); 0.03 (m, 2H); '\n",
      " '&#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0252\" level=\"1\">Example D.a17</heading>\\n'\n",
      " '<heading id=\"h-0253\" level=\"1\">Methyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0643\" num=\"2447\">Starting from methyl '\n",
      " '4-chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example A.11) and '\n",
      " '2-(2-cyclopropylmethoxy-5-fluoro-4-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " '(example B.c15) the title compound is obtained as off white solid.</p>\\n'\n",
      " '<p id=\"p-0644\" num=\"2448\">MS (ESI): 530 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-0645\" num=\"2449\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.29 (d, J=11.5, 1H); 6.92 (d, J=7.3, 1H), 5.43 (d, J=11.0, 1H); 5.03 (d, '\n",
      " 'J=11.0, 1H); 3.95 (s, 3H); 3.85 (s, 3H); 3.83 (m, 2H); 2.95 (m, 2H); 2.80 '\n",
      " '(s, 3H); 2.67 (s, 3H); 0.88 (m, 1H); 0.55 (m, 2H); 0.31 (m, 2H); 0.04 (m, '\n",
      " '2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0254\" level=\"1\">Example D.a18</heading>\\n'\n",
      " '<heading id=\"h-0255\" level=\"1\">Methyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0646\" num=\"2450\">Starting from methyl '\n",
      " '4-chloro-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example A.11) and '\n",
      " '2-(2-cyclopropylmethoxy-4-fluoro-5-methoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane '\n",
      " 'e (example B.c2) the title compound is obtained as off white solid.</p>\\n'\n",
      " '<p id=\"p-0647\" num=\"2451\">MS (ESI): m/z=530 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0648\" num=\"2452\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.23 (d, J=9.9, 1H); 7.16 (d, J=13.1, 1H); 5.36 (d, J=10.9, 1H); 4.97 (d, '\n",
      " 'J=10.9, 1H); 3.85 (s, 3H); 3.81 (s, 3H); 3.79 (dd, J=10.2, 6.4, 1H); 3.72 '\n",
      " '(dd, J=10.2, 6.9, 1H); 3.04-2.87 (m, 2H); 2.79 (s, 3H); 2.68 (s, 3H); 0.86 '\n",
      " '(m, 1H); 0.57 (m, 2H); 0.30 (m, 2H); 0.01 (m, 2H); &#x2212;0.15 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0256\" level=\"1\">Example D.a19</heading>\\n'\n",
      " '<heading id=\"h-0257\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0649\" num=\"2453\">Starting from ethyl '\n",
      " '4-chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate (example A4) and '\n",
      " '2-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane '\n",
      " '(example B.c16) the title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-0650\" num=\"2454\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.93 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 7.81 (d, J=2.1, 1H); 7.74 (dd, '\n",
      " 'J=8.8, 2.1, 1H); 7.30 (d, J=8.8, 1H); 7.08 (t, J=55.9, 1H); 4.32 (qu, J=7.1, '\n",
      " '2H); 3.96 (d, J=6.9, 2H); 2.74 (s, 3H); 1.34 (t, J=7.1, 3H); 0.97 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0258\" level=\"1\">Example D.b1</heading>\\n'\n",
      " '<heading id=\"h-0259\" level=\"1\">Ethyl '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0651\" num=\"2455\">Sodium hydride (1.77 g; &#x2212;60% dispersion in '\n",
      " 'oil) is washed with hexane (2&#xd7;25) and suspended in dry DMF (150 mL) and '\n",
      " 'dry DMSO (50 mL). Ethyl '\n",
      " '4-(5-cyclopropylmethoxy-benzo[1,3]dioxol-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " 'from example D.a1 (14.55 g; 36.8 mmol) is added st the well stirred '\n",
      " 'suspension in several small portions. After complete addition the reaction '\n",
      " 'mixture is stirred for one hour at 60&#xb0; C. and cooled to 10&#xb0; C. '\n",
      " 'before slow addition of (2-chloromethoxy-ethyl)-trimethyl-silane (7.98 g; '\n",
      " '47.8 mmol). After stirring over night at ambient temperature the mixture is '\n",
      " 'poured on ice-cold water and repeatedly extracted with dichloromethane. The '\n",
      " 'combined organic layer is dried over MgSO4, The solvent is evaporated. The '\n",
      " 'crude product is purified by column chromatography on silica gel '\n",
      " '(ethylacetate/cyclohexane&#x2014;1:1) to yield the title compound as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0652\" num=\"2456\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0653\" num=\"2457\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.99 (s, 1H); 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.02 (d, J=0.6, 1H); '\n",
      " '5.92 (d, J=0.6, 1H); 5.39 (d, J=10.9, 1H); 5.13 (d, J=10.9, 1H); 4.35 (qu, '\n",
      " 'J=7.1, 2H); 3.76 (dd, J=10.2, 6.6, 1H); 3.67 (dd, J=10.2, 6.8, 1H); 3.01 (m, '\n",
      " '2H); 2.82 (s, 3H); 1.35 (t, J=7.1, 3H); 0.86 (m, 1H); 0.62 (m, 2H); 0.29 (m, '\n",
      " '2H); 0.00 (m, 2H); &#x2212;0.13 (s, 9H).</p>\\n'\n",
      " '<p id=\"p-0654\" num=\"2458\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in above example D.b1.</p>\\n'\n",
      " '<heading id=\"h-0260\" level=\"1\">Example D.b2</heading>\\n'\n",
      " '<heading id=\"h-0261\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0655\" num=\"2459\">Starting from '\n",
      " '4-(2-Cyclopropylmethoxy-4-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid ethyl ester (example D.a2) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is prepared as '\n",
      " 'pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0656\" num=\"2460\">MS (ESI): m/z=500 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0657\" num=\"2461\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.97 (s, 1H); 7.49 (dd, J=8.4, 6.9, 1H); 7.09 (dd, J=11.3, 2.4, 1H); 6.97 '\n",
      " '(ddd, J=8.4, 8.4, 2.4, 1H); 6.41 (d, J=10.9, 1H); 4.99 (d, J=10.9, 1H); 4.35 '\n",
      " '(qu, J=7.1, 2H); 3.89 (dd, J=10.3, 6.5, 1H); 3.80 (dd, J=10.3, 7.0, 1H); '\n",
      " '2.93 (m, 2H); 2.82 (s, 3H); 1.35 (t, J=7.1, 3H); 0.91 (m, 1H); 0.56 (dd, '\n",
      " 'J=9.5, 6.9, 2H); 0.33 (m, 2H): 0.06 (m, 2H); &#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0262\" level=\"1\">Example D.b3</heading>\\n'\n",
      " '<heading id=\"h-0263\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0658\" num=\"2462\">Starting from ethyl '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxylate '\n",
      " '(example D.a3) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is prepared as '\n",
      " 'pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0659\" num=\"2463\">MS (ESI): m/z=500 (MH<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0660\" num=\"2464\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.99 (s, 1H); 7.38 (ddd, J=9.1, 8.4, 3.2, 1H); 7.30 (dd, J=8.6, 3.2, 1H); '\n",
      " '7.19 (dd, J=9.1, 4.4, 1H); 5.42 (d, J=10.9, 1H); 5.00 (d, J=10.9, 1H); 4.35 '\n",
      " '(qu, J=7.1, 2H); 3.83 (dd, J=10.4, 6.6, 1H); 3.76 (dd, J=10.4, 6.9, 1H); '\n",
      " '2.94 (m, 2H); 2.82 (s, 3H); 1.35 (t, J=7.1, 3H); 0.88 (m, 1H); 0.56 (m, 2H); '\n",
      " '0.31 (m, 2H); 0.03 (m, 2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0264\" level=\"1\">Example D.b4</heading>\\n'\n",
      " '<heading id=\"h-0265\" level=\"1\">Ethyl '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0661\" num=\"2465\">Starting from ethyl '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a4) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0662\" num=\"2466\">MS (ESI): m/z=474 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0663\" num=\"2467\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.98 (s, 1H); 7.39 (ddd, J=9.1, 8.8, 3.3, 1H); 7.29 (dd, J=8.6, 3.3, 1H); '\n",
      " '7.20 (dd, J=9.1, 4.4, 1H); 5.40 (d, J=11.0, 1H); 4.98 (d, J=11.0, 1H); 4.35 '\n",
      " '(qu, J=7.1, 2H); 3.99 (qu, J=6.9, 2H); 2.99-2.88 (m, 2H); 2.82 (s, 3H); 1.35 '\n",
      " '(t, J=7.1, 3H); 1.01 (t, J=6.9, 3H); 0.57 (m, 2H); &#x2212;0.15 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0266\" level=\"1\">Example D.b5</heading>\\n'\n",
      " '<heading id=\"h-0267\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0664\" num=\"2468\">Starting from ethyl '\n",
      " '4-(2-cyclopropylmethoxy-4-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a5) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0665\" num=\"2469\">MS (ESI): m/z=512 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0666\" num=\"2470\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.94 (s, 1H); 7.40 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 2H); 6.69 (d, '\n",
      " 'J=2.2, 1H); 5.46 (d, J=10.9, 1H); 5.06 (d, J=10.9, 1H); 4.35 (qu, J=7.0, '\n",
      " '2H); 3.88 (dd, J=10.2, 5.5, 1H); 3.85 (s, 3H); 3.77 (dd, J=10.2, 6.9, 1H); '\n",
      " '2.91 (t, J=8.0, 2H); 2.82 (s, 3H); 1.35 (t, J=7.0, 3H); 0.88 (m, 1H); 0.52 '\n",
      " '(m, 2H); 0.32 (m, 2H); 0.06 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0268\" level=\"1\">Example D.b6</heading>\\n'\n",
      " '<heading id=\"h-0269\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0667\" num=\"2471\">Starting from ethyl '\n",
      " '4-(2-cyclopropylmethoxy-5-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a6) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0668\" num=\"2472\">MS (ESI): m/z=512 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0669\" num=\"2473\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.98 (s, 1H); 7.10 (d, J=1.5, 2H); 7.01 (t, J=1.5, 1H); 5.42 (d, J=11.0, '\n",
      " '1H); 5.04 (d, J=11.0, 1H); 4.35 (qu, J=7.1, 2H); 3.76 (s, 3H &#x26; dd, '\n",
      " 'J=10.2, 6.5, 1H); 3.70 (dd, J=10.2, 6.9, 1H); 2.92 (m, 2H); 2.82 (s, 3H); '\n",
      " '1.35 (t, J=7.1, 3H); 0.85 (m, 1H); 0.54 (m, 2H); 0.29 (m, 2H); 0.00 (m, 2H); '\n",
      " '&#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0270\" level=\"1\">Example D.b7</heading>\\n'\n",
      " '<heading id=\"h-0271\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0670\" num=\"2474\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a7) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0671\" num=\"2475\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0672\" num=\"2476\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.97 (s, 1H); 7.33 (dd, J=8.5, 2.0, 1H); 7.26 (d, J=2.0, 1H); 7.05 (d, '\n",
      " 'J=8.5, 1H); 5.43 (d, J=11.0, 1H); 5.03 (d, J=11.0, 1H); 4.35 (qu, J=7.1, '\n",
      " '2H); 3.81 (dd, J=10.2, 6.5, 1H); 3.74 (dd, J=10.2, 6.9, 1H); 2.89 (m, 2H); '\n",
      " '2.81 (s, 3H); 2.32 (s, 3H); 1.35 (t, J=7.1, 3H); 0.88 (m, 1H); 0.55 (m, 2H); '\n",
      " '0.31 (m, 2H); 0.03 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0272\" level=\"1\">Example D.b8</heading>\\n'\n",
      " '<heading id=\"h-0273\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0673\" num=\"2477\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a8) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0674\" num=\"2478\">MS (ESI): m/z=550 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0675\" num=\"2479\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.01 (s, 1H); 7.90 (dd, J=8.8, 2.1, 1H); 7.77 (d, J=2.1, 1H); 7.38 (d, '\n",
      " 'J=8.8, 1H); 5.40 (d, J=10.9, 1H); 4.96 (d, J=10.9, 1H); 4.36 (qu, J=7.1, '\n",
      " '2H); 3.98 (dd, J=10.4, 6.6, 1H); 3.91 (dd, J=10.4, 7.1, 1H); 2.92 (t, J=8.2, '\n",
      " '2H); 2.83 (s, 3H); 1.36 (t, J=7.1, 3H); 0.94 (m, 1H); 0.51 (m, 2H); 0.35 (m, '\n",
      " '2H); 0.10 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0274\" level=\"1\">Example D.b9</heading>\\n'\n",
      " '<heading id=\"h-0275\" level=\"1\">Ethyl '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0676\" num=\"2480\">Starting from ethyl '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a9) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0677\" num=\"2481\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0678\" num=\"2482\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.00 (s, 1H); 7.91 (dd, J=8.8, 2.2, 1H); 7.76 (d, J=2.2, 1H); 7.40 (d, '\n",
      " 'J=8.8, 1H); 5.38 (d, J=10.9, 1H); 4.94 (d, J=10.9, 1H); 4.30 (qu, J=7.1, '\n",
      " '2H); 4.17-4.08 (m, 2H); 2.93 (t, J=8.3, 2H); 2.83 (s, 3H); 1.35 (t, J=7.1, '\n",
      " '3H); 1.07 (t, J=7.0, 3H); 0.59-0.45 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0276\" level=\"1\">Example D.b10</heading>\\n'\n",
      " '<heading id=\"h-0277\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0679\" num=\"2483\">Starting from '\n",
      " '4-(2-cyclopropylmethoxy-4-fluoro-5-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid ethyl ester (example D.a10) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0680\" num=\"2484\">MS (ESI): m/z=552 (MNa<sup>+</sup>); 530 '\n",
      " '(MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0681\" num=\"2485\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.98 (s, 1H); 7.27 (d, J=9.7, 1H); 7.18 (d, J=13.3, 1H); 5.41 (d, J=10.9, '\n",
      " '1H); 5.03 (d, J=10.9, 1H); 4.35 (qu, J=7.1, 2H); 3.82 (s, 3H); 3.80 (dd, '\n",
      " 'J=10.4, 6.7, 1H); 3.74 (dd, J=10.4, 7.0, 1H); 2.97 (m, 2H); 2.82 (s, 3H); '\n",
      " '1.35 (t, J=7.1, 3H); 0.87 (m, 1H); 0.56 (m, 2H); 0.31 (m, 2H); 0.02 (m, 2H); '\n",
      " '&#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0278\" level=\"1\">Example D.b11</heading>\\n'\n",
      " '<heading id=\"h-0279\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0682\" num=\"2486\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a11) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow solid.</p>\\n'\n",
      " '<p id=\"p-0683\" num=\"2487\">MS (ESI): m/z=514 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0684\" num=\"2488\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.96 (s, 1H); 7.37 (d, J=8.9, 1H); 7.05 (d, J=12.1, 1H); 5.43 (d, J=11.0, '\n",
      " '1H); 5.02 (d, J=11.0, 1H); 4.35 (qu, J=7.1, 2H); 3.85 (dd, J=10.4, 6.6, 1H); '\n",
      " '3.77 (dd, J=10.4, 7.1, 1H); 2.94 (m, 2H); 2.82 (s, 3H); 2.23 (d, J=1.3, 3H); '\n",
      " '1.35 (t, J=7.1, 3H); 0.89 (m, 1H); 0.54 (m, 2H); 0.33 (m, 2H); 0.06 (m, 2H); '\n",
      " '&#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0280\" level=\"1\">Example D.b12</heading>\\n'\n",
      " '<heading id=\"h-0281\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0685\" num=\"2489\">Starting from ethyl '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-4-methoxy-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a12) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0686\" num=\"2490\">MS (ESI): m/z=552 (MNa<sup>+</sup>, 100%); 530 '\n",
      " '(MH<sup>+</sup>); 458 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>3</sub>H<sub>8</sub>Si).</p>\\n'\n",
      " '<p id=\"p-0687\" num=\"2491\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.95 (s, 1H); 7.30 (d, J=11.5, 1H); 6.92 (d, J=7.3, 1H); 5.46 (d, J=11.1, '\n",
      " '1H); 5.06 (d, J=11.1, 1H); 4.34 (qu, J=7.1, 2H); 3.94 (s, 3H); 3.87 (dd, '\n",
      " 'J=10.2, 6.6, 1H); 3.80 (dd, J=10.2, 7.0, 1H); 2.95 (m, 2H); 2.81 (s, 3H); '\n",
      " '1.34 (t, J=7.1, 3H); 0.87 (m, 1H); 0.54 (m, 2H); 0.31 (m, 2H); 0.03 (m, 2H); '\n",
      " '&#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0282\" level=\"1\">Example D.b13</heading>\\n'\n",
      " '<heading id=\"h-0283\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0688\" num=\"2492\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a13) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0689\" num=\"2493\">MS (ESI): m/z=568 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<heading id=\"h-0284\" level=\"1\">Example D.b14</heading>\\n'\n",
      " '<heading id=\"h-0285\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0690\" num=\"2494\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a14) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0691\" num=\"2495\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0692\" num=\"2496\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.97 (s, 1H); 7.41 (dd, J=8.6, 2.2, 1H); 7.29 (d, J=2.2, 1H); 7.08 (d, '\n",
      " 'J=8.6, 1H); 5.42 (d, J=10.9, 1H); 5.03 (d, J=10.9, 1H); 4.35 (qu, J=7.1, '\n",
      " '2H); 3.84 (dd, J=10.2, 6.4, 1H); 3.74 (dd, J=10.2, 6.8, 1H); 2.89 (m, 2H); '\n",
      " '2.81 (s, 3H); 2.62 (qu, J=7.5, 2H); 1.34 (t, J=7.1, 3H); 1.20 (t, J=7.5, '\n",
      " '3H); 0.93 (m, 1H); 0.52 (m, 2H); 0.32 (m, 2H); 0.04 (m, 2H); &#x2212;0.18 '\n",
      " '(s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0286\" level=\"1\">Example D.b15</heading>\\n'\n",
      " '<heading id=\"h-0287\" level=\"1\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0693\" num=\"2497\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a15) and commercially available '\n",
      " '(2-chloromethoxy-ethyl)-trimethyl-silane the title compound is obtained as '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0694\" num=\"2498\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0695\" num=\"2499\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.97 (s, 1H); 7.39 (dd, J=8.6, 2.4, 1H); 7.32 (d, J=2.4, 1H); 7.08 (d; '\n",
      " 'J=8.6, 1H); 5.41 (d, J=10.9, 1H); 5.04 (d, J=10.9, 1H); 4.35 (qu, J=7.1, '\n",
      " '2H); 3.82 (dd, J=10.2, 6.6, 1H); 3.74 (dd, J=10.2, 6.8, 1H); 2.98-2.84 (m, '\n",
      " '3H); 2.82 (s, 3H); 1.36 (t, J=7.1, 3H); 1.23 (dd, J=6.9, 2.2, 6H); 0.89 (m, '\n",
      " '1H); 0.51 (m, 2H); 0.31 (m, 2H); 0.04 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0288\" level=\"1\">Example D.c1</heading>\\n'\n",
      " '<heading id=\"h-0289\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0696\" num=\"2500\">Ethyl '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " 'from example D.b1 (15.28 g; 29.0 mmol) is dissolved in 1,4-dioxane (150 mL) '\n",
      " 'and aqueous LiOH (prepared from 1.04 g; 43.5 mmol; and 75 mL of water). The '\n",
      " 'stirred reaction mixture is heated to 80&#xb0; C. until the starting '\n",
      " 'material is consumed according to LC-MS. The mixture is concentrated under '\n",
      " 'reduced pressure, and diluted with water. The product is precipitated by '\n",
      " 'addition of 2M citric acid to adjust pH to 5, isolated by suction '\n",
      " 'filtration, washed with several small portions of water and dried in high '\n",
      " 'vacuo at 40&#xb0; C. to yield 13.55 g of the title compound as pale yellow '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-0697\" num=\"2501\">MS (ESI): m/z=498 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0698\" num=\"2502\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.93 (s, 1H); 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.02 (d, J=0.6, 1H); '\n",
      " '5.91 (d, J=0.6, 1H); 5.37 (d, J=11.0, 1H); 5.11 (d, J=11.0, 1H); 3.76 (dd, '\n",
      " 'J=10.2, 6.6, 2H); 3.68 (dd, J=10.2, 6.8, 1H); 3.01 (m, 2H); 2.84 (s, 3H); '\n",
      " '0.87 (m, 1H); 0.61 (m, 2H); 0.29 (m, 2H); 0.00 (m, 2H); &#x2212;0.13 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<p id=\"p-0699\" num=\"2503\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in above example D.c1.</p>\\n'\n",
      " '<heading id=\"h-0290\" level=\"1\">Example D.c2</heading>\\n'\n",
      " '<heading id=\"h-0291\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0700\" num=\"2504\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b2) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0701\" num=\"2505\">MS (ESI): m/z=472 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0702\" num=\"2506\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.70 (s, 1H); 7.46 (dd, J=8.4, 6.9, 1H); 7.08 (dd, J=11.5, 2.4, 1H); 6.95 '\n",
      " '(ddd, J=8.4, 8.4, 2.4, 1H); 5.32 (d, J=10.9, 1H); 4.93 (d, J=10.9, 1H); 3.89 '\n",
      " '(dd, J=10.3, 6.6, 1H); 3.79 (dd, J=10.3, 6.9, 1H); 2.90 (m, 2H); 2.89 (s, '\n",
      " '3H); 0.91 (m, 1H); 0.54 (dd, J=8.2, 7.8, 2H); 0.32 (m, 2H): 0.06 (m, 2H); '\n",
      " '&#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0292\" level=\"1\">Example D.c3</heading>\\n'\n",
      " '<heading id=\"h-0293\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0703\" num=\"2507\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b3) the title compound is obtained as yellow foam.</p>\\n'\n",
      " '<p id=\"p-0704\" num=\"2508\">MS (ESI): m/z=472 (MH<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0705\" num=\"2509\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.77 (s, 1H); 7.36 (ddd, J=9.1, 8.9, 3.3, 1H); 7.27 (dd, J=8.6, 3.3, 1H); '\n",
      " '7.18 (dd, J=9.1, 4.4, 1H); 5.35 (d, J=10.9, 1H); 4.94 (d, J=10.9, 1H); 3.83 '\n",
      " '(dd, J=10.2, 6.6, 1H); 3.76 (dd, J=10.2, 6.9, 1H); 2.92 (m, 2H); 2.88 (s, '\n",
      " '3H); 0.88 (m, 1H); 0.56 (m, 2H); 0.30 (m, 2H); 0.03 (m, 2H); &#x2212;0.16 '\n",
      " '(s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0294\" level=\"1\">Example D.c4</heading>\\n'\n",
      " '<heading id=\"h-0295\" '\n",
      " 'level=\"1\">4-(2-ethoxy-5-fluorophenyl)-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0706\" num=\"2510\">Starting from ethyl '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b4) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0707\" num=\"2511\">MS (ESI): m/z=446 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0708\" num=\"2512\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 8.78 (s, 1H); 7.37 (ddd, J=9.1, 8.9, 3.3, 1H); 7.27 '\n",
      " '(dd, J=8.8, 3.3, 1H); 7.19 (dd, J=9.1, 4.4, 1H); 5.33 (d, J=11.0, 1H); 4.94 '\n",
      " '(d, J=11.0, 1H); 3.99 (qu, J=6.9, 2H); 3.01-2.86 (m, 2H); 2.87 (s, 3H); 1.02 '\n",
      " '(t, J=6.9, 3H); 0.57 (m, 2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0296\" level=\"1\">Example D.c5</heading>\\n'\n",
      " '<heading id=\"h-0297\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0709\" num=\"2513\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b5) the title compound is obtained as yellow foam.</p>\\n'\n",
      " '<p id=\"p-0710\" num=\"2514\">MS (ESI): m/z=484 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0711\" num=\"2515\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.35 (br.s, 1H, CO<sub>2</sub>H); 8.92 (s, 1H); 7.40 (d, J=8.4, 1H); 6.72 '\n",
      " '(dd, J=8.4, 2.2, 2H); 6.69 (d, J=2.2, 1H); 5.46 (d, J=10.9, 1H); 5.06 (d, '\n",
      " 'J=10.9, 1H); 3.87 (dd, J=10.2, 6.4, 1H); 3.85 (s, 3H); 3.78 (dd, J=10.2, '\n",
      " '6.9, 1H); 2.91 (t, J=8.0, 2H); 2.82 (s, 3H); 0.89 (m, 1H); 0.52 (m, 2H); '\n",
      " '0.32 (m, 2H); 0.06 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0298\" level=\"1\">Example D.c6</heading>\\n'\n",
      " '<heading id=\"h-0299\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0712\" num=\"2516\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b6) the title compound is obtained as yellow foam.</p>\\n'\n",
      " '<p id=\"p-0713\" num=\"2517\">MS (ESI): m/z=484 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<heading id=\"h-0300\" level=\"1\">Example D.c7</heading>\\n'\n",
      " '<heading id=\"h-0301\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0714\" num=\"2518\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b7) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-0715\" num=\"2519\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.35 (br.s, 1H, CO<sub>2</sub>H); 8.96 (s, 1H); 7.33 (dd, J=8.6, 2.0, 1H); '\n",
      " '7.27 (d, J=2.0, 1H); 7.06 (d, J=8.6, 1H); 5.43 (d, J=11.0, 1H); 5.03 (d, '\n",
      " 'J=11.0, 1H); 3.82 (dd, J=10.3, 6.5, 1H); 3.75 (dd, J=10.2, 6.9, 1H); 2.89 '\n",
      " '(m, 2H); 2.83 (s, 3H); 2.32 (s, 3H); 0.89 (m, 1H); 0.52 (m, 2H); 0.31 (m, '\n",
      " '2H); 0.04 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0302\" level=\"1\">Example D.c8</heading>\\n'\n",
      " '<heading id=\"h-0303\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0716\" num=\"2520\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b8) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0717\" num=\"2521\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0718\" num=\"2522\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.91 (s, 1H); 7.90 (dd, J=8.8, 2.1, 1H); 7.76 (d, J=2.1, 1H); 7.38 (d, '\n",
      " 'J=8.8, 1H); 5.37 (d, J=11.0, 1H); 4.94 (d, J=11.0, 1H); 3.98 (dd, J=10.5, '\n",
      " '6.6, 1H); 3.91 (dd, J=10.5, 7.0, 1H); 2.91 (t, J=8.2, 2H); 2.86 (s, 3H); '\n",
      " '0.95 (m, 1H); 0.51 (m, 2H); 0.35 (m, 2H); 0.10 (m, 2H); &#x2212;0.18 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0304\" level=\"1\">Example D.c9</heading>\\n'\n",
      " '<heading id=\"h-0305\" '\n",
      " 'level=\"1\">4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0719\" num=\"2523\">Starting from ethyl '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b9) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0720\" num=\"2524\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0721\" num=\"2525\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 8.75 (s, 1H); 7.90 (dd, J=8.8, 2.2, 1H); 7.74 (d, '\n",
      " 'J=2.2, 1H); 7.39 (d, J=8.8, 1H); 5.30 (d, J=11.0, 1H); 4.89 (d, J=11.0, 1H); '\n",
      " '4.18-4.06 (m, 2H); 2.90 (t, J=8.6, 2H); 2.89 (s, 3H); 1.08 (t, J=7.0, 3H); '\n",
      " '0.52 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0306\" level=\"1\">Example D.c10</heading>\\n'\n",
      " '<heading id=\"h-0307\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0722\" num=\"2526\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b10) the title compound is obtained as yellow foam.</p>\\n'\n",
      " '<p id=\"p-0723\" num=\"2527\">MS (ESI): m/z=524 (MNa<sup>+</sup>); 502 '\n",
      " '(MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0724\" num=\"2528\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.38 (br.s, 1H, &#x2014;CO<sub>2</sub>H); 8.98 (s, 1H); 7.28 (d, J=9.7, '\n",
      " '1H); 7.19 (d, J=13.1, 1H); 5.42 (d, J=10.9, 1H); 5.03 (d, J=10.9, 1H); 3.82 '\n",
      " '(s, 3H); 3.81 (dd, J=10.3, 6.6, 1 H); 3.73 (dd, J=10.3, 7.0, 1H); 3.05-2.89 '\n",
      " '(m, 2H); 2.83 (s, 3H); 0.87 (m, 1H); 0.56 (m, 2H); 0.31 (m, 2H); 0.02 (m, '\n",
      " '2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0308\" level=\"1\">Example D.c11</heading>\\n'\n",
      " '<heading id=\"h-0309\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0725\" num=\"2529\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b11) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0726\" num=\"2530\">MS (ESI): m/z=514 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0727\" num=\"2531\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.96 (s, 1H); 7.37 (d, J=8.9, 1H); 7.05 (d, J=12.1, 1H); 5.43 (d, J=11.0, '\n",
      " '1H); 5.02 (d, J=11.0, 1H); 4.35 (qu, J=7.1, 2H); 3.85 (dd, J=10.4, 6.6, 1H); '\n",
      " '3.77 (dd, J=10.4, 7.1, 1H); 2.94 (m, 2H); 2.82 (s, 3H); 2.23 (d, J=1.3, 3H); '\n",
      " '1.35 (t, J=7.1, 3H); 0.89 (m, 1H); 0.54 (m, 2H); 0.33 (m, 2H); 0.06 (m, 2H); '\n",
      " '&#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0310\" level=\"1\">Example D.c12</heading>\\n'\n",
      " '<heading id=\"h-0311\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0728\" num=\"2532\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b12) the title compound is obtained as yellow foam.</p>\\n'\n",
      " '<p id=\"p-0729\" num=\"2533\">MS (ESI): m/z=552 (MNa<sup>+</sup>, 100%); 530 '\n",
      " '(MH<sup>+</sup>); 458 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>3</sub>H<sub>8</sub>Si).</p>\\n'\n",
      " '<p id=\"p-0730\" num=\"2534\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.95 (s, 1H); 7.30 (d, J=11.5, 1H); 6.92 (d, J=7.3, 1H); 5.46 (d, J=11.1, '\n",
      " '1H); 5.06 (d, J=11.1, 1H); 4.34 (qu, J=7.1, 2H); 3.94 (s, 3H); 3.87 (dd, '\n",
      " 'J=10.2, 6.6, 1H); 3.80 (dd, J=10.2, 7.0, 1H); 2.95 (m, 2H); 2.81 (s, 3H); '\n",
      " '1.34 (t, J=7.1, 3H); 0.87 (m, 1H); 0.54 (m, 2H); 0.31 (m, 2H); 0.03 (m, 2H); '\n",
      " '&#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0312\" level=\"1\">Example D.c13</heading>\\n'\n",
      " '<heading id=\"h-0313\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0731\" num=\"2535\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b13) the title compound is obtained as yellow foam.</p>\\n'\n",
      " '<p id=\"p-0732\" num=\"2536\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0733\" num=\"2537\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.93 (s, 1H); 7.56 (dd, J=8.8, 2.4, 1H); 7.49 (d, J=2.4, 1H); 7.14 (d, '\n",
      " 'J=8.8, 1H); 5.38 (d, J=11.1, 1H); 5.03 (d, J=11.1, 1H); 4.00 (m, 2H); 3.86 '\n",
      " '(dd, J=10.2, 6.4, 1H); 3.78 (dd, J=10.2, 6.9, 1H); 3.73 (m, 2H); 2.89 (m, '\n",
      " '2H); 2.84 (s, 3H); 1.59 (s, 3H); 0.91 (m, 1H); 0.50 (m, 2H); 0.32 (m, 2H); '\n",
      " '0.06 (m, 2H); &#x2212;0.20 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0314\" level=\"1\">Example D.c14</heading>\\n'\n",
      " '<heading id=\"h-0315\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0734\" num=\"2538\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b14) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0735\" num=\"2539\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0736\" num=\"2540\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.97 (s, 1H); 7.41 (dd, J=8.6, 2.2, 1H); 7.29 (d, J=2.2, 1H); 7.08 (d, '\n",
      " 'J=8.6, 1H); 5.42 (d, J=10.9, 1H); 5.03 (d, J=10.9, 1H); 4.35 (qu, J=7.1, '\n",
      " '2H); 3.84 (dd, J=10.2, 6.4, 1H); 3.74 (dd, J=10.2, 6.8, 1H); 2.89 (m, 2H); '\n",
      " '2.81 (s, 3H); 2.62 (qu, J=7.5, 2H); 1.34 (t, J=7.1, 3H); 1.20 (t, J=7.5, '\n",
      " '3H); 0.93 (m, 1H); 0.52 (m, 2H); 0.32 (m, 2H); 0.04 (m, 2H); &#x2212;0.18 '\n",
      " '(s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0316\" level=\"1\">Example D.c15</heading>\\n'\n",
      " '<heading id=\"h-0317\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0737\" num=\"2541\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.b15) the title compound is obtained as yellow foam.</p>\\n'\n",
      " '<p id=\"p-0738\" num=\"2542\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<heading id=\"h-0318\" level=\"1\">Example D.c16</heading>\\n'\n",
      " '<heading id=\"h-0319\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0739\" num=\"2543\">Starting from methyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a16) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0740\" num=\"2544\">MS (ESI): m/z=482 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-0741\" num=\"2545\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.32 (br.s, 1H, &#x2014;CO<sub>2</sub>H); 7.33 (dd, J=8.4, 1.8, 1H); 7.24 '\n",
      " '(d, J=1.8, 1H); 7.05 (d, J=8.4, 1H); 5.42 (d, J=11.0, 1H); 5.01 (d, J=11.0, '\n",
      " '1H); 3.80 (dd, J=10.2, 6.6, 1H); 3.76 (dd, J=10.2, 6.9, 1H); 2.89 (m, 2H); '\n",
      " '2.81 (s, 3H); 2.70 (s, 3H); 2.32 (s, 3H); 0.89 (m, 1H); 0.52 (m, 2H); 0.31 '\n",
      " '(m, 2H); 0.05 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0320\" level=\"1\">Example D.c17</heading>\\n'\n",
      " '<heading id=\"h-0321\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0742\" num=\"2546\">Starting from methyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a17) the title compound is obtained as pale yellow foam</p>\\n'\n",
      " '<p id=\"p-0743\" num=\"2547\">MS (ESI): 516 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-0744\" num=\"2548\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.32 (br.s, 1H, &#x2014;CO<sub>2</sub>H); 7.30 (d, J=11.3, 1H); 6.93 (d, '\n",
      " 'J=7.3, 1H), 5.46 (d, J=11.1, 1H); 5.05 (d, J=11.1, 1H); 3.95 (s, 3H); 3.85 '\n",
      " '(m, 2H); 2.96 (m, 2H); 2.82 (s, 3H); 2.70 (s, 3H); 0.89 (m, 1H); 0.55 (m, '\n",
      " '2H); 0.33 (m, 2H); 0.06 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0322\" level=\"1\">Example D.c18</heading>\\n'\n",
      " '<heading id=\"h-0323\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-0745\" num=\"2549\">Starting from methyl '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a18) the title compound is obtained as pale yellow foam</p>\\n'\n",
      " '<p id=\"p-0746\" num=\"2550\">MS (ESI): m/z=516 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0747\" num=\"2551\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '7.25 (d, J=9.7, 1H); 7.17 (d, J=13.1, 1H); 5.38 (d, J=10.8, 1H); 5.01 (d, '\n",
      " 'J=10.8, 1H); 3.82 (s, 3H); 3.80 (dd, J=10.4, 6.6, 1H); 3.73 (dd, J=10.4, '\n",
      " '7.0, 1H); 3.06-2.90 (m, 2H); 2.82 (s, 3H); 2.72 (s, 3H); 0.88 (m, 1H); 0.57 '\n",
      " '(m, 2H); 0.33 (m, 2H); 0.04 (m, 2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0324\" level=\"1\">Example D.d1</heading>\\n'\n",
      " '<heading id=\"h-0325\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0748\" '\n",
      " 'num=\"2552\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid from example D.c1 (3.98 g; 8.0 mmol), triethylamine (2.43 g; 24.0 mmol) '\n",
      " 'and HOBt (1.08 g; 8.0 mmol) is stirred in dry dichloromethane (40 mL) for 30 '\n",
      " 'min, before addition of EDC (1.84 g; 9.6 mmol). The reaction mixture is '\n",
      " 'stirred for one hour at ambient temperature. After addition of tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate hydrochloride (2.27 g; 9.6 mmol) the '\n",
      " 'reaction mixture is stirred at ambient temperature until the starting '\n",
      " 'material is consumed according to LC-MS and chromatographed on silica gel '\n",
      " '(ethylacetate/cyclohexane&#x2014;1:1) to yield the title compound as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0749\" num=\"2553\">MS (ESI): m/z=680 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0750\" num=\"2554\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.02 (d, J=7.2, 1H, &#x2014;NH); 9.01 (s, 1H); 7.01 (d, J=8.4, 1H); 6.57 (d, '\n",
      " 'J=8.4, 1H); 6.07 (s, 1H); 5.92 (s, 1H); 5.39 (d, J=11.0, 1H); 5.12 (d, '\n",
      " 'J=11.0, 1H); 4.06 (m, 1H); 3.85 (m, 2H); 3.76 (dd, J=10.2, 6.5, 1H); 3.68 '\n",
      " '(dd, J=10.2, 6.9, 1H); 3.13-2.94 (m, 4H); 2.91 (s, 3H); 1.93 (m, 2H); 1.46 '\n",
      " '(m, 2H); 1.42 (s, 9H); 0.86 (m, 1H); 0.61 (m, 2H); 0.29 (m, 2H); 0.01 (m, '\n",
      " '2H); &#x2212;0.13 (s, 9H).</p>\\n'\n",
      " '<p id=\"p-0751\" num=\"2555\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in above example D.d1.</p>\\n'\n",
      " '<heading id=\"h-0326\" level=\"1\">Example D.d2</heading>\\n'\n",
      " '<heading id=\"h-0327\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0752\" num=\"2556\">Starting from '\n",
      " '4-[5-(yyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c1) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil. The compound is further processed without '\n",
      " 'characterisation.</p>\\n'\n",
      " '<heading id=\"h-0328\" level=\"1\">Example D.d3</heading>\\n'\n",
      " '<heading id=\"h-0329\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0753\" num=\"2557\">Starting from '\n",
      " '4-[5-(yyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c1) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil. The compound is further processed without '\n",
      " 'characterisation.</p>\\n'\n",
      " '<heading id=\"h-0330\" level=\"1\">Example D.d4</heading>\\n'\n",
      " '<heading id=\"h-0331\" '\n",
      " 'level=\"1\">tert-Butyl(3R)-3-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0754\" num=\"2558\">Starting from '\n",
      " '4-[5-(yyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c1) and commercially available '\n",
      " 'tert-butyl(R)-3-amino-pyrrolidine-1-carboxylate the title compound is '\n",
      " 'obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0755\" num=\"2559\">MS (ESI): m/z=666 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0756\" num=\"2560\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.13 (d, J=6.8, 1H, &#x2014;NH); 8.99 (s, 1H); 7.01 (d, J=8.6, 1H); 6.57 (d, '\n",
      " 'J=8.6, 1H); 6.02 (d, J=0.6, 1H); 5.92 (d, J=0.6, 1H); 5.40 (d, J=10.9, 1H); '\n",
      " '5.12 (d, J=10.9, 1H); 4.50 (m, 1H); 3.76 (dd, J=10.2, 6.6, 1H); 3.67 (dd, '\n",
      " 'J=10.2, 6.9, 1H); 3.61 (m, 1H); 3.43 (m, 2H); 3.25 (m, 1H); 3.00 (m, 2H); '\n",
      " '2.91 (s, 3H); 2.22 (m, 1H); 1.96 (m, 1H); 1.41 (s, 9H); 0.86 (m, 1H); 0.61 '\n",
      " '(m, 2H); 0.29 (m, 2H); 0.01 (m, 2H); &#x2212;0.14 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0332\" level=\"1\">Example D.d5</heading>\\n'\n",
      " '<heading id=\"h-0333\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-3-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0757\" num=\"2561\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c1) and commercially available '\n",
      " 'tert-butyl(3R*,4R*)-3-amino-4-hydroxy-pyrrolidine-1-carboxylate the title '\n",
      " 'compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0758\" num=\"2562\">MS (ESI): m/z=682 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0759\" num=\"2563\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.06 (br.s, 1H, &#x2014;NH); 8.97 (s, 1H); 7.02 (d, J=8.6, 1H); 6.57 (d, '\n",
      " 'J=8.6, 1H); 6.02 (s, 1H); 5.92 (s, 1H); 5.48 (d, J=3.8, 1H, &#x2014;OH); '\n",
      " '5.40 (d, J=11.0, 1H); 5.12 (d, J=11.0, 1H); 4.24 (m, 2H); 3.76 (dd, J=10.2, '\n",
      " '6.6, 1H); 3.67 (dd, J=10.2, 6.9, 1H &#x26; m, 1H); 3.56 (m, 1H); 3.23 (m, '\n",
      " '2H); 3.09-2.92 (m, 2H); 2.91 (s, 3H); 1.43 (s, 9H); 0.86 (m, 1H); 0.61 (m, '\n",
      " '2H); 0.29 (m, 2H); 0.01 (m, 2H); &#x2212;0.13 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0334\" level=\"1\">Example D.d6</heading>\\n'\n",
      " '<heading id=\"h-0335\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0760\" num=\"2564\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c2) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0761\" num=\"2565\">MS (ESI): m/z=654 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0762\" num=\"2566\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.07 (d, J=7.7, 1H, &#x2014;NH); 8.99 (s, 1H); 7.49 (dd, J=8.4, 6.8, 1H); '\n",
      " '7.10 (dd, J=11.3, 2.4, 1H); 6.97 (ddd, J=8.4, 8.4, 2.4, 1H); 5.41 (d, '\n",
      " 'J=11.1, 1H); 4.98 (d, J=11.1, 1H); 4.08 (m, 1H); 3.90 (dd, J=10.2, 6.6, 1H); '\n",
      " '3.81 (dd, J=10.2, 7.1, 1H); 3.92-3.78 (m, 2H); 3.06 (m, 2H); 2.92 (m, 2H); '\n",
      " '2.91 (s, 3H); 1.93 (m, 2H); 1.45 (m, 2H); 1.42 (s, 9H); 0.91 (m, 1H); 0.54 '\n",
      " '(dd, J=9.1, 7.3, 2H); 0.34 (m, 2H): 0.08 (m, 2H); &#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0336\" level=\"1\">Example D.d7</heading>\\n'\n",
      " '<heading id=\"h-0337\" '\n",
      " 'level=\"1\">Tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0763\" num=\"2567\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c2) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0764\" num=\"2568\">MS (ESI): m/z=668 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0765\" num=\"2569\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.99 (s, 1H); 8.90 (d, J=7.7, 1H, &#x2014;NH); 7.49 (dd, 8.4, 6.9, 1H); 7.10 '\n",
      " '(dd, 11.3, 2.2, 1H); 6.97 (ddd, 8.4, 8.4, 2.2, 1H); 6.72 (d, J=7.9, 1H, '\n",
      " '&#x2014;NH); 5.40 (d, J=11.1, 1H); 4.98 (d, J=11.1, 1H); 3.90 (dd, J=10.2, '\n",
      " '6.6, 1H); 3.80 (dd, J=10.2, 7.1, 1H); 3.79 (m, 1H); 3.29 (m, 1H); 2.92 (m, '\n",
      " '2H); 2.90 (s, 3H); 2.00 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.36 (m, 4H); '\n",
      " '0.91 (m, 1H); 0.54 (m, 2H); 0.33 (m, 2H); 0.07 (m, 2H); &#x2212;0.16 (s '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0338\" level=\"1\">Example D.d8</heading>\\n'\n",
      " '<heading id=\"h-0339\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0766\" num=\"2570\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c2) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0767\" num=\"2571\">MS (ESI): m/z=668 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0768\" num=\"2572\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.29 (d, J=7.7, 1H, &#x2014;NH); 9.04 (s, 1H); 7.50 (dd, 8.4, 6.7, 1H); 7.12 '\n",
      " '(dd, 11.5, 2.4, 1H); 6.97 (ddd, 8.4, 8.4, 2.4, 1H &#x26; br.s, 1H, '\n",
      " '&#x2014;NH); 5.42 (d, J=10.9, 1H); 4.98 (d, J=10.9, 1H); 4.07 (m, 1H); 3.85 '\n",
      " '(dd, J=10.4, 6.6, 1H); 3.80 (dd, J=10.4, 7.1, 1H); 3.42 (m, 1H); 2.91 (m, 2H '\n",
      " '&#x26; s, 3H); 1.88-1.48 (m, 8H); 1.40 (s, 9H); 0.92 (m, 1H); 0.54 (dd, '\n",
      " 'J=9.1, 7.1, 2H); 0.35 (m, 2H); 0.09 (m, 2H); &#x2212;0.16 (s 9H).</p>\\n'\n",
      " '<heading id=\"h-0340\" level=\"1\">Example D.d9</heading>\\n'\n",
      " '<heading id=\"h-0341\" '\n",
      " 'level=\"1\">Tert-butyl(3R)-3-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0769\" num=\"2573\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c2) and commercially available '\n",
      " 'tert-butyl(R)-3-amino-pyrrolidine-1-carboxylate the title compound is '\n",
      " 'obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0770\" num=\"2574\">MS (ESI): m/z=640 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0771\" num=\"2575\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.17 (d, J=6.7, 1H, &#x2014;NH); 8.98 (s, 1H); 7.50 (dd, J=8.4, 6.9, 1H); '\n",
      " '7.10 (dd, J=11.3, 2.4, 1H); 6.97 (ddd, J=8.4, 8.4, 2.4, 1H); 5.42 (d, '\n",
      " 'J=11.0, 1H); 4.99 (d, J=11.0, 1H); 4.50 (m, 1H); 3.90 (dd, J=10.2, 6.4, 1H); '\n",
      " '3.80 (dd, J=10.2, 7.1, 1H); 3.62 (m, 1H); 3.43 (m, 2H); 3.27 (m, 1H); 2.92 '\n",
      " '(m, 2H); 2.91 (s. 3H); 2.22 (m, 1H); 1.96 (m, 1H); 1.41 (s, 9H); 0.91 (m, '\n",
      " '1H); 0.54 (dd, J=9.1, 7.3, 2H); 0.33 (m, 2H); 0.07 (m, 2H); &#x2212;0.16 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0342\" level=\"1\">Example D.d10</heading>\\n'\n",
      " '<heading id=\"h-0343\" '\n",
      " 'level=\"1\">tert-Butyl(3r,4r)-3-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0772\" num=\"2576\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c2) and commercially available '\n",
      " 'tert-butyl(3R*,4R*)-3-amino-4-hydroxy-pyrrolidine-1-carboxylate the title '\n",
      " 'compound is obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0773\" num=\"2577\">MS (ESI): m/z=656 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0774\" num=\"2578\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.11 (br.s, 1H, &#x2014;NH); 8.95 (s, 1H); 7.50 (dd, J=8.4, 6.9, 1H); 7.10 '\n",
      " '(dd, J=11.5, 2.4, 1H); 6.97 (ddd, J=8.4, 8.4, 2.4, 1H); 5.48 (d, J=5.5, 1H, '\n",
      " '&#x2014;OH); 5.42 (d, J=11.1, 1H); 4.99 (d, J=11.1, 1H); 4.26 (m, 1H); 4.20 '\n",
      " '(m, 1H); 3.90 (dd, J=10.2, 6.6, 1H); 3.80 (dd, J=10.2, 6.9, 1H); 3.68 (m, '\n",
      " '1H); 3.56 (m, 1H); 3.25 (m, 2H); 2.94 (m, 2H); 2.91 (s, 3H); 1.43 (s, 9H); '\n",
      " '0.90 (m, 1H); 0.54 (m, 2H); 0.34 (m, 2H); 0.08 (m, 2H), &#x2212;0.16 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0344\" level=\"1\">Example D.d11</heading>\\n'\n",
      " '<heading id=\"h-0345\" '\n",
      " 'level=\"1\">tert-Butyl(3S*,4S*)-4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0775\" num=\"2579\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c2) and tert-butyl '\n",
      " '(3R*,4R*)-4-amino-3-hydroxy-piperidine-1-carboxylate (example C2) the title '\n",
      " 'compound is obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0776\" num=\"2580\">MS (ESI): m/z=670 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0777\" num=\"2581\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.11 (d, J=7.5, 1H, &#x2014;NH); 8.99 (s, 1H); 7.50 (dd, J=8.4, 7.1, 1H); '\n",
      " '7.11 (dd, J=11.3, 2.4, 1H); 6.98 (ddd, J=8.4, 8.4, 2.4, 1H); 5.42 (d, '\n",
      " 'J=11.0, 1H); 5.26 (t, J=5.1, 1H, &#x2014;OH); 4.99 (d, J=11.0, 1H); '\n",
      " '3.99-3.75 (m, 5H); 3.45 (m, 1H); 3.27 (m, 1H); 3.06-2.88 (m, 3H); 2.92 (s. '\n",
      " '3H); 2.79 (m, 1H); 2.07 (m, 1H); 1.43 (s, 9H &#x26; m, 1H); 0.92 (m, 1H); '\n",
      " '0.55 (m, 2H); 0.35 (m, 2H); 0.10 (m, 2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0346\" level=\"1\">Example D.d12</heading>\\n'\n",
      " '<heading id=\"h-0347\" '\n",
      " 'level=\"1\">tert-Butyl(4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0778\" num=\"2582\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c3) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0779\" num=\"2583\">MS (ESI): m/z=654 (MH<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0780\" num=\"2584\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.05 (d, J=7.7, 1H, &#x2014;NH); 9.01 (s, 1H); 7.39 (ddd, J=9.1, 8.8, 3.1, '\n",
      " '1H); 7.30 (dd, J=8.6, 3.1, 1H); 7.20 (dd, J=9.1, 4.4, 1H); 5.42 (d, J=11.0, '\n",
      " '1H); 4.99 (d, J=11.0, 1H); 4.08 (m, 1H); 3.84 (dd, J=10.4, 6.6, 1H); 3.83 '\n",
      " '(m, 2H); 3.77 (dd, J=10.4, 7.1, 1H); 3.06 (m, 2H); 2.94 (m, 2H); 2.92 (s, '\n",
      " '3H); 1.93 (m, 2H); 1.45 (m, 2H); 1.42 (s, 9H); 0.88 (m, 1H); 0.55 (m, 2H); '\n",
      " '0.32 (m, 2H); 0.04 (m, 2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0348\" level=\"1\">Example D.d13</heading>\\n'\n",
      " '<heading id=\"h-0349\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0781\" num=\"2585\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c3) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0782\" num=\"2586\">MS (ESI): m/z=668 (MH<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0783\" num=\"2587\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.01 (s, 1H); 8.89 (d, J=7.9, 1H, &#x2014;NH); 7.38 (ddd, J=9.1, 8.4, 3.3, '\n",
      " '1H); 7.30 (dd, J=8.6, 3.3, 1H); 7.20 (dd, J=9.1, 4.4, 1H); 6.73 (d, J=7.1, '\n",
      " '1H, &#x2014;NH); 5.42 (d, J=11.0, 1H); 4.99 (d, J=11.0, 1H); 3.84 (dd, '\n",
      " 'J=10.2, 6.6, 1H); 3.76 (dd, J=10.2, 6.9, 1H &#x26; m, 1H); 3.28 (m, 1H); '\n",
      " '2.93 (m, 2H); 2.91 (s, 3H); 2.01 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.34 '\n",
      " '(m, 4H); 0.88 (m, 1H); 0.55 (m, 2H); 0.31 (m, 2H); 0.04 (m, 2H); '\n",
      " '&#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0350\" level=\"1\">Example D.d14</heading>\\n'\n",
      " '<heading id=\"h-0351\" '\n",
      " 'level=\"1\">tert-Butyl(4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0784\" num=\"2588\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c3) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0785\" num=\"2589\">MS (ESI): m/z=668 (MH<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0786\" num=\"2590\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.26 (d, J=7.9, 1H, &#x2014;NH); 9.05 (s, 1H); 7.39 (ddd, J=9.1, 8.7, 3.1, '\n",
      " '1H); 7.30 (dd, J=8.7, 3.1, 1H); 7.20 (dd, J=9.1, 4.4, 1H); 6.92 (m, 1H, '\n",
      " '&#x2014;NH); 5.42 (d, J=11.1, 1H); 4.99 (d, J=11.1, 1H); 4.07 (m, 1H); 3.85 '\n",
      " '(dd, J=10.4, 6.6, 1H); 3.77 (dd, J=10.4, 7.0, 1H); 3.43 (m, 1H); 2.94 (m, '\n",
      " '2H); 2.92 (s, 3H); 1.85-1.52 (m, 8H); 1.40 (s, 9H); 0.87 (m, 1H); 0.56 (m, '\n",
      " '2H); 0.32 (m, 2H); 0.05 (m, 2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0352\" level=\"1\">Example D.d15</heading>\\n'\n",
      " '<heading id=\"h-0353\" '\n",
      " 'level=\"1\">tert-butyl(3R,4R)-4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0787\" num=\"2591\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c3) and commercially available '\n",
      " 'tert-butyl(R)-3-amino-pyrrolidine-1-carboxylate the title compound is '\n",
      " 'obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0788\" num=\"2592\">MS (ESI): m/z=640 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0789\" num=\"2593\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.16 (d, J=6.8, 1H, &#x2014;NH); 8.99 (s, 1H); 7.39 (ddd, J=9.1, 8.4, 3.3, '\n",
      " '1H); 7.30 (ddd, J=8.6, 3.3, 1.1, 1H); 7.20 (dd, J=9.1, 4.4, 1H); 5.43 (d, '\n",
      " 'J=10.9, 1H); 4.99 (d, J=10.9, 1H); 4.50 (m, 1H); 3.84 (dd, J=10.2, 6.6, 1H); '\n",
      " '3.76 (d, J=10.2, 7.0, 1H); 3.62 (m, 1H); 3.43 (m, 2H); 3.27 (m, 1H); 2.94 '\n",
      " '(m, 2H); 2.92 (s, 3H); 2.21 (m, 1H); 1.96 (m, 1H); 1.42 (s, 9H); 0.88 (m, '\n",
      " '1H); 0.56 (dd, J=9.1, 7.2, 2H); 0.31 (m, 2H); 0.04 (m, 2H); &#x2212;0.16 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0354\" level=\"1\">Example D.d16</heading>\\n'\n",
      " '<heading id=\"h-0355\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0790\" num=\"2594\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c3) and tert-butyl '\n",
      " '(3R*,4R*)-4-amino-3-hydroxy-piperidine-1-carboxylate (example C2) the title '\n",
      " 'compound is obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0791\" num=\"2595\">MS (ESI): m/z=670 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0792\" num=\"2596\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.10 (d, J=7.5, 1H, &#x2014;NH); 9.01 (s, 1H); 7.39 (ddd, J=8.9, 8.9, 3.3, '\n",
      " '1H); 7.30 (ddd, J=8.4, 3.1, 0.7, 1H); 7.20 (dd, J=8.9, 4.4, 1H); 5.43 (d, '\n",
      " 'J=11.1, 1H); 5.24 (dd, J=5.1, 5.1, 1H, &#x2014;OH); 4.99 (d, J=11.1, 1H); '\n",
      " '4.02-3.71 (m, 5H); 3.45 (m, 1H); 3.00-2.88 (m, 3H); 2.92 (s, 3H); 2.78 (m, '\n",
      " '1H); 2.07 (m, 1H); 1.42 (s, 9H &#x26; m, 1H); 0.89 (m, 1H); 0.56 (m, 2H); '\n",
      " '0.32 (m, 2H); 0.06 (m, 2H), &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0356\" level=\"1\">Example D.d17</heading>\\n'\n",
      " '<heading id=\"h-0357\" level=\"1\">tert-Butyl '\n",
      " '4-({[4-(2-ethoxy-5-fluorophenyl)-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbonyl}amino)piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0793\" num=\"2597\">Starting from '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c4) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0794\" num=\"2598\">MS (ESI): m/z=628 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0795\" num=\"2599\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.05 (d, J=7.5, 1H, &#x2014;NH); 9.00 (s, 1H); 7.40 '\n",
      " '(ddd, J=9.1, 8.9, 3.3, 1H); 7.30 (dd, J=8.6, 3.3, 1H); 7.21 (dd, J=9.1, 4.4, '\n",
      " '1H); 5.41 (d, J=11.0, 1H); 4.98 (d, J=11.0, 1H); 4.08 (m, 1H); 3.99 (qu, '\n",
      " 'J=7.1, 2H); 3.85 (m, 2H); 3.06 (m, 2H); 2.94 (m, 2H); 2.91 (s, 3H); 1.93 (m, '\n",
      " '2H); 1.42 (s, 9H &#x26;m, 2H); 1.02 (t, J=7.1, 3H); 0.56 (m, 2H); '\n",
      " '&#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0358\" level=\"1\">Example D.d18</heading>\\n'\n",
      " '<heading id=\"h-0359\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0796\" num=\"2600\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c5) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0797\" num=\"2601\">MS (ESI): m/z=666 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0798\" num=\"2602\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.09 (d, J=7.5, 1H, &#x2014;NH); 8.96 (s, 1H); 7.41 (d, J=8.4, 1H); 6.73 '\n",
      " '(dd, J=8.4, 2.2, 2H); 6.70 (d, J=2.2, 1H); 5.46 (d, J=10.9, 1H); 5.05 (d, '\n",
      " 'J=10.9, 1H); 4.06 (m, 1H); 3.87 (dd, J=10.2, 6.6, 1H); 3.85 (s, 3H); 3.83 '\n",
      " '(m, 2H); 3.78 (dd, J=10.2, 7.1, 1H); 3.08 (m, 2H); 2.91 (s, 3H &#x26; m, '\n",
      " '2H); 1.93 (m, 2H); 1.45 (m, 2H); 1.42 (s, 9H); 0.89 (m, 1H); 0.51 (m, 2H); '\n",
      " '0.33 (m, 2H); 0.07 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0360\" level=\"1\">Example D.d19</heading>\\n'\n",
      " '<heading id=\"h-0361\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0799\" num=\"2603\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c5) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0800\" num=\"2604\">MS (ESI): m/z=680 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0801\" num=\"2605\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.96 (s, 1H); 8.93 (d, J=7.9, 1H, &#x2014;NH); 7.41 (d, J=8.4, 1H); 6.73 '\n",
      " '(dd, J=8.4, 2.2, 2H); 6.70 (d, J=2.2, 1H &#x26; br.s, 1H, &#x2014;NH); 5.46 '\n",
      " '(d, J=11.1, 1H); 5.05 (d, J=11.1, 1H); 3.87 (dd, J=10.2, 6.4, 1H); 3.85 (s, '\n",
      " '3H); 3.77 (dd, J=10.2, 7.0, 1H &#x26; m, 1H); 3.28 (m, 1H); 2.90 (s, 3H '\n",
      " '&#x26; m, 2H); 2.00 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.36 (m, 4H); 0.89 '\n",
      " '(m, 1H); 0.51 (m, 2H); 0.33 (m, 2H); 0.07 (m, 2H); &#x2212;0.18 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0362\" level=\"1\">Example D.d20</heading>\\n'\n",
      " '<heading id=\"h-0363\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0802\" num=\"2606\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c5) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0803\" num=\"2607\">MS (ESI): m/z=680 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0804\" num=\"2608\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.29 (d, J=7.7, 1H, &#x2014;NH); 9.01 (s, 1H); 7.41 (d, J=8.4, 1H); 6.92 '\n",
      " '(br.s, 1H, &#x2014;NH); 6.73 (dd, J=8.4, 2.2, 2H); 6.70 (d, J=2.2, 1H); 5.46 '\n",
      " '(d, J=10.9, 1H); 5.06 (d, J=10.9, 1H); 4.07 (m, 1H); 3.88 (dd, J=10.2, 6.6, '\n",
      " '1H); 3.85 (s, 3H); 3.78 (dd, J=10.2, 7.1, 1H); 3.43 (m, 1H); 2.91 (s, 3H '\n",
      " '&#x26; m, 2H); 1.86-1.53 (m, 8H); 1.40 (s, 9H); 0.90 (m, 1H); 0.51 (m, 2H); '\n",
      " '0.34 (m, 2H); 0.08 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0364\" level=\"1\">Example D.d21</heading>\\n'\n",
      " '<heading id=\"h-0365\" '\n",
      " 'level=\"1\">tert-Butyl(3R)-3-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0805\" num=\"2609\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c5) and commercially available '\n",
      " 'tert-butyl(R)-3-amino-pyrrolidine-1-carboxylate the title compound is '\n",
      " 'obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-0806\" num=\"2610\">MS (ESI): m/z=652 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0807\" num=\"2611\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.20 (d, J=6.8, 1H, &#x2014;NH); 8.95 (s, 1H); 7.41 (d, J=8.4, 1H); 6.73 '\n",
      " '(dd, J=8.4, 2.2, 2H); 6.69 (d, J=2.2, 1H); 5.47 (d, J=11.1, 1H); 5.06 (d, '\n",
      " 'J=11.1, 1H); 4.50 (m, 1H); 3.87 (dd, J=10.2, 6.6, 1H); 3.85 (s, 3H); 3.78 '\n",
      " '(dd, J=10.2, 7.1, 1H); 3.62 (m, 1H); 3.43 (m, 2H); 3.25 (m, 1H); 2.91 (s, 3H '\n",
      " '&#x26; m, 2H); 2.22 (m, 1H); 1.96 (m, 1H); 1.41 (s, 9H); 0.88 (m, 1H); 0.51 '\n",
      " '(m, 2H); 0.33 (m, 2H); 0.07 (m, 2H); &#x2014;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0366\" level=\"1\">Example D.d22</heading>\\n'\n",
      " '<heading id=\"h-0367\" '\n",
      " 'level=\"1\">tert-Butyl(3R,4R)-3-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0808\" num=\"2612\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c5) and commercially available '\n",
      " 'tert-butyl(3R*,4R*)-3-amino-4-hydroxy-pyrrolidine-1-carboxylate the title '\n",
      " 'compound is obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-0809\" num=\"2613\">MS (ESI): m/z=668 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0810\" num=\"2614\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.13 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 7.41 (d, J=8.4, 1H); 6.73 (dd, '\n",
      " 'J=8.4, 2.2, 2H); 6.70 (d, J=2.2, 1H); 5.48 (d, J=6.2, 1H); 5.47 (d, J=11.0, '\n",
      " '1H); 5.06 (d, J=11.0, 1H); 4.26 (m, 1H); 4.20 (m, 1H); 3.87 (dd, J=10.4, '\n",
      " '6.6, 1H); 3.85 (s, 3H); 3.77 (dd, J=10.4, 7.3, 1H); 3.68 (m, 1H); 3.55 (m, '\n",
      " '1H); 3.24 (m, 2H); 2.91 (s, 3H &#x26; m, 2H); 1.43 (s, 9H); 0.89 (m, 1H); '\n",
      " '0.51 (m, 2H); 0.33 (m, 2H); 0.07 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0368\" level=\"1\">Example D.d23</heading>\\n'\n",
      " '<heading id=\"h-0369\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0811\" num=\"2615\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c6) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0812\" num=\"2616\">MS (ESI): m/z=666 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0813\" num=\"2617\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.07 (d, J=7.7, 1H, &#x2014;NH); 9.00 (s, 1H); 7.11 (d, J=1.6, 2H); 7.02 (t, '\n",
      " 'J=1.6, 1H); 5.42 (d, J=10.9, 1H); 5.04 (d, J=10.9, 1H); 4.08 (m, 1H); 3.85 '\n",
      " '(m, 2H); 3.77 (dd, J=10.2, 6.6, 1H); 3.76 (s, 3H); 3.70 (dd, J=10.2, 6.9, '\n",
      " '1H); 3.06 (m, 2H); 2.91 (s, 3H &#x26; m, 2H); 1.93 (m, 2H); 1.46 (m, 2H); '\n",
      " '1.42 (s, 9H); 0.86 (m, 1H); 0.53 (m, 2H); 0.30 (m, 2H); 0.01 (m, 2H); '\n",
      " '&#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0370\" level=\"1\">Example D.d24</heading>\\n'\n",
      " '<heading id=\"h-0371\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0814\" num=\"2618\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c6) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-0815\" num=\"2619\">MS (ESI): m/z=680 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0816\" num=\"2620\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.00 (s, 1H); 8.91 (d, J=7.7, 1H, &#x2014;NH); 7.11 (d, J=1.6, 2H); 7.02 (t, '\n",
      " 'J=1.6, 1H); 6.72 (d, J=7.5, 1H, &#x2014;NH); 5.41 (d, J=11.0, 1H); 5.03 (d, '\n",
      " 'J=11.0, 1H); 3.77 (dd, J=10.2, 6.6, 1H); 3.76 (s, 3H &#x26; m, 1H); 3.70 '\n",
      " '(dd, J=10.2, 6.9, 1H); 3.29 (m, 1H); 2.90 (s, 3H &#x26; m, 2H); 2.01 (m, '\n",
      " '2H); 1.86 (m, 2H); 1.39 (s, 9H); 1.34 (m, 4H); 0.85 (m, 1H); 0.53 (m, 2H); '\n",
      " '0.24 (m, 2H); 0.01 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0372\" level=\"1\">Example D.d25</heading>\\n'\n",
      " '<heading id=\"h-0373\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0817\" num=\"2621\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c6) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0818\" num=\"2622\">MS (ESI): m/z=680 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0819\" num=\"2623\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.27 (d, J=7.7, 1H, &#x2014;NH); 9.04 (s, 1H); 7.11 (d, J=1.6, 2H); 7.02 (t, '\n",
      " 'J=1.6, 1H); 6.92 (&#x2dc;br. d, 1H, &#x2014;NH); 5.41 (d, J=11.0, 1H); 5.03 '\n",
      " '(d, J=11.0, 1H); 4.07 (m, 2H); 3.78 (dd, J=10.2, 6.6, 1H); 3.76 (s, 3H); '\n",
      " '3.71 (dd, J=10.2, 6.9, 1H); 3.43 (m, 1H); 2.91 (s, 3H &#x26; m, 2H); '\n",
      " '1.85-1.52 (m, 8H); 1.40 (s, 9H); 0.86 (m, 1H); 0.54 (m, 2H); 0.31 (m, 2H); '\n",
      " '0.02 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0374\" level=\"1\">Example D.d26</heading>\\n'\n",
      " '<heading id=\"h-0375\" '\n",
      " 'level=\"1\">tert-butyl(3R)-3-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0820\" num=\"2624\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c6) and commercially available '\n",
      " 'tert-butyl(R)-3-amino-pyrrolidine-1-carboxylate the title compound is '\n",
      " 'obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-0821\" num=\"2625\">MS (ESI): m/z=652 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0822\" num=\"2626\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.18 (d, J=6.8, 1H, &#x2014;NH); 8.98 (s, 1H); 7.11 (d, J=1.8, 2H); 7.02 (t, '\n",
      " 'J=1.8, 1H); 5.43 (d, J=10.9, 1H); 5.03 (d, J=10.9, 1H); 4.50 (m, 1H); 3.76 '\n",
      " '(dd, J=10.4, 6.6, 1H &#x26; s, 3H); 3.70 (dd, J=10.4, 6.9, 1H); 3.62 (m, '\n",
      " '1H); 3.43 (m, 2H); 3.26 (m, 1H); 2.91 (s, 3H &#x26; m, 2H); 2.21 (m, 1H); '\n",
      " '1.96 (m, 1H); 1.41 (s, 9H); 0.85 (m, 1H); 0.53 (m, 2H); 0.29 (m, 2H); 0.01 '\n",
      " '(m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0376\" level=\"1\">Example D.d27</heading>\\n'\n",
      " '<heading id=\"h-0377\" '\n",
      " 'level=\"1\">tert-Butyl(3R,4R)-4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0823\" num=\"2627\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c6) and: '\n",
      " 'tert-butyl(3R*,4R*)-4-amino-3-hydroxy-piperidine-1-carboxylate (Example C2) '\n",
      " 'the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0824\" num=\"2628\">MS (ESI): m/z=682 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0825\" num=\"2629\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.11 (d, J=7.3, 1H, &#x2014;NH); 8.99 (s, 1H); 7.11 (d, J=1.6, 2H); 7.02 (t, '\n",
      " 'J=1.6, 1H); 5.43 (d, J=10.9, 1H); 5.24 (t, J=4.9, 1H, &#x2014;OH); 5.04 (d, '\n",
      " 'J=10.9, 1H); 3.99-3.66 (m, 5H); 3.76 (s, 3H); 3.45 (m, 1H); 2.91 (s, 3H '\n",
      " '&#x26; m, 1H); 2.79 (m, 1H); 2.07 (m, 1H); 1.42 (s, 9H &#x26; m, 1H); 0.86 '\n",
      " '(m, 1H); 0.53 (m, 2H); 0.30 (m, 2H); 0.02 (m, 2H); &#x2212;0.17 (s, '\n",
      " '9H).</p>\\n'\n",
      " '<heading id=\"h-0378\" level=\"1\">Example D.d28</heading>\\n'\n",
      " '<heading id=\"h-0379\" level=\"1\">Tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0826\" num=\"2630\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c7) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0827\" num=\"2631\">MS (ESI): m/z=650 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0828\" num=\"2632\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.08 (d, J=7.7, 1H, &#x2014;NH); 8.98 (s, 1H); 7.34 (dd, J=8.4, 2.0, 1H); '\n",
      " '7.26 (d, J=2.0, 1H); 7.07 (d, J=8.4, 1H); 5.43 (d, J=11.0, 1H); 5.02 (d, '\n",
      " 'J=11.0, 1H); 4.08 (m, 1H); 3.87 (m, 2H); 3.82 (dd, J=10.4, 6.6, 1H); 3.75 '\n",
      " '(dd, J=10.4, 7.0, 1H); 3.06 (m, 2H); 2.93-2.86 (m, 2H); 2.90 (s, 3H); 2.32 '\n",
      " '(s, 3H); 1.93 (m, 2H); 1.46 (m, 2H); 1.43 (s, 9H); 0.88 (m, 1H); 0.52 (m, '\n",
      " '2H); 0.31 (m, 2H); 0.05 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0380\" level=\"1\">Example D.d29</heading>\\n'\n",
      " '<heading id=\"h-0381\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0829\" num=\"2633\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c7) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-0830\" num=\"2634\">MS (ESI): m/z=664 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0831\" num=\"2635\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '<sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): 8.98 (s, 1H); 8.92 (d, '\n",
      " 'J=7.7, 1H, &#x2014;NH); 7.34 (dd, J=8.4, 2.0, 1H); 7.27 (d, J=2.0, 1H); 7.07 '\n",
      " '(d, J=8.4, 1H); 6.72 (d, J=6.6, 1H, &#x2014;NH); 5.42 (d, J=11.0, 1H); 5.02 '\n",
      " '(d, J=11.0, 1H); 3.81 (dd, J=10.3, 6.5, 1H); 3.78 (m, 1H); 3.74 (dd, J=10.2, '\n",
      " '7.0, 1H); 3.28 (m, 1H); 2.90 (s, 3H); 2.88 (m, 2H); 2.32 (s, 3H); 2.00 (m, '\n",
      " '2H); 1.86 (m, 2H); 1.39 (s, 9H); 1.36 (m, 4H); 0.88 (m, 1H); 0.51 (m, 2H); '\n",
      " '0.31 (m, 2H); 0.04 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0382\" level=\"1\">Example D.d30</heading>\\n'\n",
      " '<heading id=\"h-0383\" '\n",
      " 'level=\"1\">Tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0832\" num=\"2636\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c7) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0833\" num=\"2637\">MS (ESI): m/z=664 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0834\" num=\"2638\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.31 (d, J=7.7, 1H, &#x2014;NH); 9.03 (s, 1H); 7.34 (dd, J=8.4, 2.0, 1H); '\n",
      " '7.27 (d, J=2.0, 1H); 7.07 (d, J=8.4, 1H); 6.89 (br.s, 1H, &#x2014;NH); 5.42 '\n",
      " '(d, J=11.0, 1H); 5.04 (d, J=11.0, 1H); 4.09 (m, 1H); 3.83 (dd, J=10.2, 6.6, '\n",
      " '1H); 3.75 (dd, J=10.2, 6.9, 1H); 3.44 (m, 1H); 2.91 (s, 3H); 2.90 (m, 2H); '\n",
      " '2.33 (s, 3H); 1.86-1.55 (m, 8H); 1.41 (s, 9H); 0.90 (m, 1H); 0.53 (m, 2H); '\n",
      " '0.33 (m, 2H); 0.06 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0384\" level=\"1\">Example D.d31</heading>\\n'\n",
      " '<heading id=\"h-0385\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0835\" num=\"2639\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c8) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0836\" num=\"2640\">MS (ESI): m/z=704 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0837\" num=\"2641\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.05 (d, J=7.6, 1H, &#x2014;NH); 9.03 (s, 1H); 7.91 (dd, J=8.8, 2.1, 1H); '\n",
      " '7.77 (d, J=2.1, 1H); 7.39 (d, J=8.8, 1H); 5.40 (d, J=11.0, 1H); 4.95 (d, '\n",
      " 'J=11.0, 1H); 4.08 (m, 1H); 3.98 (dd, J=10.4, 6.6, 1H); 3.91 (dd, J=10.4, '\n",
      " '7.1, 1H); 3.85 (m, 2H); 3.06 (m, 2H); 2.92 (s, 3H &#x26; t, J=8.2, 2H); 1.94 '\n",
      " '(m, 2H); 1.47 (m, 2H); 1.42 (s, 9H); 0.95 (m, 1H); 0.50 (m, 2H); 0.35 (m, '\n",
      " '2H); 0.11 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0386\" level=\"1\">Example D.d32</heading>\\n'\n",
      " '<heading id=\"h-0387\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0838\" num=\"2642\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c8) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0839\" num=\"2643\">MS (ESI): m/z=718 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0840\" num=\"2644\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.03 (s, 1H); 8.89 (d, J=7.7, 1H, &#x2014;NH); 7.90 (dd, J=8.8, 2.1, 1H); '\n",
      " '7.77 (d, J=2.1, 1H); 7.39 (d, J=8.8, 1H); 6.72 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '5.40 (d, J=11.0, 1H); 4.94 (d, J=11.0, 1H); 3.98 (dd, J=10.5, 6.6, 1H); 3.91 '\n",
      " '(dd, J=10.5, 7.1, 1H); 3.78 (m, 1H); 3.29 (m, 1H); 2.91 (s, 3H &#x26; t, '\n",
      " 'J=8.0, 2H); 2.01 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.35 (m, 4H); 0.94 (m, '\n",
      " '1H); 0.50 (m, 2H); 0.35 (m, 2H); 0.11 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0388\" level=\"1\">Example D.d33</heading>\\n'\n",
      " '<heading id=\"h-0389\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0841\" num=\"2645\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c8) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0842\" num=\"2646\">MS (ESI): m/z=718 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0843\" num=\"2647\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.26 (d, J=7.7, 1H, &#x2014;NH); 9.07 (s, 1H); 7.91 (dd, J=8.8, 2.1, 1H); '\n",
      " '7.78 (d, J=2.1, 1H); 7.40 (d, J=8.8, 1H); 6.93 (br.s, 1H, &#x2014;NH); 5.40 '\n",
      " '(d, J=10.9, 1H); 4.94 (d, J=10.9, 1H); 4.08 (m, 1H); 3.99 (dd, J=10.2, 6.7, '\n",
      " '1H); 3.92 (dd, J=10.2, 7.1, 1H); 3.43 (m, 1H); 2.92 (s, 3H &#x26; t, J=8.1, '\n",
      " '2H); 1.86-1.51 (m, 8H); 1.40 (s, 9H); 0.95 (m, 1H); 0.50 (m, 2H); 0.36 (m, '\n",
      " '2H); 0.12 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0390\" level=\"1\">Example D.d34</heading>\\n'\n",
      " '<heading id=\"h-0391\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0844\" num=\"2648\">Starting from '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c9) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0845\" num=\"2649\">MS (ESI): m/z=678 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0846\" num=\"2650\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.08 (d, J=7.7, 1H, &#x2014;NH); 9.05 (s, 1H); 7.96 (dd, J=8.8, 2.2, 1H); '\n",
      " '7.80 (d, J=2.2, 1H); 7.74 (d, J=8.8, 1H); 5.41 (d, J=11.0, 1H); 4.97 (d, '\n",
      " 'J=11.0, 1H); 4.22-4.04 (m, 2H &#x26; m, 1H); 3.88 (m, 2H); 3.09 (m, 2H); '\n",
      " '2.95 (s, 3H &#x26; m, 2H); 1.97 (m, 2H); 1.50 (m, 2H); 1.46 (s, 9H); 1.11 '\n",
      " '(t, J=7.0, 3H); 0.55 (m, 2H); &#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0392\" level=\"1\">Example D.d35</heading>\\n'\n",
      " '<heading id=\"h-0393\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-cyclopropylmethoxy-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0847\" num=\"2651\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c10) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0848\" num=\"2652\">MS (ESI): m/z=684 (MH<sup>+</sup>, 100%); 628 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<p id=\"p-0849\" num=\"2653\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.06 (d, J=7.5, 1H, &#x2014;NH); 9.00 (s, 1H); 7.27 (d, J=9.7, 1H); 7.19 (d, '\n",
      " 'J=13.1, 1H); 5.42 (d, J=10.9, 1H); 5.03 (d, J=10.9, 1H); 4.08 (m, 1H); 3.87 '\n",
      " '(m, 2H); 3.82 (s, 3H); 3.80 (dd, J=10.3, 6.7, 1H); 3.75 (dd, J=10.3, 7.1, '\n",
      " '1H); 3.06 (m, 2H); 3.03-2.88 (m, 2H); 2.91 (s, 3H); 1.93 (m, 2H); 1.46 (m, '\n",
      " '2H); 1.42 (s, 9H); 0.87 (m, 1H); 0.55 (m, 2H); 0.31 (m, 2H); 0.04 (m, 2H); '\n",
      " '&#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0394\" level=\"1\">Example D.d36</heading>\\n'\n",
      " '<heading id=\"h-0395\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0850\" num=\"2654\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c10) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0851\" num=\"2655\">MS (ESI): m/z=698 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0852\" num=\"2656\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.00 (s, 1H); 8.90 (d, J=7.7, 1H); 7.27 (d, J=9.7, 1H); 7.19 (d, J=13.3, '\n",
      " '1H); 6.72 (d, J=7.5, 1H, &#x2014;NH); 5.41 (d, J=10.9, 1H); 5.03 (d, J=10.9, '\n",
      " '1H); 3.82 (s, 3H &#x26; m, 1H); 3.80 (dd, J=10.4, 6.7, 1H); 3.72 (dd, '\n",
      " 'J=10.4, 7.0, 1H); 3.29 (m, 1H); 3.03-2.88 (m, 2H); 2.91 (s, 3H); 2.00 (m, '\n",
      " '2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.36 (m, 4H); 0.86 (m, 1H); 0.55 (m, 2H); '\n",
      " '0.31 (m, 2H); 0.03 (m, 2H); &#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0396\" level=\"1\">Example D.d37</heading>\\n'\n",
      " '<heading id=\"h-0397\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0853\" num=\"2657\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c10) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0854\" num=\"2658\">MS (ESI): m/z=698 (MH<sup>+</sup>, 100%); 642 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<p id=\"p-0855\" num=\"2659\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.26 (d, J=7.8, 1H, &#x2014;NH); 9.04 (s, 1H); 7.27 (d, J=9.5, 1H); 7.19 (d, '\n",
      " 'J=13.3, 1H); 6.91 (br.s, 1H, &#x2014;NH); 5.42 (d, J=10.9, 1H); 5.02 (d, '\n",
      " 'J=10.9, 1H); 4.07 (m, 1H); 3.82 (s, 3H); 3.81 (dd, J=10.2, 6.7, 1H); 3.73 '\n",
      " '(dd, J=10.2, 7.0, 1H); 3.43 (m, 1H); 3.04-2.89 (m, 2H); 2.92 (s, 3H); '\n",
      " '1.87-1.51 (m, 8H); 1.40 (s, 9H); 0.88 (m, 1H); 0.55 (m, 2H); 0.32 (m, 2H); '\n",
      " '0.04 (m, 2H); &#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0398\" level=\"1\">Example D.d38</heading>\\n'\n",
      " '<heading id=\"h-0399\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0856\" num=\"2660\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c10) and '\n",
      " 'tert-butyl(3R*,4R*)-4-amino-3-hydroxy-piperidine-1-carboxylate (example C2) '\n",
      " 'the title compound is obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0857\" num=\"2661\">MS (ESI): m/z=700 (MH<sup>+</sup>, 100%); 644 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<p id=\"p-0858\" num=\"2662\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.12 (d, J=7.3, 1H, &#x2014;NH); 9.01 (s, 1H); 7.28 (dd, J=9.7, 1.4, 1H); '\n",
      " '7.20 (d, J=12.6, 1H); 5.44 (d, J=10.9, 1H); 5.27 (dd, J=4.9, 4.2, 1H, '\n",
      " '&#x2014;OH); 5.02 (d, J=10.9, 1 H); 3.99-3.68 (m, 5H); 3.82 (s, 3H); 3.44 '\n",
      " '(m, 1H); 3.03-2.86 (m, 3H); 2.92 (s, 3H); 2.79 (m, 1H); 2.07 (m, 1H); 1.42 '\n",
      " '(s, 9H &#x26; m, 1H); 0.87 (m, 1H); 0.55 (m, 2H); 0.32 (m, 2H); 0.05 (m, '\n",
      " '2H); &#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0400\" level=\"1\">Example D.d39</heading>\\n'\n",
      " '<heading id=\"h-0401\" '\n",
      " 'level=\"1\">tert-Butyl(3S*,4S*)-3-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0859\" num=\"2663\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c10) and '\n",
      " 'tert-butyl(3S*,4S*)-3-amino-4-hydroxy-piperidine-1-carboxylate (Example C3) '\n",
      " 'the title compound is obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0860\" num=\"2664\">MS (ESI): m/z=700 (MH<sup>+</sup>, 100%); 644 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<heading id=\"h-0402\" level=\"1\">Example D.d40</heading>\\n'\n",
      " '<heading id=\"h-0403\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0861\" num=\"2665\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c11) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0862\" num=\"2666\">MS (ESI): m/z=668 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0863\" num=\"2667\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.07 (d, J=7.7, 1H, &#x2014;NH); 8.98 (s, 1H); 7.38 (d, J=9.3, 1H); 7.06 (d, '\n",
      " 'J=12.1, 1H); 5.43 (d, J=11.0, 1H); 5.01 (d, J=11.0, 1H); 4.08 (m, 1H); 3.86 '\n",
      " '(m, 2H &#x26; dd, J=10.8, 6.6, 1H); 3.77 (dd, J=10.8, 7.1, 1H); 3.06 (m, '\n",
      " '2H); 2.94 (m, 2H); 2.91 (s, 3H); 2.24 (d, J=1.3, 3H); 1.93 (m, 2H); 1.45 (m, '\n",
      " '2H); 1.42 (s, 9H); 0.90 (m, 1H); 0.53 (m, 2H); 0.33 (m, 2H); 0.07 (m, 2H); '\n",
      " '&#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0404\" level=\"1\">Example D.d41</heading>\\n'\n",
      " '<heading id=\"h-0405\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0864\" num=\"2668\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c11) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0865\" num=\"2669\">MS (ESI): m/z=682 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0866\" num=\"2670\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.98 (s, 1H); 8.91 (d, J=7.9, 1H, &#x2014;NH); 7.38 (d, J=8.8, 1H); 7.05 (d, '\n",
      " 'J=11.9, 1H); 6.72 (br. d, J=7.9, 1H, &#x2014;NH); 5.42 (d, J=10.9, 1H); 5.00 '\n",
      " '(d, J=10.9, 1H); 3.86 (dd, J=10.2, 6.6, 1H); 3.76 (m, 1H &#x26; dd, J=10.2, '\n",
      " '7.1, 1H); 3.29 (m, 1H); 2.94 (m, 2H); 2.92 (m, 2H); 2.90 (s, 3H); 2.23 (d, '\n",
      " 'J=1.1, 3H); 2.00 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.34 (m, 4H); 0.89 (m, '\n",
      " '1H); 0.53 (m, 2H); 0.32 (m, 2H); 0.06 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0406\" level=\"1\">Example D.d42</heading>\\n'\n",
      " '<heading id=\"h-0407\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0867\" num=\"2671\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c11) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0868\" num=\"2672\">MS (ESI): m/z=682 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0869\" num=\"2673\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.28 (d, J=7.7, 1H, &#x2014;NH); 9.03 (s, 1H); 7.39 (d, J=8.9, 1H); 7.06 (d, '\n",
      " 'J=11.9, 1H); 6.91 (br.s, 1H, &#x2014;NH); 5.43 (d, J=11.1, 1H); 5.01 (d, '\n",
      " 'J=11.1, 1H); 4.07 (m, 1H); 3.87 (dd, J=10.4, 6.6, 1H); 3.77 (dd, J=10.4, '\n",
      " '7.1, 1H); 3.43 (m, 1H); 2.94 (m, 2H); 2.91 (s, 3H); 2.24 (d, J=1.3, 3H); '\n",
      " '1.86-1.51 (m, 8H); 1.40 (s, 9H); 0.90 (m, 1H); 0.53 (m, 2H); 0.34 (m, 2H); '\n",
      " '0.07 (m, 2H); &#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0408\" level=\"1\">Example D.d43</heading>\\n'\n",
      " '<heading id=\"h-0409\" '\n",
      " 'level=\"1\">tert-Butyl(3R,4R)-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0870\" num=\"2674\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c11) and '\n",
      " 'tert-butyl(3R*,4R*)-4-amino-3-hydroxy-piperidine-1-carboxylate (example C2) '\n",
      " 'the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0871\" num=\"2675\">MS (ESI): m/z=684 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0872\" num=\"2676\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.11 (d, J=7.3, 1H, &#x2014;NH); 8.98 (s, 1H); 7.39 (d, J=8.9, 1H); 7.06 (d, '\n",
      " 'J=11.9, 1H); 5.44 (d, J=11.0, 1H); 5.24 (dd, J=4.9, 3.7, 1H, &#x2014;OH); '\n",
      " '5.02 (d, J=11.0 1 H); 4.00-3.37 (m, 3H); 3.86 (ddd, J=10.4, 7.9, 1.1, 1H); '\n",
      " '3.77 (ddd, J=10.4, 7.1, 2.7, 1H); 3.45 (m, 1H); 2.98 (m, 1H); 2.93 (m, 2H); '\n",
      " '2.92 (s, 3H); 2.79 (m, 1H); 2.24 (s, 3H); 2.07 (m, 1H); 1.42 (s, 9H); 1.38 '\n",
      " '(m, 1H); 0.90 (m, 1H); 0.54 (m, 2H); 0.34 (m, 2H); 0.07 (m, 2H); '\n",
      " '&#x2212;0.16 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0410\" level=\"1\">Example D.d44</heading>\\n'\n",
      " '<heading id=\"h-0411\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0873\" num=\"2677\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c12) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0874\" num=\"2678\">MS (ESI): m/z=684 (MH<sup>+</sup>, 100%); 628 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<p id=\"p-0875\" num=\"2679\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.07 (d, J=7.7, 1H, &#x2014;NH); 8.98 (s, 1H); 7.32 (d, J=11.3, 1H); 6.94 '\n",
      " '(d, J=7.3, 1H); 5.47 (d, J=11.1, 1H); 5.07 (d, J=11.1, 1H); 4.07 (m, 1H); '\n",
      " '3.96 (s, 3H); 3.92-3.79 (m, 4H); 3.06 (m, 2H); 2.95 (m, 2H); 2.92 (s, 3H); '\n",
      " '1.93 (m, 2H); 1.45 (m, 2H); 1.41 (s, 9H); 0.88 (m, 1H); 0.54 (m, 2H); 0.33 '\n",
      " '(m, 2H); 0.06 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0412\" level=\"1\">Example D.d45</heading>\\n'\n",
      " '<heading id=\"h-0413\" '\n",
      " 'level=\"1\">tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0876\" num=\"2680\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c12) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0877\" num=\"2681\">MS (ESI): m/z=698 (MH<sup>+</sup>, 100%); 642 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<p id=\"p-0878\" num=\"2682\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.98 (s, 1H); 8.91 (d, J=7.7, 1H, &#x2014;NH); 7.32 (d, J=11.3, 1H); 6.94 '\n",
      " '(d, J=7.3, 1H); 6.72 (d, J=7.5, 1H, &#x2014;NH); 5.47 (d, J=10.9, 1H); 5.06 '\n",
      " '(d, J=10.9, 1H); 3.96 (s, 3H); 3.89 (dd, J=10.2, 6.6, 1H); 3.81 (dd, J=10.2, '\n",
      " '7.1, 1H); 3.77 (m, 2H); 2.94 (m, 2H); 2.91 (s, 3H); 2.00 (m, 2H); 1.85 (m, '\n",
      " '2H); 1.39 (s, 9H); 1.36 (m, 4H); 0.88 (m, 1H); 0.54 (m, 2H); 0.32 (m, 2H); '\n",
      " '0.05 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0414\" level=\"1\">Example D.d46</heading>\\n'\n",
      " '<heading id=\"h-0415\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0879\" num=\"2683\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c12) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as '\n",
      " 'colorless foam.</p>\\n'\n",
      " '<p id=\"p-0880\" num=\"2684\">MS (ESI): m/z=698 (MH<sup>+</sup>, 100%); 642 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<p id=\"p-0881\" num=\"2685\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.27 (s, 1H, &#x2014;NH); 9.02 (s, 1H); 7.32 (d, J=11.3, 1H); 6.91 (d, '\n",
      " 'J=7.3, 1H); 6.91 (br.s, 1H, &#x2014;NH); 5.47 (d, J=11.1 1H); 5.07 (d, '\n",
      " 'J=11.1, 1H); 4.07 (m, 1H); 3.96 (s, 3H); 3.90 (dd, J=10.3, 6.6, 1H); 3.82 '\n",
      " '(dd, J=10.3, 6.9, 1H); 3.43 (m, 1H); 3.05 (m, 2H); 2.92 (s, 3H); 1.77 (m, '\n",
      " '2H); 1.64 (m, 6H); 1.40 (s, 9H); 0.89 (m, 1H); 0.54 (m, 2H); 0.33 (m, 2H); '\n",
      " '0.07 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0416\" level=\"1\">Example D.d47</heading>\\n'\n",
      " '<heading id=\"h-0417\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0882\" num=\"2686\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c12) and '\n",
      " 'tert-butyl(3R*,4R*)-4-amino-3-hydroxy-piperidine-1-carboxylate (Example C2) '\n",
      " 'the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0883\" num=\"2687\">MS (ESI): m/z=700 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0884\" num=\"2688\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.12 (d, J=7.7, 1H, &#x2014;NH); [8.98 (s), 8.96 (s), 1H)]; 7.34 (d, J=11.5, '\n",
      " '1 H); 6.94 (d, J=7.3, 1H); [5.50 (d, J=11.0), 5.49 (d, J=11.0), 1H)]; 5.27 '\n",
      " '(t, J=4.9, 1H, &#x2014;OH); 5.07 (d, J=11.0, 1H); 3.96 (s, 3H); 3.95-3.75 '\n",
      " '(m, 5H); 3.44 (m, 1H); 2.93 (s, 3H &#x26; m, 3H); 2.79 (m, 1H); 2.07 (m, '\n",
      " '1H); 1.42 (s, 9H &#x26; m, 1H); 0.88 (m, 1H); 0.54 (m, 2H); 0.33 (m, 2H); '\n",
      " '0.06 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0418\" level=\"1\">Example D.d48</heading>\\n'\n",
      " '<heading id=\"h-0419\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0885\" num=\"2689\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c14) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0886\" num=\"2690\">MS (ESI): m/z=664 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0887\" num=\"2691\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.08 (d, J=7.5, 1H, &#x2014;NH); 8.99 (s, 1H); 7.37 (dd, J=8.6, 2.2, 1H); '\n",
      " '7.29 (d, J=2.2, 1H); 7.08 (d, J=8.6, 1H); 5.42 (d, J=11.1, 1H); 5.03 (d, '\n",
      " 'J=11.1, 1H); 4.08 (m, 1H); 3.87 (m, 2H); 3.82 (dd, J=10.2, 6.6, 1H); 3.75 '\n",
      " '(dd, J=10.2, 6.9. 1H); 3.06 (m, 2H); 2.94-2.82 (m, 2H); 2.91 (s, 3H); 2.63 '\n",
      " '(qu, J=7.6, 2H); 1.94 (m, 2H); 1.46 (m, 2H); 1.40 (s, 9H); 1.20 (t, J=7.6, '\n",
      " '3H); 0.89 (m, 1H); 0.51 (m, 2H); 0.32 (m, 2H); 0.05 (m, 2H); &#x2212;0.19 '\n",
      " '(s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0420\" level=\"1\">Example D.d49</heading>\\n'\n",
      " '<heading id=\"h-0421\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0888\" num=\"2692\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c14) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0889\" num=\"2693\">MS (ESI): m/z=678 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0890\" num=\"2694\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.99 (s, 1H); 8.92 (d, J=7.3, 1H, &#x2014;NH); 7.37 (dd, J=8.6, 2.2, 1H); '\n",
      " '7.29 (d, J=2.2, 1H); 7.08 (d, J=8.6, 1H); 6.72 (d, J=8.1, 1H, &#x2014;NH); '\n",
      " '5.42 (d, J=10.9, 1H); 5.02 (d, J=10.9, 1H); 3.82 (dd, J=10.2, 6.6, 1H); 3.74 '\n",
      " '(dd, J=10.2, 6.9. 1H &#x26; m, 1H); 3.27 (m, 1H); 2.90 (s, 3H); 2.88 (t, '\n",
      " 'J=8.2, 2H); 2.63 (qu, J=7.5, 2H); 2.00 (m, 2H); 1.85 (m, 2H); 1.40 (s, 9H); '\n",
      " '1.37 (m, 4H); 1.20 (t, J=7.6, 3H); 0.88 (m, 1H); 0.50 (m, 2H); 0.31 (m, 2H); '\n",
      " '0.04 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0422\" level=\"1\">Example D.d50</heading>\\n'\n",
      " '<heading id=\"h-0423\" '\n",
      " 'level=\"1\">tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0891\" num=\"2695\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c14) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-0892\" num=\"2696\">MS (ESI): m/z=678 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0893\" num=\"2697\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '<sup>1</sup>H9.28 (d, J=7.9, 1H, &#x2014;NH); 9.03 (s, 1H); 7.35 (dd, J=8.6, '\n",
      " '2.2, 1H); 7.30 (d, J=2.2, 1H); 7.09 (d, J=8.6, 1H); 6.92 (br. d, '\n",
      " 'J&#x2dc;7.2, 1H, &#x2014;NH); 5.42 (d, J=11.1, 1H); 5.03 (d, J=11.1, 1H); '\n",
      " '4.07 (m, 1H); 3.83 (dd, J=10.2, 6.4, 1H); 3.75 (dd, J=10.2, 6.9. 1H &#x26; '\n",
      " 'm, 1H); 3.43 (m, 1H); 2.91 (s, 3H); 2.89 (m, 2H); 2.64 (qu, J=7.5, 2H); '\n",
      " '1.86-1.51 (m, 8H); 1.40 (s, 9H); 1.20 (t, J=7.5, 3H); 0.90 (m, 1H); 0.51 (m, '\n",
      " '2H); 0.33 (m, 2H); 0.06 (m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0424\" level=\"1\">Example D.d51</heading>\\n'\n",
      " '<heading id=\"h-0425\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-3-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0894\" num=\"2698\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c14) and commercially available tert-butyl '\n",
      " '(3R*,4R*)-3-amino-4-hydroxy-pyrrolidine-1-carboxylate the title compound is '\n",
      " 'obtained as pale yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0895\" num=\"2699\">MS (ESI): m/z=666 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0896\" num=\"2700\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.13 (br.s, 1H, &#x2014;NH); 8.95 (s, 1H); 7.37 (dd, J=8.6, 2.4, 1H); 7.29 '\n",
      " '(d, J=2.4, 1H); 7.09 (d, J=8.6, 1H); 5.48 (d, J=3.8, 1H, &#x2014;OH); 5.43 '\n",
      " '(d, J=10.9, 1H); 5.03 (d, J=10.9, 1H); 4.27 (m, 1H); 4.21 (m, 1H); 3.83 (d, '\n",
      " 'J=10.2, 6.6, 1H); 3.74 (ddd, J=10.2, 7.1, 0.9, 1H); 3.69 (m, 1H); 3.56 (m, '\n",
      " '1H); 3.24 (m, 2H); 2.91 (s, 3H); 2.88 (m, 2H); 2.63 (qu, J=7.5, 2H); 1.40 '\n",
      " '(s, 9H); 1.20 (t, J=7.5, 3H); 0.87 (m, 1H); 0.50 (m, 2H); 0.32 (m, 2H); 0.05 '\n",
      " '(m, 2H); &#x2212;0.18 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0426\" level=\"1\">Example D.d52</heading>\\n'\n",
      " '<heading id=\"h-0427\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0897\" num=\"2701\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c15) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0898\" num=\"2702\">MS (ESI): m/z=678 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0899\" num=\"2703\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.08 (d, J=7.7, 1H, &#x2014;NH); 8.99 (s, 1H); 7.40 (dd, J=8.6, 2.2, 1H); '\n",
      " '7.32 (d, J=2.2, 1H); 7.09 (d; J=8.6, 1H); 5.42 (d, J=10.9, 1H); 5.04 (d, '\n",
      " 'J=10.9, 1H); 4.08 (m, 1H); 3.90-3.79 (m, 3H); 3.75 (dd, J=10.2, 6.9, 1H); '\n",
      " '3.06 (m, 2H); 2.98-2.82 (m, 3H); 2.91 (s, 3H); 1.93 (m, 2H); 1.47 (m, 2H); '\n",
      " '1.40 (s, 9H); 1.22 (dd, J=6.9, 2.2, 6H); 0.89 (m, 1H); 0.50 (m, 2H); 0.32 '\n",
      " '(m, 2H); 0.05 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0428\" level=\"1\">Example D.d53</heading>\\n'\n",
      " '<heading id=\"h-0429\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0900\" num=\"2704\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c15) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0901\" num=\"2705\">MS (ESI): m/z=692 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0902\" num=\"2706\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.99 (s, 1H); 8.92 (d, J=7.7, 1H, &#x2014;NH); 7.40 (dd, J=8.6, 2.4, 1H); '\n",
      " '7.32 (d, J=2.4, 1H); 7.09 (d; J=8.6, 1H); 6.72 (br. d, J&#x2dc;8.6, 1H, '\n",
      " '&#x2014;NH); 5.41 (d, J=11.0, 1H); 5.03 (d, J=11.0, 1H); 3.82 (dd, J=10.2, '\n",
      " '6.6, 1H); 3.74 (dd, J=10.2, 6.9, 1H &#x26;m, 2H); 3.27 (m, 1H); 2.99-2.80 '\n",
      " '(sept, J=6.9, 1H &#x26; m, 2H); 2.90 (s, 3H); 2.01 (m, 2H); 1.86 (m, 2H); '\n",
      " '1.39 (s, 9H); 1.37 (m, 4H); 1.22 (dd, J=6.9, 2.4, 6H); 0.89 (m, 1H); 0.49 '\n",
      " '(m, 2H); 0.32 (m, 2H); 0.05 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0430\" level=\"1\">Example D.d54</heading>\\n'\n",
      " '<heading id=\"h-0431\" '\n",
      " 'level=\"1\">tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0903\" num=\"2707\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c15) and commercially available tert-butyl '\n",
      " 'cis-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0904\" num=\"2708\">MS (ESI): m/z=692 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0905\" num=\"2709\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.28 (d, J=7.9, 1H, &#x2014;NH); 9.03 (s, 1H); 7.41 (dd, J=8.6, 2.4, 1H); '\n",
      " '7.33 (d, J=2.4, 1H); 7.09 (d; J=8.6, 1H); 6.92 (br. d, J&#x2dc;6.9, 1H, '\n",
      " '&#x2014;NH); 5.41 (d, J=11.0, 1H); 5.04 (d, J=11.0, 1H); 4.07 (m, 1H); 3.83 '\n",
      " '(dd, J=10.4, 6.6, 1H); 3.75 (dd, J=10.4, 6.9, 1H); 3.43 (m, 1H); 2.91 (s, 3H '\n",
      " '&#x26; m, 2H &#x26; sept, J=6.9, 1H); 1.85-1.53 (m, 8H); 1.40 (s, 9H); 1.24 '\n",
      " '(dd, J=6.9, 2.4, 6H); 0.90 (m, 1H); 0.51 (m, 2H); 0.33 (m, 2H); 0.06 (m, '\n",
      " '2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0432\" level=\"1\">Example D.d55</heading>\\n'\n",
      " '<heading id=\"h-0433\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0906\" num=\"2710\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c13) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0907\" num=\"2711\">MS (ESI): m/z=722 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0908\" num=\"2712\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.08 (d, J=7.6, 1H, &#x2014;NH); 9.00 (s, 1H); 7.57 (dd, J=8.7, 2.3, 1H); '\n",
      " '7.50 (d, J=2.3, 1H); 7.15 (d, J=8.7, 1H); 5.40 (d, J=11.0, 1H); 5.04 (d, '\n",
      " 'J=11.0, 1H); 4.09 (m, 1H); 4.00 (m, 2H); 3.90-3.70 (m, 6H); 3.06 (m, 2H); '\n",
      " '2.97-2.83 (s, 3H &#x26; m, 2H); 1.99 (s, 3H); 1.94 (m, 2H); 1.46 (m, 2H); '\n",
      " '1.43 (s, 9H); 0.90 (m, 1H); 0.49 (m, 2H); 0.33 (m, 2H); 0.07 (m, 2H); '\n",
      " '&#x2212;0.20 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0434\" level=\"1\">Example D.d56</heading>\\n'\n",
      " '<heading id=\"h-0435\" '\n",
      " 'level=\"1\">tert-Butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate</heading>\\n'\n",
      " '<p id=\"p-0909\" num=\"2713\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c13) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0910\" num=\"2714\">MS (ESI): m/z=736 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0911\" num=\"2715\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.00 (s, 1H); 8.93 (d, J=7.6, 1H, &#x2014;NH); 7.56 (dd, J=8.7, 2.3, 1H); '\n",
      " '7.50 (d, J=2.3, 1H); 7.15 (d, J=8.7, 1H); 6.72 (br. d, J&#x2dc;7.5, 1H, '\n",
      " '&#x2014;NH); 5.40 (d, J=11.1, 1H); 5.03 (d, J=11.1, 1H); 4.00 (m, 2H); 3.86 '\n",
      " '(dd, J=10.2, 6.6, 1H); 3.78 (dd. J=10.2, 6.9, 1H); 3.73 (m, 2H &#x26; m, '\n",
      " '1H); 3.27 (m, 1H); 2.97-2.82 (m, 2H); 2.91 (s, 3H); 2.01 (m, 2H); 1.99 (s, '\n",
      " '3H); 1.86 (m, 2H); 1.39 (s, 9H); 1.34 (m, 4H); 0.90 (m, 1H); 0.49 (m, 2H); '\n",
      " '0.33 (m, 2H); 0.06 (m, 2H); &#x2212;0.20 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0436\" level=\"1\">Example D.d57</heading>\\n'\n",
      " '<heading id=\"h-0437\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0912\" num=\"2716\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c16) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow viscous oil.</p>\\n'\n",
      " '<p id=\"p-0913\" num=\"2717\">MS (ESI): m/z=664 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-0914\" num=\"2718\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.31 (d, J=7.5, 1H, &#x2014;NH); 7.32 (dd, J=8.4, 2.0, 1H); 7.22 (d, J=2.0, '\n",
      " '1H); 7.04 (d, J=8.4, 1H); 5.39 (d, J=11.0, 1H); 4.98 (d, J=11.0, 1H); '\n",
      " '4.15-4.01 (m, 1H); 3.87-3.69 (m, 4H); 3.12 (m, 2H); 2.87 (m, 5H); 2.71 (s, '\n",
      " '3H); 2.32 (s, 3H); 1.99-1.87 (m, 2H); 1.46 (m, 2H); 1.43 (s, 9H); 0.89 (m, '\n",
      " '1H); 0.51 (m, 2H); 0.32 (m, 2H); 0.05 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0438\" level=\"1\">Example D.d58</heading>\\n'\n",
      " '<heading id=\"h-0439\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0915\" num=\"2719\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c17) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0916\" num=\"2720\">MS (ESI): 698 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-0917\" num=\"2721\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.30 (d, J=7.5, 1H, &#x2014;NH); 7.28 (d, J=11.3, 1H); 6.93 (d, J=7.3, 1H), '\n",
      " '5.43 (d, J=11.0, 1H); 5.02 (d, J=11.0, 1H); 4.13-4.00 (m, 1H); 3.95 (s, 3H); '\n",
      " '3.93-3.74 (m, 4H); 3.12 (m, 2H); 2.94 (m, 2H); 2.89 (s, 3H); 2.71 (s, 3H); '\n",
      " '1.98-1.86 (m, 2H); 1.47 (m, 2H); 1.42 (s, 9H); 0.88 (m, 1H); 0.54 (m, 2H); '\n",
      " '0.33 (m, 2H); 0.07 (m, 2H); &#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0440\" level=\"1\">Example D.d59</heading>\\n'\n",
      " '<heading id=\"h-0441\" level=\"1\">tert-Butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0918\" num=\"2722\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c18) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0919\" num=\"2723\">MS (ESI): m/z=698 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0920\" num=\"2724\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.29 (d, J=7.5, 1H, &#x2014;NH); 7.22 (d, J=9.9, 1H); 7.17 (d, J=13.3, 1H); '\n",
      " '5.36 (d, J=10.9, 1H); 4.97 (d, J=10.9, 1H); 4.07 (m, 1H); 3.81 (s, 3H &#x26; '\n",
      " 'dd, J=10.4, 6.6, 1H &#x26; m, 2H); 3.72 (dd, J=10.4, 7.1, 1H); 3.12 (m, 2H); '\n",
      " '3.04-2.90 (m, 2H); 2.88 (s, 3H); 2.72 (s, 3H); 1.93 (m, 2H); 1.47 (m, 2H); '\n",
      " '1.40 (s, 9H); 0.87 (m, 1H); 0.56 (m, 2H); 0.32 (m, 2H); 0.04 (m, 2H); '\n",
      " '&#x2212;0.15 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0442\" level=\"1\">Example D.d60</heading>\\n'\n",
      " '<heading id=\"h-0443\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-0921\" num=\"2725\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c18) and commercially available '\n",
      " '(1S,2S)-2-amino-cyclopentanol the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0922\" num=\"2726\">MS (ESI): m/z=551 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0923\" num=\"2727\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.04 (d, J=7.1, 1H, &#x2014;NH); 8.98 (s, 1H); 7.34 (dd, J=8.6, 2.0, 1H); '\n",
      " '7.27 (d, J=2.0, 1H); 7.06 (d, J=8.6, 1H); 5.43 (d, J=11.0, 1H); 5.02 (d, '\n",
      " 'J=11.0, 1H); 4.91 (dd, J=4.2, 1.3, 1H; &#x2014;OH); 4.09 (m, 1H); 4.00 (m, '\n",
      " '1H); 3.82 (dd, J=10.2, 6.6, 1H); 3.74 (dd, J=10.2, 6.9, 1H); 2.91 (s, 3H); '\n",
      " '2.88 (t, J=7.8, 2H); 2.32 (s, 3H); 2.12 (m, 1H); 1.91 (m, 1H); 1.74 (m, 2H); '\n",
      " '1.54 (m, 2H); 0.88 (m, 1H); 0.52 (m, 2H); 0.32 (m, 2H); 0.04 (m, 2H); '\n",
      " '&#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0444\" level=\"1\">Example D.d61</heading>\\n'\n",
      " '<heading id=\"h-0445\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-0924\" num=\"2728\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c18) and commercially available '\n",
      " '(1R,2S)-2-amino-cyclopentanol the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0925\" num=\"2729\">MS (ESI): m/z=551 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0926\" num=\"2730\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.26 (d, J=7.9, 1H, &#x2014;NH); 8.96 (s, 1H); 7.34 (dd, J=8.4, 1.8, 1H); '\n",
      " '7.28 (d, J=1.8, 1H); 7.06 (d, J=8.4, 1H); 5.43 (d, J=11.1, 1H); 5.02 (d, '\n",
      " 'J=11.1, 1H); 4.92 (dd, J=4.0, 3.8, 1H; &#x2014;OH); 4.17 (m, 1H); 4.04 (m, '\n",
      " '1H); 3.82 (ddd, J=10.4, 6.6, 1.5, 1H); 3.74 (ddd, J=10.4, 6.9, 2.2, 1H); '\n",
      " '2.92 (s, 3H); 2.88 (t, J=7.9, 2H); 2.32 (s, 3H); 2.03-1.73 (m, 3H); '\n",
      " '1.71-1.47 (m, 3H); 0.88 (m, 1H); 0.52 (m, 2H); 0.31 (m, 2H); 0.05 (m, 2H); '\n",
      " '&#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0446\" level=\"1\">Example D.d62</heading>\\n'\n",
      " '<heading id=\"h-0447\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-0927\" num=\"2731\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.c18) and commercially available '\n",
      " '(1R,2R)-2-amino-cyclopentanol the title compound is obtained as colorless '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-0928\" num=\"2732\">MS (ESI): m/z=551 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0929\" num=\"2733\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.04 (d, J=7.1, 1H, &#x2014;NH); 8.98 (s, 1H); 7.34 (dd, J=8.6, 2.0, 1H); '\n",
      " '7.27 (d, J=2.0, 1H); 7.06 (d, J=8.6, 1H); 5.43 (d, J=11.0, 1H); 5.02 (d, '\n",
      " 'J=11.0, 1H); 4.91 (dd, J=4.2, 1.3, 1H; &#x2014;OH); 4.09 (m, 1H); 4.00 (m, '\n",
      " '1H); 3.82 (dd, J=10.2, 6.6, 1H); 3.74 (dd, J=10.2, 6.9, 1H); 2.91 (s, 3H); '\n",
      " '2.88 (t, J=7.8, 2H); 2.32 (s, 3H); 2.12 (m, 1H); 1.91 (m, 1H); 1.74 (m, 2H); '\n",
      " '1.54 (m, 2H); 0.88 (m, 1H); 0.52 (m, 2H); 0.32 (m, 2H); 0.04 (m, 2H); '\n",
      " '&#x2212;0.17 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0448\" level=\"1\">Example D.e1</heading>\\n'\n",
      " '<heading id=\"h-0449\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0930\" num=\"2734\">A solution of tert-butyl '\n",
      " '4-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " 'from example D.d1 (3.74 g; 5.5 mmol), tetrabutylammonium fluoride trihydrate '\n",
      " '(5.21 g; 16.5 mmol) and ethane-1,2-diamine (0.50 g; 8.25 mmol) in '\n",
      " 'tetrahydrofurane (40 mL) is heated to gentle reflux until the starting '\n",
      " 'material is completely consumed according to LC-MS. The crude is purified by '\n",
      " 'column chromatography on silica gel (ethyl acetate/cyclohexane&#x2014;1:1 to '\n",
      " '2:1) to yield the title compound as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0931\" num=\"2735\">MS (ESI): m/z=550 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0932\" num=\"2736\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.99 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.74 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 4.04 (m, 1H); 3.85 '\n",
      " '(m, 2H); 3.76 (d, J=6.8, 2H); 3.05 (m, 2H); 2.76 (s, 3H); 1.92 (m, 2H); 1.44 '\n",
      " '(m, 2H); 1.42 (s, 9H); 0.87 (m, 1H); 0.30 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-0933\" num=\"2737\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in above example D.e1.</p>\\n'\n",
      " '<heading id=\"h-0450\" level=\"1\">Example D.e2</heading>\\n'\n",
      " '<heading id=\"h-0451\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0934\" num=\"2738\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d2) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0935\" num=\"2739\">MS (ESI): m/z=564 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0936\" num=\"2740\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.96 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.58 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.71 (br. d, J&#x2dc;7.7, 1H, &#x2014;NH); 6.55 (d, '\n",
      " 'J=8.6, 1H); 6.00 (s, 2H); 3.76 (d, J=6.8, 2H &#x26; m, 1H); 3.27 (m, 1H); '\n",
      " '2.76 (s, 3H); 1.99 (m, 2H); 1.84 (m, 2H); 1.39 (s, 9H); 1.34 (m, 4H); 0.88 '\n",
      " '(m, 1H); 0.30 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0452\" level=\"1\">Example D.e3</heading>\\n'\n",
      " '<heading id=\"h-0453\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0937\" num=\"2741\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d3) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0938\" num=\"2742\">MS (ESI): m/z=694 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0939\" num=\"2743\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.23 (d, J=7.8, 1H, &#x2014;NH); 9.05 (s, 1H); 7.02 (d, J=8.6, 1H); 6.91 '\n",
      " '(br. d, J&#x2dc;6.4, 1H, &#x2014;NH); 6.57 (d, J=8.6, 1H); 6.03 (d, J=0.6, '\n",
      " '1H); 5.92 (d, J=0.6, 1H); 5.39 (d, J=10.8, 1H); 5.12 (d, J=10.8, 1H); 4.07 '\n",
      " '(m, 1H); 3.76 (dd, J=10.2, 6.6, 2H); 3.68 (dd, J=10.2, 6.9, 1H); 3.34 (m, '\n",
      " '1H); 3.01 (m, 2H); 2.92 (s, 3H); 1.86-1.51 (m, 8H); 1.40 (s, 9H); 0.87 (m, '\n",
      " '1H); 0.61 (m, 2H); 0.30 (m, 2H); 0.02 (m, 2H); &#x2212;0.13 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0454\" level=\"1\">Example D.e4</heading>\\n'\n",
      " '<heading id=\"h-0455\" '\n",
      " 'level=\"1\">tert-Butyl(3R)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0940\" num=\"2744\">Starting from '\n",
      " 'tert-butyl(3R)-3-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate '\n",
      " '(example D.d4) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0941\" num=\"2745\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0942\" num=\"2746\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.03 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.85 (d, J=6.8, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 4.49 (m, 1H); 3.76 '\n",
      " '(d, 6.8, 2H); 3.61 (m, 1H); 3.42 (m, 2H); 3.22 (m, 1H); 2.77 (s, 3H); 2.20 '\n",
      " '(m, 1H); 1.95 (m, 1H); 1.42 (s, 9H); 0.88 (m, 1H); 0.30 (m, 2H); 0.12 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0456\" level=\"1\">Example D.e5</heading>\\n'\n",
      " '<heading id=\"h-0457\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0943\" num=\"2747\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-3-{[(4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.d5) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-0944\" num=\"2748\">MS (ESI): m/z=552 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0945\" num=\"2749\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.05 (br.s, 1H, &#x2014;NH); 8.89 (s, 1H); 8.79 (br.s, 1H, &#x2014;NH); '\n",
      " '7.01 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 5.47 (d, J=3.8, 1H, '\n",
      " '&#x2014;OH); 4.21 (m, 2H); 3.76 (d, J=6.8, 2H); 3.68 (m, 1H); 3.55 (m, 1H); '\n",
      " '3.26 (m, 2H); 2.77 (s, 3H); 1.43 (s, 9H); 0.86 (m, 1H); 0.31 (m, 2H); 0.12 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0458\" level=\"1\">Example D.e6</heading>\\n'\n",
      " '<heading id=\"h-0459\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0946\" num=\"2750\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d6) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0947\" num=\"2751\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0948\" num=\"2752\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.79 (s, 1H, &#x2014;NH); 8.94 (s. 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, J=8.4, 6.9, 1H); 7.08 (dd, J=11.5, 2.4, 1H); 6.96 (ddd, J=8.4, '\n",
      " '8.4, 2.4, 1H); 4.05 (m, 1H); 3.91 (d, J=6.9, 2H); 3.85 (m, 2H); 3.05 (m, '\n",
      " '2H); 2.78 (s, 3H); 1.92 (m, 2H); 1.42 (m, 2H &#x26; s, 9H); 0.96 (m, 1H); '\n",
      " '0.38 (m, 2H): 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0460\" level=\"1\">Example D.e7</heading>\\n'\n",
      " '<heading id=\"h-0461\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0949\" num=\"2753\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d7) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0950\" num=\"2754\">MS (ESI): m/z=538 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0951\" num=\"2755\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, 8.4, 6.9, 1H); 7.09 (dd, 11.3, 2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, '\n",
      " '1H); 6.77 (d, J=7.7, 1H, &#x2014;NH); 3.90 (d, J=6.9, 2H); 3.76 (m, 1H); '\n",
      " '3.31 (m, 1H); 2.77 (s, 3H); 1.98 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.33 '\n",
      " '(m, 4H); 0.95 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0462\" level=\"1\">Example D.e8</heading>\\n'\n",
      " '<heading id=\"h-0463\" level=\"1\">Tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0952\" num=\"2756\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d8) the title compound is obtained as colorless viscous oil.</p>\\n'\n",
      " '<p id=\"p-0953\" num=\"2757\">MS (ESI): m/z=538 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0954\" num=\"2758\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.97 (d, J=6.6, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, 8.5, 7.1, 1H); 7.09 (dd, 11.6, 2.3, 1H); 6.96 (ddd, 8.5, 8.5, 2.3, '\n",
      " '1H); 6.92 (br.s, 1H, &#x2014;NH); 4.04 (m, 1H); 3.91 (d, J=7.0, 2H); 3.43 '\n",
      " '(m, 1H); 2.78 (s, 3H); 1.85-1.54 (m, 8H); 1.40 (s, 9H); 0.96 (m, 1H); 0.38 '\n",
      " '(m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0464\" level=\"1\">Example D.e9</heading>\\n'\n",
      " '<heading id=\"h-0465\" '\n",
      " 'level=\"1\">tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0955\" num=\"2759\">Starting from '\n",
      " 'tert-butyl(3R)-3-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate '\n",
      " '(example D.d9) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0956\" num=\"2760\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0957\" num=\"2761\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.91 (d, J=6.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, J=8.4, 6.9, 1H); 7.08 (dd, J=11.5, 2.4, 1H); 6.96 (ddd, J=8.4, '\n",
      " '8.4, 2.4, 1H); 4.49 (m, 1H); 3.91 (d, J=6.9, 2H); 3.62 (m, 1H); 3.43 (m, '\n",
      " '2H); 3.23 (m, 1H); 2.79 (s. 3H); 2.21 (m, 1H); 1.94 (m, 1H); 1.42 (s, 9H); '\n",
      " '0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0466\" level=\"1\">Example D.e10</heading>\\n'\n",
      " '<heading id=\"h-0467\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0958\" num=\"2762\">Starting from '\n",
      " 'tert-butyl(3R*,4S*)-3-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.d10) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0959\" num=\"2763\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0960\" num=\"2764\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.85 (s, 1H, &#x2014;NH); 8.91 (s, 1H); 8.84 (br.s, 1H, &#x2014;NH); 7.66 '\n",
      " '(dd, J=8.4, 6.9, 1H); 7.08 (dd, J=11.7, 2.4, 1H); 6.96 (ddd, J=8.4, 8.4, '\n",
      " '2.4, 1H); 5.47 (d, J=3.8, 1H, &#x2014;OH); 4.26 (m, 1H); 4.19 (m, 1H); 3.91 '\n",
      " '(d, 7.1, 2H); 3.68 (m, 1H); 3.55 (m, 1H); 3.25 (m, 2H); 2.79 (s. 3H); 1.43 '\n",
      " '(s, 9H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0468\" level=\"1\">Example D.e11</heading>\\n'\n",
      " '<heading id=\"h-0469\" '\n",
      " 'level=\"1\">Tert-butyl(3S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0961\" num=\"2765\">Starting from '\n",
      " 'tert-butyl(3S*,4S*)-4-{[(4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.d11) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0962\" num=\"2766\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0963\" num=\"2767\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.79 8s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.84 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.65 (dd, J=8.6, 6.9, 1H); 7.08 (dd, J=11.7, 2.4, 1H); 6.96 (ddd, J=8.6, '\n",
      " '8.6, 2.4, 1H); 5.24 (d, J=4.9, 1 H, &#x2014;OH); 3.98-3.74 (m, 3H); 3.91 (d, '\n",
      " 'J=6.9, 2H, &#x2014;NH; 3.43 (m, 1H); 2.98 (m, 1H); 2.78 (s. 3H); 2.06 (m, '\n",
      " '1H); 1.42 (s, 9H &#x26; m, 1H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0470\" level=\"1\">Example D.e12</heading>\\n'\n",
      " '<heading id=\"h-0471\" level=\"1\">tert-Butyl '\n",
      " '4-({1-[4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl]-methanoyl}-amino)-piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0964\" num=\"2768\">Starting from '\n",
      " 'tert-butyl(4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d12) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0965\" num=\"2769\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0966\" num=\"2770\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.79 (d, J=7.6, 1H, &#x2014;NH); '\n",
      " '7.43 (dd, J=9.0, 3.2, 1H); 7.37 (ddd, J=9.1, 8.3, 3.2, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.07 (m, 1H); 3.87 (d, J=6.9, 2H); 3.84 (m, 2H); 3.05 (m, 2H); '\n",
      " '2.79 (s, 3H); 1.92 (m, 2H); 1.42 (s, 9H &#x26; m, 2H); 0.94 (m, 1H); 0.36 '\n",
      " '(m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0472\" level=\"1\">Example D.e13</heading>\\n'\n",
      " '<heading id=\"h-0473\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0967\" num=\"2771\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d13) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-0968\" num=\"2772\">MS (ESI): m/z=538 (MH<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0969\" num=\"2773\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (br.s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.62 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=8.9, 3.1, 1H); 7.36 (ddd, J=9.0, 8.6, 3.1, 1H); 7.18 (dd, J=9.0, '\n",
      " '4.4, 1H); 6.72 (d, J=7.5, 1 H, &#x2014;NH); 3.87 (d, J=6.9, 2H); 3.82-3.70 '\n",
      " '(m, 2H); 2.78 (s, 3H); 1.98 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.35 (m, '\n",
      " '4H); 0.93 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0474\" level=\"1\">Example D.e14</heading>\\n'\n",
      " '<heading id=\"h-0475\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0970\" num=\"2774\">Starting from '\n",
      " 'tert-butyl(4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d14) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0971\" num=\"2775\">MS (ESI): m/z=538 (MH<sup>+</sup>).</p>\\n'\n",
      " '<p id=\"p-0972\" num=\"2776\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (br.s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.96 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (dd, J=8.9, 3.3, 1H); 7.38 (ddd, J=8.9, 8.2, 3.3, 1H); 7.19 (dd, J=8.9, '\n",
      " '4.4, 1H); 6.92 (br.s, 1H, &#x2014;NH); 4.04 (m, 1H); 3.88 (d, J=6.9, 2H); '\n",
      " '3.42 (m, 1H); 2.79 (s, 3H); 1.85-1.53 (m, 8H); 1.40 (s, 9H); 0.94 (m, 1H); '\n",
      " '0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0476\" level=\"1\">Example D.e15</heading>\\n'\n",
      " '<heading id=\"h-0477\" '\n",
      " 'level=\"1\">tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0973\" num=\"2777\">Starting from '\n",
      " 'tert-butyl(3R)-3-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate '\n",
      " '(example D.d15) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0974\" num=\"2778\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0975\" num=\"2779\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.89 (d, J=6.8, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=8.9, 3.3, 1H); 7.38 (ddd, J=9.1, 8.4, 3.3, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.49 (m, 1H); 3.87 (d, J=6.9, 2H); 3.62 (m, 1H); 3.42 (m, 2H); '\n",
      " '3.22 (m, 1H); 2.79 (s, 3H); 2.20 (m, 1H); 1.94 (m, 1H); 1.42 (s, 9H); 0.93 '\n",
      " '(m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0478\" level=\"1\">Example D.e16</heading>\\n'\n",
      " '<heading id=\"h-0479\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0976\" num=\"2780\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.d16) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0977\" num=\"2781\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0978\" num=\"2782\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.83 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.42 (ddd, J=9.1, 8.9, 3.3, 1H); 7.36 (dd, J=8.2, 3.2, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 5.24 (d, J=4.9, 1 H, &#x2014;OH); 3.99-3.74 (m, 3H); 3.87 (d, '\n",
      " 'J=6.8, 2H); 3.43 (m, 1H); 2.98 (m, 1H); 2.79 (s, 3H &#x26; m, 1H); 2.06 (m, '\n",
      " '1H); 1.42 (s, 9H &#x26; m, 1H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0480\" level=\"1\">Example D.e17</heading>\\n'\n",
      " '<heading id=\"h-0481\" level=\"1\">tert-Butyl '\n",
      " '4-({[4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbonyl}amino)piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0979\" num=\"2783\">Starting from tert-butyl '\n",
      " '4-({[4-(2-ethoxy-5-fluorophenyl)-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbonyl}amino)piperidine-1-carboxylate '\n",
      " '(example D.d17) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0980\" num=\"2784\">MS (ESI): m/z=498 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0981\" num=\"2785\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 11.87 (br.s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.78 (d, '\n",
      " 'J=7.7, 1H, &#x2014;NH); 7.43 (ddd, J=9.1, 8.9, 3.3, 1H); 7.38 (dd, J=8.2, '\n",
      " '3.3, 1H); 7.22 (dd, J=9.1, 4.4, 1H); 4.08 (qu, J=6.9, 2H &#x26; m, 1H); 3.85 '\n",
      " '(m, 2H); 3.05 (m, 2H); 2.78 (s, 3H); 1.92 (m, 2H); 1.42 (s, 9H &#x26;m, 2H); '\n",
      " '1.11 (t, J=6.9, 3H).</p>\\n'\n",
      " '<heading id=\"h-0482\" level=\"1\">Example D.e18</heading>\\n'\n",
      " '<heading id=\"h-0483\" level=\"1\">tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0982\" num=\"2786\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d18) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-0983\" num=\"2787\">MS (ESI): m/z=</p>\\n'\n",
      " '<p id=\"p-0984\" num=\"2788\"><sup>1</sup>H-NMR (300 MHz, '\n",
      " 'DMSO-d<sub>6</sub>):</p>\\n'\n",
      " '<heading id=\"h-0484\" level=\"1\">Example D.e19</heading>\\n'\n",
      " '<heading id=\"h-0485\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0985\" num=\"2789\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d19) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0986\" num=\"2790\">MS (ESI): m/z=550 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0987\" num=\"2791\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.64 (s, 1H, &#x2014;NH); 8.91 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.58 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 1H); 6.68 (d, J=2.2, 1H &#x26; '\n",
      " 'br.s, 1H, &#x2014;NH); 3.90 (d, J=6.9, 2H); 3.85 (s, 3H); 3.76 (m, 1H); 3.28 '\n",
      " '(m, 1H); 2.77 (s, 3H); 1.99 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.37-1.21 '\n",
      " '(m, 4H); 0.95 (m, 1H); 0.37 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0486\" level=\"1\">Example D.e20</heading>\\n'\n",
      " '<heading id=\"h-0487\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-0988\" num=\"2792\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d20) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0989\" num=\"2793\">MS (ESI): m/z=550 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0990\" num=\"2794\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.64 (s, 1H, &#x2014;NH); 8.99 (d, J=7.9, 1H, &#x2014;NH); 8.94 (s, 1H); '\n",
      " '7.59 (d, J=8.4, 1H); 6.92 (br.s, 1H, &#x2014;NH); 6.72 (dd, J=8.4, 2.2, 1H); '\n",
      " '6.69 (d, J=2.2, 1H); 4.03 (m, 1H); 3.91 (d, J=6.9, 2H); 3.86 (s, 3H); 3.43 '\n",
      " '(m, 1H); 2.77 (s, 3H); 1.84-1.54 (m, 8H); 1.40 (s, 9H); 0.96 (m, 1H); 0.38 '\n",
      " '(m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0488\" level=\"1\">Example D.e21</heading>\\n'\n",
      " '<heading id=\"h-0489\" '\n",
      " 'level=\"1\">tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0991\" num=\"2795\">Starting from '\n",
      " 'tert-butyl(3R)-3-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate '\n",
      " '(example D.d21) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-0992\" num=\"2796\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0993\" num=\"2797\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.93 (d, J=6.8, 1H, &#x2014;NH); 8.89 (s, 1H); '\n",
      " '7.59 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 1H); 6.69 (d, J=2.2, 1H); 4.48 '\n",
      " '(m, 1H); 3.91 (d, J=6.9, 2H); 3.86 (s, 3H); 3.61 (m, 1H); 3.43 (m, 2H); 3.22 '\n",
      " '(m, 1H); 2.78 (s, 3H); 2.21 (m, 1H); 1.93 (m, 1H); 1.42 (s, 9H); 0.96 (m, '\n",
      " '1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0490\" level=\"1\">Example D.e22</heading>\\n'\n",
      " '<heading id=\"h-0491\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0994\" num=\"2798\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-3-{[(4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.d22) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-0995\" num=\"2799\">MS (ESI): m/z=538 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0996\" num=\"2800\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (br.s, 1H, &#x2014;NH); 8.87 (s, 1H &#x26; br.s, 1H, &#x2014;NH); 7.59 '\n",
      " '(d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 1H); 6.69 (d, J=2.2, 1H); 5.46 (d, '\n",
      " 'J=3.8, 1H, &#x2014;OH); 4.25 (m, 1H); 3.90 (d, J=6.9, 2H); 3.86 (s, 3H); '\n",
      " '3.68 (m, 1H); 3.54 (m, 1H); 3.23 (m, 2H); 2.78 (s, 3H); 1.43 (s, 9H); 0.96 '\n",
      " '(m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0492\" level=\"1\">Example D.e23</heading>\\n'\n",
      " '<heading id=\"h-0493\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-0997\" num=\"2801\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d23) the title compound is obtained as colorless viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-0998\" num=\"2802\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-0999\" num=\"2803\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.17 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); 4.07 (m, 1H); 3.87 (m, 2H); 3.82 '\n",
      " '(d, J=6.8, 2H); 3.77 (s, 3H); 3.05 (m, 2H); 2.78 (s, 3H); 1.92 (m, 2H); 1.42 '\n",
      " '(s, 9H &#x26; m, 2H); 0.92 (m, 1H); 0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0494\" level=\"1\">Example D.e24</heading>\\n'\n",
      " '<heading id=\"h-0495\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1000\" num=\"2804\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d24) the title compound is obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-1001\" num=\"2805\">MS (ESI): m/z=450 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1002\" num=\"2806\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.07 (s, 1H, &#x2014;NH); 9.01 (s, 1H); 8.59 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.03 (br. d, J&#x2dc;4.8, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.20 (t, '\n",
      " 'J=1.8, 1H); 7.14 (d, J=1.8, 2H); 3.84 (d, J=6.9, 2H &#x26; m, 1H); 3.78 (s, '\n",
      " '3H); 3.09 (m, 1H); 2.80 (s, 3H); 2.04 (m, 4H); 1.47 (m, 4H); 0.92 (m, 1H); '\n",
      " '0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0496\" level=\"1\">Example D.e25</heading>\\n'\n",
      " '<heading id=\"h-0497\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1003\" num=\"2807\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d25) the title compound is obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-1004\" num=\"2808\">MS (ESI): m/z=549 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1005\" num=\"2809\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.97 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.18 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); 6.92 (br. d, J&#x2dc;7.1, 1H, '\n",
      " '&#x2014;NH); 4.03 (m, 1H); 3.83 (d, J=6.9, 2H); 3.77 (s, 3H); 3.43 (m, 1H); '\n",
      " '2.78 (s, 3H); 1.85-1.52 (m, 8H); 1.40 (s, 9H); 0.92 (m, 1H); 0.35 (m, 2H); '\n",
      " '0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0498\" level=\"1\">Example D.e26</heading>\\n'\n",
      " '<heading id=\"h-0499\" '\n",
      " 'level=\"1\">tert-Butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1006\" num=\"2810\">Starting from '\n",
      " 'tert-butyl(3R)-3-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}pyrrolidine-1-carboxylate '\n",
      " '(example D.d26) the title compound is obtained as colorless viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1007\" num=\"2811\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1008\" num=\"2812\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.91 (d, J=6.8, 1H, &#x2014;NH); '\n",
      " '7.18 (t, J=1.6, 2H); 7.11 (d, J=1.6, 1H); 4.49 (m, 1H); 3.82 (d, J=6.9, 2H); '\n",
      " '3.77 (s, 2H); 3.62 (m, 1H); 3.42 (m, 2H); 3.22 (m, 1H); 2.78 (s, 3H); 2.21 '\n",
      " '(m, 1H); 1.94 (m, 1H); 1.42 (s, 9H); 0.92 (m, 1H); 0.34 (m, 2H); 0.19 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0500\" level=\"1\">Example D.e27</heading>\\n'\n",
      " '<heading id=\"h-0501\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1009\" num=\"2813\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.d27) the title compound is obtained as colorless viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1010\" num=\"2814\">MS (ESI): m/z=552 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1011\" num=\"2815\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H); 8.95 (s, 1H); 8.85 (d, J=7.3, 1H, &#x2014;NH); 7.18 (t, '\n",
      " 'J=1.6, 1H); 7.11 (d, J=1.6, 2H); 5.24 (d, J=4.9, 1H, &#x2014;OH); 3.98-3.79 '\n",
      " '(m, 3H); 3.82 (d, J=6.8, 2H); 3.77 (s, 3H); 3.43 (m, 1H); 2.98 (m, 1H); 2.78 '\n",
      " '(s, 3H &#x26; m, 1H); 2.06 (m, 1H); 1.42 (s, 9H); 1.38 (m, 1H); 0.92 (m, '\n",
      " '1H); 0.35 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0502\" level=\"1\">Example D.e28</heading>\\n'\n",
      " '<heading id=\"h-0503\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1012\" num=\"2816\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d28) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1013\" num=\"2817\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1014\" num=\"2818\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (d, J=2.2, 1H); 7.33 (dd, J=8.6, 2.0, 1H); 7.06 (d, J=8.6, 1H); 4.06 '\n",
      " '(m, 1H); 3.86 (d, J=6.9, 2H &#x26; m, 2H); 3.05 (m, 2H); 2.78 (s, 3H); 2.33 '\n",
      " '(s, 3H); 1.92 (m, 2H); 1.43 (s, 9H &#x26; m, 2H); 0.94 (m, 1H); 0.35 (m, '\n",
      " '2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0504\" level=\"1\">Example D.e29</heading>\\n'\n",
      " '<heading id=\"h-0505\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1015\" num=\"2819\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d29) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1016\" num=\"2820\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1017\" num=\"2821\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (d, J=2.2, 1H); 7.32 (dd, J=8.6, 2.0, 1H); 7.05 (d, J=8.6, 1H); 6.72 '\n",
      " '(d, J=7.1, 1H, &#x2014;NH); 3.85 (d, J=6.9, 2H); 3.76 (m, 1H); 3.30 (m, 1H); '\n",
      " '2.77 (s, 3H); 2.33 (s, 3H); 1.99 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.33 '\n",
      " '(m, 4H); 0.94 (m, 1H); 0.35 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0506\" level=\"1\">Example D.e30</heading>\\n'\n",
      " '<heading id=\"h-0507\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1018\" num=\"2822\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d30) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1019\" num=\"2823\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1020\" num=\"2824\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 9.00 (d, J=9.3, 1H, &#x2014;NH); 8.98 (s, 1H); '\n",
      " '7.43 (d, J=2.1, 1H); 7.33 (dd, J=8.4, 2.1, 1H); 7.06 (d, J=8.4, 1H); 6.97 '\n",
      " '(d, J=7.7, 1H, &#x2014;NH); 4.03 (m, 1H); 3.86 (d, J=6.9, 2H); 3.42 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.32 (s, 3H); 1.81-1.51 (m, 8H); 1.40 (s, 9H); 0.94 (m, 1H); '\n",
      " '0.37 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0508\" level=\"1\">Example D.e31</heading>\\n'\n",
      " '<heading id=\"h-0509\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1021\" num=\"2825\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d31) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1022\" num=\"2826\">MS (ESI): m/z=574 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1023\" num=\"2827\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.90 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.38 (d, J=8.8, 1H); 4.05 '\n",
      " '(m, 1H); 4.00 (d, J=6.9, 2H); 3.85 (m, 2H); 3.05 (m, 2H); 2.79 (s, 3H); 1.93 '\n",
      " '(m, 2H); 1.45 (m, 2H); 1.43 (s, 9H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0510\" level=\"1\">Example D.e32</heading>\\n'\n",
      " '<heading id=\"h-0511\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1024\" num=\"2828\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d32) the title compound is obtained as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-1025\" num=\"2829\">Alternatively, following the procedure as '\n",
      " 'described for example D.d1 the title compound is prepared from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g2) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate.</p>\\n'\n",
      " '<p id=\"p-1026\" num=\"2830\">MS (ESI): m/z=588 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1027\" num=\"2831\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.62 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.6, 2.0, 1H); 7.38 (d, J=8.6, 1H); 6.72 '\n",
      " '(d, J=7.2, 1H, &#x2014;NH); 4.00 (d, J=7.0, 2H); 3.76 (m, 1H); 3.29 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.00 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.36 (m, 4H); 0.98 '\n",
      " '(m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0512\" level=\"1\">Example D.e33</heading>\\n'\n",
      " '<heading id=\"h-0513\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1028\" num=\"2832\">Starting from '\n",
      " 'tert-Butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d33) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1029\" num=\"2833\">MS (ESI): m/z=588 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1030\" num=\"2834\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.96 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.1, 1H); 7.89 (dd, J=8.5, 2.1, 1H); 7.38 (d, J=8.5, 1H); 6.92 '\n",
      " '(br.s, 1H, &#x2014;NH); 4.06 (m, 1H); 4.00 (d, J=6.9, 2H); 3.43 (m, 1H); '\n",
      " '2.79 (s, 3H); 1.84-1.54 (m, 8H); 1.40 (s, 9H); 0.99 (m, 1H); 0.40 (m, 2H); '\n",
      " '0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0514\" level=\"1\">Example D.e34</heading>\\n'\n",
      " '<heading id=\"h-0515\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1031\" num=\"2835\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d34) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1032\" num=\"2836\">MS (ESI): m/z=548 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1033\" num=\"2837\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.92 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.78 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.92 (d, J=2.2, 1H); 7.90 (dd, J=9.5, 2.2, 1H); 7.42 (d, J=9.5, 1H); 4.21 '\n",
      " '(qu, J=7.0, 2H); 4.06 (m, 1H); 3.85 (m, 2H); 3.05 (m, 2H); 2.79 (s, 3H); '\n",
      " '1.97 (m, 2H); 1.92 (m, 2H); 1.42 (s, 9H &#x26; m, 2H); 1.15 (t, J=7.0, '\n",
      " '3H).</p>\\n'\n",
      " '<heading id=\"h-0516\" level=\"1\">Example D.e35</heading>\\n'\n",
      " '<heading id=\"h-0517\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1034\" num=\"2838\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-cyclopropylmethoxy-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d35) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1035\" num=\"2839\">MS (ESI): m/z=554 (MH<sup>+</sup>, 100%); 498 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>); 454 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>5</sub>H<sub>8</sub>O<sub>2</sub>).</p>\\n'\n",
      " '<p id=\"p-1036\" num=\"2840\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.78 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.79 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.8, 1H); 7.18 (d, J=13.5, 1H); 4.04 (m, 1H); 3.87 (m, 2H); 3.84 '\n",
      " '(s, 3H &#x26; d, J=6.9, 2H); 3.05 (m, 2H); 2.78 (s, 3H); 1.93 (m, 2H); 1.42 '\n",
      " '(s, 9H &#x26; m, 1H); 1.29 (m, 1H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0518\" level=\"1\">Example D.e36</heading>\\n'\n",
      " '<heading id=\"h-0519\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1037\" num=\"2841\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d36) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1038\" num=\"2842\">MS (ESI): m/z=568 (MH<sup>+</sup>, 100%); 512 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>).</p>\\n'\n",
      " '<p id=\"p-1039\" num=\"2843\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.64 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 6.72 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.76 (m, 1H); 3.27 (m, 1H); 2.78 (s, 3H); '\n",
      " '1.99 (m, 2H); 1.85 (m, 2H); 1.39 (s, 9H); 1.35 (m, 4H); 0.93 (m, 1H); 0.36 '\n",
      " '(m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0520\" level=\"1\">Example D.e37</heading>\\n'\n",
      " '<heading id=\"h-0521\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1040\" num=\"2844\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d37) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1041\" num=\"2845\">MS (ESI): m/z=568 (MH<sup>+</sup>, 100%); 512 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>); 468 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>5</sub>H<sub>8</sub>O<sub>2</sub>).</p>\\n'\n",
      " '<p id=\"p-1042\" num=\"2846\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.96 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.19 (d, J=13.3, 1H); 6.91 (br.s, 1H, &#x2014;NH); 4.03 '\n",
      " '(m, 1H); 3.85 (s, 3H); 3.84 (d, J=6.8, 2H); 3.43 (m, 1H); 2.78 (s, 3H); 1.77 '\n",
      " '(m, 2H); 1.64 (m, 6H); 1.40 (s, 9H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0522\" level=\"1\">Example D.e38</heading>\\n'\n",
      " '<heading id=\"h-0523\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1043\" num=\"2847\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.d38) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1044\" num=\"2848\">MS (ESI): m/z=570 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1045\" num=\"2849\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.84 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.40 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 5.24 (d, J=4.9, 1H, &#x2014;OH); '\n",
      " '3.99-3.73 (m, 3H); 3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.43 (m, 1H); 2.98 (m, '\n",
      " '1H); 2.79 (s, 3H &#x26; m, 1H); 2.06 (m, 1H); 1.42 (s, 9H); 1.37 (m, 1H); '\n",
      " '0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0524\" level=\"1\">Example D.e39</heading>\\n'\n",
      " '<heading id=\"h-0525\" '\n",
      " 'level=\"1\">tert-Butyl(3S*,4S*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1046\" num=\"2850\">Starting from '\n",
      " 'tert-butyl(3S*,4S*)-3-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.d39) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1047\" num=\"2851\">MS (ESI): m/z=570 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1048\" num=\"2852\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.86 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.40 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 5.09 (d, J=4.6, 1H, &#x2014;OH); '\n",
      " '3.84 (s, 3H &#x26; d, J=6.8, 2H &#x26; m, 3H); 3.69 (m, 1H); 3.53 (m, 1H); '\n",
      " '3.31 (m, 1H); 2.79 (s, 3H); 1.90 (m, 1H); 1.47 (m, 1H); 1.31 (br.s, 9H); '\n",
      " '0.92 (m, 1H); 0.36 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0526\" level=\"1\">Example D.e40</heading>\\n'\n",
      " '<heading id=\"h-0527\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1049\" num=\"2853\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d40) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1050\" num=\"2854\">MS (ESI): m/z=538 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1051\" num=\"2855\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H); 7.03 (d, J=12.2, 1H); 4.06 (m, 1H); 3.87 (d, J=6.9, '\n",
      " '2H); 3.84 (m, 2H); 3.05 (m, 2H); 2.78 (s, 3H); 2.25 (d, J=1.1, 3H); 1.92 (m, '\n",
      " '2H); 1.42 (s, 9H &#x26; m, 2H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0528\" level=\"1\">Example D.e41</heading>\\n'\n",
      " '<heading id=\"h-0529\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1052\" num=\"2856\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d41) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1053\" num=\"2857\">MS (ESI): m/z=552 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1054\" num=\"2858\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.63 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.54 (dd, J=9.1, 0.6, 1H); 7.03 (d, J=11.9, 1H); 6.72 (d, J=6.9, 1H, '\n",
      " '&#x2014;NH); 3.87 (d, J=6.9, 2H); 3.76 (m, 1H); 3.29 (m, 1H); 2.77 (s, 3H); '\n",
      " '2.25 (d, J=1.1, 3H); 1.99 (m, 2H); 1.86 (m, 2H); 1.39 (s, 9H); 1.35 (m, 4H); '\n",
      " '0.95 (m, 1H); 0.37 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0530\" level=\"1\">Example D.e42</heading>\\n'\n",
      " '<heading id=\"h-0531\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1055\" num=\"2859\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d42) the title compound is obtained as colorless viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1056\" num=\"2860\">MS (ESI): m/z=552 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1057\" num=\"2861\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.97 (s, 1H &#x26; d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.7, 1H); 7.03 (d, J=12.2, 1H); 6.92 (br.s, 1H, &#x2014;NH); 4.04 '\n",
      " '(m, 1H); 3.88 (d, J=6.9, 2H); 3.43 (m, 1H); 2.78 (s, 3H); 2.25 (d, J=1.1, '\n",
      " '3H); 1.81-1.52 (m, 8H); 1.40 (s, 9H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0532\" level=\"1\">Example D.e43</heading>\\n'\n",
      " '<heading id=\"h-0533\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methyl '\n",
      " 'phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1058\" num=\"2862\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.d43) the title compound is obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-1059\" num=\"2863\">MS (ESI): m/z=554 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1060\" num=\"2864\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.84 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H); 7.03 (d, J=12.0, 1H); 5.23 (d, J=5.1, 1H, &#x2014;OH); '\n",
      " '3.99-3.74 (m, 3H); 3.87 (d, J=6.9, 2H); 3.43 (m, 1H); 2.98 (m, 1H); 2.81 (m, '\n",
      " '1H); 2.78 (s, 3H); 2.25 (d, J=1.1, 3H); 2.06 (m, 1H); 1.42 (s, 9H); 1.37 (m, '\n",
      " '1H); 0.94 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0534\" level=\"1\">Example D.e44</heading>\\n'\n",
      " '<heading id=\"h-0535\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1061\" num=\"2865\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d44) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1062\" num=\"2866\">MS (ESI): m/z=554 (MH<sup>+</sup>, 100%); 498 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>); 454 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>5</sub>H<sub>8</sub>O).</p>\\n'\n",
      " '<p id=\"p-1063\" num=\"2867\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 6.92 (d, J=7.3, 1H); 4.05 (m, 1H); 3.97 (s, 3H); 3.94 '\n",
      " '(d, J=6.9, 2H); 3.84 (m, 2H); 3.05 (m, 2H); 2.98 (s, 3H); 1.92 (m, 2H); 1.42 '\n",
      " '(s, 9H &#x26; m, 2H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0536\" level=\"1\">Example D.e45</heading>\\n'\n",
      " '<heading id=\"h-0537\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1064\" num=\"2868\">Starting from (example D.d45) the title compound '\n",
      " 'is obtained as colorless foam. The compound is further processed without '\n",
      " 'characterisation.</p>\\n'\n",
      " '<heading id=\"h-0538\" level=\"1\">Example D.e46</heading>\\n'\n",
      " '<heading id=\"h-0539\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1065\" num=\"2869\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d46) the title compound is obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-1066\" num=\"2870\">MS (ESI): m/z=568 (MH<sup>+</sup>, 100%); 512 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>4</sub>H<sub>8</sub>); 468 '\n",
      " '(MH<sup>+</sup>&#x2014;C<sub>5</sub>H<sub>8</sub>O<sub>2</sub>).</p>\\n'\n",
      " '<p id=\"p-1067\" num=\"2871\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.69 (s, 1H, &#x2014;NH); 8.98 (d, J=7.8, 1H, &#x2014;NH); 8.96 (s, 1H); '\n",
      " '7.47 (d, J=11.9, 1H); 6.93 (d, J=7.1, 1H); 6.92 (br.s, 1H, &#x2014;NH); 4.04 '\n",
      " '(m, 1H); 3.97 (s, 3H); 3.94 (d, J=6.9, 2H); 3.43 (m, 1H); 2.79 (s, 3H); 1.76 '\n",
      " '(m, 2H); 1.64 (m, 6H); 1.40 (s, 9H); 0.96 (m, 1H); 0.39 (m, 2H); 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0540\" level=\"1\">Example D.e47</heading>\\n'\n",
      " '<heading id=\"h-0541\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1068\" num=\"2872\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.d47) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1069\" num=\"2873\">MS (ESI): m/z=570 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1070\" num=\"2874\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.85 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.42 (d, J=11.9, 1H); 6.92 (d, J=7.3, 1H); 5.23 (d, J=4.9, 1H, &#x2014;OH); '\n",
      " '3.97 (s, 3H); 3.94 (d, J=6.9, 2H &#x26; m, 2H); 3.82 (m, 1H); 3.43 (m, 1H); '\n",
      " '2.99 (m, 1H); 2.79 (s, 3H &#x26; m, 1H); 2.06 (m, 1H); 1.42 (s, 9H &#x26; m, '\n",
      " '1H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0542\" level=\"1\">Example D.e48</heading>\\n'\n",
      " '<heading id=\"h-0543\" level=\"1\">tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1071\" num=\"2875\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d48) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1072\" num=\"2876\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1073\" num=\"2877\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.4, 1H); 7.36 (dd, J=8.4, 2.4, 1H); 7.08 (d, J=8.4, 1H); 4.06 '\n",
      " '(m, 1H); 3.86 (d, J=6.8, 2H); 3.84 (m, 2H); 3.05 (m, 2H); 2.78 (s, 3H); 2.64 '\n",
      " '(qu, J=7.6, 2H); 1.93 (m, 2H); 1.45 (m, 2H); 1.43 (s, 9H); 1.18 (t, J=7.6, '\n",
      " '3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0544\" level=\"1\">Example D.e49</heading>\\n'\n",
      " '<heading id=\"h-0545\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1074\" num=\"2878\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d49) the title compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1075\" num=\"2879\">MS (ESI): m/z=548 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1076\" num=\"2880\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.4, 1H); 7.35 (dd, J=8.4, 2.4, 1H); 7.07 (d, J=8.4, 1H); 6.72 '\n",
      " '(d, J=7.3, 1H, &#x2014;NH); 3.86 (d, J=6.8, 2H); 3.75 (m, 1H); 3.27 (m, 1H); '\n",
      " '2.77 (s, 3H); 2.63 (qu, J=7.5, 2H); 2.00 (m, 2H); 1.85 (m, 2H); 1.39 (s, '\n",
      " '9H); 1.34 (m, 4H); 1.17 (t, J=7.6, 3H); 0.94 (m, 1H); 0.35 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0546\" level=\"1\">Example D.e50</heading>\\n'\n",
      " '<heading id=\"h-0547\" level=\"1\">tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1077\" num=\"2881\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d50) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1078\" num=\"2882\">MS (ESI): m/z=548 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1079\" num=\"2883\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.98 (s, 1H &#x26; d, J=7.1, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.4, 1H); 7.36 (dd, J=8.4, 2.4, 1H); 7.08 (d, J=8.6, 1H); 6.93 '\n",
      " '(br.s, 1H, &#x2014;NH); 4.04 (m, 1H); 3.87 (d, J=6.8, 2H); 3.43 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.64 (qu, J=7.5, 2H); 1.85-1.54 (m, 8H); 1.40 (s, 9H); 1.19 '\n",
      " '(t, J=7.5, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0548\" level=\"1\">Example D.e51</heading>\\n'\n",
      " '<heading id=\"h-0549\" '\n",
      " 'level=\"1\">tert-Butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1080\" num=\"2884\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-3-{[(4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.d51) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1081\" num=\"2885\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1082\" num=\"2886\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.91 (s, 1H); 8.85 (br.s, 1H, &#x2014;NH); 7.45 '\n",
      " '(d, J=2.4, 1H); 7.36 (dd, J=8.4, 2.4, 1H); 7.08 (d, J=8.4, 1H); 5.47 (d, '\n",
      " 'J=3.8, 1H, &#x2014;OH); 4.25 (m, 1H); 4.19 (m, 1H); 3.86 (d, J=6.8, 2H); '\n",
      " '3.68 (m, 1H); 3.55 (m, 1H); 3.22 (m, 2H); 2.78 (s, 3H); 2.63 (qu, J=7.6, '\n",
      " '2H); 1.43 (s, 9H); 1.18 (t, J=7.6, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0550\" level=\"1\">Example D.e52</heading>\\n'\n",
      " '<heading id=\"h-0551\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1083\" num=\"2887\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d52) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1084\" num=\"2888\">MS (ESI): m/z=548 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1085\" num=\"2889\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, 1H); 7.08 (d; J=8.6, 1H); 4.06 '\n",
      " '(m, 1H); 3.87 (d, J=6.8, 2H &#x26; m, 2H); 3.05 (m, 2H); 2.94 (sept, J=6.9, '\n",
      " '1H); 2.77 (s, 3H); 1.92 (m, 2H); 1.45 (m, 2H); 1.43 (s, 9H); 1.22 (d, J=6.9, '\n",
      " '6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0552\" level=\"1\">Example D.e53</heading>\\n'\n",
      " '<heading id=\"h-0553\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1086\" num=\"2890\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d53) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1087\" num=\"2891\">MS (ESI): m/z=692 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1088\" num=\"2892\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '8.99 (s, 1H); 8.92 (d, J=7.7, 1H, &#x2014;NH); 7.40 (dd, J=8.6, 2.4, 1H); '\n",
      " '7.32 (d, J=2.4, 1H); 7.09 (d; J=8.6, 1H); 6.72 (br. d, J&#x2dc;8.6, 1H, '\n",
      " '&#x2014;NH); 5.41 (d, J=11.0, 1H); 5.03 (d, J=11.0, 1H); 3.82 (dd, J=10.2, '\n",
      " '6.6, 1H); 3.74 (dd, J=10.2, 6.9, 1H &#x26;m, 2H); 3.27 (m, 1H); 2.99-2.80 '\n",
      " '(sept, J=6.9, 1H &#x26; m, 2H); 2.90 (s, 3H); 2.01 (m, 2H); 1.86 (m, 2H); '\n",
      " '1.39 (s, 9H); 1.37 (m, 4H); 1.22 (dd, J=6.9, 2.4, 6H); 0.89 (m, 1H); 0.49 '\n",
      " '(m, 2H); 0.32 (m, 2H); 0.05 (m, 2H); &#x2212;0.19 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0554\" level=\"1\">Example D.e54</heading>\\n'\n",
      " '<heading id=\"h-0555\" level=\"1\">tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1089\" num=\"2893\">Starting from '\n",
      " 'tert-butyl(cis-4-{[(4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d54) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1090\" num=\"2894\">MS (ESI): m/z=562 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1091\" num=\"2895\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.98 (d, J=7.1, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=2.4, 1H); 7.40 (dd, J=8.6, 2.4, 1H); 7.09 (d; J=8.6, 1H); 6.82 '\n",
      " '(br. d, J&#x2dc;6.0, 1H, &#x2014;NH); 4.04 (m, 1H); 3.87 (d, J=6.8, 2H); '\n",
      " '3.43 (m, 1H); 2.95 (sept, J=6.9, 1H); 2.77 (s, 3H); 1.85-1.52 (m, 8H); 1.40 '\n",
      " '(s, 9H); 1.22 (d, J=6.9, 6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0556\" level=\"1\">Example D.e55</heading>\\n'\n",
      " '<heading id=\"h-0557\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1092\" num=\"2896\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d55) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1093\" num=\"2897\">MS (ESI): m/z=722 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1094\" num=\"2898\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '9.08 (d, J=7.6, 1H, &#x2014;NH); 9.00 (s, 1H); 7.57 (dd, J=8.7, 2.3, 1H); '\n",
      " '7.50 (d, J=2.3, 1H); 7.15 (d, J=8.7, 1H); 5.40 (d, J=11.0, 1H); 5.04 (d, '\n",
      " 'J=11.0, 1H); 4.09 (m, 1H); 4.00 (m, 2H); 3.90-3.70 (m, 6H); 3.06 (m, 2H); '\n",
      " '2.97-2.83 (s, 3H &#x26; m, 2H); 1.99 (s, 3H); 1.94 (m, 2H); 1.46 (m, 2H); '\n",
      " '1.43 (s, 9H); 0.90 (m, 1H); 0.49 (m, 2H); 0.33 (m, 2H); 0.07 (m, 2H); '\n",
      " '&#x2212;0.20 (s, 9H).</p>\\n'\n",
      " '<heading id=\"h-0558\" level=\"1\">Example D.e56</heading>\\n'\n",
      " '<heading id=\"h-0559\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1095\" num=\"2899\">Starting from '\n",
      " 'tert-butyl(trans-4-{[(4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}cyclohexyl)carbamate '\n",
      " '(example D.d56) the title compound is obtained as pale yellow viscous '\n",
      " 'oil.</p>\\n'\n",
      " '<p id=\"p-1096\" num=\"2900\">MS (ESI): m/z=606 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1097\" num=\"2901\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (d, J=2.4, 1H); 7.55 (dd, J=8.7, 2.4, 1H); 7.14 (d, J=8.7, 1H); 6.72 '\n",
      " '(br. d, J&#x2dc;7.3, 1H, &#x2014;NH); 3.99 (m, 2H); 3.90 (d, J=6.9, 2H); '\n",
      " '3.76 (m, 1H); 3.71 (m, 2H); 3.27 (m, 1H); 2.77 (s, 3H); 2.01 (m, 2H); 1.99 '\n",
      " '(s, 3H); 1.86 (m, 2H); 1.39 (s, 9H); 1.34 (m, 4H); 0.95 (m, 1H); 0.37 (m, '\n",
      " '2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0560\" level=\"1\">Example D.e57</heading>\\n'\n",
      " '<heading id=\"h-0561\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1098\" num=\"2902\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d57) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1099\" num=\"2903\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1100\" num=\"2904\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.58 (s, 1H, &#x2014;NH); 9.04 (d, J=7.7, 1H, &#x2014;NH); 7.38 (d, J=2.2, '\n",
      " '1H); 7.31 (dd, J=8.4, 2.2, 1H); 7.04 (d, J=8.4, 1H); 4.13-3.99 (m, 1H); '\n",
      " '3.89-3.74 (m, 4H); 3.12 (m, 2H); 2.74 (s, 3H); 2.72 (s, 3H); 2.32 (s, 3H); '\n",
      " '1.97-1.86 (m, 2H); 1.48 (m, 2H); 1.43 (s, 9H); 0.93 (m, 1H); 0.35 (m, 2H); '\n",
      " '0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0562\" level=\"1\">Example D.e58</heading>\\n'\n",
      " '<heading id=\"h-0563\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1101\" num=\"2905\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d58) the title compound is obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-1102\" num=\"2906\">MS (ESI): 568 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1103\" num=\"2907\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.56 (s, 1H, &#x2014;NH); 9.04 (d, J=7.7, 1H, &#x2014;NH); 7.43 (d, J=11.7, '\n",
      " '1H); 6.91 (d, J=7.3, 1H); 4.06 (m, 1H); 3.96 (s, 3H); 3.93 (d, J=6.9, 2H); '\n",
      " '3.87-3.73 (m, 2H); 3.12 (m, 2H); 2.75 (s, 3H); 2.71 (s, 3); 1.98-1.85 (m, '\n",
      " '2H); 1.46 (m, 2H); 1.42 (s, 9H); 0.95 (m, 1H); 0.38 (m, 2H); 0.24 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0564\" level=\"1\">Example D.e59</heading>\\n'\n",
      " '<heading id=\"h-0565\" level=\"1\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1104\" num=\"2908\">Starting from tert-butyl '\n",
      " '4-{[(4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidin-7-yl)carbonyl]amino}piperidine-1-carboxylate '\n",
      " '(example D.d59) the title compound is obtained as colorless foam.</p>\\n'\n",
      " '<p id=\"p-1105\" num=\"2909\">MS (ESI): m/z=568 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1106\" num=\"2910\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.60 (s, 1H, &#x2014;NH); 9.02 (d, J=7.7, 1H, &#x2014;NH); 7.33 (d, J=9.9, '\n",
      " '1H); 7.16 (d, J=13.3, 1H); 4.05 (m, 1H); 3.84 (s, 3H); 3.82 (d, J=6.8, 2H); '\n",
      " '3.78 (m, 2H); 3.12 (m, 2H); 2.74 (s, 3H); 2.73 (s, 3H); 1.99-1.86 (m, 2H); '\n",
      " '1.47 (m, 2H); 1.42 (s, 9H); 0.92 (m, 1H); 0.35 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-1107\" num=\"2911\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in above example D.d1</p>\\n'\n",
      " '<heading id=\"h-0566\" level=\"1\">Example D.e60</heading>\\n'\n",
      " '<heading id=\"h-0567\" level=\"1\">tert.-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1108\" num=\"2912\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and commercially available tert-butyl '\n",
      " '4-amino-piperidine-1-carboxylate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-1109\" num=\"2913\">MS (ESI): m/z=556 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1110\" num=\"2914\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.85 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.83 (d, J=2.0, 1H); 7.74 (dd, J=8.8, 2.0, 1H); 7.31 (d, J=8.8, 1H); 7.08 '\n",
      " '(t, J=56.0, 1H); 4.07 (m, 1H); 3.96 (d, J=6.9, 2H); 3.91-3.79 (m, 2H); 3.05 '\n",
      " '(m, 2H); 2.79 (s, 3H); 1.93 (m, 2H); 1.43 (s, 9H &#x26; m, 2H); 0.97 (m, '\n",
      " '1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0568\" level=\"1\">Example D.e61</heading>\\n'\n",
      " '<heading id=\"h-0569\" level=\"1\">tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1111\" num=\"2915\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and commercially available tert-butyl '\n",
      " 'trans-(4-amino-cyclohexyl)-carbamate the title compound is obtained as pale '\n",
      " 'yellow foam.</p>\\n'\n",
      " '<p id=\"p-1112\" num=\"2916\">MS (ESI): m/z=570 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1113\" num=\"2917\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.82 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.64 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.82 (d, J=2.0, 1H); 7.74 (dd, J=8.6, 2.0, 1H); 7.31 (d, J=8.6, 1H); 7.08 '\n",
      " '(t, J=56.0, 1H); 6.72 (br. d, J=8.2, 1H, &#x2014;NH); 3.96 (d, J=6.9, 2H); '\n",
      " '3.76 (m, 1H); 3.29 (m, 1H); 2.78 (s, 3H); 1.98 (m, 2H); 1.85 (m, 2H); 1.39 '\n",
      " '(s, 9H); 1.36 (m, 4H); 0.97 (m, 1H); 0.37 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0570\" level=\"1\">Example D.e62</heading>\\n'\n",
      " '<heading id=\"h-0571\" level=\"1\">tert-Butyl '\n",
      " '{(1S*,2S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-fluorocyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1114\" num=\"2918\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and tert-butyl '\n",
      " '[(1S*,2S*,4S*)-4-amino-2-fluorocyclohexyl]carbamate (example C22) the title '\n",
      " 'compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1115\" num=\"2919\">MS (ESI): m/z=588 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1116\" num=\"2920\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.85 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.73 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.83 (d, J=2.0, 1H); 7.74 (dd, J=8.6, 2.0, 1H); 7.31 (d, J=8.6, 1H); 7.08 '\n",
      " '(t, J=56.0, 1H); 6.93 (br.s, 1H, &#x2014;NH); 4.41 (m, 1H); 3.96 (d, J=6.9, '\n",
      " '2H); 3.90 (m, 1H); 3.51 (m, 1H); 2.78 (s, 3H); 2.41 (m, 1H); 1.99-1.77 (m, '\n",
      " '2H); 1.65 (m, 1H); 1.40 (s, 9H &#x26; m, 2H); 0.97 (m, 1H); 0.38 (m, 2H); '\n",
      " '0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0572\" level=\"1\">Example D.e63</heading>\\n'\n",
      " '<heading id=\"h-0573\" level=\"1\">tert-Butyl '\n",
      " '{(1S*,3S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-methylcyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1117\" num=\"2921\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and tert-butyl '\n",
      " '[(1R*,3R*,4R*)-4-amino-3-methylcyclohexyl]carbamate (example C11) the title '\n",
      " 'compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1118\" num=\"2922\">MS (ESI): m/z=584 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1119\" num=\"2923\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.58 (d, J=8.6, 1H, &#x2014;NH); '\n",
      " '7.83 (s, 1H); 7.75 (d, J=8.8, 1H); 7.31 (d, J=8.8, 1H); 7.09 (t, J=56.2, '\n",
      " '1H); 6.78 (d, J=7.7, 1H, &#x2014;NH); 3.96 (d, J=6.8, 2H); 3.49 (m, 1H); '\n",
      " '3.35 (m, 1H); 2.79 (s, 3H); 2.03-1.75 (m, 4H); 1.58 (m, 1H); 1.391 (s, 9H); '\n",
      " '1.38-1.21 (m, 1H); 1.06 (m, 1H); 0.99 (m, 1H); 0.94 (d, J=6.4, 3H); 0.39 (m, '\n",
      " '2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0574\" level=\"1\">Example D.e64</heading>\\n'\n",
      " '<heading id=\"h-0575\" level=\"1\">tert-Butyl '\n",
      " '{(1S,3S)-3-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclopentyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1120\" num=\"2924\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and tert-butyl [(1S,3S)-3-aminocyclopentyl]carbamate '\n",
      " 'hydrochloride (example C6) the title compound is obtained as pale yellow '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-1121\" num=\"2925\">MS (ESI): m/z=556 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1122\" num=\"2926\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.82 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.75 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.83 (t, J=1.1, 1H); 7.74 (td, J=8.7, 1.1, 1H); 7.31 (d, J=8.7, 1H); 7.08 '\n",
      " '(t, J=56.0, 1H); 6.95 (br. d, J 5.5, 1H, &#x2014;NH); 4.42 (m, 1H); 3.98 (m, '\n",
      " '1H); 3.96 (d, J=7.1, 2H); 2.78 (s, 3H); 2.20-1.98 (m, 2H); 1.84 (m, 2H); '\n",
      " '1.49 (m, 2H); 1.40 (s, 9H); 0.97 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0576\" level=\"1\">Example D.e65</heading>\\n'\n",
      " '<heading id=\"h-0577\" '\n",
      " 'level=\"1\">N-[(1S*,3S*,4S*)-4-Azido-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1123\" num=\"2927\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and (1R*,3R*,4R*)-4-azido-3-methylcyclohexanamine '\n",
      " 'hydrochloride (example C12) the title compound is obtained as pale yellow '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-1124\" num=\"2928\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1125\" num=\"2929\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.65 (d, J=8.4, 1H, &#x2014;NH); '\n",
      " '7.83 (s, 1H); 7.75 (d, J=8.6, 1H); 7.31 (d, J=8.6, 1H); 7.09 (t, J=55.8, '\n",
      " '1H); 3.96 (d, J=7.1, 2H); 3.88 (m, 1H); 3.12 (m, 1H); 2.78 (s, 3H); '\n",
      " '2.13-1.99 (m, 3H); 1.62-1.37 (m, 3H); 1.21 (m, 1H); 1.02 (d, J=6.5, 3H); '\n",
      " '0.97 (m, 1H); 0.38 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0578\" level=\"1\">Example D.e66</heading>\\n'\n",
      " '<heading id=\"h-0579\" '\n",
      " 'level=\"1\">tert-Butyl(2S,4S)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-methylpyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1126\" num=\"2930\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and commercially available '\n",
      " 'tert-butyl(2S,4S)-4-amino-2-methylpyrrolidine-1-carboxylate the title '\n",
      " 'compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1127\" num=\"2931\">MS (ESI): m/z=557 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1128\" num=\"2932\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.87 (d, J=6.2, 1H, &#x2014;NH); '\n",
      " '7.83 (s, 1H); 7.74 (d, J=8.7, 1H); 7.31 (d, J=8.7, 1H); 7.08 (t, J=56.0, '\n",
      " '1H); 4.55 (m, 1H); 3.96 (d, J=7.0, 2H &#x26; m, 1H); 3.61 (m, 1H); 3.29 (m, '\n",
      " '1H); 2.79 (s, 3H); 2.14 (m, 1H); 1.92 (m, 1H); 1.41 (s, 9H); 1.23 (d, J=5.6, '\n",
      " '3H); 0.97 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0580\" level=\"1\">Example D.e67</heading>\\n'\n",
      " '<heading id=\"h-0581\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4R*)-4-Azido-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1129\" num=\"2933\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and (1S*,2S*,4S*)-4-azido-2-fluorocyclohexanamine '\n",
      " 'hydrochloride (example C23) the title compound is obtained as pale yellow '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-1130\" num=\"2934\">MS (ESI): m/z=514 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1131\" num=\"2935\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.89 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.80 (d, J=8.2, 1H, &#x2014;NH); '\n",
      " '7.83 (t, J=1.0, 1H); 7.75 (td, J=8.6, 1.0, 1H); 7.31 (d, J=8.6, 1H); 7.09 '\n",
      " '(t, J=56.0, 1H); 4.69 (tdd, J=49.9, 10.0, 4.5, 1H); 4.11 (m, 1H); 3.96 (d, '\n",
      " 'J=6.9, 2H); 3.69 (m, 1H); 2.79 (s, 3H); 2.43 (m, 1H); 2.06 (m, 1H); 1.95 (m, '\n",
      " '1H); 1.68 (m, 1H); 1.50 (m, 2H); 0.98 (m, 1H); 0.39 (m, 2H); 0.26 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0582\" level=\"1\">Example D.e68</heading>\\n'\n",
      " '<heading id=\"h-0583\" level=\"1\">tert-Butyl '\n",
      " '{(1S*,2S*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-methylcyclopentyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1132\" num=\"2936\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and tert-butyl '\n",
      " '[(1S*,2S*,4R*)-4-amino-2-methylcyclopentyl]carbamate (example C33) the title '\n",
      " 'compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1133\" num=\"2937\">MS (ESI): m/z=570 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1134\" num=\"2938\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.78 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.83 (d, J=1.1, 1H); 7.74 (dd, J=8.7, 1.1, 1H); 7.31 (d, J=8.7, 1H); 7.09 '\n",
      " '(t, J=56.0, 1H); 6.87 (d, J=8.2, 1H, &#x2014;NH); 4.37 (m, 1H); 3.97 (d, '\n",
      " 'J=6.9, 2H); 3.55 (m, 1H); 2.78 (s, 3H); 2.30 (m, 1H); 1.95-1.72 (m, 3H); '\n",
      " '1.40 (s, 9H); 1.20 (m, 1H); 1.04 (d, J=6.6, 3H); 0.98 (m, 1H); 0.39 (m, 2H); '\n",
      " '0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0584\" level=\"1\">Example D.e69</heading>\\n'\n",
      " '<heading id=\"h-0585\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4S*)-4-Azido-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1135\" num=\"2939\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and (1S*,2S*,4R*)-4-azido-2-methylcyclopentanamine '\n",
      " 'hydrochloride (example C34) the title compound is obtained as pale yellow '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-1136\" num=\"2940\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1137\" num=\"2941\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.86 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.74 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.83 (dd, J=0.9, 0.9, 1H); 7.74 (ddd, J=8.7, 0.9, 0.9, 1H); 7.31 (d, J=8.7, '\n",
      " '1H); 7.08 (t, J=56.0, 1H); 4.20 (m, 1H); 4.04 (m, 1H); 3.96 (d, J=7.1, 2H); '\n",
      " '2.79 (s, 3H); 2.39 (m, 1H); 2.13 (m, 1H); 2.03-1.83 (m, 2H); 1.31 (m, 1H); '\n",
      " '1.09 (d, J=7.1, 3H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0586\" level=\"1\">Example D.e70</heading>\\n'\n",
      " '<heading id=\"h-0587\" level=\"1\">tert-Butyl '\n",
      " '{(1S*,2S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-fluorocyclopentyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1138\" num=\"2942\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and tert-butyl '\n",
      " '[(1R*,2R*,4R*)-4-amino-2-fluorocyclopentyl]carbamate (example C44) the title '\n",
      " 'compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1139\" num=\"2943\">MS (ESI): m/z=574 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1140\" num=\"2944\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.90 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.83 (&#x2dc;s, 1H); 7.74 (&#x2dc;d, J=8.6, 1H); 7.31 (d, J=8.6, 1H); 7.14 '\n",
      " '(br. d, J&#x2dc;5.1, 1H, &#x2014;NH); 7.08 (t, J=55.9, 1 H); 4.93 (dm, '\n",
      " 'J=52.2, 1H); 4.60 (m, 1H); 4.09 (m, 1H); 3.96 (d, J=6.9, 2H); 2.79 (s, 3H); '\n",
      " '2.44 (m, 1H); 2.03 (m, 2H); 1.83 (m, 1H); 1.41 (s, 9H); 0.98 (m, 1H); 0.38 '\n",
      " '(m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0588\" level=\"1\">Example D.e71</heading>\\n'\n",
      " '<heading id=\"h-0589\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4R*)-4-azido-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1141\" num=\"2945\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and (1R*,2R*,4R*)-4-azido-2-fluorocyclopentanamine '\n",
      " 'hydrochloride (example C45) the title compound is obtained as pale yellow '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-1142\" num=\"2946\">MS (ESI): m/z=500 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1143\" num=\"2947\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.90 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.85 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.83 (&#x2dc;s, 1H); 7.74 (&#x2dc;d, J=8.7, 1H); 7.31 (d, J=8.7, 1H); 7.08 '\n",
      " '(t, J=56.0, 1H); 5.16 (dm, J=53.7, 1H); 4.59 (m, 1H); 4.37 (m, 1H); 3.96 (d, '\n",
      " 'J=7.1, 2H); 2.79 (s, 3H); 2.67-2.47 (m, 1H); 2.26-1.86 (m, 3H); 0.97 (m, '\n",
      " '1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0590\" level=\"1\">Example D.e72</heading>\\n'\n",
      " '<heading id=\"h-0591\" level=\"1\">tert-Butyl '\n",
      " '{(1S*,2R*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-fluorocyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1144\" num=\"2948\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and tert-butyl '\n",
      " '[(1R*,2S*,4R*)-4-amino-2-fluorocyclohexyl]carbamate (example C55) the title '\n",
      " 'compound is obtained as pale yellow foam.</p>\\n'\n",
      " '<p id=\"p-1145\" num=\"2949\">HR-MS (ESI): m/z=588.2797 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>30</sub>H<sub>37</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 588.2792).</p>\\n'\n",
      " '<p id=\"p-1146\" num=\"2950\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.63 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.83 (s, 1H); 7.75 (d, J=8.7, 1H); 7.31 (d, J=8.7, 1H); 7.09 (t, J=55.8, '\n",
      " '1H); 6.97 (d, J=7.7, 1H); 4.86 (&#x2dc;d, J=50.3, 1H); 4.12 (m, 1H); 3.96 '\n",
      " '(d, J=7.1, 2H); 3.55 (m, 1H); 2.79 (s, 3H); 2.30 (m, 1H); 1.99 (m, 1H); '\n",
      " '1.85-1.60 (m, 3H); 1.55 (m, 1H); 1.41 (s, 9H); 0.95 (m, 1H); 0.39 (m, 2H); '\n",
      " '0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0592\" level=\"1\">Example D.e73</heading>\\n'\n",
      " '<heading id=\"h-0593\" '\n",
      " 'level=\"1\">N-[(1S*,2R*,4S*)-4-Azido-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1147\" num=\"2951\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (example D.g1) and (1R*,2S*,4R*)-4-azido-2-fluorocyclohexanamine '\n",
      " 'hydrochloride (example C56) the title compound is obtained as pale yellow '\n",
      " 'foam.</p>\\n'\n",
      " '<p id=\"p-1148\" num=\"2952\">HR-MS (ESI): m/z=514.2176 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>27</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 514.2173).</p>\\n'\n",
      " '<p id=\"p-1149\" num=\"2953\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.92 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.98 (d, J=6.9, 1H, &#x2014;NH); '\n",
      " '7.84 (&#x2dc;s, 1H); 7.75 (&#x2dc;d, J=8.7, 1H); 7.32 (d, J=8.7, 1H); 7.09 '\n",
      " '(t, J=56.0, 1H); 4.99 (&#x2dc;d, J=50.1, 1H); 4.20 (dm, J=31.9, 1H); 3.97 '\n",
      " '(d, J=7.0, 2H); 3.77 (m, 1H); 2.80 (s, 3H); 2.33 (m, 1H); 2.05 (m, 1H); '\n",
      " '1.96-1.67 (m, 3H); 1.59 (m, 1H); 0.98 (m, 1H); 0.39 (m, 2H); 0.28 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0594\" level=\"1\">Example D.f1</heading>\\n'\n",
      " '<heading id=\"h-0595\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1150\" num=\"2954\">tert-Butyl 4-[({4-[5-(cyclopropyl '\n",
      " 'methoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " 'from example D.e1 (2.72 g; 4.95 mmol) is dissolved in dry 2-propanol (50 '\n",
      " 'mL). After addition of 4M HCl in dioxane (5.0 mL) the stirred reaction '\n",
      " 'mixture is heated to 80&#xb0; C. for two hours. At ambient temperature '\n",
      " 'tert.-butyl methyl ether (100 mL) is added.</p>\\n'\n",
      " '<p id=\"p-1151\" num=\"2955\">The precipitated product is isolated by suction '\n",
      " 'filtration, washed with several portions of tert.-butyl methyl ether and '\n",
      " 'dried in high vacuo at 40&#xb0; C. to yield the title compound as yellow '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-1152\" num=\"2956\">MS (ESI): m/z=450 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1153\" num=\"2957\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.38 (s, 1H, &#x2014;NH); 9.03 (s, 1H); 9.00 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.66 (d, J=7.5, 1H, &#x2014;NH); 7.04 '\n",
      " '(d, J=8.6, 1H); 6.58 (d, J=8.6, 1H); 6.03 (s, 2H); 4.15 (m, 1H); 3.78 (d, '\n",
      " 'J=6.8, 2H); 3.31 (m, 2H); 3.08 (m, 2H); 2.80 (s, 3H); 2.13 (m, 2H); 1.79 (m, '\n",
      " '2H); 0.90 (m, 1H); 0.32 (m, 2H); 0.15 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-1154\" num=\"2958\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in above example D.f1.</p>\\n'\n",
      " '<heading id=\"h-0596\" level=\"1\">Example D.f2</heading>\\n'\n",
      " '<heading id=\"h-0597\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1155\" num=\"2959\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e2) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1156\" num=\"2960\">MS (ESI): m/z=464 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1157\" num=\"2961\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.27 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.54 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.04 (br. d, J&#x2dc;4.8, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.04 (d, '\n",
      " 'J=8.6, 1H); 6.57 (d, J=8.6, 1H); 6.02 (s, 2H); 3.80 (m, 1H); 3.77 (d, J=6.8, '\n",
      " '2H); 3.09 (m, 1H); 2.79 (s, 3H); 2.04 (m, 4H); 1.47 (m, 4H); 0.89 (m, 1H); '\n",
      " '0.31 (m, 2H); 0.14 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0598\" level=\"1\">Example D.f3</heading>\\n'\n",
      " '<heading id=\"h-0599\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1158\" num=\"2962\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e3) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1159\" num=\"2963\">MS (ESI): m/z=464 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1160\" num=\"2964\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.40 (s, 1H, &#x2014;NH); 9.10 (s, 1H); 8.91 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '8.15 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.05 (d, J=8.6, 1H); '\n",
      " '6.58 (d, J=8.6, 1H); 6.04 (s, 2H); 4.12 (m, 1H); 3.79 (d, J=6.8, 2H); 3.17 '\n",
      " '(m, 1H); 2.81 (s, 3H); 1.96-1.64 (m, 8H); 0.91 (m, 1H); 0.33 (m, 2H); 0.16 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0600\" level=\"1\">Example D.f4</heading>\\n'\n",
      " '<heading id=\"h-0601\" '\n",
      " 'level=\"1\">4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1161\" num=\"2965\">Starting from '\n",
      " 'tert-butyl(3R)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate '\n",
      " '(example D.e4) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1162\" num=\"2966\">MS (ESI): m/z=436 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1163\" num=\"2967\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.39 (s, 1H, &#x2014;NH); 9.32 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.02 (s, 1H); 8.80 (d, J=6.8, 1H, '\n",
      " '&#x2014;NH); 7.04 (d, J=8.6, 1H); 6.58 (d, J=8.6, 1H); 6.03 (s, 2H); 4.63 '\n",
      " '(m, 1H); 3.78 (d, 6.8, 2H); 3.52 (m, 1H); 3.39 (m, 1H); 3.26 (m, 1H); 3.17 '\n",
      " '(m, 1H); 2.79 (s, 3H); 2.34 (m, 1H); 2.01 (m, 1H); 0.89 (m, 1H); 0.31 (m, '\n",
      " '2H); 0.14 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0602\" level=\"1\">Example D.f5</heading>\\n'\n",
      " '<heading id=\"h-0603\" '\n",
      " 'level=\"1\">4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1164\" num=\"2968\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-3-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.e5) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1165\" num=\"2969\">MS (ESI): m/z=452 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1166\" num=\"2970\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.04 (s, 1H); 7.05 (d, J=8.6, 1H); 6.60 (d, J=8.6, 1H); '\n",
      " '6.04 (s, 2H); 4.43 (m, 2H); 3.79 (d, J=6.9, 2H); 3.67 (m, 1H); 3.47 (m, 1H); '\n",
      " '3.33 (m, 1H); 3.20 (m, 1H); 2.81 (s, 3H); 0.91 (m, 1H); 0.33 (m, 2H); 0.16 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0604\" level=\"1\">Example D.f6</heading>\\n'\n",
      " '<heading id=\"h-0605\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1167\" num=\"2971\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e6) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1168\" num=\"2972\">MS (ESI): m/z=424 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1169\" num=\"2973\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (s, 1H, &#x2014;NH); 9.03 (s. 1H); 8.99 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.71 (d, J=7.7, 1H, &#x2014;NH); 7.68 '\n",
      " '(dd, J=8.4, 6.9, 1H); 7.12 (dd, J=11.7, 2.4, 1H); 6.99 (ddd, J=8.4, 8.4, '\n",
      " '2.4, 1H); 4.15 (m, 1H); 3.93 (d, J=7.1, 2H); 3.31 (m, 2H); 3.07 (m, 2H); '\n",
      " '2.80 (s, 3H); 2.13 (m, 2H); 1.79 (m, 2H); 0.96 (m, 1H); 0.38 (m, 2H): 0.26 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0606\" level=\"1\">Example D.f7</heading>\\n'\n",
      " '<heading id=\"h-0607\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1170\" num=\"2974\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e7) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1171\" num=\"2975\">MS (ESI): m/z=438 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1172\" num=\"2976\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.18 (s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.56 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '8.10 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.68 (dd, 8.4, 6.9, '\n",
      " '1H); 7.12 (dd, 11.7, 2.4, 1H); 7.00 (ddd, 8.4, 8.4, 2.4, 1H); 3.93 (d, '\n",
      " 'J=6.9, 2H); 3.81 (m, 1H); 3.08 (m, 1H); 2.81 (s, 3H); 2.04 (m, 4H); 1.47 (m, '\n",
      " '4H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0608\" level=\"1\">Example D.f8</heading>\\n'\n",
      " '<heading id=\"h-0609\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1173\" num=\"2977\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e8) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1174\" num=\"2978\">MS (ESI): m/z=438 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1175\" num=\"2979\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (s, 1H, &#x2014;NH); 9.09 (s, 1H); 8.97 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '8.14 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.69 (dd, 8.6, 6.9, '\n",
      " '1H); 7.12 (dd, 11.7, 2.4, 1H); 7.00 (ddd, 8.6, 8.6, 2.4, 1H); 4.13 (m, 1H); '\n",
      " '3.93 (d, J=7.1, 2H); 3.18 (m, 1H); 2.81 (s, 3H); 1.87 (m, 4H); 1.74 (m, 4H); '\n",
      " '0.97 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0610\" level=\"1\">Example D.f9</heading>\\n'\n",
      " '<heading id=\"h-0611\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1176\" num=\"2980\">Starting from '\n",
      " 'tert-butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate '\n",
      " '(example D.e9) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1177\" num=\"2981\">MS (ESI): m/z=410 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1178\" num=\"2982\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (s, 1H, &#x2014;NH); 9.31 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.01 (s, 1H); 8.85 (d, J=6.6, 1H, '\n",
      " '&#x2014;NH); 7.68 (dd, J=8.4, 6.9, 1H); 7.11 (dd, J=11.7, 2.4, 1H); 6.99 '\n",
      " '(ddd, J=8.4, 8.4, 2.4, 1H); 4.63 (m, 1H); 3.93 (d, J=7.1, 2H); 3.51 (m, 1H); '\n",
      " '3.39 (m, 1H); 3.27 (m, 1H); 3.16 (m, 1H); 2.80 (s. 3H); 2.35 (m, 1H); 2.01 '\n",
      " '(m, 1H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0612\" level=\"1\">Example D.f10</heading>\\n'\n",
      " '<heading id=\"h-0613\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1179\" num=\"2983\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.e10) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1180\" num=\"2984\">MS (ESI): m/z=426 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1181\" num=\"2985\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.07 (s, 1H, &#x2014;NH); 9.42 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.99 (s, 1H); 8.85 (d, J=6.0, 1H, '\n",
      " '&#x2014;NH); 7.68 (dd, J=8.4, 6.9, 1H); 7.11 (dd, J=11.7, 2.4, 1H); 6.98 '\n",
      " '(ddd, J=8.4, 8.4, 2.4, 1H); 4.53-4.34 (m, 2H); 3.92 (d, 7.1, 2H); 3.63 (m, '\n",
      " '1H); 3.43 (m, 1H); 3.27 (m, 1H); 3.16 (m, 1H); 2.80 (s. 3H); 0.95 (m, 1H); '\n",
      " '0.37 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0614\" level=\"1\">Example D.f11</heading>\\n'\n",
      " '<heading id=\"h-0615\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4S*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1182\" num=\"2986\">Starting from '\n",
      " 'tert-butyl(3S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.e11) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1183\" num=\"2987\">MS (ESI): m/z=440 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1184\" num=\"2988\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.20 (s, 1H, &#x2014;NH); [9.37 (br. s), 9.04 (br. s), 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.04 (s, 1H); 8.78 (d, J=7.3, 1H, '\n",
      " '&#x2014;NH); 7.69 (dd, J=8.6, 6.9, 1H); 7.12 (dd, J=11.7, 2.4, 1H); 7.00 '\n",
      " '(ddd, J=8.6, 8.6, 2.4, 1H); 4.02 (m, 1H); 3.93 (d, 7.1, 2H); 3.63 (m, 1H); '\n",
      " '3.88 (m, 1H); 3.26 (m, 2H); 3.05 (m, 1H); 2.86 (m, 1H); 2.82 (s. 3H); 2.24 '\n",
      " '(m, 1H); 1.76 (m, 1H); 0.97 (m, 1H); 0.38 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0616\" level=\"1\">Example D.f12</heading>\\n'\n",
      " '<heading id=\"h-0617\" '\n",
      " 'level=\"1\">4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid piperidin-4-ylamide hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1185\" num=\"2989\">Starting from tert-butyl '\n",
      " '4-({1-[4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl]-methanoyl}-amino)-piperidine-1-carboxylate '\n",
      " '(example D.e12) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1186\" num=\"2990\">MS (ESI): m/z=424 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1187\" num=\"2991\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.03 (br.s, 1H, &#x2014;NH); 9.02 (s, 1H); 8.78 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.75 (d, J=6.5, 1H, &#x2014;NH); 7.44 '\n",
      " '(dd, J=9.0, 3.2, 1H); 7.40 (ddd, J=9.1, 8.2, 3.2, 1H); 7.20 (dd, J=9.1, 4.4, '\n",
      " '1H); 4.15 (m, 1H); 3.88 (d, J=7.0, 2H); 3.32 (m, 2H); 3.08 (m, 2H); 2.80 (s, '\n",
      " '3H); 2.13 (m, 2H); 1.78 (m, 2H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0618\" level=\"1\">Example D.f13</heading>\\n'\n",
      " '<heading id=\"h-0619\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1188\" num=\"2992\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e13) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1189\" num=\"2993\">MS (ESI): m/z=438 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1190\" num=\"2994\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.04 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.60 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.07 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.44 (dd, J=8.4, 3.2, '\n",
      " '1H); 7.39 (ddd, J=8.9, 8.3, 3.2, 1H); 7.20 (dd, J=8.9, 4.3, 1H); 3.88 (d, '\n",
      " 'J=7.1, 2H); 3.81 (m, 1H); 3.09 (m, 1H); 2.80 (s, 3H); 2.04 (m, 4H); 1.47 (m, '\n",
      " '4H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0620\" level=\"1\">Example D.f14</heading>\\n'\n",
      " '<heading id=\"h-0621\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1191\" num=\"2995\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e14) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1192\" num=\"2996\">MS (ESI): m/z=438 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1193\" num=\"2997\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.10 (br.s, 1H, &#x2014;NH); 9.08 (s, 1H); 8.98 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '8.15 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.46 (dd, J=8.9, 3.3, '\n",
      " '1H); 7.41 (ddd, J=8.9, 8.6, 3.3, 1H); 7.21 (dd, J=9.1, 4.4, 1H); 4.12 (m, '\n",
      " '1H); 3.89 (d, J=6.9, 2H); 3.18 (m, 1H); 2.81 (s, 3H); 1.95-1.67 (m, 8H); '\n",
      " '0.95 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0622\" level=\"1\">Example D.f15</heading>\\n'\n",
      " '<heading id=\"h-0623\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1194\" num=\"2998\">Starting from '\n",
      " 'tert-butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate '\n",
      " '(example D.e15) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1195\" num=\"2999\">MS (ESI): m/z=410 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1196\" num=\"3000\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (s, 1H, &#x2014;NH); 9.34 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.02 (s, 1H); 8.86 (d, J=6.6, 1H, '\n",
      " '&#x2014;NH); 7.46 (dd, J=8.9, 3.2, 1H); 7.41 (ddd, J=9.1, 8.4, 3.2, 1H); '\n",
      " '7.21 (dd, J=9.1, 4.4, 1H); 4.64 (m, 1H); 3.89 (d, J=6.9, 2H); 3.50 (m, 1H); '\n",
      " '3.39 (m, 1H); 3.27 (m, 1H); 3.16 (m, 1H); 2.81 (s, 3H); 2.35 (m, 1H); 2.01 '\n",
      " '(m, 1H); 0.94 (m, 1H); 0.35 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0624\" level=\"1\">Example D.f16</heading>\\n'\n",
      " '<heading id=\"h-0625\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1197\" num=\"3001\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.e16) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1198\" num=\"3002\">MS (ESI): m/z=440 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1199\" num=\"3003\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.05 (s, 1H); 7.46 (ddd, J=9.1, 8.8, 3.1, 1H); 7.40 '\n",
      " '(dd, J=8.2, 3.1, 1H); 7.22 (dd, J=9.1, 4.4, 1H); 4.03 (m, 1H); 3.90 (d, '\n",
      " 'J=6.9, 2H &#x26; m, 1H); 3.30 (m, 1H); 3.25 (m, 1H); 3.09 (m, 1H); 2.90 (m, '\n",
      " '1H); 2.82 (s, 3H); 2.27 (m, 1H); 1.76 (m, 1H); 0.95 (m, 1H); 0.37 (m, 2H); '\n",
      " '0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0626\" level=\"1\">Example D.f17</heading>\\n'\n",
      " '<heading id=\"h-0627\" '\n",
      " 'level=\"1\">4-(2-Ethoxy-5-fluorophenyl)-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1200\" num=\"3004\">Starting from tert-butyl '\n",
      " '4-({[4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbonyl}amino)piperidine-1-carboxylate '\n",
      " '(example D.e17) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1201\" num=\"3005\">MS (ESI): m/z=398 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1202\" num=\"3006\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.11 (br.s, 1H, &#x2014;NH); 9.02 (s, 1H); 8.96 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.72 (d, J=7.5, 1H, &#x2014;NH); 7.45 '\n",
      " '(ddd, J=9.1, 8.9, 3.3, 1H); 7.41 (dd, J=8.2, 3.3, 1H); 7.24 (dd, J=9.1, 4.4, '\n",
      " '1H); 4.14 (m, 1H); 4.08 (qu, J=6.9, 2H); 3.31 (m, 2H); 3.08 (m, 2H); 2.80 '\n",
      " '(s, 3H); 2.12 (m, 2H); 1.78 (m, 2H); 1.11 (t, J=6.9, 3H).</p>\\n'\n",
      " '<heading id=\"h-0628\" level=\"1\">Example D.f18</heading>\\n'\n",
      " '<heading id=\"h-0629\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1203\" num=\"3007\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e18) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1204\" num=\"3008\">MS (ESI): m/z=436 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1205\" num=\"3009\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.28 (br.s, 1H, &#x2014;NH); 9.04 (s, 1H); 8.98 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.66 (d, J=7.5, 1H, &#x2014;NH); 7.62 '\n",
      " '(d, J=8.4, 1H); 6.77 (dd, J=8.4, 2.2, 2H); 6.73 (d, J=2.2, 1H); 4.03 (m, '\n",
      " '1H); 3.93 (d, J=6.9, 2H); 3.88 (s, 3H); 3.31 (m, 2H); 3.08 (m, 2H); 2.82 (s, '\n",
      " '3H); 2.12 (m, 2H); 1.79 (m, 2H); 0.97 (m, 1H); 0.39 (m, 2H); 0.27 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0630\" level=\"1\">Example D.f19</heading>\\n'\n",
      " '<heading id=\"h-0631\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1206\" num=\"3010\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e19) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1207\" num=\"3011\">MS (ESI): m/z=450 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1208\" num=\"3012\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.39 (s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.48 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.11 (br. d, J&#x2dc;4.2, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.62 (d, '\n",
      " 'J=8.4, 1H); 6.78 (dd, J=8.4, 2.2, 1H); 6.74 (d, J=2.2, 1H); 3.94 (d, J=6.9, '\n",
      " '2H); 3.88 (s, 3H); 3.81 (m, 1H); 3.08 (m, 1H); 2.83 (s, 3H); 2.04 (m, 4H); '\n",
      " '1.47 (m, 4H); 0.97 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0632\" level=\"1\">Example D.f20</heading>\\n'\n",
      " '<heading id=\"h-0633\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1209\" num=\"3013\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e20) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1210\" num=\"3014\">MS (ESI): m/z=450 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1211\" num=\"3015\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.35 (br.s, 1H, &#x2014;NH); 9.14 (s, 1H); 8.94 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.19 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.63 (d, J=8.4, 1H); '\n",
      " '6.78 (dd, J=8.4, 2.2, 2H); 6.75 (d, J=2.2, 1H); 4.14 (m, 1H); 3.94 (d, '\n",
      " 'J=6.9, 2H); 3.88 (s, 3H); 3.18 (m, 1H); 2.83 (s, 3H); 1.96-1.66 (m, 8H); '\n",
      " '0.98 (m, 1H); 0.39 (m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0634\" level=\"1\">Example D.f21</heading>\\n'\n",
      " '<heading id=\"h-0635\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1212\" num=\"3016\">Starting from '\n",
      " 'tert-butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate '\n",
      " '(example D.e21) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1213\" num=\"3017\">MS (ESI): m/z=422 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1214\" num=\"3018\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.28 (br.s, 1H, &#x2014;NH); 9.31 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.02 (s, 1H); 8.81 (d, J=6.8, 1H, '\n",
      " '&#x2014;NH); 7.63 (d, J=8.4, 1H); 6.77 (dd, J=8.4, 2.2, 2H); 6.73 (d, J=2.2, '\n",
      " '1H); 4.63 (m, 1H); 3.93 (d, J=7.1, 2H); 3.88 (s, 3H); 3.51 (m, 1H); 3.39 (m, '\n",
      " '1H); 3.27 (m, 1H); 3.16 (m, 1H); 2.82 (s, 3H); 2.35 (m, 1H); 2.01 (m, 1H); '\n",
      " '0.97 (m, 1H); 0.38 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0636\" level=\"1\">Example D.f22</heading>\\n'\n",
      " '<heading id=\"h-0637\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1215\" num=\"3019\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.e22) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1216\" num=\"3020\">MS (ESI): m/z=438 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1217\" num=\"3021\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.36 (br.s, 1H, &#x2014;NH); [9.64 (br.s, 1H), 9.48 (br.s, 1H), '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>]; 9.01 (s, 1H); 8.78 (d, J=6.2, 1H, '\n",
      " '&#x2014;NH); 7.63 (d, J=8.4, 1H); 6.77 (dd, J=8.4, 2.2, 2H); 6.74 (d, J=2.2, '\n",
      " '1H); 4.39 (m, 2H); 3.94 (d, J=6.9, 2H); 3.88 (s, 3H); 3.63 (m, 1H); 3.43 (m, '\n",
      " '1H); 3.26 (m, 1H); 3.15 (m, 1H); 2.82 (s, 3H); 0.97 (m, 1H); 0.38 (m, 2H); '\n",
      " '0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0638\" level=\"1\">Example D.f23</heading>\\n'\n",
      " '<heading id=\"h-0639\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1218\" num=\"3022\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e23) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1219\" num=\"3023\">MS (ESI): m/z=436 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1220\" num=\"3024\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.12 (s, 1H, &#x2014;NH); 9.04 (s, 1H); 8.94 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.72 (d, J=7.5, 1H, &#x2014;NH); 7.20 '\n",
      " '(t, J=1.6, 1H); 7.15 (d, J=1.6, 1H); 4.16 (m, 1H); 3.84 (d, J=6.8, 2H); 3.78 '\n",
      " '(s, 3H); 3.31 (m, 2H); 3.08 (m, 2H); 2.81 (s, 3H); 2.13 (m, 2H); 1.79 (m, '\n",
      " '2H); 0.93 (m, 1H); 0.35 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0640\" level=\"1\">Example D.f24</heading>\\n'\n",
      " '<heading id=\"h-0641\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1221\" num=\"3025\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e24) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1222\" num=\"3026\">MS (ESI): m/z=450 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1223\" num=\"3027\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.07 (s, 1H, &#x2014;NH); 9.01 (s, 1H); 8.59 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.03 (br. d, J&#x2dc;4.8, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.20 (t, '\n",
      " 'J=1.8, 1H); 7.14 (d, J=1.8, 2H); 3.84 (d, J=6.9, 2H &#x26; m, 1H); 3.78 (s, '\n",
      " '3H); 3.09 (m, 1H); 2.80 (s, 3H); 2.04 (m, 4H); 1.47 (m, 4H); 0.92 (m, 1H); '\n",
      " '0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0642\" level=\"1\">Example D.f25</heading>\\n'\n",
      " '<heading id=\"h-0643\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1224\" num=\"3028\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e25) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1225\" num=\"3029\">MS (ESI): m/z=450 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1226\" num=\"3030\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (br.s, 1H, &#x2014;NH); 9.11 (s, 1H); 8.96 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '8.13 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.22 (t, J=1.6, 1H); '\n",
      " '7.15 (d, J=1.6, 2H); 4.13 (m, 1H); 3.85 (d, J=6.9, 2H); 3.78 (s, 3H); 3.18 '\n",
      " '(m, 1H); 2.82 (s, 3H); 1.95-1.67 (m, 8H); 0.93 (m, 1H); 0.35 (m, 2H); 0.21 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0644\" level=\"1\">Example D.f26</heading>\\n'\n",
      " '<heading id=\"h-0645\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1227\" num=\"3031\">Starting from '\n",
      " 'tert-butyl(3R)-3-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate '\n",
      " '(example D.e26) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1228\" num=\"3032\">MS (ESI): m/z=422 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1229\" num=\"3033\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.07 (s, 1H); 7.24 (dd, J=2.2, 0.9, 2H); 7.17 (d, '\n",
      " 'J=2.2, 1H); 7.16 (d, J=0.9, 1H); 4.64 (m, 1H); 3.85 (d, J=6.9, 2H); 3.78 (s, '\n",
      " '2H); 3.53 (m, 1H); 3.44 (m, 1H); 3.29 (m, 1H); 3.22 (m, 1H); 2.83 (s, 3H); '\n",
      " '2.37 (m, 1H); 2.04 (m, 1H); 0.93 (m, 1H); 0.35 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0646\" level=\"1\">Example D.f27</heading>\\n'\n",
      " '<heading id=\"h-0647\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1230\" num=\"3034\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.e27) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1231\" num=\"3035\">MS (ESI): m/z=452 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1232\" num=\"3036\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.09 (s, 1H); 7.24 (s, 1H); 7.18 (s, 2H); 4.04 (m, 1H); '\n",
      " '3.93 (m, 1H); 3.86 (d, J=6.8, 2H); 3.80 (m, 3H); 3.32 (m, 1H); 3.25 (m, 1H); '\n",
      " '3.09 (m, 1H); 2.90 (m, 1H); 2.84 (s, 3H); 2.27 (m, 1H); 1.77 (m, 1H); 0.94 '\n",
      " '(m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0648\" level=\"1\">Example D.f28</heading>\\n'\n",
      " '<heading id=\"h-0649\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1233\" num=\"3037\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e28) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1234\" num=\"3038\">MS (ESI): m/z=420 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1235\" num=\"3039\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.25 (br.s, 1H, &#x2014;NH); 9.11 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.06 (s, 1H); 7.47 (d, J=2.1, 1H); 7.39 '\n",
      " '(dd, J=8.4, 2.1, 1H); 7.10 (d, J=8.6, 1H); 4.12 (m, 1H); 3.88 (d, J=6.9, '\n",
      " '2H); 3.31 (m, 2H); 3.08 (m, 2H); 2.81 (s, 3H); 2.34 (s, 3H); 2.13 (m, 2H); '\n",
      " '1.79 (m, 2H); 0.93 (m, 1H); 0.36 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0650\" level=\"1\">Example D.f29</heading>\\n'\n",
      " '<heading id=\"h-0651\" '\n",
      " 'level=\"1\">N-(Trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1236\" num=\"3040\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e29) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1237\" num=\"3041\">MS (ESI): m/z=434 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1238\" num=\"3042\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.25 (br.s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.55 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.09 (br. d, J=4.2, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.46 (d, J=2.1, '\n",
      " '1H); 7.39 (dd, J=8.4, 2.1, 1H); 7.11 (d, J=8.6, 1H); 3.88 (d, J=6.9, 2H); '\n",
      " '3.82 (m, 1H); 3.09 (m, 1H); 2.81 (s, 3H); 2.34 (s, 3H); 2.04 (m, 4H); 1.47 '\n",
      " '(m, 4H); 0.93 (m, 1H); 0.36 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0652\" level=\"1\">Example D.f30</heading>\\n'\n",
      " '<heading id=\"h-0653\" '\n",
      " 'level=\"1\">N-(Cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1239\" num=\"3043\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e30) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1240\" num=\"3044\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1241\" num=\"3045\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 9.00 (d, J=9.3, 1H, &#x2014;NH); 8.98 (s, 1H); '\n",
      " '7.43 (d, J=2.1, 1H); 7.33 (dd, J=8.4, 2.1, 1H); 7.06 (d, J=8.4, 1H); 6.97 '\n",
      " '(d, J=7.7, 1H, &#x2014;NH); 4.03 (m, 1H); 3.86 (d, J=6.9, 2H); 3.42 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.32 (s, 3H); 1.81-1.51 (m, 8H); 1.40 (s, 9H); 0.94 (m, 1H); '\n",
      " '0.37 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0654\" level=\"1\">Example D.f31</heading>\\n'\n",
      " '<heading id=\"h-0655\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1242\" num=\"3046\">Starting tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " 'from (example D.e31) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1243\" num=\"3047\">MS (ESI): m/z=474 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1244\" num=\"3048\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.11 (s, 1H, &#x2014;NH); 9.04 (s, 1H); 8.98 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.75 (d, J=7.5, 1H, &#x2014;NH); 7.93 '\n",
      " '(d, J=2.0, 1H); 7.91 (dd, J=8.8, 2.0, 1H); 7.39 (d, J=8.8, 1H); 4.16 (m, '\n",
      " '1H); 4.01 (d, J=6.9, 2H); 3.32 (m, 2H); 3.08 (m, 2H); 2.80 (s, 3H); 2.13 (m, '\n",
      " '2H); 1.79 (m, 2H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0656\" level=\"1\">Example D.f32</heading>\\n'\n",
      " '<heading id=\"h-0657\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1245\" num=\"3049\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e32) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1246\" num=\"3050\">MS (ESI): m/z=488 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1247\" num=\"3051\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.08 (s, 1H, &#x2014;NH); 9.01 (s, 1H); 8.61 (d, J=8.6, 1H, &#x2014;NH); '\n",
      " '8.07 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.92 (d, J=2.0, 1H); '\n",
      " '7.91 (dd, J=8.8, 2.0, 1H); 7.39 (d, J=8.8, 1H); 4.01 (d, J=7.0, 2H); 3.81 '\n",
      " '(m, 2H); 3.09 (m, 2H); 2.80 (s, 3H); 2.04 (m, 4H); 1.48 (m, 4H); 0.98 (m, '\n",
      " '1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0658\" level=\"1\">Example D.f33</heading>\\n'\n",
      " '<heading id=\"h-0659\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1248\" num=\"3052\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e33) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1249\" num=\"3053\">MS (ESI): m/z=488 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1250\" num=\"3054\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.04 (s, 1H, &#x2014;NH); 9.08 (s, 1H); 8.98 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.99 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.94 (d, J=2.1, 1H); '\n",
      " '7.92 (dd, J=8.7, 2.1, 1H); 7.40 (d, J=8.7, 1H); 4.13 (m, 1H); 4.02 (d, '\n",
      " 'J=6.9, 2H); 3.20 (m, 1H); 2.82 (s, 3H); 1.89 (m, 4H); 1.75 (m, 4H); 0.99 (m, '\n",
      " '1H); 0.41 (m, 2H); 0.29 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0660\" level=\"1\">Example D.f34</heading>\\n'\n",
      " '<heading id=\"h-0661\" '\n",
      " 'level=\"1\">4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1251\" num=\"3055\">Starting from tert-butyl '\n",
      " '4-[({4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e34) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1252\" num=\"3056\">MS (ESI): m/z=448 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1253\" num=\"3057\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (br.s, 1H, &#x2014;NH); 9.04 (s, 1H); 8.99 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.73 (d, J=7.1, 1H, &#x2014;NH); 7.93 '\n",
      " '(d, J=2.2, 1H); 7.92 (dd, J=9.5, 2.2, 1H); 7.43 (d, J=9.5, 1H); 4.22 (qu, '\n",
      " 'J=6.9, 2H); 4.17 (m, 1H); 3.31 (m, 2H); 3.08 (m, 2H); 2.80 (s, 3H); 2.13 (m, '\n",
      " '2H); 1.79 (m, 2H); 1.16 (t, J=6.9, 3H).</p>\\n'\n",
      " '<heading id=\"h-0662\" level=\"1\">Example D.f35</heading>\\n'\n",
      " '<heading id=\"h-0663\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1254\" num=\"3058\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e35) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1255\" num=\"3059\">MS (ESI): m/z=454 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1256\" num=\"3060\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.11 (s, 1H, &#x2014;NH); 9.04 (s, 1H); 8.96 (br.s, 3H, '\n",
      " 'NH<sub>2</sub><sup>+</sup>); 8.72 (d, J=6.9, 1H, &#x2014;NH); 7.43 (d, '\n",
      " 'J=9.9, 1H); 7.22 (d, J=13.3, 1H); 4.15 (m, 1H); 3.86 (d, J=6.9, 2H); 3.85 '\n",
      " '(s, 3H); 3.31 (m, 2H); 3.08 (m, 2H); 2.81 (s, 3H); 2.13 (m, 2H); 1.79 (m, '\n",
      " '2H); 0.93 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0664\" level=\"1\">Example D.f36</heading>\\n'\n",
      " '<heading id=\"h-0665\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1257\" num=\"3061\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e36) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1258\" num=\"3062\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1259\" num=\"3063\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (s, 1H, &#x2014;NH); 9.02 (s, 1H); 8.56 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.09 (br.s, 3H, NH<sub>3</sub><sup>+</sup>); 7.43 (d, J=9.7, 1H); 7.22 (d, '\n",
      " 'J=13.5, 1H); 3.86 (d, J=6.9, 2H); 3.85 (s, 3H); 3.79 (m, 1H); 3.08 (m, 1H); '\n",
      " '2.81 (s, 3H); 2.04 (m, 4H); 1.47 (m, 4H); 0.92 (m, 1H); 0.36 (m, 2H); 0.22 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0666\" level=\"1\">Example D.f37</heading>\\n'\n",
      " '<heading id=\"h-0667\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1260\" num=\"3064\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e37) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1261\" num=\"3065\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1262\" num=\"3066\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.19 (s, 1H, &#x2014;NH); 9.12 (s, 1H); 8.95 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '8.18 (br.s, 3H, NH<sub>3</sub><sup>+</sup>); 7.45 (d, J=9.7, 1H); 7.23 (d, '\n",
      " 'J=13.5, 1H); 4.14 (m, 1H); 3.87 (d, J=6.9, 2H); 3.86 (s, 3H); 3.17 (m, 1H); '\n",
      " '2.82 (s, 3H); 1.81 (m, 8H); 0.94 (m, 1H); 0.37 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0668\" level=\"1\">Example D.f38</heading>\\n'\n",
      " '<heading id=\"h-0669\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1263\" num=\"3067\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.e38) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1264\" num=\"3068\">MS (ESI): m/z=470 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1265\" num=\"3069\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.08 (s, 1H); 7.47 (d, J=9.9, 1H); 7.24 (d, J=13.3, '\n",
      " '1H); 4.05 (m, 1H); 3.87 (s, 3H &#x26; d, J=6.9, 2H &#x26; m, 1H); 3.29 (m, '\n",
      " '2H); 3.11 (m, 1H); 2.92 (m, 1H); 2.84 (s, 3H); 2.28 (m, 1H); 1.76 (m, 1H); '\n",
      " '0.95 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0670\" level=\"1\">Example D.f39</heading>\\n'\n",
      " '<heading id=\"h-0671\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1266\" num=\"3070\">Starting from '\n",
      " 'tert-butyl(3S*,4S*)-3-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.e39) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1267\" num=\"3071\">MS (ESI): m/z=470 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1268\" num=\"3072\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.05 (s, 1H); 7.45 (d, J=9.7, 1H); 7.23 (d, J=13.3, '\n",
      " '1H); 4.08 (m, 1H); 3.86 (s, 3H &#x26; d, J=6.8, 2H &#x26; m, 1H); 3.50 (m, '\n",
      " '1H); 3.30 (m, 1H); 3.00 (m, 1H); 2.83 (s, 3H); 2.10 (m, 1H); 1.73 (m, 1H); '\n",
      " '0.94 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0672\" level=\"1\">Example D.f40</heading>\\n'\n",
      " '<heading id=\"h-0673\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1269\" num=\"3073\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e40) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1270\" num=\"3074\">MS (ESI): m/z=438/(MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1271\" num=\"3075\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.32 (s, 1H, &#x2014;NH); 9.10 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.06 (s, 1H); 8.66 (d, J=7.5, 1H, '\n",
      " '&#x2014;NH); 7.58 (d, J=8.9, 1H); 7.09 (d, J=12.1, 1H); 4.14 (m, 1H); 3.90 '\n",
      " '(d, J=7.1, 2H); 3.31 (m, 2H); 3.07 (m, 2H); 2.82 (s, 3H); 2.26 (d, J=0.9, '\n",
      " '3H); 2.13 (m, 1H); 1.80 (m, 2H); 0.96 (m, 1H); 0.37 (m, 2H); 0.24 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0674\" level=\"1\">Example D.f41</heading>\\n'\n",
      " '<heading id=\"h-0675\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1272\" num=\"3076\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e41) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1273\" num=\"3077\">MS (ESI): m/z=452 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1274\" num=\"3078\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.66 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.98 (br. d, J&#x2dc;4.6, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.55 (dd, '\n",
      " 'J=9.1, 0.6, 1H); 7.06 (d, J=12.0, 1H); 3.88 (d, J=7.1, 2H); 3.82 (m, 1H); '\n",
      " '3.09 (m, 1H); 2.79 (s, 3H); 2.25 (d, J=1.1, 3H); 2.04 (m, 4H); 1.47 (m, 4H); '\n",
      " '0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0676\" level=\"1\">Example D.f42</heading>\\n'\n",
      " '<heading id=\"h-0677\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1275\" num=\"3079\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e42) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1276\" num=\"3080\">MS (ESI): m/z=452 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1277\" num=\"3081\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.20 (br.s, 1H, &#x2014;NH); 9.10 (s, 1H); 8.96 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '8.16 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.58 (dd, J=8.9, 0.6, '\n",
      " '1H); 7.08 (d, J=12.1, 1H); 4.13 (m, 1H); 3.90 (d, J=6.9, 2H); 3.17 (m, 1H); '\n",
      " '2.82 (s, 3H); 2.26 (d, J=1.1, 3H); 1.93-1.56 (m, 8H); 0.96 (m, 1H); 0.38 (m, '\n",
      " '2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0678\" level=\"1\">Example D.f43</heading>\\n'\n",
      " '<heading id=\"h-0679\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1278\" num=\"3082\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.e43) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1279\" num=\"3083\">MS (ESI): m/z=454 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1280\" num=\"3084\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.51 (s, 1H, &#x2014;NH); [9.62 (br. m, 1H), 9.18 (br. m, 1H), '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>]; 9.06 (s, 1H); 8.70 (d, J=7.1, 1H, '\n",
      " '&#x2014;NH); 7.60 (d, J=8.9, 1H); 7.10 (d, J=12.0, 1H); 4.01 (m, 1H); 3.91 '\n",
      " '(d, J=7.1, 2H &#x26; m, 1H); 3.26 (m, 2H); 3.04 (m, 2H); 2.84 (s, 3H &#x26; '\n",
      " 'm, 1H); 2.26 (s, 3H); 2.23 (m, 1H); 1.78 (m, 1H); 0.97 (m, 1H); 0.38 (m, '\n",
      " '2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0680\" level=\"1\">Example D.f44</heading>\\n'\n",
      " '<heading id=\"h-0681\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1281\" num=\"3085\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e44) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1282\" num=\"3086\">MS (ESI): m/z=454 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1283\" num=\"3087\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.27 (br.s, 1H, &#x2014;NH); 9.10 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.04 (s, 1H); 8.67 (d, J=7.5, 1H, '\n",
      " '&#x2014;NH); 7.53 (d, J=11.9, 1H); 6.96 (d, J=7.3, 1H); 4.15 (m, 1H); 3.99 '\n",
      " '(s, 3H); 3.97 (d, J=6.9, 2H); 3.31 (m, 2H); 3.07 (m, 2H); 2.82 (s, 3H); 2.13 '\n",
      " '(m, 2H); 1.80 (m, 2H); 0.97 (m, 1H); 0.39 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0682\" level=\"1\">Example D.f45</heading>\\n'\n",
      " '<heading id=\"h-0683\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1284\" num=\"3088\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e45) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1285\" num=\"3089\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1286\" num=\"3090\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.32 (br.s, 1H, &#x2014;NH); 9.01 (s, 1H); 8.51 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.18 (br. d, J=4.6, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.54 (d, '\n",
      " 'J=11.7, 1H); 6.96 (d, J=7.3, 1H); 3.99 (s, 3H); 3.97 (d, J=7.4, 2H); 3.81 '\n",
      " '(m, 1H); 3.07 (m, 1H); 2.83 (s, 3H); 2.05 (m, 4H); 1.48 (m, 4H); 0.97 (m, '\n",
      " '1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0684\" level=\"1\">Example D.f46</heading>\\n'\n",
      " '<heading id=\"h-0685\" '\n",
      " 'level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1287\" num=\"3091\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e46) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1288\" num=\"3092\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1289\" num=\"3093\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.36 (br.s, 1H, &#x2014;NH); 9.14 (s, 1H); 8.94 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.25 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.55 (d, J=11.7, 1H); '\n",
      " '6.97 (d, J=7.3, 1H); 4.14 (m, 1H); 3.99 (s, 3H); 3.97 (d, J=7.1, 2H); 3.16 '\n",
      " '(m, 1H); 2.84 (s, 3H); 1.86 (m, 4H); 1.74 (m, 4H); 0.98 (m, 1H); 0.39 (m, '\n",
      " '2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0686\" level=\"1\">Example D.f47</heading>\\n'\n",
      " '<heading id=\"h-0687\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1290\" num=\"3094\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-hydroxypiperidine-1-carboxylate '\n",
      " '(example D.e47) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1291\" num=\"3095\">MS (ESI): m/z=470 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1292\" num=\"3096\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 9.04 (s, 1H); 7.54 (d, J=11.9, 1H); 6.96 (d, J=7.3, '\n",
      " '1H); 4.02 (m, 1H); 3.99 (s, 3H); 3.94 (d, J=6.9, 2H); 3.88 (m, 1H); 3.29 (m, '\n",
      " '2H); 3.10 (m, 1H); 2.93 (m, 1H); 2.84 (s, 3H); 2.29 (m, 1H); 1.78 (m, 1H); '\n",
      " '0.98 (m, 1H); 0.40 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0688\" level=\"1\">Example D.f48</heading>\\n'\n",
      " '<heading id=\"h-0689\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1293\" num=\"3097\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e48) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1294\" num=\"3098\">MS (ESI): m/z=434 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1295\" num=\"3099\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.22 (s, 1H, &#x2014;NH); 9.06 (s, 1H); 9.00 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.69 (d, J=7.5, 1H, &#x2014;NH); 7.48 '\n",
      " '(d, J=2.2, 1H); 7.42 (dd, J=8.6, 2.2, 1H); 7.12 (d, J=8.6, 1H); 4.16 (m, '\n",
      " '1H); 3.89 (d, J=6.9, 2H); 3.31 (m, 2H); 3.08 (m, 2H); 2.81 (s, 3H); 2.65 '\n",
      " '(qu, J=7.5, 2H); 2.13 (m, 2H); 1.79 (m, 2H); 1.20 (t, J=7.5, 3H); 0.95 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0690\" level=\"1\">Example D.f49</heading>\\n'\n",
      " '<heading id=\"h-0691\" '\n",
      " 'level=\"1\">N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1296\" num=\"3100\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e49) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1297\" num=\"3101\">MS (ESI): m/z=448 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1298\" num=\"3102\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.21 (s, 1H, &#x2014;NH); 9.02 (s, 1H); 8.55 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.09 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.48 (d, J=2.2, 1H); '\n",
      " '7.42 (dd, J=8.6, 2.2, 1H); 7.12 (d, J=8.6, 1H); 3.89 (d, J=6.9, 2H); 3.81 '\n",
      " '(m, 1H); 3.08 (m, 1H); 3.08 (m, 2H); 2.81 (s, 3H); 2.64 (qu, J=7.5, 2H); '\n",
      " '2.05 (m, 4H); 1.48 (m, 4H); 1.20 (t, J=7.5, 3H); 0.95 (m, 1H); 0.36 (m, 2H); '\n",
      " '0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0692\" level=\"1\">Example D.f50</heading>\\n'\n",
      " '<heading id=\"h-0693\" level=\"1\">N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropyl '\n",
      " 'methoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1299\" num=\"3103\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e50) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1300\" num=\"3104\">MS (ESI): m/z=448 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1301\" num=\"3105\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.18 (br.s, 1H, &#x2014;NH); 9.11 (s, 1H); 8.96 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.15 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.48 (d, J=2.2, 1H); '\n",
      " '7.42 (dd, J=8.6, 2.2, 1H); 7.13 (d, J=8.6, 1H); 4.13 (m, 1H); 3.89 (d, '\n",
      " 'J=6.8, 2H); 3.18 (m, 1H); 3.08 (m, 1H); 2.82 (s, 3H); 2.65 (qu, J=7.5, 2H); '\n",
      " '1.96-1.66 (m, 8H); 1.20 (t, J=7.5, 3H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0694\" level=\"1\">Example D.f51</heading>\\n'\n",
      " '<heading id=\"h-0695\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1302\" num=\"3106\">Starting from '\n",
      " 'tert-butyl(3R*,4R*)-3-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-4-hydroxypyrrolidine-1-carboxylate '\n",
      " '(example D.e51) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1303\" num=\"3107\">MS (ESI): m/z=436 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<heading id=\"h-0696\" level=\"1\">Example D.f52</heading>\\n'\n",
      " '<heading id=\"h-0697\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1304\" num=\"3108\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e52) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1305\" num=\"3109\">MS (ESI): m/z=548 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1306\" num=\"3110\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, 1H); 7.08 (d; J=8.6, 1H); 4.06 '\n",
      " '(m, 1H); 3.87 (d, J=6.8, 2H &#x26; m, 2H); 3.05 (m, 2H); 2.94 (sept, J=6.9, '\n",
      " '1H); 2.77 (s, 3H); 1.92 (m, 2H); 1.45 (m, 2H); 1.43 (s, 9H); 1.22 (d, J=6.9, '\n",
      " '6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0698\" level=\"1\">Example D.f53</heading>\\n'\n",
      " '<heading id=\"h-0699\" '\n",
      " 'level=\"1\">N-(trans-4-Aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1307\" num=\"3111\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e53) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1308\" num=\"3112\">MS (ESI): m/z=462 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1309\" num=\"3113\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (br.s, 1H, &#x2014;NH); 9.02 (s, 1H); 8.56 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.06 (br. d, J&#x2dc;4.0, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.49 (d, '\n",
      " 'J=2.4, 1H); 7.45 (dd, J=8.6, 2.4, 1H); 7.12 (d; J=8.6, 1H); 3.89 (d, J=6.9, '\n",
      " '2H); 3.81 (m, 1H); 3.10 (m, 1H); 2.95 (sept, J=6.9, 1H); 2.80 (s, 3H); 2.04 '\n",
      " '(m, 4H); 1.47 (m, 4H); 1.22 (d, J=6.9, 6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0700\" level=\"1\">Example D.f54</heading>\\n'\n",
      " '<heading id=\"h-0701\" '\n",
      " 'level=\"1\">N-(cis-4-Aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1310\" num=\"3114\">Starting from tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e54) the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1311\" num=\"3115\">MS (ESI): m/z=462 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1312\" num=\"3116\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.28 (br.s, 1H, &#x2014;NH); 9.15 (s, 1H); 8.95 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.19 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.51 (d, J=2.4, 1H); '\n",
      " '7.47 (dd, J=8.6, 2.4, 1H); 7.14 (d; J=8.6, 1H); 4.14 (m, 1H); 3.90 (d, '\n",
      " 'J=6.9, 2H); 3.18 (m, 1H); 2.96 (sept, J=6.9, 1H); 2.82 (s, 3H); 1.96-1.66 '\n",
      " '(m, 8H); 1.23 (d, J=6.9, 6H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0702\" level=\"1\">Example D.f55</heading>\\n'\n",
      " '<heading id=\"h-0703\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1313\" num=\"3117\">tert-Butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " 'from example D.e55 (1.77 g; 2.99 mmol) is dissolved in dry acetone (30 mL). '\n",
      " 'After addition of 4M HCl in dioxane (3 mL) the stirred mixture is gently '\n",
      " 'refluxed until the starting material is consumed according to LC-MS. At '\n",
      " 'ambient temperature the product is precipitated by addition of tert.-butyl '\n",
      " 'methyl ether, isolated by suction filtration, washed with several portions '\n",
      " 'of tert.-butyl methyl ether and dried in high vacuo at 40&#xb0; C. to yield '\n",
      " '1.40 g of the title compound as pale yellow solid.</p>\\n'\n",
      " '<p id=\"p-1314\" num=\"3118\">MS (ESI): m/z=448 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1315\" num=\"3119\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.18 (s, 1H, &#x2014;NH); 9.06 (s, 1H); 8.99 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 8.73 (d, J=7.5, 1H, &#x2014;NH); 8.23 '\n",
      " '(d, J=2.3, 1H); 8.17 (dd, J=8.8, 2.3, 1H); 7.32 (d, J=8.8, 1H); 4.10 (m, '\n",
      " '1H); 4.02 (d, J=7.1, 2H); 3.31 (m, 2H); 3.08 (m, 2H); 2.81 (s, 3H); 2.59 (s, '\n",
      " '3H); 2.13 (m, 2H); 1.80 (m, 2H); 0.99 (m, 1H); 0.39 (m, 2H); 0.29 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0704\" level=\"1\">Example D.f56</heading>\\n'\n",
      " '<heading id=\"h-0705\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-aminocyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1316\" num=\"3120\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e56) and following the procedure as described for above example '\n",
      " 'D.f55 the title compound is obtained as yellow solid.</p>\\n'\n",
      " '<p id=\"p-1317\" num=\"3121\">MS (ESI): m/z=462 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1318\" num=\"3122\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.15 (s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.60 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.23 (d, J=2.2, 1H); 8.17 (dd, J=8.8, 2.2, 1H); 8.08 (br.s, 3H, '\n",
      " '&#x2014;NH<sub>3</sub><sup>+</sup>); 7.31 (d, J=8.8, 1H); 4.02 (d, J=6.9, '\n",
      " '2H); 3.80 (m, 1H); 3.09 (m, 1H); 2.81 (s, 3H); 2.59 (s, 3H); 2.05 (m, 4H); '\n",
      " '1.48 (m, 4H); 0.99 (m, 1H); 0.39 (m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0706\" level=\"1\">Example D.f57</heading>\\n'\n",
      " '<heading id=\"h-0707\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1319\" num=\"3123\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e57) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1320\" num=\"3124\">MS (ESI): m/z=434 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-1321\" num=\"3125\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 7.49 (d, J=2.0, 1H); 7.45 (dd, J=8.6, 2.0, 1H); 7.15 '\n",
      " '(d, J=8.6, 1H); 4.22-4.08 (m, 1H); 3.90 (d, J=6.9, 2H); 3.35-3.22 (m, 2H); '\n",
      " '3.16-3.00 (m, 2H); 2.87 (s, 3H); 2.83 (s, 3H); 2.35 (s, 3H); 2.20-2.07 (m, '\n",
      " '2H); 1.83 (m, 2H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0708\" level=\"1\">Example D.f58</heading>\\n'\n",
      " '<heading id=\"h-0709\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1322\" num=\"3126\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e58) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1323\" num=\"3127\">MS (ESI): 468 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-1324\" num=\"3128\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 7.60 (d, J=11.7, 1H); 6.98 (d, J=7.1, 1H); 4.21-4.07 '\n",
      " '(m, 1H); 4.03-3.94 (m, 5H); 3.34-3.22 (m, 2H); 3.18-3.00 (m, 1H); 2.86 (s, '\n",
      " '3H); 2.83 (s, 3H); 2.19-2.08 (m, 2H); 1.91-1.74 (m, 2H); 0.98 (m, 1H); 0.40 '\n",
      " '(m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0710\" level=\"1\">Example D.f59</heading>\\n'\n",
      " '<heading id=\"h-0711\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1325\" num=\"3129\">Starting from tert-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e59) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1326\" num=\"3130\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1327\" num=\"3131\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 7.49 (d, J=9.5, 1H); 7.27 (d, J=13.3, 1H); 4.16 (m, '\n",
      " '1H); 3.88 (s, 3H &#x26; d, J=6.9, 2H); 3.35 (m, 1H); 3.30 (m, 1H); 3.14 (m, '\n",
      " '2H); 2.86 (s, 3H); 2.83 (s, 3H); 2.15 (m, 2H); 1.81 (m, 2H); 0.95 (m, 1H); '\n",
      " '0.39 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0712\" level=\"1\">Example D.f60</heading>\\n'\n",
      " '<heading id=\"h-0713\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1328\" num=\"3132\">Starting from tert.-butyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate '\n",
      " '(example D.e60) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1329\" num=\"3133\">HR-MS (ESI): m/z=456.2210 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>24</sub>H<sub>28</sub>F<sub>2</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 456.2206).</p>\\n'\n",
      " '<heading id=\"h-0714\" level=\"1\">Example D.f61</heading>\\n'\n",
      " '<heading id=\"h-0715\" '\n",
      " 'level=\"1\">N-(trans-4-Aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1330\" num=\"3134\">Starting from tert-butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate '\n",
      " '(example D.e61) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1331\" num=\"3135\">HR-MS (ESI): m/z=470.2347 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>30</sub>F<sub>2</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 470.2362).</p>\\n'\n",
      " '<heading id=\"h-0716\" level=\"1\">Example D.f62</heading>\\n'\n",
      " '<heading id=\"h-0717\" '\n",
      " 'level=\"1\">N-[(1S*,3S*,4S*)-4-Amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1332\" num=\"3136\">Starting from tert-butyl '\n",
      " '{(1S*,2S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-fluorocyclohexyl}carbamate '\n",
      " '(example D.e62) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1333\" num=\"3137\">MS (ESI): m/z=488 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1334\" num=\"3138\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.11 (s, 1H, &#x2014;NH); 9.01 (s, 1H); 8.71 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.45 (br. d, J&#x2dc;3.1, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.84 (d, '\n",
      " 'J=2.0, 1H); 7.76 (dd, J=8.8, 2.0, 1H); 7.33 (d, J=8.8, 1H); 7.09 (t, J=55.9, '\n",
      " '1H); 4.76 (m, 1H); 4.01 (m, 1H); 3.97 (d, J=7.1, 2H); 3.33 (m, 1H); 2.81 (s, '\n",
      " '3H); 2.46 (m, 1H); 2.10 (m, 1H); 2.00 (m, 1H); 1.77 (m, 1H); 1.54 (m, 2H); '\n",
      " '0.98 (m, 1H); 0.38 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0718\" level=\"1\">Example D.f63</heading>\\n'\n",
      " '<heading id=\"h-0719\" '\n",
      " 'level=\"1\">N-[(1S*,2S*,4S*)-4-Amino-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1335\" num=\"3139\">Starting from tert-butyl '\n",
      " '{(1S*,3S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-3-methylcyclohexyl}carbamate '\n",
      " '(example D.e63) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1336\" num=\"3140\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.00 (s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.59 (d, J=8.6, 1H, &#x2014;NH); '\n",
      " '7.98 (br.s, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.82 (s, 1H); 7.76 (d, '\n",
      " 'J=8.7, 1H); 7.32 (d, J=8.7, 1H); 7.10 (t, J=55.8, 1H); 3.97 (d, J=6.9, 2H); '\n",
      " '3.56 (m, 1H); 3.16 (m, 1H); 2.80 (s, 3H); 2.01 (m, 3H); 1.69 (m, 1H); 1.45 '\n",
      " '(m, 2H); 1.24 (m, 1H); 0.98 (m, 1H &#x26; d, J=6.4, 3H); 0.39 (m, 2H); 0.28 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0720\" level=\"1\">Example D.f64</heading>\\n'\n",
      " '<heading id=\"h-0721\" '\n",
      " 'level=\"1\">N-[(1S,3S)-3-Aminocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1337\" num=\"3141\">Starting from tert-butyl '\n",
      " '{(1S,3S)-3-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclopentyl}carbamate '\n",
      " '(example D.e64) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1338\" num=\"3142\">HR-MS (ESI): m/z=456.2218 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>24</sub>H<sub>28</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 456.2206).</p>\\n'\n",
      " '<heading id=\"h-0722\" level=\"1\">Example D.f66</heading>\\n'\n",
      " '<heading id=\"h-0723\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S,5S)-5-methylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1339\" num=\"3143\">Starting from '\n",
      " 'tert-butyl(2S,4S)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-methylpyrrolidine-1-carboxylate '\n",
      " '(example D.e66) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1340\" num=\"3144\">HR-MS (ESI): m/z=456.2210 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>24</sub>H<sub>28</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 456.2206).</p>\\n'\n",
      " '<heading id=\"h-0724\" level=\"1\">Example D.f68</heading>\\n'\n",
      " '<heading id=\"h-0725\" '\n",
      " 'level=\"1\">N-[(1R*,3S*,4S*)-3-amino-4-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1341\" num=\"3145\">Starting from tert-butyl '\n",
      " '{(1S*,2S*,4R*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-methylcyclopentyl}carbamate '\n",
      " '(example D.e68) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1342\" num=\"3146\">HR-MS (ESI): m/z=470.2363 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>30</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 470.2362).</p>\\n'\n",
      " '<heading id=\"h-0726\" level=\"1\">Example D.f70</heading>\\n'\n",
      " '<heading id=\"h-0727\" '\n",
      " 'level=\"1\">N-[(1S*,3S*,4S*)-3-Amino-4-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1343\" num=\"3147\">Starting from tert-butyl '\n",
      " '{(1S*,2S*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-fluorocyclopentyl}carbamate '\n",
      " '(example D.e70) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1344\" num=\"3148\">HR-MS (ESI): m/z=474.2117 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>24</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 474.2111).</p>\\n'\n",
      " '<heading id=\"h-0728\" level=\"1\">Example D.f72</heading>\\n'\n",
      " '<heading id=\"h-0729\" '\n",
      " 'level=\"1\">N-[(1S*,3R*,4S*)-4-amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1345\" num=\"3149\">Starting from tert-butyl '\n",
      " '{(1S*,2R*,4S*)-4-[({4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]-2-fluorocyclohexyl}carbamate '\n",
      " '(example D.e72) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1346\" num=\"3150\">HR-MS (ESI): m/z=488.2271 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 488.2268).</p>\\n'\n",
      " '<heading id=\"h-0730\" level=\"1\">Example D.f65</heading>\\n'\n",
      " '<heading id=\"h-0731\" '\n",
      " 'level=\"1\">N-[(1S*,3S*,4S*)-4-Amino-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride</heading>\\n'\n",
      " '<p id=\"p-1347\" '\n",
      " 'num=\"3151\">N-[(1S*,3S*,4S*)-4-azido-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.e65; 1.3 g; 2.6 mmol) is dissolved in MeOH (25 mL) and pressure '\n",
      " 'hydrogenated over Pd(OH)<sub>2 </sub>(20% on charcoal; 70.0 mg) at 20 bar '\n",
      " 'and ambient temperature over night. After filtration through a pad of celite '\n",
      " 'the solvent is removed under reduced pressure. The residual amine is '\n",
      " 'dissolved in dioxane (5 mL). At ice bath temperature HCl (4M in dioxane; 0.7 '\n",
      " 'mL) is added followed by tert-BuOMe (10 mL). The precipitate is collected by '\n",
      " 'suction filtration, washed with several small portions of tert-BuOMe and '\n",
      " 'dried under reduced pressure to yield 1.3 g of the title compound as pale '\n",
      " 'yellow solid.</p>\\n'\n",
      " '<p id=\"p-1348\" num=\"3152\">HR-MS (ESI): m/z=484.2525 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 484.2519).</p>\\n'\n",
      " '<p id=\"p-1349\" num=\"3153\">The following compounds were prepared analogously '\n",
      " 'to the procedure described in the above example D.f65. The compounds were '\n",
      " 'obtained after pressure hydrogenation and removal of the catalyst and '\n",
      " 'solvent.</p>\\n'\n",
      " '<heading id=\"h-0732\" level=\"1\">Example D.f67</heading>\\n'\n",
      " '<heading id=\"h-0733\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4R*)-4-Amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1350\" num=\"3154\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-azido-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.e67) the title compound (free base) is obtained as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-1351\" num=\"3155\">HR-MS (ESI): m/z=488.2265 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 488.2268).</p>\\n'\n",
      " '<heading id=\"h-0734\" level=\"1\">Example D.f69</heading>\\n'\n",
      " '<heading id=\"h-0735\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4S*)-4-amino-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1352\" num=\"3156\">Starting from '\n",
      " 'N-[(1R*,2R*,4S*)-4-azido-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.e69) the title compound (free base) is obtained as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-1353\" num=\"3157\">HR-MS (ESI): m/z=470.2369 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>30</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 470.2363).</p>\\n'\n",
      " '<heading id=\"h-0736\" level=\"1\">Example D.f71</heading>\\n'\n",
      " '<heading id=\"h-0737\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4R*)-4-Amino-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1354\" num=\"3158\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-azido-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.e71) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1355\" num=\"3159\">HR-MS (ESI): m/z=474.2115 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>24</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 474.2111).</p>\\n'\n",
      " '<heading id=\"h-0738\" level=\"1\">Example D.f73</heading>\\n'\n",
      " '<heading id=\"h-0739\" '\n",
      " 'level=\"1\">N-[(1S*,2R*,4S*)-4-Amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1356\" num=\"3160\">Starting from '\n",
      " 'N-[(1S*,2R*,4S*)-4-azido-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.e73) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1357\" num=\"3161\">HR-MS (ESI): m/z=488.2265 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup>, '\n",
      " 'calc. 488.2268).</p>\\n'\n",
      " '<heading id=\"h-0740\" level=\"1\">Example D.g1</heading>\\n'\n",
      " '<heading id=\"h-0741\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-1358\" num=\"3162\">Ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a19; 52.73 g; 131.4 mmol) is dissolved in tert. BuOH (500.0 mL) '\n",
      " 'and water (5.0 mL). After addition of commercially available KOtBu (73.70 g; '\n",
      " '656.8 mmol) the reaction mixture is stirred at 100&#xb0; C. over night and '\n",
      " 'cooled to ambient temperature. Water (1500 mL) is added and pH is adjusted '\n",
      " 'to 6.0 by careful addition of 2M aqueous citric acid. The precipitated '\n",
      " 'product is filtered washed with several portions of water and dried under '\n",
      " 'reduced pressure to yield 45.3 g of the title compound as off-white '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-1359\" num=\"3163\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.22-11.77 (br.s, 2H, &#x2014;NH, &#x2014;CO<sub>2</sub>H); 8.96 (s, 1H); '\n",
      " '7.82 (d, J=2.0, 1H); 7.74 (dd, J=8.6, 2.0, 1H); 7.31 (d, J=8.6, 1H); 7.08 '\n",
      " '(t, J=56.0, 1H); 3.96 (d, J=6.9, 2H); 2.74 (s, 3H); 0.98 (m, 1H); 0.39 (m, '\n",
      " '2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0742\" level=\"1\">Example D.g2</heading>\\n'\n",
      " '<heading id=\"h-0743\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid</heading>\\n'\n",
      " '<p id=\"p-1360\" num=\"3164\">Starting from ethyl '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate '\n",
      " '(example D.a8) and following the procedure as described in example D.g1 the '\n",
      " 'title compound is obtained as off-white solid.</p>\\n'\n",
      " '<p id=\"p-1361\" num=\"3165\"><sup>1</sup>H-NMR (300 MHz, '\n",
      " 'DMSO-d<sub>6</sub>/MeOH-d<sub>4</sub>): 8.95 (s, 1H); 7.89 (d, J=2.1, 1H); '\n",
      " '7.88 (dd, J=8.4, 2.1, 1H); 7.37 (d, J=8.4, 1H); 4.00 (d, J=7.1, 2H); 2.74 '\n",
      " '(s, 3H); 1.00 (m, 1H); 0.40 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0744\" level=\"1\">Example E1</heading>\\n'\n",
      " '<heading id=\"h-0745\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1362\" '\n",
      " 'num=\"3166\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride from example D.f1 (486 mg; 1.0 mmol) and DBU (2.5 mmol) is '\n",
      " 'dissolved in dry dichloromethane (5 mL). Acetyl chloride (1.1 mmol) is '\n",
      " 'syringed into the reaction mixture at ice bath temperature. After addition '\n",
      " 'the mixture is stirred at ambient temperature over night. Methanol (1 mL) is '\n",
      " 'added and stirring is continued for two hours. The volatiles are evaporated. '\n",
      " 'The residue is purified by reversed phase preparative HPLC. The collected '\n",
      " 'product fraction is freeze-dried to yield the title compound as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-1363\" num=\"3167\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1364\" num=\"3168\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.00 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.76 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 4.23-4.04 (m, 2H); '\n",
      " '3.80 (m, 1H); 3.76 (d, J=6.8, 2H); 3.28 (m, 1H); 2.95 (m, 1H); 2.77 (s, 3H); '\n",
      " '2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, 1H); 1.38 (m, 1H); 0.88 (m, 1H); 0.31 '\n",
      " '(m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-1365\" num=\"3169\">The following compounds are prepared analogously '\n",
      " 'to the procedure described in above example E1.</p>\\n'\n",
      " '<heading id=\"h-0746\" level=\"1\">Example E2</heading>\\n'\n",
      " '<heading id=\"h-0747\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1366\" num=\"3170\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f1) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1367\" num=\"3171\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1368\" num=\"3172\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.00 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.75 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 4.25-4.03 (m, 2H); '\n",
      " '3.79 (m, 1H); 3.76 (d, J=6.8, 2H); 3.25 (m, 1H); 2.95 (m, 1H); 2.77 (s, 3H); '\n",
      " '2.36 (qu, J=7.5, 2H); 1.96 (m, 2H); 1.52 (m, 1H); 1.39 (m, 1H); 1.01 (t, '\n",
      " 'J=7.5, 3H); 0.88 (m, 1H); 0.31 (m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0748\" level=\"1\">Example E3</heading>\\n'\n",
      " '<heading id=\"h-0749\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1369\" num=\"3173\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f1) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1370\" num=\"3174\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1371\" num=\"3175\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.00 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.75 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.55 (d, J=8.6, 1H); 6.00 (s, 2H); 422-4.03 (m, 2H); '\n",
      " '4.12 (d, J=1.8, 2H); 3.76 (d, J=6.8, 2H); 3.73 (m, 1H); 3.31 (s, 3H); 3.22 '\n",
      " '(m, 1H); 2.98 (m, 1H); 2.77 (s, 3H); 1.97 (m, 2H); 1.54 (m, 1H); 1.41 (m, '\n",
      " '1H); 0.88 (m, 1H); 0.31 (m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0750\" level=\"1\">Example E4</heading>\\n'\n",
      " '<heading id=\"h-0751\" level=\"1\">Ethyl '\n",
      " '4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1372\" num=\"3176\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f1) and commercially available ethyl chloroformate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1373\" num=\"3177\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1374\" num=\"3178\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.99 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.75 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 4.06 (m, 1H &#x26; '\n",
      " 'qu, J=7.1, 2H); 3.88 (m, 2H); 3.76 (d, J=6.8, 2H); 3.11 (m, 2H); 2.77 (s, '\n",
      " '3H); 1.94 (m, 2H); 1.46 (m, 2H); 1.20 (t, J=7.1, 3H); 0.88 (m, 1H); 0.31 (m, '\n",
      " '2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0752\" level=\"1\">Example E5</heading>\\n'\n",
      " '<heading id=\"h-0753\" '\n",
      " 'level=\"1\">N-(trans-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1375\" num=\"3179\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f2) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1376\" num=\"3180\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1377\" num=\"3181\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.59 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.9, 1H, &#x2014;NH); 7.00 (d, J=8.6, 1H); 6.55 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 3.80 (m, 1H); 3.76 (d, J=6.8, 2H); 3.58 (m, 1H); 2.76 (s, 3H); '\n",
      " '2.00 (m, 2H); 1.86 (m, 2H); 1.79 (s, 3H); 1.35 (m, 4H); 0.88 (m, 1H); 0.31 '\n",
      " '(m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0754\" level=\"1\">Example E6</heading>\\n'\n",
      " '<heading id=\"h-0755\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1378\" num=\"3182\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f2) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1379\" num=\"3183\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1380\" num=\"3184\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.60 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.9, 1H, &#x2014;NH); 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 3.79 (m, 1H); 3.76 (d, J=6.8, 2H); 3.59 (m, 1H); 2.76 (s, 3H); '\n",
      " '2.05 (qu, J=7.6, 2H); 2.01 (m, 2H); 1.86 (m, 2H); 1.35 (m, 4H); 0.99 (t, '\n",
      " 'J=7.6, 3H); 0.88 (m, 1H); 0.30 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0756\" level=\"1\">Example E7</heading>\\n'\n",
      " '<heading id=\"h-0757\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1381\" num=\"3185\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f2) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1382\" num=\"3186\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1383\" num=\"3187\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.59 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.57 (d, J=8.2, 1H, &#x2014;NH); 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 3.78 (m, 1H &#x26; s, 2H); 3.76 (d, J=6.8, 2H); 3.68 (m, 1H); '\n",
      " '3.31 (s, 3H); 2.76 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); 0.88 '\n",
      " '(m, 1H); 0.30 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0758\" level=\"1\">Example E8</heading>\\n'\n",
      " '<heading id=\"h-0759\" level=\"1\">Ethyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1384\" num=\"3188\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f2) and commercially available ethyl chloroformate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1385\" num=\"3189\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1386\" num=\"3190\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.59 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=6.8, 1H &#x26; d, J=8.6, 1H, &#x2014;NH); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 3.98 (qu, J=6.9, 2H); 3.94 (m, 1H); 3.76 (m, 1H &#x26; d, '\n",
      " 'J=6.8, 2H); 3.33 (m, 1H); 2.76 (s, 3H); 2.00 (m, 2H); 1.87 (m, 2H); 1.35 (m, '\n",
      " '4H); 1.16 (t, J=6.9, 3H); 0.88 (m, 1H); 0.30 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0760\" level=\"1\">Example E9</heading>\\n'\n",
      " '<heading id=\"h-0761\" '\n",
      " 'level=\"1\">N-(cis-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1387\" num=\"3191\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f3) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1388\" num=\"3192\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1389\" num=\"3193\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.98 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.87 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.84 (d, J=7.3, 1H, &#x2014;NH); 7.01 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 4.01 (m, 1H); 3.77 (m, 1H &#x26; d, J=6.8, 2H); 2.77 (s, 3H); '\n",
      " '1.83 (s, 3H); 1.82-1.51 (m, 8H); 0.88 (m, 1H); 0.31 (m, 2H); 0.13 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0762\" level=\"1\">Example E10</heading>\\n'\n",
      " '<heading id=\"h-0763\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1390\" num=\"3194\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f3) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1391\" num=\"3195\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1392\" num=\"3196\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.98 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.87 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.5, 1H, &#x2014;NH); 7.01 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 4.01 (m, 1H); 3.76 (m, 1H &#x26; d, J=6.8, 2H); 2.77 (s, 3H); '\n",
      " '2.11 (qu, J=7.5, 2H); 1.87-1.50 (m, 8H); 1.00 (t, J=7.6, 3H); 0.88 (m, 1H); '\n",
      " '0.31 (m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0764\" level=\"1\">Example E11</heading>\\n'\n",
      " '<heading id=\"h-0765\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1393\" num=\"3197\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f3) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1394\" num=\"3198\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1395\" num=\"3199\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.98 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.91 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.67 (d, J=7.9, 1H, &#x2014;NH); 7.01 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 4.04 (m, 1H); 3.81 (s, 2H); 3.76 (m, 1H &#x26; d, J=6.8, 2H); '\n",
      " '3.31 (s, 3H); 2.77 (s, 3H); 1.87-1.57 (m, 8H); 0.89 (m, 1H); 0.31 (m, 2H); '\n",
      " '0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0766\" level=\"1\">Example E12</heading>\\n'\n",
      " '<heading id=\"h-0767\" level=\"1\">Ethyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1396\" num=\"3200\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f3) and commercially available ethyl chloroformate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1397\" num=\"3201\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1398\" num=\"3202\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.91 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.20 (br. d, J&#x2dc;6.2, 1H, &#x2014;NH); 7.01 (d, J=8.6, 1H); 6.56 (d, '\n",
      " 'J=8.6, 1H); 6.00 (s, 2H); 3.99 (m, 1H &#x26; qu, J=7.1, 2H); 3.76 (d, J=6.8, '\n",
      " '2H); 3.48 (m, 1H); 2.77 (s, 3H); 1.85-1.54 (m, 8H); 1.17 (t, J=7.1, 3H); '\n",
      " '0.89 (m, 1H); 0.31 (m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0768\" level=\"1\">Example E13</heading>\\n'\n",
      " '<heading id=\"h-0769\" '\n",
      " 'level=\"1\">N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1399\" num=\"3203\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f4) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1400\" num=\"3204\">MS (ESI): m/z=478 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1401\" num=\"3205\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.03 (s, 1H, &#x2014;NH); 8.93 (s, 1H); [8.88 (d, J=7.0), 8.85 (d, 6.7), '\n",
      " '1H, &#x2014;NH]; 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); '\n",
      " '[4.59 (m), 4.49 (m), 1H]; [3.84 (m), 3.68-3.58 (m), 2H]; 3.76 (d, J=6.7, '\n",
      " '2H); 3.56-3.27 (m, 2H); [2.78 (s), 2.77 (s), 3H]; 2.34-2.16 (m, 1H); '\n",
      " '2.08-1.87 (m, 1H); [1.98 (s), 1.96 (s), 3H]; 0.88 (m, 1H); 0.31 (m, 2H); '\n",
      " '0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0770\" level=\"1\">Example E14</heading>\\n'\n",
      " '<heading id=\"h-0771\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1402\" num=\"3206\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f4) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1403\" num=\"3207\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1404\" num=\"3208\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.03 (s, 1H, &#x2014;NH); 8.92 (s, 1H); [8.88 (d, J=7.0), 8.85 (d, 6.7), '\n",
      " '1H, &#x2014;NH]; 7.01 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); '\n",
      " '[4.59 (m), 4.49 (m), 1H]; [3.82 (m), 3.69-3.57 (m), 2H]; 3.76 (d, J=6.7, '\n",
      " '2H); 3.55-3.26 (m, 2H); [2.78 (s), 2.77 (s), 3H]; 2.34-2.16 (m, 1H); [2.29 '\n",
      " '(qu, J=7.5), 2.25 (qu, J=7.5), 2H]; [2.03 (m), 1.92 (m), 1H]; [1.01 (t, '\n",
      " 'J=7.5), 0.99 (t, J=7.5), 3H]; 0.88 (m, 1H); 0.31 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0772\" level=\"1\">Example E15</heading>\\n'\n",
      " '<heading id=\"h-0773\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1405\" num=\"3209\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f4) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1406\" num=\"3210\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1407\" num=\"3211\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.03 (s, 1H, &#x2014;NH); [8.93 (s), 8.92 (s), 1H]; [8.87 (d, J=7.2), 8.85 '\n",
      " '(d, 6.9), 1H, &#x2014;NH]; 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 '\n",
      " '(s, 2H); [4.59 (m), 4.49 (m), 1H]; [4.06 (d, J=6.6), 4.01 (d, J=2.2), 2H]; '\n",
      " '[3.80 (m), 3.68 (m), 1H]; 3.76 (d, J=6.7, 2H); 3.63-3.42 (m, 2H); 3.39-3.26 '\n",
      " '(m, 1H); [3.32 (s), 3.30 (s), 3H]; 2.77 (s, 3H); 2.34-2.15 (m, 1H); [2.03 '\n",
      " '(m), 1.91 (m), 1H]; 0.88 (m, 1H); 0.30 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0774\" level=\"1\">Example E16</heading>\\n'\n",
      " '<heading id=\"h-0775\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1408\" num=\"3212\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f5) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1409\" num=\"3213\">HR-MS (ESI): m/z=494.2040 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>28</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '494.2034).</p>\\n'\n",
      " '<heading id=\"h-0776\" level=\"1\">Example E17</heading>\\n'\n",
      " '<heading id=\"h-0777\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1410\" num=\"3214\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f5) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1411\" num=\"3215\">HR-MS (ESI): m/z=508.2191 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>30</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '508.2191).</p>\\n'\n",
      " '<heading id=\"h-0778\" level=\"1\">Example E18</heading>\\n'\n",
      " '<heading id=\"h-0779\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1412\" num=\"3216\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f5) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1413\" num=\"3217\">HR-MS (ESI): m/z=524.2140 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>30</sub>N<sub>6</sub>O<sub>7</sub><sup>+</sup>, calc. '\n",
      " '524.2140).</p>\\n'\n",
      " '<heading id=\"h-0780\" level=\"1\">Example E19</heading>\\n'\n",
      " '<heading id=\"h-0781\" '\n",
      " 'level=\"1\">N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1414\" num=\"3218\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f6) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1415\" num=\"3219\">MS (ESI): m/z=466 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1416\" num=\"3220\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.94 (s. 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, J=8.4, 6.9, 1H); 7.08 (dd, J=11.7, 2.4, 1H); 6.96 (ddd, J=8.4, '\n",
      " '8.4, 2.4, 1H); 4.23-4.04 (m, 2H); 3.91 (d, J=6.9, 2H); 3.78 (m, 1H); 3.28 '\n",
      " '(m, 1H); 2.95 (m, 1H); 2.79 (s, 3H); 2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, '\n",
      " '1H); 1.38 (m, 1H); 0.96 (m, 1H); 0.38 (m, 2H): 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0782\" level=\"1\">Example E20</heading>\\n'\n",
      " '<heading id=\"h-0783\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1417\" num=\"3221\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f6) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1418\" num=\"3222\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1419\" num=\"3223\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.94 (s. 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, J=8.6, 7.1, 1H); 7.08 (dd, J=11.7, 2.4, 1H); 6.96 (ddd, J=8.6, '\n",
      " '8.6, 2.4, 1H); 4.26-4.04 (m, 2H); 3.91 (d, J=6.9, 2H); 3.81 (m, 1H); 3.25 '\n",
      " '(m, 1H); 2.96 (m, 1H); 2.78 (s, 3H); 2.36 (qu, J=7.5, 3H); 1.95 (m, 2H); '\n",
      " '1.51 (m, 1H); 1.38 (m, 1H); 1.01 (t, J=7.5, 3H); 0.96 (m, 1H); 0.38 (m, 2H): '\n",
      " '0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0784\" level=\"1\">Example E21</heading>\\n'\n",
      " '<heading id=\"h-0785\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1420\" num=\"3224\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f6) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1421\" num=\"3225\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1422\" num=\"3226\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.94 (s. 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, J=8.6, 7.1, 1H); 7.09 (dd, J=11.7, 2.4, 1H); 6.96 (ddd, J=8.6, '\n",
      " '8.6, 2.4, 1H); 4.24-4.04 (m, 2H); 4.12 (d, J=1.6, 2H); 3.91 (d, J=7.1, 2H); '\n",
      " '3.75 (m, 1H); 3.31 (s, 3H); 3.24 (m, 1H); 2.98 (m, 1H); 2.78 (s, 3H); 1.96 '\n",
      " '(m, 2H); 1.54 (m, 1H); 1.41 (m, 1H); 0.96 (m, 1H); 0.38 (m, 2H): 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0786\" level=\"1\">Example E22</heading>\\n'\n",
      " '<heading id=\"h-0787\" '\n",
      " 'level=\"1\">N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1423\" num=\"3227\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f7) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1424\" num=\"3228\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1425\" num=\"3229\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.65 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.7, 1H, &#x2014;NH); 7.66 (dd, 8.4, 7.1, 1H); 7.08 (dd, 11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 3.91 (d, J=6.9, 2H); 3.80 (m, 1H); '\n",
      " '3.58 (m, 1H); 2.78 (s, 3H); 2.00 (m, 2H); 1.86 (m, 2H); 1.79 (s, 3H); 1.35 '\n",
      " '(m, 4H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0788\" level=\"1\">Example E23</heading>\\n'\n",
      " '<heading id=\"h-0789\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1426\" num=\"3230\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f7) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1427\" num=\"3231\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1428\" num=\"3232\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.65 (dd, 8.4, 7.1, 1H); 7.62 (d, J=7.6, 1H, &#x2014;NH); 7.08 (dd, 11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 3.91 (d, J=6.9, 2H); 3.80 (m, 1H); '\n",
      " '3.59 (m, 1H); 2.78 (s, 3H); 2.06 (qu, J=7.5, 2H); 2.01 (m, 2H); 1.86 (m, '\n",
      " '2H); 1.35 (m, 4H); 0.99 (t, J=7.5, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0790\" level=\"1\">Example E24</heading>\\n'\n",
      " '<heading id=\"h-0791\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1429\" num=\"3233\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f7) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1430\" num=\"3234\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1431\" num=\"3235\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.64 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, 8.4, 6.9, 1H); 7.57 (d, J=8.4, 1H, &#x2014;NH); 7.08 (dd, 11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 3.91 (d, J=6.9, 2H); 3.78 (s, 2H '\n",
      " '&#x26; m, 1H); 3.68 (m, 1H); 3.31 (s, 3H); 2.78 (s, 3H); 2.01 (m, 2H); 1.82 '\n",
      " '(m, 2H); 1.43 (m, 4H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0792\" level=\"1\">Example E25</heading>\\n'\n",
      " '<heading id=\"h-0793\" '\n",
      " 'level=\"1\">N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1432\" num=\"3236\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f8) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1433\" num=\"3237\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1434\" num=\"3238\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.78 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.93 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.84 (d, J=7.7, 1H, &#x2014;NH); 7.66 (dd, 8.4, 7.1, 1H); 7.09 (dd, 11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 4.02 (m, 1H); 3.91 (d, J=7.1, 2H); '\n",
      " '3.75 (m, 1H); 2.79 (s, 3H); 1.84 (s, 3H); 1.84-1.51 (m, 8H); 0.96 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0794\" level=\"1\">Example E26</heading>\\n'\n",
      " '<heading id=\"h-0795\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1435\" num=\"3239\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f8) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1436\" num=\"3240\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1437\" num=\"3241\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.78 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.93 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.7, 1H, &#x2014;NH); 7.66 (dd, 8.4, 6.9, 1H); 7.09 (dd, 11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 4.02 (m, 1H); 3.92 (d, J=7.1, 2H); '\n",
      " '3.75 (m, 1H); 2.79 (s, 3H); 2.11 (qu, J=7.5, 2H); 1.84-1.51 (m, 8H); 1.00 '\n",
      " '(t, J=7.5, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0796\" level=\"1\">Example E27</heading>\\n'\n",
      " '<heading id=\"h-0797\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1438\" num=\"3242\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f8) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1439\" num=\"3243\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1440\" num=\"3244\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.78 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.96 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.67 (d, J=7.6, 1H, &#x2014;NH); 7.66 (dd, 8.4, 6.9, 1H); 7.09 (dd, 11.5, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 4.05 (m, 1H); 3.91 (d, J=7.1, 2H); '\n",
      " '3.82 (s, 2H); 3.79 (m, 1H); 3.31 (s, 3H); 2.79 (s, 3H); 1.86-1.58 (m, 8H); '\n",
      " '0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0798\" level=\"1\">Example E28</heading>\\n'\n",
      " '<heading id=\"h-0799\" '\n",
      " 'level=\"1\">N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1441\" num=\"3245\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f9) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1442\" num=\"3246\">MS (ESI): m/z=452 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1443\" num=\"3247\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.94 (s, 1H); [8.93 (d, J=6.8), 8.90 (d, J=6.9), '\n",
      " '1H, &#x2014;NH]; 7.66 (ddd, J=8.4, 7.1, 1.1, 1H); 7.09 (dd, J=11.5, 2.4, '\n",
      " '1H); 6.96 (ddd, J=8.4, 8.4, 2.4, 1H); [4.59 (m), 4.49 (m), 1H]; 3.91 (d, '\n",
      " 'J=7.1, 2H); [3.84 (m), 3.69-3.58 (m), 2H]; 3.56-3.27 (m, 2H); [2.79 (s), '\n",
      " '2.78 (s), 3H]; 2.35-2.16 (m, 1H); 2.08-1.86 (m, 1H); [1.98 (s), 1.96 (s), '\n",
      " '3H]; 0.95 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0800\" level=\"1\">Example E29</heading>\\n'\n",
      " '<heading id=\"h-0801\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1444\" num=\"3248\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f9) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1445\" num=\"3249\">MS (ESI): m/z=466 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1446\" num=\"3250\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); [8.93 (d, J=7.1), 8.90 (d, J=6.8), 1H, '\n",
      " '&#x2014;NH]; [8.93 (s), 8.92 (s), 1H]; 7.66 (ddd, J=8.4, 7.1, 0.7, 1H); 7.08 '\n",
      " '(dd, J=11.7, 2.4, 1H); 6.96 (ddd, J=8.4, 8.4, 2.4, 1H); [4.59 (m), 4.49 (m), '\n",
      " '1H]; 3.91 (d, J=7.1, 2H); [3.82 (m), 3.70-3.58 (m), 2H]; 3.55-3.27 (m, 2H); '\n",
      " '[2.79 (s), 2.78 (s), 3H]; 2.34-2.15 (m, 1H); [2.29 (qu, J=7.5), 2.25 (qu, '\n",
      " 'J=7.5), 2H]; 2.08-1.86 (m, 1H); [1.01 (t, J=7.5), 0.99 (t, J=7.5), 3H]; 0.95 '\n",
      " '(m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0802\" level=\"1\">Example E30</heading>\\n'\n",
      " '<heading id=\"h-0803\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1447\" num=\"3251\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f9) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1448\" num=\"3252\">MS (ESI): m/z=482 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1449\" num=\"3253\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); [8.94 (s), 8.93 (s), 1H]; [8.92 (d, J=7.1), 8.90 '\n",
      " '(d, J=6.8), 1H, &#x2014;NH]; 7.66 (ddd, J=8.4, 6.9, 0.7, 1H); 7.09 (dd, '\n",
      " 'J=11.5, 2.4, 1H); 6.96 (ddd, J=8.4, 8.4, 2.4, 1H); [4.59 (m), 4.49 (m), 1H]; '\n",
      " '[4.06 (d, J=4.0), 4.01 (d, J=1.1), 2H]; 3.91 (d, J=6.9, 2H); [3.79 (m), 3.68 '\n",
      " '(m), 1H]; 3.62-3.42 (m, 2H); 3.38-3.27 (m, 1H); [3.32 (s), 3.29 (s), 3H]; '\n",
      " '2.79 (s, 3H); 2.33-2.15 (m, 1H); [2.03 (m), 1.91 (m), 1H]; 0.95 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0804\" level=\"1\">Example E31</heading>\\n'\n",
      " '<heading id=\"h-0805\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1450\" num=\"3254\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f10) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1451\" num=\"3255\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1452\" num=\"3256\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (s, 1H, &#x2014;NH); 8.93 (s, 1H); [8.88 (d, J=7.2), 8.83 (d, J=6.6), '\n",
      " '1H, &#x2014;NH]; 7.65 (dd, J=8.4, 7.1, 1H); 7.09 (dd, J=11.7, 2.0, 1H); 6.96 '\n",
      " '(ddd, J=8.4, 8.4, 2.0, 1H); [5.56 (d, J=3.2), 5.48 (d, J=3.9), 1H, '\n",
      " '&#x2014;OH]; [4.36 (m), 4.19 (m), 1H]; 4.27 (m, 1H); 3.91 (d, 7.2, 2H); '\n",
      " '[3.76 (m), 3.69 (m), 3.58 (m), 3.45 (m), 2H]; 3.41-3.27 (m, 2H); 2.79 (s. '\n",
      " '3H); [1.99 (s), 1.98 (s), 3H]; 0.95 (m, 1H); 0.38 (m, 2H); 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0806\" level=\"1\">Example E32</heading>\\n'\n",
      " '<heading id=\"h-0807\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1453\" num=\"3257\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f10) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1454\" num=\"3258\">MS (ESI): m/z=482 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1455\" num=\"3259\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (s, 1H, &#x2014;NH); 8.91 (s, 1H); [8.88 (d, J=7.1), 8.82 (d, J=6.8), '\n",
      " '1H, &#x2014;NH]; 7.65 (dd, J=8.4, 7.1, 1H); 7.09 (dd, J=11.7, 2.4, 1H); 6.96 '\n",
      " '(ddd, J=8.4, 8.4, 2.4, 1H); [5.55 (d, J=3.8), 5.47 (d, J=4.0), 1H, '\n",
      " '&#x2014;OH]; [4.36 (m), 4.19 (m), 1H]; 4.27 (m, 1H); 3.91 (d, 6.9, 2H); '\n",
      " '[3.86 (m), 3.59 (m), 1H]; 3.72 (m, 1H); 3.49-3.27 (m, 2H); 2.78 (s. 3H); '\n",
      " '[2.28 (qu, J=7.5), 2.27 (qu, J=7.5), 2H]; [1.03 (t, J=7.5), 1.01 (t, J=7.5), '\n",
      " '3H]; 0.95 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0808\" level=\"1\">Example E33</heading>\\n'\n",
      " '<heading id=\"h-0809\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1456\" num=\"3260\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f10) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1457\" num=\"3261\">MS (ESI): m/z=498 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1458\" num=\"3262\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.85 (s, 1H, &#x2014;NH); [8.91 (s), 8.90 (s), 1H]; [8.87 (d, J=7.1), 8.83 '\n",
      " '(d, J=6.6), 1H, &#x2014;NH]; 7.65 (dd, J=8.4, 7.3, 1H); 7.09 (dd, J=11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, J=8.4, 8.4, 2.4, 1H); [5.56 (d, J=3.8), 5.50 (d, '\n",
      " 'J=4.0), 1H, &#x2014;OH]; [4.36 (m), 4.19 (m), 1H]; 4.27 (m, 1H); [4.09 (dd, '\n",
      " 'J=14.6, 3.5) 4.02 (d, J=14.6) 2H]; 3.91 (d, 6.9, 2H); [3.85 (m), 3.62 (m), '\n",
      " '1H]; 3.73 (m, 1H); 3.49-3.27 (m, 2H); [3.34 (s), 3.32 (s), 3H]; 2.78 (s. '\n",
      " '3H); 0.95 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0810\" level=\"1\">Example E34</heading>\\n'\n",
      " '<heading id=\"h-0811\" '\n",
      " 'level=\"1\">N-[(3S*,4S*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1459\" num=\"3263\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4S*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f11) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1460\" num=\"3264\">HR-MS (ESI): m/z=482.2196 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>FN<sub>5</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '482.2198).</p>\\n'\n",
      " '<heading id=\"h-0812\" level=\"1\">Example E35</heading>\\n'\n",
      " '<heading id=\"h-0813\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1461\" num=\"3265\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4S*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f11) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1462\" num=\"3266\">HR-MS (ESI): m/z=496.2345 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '496.2355).</p>\\n'\n",
      " '<heading id=\"h-0814\" level=\"1\">Example E36</heading>\\n'\n",
      " '<heading id=\"h-0815\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1463\" num=\"3267\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4S*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f11) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1464\" num=\"3268\">HR-MS (ESI): m/z=512.2288 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>5</sub>O<sub>5</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-0816\" level=\"1\">Example E37</heading>\\n'\n",
      " '<heading id=\"h-0817\" '\n",
      " 'level=\"1\">4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid (1-acetyl-piperidin-4-yl)-amide</heading>\\n'\n",
      " '<p id=\"p-1465\" num=\"3269\">Starting from '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid piperidin-4-ylamide hydrochloride (example D.f12) and commercially '\n",
      " 'acetyl chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1466\" num=\"3270\">MS (ESI): m/z=466 (MH<sup>+</sup>, 100%), 356, '\n",
      " '302.</p>\\n'\n",
      " '<p id=\"p-1467\" num=\"3271\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (br.s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (dd, J=9.0, 3.3, 1H); 7.37 (ddd, J=9.1, 8.3, 3.3, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.22-4.06 (m, 2H); 3.87 (d, J=6.9, 2H); 3.78 (m, 1H); 3.27 (m, '\n",
      " '1H); 2.95 (m, 1H); 2.79 (s, 3H); 2.04 (s, 3H); 1.96 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.39 (m, 1H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0818\" level=\"1\">Example E38</heading>\\n'\n",
      " '<heading id=\"h-0819\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1468\" num=\"3272\">Starting from '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid piperidin-4-ylamide hydrochloride (example D.f12) and commercially '\n",
      " 'propionyl chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1469\" num=\"3273\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1470\" num=\"3274\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=9.0, 3.2, 1H); 7.36 (ddd, J=9.1, 8.3, 3.2, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.25-4.04 (m, 2H); 3.87 (d, J=6.9, 2H); 3.81 (m, 1H); 3.27 (m, '\n",
      " '1H); 2.96 (m, 1H); 2.79 (s, 3H); 2.36 (qu, J=7.5, 2H); 1.96 (m, 2H); 1.52 '\n",
      " '(m, 1H); 1.39 (m, 1H); 1.01 (t, J=7.5, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0820\" level=\"1\">Example E39</heading>\\n'\n",
      " '<heading id=\"h-0821\" '\n",
      " 'level=\"1\">4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-(2-methoxy-acetyl)-piperidin-4-yl]-amide</heading>\\n'\n",
      " '<p id=\"p-1471\" num=\"3275\">Starting from '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid piperidin-4-ylamide hydrochloride (example D.f12) and commercially '\n",
      " 'methoxy-acetyl chloride the title compound is obtained as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-1472\" num=\"3276\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%), 356, '\n",
      " '302.</p>\\n'\n",
      " '<p id=\"p-1473\" num=\"3277\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (br.s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (dd, J=9.0, 3.3, 1H); 7.37 (ddd, J=9.1, 8.3, 3.3, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.23-4.07 (m, 2H); 4.12 (d, J=1.6, 2H); 3.87 (d, J=6.9, 2H); 3.75 '\n",
      " '(m, 1H); 3.31 (s, 3H); 3.22 (m, 1H); 2.98 (m, 1H); 2.79 (s, 3H); 1.97 (m, '\n",
      " '2H); 1.54 (m, 1H); 1.41 (m, 1H); 0.87 (m, 1H); 0.36 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0822\" level=\"1\">Example E40</heading>\\n'\n",
      " '<heading id=\"h-0823\" level=\"1\">Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1474\" num=\"3278\">Starting from '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxylic '\n",
      " 'acid piperidin-4-ylamide hydrochloride (example D.f12) and commercially '\n",
      " 'ethyl chloroformate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1475\" num=\"3279\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1476\" num=\"3280\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=9.1, 3.3, 1H); 7.37 (ddd, J=9.1, 8.2, 3.3, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.06 (qu, J=7.2, 2H &#x26; m, 1H); 3.87 (d, J=6.9, 2H &#x26; m, '\n",
      " '2H); 3.11 (m, 2H); 2.79 (s, 3H); 1.94 (m, 2H); 1.46 (m, 2H); 1.20 (t, J=7.2, '\n",
      " '3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0824\" level=\"1\">Example E41</heading>\\n'\n",
      " '<heading id=\"h-0825\" '\n",
      " 'level=\"1\">N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1477\" num=\"3281\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f13) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1478\" num=\"3282\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1479\" num=\"3283\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.67 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.7, 1H, &#x2014;NH); 7.42 (dd, J=8.9, 3.2, 1H); 7.36 (ddd, '\n",
      " 'J=9.1, 8.4, 3.2, 1H); 7.18 (dd, J=9.1, 4.4, 1H); 3.87 (d, J=6.9, 2H); 3.80 '\n",
      " '(m, 1H); 3.58 (m, 1H); 2.78 (s, 3H); 2.00 (m, 2H); 1.86 (m, 2H); 1.79 (s, '\n",
      " '3H); 1.35 (m, 4H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0826\" level=\"1\">Example E42</heading>\\n'\n",
      " '<heading id=\"h-0827\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1480\" num=\"3284\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f13) and commercially propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1481\" num=\"3285\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1482\" num=\"3286\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.7, 1H, &#x2014;NH); 7.42 (dd, J=8.9, 3.3, 1H); 7.36 (ddd, '\n",
      " 'J=9.1, 8.2, 3.3, 1H); 7.18 (dd, J=9.1, 4.4, 1H); 3.87 (d, J=6.9, 2H); 3.80 '\n",
      " '(m, 1H); 3.60 (m, 1H); 2.78 (s, 3H); 2.06 (m, 2H); 1.86 (m, 2H); 1.79 (s, '\n",
      " '3H); 1.35 (m, 4H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0828\" level=\"1\">Example E43</heading>\\n'\n",
      " '<heading id=\"h-0829\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1483\" num=\"3287\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f13) and commercially methoxy-acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1484\" num=\"3288\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1485\" num=\"3289\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.63 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.57 (d, J=8.2, 1H, &#x2014;NH); 7.42 (dd, J=8.9, 3.3, 1H); 7.36 (ddd, '\n",
      " 'J=8.9, 8.2, 3.3, 1H); 7.18 (dd, J=8.9, 4.4, 1 H); 3.87 (d, J=6.9, 2H); 3.78 '\n",
      " '(s, 2H &#x26; m, 1H); 3.69 (m, 1H); 3.31 (s, 3H); 2.78 (s, 3H); 2.01 (m, '\n",
      " '2H); 1.82 (m, 2H); 1.43 (m, 4H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0830\" level=\"1\">Example E44</heading>\\n'\n",
      " '<heading id=\"h-0831\" level=\"1\">Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1486\" num=\"3290\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f13) and commercially ethyl chloroformate the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1487\" num=\"3291\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1488\" num=\"3292\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.63 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=8.9, 3.3, 1H); 7.36 (ddd, J=9.1, 8.3, 3.3, 1H); 7.18 (dd, J=9.1, '\n",
      " '4.4, 1H); 7.01 (d, J=7.3, 1H, &#x2014;NH); 3.98 (qu, J=7.1, 2H); 3.87 (d, '\n",
      " 'J=6.9, 2H); 3.77 (m, 1H); 3.34 (m, 1H); 2.78 (s, 3H); 2.00 (m, 2H); 1.87 (m, '\n",
      " '2H); 1.36 (m, 4H); 1.16 (d, J=6.7, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0832\" level=\"1\">Example E45</heading>\\n'\n",
      " '<heading id=\"h-0833\" '\n",
      " 'level=\"1\">N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1489\" num=\"3293\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f14) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1490\" num=\"3294\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1491\" num=\"3295\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.92 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.85 (d, J=7.7, 1H, &#x2014;NH); 7.43 (dd, J=8.9, 3.3, 1H); 7.38 (ddd, '\n",
      " 'J=8.9, 8.2, 3.3, 1H); 7.19 (dd, J=8.9, 4.4, 1 H); 4.03 (m, 1H); 3.88 (d, '\n",
      " 'J=6.8, 2H); 3.75 (m, 1H); 2.79 (s, 3H); 1.84 (s, 3H); 1.82-1.52 (m, 8H); '\n",
      " '0.94 (m, 1H); 0.37 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0834\" level=\"1\">Example E46</heading>\\n'\n",
      " '<heading id=\"h-0835\" '\n",
      " 'level=\"1\">N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1492\" num=\"3296\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f15) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1493\" num=\"3297\">MS (ESI): m/z=452 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1494\" num=\"3298\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.97 (s, 1H); [8.93 (d, J=6.9), 8.89 (d, J=6.9), '\n",
      " '1H, &#x2014;NH]; 7.43 (dd, J=8.9, 3.2, 1H); 7.38 (ddd, J=9.0, 8.6, 3.2, 1H); '\n",
      " '7.19 (dd, J=9.0, 4.4, 1H); [4.59 (m), 4.49 (m), 1H]; 3.88 (d, J=6.9, 2H); '\n",
      " '[3.84 (m), 3.65 (m), 1H]; 3.62 (m, 1H); 3.55-3.26 (m, 2H); [2.80 (s); 2.79 '\n",
      " '(s), 3H]; 2.35-2.16 (m, 1H); 2.09-1.87 (m, 1H); [1.98 (s), 1.96 (s), 3H]; '\n",
      " '0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0836\" level=\"1\">Example E47</heading>\\n'\n",
      " '<heading id=\"h-0837\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1495\" num=\"3299\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f15) and commercially propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1496\" num=\"3300\">MS (ESI): m/z=466 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1497\" num=\"3301\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.96 (s, 1H); [8.92 (d, J=7.1), 8.89 (d, J=6.8), '\n",
      " '1H, &#x2014;NH]; 7.42 (dd, J=8.9, 3.3, 1H); 7.38 (ddd, J=9.1, 8.4, 3.3, 1H); '\n",
      " '7.19 (dd, J=9.1, 4.4, 1H); [4.59 (m), 4.49 (m), 1H]; 3.87 (d, J=6.9, 2H); '\n",
      " '[3.82 (m), 3.66 (m), 1H]; 3.61 (m, 1H); 3.55-3.26 (m, 2H); [2.80 (s); 2.79 '\n",
      " '(s), 3H]; 2.34-2.15 (m, 1H); [2.29 (qu, J=7.5), 2.25 (qu, J=7.5), 2H]; [2.03 '\n",
      " '(m), 1.92 (m), 1H]; [1.01 (t, J=7.5), 1.00 (t, J=7.5), 3H]; 0.93 (m, 1H); '\n",
      " '0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0838\" level=\"1\">Example E48</heading>\\n'\n",
      " '<heading id=\"h-0839\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1498\" num=\"3302\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f15) and commercially methoxy-acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1499\" num=\"3303\">MS (ESI): m/z=482 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1500\" num=\"3304\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.96 (s, 1H); [8.91 (d, J=7.1), 8.89 (d, J=6.8), '\n",
      " '1H, &#x2014;NH]; 7.42 (ddd, J=8.9, 3.3, 0.6, 1H); 7.38 (ddd, J=9.1, 8.4, '\n",
      " '3.3, 1H); 7.19 (dd, J=9.1, 4.4, 1H); [4.59 (m), 4.50 (m), 1H]; [4.06 (d, '\n",
      " 'J=4.0), 4.01 (d, J=1.1), 2H]; 3.87 (d, J=6.9, 2H); [3.80 (m), 3.68 (m), 1H]; '\n",
      " '3.63-3.42 (m, 2H); 3.36 (m, 1H); [3.32 (s), 3.30 (s), 3H]; 2.79 (s, 3H); '\n",
      " '2.34-2.13 (m, 1H); [2.03 (m), 1.92 (m), 1H]; 0.93 (m, 1H); 0.36 (m, 2H); '\n",
      " '0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0840\" level=\"1\">Example E49</heading>\\n'\n",
      " '<heading id=\"h-0841\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1501\" num=\"3305\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f16) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1502\" num=\"3306\">HR-MS (ESI): m/z=482.2199 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '482.2198).</p>\\n'\n",
      " '<heading id=\"h-0842\" level=\"1\">Example E50</heading>\\n'\n",
      " '<heading id=\"h-0843\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1503\" num=\"3307\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f16) and commercially propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1504\" num=\"3308\">HR-MS (ESI): m/z=496.2359 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '496.2355).</p>\\n'\n",
      " '<heading id=\"h-0844\" level=\"1\">Example E51</heading>\\n'\n",
      " '<heading id=\"h-0845\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1505\" num=\"3309\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f16) and commercially methoxy-acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1506\" num=\"3310\">HR-MS (ESI): m/z=512.2294 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-0846\" level=\"1\">Example E52</heading>\\n'\n",
      " '<heading id=\"h-0847\" '\n",
      " 'level=\"1\">N-(1-acetylpiperidin-4-yl)-4-(2-ethoxy-5-fluorophenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1507\" num=\"3311\">Starting from '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f17) and commercially acetyl chloride the title compound is '\n",
      " 'obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1508\" num=\"3312\">MS (ESI): m/z=440 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1509\" num=\"3313\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (ddd, J=9.1, 8.9, 3.2, 1H); 7.38 (dd, J=8.2, 3.2, 1H); 7.22 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.22-4.06 (m, 2H); 4.08 (qu, J=7.0, 2H); 3.78 (m, 1H); 3.27 (m, '\n",
      " '1H); 2.95 (m, 2H); 2.79 (s, 3H); 2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.38 (m, 1H); 1.10 (t, J=7.0, 3H).</p>\\n'\n",
      " '<heading id=\"h-0848\" level=\"1\">Example E53</heading>\\n'\n",
      " '<heading id=\"h-0849\" '\n",
      " 'level=\"1\">4-(2-Ethoxy-5-fluorophenyl)-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1510\" num=\"3314\">Starting from '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f17) and commercially propionyl chloride the title compound is '\n",
      " 'obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1511\" num=\"3315\">MS (ESI): m/z=454 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1512\" num=\"3316\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>, '\n",
      " 'MeOH-d<sub>4</sub>): 11.87 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.79 (d, '\n",
      " 'J=7.7, 1H, &#x2014;NH); 7.42 (ddd, J=9.1, 8.9, 3.2, 1H); 7.38 (dd, J=8.2, '\n",
      " '3.2, 1H); 7.22 (dd, J=9.1, 4.4, 1H); 4.25-4.03 (m, 2H); 4.08 (qu, J=6.9, '\n",
      " '2H); 3.81 (m, 1H); 3.25 (m, 1H); 2.96 (m, 2H); 2.78 (s, 3H); 2.36 (qu, '\n",
      " 'J=7.3, 2H); 1.95 (m, 2H); 1.52 (m, 1H); 1.38 (m, 1H); 1.11 (t, J=6.9, 3H); '\n",
      " '1.01 (t, J=7.3, 3H).</p>\\n'\n",
      " '<heading id=\"h-0850\" level=\"1\">Example E54</heading>\\n'\n",
      " '<heading id=\"h-0851\" '\n",
      " 'level=\"1\">4-(2-Ethoxy-5-fluorophenyl)-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1513\" num=\"3317\">Starting from '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f17) and commercially methoxy-acetyl chloride the title compound '\n",
      " 'is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1514\" num=\"3318\">MS (ESI): m/z=470 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1515\" num=\"3319\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (ddd, J=9.1, 8.9, 3.2, 1H); 7.38 (dd, J=8.3, 3.2, 1H); 7.22 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.21-4.06 (m, 2H); 4.12 (d, J=3.0, 2H); 4.08 (qu, J=7.0, 2H); 3.75 '\n",
      " '(m, 1H); 3.31 (s, 3H); 3.22 (m, 1H); 2.98 (m, 1H); 2.78 (s, 3H); 1.97 (m, '\n",
      " '2H); 1.53 (m, 1H); 1.41 (m, 1H); 1.11 (t, J=6.9, 3H).</p>\\n'\n",
      " '<heading id=\"h-0852\" level=\"1\">Example E55</heading>\\n'\n",
      " '<heading id=\"h-0853\" '\n",
      " 'level=\"1\">N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1516\" num=\"3320\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f18) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1517\" num=\"3321\">MS (ESI): m/z=478 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1518\" num=\"3322\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.68 (s, 1H, &#x2014;NH); 8.90 (s, 1H); 8.84 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.59 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 2H); 6.69 (d, J=2.2, 1H); '\n",
      " '4.21-4.04 (m, 2H); 3.91 (d, J=6.9, 2H); 3.86 (s, 3H); 3.78 (m, 1H); 3.27 (m, '\n",
      " '1H); 2.95 (m, 1H); 2.78 (s, 3H); 2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.38 (m, 1H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0854\" level=\"1\">Example E56</heading>\\n'\n",
      " '<heading id=\"h-0855\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1519\" num=\"3323\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f18) and commercially propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1520\" num=\"3324\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1521\" num=\"3325\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.68 (s, 1H, &#x2014;NH); 8.90 (s, 1H); 8.84 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.59 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 2H); 6.69 (d, J=2.2, 1H); '\n",
      " '4.25-4.03 (m, 2H); 3.90 (d, J=6.9, 2H); 3.86 (s, 3H); 3.81 (m, 1H); 3.25 (m, '\n",
      " '1H); 2.96 (m, 1H); 2.78 (s, 3H); 2.36 (qu, J=7.3, 2H); 1.95 (m, 2H); 1.51 '\n",
      " '(m, 1H); 1.38 (m, 1H); 1.01 (t, J=7.3, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0856\" level=\"1\">Example E57</heading>\\n'\n",
      " '<heading id=\"h-0857\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1522\" num=\"3326\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f18) and commercially methoxy-acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1523\" num=\"3327\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1524\" num=\"3328\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.68 (s, 1H, &#x2014;NH); 8.90 (s, 1H); 8.84 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.59 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 2H); 6.69 (d, J=2.2, 1H); '\n",
      " '4.21-4.06 (m, 2H); 4.12 (d, J=1.5, 2H); 3.90 (d, J=6.8, 2H); 3.86 (s, 3H); '\n",
      " '3.75 (m, 1H); 3.31 (s, 3H); 3.22 (m, 1H); 2.99 (m, 1H); 2.78 (s, 3H); 1.96 '\n",
      " '(m, 2H); 1.53 (m, 1H); 1.41 (m, 1H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0858\" level=\"1\">Example E58</heading>\\n'\n",
      " '<heading id=\"h-0859\" '\n",
      " 'level=\"1\">N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1525\" num=\"3329\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f19) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1526\" num=\"3330\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1527\" num=\"3331\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.66 (s, 1H, &#x2014;NH); 8.91 (s, 1H); 8.67 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.9, 1H, &#x2014;NH); 7.58 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, '\n",
      " '1H); 6.68 (d, J=2.2, 1H); 3.90 (d, J=6.9, 2H); 3.86 (s, 3H); 3.80 (m, 1H); '\n",
      " '3.58 (m, 1H); 2.77 (s, 3H); 2.00 (m, 2H); 1.86 (m, 2H); 1.79 (s, 3H); 1.35 '\n",
      " '(m, 4H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0860\" level=\"1\">Example E59</heading>\\n'\n",
      " '<heading id=\"h-0861\" '\n",
      " 'level=\"1\">N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1528\" num=\"3332\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f20) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1529\" num=\"3333\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1530\" num=\"3334\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.66 (s, 1H, &#x2014;NH); 8.95 (d, J=6.9, 1H, &#x2014;NH); 8.94 (s, 1H); '\n",
      " '7.84 (d, J=7.5, 1H, &#x2014;NH); 7.59 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, '\n",
      " '2H); 6.69 (d, J=2.2, 1H); 4.02 (m, 1H); 3.91 (d, J=6.8, 2H); 3.86 (s, 3H); '\n",
      " '3.75 (m, 1H); 2.78 (s, 3H); 1.84 (s, 3H); 1.81-1.51 (m, 8H); 0.96 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0862\" level=\"1\">Example E60</heading>\\n'\n",
      " '<heading id=\"h-0863\" '\n",
      " 'level=\"1\">N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1531\" num=\"3335\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f21) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1532\" num=\"3336\">MS (ESI): m/z=464 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1533\" num=\"3337\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (br.s, 1H, &#x2014;NH); [8.96 (d, J=6.8), 8.93 (d, J=6.8), 1H, '\n",
      " '&#x2014;NH]; 8.91 (s, 1H); 7.59 (dd, J=8.4, 0.9, 1H); 6.72 (dd, J=8.4, 2.2, '\n",
      " '1H); 6.69 (d, J=2.2, 1H); [4.58 (m), 4.49 (m), 1H]; 3.90 (d, J=6.9, 2H); '\n",
      " '3.86 (s, 3H); [3.83 (m), 3.65 (m), 1H]; 3.62 (m, 1H); 3.55-3.27 (m, 2H); '\n",
      " '[2.78 (s), 2.77 (s), 3H]; 2.34-2.15 (m 1H); 2.08-1.86 (m, 1H); [1.98 (s), '\n",
      " '1.96 (s), 3H]; 0.95 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0864\" level=\"1\">Example E61</heading>\\n'\n",
      " '<heading id=\"h-0865\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1534\" num=\"3338\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f21) and commercially propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1535\" num=\"3339\">MS (ESI): m/z=478 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1536\" num=\"3340\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (br.s, 1H, &#x2014;NH); [8.96 (d, J=6.8), 8.93 (d, J=6.8), 1H, '\n",
      " '&#x2014;NH]; [8.90 (s), 8.89 (s), 1H]; 7.59 (dd, J=8.4, 0.7, 1H); 6.72 (dd, '\n",
      " 'J=8.4, 2.2, 1H); 6.69 (d, J=2.2, 1H); [4.58 (m), 4.48 (m), 1H]; 3.90 (d, '\n",
      " 'J=6.9, 2H); 3.86 (s, 3H); [3.81 (m), 3.67 (m), 1H]; 3.60 (m, 1H); 3.55-3.26 '\n",
      " '(m, 2H); [2.79 (s), 2.78 (s), 3H]; 2.34-2.15 (m 1H); [2.28 (qu, J=7.5), 2.25 '\n",
      " '(qu, J=7.5), 2H]; [2.03 (m), 1.91 (m), 1H]; [1.01 (t, J=7.5), 0.99 (t, '\n",
      " 'J=7.5), 3H]; 0.95 (m, 1H); 0.37 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0866\" level=\"1\">Example E62</heading>\\n'\n",
      " '<heading id=\"h-0867\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1537\" num=\"3341\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f21) and commercially methoxy-acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1538\" num=\"3342\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1539\" num=\"3343\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (br.s, 1H, &#x2014;NH); [8.95 (d, J=6.8), 8.93 (d, J=6.8), 1H, '\n",
      " '&#x2014;NH]; [8.90 (s), 8.89 (s), 1H]; 7.59 (dd, J=8.4, 0.7, 1H); 6.72 (dd, '\n",
      " 'J=8.4, 2.2, 1H); 6.69 (d, J=2.2, 1H); [4.58 (m), 4.49 (m), 1H]; [4.06 (d, '\n",
      " 'J=3.8), 4.01 (d, J=1.1), 2H]; 3.90 (d, J=6.9, 2H); 3.86 (s, 3H); [3.79 (m), '\n",
      " '3.68 (m), 1H]; 3.62-3.42 (m, 2H); 3.38-327 (m, 1H); [3.32 (s), 3.29 (s), '\n",
      " '3H]; 2.78 (s, 3H); 2.33-2.14 (m 1H); [2.03 (m), 1.90 (m), 1H]; 0.95 (m, 1H); '\n",
      " '0.37 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0868\" level=\"1\">Example E63</heading>\\n'\n",
      " '<heading id=\"h-0869\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1540\" num=\"3344\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f22) and commercially acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1541\" num=\"3345\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1542\" num=\"3346\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (br.s, 1H, &#x2014;NH); [8.91 (d, J=7.1), 8.85 (d, J=6.8), 1H, '\n",
      " '&#x2014;NH]; 8.89 (s, 1H); 7.59 (dd, J=8.4, 0.7, 1H); 6.72 (dd, J=8.4, 2.2, '\n",
      " '1H); 6.69 (d, J=2.2, 1H); 5.50 (br.s, 1H, &#x2014;OH); [4.35 (m), 4.19 (m), '\n",
      " '1H]; 4.27 (m, 1H); 3.90 (d, J=6.9, 2H); 3.86 (s, 3H); 3.79-3.65 (m, 1H); '\n",
      " '3.62-3.53 (m, 1H); 3.48-3.32 (m, 2H); 2.78 (s, 3H); [1.99 (s); 1.98 (s), '\n",
      " '3H]; 0.95 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0870\" level=\"1\">Example E64</heading>\\n'\n",
      " '<heading id=\"h-0871\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1543\" num=\"3347\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f22) and commercially propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1544\" num=\"3348\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1545\" num=\"3349\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (br.s, 1H, &#x2014;NH); [8.90 (d, J=7.1), 8.85 (d, J=6.6), 1H, '\n",
      " '&#x2014;NH]; 8.87 (s, 1H); 7.58 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 1H); '\n",
      " '6.69 (d, J=2.2, 1H); [5.54 (br. s), 5.46 (br. s), 1H, &#x2014;OH]; [4.35 '\n",
      " '(m), 4.18 (m), 1H]; 4.27 (m, 1H); 3.91 (d, J=7.1, 2H); 3.86 (s, 3H); '\n",
      " '3.79-3.66 (m, 1H); 3.63-3.55 (m, 1H); 3.48-3.32 (m, 2H); 2.78 (s, 3H); [2.28 '\n",
      " '(qu, J=7.5), 2.27 (qu, J=7.5), 2H]; [1.03 (d, J=7.5); 1.01 (d, J=7.5), 3H]; '\n",
      " '0.95 (m, 1H); 0.37 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0872\" level=\"1\">Example E65</heading>\\n'\n",
      " '<heading id=\"h-0873\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1546\" num=\"3350\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f22) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1547\" num=\"3351\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1548\" num=\"3352\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (br.s, 1H, &#x2014;NH); [8.90 (d, J=7.1), 8.85 (d, J=6.6), 1H, '\n",
      " '&#x2014;NH]; [8.87 (s), 8.86 (s), 1H]; 7.58 (d, J=8.4, 1H); 6.72 (dd, J=8.4, '\n",
      " '2.2, 1H); 6.69 (d, J=2.2, 1H); 5.68-5.36 (br.s, 1H, &#x2014;OH); [4.36 (m), '\n",
      " '4.19 (m), 1H]; 4.27 (m, 1H); [4.09 (dd, J=14.6, 3.5), 4.01 [d, J=14.6), 2H]; '\n",
      " '3.90 (d, J=6.9, 2H); 3.86 (s, 3H); 3.78-3.68 (m, 1H); 3.66-3.58 (m, 1H); '\n",
      " '3.48-3.32 (m, 2H); [3.33 (s), 3.31 (s), 3H]; 2.78 (s, 3H); 0.95 (m, 1H); '\n",
      " '0.37 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0874\" level=\"1\">Example E66</heading>\\n'\n",
      " '<heading id=\"h-0875\" '\n",
      " 'level=\"1\">N-(1-acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1549\" num=\"3353\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f23) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1550\" num=\"3354\">MS (ESI): m/z=478 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1551\" num=\"3355\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.18 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); 4.22-3.93 (m, 2H); 3.82 (d, J=6.8, '\n",
      " '2H); 3.77 (s, 3H &#x26; m, 1H); 3.27 (m, 1H); 2.95 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, 1H); 1.39 (m, 1H); 0.92 (m, 1H); 0.34 '\n",
      " '(m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0876\" level=\"1\">Example E67</heading>\\n'\n",
      " '<heading id=\"h-0877\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1552\" num=\"3356\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f23) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1553\" num=\"3357\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1554\" num=\"3358\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.17 (t, J=1.8, 1H); 7.11 (d, J=1.8, 1H); 4.25-4.05 (m, 2H); 3.82 (d, J=6.9, '\n",
      " '2H); 3.79 (m, 1H); 3.77 (s, 3H); 3.25 (m, 1H); 2.96 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.36 (qu, J=7.5, 2H); 1.96 (m, 2H); 1.52 (m, 1H); 1.38 (m, 1H); 1.01 (t, '\n",
      " 'J=7.5, 3H); 0.92 (m, 1H); 0.34 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0878\" level=\"1\">Example E68</heading>\\n'\n",
      " '<heading id=\"h-0879\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1555\" num=\"3359\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f23) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1556\" num=\"3360\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1557\" num=\"3361\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.17 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); 4.21-4.06 (m, 2H); 4.12 (d, J=1.6, '\n",
      " '2H); 3.82 (d, J=6.8, 2H); 3.77 (s, 3H); 3.73 (m, 1H); 3.31 (s, 3H); 3.22 (m, '\n",
      " '1H); 2.98 (m, 1H); 2.79 (s, 3H); 1.97 (m, 2H); 1.54 (m, 1H); 1.41 (m, 1H); '\n",
      " '0.92 (m, 1H); 0.34 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0880\" level=\"1\">Example E69</heading>\\n'\n",
      " '<heading id=\"h-0881\" '\n",
      " 'level=\"1\">N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1558\" num=\"3362\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f24) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1559\" num=\"3363\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1560\" num=\"3364\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.7, 1H, &#x2014;NH); 7.17 (t, J=1.8, 1H); 7.10 (d, J=1.8, 2H); '\n",
      " '3.82 (d, J=6.8, 2H); 3.77 (s, 3H &#x26; m, 1H); 3.59 (m, 1H); 2.78 (s, 3H); '\n",
      " '2.01 (m, 2H); 1.86 (m, 2H); 1.79 (s, 3H); 1.35 (m, 4H); 0.92 (m, 1H); 0.34 '\n",
      " '(m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0882\" level=\"1\">Example E70</heading>\\n'\n",
      " '<heading id=\"h-0883\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1561\" num=\"3365\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f24) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1562\" num=\"3366\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1563\" num=\"3367\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.7, 1H, &#x2014;NH); 7.17 (t, J=1.8, 1H); 7.10 (d, J=1.8, 2H); '\n",
      " '3.82 (d, J=6.8, 2H); 3.79 (m, 1H); 3.77 (s, 3H); 3.59 (m, 1H); 2.78 (s, 3H); '\n",
      " '2.06 (qu, J=7.5, 2H); 2.01 (m, 2H); 1.86 (m, 2H); 1.35 (m, 4H); 0.99 (t, '\n",
      " 'J=7.5, 3H); 0.92 (m, 1H); 0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0884\" level=\"1\">Example E71</heading>\\n'\n",
      " '<heading id=\"h-0885\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1564\" num=\"3368\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f24) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1565\" num=\"3369\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1566\" num=\"3370\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.57 (d, J=8.2, 1H, &#x2014;NH); 7.17 (t, J=1.8, 1H); 7.10 (d, J=1.8, 2H); '\n",
      " '3.82 (d, J=6.8, 2H); 3.78 (s, 2H); 3.77 (s, 3H &#x26; m, 1H); 3.69 (m, 1H); '\n",
      " '3.31 (s, 3H); 2.78 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); 0.92 '\n",
      " '(m, 1H); 0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0886\" level=\"1\">Example E72</heading>\\n'\n",
      " '<heading id=\"h-0887\" '\n",
      " 'level=\"1\">N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1567\" num=\"3371\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f25) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1568\" num=\"3372\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1569\" num=\"3373\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.93 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.85 (d, J=7.3, 1H, &#x2014;NH); 7.18 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); '\n",
      " '4.02 (m, 1H); 3.83 (d, J=6.8, 2H); 3.77 (s, 3H); 3.75 (m, 1H); 2.79 (s, 3H); '\n",
      " '1.84 (s, 3H); 1.81-1.52 (m, 8H); 0.92 (m, 1H); 0.35 (m, 2H); 0.20 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0888\" level=\"1\">Example E73</heading>\\n'\n",
      " '<heading id=\"h-0889\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1570\" num=\"3374\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f25) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1571\" num=\"3375\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1572\" num=\"3376\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.92 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.7, 1H, &#x2014;NH); 7.18 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); '\n",
      " '4.02 (m, 1H); 3.83 (d, J=6.9, 2H); 3.77 (s, 3H); 3.75 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.11 (qu, J=7.5, 2H); 1.86-1.50 (m, 8H); 1.00 (t, J=7.5, 3H); 0.92 (m, 1H); '\n",
      " '0.35 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0890\" level=\"1\">Example E74</heading>\\n'\n",
      " '<heading id=\"h-0891\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1573\" num=\"3377\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f25) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1574\" num=\"3378\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1575\" num=\"3379\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.96 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.67 (d, J=7.7, 1H, &#x2014;NH); 7.18 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); '\n",
      " '4.05 (m, 1H); 3.83 (d, J=6.7, 2H); 3.80 (s, 2H &#x26; m, 1H); 3.77 (s, 3H); '\n",
      " '3.31 (s, 3H); 2.79 (s, 3H); 1.87-1.58 (m, 8H); 0.92 (m, 1H); 0.35 (m, 2H); '\n",
      " '0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0892\" level=\"1\">Example E75</heading>\\n'\n",
      " '<heading id=\"h-0893\" '\n",
      " 'level=\"1\">N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1576\" num=\"3380\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f26) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1577\" num=\"3381\">HR-MS (ESI): m/z=464.2290 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>30</sub>N<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '464.2292).</p>\\n'\n",
      " '<heading id=\"h-0894\" level=\"1\">Example E76</heading>\\n'\n",
      " '<heading id=\"h-0895\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1578\" num=\"3382\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f26) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1579\" num=\"3383\">HR-MS (ESI): m/z=478.2450 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>32</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '478.2449).</p>\\n'\n",
      " '<heading id=\"h-0896\" level=\"1\">Example E77</heading>\\n'\n",
      " '<heading id=\"h-0897\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1580\" num=\"3384\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f26) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1581\" num=\"3385\">HR-MS (ESI): m/z=494.2393 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>32</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '494.2398).</p>\\n'\n",
      " '<heading id=\"h-0898\" level=\"1\">Example E78</heading>\\n'\n",
      " '<heading id=\"h-0899\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1582\" num=\"3386\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f27) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1583\" num=\"3387\">HR-MS (ESI): m/z=494.2405 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>32</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '494.2398).</p>\\n'\n",
      " '<heading id=\"h-0900\" level=\"1\">Example E79</heading>\\n'\n",
      " '<heading id=\"h-0901\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1584\" num=\"3388\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f27) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1585\" num=\"3389\">HR-MS (ESI): m/z=508.2551 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>34</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '508.2554).</p>\\n'\n",
      " '<heading id=\"h-0902\" level=\"1\">Example E80</heading>\\n'\n",
      " '<heading id=\"h-0903\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1586\" num=\"3390\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f27) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1587\" num=\"3391\">HR-MS (ESI): m/z=524.2501 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>34</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '524.2504).</p>\\n'\n",
      " '<heading id=\"h-0904\" level=\"1\">Example E81</heading>\\n'\n",
      " '<heading id=\"h-0905\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1588\" num=\"3392\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f28) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1589\" num=\"3393\">MS (ESI): m/z=420 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1590\" num=\"3394\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.25 (br.s, 1H, &#x2014;NH); 9.11 (br.s, 2H, '\n",
      " '&#x2014;NH<sub>2</sub><sup>+</sup>); 9.06 (s, 1H); 7.47 (d, J=2.1, 1H); 7.39 '\n",
      " '(dd, J=8.4, 2.1, 1H); 7.10 (d, J=8.6, 1H); 4.12 (m, 1H); 3.88 (d, J=6.9, '\n",
      " '2H); 3.31 (m, 2H); 3.08 (m, 2H); 2.81 (s, 3H); 2.34 (s, 3H); 2.13 (m, 2H); '\n",
      " '1.79 (m, 2H); 0.93 (m, 1H); 0.36 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0906\" level=\"1\">Example E82</heading>\\n'\n",
      " '<heading id=\"h-0907\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1591\" num=\"3395\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f28) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1592\" num=\"3396\">MS (ESI): m/z=476 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1593\" num=\"3397\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.68 (br.s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (d, J=1.8, 1H); 7.32 (dd, J=8.4, 1.8, 1H); 7.05 (d, J=8.4, 1H); '\n",
      " '4.26-4.05 (m, 2H); 3.86 (d, J=6.9, 2H); 3.81 (m, 1H); 3.25 (m, 1H); 2.96 (m, '\n",
      " '1H); 2.78 (s, 3H); 2.36 (qu, J=7.3, 2H); 2.33 (s, 3H); 1.96 (m, 2H); 1.51 '\n",
      " '(m, 1H); 1.39 (m, 1H); 1.01 (t, J=7.3, 3H); 0.94 (m, 1H); 0.35 (m, 2H); 0.22 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0908\" level=\"1\">Example E83</heading>\\n'\n",
      " '<heading id=\"h-0909\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1594\" num=\"3398\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f28) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1595\" num=\"3399\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1596\" num=\"3400\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.67 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.83 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (d, J=1.8, 1H); 7.32 (dd, J=8.4, 1.8, 1H); 7.06 (d, J=8.4, 1H); '\n",
      " '4.23-4.04 (m, 2H); 4.12 (d, J=1.8, 2H); 3.86 (d, J=6.8, 2H); 3.75 (m, 1H); '\n",
      " '3.31 (s, 3H); 3.22 (m, 1H); 2.99 (m, 1H); 2.77 (s, 3H); 2.33 (s, 3H); 1.97 '\n",
      " '(m, 2H); 1.53 (m, 1H); 1.40 (m, 1H); 0.94 (m, 1H); 0.35 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0910\" level=\"1\">Example E84</heading>\\n'\n",
      " '<heading id=\"h-0911\" '\n",
      " 'level=\"1\">N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1597\" num=\"3401\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f29) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1598\" num=\"3402\">MS (ESI): m/z=434 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1599\" num=\"3403\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.25 (br.s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.55 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '8.09 (br. d, J=4.2, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.46 (d, J=2.1, '\n",
      " '1H); 7.39 (dd, J=8.4, 2.1, 1H); 7.11 (d, J=8.6, 1H); 3.88 (d, J=6.9, 2H); '\n",
      " '3.82 (m, 1H); 3.09 (m, 1H); 2.81 (s, 3H); 2.34 (s, 3H); 2.04 (m, 4H); 1.47 '\n",
      " '(m, 4H); 0.93 (m, 1H); 0.36 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0912\" level=\"1\">Example E85</heading>\\n'\n",
      " '<heading id=\"h-0913\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1600\" num=\"3404\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f29) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1601\" num=\"3405\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1602\" num=\"3406\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.67 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.9, 1H, &#x2014;NH); 7.43 (d, J=2.0, 1H); 7.32 (dd, J=8.4, 2.0, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 3.86 (d, J=6.9, 2H); 3.80 (m, 1H); 3.59 (m, 1H); '\n",
      " '2.77 (s, 3H); 2.33 (s, 3H); 2.05 (qu, J=7.5, 2H); 2.01 (m, 2H); 1.86 (m, '\n",
      " '2H); 1.35 (m, 4H); 0.99 (t, J=7.5, 3H); 0.94 (m, 1H); 0.35 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0914\" level=\"1\">Example E86</heading>\\n'\n",
      " '<heading id=\"h-0915\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1603\" num=\"3407\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f29) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1604\" num=\"3408\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1605\" num=\"3409\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.57 (d, J=8.4, 1H, &#x2014;NH); 7.43 (d, J=2.1, 1H); 7.32 (dd, J=8.4, 2.1, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 5.40 (t, J=5.9, 1H, &#x2014;OH); 3.86 (d, J=6.9, '\n",
      " '2H); 3.78 (s, 2H &#x26; m, 1H); 3.69 (m, 1H); 3.31 (s, 3H); 2.77 (s, 3H); '\n",
      " '2.33 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); 1.34 (m, 4H); 0.94 (m, 1H); 0.35 '\n",
      " '(m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0916\" level=\"1\">Example E87</heading>\\n'\n",
      " '<heading id=\"h-0917\" '\n",
      " 'level=\"1\">N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1606\" num=\"3410\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f30) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1607\" num=\"3411\">MS (ESI): m/z=476 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1608\" num=\"3412\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.94 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.85 (d, J=7.7, 1H, &#x2014;NH); 7.44 (d, J=1.8, 1H); 7.33 (dd, J=8.4, 1.8, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 4.02 (m, 1H); 3.86 (d, J=6.9, 2H); 3.75 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.33 (s, 3H); 1.84 (s, 3H); 1.81-1.51 (m, 8H); 0.94 (m, 1H); '\n",
      " '0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0918\" level=\"1\">Example E88</heading>\\n'\n",
      " '<heading id=\"h-0919\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1609\" num=\"3413\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f30) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1610\" num=\"3414\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1611\" num=\"3415\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.94 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.7, 1H, &#x2014;NH); 7.44 (d, J=1.8, 1H); 7.33 (dd, J=8.4, 1.8, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 4.02 (m, 1H); 3.86 (d, J=6.9, 2H); 3.75 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.33 (s, 3H); 2.11 (qu, J=7.7, 2H); 1.83-1.53 (m, 8H); 1.00 '\n",
      " '(t, J=7.7, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0920\" level=\"1\">Example E89</heading>\\n'\n",
      " '<heading id=\"h-0921\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1612\" num=\"3416\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f30) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1613\" num=\"3417\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1614\" num=\"3418\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.97 (s, 1H &#x26; d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.67 (d, J=7.7, 1H, &#x2014;NH); 7.44 (d, J=2.1, 1H); 7.33 (dd, J=8.4, 2.1, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 4.05 (m, 1H); 3.86 (d, J=6.9, 2H); 3.82 (s, 2H); '\n",
      " '3.79 (m, 1H); 3.31 (s, 3H); 2.78 (s, 3H); 2.33 (s, 3H); 1.84-1.61 (m, 8H); '\n",
      " '0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0922\" level=\"1\">Example E90</heading>\\n'\n",
      " '<heading id=\"h-0923\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1615\" num=\"3419\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f31) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1616\" num=\"3420\">MS (ESI): m/z=516 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1617\" num=\"3421\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.90 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.80 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.38 (d, J=8.8, 1H); '\n",
      " '4.23-4.05 (m, 2H); 4.00 (d, J=7.0, 2H); 3.79 (m, 1H); 3.28 (m, 1H); 2.95 (m, '\n",
      " '1H); 2.80 (s, 3H); 2.04 (s, 3H); 1.96 (m, 2H); 1.55 (m, 1H); 1.39 (m, 1H); '\n",
      " '0.99 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0924\" level=\"1\">Example E91</heading>\\n'\n",
      " '<heading id=\"h-0925\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1618\" num=\"3422\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f31) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1619\" num=\"3423\">MS (ESI): m/z=530 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1620\" num=\"3424\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.90 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.38 (d, J=8.8, 1H); '\n",
      " '4.26-4.06 (m, 2H); 4.00 (d, J=6.9, 2H); 3.82 (m, 1H); 3.28 (m, 1H); 2.96 (m, '\n",
      " '1H); 2.79 (s, 3H); 2.36 (qu, J=7.4, 2H); 1.96 (m, 2H); 1.52 (m, 1H); 1.39 '\n",
      " '(m, 1H); 1.01 (t, J=7.4, 3H); 0.99 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0926\" level=\"1\">Example E92</heading>\\n'\n",
      " '<heading id=\"h-0927\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1621\" num=\"3425\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f31) and commercially available methoxy-methyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1622\" num=\"3426\">MS (ESI): m/z=546 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1623\" num=\"3427\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.90 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.38 (d, J=8.8, 1H); '\n",
      " '4.24-4.06 (m, 2H); 4.12 (s, 2H); 4.00 (d, J=6.9, 2H); 3.75 (m, 1H); 3.31 (s, '\n",
      " '3H); 3.23 (m, 1H); 2.99 (m, 1H); 2.79 (s, 3H); 1.97 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.41 (m, 1H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0928\" level=\"1\">Example E93</heading>\\n'\n",
      " '<heading id=\"h-0929\" '\n",
      " 'level=\"1\">N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1624\" num=\"3428\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f32) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1625\" num=\"3429\">MS (ESI): m/z=530 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1626\" num=\"3430\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.72 (d, J=7.7, 1H, '\n",
      " '&#x2014;NH); 7.38 (d, J=8.8, 1H); 4.00 (d, J=6.9, 2H); 3.81 (m, 1H); 3.59 '\n",
      " '(m, 1H); 2.79 (s, 3H); 2.01 (m, 2H); 1.86 (m, 2H); 1.79 (s, 3H); 1.36 (m, '\n",
      " '4H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0930\" level=\"1\">Example E94</heading>\\n'\n",
      " '<heading id=\"h-0931\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1627\" num=\"3431\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f32) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid. Alternative the above '\n",
      " 'obtained solid is re-crystalised from ethylene glycol/water mixture '\n",
      " '(5/1).</p>\\n'\n",
      " '<p id=\"p-1628\" num=\"3432\">MS (ESI): m/z=544 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1629\" num=\"3433\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.90 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.63 (d, J=7.8, 1H, '\n",
      " '&#x2014;NH); 7.38 (d, J=8.8, 1H); 3.99 (d, J=6.9, 2H); 3.80 (m, 1H); 3.59 '\n",
      " '(m, 1H); 2.79 (s, 3H); 2.06 (qu, J=7.5, 2H); 2.01 (m, 2H); 1.86 (m, 2H); '\n",
      " '1.36 (m, 4H); 0.98 (t, J=7.5, 3H &#x26; m, 1H); 0.39 (m, 2H); 0.27 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0932\" level=\"1\">Example E95</heading>\\n'\n",
      " '<heading id=\"h-0933\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1630\" num=\"3434\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f32) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1631\" num=\"3435\">MS (ESI): m/z=560 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1632\" num=\"3436\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.63 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.57 (d, J=8.2, 1H, '\n",
      " '&#x2014;NH); 7.38 (d, J=8.8, 1H); 4.00 (d, J=7.0, 2H); 3.78 (s, 2H &#x26; m, '\n",
      " '1H); 3.70 (m, 1H); 3.31 (s, 3H); 2.79 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); '\n",
      " '1.44 (m, 4H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0934\" level=\"1\">Example E96</heading>\\n'\n",
      " '<heading id=\"h-0935\" '\n",
      " 'level=\"1\">N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1633\" num=\"3437\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f33) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1634\" num=\"3438\">MS (ESI): m/z=530 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1635\" num=\"3439\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (br.s, 1H, &#x2014;NH); 9.02 (s, 1H); 8.92 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.91 (s, 1H); 7.88 (d, J=8.2, 1H); 7.85 (d, J=7.6, 1H, &#x2014;NH); 7.38 (d, '\n",
      " 'J=8.2, 1H); 4.04 (m, 1H); 4.00 (d, J=6.9, 2H); 3.75 (m, 1H); 2.80 (s, 3H); '\n",
      " '1.84 (s, 3H); 1.81-1.52 (m, 8H); 0.99 (m, 1H); 0.40 (m, 2H); 0.28 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0936\" level=\"1\">Example E97</heading>\\n'\n",
      " '<heading id=\"h-0937\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1636\" num=\"3440\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f33) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1637\" num=\"3441\">MS (ESI): m/z=544 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1638\" num=\"3442\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (br.s, 1H, &#x2014;NH); 9.01 (s, 1H); 8.92 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.91 (s, 1H); 7.89 (d, J=8.7, 1H); 7.79 (d, J=7.6, 1H, &#x2014;NH); 7.38 (d, '\n",
      " 'J=8.7, 1H); 4.03 (m, 1H); 4.00 (d, J=7.0, 2H); 3.75 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.12 (qu, J=7.6, 2H); 1.83-1.52 (m, 8H); 1.00 (t, J=7.6, 3H); 0.98 (m, 1H); '\n",
      " '0.40 (m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0938\" level=\"1\">Example E98</heading>\\n'\n",
      " '<heading id=\"h-0939\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1639\" num=\"3443\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f33) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1640\" num=\"3444\">MS (ESI): m/z=560 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1641\" num=\"3445\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.91 (s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.96 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.91 (s, 1H); 7.90 (d, J=8.8, 1H); 7.72 (d, J=7.8, 1H, &#x2014;NH); 7.39 (d, '\n",
      " 'J=8.8, 1H); 4.06 (m, 1H); 4.00 (d, J=7.0, 2H); 3.82 (s, 2H); 3.79 (m, 1H); '\n",
      " '3.31 (s, 3H); 2.80 (s, 3H); 1.85-1.60 (m, 8H); 0.98 (m, 1H); 0.40 (m, 2H); '\n",
      " '0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0940\" level=\"1\">Example E99</heading>\\n'\n",
      " '<heading id=\"h-0941\" '\n",
      " 'level=\"1\">N-(1-acetylpiperidin-4-yl)-4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1642\" num=\"3446\">Starting from '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f34) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1643\" num=\"3447\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1644\" num=\"3448\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.92 (br.s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.92 (d, J=2.2, 1H); 7.91 (dd, J=9.4, 2.2, 1H); 7.43 (d, J=9.4, 1H); 4.21 '\n",
      " '(qu, J=7.0, 2H); 4.18-4.07 (m, 2H); 3.78 (m, 1H); 3.28 (m, 1H); 2.95 (m, '\n",
      " '1H); 2.79 (s, 3H); 2.04 (s, 3H); 1.96 (m, 2H); 1.54 (m, 1H); 1.39 (m, 1H); '\n",
      " '1.16 (t, J=7.0, 3H).</p>\\n'\n",
      " '<heading id=\"h-0942\" level=\"1\">Example E100</heading>\\n'\n",
      " '<heading id=\"h-0943\" '\n",
      " 'level=\"1\">4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1645\" num=\"3449\">Starting from '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f34) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1646\" num=\"3450\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1647\" num=\"3451\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.93 (br.s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.92 (d, J=2.2, 1H); 7.91 (dd, J=9.4, 2.2, 1H); 7.42 (d, J=9.4, 1H); 4.21 '\n",
      " '(qu, J=7.0, 2H); 4.17-4.07 (m, 2H); 3.82 (m, 1H); 3.26 (m, 1H); 2.96 (m, '\n",
      " '1H); 2.79 (s, 3H); 2.36 (qu, J=7.1, 2H); 1.96 (m, 2H); 1.52 (m, 1H); 1.38 '\n",
      " '(m, 1H); 1.16 (t, J=7.0, 3H); 1.01 (t, J=7.1, 3H).</p>\\n'\n",
      " '<heading id=\"h-0944\" level=\"1\">Example E101</heading>\\n'\n",
      " '<heading id=\"h-0945\" '\n",
      " 'level=\"1\">4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1648\" num=\"3452\">Starting from '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f34) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1649\" num=\"3453\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1650\" num=\"3454\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.93 (br.s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.92 (d, J=2.2, 1H); 7.91 (dd, J=9.5, 2.2, 1H); 7.42 (d, J=9.5, 1H); 4.21 '\n",
      " '(qu, J=7.0, 2H); 4.17-4.06 (m, 2H); 4.12 (d, J=2.8, 2H); 3.75 (m, 1H); 3.31 '\n",
      " '(s, 3H); 3.23 (m, 1H); 2.99 (m, 1H); 2.79 (s, 3H); 1.97 (m, 2H); 1.54 (m, '\n",
      " '1H); 1.41 (m, 1H); 1.16 (t, J=7.0, 3H).</p>\\n'\n",
      " '<heading id=\"h-0946\" level=\"1\">Example E102</heading>\\n'\n",
      " '<heading id=\"h-0947\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1651\" num=\"3455\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f35) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1652\" num=\"3456\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1653\" num=\"3457\"><sup>1</sup>H-NMR (300 MHz, 11.76 (s, 1H, '\n",
      " '&#x2014;NH); 8.95 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); 7.39 (d, J=9.9, '\n",
      " '1H); 7.18 (d, J=13.3, 1H); 4.23-4.05 (m, 2H); 3.84 (s, 3H &#x26; d, J=6.8, '\n",
      " '2H); 3.78 (m, 1H); 3.28 (m, 1H); 2.95 (m, 1H); 2.79 (s, 3H); 2.04 (s, 3H); '\n",
      " '1.96 (m, 2H); 1.54 (m, 1H); 1.38 (m, 1H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0948\" level=\"1\">Example E103</heading>\\n'\n",
      " '<heading id=\"h-0949\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1654\" num=\"3458\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f35) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1655\" num=\"3459\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1656\" num=\"3460\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 4.25-4.05 (m, 2H); 3.84 (s, 3H '\n",
      " '&#x26; d, J=6.8, 2H); 3.79 (m, 1H); 3.26 (m, 1H); 2.96 (m, 1H); 2.79 (s, '\n",
      " '3H); 2.36 (qu J=7.4, 2H); 1.96 (m, 2H); 1.52 (m, 1H); 1.38 (m, 1H); 1.01 (t, '\n",
      " 'J=7.4, 3H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0950\" level=\"1\">Example E104</heading>\\n'\n",
      " '<heading id=\"h-0951\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1657\" num=\"3461\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f35) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1658\" num=\"3462\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1659\" num=\"3463\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 4.22-4.05 (m, 2H); 4.11 (s, 2H); '\n",
      " '3.84 (s, 3H &#x26; d, J=6.9, 2H); 3.75 (m, 1H); 3.24 (m, 1H); 2.98 (m, 1H); '\n",
      " '2.79 (s, 3H); 1.97 (m, 2H); 1.54 (m, 1H); 1.41 (m, 1H); 0.93 (m, 1H); 0.36 '\n",
      " '(m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0952\" level=\"1\">Example E105</heading>\\n'\n",
      " '<heading id=\"h-0953\" level=\"1\">Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1660\" num=\"3464\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f35) and commercially available ethyl chloroformate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1661\" num=\"3465\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1662\" num=\"3466\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 4.06 (qu, J=7.1, 2H &#x26; m, '\n",
      " '1H); 3.88 (m, 2H); 3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.11 (m, 2H); 2.78 (s, '\n",
      " '3H); 1.94 (m, 2H); 1.46 (m, 1H); 1.20 (t, J=7.1, 3H); 0.93 (m, 1H); 0.36 (m, '\n",
      " '2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0954\" level=\"1\">Example E106</heading>\\n'\n",
      " '<heading id=\"h-0955\" '\n",
      " 'level=\"1\">N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1663\" num=\"3467\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f36) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1664\" num=\"3468\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1665\" num=\"3469\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.65 (s, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.7, 1H, &#x2014;NH); 7.40 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); '\n",
      " '3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.80 (m, 1H); 3.58 (m, 1H); 2.78 (s, 3H); '\n",
      " '2.01 (m, 2H); 1.86 (m, 2H); 1.79 (s, 3H); 1.35 (m, 4H); 0.93 (m, 1H); 0.36 '\n",
      " '(m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0956\" level=\"1\">Example E107</heading>\\n'\n",
      " '<heading id=\"h-0957\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1666\" num=\"3470\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f36) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1667\" num=\"3471\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1668\" num=\"3472\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.7, 1H, &#x2014;NH); 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); '\n",
      " '3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.80 (m, 1H); 3.59 (m, 1H); 2.78 (s, 3H); '\n",
      " '2.06 (qu, J=7.6, 2H); 2.01 (m, 2H); 1.86 (m, 2H); 1.35 (m, 4H); 0.99 (t, '\n",
      " 'J=7.6, 3H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0958\" level=\"1\">Example E108</heading>\\n'\n",
      " '<heading id=\"h-0959\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1669\" num=\"3473\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f36) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1670\" num=\"3474\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1671\" num=\"3475\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.64 (s, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.56 (d, J=8.2, 1H, &#x2014;NH); 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); '\n",
      " '3.84 (s, 3H); 3.83 (d, J=6.8, 2H); 3.78 (s, 2H &#x26; m, 1H); 3.69 (m, 1H); '\n",
      " '3.31 (s, 3H); 2.78 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); 0.93 '\n",
      " '(m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0960\" level=\"1\">Example E109</heading>\\n'\n",
      " '<heading id=\"h-0961\" level=\"1\">Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1672\" num=\"3476\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f36) and commercially available ethyl chloroformate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1673\" num=\"3477\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1674\" num=\"3478\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 7.01 (d, J=7.1, 1H, &#x2014;NH); '\n",
      " '3.98 (qu, J=7.0, 2H); 3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.76 (m, 1H); 3.33 '\n",
      " '(m, 1H); 2.78 (s, 3H); 2.00 (m, 2H); 1.87 (m, 2H); 1.36 (m, 4H); 1.16 (t, '\n",
      " 'J=7.0, 3H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0962\" level=\"1\">Example E110</heading>\\n'\n",
      " '<heading id=\"h-0963\" '\n",
      " 'level=\"1\">N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1675\" num=\"3479\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f37) and commercially available acetyl chloride '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1676\" num=\"3480\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1677\" num=\"3481\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.91 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.84 (d, J=7.3, 1H, &#x2014;NH); 7.40 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); '\n",
      " '4.02 (m, 1H); 3.85 (s, 3H &#x26; d, J=6.7, 2H); 3.75 (m, 1H); 2.79 (s, 3H); '\n",
      " '1.84 (s, 3H); 1.82-1.51 (m, 8H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-0964\" level=\"1\">Example E111</heading>\\n'\n",
      " '<heading id=\"h-0965\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1678\" num=\"3482\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f37) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1679\" num=\"3483\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1680\" num=\"3484\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.91 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.3, 1H, &#x2014;NH); 7.40 (d, J=9.9, 1H); 7.19 (d, J=13.3, 1H); '\n",
      " '4.02 (m, 1H); 3.85 (s, 3H &#x26; d, J=6.9, 2H); 3.75 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.11 (qu, J=7.7, 2H); 1.85-1.51 (m, 8H); 1.00 (t, J=7.7, 3H); 0.93 (m, 1H); '\n",
      " '0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0966\" level=\"1\">Example E112</heading>\\n'\n",
      " '<heading id=\"h-0967\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1681\" num=\"3485\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f37) and commercially available mehoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1682\" num=\"3486\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1683\" num=\"3487\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.95 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.66 (d, J=7.7, 1H, &#x2014;NH); 7.39 (d, J=9.7, 1H); 7.19 (d, J=13.5, 1H); '\n",
      " '4.05 (m, 1H); 3.85 (s, 3H &#x26; d, J=6.9, 2H); 3.82 (s, 2H); 3.79 (m, 1H); '\n",
      " '3.29 (s, 3H); 2.79 (s, 3H); 1.86-1.58 (m, 8H); 0.93 (m, 1H); 0.36 (m, 2H); '\n",
      " '0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0968\" level=\"1\">Example E113</heading>\\n'\n",
      " '<heading id=\"h-0969\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1684\" num=\"3488\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f38) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1685\" num=\"3489\">HR-MS (ESI): m/z=512.2310 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>5</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-0970\" level=\"1\">Example E114</heading>\\n'\n",
      " '<heading id=\"h-0971\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propionylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1686\" num=\"3490\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f38) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1687\" num=\"3491\">HR-MS (ESI): m/z=526.2462 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>5</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '526.2460).</p>\\n'\n",
      " '<heading id=\"h-0972\" level=\"1\">Example E115</heading>\\n'\n",
      " '<heading id=\"h-0973\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1688\" num=\"3492\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f38) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1689\" num=\"3493\">HR-MS (ESI): m/z=542.2399 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>5</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '542.2409).</p>\\n'\n",
      " '<heading id=\"h-0974\" level=\"1\">Example E116</heading>\\n'\n",
      " '<heading id=\"h-0975\" '\n",
      " 'level=\"1\">N-[(3S*,4S*)-1-Acetyl-4-hydroxypiperidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1690\" num=\"3494\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f39) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1691\" num=\"3495\">HR-MS (ESI): m/z=512.2302 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>5</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-0976\" level=\"1\">Example E117</heading>\\n'\n",
      " '<heading id=\"h-0977\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxy-1-propionylpiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1692\" num=\"3496\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f39) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1693\" num=\"3497\">HR-MS (ESI): m/z=526.2462 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>5</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '526.2460).</p>\\n'\n",
      " '<heading id=\"h-0978\" level=\"1\">Example E118</heading>\\n'\n",
      " '<heading id=\"h-0979\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxy-1-(methoxyacetyl)piperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1694\" num=\"3498\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f39) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1695\" num=\"3499\">HR-MS (ESI): m/z=542.2401 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '542.2409).</p>\\n'\n",
      " '<heading id=\"h-0980\" level=\"1\">Example E119</heading>\\n'\n",
      " '<heading id=\"h-0981\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1696\" num=\"3500\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f40) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1697\" num=\"3501\">MS (ESI): m/z=554 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1698\" num=\"3502\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H); 7.04 (d, J=12.0, 1H); 4.22-4.05 (m, 2H); 3.87 (d, '\n",
      " 'J=6.9, 2H); 3.78 (m, 1H); 3.28 (m, 1H); 2.95 (m, 1H); 2.78 (s, 3H); 2.25 (d, '\n",
      " 'J=1.1, 3H); 2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, 1H); 1.38 (m, 1H); 0.95 (m, '\n",
      " '1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0982\" level=\"1\">Example E120</heading>\\n'\n",
      " '<heading id=\"h-0983\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1699\" num=\"3503\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f40) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1700\" num=\"3504\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1701\" num=\"3505\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.81 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H); 7.04 (d, J=12.0, 1H); 4.25-4.05 (m, 2H); 3.87 (d, '\n",
      " 'J=6.9, 2H); 3.81 (m, 1H); 3.26 (m, 1H); 2.96 (m, 1H); 2.78 (s, 3H); 2.36 '\n",
      " '(qu, J=7.5, 2H); 2.24 (d, J=1.1, 3H); 1.95 (m, 2H); 1.51 (m, 1H); 1.38 (m, '\n",
      " '1H); 1.01 (t, J=7.5, 3H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0984\" level=\"1\">Example E121</heading>\\n'\n",
      " '<heading id=\"h-0985\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1702\" num=\"3506\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f40) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1703\" num=\"3507\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1704\" num=\"3508\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H); 7.04 (d, J=12.0, 1H); 4.22-4.06 (m, 2H); 4.12 (d, '\n",
      " 'J=1.6, 2H); 3.87 (d, J=6.9, 2H); 3.75 (m, 1H); 3.31 (s, 3H); 3.22 (m, 1H); '\n",
      " '2.98 (m, 1H); 2.78 (s, 3H); 2.24 (d, J=1.1, 3H); 1.96 (m, 2H); 1.53 (m, 1H); '\n",
      " '1.41 (m, 1H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0986\" level=\"1\">Example E122</heading>\\n'\n",
      " '<heading id=\"h-0987\" '\n",
      " 'level=\"1\">N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1705\" num=\"3509\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f41) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1706\" num=\"3510\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1707\" num=\"3511\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.7, 1H, &#x2014;NH); 7.54 (d, J=9.1, 1H); 7.03 (d, J=12.0, 1H); '\n",
      " '3.87 (d, J=6.9, 2H); 3.80 (m, 1H); 3.58 (m, 1H); 2.77 (s, 3H); 2.25 (d, '\n",
      " 'J=1.1, 3H); 2.00 (m, 2H); 1.86 (m, 2H); 1.79 (s, 3H); 1.35 (m, 4H); 0.95 (m, '\n",
      " '1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0988\" level=\"1\">Example E123</heading>\\n'\n",
      " '<heading id=\"h-0989\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1708\" num=\"3512\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f41) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1709\" num=\"3513\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1710\" num=\"3514\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.7, 1H, &#x2014;NH); 7.54 (d, J=9.1, 1H); 7.03 (d, J=12.0, 1H); '\n",
      " '3.87 (d, J=6.9, 2H); 3.80 (m, 1H); 3.59 (m, 1H); 2.77 (s, 3H); 2.25 (d, '\n",
      " 'J=0.9, 3H); 2.05 (qu, J=7.7, 2H); 2.01 (m, 2H); 1.85 (m, 2H); 1.35 (m, 4H); '\n",
      " '0.99 (t, J=7.7, 3H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0990\" level=\"1\">Example E124</heading>\\n'\n",
      " '<heading id=\"h-0991\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1711\" num=\"3515\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f41) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1712\" num=\"3516\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1713\" num=\"3517\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.57 (d, J=7.7, 1H, &#x2014;NH); 7.54 (d, J=9.1, 1H); 7.03 (d, J=12.0, 1H); '\n",
      " '3.87 (d, J=6.9, 2H); 3.78 (m, 1H &#x26; s, 2H); 3.68 (m, 1H); 3.31 (s, 3H); '\n",
      " '2.77 (s, 3H); 2.25 (d, J=1.1, 3H); 2.01 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); '\n",
      " '0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0992\" level=\"1\">Example E125</heading>\\n'\n",
      " '<heading id=\"h-0993\" '\n",
      " 'level=\"1\">N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1714\" num=\"3518\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f42) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1715\" num=\"3519\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1716\" num=\"3520\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.93 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.84 (d, J=7.7, 1H, &#x2014;NH); 7.54 (d, J=9.1, 1H); 7.04 (d, J=12.0, 1H); '\n",
      " '4.03 (m, 1H); 3.88 (d, J=6.9, 2H); 3.75 (m, 1H); 2.78 (s, 3H); 2.25 (d, '\n",
      " 'J=1.1, 3H); 1.84 (s, 3H); 1.84-1.51 (m, 8H); 0.95 (m, 1H); 0.37 (m, 2H); '\n",
      " '0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0994\" level=\"1\">Example E126</heading>\\n'\n",
      " '<heading id=\"h-0995\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1717\" num=\"3521\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f42) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1718\" num=\"3522\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1719\" num=\"3523\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.93 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.5, 1H, &#x2014;NH); 7.54 (d, J=9.1, 1H); 7.04 (d, J=12.2, 1H); '\n",
      " '4.03 (m, 1H); 3.88 (d, J=7.1, 2H); 3.75 (m, 1H); 2.78 (s, 3H); 2.25 (d, '\n",
      " 'J=1.1, 3H); 2.11 (qu, J=7.5, 2H); 1.84-1.51 (m, 8H); 1.00 (t, J=7.5, 3H); '\n",
      " '0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0996\" level=\"1\">Example E127</heading>\\n'\n",
      " '<heading id=\"h-0997\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1720\" num=\"3524\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f42) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1721\" num=\"3525\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1722\" num=\"3526\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.96 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.66 (d, J=7.8, 1H, &#x2014;NH); 7.54 (d, J=9.1, 1H); 7.04 (d, J=12.2, 1H); '\n",
      " '4.05 (m, 1H); 3.88 (d, J=6.9, 2H); 3.82 (s, 2H); 3.79 (m, 1H); 3.31 (s 3H); '\n",
      " '2.78 (s, 3H); 2.25 (d, J=1.1, 3H); 1.86-1.59 (m, 8H); 0.95 (m, 1H); 0.37 (m, '\n",
      " '2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-0998\" level=\"1\">Example E128</heading>\\n'\n",
      " '<heading id=\"h-0999\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1723\" num=\"3527\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f43) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1724\" num=\"3528\">HR-MS (ESI): m/z=496.2373 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '496.2355).</p>\\n'\n",
      " '<heading id=\"h-1000\" level=\"1\">Example E129</heading>\\n'\n",
      " '<heading id=\"h-1001\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1725\" num=\"3529\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f43) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1726\" num=\"3530\">HR-MS (ESI): m/z=510.2534 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '510.2511).</p>\\n'\n",
      " '<heading id=\"h-1002\" level=\"1\">Example E130</heading>\\n'\n",
      " '<heading id=\"h-1003\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1727\" num=\"3531\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f43) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1728\" num=\"3532\">HR-MS (ESI): m/z=526.2474 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '526.2460).</p>\\n'\n",
      " '<heading id=\"h-1004\" level=\"1\">Example E131</heading>\\n'\n",
      " '<heading id=\"h-1005\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1729\" num=\"3533\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f44) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1730\" num=\"3534\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1731\" num=\"3535\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 6.93 (d, J=7.3, 1H); 4.22-4.04 (m, 2H); 3.97 (s, 3H); '\n",
      " '3.94 (d, J=6.9, 2H); 3.78 (m, 1H); 3.27 (m, 1H); 2.95 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, 1H); 1.38 (m, 1H); 0.96 (m, 1H); 0.38 '\n",
      " '(m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1006\" level=\"1\">Example E132</heading>\\n'\n",
      " '<heading id=\"h-1007\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-(1-propionylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1732\" num=\"3536\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f44) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1733\" num=\"3537\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1734\" num=\"3538\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (br.s, 1H, &#x2014;NH); 8.91 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 6.92 (d, J=7.3, 1H); 4.19 (m, 1H); 4.12 (m, 1H); 3.97 '\n",
      " '(s, 3H); 3.94 (d, J=6.9, 2H); 3.81 (m, 1H); 3.25 (m, 1H); 2.96 (m, 1H); 2.79 '\n",
      " '(s, 3H); 2.36 (qu, J=7.3, 2H); 1.95 (m, 2H); 1.51 (m, 1H); 1.38 (m, 1H); '\n",
      " '1.01 (t, J=7.3, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1008\" level=\"1\">Example E133</heading>\\n'\n",
      " '<heading id=\"h-1009\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1735\" num=\"3539\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f44) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1736\" num=\"3540\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1737\" num=\"3541\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 6.92 (d, J=7.3, 1H); 4.22-4.06 (s, 2H &#x26; m, 2H); '\n",
      " '3.97 (s, 3H); 3.94 (d, J=6.9, 2H); 3.75 (m, 1H); 3.31 (m, 1H); 3.22 (m, 1H); '\n",
      " '2.98 (m, 1H); 2.79 (s, 3H); 1.96 (m, 2H); 1.53 (m, 1H); 1.40 (m, 1H); 0.96 '\n",
      " '(m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1010\" level=\"1\">Example E134</heading>\\n'\n",
      " '<heading id=\"h-1011\" level=\"1\">Ethyl '\n",
      " '4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]piperidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1738\" num=\"3542\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f44) and commercially available ethyl chloroformate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1739\" num=\"3543\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1740\" num=\"3544\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 6.93 (d, J=7.3, 1H); 4.06 (qu, J=7.1, 2H &#x26; m, '\n",
      " '1H); 3.97 (s, 3H); 3.94 (d, J=7.1, 2H); 3.88 (m, 2H); 3.11 (m, 2H); 2.79 (s, '\n",
      " '3H); 1.94 (m, 2H); 1.45 (m, 1H); 1.20 (t, J=7.1, 3H); 0.96 (m, 1H); 0.39 (m, '\n",
      " '2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1012\" level=\"1\">Example E135</heading>\\n'\n",
      " '<heading id=\"h-1013\" '\n",
      " 'level=\"1\">N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1741\" num=\"3545\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f45) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1742\" num=\"3546\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1743\" num=\"3547\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.32 (br.s, 1H, &#x2014;NH); 9.01 (s, 1H); 8.51 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.18 (br. d, J=4.6, 3H, &#x2014;NH<sub>3</sub><sup>+</sup>); 7.54 (d, '\n",
      " 'J=11.7, 1H); 6.96 (d, J=7.3, 1H); 3.99 (s, 3H); 3.97 (d, J=7.4, 2H); 3.81 '\n",
      " '(m, 1H); 3.07 (m, 1H); 2.83 (s, 3H); 2.05 (m, 4H); 1.48 (m, 4H); 0.97 (m, '\n",
      " '1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1014\" level=\"1\">Example E136</heading>\\n'\n",
      " '<heading id=\"h-1015\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1744\" num=\"3548\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f45) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1745\" num=\"3549\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1746\" num=\"3550\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.70 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.7, 1H, &#x2014;NH); 7.47 (d, J=11.8, 1H); 6.92 (d, J=7.5, 1H); '\n",
      " '3.97 (s, 3H); 3.94 (d, J=6.9, 2H); 3.80 (m, 1H); 3.59 (m, 1H); 2.78 (s, 3H); '\n",
      " '2.05 (qu, J=7.7, 2H); 2.00 (m, 2H); 1.86 (m, 2H); 1.35 (m, 4H); 0.99 (t, '\n",
      " 'J=7.7, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1016\" level=\"1\">Example E137</heading>\\n'\n",
      " '<heading id=\"h-1017\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1747\" num=\"3551\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f45) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1748\" num=\"3552\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1749\" num=\"3553\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.70 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.56 (d, J=8.2, 1H, &#x2014;NH); 7.47 (d, J=11.7, 1H); 6.92 (d, J=7.3, 1H); '\n",
      " '3.97 (s, 3H); 3.94 (d, J=6.9, 2H); 3.78 (s, 2H &#x26; m, 1H); 3.69 (m, 1H); '\n",
      " '3.31 (s, 3H); 2.78 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); 0.96 '\n",
      " '(m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1018\" level=\"1\">Example E138</heading>\\n'\n",
      " '<heading id=\"h-1019\" '\n",
      " 'level=\"1\">N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1750\" num=\"3554\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f46) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1751\" num=\"3555\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1752\" num=\"3556\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.94 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.84 (d, J=7.5, 1H, &#x2014;NH); 7.48 (d, J=11.9, 1H); 6.93 (d, J=7.3, 1H); '\n",
      " '4.02 (m, 1H); 3.97 (s, 3H); 3.95 (d, J=6.9, 2H); 3.75 (m, 1H); 2.79 (s, 3H); '\n",
      " '1.84 (s, 3H); 1.80-1.52 (m, 8H); 0.96 (m, 1H); 0.39 (m, 2H); 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1020\" level=\"1\">Example E139</heading>\\n'\n",
      " '<heading id=\"h-1021\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1753\" num=\"3557\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f46) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1754\" num=\"3558\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1755\" num=\"3559\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.93 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.5, 1H, &#x2014;NH); 7.47 (d, J=11.9, 1H); 6.93 (d, J=7.3, 1H); '\n",
      " '4.02 (m, 1H); 3.97 (s, 3H); 3.94 (d, J=6.9, 2H); 3.75 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.11 (qu, J=7.6, 2H); 1.83-1.52 (m, 8H); 1.00 (t, J=7.6, 1H); 0.96 (m, 1H); '\n",
      " '0.39 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1022\" level=\"1\">Example E140</heading>\\n'\n",
      " '<heading id=\"h-1023\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1756\" num=\"3560\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f46) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1757\" num=\"3561\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1758\" num=\"3562\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.70 (s, 1H, &#x2014;NH); 8.97 (d, J=7.7, 1H, &#x2014;NH); 8.96 (s, 1H); '\n",
      " '7.67 (d, J=7.7, 1H, &#x2014;NH); 7.47 (d, J=11.9, 1H); 6.93 (d, J=7.3, 1H); '\n",
      " '4.05 (m, 1H); 3.97 (s, 3H); 3.94 (d, J=7.1, 2H); 3.82 (s, 2H); 3.79 (m, 1H); '\n",
      " '3.31 (s, 3H); 2.79 (s, 3H); 1.85-1.59 (m, 8H); 0.96 (m, 1H); 0.39 (m, 2H); '\n",
      " '0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1024\" level=\"1\">Example E141</heading>\\n'\n",
      " '<heading id=\"h-1025\" level=\"1\">Ethyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate</heading>\\n'\n",
      " '<p id=\"p-1759\" num=\"3563\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f46) and commercially available ethyl chloroformate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1760\" num=\"3564\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1761\" num=\"3565\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.69 (s, 1H, &#x2014;NH); 8.98 (d, J=7.7, 1H, &#x2014;NH); 8.95 (s, 1H); '\n",
      " '7.47 (d, J=11.9, 1H); 7.21 (br. d, J=6.0, 1H, &#x2014;NH); 6.93 (d, J=7.3, '\n",
      " '1H); 4.03 (m, 1H); 3.99 (qu, J=7.1, 2H); 3.97 (s, 3H); 3.94 (d, J=7.1, 2H); '\n",
      " '3.48 (m, 1H); 2.78 (s, 3H); 1.85-1.54 (m, 8H); 1.17 (t, J=7.1, 3H); 0.96 (m, '\n",
      " '1H); 0.39 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1026\" level=\"1\">Example E142</heading>\\n'\n",
      " '<heading id=\"h-1027\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-Acetyl-3-hydroxypiperidin-4-yl]-4-[2-(cyclopropyl '\n",
      " 'methoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1762\" num=\"3566\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f47) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1763\" num=\"3567\">HR-MS (ESI): m/z=512.2301 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-1028\" level=\"1\">Example E143</heading>\\n'\n",
      " '<heading id=\"h-1029\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1764\" num=\"3568\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f47) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1765\" num=\"3569\">HR-MS (ESI): m/z=HR-MS (ESI): m/z=526.2454 '\n",
      " '([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '526.2460).</p>\\n'\n",
      " '<heading id=\"h-1030\" level=\"1\">Example E144</heading>\\n'\n",
      " '<heading id=\"h-1031\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1766\" num=\"3570\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f47) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1767\" num=\"3571\">HR-MS (ESI): m/z=542.2398 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>5</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '542.2409).</p>\\n'\n",
      " '<heading id=\"h-1032\" level=\"1\">Example E145</heading>\\n'\n",
      " '<heading id=\"h-1033\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1768\" num=\"3572\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f48) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1769\" num=\"3573\">MS (ESI): m/z=476 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1770\" num=\"3574\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.83 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.2, 1H); 7.36 (dd, J=8.6, 2.2, 1H); 7.08 (d, J=8.6, 1H); '\n",
      " '4.22-4.04 (m, 2H); 3.87 (d, J=6.9, 2H); 3.78 (m, 1H); 3.28 (m, 1H); 2.95 (m, '\n",
      " '1H); 2.78 (s, 3H); 2.64 (qu, J=7.5, 2H); 2.04 (s, 3H); 1.96 (m, 2H); 1.54 '\n",
      " '(m, 1H); 1.39 (m, 1H); 1.18 (t, J=7.5, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.25 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1034\" level=\"1\">Example E146</heading>\\n'\n",
      " '<heading id=\"h-1035\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1771\" num=\"3575\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f48) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1772\" num=\"3576\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1773\" num=\"3577\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.4, 1H); 7.36 (dd, J=8.6, 2.4, 1H); 7.08 (d, J=8.6, 1H); '\n",
      " '4.25-4.04 (m, 2H); 3.87 (d, J=6.9, 2H); 3.82 (m, 1H); 3.25 (m, 1H); 2.97 (m, '\n",
      " '1H); 2.78 (s, 3H); 2.64 (qu, J=7.5, 2H); 2.36 (qu, J=7.5, 2H); 1.96 (m, 2H); '\n",
      " '1.52 (m, 1H); 1.38 (m, 1H); 1.18 (t, J=7.5, 3H); 1.01 (t, J=7.5, 3H); 0.94 '\n",
      " '(m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1036\" level=\"1\">Example E147</heading>\\n'\n",
      " '<heading id=\"h-1037\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1774\" num=\"3578\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f48) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1775\" num=\"3579\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1776\" num=\"3580\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.4, 1H); 7.36 (dd, J=8.6, 2.4, 1H); 7.08 (d, J=8.6, 1H); '\n",
      " '4.22-4.04 (m, 2H); 4.12 (d, J=1.6, 2H); 3.87 (d, J=6.9, 2H); 3.75 (m, 1H); '\n",
      " '3.31 (s, 3H); 3.22 (m, 1H); 2.99 (m, 1H); 2.78 (s, 3H); 2.64 (qu, J=7.5, '\n",
      " '2H); 1.96 (m, 2H); 1.54 (m, 1H); 1.41 (m, 1H); 1.18 (t, J=7.5, 3H); 0.94 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1038\" level=\"1\">Example E148</heading>\\n'\n",
      " '<heading id=\"h-1039\" '\n",
      " 'level=\"1\">N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1777\" num=\"3581\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f49) and commercially available acetylchloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1778\" num=\"3582\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1779\" num=\"3583\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.7, 1H, &#x2014;NH); 7.45 (d, J=2.2, 1H); 7.35 (dd, J=8.6, 2.2, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 3.86 (d, J=6.9, 2H); 3.80 (m, 1H); 3.58 (m, 1H); '\n",
      " '2.77 (s, 3H); 2.64 (qu, J=7.5, 2H); 2.00 (m, 2H); 1.87 (m, 2H); 1.79 (s, '\n",
      " '3H); 1.35 (m, 4H); 1.18 (t, J=7.5, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1040\" level=\"1\">Example E149</heading>\\n'\n",
      " '<heading id=\"h-1041\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1780\" num=\"3584\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f49) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1781\" num=\"3585\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1782\" num=\"3586\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.67 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.62 (d, J=7.7, 1H, &#x2014;NH); 7.45 (d, J=2.2, 1H); 7.36 (dd, J=8.6, 2.2, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 3.86 (d, J=6.9, 2H); 3.80 (m, 1H); 3.58 (m, 1H); '\n",
      " '2.77 (s, 3H); 2.64 (qu, J=7.5, 2H); 2.06 (qu, J=7.7, 2H); 2.01 (m, 2H); 1.86 '\n",
      " '(m, 2H); 1.35 (m, 4H); 1.18 (t, J=7.5, 3H); 0.99 (t, J=7.5, 3H); 0.94 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1042\" level=\"1\">Example E150</heading>\\n'\n",
      " '<heading id=\"h-1043\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1783\" num=\"3587\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f49) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1784\" num=\"3588\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1785\" num=\"3589\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.86 (br.s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.57 (d, J=8.2, 1H, &#x2014;NH); 7.44 (d, J=2.4, 1H); 7.35 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.07 (d, J=8.6, 1H); 3.86 (d, J=6.9, 2H); 3.78 (s, 2H &#x26; m, 1H); '\n",
      " '3.69 (m, 1H); 3.31 (s, 3H); 2.77 (s, 3H); 2.63 (qu, J=7.5, 2H); 2.01 (m, '\n",
      " '2H); 1.82 (m, 2H); 1.43 (m, 4H); 1.18 (t, J=7.5, 3H); 0.94 (m, 1H); 0.35 (m, '\n",
      " '2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1044\" level=\"1\">Example E151</heading>\\n'\n",
      " '<heading id=\"h-1045\" '\n",
      " 'level=\"1\">N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1786\" num=\"3590\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f50) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1787\" num=\"3591\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1788\" num=\"3592\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.94 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.85 (d, J=7.5, 1H, &#x2014;NH); 7.45 (d, J=2.4, 1H); 7.36 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 4.03 (m, 1H); 3.87 (d, J=6.9, 2H); 3.75 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.64 (qu, J=7.5, 2H); 1.84 (s, 3H); 1.82-1.51 (m, 8H); 1.19 '\n",
      " '(t, J=7.5, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1046\" level=\"1\">Example E152</heading>\\n'\n",
      " '<heading id=\"h-1047\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1789\" num=\"3593\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f50) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1790\" num=\"3594\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1791\" num=\"3595\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.94 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.75 (d, J=7.5, 1H, &#x2014;NH); 7.45 (d, J=2.2, 1H); 7.36 (dd, J=8.6, 2.2, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 4.02 (m, 1H); 3.87 (d, J=6.8, 2H); 3.75 (m, 1H); '\n",
      " '2.78 (s, 3H); 2.64 (qu, J=7.5, 2H); 2.11 (qu, J=7.5, 2H); 1.89-1.52 (m, 8H); '\n",
      " '1.19 (t, J=7.5, 3H); 1.00 (t, J=7.5, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1048\" level=\"1\">Example E153</heading>\\n'\n",
      " '<heading id=\"h-1049\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1792\" num=\"3596\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f50) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1793\" num=\"3597\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1794\" num=\"3598\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.97 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.67 (d, J=7.5, 1H, &#x2014;NH); 7.45 (d, J=2.2, 1H); 7.36 (dd, J=8.6, 2.2, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 4.06 (m, 1H); 3.87 (d, J=6.8, 2H); 3.82 (s, 2H); '\n",
      " '3.79 (m, 1H); 3.31 (s, 3H); 2.78 (s, 3H); 2.64 (qu, J=7.6, 2H); 1.89-1.55 '\n",
      " '(m, 8H); 1.19 (t, J=7.6, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1050\" level=\"1\">Example E154</heading>\\n'\n",
      " '<heading id=\"h-1051\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1795\" num=\"3599\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f51) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1796\" num=\"3600\">MS (ESI): m/z=478 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1797\" num=\"3601\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.93 (s, 1H); [8.90 (d, J=7.1), 8.84 (d, J=6.6), '\n",
      " '1H, &#x2014;NH]; 7.45 (d, J=2.4, 1H); 7.36 (dd, J=8.4, 2.4, 1H); 7.08 (d, '\n",
      " 'J=8.4, 1H); [5.56 (d, J=3.8), 5.48 (J=4.0), 1H, &#x2014;OH]; [4.36 (m), 4.19 '\n",
      " '(m), 1H]; 4.27 (m, 1H); 3.86 (d, J=6.9, 2H); 3.80-3.65 (m, 1H); [3.58 (m), '\n",
      " '3.45 (m), 1H]; 3.41-3.27 (m, 2H); [2.78 (s), 2.77 (s), 3H]; 2.63 (qu, J=7.6, '\n",
      " '2H); [1.99 (s)-1.98 (s), 3H]; 1.18 (t, J=7.6, 3H); 0.94 (m, 1H); 0.36 (m, '\n",
      " '2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1052\" level=\"1\">Example E155</heading>\\n'\n",
      " '<heading id=\"h-1053\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1798\" num=\"3602\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f51) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1799\" num=\"3603\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1800\" num=\"3604\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.79 (s, 1H, &#x2014;NH); 8.91 (s, 1H); [8.88 (d, J=7.1), 8.84 (d, J=6.6), '\n",
      " '1H, &#x2014;NH]; 7.44 (d, J=2.4, 1H); 7.36 (dd, J=8.6, 2.4, 1H); 7.08 (d, '\n",
      " 'J=8.6, 1H); [5.55 (d, J=3.7), 5.47 (d, J=3.9), 1H, &#x2014;OH]; [4.36 (m), '\n",
      " '4.19 (m), 1H]; 4.27 (m, 1H); 3.86 (d, J=6.8, 2H); 3.73 (m, 1H); [3.59 (m), '\n",
      " '3.45 (m), 1H]; 3.42-3.27 (m, 2H); 2.78 (s, 3H); 2.63 (qu, J=7.6, 2H); [2.29 '\n",
      " '(qu, J=7.5), 2.28 (qu, J=7.5), 2H]; 1.18 (t, J=7.6, 3H); [1.03 (t, J=7.5), '\n",
      " '1.01 (t, J=7.5), 3H]; 0.93 (m, 1H); 0.35 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1054\" level=\"1\">Example E156</heading>\\n'\n",
      " '<heading id=\"h-1055\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1801\" num=\"3605\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f51) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1802\" num=\"3606\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1803\" num=\"3607\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); [8.91 (s), 8.90 (s), 1H]; [8.88 (d, J=7.1), 8.84 '\n",
      " '(d, J=6.6), 1H, &#x2014;NH]; 7.44 (d, J=2.4, 1H); 7.36 (dd, J=8.4, 2.4, 1H); '\n",
      " '7.08 (d, J=8.4, 1H); [5.57 (d, J=3.7), 5.50 (d, J=3.9), 1H, &#x2014;OH]; '\n",
      " '[4.36 (m), 4.19 (m), 1H]; 4.27 (m, 1H); [4.07 (d, J=3.5), 4.04 (s), 2H]; '\n",
      " '3.86 (d, J=6.9, 2H); 3.73 (m, 1H); [3.62 (m), 3.46 (m), 1H]; 3.44-3.27 (m, '\n",
      " '2H); [3.34 (s), 3.32 (s), 3H]; 2.78 (s, 3H); 2.63 (qu, J=7.6, 2H); 1.18 (t, '\n",
      " 'J=7.6, 3H); 0.93 (m, 1H); 0.35 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1056\" level=\"1\">Example E157</heading>\\n'\n",
      " '<heading id=\"h-1057\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1804\" num=\"3608\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f52) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1805\" num=\"3609\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1806\" num=\"3610\">1H-NMR (300 MHz, DMSO-d<sub>6</sub>): 11.76 (s, '\n",
      " '1H, &#x2014;NH); 8.95 (s, 1H); 8.83 (d, J=7.7, 1H, &#x2014;NH); 7.47 (d, '\n",
      " 'J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, 1H); 7.09 (d; J=8.6, 1H); 4.23-4.05 (m, '\n",
      " '2H); 3.87 (d, J=6.9, 2H); 3.78 (m, 1H); 3.28 (m, 1H); 2.94 (m, 1H &#x26; '\n",
      " 'sept J=6.9, 1H); 2.78 (s, 3H); 2.04 (s, 3H); 1.96 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.39 (m, 1H); 1.22 (d, J=6.9, 6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1058\" level=\"1\">Example E158</heading>\\n'\n",
      " '<heading id=\"h-1059\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1807\" num=\"3611\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f52) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1808\" num=\"3612\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1809\" num=\"3613\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.82 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, 1H); 7.09 (d; J=8.6, 1H); '\n",
      " '4.21-4.05 (m, 2H); 4.12 (d, J=1.6, 2H); 3.87 (d, J=6.9, 2H); 3.75 (m, 1H); '\n",
      " '3.31 (s, 3H); 3.22 (m, 1H); 2.94 (m, 1H &#x26; sept, J=6.9, 1 H); 2.78 (s, '\n",
      " '3H); 1.96 (m, 2H); 1.54 (m, 1H); 1.41 (m, 1H); 1.22 (d, J=6.9, 6H); 0.94 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1060\" level=\"1\">Example E159</heading>\\n'\n",
      " '<heading id=\"h-1061\" '\n",
      " 'level=\"1\">N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1810\" num=\"3614\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f53) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1811\" num=\"3615\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1812\" num=\"3616\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.72 (d, J=7.7, 1H, &#x2014;NH); 7.47 (d, J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.08 (d; J=8.6, 1H); 3.87 (d, J=6.9, 2H); 3.80 (m, 1H); 3.58 (m, 1H); '\n",
      " '2.94 (sept, J=6.9, 1H); 2.77 (s, 3H); 2.01 (m, 2H); 1.87 (m, 2H); 1.79 (s, '\n",
      " '3H); 1.35 (m, 4H); 1.22 (d, J=6.9, 6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1062\" level=\"1\">Example E160</heading>\\n'\n",
      " '<heading id=\"h-1063\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1813\" num=\"3617\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f53) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1814\" num=\"3618\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1815\" num=\"3619\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.57 (d, J=8.2, 1H, &#x2014;NH); 7.47 (d, J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.08 (d; J=8.6, 1H); 3.87 (d, J=6.9, 2H); 3.78 (s, 2H &#x26; m, 1H); '\n",
      " '3.69 (m, 1H); 3.31 (s, 3H); 2.94 (sept, J=6.9, 1H); 2.77 (s, 3H); 2.01 (m, '\n",
      " '2H); 1.82 (m, 2H); 1.43 (m, 4H); 1.22 (d, J=6.9, 6H); 0.94 (m, 1H); 0.36 (m, '\n",
      " '2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1064\" level=\"1\">Example E161</heading>\\n'\n",
      " '<heading id=\"h-1065\" '\n",
      " 'level=\"1\">N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1816\" num=\"3620\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f54) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1817\" num=\"3621\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1818\" num=\"3622\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.93 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.85 (d, J=7.7, 1H, &#x2014;NH); 7.47 (d, J=2.4, 1H); 7.40 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.09 (d; J=8.6, 1H); 4.02 (m, 1H); 3.87 (d, J=6.9, 2H); 3.75 (m, 1H); '\n",
      " '2.94 (sept, J=6.8, 1H); 2.78 (s, 3H); 1.84 (s, 3H); 1.81-1.51 (m, 8H); 1.22 '\n",
      " '(d, J=6.8, 6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1066\" level=\"1\">Example E162</heading>\\n'\n",
      " '<heading id=\"h-1067\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1819\" num=\"3623\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f54) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1820\" num=\"3624\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1821\" num=\"3625\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.97 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.67 (d, J=7.7, 1H, &#x2014;NH); 7.47 (d, J=2.4, 1H); 7.40 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.09 (d; J=8.6, 1H); 4.06 (m, 1H); 3.86 (d, J=6.9, 2H); 3.82 (s, 2H); '\n",
      " '3.79 (m, 1H); 3.31 (s, 3H); 2.95 (sept, J=6.9, 1H); 2.78 (s, 3H); 1.86-1.61 '\n",
      " '(m, 8H); 1.22 (d, J=6.9, 6H); 0.94 (m, 1H); 0.36 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1068\" level=\"1\">Example E163</heading>\\n'\n",
      " '<heading id=\"h-1069\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-(1-acetylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1822\" num=\"3626\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f55) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1823\" num=\"3627\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1824\" num=\"3628\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.92 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.3, 1H); 8.15 (dd, J=8.8, 2.3, 1H); 7.30 (d, J=8.8, 1H); '\n",
      " '4.22-4.07 (m, 2H); 4.01 (d, J=7.1, 2H); 3.79 (m, 1H); 3.28 (m, 1H); 2.95 (m, '\n",
      " '1H); 2.79 (s, 3H); 2.58 (s, 3H); 2.04 (s, 3H); 1.96 (m, 2H); 1.55 (m, 1H); '\n",
      " '1.40 (m, 1H); 0.99 (m, 1H); 0.39 (m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1070\" level=\"1\">Example E164</heading>\\n'\n",
      " '<heading id=\"h-1071\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1825\" num=\"3629\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f55) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1826\" num=\"3630\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1827\" num=\"3631\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.2, 1H); 8.15 (dd, J=8.8, 2.2, 1H); 7.30 (d, J=8.8, 1H); 4.20 '\n",
      " '(m, 1H); 4.13 (m, 1H); 4.01 (d, J=7.0, 2H); 3.82 (m, 1H); 3.27 (m, 1H); 2.96 '\n",
      " '(m, 1H); 2.79 (s, 3H); 2.58 (s, 3H); 2.36 (dqu, J=7.5, 1.3, 2H); 1.96 (m, '\n",
      " '2H); 1.53 (m, 1H); 1.39 (m, 1H); 1.01 (t, J=7.5, 3H); 0.99 (m, 1H); 0.39 (m, '\n",
      " '2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1072\" level=\"1\">Example E165</heading>\\n'\n",
      " '<heading id=\"h-1073\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1828\" num=\"3632\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f55) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1829\" num=\"3633\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1830\" num=\"3634\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.3, 1H); 8.15 (dd, J=8.8, 2.3, 1H); 7.30 (d, J=8.8, 1H); '\n",
      " '4.22-4.07 (m, 2H); 4.12 (d, J=3.0, 2H); 4.01 (d, J=7.0, 2H); 3.75 (m, 1H); '\n",
      " '3.31 (s, 3H); 3.23 (m, 1H); 2.98 (m, 1H); 2.79 (s, 3H); 2.58 (s, 3H); 1.97 '\n",
      " '(m, 2H); 1.55 (m, 1H); 1.42 (m, 1H); 0.99 (m, 1H); 0.39 (m, 2H); 0.28 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1074\" level=\"1\">Example E166</heading>\\n'\n",
      " '<heading id=\"h-1075\" '\n",
      " 'level=\"1\">N-[trans-4-(Acetylamino)cyclohexyl]-4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1831\" num=\"3635\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-aminocyclohexyl)-6-methyl-5&#x2032;-1-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f56) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1832\" num=\"3636\">MS (ESI): m/z=504 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1833\" num=\"3637\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.23 (br.s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.20 (d, J=2.2, 1H); 8.14 (dd, J=8.8, 2.2, 1H); 7.73 (d, J=7.7, 1H, '\n",
      " '&#x2014;NH); 7.29 (d, J=8.8, 1H); 4.01 (d, J=7.0, 2H); 3.80 (m, 1H); 3.59 '\n",
      " '(m, 1H); 2.77 (s, 3H); 2.58 (s, 3H); 2.01 (m, 2H); 1.86 (m, 2H); 1.79 (s, '\n",
      " '3H); 1.35 (m, 4H); 0.99 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1076\" level=\"1\">Example E167</heading>\\n'\n",
      " '<heading id=\"h-1077\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1834\" num=\"3638\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-aminocyclohexyl)-6-methyl-5&#x2032;-1-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f56) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1835\" num=\"3639\">MS (ESI): m/z=518 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1836\" num=\"3640\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.78 (br.s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.20 (d, J=2.3, 1H); 8.14 (dd, J=8.9, 2.3, 1H); 7.62 (d, J=7.7, 1H, '\n",
      " '&#x2014;NH); 7.29 (d, J=8.9, 1H); 4.01 (d, J=7.0, 2H); 3.80 (m, 1H); 3.59 '\n",
      " '(m, 1H); 2.78 (s, 3H); 2.58 (s, 3H); 2.05 (qu, J=7.7, 2H); 2.01 (m, 2H); '\n",
      " '1.86 (m, 2H); 1.36 (m, 4H); 0.99 (t, J=7.7, 3H &#x26; m, 1H); 0.39 (m, 2H); '\n",
      " '0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1078\" level=\"1\">Example E168</heading>\\n'\n",
      " '<heading id=\"h-1079\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1837\" num=\"3641\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-aminocyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f56) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1838\" num=\"3642\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1839\" num=\"3643\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (br.s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.64 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.3, 1H); 8.14 (dd, J=8.8, 2.3, 1H); 7.57 (d, J=8.2, 1H, '\n",
      " '&#x2014;NH); 7.30 (d, J=8.8, 1H); 4.01 (d, J=7.0, 2H); 3.81 (m, 1H); 3.78 '\n",
      " '(s, 2H); 3.70 (m, 1H); 3.31 (s, 3H); 2.78 (s, 3H); 2.58 (s, 3H); 2.02 (m, '\n",
      " '2H); 1.82 (m, 2H); 1.44 (m, 4H); 0.99 (m, 1H); 0.39 (m, 2H); 0.28 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1080\" level=\"1\">Example E169</heading>\\n'\n",
      " '<heading id=\"h-1081\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-d '\n",
      " 'methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1840\" num=\"3644\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f57) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1841\" num=\"3645\">MS (ESI): m/z=476 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-1842\" num=\"3646\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.59 (s, 1H, &#x2014;NH); 9.05 (d, J=7.7, 1H, &#x2014;NH); 7.39 (d, J=1.8, '\n",
      " '1H); 7.31 (dd, J=8.4, 1.8, 1H); 7.04 (d, J=8.4, 1H); 4.18-4.03 (m, 2H); 3.85 '\n",
      " '(d, J=6.9, 2H); 3.77 (m, 1H); 3.40-3.23 (m, 1H); 3.06 (m, 1H); 2.75 (s, 3H); '\n",
      " '2.72 (s, 3H); 2.33 (s, 3H); 2.04 (s, 3H); 1.95 (m, 2H); 1.63-1.33 (m, 2H); '\n",
      " '0.93 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1082\" level=\"1\">Example E170</heading>\\n'\n",
      " '<heading id=\"h-1083\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1843\" num=\"3647\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f57) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1844\" num=\"3648\">MS (ESI): m/z=490 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-1845\" num=\"3649\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.58 (s, 1H, &#x2014;NH); 9.05 (d, J=7.7, 1H, &#x2014;NH); 7.39 (d, J=2.0, '\n",
      " '1H); 7.31 (dd, J=8.4, 2.0, 1H); 7.04 (d, J=8.4, 1H); 4.18-4.03 (m, 2H); 3.85 '\n",
      " '(d, J=6.9, 2H); 3.77 (m, 1H); 3.37-3.22 (m, 1H); 3.07 (m, 1H); 2.75 (s, 3H); '\n",
      " '2.72 (s, 3H); 2.36 (qu, J=7.3, 2H); 2.33 (s, 3H); 1.95 (m, 2H); 1.60-1.34 '\n",
      " '(m, 2H); 1.01 (t, J=7.3, 3H); 0.92 (m, 1H); 0.35 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1084\" level=\"1\">Example E171</heading>\\n'\n",
      " '<heading id=\"h-1085\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1846\" num=\"3650\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f57) and commercially available available '\n",
      " 'methoxy-acetyl chloride the title compound is obtained as colorless '\n",
      " 'solid.</p>\\n'\n",
      " '<p id=\"p-1847\" num=\"3651\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-1848\" num=\"3652\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.58 (s, 1H, &#x2014;NH); 9.05 (d, J=7.7, 1H, &#x2014;NH); 7.39 (d, J=1.8, '\n",
      " '1H); 7.31 (dd, J=8.6, 1.8, 1H); 7.04 (d, J=8.6, 1H); 4.20-4.02 (m, 2H); 4.12 '\n",
      " '(d, J=0.9, 2H); 3.85 (d, J=6.9, 2H); 3.72 (m, 1H); 3.31 (s, 3H); 3.27 (m, '\n",
      " '1H); 3.09 (m, 1H); 2.75 (s, 3H); 2.72 (s, 3H); 2.33 (s, 3H); 1.97 (m, 2H); '\n",
      " '1.63-1.35 (m, 2H); 0.93 (m, 1H); 0.35 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1086\" level=\"1\">Example E172</heading>\\n'\n",
      " '<heading id=\"h-1087\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1849\" num=\"3653\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f58) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1850\" num=\"3654\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-1851\" num=\"3655\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.56 (s, 1H, &#x2014;NH); 9.04 (d, J=7.7, 1H, &#x2014;NH); 7.43 (d, J=11.9, '\n",
      " '1H); 6.91 (d, J=7.3, 1H); 4.18-4.03 (m, 2H); 3.96 (s, 3H); 3.93 (d, J=6.9, '\n",
      " '2H); 3.81-3.70 (m, 1H); 3.38-3.25 (m, 1H); 3.06 (m, 1H); 2.76 (s, 3H); 2.71 '\n",
      " '(s, 3H); 2.04 (s, 3H); 1.94 (m, 2H); 1.62-1.33 (m, 2H); 0.95 (m, 1H); 0.39 '\n",
      " '(m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1088\" level=\"1\">Example E173</heading>\\n'\n",
      " '<heading id=\"h-1089\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1852\" num=\"3656\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f59) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1853\" num=\"3657\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1854\" num=\"3658\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.59 (br.s, 1H, &#x2014;NH); 9.02 (d, J=7.7, 1H, &#x2014;NH); 7.33 (d, '\n",
      " 'J=9.9, 1H); 7.16 (d, J=13.5, 1H); 4.19-4.03 (m, 2H); 3.84 (s, 3H); 3.82 (d, '\n",
      " 'J=6.8, 2H); 3.76 (m, 2H); 3.34 (m, 1H); 3.05 (m, 1H); 2.75 (s, 3H); 2.73 (s, '\n",
      " '3H); 2.04 (s, 3H); 1.95 (m, 2H); 1.54 (m, 1H); 1.41 (m, 1H); 0.92 (m, 1H); '\n",
      " '0.35 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1090\" level=\"1\">Example E174</heading>\\n'\n",
      " '<heading id=\"h-1091\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1855\" num=\"3659\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f59) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1856\" num=\"3660\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1857\" num=\"3661\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.60 (br.s, 1H, &#x2014;NH); 9.02 (d, J=7.7, 1H, &#x2014;NH); 7.33 (d, '\n",
      " 'J=9.9, 1H); 7.16 (d, J=13.3, 1H); 4.19-4.03 (m, 2H); 3.84 (s, 3H); 3.83 (d, '\n",
      " 'J=6.8, 2H); 3.77 (m, 2H); 3.28 (m, 1H); 3.07 (m, 1H); 2.75 (s, 3H); 2.73 (s, '\n",
      " '3H); 2.36 (qu, J=7.3, 2H); 1.95 (m, 2H); 1.52 (m, 1H); 1.41 (m, 1H); 1.01 '\n",
      " '(t, J=7.3, 3H); 0.92 (m, 1H); 0.35 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1092\" level=\"1\">Example E175</heading>\\n'\n",
      " '<heading id=\"h-1093\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1858\" num=\"3662\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f59) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1859\" num=\"3663\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1860\" num=\"3664\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.60 (br.s, 1H, &#x2014;NH); 9.02 (d, J=7.7, 1H, &#x2014;NH); 7.33 (d, '\n",
      " 'J=9.9, 1H); 7.16 (d, J=13.5, 1H); 4.20-4.01 (m, 2H); 4.12 (s, 2H); 3.84 (s, '\n",
      " '3H); 3.83 (d, J=6.8, 2H); 3.72 (m, 1H); 3.31 (s, 3H); 3.24 (m, 1H); 3.08 (m, '\n",
      " '1H); 2.75 (s, 3H); 2.73 (s, 3H); 1.96 (m, 2H); 1.63-1.33 (m, 2H); 0.92 (m, '\n",
      " '1H); 0.35 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1094\" level=\"1\">Example E176</heading>\\n'\n",
      " '<heading id=\"h-1095\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1861\" num=\"3665\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.d60) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1862\" num=\"3666\">MS (ESI): m/z=421 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1863\" num=\"3667\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.78 (d, J=7.1, 1H, &#x2014;NH); '\n",
      " '7.44 (d, J=2.2, 1H); 7.33 (dd, J=8.6, 2.2, 1H); 7.06 (d, J=8.6, 1H); 4.92 '\n",
      " '(d, J=4.0, 1H; &#x2014;OH); 4.07 (m, 1H); 3.99 (m, 1H); 3.86 (d, J=6.9, 2H); '\n",
      " '2.78 (s, 3H); 2.33 (s, 3H); 2.12 (m, 1H); 1.91 (m, 1H); 1.74 (m, 2H); 1.53 '\n",
      " '(m, 2H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1096\" level=\"1\">Example E177</heading>\\n'\n",
      " '<heading id=\"h-1097\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1864\" num=\"3668\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.d61) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1865\" num=\"3669\">MS (ESI): m/z=421 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1866\" num=\"3670\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.66 (s, 1H, &#x2014;NH); 8.99 (d, J=7.1, 1H, &#x2014;NH); 8.92 (s, 1H); '\n",
      " '7.43 (d, J=2.0, 1H); 7.32 (dd, J=8.6, 2.0, 1H); 7.06 (d, J=8.6, 1H); 4.882 '\n",
      " '(d, J=4.2, 1H; &#x2014;OH); 4.16 (m, 1H); 4.02 (m, 1H); 3.86 (d, J=6.9, 2H); '\n",
      " '2.79 (s, 3H); 2.33 (s, 3H); 2.01-1.73 (m, 3H); 1.70-1.46 (m, 3H); 0.94 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1098\" level=\"1\">Example E178</heading>\\n'\n",
      " '<heading id=\"h-1099\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1867\" num=\"3671\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-6-methyl-5-{[2-(trimethylsilyl)ethoxy]methyl}-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.d62) the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1868\" num=\"3672\">MS (ESI): m/z=421 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1869\" num=\"3673\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.77 (d, J=7.1, 1H, &#x2014;NH); '\n",
      " '7.44 (d, J=2.2, 1H); 7.32 (dd, J=8.6, 2.2, 1H); 7.05 (d, J=8.6, 1H); 4.92 '\n",
      " '(d, J=4.0, 1H; &#x2014;OH); 4.07 (m, 1H); 3.98 (m, 1H); 3.85 (d, J=6.9, 2H); '\n",
      " '2.78 (s, 3H); 2.33 (s, 3H); 2.11 (m, 1H); 1.91 (m, 1H); 1.74 (m, 2H); 1.53 '\n",
      " '(m, 2H); 0.94 (m, 1H); 0.35 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1100\" level=\"1\">Example E179</heading>\\n'\n",
      " '<heading id=\"h-1101\" '\n",
      " 'level=\"1\">N-[(3R)-1-Acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1870\" num=\"3674\">MS (ESI): m/z=482 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-1871\" num=\"3675\">1H-NMR (300 MHz, DMSO-d6): 11.69 (s, 1H, '\n",
      " '&#x2014;NH); 8.93 (s, 1H); [8.92 (d, J=6.9), 8.89 (d, J=6.7), 1H, '\n",
      " '&#x2014;NH]; 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.5, 1H); [4.58 (m), 4.49 (m), '\n",
      " '1H]; 3.84 (d, J=6.8, 2H &#x26; s, 3H); 3.68-3.57 (m, 1H); 3.55-3.35 (m, 2H); '\n",
      " '3.32-3.21 (m, 1H); 2.77 (s, 3H); 2.34-2.16 (m, 1H); [2.04 (m), 1.91 (m), '\n",
      " '1H]; [1.98 (s), 1.96 (s), 3H]; 0.93 (m, 1H); 0.35 (m, 2H); 0.20 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1102\" level=\"1\">Example E180</heading>\\n'\n",
      " '<heading id=\"h-1103\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1872\" num=\"3676\">MS (ESI): m/z=496 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-1873\" num=\"3677\">1H-NMR (300 MHz, DMSO-d6): 11.70 (s, 1H, '\n",
      " '&#x2014;NH); 8.93 (s, 1H); [8.92 (d, J=6.9), 8.89 (d, J=6.9), 1H, '\n",
      " '&#x2014;NH]; 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.5, 1H); [4.58 (m), 4.49 (m), '\n",
      " '1H]; 3.84 (d, J=6.9, 2H &#x26; s, 3H); 3.69-3.57 (m, 1H); 3.55-3.42 (m, 1H); '\n",
      " '3.40-3.22 (m, 2H); 2.78 (s, 3H); 2.34-2.15 (m, 1H); [2.29 (qu, J=7.4), 2.25 '\n",
      " '(qu, J=7.4), 2H]; [2.04 (m), 1.91 (m), 1H]; [1.01 (t, J=7.4), 0.99 (t, '\n",
      " 'J=7.4), 3H]; 0.93 (m, 1H); 0.36 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1104\" level=\"1\">Example E181</heading>\\n'\n",
      " '<heading id=\"h-1105\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1874\" num=\"3678\">MS (ESI): m/z=512 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-1875\" num=\"3679\">1H-NMR (300 MHz, DMSO-d6): 11.78 (s, 1H, '\n",
      " '&#x2014;NH); 8.94 (s, 1H); [8.92 (d, J=7.4), 8.90 (d, J=7.9, 1H, '\n",
      " '&#x2014;NH); 7.39 (d, J=9.7, 1H); 7.18 (d, J=13.4, 1H); [4.58 (m), 4.49 (m), '\n",
      " '1H]; [4.06 (d, J=4.2), 4.01 (d, J=1.3), 2H]; 3.84 (d, J=6.9, 2H &#x26; s, '\n",
      " '3H); [3.80 (m), 3.68 (m), 1H]; 3.62-3.43 (m, 2H); 3.36 (m, 1H); 3.32 (s, '\n",
      " '3H); 2.78 (s, 3H); 2.33-2.15 (m, 1H); [2.04 (m), 1.90 (m), 1H]; 0.92 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1106\" level=\"1\">Example E182</heading>\\n'\n",
      " '<heading id=\"h-1107\" level=\"1\">Ethyl '\n",
      " '(3R)-3-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]pyrrolidine-1-carboxylate</heading>\\n'\n",
      " '<p id=\"p-1876\" num=\"3680\">MS (ESI): m/z=512 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-1877\" num=\"3681\">1H-NMR (300 MHz, DMSO-d6): 11.80 (s, 1H, '\n",
      " '&#x2014;NH); 8.95 (s, 1H); 8.91 (d, J=6.7, 1H, &#x2014;NH); 7.40 (d, J=9.9, '\n",
      " '1H); 7.19 (d, J=13.5, 1H); 4.51 (m, 1H); 4.05 (qu, J=6.9, 2H); 3.84 (d, '\n",
      " 'J=6.9, 2H &#x26; s, 3H); 3.66 (m, 1H); 3.47 (m, 2H); 3.27 (m, 1H); 2.78 (s, '\n",
      " '3H); 2.23 (m, 1H); 1.91 (m, 1H); 1.19 (t, J=6.9, 3H); 0.93 (m, 1H); 0.36 (m, '\n",
      " '2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1108\" level=\"1\">Example E183</heading>\\n'\n",
      " '<heading id=\"h-1109\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1878\" num=\"3682\">MS (ESI): m/z=498 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-1879\" num=\"3683\">1H-NMR (300 MHz, DMSO-d6): 11.75 (br.s, 1H, '\n",
      " '&#x2014;NH); 8.93 (s, 1H); [8.88 (d, J=7.1), 8.82 (d, J=6.6), 1H, '\n",
      " '&#x2014;NH]; 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.5, 1H); [5.56 (d, J=3.8), '\n",
      " '5.49 (d, J=4.0), 1H, &#x2014;OH]; 4.39-4.16 (m, 2H); 3.91 (m, 1H); 3.83 (d, '\n",
      " 'J=6.9, 2H &#x26; s, 3H); 3.73 (m, 1H); 3.47-3.22 (m, 2H); 2.78 (s, 3H); '\n",
      " '[1.99 (s), 1.98 (s), 3H]; 0.92 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1110\" level=\"1\">Example E184</heading>\\n'\n",
      " '<heading id=\"h-1111\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1880\" num=\"3684\">MS (ESI): m/z=512 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-1881\" num=\"3685\">1H-NMR (300 MHz, DMSO-d6): 11.69 (br.s, 1H, '\n",
      " '&#x2014;NH); 8.90 (s, 1H); [8.87 (d, J=7.1), 8.82 (d, J=6.6), 1H, '\n",
      " '&#x2014;NH]; 7.38 (d, J=9.9, 1H); 7.18 (d, J=13.5, 1H); [5.56 (d, J=3.5), '\n",
      " '5.47 (d, J=3.8), 1H, &#x2014;OH]; 4.39-4.14 (m, 2H); 3.88 (m, 1H); 3.84 (d, '\n",
      " 'J=6.9, 2H &#x26; s, 3H); 3.72 (m, 1H); 3.63-3.20 (m, 2H); 2.78 (s, 3H); 2.28 '\n",
      " '(m, 2H); [1.03 (t, J=7.7), 1.01 (t, J=7.5), 3H]; 0.92 (m, 1H); 0.36 (m, 2H); '\n",
      " '0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1112\" level=\"1\">Example E185</heading>\\n'\n",
      " '<heading id=\"h-1113\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1882\" num=\"3686\">MS (ESI): m/z=528 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-1883\" num=\"3687\">1H-NMR (300 MHz, DMSO-d6): 11.68 (br.s, 1H, '\n",
      " '&#x2014;NH); [8.90 (s), 8.89 (s), 1H]; [8.86 (d, J=7.1), 8.82 (d, J=6.8), '\n",
      " '1H, &#x2014;NH]; 7.38 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); [5.57 (d, '\n",
      " 'J=2.4), 5.50 (d, J=3.7), 1H, &#x2014;OH]; 4.40-4.15 (m, 2H); [4.06 (d, '\n",
      " 'J=3.3), 4.04 (s), 2H]; 3.86 (m, 1H); 3.84 (d, J=6.8, 2H &#x26; s, 3H); 3.73 '\n",
      " '(m, 1H); 3.65-3.22 (m, 2H); [3.33 (s), 3.31 (s), 3H]; 2.77 (s, 3H); 0.92 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1114\" level=\"1\">Example E186</heading>\\n'\n",
      " '<heading id=\"h-1115\" '\n",
      " 'level=\"1\">N-[(3R)-1-Acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1884\" num=\"3688\">MS (ESI): m/z=482 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1116\" level=\"1\">Example E187</heading>\\n'\n",
      " '<heading id=\"h-1117\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[(3R)-1-propionylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1885\" num=\"3689\">MS (ESI): m/z=496 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1118\" level=\"1\">Example E188</heading>\\n'\n",
      " '<heading id=\"h-1119\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1886\" num=\"3690\">MS (ESI): m/z=512 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1120\" level=\"1\">Example E189</heading>\\n'\n",
      " '<heading id=\"h-1121\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1887\" num=\"3691\">MS (ESI): m/z=498 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1122\" level=\"1\">Example E190</heading>\\n'\n",
      " '<heading id=\"h-1123\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1888\" num=\"3692\">MS (ESI): m/z=512 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1124\" level=\"1\">Example E191</heading>\\n'\n",
      " '<heading id=\"h-1125\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1889\" num=\"3693\">MS (ESI): m/z=528 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1126\" level=\"1\">Example E192</heading>\\n'\n",
      " '<heading id=\"h-1127\" '\n",
      " 'level=\"1\">N-[(3R*,4R*)-1-Acetyl-4-hydroxypyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1890\" num=\"3694\">MS (ESI): m/z=480 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1128\" level=\"1\">Example E193</heading>\\n'\n",
      " '<heading id=\"h-1129\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-propionylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1891\" num=\"3695\">MS (ESI): m/z=494 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1130\" level=\"1\">Example E194</heading>\\n'\n",
      " '<heading id=\"h-1131\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1892\" num=\"3696\">MS (ESI): m/z=510 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1132\" level=\"1\">Example E195</heading>\\n'\n",
      " '<heading id=\"h-1133\" '\n",
      " 'level=\"1\">N-[(1R*,3S*,4S*)-3-(Acetylamino)-4-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1893\" num=\"3697\">Starting from '\n",
      " 'N-[(1R*,3S*,4S*)-3-amino-4-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f68) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1894\" num=\"3698\">HR-MS (ESI): m/z=512.2463 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 512.2468).</p>\\n'\n",
      " '<heading id=\"h-1134\" level=\"1\">Example E196</heading>\\n'\n",
      " '<heading id=\"h-1135\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,3S*,4S*)-3-methyl-4-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1895\" num=\"3699\">Starting from '\n",
      " 'N-[(1R*,3S*,4S*)-3-amino-4-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f68) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1896\" num=\"3700\">HR-MS (ESI): m/z=526.2624 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 526.2624).</p>\\n'\n",
      " '<heading id=\"h-1136\" level=\"1\">Example E197</heading>\\n'\n",
      " '<heading id=\"h-1137\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3S*,4S*)-3-[(methoxyacetyl)amino]-4-methylcyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1897\" num=\"3701\">Starting from '\n",
      " 'N-[(1R*,3S*,4S*)-3-amino-4-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f68) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1898\" num=\"3702\">HR-MS (ESI): m/z=542.2570 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 542.2573).</p>\\n'\n",
      " '<heading id=\"h-1138\" level=\"1\">Example E198</heading>\\n'\n",
      " '<heading id=\"h-1139\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1899\" num=\"3703\">Starting from '\n",
      " 'N-[(1R*,2R*,4S*)-4-amino-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f69) and commercially available acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1900\" num=\"3704\">HR-MS (ESI): m/z=512.2475 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 512.2468).</p>\\n'\n",
      " '<heading id=\"h-1140\" level=\"1\">Example E199</heading>\\n'\n",
      " '<heading id=\"h-1141\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-methyl-4-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1901\" num=\"3705\">Starting from '\n",
      " 'N-[(1R*,2R*,4S*)-4-amino-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f69) and commercially available propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1902\" num=\"3706\">HR-MS (ESI): m/z=526.2622 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 526.2624).</p>\\n'\n",
      " '<heading id=\"h-1142\" level=\"1\">Example E200</heading>\\n'\n",
      " '<heading id=\"h-1143\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-4-[(methoxyacetyl)amino]-2-methylcyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1903\" num=\"3707\">Starting from '\n",
      " 'N-[(1R*,2R*,4S*)-4-amino-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f69) and commercially available methoxy-acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1904\" num=\"3708\">HR-MS (ESI): m/z=542.2575 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 542.2573).</p>\\n'\n",
      " '<heading id=\"h-1144\" level=\"1\">Example E201</heading>\\n'\n",
      " '<heading id=\"h-1145\" '\n",
      " 'level=\"1\">N-[(1S*,3S*,4S*)-3-(Acetylamino)-4-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1905\" num=\"3709\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-3-amino-4-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f70) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1906\" num=\"3710\">HR-MS (ESI): m/z=516.2215 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>29</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 516.2217).</p>\\n'\n",
      " '<heading id=\"h-1146\" level=\"1\">Example E202</heading>\\n'\n",
      " '<heading id=\"h-1147\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3S*,4S*)-3-fluoro-4-(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1907\" num=\"3711\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-3-amino-4-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f70) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1908\" num=\"3712\">HR-MS (ESI): m/z=530.2382 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 530.2374).</p>\\n'\n",
      " '<heading id=\"h-1148\" level=\"1\">Example E203</heading>\\n'\n",
      " '<heading id=\"h-1149\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-3-fluoro-4-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1909\" num=\"3713\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-3-amino-4-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f70) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1910\" num=\"3714\">HR-MS (ESI): m/z=546.2323 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 546.2323).</p>\\n'\n",
      " '<heading id=\"h-1150\" level=\"1\">Example F1</heading>\\n'\n",
      " '<heading id=\"h-1151\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1911\" '\n",
      " 'num=\"3715\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride from example D.f1 (486 mg; 1.0 mmol) is dissolved in dry '\n",
      " 'dichloromethane (5 mL) and DBU (2.5 mmol). Commercially available '\n",
      " '2-chloro-2-oxoethyl acetate (1.1 mmol) is syringed into the reaction mixture '\n",
      " 'at ice bath temperature. After addition stirring is continued at ambient '\n",
      " 'temperature overnight. Methanol (1 mL) is added and stirring is continued '\n",
      " 'for two hours. The volatiles are evaporated.</p>\\n'\n",
      " '<p id=\"p-1912\" num=\"3716\">The residue is dissolved in methanol (5 mL), '\n",
      " 'treated with 5M KOH (1.5 mmol) and stirred overnight at ambient temperature. '\n",
      " 'The pH of the reaction mixture is adjusted to 6-7 by addition of 2M citric '\n",
      " 'acid. The volatiles are evaporated. The residue is purified by reversed '\n",
      " 'phase preparative HPLC. The collected product fraction is freeze-dried to '\n",
      " 'yield the title compound as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1913\" num=\"3717\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1914\" num=\"3718\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.00 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.76 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 4.50 (t, J=5.3, 1H, '\n",
      " '&#x2014;OH); 4.25-4.03 (m, 2H); 4.12 (m, 2H); 3.76 (d, J=6.8, 2H); 3.67 (m, '\n",
      " '1H); 3.19 (m, 1H); 3.02 (m, 1H); 2.77 (s, 3H); 1.97 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.42 (m, 1H); 0.88 (m, 1H); 0.31 (m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<p id=\"p-1915\" num=\"3719\">The following compounds are prepared analogously '\n",
      " 'to the procedure described in above example F1.</p>\\n'\n",
      " '<heading id=\"h-1152\" level=\"1\">Example F2</heading>\\n'\n",
      " '<heading id=\"h-1153\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1916\" num=\"3720\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f1) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1917\" num=\"3721\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1918\" num=\"3722\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.00 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.76 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.01 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); 4.86 (d, J=6.8, 1H, '\n",
      " '&#x2014;OH); 4.46 (m, 1H); 4.28-4.07 (m, 2H); 3.95 (m, 1H); 3.76 (d, J=6.8, '\n",
      " '2H); 3.26 (m, 1H); 2.99 (m, 1H); 2.77 (s, 3H); 1.98 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.42 (m, 1H); 1.21 (br.s, 3H); 0.88 (m, 1H); 0.31 (m, 2H); 0.13 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1154\" level=\"1\">Example F3</heading>\\n'\n",
      " '<heading id=\"h-1155\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1919\" num=\"3723\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f2) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1920\" num=\"3724\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1921\" num=\"3725\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.60 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=8.2, 1H, &#x2014;NH); 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 5.40 (t, J=5.8, 1H, &#x2014;OH); 3.79 (m, 1H &#x26; d, J=5.8, '\n",
      " '2H); 3.76 (d, J=6.8, 2H); 3.68 (m, 1H); 2.76 (s, 3H); 2.00 (m, 2H); 1.83 (m, '\n",
      " '2H); 1.44 (m, 4H); 0.88 (m, 1H); 0.30 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1156\" level=\"1\">Example F4</heading>\\n'\n",
      " '<heading id=\"h-1157\" '\n",
      " 'level=\"1\">4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1922\" num=\"3726\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f2) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1923\" num=\"3727\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1924\" num=\"3728\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.59 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (d, J=8.2, 1H, &#x2014;NH); 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 5.40 (d, J=5.1, 1H, &#x2014;OH); 3.94 (m, 1H); 3.80 (m, 1H); '\n",
      " '3.76 (d, J=6.8, 2H); 3.63 (m, 1H); 2.76 (s, 3H); 2.00 (m, 2H); 1.83 (m, 2H); '\n",
      " '1.42 (m, 4H); 1.21 (d, J=6.8, 3H); 0.88 (m, 1H); 0.30 (m, 2H); 0.12 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1158\" level=\"1\">Example F5</heading>\\n'\n",
      " '<heading id=\"h-1159\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1925\" num=\"3729\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f3) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1926\" num=\"3730\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1927\" num=\"3731\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.97 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.90 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.53 (d, J=7.9, 1H, &#x2014;NH); 7.01 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 5.32 (t, J=5.8, 1H, &#x2014;OH); 4.05 (m, 1H); 3.82 (d, J=5.8, '\n",
      " '2H); 3.76 (m, 1H &#x26; d, J=6.8, 2H); 2.77 (s, 3H); 1.85-1.57 (m, 8H); 0.89 '\n",
      " '(m, 1H); 0.31 (m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1160\" level=\"1\">Example F6</heading>\\n'\n",
      " '<heading id=\"h-1161\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1928\" num=\"3732\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f3) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1929\" num=\"3733\">MS (ESI): m/z=536 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1930\" num=\"3734\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.98 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.89 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.48 (d, J=7.9, 1H, &#x2014;NH); 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); '\n",
      " '6.00 (s, 2H); 5.36 (d, J=5.5, 1H, &#x2014;OH); 4.05 (m, 1H); 3.98 (m, 1H); '\n",
      " '3.76 (m, 1H &#x26; d, J=6.8, 2H); 2.77 (s, 3H); 1.83-1.57 (m, 8H); 1.22 (d, '\n",
      " 'J=6.8, 3H); 0.89 (m, 1H); 0.31 (m, 2H); 0.13 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1162\" level=\"1\">Example F7</heading>\\n'\n",
      " '<heading id=\"h-1163\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1931\" num=\"3735\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f4) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1932\" num=\"3736\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1933\" num=\"3737\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.03 (s, 1H, &#x2014;NH); 8.93 (s, 1H); [8.87 (d, J=7.0), 8.84 (d, 6.7), '\n",
      " '1H, &#x2014;NH]; 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 (s, 2H); '\n",
      " '[4.60 (m), 4.49 (m), 1H]; 4.55 (t, J=5.6, 1H, &#x2014;OH); [4.05 (d, J=5.6), '\n",
      " '4.01 (d, J=5.6), 2H]; 3.79-3.69 (m, 1H), 3.76 (d, J=6.7, 2H); 3.61-3.45 (m, '\n",
      " '2H); 3.40-3.27 (m, 1H); 2.77 (s, 3H); 2.33-2.16 (m, 1H); [2.04 (m), 1.92 '\n",
      " '(m), 1H]; 0.88 (m, 1H); 0.31 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1164\" level=\"1\">Example F8</heading>\\n'\n",
      " '<heading id=\"h-1165\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1934\" num=\"3738\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f4) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1935\" num=\"3739\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1936\" num=\"3740\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '12.03 (s, 1H, &#x2014;NH); [8.92 (s), 8.89 (s), 1H]; [8.88 (d, J=6.9), 8.87 '\n",
      " '(d, 6.6), 1H, &#x2014;NH]; 7.00 (d, J=8.6, 1H); 6.56 (d, J=8.6, 1H); 6.00 '\n",
      " '(s, 2H); [4.91 (d, J=6.8), 4.84 (d, J=6.8), 1H, &#x2014;OH]; [4.58 (m), 4.51 '\n",
      " '(m), 1H]; [4.33 (m), 4.25 (m), 1H]; [3.84 (m), 3.78 (m), 1H], 3.76 (d, '\n",
      " 'J=6.6, 2H); 3.71-3.53 (m, 2H); 3.46 (m), 3.36 (m), 1H]; 2.77 (s, 3H); [2.27 '\n",
      " '(m), 2.20 (m), 1H]; [2.04 (m), 1.92 (m), 1H]; [1.23 (d, J=6.5), 1.20 (d, '\n",
      " 'J=6.5), 3H]; 0.88 (m, 1H); 0.31 (m, 2H); 0.12 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1166\" level=\"1\">Example F9</heading>\\n'\n",
      " '<heading id=\"h-1167\" '\n",
      " 'level=\"1\">4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1937\" num=\"3741\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f5) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1938\" num=\"3742\">HR-MS (ESI): m/z=510.1963 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>30</sub>N5O<sub>7</sub><sup>+</sup>, calc. '\n",
      " '510.1983).</p>\\n'\n",
      " '<heading id=\"h-1168\" level=\"1\">Example F10</heading>\\n'\n",
      " '<heading id=\"h-1169\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1939\" num=\"3743\">Starting from '\n",
      " '4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f5) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1940\" num=\"3744\">HR-MS (ESI): m/z=524.2123 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>30</sub>N<sub>6</sub>O<sub>7</sub><sup>+</sup>, calc. '\n",
      " '524.2140).</p>\\n'\n",
      " '<heading id=\"h-1170\" level=\"1\">Example F11</heading>\\n'\n",
      " '<heading id=\"h-1171\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1941\" num=\"3745\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f6) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1942\" num=\"3746\">MS (ESI): m/z=482 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1943\" num=\"3747\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.94 (s. 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, J=8.4, 6.9, 1H); 7.08 (dd, J=11.7, 2.4, 1H); 6.96 (ddd, J=8.4, '\n",
      " '8.4, 2.4, 1H); 4.51 (t, J=5.3, 1H, &#x2014;OH); 4.25-4.04 (m, 2H); 4.13 (dd, '\n",
      " 'J=5.3, 4.9, 2H); 3.91 (d, J=6.9, 2H); 3.68 (m, 1H); 3.20 (m, 1H); 3.02 (m, '\n",
      " '1H); 2.79 (s, 3H); 1.97 (m, 2H); 1.54 (m, 1H); 1.42 (m, 1H); 0.96 (m, 1H); '\n",
      " '0.38 (m, 2H): 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1172\" level=\"1\">Example F12</heading>\\n'\n",
      " '<heading id=\"h-1173\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1944\" num=\"3748\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f6) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1945\" num=\"3749\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1946\" num=\"3750\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.94 (s. 1H); 8.81 (d, J=5.9, 1H, &#x2014;NH); '\n",
      " '7.65 (dd, J=8.4, 7.1, 1H); 7.08 (dd, J=11.5, 2.3, 1H); 6.96 (ddd, J=8.4, '\n",
      " '8.4, 2.3, 1H); 4.88 (d, J=6.7, 1H, &#x2014;OH); 4.47 (m, 1H); 4.28-4.09 (m, '\n",
      " '2H); 3.96 (m, 1H); 3.91 (d, J=6.9, 2H); 3.27 (m, 1H); 3.00 (m, 1H); 2.79 (s, '\n",
      " '3H); 1.97 (m, 2H); 1.53 (m, 1H); 1.41 (m, 1H); 1.21 (br.s, 3H); 0.96 (m, '\n",
      " '1H); 0.38 (m, 2H): 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1174\" level=\"1\">Example F13</heading>\\n'\n",
      " '<heading id=\"h-1175\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1947\" num=\"3751\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f7) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1948\" num=\"3752\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1949\" num=\"3753\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.65 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, 8.4, 6.9, 1H); 7.48 (d, J=8.2, 1H, &#x2014;NH); 7.08 (dd, 11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 5.40 (t, J=5.7, 1H, &#x2014;OH); '\n",
      " '3.91 (d, J=7.1, 2H); 3.79 (d, J=5.7, 2H &#x26; m, 1H); 3.68 (m, 1H); 2.78 '\n",
      " '(s, 3H); 2.01 (m, 2H); 1.83 (m, 2H); 1.44 (m, 4H); 0.96 (m, 1H); 0.38 (m, '\n",
      " '2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1176\" level=\"1\">Example F14</heading>\\n'\n",
      " '<heading id=\"h-1177\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1950\" num=\"3754\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f7) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1951\" num=\"3755\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1952\" num=\"3756\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, 8.4, 7.1, 1H); 7.42 (d, J=8.2, 1H, &#x2014;NH); 7.08 (dd, 11.7, '\n",
      " '2.4, 1H); 6.95 (ddd, 8.4, 8.4, 2.4, 1H); 5.40 (d, J=5.1, 1H, &#x2014;OH); '\n",
      " '3.94 (m, 1H); 3.91 (d, J=6.9, 2H); 3.81 (m, 1H); 3.63 (m, 1H); 2.78 (s, 3H); '\n",
      " '1.99 (m, 2H); 1.82 (m, 2H); 1.42 (m, 4H); 1.21 (d, J=6.8, 3H); 0.96 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1178\" level=\"1\">Example F15</heading>\\n'\n",
      " '<heading id=\"h-1179\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1953\" num=\"3757\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f8) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1954\" num=\"3758\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1955\" num=\"3759\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.78 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.96 (d, J=7.6, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, 8.4, 6.9, 1H); 7.53 (d, J=7.7, 1H, &#x2014;NH); 7.09 (dd, 11.7, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 5.33 (t, J=5.8, 1H, &#x2014;OH); '\n",
      " '4.06 (m, 1H); 3.91 (d, J=6.9, 2H); 3.82 (d, J=5.8, 2H); 3.80 (m, 1H); 2.79 '\n",
      " '(s, 3H); 1.82-1.58 (m, 8H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1180\" level=\"1\">Example F16</heading>\\n'\n",
      " '<heading id=\"h-1181\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1956\" num=\"3760\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f8) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1957\" num=\"3761\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1958\" num=\"3762\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.78 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.95 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.66 (dd, 8.4, 7.1, 1H); 7.48 (d, J=7.9, 1H, &#x2014;NH); 7.09 (dd, 11.5, '\n",
      " '2.4, 1H); 6.96 (ddd, 8.4, 8.4, 2.4, 1H); 5.37 (d, J=5.5, 1H, &#x2014;OH); '\n",
      " '4.06 (m, 1H); 3.99 (m, 1H); 3.92 (d, J=6.9, 2H); 3.74 (m, 1H); 2.79 (s, 3H); '\n",
      " '1.83-1.56 (m, 8H); 1.22 (d, J=6.8, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1182\" level=\"1\">Example F17</heading>\\n'\n",
      " '<heading id=\"h-1183\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R)-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1959\" num=\"3763\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f9) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1960\" num=\"3764\">MS (ESI): m/z=468 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1961\" num=\"3765\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.83 (s, 1H, &#x2014;NH); 8.94 (s, 1H); [8.93 (d, J=7.1), 8.90 (d, J=7.0), '\n",
      " '1H, &#x2014;NH]; 7.66 (dd, J=8.4, 7.1, 1H); 7.09 (dd, J=11.7, 2.4, 1H); 6.96 '\n",
      " '(ddd, J=8.4, 8.4, 2.4, 1H); [4.60 (m), 4.50 (m), 1H]; 4.56 (t, J=5.7, 1H, '\n",
      " '&#x2014;OH); [4.06 (d, J=5.7), 4.01 (d, J=5.7), 2H]; 3.91 (d, J=6.9, 2H); '\n",
      " '3.80-3.68 (m, 1H); 3.62-3.43 (m, 2H); 3.40-3.27 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.34-2.16 (m, 1H); [2.05 (m), 1.92 (m), 1H]; 0.95 (m, 1H); 0.38 (m, 2H); '\n",
      " '0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1184\" level=\"1\">Example F18</heading>\\n'\n",
      " '<heading id=\"h-1185\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1962\" num=\"3766\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f9) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1963\" num=\"3767\">HR-MS (ESI): m/z=498.2129 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '498.2147).</p>\\n'\n",
      " '<heading id=\"h-1186\" level=\"1\">Example F19</heading>\\n'\n",
      " '<heading id=\"h-1187\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxy-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1964\" num=\"3768\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f10) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1965\" num=\"3769\">MS (ESI): m/z=484 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1966\" num=\"3770\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (br.s, 1H, &#x2014;NH); [8.93 (s), 8.92 (s), 1H]; [8.87 (d, J=7.1), '\n",
      " '8.82 (d, J=6.8), 1H, &#x2014;NH]; 7.65 (dd, J=8.4, 7.0, 1H); 7.09 (dd, '\n",
      " 'J=11.5, 2.4, 1H); 6.96 (ddd, J=8.4, 8.4, 2.4, 1H); [5.57 (br. s), 5.51 (br. '\n",
      " 's), 1H, &#x2014;OH]; 4.60 (m, 1H, &#x2014;OH); [4.37 (m), 4.20 (m), 1H]; '\n",
      " '4.28 (m, 1H); 4.05 (br. d, J&#x2dc;2.0, 2H); 3.91 (d, 6.9, 2H); 3.87-3.59 '\n",
      " '(m, 2H); 3.48-3.27 (m, 2H); 2.78 (s. 3H); 0.95 (m, 1H); 0.38 (m, 2H); 0.25 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1188\" level=\"1\">Example F20</heading>\\n'\n",
      " '<heading id=\"h-1189\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1967\" num=\"3771\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f10) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1968\" num=\"3772\">HR-MS (ESI): m/z=482.2178 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '482.2198).</p>\\n'\n",
      " '<heading id=\"h-1190\" level=\"1\">Example F21</heading>\\n'\n",
      " '<heading id=\"h-1191\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-[(3S*,4S*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1969\" num=\"3773\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4S*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f11) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1970\" num=\"3774\">HR-MS (ESI): m/z=498.2134 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>28</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '498.2147).</p>\\n'\n",
      " '<heading id=\"h-1192\" level=\"1\">Example F22</heading>\\n'\n",
      " '<heading id=\"h-1193\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1971\" num=\"3775\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-N-[(3R*,4S*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f11) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1972\" num=\"3776\">HR-MS (ESI): m/z=512.2293 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-1194\" level=\"1\">Example F23</heading>\\n'\n",
      " '<heading id=\"h-1195\" '\n",
      " 'level=\"1\">4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-(2-hydroxy-acetyl)-piperidin-4-yl]-amide</heading>\\n'\n",
      " '<p id=\"p-1973\" num=\"3777\">Starting from '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid piperidin-4-ylamide hydrochloride (example D.f12) and commercially '\n",
      " 'available 2-chloro-2-oxoethyl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1974\" num=\"3778\">MS (ESI): m/z=482 (MH<sup>+</sup>, 100%), 356, '\n",
      " '302.</p>\\n'\n",
      " '<p id=\"p-1975\" num=\"3779\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (br.s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=9.0, 3.2, 1H); 7.37 (ddd, J=9.1, 8.3, 3.2, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.50 (br.s, 1H, &#x2014;OH); 4.25-4.03 (m, 2H); 4.13 (br.s, 2H); '\n",
      " '3.87 (d, J=6.9, 2H); 3.68 (m, 1H); 3.20 (m, 1H); 3.02 (m, 1H); 2.79 (s, 3H); '\n",
      " '1.97 (m, 2H); 1.55 (m, 1H); 1.42 (m, 1H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1196\" level=\"1\">Example F24</heading>\\n'\n",
      " '<heading id=\"h-1197\" '\n",
      " 'level=\"1\">4-(2-Cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid [1-((S)-2-hydroxy-propionyl)-piperidin-4-yl]-amide</heading>\\n'\n",
      " '<p id=\"p-1976\" num=\"3780\">Starting from '\n",
      " '4-(2-cyclopropylmethoxy-5-fluoro-phenyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic '\n",
      " 'acid piperidin-4-ylamide hydrochloride (example D.f12) and commercially '\n",
      " 'available (2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is '\n",
      " 'obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1977\" num=\"3781\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%), 356, '\n",
      " '302.</p>\\n'\n",
      " '<p id=\"p-1978\" num=\"3782\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.84 (br.s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=9.0, 3.2, 1H); 7.37 (ddd, J=9.1, 8.3, 3.2, 1H); 7.19 (dd, J=9.1, '\n",
      " '4.4, 1H); 5.01-4.58 (s, 1H, &#x2014;OH); 4.28-4.07 (m, 2H); 3.95 (m, 1H); '\n",
      " '3.87 (d, J=6.9, 2H); 3.29 (m, 1H); 3.01 (m, 1H); 2.79 (s, 3H); 1.98 (m, 2H); '\n",
      " '1.54 (m, 1H); 1.42 (m, 1H); 1.22 (br.s, 3H); 0.94 (m, 1H); 0.36 (m, 2H); '\n",
      " '0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1198\" level=\"1\">Example F25</heading>\\n'\n",
      " '<heading id=\"h-1199\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1979\" num=\"3783\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f13) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1980\" num=\"3784\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1981\" num=\"3785\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.64 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=8.4, 1H, &#x2014;NH); 7.42 (dd, J=8.9, 3.3, 1H); 7.36 (ddd, '\n",
      " 'J=9.1, 8.2, 3.3, 1H); 7.18 (dd, J=9.1, 4.4, 1H); 5.40 (t, J=5.7, 1H, '\n",
      " '&#x2014;OH); 3.87 (d, J=6.8, 2H); 3.82 (m, 1H); 3.79 (d, J=5.7, 2H); 3.68 '\n",
      " '(m, 1H); 2.79 (s, 3H); 2.01 (m, 2H); 1.83 (m, 2H); 1.44 (m, 4H); 0.94 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1200\" level=\"1\">Example F26</heading>\\n'\n",
      " '<heading id=\"h-1201\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1982\" num=\"3786\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f13) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1983\" num=\"3787\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1984\" num=\"3788\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.81 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (dd, J=8.9, 3.3, 1H &#x26; d, J=8.4, 1H, &#x2014;NH); 7.36 (ddd, J=9.1, '\n",
      " '8.4, 3.3, 1H); 7.18 (dd, J=9.1, 4.4, 1 H); 5.40 (d, J=5.3, 1H, &#x2014;OH); '\n",
      " '3.94 (m, 1H); 3.87 (d, J=6.9, 2H); 3.82 (m, 1H); 3.63 (m, 1H); 2.78 (s, 3H); '\n",
      " '2.01 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); 1.21 (d, J=6.7, 3H); 0.94 (m, 1H); '\n",
      " '0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1202\" level=\"1\">Example F27</heading>\\n'\n",
      " '<heading id=\"h-1203\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1985\" num=\"3789\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f14) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1986\" num=\"3790\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1987\" num=\"3791\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.82 (s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.94 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.48 (d, J=7.9, 1H, &#x2014;NH); 7.43 (dd, J=9.1, 3.3, 1H); 7.38 (ddd, '\n",
      " 'J=8.9, 8.4, 3.3, 1H); 7.19 (dd, J=8.9, 4.4, 1 H); 5.37 (d, J=5.5, 1H, '\n",
      " '&#x2014;OH); 4.05 (m, 1H); 3.99 (td, J=6.8, 5.5, 1H); 3.88 (d, J=6.8, 2H); '\n",
      " '3.75 (m, 1H); 2.79 (s, 3H); 1.81-1.58 (m, 8H); 1.22 (d, J=6.8, 3H); 0.94 (m, '\n",
      " '1H); 0.37 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1204\" level=\"1\">Example F28</heading>\\n'\n",
      " '<heading id=\"h-1205\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R)-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1988\" num=\"3792\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f15) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1989\" num=\"3793\">HR-MS (ESI): m/z=468.2039 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>24</sub>H<sub>26</sub>FN<sub>5</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '468.2042).</p>\\n'\n",
      " '<heading id=\"h-1206\" level=\"1\">Example F29</heading>\\n'\n",
      " '<heading id=\"h-1207\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1990\" num=\"3794\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f15) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1991\" num=\"3795\">HR-MS (ESI): m/z=482.2199 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>24</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>4</sub><sup>+</sup>, calc. '\n",
      " '482.2198).</p>\\n'\n",
      " '<heading id=\"h-1208\" level=\"1\">Example F30</heading>\\n'\n",
      " '<heading id=\"h-1209\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1992\" num=\"3796\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f16) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1993\" num=\"3797\">HR-MS (ESI): m/z=498.2142 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>29</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '498.2147).</p>\\n'\n",
      " '<heading id=\"h-1210\" level=\"1\">Example F31</heading>\\n'\n",
      " '<heading id=\"h-1211\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1994\" num=\"3798\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f16) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-1995\" num=\"3799\">HR-MS (ESI): m/z=512.2298 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-1212\" level=\"1\">Example F32</heading>\\n'\n",
      " '<heading id=\"h-1213\" '\n",
      " 'level=\"1\">4-(2-Ethoxy-5-fluorophenyl)-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1996\" num=\"3800\">Starting from '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f17) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-1997\" num=\"3801\">MS (ESI): m/z=456 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-1998\" num=\"3802\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (ddd, J=9.1, 8.9, 3.2, 1H); 7.38 (dd, J=8.3, 3.2, 1H); 7.22 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.50 (t, J=5.5, 1H, &#x2014;OH); 4.23-4.06 (m, 2H); 4.13 (d, '\n",
      " 'J=5.5, 2H); 4.08 (qu, J=6.9, 2H); 3.68 (m, 1H); 3.20 (m, 1H); 3.02 (m, 1H); '\n",
      " '2.78 (s, 3H); 1.97 (m, 2H); 1.53 (m, 1H); 1.42 (m, 1H); 1.11 (t, J=6.9, '\n",
      " '3H).</p>\\n'\n",
      " '<heading id=\"h-1214\" level=\"1\">Example F33</heading>\\n'\n",
      " '<heading id=\"h-1215\" '\n",
      " 'level=\"1\">4-(2-Ethoxy-5-fluorophenyl)-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-1999\" num=\"3803\">Starting from '\n",
      " '4-(2-ethoxy-5-fluorophenyl)-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f17) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2000\" num=\"3804\">MS (ESI): m/z=470 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2001\" num=\"3805\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.79 (d, J=6.7, 1H, &#x2014;NH); '\n",
      " '7.42 (ddd, J=9.1, 8.9, 3.3, 1H); 7.38 (dd, J=8.3, 3.3, 1H); 7.22 (dd, J=9.1, '\n",
      " '4.4, 1H); 4.86 (d, J=6.7, 1H, &#x2014;OH); 4.47 (m, 1H); 4.26-4.11 (m, 2H); '\n",
      " '4.08 (qu, J=6.9, 2H); 3.95 (m, 1H); 3.27 (m, 1H); 3.00 (m, 1H); 2.79 (s, '\n",
      " '3H); 1.98 (m, 2H); 1.53 (m, 1H); 1.41 (m, 1H); 1.21 (br.s, 3H); 1.11 (t, '\n",
      " 'J=6.9, 3H).</p>\\n'\n",
      " '<heading id=\"h-1216\" level=\"1\">Example F34</heading>\\n'\n",
      " '<heading id=\"h-1217\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2002\" num=\"3806\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f18) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2003\" num=\"3807\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2004\" num=\"3808\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.68 (s, 1H, &#x2014;NH); 8.90 (s, 1H); 8.84 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.58 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 2H); 6.69 (d, J=2.2, 1H); 4.50 '\n",
      " '(t, J=5.5, 1H, &#x2014;OH); 4.24-4.02 (m, 2H); 4.13 (m, 2H); 3.90 (d, J=6.9, '\n",
      " '2H); 3.86 (s, 3H); 3.67 (m, 1H); 3.20 (m, 1H); 3.02 (m, 1H); 2.78 (s, 3H); '\n",
      " '1.96 (m, 2H); 1.54 (m, 1H); 1.41 (m, 1H); 0.96 (m, 1H); 0.38 (m, 2H); 0.26 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1218\" level=\"1\">Example F35</heading>\\n'\n",
      " '<heading id=\"h-1219\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2005\" num=\"3809\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f18) and commercially available (2S)-1-chloro-1-oxopropan-2-yl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2006\" num=\"3810\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2007\" num=\"3811\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.68 (s, 1H, &#x2014;NH); 8.91 (s, 1H); 8.84 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.59 (d, J=8.4, 1H); 6.79 (d, J=2.2, 1H); 6.72 (dd, J=8.4, 2.2, 1H); 4.86 '\n",
      " '(t, J=6.9, 1H, &#x2014;OH); 4.46 (m, 1H); 4.28-4.06 (m, 2H); 3.96 (m, 1H); '\n",
      " '3.90 (d, J=6.9, 2H); 3.86 (s, 3H); 3.26 (m, 1H); 3.00 (m, 1H); 2.78 (s, 3H); '\n",
      " '1.97 (m, 2H); 1.53 (m, 1H); 1.41 (m, 1H); 1.21 (br.s, 3H); 0.96 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1220\" level=\"1\">Example F36</heading>\\n'\n",
      " '<heading id=\"h-1221\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2008\" num=\"3812\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f19) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2009\" num=\"3813\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2010\" num=\"3814\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.65 (s, 1H, &#x2014;NH); 8.91 (s, 1H); 8.67 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.59 (d, J=8.4, 1H); 7.42 (d, J=8.4, 1H, &#x2014;NH); 6.72 (dd, J=8.4, 2.2, '\n",
      " '2H); 6.68 (d, J=2.2, 1H); 5.40 (d, J=5.3, 1H, &#x2014;OH); 3.94 (m, 1H); '\n",
      " '3.90 (d, J=6.9, 2H); 3.86 (s, 3H); 3.80 (m, 1H); 3.63 (m, 1H); 2.77 (s, 3H); '\n",
      " '2.01 (m, 2H); 1.82 (m, 2H); 1.42 (m, 4H); 1.21 (d, J=6.8, 3H); 0.96 (m, 1H); '\n",
      " '0.38 (m, 2H); 0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1222\" level=\"1\">Example F37</heading>\\n'\n",
      " '<heading id=\"h-1223\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2011\" num=\"3815\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f21) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2012\" num=\"3816\">MS (ESI): m/z=480 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2013\" num=\"3817\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (br.s, 1H, &#x2014;NH); [8.95 (d, J=7.6), 8.93 (d, J=7.6), 1H, '\n",
      " '&#x2014;NH]; 8.90 (s, 1H); 7.59 (d, J=8.4, 1H); 6.72 (dd, J=8.4, 2.2, 1H); '\n",
      " '6.69 (d, J=2.2, 1H); [4.59 (m), 4.49 (m), 1H]; 4.55 (t, J=5.8, 1H, '\n",
      " '&#x2014;OH); [4.06 (d, J=5.8), 4.01 (d, J=5.8), 1H]; 3.90 (d, J=6.9, 2H); '\n",
      " '3.86 (s, 3H); 3.79-3.68 (m, 1H); 3.62-3.43 (m, 1H); 3.39-3.27 (m, 1H); 2.78 '\n",
      " '(s, 3H); 2.34-2.15 (m 1H); 2.09-1.86 (m, 1H); 0.95 (m, 1H); 0.37 (m, 2H); '\n",
      " '0.26 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1224\" level=\"1\">Example F38</heading>\\n'\n",
      " '<heading id=\"h-1225\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2014\" num=\"3818\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f21) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2015\" num=\"3819\">HR-MS (ESI): m/z=494.2402 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>32</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '494.2389).</p>\\n'\n",
      " '<heading id=\"h-1226\" level=\"1\">Example F39</heading>\\n'\n",
      " '<heading id=\"h-1227\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2016\" num=\"3820\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f22) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2017\" num=\"3821\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2018\" num=\"3822\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (br.s, 1H, &#x2014;NH); [8.90 (d, J=7.1), 8.85 (d, J=6.6), 1H, '\n",
      " '&#x2014;NH]; [8.89 (s), 8.88 (s), 1H]; 7.58 (d, J=8.4, 1H); 6.72 (dd, J=8.4, '\n",
      " '2.2, 1H); 6.69 (d, J=2.2, 1H); [5.56 (d, J=4.0), 5.50 (d, J=4.2), 1H, '\n",
      " '&#x2014;OH]; [4.63 (t, J=5.7), 4.60 (t, J=5.7), 1H, &#x2014;OH]; [4.37 (m), '\n",
      " '4.19 (m), 1H]; 4.28 (m, 1H); [4.05 (d, J=5.7), 4.04 [d, J=5.7), 2H]; 3.90 '\n",
      " '(d, J=6.9, 2H); 3.86 (s, 3H); 3.84-3.69 (m, 1H); 3.68-3.59 (m, 1H); '\n",
      " '3.46-3.32 (m, 2H); 2.78 (s, 3H); 0.95 (m, 1H); 0.37 (m, 2H); 0.26 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1228\" level=\"1\">Example F40</heading>\\n'\n",
      " '<heading id=\"h-1229\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2019\" num=\"3823\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f22) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2020\" num=\"3824\">HR-MS (ESI): m/z=510.2352 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>32</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '510.2347).</p>\\n'\n",
      " '<heading id=\"h-1230\" level=\"1\">Example F41</heading>\\n'\n",
      " '<heading id=\"h-1231\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2021\" num=\"3825\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f23) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2022\" num=\"3826\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2023\" num=\"3827\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.17 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); 4.50 (t, J=5.5, 1H, &#x2014;OH); '\n",
      " '4.24-4.04 (m, 2H); 4.13 (m, 2H); 3.82 (d, J=6.9, 2H); 3.77 (s, 3H); 3.68 (m, '\n",
      " '1H); 3.19 (m, 1H); 3.02 (m, 1H); 2.79 (s, 3H); 1.97 (m, 2H); 1.55 (m, 1H); '\n",
      " '1.42 (m, 1H); 0.92 (m, 1H); 0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1232\" level=\"1\">Example F42</heading>\\n'\n",
      " '<heading id=\"h-1233\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2024\" num=\"3828\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f23) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2025\" num=\"3829\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2026\" num=\"3830\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.17 (t, J=1.8, 1H); 7.11 (d, J=1.8, 2H); 4.86 (d, J=6.9, 1H, &#x2014;OH); '\n",
      " '4.47 (m, 1H); 4.27-4.06 (m, 2H); 3.95 (m, 1H); 3.82 (d, J=6.9, 2H); 3.77 (s, '\n",
      " '3H); 3.27 (m, 1H); 3.00 (m, 1H); 2.79 (s, 3H); 1.99 (m, 2H); 1.63-1.31 (m, '\n",
      " '2H); 1.22 (br.s, 3H); 0.92 (m, 1H); 0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1234\" level=\"1\">Example F43</heading>\\n'\n",
      " '<heading id=\"h-1235\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2027\" num=\"3831\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f24) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2028\" num=\"3832\">MS (ESI): m/z=508 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2029\" num=\"3833\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.65 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=8.2, 1H, &#x2014;NH); 7.17 (t, J=1.8, 1H); 7.10 (d, J=1.8, 2H); '\n",
      " '5.50 (t, J=5.8, 1H, &#x2014;OH); 3.82 (d, J=6.9, 2H); 3.79 (d, J=5.8, 2H); '\n",
      " '3.77 (s, 3H &#x26; m, 1H); 3.69 (m, 1H); 2.78 (s, 3H); 2.01 (m, 2H); 1.83 '\n",
      " '(m, 2H); 1.44 (m, 4H); 0.92 (m, 1H); 0.34 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1236\" level=\"1\">Example F44</heading>\\n'\n",
      " '<heading id=\"h-1237\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2030\" num=\"3834\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f24) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2031\" num=\"3835\">MS (ESI): m/z=522 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2032\" num=\"3836\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.65 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.42 (d, J=8.2, 1H, &#x2014;NH); 7.18 (t, J=1.8, 1H); 7.10 (d, J=1.8, 2H); '\n",
      " '5.40 (d, J=5.1, 1H, &#x2014;OH); 3.94 (m, 1H); 3.82 (d, J=6.9, 2H &#x26; m, '\n",
      " '1H); 3.77 (s, 3H); 3.63 (m, 1H); 2.78 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); '\n",
      " '1.43 (m, 4H); 1.21 (d, J=6.8, 3H); 0.92 (m, 1H); 0.34 (m, 2H); 0.19 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1238\" level=\"1\">Example F45</heading>\\n'\n",
      " '<heading id=\"h-1239\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2033\" num=\"3837\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f25) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2034\" num=\"3838\">HR-MS (ESI): m/z=508.2558 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>34</sub>N<sub>5</sub>O<sub>5</sub><sup>+</sup>, calc. '\n",
      " '508.2554).</p>\\n'\n",
      " '<heading id=\"h-1240\" level=\"1\">Example F46</heading>\\n'\n",
      " '<heading id=\"h-1241\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2035\" num=\"3839\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f25) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2036\" num=\"3840\">HR-MS (ESI): m/z=522.2710 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>36</sub>N<sub>5</sub>O<sub>5</sub><sup>+</sup>, calc. '\n",
      " '522.2711).</p>\\n'\n",
      " '<heading id=\"h-1242\" level=\"1\">Example F47</heading>\\n'\n",
      " '<heading id=\"h-1243\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2037\" num=\"3841\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f26) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2038\" num=\"3842\">HR-MS (ESI): m/z=480.2243 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>30</sub>N<sub>5</sub>O<sub>5</sub><sup>+</sup>, calc. '\n",
      " '480.2241).</p>\\n'\n",
      " '<heading id=\"h-1244\" level=\"1\">Example F48</heading>\\n'\n",
      " '<heading id=\"h-1245\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2039\" num=\"3843\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[(3R)-pyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f26) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2040\" num=\"3844\">HR-MS (ESI): m/z=494.2399 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>32</sub>N<sub>5</sub>O<sub>5</sub><sup>+</sup>, calc. '\n",
      " '494.2398).</p>\\n'\n",
      " '<heading id=\"h-1246\" level=\"1\">Example F49</heading>\\n'\n",
      " '<heading id=\"h-1247\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2041\" num=\"3845\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f27) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2042\" num=\"3846\">HR-MS (ESI): m/z=510.2349 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>32</sub>N<sub>5</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '510.2347).</p>\\n'\n",
      " '<heading id=\"h-1248\" level=\"1\">Example F50</heading>\\n'\n",
      " '<heading id=\"h-1249\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2043\" num=\"3847\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f27) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2044\" num=\"3848\">HR-MS (ESI): m/z=524.2495 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>34</sub>N<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '514.2504).</p>\\n'\n",
      " '<heading id=\"h-1250\" level=\"1\">Example F51</heading>\\n'\n",
      " '<heading id=\"h-1251\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2045\" num=\"3849\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f28) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2046\" num=\"3850\">MS (ESI): m/z=478 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2047\" num=\"3851\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (br.s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.83 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (d, J=1.8, 1H); 7.33 (dd, J=8.4, 1.8, 1H); 7.06 (d, J=8.4, 1H); 4.51 '\n",
      " '(t, J=5.3, 1H, &#x2014;OH); 4.24-4.05 (m, 2H); 4.13 (m, 2H); 3.86 (d, J=6.9, '\n",
      " '2H); 3.68 (m, 1H); 3.20 (m, 1H); 3.03 (m, 1H); 2.78 (s, 3H); 2.33 (s, 3H); '\n",
      " '1.97 (m, 2H); 1.54 (m, 1H); 1.42 (m, 1H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1252\" level=\"1\">Example F52</heading>\\n'\n",
      " '<heading id=\"h-1253\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2048\" num=\"3852\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f28) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2049\" num=\"3853\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2050\" num=\"3854\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (br.s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.83 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (d, J=1.8, 1H); 7.33 (dd, J=8.6, 1.8, 1H); 7.06 (d, J=8.6, 1H); 4.86 '\n",
      " '(d, J=6.9, 1H, &#x2014;OH); 4.47 (m, 1H); 4.24-4.08 (m, 2H); 4.95 (m, 1H); '\n",
      " '3.86 (d, J=6.8, 2H); 3.27 (m, 1H); 3.00 (m, 1H); 2.78 (s, 3H); 2.33 (s, 3H); '\n",
      " '1.98 (m, 2H); 1.63-1.32 (m, 2H); 1.21 (br.s, 3H); 0.94 (m, 1H); 0.36 (m, '\n",
      " '2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1254\" level=\"1\">Example F53</heading>\\n'\n",
      " '<heading id=\"h-1255\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2051\" num=\"3855\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f29) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2052\" num=\"3856\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2053\" num=\"3857\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=8.4, 1H, &#x2014;NH); 7.43 (d, J=2.1, 1H); 7.32 (dd, J=8.4, 2.1, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 5.40 (t, J=5.9, 1H, &#x2014;OH); 3.86 (d, J=6.8, '\n",
      " '2H); 3.79 (d, J=5.9, 2H &#x26; m, 1H); 3.68 (m, 1H); 2.77 (s, 3H); 2.33 (s, '\n",
      " '3H); 2.01 (m, 2H); 1.83 (m, 2H); 1.44 (m, 4H); 0.94 (m, 1H); 0.35 (m, 2H); '\n",
      " '0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1256\" level=\"1\">Example F54</heading>\\n'\n",
      " '<heading id=\"h-1257\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2054\" num=\"3858\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f29) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2055\" num=\"3859\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2056\" num=\"3860\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.71 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.43 (d, J=2.0, 1H); 7.42 (d, J=7.8, 1H, &#x2014;NH); 7.33 (dd, J=8.4, 2.0, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 5.40 (d, J=5.3, 1H, &#x2014;OH); 3.94 (m, 1H); '\n",
      " '3.86 (d, J=6.8, 2H); 3.80 (m, 1H); 3.63 (m, 1H); 2.77 (s, 3H); 2.33 (s, 3H); '\n",
      " '2.01 (m, 2H); 1.83 (m, 2H); 1.43 (m, 4H); 1.21 (d, J=6.8, 3H); 0.94 (m, 1H); '\n",
      " '0.35 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1258\" level=\"1\">Example F55</heading>\\n'\n",
      " '<heading id=\"h-1259\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2057\" num=\"3861\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f30) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2058\" num=\"3862\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2059\" num=\"3863\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.97 (s, 1H &#x26; d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.53 (d, J=7.7, 1H, &#x2014;NH); 7.44 (d, J=2.0, 1H); 7.33 (dd, J=8.4, 2.0, '\n",
      " '1H); 7.06 (d, J=8.4, 1H); 5.33 (t, J=5.8, 1 H, &#x2014;OH); 4.06 (m, 1H); '\n",
      " '3.86 (d, J=6.9, 2H); 3.83 (d, J=5.8, 3H); 3.80 (m, 1H); 2.76 (s, 3H); 2.33 '\n",
      " '(s, 3H); 1.81-1.61 (m, 8H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1260\" level=\"1\">Example F56</heading>\\n'\n",
      " '<heading id=\"h-1261\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2060\" num=\"3864\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f30) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2061\" num=\"3865\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2062\" num=\"3866\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.96 (d, J=6.4, 1H, &#x2014;NH); '\n",
      " '7.48 (d, J=7.9, 1H, &#x2014;NH); 7.44 (d, J=1.8, 1H); 7.33 (dd, J=8.6, 1.8, '\n",
      " '1H); 7.06 (d, J=8.6, 1H); 5.37 (d, J=5.5, 1H, &#x2014;OH); 4.05 (m, 1H); '\n",
      " '3.99 (m, 1H); 3.86 (d, J=6.9, 2H); 3.75 (m, 1H); 2.78 (s, 3H); 2.33 (s, 3H); '\n",
      " '1.81-1.57 (m, 8H); 1.22 (d, J=6.8, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1262\" level=\"1\">Example F57</heading>\\n'\n",
      " '<heading id=\"h-1263\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2063\" num=\"3867\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f31) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2064\" num=\"3868\">MS (ESI): m/z=532 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2065\" num=\"3869\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.90 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.80 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.38 (d, J=8.8, 1H); 4.51 '\n",
      " '(t, J=5.5, 1H, &#x2014;OH); 4.25-4.06 (m, 2H); 4.13 (m, 2H); 4.00 (d, J=6.9, '\n",
      " '2H); 3.69 (m, 1H); 3.20 (m, 1H); 3.03 (m, 1H); 2.79 (s, 3H); 1.97 (m, 2H); '\n",
      " '1.55 (m, 1H); 1.43 (m, 1H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1264\" level=\"1\">Example F58</heading>\\n'\n",
      " '<heading id=\"h-1265\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2066\" num=\"3870\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f31) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2067\" num=\"3871\">MS (ESI): m/z=546 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2068\" num=\"3872\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.90 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.80 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.38 (d, J=8.8, 1H); 4.87 '\n",
      " '(d, J=6.9, 1H, &#x2014;OH); 4.47 (m, 1H); 4.28-4.07 (m, 2H); 3.99 (d, J=6.9, '\n",
      " '2H); 3.93 (m, 1H); 3.28 (m, 1H); 3.01 (m, 1H); 2.80 (s, 3H); 1.98 (m, 2H); '\n",
      " '1.64-1.31 (m, 2H); 1.22 (br.s, 3H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1266\" level=\"1\">Example F59</heading>\\n'\n",
      " '<heading id=\"h-1267\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2069\" num=\"3873\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f32) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2070\" num=\"3874\">MS (ESI): m/z=546 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2071\" num=\"3875\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.63 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.48 (d, J=8.2, 1H, '\n",
      " '&#x2014;NH); 7.38 (d, J=8.8, 1H); 5.40 (t, J=5.9, 1H, &#x2014;OH); 3.99 (d, '\n",
      " 'J=6.9, 2H); 3.82 (m, 1H); 3.79 (d, J=5.9, 2H); 3.69 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.02 (m, 2H); 1.83 (m, 2H); 1.44 (m, 4H); 0.98 (m, 1H); 0.39 (m, 2H); 0.27 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1268\" level=\"1\">Example F60</heading>\\n'\n",
      " '<heading id=\"h-1269\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2072\" num=\"3876\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f32) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2073\" num=\"3877\">MS (ESI): m/z=560 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2074\" num=\"3878\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.87 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.64 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.91 (d, J=2.0, 1H); 7.89 (dd, J=8.8, 2.0, 1H); 7.42 (d, J=8.2, 1H, '\n",
      " '&#x2014;NH); 7.38 (d, J=8.8, 1H); 5.40 (d, J=5.1, 1H, &#x2014;OH); 4.00 (d, '\n",
      " 'J=6.9, 2H); 3.94 (m, 1H); 3.81 (m, 1H); 3.63 (m, 1H); 2.79 (s, 3H); 2.02 (m, '\n",
      " '2H); 1.83 (m, 2H); 1.43 (m, 4H); 1.21 (d, J=6.8, 3H); 0.98 (m, 1H); 0.39 (m, '\n",
      " '2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1270\" level=\"1\">Example F61</heading>\\n'\n",
      " '<heading id=\"h-1271\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2075\" num=\"3879\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f33) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2076\" num=\"3880\">MS (ESI): m/z=546 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2077\" num=\"3881\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.91 (s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.96 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.91 (s, 1H); 7.90 (d, J=8.8, 1H); 7.58 (d, J=7.8, 1H, &#x2014;NH); 7.39 (d, '\n",
      " 'J=8.8, 1H); 5.37 (t, J=5.9, 1H, &#x2014;OH); 4.07 (m, 1H); 4.00 (d, J=7.0, '\n",
      " '2H); 3.83 (d, J=5.9, 2H); 3.80 (m, 1H); 2.80 (s, 3H); 1.83-1.59 (m, 8H); '\n",
      " '0.98 (m, 1H); 0.40 (m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1272\" level=\"1\">Example F62</heading>\\n'\n",
      " '<heading id=\"h-1273\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2078\" num=\"3882\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f33) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2079\" num=\"3883\">MS (ESI): m/z=560 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2080\" num=\"3884\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.91 (s, 1H, &#x2014;NH); 9.03 (s, 1H); 8.95 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.91 (s, 1H); 7.90 (d, J=8.8, 1H); 7.52 (d, J=7.6, 1H, &#x2014;NH); 7.39 (d, '\n",
      " 'J=8.8, 1H); 5.40 (d, J=5.5, 1H, &#x2014;OH); 4.06 (m, 1H); 4.00 (d, J=7.0, '\n",
      " '2H &#x26; m, 1H); 3.75 (m, 1H); 2.80 (s, 3H); 1.83-1.57 (m, 8H); 1.22 (d, '\n",
      " 'J=6.8, 3H); 0.98 (m, 1H); 0.40 (m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1274\" level=\"1\">Example F63</heading>\\n'\n",
      " '<heading id=\"h-1275\" '\n",
      " 'level=\"1\">4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2081\" num=\"3885\">Starting from '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f34) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2082\" num=\"3886\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2083\" num=\"3887\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.93 (br.s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.79 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.92 (d, J=2.2, 1H); 7.91 (dd, J=9.4, 2.2, 1H); 7.42 (d, J=9.4, 1H); 4.50 '\n",
      " '(t, J=5.4, 1H, &#x2014;OH); 4.21 (qu, J=7.0, 2H); 4.18-4.07 (m, 4H); 3.68 '\n",
      " '(m, 1H); 3.20 (m, 1H); 3.03 (m, 1H); 2.79 (s, 3H); 1.97 (m, 2H); 1.55 (m, '\n",
      " '1H); 1.42 (m, 1H); 1.16 (t, J=7.0, 3H).</p>\\n'\n",
      " '<heading id=\"h-1276\" level=\"1\">Example F64</heading>\\n'\n",
      " '<heading id=\"h-1277\" '\n",
      " 'level=\"1\">4-[2-Ethoxy-5-(trifluoromethyl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2084\" num=\"3888\">Starting from '\n",
      " '4-[2-ethoxy-5-(trifluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f34) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2085\" num=\"3889\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2086\" num=\"3890\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.93 (br.s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.79 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.92 (d, J=2.2, 1H); 7.91 (dd, J=9.5, 2.2, 1H); 7.42 (d, J=9.5, 1H); 4.86 '\n",
      " '(d, J=6.6, 1H, &#x2014;OH); 4.46 (m, 1H); 4.21 (qu, J=7.0, 2H); 4.18-4.09 '\n",
      " '(m, 2H); 3.95 (m, 1H); 3.28 (m, 1H); 3.00 (m, 1H); 2.79 (s, 3H); 1.98 (m, '\n",
      " '2H); 1.54 (m, 1H); 1.42 (m, 1H); 1.21 (br.s, 3H); 1.16 (t, J=7.0, 3H).</p>\\n'\n",
      " '<heading id=\"h-1278\" level=\"1\">Example F65</heading>\\n'\n",
      " '<heading id=\"h-1279\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2087\" num=\"3891\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f35) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2088\" num=\"3892\">MS (ESI): m/z=512 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2089\" num=\"3893\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.77 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.81 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 4.50 (t, J=5.5, 1H, &#x2014;OH); '\n",
      " '4.24-4.04 (m, 2H); 4.13 (m, 2H); 3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.68 (m, '\n",
      " '1H); 3.20 (m, 1H); 3.02 (m, 1H); 2.79 (s, 3H); 1.97 (m, 2H); 1.54 (m, 1H); '\n",
      " '1.42 (m, 1H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1280\" level=\"1\">Example F66</heading>\\n'\n",
      " '<heading id=\"h-1281\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2090\" num=\"3894\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f35) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2091\" num=\"3895\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2092\" num=\"3896\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.81 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); 4.86 (d, J=6.9, 1H, &#x2014;OH); '\n",
      " '4.47 (m, 1H); 4.27-4.06 (m, 2H); 3.95 (m. 1H); 3.84 (s, 3H &#x26; d, J=6.9, '\n",
      " '2H); 3.28 (m, 1H); 3.00 (m, 1H); 2.79 (s, 3H); 1.98 (m, 2H); 1.53 (m, 1H); '\n",
      " '1.42 (m, 1H); 1.21 (br.s, 3H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1282\" level=\"1\">Example F67</heading>\\n'\n",
      " '<heading id=\"h-1283\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2093\" num=\"3897\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f36) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2094\" num=\"3898\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2095\" num=\"3899\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.64 (s, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=8.2, 1H, &#x2014;NH); 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); '\n",
      " '5.40 (t, J=5.8, 1H, &#x2014;OH); 3.84 (s, 3H &#x26; d, J=6.8, 2H); 3.79 (d, '\n",
      " 'J=5.8, 2H &#x26; m, 1H); 3.68 (m, 1H); 2.78 (s, 3H); 2.01 (m, 2H); 1.83 (m, '\n",
      " '2H); 1.44 (m, 4H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1284\" level=\"1\">Example F68</heading>\\n'\n",
      " '<heading id=\"h-1285\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2096\" num=\"3900\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f36) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2097\" num=\"3901\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2098\" num=\"3902\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.64 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.42 (d, J=8.1, 1H, &#x2014;NH); 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); '\n",
      " '5.40 (d, J=5.1, 1H, &#x2014;OH); 3.94 (m, 1H); 3.84 (s, 3H &#x26; d, J=6.8, '\n",
      " '2H); 3.79 (d, J=5.8, 2H &#x26; m, 1H); 3.63 (m, 1H); 2.78 (s, 3H); 2.01 (m, '\n",
      " '2H); 1.82 (m, 2H); 1.43 (m, 4H); 1.21 (d, J=6.7, 3H); 0.93 (m, 1H); 0.36 (m, '\n",
      " '2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1286\" level=\"1\">Example F69</heading>\\n'\n",
      " '<heading id=\"h-1287\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2099\" num=\"3903\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f37) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2100\" num=\"3904\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2101\" num=\"3905\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.95 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.52 (d, J=7.7, 1H, &#x2014;NH); 7.43 (d, J=9.9, 1H); 7.19 (d, J=13.3, 1H); '\n",
      " '5.33 (t, J=5.1, 1H, &#x2014;OH); 4.06 (m, 1H); 3.85 (s, 3H &#x26; d, J=6.9, '\n",
      " '2H); 3.82 (d, J=5.1, 2H &#x26; m, 1H); 2.79 (s, 3H); 1.72 (m, 8H); 0.93 (m, '\n",
      " '1H); 0.37 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1288\" level=\"1\">Example F70</heading>\\n'\n",
      " '<heading id=\"h-1289\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2102\" num=\"3906\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f37) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2103\" num=\"3907\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2104\" num=\"3908\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.94 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=7.8, 1H, &#x2014;NH); 7.40 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); '\n",
      " '5.36 (d, J=5.5, 1H, &#x2014;OH); 4.04 (m, 1H); 3.99 (m, 1H); 3.85 (s, 3H '\n",
      " '&#x26; d, J=6.9, 2H); 3.75 (m, 1H); 2.79 (s, 3H); 1.71 (m, 8H); 1.22 (d, '\n",
      " 'J=6.7, 3H); 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1290\" level=\"1\">Example F71</heading>\\n'\n",
      " '<heading id=\"h-1291\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2105\" num=\"3909\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f38) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2106\" num=\"3910\">HR-MS (ESI): m/z=528.2258 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '528.2253).</p>\\n'\n",
      " '<heading id=\"h-1292\" level=\"1\">Example F72</heading>\\n'\n",
      " '<heading id=\"h-1293\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2107\" num=\"3911\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f38) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2108\" num=\"3912\">HR-MS (ESI): m/z=542.2410 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '542.2409).</p>\\n'\n",
      " '<heading id=\"h-1294\" level=\"1\">Example F73</heading>\\n'\n",
      " '<heading id=\"h-1295\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-1-glycoloyl-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2109\" num=\"3913\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f39) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2110\" num=\"3914\">HR-MS (ESI): m/z=528.2252 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '528.2253).</p>\\n'\n",
      " '<heading id=\"h-1296\" level=\"1\">Example F74</heading>\\n'\n",
      " '<heading id=\"h-1297\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin '\n",
      " '3 yl}-6 methyl 5H pyrrolo[3,2-d]pyrimidine-7-carboxamide and '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(rac.-3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2111\" num=\"3915\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3S*,4S*)-4-hydroxypiperidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f39) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2112\" num=\"3916\">HR-MS (ESI): m/z=542.2393 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '542.2409).</p>\\n'\n",
      " '<heading id=\"h-1298\" level=\"1\">Example F75</heading>\\n'\n",
      " '<heading id=\"h-1299\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2113\" num=\"3917\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f40) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2114\" num=\"3918\">MS (ESI): m/z=496 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2115\" num=\"3919\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.53 (d, J=9.0, 1H); 7.03 (d, J=12.0, 1H); 4.50 (t, J=5.5, 1H, &#x2014;OH); '\n",
      " '4.25-4.05 (m, 2H &#x26; m, 2H); 3.87 (d, J=6.9, 2H); 3.68 (m, 1H); 3.20 (m, '\n",
      " '1H); 3.02 (m, 1H); 2.78 (s, 3H); 2.25 (d, J=1.3, 3H); 1.97 (m, 2H); 1.53 (m, '\n",
      " '1H); 1.42 (m, 1H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1300\" level=\"1\">Example F76</heading>\\n'\n",
      " '<heading id=\"h-1301\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2116\" num=\"3920\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f40) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2117\" num=\"3921\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2118\" num=\"3922\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.81 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.54 (dd, J=9.1, 0.6, 1H); 7.03 (d, J=12.0, 1H); 4.86 (d, J=6.9, 1H, '\n",
      " '&#x2014;OH); 4.46 (m, 1H); 4.27-4.07 (m, 2H); 3.95 (m, 1H); 3.87 (d, J=6.9, '\n",
      " '2H); 3.27 (m, 1H); 3.00 (m, 1H); 2.78 (s, 3H); 2.25 (d, J=1.3, 3H); 1.98 (m, '\n",
      " '2H); 1.62-1.31 (m, 2H); 1.22 (br.s, 3H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 '\n",
      " '(m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1302\" level=\"1\">Example F77</heading>\\n'\n",
      " '<heading id=\"h-1303\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2119\" num=\"3923\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f41) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2120\" num=\"3924\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2121\" num=\"3925\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.93 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.53 (d, J=9.1, 1H); 7.47 (d, J=8.2, 1H, &#x2014;NH); 7.03 (d, J=12.2, 1H); '\n",
      " '5.40 (t, J=5.7, 1H, &#x2014;OH); 3.87 (d, J=6.9, 2H); 3.79 (m, 1H &#x26; d, '\n",
      " 'J=5.7, 2H); 3.68 (m, 1H); 2.77 (s, 3H); 2.25 (d, J=1.1, 3H); 2.01 (m, 2H); '\n",
      " '1.82 (m, 2H); 1.44 (m, 4H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1304\" level=\"1\">Example F78</heading>\\n'\n",
      " '<heading id=\"h-1305\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2122\" num=\"3926\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f41) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2123\" num=\"3927\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2124\" num=\"3928\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H); 7.42 (d, J=8.4, 1H, &#x2014;NH); 7.03 (d, J=12.2, 1H); '\n",
      " '5.40 (d, J=5.2, 1H, &#x2014;OH); 3.94 (dt, J=6.8, 5.2, 2H); 3.87 (d, J=6.9, '\n",
      " '2H); 3.80 (m, 1H); 3.63 (m, 1H); 2.77 (s, 3H); 2.25 (d, J=1.1, 3H); 2.01 (m, '\n",
      " '2H); 1.82 (m, 2H); 1.42 (m, 4H); 1.21 (d, J=6.8, 3H); 0.95 (m, 1H); 0.37 (m, '\n",
      " '2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1306\" level=\"1\">Example F79</heading>\\n'\n",
      " '<heading id=\"h-1307\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2125\" num=\"3929\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f42) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2126\" num=\"3930\">MS (ESI): m/z=510 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2127\" num=\"3931\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.96 (d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H &#x26; d, J=7.5, 1H, &#x2014;NH); 7.04 (d, J=12.2, 1H); '\n",
      " '5.33 (t, J=5.8, 1H, &#x2014;OH); 4.06 (m, 1H); 3.88 (d, J=6.9, 2H); 3.82 (d, '\n",
      " 'J=5.8, 2H); 3.80 (m, 1H); 2.78 (s, 3H); 2.25 (d, J=0.9, 3H); 1.81-1.59 (m, '\n",
      " '8H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1308\" level=\"1\">Example F80</heading>\\n'\n",
      " '<heading id=\"h-1309\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2128\" num=\"3932\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f42) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2129\" num=\"3933\">MS (ESI): m/z=524 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2130\" num=\"3934\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.97 (s, 1H); 8.95 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.54 (d, J=9.1, 1H); 7.48 (d, J=7.8, 1H, &#x2014;NH); 7.04 (d, J=12.2, 1H); '\n",
      " '5.36 (d, J=5.5, 1H, &#x2014;OH); 4.05 (m, 1H); 3.99 (dt, J=6.8, 5.5, 1H); '\n",
      " '3.88 (d, J=6.9, 2H); 3.75 (m, 1H); 2.78 (s, 3H); 2.25 (d, J=0.9, 3H); '\n",
      " '1.80-1.59 (m, 8H); 1.22 (d, J=6.8, 3H); 0.95 (m, 1H); 0.37 (m, 2H); 0.24 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1310\" level=\"1\">Example F81</heading>\\n'\n",
      " '<heading id=\"h-1311\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2131\" num=\"3935\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f43) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2132\" num=\"3936\">HR-MS (ESI): m/z=512.2324 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '512.2304).</p>\\n'\n",
      " '<heading id=\"h-1312\" level=\"1\">Example F82</heading>\\n'\n",
      " '<heading id=\"h-1313\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2133\" num=\"3937\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f43) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2134\" num=\"3938\">HR-MS (ESI): m/z=526.2470 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '526.2460).</p>\\n'\n",
      " '<heading id=\"h-1314\" level=\"1\">Example F83</heading>\\n'\n",
      " '<heading id=\"h-1315\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(1-glycoloylpiperidin-4-yl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2135\" num=\"3939\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f44) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2136\" num=\"3940\">MS (ESI): m/z=512 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2137\" num=\"3941\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 6.92 (d, J=7.3, 1H); 4.50 (t, J=5.3, 1H, &#x2014;OH); '\n",
      " '4.22-4.06 (m, 2H &#x26; d, J=5.3, 2H); 3.97 (s, 3H); 3.94 (d, J=6.9, 2H); '\n",
      " '3.68 (m, 1H); 3.19 (m, 1H); 3.02 (m, 1H); 2.79 (s, 3H); 1.96 (m, 2H); 1.54 '\n",
      " '(m, 1H); 1.41 (m, 1H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1316\" level=\"1\">Example F84</heading>\\n'\n",
      " '<heading id=\"h-1317\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2138\" num=\"3942\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f44) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2139\" num=\"3943\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2140\" num=\"3944\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (br.s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 6.92 (d, J=7.3, 1H); 4.86 (d, J=6.9, 1H, &#x2014;OH); '\n",
      " '4.46 (m, 1H); 4.28-4.07 (m, 2H); 3.97 (s, 3H); 3.94 (d, J=6.9, 2H); 3.30 (m, '\n",
      " '1H); 3.00 (m, 1H); 2.79 (s, 3H); 1.98 (m, 2H); 1.53 (m, 1H); 1.41 (m, 1H); '\n",
      " '1.21 (br.s, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1318\" level=\"1\">Example F85</heading>\\n'\n",
      " '<heading id=\"h-1319\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[trans-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2141\" num=\"3945\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f45) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2142\" num=\"3946\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2143\" num=\"3947\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.70 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=8.2, 1H, &#x2014;NH &#x26; d, J=11.7, 1H); 6.93 (d, J=7.3, 1H); '\n",
      " '5.40 (t, J=5.8, 1H, &#x2014;OH); 3.97 (s, 3H); 3.94 (d, J=6.9, 2H); 3.79 (m, '\n",
      " '1H &#x26; d, J=5.8, 2H); 3.69 (m, 1H); 2.78 (s, 3H); 2.01 (m, 2H); 1.82 (m, '\n",
      " '2H); 1.44 (m, 4H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1320\" level=\"1\">Example F86</heading>\\n'\n",
      " '<heading id=\"h-1321\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2144\" num=\"3948\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f45) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2145\" num=\"3949\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2146\" num=\"3950\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.70 (s, 1H, &#x2014;NH); 8.92 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 7.42 (d, J=8.2, 1H, &#x2014;NH); 6.92 (d, J=7.3, 1H); '\n",
      " '5.40 (d, J=5.1, 1H, &#x2014;OH); 3.97 (s, 3H); 3.94 (d, J=6.9, 2H &#x26; m, '\n",
      " '1H); 3.80 (m, 1H); 3.63 (m, 1H); 2.78 (s, 3H); 2.00 (m, 2H); 1.82 (m, 2H); '\n",
      " '1.42 (m, 4H); 1.21 (d, J=6.7, 3H); 0.96 (m, 1H); 0.38 (m, 2H); 0.25 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1322\" level=\"1\">Example F87</heading>\\n'\n",
      " '<heading id=\"h-1323\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[cis-4-(glycoloylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2147\" num=\"3951\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f46) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2148\" num=\"3952\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2149\" num=\"3953\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.70 (s, 1H, &#x2014;NH); 8.97 (d, J=7.7, 1H, &#x2014;NH); 8.95 (s, 1H); '\n",
      " '7.53 (d, J=7.8, 1H, &#x2014;NH); 7.47 (d, J=11.9, 1H); 6.93 (d, J=7.3, 1H); '\n",
      " '5.33 (t, J=5.8, 1H, &#x2014;OH); 4.06 (m, 1H); 3.97 (s, 3H); 3.94 (d, J=7.1, '\n",
      " '2H); 3.82 (d, J=5.8, 1H); 3.80 (m, 1H); 2.79 (s, 3H); 1.82-1.59 (m, 8H); '\n",
      " '0.96 (m, 1H); 0.39 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1324\" level=\"1\">Example F88</heading>\\n'\n",
      " '<heading id=\"h-1325\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2150\" num=\"3954\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f46) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2151\" num=\"3955\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2152\" num=\"3956\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.70 (s, 1H, &#x2014;NH); 8.96 (s, 1H &#x26; d, J=7.3, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=11.9, 1H); 7.46 (d, J=7.7, 1H, &#x2014;NH); 6.93 (d, J=7.3, 1H); '\n",
      " '5.36 (d, J=5.5, 1H, &#x2014;OH); 4.05 (m, 1H); 4.00 (m, 1H); 3.97 (s, 3H); '\n",
      " '3.94 (d, J=6.9, 2H); 3.75 (m, 1H); 2.79 (s, 3H); 1.80-1.58 (m, 8H); 1.22 (d, '\n",
      " 'J=6.8, 3H); 0.96 (m, 1H); 0.39 (m, 2H); 0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1326\" level=\"1\">Example F89</heading>\\n'\n",
      " '<heading id=\"h-1327\" '\n",
      " 'level=\"1\">4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxy-1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2153\" num=\"3957\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f47) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2154\" num=\"3958\">HR-MS (ESI): m/z=528.2267 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>31</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '528.2253).</p>\\n'\n",
      " '<heading id=\"h-1328\" level=\"1\">Example F90</heading>\\n'\n",
      " '<heading id=\"h-1329\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R,4R)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3S,4S)-3-hydroxy-1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2155\" num=\"3959\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-3-hydroxypiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f47) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2156\" num=\"3960\">HR-MS (ESI): m/z=542.2406 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>6</sub><sup>+</sup>, calc. '\n",
      " '542.2409).</p>\\n'\n",
      " '<heading id=\"h-1330\" level=\"1\">Example F91</heading>\\n'\n",
      " '<heading id=\"h-1331\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2157\" num=\"3961\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f48) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2158\" num=\"3962\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2159\" num=\"3963\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.94 (s, 1H); 8.83 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.2, 1H); 7.36 (dd, J=8.4, 2.2, 1H); 7.08 (d, J=8.4, 1H); 4.49 '\n",
      " '(br.s, 1H, &#x2014;OH); 4.24-4.03 (m, 2H); 4.13 (d, J=4.6, 2H); 3.87 (d, '\n",
      " 'J=6.9, 2H); 3.68 (m, 1H); 3.22 (m, 1H); 3.03 (m, 1H); 2.78 (s, 3H); 2.64 '\n",
      " '(qu, J=7.5, 2H); 1.97 (m, 2H); 1.54 (m, 1H); 1.42 (m, 1H); 1.18 (t, J=7.5, '\n",
      " '3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1332\" level=\"1\">Example F92</heading>\\n'\n",
      " '<heading id=\"h-1333\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2160\" num=\"3964\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f48) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2161\" num=\"3965\">MS (ESI): m/z=505 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2162\" num=\"3966\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.75 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.83 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.4, 1H); 7.36 (dd, J=8.6, 2.4, 1H); 7.08 (d, J=8.6, 1H); 4.86 '\n",
      " '(d, J=6.9, 1H, &#x2014;OH); 4.47 (m, 1H); 4.25-4.11 (m, 2H); 3.95 (m, 1H); '\n",
      " '3.87 (d, J=6.9, 2H); 3.27 (m, 1H); 3.00 (m, 1H); 2.78 (s, 3H); 2.64 (qu, '\n",
      " 'J=7.6, 2H); 1.98 (m, 2H); 1.53 (m, 1H); 1.42 (m, 1H); 1.21 (br.s, 3H); 1.18 '\n",
      " '(t, J=7.6, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1334\" level=\"1\">Example F93</heading>\\n'\n",
      " '<heading id=\"h-1335\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2163\" num=\"3967\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f49) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2164\" num=\"3968\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2165\" num=\"3969\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (br.s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.66 (d, J=7.9, 1H, &#x2014;NH); '\n",
      " '7.48 (d, J=8.4, 1H, &#x2014;NH); 7.45 (d, J=2.4, 1H); 7.35 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 5.40 (t, J=5.7, 1H, &#x2014;OH); 3.87 (d, J=6.9, '\n",
      " '2H); 3.79 (d, J=5.7, 2H &#x26; m, 1H); 3.68 (m, 1H); 2.77 (s, 3H); 2.64 (qu, '\n",
      " 'J=7.5, 2H); 2.02 (m, 2H); 1.83 (m, 2H); 1.44 (m, 4H); 1.18 (t, J=7.5, 3H); '\n",
      " '0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1336\" level=\"1\">Example F94</heading>\\n'\n",
      " '<heading id=\"h-1337\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2166\" num=\"3970\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f49) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2167\" num=\"3971\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2168\" num=\"3972\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.72 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.66 (d, J=7.8, 1H, &#x2014;NH); '\n",
      " '7.45 (d, J=2.4, 1H); 7.42 (d, J=8.4, 1H, &#x2014;NH); 7.36 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 5.40 (t, J=5.1, 1H, &#x2014;OH); 3.94 (m, 1H); '\n",
      " '3.86 (d, J=6.9, 2H); 3.82 (m, 1H); 3.63 (m, 1H); 2.77 (s, 3H); 2.64 (qu, '\n",
      " 'J=7.5, 2H); 2.00 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); 1.21 (d, J=6.8, 3H); '\n",
      " '1.18 (t, J=7.5, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1338\" level=\"1\">Example F95</heading>\\n'\n",
      " '<heading id=\"h-1339\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2169\" num=\"3973\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f50) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2170\" num=\"3974\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2171\" num=\"3975\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.97 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.53 (d, J=7.8, 1H, &#x2014;NH); 7.45 (d, J=2.3, 1H); 7.36 (dd, J=8.6, 2.3, '\n",
      " '1H); 7.08 (d, J=8.6, 1H); 5.33 (br.s, 1H, &#x2014;OH); 4.06 (m, 1H); 3.87 '\n",
      " '(d, J=6.8, 2H); 3.83 (s, 2H); 3.80 (m, 1H); 2.78 (s, 3H); 2.64 (qu, J=7.5, '\n",
      " '2H); 1.85-1.55 (m, 8H); 1.19 (t, J=7.6, 53H); 0.94 (m, 1H); 0.36 (m, 2H); '\n",
      " '0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1340\" level=\"1\">Example F96</heading>\\n'\n",
      " '<heading id=\"h-1341\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2172\" num=\"3976\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f50) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2173\" num=\"3977\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2174\" num=\"3978\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.98 (s, 1H); 8.96 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.48 (d, J=7.8, 1H, &#x2014;NH); 7.45 (d, J=2.2, 1H); 7.36 (dd, J=8.4, 2.2, '\n",
      " '1H); 7.08 (d, J=8.4, 1H); 5.37 (d, J=5.3, 1H, &#x2014;OH); 4.06 (m, 1H); '\n",
      " '3.99 (m, 1H); 3.87 (d, J=6.8, 2H); 3.75 (m, 1H); 2.78 (s, 3H); 2.64 (qu, '\n",
      " 'J=7.6, 2H); 1.83-1.56 (m, 8H); 1.21 (t, J=7.6, 3H); 1.17 (d, J=7.7, 1H); '\n",
      " '0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1342\" level=\"1\">Example F97</heading>\\n'\n",
      " '<heading id=\"h-1343\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxy-1-(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2175\" num=\"3979\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f51) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2176\" num=\"3980\">MS (ESI): m/z=494 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2177\" num=\"3981\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.80 (s, 1H, &#x2014;NH); 8.92 (s, 1H); [8.88 (d, J=7.1), 8.84 (d, J=6.6), '\n",
      " '1H, &#x2014;NH]; 7.44 (d, J=2.4, 1H); 7.36 (dd, J=8.4, 2.4, 1H); 7.08 (d, '\n",
      " 'J=8.4, 1H); [5.57 (d, J=3.8), 5.51 (d, J=4.0), 1H, &#x2014;OH]; [4.64 (t, '\n",
      " 'J=5.6), 4.60 (t, J=5.6), 1H, &#x2014;OH]; [4.38 (m), 4.20 (m, 1H]; 4.28 (m, '\n",
      " '1H); [4.06 (br. s), 4.04 (br. s), 2H]; 3.86 (d, J=6.9, 2H); 3.84-3.60 (m, '\n",
      " '2H); 3.46-3.27 (m, 2H); 2.78 (s, 3H); 2.63 (qu, J=7.5, 2H); 1.18 (t, J=7.5, '\n",
      " '3H); 0.93 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1344\" level=\"1\">Example F98</heading>\\n'\n",
      " '<heading id=\"h-1345\" level=\"1\">Diastereomeric mixture of '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-{(3R,4R)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'and '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-{(3S,4S)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2178\" num=\"3982\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-N-[(3R*,4R*)-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f51) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2179\" num=\"3983\">HR-MS (ESI): m/z=508.2548 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>34</sub>N<sub>5</sub>O<sub>5</sub><sup>+</sup>, calc. '\n",
      " '508.2554).</p>\\n'\n",
      " '<heading id=\"h-1346\" level=\"1\">Example F99</heading>\\n'\n",
      " '<heading id=\"h-1347\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2180\" num=\"3984\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f52) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2181\" num=\"3985\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2182\" num=\"3986\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.76 (s, 1H, &#x2014;NH); 8.95 (s, 1H); 8.83 (d, J=7.1, 1H, &#x2014;NH); '\n",
      " '7.46 (d, J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, 1H); 7.08 (d; J=8.6, 1H); 4.86 '\n",
      " '(d, J=6.9, 1H, &#x2014;OH); 4.47 (m, 1H); 4.27-4.08 (m, 2H); 3.95 (m, 1H); '\n",
      " '3.87 (d, J=6.9, 2H); 3.27 (m, 1H); 3.09-2.87 (m, 1H &#x26; sept, J=6.9, 1H); '\n",
      " '2.78 (s, 3H); 1.98 (m, 2H); 1.53 (m, 1H); 1.42 (m, 1H); 1.22 (d, J=6.9, 6H '\n",
      " '&#x26; br.s, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1348\" level=\"1\">Example F100</heading>\\n'\n",
      " '<heading id=\"h-1349\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2183\" num=\"3987\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f53) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2184\" num=\"3988\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2185\" num=\"3989\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.73 (s, 1H, &#x2014;NH); 8.96 (s, 1H); 8.66 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '7.47 (d, J=2.4, 1H); 7.42 (d, J=7.9, 1H, &#x2014;NH); 7.39 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.08 (d; J=8.6, 1H); 5.40 (d, J=5.3, 1H, &#x2014;OH); 3.94 (td, J=6.8, '\n",
      " '5.3, 1H); 3.87 (d, J=6.9, 2H); 3.81 (m, 1H); 3.64 (m, 1H); 2.94 (sept, '\n",
      " 'J=6.9, 1H); 2.77 (s, 3H); 2.01 (m, 2H); 1.82 (m, 2H); 1.43 (m, 4H); 1.22 (d, '\n",
      " 'J=6.9, 6H); 1.21 (d, J=6.8, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1350\" level=\"1\">Example F101</heading>\\n'\n",
      " '<heading id=\"h-1351\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2186\" num=\"3990\">Starting from '\n",
      " 'N-(cis-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f54) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2187\" num=\"3991\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2188\" num=\"3992\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.74 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.96 (d, J=7.5, 1H, &#x2014;NH); '\n",
      " '7.48 (d, J=7.7, 1H, &#x2014;NH); 7.47 (d, J=2.4, 1H); 7.39 (dd, J=8.6, 2.4, '\n",
      " '1H); 7.09 (d; J=8.6, 1H); 5.37 (d, J=5.4, 1H, &#x2014;OH); 4.05 (m, 1H); '\n",
      " '3.99 (td, J=6.8, 5.4, 1H); 3.87 (d, J=6.9, 2H); 3.75 (m, 1H); 2.95 (sept, '\n",
      " 'J=6.9, 1H); 2.78 (s, 3H); 1.81-1.59 (m, 8H); 1.22 (d, J=6.9, 6H &#x26; d, '\n",
      " 'J=6.9, 3H); 0.94 (m, 1H); 0.36 (m, 2H); 0.23 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1352\" level=\"1\">Example F102</heading>\\n'\n",
      " '<heading id=\"h-1353\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2189\" num=\"3993\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f55) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2190\" num=\"3994\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2191\" num=\"3995\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 8.99 (s, 1H); 8.82 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.3, 1H); 8.15 (dd, J=8.8, 2.3, 1H); 7.30 (d, J=8.8, 1H); 4.51 '\n",
      " '(t, J=5.5, 1H, &#x2014;OH); 4.24-4.06 (m, 4H); 4.01 (d, J=7.0, 2H); 3.68 (m, '\n",
      " '1H); 3.20 (m, 1H); 3.03 (m, 1H); 2.79 (s, 3H); 2.58 (s, 3H); 1.97 (m, 2H); '\n",
      " '1.55 (m, 1H); 1.44 (m, 1H); 0.99 (m, 1H); 0.39 (m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1354\" level=\"1\">Example F103</heading>\\n'\n",
      " '<heading id=\"h-1355\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2192\" num=\"3996\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f55) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2193\" num=\"3997\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2194\" num=\"3998\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.88 (s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.81 (d, J=6.7, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.3, 1H); 8.15 (dd, J=8.8, 2.3, 1H); 7.30 (d, J=8.8, 1H); 4.47 '\n",
      " '(br.s, 1H, &#x2014;OH); 4.27-4.10 (m, 2H); 4.01 (d, J=7.1, 2H); 3.95 (m, '\n",
      " '1H); 3.27 (m, 1H); 3.00 (m, 1H); 2.79 (s, 3H); 2.58 (s, 3H); 1.99 (m, 2H); '\n",
      " '1.55 (m, 1H); 1.41 (m, 1H); 1.21 (br.s, 3H); 0.99 (m, 1H); 0.39 (m, 2H); '\n",
      " '0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1356\" level=\"1\">Example F104</heading>\\n'\n",
      " '<heading id=\"h-1357\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2195\" num=\"3999\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-aminocyclohexyl)-6-methyl-5&#x2032;-1-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f56) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2196\" num=\"4000\">MS (ESI): m/z=520 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2197\" num=\"4001\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.85 (s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.3, 1H); 8.15 (dd, J=8.8, 2.3, 1H); 7.48 (d, J=8.3, 1H, '\n",
      " '&#x2014;NH); 7.30 (d, J=8.8, 1H); 5.40 (t, J=5.8, 1H, &#x2014;OH); 4.01 (d, '\n",
      " 'J=7.0, 2H); 3.82 (m, 1H); 3.79 (d, J=5.8, 2H); 3.69 (m, 1H); 2.79 (s, 3H); '\n",
      " '2.58 (s, 3H); 2.01 (m, 2H); 1.83 (m, 2H); 1.45 (m, 4H); 0.99 (m, 1H); 0.39 '\n",
      " '(m, 2H); 0.28 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1358\" level=\"1\">Example F105</heading>\\n'\n",
      " '<heading id=\"h-1359\" '\n",
      " 'level=\"1\">4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2198\" num=\"4002\">Starting from '\n",
      " '4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-N-(trans-4-aminocyclohexyl)-6-methyl-5&#x2032;-1-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f56) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2199\" num=\"4003\">MS (ESI): m/z=534 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2200\" num=\"4004\"><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.85 (s, 1H, &#x2014;NH); 9.00 (s, 1H); 8.65 (d, J=7.7, 1H, &#x2014;NH); '\n",
      " '8.21 (d, J=2.2, 1H); 8.15 (dd, J=8.9, 2.2, 1H); 7.42 (d, J=8.3, 1H, '\n",
      " '&#x2014;NH); 7.30 (d, J=8.9, 1H); 5.40 (d, J=5.1, 1H, &#x2014;OH); 4.01 (d, '\n",
      " 'J=7.0, 2H); 3.94 (td, J=6.8, 5.1, 1H); 3.82 (m, 1H); 3.64 (m, 1H); 2.78 (s, '\n",
      " '3H); 2.58 (s, 3H); 2.01 (m, 2H); 1.84 (m, 2H); 1.44 (m, 4H); 1.21 (d, J=6.8, '\n",
      " '3H); 0.99 (m, 1H); 0.39 (m, 2H); 0.27 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1360\" level=\"1\">Example F106</heading>\\n'\n",
      " '<heading id=\"h-1361\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2201\" num=\"4005\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f57) and commercially available 2-chloro-2-oxoethyl '\n",
      " 'acetate the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2202\" num=\"4006\">MS (ESI): m/z=492 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-2203\" num=\"4007\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.60 (s, 1H, &#x2014;NH); 9.05 (d, J=7.5, 1H, &#x2014;NH); 7.39 (d, J=2.0, '\n",
      " '1H); 7.31 (dd, J=8.6, 2.0, 1H); 7.04 (d, J=8.6, 1H); 4.52 (t, J=5.3, 1H, '\n",
      " '&#x2014;OH); 4.24-4.04 (m, 2H); 4.13 (m, 2H); 3.85 (d, J=6.9, 2H); 3.67 (m, '\n",
      " '1H); 3.24 (m, 1H); 3.12 (m, 1H); 2.75 (s, 3H); 2.72 (s, 3H); 2.32 (s, 3H); '\n",
      " '1.96 (m, 2H); 1.69-1.36 (m, 2H); 0.93 (m, 1H); 0.35 (m, 2H); 0.22 (m, '\n",
      " '2H).</p>\\n'\n",
      " '<heading id=\"h-1362\" level=\"1\">Example F107</heading>\\n'\n",
      " '<heading id=\"h-1363\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2204\" num=\"4008\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-methylphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f57) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2205\" num=\"4009\">MS (ESI): m/z=506 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-2206\" num=\"4010\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.58 (s, 1H, &#x2014;NH); 9.05 (br.s, 1H, &#x2014;NH); 7.39 (d, J=1.8, 1H); '\n",
      " '7.31 (dd, J=8.4, 1.8, 1H); 7.04 (d, J=8.4, 1H); 4.86 (m, 1H, &#x2014;OH); '\n",
      " '4.47 (m, 1H); 4.21-3.99 (m, 2H); 3.99-3.80 (m, 1H); 3.84 (d, J=6.9, 2H); '\n",
      " '3.43-3.24 (m, 1H); 3.24-2.98 (m, 1H); 2.75 (s, 3H); 2.72 (s, 3H); 2.33 (s, '\n",
      " '3H); 2.05-1.89 (m, 2H); 1.63-1.36 (m, 2H); 1.21 (d, J=6.0, 3H); 0.93 (m, '\n",
      " '1H); 0.35 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1364\" level=\"1\">Example F108</heading>\\n'\n",
      " '<heading id=\"h-1365\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2207\" num=\"4011\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f58) and commercially available '\n",
      " '(2S)-1-chloro-1-oxopropan-2-yl acetate the title compound is obtained as '\n",
      " 'colorless solid.</p>\\n'\n",
      " '<p id=\"p-2208\" num=\"4012\">MS (ESI): 540 (MH<sup>+</sup>, 100%)</p>\\n'\n",
      " '<p id=\"p-2209\" num=\"4013\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.56 (s, 1H, &#x2014;NH); 9.04 (m, 1H, &#x2014;NH); 7.43 (d, J=11.9, 1H); '\n",
      " '6.91 (d, J=7.3, 1H); 4.91-4.80 (m, 1H, &#x2014;OH); 4.47 (m, 1H); 4.21-4.07 '\n",
      " '(m, 2H); 3.96 (s, 3H); 3.93 (d, J=6.9, 2H); 3.89 (m, 1H); 3.44-3.25 (m, 1H); '\n",
      " '3.38-3.25 (m, 1H); 3.25-2.99 (m, 1H); 2.76 (s, 3H); 2.71 (s, 3H); 2.04-1.89 '\n",
      " '(m, 2H); 1.64-1.34 (m, 2H); 1.21 (d, J=6.2, 3H); 0.95 (m, 1H); 0.38 (m, 2H); '\n",
      " '0.25 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1366\" level=\"1\">Example F109</heading>\\n'\n",
      " '<heading id=\"h-1367\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2210\" num=\"4014\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f59) and commercially 2-chloro-2-oxoethyl acetate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2211\" num=\"4015\">MS (ESI): m/z=526 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2212\" num=\"4016\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.61 (s, 1H, &#x2014;NH); 9.02 (d, J=7.7, 1H, &#x2014;NH); 7.34 (d, J=9.9, '\n",
      " '1H); 7.16 (d, J=13.3, 1H); 4.50 (t, J=5.5, 1H, &#x2014;OH); 4.21-4.05 (m, '\n",
      " '2H); 4.13 (s, 2H); 3.84 (s, 3H); 3.82 (d, J=6.8, 2H); 3.66 (m, 1H); 3.24 (m, '\n",
      " '1H); 3.11 (m, 1H); 2.75 (s, 3H); 2.73 (s, 3H); 1.96 (m, 2H); 1.64-1.37 (m, '\n",
      " '2H); 0.92 (m, 1H); 0.35 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1368\" level=\"1\">Example F110</heading>\\n'\n",
      " '<heading id=\"h-1369\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-2,6-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2213\" num=\"4017\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-2,6-dimethyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f59) and commercially 2-chloro-2-oxoethyl acetate '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2214\" num=\"4018\">MS (ESI): m/z=540 (MH<sup>+</sup>, 100%).</p>\\n'\n",
      " '<p id=\"p-2215\" num=\"4019\"><sup>1</sup>H-NMR (300 MHz, DMSO-d<sub>6</sub>): '\n",
      " '11.61 (s, 1H, &#x2014;NH); 9.03 (br.s, 1H, &#x2014;NH); 7.33 (d, J=9.9, 1H); '\n",
      " '7.16 (d, J=13.5, 1H); 4.86 (br.s, 1H, &#x2014;OH); 4.47 (m, 1H); 4.23-4.00 '\n",
      " '(m, 2H); 3.88 (m, 1H); 3.84 (s, 3H); 3.82 (d, J=6.8, 2H); 3.36 (m, 1H); 3.10 '\n",
      " '(m, 1H); 2.75 (s, 3H); 2.73 (s, 3H); 1.97 (m, 2H); 1.62-1.37 (m, 2H); 1.21 '\n",
      " '(d, J=6.0, 3H); 0.91 (m, 1H); 0.35 (m, 2H); 0.19 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1370\" level=\"1\">Example F111</heading>\\n'\n",
      " '<heading id=\"h-1371\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2216\" num=\"4020\">MS (ESI): m/z=498 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-2217\" num=\"4021\">1H-NMR (300 MHz, DMSO-d6): 11.80 (s, 1H, '\n",
      " '&#x2014;NH); 8.95 (s, 1H); [8.92 (d, J=7.3), 8.90 (d, J=7.9), 1H, '\n",
      " '&#x2014;NH]; 7.93 (d, J=9.8, 1H); 7.18 (d, J=13.4, 1H); 4.67-4.46 (m, 1H); '\n",
      " '4.56 T, J=5.7, 1H, &#x2014;OH); [4.06 (d, J=5.7), 4.01 (d, J=5.7), 1H]; 3.85 '\n",
      " '(d, J=6.9, 2H &#x26; s, 3H); 3.81-3.69 (m, 1H); 3.64-3.46 (m, 2H); 3.38-3.31 '\n",
      " '(m, 1H); 2.79 (s, 3H); 2.35-2.17 (m, 1H); [2.05 (m), 1.93 (m), 1H]; 0.93 (m, '\n",
      " '1H); 0.36 (m, 2H); 0.22 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1372\" level=\"1\">Example F112</heading>\\n'\n",
      " '<heading id=\"h-1373\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2218\" num=\"4022\">MS (ESI): m/z=512 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-2219\" num=\"4023\">1H-NMR (300 MHz, DMSO-d6): 11.80 (s, 1H, '\n",
      " '&#x2014;NH); [8.95 (s), 8.92 (s), 1H]; 8.92 (d, J=7.1, 1H, &#x2014;NH); 7.39 '\n",
      " '(d, J=9.9, 1H); 7.18 (d, J=13.5, 1H); [4.91 (d, J=6.9), 4.84 (d, J=6.9), 1H, '\n",
      " '&#x2014;OH]; [4.58 (m), 4.51 (m), 1H]; [4.33 (m), 4.26 (m), 1H]; 3.84 (d, '\n",
      " 'J=6.6, 2H &#x26; s, 3H); 3.87-3.79 (m, 1H); 3.87-3.42 (m, 2H); 3.39-3.27 (m, '\n",
      " '1H); 2.79 (s, 3H); 2.33-2.15 (m, 1H); [2.05 (m), 1.92 (m), 1H]; [1.23 (d, '\n",
      " 'J=6.6), 1.20 (d, J=6.6), 3H]; 0.93 (m, 1H); 0.36 (m, 2H); 0.21 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1374\" level=\"1\">Example F113</heading>\\n'\n",
      " '<heading id=\"h-1375\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2220\" num=\"4024\">MS (ESI): m/z=514 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-2221\" num=\"4025\">1H-NMR (300 MHz, DMSO-d6): 11.81 (s, 1H, '\n",
      " '&#x2014;NH); [8.94 (s), 8.93 (s), 1H]; [8.86 (d, J=7.3), 8.82 (d, J=6.6), '\n",
      " '1H, &#x2014;NH]; 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); [5.57 (d, '\n",
      " 'J=3.8), 5.50 (d, J=4.0), 1H, &#x2014;OH]; [4.64 (t, J=5.7), 4.60 (t, J=5.7), '\n",
      " '1H, &#x2014;OH]; 4.41-4.17 (m, 2H); [4.06 (br. s), 4.04 (br. s), 2H]; 3.84 '\n",
      " '(d, J=6.8, 2H &#x26; s, 3H); 3.80-3.60 (m, 2H); 3.46-3.27 (m, 2H); 2.79 (s, '\n",
      " '3H); 0.92 (m, 1H); 0.36 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1376\" level=\"1\">Example F114</heading>\\n'\n",
      " '<heading id=\"h-1377\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(mixture of diastereomers)</heading>\\n'\n",
      " '<p id=\"p-2222\" num=\"4026\">MS (ESI): m/z=528 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-2223\" num=\"4027\">1H-NMR (300 MHz, DMSO-d6): 11.81 (s, 1H, '\n",
      " '&#x2014;NH); [8.93 (s), 8.91 (s), 8.89 (s), 8.88 (s), 1H]; 8.87-8.82 (m, 1H, '\n",
      " '&#x2014;NH]; 7.39 (d, J=9.9, 1H); 7.18 (d, J=13.3, 1H); [5.57 (d, J=3.7), '\n",
      " '5.55 (d, J=3.7), 5.50 (d, J=2.0), 5.49 (d, J=1.8), 1H, &#x2014;OH]; [4.64 '\n",
      " '(t, J=5.7), 4.60 (t, J=5.7), 1H, &#x2014;OH]; 4.41-4.17 (m, 2H); [4.97 (d, '\n",
      " 'J=6.8), 4.95 (d, J=7.1), 4.89 (d, J=3.5), 4.87 (d, J=3.5), 1H, &#x2014;OH]; '\n",
      " '4.38-4.17 (m, 3H); 4.03-3.27 (m, 4H); 3.84 (d, J=6.9, 2H &#x26; s, 3H); 2.79 '\n",
      " '(s, 3H); 1.27-1.21 (m, 3H); 0.92 (m, 1H); 0.36 (m, 2H); 0.20 (m, 2H).</p>\\n'\n",
      " '<heading id=\"h-1378\" level=\"1\">Example F115</heading>\\n'\n",
      " '<heading id=\"h-1379\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R)-1-glycoloylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2224\" num=\"4028\">MS (ESI): m/z=498 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1380\" level=\"1\">Example F116</heading>\\n'\n",
      " '<heading id=\"h-1381\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R)-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2225\" num=\"4029\">MS (ESI): m/z=512 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1382\" level=\"1\">Example F117</heading>\\n'\n",
      " '<heading id=\"h-1383\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2226\" num=\"4030\">MS (ESI): m/z=514 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1384\" level=\"1\">Example F118</heading>\\n'\n",
      " '<heading id=\"h-1385\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(mixture of diastereomeres)</heading>\\n'\n",
      " '<p id=\"p-2227\" num=\"4031\">MS (ESI): m/z=528 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1386\" level=\"1\">Example F119</heading>\\n'\n",
      " '<heading id=\"h-1387\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-[(3R*,4R*)-1-glycoloyl-4-hydroxypyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2228\" num=\"4032\">MS (ESI): m/z=496 (MH+, 100%).</p>\\n'\n",
      " '<heading id=\"h-1388\" level=\"1\">Example F120</heading>\\n'\n",
      " '<heading id=\"h-1389\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{(3R*,4R*)-4-hydroxy-1-[(2S)-2-hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(mixture of diastereomeres)</heading>\\n'\n",
      " '<p id=\"p-2229\" num=\"4033\">MS (ESI): m/z=510 (MH+, 100%).</p>\\n'\n",
      " '<p id=\"p-2230\" num=\"4034\">The following compounds in the table would fall '\n",
      " 'within the scope of the genus of formula I as described in claim '\n",
      " '<b>1</b>:</p>\\n'\n",
      " '<p id=\"p-2231\" num=\"4035\">\\n'\n",
      " '<tables id=\"TABLE-US-00001\" num=\"00001\">\\n'\n",
      " '<table frame=\"none\" colsep=\"0\" rowsep=\"0\" pgwide=\"1\">\\n'\n",
      " '<tgroup align=\"left\" colsep=\"0\" rowsep=\"0\" cols=\"2\">\\n'\n",
      " '<colspec colname=\"1\" colwidth=\"28pt\" align=\"left\"/>\\n'\n",
      " '<colspec colname=\"2\" colwidth=\"371pt\" align=\"left\"/>\\n'\n",
      " '<thead>\\n'\n",
      " '<row>\\n'\n",
      " '<entry namest=\"1\" nameend=\"2\" align=\"center\" rowsep=\"1\"/>\\n'\n",
      " '</row>\\n'\n",
      " '</thead>\\n'\n",
      " '<tbody valign=\"top\">\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1</entry>\\n'\n",
      " '<entry>N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P2</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-(1-propionylpiperidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P3</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P4</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-(1-glycoloylpiperidin-4-yl)-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P5</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P6</entry>\\n'\n",
      " '<entry>N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P7</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[trans-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P8</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{trans-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P9</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{trans-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P10</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-(trans-4-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P11</entry>\\n'\n",
      " '<entry>N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P12</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[cis-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P13</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{cis-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P14</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{cis-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P15</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-(cis-4-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P16</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,3S)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P17</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,3R)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P18</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,3S)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P19</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,3R)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P20</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,2S)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P21</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P22</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P23</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P24</entry>\\n'\n",
      " '<entry>N-[(3S,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P25</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P26</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P27</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P28</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S,5S)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P29</entry>\\n'\n",
      " '<entry>N-[(3S,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P30</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P31</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P32</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P33</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S,5R)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P34</entry>\\n'\n",
      " '<entry>N-[(3R,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P35</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3R,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P36</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P37</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P38</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3R,5R)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P39</entry>\\n'\n",
      " '<entry>N-[(3R,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P40</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3R,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P41</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P42</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P43</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3R,5S)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P44</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P45</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P46</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P47</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P48</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P49</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P50</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P51</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P52</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P53</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3R,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P54</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P55</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P56</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P57</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P58</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3R,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P59</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P60</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P61</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P62</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P63</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P64</entry>\\n'\n",
      " '<entry>N-[(3S*,4R*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P65</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S*,4R*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P66</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S*,4R*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P67</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S*,4R*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P68</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S*,4R*)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P69</entry>\\n'\n",
      " '<entry>N-[(3S*,4S*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P70</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S*,4S*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P71</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S*,4S*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P72</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S*,4S*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P73</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S*,4S*)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P74</entry>\\n'\n",
      " '<entry>N-[(3S*)-1-Acetyl-4,4-dimethylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P75</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S*)-4,4-dimethyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P76</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S*)-1-(methoxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P77</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S*)-1-(hydroxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P78</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S*)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>4,4-dimethylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P79</entry>\\n'\n",
      " '<entry>N-[(7S*)-5-Acetyl-5-azaspiro[2.4]hept-7-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P80</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(7S*)-5-propanoyl-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P81</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(7S*)-5-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P82</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(7S*)-5-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P83</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(7S*)-5-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-azaspiro[2.4]hept-7-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P84</entry>\\n'\n",
      " '<entry>N-[(3R*)-1-Acetyl-4,4-difluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P85</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P86</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P87</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P88</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3R*)-4,4-difluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P89</entry>\\n'\n",
      " '<entry>N-[(1S*,3S*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P90</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P91</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P92</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P93</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3S*)-3-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P94</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P95</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P96</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P97</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P98</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*)-3-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P99</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P100</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P101</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P102</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P103</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P104</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P105</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P106</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P107</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P108</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P109</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,2S)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P110</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,2R)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P111</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P112</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,2R)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P113</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,3R)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P114</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S,3S)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P115</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,3R)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P116</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R,3S)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P117</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-(trans-4-hydroxycyclohexyl)-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P118</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-(cis-4-hydroxycyclohexyl)-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P119</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P120</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P121</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P122</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P123</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P124</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P125</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P126</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P127</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P128</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3R,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P129</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P130</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P131</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P132</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P133</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3S,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P134</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P135</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P136</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P137</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P138</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(3R,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P139</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P140</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,2R*,4R*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P141</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P142</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P143</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P144</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P145</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P146</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P147</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P148</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P149</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P150</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,2R*,4S*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P151</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P152</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P153</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P154</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P155</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,2R*,4R*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P156</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P157</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P158</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P159</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P160</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P161</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P162</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P163</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P164</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P165</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P166</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P167</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P168</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P169</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P170</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P171</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P172</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P173</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P174</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P175</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P176</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P177</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P178</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P179</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P180</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,3R*,4S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P181</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P182</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P183</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P184</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P185</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,3R*,4R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P186</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P187</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P188</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P189</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P190</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,3R*,4R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P191</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P192</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P193</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,3R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P194</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P195</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,3R*,4S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P196</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P197</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P198</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,3R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P199</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P200</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P201</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P202</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P203</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P204</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P205</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P206</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P207</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P208</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P209</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P210</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P211</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P212</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P213</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P214</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P215</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P216</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P217</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P218</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P219</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,3S)-3-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P220</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,3R)-3-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P221</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,3S)-3-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P222</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,3R)-3-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P223</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,2S)-2-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P224</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P225</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P226</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P227</entry>\\n'\n",
      " '<entry>N-[(3S,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P228</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3S,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P229</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P230</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P231</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,5S)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P232</entry>\\n'\n",
      " '<entry>N-[(3S,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P233</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3S,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P234</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P235</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P236</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,5R)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P237</entry>\\n'\n",
      " '<entry>N-[(3R,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P238</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P239</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P240</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P241</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,5R)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P242</entry>\\n'\n",
      " '<entry>N-[(3R,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P243</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3R,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P244</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P245</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P246</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,5S)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P247</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P248</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4S)-4-fluoro-1-propanoylpyrrolidin-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P249</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P250</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P251</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P252</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P253</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4S)-4-fluoro-1-propanoylpyrrolidin-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P254</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P255</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P256</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P257</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P258</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4R)-4-fluoro-1-propanoylpyrrolidin-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P259</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P260</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P261</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P262</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P263</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4R)-4-fluoro-1-propanoylpyrrolidin-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P264</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P265</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P266</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P267</entry>\\n'\n",
      " '<entry>N-[(3S*,4R*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P268</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl)phenyl]-6-methyl-N-[(3S*,4R*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P269</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S*,4R*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P270</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S*,4R*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P271</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S*,4R*)-1-[(2S)-2-hydroxypropanoyl]-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P272</entry>\\n'\n",
      " '<entry>N-[(3S*,4S*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P273</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(3S*,4S*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P274</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S*,4S*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P275</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S*,4S*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P276</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S*,4S*)-1-[(2S)-2-hydroxypropanoyl]-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P277</entry>\\n'\n",
      " '<entry>N-[(3S*)-1-Acetyl-4,4-dimethylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P278</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S*)-4,4-dimethyl-1-propanoylpyrrolidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P279</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S*)-1-(methoxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P280</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S*)-1-(hydroxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P281</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S*)-1-[(2S)-2-hydroxypropanoyl]-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P282</entry>\\n'\n",
      " '<entry>N-[(7S*)-5-Acetyl-5-azaspiro[2.4]hept-7-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P283</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(7S*)-5-propanoyl-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P284</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(7S*)-5-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P285</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(7S*)-5-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P286</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(7S*)-5-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P287</entry>\\n'\n",
      " '<entry>N-[(3R*)-1-Acetyl-4,4-difluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P288</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*)-4,4-difluoro-1-propanoylpyrrolidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P289</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P290</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P291</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R*)-4,4-difluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P292</entry>\\n'\n",
      " '<entry>N-[(1S*,3S*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P293</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P294</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P295</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P296</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3S*)-3-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P297</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P298</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P299</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P300</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P301</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3R*)-3-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P302</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P303</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P304</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P305</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P306</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P307</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P308</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P309</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P310</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P311</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P312</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,2S)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P313</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,2R)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P314</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P315</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,2R)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P316</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,3R)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P317</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S,3S)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P318</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,3R)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P319</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R,3S)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P320</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(trans-4-hydroxycyclohexyl)-6-methyl-5H-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P321</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-(cis-4-hydroxycyclohexyl)-6-methyl-5H-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P322</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P323</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4R)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P324</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P325</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P326</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P327</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P328</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4R)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P329</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P330</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P331</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P332</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P333</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4S)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P334</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P335</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P336</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3S,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P337</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P338</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4S)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P339</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P340</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P341</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(3R,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P342</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P343</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1R*,2R*,4R*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P344</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4R*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P345</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4R*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P346</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4R*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P347</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P348</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P349</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4S*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P350</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4S*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P351</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P352</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P353</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1S*,2R*,4S*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P354</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4S*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P355</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4S*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P356</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,2R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P357</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P358</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1S*,2R*,4R*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P359</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4R*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P360</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4R*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P361</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,2R*,4R*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P362</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P363</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P364</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P365</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P366</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P367</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P368</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P369</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P370</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P371</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P372</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P373</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P374</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P375</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P376</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P377</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P378</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P379</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P380</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P381</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P382</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*4S*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P383</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1S*,3R*,4S*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P384</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4S*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P385</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4S*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P386</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P387</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P388</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1S*,3R*,4R*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P389</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4R*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P390</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4R*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P391</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3R*,4R*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P392</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P393</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1R*,3R*,4R*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P394</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4R*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P395</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4R*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P396</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,3R*,4R*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P397</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P398</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[(1R*,3R*,4S*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P399</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4S*)-4-[(methoxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P400</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4S*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P401</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,3R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P402</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P403</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P404</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P405</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P406</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P407</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(acetylamino)-3-fluolocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P408</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P409</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P410</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P411</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P412</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P413</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P414</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P415</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P416</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P417</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P418</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P419</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P420</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P421</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P422</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,3S)-3-hydroxycyclopentyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P423</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,3R)-3-hydroxycyclopentyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P424</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,3S)-3-hydroxycyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P425</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,3R)-3-hydroxycyclopentyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P427</entry>\\n'\n",
      " '<entry>N-[(3S,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P428</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(3S,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P429</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P430</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P431</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S,5S)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P432</entry>\\n'\n",
      " '<entry>N-[(3S,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P433</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(3S,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P434</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P435</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P436</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S,5R)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P437</entry>\\n'\n",
      " '<entry>N-[(3R,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P438</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(3R,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P439</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P440</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P441</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3R,5R)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P442</entry>\\n'\n",
      " '<entry>N-[(3R,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P443</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(3R,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P444</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P445</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P446</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3R,5S)-1-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P447</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P448</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4S)-4-fluoro-1-propanoylpyrrolidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P449</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P450</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P451</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P452</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P453</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4S)-4-fluoro-1-propanoylpyrrolidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P454</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P455</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P456</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3R,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P457</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P458</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4R)-4-fluoro-1-propanoylpyrrolidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P459</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P460</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P461</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3R,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P462</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P463</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4R)-4-fluoro-1-propanoylpyrrolidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P464</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P465</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P466</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P467</entry>\\n'\n",
      " '<entry>N-[(3S*,4R*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P468</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(3S*,4R*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P469</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S*,4R*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P470</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S*,4R*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P471</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S*,4R*)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P472</entry>\\n'\n",
      " '<entry>N-[(3S*,4S*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P473</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(3S*,4S*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P474</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S*,4S*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P475</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S*,4S*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P476</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S*,4S*)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P477</entry>\\n'\n",
      " '<entry>N-[(3S*)-1-Acetyl-4,4-dimethylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P478</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S*)-4,4-dimethyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P479</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S*)-1-(methoxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P480</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S*)-1-(hydroxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P481</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S*)-1-[(2S)-2-hydroxypropanoyl]-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P482</entry>\\n'\n",
      " '<entry>N-[(7S*)-5-Acetyl-5-azaspiro[2.4]hept-7-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P483</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(7S*)-5-propanoyl-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P484</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(7S*)-5-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P485</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(7S)-5-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P486</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(7S*)-5-[(2S)-2-hydroxypropanoyl]-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P487</entry>\\n'\n",
      " '<entry>N-[(3R*)-1-Acetyl-4,4-difluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P488</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R*)-4,4-difluoro-1-propanoylpyrrolidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P489</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P490</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P491</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3R*)-4,4-difluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P492</entry>\\n'\n",
      " '<entry>N-[(1S*,3S*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P493</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P494</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P495</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P496</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3S*)-3-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P497</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P498</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P499</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P500</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P501</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3R*)-3-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P502</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P503</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P504</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P505</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P506</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclopentyl]-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P507</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P508</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P509</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P510</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P511</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P512</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,2S)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P513</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,2R)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P514</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P515</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,2R)-2-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P516</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,3R)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P517</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S,3S)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P518</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,3R)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P519</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R,3S)-3-hydroxycyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P520</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(trans-4-hydroxycyclohexyl)-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P521</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-(cis-4-hydroxycyclohexyl)-6-methyl-5H-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P522</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P523</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4R)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P524</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P525</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P526</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P527</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P528</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4R)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P529</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P530</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P531</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3R,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P532</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P533</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4S)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P534</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P535</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P536</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3S,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P537</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P538</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4S)-3-fluoro-1-propanoylpiperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P539</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P540</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P541</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(3R,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P542</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P543</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1R*,2R*,4R*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P544</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P545</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R,2R,4R)-4-[(hydroxyacetyl)amino]-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P546</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4R*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P547</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P548</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P549</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P550</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P551</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P552</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P553</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1S*,2R*,4S*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P554</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4S*)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P555</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4S*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P556</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,2R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P557</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P558</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1S*,2R*,4R*)-2-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P559</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P560</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P561</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,2R*,4R*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P562</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P563</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P564</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P565</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P566</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P567</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P568</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P569</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P570</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P571</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P572</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P573</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P574</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P575</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P576</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P577</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P578</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P579</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P580</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P581</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P582</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P583</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1S*,3R*,4S*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P584</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P585</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4S*)-4-[(hydroxyacetyl)amino]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P586</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P587</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P588</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1S*,3R*,4R*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P589</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P590</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P591</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3R*,4R*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P592</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P593</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1R*,3R*,4R*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P594</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P595</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P596</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,3R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P597</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P598</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[(1R*,3R*,4S*)-3-methyl-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P599</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P600</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P601</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,3R*,4S*)-4-{[(2S)-2-hydroxypropanoyl]amino}-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P602</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P603</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P604</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P605</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P606</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P607</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P608</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P609</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P610</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P611</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P612</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P613</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P614</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P615</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P616</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P617</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P618</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P619</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P620</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P621</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P622</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,3S)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P623</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,3R)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P624</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,3S)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P625</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,3R)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P627</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,2S)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P628</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,2R)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxycyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P629</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P630</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P631</entry>\\n'\n",
      " '<entry>N-[(3S,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P632</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(3S,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P633</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P634</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P635</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S,5S)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P636</entry>\\n'\n",
      " '<entry>N-[(3S,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P637</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(3S,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P638</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P639</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P640</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S,5R)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P641</entry>\\n'\n",
      " '<entry>N-[(3R,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P642</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(3R,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P643</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P644</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P645</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3R,5R)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P646</entry>\\n'\n",
      " '<entry>N-[(3R,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P647</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(3R,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P648</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P649</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P650</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3R,5S)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P651</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P652</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P653</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P654</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P655</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P656</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P657</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P658</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P659</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P660</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3R,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P661</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P662</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P663</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P664</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P665</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3R,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P666</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P667</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P668</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P669</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P670</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P671</entry>\\n'\n",
      " '<entry>N-[(3S*,4R*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P672</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(3S*,4R*)-4-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P673</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S*,4R*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P674</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S*,4R*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P675</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S*,4R*)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P676</entry>\\n'\n",
      " '<entry>N-[(3S*,4S*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P677</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(3S*,4S*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P678</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S*,4S*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P679</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S*,4S*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P680</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S*,4S*)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P681</entry>\\n'\n",
      " '<entry>N-[(3S*)-1-Acetyl-4,4-dimethylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P682</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S*)-4,4-dimethyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P683</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S*)-1-(methoxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P684</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S*)-1-(hydroxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P685</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S*)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>4,4-dimethylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P686</entry>\\n'\n",
      " '<entry>N-[(7S*)-5-Acetyl-5-azaspiro[2.4]hept-7-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P687</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(7S*)-5-propanoyl-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P688</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(7S*)-5-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P689</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(7S*)-5-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P690</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(7S*)-5-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5-azaspiro[2.4]hept-7-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P691</entry>\\n'\n",
      " '<entry>N-[(3R*)-1-Acetyl-4,4-difluoropyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P692</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P693</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P694</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P695</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3R*)-4,4-difluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P696</entry>\\n'\n",
      " '<entry>N-[(1S*,3S*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P697</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P698</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P699</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P700</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3S*)-3-{[(2S)-2-hydroxypropanoyl]amino}cyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P701</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P702</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P703</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P704</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P705</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3R*)-3-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P706</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P707</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P708</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P709</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P710</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P711</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P712</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P713</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P714</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P715</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P716</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,2S)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P717</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,2R)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P718</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P719</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,2R)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P720</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,3R)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P721</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S,3S)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P722</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,3R)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P723</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R,3S)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P724</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(trans-4-hydroxycyclohexyl)-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P725</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(cis-4-hydroxycyclohexyl)-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P726</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P727</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P728</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P729</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P730</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P731</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P732</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P733</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P734</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P735</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3R,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P736</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P737</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P738</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P739</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P740</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3S,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P741</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P742</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P743</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P744</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P745</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(3R,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P746</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P747</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1R*,2R*,4R*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P748</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P749</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P750</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P751</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P752</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P753</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P754</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P755</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P756</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P757</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1S*,2R*,4S*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P758</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P759</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P760</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P761</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P762</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1S*,2R*,4R*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P763</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P764</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P765</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,2R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P766</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P767</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P768</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P769</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P770</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P771</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P772</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P773</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P774</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P775</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P776</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P777</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P778</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P779</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P780</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P781</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P782</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P783</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P784</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P785</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P786</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P787</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1S*,3R*,4S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P788</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P789</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P790</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P791</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P792</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1S*,3R*,4R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P793</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P794</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P795</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P796</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P797</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1R*,3R*,4R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P798</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P799</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P800</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,3R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P801</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P802</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[(1R*,3R*,4S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P803</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P804</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P805</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,3R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P806</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P807</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P808</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P809</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P810</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P811</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P812</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P813</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P814</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P815</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P816</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P817</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P818</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P819</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P820</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P821</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P822</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P823</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P824</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P825</entry>\\n'\n",
      " '<entry>4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P826</entry>\\n'\n",
      " '<entry>N-(1-Acetylpiperidin-4-yl)-4-[6-(cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P827</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-(1-propanoylpiperidin-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P828</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[1-(methoxyacetyl)piperidin-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P829</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[1-(hydroxyacetyl)piperidin-4-yl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P830</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P831</entry>\\n'\n",
      " '<entry>N-[trans-4-(Acetylamino)cyclohexyl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P832</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[trans-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P833</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{trans-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P834</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{trans-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P835</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-(trans-4-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P836</entry>\\n'\n",
      " '<entry>N-[cis-4-(Acetylamino)cyclohexyl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P837</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[cis-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P838</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{cis-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P839</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{cis-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P840</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-(cis-4-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P841</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,3S)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P842</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,3R)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P843</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,3S)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P844</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,3R)-3-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P845</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,2S)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P846</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,2R)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P847</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,2S)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P848</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,2R)-2-hydroxycyclopentyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P849</entry>\\n'\n",
      " '<entry>N-[(3S,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P850</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(3S,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P851</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P852</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P853</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S,5S)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P854</entry>\\n'\n",
      " '<entry>N-[(3S,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P855</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(3S,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P856</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P857</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P858</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S,5R)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P859</entry>\\n'\n",
      " '<entry>N-[(3R,5R)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P860</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(3R,5R)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P861</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,5R)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P862</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,5R)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P863</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3R,5R)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P864</entry>\\n'\n",
      " '<entry>N-[(3R,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P865</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(3R,5S)-5-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P866</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,5S)-1-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P867</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,5S)-1-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P868</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3R,5S)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P869</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P870</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P871</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P872</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P873</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P874</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P875</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P876</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P877</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4S)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P878</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3R,4S)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P879</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P880</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P881</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P882</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P883</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3R,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P884</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-4-fluoropyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P885</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P886</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P887</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4R)-4-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P888</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S,4R)-4-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P889</entry>\\n'\n",
      " '<entry>N-[(3S*,4R*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P890</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(3S*,4R*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P891</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S*,4R*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P892</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S*,4R*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P893</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S*,4R*)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P894</entry>\\n'\n",
      " '<entry>N-[(3S*,4S*)-1-Acetyl-4-methylpyrrolidin-3-yl]-4-[6-(Cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P895</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(3S*,4S*)-4-methyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P896</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S*,4S*)-1-(methoxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P897</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S*,4S*)-1-(hydroxyacetyl)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P898</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S*,4S*)-1-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-4-methylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P899</entry>\\n'\n",
      " '<entry>N-[(3S*)-1-Acetyl-4,4-dimethylpyrrolidin-3-yl]-4-[6-(Cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P900</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S*)-4,4-dimethyl-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P901</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S*)-1-(methoxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P902</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S*)-1-(hydroxyacetyl)-4,4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>dimethylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P903</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S*)-1-[(2S)-2-hydroxypropanoyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>4,4-dimethylpyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P904</entry>\\n'\n",
      " '<entry>N-[(7S*)-5-Acetyl-5-azaspiro[2.4]hept-7-yl]-4-[6-(Cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P905</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(7S*)-5-propanoyl-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P906</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(7S*)-5-(methoxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P907</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(7S)-5-(hydroxyacetyl)-5-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>azaspiro[2.4]hept-7-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P908</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(7S*)-5-[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]-5-azaspiro[2.4]hept-7-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P909</entry>\\n'\n",
      " '<entry>N-[(3R*)-1-Acetyl-4,4-difluoropyrrolidin-3-yl]-4-[6-(Cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P910</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P911</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P912</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R*)-4,4-difluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P913</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3R*)-4,4-difluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]pyrrolidin-3-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P914</entry>\\n'\n",
      " '<entry>N-[(1S*,3S*)-3-(Acetylamino)cyclopentyl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P915</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P916</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P917</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P918</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3S*)-3-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P919</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*)-3-(Acetylamino)cyclopentyl]-4-[6-(Cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P920</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P921</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P922</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P923</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3R*)-3-{[(2S)-2-hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P924</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P925</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P926</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P927</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P928</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P929</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P930</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P931</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P932</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P933</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P934</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,2S)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P935</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,2R)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P926</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P937</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,2R)-2-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P938</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,3R)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P939</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S,3S)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P940</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,3R)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P941</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R,3S)-3-hydroxycyclohexyl]-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P942</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-(trans-4-hydroxycyclohexyl)-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P943</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-(cis-4-hydroxycyclohexyl)-6-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P944</entry>\\n'\n",
      " '<entry>N-[(3S,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P945</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P946</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P947</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P948</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P949</entry>\\n'\n",
      " '<entry>N-[(3R,4R)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P950</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P951</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P952</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4R)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P953</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3R,4R)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P954</entry>\\n'\n",
      " '<entry>N-[(3S,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P955</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P956</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P957</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3S,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P958</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3S,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P959</entry>\\n'\n",
      " '<entry>N-[(3R,4S)-1-Acetyl-3-fluoropiperidin-4-yl]-4-[6-(cyclopropylmethoxy)-2-fluoro-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P960</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>propanoylpiperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P961</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P962</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(3R,4S)-3-fluoro-1-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(hydroxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P963</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(3R,4S)-3-fluoro-1-[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]piperidin-4-yl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P964</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P965</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1R*,2R*,4R*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P966</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P967</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P968</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P969</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P970</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P971</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P972</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P973</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P974</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(acetylamino)-2-methylcyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P975</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1S*,2R*,4S*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P976</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P977</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P978</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,2R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P979</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P980</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1S*,2R*,4R*)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P981</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P982</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4R*)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P983</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,2R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-2-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P984</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P985</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P986</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P987</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P988</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P989</entry>\\n'\n",
      " '<entry>N-[(1R*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P990</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P991</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P992</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P993</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,2R*,4S*)-2-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P994</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P994</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P996</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P997</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P998</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P999</entry>\\n'\n",
      " '<entry>N-[(1S*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1000</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1001</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1002</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,2R*,4R*)-2-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1003</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,2R*,4R*)-2-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1004</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-methylcyclohexyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1005</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1S*,3R*,4S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1006</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1007</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4S*)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1008</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1009</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1010</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1S*,3R*,4R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1011</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4R*)-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1012</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1013</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1014</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(acetylamino)-3-methylcyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1015</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1R*,3R*,4R*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1016</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4R*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1017</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4R*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1018</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,3R*,4R*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1019</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1020</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-6-methyl-N-[(1R*,3R*,4S*)-3-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1021</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4S*)-4-[(methoxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1022</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4S*)-4-[(hydroxy-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>acetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1023</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,3R*,4S*)-4-{[(2S)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>hydroxypropanoyl]amino}-3-methylcyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1024</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4S*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1025</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1026</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1027</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1028</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1029</entry>\\n'\n",
      " '<entry>N-[(1S*,3R*,4R*)-4-(acetylamino)-3-fluorocyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1030</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1031</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1032</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1S*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1033</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1S*,3R*,4R*)-3-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1034</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4R*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[6-(Cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1035</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1036</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1037</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4R*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1038</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,3R*,4R*)-3-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1039</entry>\\n'\n",
      " '<entry>N-[(1R*,3R*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[6-(cyclopropylmethoxy)-2-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>fluoro-3-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1040</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1041</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1042</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-{(1R*,3R*,4S*)-3-fluoro-4-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1043</entry>\\n'\n",
      " '<entry>4-[6-(Cyclopropylmethoxy)-2-fluoro-3-methylphenyl]-N-[(1R*,3R*,4S*)-3-fluoro-4-{[(2S)-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>2-hydroxypropanoyl]amino}cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1044</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2S*)-2-fluorocyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1045</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*)-2-fluorocyclopentyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1046</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2S*)-2-fluorocyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1047</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-[(1R*,2R*)-2-fluorocyclohexyl]-6-methyl-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1048</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-(trans-4-fluorocyclohexyl)-6-methyl-5H-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry>P1049</entry>\\n'\n",
      " '<entry>4-[2-(cyclopropylmethoxy)-5-methylphenyl]-N-(cis-4-fluorocyclohexyl)-6-methyl-5H-</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry/>\\n'\n",
      " '<entry>pyrrolo[3,2-d]pyrimidine-7-carboxamide</entry>\\n'\n",
      " '</row>\\n'\n",
      " '<row>\\n'\n",
      " '<entry namest=\"1\" nameend=\"2\" align=\"center\" rowsep=\"1\"/>\\n'\n",
      " '</row>\\n'\n",
      " '</tbody>\\n'\n",
      " '</tgroup>\\n'\n",
      " '</table>\\n'\n",
      " '</tables>\\n'\n",
      " '<br/>\\n'\n",
      " 'a salt thereof, or a stereoisomer of the compound or a salt thereof.\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-2232\" num=\"4036\">The following compounds of the above table are '\n",
      " 'prepared analogously to the procedure described in above example E1.</p>\\n'\n",
      " '<heading id=\"h-1390\" level=\"1\">Example P1</heading>\\n'\n",
      " '<heading id=\"h-1391\" '\n",
      " 'level=\"1\">N-(1-Acetylpiperidin-4-yl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2233\" num=\"4037\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f60) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2234\" num=\"4038\">HR-MS (ESI): m/z=498.2303 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>30</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 498.2311).</p>\\n'\n",
      " '<heading id=\"h-1392\" level=\"1\">Example P2</heading>\\n'\n",
      " '<heading id=\"h-1393\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-(1-propanoylpiperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2235\" num=\"4039\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f60) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2236\" num=\"4040\">HR-MS (ESI): m/z=512.2453 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 512.2468).</p>\\n'\n",
      " '<heading id=\"h-1394\" level=\"1\">Example P3</heading>\\n'\n",
      " '<heading id=\"h-1395\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[1-(methoxyacetyl)piperidin-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2237\" num=\"4041\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-(piperidin-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f60) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2238\" num=\"4042\">HR-MS (ESI): m/z=528.2394 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 528.2417).</p>\\n'\n",
      " '<heading id=\"h-1396\" level=\"1\">Example P6</heading>\\n'\n",
      " '<heading id=\"h-1397\" '\n",
      " 'level=\"1\">N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2239\" num=\"4043\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f61) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2240\" num=\"4044\">HR-MS (ESI): m/z=512.2457 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 512.2468).</p>\\n'\n",
      " '<heading id=\"h-1398\" level=\"1\">Example P7</heading>\\n'\n",
      " '<heading id=\"h-1399\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5<sup>H</sup>-pyrrolo[3,2-<sup>d</sup>]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2241\" num=\"4045\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f61) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2242\" num=\"4046\">HR-MS (ESI): m/z=526.2621 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 526.2624).</p>\\n'\n",
      " '<heading id=\"h-1400\" level=\"1\">Example P8</heading>\\n'\n",
      " '<heading id=\"h-1401\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2243\" num=\"4047\">Starting from '\n",
      " 'N-(trans-4-aminocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f61) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2244\" num=\"4048\">HR-MS (ESI): m/z=542.2571 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 542.2573).</p>\\n'\n",
      " '<heading id=\"h-1402\" level=\"1\">Example P24</heading>\\n'\n",
      " '<heading id=\"h-1403\" '\n",
      " 'level=\"1\">N-[(3S,5S)-1-Acetyl-5-methylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2245\" num=\"4049\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S*,5S*)-5-methylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f66) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2246\" num=\"4050\">HR-MS (ESI): m/z=498.2316 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>30</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 498.2311).</p>\\n'\n",
      " '<heading id=\"h-1404\" level=\"1\">Example P25</heading>\\n'\n",
      " '<heading id=\"h-1405\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S,5S)-5-methyl-1-propanoylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2247\" num=\"4051\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S*,5S*)-5-methylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f66) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2248\" num=\"4052\">HR-MS (ESI): m/z=512.2466 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 512.2468).</p>\\n'\n",
      " '<heading id=\"h-1406\" level=\"1\">Example P26</heading>\\n'\n",
      " '<heading id=\"h-1407\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(3S,5S)-1-(methoxyacetyl)-5-methylpyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2249\" num=\"4053\">Starting from '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(3S*,5S*)-5-methylpyrrolidin-3-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f66) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2250\" num=\"4054\">HR-MS (ESI): m/z=528.2411 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 528.2417).</p>\\n'\n",
      " '<heading id=\"h-1408\" level=\"1\">Example P89</heading>\\n'\n",
      " '<heading id=\"h-1409\" '\n",
      " 'level=\"1\">N-[(1S,3S)-3-(Acetylamino)cyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2251\" num=\"4055\">Starting from '\n",
      " 'N-[(1S,3S)-3-aminocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f64) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2252\" num=\"4056\">HR-MS (ESI): m/z=498.2305 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>25</sub>H<sub>30</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 498.2311).</p>\\n'\n",
      " '<heading id=\"h-1410\" level=\"1\">Example P90</heading>\\n'\n",
      " '<heading id=\"h-1411\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S,3S)-3-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2253\" num=\"4057\">Starting from '\n",
      " 'N-[(1S,3S)-3-aminocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f64) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2254\" num=\"4058\">HR-MS (ESI): m/z=512.2474 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 512.2468).</p>\\n'\n",
      " '<heading id=\"h-1412\" level=\"1\">Example P91</heading>\\n'\n",
      " '<heading id=\"h-1413\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S,3S)-3-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2255\" num=\"4059\">Starting from '\n",
      " 'N-[(1S,3S)-3-aminocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f64) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2256\" num=\"4060\">HR-MS (ESI): m/z=528.2418 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 528.2417).</p>\\n'\n",
      " '<heading id=\"h-1414\" level=\"1\">Example P99</heading>\\n'\n",
      " '<heading id=\"h-1415\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2257\" num=\"4061\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-amino-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f71) and commercially available acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2258\" num=\"4062\">HR-MS (ESI): m/z=516.2221 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>26</sub>H<sub>29</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 516.2217).</p>\\n'\n",
      " '<heading id=\"h-1416\" level=\"1\">Example P100</heading>\\n'\n",
      " '<heading id=\"h-1417\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2259\" num=\"4063\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-amino-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f71) and commercially available propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2260\" num=\"4064\">HR-MS (ESI): m/z=530.2375 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 530.2374).</p>\\n'\n",
      " '<heading id=\"h-1418\" level=\"1\">Example P101</heading>\\n'\n",
      " '<heading id=\"h-1419\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2261\" num=\"4065\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-amino-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f71) and commercially available methoxy-acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2262\" num=\"4066\">HR-MS (ESI): m/z=546.2324 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 546.2323).</p>\\n'\n",
      " '<heading id=\"h-1420\" level=\"1\">Example P139</heading>\\n'\n",
      " '<heading id=\"h-1421\" '\n",
      " 'level=\"1\">N-[(1S*,2S*,4S*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2263\" num=\"4067\">Starting from '\n",
      " 'N-[(1S*,2S*,4S*)-4-amino-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f63) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2264\" num=\"4068\">HR-MS (ESI): m/z=526.2625 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 526.2624).</p>\\n'\n",
      " '<heading id=\"h-1422\" level=\"1\">Example P140</heading>\\n'\n",
      " '<heading id=\"h-1423\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,2S*,4S*)-2-methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2265\" num=\"4069\">Starting from '\n",
      " 'N-[(1S*,2S*,4S*)-4-amino-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f63) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2266\" num=\"4070\">HR-MS (ESI): m/z=540.2773 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>29</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 540.2781).</p>\\n'\n",
      " '<heading id=\"h-1424\" level=\"1\">Example P141</heading>\\n'\n",
      " '<heading id=\"h-1425\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2S*,4S*)-4-[(methoxyacetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2267\" num=\"4071\">Starting from '\n",
      " 'N-[(1S*,2S*,4S*)-4-amino-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f63) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2268\" num=\"4072\">HR-MS (ESI): m/z=556.2726 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>29</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 556.2730).</p>\\n'\n",
      " '<heading id=\"h-1426\" level=\"1\">Example P159</heading>\\n'\n",
      " '<heading id=\"h-1427\" '\n",
      " 'level=\"1\">N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2269\" num=\"4073\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f67) and commercially available acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2270\" num=\"4074\">HR-MS (ESI): m/z=530.2386 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 530.2374).</p>\\n'\n",
      " '<heading id=\"h-1428\" level=\"1\">Example P160</heading>\\n'\n",
      " '<heading id=\"h-1429\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2271\" num=\"4075\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f67) and commercially available propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2272\" num=\"4076\">HR-MS (ESI): m/z=544.2539 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 544.2530).</p>\\n'\n",
      " '<heading id=\"h-1430\" level=\"1\">Example P161</heading>\\n'\n",
      " '<heading id=\"h-1431\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2273\" num=\"4077\">Starting from '\n",
      " 'N-[(1R*,2R*,4R*)-4-amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f67) and commercially available methoxy-acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2274\" num=\"4078\">HR-MS (ESI): m/z=560.2487 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>32</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 560.2479).</p>\\n'\n",
      " '<heading id=\"h-1432\" level=\"1\">Example P169</heading>\\n'\n",
      " '<heading id=\"h-1433\" '\n",
      " 'level=\"1\">N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2275\" num=\"4079\">Starting from '\n",
      " 'N-[(1S*,2R*,4S*)-4-amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f73) and commercially available acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2276\" num=\"4080\">HR-MS (ESI): m/z=530.2378 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 530.2374).</p>\\n'\n",
      " '<heading id=\"h-1434\" level=\"1\">Example P170</heading>\\n'\n",
      " '<heading id=\"h-1435\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2277\" num=\"4081\">Starting from '\n",
      " 'N-[(1S*,2R*,4S*)-4-amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f73) and commercially available propionyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2278\" num=\"4082\">HR-MS (ESI): m/z=544.2528 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 544.2530).</p>\\n'\n",
      " '<heading id=\"h-1436\" level=\"1\">Example P171</heading>\\n'\n",
      " '<heading id=\"h-1437\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2279\" num=\"4083\">Starting from '\n",
      " 'N-[(1S*,2R*,4S*)-4-amino-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " '(example D.f73) and commercially available methoxy-acetyl chloride the title '\n",
      " 'compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2280\" num=\"4084\">HR-MS (ESI): m/z=560.2479 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 560.2479).</p>\\n'\n",
      " '<heading id=\"h-1438\" level=\"1\">Example P189</heading>\\n'\n",
      " '<heading id=\"h-1439\" '\n",
      " 'level=\"1\">N-[(1S*,3S*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2281\" num=\"4085\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-4-amino-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f65) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2282\" num=\"4086\">HR-MS (ESI): m/z=540.2788 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>29</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 540.2781).</p>\\n'\n",
      " '<heading id=\"h-1440\" level=\"1\">Example P190</heading>\\n'\n",
      " '<heading id=\"h-1441\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,3S*,4S*)-3-methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2283\" num=\"4087\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-4-amino-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f65) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2284\" num=\"4088\">HR-MS (ESI): m/z=526.2615 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 526.2624).</p>\\n'\n",
      " '<heading id=\"h-1442\" level=\"1\">Example P191</heading>\\n'\n",
      " '<heading id=\"h-1443\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-4-[(methoxyacetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2285\" num=\"4089\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-4-amino-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f65) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2286\" num=\"4090\">HR-MS (ESI): m/z=556.2729 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>29</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 556.2730).</p>\\n'\n",
      " '<heading id=\"h-1444\" level=\"1\">Example P199</heading>\\n'\n",
      " '<heading id=\"h-1445\" '\n",
      " 'level=\"1\">N-[(1S*,3R*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2287\" num=\"4091\">Starting from '\n",
      " 'N-[(1S*,3R*,4S*)-4-amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f72) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2288\" num=\"4092\">HR-MS (ESI): m/z=530.2381 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 530.2374).</p>\\n'\n",
      " '<heading id=\"h-1446\" level=\"1\">Example P200</heading>\\n'\n",
      " '<heading id=\"h-1447\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3R*,4S*)-3-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2289\" num=\"4093\">Starting from '\n",
      " 'N-[(1S*,3R*,4S*)-4-amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f72) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2290\" num=\"4094\">HR-MS (ESI): m/z=544.2525 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 544.2530).</p>\\n'\n",
      " '<heading id=\"h-1448\" level=\"1\">Example P201</heading>\\n'\n",
      " '<heading id=\"h-1449\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3R*,4S*)-3-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2291\" num=\"4095\">Starting from '\n",
      " 'N-[(1S*,3R*,4S*)-4-amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f72) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2292\" num=\"4096\">HR-MS (ESI): m/z=560.2478 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 560.2479).</p>\\n'\n",
      " '<heading id=\"h-1450\" level=\"1\">Example P209</heading>\\n'\n",
      " '<heading id=\"h-1451\" '\n",
      " 'level=\"1\">N-[(1S*,3S*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2293\" num=\"4097\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-4-amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f62) and commercially available acetyl chloride the '\n",
      " 'title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2294\" num=\"4098\">HR-MS (ESI): m/z=530.2359 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 530.2374).</p>\\n'\n",
      " '<heading id=\"h-1452\" level=\"1\">Example P210</heading>\\n'\n",
      " '<heading id=\"h-1453\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3S*,4S*)-3-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2295\" num=\"4099\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-4-amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f62) and commercially available propionyl chloride '\n",
      " 'the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2296\" num=\"4100\">HR-MS (ESI): m/z=544.2536 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, '\n",
      " 'calc. 544.2530).</p>\\n'\n",
      " '<heading id=\"h-1454\" level=\"1\">Example P211</heading>\\n'\n",
      " '<heading id=\"h-1455\" '\n",
      " 'level=\"1\">4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-3-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide</heading>\\n'\n",
      " '<p id=\"p-2297\" num=\"4101\">Starting from '\n",
      " 'N-[(1S*,3S*,4S*)-4-amino-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide '\n",
      " 'hydrochloride (example D.f62) and commercially available methoxy-acetyl '\n",
      " 'chloride the title compound is obtained as colorless solid.</p>\\n'\n",
      " '<p id=\"p-2298\" num=\"4102\">HR-MS (ESI): m/z=560.2466 ([MH]<sup>+</sup>, '\n",
      " 'C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub><sup>+</sup>, '\n",
      " 'calc. 560.2479).</p>\\n'\n",
      " '<p id=\"h-1456\" num=\"0000\">Commercial Utility</p>\\n'\n",
      " '<p id=\"p-2299\" num=\"4103\">The compounds of formula (I), the salts thereof, '\n",
      " 'and the stereoisomers of the compounds and the salts thereof are hereinafter '\n",
      " 'referred to as the compounds of the present subject matter. In particular, '\n",
      " 'the compounds of the present subject matter are pharmaceutically '\n",
      " 'acceptable.</p>\\n'\n",
      " '<p id=\"p-2300\" num=\"4104\">The compounds of the present subject matter have '\n",
      " 'valuable pharmaceutical properties which make them commercially utilizable. '\n",
      " 'In particular, as type 5 phosphodiesterase (PDE5) inhibitors, they are able '\n",
      " 'to influence the physiological and pathophysiological function of various '\n",
      " 'cells, e.g., but not limited to, smooth muscle cells, fibroblasts, '\n",
      " 'myofibroblasts and platelets, which are involved in a great variety of '\n",
      " 'physiological and pathophysiological mechanisms. In particular, the PDE5 '\n",
      " 'inhibiting compounds of the present subject matter can effect relaxation of '\n",
      " 'the vasculature, thus increasing blood flow, improve the spatial balance '\n",
      " 'between blood perfusion and ventilation within the lung '\n",
      " '(&#x201c;re-matching&#x201d; effect) thereby reducing the amount of '\n",
      " 'so-called low V/Q-areas [areas within the lung with high perfusion (Q) but '\n",
      " 'no or reduced ventilation (V)] and high V/Q-areas (areas within the lung '\n",
      " 'with low perfusion but high ventilation), induce neurogenesis, inhibit '\n",
      " 'platelet function, such as aggregation, adhesion and mediator release and, '\n",
      " 'thus, have an anti-inflammatory effect. The compounds of the present subject '\n",
      " 'matter are distinguished by valuable and desirable properties, such as, for '\n",
      " 'example, high efficacy, low toxicity, superior bioavailability in general '\n",
      " '(e.g. good enteral absorption), superior therapeutic window, superior '\n",
      " 'pharmacokinetics (e.g. half-life), absence of significant side effects, and '\n",
      " 'further beneficial effects related with their therapeutic and pharmaceutical '\n",
      " 'suitability.</p>\\n'\n",
      " '<p id=\"p-2301\" num=\"4105\">Accordingly, the present subject matter further '\n",
      " 'relates to the compounds of the present subject matter for the treatment or '\n",
      " 'prophylaxis of diseases, especially diseases alleviated by inhibition of the '\n",
      " 'type 5 phosphodiesterase. In particular, the present subject matter relates '\n",
      " 'to the compounds of the present subject matter for the treatment or '\n",
      " 'prophylaxis of the following diseases: male and female sexual dysfunction, '\n",
      " 'such as, but not limited to, male erectile dysfunction, premature '\n",
      " \"ejaculation, Peyronie's disease;</p>\\n\"\n",
      " '<p id=\"p-2302\" num=\"4106\">acute and chronic airway diseases, such as, but '\n",
      " 'not limited to, COPD (chronic obstructive pulmonary disease), bronchitis, '\n",
      " 'emphysema, pulmonary vascular remodeling, pulmonary hypertension, lung '\n",
      " 'fibrosis, idiopathic pulmonary lung fibrosis (IPF), asthma, cystic fibrosis, '\n",
      " 'bronchiectasis, bronchiolitis obliterans, connective tissue diseases, '\n",
      " 'sarcoidosis, kyphoscoliosis, pneumoconiosis, amyotrophic lateral sclerosis, '\n",
      " 'thoracoplasty, extrinsic allergic alveolitis; inflammatory diseases, such '\n",
      " 'as, but not limited to, vasculature inflammation, acute respiratory distress '\n",
      " 'syndrome, nephritis, mesangial glomerulonephritis, chronic inflammatory '\n",
      " 'bowel disease, disseminated intravascular inflammation, allergic vasculitis, '\n",
      " 'dermatoses (e.g., but not limited to, psoriasis, toxic and allergic contact '\n",
      " 'eczema, atopic eczema, seborrhoeic eczema, Lichen simplex, sunburn, pruritus '\n",
      " 'in the anogenital area, alopecia areata, hypertrophic scars, discoid lupus '\n",
      " 'erythematosus, follicular and widespread pyodermias, endogenous and '\n",
      " 'exogenous acne, acne rosacea), disorders of the arthritis type (e.g., but '\n",
      " 'not limited to, rheumatoid arthritis, rheumatoid spondylitis, '\n",
      " 'osteoarthritis), disorders of the immune system [e.g., but not limited to, '\n",
      " 'AIDS (acquired immunodeficiency syndrome), multiple sclerosis], graft versus '\n",
      " 'host reaction, allograft rejections, shock [e.g., but not limited to, septic '\n",
      " 'shock, endotoxin shock, gram-negative sepsis shock, toxic shock syndrome and '\n",
      " 'ARDS (adult respiratory distress syndrome)], gastrointestinal inflammations '\n",
      " \"(e.g., but not limited to, Crohn's disease and ulcerative colitis); \"\n",
      " 'disorders which are based on allergic and/or chronic, immunological false '\n",
      " 'reactions (e.g., but not limited to, allergic rhinitis, allergic sinusitis, '\n",
      " 'chronic rhinitis, chronic sinusitis, allergic conjunctivitis, nasal polyps); '\n",
      " 'pain, such as, but not limited to, inflammatory pain;\\n'\n",
      " '<br/>\\n'\n",
      " 'right-heart failure, right heart hypertrophy (cor pulmonale), hypertension, '\n",
      " 'hypercholesterolemia,\\n'\n",
      " '<br/>\\n'\n",
      " 'hypertriglyceridemia;\\n'\n",
      " '<br/>\\n'\n",
      " 'ischaemic diseases, such as, but not limited to, diabetes mellitus, stroke, '\n",
      " 'coronary artery disease, angina (including, but not limited to, vasospastic '\n",
      " 'angina), myocardial infarction, peripheral artery disease, cerebrovascular '\n",
      " 'obstruction, sleep apnea, macular ischaemia, arterial and venous occlusion, '\n",
      " 'congestive heart failure;\\n'\n",
      " '<br/>\\n'\n",
      " 'diabetic gastroparesis and diseases with symptoms of gastroparesis;\\n'\n",
      " '<br/>\\n'\n",
      " 'diseases or conditions in which it is desirable to suppress platelet '\n",
      " 'function, for example, but not limited to, after stent implantations (e.g., '\n",
      " 'but not limited to, coronary stenting), after bypass operations, in '\n",
      " 'pulmonary hypertension, thrombotic diseases, post-angioplasty stenosis, '\n",
      " 'coronary artery disease, infarction (e.g., but not limited to, myocardial '\n",
      " 'infarction), instable angina pectoris, stroke, and arterial and venous '\n",
      " 'occlusion diseases (e.g., but not limited to, claudicatio intermittens); '\n",
      " 'diseases or conditions with an impairment or dysfunction of cerebral '\n",
      " 'vascular reactivity and/or neurovascular coupling, such as, but not limited '\n",
      " 'to, arteriosclerotic dementia, multiinfarct dementia, cerebral senility;\\n'\n",
      " '<br/>\\n'\n",
      " 'diseases which are based on neuronal damage or degradation, such as but not '\n",
      " 'limited to, stroke, spinal cord injury, brain injury, morbus parkinson, '\n",
      " 'amyotrophic lateral sclerosis, morbus alzheimer, amyloidosis, prion diseases '\n",
      " 'and neuropathy;\\n'\n",
      " '<br/>\\n'\n",
      " 'peripheral arterial diseases, chronic renal failure, chronic heart failure, '\n",
      " \"sepsis, senile dementia (Alzheimer's disease), Creutzfeld-Jacob disease, \"\n",
      " 'septic encephalopathy, arteriosclerotic encephalopathy, diabetes associated '\n",
      " 'encephalopathy, toxic encephalopathy, vascular and neuronal dementia, '\n",
      " \"Huntington's disease, Parkinson's disease, multiple sclerosis and \"\n",
      " 'preeclampsia;\\n'\n",
      " '<br/>\\n'\n",
      " 'portal hypertension, liver cirrhosis, toxic liver damage (e.g., but not '\n",
      " 'limited to, alcohol-induced liver damage), hepatitis, thrombosis of the '\n",
      " 'portal vein, Budd-Chiari syndrome, malformation of liver veins, compression '\n",
      " 'of liver veins (e.g., but without limitation, due to tumors), arteriovenous '\n",
      " 'fistula, diseases associated with an enlarged spleen, schistosomiasis '\n",
      " '(bilharziosis), sarcoidosis and other granulomatous diseases, primary '\n",
      " 'biliary cirrhosis, myeloproliferative disorders (e.g., but not limited to, '\n",
      " 'chronic myeloid leukemia, osteomyelofibrosis), lymphatic systemic diseases, '\n",
      " 'collagenosis (e.g., but not limited to, systemic lupus erythematodes, '\n",
      " 'sclerodermia), morbus Osler (congenital arteriovenous malformations, inter '\n",
      " 'alia in the liver), nodular regenerative hyperplasia, tricuspid '\n",
      " 'insufficiency, pericarditis constrictive, veno-occlusive disease (VOD), '\n",
      " 'non-alcoholic steatohepatitis (NASH), liver fibrosis;\\n'\n",
      " '<br/>\\n'\n",
      " 'benign prostatic hyperplasia;\\n'\n",
      " '<br/>\\n'\n",
      " 'insufficient uteroplacental blood flow in pregnancies with fetal growth '\n",
      " 'restriction;\\n'\n",
      " '<br/>\\n'\n",
      " 'insufficient brain skills, such as but not limited to, verbal attainment, '\n",
      " 'attention, concentration, deductive thinking, central auditory processing, '\n",
      " 'cognition, learning, vigilance, apprehension and rea-gibility;\\n'\n",
      " '<br/>\\n'\n",
      " 'Overactive Bladder; LUTS=lower urinary tract symptoms; Raynauds '\n",
      " 'syndrome/phenomenon.\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-2303\" num=\"4107\">In this respect, the term &#x201c;pulmonary '\n",
      " 'hypertension&#x201d; in particular embraces\\n'\n",
      " '<ul id=\"ul0110\" list-style=\"none\">\\n'\n",
      " '    <li id=\"ul0110-0001\" num=\"0000\">\\n'\n",
      " '    <ul id=\"ul0111\" list-style=\"none\">\\n'\n",
      " '        <li id=\"ul0111-0001\" num=\"4108\">pulmonary arterial hypertension '\n",
      " 'including primary pulmonary hypertension (e.g. sporadic or familial) and '\n",
      " 'pulmonary arterial hypertension related, for example, but without '\n",
      " 'limitation, to collagen vascular disease, congenital systemic-to-pulmonary '\n",
      " 'shunts, portal hypertension, human immunodeficiency virus infection, drugs '\n",
      " 'or toxins (e.g., but not limited to, anorexigens), persistent pulmonary '\n",
      " 'hypertension of the newborn;</li>\\n'\n",
      " '        <li id=\"ul0111-0002\" num=\"4109\">pulmonary venous hypertension due '\n",
      " 'to, for example, but without limitation, left-sided atrial or ventricular '\n",
      " 'heart disease, left-sided valvular heart disease, extrinsic compression of '\n",
      " 'central pulmonary veins (e.g. fibrosing mediastinitis, adenopathy in '\n",
      " 'relation to tumors), pulmonary veno-occlusive disease;</li>\\n'\n",
      " '        <li id=\"ul0111-0003\" num=\"4110\">pulmonary hypertension associated '\n",
      " 'with disorders of the respiratory system or hypoxemia including, for '\n",
      " 'example, but without limitation, chronic obstructive pulmonary disease '\n",
      " '(COPD), interstitial lung disease, sleep-disordered breathing, alveolar '\n",
      " 'hypoventilation disorders, chronic exposure to high altitude, neonatal lung '\n",
      " 'disease, alveolar-capillary dysplasia;</li>\\n'\n",
      " '        <li id=\"ul0111-0004\" num=\"4111\">pulmonary hypertension caused by '\n",
      " 'chronic thrombotic or embolic diseases including thromboembolic obstruction '\n",
      " 'of proximal pulmonary arteries and obstruction of distal pulmonary arteries, '\n",
      " 'such as pulmonary embolism (due to thrombus, tumor, ova, parasites, or '\n",
      " 'foreign material), in situ thrombosis and sickle-cell disease, in particular '\n",
      " 'chronic thromboembolic pulmonary hypertension (CTEPH);</li>\\n'\n",
      " '        <li id=\"ul0111-0005\" num=\"4112\">pulmonary hypertension caused by '\n",
      " 'disorders directly affecting the pulmonary vasculature including '\n",
      " 'inflammatory disorders (e.g., but not limited to, schistosomiasis, '\n",
      " 'sarcoidosis) and pulmonary capillary hemangiomatosis.</li>\\n'\n",
      " '    </ul>\\n'\n",
      " '    </li>\\n'\n",
      " '</ul>\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-2304\" num=\"4113\">Preferably, the present subject matter further '\n",
      " 'relates to the compounds of the present subject matter for the treatment or '\n",
      " 'prophylaxis of the following diseases, especially diseases alleviated by '\n",
      " 'inhibition of the type 5 phosphodiesterase: acute and chronic airway '\n",
      " 'diseases, such as pulmonary hypertension, in particular chronic '\n",
      " 'thromboembolic pulmonary hypertension, lung fibrosis, sarcoidosis, asthma, '\n",
      " 'bronchitis, emphysema and chronic obstructive pulmonary disease.</p>\\n'\n",
      " '<p id=\"p-2305\" num=\"4114\">Beside the inhibition of type 5 phosphodiesterase '\n",
      " 'some of the compounds of the present subject matter have also substantial '\n",
      " 'activity in inhibition of type 4 phosphodiesterase and thus have valuable '\n",
      " 'pharmaceutical properties, which make them commercially utilizable.</p>\\n'\n",
      " '<p id=\"p-2306\" num=\"4115\">PDE4 inhibitors are thought to be useful in the '\n",
      " 'treatment or prophylaxis of a variety of diseases and disorders. They are '\n",
      " 'thought to be suitable on the one hand as bronchial therapeutics (for the '\n",
      " 'treatment of airway obstructions on account of their dilating action but '\n",
      " 'also on account of their respiratory rate- or respiratory drive-increasing '\n",
      " 'action) and for the removal of erectile dysfunction on account of their '\n",
      " 'vascular dilating action, but on the other hand especially for the treatment '\n",
      " 'of disorders, in particular of an inflammatory nature, e.g. of the airways, '\n",
      " 'of the skin, of the intestine, of the eyes, of the CNS and of the joints, '\n",
      " 'which are mediated by mediators such as histamine, PAF (platelet-activating '\n",
      " 'factor), arachidonic acid derivatives such as leukotrienes and '\n",
      " 'prostaglandins, cytokines, interleukins, chemokines, alpha-, beta- and '\n",
      " 'gamma-interferon, tumor necrosis factor (TNF) or oxygen free radicals and '\n",
      " 'proteases.</p>\\n'\n",
      " '<p id=\"p-2307\" num=\"4116\">Thus, PDE4 inhibitors are thought to be useful in '\n",
      " 'the treatment or prophylaxis of a variety of diseases and disorders, such as '\n",
      " 'for example:</p>\\n'\n",
      " '<p id=\"h-1457\" num=\"0000\">acute and chronic airway diseases, such as, but '\n",
      " 'not limited to, bronchitis, allergic bronchitis, asthma, emphysema, COPD '\n",
      " '(chronic obstructive pulmonary disease), sarcoidosis, pulmonary hypertension '\n",
      " 'and lung fibrosis;</p>\\n'\n",
      " '<p id=\"p-2308\" num=\"4117\">diseases which are based on allergic and/or '\n",
      " 'chronic, immunological false reactions in the region of the upper airways '\n",
      " '(pharynx, nose) and the adjacent regions (paranasal sinuses, eyes), such as, '\n",
      " 'but not limited to, allergic rhinitis/sinusitis, chronic rhinitis/sinusitis, '\n",
      " 'allergic conjunctivitis and also nasal polyps;\\n'\n",
      " '<br/>\\n'\n",
      " 'dermatological diseases especially of proliferative, inflammatory and '\n",
      " 'allergic type, such as, but not limited to psoriasis (vulgaris), toxic and '\n",
      " 'allergic contact eczema, atopic dermatitis (eczema), seborrhoeic eczema, '\n",
      " 'Lichen simplex, sunburn, pruritus in the anogenital area, alopecia areata, '\n",
      " 'hypertrophic scars, discoid lupus erythematosus, follicular and widespread '\n",
      " 'pyodermias, endogenous and exogenous acne, acne rosacea and other '\n",
      " 'proliferative, inflammatory and allergic skin disorders;\\n'\n",
      " '<br/>\\n'\n",
      " 'diseases which are based on an excessive release of TNF and leukotrienes, '\n",
      " 'such as, for example, diseases of the arthritis type like rheumatoid '\n",
      " 'arthritis, rheumatoid spondylitis, osteoarthritis and other arthritic '\n",
      " 'conditions;\\n'\n",
      " '<br/>\\n'\n",
      " 'fibrotic diseases, such as, but not limited to, cystic fibrosis, pulmonary '\n",
      " 'fibrosis, hepatic fibrosis and renal fibrosis;\\n'\n",
      " '<br/>\\n'\n",
      " 'viral, alcoholic or drug-induced acute and fulminant hepatitis, hepatic '\n",
      " 'steatosis (alcoholic and non-alcoholic steatio-hepatitis);\\n'\n",
      " '<br/>\\n'\n",
      " 'diseases of the immune system, such as, but not limited to, AIDS, multiple '\n",
      " 'sclerosis, graft versus host reaction, allograft rejections;\\n'\n",
      " '<br/>\\n'\n",
      " 'cachexia, cancer cachexia, AIDS cachexia;\\n'\n",
      " '<br/>\\n'\n",
      " 'types of shock, such as, but not limited to, septic shock, endotoxin shock, '\n",
      " 'gram-negative sepsis, toxic shock syndrome and ARDS (adult respiratory '\n",
      " 'distress syndrome);\\n'\n",
      " '<br/>\\n'\n",
      " \"diseases in the gastrointestinal region, such as Crohn's disease and \"\n",
      " 'ulcerative colitis;\\n'\n",
      " '<br/>\\n'\n",
      " 'diseases of the heart which can be treated by PDE inhibitors, such as '\n",
      " 'cardiac insufficiency;\\n'\n",
      " '<br/>\\n'\n",
      " 'diseases which can be treated on account of the tissue-relaxant action of '\n",
      " 'the PDE inhibitors, such as, for example, erectile dysfunction, colics of '\n",
      " 'the kidneys and of the ureters in connection with kidney stones or oncolytic '\n",
      " 'action (to treat preterm delivery); glomerulonephritis and other urinary '\n",
      " 'tract infections;\\n'\n",
      " '<br/>\\n'\n",
      " 'diabetes insipidus, diabetes mellitus (type I and in particular type II); '\n",
      " 'cancer (in particular lymphoid and myeloid leukaemia); osteoporosis;\\n'\n",
      " '<br/>\\n'\n",
      " 'conditions associated with cerebral metabolic inhibition, such as, but not '\n",
      " \"limited to, cerebral senility, senile dementia (Alzheimer's disease), memory \"\n",
      " \"impairment associated with Parkinson's disease or multiinfarct dementia;\\n\"\n",
      " '<br/>\\n'\n",
      " 'and also diseases of the central nervous system, such as, but not limited '\n",
      " 'to, depressions, anxiety states, spinal cord injury, schizophrenia or '\n",
      " 'arteriosclerotic dementia.\\n'\n",
      " '</p>\\n'\n",
      " '<p id=\"p-2309\" num=\"4118\">Preferably, inhibitors of the type 4 '\n",
      " 'phosphodiesterase are used in the treatment or prophylaxis of the following '\n",
      " 'diseases:</p>\\n'\n",
      " '<p id=\"h-1458\" num=\"0000\">acute and chronic airway diseases, such as '\n",
      " 'bronchitis, allergic bronchitis, asthma, emphysema, COPD, pulmonary '\n",
      " 'hypertension and lung fibrosis;</p>\\n'\n",
      " '<p id=\"h-1459\" num=\"0000\">allergic rhinitis;</p>\\n'\n",
      " '<p id=\"h-1460\" num=\"0000\">and dermatological diseases, such as psoriasis and '\n",
      " 'atopic dermatitis (eczema);</p>\\n'\n",
      " '<p id=\"h-1461\" num=\"0000\">rheumatoid arthritis;</p>\\n'\n",
      " '<p id=\"h-1462\" num=\"0000\">and inflammations in the gastrointestinal region, '\n",
      " \"such as Crohn's disease and ulcerative colitis.</p>\\n\"\n",
      " '<p id=\"p-2310\" num=\"4119\">It is noteworthy that compounds of the present '\n",
      " 'subject matter, which are inhibitors of type 5 phosphodiesterase (PDE5) as '\n",
      " 'well as of type 4 phosphodiesterase (PDE4), mentioned herein as dual type '\n",
      " '4/5 phosphodiesterase inhibitors, are thought to be useful in the treatment '\n",
      " 'or prophylaxis of the above mentioned diseases like inhibitors of the type 5 '\n",
      " 'phosphodiesterase and/or inhibitors of the type 4 phosphodiesterase. Dual '\n",
      " 'type 4/5 phosphodiesterase inhibitors have the potential to be more '\n",
      " 'effective in treatment of distinct disease identities than compounds '\n",
      " 'inhibiting one of those two enzymes only, since inhibition of PDE4 and PDE5 '\n",
      " 'might address divers and different pathophysiologies occurring within one '\n",
      " 'disease as e.g. lung fibrosis. In respect to lung fibrosis it has been '\n",
      " 'described that inhibitors of type 4 phosphodiesterase inhibit TGF-&#x3b2; '\n",
      " 'induced transition of lung fibroblasts to myofibroblasts (Dunkern et al., '\n",
      " 'Eur. J. Pharmacol., 572(1): 12-22, 2007), which is a hallmark of fibrosis '\n",
      " 'progression. They have further been described to inhibit matrix '\n",
      " 'metalloproteinase production from lung fibroblasts (Martin-Chouly C A et '\n",
      " 'al., Life Sci. 75(7): 823-40, 2004) and to prevent chemotaxis of these cells '\n",
      " '(Kohyama T et al., Am. J. Respir. Cell Mol. Biol., 26(6): 694-701, 2002), '\n",
      " 'which are important pathophysiological aspects of lung fibrosis. In addition '\n",
      " 'the selective type 4 phosphodiesterase inhibitor roflumilast have also been '\n",
      " 'shown in-vivo in the bleomycin-induced lung fibrosis model in mice to '\n",
      " 'inhibit fibrosis development (Cortijo J et al., Br. J. Pharmacol., 156(3): '\n",
      " '534-44, 2009).</p>\\n'\n",
      " '<p id=\"p-2311\" num=\"4120\">On the other hand it has been shown in respect to '\n",
      " 'lung fibrosis that PDE5 inhibition by means of the selective PDE5 inhibitor '\n",
      " 'sildenafil attenuates bleomycin-induced pulmonary fibrosis and pulmonary '\n",
      " 'hypertension through inhibition of ROS generation and RhoA/Rho kinase '\n",
      " 'activation (Hemnes A R, Zaiman A, Champion H C, Am. J. Physiol. Lung Cell. '\n",
      " 'Mol. Physiol. 2008 January; 294(1):L24-33. Epub 2007 Oct. 26) and it has '\n",
      " 'been shown in clinical human open-label trials that sildenafil improves lung '\n",
      " 'hemodynamic (vascular resistance and ventilation/perfusion matching) and '\n",
      " 'increases exercise tolerance in patients with pulmonary fibrosis (Ghofrani '\n",
      " 'et al., Lancet 360, 895-900, 2002; Collard et al., Chest 131, 897-899, '\n",
      " '2007).</p>\\n'\n",
      " '<p id=\"p-2312\" num=\"4121\">As described above the present subject matter '\n",
      " 'covers beside type 5 phosphodiesterase inhibitors also dual type 4/5 '\n",
      " 'phosphodiesterase inhibitors. In connection with this application preferred '\n",
      " 'dual type 4/5 phosphodiesterase inhibitors have a &#x2212;log IC<sub>50 '\n",
      " '</sub>(mol/l)] higher than 6.0 for inhibition of PDE4 and a &#x2212;log '\n",
      " 'IC<sub>50 </sub>(mol/l) higher than 8.0 for inhibition of PDE5. More '\n",
      " 'preferred dual type 4/5 phosphodiesterase inhibitors have a &#x2212;log '\n",
      " 'IC<sub>50 </sub>(mol/l) higher than 7.0 for inhibition of PDE4 and a '\n",
      " '&#x2212;log IC<sub>50 </sub>(mol/l) higher than 8.0 for inhibition of '\n",
      " 'PDE5.</p>\\n'\n",
      " '<p id=\"p-2313\" num=\"4122\">Preferably, the present subject matter relates to '\n",
      " 'the compounds of the present subject matter for use in the treatment or '\n",
      " 'prophylaxis of the following diseases, particularly diseases alleviated by '\n",
      " 'inhibition of the dual type 4/5 phosphodiesterase:</p>\\n'\n",
      " '<p id=\"p-2314\" num=\"4123\">lung fibrosis such as idiopathic pulmonary '\n",
      " 'fibrosis, pulmonary arterial hypertension respectively pulmonary '\n",
      " 'hypertension, COPD, asthma, bronchitis, emphysema, nephritis such as '\n",
      " 'proliferative glomerulonephritis, liver fibrosis, sarcoidosis, fibrotic '\n",
      " 'conditions in general such as myelofibrosis, retroperitoneal fibrosis, '\n",
      " 'endomyocardial fibrosis, mediastinal fibrosis, nephrogenic systemic '\n",
      " 'fibrosis, hypertrophic scars and toxic liver damage.</p>\\n'\n",
      " '<p id=\"p-2315\" num=\"4124\">The present subject matter also relates to the use '\n",
      " 'of a compound of the present subject matter in the manufacture of a '\n",
      " 'pharmaceutical composition inhibiting the type 5 phosphodiesterase, in '\n",
      " 'particular a pharmaceutical composition for the treatment or prophylaxis of '\n",
      " 'diseases alleviated by inhibition of the type 5 phosphodiesterase, '\n",
      " 'preferably, a pharmaceutical composition for the treatment or prophylaxis of '\n",
      " 'the diseases exemplified above.</p>\\n'\n",
      " '<p id=\"p-2316\" num=\"4125\">The present subject matter also further relates to '\n",
      " 'the use of a compound of the present subject matter in the manufacture of a '\n",
      " 'pharmaceutical composition inhibiting the dual type 4/5 phosphodiesterase, '\n",
      " 'in particular a pharmaceutical composition for the treatment or prophylaxis '\n",
      " 'of diseases alleviated by inhibition of the dual type 4/5 phosphodiesterase, '\n",
      " 'preferably, a pharmaceutical composition for the treatment or prophylaxis of '\n",
      " 'the diseases exemplified above.</p>\\n'\n",
      " '<p id=\"p-2317\" num=\"4126\">Preferably, the present subject matter relates to '\n",
      " 'the use of a compound of the present subject matter in the manufacture of a '\n",
      " 'pharmaceutical composition for the treatment or prophylaxis of an acute or '\n",
      " 'chronic airway disease, such as, but not limited to, pulmonary hypertension, '\n",
      " 'lung fibrosis, sarcoidosis, asthma, bronchitis, emphysema and chronic '\n",
      " 'obstructive pulmonary disease.</p>\\n'\n",
      " '<p id=\"p-2318\" num=\"4127\">Preferably, the present subject matter relates to '\n",
      " 'the use of a compound of the present subject matter in the manufacture of a '\n",
      " 'pharmaceutical composition for the treatment or prophylaxis of an acute or '\n",
      " 'chronic airway disease, such as, but not limited to, pulmonary hypertension, '\n",
      " 'pulmonary arterial hypertension, lung fibrosis, idiopathic pulmonary lung '\n",
      " 'fibrosis, sarcoidosis, asthma, bronchitis, emphysema and chronic obstructive '\n",
      " 'pulmonary disease.</p>\\n'\n",
      " '<p id=\"p-2319\" num=\"4128\">In a particularly preferred embodiment of the '\n",
      " 'present subject matter, the present subject matter relates to the use of a '\n",
      " 'compound of the above examples in the manufacture of a pharmaceutical '\n",
      " 'composition for the treatment or prophylaxis of an acute or chronic airway '\n",
      " 'disease, such as, but not limited to, pulmonary hypertension, lung fibrosis, '\n",
      " 'sarcoidosis, asthma, bronchitis, emphysema and chronic obstructive pulmonary '\n",
      " 'disease.</p>\\n'\n",
      " '<p id=\"p-2320\" num=\"4129\">In a particularly preferred embodiment of the '\n",
      " 'present subject matter, the present subject matter relates to the use of a '\n",
      " 'compound of the above examples in the manufacture of a pharmaceutical '\n",
      " 'composition for the treatment or prophylaxis of an acute or chronic airway '\n",
      " 'disease, such as, but not limited to, pulmonary hypertension, pulmonary '\n",
      " 'arterial hypertension, lung fibrosis, idiopathic pulmonary lung fibrosis, '\n",
      " 'sarcoidosis, asthma, bronchitis, emphysema and chronic obstructive pulmonary '\n",
      " 'disease.</p>\\n'\n",
      " '<p id=\"p-2321\" num=\"4130\">The present subject matter further relates to a '\n",
      " 'method of treating or preventing a disease comprising administering to a '\n",
      " 'patient in need thereof a therapeutically effective amount of at least one '\n",
      " 'of the compounds of the present subject matter.</p>\\n'\n",
      " '<p id=\"p-2322\" num=\"4131\">In particular, the present subject matter relates '\n",
      " 'to a method of treating or preventing one of the above mentioned diseases '\n",
      " 'comprising administering to a patient in need thereof a therapeutically '\n",
      " 'effective amount of at least one of the compounds of the present subject '\n",
      " 'matter.</p>\\n'\n",
      " '<p id=\"p-2323\" num=\"4132\">Especially, the present subject matter relates to '\n",
      " 'a method of treating or preventing a disease which is alleviated by '\n",
      " 'inhibition of the type 5 phosphodiesterase comprising administering to a '\n",
      " 'patient in need thereof a therapeutically effective amount of at least one '\n",
      " 'of the compounds of the present subject matter.</p>\\n'\n",
      " '<p id=\"p-2324\" num=\"4133\">The present subject matter further relates to a '\n",
      " 'method of treating or preventing a disease which is alleviated by inhibition '\n",
      " 'of the dual type 4/5 phosphodiesterase comprising administering to a patient '\n",
      " 'in need thereof a therapeutically effective amount of at least one of the '\n",
      " 'compounds of the present subject matter.</p>\\n'\n",
      " '<p id=\"p-2325\" num=\"4134\">Preferably, the present subject matter relates to '\n",
      " 'a method of treating or preventing of an acute or chronic airway disease, '\n",
      " 'for example, but not limited to, pulmonary hypertension, lung fibrosis, '\n",
      " 'sarcoidosis, asthma, bronchitis, emphysema and chronic obstructive pulmonary '\n",
      " 'disease, comprising administering to a patient in need thereof a '\n",
      " 'therapeutically effective amount of at least one of the compounds of the '\n",
      " 'present subject matter.</p>\\n'\n",
      " '<p id=\"p-2326\" num=\"4135\">Preferably, the present subject matter relates to '\n",
      " 'a method of treating or preventing of an acute or chronic airway disease, '\n",
      " 'for example, but not limited to, pulmonary hypertension, pulmonary arterial '\n",
      " 'hypertension, lung fibrosis, idiopathic pulmonary lung fibrosis, '\n",
      " 'sarcoidosis, asthma, bronchitis, emphysema and chronic obstructive pulmonary '\n",
      " 'disease, comprising administering to a patient in need thereof a '\n",
      " 'therapeutically effective amount of at least one of the compounds of the '\n",
      " 'present subject matter.</p>\\n'\n",
      " '<p id=\"p-2327\" num=\"4136\">In the above methods, the patient is preferably a '\n",
      " 'mammal, more preferably a human. Furthermore, in the above methods, at least '\n",
      " 'one of the compounds of the present subject matter can be used.</p>\\n'\n",
      " '<p id=\"p-2328\" num=\"4137\">Preferably, one or two of the compounds of the '\n",
      " 'present subject matter are used, more preferably, one of the compounds of '\n",
      " 'the present subject matter is used.</p>\\n'\n",
      " '<p id=\"p-2329\" num=\"4138\">In a particularly preferred embodiment of the '\n",
      " 'present subject matter, the above methods of treating or preventing one of '\n",
      " 'the above mentioned diseases comprise administering to a patient in need '\n",
      " 'thereof a therapeutically effective amount of one compound of the examples '\n",
      " 'according to the present subject matter.</p>\\n'\n",
      " '<p id=\"p-2330\" num=\"4139\">The present subject matter furthermore relates to '\n",
      " 'a pharmaceutical composition which comprises at least one of the compounds '\n",
      " 'of the present subject matter together with at least one pharmaceutically '\n",
      " 'acceptable auxiliary.</p>\\n'\n",
      " '<p id=\"p-2331\" num=\"4140\">The present subject matter additionally relates to '\n",
      " 'a pharmaceutical composition for the treatment or prophylaxis of an acute or '\n",
      " 'chronic airway disease, in particular for the treatment or prophylaxis of '\n",
      " 'pulmonary hypertension, lung fibrosis, sarcoidosis, asthma, bronchitis, '\n",
      " 'emphysema and chronic obstructive pulmonary disease.</p>\\n'\n",
      " '<p id=\"p-2332\" num=\"4141\">The present subject matter additionally relates to '\n",
      " 'a pharmaceutical composition for the treatment or prophylaxis of an acute or '\n",
      " 'chronic airway disease, in particular for the treatment or prophylaxis of '\n",
      " 'pulmonary hypertension, pulmonary arterial hypertension, lung fibrosis, '\n",
      " 'idiopathic pulmonary lung fibrosis, sarcoidosis, asthma, bronchitis, '\n",
      " 'emphysema and chronic obstructive pulmonary disease.</p>\\n'\n",
      " '<p id=\"p-2333\" num=\"4142\">Preferably, the pharmaceutical composition '\n",
      " 'comprises one or two of the compounds of the present subject matter. More '\n",
      " 'preferably, the pharmaceutical composition comprises one of the compounds of '\n",
      " 'the present subject matter.</p>\\n'\n",
      " '<p id=\"p-2334\" num=\"4143\">In a particularly preferred embodiment of the '\n",
      " 'present subject matter, the pharmaceutical composition comprises a compound '\n",
      " 'of the examples according to the present subject matter together with at '\n",
      " 'least one pharmaceutically acceptable auxiliary.</p>\\n'\n",
      " '<p id=\"p-2335\" num=\"4144\">The present subject matter additionally relates to '\n",
      " 'a pharmaceutical composition comprising at least one of the compounds of the '\n",
      " 'present subject matter, at least one pharmaceutically acceptable auxiliary '\n",
      " 'and at least one therapeutic agent selected from the group consisting of '\n",
      " 'corticosteroids, anticholinergics, beta-mimetics, lung surfactants, '\n",
      " 'endothelin antagonists, prostacyclins, calcium channel blockers, '\n",
      " 'beta-blockers, type 4 phosphodiesterase inhibitors, guanyl-cyclase '\n",
      " 'activators/stimulators, pirfenidone, antidepressants, antibiotics, '\n",
      " 'anticoagulants, diuretics and digitalis glycosides.</p>\\n'\n",
      " '<p id=\"p-2336\" num=\"4145\">In this respect, the therapeutic agent includes '\n",
      " 'the corticosteroids, anticholinergics, beta-mimetics, lung surfactants, '\n",
      " 'endothelin antagonists, prostacyclins, calcium channel blockers, '\n",
      " 'beta-blockers, type 4 phosphodiesterase inhibitors, guanyl-cyclase '\n",
      " 'activators/stimulators, pirfenidone, antidepressants, antibiotics, '\n",
      " 'anticoagulants, diuretics and digitalis glycosides in form of the free '\n",
      " 'compounds, the pharmaceutically acceptable salts thereof, the '\n",
      " 'pharmaceutically acceptable derivatives thereof (e.g., but not limited to, '\n",
      " 'ester derivatives), the solvates thereof and the stereoisomers of the '\n",
      " 'compounds, salts, derivatives and solvates.</p>\\n'\n",
      " '<p id=\"p-2337\" num=\"4146\">Co-administration of at least one of the compounds '\n",
      " 'of the present subject matter with at least one therapeutic agent selected '\n",
      " 'from the group consisting of corticosteroids, anticholinergics, '\n",
      " 'beta-mimetics, lung surfactants, endothelin antagonists, prostacyclins, '\n",
      " 'calcium channel blockers, beta-blockers, type 4 phosphodiesterase '\n",
      " 'inhibitors, guanyl-cyclase activators/stimulators, pirfenidone, '\n",
      " 'antidepressants, antibiotics, anticoagulants, diuretics and digitalis '\n",
      " 'glycosides can take place in form of a fixed combination, a non-fixed '\n",
      " 'combination or a kit of parts.</p>\\n'\n",
      " '<p id=\"p-2338\" num=\"4147\">A &#x201c;fixed combination&#x201d; is defined as '\n",
      " 'a combination wherein the compound of the present subject matter and the '\n",
      " 'therapeutic agent intended for co-administration are present in one dosing '\n",
      " 'unit or in a single entity. One example of a fixed combination is a '\n",
      " 'pharmaceutical composition wherein the compound of the present subject '\n",
      " 'matter and the therapeutic agent are present in admixture for simultaneous '\n",
      " 'administration. Another example of a fixed combination is a pharmaceutical '\n",
      " 'composition wherein the compound of the present subject matter and the '\n",
      " 'therapeutic compound are present in one dosing unit without being in '\n",
      " 'admixture.</p>\\n'\n",
      " '<p id=\"p-2339\" num=\"4148\">A &#x201c;non-fixed combination&#x201d; or '\n",
      " '&#x201c;kit of parts&#x201d; is defined as a combination wherein the '\n",
      " 'compound of the present subject matter and the therapeutic agent are present '\n",
      " 'in more than one dosing unit. In a non-fixed combination or a kit of parts '\n",
      " 'the compound of the present subject matter and the therapeutic agent are '\n",
      " 'provided as separate formulations. They might be packaged and presented '\n",
      " 'together as separate components of a combination pack for simultaneous, '\n",
      " 'sequential or separate use in combination therapy. Simultaneous or '\n",
      " 'sequential administration of the compound of the present subject matter and '\n",
      " 'the therapeutic agent are preferred. In case of sequential or separate '\n",
      " 'administration of the compound of the present subject matter and the '\n",
      " 'therapeutic agent, the compound of the present subject matter can be '\n",
      " 'administered before or after administration of the therapeutic agent.</p>\\n'\n",
      " '<p id=\"p-2340\" num=\"4149\">In case of sequential or separate administration '\n",
      " 'of the compound of the present subject matter and the therapeutic agent, the '\n",
      " 'compound of the present subject matter can be administered before or after '\n",
      " 'administration of the therapeutic agent.</p>\\n'\n",
      " '<p id=\"p-2341\" num=\"4150\">Sequential administration encompasses a short time '\n",
      " 'period between the administration of the compound of the present subject '\n",
      " 'matter and the therapeutic agent or vice versa (for example, the time that '\n",
      " 'is needed to swallow one tablet after the other).</p>\\n'\n",
      " '<p id=\"p-2342\" num=\"4151\">Separate administration encompasses longer time '\n",
      " 'periods between the administration of the compound of the present subject '\n",
      " 'matter and the therapeutic agent. In a preferred embodiment of the present '\n",
      " 'subject matter, the compound of the present subject matter is administered '\n",
      " 'while the therapeutic agent (or vice versa) still has an therapeutic effect '\n",
      " 'on the patient being treated.</p>\\n'\n",
      " '<p id=\"p-2343\" num=\"4152\">The type of formulation of the compound of the '\n",
      " 'present subject matter and the therapeutic agent of a non-fixed combination '\n",
      " 'or a kit of parts can be identical, i.e. both, the compound of the present '\n",
      " 'subject matter and the therapeutic agent are formulated, for example, as '\n",
      " 'powder, solution or suspension suitable for inhalative administration, or '\n",
      " 'can be different, i.e. suited for different administration forms, such as '\n",
      " 'e.g. the compound of the present subject matter is formulated as powder, '\n",
      " 'solution or suspension suitable for inhalative administration and the '\n",
      " 'therapeutic agent is formulated as tablet or capsule for oral '\n",
      " 'administration.</p>\\n'\n",
      " '<p id=\"p-2344\" num=\"4153\">Accordingly, the present subject matter '\n",
      " 'additionally relates to a pharmaceutical composition presented either as a '\n",
      " 'fixed combination, a non-fixed combination or kit of parts comprising at '\n",
      " 'least one of the compounds of the present subject matter, at least one '\n",
      " 'therapeutic agent selected from the group consisting of corticosteroids, '\n",
      " 'anticholinergics, beta-mimetics, lung surfactants, endothelin antagonists, '\n",
      " 'prostacyclins, calcium channel blockers, beta-blockers, type 4 '\n",
      " 'phosphodiesterase inhibitors, guanyl-cyclase activators/stimulators, '\n",
      " 'pirfenidone, antidepressants, antibiotics, anticoagulants, diuretics and '\n",
      " 'digitalis glycosides, and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2345\" num=\"4154\">Examples of corticosteroids include without '\n",
      " 'limitation budesonide, fluticasone such as fluticasone propionate, '\n",
      " 'beclometasone such as beclometasone dipropionate, triamcinolone such as '\n",
      " 'triamcinolone acetonide, mometasone, and ciclesonide. Examples of '\n",
      " 'anticholinergics include without limitation tiotropium such as tiotropium '\n",
      " 'bromide, and ipratropium such as ipratropium bromide, aclinidinium such as '\n",
      " 'aclinidinium bromide, glycopyrronium such as glycopyrronium bromide. '\n",
      " 'Examples of beta-mimetics include without limitation indacaterol, formoterol '\n",
      " 'such as formoterol fumarate, and salmeterol such as salmeterol xinafoate, '\n",
      " 'salbutamol, milveterol, carmoterol. Examples of lung surfactants include '\n",
      " 'without limitation lusupultide, poractant alfa, sinapultide, beractant, '\n",
      " 'bovactant, colfosceril such as colfosceril palmitate, surfactant-TA, and '\n",
      " 'calfactant. Examples of endothelin antagonists include without limitation '\n",
      " 'bosentan, ambrisentan, atrasentan, darusentan, clazosentan, avosentan and '\n",
      " 'sitaxsentan such as sitaxsentan sodium. Examples of prostacyclins include '\n",
      " 'without limitation iloprost such as iloprost tromethamine, epoprostenol such '\n",
      " 'as epoprostenol sodium and treprostinil such as treprostinil sodium. '\n",
      " 'Examples of calcium channel blockers include without limitation amlodipine '\n",
      " 'such as amlodipine besylate and amlodipine maleate, nifedipine, diltiazem '\n",
      " 'such as diltiazem hydrochloride, verapamil such as verapamil hydrochloride, '\n",
      " 'and felodipine. Examples of beta-blockers include without limitation '\n",
      " 'bisoprolol such as bisoprolol fumarate, nebivolol, metoprolol such as '\n",
      " 'metoprolol succinate and metoprolol tartrate, carvedilol, atenolol and '\n",
      " 'nadolol. Examples of type 4 phosphodiesterase inhibitors include without '\n",
      " 'limitation roflumilast, roflumilast N-oxide, cilomilast, tetomilast, '\n",
      " 'apremilast and oglemilast. Examples of antidepressants include without '\n",
      " 'limitation bupropion such as bupropion hydrochloride. Examples of '\n",
      " 'antibiotics include without limitation amoxicillin, ampicillin, '\n",
      " 'levofloxacin, clarithromycin, ciprofloxacin such as ciprofloxacin '\n",
      " 'hydrochloride, telithromycin and azithromycin. Examples of anticoagulants '\n",
      " 'include without limitation clopidogrel, enoxaparin, cilostazol, nadroparin, '\n",
      " 'warfarin and abciximab. Examples of diuretics include without limitation '\n",
      " 'furosemide, bumetanide and torsemide. Examples of digitalis glycosides '\n",
      " 'include without limitation digoxin and digitoxin. Examples of Guanyl-cyclase '\n",
      " 'activator/stimulators include without limitation BAY63-2521 (Riociguat) and '\n",
      " 'Ataciguat.</p>\\n'\n",
      " '<p id=\"p-2346\" num=\"4155\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a corticosteroid and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1463\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'budesonide,</p>\\n'\n",
      " '<p id=\"h-1464\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'fluticasone,</p>\\n'\n",
      " '<p id=\"h-1465\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'beclometasone,</p>\\n'\n",
      " '<p id=\"h-1466\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'mometasone,</p>\\n'\n",
      " '<p id=\"h-1467\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'triamcinolone acetonide, or</p>\\n'\n",
      " '<p id=\"h-1468\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'ciclesonide,</p>\\n'\n",
      " '<p id=\"h-1469\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2347\" num=\"4156\">In an alternative embodiment, the pharmaceutically '\n",
      " 'acceptable derivative of fluticasone is fluticasone-17-propionate. In '\n",
      " 'another alternative embodiment, the pharmaceutically acceptable derivative '\n",
      " 'of beclometasone is beclometasone 17,21-dipropionate ester. In an '\n",
      " 'alternative embodiment, the pharmaceutically acceptable derivative of '\n",
      " 'mometasone is mometasone furoate.</p>\\n'\n",
      " '<p id=\"p-2348\" num=\"4157\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), an anticholinergic and at least '\n",
      " 'one pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1470\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1471\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1472\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'tiotropium bromide, or</p>\\n'\n",
      " '<p id=\"h-1473\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1474\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2349\" num=\"4158\">In an alternative embodiment, the stereoisomer of '\n",
      " 'glycopyrronium bromide is (R,R)-glycopyrronium bromide. In an alternative '\n",
      " 'embodiment, tiotropium bromide is used in form of its monohydrate.</p>\\n'\n",
      " '<p id=\"p-2350\" num=\"4159\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a beta-mimetic and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In</p>\\n'\n",
      " '<p id=\"h-1475\" num=\"0000\">a particularly alternative embodiment, the '\n",
      " 'above-mentioned fixed combination, non-fixed combination or kit of parts '\n",
      " 'comprise:</p>\\n'\n",
      " '<p id=\"h-1476\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'salbutamol,</p>\\n'\n",
      " '<p id=\"h-1477\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'milveterol,</p>\\n'\n",
      " '<p id=\"h-1478\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'indacaterol,</p>\\n'\n",
      " '<p id=\"h-1479\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'carmoterol,</p>\\n'\n",
      " '<p id=\"h-1480\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'salmeterol,</p>\\n'\n",
      " '<p id=\"h-1481\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'formoterol,</p>\\n'\n",
      " '<p id=\"h-1482\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2351\" num=\"4160\">In an alternative embodiment, the pharmaceutically '\n",
      " 'acceptable salt of salbutamol is salbutamol sulfate. In an alternative '\n",
      " 'embodiment, the pharmaceutically acceptable salt of milveterol is milveterol '\n",
      " 'hydrochloride. In an alternative embodiment, the pharmaceutically acceptable '\n",
      " 'salt of carmoterol is carmoterol hydrochloride. In an alternative '\n",
      " 'embodiment, the pharmaceutically acceptable salt of salmeterol is salmeterol '\n",
      " 'xinafoate. In another alternative embodiment, the pharmaceutically '\n",
      " 'acceptable salt of formoterol is formoterol hemifumarate monohydrate. In '\n",
      " 'another alternative embodiment, the stereoisomer of formoterol is '\n",
      " 'R,R-formoterol. In another alternative embodiment, the pharmaceutically '\n",
      " 'acceptable salt of R,R-formoterol is R,R-formoterol L-tartrate.</p>\\n'\n",
      " '<p id=\"p-2352\" num=\"4161\">Preferably the beta-mimetic is a long-acting '\n",
      " 'beta-mimetic; particularly an alternative in this respect are those '\n",
      " 'beta-mimetics having a therapeutic effect over a 12-24 hours period.</p>\\n'\n",
      " '<p id=\"p-2353\" num=\"4162\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter), a lung '\n",
      " 'surfactant and at least one pharmaceutically acceptable auxiliary. In a '\n",
      " 'particularly alternative embodiment, the above-mentioned fixed combination, '\n",
      " 'non-fixed combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1483\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'lusupultide,</p>\\n'\n",
      " '<p id=\"h-1484\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'poracant alfa,</p>\\n'\n",
      " '<p id=\"h-1485\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'sinapultide,</p>\\n'\n",
      " '<p id=\"h-1486\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'beracant,</p>\\n'\n",
      " '<p id=\"h-1487\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'bovacant,</p>\\n'\n",
      " '<p id=\"h-1488\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'colfosceril palmitate,</p>\\n'\n",
      " '<p id=\"h-1489\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'surfactant-TA, or</p>\\n'\n",
      " '<p id=\"h-1490\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'calfacant,</p>\\n'\n",
      " '<p id=\"h-1491\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2354\" num=\"4163\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), an endothelin antagonist and at '\n",
      " 'least one pharmaceutically acceptable auxiliary. In a particularly '\n",
      " 'alternative embodiment, the above-mentioned fixed combination, non-fixed '\n",
      " 'combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1492\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'bosentan,</p>\\n'\n",
      " '<p id=\"h-1493\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'ambrisentan,</p>\\n'\n",
      " '<p id=\"h-1494\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'atrasentan,</p>\\n'\n",
      " '<p id=\"h-1495\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'darusentan,</p>\\n'\n",
      " '<p id=\"h-1496\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'clazosentan, or</p>\\n'\n",
      " '<p id=\"h-1497\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'avosentan,</p>\\n'\n",
      " '<p id=\"h-1498\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2355\" num=\"4164\">In another alternative embodiment, bosentan is '\n",
      " 'used in form of its monohydrate. In another alternative embodiment the '\n",
      " 'pharmaceutically acceptable salt of clazosentan is the disodium salt of '\n",
      " 'clazosentan. In another alternative embodiment the pharmaceutically '\n",
      " 'acceptable salts of atrasentan are atrasentan hydrochloride or the sodium '\n",
      " 'salt of atrasentan. In another alternative embodiment the R-enantiomer of '\n",
      " 'atrasentan is used. In another alternative embodiment the S-enantiomer of '\n",
      " 'darusentan is used.</p>\\n'\n",
      " '<p id=\"p-2356\" num=\"4165\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a prostacyclin and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1499\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'iloprost,</p>\\n'\n",
      " '<p id=\"h-1500\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'epoprostenol,</p>\\n'\n",
      " '<p id=\"h-1501\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'triprostinil,</p>\\n'\n",
      " '<p id=\"h-1502\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2357\" num=\"4166\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a calcium channel blocker and at '\n",
      " 'least one pharmaceutically acceptable auxiliary. In a particularly '\n",
      " 'alternative embodiment, the above-mentioned fixed combination, non-fixed '\n",
      " 'combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1503\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'amlodipine,</p>\\n'\n",
      " '<p id=\"h-1504\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'nifedipine,</p>\\n'\n",
      " '<p id=\"h-1505\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'diltiazem,</p>\\n'\n",
      " '<p id=\"h-1506\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'verapamil, or</p>\\n'\n",
      " '<p id=\"h-1507\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'felodipine,</p>\\n'\n",
      " '<p id=\"h-1508\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2358\" num=\"4167\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a beta-blocker and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1509\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'bisoprolol,</p>\\n'\n",
      " '<p id=\"h-1510\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'nebivolol,</p>\\n'\n",
      " '<p id=\"h-1511\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'metoprolol,</p>\\n'\n",
      " '<p id=\"h-1512\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'carvedilol,</p>\\n'\n",
      " '<p id=\"h-1513\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'atenolol, or</p>\\n'\n",
      " '<p id=\"h-1514\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'nadolol,</p>\\n'\n",
      " '<p id=\"h-1515\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2359\" num=\"4168\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a type 4 phosphodiesterase '\n",
      " 'inhibitor and at least one pharmaceutically acceptable auxiliary. In a '\n",
      " 'particularly alternative embodiment, the above-mentioned fixed combination, '\n",
      " 'non-fixed combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1516\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'roflumilast,</p>\\n'\n",
      " '<p id=\"h-1517\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'roflumilast N-oxide,</p>\\n'\n",
      " '<p id=\"h-1518\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'cilomilast,</p>\\n'\n",
      " '<p id=\"h-1519\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'tetomilast</p>\\n'\n",
      " '<p id=\"h-1520\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'apremilast, or</p>\\n'\n",
      " '<p id=\"h-1521\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'oglemilast,</p>\\n'\n",
      " '<p id=\"h-1522\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2360\" num=\"4169\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), an antidepressant and at least '\n",
      " 'one pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1523\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'bupropion,</p>\\n'\n",
      " '<p id=\"h-1524\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2361\" num=\"4170\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), an antibiotic and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1525\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'amoxicillin,</p>\\n'\n",
      " '<p id=\"h-1526\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'ampicillin,</p>\\n'\n",
      " '<p id=\"h-1527\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'levofloxacin,</p>\\n'\n",
      " '<p id=\"h-1528\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'clarithromycin,</p>\\n'\n",
      " '<p id=\"h-1529\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'ciprofloxacin,</p>\\n'\n",
      " '<p id=\"h-1530\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'telithromycin, or</p>\\n'\n",
      " '<p id=\"h-1531\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'azithromycin,</p>\\n'\n",
      " '<p id=\"h-1532\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2362\" num=\"4171\">In an alternative embodiment, amoxicillin is used '\n",
      " 'in form of its trihydrate. In another alternative embodiment, ampicillin is '\n",
      " 'used in form of its trihydrate. In another alternative embodiment, the '\n",
      " 'pharmaceutically acceptable salt of ampicillin is ampicillin natrium. In '\n",
      " 'another alternative embodiment levofloxacin is used in form of its hemi '\n",
      " 'hydrate. In another alternative embodiment, the pharmaceutically acceptable '\n",
      " 'salt of ciprofloxacin is ciprofloxacin hydrochloride monohydrate. In another '\n",
      " 'alternative embodiment, azithromycin is used in form of its '\n",
      " 'monohydrate.</p>\\n'\n",
      " '<p id=\"p-2363\" num=\"4172\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), an anticoagulant and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1533\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'clopidogrel,</p>\\n'\n",
      " '<p id=\"h-1534\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'enoxaparin,</p>\\n'\n",
      " '<p id=\"h-1535\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'cilostazol,</p>\\n'\n",
      " '<p id=\"h-1536\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'nadroparin,</p>\\n'\n",
      " '<p id=\"h-1537\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'warfarin, or</p>\\n'\n",
      " '<p id=\"h-1538\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'abciximab,</p>\\n'\n",
      " '<p id=\"h-1539\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2364\" num=\"4173\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a diuretic and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1540\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'furosemide,</p>\\n'\n",
      " '<p id=\"h-1541\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'bumetanide, or</p>\\n'\n",
      " '<p id=\"h-1542\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'torsemide,</p>\\n'\n",
      " '<p id=\"h-1543\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2365\" num=\"4174\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a digitalis glycoside and at '\n",
      " 'least one pharmaceutically acceptable auxiliary. In a particularly '\n",
      " 'alternative embodiment, the above-mentioned fixed combination, non-fixed '\n",
      " 'combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1544\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'digoxin, or</p>\\n'\n",
      " '<p id=\"h-1545\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'digitoxin,</p>\\n'\n",
      " '<p id=\"h-1546\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2366\" num=\"4175\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a corticosteroid, a beta-mimetic '\n",
      " 'and at least one pharmaceutically acceptable auxiliary. In a particularly '\n",
      " 'alternative embodiment, the above-mentioned fixed combination, non-fixed '\n",
      " 'combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1547\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and salbutamol,</p>\\n'\n",
      " '<p id=\"h-1548\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and milveterol,</p>\\n'\n",
      " '<p id=\"h-1549\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and indacaterol,</p>\\n'\n",
      " '<p id=\"h-1550\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and carmoterol,</p>\\n'\n",
      " '<p id=\"h-1551\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and salmeterol,</p>\\n'\n",
      " '<p id=\"h-1552\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and formoterol,</p>\\n'\n",
      " '<p id=\"h-1553\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and salbutamol,</p>\\n'\n",
      " '<p id=\"h-1554\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and milveterol,</p>\\n'\n",
      " '<p id=\"h-1555\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and indacaterol,</p>\\n'\n",
      " '<p id=\"h-1556\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and carmoterol,</p>\\n'\n",
      " '<p id=\"h-1557\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and salmeterol,</p>\\n'\n",
      " '<p id=\"h-1558\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and formoterol,</p>\\n'\n",
      " '<p id=\"h-1559\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and salbutamol,</p>\\n'\n",
      " '<p id=\"h-1560\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and milveterol,</p>\\n'\n",
      " '<p id=\"h-1561\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and indacaterol,</p>\\n'\n",
      " '<p id=\"h-1562\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and carmoterol,</p>\\n'\n",
      " '<p id=\"h-1563\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and salmeterol,</p>\\n'\n",
      " '<p id=\"h-1564\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and formoterol,</p>\\n'\n",
      " '<p id=\"h-1565\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and salbutamol,</p>\\n'\n",
      " '<p id=\"h-1566\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and milveterol,</p>\\n'\n",
      " '<p id=\"h-1567\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and indacaterol,</p>\\n'\n",
      " '<p id=\"h-1568\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and carmoterol,</p>\\n'\n",
      " '<p id=\"h-1569\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and salmeterol,</p>\\n'\n",
      " '<p id=\"h-1570\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and formoterol,</p>\\n'\n",
      " '<p id=\"h-1571\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and salbutamol,</p>\\n'\n",
      " '<p id=\"h-1572\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and milveterol,</p>\\n'\n",
      " '<p id=\"h-1573\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and indacaterol,</p>\\n'\n",
      " '<p id=\"h-1574\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and carmoterol,</p>\\n'\n",
      " '<p id=\"h-1575\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and salmeterol,</p>\\n'\n",
      " '<p id=\"h-1576\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and formoterol,</p>\\n'\n",
      " '<p id=\"h-1577\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and salbutamol,</p>\\n'\n",
      " '<p id=\"h-1578\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and milveterol,</p>\\n'\n",
      " '<p id=\"h-1579\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and indacaterol,</p>\\n'\n",
      " '<p id=\"h-1580\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and carmoterol,</p>\\n'\n",
      " '<p id=\"h-1581\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and salmeterol, or</p>\\n'\n",
      " '<p id=\"h-1582\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and formoterol,</p>\\n'\n",
      " '<p id=\"h-1583\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2367\" num=\"4176\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a beta-mimetic, an '\n",
      " 'anticholinergic and at least one pharmaceutically acceptable auxiliary. In a '\n",
      " 'particularly alternative embodiment, the above-mentioned fixed combination, '\n",
      " 'non-fixed combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1584\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salbutamol and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1585\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salbutamol and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1586\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salbutamol and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1587\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salbutamol and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1588\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'milveterol and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1589\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'milveterol and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1590\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'milveterol and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1591\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'milveterol and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1592\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salmeterol and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1593\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salmeterol and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1594\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salmeterol and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1595\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'salmeterol and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1596\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'formoterol and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1597\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'formoterol and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1598\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'formoterol and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1599\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'formoterol and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1600\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'indacaterol and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1601\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'indacaterol and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1602\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'indacaterol and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1603\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'indacaterol and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1604\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'carmoterol and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1605\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'carmoterol and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1606\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'carmoterol and tiotropium bromide, or</p>\\n'\n",
      " '<p id=\"h-1607\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'carmoterol and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1608\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2368\" num=\"4177\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), a corticosteroid, an '\n",
      " 'anticholinergic and at least one pharmaceutically acceptable auxiliary. In a '\n",
      " 'particularly alternative embodiment, the above-mentioned fixed combination, '\n",
      " 'non-fixed combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1609\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1610\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1611\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1612\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'budesonide and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1613\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1614\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1615\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1616\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'fluticasone and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1617\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1618\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1619\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1620\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'beclometasone and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1621\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1622\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1623\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1624\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'mometasone and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1625\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1626\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1627\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and tiotropium bromide,</p>\\n'\n",
      " '<p id=\"h-1628\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'triamcinolone acetonide and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1629\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and glycopyrronium bromide,</p>\\n'\n",
      " '<p id=\"h-1630\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and aclidinium bromide,</p>\\n'\n",
      " '<p id=\"h-1631\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and tiotropium bromide, or</p>\\n'\n",
      " '<p id=\"h-1632\" num=\"0000\">a compound of the present subject matter, '\n",
      " 'ciclesonide and ipratropium bromide,</p>\\n'\n",
      " '<p id=\"h-1633\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2369\" num=\"4178\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), an guanyl-cyclase '\n",
      " 'activator/stimulator and at least one pharmaceutically acceptable auxiliary. '\n",
      " 'In a particularly alternative embodiment, the above-mentioned fixed '\n",
      " 'combination, non-fixed combination or kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1634\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'BAY63-2521 (Riociguat),</p>\\n'\n",
      " '<p id=\"h-1635\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'Ataciguat,</p>\\n'\n",
      " '<p id=\"h-1636\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2370\" num=\"4179\">In an alternative embodiment, the above-mentioned '\n",
      " 'fixed combination, non-fixed combination or kit of parts comprise a compound '\n",
      " 'of the present subject matter (in particular the compound of the present '\n",
      " 'subject matter is one of the examples of the present subject matter or a '\n",
      " 'pharmaceutically acceptable salt thereof), pirfenidone and at least one '\n",
      " 'pharmaceutically acceptable auxiliary. In a particularly alternative '\n",
      " 'embodiment, the above-mentioned fixed combination, non-fixed combination or '\n",
      " 'kit of parts comprise:</p>\\n'\n",
      " '<p id=\"h-1637\" num=\"0000\">a compound of the present subject matter and '\n",
      " 'pirfenidone,</p>\\n'\n",
      " '<p id=\"h-1638\" num=\"0000\">and at least one pharmaceutically acceptable '\n",
      " 'auxiliary.</p>\\n'\n",
      " '<p id=\"p-2371\" num=\"4180\">The above mentioned compound of the present '\n",
      " 'subject matter is preferably a compound according to the examples.</p>\\n'\n",
      " '<p id=\"p-2372\" num=\"4181\">The present subject matter furthermore relates to '\n",
      " 'pharmaceutical compositions according to the present subject matter, as '\n",
      " 'defined above, inhibiting the type 5 phosphodiesterase, especially for the '\n",
      " 'treatment or prophylaxis of diseases alleviated by inhibition of type 5 '\n",
      " 'phosphodiesterase, in particular for the treatment or prophylaxis of the '\n",
      " 'diseases exemplified above.</p>\\n'\n",
      " '<p id=\"p-2373\" num=\"4182\">The present subject matter even furthermore '\n",
      " 'relates to pharmaceutical compositions according to the present subject '\n",
      " 'matter, as defined above, inhibiting the dual type 4/5 phosphodiesterase, '\n",
      " 'especially for the treatment or prophylaxis of diseases alleviated by '\n",
      " 'inhibition of dual type 4/5 phosphodiesterase, in particular for the '\n",
      " 'treatment or prophylaxis of the diseases exemplified above.</p>\\n'\n",
      " '<p id=\"p-2374\" num=\"4183\">The present subject matter also encompasses '\n",
      " 'pharmaceutical compositions according to the present subject matter, as '\n",
      " 'defined above, for the treatment or prophylaxis of the following diseases: '\n",
      " 'acute and chronic airway diseases, such as pulmonary hypertension, lung '\n",
      " 'fibrosis, asthma, bronchitis, emphysema and chronic obstructive pulmonary '\n",
      " 'disease.</p>\\n'\n",
      " '<p id=\"p-2375\" num=\"4184\">The pharmaceutical compositions according to the '\n",
      " 'present subject matter preferably contain the compound or compounds of the '\n",
      " 'present subject matter in a total amount of from 0.1 to 99.9 wt %, more '\n",
      " 'preferably 5 to 95 wt %, in particular 20 to 80 wt %. In case at least one '\n",
      " 'therapeutic agent selected from the group consisting of corticosteroids, '\n",
      " 'anticholinergics, beta-mimetics, lung surfactants, endothelin antagonists, '\n",
      " 'prostacyclins, calcium channel blockers, beta-blockers, type 4 '\n",
      " 'phosphodiesterase inhibitors, guanyl-cyclase activators/stimulators, '\n",
      " 'pirfenidone, antidepressants, antibiotics, anticoagulants, diuretics and '\n",
      " 'digitalis glycosides is present in the pharmaceutical compositions of the '\n",
      " 'present subject matter, the total amount of said therapeutic agent or '\n",
      " 'therapeutic agents in the pharmaceutical compositions is preferably in the '\n",
      " 'range of from 0.1 to 99.9 wt %, more preferably 5 to 95 wt %, in particular '\n",
      " '20 to 80 wt %, under the provision that the total amount of the compound or '\n",
      " 'compounds of the present subject matter and the therapeutic agent or '\n",
      " 'therapeutic agents is less than 100 wt %. Preferably, the at least one '\n",
      " 'compound of the present subject matter and the at least one therapeutic '\n",
      " 'agent are present in the pharmaceutical composition in a weight ratio of '\n",
      " 'from 1000:1 to 1:1000, more preferably 500:1 to 1:500.</p>\\n'\n",
      " '<p id=\"p-2376\" num=\"4185\">As pharmaceutically acceptable auxiliaries, any '\n",
      " 'auxiliaries known to be suitable for preparing pharmaceutical compositions '\n",
      " 'can be used. Examples thereof include, but are not limited to, solvents, '\n",
      " 'excipients, dispersants, emulsifiers, solubilizers, gel formers, ointment '\n",
      " 'bases, antioxidants, preservatives, stabilizers, carriers, fillers, binders, '\n",
      " 'thickeners, complexing agents, disintegrating agents, buffers, permeation '\n",
      " 'promoters, polymers, lubricants, coating agents, propellants, tonicity '\n",
      " 'adjusting agents, surfactants, colorants, flavorings, sweeteners and dyes. '\n",
      " 'In particular, auxiliaries of a type appropriate to the desired formulation '\n",
      " 'and the desired mode of administration are used.</p>\\n'\n",
      " '<p id=\"p-2377\" num=\"4186\">The pharmaceutical compositions can be formulated, '\n",
      " 'for example, into tablets, coated tablets (dragees), pills, cachets, '\n",
      " 'capsules (caplets), granules, powders, suppositories, solutions (e.g., but '\n",
      " 'not limited to, sterile solutions), emulsions, suspensions, ointments, '\n",
      " 'creams, lotions, pastes, oils, gels, sprays and patches (e.g., but not '\n",
      " 'limited to, transdermal therapeutic systems). Additionally, the '\n",
      " 'pharmaceutical compositions can be prepared as e.g. liposome delivery '\n",
      " 'systems, systems in which the compound of the present subject matter is '\n",
      " 'coupled to monoclonal antibodies and systems in which the compound of the '\n",
      " 'present subject matter is coupled to polymers (e.g., but not limited to, '\n",
      " 'soluble or biodegradable polymers).</p>\\n'\n",
      " '<p id=\"p-2378\" num=\"4187\">In case of pharmaceutical compositions comprising '\n",
      " 'at least one of the compounds of the present subject matter and at least one '\n",
      " 'therapeutic agent selected from the group consisting of corticosteroids, '\n",
      " 'anticholinergics, beta-mimetics, lung surfactants, endothelin antagonists, '\n",
      " 'prostacyclins, calcium channel blockers, beta-blockers, type 4 '\n",
      " 'phosphodiesterase inhibitors, guanyl-cyclase activators/stimulators, '\n",
      " 'pirfenidone, antidepressants, antibiotics, anticoagulants, diuretics and '\n",
      " 'digitalis glycosides, the compound of the present subject matter and the '\n",
      " 'therapeutic agent may be formulated together into the same dosage form '\n",
      " '(e.g., but not limited to, tablets), separately into the same dosage form '\n",
      " '(e.g., but not limited to, tablets), or into different dosage forms (without '\n",
      " 'limitation e.g. the compound of the present subject matter may be formulated '\n",
      " 'as tablet and the therapeutic agent may be formulated as powder, solution or '\n",
      " 'suspension).</p>\\n'\n",
      " '<p id=\"p-2379\" num=\"4188\">The pharmaceutical compositions can be '\n",
      " 'manufactured in a manner known to a person skilled in the art, e.g. by '\n",
      " 'dissolving, mixing, granulating, dragee-making, levigating, emulsifying, '\n",
      " 'encapsulating, entrapping or lyophilizing processes.</p>\\n'\n",
      " '<p id=\"p-2380\" num=\"4189\">The selected formulation depends inter alia on the '\n",
      " 'route of administering the pharmaceutical composition. The pharmaceutical '\n",
      " 'compositions of the present subject matter can be administered by any '\n",
      " 'suitable route, for example, by the oral, sublingual, buccal, intravenous, '\n",
      " 'intraarterial, intramuscular, subcutaneous, intracutaneous, topical, '\n",
      " 'transdermal, intranasal, intraocular, intraperitoneal, intrasternal, '\n",
      " 'intracoronary, transurethral, rectal or vaginal route, by inhalation or by '\n",
      " 'insufflation. Oral administration is preferred.</p>\\n'\n",
      " '<p id=\"p-2381\" num=\"4190\">In case of pharmaceutical compositions comprising '\n",
      " 'at least one of the compounds of the present subject matter and at least one '\n",
      " 'therapeutic agent selected from the group consisting of corticosteroids, '\n",
      " 'anticholinergics, beta-mimetics, lung surfactants, endothelin antagonists, '\n",
      " 'prostacyclins, calcium channel blockers, beta-blockers, type 4 '\n",
      " 'phosphodiesterase inhibitors, guanyl-cyclase activators/stimulators, '\n",
      " 'pirfenidone, antidepressants, antibiotics, anticoagulants, diuretics and '\n",
      " 'digitalis glycosides, the compound of the present subject matter and the '\n",
      " 'therapeutic agent may be administered by the same route, e.g., without '\n",
      " 'limitation, orally, or by different routes, e.g., without limitation, the '\n",
      " 'compound of the present subject matter can be administered orally and the '\n",
      " 'therapeutic agent can be administered by inhalation or instillation.</p>\\n'\n",
      " '<p id=\"p-2382\" num=\"4191\">Tablets, coated tablets (dragees), pills, cachets, '\n",
      " 'capsules (caplets), granules, solutions, emulsions and suspensions are e.g. '\n",
      " 'suitable for oral administration. In particular, said formulations can be '\n",
      " 'adapted so as to represent, for example, an enteric form, an immediate '\n",
      " 'release form, a delayed release form, a repeated dose release form, a '\n",
      " 'prolonged release form or a sustained release form. Said forms can be '\n",
      " 'obtained, for example, by coating tablets, by dividing tablets into several '\n",
      " 'compartments separated by layers disintegrating under different conditions '\n",
      " '(e.g. pH conditions) or by coupling the compound of the present subject '\n",
      " 'matter to a biodegradable polymer.</p>\\n'\n",
      " '<p id=\"p-2383\" num=\"4192\">Administration by inhalation or instillation is '\n",
      " 'preferably made by using an aerosol. The aerosol is a liquid-gaseous '\n",
      " 'dispersion, a solid-gaseous dispersion or a mixed liquid/solid-gaseous '\n",
      " 'dispersion.</p>\\n'\n",
      " '<p id=\"p-2384\" num=\"4193\">The aerosol may be generated by means of '\n",
      " 'aerosol-producing devices such as dry powder inhalers (DPIs), pressurized '\n",
      " 'metered dose inhalers (PMDIs) and nebulizers. Depending on the kind of the '\n",
      " 'compound of the present subject matter, and optionally the therapeutic '\n",
      " 'agent, to be administered, the aerosol-producing device can contain the '\n",
      " 'compound and, optionally, the therapeutic agent in form of a powder, a '\n",
      " 'solution or a dispersion. The powder may contain, for example, one or more '\n",
      " 'of the following auxiliaries: carriers, stabilizers and fillers. The '\n",
      " 'solution may contain in addition to the solvent, for example, one or more of '\n",
      " 'the following auxiliaries: propellants, solubilizers (co-solvents), '\n",
      " 'surfactants, stabilizers, buffers, tonicity adjusting agents, preservatives '\n",
      " 'and flavorings. The dispersion may contain in addition to the dispersant, '\n",
      " 'for example, one or more of the following auxiliaries: propellants, '\n",
      " 'surfactants, stabilizers, buffers, preservatives and flavorings. Examples of '\n",
      " 'carriers include, but are not limited to, saccharides, e.g. lactose and '\n",
      " 'glucose. Examples of propellants include, but are not limited to, '\n",
      " 'fluorohydrocarbons, e.g. 1,1,1,2-tetrafluoroethane and '\n",
      " '1,1,1,2,3,3,3-heptafluoropropane.</p>\\n'\n",
      " '<p id=\"p-2385\" num=\"4194\">The particle size of the aerosol particles (solid, '\n",
      " 'liquid or solid/liquid particles) is preferably less than 100 &#x3bc;m, more '\n",
      " 'preferably it is in the range of from 0.5 to 10 &#x3bc;m, in particular in '\n",
      " 'the range of from 2 to 6 &#x3bc;m (D50 value, measured by laser '\n",
      " 'diffraction).</p>\\n'\n",
      " '<p id=\"p-2386\" num=\"4195\">Specific aerosol-producing devices which may be '\n",
      " 'used for inhaled administration include, but are not limited to, '\n",
      " 'Cyclohaler&#xae;, Diskhaler&#xae;, Rotadisk&#xae;, Turbohaler&#xae;, '\n",
      " 'Autohaler&#xae;, Turbohaler&#xae;, Novolizer&#xae;, Easyhaler&#xae;, '\n",
      " 'Aerolizer&#xae;, Jethaler&#xae;, Diskus&#xae;, Ultrahaler&#xae; and '\n",
      " 'Mystic&#xae; inhalers. The aerosol-producing devices may be combined with '\n",
      " 'spacers or expanders, e.g. Aerochamber&#xae;, Nebulator&#xae;, '\n",
      " 'Volumatic&#xae; and Rondo&#xae;, for improving inhalation efficiency.</p>\\n'\n",
      " '<p id=\"p-2387\" num=\"4196\">In case of topical administration, suitable '\n",
      " 'pharmaceutical formulations are, for example, ointments, creams, lotions, '\n",
      " 'pastes, gels, powders, solutions, emulsions, suspensions, oils, sprays and '\n",
      " 'patches (e.g., but not limited to, transdermal therapeutic systems).</p>\\n'\n",
      " '<p id=\"p-2388\" num=\"4197\">For parenteral modes of administration such as, '\n",
      " 'for example, intravenous, intraarterial, intramuscular, subcutaneous, '\n",
      " 'intracutaneous, intraperitoneal and intrasternal administration, preferably '\n",
      " 'solutions (e.g., but not limited to, sterile solutions, isotonic solutions) '\n",
      " 'are used. They are preferably administered by injection or infusion '\n",
      " 'techniques.</p>\\n'\n",
      " '<p id=\"p-2389\" num=\"4198\">In case of intranasal administration, for example, '\n",
      " 'sprays and solutions to be applied in drop form are preferred '\n",
      " 'formulations.</p>\\n'\n",
      " '<p id=\"p-2390\" num=\"4199\">For intraocular administration, solutions to be '\n",
      " 'applied in drop form, gels and ointments are exemplified formulations.</p>\\n'\n",
      " '<p id=\"p-2391\" num=\"4200\">Generally, the pharmaceutical compositions '\n",
      " 'according to the present subject matter can be administered such that the '\n",
      " 'dose of the compound of the present subject matter is in the range customary '\n",
      " 'for type 5 phosphodiesterase inhibitors or dual type 4/5 phosphodiesterase '\n",
      " 'inhibitors. In particular, a dose in the range of from 0.01 to 4000 mg of '\n",
      " 'the compound of the present subject matter per day is preferred. In this '\n",
      " 'respect, it is to be noted that the dose is dependent, for example, on the '\n",
      " 'specific compound used, the species treated, age, body weight, general '\n",
      " 'health, sex and diet of the subject treated, mode and time of '\n",
      " 'administration, rate of excretion, severity of the disease to be treated and '\n",
      " 'drug combination. In case the pharmaceutical composition of the present '\n",
      " 'subject matter comprises at least one of the compounds of the present '\n",
      " 'subject matter and at least one therapeutic agent selected from the group '\n",
      " 'consisting of corticosteroids, anticholinergics, beta-mimetics, lung '\n",
      " 'surfactants, endothelin antagonists, prostacyclins, calcium channel '\n",
      " 'blockers, beta-blockers, type 4 phosphodiesterase inhibitors, guanyl-cyclase '\n",
      " 'activators/stimulators, pirfenidone, antidepressants, antibiotics, '\n",
      " 'anticoagulants, diuretics and digitalis glycosides, the same dose ranges '\n",
      " 'apply to the therapeutic agent.</p>\\n'\n",
      " '<p id=\"p-2392\" num=\"4201\">The pharmaceutical compositions according to the '\n",
      " 'present subject matter can be administered in a single dose per day or in '\n",
      " 'multiple subdoses, for example, 2 to 4 doses per day. A single dose unit of '\n",
      " 'the pharmaceutical composition can contain e.g. from 0.01 mg to 4000 mg, '\n",
      " 'preferably 0.1 mg to 2000 mg, more preferably 0.5 to 1000 mg, most '\n",
      " 'preferably 1 to 500 mg, of the compound of the present subject matter. In '\n",
      " 'case the pharmaceutical composition of the present subject matter comprises '\n",
      " 'at least one of the compounds of the present subject matter and at least one '\n",
      " 'therapeutic agent selected from the group consisting of corticosteroids, '\n",
      " 'anticholinergics, beta-mimetics, lung surfactants, endothelin antagonists, '\n",
      " 'prostacyclins, calcium channel blockers, beta-blockers, type 4 '\n",
      " 'phosphodiesterase inhibitors, guanyl-cyclase activators/stimulators, '\n",
      " 'pirfenidone, antidepressants, antibiotics, anticoagulants, diuretics and '\n",
      " 'digitalis glycosides, a single dose unit of the pharmaceutical composition '\n",
      " 'can contain e.g. from 0.01 mg to 4000 mg, preferably 0.1 mg to 2000 mg, more '\n",
      " 'preferably 0.5 to 1000 mg, most preferably 1 to 500 mg, of the therapeutic '\n",
      " 'agent. Furthermore, the pharmaceutical composition can be adapted to weekly, '\n",
      " 'monthly or even more infrequent administration, for example by using an '\n",
      " 'implant, e.g. a subcutaneous or intramuscular implant, by using the compound '\n",
      " 'of the present subject matter in form of a sparingly soluble salt or by '\n",
      " 'using the compound of the present subject matter coupled to a polymer. '\n",
      " 'Administration of the pharmaceutical composition in a single dose per day is '\n",
      " 'preferred.</p>\\n'\n",
      " '<p id=\"p-2393\" num=\"4202\">In case the pharmaceutical composition of the '\n",
      " 'present subject matter comprises at least one of the compounds of the '\n",
      " 'present subject matter and at least one therapeutic agent selected from the '\n",
      " 'group consisting of corticosteroids, anticholinergics, beta-mimetics, lung '\n",
      " 'surfactants, endothelin antagonists, prostacyclins, calcium channel '\n",
      " 'blockers, beta-blockers, type 4 phosphodiesterase inhibitors, guanyl-cyclase '\n",
      " 'activators/stimulators, pirfenidone, antidepressants, antibiotics, '\n",
      " 'anticoagulants, diuretics and digitalis glycosides, administration of the '\n",
      " 'compound of the present subject matter and administration of the therapeutic '\n",
      " 'agent can be made simultaneously or sequentially. In case of sequential '\n",
      " 'administration, the compound of the present subject matter can be '\n",
      " 'administered before or after administration of the therapeutic agent.</p>\\n'\n",
      " '<p id=\"h-1639\" num=\"0000\">Biological Investigations</p>\\n'\n",
      " '<p id=\"h-1640\" num=\"0000\">Method for Measuring Inhibition of the Type 5 '\n",
      " 'Phosphodiesterase (PDE5) Activity:</p>\\n'\n",
      " '<p id=\"p-2394\" num=\"4203\">As a source for human PDE5, platelets are used. '\n",
      " 'For that purpose, 150 ml fresh blood from human donors anticoagulated with '\n",
      " 'citrate [final concentration 0.3% (w/v)] is centrifuged at 200 g for 10 min '\n",
      " 'to obtain the so-called platelet-rich-plasma (PRP) as a supernatant. 1/10 '\n",
      " 'volume of ACD solution (85 mM Na<sub>3</sub>-citrate, 111 mM D-glucose, 71 '\n",
      " 'mM citric acid, pH 4.4) is added to 9/10 volume of PRP. After centrifugation '\n",
      " '(1,400 g, 10 min) the cell pellet is resuspended in 3 ml homogenization '\n",
      " 'buffer (NaCl 140 mM, KCl 3.8 mM, EGTA (ethylene glycol tetraacetic acid) 1 '\n",
      " 'mM, MgCl<sub>2 </sub>1 mM, Tris-HCl 20 mM, beta-mercaptoethanol 1 mM, pH '\n",
      " '8.2) plus protease-inhibitor mix giving rise to the final concentrations of '\n",
      " '0.5 mM Pefablock (Roche), 10 &#x3bc;M Leupeptin, 5 &#x3bc;M '\n",
      " 'Trypsininhibitor, 2 mM Benzamidin and 10 &#x3bc;M Pepstatin A. The '\n",
      " 'suspension is sonified and thereafter centrifuged for 15 min at 10,000 g. '\n",
      " 'The resulting supernatant (platelet lysate) is used for enzymatic '\n",
      " 'testings.</p>\\n'\n",
      " '<p id=\"p-2395\" num=\"4204\">PDE5A1 activity is inhibited by the compounds of '\n",
      " 'the present subject matter in a modified SPA (scintillation proximity assay) '\n",
      " 'test, supplied by Amersham Biosciences (see procedural instructions '\n",
      " '&#x201c;phosphodiesterase [3H]cAMP SPA enzyme assay, code TRKQ '\n",
      " \"7090&#x201d;), carried out in 96-well microtitre plates (MTP's). The test \"\n",
      " 'volume is 100 &#x3bc;l and contains 20 mM Tris buffer (pH 7.4), 0.1 mg of '\n",
      " 'BSA (bovine serum albumin)/ml, 5 mM Mg<sup>2+</sup>, 1 &#x3bc;M motapizone, '\n",
      " '10 nM PDE2 inhibitor '\n",
      " '2-(3,4-dimethoxybenzyl)-7-[(1R,2R)-2-hydroxy-1-(2-phenylethyl)propyl]-5-methylimidazo[5,1-t][1,2,4]triazin-4(3H)-one, '\n",
      " '0.5 &#x3bc;M cGMP (cyclic guanosine monophosphate) (including about 50,000 '\n",
      " 'cpm of [3H]cGMP as a tracer), 1 &#x3bc;l of the respective compound dilution '\n",
      " 'in dimethylsulfoxide (DMSO) and sufficient PDE5-containing platelet lysat '\n",
      " '(10,000&#xd7;g supernatant, see above) to ensure that 10-20 wt % of the cGMP '\n",
      " 'is converted under the said experimental conditions. The final concentration '\n",
      " 'of DMSO in the assay (1% v/v) does not substantially affect the activity of '\n",
      " 'the PDE investigated. After a preincubation of 5 min at 37&#xb0; C., the '\n",
      " 'reaction is started by adding the substrate (cGMP) and the assay is '\n",
      " 'incubated for a further 15 min; after that, it is stopped by adding SPA '\n",
      " \"beads (50 &#x3bc;l). In accordance with the manufacturer's instructions, the \"\n",
      " 'SPA beads had previously been resuspended in water, but are then diluted 1:3 '\n",
      " '(v/v) in water; the diluted solution also contains 3 mM '\n",
      " '8-methoxymethyl-3-isobutyl-1-methylxanthine (IBMX) to ensure a complete PDE '\n",
      " 'activity stop. After the beads have been sedimented (&#x3e;30 min), the '\n",
      " \"MTP's are analyzed in commercially available luminescence detection devices. \"\n",
      " 'The corresponding IC<sub>50 </sub>values of the compounds for the inhibition '\n",
      " 'of PDE activity are determined from the concentration-effect curves by means '\n",
      " 'of non-linear regression.</p>\\n'\n",
      " '<p id=\"p-2396\" num=\"4205\">For the following compounds PDE5A1 inhibitory '\n",
      " 'values [measured as &#x2212;log IC<sub>50 </sub>(mol/l)] between 8.0 and 9.0 '\n",
      " 'have been determined. The numbers of the compounds correspond to the numbers '\n",
      " 'of the examples.</p>\\n'\n",
      " '<p id=\"p-2397\" num=\"4206\">Compounds: E28, E31-E33, E36, E39, E45-E54, E80, '\n",
      " 'E154, E156, E158, E162, E177, E192-E194, F17, F19-F23, F27-F33, F97-F98, '\n",
      " 'F119-F120, P3, P24-P26.</p>\\n'\n",
      " '<p id=\"p-2398\" num=\"4207\">For the following compounds PDE5A1 inhibitory '\n",
      " 'values [measured as &#x2212;log IC<sub>50 </sub>(mol/l)] higher than 9.0 '\n",
      " 'have been determined. The numbers of the compounds correspond to the numbers '\n",
      " 'of the examples.</p>\\n'\n",
      " '<p id=\"p-2399\" num=\"4208\">Compounds: E1-E27, E29-E30, E34-E35, E37-E38, '\n",
      " 'E40-E44, E55-E79, E81-E153, E155, E157, E159-E161, E163-E176, E178-E191, '\n",
      " 'E-195-E203, F1-F16, F18, F24-F26, F34-F74, F76-F96, F99-F118, P1-P2, P6-P8, '\n",
      " 'P89-P91, P139-P141, P159-P161, P169-P171, P189-P191, P199-201, '\n",
      " 'P209-P211.</p>\\n'\n",
      " '<p id=\"h-1641\" num=\"0000\">Method for Measuring Inhibition of the Type 4 '\n",
      " 'Phosphodiesterase (PDE4) Activity:</p>\\n'\n",
      " '<p id=\"p-2400\" num=\"4209\">The PDE4B1 (GB no. L20966) was a gift of Prof. M. '\n",
      " 'Conti (Stanford University, USA). It was amplified from the original plasmid '\n",
      " '(pCMV5) via PCR with primers Rb18 '\n",
      " '(5&#x2032;-CAGACATCCTAA-GAGGGGAT-3&#x2032;) and Rb10 '\n",
      " '(5&#x2032;-AGAGGGGGATTATGTATCCAC-3&#x2032;) and cloned into the pCR-Bac '\n",
      " 'vector (Invitrogen, Groningen, NL).</p>\\n'\n",
      " '<p id=\"p-2401\" num=\"4210\">The recombinant baculovirus was prepared by means '\n",
      " 'of homologous recombination in SF9 insect cells. The expression plasmids '\n",
      " 'were cotransfected with Baculo-Gold DNA (Pharmingen, Hamburg) using a '\n",
      " 'standard protocol (Pharmingen, Hamburg). Wt virus-free recombinant virus '\n",
      " 'supernatants were selected using plaque assay methods. After that, '\n",
      " 'high-titre virus supernatants were prepared by amplifying 3 times. PDE4B1 '\n",
      " 'was expressed in SF21 cells by infecting 2&#xd7;10<sup>6 </sup>cells/ml with '\n",
      " 'an MOI (multiplicity of infection) between 1 and 10 in the serum-free medium '\n",
      " 'Insect Express Sf9-52 (PAA, Pasching, Austria). The cells were cultured at '\n",
      " '28&#xb0; C. for 48-72 hours, after which they were pelleted for 5-10 min at '\n",
      " '1000&#xd7;g and 4&#xb0; C.</p>\\n'\n",
      " '<p id=\"p-2402\" num=\"4211\">The SF21 insect cells were resuspended, at a '\n",
      " 'concentration of approx. 10<sup>7 </sup>cells/ml, in ice-cold (4&#xb0; C.) '\n",
      " 'homogenization buffer (20 mM Tris, pH 8.2, containing the following '\n",
      " 'additions: 140 mM NaCl, 3.8 mM KCl, 1 mM EGTA, 1 mM MgCl<sub>2</sub>, 10 mM '\n",
      " '(3-mercaptoethanol, 2 mM benzamidine, 0.4 mM Pefablock, 10 &#x3bc;M '\n",
      " 'leupeptin, 10 &#x3bc;M pepstatin A, 5 &#x3bc;M trypsin inhibitor) and '\n",
      " 'disrupted by ultrasonication. The homogenate was then centrifuged for 10 min '\n",
      " 'at 1000&#xd7;g and the supernatant was stored at &#x2212;80&#xb0; C. until '\n",
      " 'subsequent use (see below). The protein content was determined by the '\n",
      " 'Bradford method (BioRad, Munich) using BSA as the standard.</p>\\n'\n",
      " '<p id=\"p-2403\" num=\"4212\">PDE4B1 activity was inhibited by the compounds '\n",
      " 'according to the present subject matter in a modified SPA (scintillation '\n",
      " 'proximity assay) test, supplied by Amersham Biosciences (see procedural '\n",
      " 'instructions &#x201c;phosphodiesterase [3H]cAMP SPA enzyme assay, code TRKQ '\n",
      " \"7090&#x201d;), carried out in 96-well microtitre plates (MTP's). The test \"\n",
      " 'volume is 100 &#x3bc;l and contains 20 mM Tris buffer (pH 7.4), 0.1 mg/ml of '\n",
      " 'BSA, 5 mM Mg<sup>2+</sup>, 0.5 &#x3bc;M cAMP (including about 50,000 cpm of '\n",
      " '[3H]cAMP), 1 &#x3bc;l of the respective substance dilution in DMSO and '\n",
      " 'sufficient recombinant PDE (1000&#xd7;g supernatant, see above) to ensure '\n",
      " 'that 10-20% of the cAMP is converted under the said experimental conditions. '\n",
      " 'The final concentration of DMSO in the assays (1% v/v) does not '\n",
      " 'substantially affect the activity of the PDE investigated. After a '\n",
      " 'preincubation of 5 min at 37&#xb0; C., the reaction is started by adding the '\n",
      " 'substrate (cAMP) and the assays are incubated for a further 15 min; after '\n",
      " 'that, they are stopped by adding SPA beads (50 &#x3bc;l). In accordance with '\n",
      " \"the manufacturer's instructions, the SPA beads had previously been \"\n",
      " 'resuspended in water, but were then diluted 1:3 (v/v) in water; the diluted '\n",
      " 'solution also contains 3 mM IBMX to ensure a complete PDE activity stop. '\n",
      " \"After the beads have been sedimented (&#x3e;30 min), the MTP's are analyzed \"\n",
      " 'in commercially available luminescence detection devices. The corresponding '\n",
      " 'IC<sub>50 </sub>values of the compounds for the inhibition of PDE4B1 '\n",
      " 'activity are determined from the concentration-effect curves by means of '\n",
      " 'non-linear regression.</p>\\n'\n",
      " '<p id=\"p-2404\" num=\"4213\">For the following compounds PDE4B1 inhibitory '\n",
      " 'values [measured as &#x2212;log IC<sub>50 </sub>(mol/l)] between 6.0 and 7.0 '\n",
      " 'have been determined. The numbers of the compounds correspond to the numbers '\n",
      " 'of the examples.</p>\\n'\n",
      " '<p id=\"p-2405\" num=\"4214\">Compounds: E37-E40, E45, E66-E74, E96, E145-E147, '\n",
      " 'E151-E157, E159-E160, E169-E171, E177-E178, F23-F24, F27, F41-F46, F58, F97, '\n",
      " 'F99-F101, F106.</p>\\n'\n",
      " '<p id=\"p-2406\" num=\"4215\">For the following compounds PDE4B1 inhibitory '\n",
      " 'values [measured as &#x2212;log IC<sub>50 </sub>(mol/l)] higher than 7.0 '\n",
      " 'have been determined. The numbers of the compounds correspond to the numbers '\n",
      " 'of the examples.</p>\\n'\n",
      " '<p id=\"p-2407\" num=\"4216\">Compounds: E41-E44, E81-E95, E97-E98, E148-E150, '\n",
      " 'E176, E-195-E203, F25-F26, F51-F57, F59-F62, F93-F96, P1-P3, P6-P8, P24-P26, '\n",
      " 'P89-P91, P99-P101, P139-P141, P159-P161, P169-P171, P189-P191, P199-201, '\n",
      " 'P209-P211.</p>\\n'\n",
      " '<p id=\"h-1642\" num=\"0000\">Animal Pharmacological Testing of PDE5 Inhibitory '\n",
      " 'Action of Compounds</p>\\n'\n",
      " '<p id=\"p-2408\" num=\"4217\">Nitric oxide regulates smooth muscle tone by '\n",
      " 'elevation of cGMP via activation of guanylate cyclase and subsequent '\n",
      " 'activation of cyclic GMP-dependent protein kinase. The amplitude and '\n",
      " 'duration of the cGMP signal in smooth muscle is largely regulated by '\n",
      " 'cGMP-specific cyclic nucleotide phosphodiesterase 5 (PDE5). Therefore, '\n",
      " 'inhibition of PDE5 or activation of guanylate cyclase causes altered '\n",
      " 'arterial blood pressure response, which is more pronounced under conditions '\n",
      " 'of acute arterial hypertension, which can be easily induced by continuous '\n",
      " 'intravenous (i.v.) phenylephrine (PE)-infusion. The aim of the study was to '\n",
      " 'evaluate the effects of the selective PDE5 inhibitors described in this '\n",
      " 'present subject matter on phenylephrine-induced acute arterial hypertension '\n",
      " 'and sodium-nitroprusside (SNP) induced blood pressure response in '\n",
      " 'anaesthetised male Sprague Dawley rats.</p>\\n'\n",
      " '<p id=\"h-1643\" num=\"0000\">Method</p>\\n'\n",
      " '<p id=\"p-2409\" num=\"4218\">The test compound (suspended in a 4% w/v aqueous '\n",
      " 'methylcellulose solution either 3 or 10 mg/kg) or placebo (i.e. 4% aqueous '\n",
      " 'methylcellulose solution) is administered orally to conscious Sprague Dawley '\n",
      " 'rats 90 min prior to SNP administration. 40 min later, rats are '\n",
      " 'anaesthetised by intramuscular administration of 80 mg/kg ketamine-HCl+4 '\n",
      " 'mg/kg xylazin-HCl and ventilated with &#x2dc;1.5% isoflurane in a mixture of '\n",
      " 'ambient air and 40% oxygen. Catheters for i.v. PE- and SNP-administration '\n",
      " 'and recording of mean arterial blood pressure (MAP) are inserted. One hour '\n",
      " 'after compound or placebo administration, a continuous i.v. (V. femoralis) '\n",
      " 'PE-infusion (3 &#x3bc;g/kg/min at an infusion rate of 0.06 ml/min) is '\n",
      " 'started and maintained till the end of the experiment. 30 min after start of '\n",
      " 'the PE-infusion, an i.v.-bolus of the NO-donor sodium nitroprusside (SNP, 30 '\n",
      " '&#x3bc;g/kg at a volume of 1.0 ml/kg) is administered. To assess the effect '\n",
      " 'of test compounds (PDE5 inhibitory activity) in comparison to placebo, MAP '\n",
      " 'response is analysed. MAP prior to SNP-administration and area under the '\n",
      " 'curve of MAP within 180 s following SNP-administration, corrected for '\n",
      " 'initial MAP (corr. AUC<sub>MAP 0-180s</sub>) is used, to describe altered '\n",
      " 'arterial vascular response and thus in vivo PDE5-inhibitory activity. The '\n",
      " 'efficacy (% change vs. control) achievable in this model is approximately '\n",
      " 'between &#x2212;11% and &#x2212;40% effect for the examples E1, E94, E102, '\n",
      " 'E131, F24, F65, F69, F84 and F112.</p>\\n'\n",
      " '<p id=\"h-1644\" num=\"0000\">Animal Pharmacological Testing of PDE4 Inhibitory '\n",
      " 'Action of Compounds</p>\\n'\n",
      " '<p id=\"p-2410\" num=\"4219\">The PDE4 inhibitory activity of compounds is well '\n",
      " 'described to result in anti-inflammatory effects. Therefore compounds of the '\n",
      " 'present subject matter have been tested for inhibition of lipopolysaccharide '\n",
      " 'induced tumor necrosis factor &#x3b1; (TNF&#x3b1;) release in male Sprague '\n",
      " 'Daley rats. The inhibition of LPS-induced TNF&#x3b1; production obtained by '\n",
      " 'testing of compounds in this model is between 7% and 99% for the examples '\n",
      " 'E84, E86, E87, E89, E93, E94, E95, F12, F53, F55, F56, P7, P8, P89, P90, '\n",
      " 'P140, P141, P160, P161, P170, P171, P189-P191, P199-P201, P210 and '\n",
      " 'P211.</p>\\n'\n",
      " '<p id=\"h-1645\" num=\"0000\">Method</p>\\n'\n",
      " '<p id=\"p-2411\" num=\"4220\">Compounds were administered at different doses to '\n",
      " 'male Sprague Daley rats (n=6-8 animals per dose group). A LPS and placebo '\n",
      " 'treated control group (n=6 to 8 animals) was enclosed.</p>\\n'\n",
      " '<p id=\"p-2412\" num=\"4221\">Compound and placebo were administered per os '\n",
      " '(p.o.) by gavage (administration volume: 10 ml/kg) one hour before LPS '\n",
      " 'challenge.</p>\\n'\n",
      " '<p id=\"p-2413\" num=\"4222\">LPS was injected intravenously (i.v.) at a dose of '\n",
      " '1 mg/kg (administration volume: 10 ml/kg). 1.5 h after LPS-challenge animals '\n",
      " 'were sacrificed by i.v. injection of sodium pentobarbital (120 mg/kg). '\n",
      " 'Heparinized blood was obtained by heart puncture. Blood was centrifuged '\n",
      " '(21,000&#xd7;g, 4&#xb0; C., 15 min), and plasma samples were kept frozen at '\n",
      " '&#x2212;80&#xb0; C. until determination of TNF&#x3b1; levels by ELISA.</p>\\n'\n",
      " '<?DETDESC description=\"Detailed Description\" end=\"tail\"?>\\n'\n",
      " '</description>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00001\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00001.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00001.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00002\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00002.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00002.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00003\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00003.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00003.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00004\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00004.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00004.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00005\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00005.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00005.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00006\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00006.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00006.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00007\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00007.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00007.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00008\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00008.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00008.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00009\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00009.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00009.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00010\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00010.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00010.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00011\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00011.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00011.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00012\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00012.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00012.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00013\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00013.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00013.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00014\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00014.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00014.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00015\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00015.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00015.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00016\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00016.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00016.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00017\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00017.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00017.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00018\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00018.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00018.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00019\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00019.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00019.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00020\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00020.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00020.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00021\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00021.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00021.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00022\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00022.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00022.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00023\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00023.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00023.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00024\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00024.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00024.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00025\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00025.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00025.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00026\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00026.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00026.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00027\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00027.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00027.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00028\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00028.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00028.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00029\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00029.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00029.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00030\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00030.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00030.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00031\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00031.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00031.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00032\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00032.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00032.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00033\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00033.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00033.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00034\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00034.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00034.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00035\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00035.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00035.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00036\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00036.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00036.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00037\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00037.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00037.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00038\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00038.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00038.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00039\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00039.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00039.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00040\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00040.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00040.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00041\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00041.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00041.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00042\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00042.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00042.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00043\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00043.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00043.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00044\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00044.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00044.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00045\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00045.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00045.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00046\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00046.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00046.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00047\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00047.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00047.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00048\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00048.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00048.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00049\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00049.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00049.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00050\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00050.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00050.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00051\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00051.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00051.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00052\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00052.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00052.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00053\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00053.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00053.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00054\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00054.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00054.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00055\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00055.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00055.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00056\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00056.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00056.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00057\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00057.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00057.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00058\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00058.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00058.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00059\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00059.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00059.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00060\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00060.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00060.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00061\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00061.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00061.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00062\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00062.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00062.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00063\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00063.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00063.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00064\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00064.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00064.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00065\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00065.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00065.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00066\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00066.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00066.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00067\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00067.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00067.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00068\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00068.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00068.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00069\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00069.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00069.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00070\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00070.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00070.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00071\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00071.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00071.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00072\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00072.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00072.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00073\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00073.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00073.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00074\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00074.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00074.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00075\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00075.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00075.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00076\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00076.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00076.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00077\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00077.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00077.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00078\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00078.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00078.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00079\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00079.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00079.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00080\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00080.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00080.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00081\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00081.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00081.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00082\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00082.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00082.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00083\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00083.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00083.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00084\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00084.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00084.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00085\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00085.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00085.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00086\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00086.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00086.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00087\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00087.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00087.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00088\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00088.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00088.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00089\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00089.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00089.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00090\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00090.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00090.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00091\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00091.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00091.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00092\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00092.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00092.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00093\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00093.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00093.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00094\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00094.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00094.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00095\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00095.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00095.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00096\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00096.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00096.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00097\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00097.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00097.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00098\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00098.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00098.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00099\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00099.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00099.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00100\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00100.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00100.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00101\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00101.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00101.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00102\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00102.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00102.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00103\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00103.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00103.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00104\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00104.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00104.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00105\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00105.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00105.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00106\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00106.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00106.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00107\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00107.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00107.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00108\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00108.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00108.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00109\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00109.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00109.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00110\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00110.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00110.MOL\"/>\\n'\n",
      " '<us-chemistry idref=\"CHEM-US-00111\" '\n",
      " 'cdx-file=\"US08927557-20150106-C00111.CDX\" '\n",
      " 'mol-file=\"US08927557-20150106-C00111.MOL\"/>\\n'\n",
      " '<us-claim-statement>The invention claimed is:</us-claim-statement>\\n'\n",
      " '<claims id=\"claims\">\\n'\n",
      " '<claim id=\"CLM-00001\" num=\"00001\">\\n'\n",
      " '<claim-text>1. A compound of formula (I)</claim-text>\\n'\n",
      " '<claim-text><chemistry id=\"CHEM-US-00110\" num=\"00110\">\\n'\n",
      " '<img id=\"EMI-C00110\" he=\"49.28mm\" wi=\"61.72mm\" '\n",
      " 'file=\"US08927557-20150106-C00110.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</claim-text>\\n'\n",
      " '<claim-text>wherein\\n'\n",
      " '<claim-text>R1 is &#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</claim-text>\\n'\n",
      " '<claim-text>R2 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R21 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R22 is hydrogen, halogen, 1-4C-alkyl, 1-4C-alkoxy, '\n",
      " '&#x2014;C(O)-1-4C-alkyl or 1-4C-fluoroalkyl, or R21 and R22 combine to form '\n",
      " 'a group &#x2014;O&#x2014;CH<sub>2</sub>&#x2014;O&#x2014;,</claim-text>\\n'\n",
      " '<claim-text>R23 is hydrogen, halogen or 1-4C-alkoxy,</claim-text>\\n'\n",
      " '<claim-text>R24 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>Y is &#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</claim-text>\\n'\n",
      " '<claim-text>n is 0,</claim-text>\\n'\n",
      " '<claim-text>R3 is a cyclohexyl or cyclopentyl group substituted by R6 and '\n",
      " 'optionally substituted by R61,</claim-text>\\n'\n",
      " '<claim-text>R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7,</claim-text>\\n'\n",
      " '<claim-text>R61 is halogen or 1-4C-alkyl,</claim-text>\\n'\n",
      " '<claim-text>R7 is 1-4C-alkyl, which is optionally substituted by R71, or R7 '\n",
      " 'is 1-4C-alkoxy,</claim-text>\\n'\n",
      " '<claim-text>R71 is 1-4C-alkoxy,</claim-text>\\n'\n",
      " '<claim-text>or a salt thereof, a stereoisomer of the compound or a salt of '\n",
      " 'the stereoisomer.</claim-text>\\n'\n",
      " '</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00002\" num=\"00002\">\\n'\n",
      " '<claim-text>2. A compound of formula (I)</claim-text>\\n'\n",
      " '<claim-text><chemistry id=\"CHEM-US-00111\" num=\"00111\">\\n'\n",
      " '<img id=\"EMI-C00111\" he=\"49.28mm\" wi=\"61.72mm\" '\n",
      " 'file=\"US08927557-20150106-C00111.TIF\" alt=\"embedded image\" '\n",
      " 'img-content=\"chem\" img-format=\"tif\"/>\\n'\n",
      " '</chemistry>\\n'\n",
      " '</claim-text>\\n'\n",
      " '<claim-text>wherein\\n'\n",
      " '<claim-text>R1 is &#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</claim-text>\\n'\n",
      " '<claim-text>R2 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R21 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R22 is difluoromethyl or trifluoromethyl,</claim-text>\\n'\n",
      " '<claim-text>R23 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R24 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>Y is &#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</claim-text>\\n'\n",
      " '<claim-text>n is 0,</claim-text>\\n'\n",
      " '<claim-text>R3 is a cyclohexyl group substituted by R6 and optionally '\n",
      " 'substituted by R61,</claim-text>\\n'\n",
      " '<claim-text>R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7,</claim-text>\\n'\n",
      " '<claim-text>R61 is fluoro or methyl,</claim-text>\\n'\n",
      " '<claim-text>R7 is methyl or ethyl, which are optionally substituted by '\n",
      " 'R71,</claim-text>\\n'\n",
      " '<claim-text>R71 is methoxy or hydroxy,</claim-text>\\n'\n",
      " '<claim-text>or a salt thereof, a stereoisomer of the compound or a salt of '\n",
      " 'the stereoisomer.</claim-text>\\n'\n",
      " '</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00003\" num=\"00003\">\\n'\n",
      " '<claim-text>3. A compound of formula I according to <claim-ref '\n",
      " 'idref=\"CLM-00002\">claim 2</claim-ref>, wherein\\n'\n",
      " '<claim-text>R1 is &#x2014;CH<sub>2</sub>-3-4C-cycloalkyl,</claim-text>\\n'\n",
      " '<claim-text>R2 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R21 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R22 is difluoromethyl,</claim-text>\\n'\n",
      " '<claim-text>R23 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>R24 is hydrogen,</claim-text>\\n'\n",
      " '<claim-text>Y is &#x2014;(CH<sub>2</sub>)<sub>n</sub>&#x2014;,</claim-text>\\n'\n",
      " '<claim-text>n is 0,</claim-text>\\n'\n",
      " '<claim-text>R3 is a cyclohexyl group substituted by R6 and optionally '\n",
      " 'substituted by R61,</claim-text>\\n'\n",
      " '<claim-text>R6 is &#x2014;NH&#x2014;C(O)&#x2014;R7,</claim-text>\\n'\n",
      " '<claim-text>R61 is fluoro or methyl,</claim-text>\\n'\n",
      " '<claim-text>R7 is methyl or ethyl, which are optionally substituted by '\n",
      " 'R71,</claim-text>\\n'\n",
      " '<claim-text>R71 is methoxy or hydroxy,</claim-text>\\n'\n",
      " '<claim-text>or a salt thereof, a stereoisomer of the compound or a salt of '\n",
      " 'the stereoisomer.</claim-text>\\n'\n",
      " '</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00004\" num=\"00004\">\\n'\n",
      " '<claim-text>4. A compound according to <claim-ref idref=\"CLM-00001\">claim '\n",
      " '1</claim-ref> selected from the group consisting of '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-(Cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluorophenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(trans-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[trans-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-(cis-4-Acetamidocyclohexyl)-4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-N-[cis-4-(propionylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'Ethyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-N-[cis-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-ethylphenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[cis-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-N-{cis-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[5-acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[5-Acetyl-2-(cyclopropylmethoxy)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluorophenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-c]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo '\n",
      " 'yl}carbonyl)amino]cyclohexyl}carbamate; tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-fluoro-4-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-ethylphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{cis-4-[({4-[2-(cyclopropylmethoxy)-5-(propan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'tert-Butyl '\n",
      " '{trans-4-[({4-[2-(cyclopropylmethoxy)-5-(2-methyl-1,3-dioxolan-2-yl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl}carbonyl)amino]cyclohexyl}carbamate; '\n",
      " 'N-[trans-4-(Acetylamino)cyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S,3S)-3-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S,3S)-3-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,2S*,4S*)-4-(Acetylamino)-2-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,2S*,4S*)-2-methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2S*,4S*)-4-[(methoxyacetyl)amino]-2-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,2R*,4R*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,3S*,4S*)-4-(Acetylamino)-3-methylcyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1S*,3S*,4S*)-3-methyl-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3 '\n",
      " 'S*,4S*)-4-[(methoxyacetyl)amino]-3-methylcyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,3S*,4S*)-4-(Acetylamino)-3-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3S*,4S*)-3-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-3-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,3S*,4S*)-3-(Acetylamino)-4-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,3S*,4S*)-3-methyl-4-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,3S*,4S*)-3-[(methoxyacetyl)amino]-4-methylcyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1R*,2R*,4S*)-4-(acetylamino)-2-methylcyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[(1R*,2R*,4S*)-2-methyl-4-(propanoylamino)cyclopentyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4S*)-4-[(methoxyacetyl)amino]-2-methylcyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,3S*,4S*)-3-(Acetylamino)-4-fluorocyclopentyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,3S*,4S*)-3-fluoro-4-(propanoylamino)cyclopentyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,3S*,4S*)-3-fluoro-4-[(methoxyacetyl)amino]cyclopentyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'N-[(1S*,2R*,4S*)-4-(Acetylamino)-2-fluorocyclohexyl]-4-[2-(cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1S*,2R*,4S*)-2-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1S*,2R*,4S*)-2-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'salts of these compounds, stereoisomers of these compounds, and salts of the '\n",
      " 'stereoisomers of these compounds.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00005\" num=\"00005\">\\n'\n",
      " '<claim-text>5. A compound according to <claim-ref idref=\"CLM-00002\">claim '\n",
      " '2</claim-ref> selected from the group consisting of '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{trans-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(trans-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-{cis-4-[(hydroxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-N-(cis-4-{[(2S)-2-hydroxypropanoyl]amino}cyclohexyl)-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide; '\n",
      " 'salts of these compounds, stereoisomers of these compounds, and salts of the '\n",
      " 'stereoisomers of these compounds.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00006\" num=\"00006\">\\n'\n",
      " '<claim-text>6. A compound according to <claim-ref idref=\"CLM-00001\">claim '\n",
      " '1</claim-ref> selected from the group consisting of '\n",
      " '4-[2-(cyclopropylmethoxy)-5-(trifluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide, '\n",
      " 'a salt thereof, a stereoisomer of the compound and a salt of the '\n",
      " 'stereoisomer.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00007\" num=\"00007\">\\n'\n",
      " '<claim-text>7. A compound according to <claim-ref idref=\"CLM-00001\">claim '\n",
      " '1</claim-ref> selected from the group consisting of '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-6-methyl-N-[trans-4-(propanoylamino)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide, '\n",
      " 'a salt thereof, a stereoisomer of the compound and a salt of the '\n",
      " 'stereoisomer.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00008\" num=\"00008\">\\n'\n",
      " '<claim-text>8. A compound according to <claim-ref idref=\"CLM-00001\">claim '\n",
      " '1</claim-ref> selected from the group consisting of '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{trans-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide, '\n",
      " 'a salt thereof, a stereoisomer of the compound and a salt of the '\n",
      " 'stereoisomer.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00009\" num=\"00009\">\\n'\n",
      " '<claim-text>9. A compound according to <claim-ref idref=\"CLM-00001\">claim '\n",
      " '1</claim-ref> selected from the group consisting of '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-[(1R*,2R*,4R*)-2-fluoro-4-(propanoylamino)cyclohexyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide, '\n",
      " 'a salt thereof, a stereoisomer of the compound and a salt of the '\n",
      " 'stereoisomer.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00010\" num=\"00010\">\\n'\n",
      " '<claim-text>10. A compound according to <claim-ref idref=\"CLM-00001\">claim '\n",
      " '1</claim-ref> selected from the group consisting of '\n",
      " '4-[2-(Cyclopropylmethoxy)-5-(difluoromethyl)phenyl]-N-{(1R*,2R*,4R*)-2-fluoro-4-[(methoxyacetyl)amino]cyclohexyl}-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide, '\n",
      " 'a salt thereof, a stereoisomer of the compound and a salt of the '\n",
      " 'stereoisomer.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00011\" num=\"00011\">\\n'\n",
      " '<claim-text>11. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds, or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00012\" num=\"00012\">\\n'\n",
      " '<claim-text>12. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00004\">claim 4</claim-ref>, together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00013\" num=\"00013\">\\n'\n",
      " '<claim-text>13. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00005\">claim 5</claim-ref>, together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00014\" num=\"00014\">\\n'\n",
      " '<claim-text>14. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00006\">claim 6</claim-ref>, together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00015\" num=\"00015\">\\n'\n",
      " '<claim-text>15. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00006\">claim 6</claim-ref>, together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00016\" num=\"00016\">\\n'\n",
      " '<claim-text>16. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00008\">claim 8</claim-ref>, together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00017\" num=\"00017\">\\n'\n",
      " '<claim-text>17. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00018\" num=\"00018\">\\n'\n",
      " '<claim-text>18. A pharmaceutical composition comprising at least one of the '\n",
      " 'compounds, pharmaceutically acceptable salts thereof, stereoisomers of the '\n",
      " 'compounds or the pharmaceutically acceptable salts thereof according to '\n",
      " '<claim-ref idref=\"CLM-00010\">claim 10</claim-ref> together with at least one '\n",
      " 'pharmaceutically acceptable auxiliary.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00019\" num=\"00019\">\\n'\n",
      " '<claim-text>19. A method for treating portal hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00020\" num=\"00020\">\\n'\n",
      " '<claim-text>20. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00021\" num=\"00021\">\\n'\n",
      " '<claim-text>21. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00004\">claim 4</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00022\" num=\"00022\">\\n'\n",
      " '<claim-text>22. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00005\">claim 5</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00023\" num=\"00023\">\\n'\n",
      " '<claim-text>23. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00006\">claim 6</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00024\" num=\"00024\">\\n'\n",
      " '<claim-text>24. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00007\">claim 7</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00025\" num=\"00025\">\\n'\n",
      " '<claim-text>25. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00008\">claim 8</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00026\" num=\"00026\">\\n'\n",
      " '<claim-text>26. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '<claim id=\"CLM-00027\" num=\"00027\">\\n'\n",
      " '<claim-text>27. A method for treating pulmonary hypertension comprising '\n",
      " 'administering to a patient in need thereof a therapeutically effective '\n",
      " 'amount of a compound, a pharmaceutically acceptable salt thereof, a '\n",
      " 'stereoisomer of the compound or a pharmaceutically acceptable salt thereof '\n",
      " 'according to <claim-ref idref=\"CLM-00010\">claim '\n",
      " '10</claim-ref>.</claim-text>\\n'\n",
      " '</claim>\\n'\n",
      " '</claims>\\n'\n",
      " '</us-patent-grant>\\n')\n"
     ]
    }
   ],
   "source": [
    "import pprint as pp\n",
    "pp.pprint(merged[merged.patentnumber == \"8927557\"][\"xml\"].values[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>difference</th>\n",
       "      <th>patentnumber</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>56.0</td>\n",
       "      <td>8933072</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>15.0</td>\n",
       "      <td>8927721</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>12.0</td>\n",
       "      <td>8933042</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>11.0</td>\n",
       "      <td>8926966</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>7.0</td>\n",
       "      <td>8927710</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>6.0</td>\n",
       "      <td>8937055</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>6.0</td>\n",
       "      <td>8933229</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>6.0</td>\n",
       "      <td>8926862</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>6.0</td>\n",
       "      <td>8932717</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>6.0</td>\n",
       "      <td>8927588</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     difference patentnumber\n",
       "67         56.0      8933072\n",
       "36         15.0      8927721\n",
       "63         12.0      8933042\n",
       "8          11.0      8926966\n",
       "35          7.0      8927710\n",
       "100         6.0      8937055\n",
       "82          6.0      8933229\n",
       "4           6.0      8926862\n",
       "55          6.0      8932717\n",
       "23          6.0      8927588"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mosftdf = pd.DataFrame(stats[\"most_differences\"])\n",
    "mosftdf.columns = [\"difference\",\"patentnumber\"]\n",
    "mosftdf.sort_values(\"difference\",ascending=False).head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'8927557': {'past': 1, 'present': 0, 'unknown': 0},\n",
       " '8927542': {'past': 0, 'present': 0, 'unknown': 0}}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dic_to_dic_w_tense_test({\"8927557\":stats[\"documents_with_examples\"][\"8927557\"],\"8927542\" : stats[\"documents_with_examples\"][\"8927542\"]})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# gib_path = \"gilberish_xmls\"\n",
    "# os.makedirs(gib_path, exist_ok=True)\n",
    "# for i, xml in enumerate(stats[\"gibs\"]):\n",
    "    \n",
    "#     save_xml_string(xml, f\"{gib_path}/gibberish_{find_doc_number(xml)}.xml\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'number': 'Example 1',\n",
       "  'title': 'Preferred Embodiment of the Invention',\n",
       "  'content': ['In its preferred embodiment the device is composed by a thin flexible hollow shaft with inflatable balloons as retractor and anchor members (FIG. 5 A). The materials and manufacture of such a device is well known in the art as exemplified by angioplasty catheters, tracheotomy tubes, jejunostomy tubes and other biocompatible medical devices that are temporarily or permanently implanted within body tissue. As representative examples of the art, U.S. Pat. No. 3,659,612 to Shiley describes a cannula that is placed in the trachea with a refillable balloon at its internal end; U.S. Pat. No. 4,335,723 to Patel describes the use of thermoplastic elastomer material for balloon cathers; U.S. Pat. No. 6,013,728 to Chen describes biocompatible polymers used in construction of vascular catheters and expansion balloons, U.S. Pat. No. 4,254,774 to Beritos teaches the manufacture of catheters with external diameters less than 1 mm and external balloons with walls less than 0.002 inches in thickness.',\n",
       "   'Preferably the retractor is a spherical balloon which has a diameter of 0.5 cm when inflated. The force that acts on the balloon comes from a 5 cm long shaft with an external diameter of 2 mm that passes through the center of the balloon. The retractor balloon is attached to the shaft in two places, where the shaft enters the balloon and at the tip of the shaft. These attachments are airtight and securely connect the balloon to the shaft.',\n",
       "   'At the exit of the shaft from the tongue there is a second balloon attached that serves as an anchor. The anchor balloon is 1 cm long and tapered with its narrow end embedded in tissue and the wider end outside tissue. The taper is a wedge which resists the anchor from being drawn into the tongue (FIG. 7). When the patient swallows the tongue curve rises and the anchor balloon is drawn into the tongue. After the swallow the anchor balloon gently repositions the device. The amount of resistance and counterforce provided by the anchor balloon is directly related to its degree of inflation. The greater the volume of air in the balloon the greater the resistance of the balloon to being drawn into the tongue.',\n",
       "   'The force imparted to the balloon indents the tissue at the tongue curve and prevents it from deforming and collapsing into the airway under negative pressure. This force is conveyed to the balloon by the shaft. This shaft passes through the center of the tongue to exit from the its undersurface at the point where the frenulum connects to the tongue blade.',\n",
       "   'The shaft is hollow with an internal diameter of 1 mm to allow it to be mounted over a trocar needle for insertion (FIG. 5). When the balloons are deflated they lie flush against the shaft such that the shaft has a smooth surface. In the deflated condition the device can be easily inserted or removed from the tongue. For example, in the morning the balloons can be deflated to slide the entire device out of the tongue. The presence of a tapered anchor balloon causes slight widening of the tongue tissue at its exit from the tongue. After a week this widening of the tissue is maintained even if the device is removed for a day and serves to easily guide the device into its tissue conduit. When the retractor tip is passed through the tongue and exits from the tongue base the balloons can be inflated to a proper size that is effective yet comfortable for the patient.',\n",
       "   'The balloons can be inflated separately or more preferably they are connected by a small tube that runs along the side of the shaft (FIG. 6). In this manner inflation of the anchor balloon, which is easily accessed by the patient, also inflates the retractor balloon. The anchor balloon has a small resealable rubber diaphragm through which a needle can be inserted to insert or remove air or liquid. U.S. Pat. No. 4,387,879 to Tauschinski describes a self-sealing connector for use with plastic cannulas and vessel catheters, U.S. Pat. No. 5,498,247 to Brimhall describes an elastomeric injection port that reseals after needle punctures for injection of fluid. A variety of other reusable interfaces for transferring air or fluid are known in the art and can be substituted.',\n",
       "   'A non-limiting example of the method of this invention is described. A 60 year male complains of awakening during the night with choking sensations, morning headaches, daytime sleepiness, difficulty in concentrating, irritability and acid reflux. Physical examination shows moderate obesity, an elongated soft palate and enlarged tongue base. Endoscopy shows diffuse mild swelling and redness throughout his pharyngeal mucosa. The area of the velopharynx is notably narrow and collapses when the patient attempts a forceful inspiration. The patient has a sleep study performed that shows he has obstructive sleep apnea with an apnea-hypopnea index of 30 with episodes of oxygen desaturation.',\n",
       "   'After discussing the therapeutic options with his physician he elects to try CPAP. He then undergoes a second overnight sleep study with CPAP testing and titration of pressure. He is found to have the best response a CPAP pressure of 14 cm of water. He obtains a CPAP machine and is instructed on its use. The patient finds that the device is uncomfortable, he complains of feeling claustrophobic and that it is difficult to maintain an airtight seal of the mask on his face throughout the night.',\n",
       "   'The patient requests that a tongue retractor be inserted. The procedure is performed in an ambulatory surgical center under mild sedation and with continuous monitoring of electrocardiogram and oxygen saturation.',\n",
       "   \"A small amount of 1% lidocaine is sprayed onto the inferior surface of the patient's tongue to provide surface anesthesia. Using a 1 cc syringe with a 30 gauge needle the intended insertion tract in injected with suitable local anesthetic, preferably 1% lidocaine with 1:100,000 epinephrine. The needle is passed through the tongue from the undersurface to the tongue base and the anesthetic is injected.\",\n",
       "   'After allowing 10 minutes for onset of the anesthetic action the physician gently grasps the tongue blade with a cotton 4×4 and lifts it to expose the undersurface of the tongue.',\n",
       "   'For initial insertion of the device it is mounted on a 5.25 cm trocar needle with a 1 mm external diameter. After the trocar is based through the hollow core of the device it covers the entire length of the trocar needle except thee tapered tip that projects 0.25 cm beyond the device.',\n",
       "   \"The initial insertion point is at the junction of the frenulum with the tongue blade. The tip of the needle in inserted into the frenulum and oriented toward the tongue curve. The device is advanced slowly until it's tip is seen exiting the base of the tongue. The needle is pushed further until the retractor balloon is seen and then the needle is removed while the position of the device is maintained by holding the anchor. Once the needle is removed the balloons are inflated by injecting 2 cc of air though the resealable injection port. The patient is observed for 2 hours to ensure that no significant swelling occurs and then is sent home with mild analgesics and antibiotics for 3 days. Every morning the patient removes 1 cc of air from the device to decrease the size of the balloons so that the device is more comfortable. In the evening he reinjects 1 cc of air into the device.\",\n",
       "   'After 1 week the patient returns to his physician for follow-up and reports that he has been sleeping well without awakening during the night and that feels well rested each morning without any headaches. His wife has told him that she has not noticed any snoring. The patient also notes that symptoms of acid reflux have decreased. The physician deflates the balloons and removes the device. He examines the openings of the tongue tract for any sign of infection or erosion. The physician then instructs the patient on how to remove and replace the device. From then on the patient completely deflates the balloons each morning and extracts the device by pulling on the anchor. In the evening he threads the retractor end into the tract opening underneath his tongue and then reinjects 2 cc of air.',\n",
       "   'This example is illustrative of a preferred embodiment and is not limiting. Non-limiting alternative embodiments include devices containing 1 to 10 balloons or a single balloon spanning the length of the shaft. The shaft itself may be composed of a solid or hollow cylindrical balloon. Those skilled in the art can perform the method of the device without undo experimentation. The device itself can be modified by the use of a variety of materials, and shape and nature of its components can be readily varied in multiple ways by those skilled in the art.']},\n",
       " {'number': 'Example 2',\n",
       "  'title': 'Alternative Embodiment (FIG. 8)',\n",
       "  'content': ['In another embodiment of the invention used in the tongue the tongue retractor consists of a small flexible disc to which the retractor shaft connects in the center of one surface. This shaft would have a terminal end to which an anchor attached.',\n",
       "   'The disc would preferably be elliptical with a 1 cm long axis oriented along the centerline of the tongue, and a 5 mm short axis oriented perpendicular to the centerline. Preferably the undersurface of the retaining disc would have a slight taper in thickness from the lateral edges to the centerline.',\n",
       "   'The retaining disc would lay flush against the tongue surface and exert a small amount of force to prevent deformation of this area. More counterforce would cause an indentation or reverse deformation of the tongue curve (FIG. 8 D). This reverse deformation would maintain an open conduit so that even if the tongue were to collapse against the pharynx or soft palate, there would never be complete obstruction.',\n",
       "   'Preferably the disc would be composed of soft and pliable biocompatible material so that it can exert pressure onto tongue mucosa without causing tissue damage. The amount of pressure that an implant can exert without causing damage is largely related to the pressure at which blood flow is compromised. For the purpose of retaining the tongue curve the counter pressure is preferably 0.01 to 1000 grams per cm2, more preferably 0.1 to 100 grams per cm2, and most preferably 1 to 10 grams per cm2.',\n",
       "   'The shaft would pass through the body of the tongue and exit through its undersurface. Preferably the shaft would be solid yet flexible, able to deform in shear and strain. This would allow the shaft to flex during when tongue movements cause internal changes in relative position along its length.',\n",
       "   'Preferably the shaft would be able to stretch. More preferably the shaft would be very compliant, able to easily stretch during forceful movements of the tongue base during speech and swallowing, yet retain sufficient strength to prevent deformation of the relaxed tongue curve during sleep. The force exerted by the tongue during swallowing has been measured to be approximately 100 grams per cm2 (Proffit, W. R., Muscle pressures and tooth position: a review of current research. Aust. Orthod, J., 1973. 3: p. 104-108). Preferably the resistance to stretch would be adjustable by intrinsic qualities of the shaft. Non-limiting examples being the presence of a spring or by the use of elastomeric materials. In other embodiments the adjustment in tension and movement would be imparted by the anchor. A non-limiting example is a wedge shape similar to that described for the anchor balloon in the preferred embodiment.',\n",
       "   'Preferably the length of the shaft would be 1 mm to 20 cm, more preferable 1 to 10 cm and most preferably 5 cm. The diameter of the shaft could be from 0.1 mm to 5 cm. 1 mm in diameter and circular in cross section throughout most of its length.',\n",
       "   'Preferably the proximal end of the shaft has an anchor is detachable. The mechanism of attachment could be by screw, clip, ratchet, magnet, or other mechanism known in the art. In this manner the anchor could be either easily unattached from the anchor. When unattached the retractor head and shaft would preferably remain in position within the tongue. Preferably there would be a small flange on the anchor end of the shaft such as illustrated in FIG. 11 A.',\n",
       "   'If desired the device could be removed in its entirety during the day. After a period of time conduits that pass through body tissues become mature, that is they do not close immediately when the external object is removed temporarily. Therefore the device could be removed in the morning by pulling on the retaining disc leaving only the collapsed tract through tongue tissue. The following night the distal end would be again threaded through this tract into position and secured to the anchor.']},\n",
       " {'number': 'Example 3',\n",
       "  'title': 'Alternative Embodiments Related to Soft Tissue Location',\n",
       "  'content': ['Although the tongue is the major cause of OSAS other soft tissue structures also contribute. Alternative embodiments of this invention can be used to prevent the deformation of lax soft tissue in these organs.',\n",
       "   'a) Placement of the Device in the Softpalate.',\n",
       "   'An elongated or thickened soft palate often contributes to OSAS or snoring. One embodiment of the invention is to reversible retract the soft palate tissue away from the area of obstruction to treat OSAS or snoring. Another object of the invention is to stiffen the soft palate to dampen its oscillation to prevent snoring. A preferred embodiment of the device in the soft palate would have a retractor on the external surface of the free end of the soft palate and a shaft passing forward within the soft palate to an anchor on the external surface of the soft palate near the hard palate (FIG. 10, SR). Numerous embodiments that achieve the object of the invention can be understood by those skilled in the art.',\n",
       "   'b) Placement of the Device in the Pharyngeal Walls',\n",
       "   'In certain cases excess soft tissue of the pharyngeal walls contributes to airway narrowing. The device can be inserted in pharyngeal walls to retract excess soft tissue away from the areas of obstruction (FIG. 10, SR).',\n",
       "   'c) Placement of the Device in Laryngeal Soft Tissue.',\n",
       "   'In certain cases the larynx contributes to OSAS. The epiglottis can be flail and rest against the posterior pharyngeal wall, or the soft tissue connected to the epiglottis, the aryepiglottic folds and vallecula, can be swollen. The internal side of these structures contains a dense sensory innervation and is hot a preferred location for retractor member. Most preferred is the mucosa of the vallecula, the area between the epiglottis and the tongue base. Retraction of this location raises the epiglottis and stiffens the soft tissue of the larynx.']},\n",
       " {'number': 'Example 4',\n",
       "  'title': 'Alternative Embodiment that is Implanted within Soft Tissue',\n",
       "  'content': ['There are advantages to having the device pass completely through an upper airway organ. Without limitation these include easy access to the retractor and anchor components and the ability to easily remove the device. However, this is not essential. The device could also be completely implanted within tissue. Although not wishing to be bound by theory, the important action of the invention is to mechanically couple the soft tissue of a structure that relaxes during sleep to another structure. Preferably the second structure is an external muscle that remains active during sleep (genioglossus, geniohyoid, myelohyoid, digastric muscle) thereby providing active retraction. Other muscles within the neck (strenohyoid, sternothyroid, thryohyoid) and chest (diaphragm intercostals) could also be use however these would require long shafts. In the tongue one embodiment is a retractor implanted in the soft tissue of the tongue curve that is connected by a shaft to an anchor embedded in the genioglossus muscle (FIG. 9 C).',\n",
       "   'External retractors and anchors pull on mucosa and the underlying soft tissue. Their preferred mechanical interaction is to distribute force along a surface interface so as not cause pressure necrosis to tissue. In contrast, implanted embodiments can mechanically interface with tissue in additional ways.',\n",
       "   'FIG. 11 is an illustrative example of a an implantable device that has hook elements as both retractor and anchor components (FIG. 11A). The implanted device can be inserted using a hollow bore needle (FIG. 11 B) by placing the device such that the retractor end hooks extend laterally out from the opening of the needle near the tip (FIG. 11 C). Insertion can be done by piercing the mucosa at the site of insertion and passing the needle tip to the preferred depth. Then when the needle is withdrawn the hooks of the retractor grab tissue and pull the device out of the needle bore when the needle is withdrawn.',\n",
       "   'FIG. 11 D illustrates a preferred position and orientation within the tongue. The retractor hooks interface on soft tissue within the tongue so that they directly and indirectly can retract the tongue curve. The anchor hooks interface with the genioglossus muscle. During sleep the contraction of the genioglossus muscle actively retracts the tongue curve.']},\n",
       " {'number': 'Example 5',\n",
       "  'title': 'Further Alternative Embodiments',\n",
       "  'content': ['The retractor components could vary in their number, position, material composition, mechanical properties, shape, dimensions, and the manner of attachment of the components to each other (permanent to removable).',\n",
       "   'In some embodiments the materials of the device could be flexible, non-limiting examples being silastic, teflon, or nylon. In other embodiments the materials could be rigid, non-limiting examples being stainless steel or titanium. In some embodiments different components are composed of different materials. Many biocompatible materials are known in the art that could be used. (Ratner et al, Biomaterials Science, Academic Press San Diego 1996). The materials used may be natural body substances, two common proteins used for implantation within the body are collagen and elastin and examples of the art using these materials are U.S. Pat. No. 5,989,244 to Gregory that describes the use of elastin as a material for implanted devices and U.S. Pat. No. 5,376,110 to Tu describing methods of preparing collagen for implants.',\n",
       "   'Preferably the retractor, anchor and shaft would be molded as a single continuous structure such that this junction would be less likely to have small niches where biological debris and bacteria could accumulate. In other embodiments components could be detachable. Many mechanisms for reversible mechanical detachment are known in the art, one non-limiting example is the presence of threads on the end of the shaft and in the center of the retractor head, such that that retractor head could be screwed onto the shaft like a nut onto a bolt.',\n",
       "   'In different embodiments the shape and size of the retractor would preferably reflect the anatomy of the region. In certain embodiments the retractor presses on the mucosal surface of the tongue, soft palate, pharyngeal walls, or supraglottic larynx. In these different embodiments the size and shape of the retractor could vary to conform to the shape of the surface that its rests against. Preferably the retractor would distribute force to the mucosa evenly to minimize tissue trauma. The largest diameter of the retractor head could range from 0.1 mm to 10 cm, preferably 1 mm to 1 cm and most preferably 5 mm.',\n",
       "   'The anchor serves to provide counterforce to the retractor during sleep. In a preferred embodiment the surface area of the bolster is the same or greater than the retractor thereby distributing the forces over a larger area. In some embodiments the anchor would serve to allow adjustment of tension between the anchor and the retractor.',\n",
       "   'In alternative embodiments the length of the shaft could vary from 0.1 mm to 20 cm, preferably 1 mm to 10 cm, and most preferably 1 to 5 cm. The diameter of the shaft could range from 0.01 mm to 100 mm, more preferably 0.1 mm to 10 mm, and most preferrably 1 mm to 5 mm. The shaft could have a hollow core that extends from one end of the shaft to the other, in other embodiments only a segment of the shaft would be hollow, or the shaft would be solid with no hollow core. The diameter of the shaft could taper with the largest diameter at one end with decreasing diameter toward the other end, largest diameter in the center with narrowing toward each end or smallest diameter in the center with increasing diameters toward each end.',\n",
       "   'The position and orientation of the shaft could vary. The retractor head could be placed at other points along the midline of the tongue. The angle of the shaft could vary. In addition the shaft could be angled laterally to exit at any point lateral to the midline. The course of the shaft need not remain constant. It could start at one orientation and change to another.',\n",
       "   'In some embodiments the adjustment of tension between the retractor and the anchor would involve mechanically coupling the anchor to another object. This object could be another device implanted in another soft tissue area, teeth or dental appliances attached to the teeth, or objects external to the mouth. The component attaching the anchor to a second object could be a rubber band, a wire, string, chain, rod. Attachments could be by hooks, clips, magnets or other mechanical coupling methods known in the art.',\n",
       "   'One or both of the retaining components could be implanted such that the entire device would be implanted beneath the mucosa. In another embodiment, one end would be implanted and the other exit externally.',\n",
       "   'There could be multiple retractor heads and shafts in various combination. As an example a single retractor head at the tongue base could attach to two or more shafts. Areas through which the implant might be placed include the tongue, velopharyngeal, hypopharyngeal and nasopharyngeal walls, including the cheeks, hard and soft palate, and floor of the mouth. There may be one or more implants. The implant may retract the tissue by itself because of the area it is placed or may be attached to an another object by solid rods, wires, rubber bands. Non limiting examples are another device in the soft palate, cheek or lip, the teeth or intraoral dental devices, in addition the device can be attached to objects external to the mouth.']},\n",
       " {'number': 'Example 6',\n",
       "  'title': 'The Device as a Conduit Between the Oral Cavity and Pharynx',\n",
       "  'content': ['In an alternative embodiment of the invention the shaft of the device is hollow and therefore functions as a conduit through the tongue. In those cases the device would more preferably be placed lower and oriented horizontally (FIG. 12). In this manner the shaft would pass parallel to the horizontal part of the genioglossus muscle or even lower through the geniohyoid or myelohyoid muscles. In this area of the tongue there is almost no tongue displacement in the superior or lateral direction, almost all movement is to shorten or lengthen in the anterior to posterior direction. As a result the conduit is not exposed to strong flexing forces, thereby allowing it to have a large diameter without interfering with tongue function.',\n",
       "   'In one alternative embodiment of the invention the shaft would be relatively larger and the retractor and anchor would be smaller, preferable reduced to a small flange around the edge of the openings to prevent the conduit from moving out of place (FIG. 12 A). The anchor end in the mouth could have a removable cap and/or a connector to interface with other devices.',\n",
       "   'In one embodiment the conduit between the pharynx and mouth would allow passive equalization of air pressure in the pharyngeal space, attenuating the negative pressure that leads to collapse of the pharyngeal walls. Further embodiments would add mechanisms for sensing airflow or pressure that control a source of oxygen or air that could be delivered through the conduit. An attachment to an external pressure source could pump air to actively increase pharyngeal pressures. U.S. Pat. No. 5,954,050 to Christopher describes an invention where a conduit through the neck directly into the trachea is used to pass catheters capable of sensing airflow, pressure or carbon dioxide levels of the tracheal. These signals are all relevant indicators of sleep apnea and other respiratory diseases. In turn these signals could be used to control the delivery of oxygen or pressurized air.',\n",
       "   'A 60 year old male with severe obesity and OSAS yet declines a tongue retractor. Instead 1 cm removable conduit is be placed throughout the midline of the frenulum to the lower tongue base. The conduit is hollow and capped at the anterior end. At night the patient removes the cap and connects a 2 foot extension that connects to a small ventilator that delivers air continually through the conduit. The ventilator can be adjusted to deliver air at positive pressure. In an alternative embodiment the retractor end of the conduit has a sensor that measures pharyngeal pressure, carbon dioxide, and mechanical vibration, these signals are transferred to the ventilator by a wire running through the inside of the conduit and connection tubing, or sent by a small radio transmitter. The ventilator is programmed to recognize acute increases in negative pressure or carbon dioxide as indicative of airway obstruction while mechanical vibration indicates snoring. The signals triggers rapid delivery of air through the conduit to relieve the negative pressure.',\n",
       "   'Still further alternative embodiments of the invention are to introduce devices through the conduit that control the airway. Preferably these additional devices would be similar to the laryngeal mask or endotracheal tube by having a mechanism, preferably an inflatable balloon, that would occlude the airway around the tube. In this manner a controlled airway could be obtained for ventilation of the patient.',\n",
       "   'In further alternative embodiments the shaft of the conduit would be highly flexible so that after insertion it would be collapsed. However, an endotracheal tube or similar airway control device could be passed through the collapsed conduit easily. In this way patients who require temporary assisted ventilation could avoid having a tracheostomy tube placed (FIG. 15).',\n",
       "   'A non-limiting illustrative example is a 50 year old female with severe myasthenia gravis. The patient is able to breathe and swallow most of the time without assistance, however, almost every day she has periods where she feels weak and cannot breathe adequately. The patients has a conduit placed beneath her tongue in the centerline. The anchor is at the anterior floor of the mouth and the shaft passes between the genioglossus and geniohyoid muscles to the retractor end at the inferior aspect of the base of the tongue. The device is composed of soft reinforced silastic with a constant fully expanded diameter of 1 cm, however, after placement the surrounding tissue pressure causes it to collapse to a diameter of 2 mm. A cap that is also very flexible seals the anchor end. When not in use the device is comfortable and barely noticed by the patient and cannot be seen by other people. When the patient feels the need for assisted ventilation the cap can be opened to access the interior of the conduit. A ventilation tube of 8 mm external diameter is passed through the conduit into the hypopharynx. A balloon at the hypopharyngeal end of the ventilation tube can be inflated via a connector at its anchor end. The inflated balloon largely but does not completely block the hypopharynx above the opening of the tube, so there is some airleak when pressurized air is delivered through the tube. The patient connects the ventilator tube to a ventilator and adjusts the respiratory rate and tidal volume to comfortable levels. After two hours the patient feels stronger and turns the ventilator off, disconnects the tube, deflates the balloon and removes the ventilation tube.']},\n",
       " {'number': 'Example 7',\n",
       "  'title': 'Suctioning Secretions',\n",
       "  'content': ['Many patients with neurological diseases have difficulty swallowing their salivary secretions and are at risk of aspiration and pneumonia. Moreover, some patients have excess pulmonary secretions that they cannot expel by themselves. It is well known in the art that suction catheters can be passed through the mouth or nose to suction secretions, however, these methods of suctioning secretions are extremely uncomfortable and labor intensive. If these methods are insufficient some patients undergo tracheotomy, intubation or other surgical procedures that allow more direct access for suctioning.',\n",
       "   'In an alternative embodiment the device can serve as a conduit to allow relatively easy suctioning of secretions. A flexible suctioning catheter could be inserted through the conduit to suction secretions from the hypopharynx or lungs. Alternatively an indwelling suction tube could be passed through the conduit such that it lies in the hypopharynx. The proximal end of said catheter is at the anchor end of the conduit and can be secured to the conduit by many mechanical means well known in the art. When necessary a source of negative air pressure could be attached to the conduit suction catheter. When not needed the negative pressure tube can be disconnected. In this manner suctioning could be easily performed at will with minimum discomfort to the patient. When the external tubing is disconnected the conduit would be unobtrusive.',\n",
       "   'In another embodiment of this invention a suction pump and energy supply is incorporated into the device. Secretions are suctioned from the floor of the mouth through the anchor side of the device. These secretions are passed to a catheter attached to the retractor end that passes into the esophagus or stomach. In this manner secretions are removed and appropriately delivered to the stomach before they cause a risk of aspiration to the patient.',\n",
       "   'Methods and devices representative of the prior art include U.S. Pat. No. 3,517,669 to Buono describes a valved device for suctioning secretions; U.S. Pat. No. 4,981,477 to Schon that describes a suction catheter for introduction into the trachea and the bronchial system; U.S. Pat. No. 5,694,922 describes methods and devices for accessing the resouratory system to ventilate the lungs of the patient with gas or gases, to aspirate secretions from the lungs, to oxygenate the lungs to eliminate or reduce residual CO2 therefrom, to visually inspect selected parts of the respiratory system, to sample sputum and gases, to sense parameters such as flow rates, pressure, and temperature, to flush with washing solution, and/or to administer medication, gases, and/or lavage.']},\n",
       " {'number': 'Example 8',\n",
       "  'title': 'Gastric or Pulmonary Tubes',\n",
       "  'content': ['Still another embodiment would be to use the device as an conduit for passing other tubes to the pharynx, esophagus, stomach or lungs.',\n",
       "   \"Many patients with impaired swallowing require direct tube feeding into their stomachs. If the need for a tube is temporary the tube is passed through the nose and into the stomach (nasogastric tube). Generally the proximal attachment end of the tube is taped securely to the nose and also looped upward and taped directly to the face. At intervals liquid feedings are attached to the nasogastric tube. U.S. Pat. No. 4,704,111 to Moss describes one embodiment of a nasogastric feeding tube. If tube feedings are needed for a prolonged period a tube can be surgically implanted across the abdominal and into the stomach of small intestine (gastric tube). Both methods are uncomfortable, have significant complications, and impair the patient's mobility.\",\n",
       "   'In one embodiment a thin wall tube could be passed through the shaft and extend into the esophagus or stomach (FIG. 13). In this embodiment direct gastric feeding could be done, eliminating the need for a nasogastric tube or percutaneous gastric tube. As the opening of the device is under the tongue it is not noticeable.',\n",
       "   'The implant may be temporary or permanent. It is one embodiment that part or all be removed during the day and replaced at night. The tissue conduit could be kept patent by a second item placed after the implant removal that was more comfortable.',\n",
       "   'In another embodiment the conduit is used to pass a temporary or permanent tube into the pharynx, larynx, trachea or lungs. Some patients with lung disease need supplemental oxygen. In another embodiment the tube could deliver medication locally to the structures of the upper airway or lung.']},\n",
       " {'number': 'Example 9',\n",
       "  'title': 'Drug Delivery',\n",
       "  'content': ['The implant could also contain biologically active agents. Various inventions are known that store medication in reservoirs or pumps for controlled release and these could be incorporated into an embodiment of this invention. As an example of the art U.S. Pat. No. 5,976,109 to Heruth describe an implantable drug reservoir.',\n",
       "   'Another embodiment would have a drug that is useful for an entirely different purpose then sleep apnea. One example would be antibiotic for the treatment of peri-dontal disease. The antibiotic could be inserted into the conduit in biodegradable form or into a slow release pump, and would be released from the anchor end during the night to combat periodontal disease.',\n",
       "   'Another embodiment is medicine for gastrointestinal tract disease, a non-limiting example might be anti acid medication for acid reflux into the esophagus. This could be released directly from the retractor end into the pharynx. An additional embodiment would combine a sensor for pH and supply of the medication together, such that acidic pH could be sensed and treated efficiently.',\n",
       "   'Another embodiment is for the treatment of pulmonary disease. Currently, aerosolized medicines for lung diseases such as asthma or bronchitis are inhaled through the mouth. This is less efficient then direct delivery to the pharynx via the retractor side of the device, or to the trachea through catheters that pass from device to or through the larynx to the lungs. Medications preferably delivered by this method would include, without limitation, corticosteroids, bronchodilators, anti-inflammatory, mucolytic medications and antibiotics.',\n",
       "   'In another embodiment device could be releasing a medication that diffuses into the oral cavity or through the walls of the conduit into tongue tissue. U.S. Pat. No. 5,464,395 to Faxon describes a catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway. An illustrative and non-limiting example might be a medication that reduces fat in the tongue base such as a mixture of phosphatidylcholine and sodium deoxycholate. These medicines have been injected subcutaneously to cause localized dissolution of fat (Rotunda, A M et al, (2004), Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 2004; 30:1001-1008). Therefore the volume of the tongue base could be gradually decreased to improve OSAS. In an alternative embodiment the drug could be a chemotherapeutic agent for the treatment of cancer. As a further alternative embodiment the device would deliver radiation to a cancer of the soft tissue of the tongue, soft palate, pharynx or larynx. Representative examples of the prior art are U.S. Pat. No. 6,251,059 to Apple; U.S. Pat. No. 6,267,775 to Clerc describes a medical device for centering radioactive treatment sources in body vessels.']},\n",
       " {'number': 'Example 8',\n",
       "  'title': 'Sensors and Neuroprosthetics',\n",
       "  'content': ['Sensors could be incorporated into the device to sense levels of gases or metabolites in the local blood flow around the device, which in turn reflect the systemic circulation. Alternatively sensors could detect the electrocardiogram, blood pressure, blood flow, position of the patient, vibration, temperature, tissue pressure or other physiological parameters. A transmitter could be incorporated within the device to transmit this signal to receivers outside the body. As a further embodiment the remote computer system would analyze the signals and send controlling signals back to the implanted device to control the release of drugs from the device, a neuroprosthetic device, or other medical device.',\n",
       "   'Examples of prior art are U.S. Pat. No. 6,636,769 to Govani describing an implanted sensor and telemetric system. U.S. Pat. No. 6,558,321 to Burd describing a system whereby the monitored signal is sent by telemetry to a remote computer which in turn sends signals back to control an implanted medical device; U.S. Pat. No. 5,109,850 to Bianco describes an implanted drug reservoir with a sensor that samples blood and controls the delivery of medication; U.S. Pat. No. 6,764,446 to Wolinsky describes an implant for surgical insertion in the mammalian body to monitor pressure or other physiological parameters and/or perform therapeutic functions, has a pressure sensor, controller, acoustic transducers, and an energy storage device',\n",
       "   'A non-limiting example of this alternative a sensor in the device measures blood glucose levels, and in turn controls the release of appropriate amounts of insulin from a depot of this medication also incorporated into the device.',\n",
       "   'In another embodiment that treats OSAS the implant could have electrodes, battery power and stimulation electronics implanted to stimulate surrounding tissue. In one embodiment of the invention the implant contains sensors for negative pressure at the retractor end. These sensor detect airway obstruction. These signals in turn trigger electrical stimulation to the genioglossus muscle via surface electrodes on the exterior of the device in direct contact with the muscle. The stimulation causes contraction of the genioglossus muscle and anterior displacement of the tongue thereby relieving the obstruction.',\n",
       "   \"In an alternative embodiment a patient has Parkinson's disease and has difficulty initiating a swallow when eating. An embodiment of the device is implanted that in the centerline of the tongue from the frenulum to the lower tongue base. The implant has a energy supply a receiver, and stimulation electronics. The retractor end of the device has electrodes on either side of a 1 cm flange in the valecullae. The patient has a small control unit that can send a signal to the device and cause electrical stimulation to excite sensory nerves in the valleculae thereby initiating a swallow.\"]},\n",
       " {'number': 'Example 9',\n",
       "  'title': 'Surgical Access',\n",
       "  'content': ['Surgical procedures on the pharynx, larynx, lungs and esophagus have notably high morbidity. Although topologically these areas are outside the body the mouth and pharynx are a functional barrier to accessing these areas. As the neck contains so many different important structures surgical access almost invaribaly requires injuring normal structures. Moreover many surgical procedures, such as those for the treatment of cancer, are designed to accomplish their aims in the short time period that the interior of the body is accessible under anesthesia. Therefore surgical procedures are often more extensive they necessary. In contrast cancer that is located on the skin is often handled quite differently. The ready access to the area allows excision of minimum tissue, and repeated followup as necessary. In the upper airway almost all cancer begins on the surface. Therefore if access were easier some procedures on the pharynx and neighboring areas could be performed with less collatteral damage and shorter recovery times.',\n",
       "   'At present the technology for minimally invasive endoscopic surgery has advanced tremendously. Many procedures that once required wide incisions and large exposure are now performed through small percutaneous punctures using endoscopic and microsurgical equipment. The difference in morbidity and post operative recovery between the two methods are dramatic.',\n",
       "   'One alternative embodiment of this invention to provide conduits for surgical access to the pharynx and neighboring structures. In one embodiment the number, diameter and orientation of the conduits would be implanted specifically for the disease to be treated so as to provide maximum ease in performing endoscopic surgery. In a further embodiment these conduits could be accessed repeatedly over long periods of time to allow direct examination and continuing therapy.',\n",
       "   'As a non-limiting example a 65 year old male has a 2 cm ulcerated lesion of his pharyngeal wall. The lesion is biopsied and found to be squamous cell carcinoma. Medical and radiological examination suggest the lesion is localized to the pharyngeal wall and does not appear to have spread beyond the mucosa. After consultation with the patient on his treatment options it is decided to remove the lesion with endoscopic methods. Two collapsable conduits are implanted to access the lesion, the first passes through the centerline of the tongue from the frenulum to the midtongue base. The second passes through the skin of the undersurface of the jaw to enter at the base of the tongue 1 cm below the first conduit. The patients first procedure is performed under general anesthesia. Using a laser the lesion is vaporized via a rigid endoscope passed through the mouth. However, after the initial procedure the patient returns for followup examinations to the surgeons office every two weeks. Under minimal local anesthesia microsurgical endoscopes are passed through each conduit. Each is equipped with 1 mm fiber optic cable that delivers hi intensity illumination and captures video images. The surgeon examines the lesion closely and biopsies any suspicious tissue. When indicated the surgeon injects chemotherapeutic agents into and around the area biopsied. After six months the percutaneous conduit is removed and the patient is instructed to return monthly. After 1 year, no recurrence is evident and the second conduit is removed.',\n",
       "   'BA, Tongue base\\na, anchor,\\n\\n\\n\\nBD, Tongue body\\nab, airway ballon\\n\\n\\n\\nBL, Tongue blade\\nc, collar\\n\\n\\n\\nBo, Boundary between tongue and\\ncc, collapsible conduit (cc)\\n\\n\\n\\ngenioglossus\\n\\n\\n\\nC, Tongue curve\\nd, diaphragm,\\n\\n\\n\\nF, Frenulum\\nh, handle\\n\\n\\n\\nGG, Genioglossus muscle\\ni, injection port,\\n\\n\\n\\nGT, Gastric tube\\nn, needle,\\n\\n\\n\\nHP, Hypopharynyx\\np, open end of tube\\n\\n\\n\\nLR, Laryngeal soft tissue retractor\\npa, pressurized air\\n\\n\\n\\nNP, Nasopharynx\\nr, retractor balloon,\\n\\n\\n\\nP, Hard palate\\nrc, resealable cap\\n\\n\\n\\nPR, Pharyngeal wall retractor;\\ns, shaft,\\n\\n\\n\\nPT, Pulmonary tube\\nsc, surgical conduit\\n\\n\\n\\nSP, Soft palate\\nst, suction tube\\n\\n\\n\\nSR, Soft palate retractor;\\nt, tube,\\n\\n\\n\\nT, Tongue\\nv, vacuum source\\n\\n\\n\\nVP, Velopharynx']}]"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stats[\"documents_with_examples\"][\"8925551\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Past\n",
      "Propane-Propene Adsorption Isotherms in CPO-27 (Fe).Propane and propylene adsorption measurements can be performed at thermodynamic equilibrium at 40° C. from 1 g of CPO-27(Fe) solid previously activated at different temperatures (20, 50, 100, 150, 200, 250° C.) under primary vacuum (P=1 Pa for 16 hours)The expected profile of the adsorption isotherms of propane and propylene will be very similar to that obtained for the Ni compound (shown in the previous example), with a higher propane-propylene selectivity at low pressures and larger values at higher pressures. Considering the retrodonation effect of the iron, a better propane-propylene separation is expected.\n",
      "Past\n",
      "Gel and Gel Sandwich Natrosol® and like HMHECs of the disclosure can additionally or alternatively be used to encapsulate cells or cell clusters. The HMHEC powder, for example, can be directly dissolved in culture media, autoclaved, and then poured into, or used to coat, the cell culture vessels. Depending on the strength of the gel and, for example, on the amount and type of HMHEC, cells will either reside at the surface (having higher modulus) or sink (having a lower modulus) into the gel. Alternatively, an additional layer can be poured onto a layer of cells if a sandwich configuration is desired..Gel and Gel Sandwich Natrosol® and like HMHECs of the disclosure can additionally or alternatively be used to encapsulate cells or cell clusters. The HMHEC powder, for example, can be directly dissolved in culture media, autoclaved, and then poured into, or used to coat, the cell culture vessels. Depending on the strength of the gel and, for example, on the amount and type of HMHEC, cells will either reside at the surface (having higher modulus) or sink (having a lower modulus) into the gel. Alternatively, an additional layer can be poured onto a layer of cells if a sandwich configuration is desired.\n",
      "Present\n",
      "Hydrogenation of Unsaturated Oil Or Fatty Acid Esters To Produce Biodiesel.Hydrogenation may be achieved by passing a stream of hydrogen gas, generated by means known in the art, through the heated oil feedstock produced by a thraustochytrid, or a transesterified oil feedstock produced by a thraustochytrid, in which is suspended a finely powdered catalyst (typically a Pt or Ni related material). Modifications and variations of the process may be made, including to the catalyst, process parameters, and methods of recovery of the catalyst, to tailor selectivity and maximise yield of less polyunsaturated product. This hydrogenation process may be conducted either before or after transesterification.It will be understood that the invention disclosed and defined in this specification extends to all alternative combinations of two or more of the individual features mentioned or evident from the text or drawings. All of these different combinations constitute various alternative aspects of the invention.\n",
      "Number of exact matches: 574 out of 799 , Percentage: 71.8397997496871\n",
      "Number of exact num of patent extracted: 699 out of 799\n",
      "Avg Total error: 0.3241551939924906, num of corrects:  699\n",
      "Avg Total prophetic error: 0.6933667083854819, num of corrects: 640\n",
      "Avg Total nonprophetic error: 0.8748435544430538, num of corrects: 592\n",
      "1512.0\n",
      "number of unknown tensed examples: 0\n",
      "Total of examples in freilich 11897.0,Total examples extracted 12150\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patentnumber</th>\n",
       "      <th>present</th>\n",
       "      <th>past</th>\n",
       "      <th>unknown</th>\n",
       "      <th>prophetic</th>\n",
       "      <th>nonprophetic</th>\n",
       "      <th>allprophetic</th>\n",
       "      <th>someprophetic</th>\n",
       "      <th>Total_Extracted</th>\n",
       "      <th>Total_Freilich</th>\n",
       "      <th>prophetic_error</th>\n",
       "      <th>nonprophetic_error</th>\n",
       "      <th>Total_Mean_error</th>\n",
       "      <th>Sum_error</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>558</th>\n",
       "      <td>8933072</td>\n",
       "      <td>4</td>\n",
       "      <td>61</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>65</td>\n",
       "      <td>9.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>52.0</td>\n",
       "      <td>56.0</td>\n",
       "      <td>112.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>8927721</td>\n",
       "      <td>9</td>\n",
       "      <td>7</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>16</td>\n",
       "      <td>1.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>15.0</td>\n",
       "      <td>30.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>8933042</td>\n",
       "      <td>1</td>\n",
       "      <td>12</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>13</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>11.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>24.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>8927710</td>\n",
       "      <td>2</td>\n",
       "      <td>569</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>564.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>571</td>\n",
       "      <td>564.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>7.0</td>\n",
       "      <td>14.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>8933229</td>\n",
       "      <td>0</td>\n",
       "      <td>33</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>27.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>33</td>\n",
       "      <td>27.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>8926862</td>\n",
       "      <td>5</td>\n",
       "      <td>4</td>\n",
       "      <td>0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>9</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>485</th>\n",
       "      <td>8932717</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>9</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>8927588</td>\n",
       "      <td>4</td>\n",
       "      <td>285</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>283.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>289</td>\n",
       "      <td>283.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>795</th>\n",
       "      <td>8937055</td>\n",
       "      <td>0</td>\n",
       "      <td>20</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>14.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>20</td>\n",
       "      <td>14.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>8927583</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8</td>\n",
       "      <td>4.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>8932480</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>8926864</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>8932705</td>\n",
       "      <td>9</td>\n",
       "      <td>2</td>\n",
       "      <td>0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>11</td>\n",
       "      <td>7.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>8926548</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>685</th>\n",
       "      <td>8933318</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>762</th>\n",
       "      <td>8936849</td>\n",
       "      <td>5</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>5</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>766</th>\n",
       "      <td>8936859</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>403</th>\n",
       "      <td>8932470</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>11</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>770</th>\n",
       "      <td>8936910</td>\n",
       "      <td>3</td>\n",
       "      <td>17</td>\n",
       "      <td>0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>14.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>20</td>\n",
       "      <td>17.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>8933224</td>\n",
       "      <td>1</td>\n",
       "      <td>16</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>14.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>17</td>\n",
       "      <td>14.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patentnumber  present  past  unknown  prophetic  nonprophetic  \\\n",
       "558      8933072        4    61        0        0.0           9.0   \n",
       "298      8927721        9     7        0        0.0           1.0   \n",
       "545      8933042        1    12        0        0.0           1.0   \n",
       "289      8927710        2   569        0        0.0         564.0   \n",
       "647      8933229        0    33        0        0.0          27.0   \n",
       "45       8926862        5     4        0        3.0           0.0   \n",
       "485      8932717        0     9        0        0.0           3.0   \n",
       "227      8927588        4   285        0        0.0         283.0   \n",
       "795      8937055        0    20        0        0.0          14.0   \n",
       "223      8927583        4     4        0        0.0           4.0   \n",
       "405      8932480        0     6        0        0.0           2.0   \n",
       "47       8926864        0     6        0        0.0           2.0   \n",
       "480      8932705        9     2        0        5.0           2.0   \n",
       "17       8926548        0     5        0        0.0           1.0   \n",
       "685      8933318        0     8        0        0.0           5.0   \n",
       "762      8936849        5     0        0        1.0           1.0   \n",
       "766      8936859        0     8        0        0.0           5.0   \n",
       "403      8932470        0    11        0        0.0           8.0   \n",
       "770      8936910        3    17        0        3.0          14.0   \n",
       "644      8933224        1    16        0        0.0          14.0   \n",
       "\n",
       "     allprophetic  someprophetic  Total_Extracted  Total_Freilich  \\\n",
       "558           0.0            0.0               65             9.0   \n",
       "298           0.0            0.0               16             1.0   \n",
       "545           0.0            0.0               13             1.0   \n",
       "289           0.0            0.0              571           564.0   \n",
       "647           0.0            0.0               33            27.0   \n",
       "45            1.0            0.0                9             3.0   \n",
       "485           0.0            0.0                9             3.0   \n",
       "227           0.0            0.0              289           283.0   \n",
       "795           0.0            0.0               20            14.0   \n",
       "223           0.0            0.0                8             4.0   \n",
       "405           0.0            0.0                6             2.0   \n",
       "47            0.0            0.0                6             2.0   \n",
       "480           0.0            1.0               11             7.0   \n",
       "17            0.0            0.0                5             1.0   \n",
       "685           0.0            0.0                8             5.0   \n",
       "762           0.0            1.0                5             2.0   \n",
       "766           0.0            0.0                8             5.0   \n",
       "403           0.0            0.0               11             8.0   \n",
       "770           0.0            1.0               20            17.0   \n",
       "644           0.0            0.0               17            14.0   \n",
       "\n",
       "     prophetic_error  nonprophetic_error  Total_Mean_error  Sum_error  \n",
       "558              4.0                52.0              56.0      112.0  \n",
       "298              9.0                 6.0              15.0       30.0  \n",
       "545              1.0                11.0              12.0       24.0  \n",
       "289              2.0                 5.0               7.0       14.0  \n",
       "647              0.0                 6.0               6.0       12.0  \n",
       "45               2.0                 4.0               6.0       12.0  \n",
       "485              0.0                 6.0               6.0       12.0  \n",
       "227              4.0                 2.0               6.0       12.0  \n",
       "795              0.0                 6.0               6.0       12.0  \n",
       "223              4.0                 0.0               4.0        8.0  \n",
       "405              0.0                 4.0               4.0        8.0  \n",
       "47               0.0                 4.0               4.0        8.0  \n",
       "480              4.0                 0.0               4.0        8.0  \n",
       "17               0.0                 4.0               4.0        8.0  \n",
       "685              0.0                 3.0               3.0        6.0  \n",
       "762              4.0                 1.0               3.0        8.0  \n",
       "766              0.0                 3.0               3.0        6.0  \n",
       "403              0.0                 3.0               3.0        6.0  \n",
       "770              0.0                 3.0               3.0        6.0  \n",
       "644              1.0                 2.0               3.0        6.0  "
      ]
     },
     "execution_count": 129,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "final = dic_to_dic_w_tense_test(stats[\"documents_with_examples\"],threshold = 0)\n",
    "df_final = pd.DataFrame(final).T.reset_index()\n",
    "df_final.columns = [\"patentnumber\",\"past\",\"present\",\"unknown\"]\n",
    "df_final[\"patentnumber\"] = df_final[\"patentnumber\"].apply(remove_leadiong_zeros)\n",
    "df_check = df_final.merge(merged,on= \"patentnumber\",how=\"left\")[[\"patentnumber\",\"present\",\"past\",\"unknown\",\"prophetic\",\"nonprophetic\",\"allprophetic\",\"someprophetic\"]]\n",
    "#df_check[\"past\"] = df_check[\"past\"] + df_check[\"Unknown\"]\n",
    "df_check[\"Total_Extracted\"] = df_check[\"past\"] + df_check[\"present\"]  #+ df_check[\"unknown\"]\n",
    "df_check[\"Total_Freilich\"] = df_check[\"prophetic\"] + df_check[\"nonprophetic\"]\n",
    "df_check[\"prophetic_error\"] = np.sqrt((df_check[\"prophetic\"] - df_check[\"present\"])**2)\n",
    "df_check[\"nonprophetic_error\"] = np.sqrt((df_check[\"nonprophetic\"] - df_check[\"past\"])**2)\n",
    "df_check[\"Total_Mean_error\"] = np.sqrt((df_check[\"Total_Freilich\"] - df_check[\"Total_Extracted\"])**2)\n",
    "df_check[\"Sum_error\"] = df_check[\"prophetic_error\"] + df_check[\"nonprophetic_error\"] + df_check[\"Total_Mean_error\"]\n",
    "print(f\"Number of exact matches: {len(df_check[(df_check.prophetic_error ==0) & (df_check.nonprophetic_error ==0) & (df_check.Total_Mean_error ==0)])} out of {len(df_check)} , Percentage: {len(df_check[(df_check.prophetic_error ==0) & (df_check.nonprophetic_error ==0) & (df_check.Total_Mean_error ==0)])/len(df_check)*100}\")\n",
    "print(f\"Number of exact num of patent extracted: {len(df_check[(df_check.Total_Extracted == df_check.Total_Freilich)])} out of {len(df_check)}\")\n",
    "print(f\"Avg Total error: {df_check['Total_Mean_error'].mean()}, num of corrects:  {df_check[df_check['Total_Mean_error'] == 0].shape[0]}\")\n",
    "print(f\"Avg Total prophetic error: {df_check['prophetic_error'].mean()}, num of corrects: {df_check[df_check['prophetic_error'] == 0].shape[0]}\")\n",
    "print(f\"Avg Total nonprophetic error: {df_check['nonprophetic_error'].mean()}, num of corrects: {df_check[df_check['nonprophetic_error'] == 0].shape[0]}\")\n",
    "print(f\"{df_check['Sum_error'].sum()}\")\n",
    "print(f\"number of unknown tensed examples: {df_check['unknown'].sum()}\")\n",
    "print(f\"Total of examples in freilich {df_check.Total_Freilich.sum()},Total examples extracted {df_check.Total_Extracted.sum()}\")\n",
    "df_check.sort_values(\"Total_Mean_error\",ascending=False).head(20)\n",
    "\n",
    "\n",
    "# Number of exact matches: 386 out of 799 , Percentage: 48.310387984981226\n",
    "# Number of exact num of patent extracted: 680 out of 799\n",
    "# Avg Total error: 1.1476846057571966, num of corrects:  680\n",
    "# Avg Total prophetic error: 1.4292866082603255, num of corrects: 439\n",
    "# Avg Total nonprophetic error: 2.3642052565707132, num of corrects: 402\n",
    "# 3948.0\n",
    "# number of unknown tensed examples: 670\n",
    "# Total of examples in freilich 11897.0,Total examples extracted 11388\n",
    "\n",
    "\n",
    "# Number of exact matches: 254 out of 406 , Percentage: 62.5615763546798\n",
    "# Number of exact num of patent extracted: 359 out of 406\n",
    "# Avg Total error: 0.2684729064039409, num of corrects:  359\n",
    "# Avg Total prophetic error: 3.7660098522167487, num of corrects: 286\n",
    "# Avg Total nonprophetic error: 3.9753694581280787, num of corrects: 256\n",
    "# 3252.0\n",
    "# number of unknown tensed examples: 2\n",
    "# Total of examples in freilich 7238.0,Total examples extracted 7283\n",
    "\n",
    "#patent 8933072 in janets says 9 nonproph we find 36 present 29past\n",
    "# 8927721 she doesnt extract experiments or test she only extracts example\n",
    "#8933042 janet found 1 threres more\n",
    "#8933072 janet found 9,theremany more\n",
    "#8926862 janets found 3 theres more\n",
    "\n",
    "# Number of exact matches: 574 out of 799 , Percentage: 71.8397997496871\n",
    "# Number of exact num of patent extracted: 699 out of 799\n",
    "# Avg Total error: 0.3241551939924906, num of corrects:  699\n",
    "# Avg Total prophetic error: 0.6933667083854819, num of corrects: 640\n",
    "# Avg Total nonprophetic error: 0.8748435544430538, num of corrects: 592\n",
    "# 1512.0\n",
    "# number of unknown tensed examples: 0\n",
    "# Total of examples in freilich 11897.0,Total examples extracted 12150"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patentnumber</th>\n",
       "      <th>present</th>\n",
       "      <th>past</th>\n",
       "      <th>unknown</th>\n",
       "      <th>prophetic</th>\n",
       "      <th>nonprophetic</th>\n",
       "      <th>allprophetic</th>\n",
       "      <th>someprophetic</th>\n",
       "      <th>Total_Extracted</th>\n",
       "      <th>Total_Freilich</th>\n",
       "      <th>prophetic_error</th>\n",
       "      <th>nonprophetic_error</th>\n",
       "      <th>Total_Mean_error</th>\n",
       "      <th>Sum_error</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>8927555</td>\n",
       "      <td>51</td>\n",
       "      <td>53</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>104.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>104</td>\n",
       "      <td>104.0</td>\n",
       "      <td>51.0</td>\n",
       "      <td>51.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>102.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>8933104</td>\n",
       "      <td>43</td>\n",
       "      <td>75</td>\n",
       "      <td>0</td>\n",
       "      <td>18.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>118</td>\n",
       "      <td>118.0</td>\n",
       "      <td>25.0</td>\n",
       "      <td>25.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>50.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>8927550</td>\n",
       "      <td>1</td>\n",
       "      <td>22</td>\n",
       "      <td>0</td>\n",
       "      <td>22.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>23</td>\n",
       "      <td>23.0</td>\n",
       "      <td>21.0</td>\n",
       "      <td>21.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>42.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>577</th>\n",
       "      <td>8933098</td>\n",
       "      <td>4</td>\n",
       "      <td>25</td>\n",
       "      <td>0</td>\n",
       "      <td>24.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>29</td>\n",
       "      <td>29.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>40.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>8927757</td>\n",
       "      <td>17</td>\n",
       "      <td>21</td>\n",
       "      <td>0</td>\n",
       "      <td>37.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>38</td>\n",
       "      <td>38.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>40.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>8927795</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>8927775</td>\n",
       "      <td>0</td>\n",
       "      <td>22</td>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>21.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>22</td>\n",
       "      <td>22.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>8926736</td>\n",
       "      <td>6</td>\n",
       "      <td>27</td>\n",
       "      <td>0</td>\n",
       "      <td>7.0</td>\n",
       "      <td>26.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>33</td>\n",
       "      <td>33.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>8927744</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3</td>\n",
       "      <td>3.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>8925551</td>\n",
       "      <td>7</td>\n",
       "      <td>4</td>\n",
       "      <td>0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>11</td>\n",
       "      <td>11.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>159 rows × 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    patentnumber  present  past  unknown  prophetic  nonprophetic  \\\n",
       "207      8927555       51    53        0        0.0         104.0   \n",
       "581      8933104       43    75        0       18.0         100.0   \n",
       "205      8927550        1    22        0       22.0           1.0   \n",
       "577      8933098        4    25        0       24.0           5.0   \n",
       "321      8927757       17    21        0       37.0           1.0   \n",
       "..           ...      ...   ...      ...        ...           ...   \n",
       "337      8927795        1     0        0        0.0           1.0   \n",
       "330      8927775        0    22        0        1.0          21.0   \n",
       "30       8926736        6    27        0        7.0          26.0   \n",
       "313      8927744        2     1        0        1.0           2.0   \n",
       "3        8925551        7     4        0        6.0           5.0   \n",
       "\n",
       "     allprophetic  someprophetic  Total_Extracted  Total_Freilich  \\\n",
       "207           0.0            0.0              104           104.0   \n",
       "581           0.0            1.0              118           118.0   \n",
       "205           0.0            1.0               23            23.0   \n",
       "577           0.0            1.0               29            29.0   \n",
       "321           0.0            1.0               38            38.0   \n",
       "..            ...            ...              ...             ...   \n",
       "337           0.0            0.0                1             1.0   \n",
       "330           0.0            1.0               22            22.0   \n",
       "30            0.0            1.0               33            33.0   \n",
       "313           0.0            1.0                3             3.0   \n",
       "3             0.0            1.0               11            11.0   \n",
       "\n",
       "     prophetic_error  nonprophetic_error  Total_Mean_error  Sum_error  \n",
       "207             51.0                51.0               0.0      102.0  \n",
       "581             25.0                25.0               0.0       50.0  \n",
       "205             21.0                21.0               0.0       42.0  \n",
       "577             20.0                20.0               0.0       40.0  \n",
       "321             20.0                20.0               0.0       40.0  \n",
       "..               ...                 ...               ...        ...  \n",
       "337              1.0                 1.0               0.0        2.0  \n",
       "330              1.0                 1.0               0.0        2.0  \n",
       "30               1.0                 1.0               0.0        2.0  \n",
       "313              1.0                 1.0               0.0        2.0  \n",
       "3                1.0                 1.0               0.0        2.0  \n",
       "\n",
       "[159 rows x 14 columns]"
      ]
     },
     "execution_count": 130,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_check[(df_check.Total_Extracted == df_check.Total_Extracted) & (df_check.present != df_check.prophetic)].sort_values(\"prophetic_error\",ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 132,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patentnumber</th>\n",
       "      <th>present</th>\n",
       "      <th>past</th>\n",
       "      <th>unknown</th>\n",
       "      <th>prophetic</th>\n",
       "      <th>nonprophetic</th>\n",
       "      <th>allprophetic</th>\n",
       "      <th>someprophetic</th>\n",
       "      <th>Total_Extracted</th>\n",
       "      <th>Total_Freilich</th>\n",
       "      <th>prophetic_error</th>\n",
       "      <th>nonprophetic_error</th>\n",
       "      <th>Total_Mean_error</th>\n",
       "      <th>Sum_error</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>558</th>\n",
       "      <td>8933072</td>\n",
       "      <td>4</td>\n",
       "      <td>61</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>65</td>\n",
       "      <td>9.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>52.0</td>\n",
       "      <td>56.0</td>\n",
       "      <td>112.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>8927555</td>\n",
       "      <td>51</td>\n",
       "      <td>53</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>104.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>104</td>\n",
       "      <td>104.0</td>\n",
       "      <td>51.0</td>\n",
       "      <td>51.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>102.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>8933104</td>\n",
       "      <td>43</td>\n",
       "      <td>75</td>\n",
       "      <td>0</td>\n",
       "      <td>18.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>118</td>\n",
       "      <td>118.0</td>\n",
       "      <td>25.0</td>\n",
       "      <td>25.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>50.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>8927550</td>\n",
       "      <td>1</td>\n",
       "      <td>22</td>\n",
       "      <td>0</td>\n",
       "      <td>22.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>23</td>\n",
       "      <td>23.0</td>\n",
       "      <td>21.0</td>\n",
       "      <td>21.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>42.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>8927757</td>\n",
       "      <td>17</td>\n",
       "      <td>21</td>\n",
       "      <td>0</td>\n",
       "      <td>37.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>38</td>\n",
       "      <td>38.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>40.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>577</th>\n",
       "      <td>8933098</td>\n",
       "      <td>4</td>\n",
       "      <td>25</td>\n",
       "      <td>0</td>\n",
       "      <td>24.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>29</td>\n",
       "      <td>29.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>40.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>8927533</td>\n",
       "      <td>17</td>\n",
       "      <td>32</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>49.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>49</td>\n",
       "      <td>49.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>34.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>8927513</td>\n",
       "      <td>32</td>\n",
       "      <td>33</td>\n",
       "      <td>0</td>\n",
       "      <td>49.0</td>\n",
       "      <td>16.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>65</td>\n",
       "      <td>65.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>34.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>8927698</td>\n",
       "      <td>7</td>\n",
       "      <td>20</td>\n",
       "      <td>0</td>\n",
       "      <td>23.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>27</td>\n",
       "      <td>26.0</td>\n",
       "      <td>16.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>34.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>8932558</td>\n",
       "      <td>38</td>\n",
       "      <td>26</td>\n",
       "      <td>0</td>\n",
       "      <td>55.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>64</td>\n",
       "      <td>64.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>34.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>8933042</td>\n",
       "      <td>1</td>\n",
       "      <td>12</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>13</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>11.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>24.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>673</th>\n",
       "      <td>8933269</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>11</td>\n",
       "      <td>11.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>8927542</td>\n",
       "      <td>67</td>\n",
       "      <td>10</td>\n",
       "      <td>0</td>\n",
       "      <td>77.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>77</td>\n",
       "      <td>77.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>8927541</td>\n",
       "      <td>9</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>20</td>\n",
       "      <td>21.0</td>\n",
       "      <td>11.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>22.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>585</th>\n",
       "      <td>8933109</td>\n",
       "      <td>10</td>\n",
       "      <td>13</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>23.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>23</td>\n",
       "      <td>23.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>8932484</td>\n",
       "      <td>10</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>11</td>\n",
       "      <td>11.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>18.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>8931852</td>\n",
       "      <td>3</td>\n",
       "      <td>10</td>\n",
       "      <td>0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>13</td>\n",
       "      <td>13.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>18.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>747</th>\n",
       "      <td>8936799</td>\n",
       "      <td>8</td>\n",
       "      <td>8</td>\n",
       "      <td>0</td>\n",
       "      <td>16.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>16</td>\n",
       "      <td>16.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>16.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>8927746</td>\n",
       "      <td>5</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>16</td>\n",
       "      <td>15.0</td>\n",
       "      <td>7.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>16.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>797</th>\n",
       "      <td>8937057</td>\n",
       "      <td>9</td>\n",
       "      <td>5</td>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>14</td>\n",
       "      <td>14.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>16.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patentnumber  present  past  unknown  prophetic  nonprophetic  \\\n",
       "558      8933072        4    61        0        0.0           9.0   \n",
       "207      8927555       51    53        0        0.0         104.0   \n",
       "581      8933104       43    75        0       18.0         100.0   \n",
       "205      8927550        1    22        0       22.0           1.0   \n",
       "321      8927757       17    21        0       37.0           1.0   \n",
       "577      8933098        4    25        0       24.0           5.0   \n",
       "195      8927533       17    32        0        0.0          49.0   \n",
       "182      8927513       32    33        0       49.0          16.0   \n",
       "286      8927698        7    20        0       23.0           3.0   \n",
       "421      8932558       38    26        0       55.0           9.0   \n",
       "545      8933042        1    12        0        0.0           1.0   \n",
       "673      8933269        0    11        0       10.0           1.0   \n",
       "200      8927542       67    10        0       77.0           0.0   \n",
       "199      8927541        9    11        0       20.0           1.0   \n",
       "585      8933109       10    13        0        0.0          23.0   \n",
       "407      8932484       10     1        0        1.0          10.0   \n",
       "367      8931852        3    10        0       12.0           1.0   \n",
       "747      8936799        8     8        0       16.0           0.0   \n",
       "314      8927746        5    11        0       12.0           3.0   \n",
       "797      8937057        9     5        0        1.0          13.0   \n",
       "\n",
       "     allprophetic  someprophetic  Total_Extracted  Total_Freilich  \\\n",
       "558           0.0            0.0               65             9.0   \n",
       "207           0.0            0.0              104           104.0   \n",
       "581           0.0            1.0              118           118.0   \n",
       "205           0.0            1.0               23            23.0   \n",
       "321           0.0            1.0               38            38.0   \n",
       "577           0.0            1.0               29            29.0   \n",
       "195           0.0            0.0               49            49.0   \n",
       "182           0.0            1.0               65            65.0   \n",
       "286           0.0            1.0               27            26.0   \n",
       "421           0.0            1.0               64            64.0   \n",
       "545           0.0            0.0               13             1.0   \n",
       "673           0.0            1.0               11            11.0   \n",
       "200           1.0            0.0               77            77.0   \n",
       "199           0.0            1.0               20            21.0   \n",
       "585           0.0            0.0               23            23.0   \n",
       "407           0.0            1.0               11            11.0   \n",
       "367           0.0            1.0               13            13.0   \n",
       "747           1.0            0.0               16            16.0   \n",
       "314           0.0            1.0               16            15.0   \n",
       "797           0.0            1.0               14            14.0   \n",
       "\n",
       "     prophetic_error  nonprophetic_error  Total_Mean_error  Sum_error  \n",
       "558              4.0                52.0              56.0      112.0  \n",
       "207             51.0                51.0               0.0      102.0  \n",
       "581             25.0                25.0               0.0       50.0  \n",
       "205             21.0                21.0               0.0       42.0  \n",
       "321             20.0                20.0               0.0       40.0  \n",
       "577             20.0                20.0               0.0       40.0  \n",
       "195             17.0                17.0               0.0       34.0  \n",
       "182             17.0                17.0               0.0       34.0  \n",
       "286             16.0                17.0               1.0       34.0  \n",
       "421             17.0                17.0               0.0       34.0  \n",
       "545              1.0                11.0              12.0       24.0  \n",
       "673             10.0                10.0               0.0       20.0  \n",
       "200             10.0                10.0               0.0       20.0  \n",
       "199             11.0                10.0               1.0       22.0  \n",
       "585             10.0                10.0               0.0       20.0  \n",
       "407              9.0                 9.0               0.0       18.0  \n",
       "367              9.0                 9.0               0.0       18.0  \n",
       "747              8.0                 8.0               0.0       16.0  \n",
       "314              7.0                 8.0               1.0       16.0  \n",
       "797              8.0                 8.0               0.0       16.0  "
      ]
     },
     "execution_count": 132,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_check[(df_check.Total_Extracted == df_check.Total_Extracted) & (df_check.past != df_check.nonprophetic)].sort_values(\"nonprophetic_error\",ascending=False).head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<?xml version=\"1.0\" encoding=\"utf-8\"?>\n",
       "<!DOCTYPE us-patent-grant SYSTEM \"us-patent-grant-v45-2014-04-03.dtd\">\n",
       "<us-patent-grant country=\"US\" date-produced=\"20141219\" date-publ=\"20150106\" dtd-version=\"v4.5 2014-04-03\" file=\"US08927710-20150106.XML\" id=\"us-patent-grant\" lang=\"EN\" status=\"PRODUCTION\">\n",
       "<us-bibliographic-data-grant>\n",
       "<publication-reference>\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>08927710</doc-number>\n",
       "<kind>B2</kind>\n",
       "<date>20150106</date>\n",
       "</document-id>\n",
       "</publication-reference>\n",
       "<application-reference appl-type=\"utility\">\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>13378334</doc-number>\n",
       "<date>20100614</date>\n",
       "</document-id>\n",
       "</application-reference>\n",
       "<us-application-series-code>13</us-application-series-code>\n",
       "<priority-claims>\n",
       "<priority-claim kind=\"national\" sequence=\"01\">\n",
       "<country>JP</country>\n",
       "<doc-number>2009-142166</doc-number>\n",
       "<date>20090615</date>\n",
       "</priority-claim>\n",
       "</priority-claims>\n",
       "<us-term-of-grant>\n",
       "<us-term-extension>325</us-term-extension>\n",
       "</us-term-of-grant>\n",
       "<classifications-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>471</main-group>\n",
       "<subgroup>04</subgroup>\n",
       "<symbol-position>F</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>401</main-group>\n",
       "<subgroup>06</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>413</main-group>\n",
       "<subgroup>06</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>A</section>\n",
       "<class>61</class>\n",
       "<subclass>K</subclass>\n",
       "<main-group>31</main-group>\n",
       "<subgroup>53</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>A</section>\n",
       "<class>61</class>\n",
       "<subclass>K</subclass>\n",
       "<main-group>31</main-group>\n",
       "<subgroup>4427</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>A</section>\n",
       "<class>61</class>\n",
       "<subclass>K</subclass>\n",
       "<main-group>31</main-group>\n",
       "<subgroup>506</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>A</section>\n",
       "<class>61</class>\n",
       "<subclass>K</subclass>\n",
       "<main-group>31</main-group>\n",
       "<subgroup>5377</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>A</section>\n",
       "<class>61</class>\n",
       "<subclass>P</subclass>\n",
       "<main-group>31</main-group>\n",
       "<subgroup>16</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>498</main-group>\n",
       "<subgroup>14</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "<classification-ipcr>\n",
       "<ipc-version-indicator><date>20060101</date></ipc-version-indicator>\n",
       "<classification-level>A</classification-level>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>471</main-group>\n",
       "<subgroup>14</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "</classification-ipcr>\n",
       "</classifications-ipcr>\n",
       "<classifications-cpc>\n",
       "<main-cpc>\n",
       "<classification-cpc>\n",
       "<cpc-version-indicator><date>20130101</date></cpc-version-indicator>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>471</main-group>\n",
       "<subgroup>04</subgroup>\n",
       "<symbol-position>F</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "<scheme-origination-code>C</scheme-origination-code>\n",
       "</classification-cpc>\n",
       "</main-cpc>\n",
       "<further-cpc>\n",
       "<classification-cpc>\n",
       "<cpc-version-indicator><date>20130101</date></cpc-version-indicator>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>498</main-group>\n",
       "<subgroup>14</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "<scheme-origination-code>C</scheme-origination-code>\n",
       "</classification-cpc>\n",
       "<classification-cpc>\n",
       "<cpc-version-indicator><date>20130101</date></cpc-version-indicator>\n",
       "<section>C</section>\n",
       "<class>07</class>\n",
       "<subclass>D</subclass>\n",
       "<main-group>471</main-group>\n",
       "<subgroup>14</subgroup>\n",
       "<symbol-position>L</symbol-position>\n",
       "<classification-value>I</classification-value>\n",
       "<action-date><date>20150106</date></action-date>\n",
       "<generating-office><country>US</country></generating-office>\n",
       "<classification-status>B</classification-status>\n",
       "<classification-data-source>H</classification-data-source>\n",
       "<scheme-origination-code>C</scheme-origination-code>\n",
       "</classification-cpc>\n",
       "</further-cpc>\n",
       "</classifications-cpc>\n",
       "<classification-national>\n",
       "<country>US</country>\n",
       "<main-classification>544183</main-classification>\n",
       "<further-classification>514243</further-classification>\n",
       "<further-classification>5142315</further-classification>\n",
       "<further-classification>544111</further-classification>\n",
       "</classification-national>\n",
       "<invention-title id=\"d2e71\">Substituted polycyclic carbamoylpyridone derivative</invention-title>\n",
       "<us-references-cited>\n",
       "<us-citation>\n",
       "<patcit num=\"00001\">\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>5475109</doc-number>\n",
       "<kind>A</kind>\n",
       "<name>Selnick et al.</name>\n",
       "<date>19951200</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00002\">\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>5618830</doc-number>\n",
       "<kind>A</kind>\n",
       "<name>Selnick et al.</name>\n",
       "<date>19970400</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00003\">\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>8188271</doc-number>\n",
       "<kind>B2</kind>\n",
       "<name>Yoshida et al.</name>\n",
       "<date>20120500</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by examiner</category>\n",
       "<classification-national><country>US</country><main-classification>544183</main-classification></classification-national>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00004\">\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>2008/0161271</doc-number>\n",
       "<kind>A1</kind>\n",
       "<name>Yoshida et al.</name>\n",
       "<date>20080700</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00005\">\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>2009/0143356</doc-number>\n",
       "<kind>A1</kind>\n",
       "<name>Yoshida et al.</name>\n",
       "<date>20090600</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00006\">\n",
       "<document-id>\n",
       "<country>EP</country>\n",
       "<doc-number>1 544 199</doc-number>\n",
       "<kind>A1</kind>\n",
       "<date>20050600</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00007\">\n",
       "<document-id>\n",
       "<country>GB</country>\n",
       "<doc-number>2 280 435</doc-number>\n",
       "<kind>A</kind>\n",
       "<date>19950200</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00008\">\n",
       "<document-id>\n",
       "<country>WO</country>\n",
       "<doc-number>WO 2004/024078</doc-number>\n",
       "<kind>A2</kind>\n",
       "<date>20040300</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00009\">\n",
       "<document-id>\n",
       "<country>WO</country>\n",
       "<doc-number>WO 2005/087766</doc-number>\n",
       "<kind>A1</kind>\n",
       "<date>20050900</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00010\">\n",
       "<document-id>\n",
       "<country>WO</country>\n",
       "<doc-number>WO 2005/092099</doc-number>\n",
       "<kind>A1</kind>\n",
       "<date>20051000</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00011\">\n",
       "<document-id>\n",
       "<country>WO</country>\n",
       "<doc-number>WO 2006/066414</doc-number>\n",
       "<kind>A1</kind>\n",
       "<date>20060600</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<patcit num=\"00012\">\n",
       "<document-id>\n",
       "<country>WO</country>\n",
       "<doc-number>WO 2006/116764</doc-number>\n",
       "<kind>A1</kind>\n",
       "<date>20061100</date>\n",
       "</document-id>\n",
       "</patcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00013\">\n",
       "<othercit>International Search Report from the Japanese Patent Office for International Application No. PCT/JP2010/060006, mailing date Aug. 24, 2010.</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00014\">\n",
       "<othercit>Hensens et al.; “Isolation and Structure of Flutimide, A Novel Endonuclease Inhibitor of Influenza Virus”, Tetrahedron Letters, vol. 36, No. 12, pp. 2005-2008, (1995).</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00015\">\n",
       "<othercit>Singh; “Total Synthesis of Flutimide, A Novel Endonuclease Inhibitor of Influenza Virus”, Tetrahedron Letters, vol. 36, No. 12, pp. 2009-2012, (1995).</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00016\">\n",
       "<othercit>Tomassini et al.; “Inhibition of Cap (M<sup>7</sup>GpppXm)-Dependent Endonuclease of Influenza Virus by 4-Substituted 2,4-Dioxobutanoic Acid Compounds”, Antimicrobial Agents and Chemotherapy, vol. 38, No. 12, pp. 2827-2837, (1994).</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00017\">\n",
       "<othercit>Hastings et al.; “Anti-Influenza Virus Activities of 4-Substituted 2,4-Dioxobutanoic Acid Inhibitors”, Antimicrobial Agents and Chemotherapy, vol. 40, No. 5, pp. 1304-1307, (1996).</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00018\">\n",
       "<othercit>Parkes et al.; “Use of a Pharmacophore Model to Discover a New Class of Influenza Endonuclease Inhibitors”, Journal of Medicinal Chemistry, vol. 46, No. 7, pp. 1153-1164, (2003).</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00019\">\n",
       "<othercit>Wai et al.; “Dihydroxypyridopyrazine-1,6-Dione HIV-1 Integrase Inhibitors”, Bioorganic &amp; Medicinal Chemistry Letters, vol. 17, pp. 5595-5599, (2007).</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "<us-citation>\n",
       "<nplcit num=\"00020\">\n",
       "<othercit>Dias et al.; “The Cap-Snatching Endonuclease of Influenza Virus Polymerase Resides in the PA Subunit”, Nature, pp. 1-5, (2009).</othercit>\n",
       "</nplcit>\n",
       "<category>cited by applicant</category>\n",
       "</us-citation>\n",
       "</us-references-cited>\n",
       "<number-of-claims>23</number-of-claims>\n",
       "<us-exemplary-claim>1</us-exemplary-claim>\n",
       "<us-field-of-classification-search>\n",
       "<classification-national>\n",
       "<country>US</country>\n",
       "<main-classification>544183</main-classification>\n",
       "</classification-national>\n",
       "<classification-national>\n",
       "<country>US</country>\n",
       "<main-classification>544111</main-classification>\n",
       "</classification-national>\n",
       "<classification-national>\n",
       "<country>US</country>\n",
       "<main-classification>514243</main-classification>\n",
       "</classification-national>\n",
       "<classification-national>\n",
       "<country>US</country>\n",
       "<main-classification>5142315</main-classification>\n",
       "</classification-national>\n",
       "</us-field-of-classification-search>\n",
       "<us-related-documents>\n",
       "<related-publication>\n",
       "<document-id>\n",
       "<country>US</country>\n",
       "<doc-number>20120184734</doc-number>\n",
       "<kind>A1</kind>\n",
       "<date>20120719</date>\n",
       "</document-id>\n",
       "</related-publication>\n",
       "</us-related-documents>\n",
       "<us-parties>\n",
       "<us-applicants>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"001\">\n",
       "<addressbook>\n",
       "<last-name>Akiyama</last-name>\n",
       "<first-name>Toshiyuki</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"002\">\n",
       "<addressbook>\n",
       "<last-name>Takaya</last-name>\n",
       "<first-name>Kenji</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"003\">\n",
       "<addressbook>\n",
       "<last-name>Kawai</last-name>\n",
       "<first-name>Makoto</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"004\">\n",
       "<addressbook>\n",
       "<last-name>Taoda</last-name>\n",
       "<first-name>Yoshiyuki</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"005\">\n",
       "<addressbook>\n",
       "<last-name>Mikamiyama</last-name>\n",
       "<first-name>Minako</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"006\">\n",
       "<addressbook>\n",
       "<last-name>Morimoto</last-name>\n",
       "<first-name>Kenji</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"007\">\n",
       "<addressbook>\n",
       "<last-name>Kageyama</last-name>\n",
       "<first-name>Chika</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"008\">\n",
       "<addressbook>\n",
       "<last-name>Tomita</last-name>\n",
       "<first-name>Kenji</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"009\">\n",
       "<addressbook>\n",
       "<last-name>Mikamiyama</last-name>\n",
       "<first-name>Hidenori</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "<us-applicant app-type=\"applicant\" designation=\"us-only\" sequence=\"010\">\n",
       "<addressbook>\n",
       "<last-name>Suzuki</last-name>\n",
       "<first-name>Naoyuki</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "<residence>\n",
       "<country>JP</country>\n",
       "</residence>\n",
       "</us-applicant>\n",
       "</us-applicants>\n",
       "<inventors>\n",
       "<inventor designation=\"us-only\" sequence=\"001\">\n",
       "<addressbook>\n",
       "<last-name>Akiyama</last-name>\n",
       "<first-name>Toshiyuki</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"002\">\n",
       "<addressbook>\n",
       "<last-name>Takaya</last-name>\n",
       "<first-name>Kenji</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"003\">\n",
       "<addressbook>\n",
       "<last-name>Kawai</last-name>\n",
       "<first-name>Makoto</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"004\">\n",
       "<addressbook>\n",
       "<last-name>Taoda</last-name>\n",
       "<first-name>Yoshiyuki</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"005\">\n",
       "<addressbook>\n",
       "<last-name>Mikamiyama</last-name>\n",
       "<first-name>Minako</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"006\">\n",
       "<addressbook>\n",
       "<last-name>Morimoto</last-name>\n",
       "<first-name>Kenji</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"007\">\n",
       "<addressbook>\n",
       "<last-name>Kageyama</last-name>\n",
       "<first-name>Chika</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"008\">\n",
       "<addressbook>\n",
       "<last-name>Tomita</last-name>\n",
       "<first-name>Kenji</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"009\">\n",
       "<addressbook>\n",
       "<last-name>Mikamiyama</last-name>\n",
       "<first-name>Hidenori</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "<inventor designation=\"us-only\" sequence=\"010\">\n",
       "<addressbook>\n",
       "<last-name>Suzuki</last-name>\n",
       "<first-name>Naoyuki</first-name>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</inventor>\n",
       "</inventors>\n",
       "<agents>\n",
       "<agent rep-type=\"attorney\" sequence=\"01\">\n",
       "<addressbook>\n",
       "<orgname>Finnegan, Henderson, Farabow, Garrett &amp; Dunner, LLP</orgname>\n",
       "<address>\n",
       "<country>unknown</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</agent>\n",
       "</agents>\n",
       "</us-parties>\n",
       "<assignees>\n",
       "<assignee>\n",
       "<addressbook>\n",
       "<orgname>Shionogi &amp; Co., Ltd.</orgname>\n",
       "<role>03</role>\n",
       "<address>\n",
       "<city>Osaka</city>\n",
       "<country>JP</country>\n",
       "</address>\n",
       "</addressbook>\n",
       "</assignee>\n",
       "</assignees>\n",
       "<examiners>\n",
       "<primary-examiner>\n",
       "<last-name>Balasubramanian</last-name>\n",
       "<first-name>Venkataraman</first-name>\n",
       "<department>1624</department>\n",
       "</primary-examiner>\n",
       "</examiners>\n",
       "<pct-or-regional-filing-data>\n",
       "<document-id>\n",
       "<country>WO</country>\n",
       "<doc-number>PCT/JP2010/060006</doc-number>\n",
       "<kind>00</kind>\n",
       "<date>20100614</date>\n",
       "</document-id>\n",
       "<us-371c124-date>\n",
       "<date>20120302</date>\n",
       "</us-371c124-date>\n",
       "</pct-or-regional-filing-data>\n",
       "<pct-or-regional-publishing-data>\n",
       "<document-id>\n",
       "<country>WO</country>\n",
       "<doc-number>WO2010/147068</doc-number>\n",
       "<kind>A </kind>\n",
       "<date>20101223</date>\n",
       "</document-id>\n",
       "</pct-or-regional-publishing-data>\n",
       "</us-bibliographic-data-grant>\n",
       "<abstract id=\"abstract\">\n",
       "<p id=\"p-0001\" num=\"0000\">This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.</p>\n",
       "</abstract>\n",
       "<description id=\"description\">\n",
       "<?BRFSUM description=\"Brief Summary\" end=\"lead\"?>\n",
       "<heading id=\"h-0001\" level=\"1\">TECHNICAL FIELD</heading>\n",
       "<p id=\"p-0002\" num=\"0001\">This invention relates to substituted polycyclic carbamoylpyridone derivatives having cap-dependent endonuclease inhibitory activity, and pharmaceutical compositions including thereof.</p>\n",
       "<heading id=\"h-0002\" level=\"1\">BACKGROUND ART</heading>\n",
       "<p id=\"p-0003\" num=\"0002\">Influenza is an acute respiratory infectious disease caused by infection with an influenza virus. In Japan, there is a report of a few millions of influenza-like patients every winter, and influenza is accompanied with high morbidity and mortality. Influenza is a particularly important disease in a high risk population such as baby and elderly, a complication rate with pneumonia is high in elderly, and death with influenza is occupied with elderly in many cases.</p>\n",
       "<p id=\"p-0004\" num=\"0003\">As anti-influenza drugs, Symmetrel (trade name: Amantadine) and Flumadine (trade name: Rimantadine) which inhibit the denucleation process of a virus, and Oseltamivir (trade name: Tamiflu) and Zanamivir (trade name: Relenza) which are neuraminidase inhibitors suppressing virus budding and release from a cell are known. However, since problems of appearances of resistant strains and side effects, and worldwide epidemic of a new-type influenza virus having high pathogenicity and mortality are feared, development of an anti-influenza drug having a novel mechanism has been desired.</p>\n",
       "<p id=\"p-0005\" num=\"0004\">Since a cap-dependent endonuclease which is an influenza virus-derived enzyme is essential for virus proliferation, and has the virus-specific enzymatic activity which is not possessed by a host, it is believed that the endonuclease is suitable for a target of an anti-influenza drug. The cap-dependent endonuclease has a host mRNA precursor as a substrate, and has the endonuclease activity of producing a fragment of 9 to 13 bases including a cap structure (not including the number of bases of the cap structure). This fragment functions as a primer of a virus RNA polymerase, and is used in synthesizing mRNA encoding a virus protein. That is, it is believed that a substance which inhibits the cap-dependent endonuclease inhibits synthesis of a virus protein by inhibiting synthesis of virus mRNA and, as a result, inhibits virus proliferation.</p>\n",
       "<p id=\"p-0006\" num=\"0005\">As the substance which inhibits the cap-dependent endo nuclease, flutimide (Patent Document 1 and Non-Patent Documents 1 and 2) and 4-substituted 2,4-dioxobutanoic acid (Non-Patent Documents 3 to 5) are reported, but they have not yet led to clinical use as anti-influenza drugs. In addition, Patent Documents 2 to 9 and Non-Patent Document 6 describe compounds having a similar structure to that of this invention, however, the documents do not describe cap-dependent endonuclease.</p>\n",
       "<heading id=\"h-0003\" level=\"1\">PRIOR ART DOCUMENTS</heading>\n",
       "<heading id=\"h-0004\" level=\"1\">Patent Documents</heading>\n",
       "<p id=\"p-0007\" num=\"0000\">\n",
       "<ul id=\"ul0001\" list-style=\"none\">\n",
       "<li id=\"ul0001-0001\" num=\"0006\">[Patent Document 1] GB No. 2280435 specification</li>\n",
       "<li id=\"ul0001-0002\" num=\"0007\">[Patent Document 2] International Publication No. 2007/049675pamphlet</li>\n",
       "<li id=\"ul0001-0003\" num=\"0008\">[Patent Document 3] International Publication No. 2006/088173pamphlet</li>\n",
       "<li id=\"ul0001-0004\" num=\"0009\">[Patent Document 4] International Publication No. 2006/066414pamphlet</li>\n",
       "<li id=\"ul0001-0005\" num=\"0010\">[Patent Document 5] International Publication No. 2005/092099pamphlet</li>\n",
       "<li id=\"ul0001-0006\" num=\"0011\">[Patent Document 6] International Publication No. 2005/087766pamphlet</li>\n",
       "<li id=\"ul0001-0007\" num=\"0012\">[Patent Document 7] International Publication No. 2005/016927pamphlet</li>\n",
       "<li id=\"ul0001-0008\" num=\"0013\">[Patent Document 8] International Publication No. 2004/024078pamphlet</li>\n",
       "<li id=\"ul0001-0009\" num=\"0014\">[Patent Document 9] International Publication No. 2006/116764pamphlet</li>\n",
       "</ul>\n",
       "</p>\n",
       "<heading id=\"h-0005\" level=\"1\">Non-Patent Documents</heading>\n",
       "<p id=\"p-0008\" num=\"0000\">\n",
       "<ul id=\"ul0002\" list-style=\"none\">\n",
       "<li id=\"ul0002-0001\" num=\"0015\">[Non-Patent Document 1] Tetrahedron Lett 1995, 36(12), 2005</li>\n",
       "<li id=\"ul0002-0002\" num=\"0016\">[Non-Patent Document 2] Tetrahedron Lett 1995, 36(12), 2009</li>\n",
       "<li id=\"ul0002-0003\" num=\"0017\">[Non-Patent Document 3] Antimicrobial Agents And Chemotherapy, December 1994, p. 2827-2837</li>\n",
       "<li id=\"ul0002-0004\" num=\"0018\">[Non-Patent Document 4] Antimicrobial Agents And Chemotherapy, May 1996, p. 1304-1307</li>\n",
       "<li id=\"ul0002-0005\" num=\"0019\">[Non-Patent Document 5] J. Med. Chem. 2003, 46, 1153-1164</li>\n",
       "<li id=\"ul0002-0006\" num=\"0020\">[Non-Patent Document 6] Bioorganic &amp; Medicinal Chemistry Letters 17 (2007)5595-5599</li>\n",
       "</ul>\n",
       "</p>\n",
       "<heading id=\"h-0006\" level=\"1\">SUMMARY OF THE INVENTION</heading>\n",
       "<heading id=\"h-0007\" level=\"1\">Problems to be Solved by the Invention</heading>\n",
       "<p id=\"p-0009\" num=\"0021\">An object of the present invention is to provide compounds having antiviral activities especially inhibiting growth activity of influenza virus. More preferably, this invention provides compounds and medicament containing the same which inhibit increase of influenza virus by exhibiting cap-dependent endonuclease inhibitory activity.</p>\n",
       "<heading id=\"h-0008\" level=\"1\">Means for Solving the Problems</heading>\n",
       "<p id=\"h-0009\" num=\"0000\">[Item 1′]</p>\n",
       "<p id=\"p-0010\" num=\"0022\">A CAP dependent endonuclease inhibitor containing a compound represented by formula (I), a pharmaceutically acceptable salt, or a solvate thereof:</p>\n",
       "<p id=\"p-0011\" num=\"0023\"><chemistry id=\"CHEM-US-00001\" num=\"00001\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00001.TIF\" he=\"31.75mm\" id=\"EMI-C00001\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein\n",
       "<br/>\n",
       "R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X3</sup>)—SO<sub>2</sub>—(R<sup>X4</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X5</sup>)—SO<sub>2</sub>—(R<sup>X6</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X7</sup>)—C(═O)—R<sup>X8</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X9</sup>)(R<sup>X10</sup>),\n",
       "<br/>\n",
       "—Z—S—R<sup>X11</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>X12</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>X13</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X14</sup>)—C(═O)—O—R<sup>X15</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X16</sup>)—C(═O)—N(R<sup>X17</sup>)(R<sup>X18</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X19</sup>)—C(═O)—N(R<sup>X20</sup>)(R<sup>X21</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>X22</sup>)—C(═O)—C(═O)—R<sup>X23 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>X1</sup>, R<sup>X2</sup>, R<sup>X3</sup>, R<sup>X5</sup>, R<sup>X7</sup>, R<sup>X8</sup>, R<sup>X9</sup>, R<sup>X10</sup>, R<sup>X11</sup>, R<sup>X14 </sup>R<sup>X15</sup>, R<sup>X16</sup>, R<sup>X17</sup>, R<sup>X18</sup>, R<sup>X19</sup>, R<sup>X20</sup>, R<sup>X21</sup>, R<sup>X22</sup>, and R<sup>X23 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>X4</sup>, R<sup>X6</sup>, R<sup>X12 </sup>and R<sup>X13 </sup>are each independently selected from a substituent group consisting of, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>X1 </sup>and R<sup>X2</sup>, R<sup>X9 </sup>and R<sup>X10</sup>, R<sup>X17 </sup>and R<sup>X18</sup>, and R<sup>X20 </sup>and R<sup>X21 </sup>each may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>2 </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>Y1</sup>)—SO<sub>2</sub>—R<sup>Y2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Y3</sup>)—C(═O)—R<sup>Y4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Y5</sup>)—C(═O)—O—R<sup>Y6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>Y7</sup>)(R<sup>Y8</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>Y9</sup>)(R<sup>Y10</sup>), or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>Y11 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>Y1</sup>, R<sup>Y3</sup>, R<sup>Y4</sup>, R<sup>Y5</sup>, R<sup>Y6</sup>, R<sup>Y7</sup>, R<sup>Y8</sup>, R<sup>Y9</sup>, and R<sup>Y10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Y2 </sup>and R<sup>Y11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Y7 </sup>and R<sup>Y8</sup>, and R<sup>Y9 </sup>and R<sup>Y10 </sup>may be taken together with an adjacent atom to form heterocycle and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>3 </sup>is hydrogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z1</sup>)—SO<sub>2</sub>—R<sup>Z2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z3</sup>)—C(═O)—R<sup>Z4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z5</sup>)—C(═O)—O—R<sup>Z6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>Z7</sup>)(R<sup>Z8</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>Z9</sup>)(R<sup>Z10</sup>),\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>Z11</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>Z12</sup>)—O—C(═O)—R<sup>Z13 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>Z1</sup>, R<sup>Z3</sup>, R<sup>Z4</sup>, R<sup>Z5</sup>, R<sup>Z6</sup>, R<sup>Z7</sup>, R<sup>Z8</sup>, R<sup>Z9</sup>, R<sup>Z10</sup>, R<sup>Z12 </sup>and R<sup>Z13 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Z2 </sup>and R<sup>Z11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Z7 </sup>and R<sup>Z8</sup>, and R<sup>Z9 </sup>and R<sup>Z10 </sup>each may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene) and;\n",
       "<br/>\n",
       "a) either A<sup>1 </sup>or A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>, and the other is NR<sup>7</sup>, or\n",
       "<br/>\n",
       "b) A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>,\n",
       "<br/>\n",
       "R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>9</sup>, R<sup>9</sup>, R<sup>10</sup>, and R<sup>11 </sup>are each independently selected from a substituent group consisting of hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyl carbonyl optionally substituted by substituent group A, lower alkyl oxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—S—R<sup>V1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>V2</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>V3</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>V4</sup>,\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>V5</sup>)(R<sup>V6</sup>)\n",
       "<br/>\n",
       "—Z—N(R<sup>V7</sup>)—C(═O)—O—R<sup>V8</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>V9</sup>)—C(═O)—R<sup>V10 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>V1</sup>, R<sup>V4</sup>, R<sup>V5</sup>, R<sup>V6</sup>, R<sup>V7</sup>, R<sup>V8</sup>, R<sup>V9</sup>, and R<sup>V10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>V2 </sup>and R<sup>V3 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>V5 </sup>and R<sup>V6 </sup>may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene), and\n",
       "<br/>\n",
       "R<sup>5 </sup>and R<sup>6 </sup>may be taken together with an adjacent atom to form carbocycle;\n",
       "<br/>\n",
       "1) when A<sup>1 </sup>is CR<sup>5</sup>R<sup>6 </sup>and A<sup>2 </sup>is NR<sup>7</sup>,\n",
       "<br/>\n",
       "R<sup>3 </sup>and R<sup>7 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form a condensed ring,\n",
       "<br/>\n",
       "2) when A<sup>1 </sup>is NR<sup>7 </sup>and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>,\n",
       "<br/>\n",
       "R<sup>3 </sup>and R<sup>6 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form condensed ring,\n",
       "<br/>\n",
       "or\n",
       "<br/>\n",
       "3) when A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>,\n",
       "<br/>\n",
       "R<sup>8 </sup>and R<sup>10 </sup>may be taken together with an adjacent atom to form a bond, and R<sup>8 </sup>and R<sup>10 </sup>may be taken together with an adjacent atom to form carbocycle or heterocycle, or\n",
       "<br/>\n",
       "R<sup>3 </sup>and R<sup>11 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form condensed ring;\n",
       "<br/>\n",
       "with a proviso that the following case of c) and d) are excluded;\n",
       "<br/>\n",
       "c) R<sup>5</sup>, R<sup>6</sup>, and R<sup>7 </sup>are all hydrogens\n",
       "<br/>\n",
       "d) R<sup>8</sup>, R<sup>9</sup>, R<sup>10</sup>, and R<sup>11 </sup>are all hydrogens;\n",
       "<br/>\n",
       "Substituent group A: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, lower alkylthio, hydroxy lower alkyl, carbocyclic group, heterocyclic group, heterocyclic group substituted by oxo, carbocycle lower alkyloxy, carbocycleoxy lower alkyl, carbocycle lower alkyloxy lower alkyl, heterocycle lower alkyloxy, heterocycleoxy lower alkyl, heterocycle lower alkyloxy lower alkyl, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkylcarbonyloxy, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, halogeno lower alkyl carbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfinyl, and lower alkylsulfonylamino;\n",
       "<br/>\n",
       "Substituent group B: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfonylamino, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A).\n",
       "<br/>\n",
       "[Item 2′]\n",
       "</p>\n",
       "<p id=\"p-0012\" num=\"0024\">A CAP dependent endonuclease inhibitor according to item 1′, wherein</p>\n",
       "<p id=\"p-0013\" num=\"0025\">R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>)\n",
       "<br/>\n",
       "—Z—N(R<sup>X3</sup>)—SO<sub>2</sub>—(R<sup>X4</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X5</sup>)—SO<sub>2</sub>—(R<sup>X6</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X7</sup>)—C(═O)—R<sup>X8</sup>,\n",
       "<br/>\n",
       "—Z—S—R<sup>X11</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>X12</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>X13</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X14</sup>)—C(═O)—O—R<sup>X15</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X16</sup>)—C(═O)—N(R<sup>X17</sup>)(R<sup>X18</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>X22</sup>)—C(═O)—C(═O)—R<sup>X23 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>X1</sup>, R<sup>X11</sup>, R<sup>X12</sup>, R<sup>X13</sup>, R<sup>X14</sup>, R<sup>X15</sup>, R<sup>X16</sup>, R<sup>X17</sup>, R<sup>X18</sup>, R<sup>X22</sup>, R<sup>X23</sup>, and\n",
       "<br/>\n",
       "Z are same meaning as those of item 1′).\n",
       "<br/>\n",
       "[Item 3′]\n",
       "</p>\n",
       "<p id=\"p-0014\" num=\"0026\">A CAP dependent endonuclease inhibitor according to item 1′, wherein</p>\n",
       "<p id=\"p-0015\" num=\"0027\">R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X7</sup>)—C(═O)—R<sup>X8</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>X14</sup>)—C(═O)—O—R<sup>X15 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>X1</sup>, R<sup>X2</sup>, R<sup>X7</sup>, R<sup>X8</sup>, R<sup>X14</sup>, R<sup>X15</sup>, and Z are same meaning as those of item 1′).\n",
       "<br/>\n",
       "[Item 4′]\n",
       "</p>\n",
       "<p id=\"p-0016\" num=\"0028\">A CAP dependent endonuclease inhibitor according to item 1′, wherein</p>\n",
       "<p id=\"p-0017\" num=\"0029\">R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkyl carbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, or\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>)\n",
       "<br/>\n",
       "(Substituent group A, R<sup>X1</sup>, R<sup>X2</sup>, and Z are same meaning as those of item 1′).\n",
       "<br/>\n",
       "[Item 5′]\n",
       "</p>\n",
       "<p id=\"p-0018\" num=\"0030\">A CAP dependent endonuclease inhibitor according to item 1′, wherein R<sup>1 </sup>is hydrogen or carboxy.</p>\n",
       "<p id=\"h-0010\" num=\"0000\">[Item 6′]</p>\n",
       "<p id=\"p-0019\" num=\"0031\">A CAP dependent endonuclease inhibitor according to any one of items 1′ to 5′, wherein</p>\n",
       "<p id=\"h-0011\" num=\"0000\">R<sup>2 </sup>is hydrogen, lower alkyl optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, or</p>\n",
       "<p id=\"h-0012\" num=\"0000\">—Z—N(R<sup>Y9</sup>)(R<sup>Y10</sup>)</p>\n",
       "<p id=\"h-0013\" num=\"0000\">(Substituent group A, R<sup>Y9</sup>, R<sup>Y10</sup>, and Z are same meaning as those of item 1′).</p>\n",
       "<p id=\"h-0014\" num=\"0000\">[Item 7′]</p>\n",
       "<p id=\"p-0020\" num=\"0032\">A CAP dependent endonuclease inhibitor according to any one of items 1′ to 5′, wherein</p>\n",
       "<p id=\"h-0015\" num=\"0000\">R<sup>2 </sup>is hydrogen or lower alkyl optionally substituted by substituent group A</p>\n",
       "<p id=\"h-0016\" num=\"0000\">(Substituent group A is same meaning as that of item 1′).</p>\n",
       "<p id=\"h-0017\" num=\"0000\">[Item 8′]</p>\n",
       "<p id=\"p-0021\" num=\"0033\">A CAP dependent endonuclease inhibitor according to any one of items 1′ to 7′, wherein</p>\n",
       "<p id=\"p-0022\" num=\"0034\">R<sup>3 </sup>is hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z1</sup>)—SO<sub>2</sub>—R<sup>Z2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z3</sup>)—C(═O)—R<sup>Z4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z5</sup>)—C(═O)—O—R<sup>Z6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>Z7</sup>)(R<sup>Z8</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>Z9</sup>)(R<sup>Z10</sup>)\n",
       "<br/>\n",
       "(Substituent group A, R<sup>Z1</sup>, R<sup>Z2</sup>, R<sup>Z3</sup>, R<sup>Z4</sup>, R<sup>Z5</sup>, R<sup>Z6</sup>, R<sup>Z7</sup>, R<sup>Z8</sup>, R<sup>Z9</sup>, R<sup>Z10</sup>, and Z are same meaning as those of item 1′).\n",
       "<br/>\n",
       "[Item 9′]\n",
       "</p>\n",
       "<p id=\"p-0023\" num=\"0035\">A CAP dependent endonuclease inhibitor according to any one of items 1′ to 8′, wherein</p>\n",
       "<p id=\"h-0018\" num=\"0000\">A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>,</p>\n",
       "<p id=\"h-0019\" num=\"0000\">R<sup>9</sup>, R<sup>10</sup>, and R<sup>11 </sup>are hydrogen or lower alkyl optionally substituted by substituent group A, and</p>\n",
       "<p id=\"p-0024\" num=\"0036\">R<sup>8 </sup>is lower alkyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—S—R<sup>V1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>V2</sup>, or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>V3 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>V1</sup>, R<sup>V2</sup>, R<sup>V3</sup>, and Z are same meaning as those of item 1′).\n",
       "<br/>\n",
       "[Item 10′]\n",
       "</p>\n",
       "<p id=\"p-0025\" num=\"0037\">A CAP dependent endonuclease inhibitor according to any one of items 1′ to 8′, wherein</p>\n",
       "<p id=\"h-0020\" num=\"0000\">A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>,</p>\n",
       "<p id=\"h-0021\" num=\"0000\">R<sup>8</sup>, R<sup>9</sup>, and R<sup>11 </sup>are hydrogen, or lower alkyl optionally substituted by substituent group A, and</p>\n",
       "<p id=\"p-0026\" num=\"0038\">R<sup>10 </sup>is lower alkyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—S—R<sup>V1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>V2</sup>, or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>V3 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>V1</sup>, R<sup>V2</sup>, R<sup>V3</sup>, and Z are same meaning as those of item 1′).\n",
       "<br/>\n",
       "[Item 11′]\n",
       "</p>\n",
       "<p id=\"p-0027\" num=\"0039\">A CAP dependent endonuclease inhibitor according to any one of items 1′ to 8′, wherein</p>\n",
       "<p id=\"h-0022\" num=\"0000\">A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>,</p>\n",
       "<p id=\"h-0023\" num=\"0000\">R<sup>9 </sup>and R<sup>11 </sup>are hydrogen,</p>\n",
       "<p id=\"h-0024\" num=\"0000\">i) either R<sup>8 </sup>or R<sup>10 </sup>is a group shown below:</p>\n",
       "<p id=\"p-0028\" num=\"0040\"><chemistry id=\"CHEM-US-00002\" num=\"00002\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00002.TIF\" he=\"205.82mm\" id=\"EMI-C00002\" img-content=\"chem\" img-format=\"tif\" wi=\"49.19mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>is selected from substituent group A,\n",
       "<br/>\n",
       "m is an integer of 0 or more, and substituent group A is same meaning as those of item 1′) and;\n",
       "<br/>\n",
       "ii) the other of R<sup>8 </sup>or R<sup>10 </sup>is hydrogen, or lower alkyl optionally substituted by substituent group A;\n",
       "<br/>\n",
       "[Item 12′]\n",
       "<br/>\n",
       "CAP dependent endonuclease inhibitor according to item 11′, wherein\n",
       "<br/>\n",
       "A<sup>1 </sup>is CR<sup>8</sup>, R<sup>9</sup>, A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>,\n",
       "<br/>\n",
       "R<sup>9 </sup>and R<sup>11 </sup>are hydrogen,\n",
       "<br/>\n",
       "i) either R<sup>8 </sup>or R<sup>10 </sup>is a group shown below:\n",
       "</p>\n",
       "<p id=\"p-0029\" num=\"0041\"><chemistry id=\"CHEM-US-00003\" num=\"00003\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00003.TIF\" he=\"95.93mm\" id=\"EMI-C00003\" img-content=\"chem\" img-format=\"tif\" wi=\"43.77mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>is selected from substituent group A,\n",
       "<br/>\n",
       "m is an integer of 0 or more, substituent group A is same meaning as that of item 1′) and;\n",
       "<br/>\n",
       "ii) the other of R<sup>8 </sup>or R<sup>10 </sup>is hydrogen or lower alkyl optionally substituted by substituent group A.\n",
       "<br/>\n",
       "[Item 13′]\n",
       "</p>\n",
       "<p id=\"p-0030\" num=\"0042\">A compound represented by formula (II), or a pharmaceutically acceptable salt thereof or a solvate thereof:</p>\n",
       "<p id=\"p-0031\" num=\"0043\"><chemistry id=\"CHEM-US-00004\" num=\"00004\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00004.TIF\" he=\"33.95mm\" id=\"EMI-C00004\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein\n",
       "<br/>\n",
       "R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>A5</sup>)—SO<sub>2</sub>—(R<sup>A6</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,\n",
       "<br/>\n",
       "—Z—S—R<sup>A9</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>A10</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>A11</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>A14</sup>)—C(═O)—N(R<sup>A15</sup>)(R<sup>A16</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>A17</sup>)—C(═O)—N(R<sup>A18</sup>)(R<sup>A19</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A3</sup>, R<sup>A5</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A9</sup>, R<sup>A12</sup>, R<sup>A13</sup>, R<sup>A14</sup>, R<sup>A15</sup>, R<sup>A16</sup>, R<sup>A17</sup>, R<sup>A18</sup>, R<sup>A19</sup>, R<sup>A20</sup>, and R<sup>A21 </sup>are each independently selected from substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>A4</sup>, R<sup>A6</sup>, R<sup>A10</sup>, and R<sup>A11 </sup>are each independently selected from substituent group consisting of, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>A1 </sup>and R<sup>A2</sup>, R<sup>A15 </sup>and R<sup>A16</sup>, and R<sup>A18 </sup>and R<sup>A19 </sup>each may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>2a </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>B1</sup>)—SO<sub>2</sub>—R<sup>B2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>B3</sup>)—C(═O)—R<sup>B4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>B5</sup>)—C(═O)—O—R<sup>B6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>B7</sup>)(R<sup>B8</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>), or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>B11 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>B1</sup>, R<sup>B3</sup>, R<sup>B4</sup>, R<sup>B5</sup>, R<sup>B6</sup>, R<sup>B7</sup>, R<sup>B8</sup>, R<sup>B9</sup>, and R<sup>B10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>B2 </sup>and R<sup>B11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>B7 </sup>and R<sup>B8</sup>, and R<sup>B9 </sup>and R<sup>B10 </sup>each may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>3a </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>C1</sup>)—SO<sub>2</sub>—R<sup>C2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C3</sup>)—C(═O)—R<sup>C4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C5</sup>)—C(═O)—O—R<sup>C6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>C7</sup>)(R<sup>C8</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>C9</sup>)(R<sup>C10</sup>),\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>C11</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>C12</sup>)—O—C(═O)—R<sup>C13 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>C1</sup>, R<sup>C3</sup>, R<sup>C4</sup>, R<sup>C5</sup>, R<sup>C6</sup>, R<sup>C7</sup>, R<sup>C8</sup>, R<sup>C9</sup>, R<sup>C10</sup>, R<sup>C12 </sup>and, R<sup>C13 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>C2</sup>, and R<sup>C11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>C7 </sup>and R<sup>C8</sup>, and R<sup>C9 </sup>and R<sup>C10 </sup>each may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene) and;\n",
       "<br/>\n",
       "a) either B<sup>1 </sup>or B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and the other is NR<sup>7a</sup>,\n",
       "<br/>\n",
       "or\n",
       "<br/>\n",
       "b) B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a </sup>and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a </sup>\n",
       "<br/>\n",
       "R<sup>5a</sup>, R<sup>6a</sup>, R<sup>7a</sup>, R<sup>8a</sup>, R<sup>9a</sup>, R<sup>10a </sup>and R<sup>11a </sup>are each independently selected from a substituent group consisting of hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyl carbonyl optionally substituted by substituent group C, lower alkyl oxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>D2</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>D3</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D4</sup>,\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D5</sup>)(R<sup>D6</sup>),\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>),\n",
       "<br/>\n",
       "—Z—CH<sub>2</sub>—R<sup>D10</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>D11</sup>)—C(═O)—O—R<sup>D12</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>D13</sup>)—C(═O)—R<sup>D14 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>D1</sup>, R<sup>D4</sup>, R<sup>D5</sup>, R<sup>D6</sup>, R<sup>D9</sup>, R<sup>D11</sup>, R<sup>D12</sup>, R<sup>D13</sup>, and R<sup>D14 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>D2 </sup>and R<sup>D3 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>D7</sup>, R<sup>D8 </sup>and R<sup>D10 </sup>are each independently selected from a substituent group consisting of carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>D5 </sup>and R<sup>D6 </sup>may be taken together with an adjacent atom to form heterocycle,\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>D5 </sup>and R<sup>D6 </sup>may be taken together with an adjacent atom to form carbocycle;\n",
       "<br/>\n",
       "1) when B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a </sup>and B<sup>2 </sup>is NR<sup>7a</sup>,\n",
       "<br/>\n",
       "R<sup>3a </sup>and R<sup>7a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D,\n",
       "<br/>\n",
       "2) when B<sup>1 </sup>is NR<sup>7a </sup>and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,\n",
       "<br/>\n",
       "R<sup>3a </sup>and R<sup>6a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, or\n",
       "<br/>\n",
       "3) when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a </sup>and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,\n",
       "<br/>\n",
       "R<sup>8a </sup>and R<sup>10a </sup>may y be taken together with an adjacent atom to form carbocycle or heterocycle optionally substituted by substituent group D, or\n",
       "<br/>\n",
       "R<sup>3a </sup>and R<sup>11a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D,\n",
       "<br/>\n",
       "wherein\n",
       "<br/>\n",
       "when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>, and R<sup>9a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen,\n",
       "<br/>\n",
       "i) either R<sup>8a </sup>or R<sup>10a </sup>is\n",
       "<br/>\n",
       "—Z—C(R<sup>E2</sup>)(R<sup>E3</sup>)\n",
       "<br/>\n",
       "—Z—C(R<sup>E4</sup>),\n",
       "<br/>\n",
       "—Y—S—R<sup>E4</sup>,\n",
       "<br/>\n",
       "—Z—CH<sub>2</sub>—R<sup>E5</sup>, or\n",
       "<br/>\n",
       "a group shown below:\n",
       "</p>\n",
       "<p id=\"p-0032\" num=\"0044\"><chemistry id=\"CHEM-US-00005\" num=\"00005\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00005.TIF\" he=\"195.50mm\" id=\"EMI-C00005\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E1 </sup>and R<sup>E2 </sup>are each independently, carbocycle optionally substituted by substituent group C, and heterocycle optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E3 </sup>is selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E4 </sup>is selected from a substituent group consisting of carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E5 </sup>is aromatic heterocycle optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E6 </sup>is selected from a substituent group C,\n",
       "<br/>\n",
       "m is an integer of 0 or more,\n",
       "<br/>\n",
       "provided that\n",
       "<br/>\n",
       "m of R<sup>E6</sup>s is same or different groups selected from substituent group C\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene); and\n",
       "<br/>\n",
       "ii) the other of R<sup>8a </sup>or R<sup>10a </sup>is\n",
       "<br/>\n",
       "hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>F1</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>F2</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>F3</sup>)(R<sup>F4</sup>)\n",
       "<br/>\n",
       "(wherein R<sup>F1</sup>, R<sup>F2</sup>, R<sup>F3</sup>, and R<sup>F4 </sup>are each independently, hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C, and\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene);\n",
       "<br/>\n",
       "with a proviso that the following c) and d) are excluded\n",
       "<br/>\n",
       "c) R<sup>5a</sup>, R<sup>6a</sup>, and R<sup>7a </sup>are all hydrogens\n",
       "<br/>\n",
       "d) R<sup>8a</sup>, R<sup>9a</sup>, R<sup>10a</sup>, and R<sup>11a </sup>are all hydrogens;\n",
       "<br/>\n",
       "Substituent group C: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, lower alkylthio, hydroxy lower alkyl, carbocyclic group, heterocyclic group, heterocyclic group substituted by oxo, carbocycle lower alkyloxy, carbocycleoxy lower alkyl, carbocycle lower alkyloxy lower alkyl, heterocycle lower alkyloxy, heterocycleoxy lower alkyl, heterocycle lower alkyloxy lower alkyl, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkylcarbonyloxy, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, halogeno lower alkyl carbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfinyl, and lower alkylsulfonylamino;\n",
       "<br/>\n",
       "Substituent group D: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfonylamino, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C).\n",
       "<br/>\n",
       "[Item 14′]\n",
       "</p>\n",
       "<p id=\"p-0033\" num=\"0045\">The compound according to item 13′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0034\" num=\"0046\">wherein R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>), —Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,\n",
       "<br/>\n",
       "—Z—S—R<sup>A9</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>A10</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup>\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A3</sup>, R<sup>A4</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A9</sup>, R<sup>A10</sup>, R<sup>A12</sup>, R<sup>A13</sup>, R<sup>A20</sup>, R<sup>A21</sup>, and Z are same meaning as those of item 13).\n",
       "<br/>\n",
       "[Item 15′]\n",
       "</p>\n",
       "<p id=\"p-0035\" num=\"0047\">The compound according to item 13′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0036\" num=\"0048\">wherein R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13 </sup>\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A12</sup>, R<sup>A13</sup>, and Z are same as those of item 13′).\n",
       "<br/>\n",
       "[Item 16′]\n",
       "</p>\n",
       "<p id=\"p-0037\" num=\"0049\">The compound according to item 13′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0038\" num=\"0050\">wherein R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, and Z are same as those of item 13′).\n",
       "<br/>\n",
       "[Item 17′]\n",
       "</p>\n",
       "<p id=\"p-0039\" num=\"0051\">The compound according to item 13′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0025\" num=\"0000\">wherein R<sup>1a </sup>is hydrogen, or carboxy.</p>\n",
       "<p id=\"h-0026\" num=\"0000\">[Item 18′]</p>\n",
       "<p id=\"p-0040\" num=\"0052\">The compound according to any one of items 13′ to 17′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0027\" num=\"0000\">wherein R<sup>2a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, or</p>\n",
       "<p id=\"h-0028\" num=\"0000\">—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>)</p>\n",
       "<p id=\"h-0029\" num=\"0000\">(substituent group C, R<sup>B9</sup>, R<sup>B10</sup>, and Z are same as those of item 13′).</p>\n",
       "<p id=\"h-0030\" num=\"0000\">[Item 19′]</p>\n",
       "<p id=\"p-0041\" num=\"0053\">The compound according to any one of items 13′ to 17′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0031\" num=\"0000\">wherein R<sup>2a </sup>is hydrogen or lower alkyl optionally substituted by substituent group C</p>\n",
       "<p id=\"h-0032\" num=\"0000\">(substituent group C is same as that of item 13′).</p>\n",
       "<p id=\"h-0033\" num=\"0000\">[Item 20′]</p>\n",
       "<p id=\"p-0042\" num=\"0054\">The compound according to any one of items 13′ to 19′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0043\" num=\"0055\">wherein R<sup>3a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>C1</sup>)—SO<sub>2</sub>—R<sup>C2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C3</sup>)—C(═O)—R<sup>C4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C5</sup>)—C(═O)—O—R<sup>C6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>C7</sup>)(R<sup>C8</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>C9</sup>)(R<sup>C10</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>C1</sup>, R<sup>C2</sup>, R<sup>C3</sup>, R<sup>C4</sup>, R<sup>C5</sup>, R<sup>C6</sup>, R<sup>C7</sup>, R<sup>C8</sup>, R<sup>C9</sup>, R<sup>C10</sup>, and Z are same as those of item 13′).\n",
       "<br/>\n",
       "[Item 21′]\n",
       "</p>\n",
       "<p id=\"p-0044\" num=\"0056\">The compound according to any one of items 13′ to 19′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0045\" num=\"0057\">wherein R<sup>3a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "(substituent group C, is same as that of item 13′).\n",
       "<br/>\n",
       "[Item 22′]\n",
       "</p>\n",
       "<p id=\"p-0046\" num=\"0058\">The compound according to any one of items 13′ to 21′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0034\" num=\"0000\">wherein B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and</p>\n",
       "<p id=\"p-0047\" num=\"0059\">R<sup>5a</sup>, R<sup>6a </sup>and R<sup>7a </sup>are each independently hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyl carbonyl optionally substituted by substituent group C, lower alkyl oxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>D2</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>D3</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D4</sup>,\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D5</sup>)(R<sup>D6</sup>),\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)\n",
       "<br/>\n",
       "—Z—N(R<sup>D11</sup>)—C(═O)—O—R<sup>D12</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>D13</sup>)—C(═O)—R<sup>D14 </sup>\n",
       "<br/>\n",
       "(substituent group C, R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, R<sup>D4</sup>, R<sup>D5</sup>, R<sup>D6</sup>, R<sup>D7</sup>, R<sup>D8 </sup>R<sup>D9</sup>, R<sup>D11</sup>, R<sup>D12</sup>, R<sup>D13</sup>, R<sup>D14</sup>, Y, and Z are same as those of item 13).\n",
       "<br/>\n",
       "[Item 23′]\n",
       "</p>\n",
       "<p id=\"p-0048\" num=\"0060\">The compound according to any one of items 13′ to 21′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0035\" num=\"0000\">wherein B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,</p>\n",
       "<p id=\"h-0036\" num=\"0000\">R<sup>5a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0037\" num=\"0000\">R<sup>6a </sup>is hydrogen, or lower alkyl optionally substituted by substituent group C, and</p>\n",
       "<p id=\"p-0049\" num=\"0061\">R<sup>7a </sup>is lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, or\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, and Z are same as item 13′).\n",
       "<br/>\n",
       "[Item 24′]\n",
       "</p>\n",
       "<p id=\"p-0050\" num=\"0062\">The compound according to any one of items 13′ to 21′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0038\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and B<sup>2 </sup>is NR<sup>7a</sup>,</p>\n",
       "<p id=\"h-0039\" num=\"0000\">R<sup>5a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0040\" num=\"0000\">R<sup>6a </sup>is hydrogen, or lower alkyl optionally substituted by substituent group C, and</p>\n",
       "<p id=\"p-0051\" num=\"0063\">R<sup>7a </sup>is lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, or\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)\n",
       "<br/>\n",
       "(Substituent group C, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, and Z are same as item 13′).\n",
       "<br/>\n",
       "[Item 25′]\n",
       "</p>\n",
       "<p id=\"p-0052\" num=\"0064\">The compound according to items 23′ or 24′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0041\" num=\"0000\">wherein R<sup>7a </sup>is a group shown below:</p>\n",
       "<p id=\"p-0053\" num=\"0065\"><chemistry id=\"CHEM-US-00006\" num=\"00006\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00006.TIF\" he=\"225.89mm\" id=\"EMI-C00006\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>and m are same as those of item 13′).\n",
       "<br/>\n",
       "[Item 26′]\n",
       "</p>\n",
       "<p id=\"p-0054\" num=\"0066\">The compound according to items 13′ or 21′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0042\" num=\"0000\">wherein</p>\n",
       "<p id=\"h-0043\" num=\"0000\">B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a </sup></p>\n",
       "<p id=\"h-0044\" num=\"0000\">R<sup>9a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen, and</p>\n",
       "<p id=\"h-0045\" num=\"0000\">i) either R<sup>8a </sup>or R<sup>10a </sup>is a group shown below:</p>\n",
       "<p id=\"p-0055\" num=\"0067\"><chemistry id=\"CHEM-US-00007\" num=\"00007\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00007.TIF\" he=\"225.89mm\" id=\"EMI-C00007\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6</sup>, and m are same as those of item 13′); and\n",
       "<br/>\n",
       "ii) the other of R<sup>8a </sup>or R<sup>10a </sup>is\n",
       "<br/>\n",
       "hydrogen, or lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "(Substituent group C is same as those of item 13′).\n",
       "<br/>\n",
       "[Item 27′]\n",
       "</p>\n",
       "<p id=\"p-0056\" num=\"0068\">The compound according to any one of items 13′ to 19′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0046\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and B<sup>2 </sup>is NR<sup>7a</sup>,</p>\n",
       "<p id=\"h-0047\" num=\"0000\">R<sup>6a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0048\" num=\"0000\">R<sup>3a </sup>and R<sup>7a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, and</p>\n",
       "<p id=\"p-0057\" num=\"0069\">R<sup>5a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D2</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D3</sup>)(R<sup>D4</sup>)\n",
       "<br/>\n",
       "(wherein R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, R<sup>D4</sup>, Y, substituent group C and substituent group D are the same as item 13′).\n",
       "<br/>\n",
       "[Item 28′]\n",
       "</p>\n",
       "<p id=\"p-0058\" num=\"0070\">The compound according to item 27′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0059\" num=\"0071\">wherein R<sup>5a </sup>is hydrogen, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, or heterocycle lower alkyl optionally substituted by substituent group C\n",
       "<br/>\n",
       "(wherein Substituent group C is same as item 13′).\n",
       "<br/>\n",
       "[Item 29′]\n",
       "</p>\n",
       "<p id=\"p-0060\" num=\"0072\">The compound according to any one of items 13′ to 19′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0049\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0050\" num=\"0000\">R<sup>9a </sup>is hydrogen, and R<sup>10a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0051\" num=\"0000\">R<sup>3a </sup>and R<sup>11a </sup>are taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, and</p>\n",
       "<p id=\"p-0061\" num=\"0073\">R<sup>8a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D2</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D3</sup>)(R<sup>D4</sup>)\n",
       "<br/>\n",
       "(wherein R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, R<sup>D4</sup>, Y, substituent group C and substituent group D is same as item 13′).\n",
       "<br/>\n",
       "[Item 30′]\n",
       "</p>\n",
       "<p id=\"p-0062\" num=\"0074\">The compound according to item 29′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0063\" num=\"0075\">wherein R<sup>8a </sup>is hydrogen, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, or heterocycle lower alkyl optionally substituted by substituent group C\n",
       "<br/>\n",
       "(wherein substituent group C is same as that of item 13′).\n",
       "<br/>\n",
       "[Item 31′]\n",
       "</p>\n",
       "<p id=\"p-0064\" num=\"0076\">The compound according to any one of items 27′ to 30′, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0065\" num=\"0077\">wherein substituent group D is carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, or heterocycle lower alkyl optionally substituted by substituent group C\n",
       "<br/>\n",
       "(wherein substituent group C is same as that of item 13′).\n",
       "<br/>\n",
       "[Item 32′]\n",
       "</p>\n",
       "<p id=\"p-0066\" num=\"0078\">A pharmaceutical composition containing a compound according to any one of items 13′ to 31′, or a pharmaceutically acceptable salt thereof or a solvate thereof.</p>\n",
       "<p id=\"h-0052\" num=\"0000\">[Item 33′]</p>\n",
       "<p id=\"p-0067\" num=\"0079\">The pharmaceutical composition according to item 32′ which exhibits anti influenza activity.</p>\n",
       "<p id=\"h-0053\" num=\"0000\">[Item 34′]</p>\n",
       "<p id=\"p-0068\" num=\"0080\">The compound according to any one of items 13′ to 31′ for treating and/or preventing influenza infectious disease.</p>\n",
       "<p id=\"h-0054\" num=\"0000\">[Item 35′]</p>\n",
       "<p id=\"p-0069\" num=\"0081\">The compound according to any one of items 13′ to 31′, or the pharmaceutically acceptable salt thereof or the solvate thereof, for treating and/or preventing influenza infectious disease.</p>\n",
       "<p id=\"h-0055\" num=\"0000\">[Item 36′]</p>\n",
       "<p id=\"p-0070\" num=\"0082\">The pharmaceutical composition according to item 32′ which exhibits CAP dependent endonuclease inhibitory activity.</p>\n",
       "<p id=\"h-0056\" num=\"0000\">This invention provides following items as another aspect.</p>\n",
       "<p id=\"h-0057\" num=\"0000\">[Item 1]</p>\n",
       "<p id=\"p-0071\" num=\"0083\">A CAP dependent endonuclease inhibitor containing a compound represented by formula (I), a pharmaceutically acceptable salt, or a solvate thereof:</p>\n",
       "<p id=\"p-0072\" num=\"0084\"><chemistry id=\"CHEM-US-00008\" num=\"00008\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00008.TIF\" he=\"33.95mm\" id=\"EMI-C00008\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein\n",
       "<br/>\n",
       "R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X3</sup>)—SO<sub>2</sub>—(R<sup>X4</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X5</sup>)—SO<sub>2</sub>—(R<sup>X6</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X7</sup>)—C(═O)—R<sup>X8</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X9</sup>)(R<sup>X10</sup>),\n",
       "<br/>\n",
       "—Z—S—R<sup>X11</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>X12</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>X13</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X14</sup>)—C(═O)—O—R<sup>X15</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X16</sup>)—C(═O)—N(R<sup>X17</sup>)(R<sup>X18</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X19</sup>)—C(═O)—N(R<sup>X20</sup>)(R<sup>X21</sup>), or\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>X23 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>X1</sup>, R<sup>X2</sup>, R<sup>X3</sup>, R<sup>X5</sup>, R<sup>X7</sup>, R<sup>X8</sup>, R<sup>X9</sup>, R<sup>X10</sup>, R<sup>X11</sup>, R<sup>X14</sup>, R<sup>X15</sup>, R<sup>X16</sup>, R<sup>X17</sup>, R<sup>X18</sup>, R<sup>X19</sup>, R<sup>X20</sup>, R<sup>X21</sup>, R<sup>X22</sup>, and R<sup>X23 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>X4</sup>, R<sup>X6</sup>, R<sup>X12</sup>, and R<sup>X13 </sup>are each independently selected from a substituent group consisting of, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>X1 </sup>and R<sup>X2</sup>, R<sup>X9 </sup>and R<sup>X10</sup>, R<sup>X17 </sup>and R<sup>X18</sup>, and R<sup>X20 </sup>and R<sup>X21 </sup>each may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>2 </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>Y1</sup>)—SO<sub>2</sub>—R<sup>Y2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Y3</sup>)—C(═O)—R<sup>Y4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Y5</sup>)—C(═O)—O—R<sup>Y6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>Y7</sup>)(R<sup>Y9</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>Y9</sup>)(R<sup>Y10</sup>), or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>Y11 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>Y1</sup>, R<sup>Y3</sup>, R<sup>Y4</sup>, R<sup>Y5</sup>, R<sup>Y6</sup>, R<sup>Y7</sup>, R<sup>Y6</sup>, R<sup>Y9</sup>, and R<sup>Y10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Y2 </sup>and R<sup>Y11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Y7 </sup>and R<sup>Y8</sup>, and R<sup>Y9 </sup>and R<sup>Y10 </sup>each may be taken together with an adjacent atom to form heterocycle and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>3 </sup>is hydrogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z1</sup>)—SO<sub>2</sub>—R<sup>Z2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z3</sup>)—C(═O)—R<sup>Z4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z5</sup>)—C(═O)—O—R<sup>Z6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>Z7</sup>)(R<sup>Z8</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>Z9</sup>)(R<sup>Z10</sup>),\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>Z11</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>Z12</sup>)—O—C(═O)—R<sup>Z13 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>Z1</sup>, R<sup>Z3</sup>, R<sup>Z4</sup>, R<sup>Z5</sup>, R<sup>Z6</sup>, R<sup>Z7</sup>, R<sup>Z8</sup>, R<sup>Z9</sup>, R<sup>Z10</sup>, R<sup>Z12</sup>, and R<sup>Z13 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Z2 </sup>and R<sup>Z11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>Z7 </sup>and R<sup>Z8</sup>, and R<sup>Z9 </sup>and R<sup>Z10 </sup>each may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene) and;\n",
       "<br/>\n",
       "a) either A<sup>1 </sup>or A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>, and the other is NR<sup>7</sup>, or A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>,\n",
       "<br/>\n",
       "b) R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>8</sup>, R<sup>9</sup>, R<sup>10 </sup>and R<sup>11 </sup>are each independently selected from a substituent group consisting of hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyl carbonyl optionally substituted by substituent group A, lower alkyl oxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—S—R<sup>V1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>V2</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>V3</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>V4</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>V5</sup>)(R<sup>V6</sup>)\n",
       "<br/>\n",
       "(wherein R<sup>V1</sup>, R<sup>V4</sup>, R<sup>V5</sup>, and R<sup>V6 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>V2 </sup>and R<sup>V3 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "R<sup>V5 </sup>and R<sup>V6 </sup>may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "1) when A<sup>1 </sup>is CR<sup>5</sup>R<sup>6 </sup>and A<sup>2 </sup>is NR<sup>7</sup>,\n",
       "<br/>\n",
       "R<sup>3 </sup>and R<sup>7 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form condensed ring,\n",
       "<br/>\n",
       "2) when A<sup>1 </sup>is NR<sup>7 </sup>and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>,\n",
       "<br/>\n",
       "R<sup>3 </sup>and R<sup>6 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form condensed ring,\n",
       "<br/>\n",
       "or\n",
       "<br/>\n",
       "3) when A<sup>1 </sup>is CR<sup>8</sup>R<sup>9 </sup>and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11 </sup>\n",
       "<br/>\n",
       "R<sup>8 </sup>and R<sup>10 </sup>may be taken together with an adjacent atom to form a bond, and R<sup>8 </sup>and R<sup>10 </sup>may be taken together with an adjacent atom to form carbocycle or heterocycle, or\n",
       "<br/>\n",
       "R<sup>3 </sup>and R<sup>11 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form condensed ring;\n",
       "<br/>\n",
       "Substituent group A: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclic group, heterocyclic group, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, and lower alkylsulfonylamino;\n",
       "<br/>\n",
       "Substituent group B: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclic group, heterocyclic group, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfonylamino, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A).\n",
       "<br/>\n",
       "[Item 2]\n",
       "</p>\n",
       "<p id=\"p-0073\" num=\"0085\">A CAP dependent endonuclease inhibitor according to item 1, wherein</p>\n",
       "<p id=\"p-0074\" num=\"0086\">R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X3</sup>)—SO<sub>2</sub>—(R<sup>X4</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>X5</sup>)—SO<sub>2</sub>—(R<sup>X6</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>X7</sup>)—C(═O)—R<sup>X8</sup>,\n",
       "<br/>\n",
       "—Z—S—R<sup>X11</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>X12</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>X13</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X14</sup>)—C(═O)—O—R<sup>X15</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>X16</sup>)—C(═O)—N(R<sup>X17</sup>)(R<sup>X18</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>X22</sup>)—C(═O)—C(═O)—R<sup>X23 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>X1</sup>, R<sup>X2</sup>, R<sup>X3</sup>, R<sup>X4</sup>, R<sup>X5</sup>, R<sup>X6</sup>, R<sup>X7</sup>, R<sup>X8</sup>, R<sup>X11</sup>, R<sup>X12</sup>, R<sup>X13</sup>, R<sup>X14</sup>, R<sup>X15</sup>, R<sup>X16</sup>, R<sup>X17</sup>, R<sup>X18</sup>, R<sup>X22</sup>, R<sup>X23</sup>, and\n",
       "<br/>\n",
       "Z are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 3]\n",
       "</p>\n",
       "<p id=\"p-0075\" num=\"0087\">A CAP dependent endonuclease inhibitor according to item 1, wherein</p>\n",
       "<p id=\"p-0076\" num=\"0088\">R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>)\n",
       "<br/>\n",
       "—Z—N(R<sup>X7</sup>)—C(═O)—R<sup>X8</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>X14</sup>)—C(═O)—O—R<sup>X15 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>X1</sup>, R<sup>X2</sup>, R<sup>X7</sup>, R<sup>X8</sup>, R<sup>X14</sup>, R<sup>X15 </sup>and Z are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 4]\n",
       "</p>\n",
       "<p id=\"p-0077\" num=\"0089\">A CAP dependent endonuclease inhibitor according to item 1, wherein</p>\n",
       "<p id=\"p-0078\" num=\"0090\">R<sup>1 </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkyl carbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, or\n",
       "<br/>\n",
       "—Z—N(R<sup>X1</sup>)(R<sup>X2</sup>)\n",
       "<br/>\n",
       "(Substituent group A, R<sup>X1</sup>, R<sup>X2 </sup>and Z are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 5]\n",
       "</p>\n",
       "<p id=\"p-0079\" num=\"0091\">A CAP dependent endonuclease inhibitor according to item 1, wherein R<sup>1 </sup>is hydrogen or carboxy.</p>\n",
       "<p id=\"h-0058\" num=\"0000\">[Item 6]</p>\n",
       "<p id=\"p-0080\" num=\"0092\">A CAP dependent endonuclease inhibitor according to any one of items 1 to 5, wherein</p>\n",
       "<p id=\"h-0059\" num=\"0000\">R<sup>2 </sup>is hydrogen, lower alkyl optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, or</p>\n",
       "<p id=\"h-0060\" num=\"0000\">—Z—N(R<sup>Y9</sup>)(R<sup>10</sup>)</p>\n",
       "<p id=\"h-0061\" num=\"0000\">(Substituent group A, R<sup>Y9</sup>, R<sup>Y10</sup>, and Z are same meaning as those of item 1).</p>\n",
       "<p id=\"h-0062\" num=\"0000\">[Item 7]</p>\n",
       "<p id=\"p-0081\" num=\"0093\">A CAP dependent endonuclease inhibitor according to any one of items 1 to 5, wherein</p>\n",
       "<p id=\"h-0063\" num=\"0000\">R<sup>2 </sup>is hydrogen or lower alkyl optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A,</p>\n",
       "<p id=\"h-0064\" num=\"0000\">(Substituent group A is same meaning as that of item 1).</p>\n",
       "<p id=\"h-0065\" num=\"0000\">[Item 8]</p>\n",
       "<p id=\"p-0082\" num=\"0094\">A CAP dependent endonuclease inhibitor according to any one of items 1 to 7, wherein</p>\n",
       "<p id=\"p-0083\" num=\"0095\">R<sup>3 </sup>is hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z1</sup>)—SO<sub>2</sub>—R<sup>Z2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z3</sup>)—C(═O)—R<sup>Z4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>Z5</sup>)—C(═O)—O—R<sup>Z6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>Z7</sup>)(R<sup>Z8</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>Z9</sup>)(R<sup>Z10</sup>)\n",
       "<br/>\n",
       "(Substituent group A, R<sup>Z1</sup>, R<sup>Z2</sup>, R<sup>Z3</sup>, R<sup>Z4</sup>, R<sup>Z5</sup>, R<sup>Z6</sup>, R<sup>Z7</sup>, R<sup>Z8</sup>, R<sup>Z9</sup>, R<sup>Z10</sup>, and Z are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 9]\n",
       "</p>\n",
       "<p id=\"p-0084\" num=\"0096\">A CAP dependent endonuclease inhibitor according to any one of items 1 to 8, wherein</p>\n",
       "<p id=\"h-0066\" num=\"0000\">A<sup>1 </sup>is NR<sup>7</sup>,</p>\n",
       "<p id=\"h-0067\" num=\"0000\">A<sup>2 </sup>is CHR<sup>6</sup>, and</p>\n",
       "<p id=\"p-0085\" num=\"0097\">R<sup>6 </sup>and R<sup>7 </sup>are each independently hydrogen, lower alkyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—S—R<sup>V1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>V2</sup>, or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>V3 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>V1</sup>, R<sup>V2</sup>, R<sup>V3</sup>, and Z are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 10]\n",
       "</p>\n",
       "<p id=\"p-0086\" num=\"0098\">A CAP dependent endonuclease inhibitor according to any one of items 1 to 8, wherein</p>\n",
       "<p id=\"h-0068\" num=\"0000\">A<sup>1 </sup>is CHR<sup>9</sup>,</p>\n",
       "<p id=\"h-0069\" num=\"0000\">A<sup>2 </sup>is CHR<sup>11</sup>, and</p>\n",
       "<p id=\"p-0087\" num=\"0099\">R<sup>9 </sup>and R<sup>11 </sup>are each independently hydrogen, lower alkyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—S—R<sup>V1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>V2</sup>, or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>V3 </sup>\n",
       "<br/>\n",
       "(Substituent group A, R<sup>V1</sup>, R<sup>V2</sup>, R<sup>V3</sup>, and Z are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 11]\n",
       "</p>\n",
       "<p id=\"p-0088\" num=\"0100\">A CAP dependent endonuclease inhibitor according to any one of items 1 to 7, wherein</p>\n",
       "<p id=\"h-0070\" num=\"0000\">A<sup>1 </sup>is CHR<sup>9</sup>,</p>\n",
       "<p id=\"h-0071\" num=\"0000\">A<sup>2 </sup>is CHR<sup>11</sup>,</p>\n",
       "<p id=\"h-0072\" num=\"0000\">R<sup>3 </sup>and R<sup>11 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B, and</p>\n",
       "<p id=\"p-0089\" num=\"0101\">R<sup>9 </sup>is hydrogen, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "(Substituent group A and substituent group B are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 12]\n",
       "</p>\n",
       "<p id=\"p-0090\" num=\"0102\">A CAP dependent endonuclease inhibitor according to any one of items 1 to 7, wherein</p>\n",
       "<p id=\"h-0073\" num=\"0000\">A<sup>1 </sup>is CHR<sup>6</sup>,</p>\n",
       "<p id=\"h-0074\" num=\"0000\">A<sup>2 </sup>is NR<sup>7</sup>,</p>\n",
       "<p id=\"h-0075\" num=\"0000\">R<sup>3 </sup>and R<sup>7 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B,</p>\n",
       "<p id=\"p-0091\" num=\"0103\">R<sup>6 </sup>is hydrogen, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A,\n",
       "<br/>\n",
       "(Substituent group A and substituent group B are same meaning as those of item 1).\n",
       "<br/>\n",
       "[Item 13]\n",
       "</p>\n",
       "<p id=\"p-0092\" num=\"0104\">A compound represented by formula (II), or a pharmaceutically acceptable salt thereof or a solvate thereof:</p>\n",
       "<p id=\"p-0093\" num=\"0105\"><chemistry id=\"CHEM-US-00009\" num=\"00009\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00009.TIF\" he=\"33.95mm\" id=\"EMI-C00009\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein\n",
       "<br/>\n",
       "R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>A5</sup>)—SO<sub>2</sub>—(R<sup>A6</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,\n",
       "<br/>\n",
       "—Z—S—R<sup>A9</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>A10</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>A14</sup>)—C(═O)—N(R<sup>A15</sup>)(R<sup>A16</sup>),\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>A17</sup>)—C(═O)—N(R<sup>A18</sup>)(R<sup>A19</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A3</sup>, R<sup>A5</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A9</sup>, R<sup>A12</sup>, R<sup>A13</sup>, R<sup>A14</sup>, R<sup>A15</sup>, R<sup>A16</sup>, R<sup>A17</sup>, R<sup>A18</sup>, R<sup>A19</sup>, R<sup>A20</sup>, and R<sup>A21 </sup>are each independently selected from substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>A4</sup>, R<sup>A6</sup>, R<sup>A10</sup>, and R<sup>A11 </sup>are each independently selected from substituent group consisting of, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>A1 </sup>and R<sup>A2</sup>, R<sup>A15 </sup>and R<sup>A16</sup>, and R<sup>A18 </sup>and R<sup>A19 </sup>may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>2a </sup>is hydrogen, halogen, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>B1</sup>)—SO<sub>2</sub>—R<sup>B2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>B3</sup>)—C(═O)—R<sup>B4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>B5</sup>)—C(═O)—O—R<sup>B6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>B7</sup>)(R<sup>B8</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>), or\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>B11 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>B1</sup>, R<sup>B3</sup>, R<sup>B4</sup>, R<sup>B5</sup>, R<sup>B6</sup>, R<sup>B7</sup>, R<sup>B8</sup>, R<sup>B9</sup>, and R<sup>B10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>B2 </sup>and R<sup>B11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>B7 </sup>and R<sup>B8</sup>, and R<sup>B9 </sup>and R<sup>B10 </sup>may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "R<sup>3a </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>C1</sup>)—SO<sub>2</sub>—R<sup>C2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C3</sup>)—C(═O)—R<sup>C4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C5</sup>)—C(═O)—O—R<sup>C6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>C7</sup>)(R<sup>C8</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>C9</sup>)(R<sup>C10</sup>),\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>C11</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>C12</sup>)—O—C(═O)—R<sup>C13 </sup>\n",
       "<br/>\n",
       "(wherein R<sup>C1</sup>, R<sup>C3</sup>, R<sup>C4</sup>, R<sup>C5</sup>, R<sup>C6</sup>, R<sup>C7</sup>, R<sup>C8</sup>, R<sup>C9</sup>, R<sup>C10</sup>, R<sup>C12 </sup>and, R<sup>C13 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>C2</sup>, and R<sup>C11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>C7 </sup>and R<sup>C8</sup>, and R<sup>C9 </sup>and R<sup>C10 </sup>may be taken together with an adjacent atom to form heterocycle, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene) and;\n",
       "<br/>\n",
       "a) either B<sup>1 </sup>or B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and the other is NR<sup>7a</sup>,\n",
       "<br/>\n",
       "ors\n",
       "<br/>\n",
       "b) B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a </sup>and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,\n",
       "<br/>\n",
       "R<sup>5a</sup>, R<sup>6a</sup>, R<sup>7a</sup>, R<sup>8a</sup>, R<sup>9a</sup>, R<sup>10a </sup>and R<sup>11a </sup>are each independently selected from a substituent group consisting of hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyl carbonyl optionally substituted by substituent group C, lower alkyl oxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>D2</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>D8</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D4</sup>,\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D5</sup>)(R<sup>D6</sup>),\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>), or\n",
       "<br/>\n",
       "—Z—CH<sub>2</sub>—R<sup>D10</sup>,\n",
       "<br/>\n",
       "(wherein R<sup>D1</sup>, R<sup>D4</sup>, R<sup>D5</sup>, R<sup>D6</sup>, and R<sup>D9 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>D2</sup>, and R<sup>D3 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>D7</sup>, R<sup>D8</sup>, and R<sup>D10 </sup>are each independently selected from a substituent group consisting of carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>D5 </sup>and R<sup>D6 </sup>may be taken together with an adjacent atom to form heterocycle,\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene);\n",
       "<br/>\n",
       "1) when B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a </sup>and B<sup>2 </sup>is NR<sup>7a</sup>,\n",
       "<br/>\n",
       "R<sup>3a </sup>and R<sup>7a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D,\n",
       "<br/>\n",
       "2) when B<sup>1 </sup>is NR<sup>7a </sup>and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,\n",
       "<br/>\n",
       "R<sup>3a </sup>and R<sup>6a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, or\n",
       "<br/>\n",
       "3) when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a </sup>and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,\n",
       "<br/>\n",
       "R<sup>8a </sup>and R<sup>10a </sup>may be taken together with an adjacent atom to form carbocycle or heterocycle optionally substituted by substituent group D, or\n",
       "<br/>\n",
       "R<sup>3a </sup>and R<sup>11a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D,\n",
       "<br/>\n",
       "wherein\n",
       "<br/>\n",
       "when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>, and R<sup>9a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen,\n",
       "<br/>\n",
       "i) either R<sup>8a </sup>or R<sup>11a </sup>is\n",
       "<br/>\n",
       "—Z—C(R<sup>E1</sup>)(R<sup>E2</sup>)(R<sup>E3</sup>)\n",
       "<br/>\n",
       "—Y—S—R<sup>E4</sup>,\n",
       "<br/>\n",
       "—Z—CH<sub>2</sub>—R<sup>E5</sup>, or\n",
       "<br/>\n",
       "a group shown below:\n",
       "</p>\n",
       "<p id=\"p-0094\" num=\"0106\"><chemistry id=\"CHEM-US-00010\" num=\"00010\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00010.TIF\" he=\"58.25mm\" id=\"EMI-C00010\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E1 </sup>and R<sup>E2 </sup>are each independently, carbocyclic group optionally substituted by substituent group C, and heterocyclic group optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E3 </sup>is selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E4 </sup>is selected from a substituent group consisting of carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E5 </sup>is aromatic heterocyclic group optionally substituted by substituent group C,\n",
       "<br/>\n",
       "R<sup>E6 </sup>is selected from a substituent group C,\n",
       "<br/>\n",
       "m is an integer of 0 or more,\n",
       "<br/>\n",
       "provided that\n",
       "<br/>\n",
       "m of R<sup>E6</sup>s is same or different groups selected from a substituent group C\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene, and\n",
       "<br/>\n",
       "Z is a bond or straight or branched lower alkylene); and\n",
       "<br/>\n",
       "ii) the other of R<sup>8a </sup>or R<sup>10a </sup>is,\n",
       "<br/>\n",
       "hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>F1</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>F2</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>F3</sup>)(R<sup>F4</sup>)\n",
       "<br/>\n",
       "(wherein R<sup>F1</sup>, R<sup>F2</sup>, R<sup>F3</sup>, and R<sup>F4 </sup>are each independently, hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C, and\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene);\n",
       "<br/>\n",
       "Substituent group C: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclic group, heterocyclic group, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, and lower alkylsulfonylamino;\n",
       "<br/>\n",
       "Substituent group D: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclic group, heterocyclic group, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfonylamino, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C).\n",
       "<br/>\n",
       "[Item 14]\n",
       "</p>\n",
       "<p id=\"p-0095\" num=\"0107\">The compound according to item 13, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0096\" num=\"0108\">wherein R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,\n",
       "<br/>\n",
       "—Z—S—R<sup>A9</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>A10</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup>\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A3</sup>, R<sup>A4</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A9</sup>, R<sup>A10</sup>, R<sup>A12</sup>, R<sup>A13</sup>, R<sup>A20</sup>, R<sup>A21</sup>, and Z are same meaning as those of item 13).\n",
       "<br/>\n",
       "[Item 15]\n",
       "</p>\n",
       "<p id=\"p-0097\" num=\"0109\">The compound according to item 13, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0098\" num=\"0110\">wherein R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13 </sup>\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A12</sup>, R<sup>A13</sup>, and Z are same as those of item 13).\n",
       "<br/>\n",
       "[Item 16]\n",
       "</p>\n",
       "<p id=\"p-0099\" num=\"0111\">The compound according to item 13, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0100\" num=\"0112\">wherein R<sup>1a </sup>is hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, and Z are same as those of item 13).\n",
       "<br/>\n",
       "[Item 17]\n",
       "</p>\n",
       "<p id=\"p-0101\" num=\"0113\">The compound according to item 13, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0076\" num=\"0000\">wherein R<sup>1a </sup>is hydrogen, or carboxy.</p>\n",
       "<p id=\"h-0077\" num=\"0000\">[Item 18]</p>\n",
       "<p id=\"p-0102\" num=\"0114\">The compound according to any one of items 13 to 17, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0078\" num=\"0000\">wherein R<sup>2a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, or)</p>\n",
       "<p id=\"h-0079\" num=\"0000\">—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>)</p>\n",
       "<p id=\"h-0080\" num=\"0000\">(substituent group C, R<sup>B9</sup>, R<sup>B10</sup>, and Z are same as those of item 13).</p>\n",
       "<p id=\"h-0081\" num=\"0000\">[Item 19]</p>\n",
       "<p id=\"p-0103\" num=\"0115\">The compound according to any one of items 13 to 17, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0082\" num=\"0000\">wherein R<sup>3a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, or heterocycle lower alkyl optionally substituted by substituent group C</p>\n",
       "<p id=\"h-0083\" num=\"0000\">(substituent group C is same as that of item 13).</p>\n",
       "<p id=\"h-0084\" num=\"0000\">[Item 20]</p>\n",
       "<p id=\"p-0104\" num=\"0116\">The compound according to any one of items 13 to 19, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0105\" num=\"0117\">wherein R<sup>3a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—N(R<sup>C1</sup>)—SO<sub>2</sub>—R<sup>C2</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C3</sup>)—C(═O)—R<sup>C4</sup>,\n",
       "<br/>\n",
       "—Z—N(R<sup>C5</sup>)—C(═O)—O—R<sup>C6</sup>,\n",
       "<br/>\n",
       "—Z—C(═O)—N(R<sup>C7</sup>)(R<sup>C8</sup>), or\n",
       "<br/>\n",
       "—Z—N(R<sup>C9</sup>)(R<sup>C10</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>C1</sup>, R<sup>C2</sup>, R<sup>C3</sup>, R<sup>C4</sup>, R<sup>C5</sup>, R<sup>C5</sup>, R<sup>C7</sup>, R<sup>C8</sup>, R<sup>C9</sup>, R<sup>C10</sup>, and Z are same as those of item 13).\n",
       "<br/>\n",
       "[Item 21]\n",
       "</p>\n",
       "<p id=\"p-0106\" num=\"0118\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0085\" num=\"0000\">wherein B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and</p>\n",
       "<p id=\"p-0107\" num=\"0119\">R<sup>5a</sup>, R<sup>6a </sup>and R<sup>7a </sup>are each independently hydrogen; carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyl carbonyl optionally substituted by substituent group C, lower alkyl oxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—Z—S(═O)—R<sup>D2</sup>,\n",
       "<br/>\n",
       "—Z—SO<sub>2</sub>—R<sup>D3</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D4</sup>,\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D5</sup>)(R<sup>D6</sup>), or\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, R<sup>D4</sup>, R<sup>D5</sup>, R<sup>D6</sup>, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, Y, and Z are same as those of item 13).\n",
       "<br/>\n",
       "[Item 22]\n",
       "</p>\n",
       "<p id=\"p-0108\" num=\"0120\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0086\" num=\"0000\">wherein B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,</p>\n",
       "<p id=\"h-0087\" num=\"0000\">R<sup>6a </sup>is hydrogen, and</p>\n",
       "<p id=\"p-0109\" num=\"0121\">R<sup>5a </sup>and R<sup>7a </sup>are each independently hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Z—S—R<sup>D1</sup>, or\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>D1</sup>, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, and Z are same as item 13).\n",
       "<br/>\n",
       "[Item 23]\n",
       "</p>\n",
       "<p id=\"p-0110\" num=\"0122\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0088\" num=\"0000\">wherein B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a </sup></p>\n",
       "<p id=\"h-0089\" num=\"0000\">R<sup>5a </sup>is hydrogen, R<sup>6a </sup>is hydrogen, and</p>\n",
       "<p id=\"p-0111\" num=\"0123\">R<sup>7a </sup>is lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, or\n",
       "<br/>\n",
       "—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>) (substituent group C, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, and Z are same as item 13).\n",
       "<br/>\n",
       "[Item 24]\n",
       "</p>\n",
       "<p id=\"p-0112\" num=\"0124\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0090\" num=\"0000\">wherein B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,</p>\n",
       "<p id=\"h-0091\" num=\"0000\">R<sup>5a </sup>is hydrogen, R<sup>6a </sup>is hydrogen, and</p>\n",
       "<p id=\"h-0092\" num=\"0000\">R<sup>7a </sup>is a group shown below:</p>\n",
       "<p id=\"p-0113\" num=\"0125\"><chemistry id=\"CHEM-US-00011\" num=\"00011\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00011.TIF\" he=\"58.25mm\" id=\"EMI-C00011\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>and m are same as those of item 13).\n",
       "<br/>\n",
       "[Item 25]\n",
       "</p>\n",
       "<p id=\"p-0114\" num=\"0126\">The compound according to items 13 or 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0093\" num=\"0000\">wherein</p>\n",
       "<p id=\"h-0094\" num=\"0000\">B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0095\" num=\"0000\">R<sup>9a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen, and</p>\n",
       "<p id=\"h-0096\" num=\"0000\">i) either R<sup>8a </sup>or R<sup>10a </sup>is</p>\n",
       "<p id=\"h-0097\" num=\"0000\">—Z—C(R<sup>E1</sup>)(R<sup>E2</sup>)(R<sup>E3</sup>)</p>\n",
       "<p id=\"h-0098\" num=\"0000\">—Y—S—R<sup>E4 </sup></p>\n",
       "<p id=\"h-0099\" num=\"0000\">—Z—CH<sub>2</sub>—R<sup>E5</sup>,</p>\n",
       "<p id=\"h-0100\" num=\"0000\">or a group shown below:</p>\n",
       "<p id=\"p-0115\" num=\"0127\"><chemistry id=\"CHEM-US-00012\" num=\"00012\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00012.TIF\" he=\"58.25mm\" id=\"EMI-C00012\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "and,\n",
       "<br/>\n",
       "ii) the other of R<sup>8a </sup>or R<sup>10a </sup>is\n",
       "<br/>\n",
       "hydrogen, or lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "(Substituent group C is same as that of item 13).\n",
       "<br/>\n",
       "—Z—S—R<sup>F1</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>F2</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>F3</sup>)(R<sup>F4</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>E1</sup>, R<sup>E2</sup>, R<sup>E3</sup>, R<sup>E4</sup>, R<sup>E5</sup>, R<sup>F1</sup>, R<sup>F2</sup>, R<sup>F3</sup>, R<sup>F4</sup>, R<sup>E6</sup>, m, Z, and Y are same as those of item 13).\n",
       "<br/>\n",
       "[Item 26]\n",
       "</p>\n",
       "<p id=\"p-0116\" num=\"0128\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0101\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0102\" num=\"0000\">R<sup>9a </sup>is hydrogen, R<sup>10a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0103\" num=\"0000\">R<sup>8a </sup>is —Z—CH(R<sup>E1</sup>)(R<sup>E2</sup>)</p>\n",
       "<p id=\"h-0104\" num=\"0000\">(R<sup>E1</sup>, R<sup>E2</sup>, and Z are same as those of item 13).</p>\n",
       "<p id=\"h-0105\" num=\"0000\">[Item 27]</p>\n",
       "<p id=\"p-0117\" num=\"0129\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0106\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0107\" num=\"0000\">R<sup>8a </sup>is hydrogen, R<sup>9a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen, and R<sup>10a</sup>) is —Z—CH(R<sup>E1</sup>)(R<sup>E2</sup>)</p>\n",
       "<p id=\"h-0108\" num=\"0000\">(R<sup>E1</sup>, R<sup>E2</sup>, and Z are same as those of item 13).</p>\n",
       "<p id=\"h-0109\" num=\"0000\">[Item 28]</p>\n",
       "<p id=\"p-0118\" num=\"0130\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0110\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0111\" num=\"0000\">R<sup>9a </sup>is hydrogen, R<sup>10a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen, and</p>\n",
       "<p id=\"h-0112\" num=\"0000\">R<sup>8a </sup>is a group shown below:</p>\n",
       "<p id=\"p-0119\" num=\"0131\"><chemistry id=\"CHEM-US-00013\" num=\"00013\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00013.TIF\" he=\"58.25mm\" id=\"EMI-C00013\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein, R<sup>E6 </sup>and m are same as those of item 13).\n",
       "<br/>\n",
       "[Item 29]\n",
       "</p>\n",
       "<p id=\"p-0120\" num=\"0132\">The compound according to any one of items 13 to 20, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0113\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0114\" num=\"0000\">R<sup>9a </sup>is hydrogen, and R<sup>11a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0115\" num=\"0000\">R<sup>8a </sup>and R<sup>18a </sup>may be taken together with an adjacent atom to form carbocycle or heterocycle optionally substituted by substituent group D,</p>\n",
       "<p id=\"h-0116\" num=\"0000\">(wherein substituent group D is same as that of item 13).</p>\n",
       "<p id=\"h-0117\" num=\"0000\">[Item 30]</p>\n",
       "<p id=\"p-0121\" num=\"0133\">The compound according to any one of items 13 to 19, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0118\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and B<sup>2 </sup>is NR<sup>7a</sup>,</p>\n",
       "<p id=\"h-0119\" num=\"0000\">R<sup>6a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0120\" num=\"0000\">R<sup>3a </sup>and R<sup>7a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, and</p>\n",
       "<p id=\"p-0122\" num=\"0134\">R<sup>5a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D2</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D3</sup>)(R<sup>D4</sup>)\n",
       "<br/>\n",
       "(wherein, R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, and R<sup>D4 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene, and\n",
       "<br/>\n",
       "Substituent group C and substituent group D are same as those of item 13).\n",
       "<br/>\n",
       "[Item 31]\n",
       "</p>\n",
       "<p id=\"p-0123\" num=\"0135\">The compound according to item 30, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0121\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and B<sup>2 </sup>is NR<sup>7a</sup>,</p>\n",
       "<p id=\"h-0122\" num=\"0000\">R<sup>6a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0123\" num=\"0000\">R<sup>3a </sup>and R<sup>7a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, and</p>\n",
       "<p id=\"p-0124\" num=\"0136\">R<sup>5a </sup>is hydrogen, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, or heterocycle lower alkyl optionally substituted by substituent group C\n",
       "<br/>\n",
       "(wherein substituent group C and substituent group D are same as those of item 13).\n",
       "<br/>\n",
       "[Item 32]\n",
       "</p>\n",
       "<p id=\"p-0125\" num=\"0137\">The compound according to any one of items 13 to 19, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0124\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0125\" num=\"0000\">R<sup>9a </sup>is hydrogen, and R<sup>10a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0126\" num=\"0000\">R<sup>3a </sup>and R<sup>11a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, and</p>\n",
       "<p id=\"p-0126\" num=\"0138\">R<sup>8a </sup>is hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "—Y—S—R<sup>D1</sup>,\n",
       "<br/>\n",
       "—C(═O)—C(═O)—R<sup>D2</sup>, or\n",
       "<br/>\n",
       "—C(═O)—N(R<sup>D3</sup>)(R<sup>D4</sup>)\n",
       "<br/>\n",
       "(wherein, R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, and R<sup>D4 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "Y is straight or branched lower alkylene, and\n",
       "<br/>\n",
       "substituent group C and substituent group D are same as those of item 13).\n",
       "<br/>\n",
       "[Item 33]\n",
       "</p>\n",
       "<p id=\"p-0127\" num=\"0139\">The compound according to item 32, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"h-0127\" num=\"0000\">wherein B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>,</p>\n",
       "<p id=\"h-0128\" num=\"0000\">R<sup>9a </sup>is hydrogen, R<sup>10a </sup>is hydrogen,</p>\n",
       "<p id=\"h-0129\" num=\"0000\">R<sup>3a </sup>and R<sup>11a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D, and</p>\n",
       "<p id=\"p-0128\" num=\"0140\">R<sup>8a </sup>is hydrogen, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, or heterocycle lower alkyl optionally substituted by substituent group C)\n",
       "<br/>\n",
       "(wherein, substituent group C and substituent group D are same as those of item 13).\n",
       "<br/>\n",
       "[Item 34]\n",
       "</p>\n",
       "<p id=\"p-0129\" num=\"0141\">The compound according to any one of items 29 to 33, or the pharmaceutically acceptable salt thereof or the solvate thereof,</p>\n",
       "<p id=\"p-0130\" num=\"0142\">wherein substituent group D is carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, or heterocycle lower alkyl optionally substituted by substituent group C\n",
       "<br/>\n",
       "[Item 35]\n",
       "</p>\n",
       "<p id=\"p-0131\" num=\"0143\">A pharmaceutical composition containing a compound according to any one of items 13 to 34, or a pharmaceutically acceptable salt thereof or a solvate thereof.</p>\n",
       "<p id=\"h-0130\" num=\"0000\">[Item 36]</p>\n",
       "<p id=\"p-0132\" num=\"0144\">The pharmaceutical composition according to item 35 which exhibits CAP dependent endonuclease inhibitory activity.</p>\n",
       "<p id=\"h-0131\" num=\"0000\">[Item 37]</p>\n",
       "<p id=\"p-0133\" num=\"0145\">The pharmaceutical composition according to item 35 which exhibits anti influenza activity.</p>\n",
       "<p id=\"h-0132\" num=\"0000\">[Item 38]</p>\n",
       "<p id=\"p-0134\" num=\"0146\">A method for treating influenza infectious disease characterized in administering the compound shown by formula (II) according to above item 13, or the pharmaceutically acceptable salt thereof or the solvate thereof.</p>\n",
       "<p id=\"h-0133\" num=\"0000\">[Item 39]</p>\n",
       "<p id=\"p-0135\" num=\"0147\">Use of the compound shown by formula (II) according to above item 13, or the pharmaceutically acceptable salt thereof or the solvate thereof, for manufacturing a therapeutic agent for influenza infectious disease.</p>\n",
       "<p id=\"h-0134\" num=\"0000\">[Item 40]</p>\n",
       "<p id=\"p-0136\" num=\"0148\">The compound shown by formula (II) according to above item 13, or the pharmaceutically acceptable salt thereof or the solvate thereof, for treating influenza infectious disease.</p>\n",
       "<p id=\"h-0135\" num=\"0000\">[Item 41]</p>\n",
       "<p id=\"p-0137\" num=\"0149\">A method of producing a compound shown by formula (X4) or a salt thereof, comprising the steps of:</p>\n",
       "<p id=\"h-0136\" num=\"0000\">(Step B)</p>\n",
       "<p id=\"p-0138\" num=\"0150\">reacting a compound shown by formula (X2):</p>\n",
       "<p id=\"p-0139\" num=\"0151\"><chemistry id=\"CHEM-US-00014\" num=\"00014\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00014.TIF\" he=\"32.09mm\" id=\"EMI-C00014\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1d </sup>is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, carbocyclic group lower alkyloxy optionally substituted by substituent E, heterocycle lower alkyloxy optionally substituted by substituent E, or\n",
       "<br/>\n",
       "—OSi(R<sup>1e</sup>)<sub>3</sub>,\n",
       "</p>\n",
       "<p id=\"p-0140\" num=\"0152\">R<sup>1e</sup>s are each independently lower alkyl optionally substituted by substituent E, carbocyclic group optionally substituted by substituent E, heterocyclic group optionally substituted by substituent E, carbocycle lower alkyl optionally substituted by substituent E or heterocycle lower alkyl optionally substituted by substituent E,</p>\n",
       "<p id=\"p-0141\" num=\"0153\">R<sup>2d </sup>is hydrogen, lower alkyl optionally substituted by substituent E, carbocycle lower alkyl optionally substituted by substituent E, or heterocycle lower alkyl optionally substituted by substituent E,</p>\n",
       "<p id=\"p-0142\" num=\"0154\">R<sup>3d </sup>is hydrogen, lower alkyl optionally substituted by substituent E, —N(R<sup>3e</sup>)<sub>2</sub>, or —OR<sup>3e</sup>,</p>\n",
       "<p id=\"h-0137\" num=\"0000\">R<sup>3e</sup>s are each independently lower alkyl optionally substituted by substituent E,</p>\n",
       "<p id=\"h-0138\" num=\"0000\">wavy line is E form and/or Z form</p>\n",
       "<p id=\"p-0143\" num=\"0155\">Substituent E: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclic group, heterocyclic group, carbocyclic group lower alkyloxy, heterocyclic group lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, and lower alkylsulfonylamino;)\n",
       "<br/>\n",
       "with a compound shown by formula (V2):\n",
       "</p>\n",
       "<p id=\"p-0144\" num=\"0156\"><chemistry id=\"CHEM-US-00015\" num=\"00015\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00015.TIF\" he=\"23.03mm\" id=\"EMI-C00015\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>4d </sup>is lower alkyl optionally substituted by substituent E, carbocycle lower alkyl optionally substituted by substituent E, or heterocycle lower alkyl optionally substituted by substituent E,\n",
       "<br/>\n",
       "R<sup>5d </sup>is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, —O—SO<sub>2</sub>—R<sup>5e</sup>, —O—SO<sub>2</sub>—R<sup>5f</sup>, or —O—SO<sub>2</sub>—R<sup>5g</sup>,\n",
       "<br/>\n",
       "R<sup>5e </sup>is lower alkyl optionally substituted by substituent E,\n",
       "<br/>\n",
       "R<sup>5f </sup>is carbocycle lower alkyl optionally substituted by substituent E, and\n",
       "<br/>\n",
       "R<sup>5g </sup>is carbocycle lower alkyl optionally substituted by substituent E, and\n",
       "<br/>\n",
       "substituent E is defined above)\n",
       "<br/>\n",
       "to obtain a compound shown by formula (X3):\n",
       "</p>\n",
       "<p id=\"p-0145\" num=\"0157\"><chemistry id=\"CHEM-US-00016\" num=\"00016\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00016.TIF\" he=\"34.54mm\" id=\"EMI-C00016\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined above); and\n",
       "<br/>\n",
       "(Step C)\n",
       "</p>\n",
       "<p id=\"p-0146\" num=\"0158\">reacting a compound shown by formula (X3) with a compound shown by formula (V3):\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>[Chemical formula 17]<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>H<sub>2</sub>NR<sup>6d</sup>  (V3)<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "(wherein R<sup>6d </sup>is lower alkyl optionally substituted by substituent E, or lower alkenyl optionally substituted by substituent E, and\n",
       "<br/>\n",
       "substituent E is defined above)\n",
       "<br/>\n",
       "to obtain a compound shown by formula (X4):\n",
       "</p>\n",
       "<p id=\"p-0147\" num=\"0159\"><chemistry id=\"CHEM-US-00017\" num=\"00017\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00017.TIF\" he=\"34.54mm\" id=\"EMI-C00017\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined above).\n",
       "<br/>\n",
       "[Item 42]\n",
       "</p>\n",
       "<p id=\"p-0148\" num=\"0160\">A method according to item 41, wherein Step B and Step C are continuously performed.</p>\n",
       "<p id=\"h-0139\" num=\"0000\">[Item 43]</p>\n",
       "<p id=\"p-0149\" num=\"0161\">A method of producing a compound shown by formula (X3), or a salt thereof:</p>\n",
       "<p id=\"p-0150\" num=\"0162\"><chemistry id=\"CHEM-US-00018\" num=\"00018\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00018.TIF\" he=\"34.54mm\" id=\"EMI-C00018\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41)\n",
       "<br/>\n",
       "reacting a compound shown by formula (X2):\n",
       "</p>\n",
       "<p id=\"p-0151\" num=\"0163\"><chemistry id=\"CHEM-US-00019\" num=\"00019\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00019.TIF\" he=\"34.80mm\" id=\"EMI-C00019\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41)\n",
       "<br/>\n",
       "with a compound shown by formula (V2):\n",
       "</p>\n",
       "<p id=\"p-0152\" num=\"0164\"><chemistry id=\"CHEM-US-00020\" num=\"00020\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00020.TIF\" he=\"24.72mm\" id=\"EMI-C00020\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41).\n",
       "<br/>\n",
       "[Item 44]\n",
       "</p>\n",
       "<p id=\"p-0153\" num=\"0165\">A method of producing a compound shown by formula (X4), or a salt thereof:</p>\n",
       "<p id=\"p-0154\" num=\"0166\"><chemistry id=\"CHEM-US-00021\" num=\"00021\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00021.TIF\" he=\"33.70mm\" id=\"EMI-C00021\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41)\n",
       "<br/>\n",
       "reacting a compound shown by formula (X3):\n",
       "</p>\n",
       "<p id=\"p-0155\" num=\"0167\"><chemistry id=\"CHEM-US-00022\" num=\"00022\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00022.TIF\" he=\"37.76mm\" id=\"EMI-C00022\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41); and\n",
       "<br/>\n",
       "with a compound shown by formula (V3):\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>[Chemical formula 23]<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>H<sub>2</sub>NR<sup>6d</sup>  (V3)<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "(wherein symbol is defined in item 41).\n",
       "<br/>\n",
       "[Item 45]\n",
       "</p>\n",
       "<p id=\"p-0156\" num=\"0168\">A method of producing a compound shown by formula (X4′), or a salt thereof:</p>\n",
       "<p id=\"p-0157\" num=\"0169\"><chemistry id=\"CHEM-US-00023\" num=\"00023\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00023.TIF\" he=\"33.70mm\" id=\"EMI-C00023\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41)\n",
       "<br/>\n",
       "comprising a step of:\n",
       "<br/>\n",
       "reacting a compound shown by formula (X2):\n",
       "</p>\n",
       "<p id=\"p-0158\" num=\"0170\"><chemistry id=\"CHEM-US-00024\" num=\"00024\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00024.TIF\" he=\"34.04mm\" id=\"EMI-C00024\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41)\n",
       "<br/>\n",
       "a compound shown by formula (V2):\n",
       "</p>\n",
       "<p id=\"p-0159\" num=\"0171\"><chemistry id=\"CHEM-US-00025\" num=\"00025\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00025.TIF\" he=\"24.98mm\" id=\"EMI-C00025\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined in item 41)\n",
       "<br/>\n",
       "and a compound shown by formula:\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>NH<sub>4</sub><sup>+</sup>X<sup>d−</sup>  [Chemical formula 27]<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "(wherein X<sup>d </sup>is halogen, CH<sub>3</sub>COO, or HSO<sub>4</sub>)\n",
       "<br/>\n",
       "[Item 46]\n",
       "</p>\n",
       "<p id=\"p-0160\" num=\"0172\">A method of producing a compound shown by formula (X4), or a salt thereof:</p>\n",
       "<p id=\"p-0161\" num=\"0173\"><chemistry id=\"CHEM-US-00026\" num=\"00026\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00026.TIF\" he=\"33.70mm\" id=\"EMI-C00026\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined above)\n",
       "<br/>\n",
       "comprising the step of:\n",
       "<br/>\n",
       "reacting the compound shown by formula (X4′):\n",
       "</p>\n",
       "<p id=\"p-0162\" num=\"0174\"><chemistry id=\"CHEM-US-00027\" num=\"00027\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00027.TIF\" he=\"33.70mm\" id=\"EMI-C00027\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined above)\n",
       "<br/>\n",
       "obtained in the production method as defined in item 45, with a compound shown by formula (V3′):\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>[Chemical formula 30]<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>R<sup>6d</sup>-L  (V3′)<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "(wherein R<sup>6d </sup>is defined above,\n",
       "<br/>\n",
       "L<sup>d </sup>is halogen, —O—SO<sub>2</sub>—CH<sub>3</sub>, or —O—SO<sub>2</sub>-Ph-CH<sub>3</sub>, and Ph is a phenyl group).\n",
       "<br/>\n",
       "[Item 47]\n",
       "</p>\n",
       "<p id=\"p-0163\" num=\"0175\">A method according to any one of items 41, 43, and 45, wherein the compound shown by formula (X2) is obtained by reacting a compound shown by formula (X1):</p>\n",
       "<p id=\"p-0164\" num=\"0176\"><chemistry id=\"CHEM-US-00028\" num=\"00028\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00028.TIF\" he=\"34.04mm\" id=\"EMI-C00028\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined above)\n",
       "<br/>\n",
       "with a compound shown by formula (V1):\n",
       "</p>\n",
       "<p id=\"p-0165\" num=\"0177\"><chemistry id=\"CHEM-US-00029\" num=\"00029\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00029.TIF\" he=\"20.07mm\" id=\"EMI-C00029\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein P<sup>d </sup>is lower alkyl optionally substituted by substituent E, and substituent E is defined in item 41).\n",
       "<br/>\n",
       "[Item 48]\n",
       "</p>\n",
       "<p id=\"p-0166\" num=\"0178\">A compound shown by formula (X3):</p>\n",
       "<p id=\"p-0167\" num=\"0179\"><chemistry id=\"CHEM-US-00030\" num=\"00030\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00030.TIF\" he=\"33.70mm\" id=\"EMI-C00030\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined above),\n",
       "<br/>\n",
       "or a pharmaceutically acceptable salt thereof or solvate thereof.\n",
       "<br/>\n",
       "[Item 49]\n",
       "</p>\n",
       "<p id=\"p-0168\" num=\"0180\">A compound shown by formula (X4):</p>\n",
       "<p id=\"p-0169\" num=\"0181\"><chemistry id=\"CHEM-US-00031\" num=\"00031\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00031.TIF\" he=\"33.70mm\" id=\"EMI-C00031\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is defined above),\n",
       "<br/>\n",
       "or a pharmaceutically acceptable salt thereof or solvate thereof.\n",
       "</p>\n",
       "<heading id=\"h-0140\" level=\"1\">Effect of the Invention</heading>\n",
       "<p id=\"p-0170\" num=\"0182\">The compounds of this invention, having inhibitory activities to cap-dependent endonuclease, are effective as therapeutic agents and/or preventive agents for influenza infectious disease.</p>\n",
       "<?BRFSUM description=\"Brief Summary\" end=\"tail\"?>\n",
       "<?DETDESC description=\"Detailed Description\" end=\"lead\"?>\n",
       "<heading id=\"h-0141\" level=\"1\">BEST MODE FOR CARRYING OUT THE INVENTION</heading>\n",
       "<p id=\"p-0171\" num=\"0183\">The meaning of each term used in the present description is explained below. Each term is used in a unified sense, and is used in the same sense when used alone, or when used in combination of other term.</p>\n",
       "<p id=\"p-0172\" num=\"0184\">“Optionally substituted by substituent group A” means that an arbitrary position may be substituted by one, two or more same or different substituents selected from substituent group A.</p>\n",
       "<p id=\"p-0173\" num=\"0185\">“Optionally substituted by substituent group B”, “optionally substituted by substituent group C”, “optionally substituted by substituent group D”, and “optionally substituted by substituent group E” are also as described above.</p>\n",
       "<p id=\"p-0174\" num=\"0186\">“Halogen” includes fluorine, chlorine, bromine and iodine. Preferable is fluorine, chlorine and bromine.</p>\n",
       "<p id=\"p-0175\" num=\"0187\">“Lower alkyl” includes straight or branched alkyl of a carbon number of 1 to 15, preferably a carbon number of 1 to 10, more preferably a carbon number of 1 to 6, further preferably a carbon number of 1 to 4, and examples include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, hexyl, isohexyl, n-heptyl, isoheptyl, n-octyl, isooctyl, n-nonyl and n-decyl etc. Examples of a preferable embodiment of “lower alkyl” include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, and n-pentyl. Examples of a further preferable embodiment include methyl, ethyl, n-propyl, isopropyl, and tert-butyl.</p>\n",
       "<p id=\"p-0176\" num=\"0188\">“Lower alkenyl” includes straight or branched alkenyl of a carbon number of 2 to 15, preferably a carbon number of 2 to 10, more preferably a carbon number of 2 to 6, further preferably a carbon number of 2 to 4, having one or more double bonds at an arbitrary position. Specifically, lower alkenyl includes vinyl, allyl, propenyl, isopropenyl, butenyl, isobutenyl, prenyl, butadienyl, pentenyl, isopentenyl, pentadienyl, hexenyl, isohexenyl, hexadienyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl etc. Examples of a preferable embodiment of “lower alkenyl” include vinyl, allyl, propenyl, isopropenyl, and butenyl.</p>\n",
       "<p id=\"p-0177\" num=\"0189\">“Lower alkynyl” includes straight or branched alkynyl of a carbon number of 2 to 10, preferably a carbon number of 2 to 8, further preferably a carbon number of 3 to 6, having one or more triple bonds at an arbitrary position. Specifically, lower alkynyl includes ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, octynyl, nonynyl, decynyl etc. These may further have a double bond at an arbitrary position. Examples of a preferable embodiment of “lower alkynyl” include ethynyl, propynyl, butynyl, and pentynyl.</p>\n",
       "<p id=\"p-0178\" num=\"0190\">A lower alkyl part of “lower alkyloxy”, “lower alkylcarbonyl”, “lower alkyloxycarbonyl”, “carbocycle lower alkyl”, “heterocycle lower alkyl”, “carbocycleoxy lower alkyl”, “heterocycleoxy lower alkyl”, “halogeno lower alkyl”, “carbocycle lower alkyloxy”, “heterocycle lower alkyloxy”, “halogeno lower alkyloxy”, “lower alkyloxy lower alkyl”, “lower alkyloxy lower alkyloxy”, “lower alkylcarbonyl”, “lower alkyloxycarbonyl”, “lower alkylamino”, “lower alkylcarbonylamino”, “lower alkylaminocarbonyl”, “lower alkylsulfonyl”, “lower alkylsulfonylamino”, “lower alkylthio”, “hydroxy lower alkyl”, “carbocycle lower alkyloxy lower alkyl”, “heterocycle lower alkyloxy lower alkyl”, “lower alkylcarbonyloxy”, “halogeno lower alkylcarbonylamino”, and “lower alkylsulfinyl” is the same as the “lower alkyl” as described above.</p>\n",
       "<p id=\"p-0179\" num=\"0191\">A lower alkenyl part of “lower alkenyloxy” is the same as the “lower alkenyl” as described above.</p>\n",
       "<p id=\"p-0180\" num=\"0192\">A halogen part of “halogeno lower alkyl”, “halogeno lower alkyloxy”, and “halogeno lower alkylcarbonylamino” is the same as the “halogen”. Herein, an arbitrary position on an alkyl group of “lower alkyl”, “lower alkyloxy”, and “lower alkylcarbonylamino” may be substituted by same or different one or plural halogen atoms, respectively.</p>\n",
       "<p id=\"p-0181\" num=\"0193\">“Carbocyclic group” or “carbocycle” means carbocyclic group of a carbon number of 3 to 20, preferably a carbon number of 3 to 16, more preferably a carbon number of 4 to 12, and includes cycloalkyl, cycloalkenyl, aryl and a non-aromatic condensed carbocyclic group, etc.</p>\n",
       "<p id=\"p-0182\" num=\"0194\">Specifically, “cycloalkyl” is carbocyclic group of a carbon number of 3 to 16, preferably a carbon number of 3 to 12, more preferably a carbon number of 4 to 8, and examples include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl and cyclodecyl, etc.</p>\n",
       "<p id=\"p-0183\" num=\"0195\">Specifically, “cycloalkenyl” includes cycloalkenyl having one or more double bonds at an arbitrary position in the cycloalkyl ring, and examples include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctynyl and cyclohexadienyl, etc.</p>\n",
       "<p id=\"p-0184\" num=\"0196\">Specifically, “aryl” includes phenyl, naphthyl, anthryl and phenanthryl, etc. and, particularly, phenyl is preferable.</p>\n",
       "<p id=\"p-0185\" num=\"0197\">Specifically, “non-aromatic condensed carbocyclic group” includes a group in which two or more cyclic groups selected from the “cycloalkyl”, the “cycloalkenyl” and the “aryl” are condensed, and examples include indanyl, indenyl, tetrahydronaphthyl, fluorenyl, adamantyl, and a group shown below:</p>\n",
       "<p id=\"p-0186\" num=\"0198\"><chemistry id=\"CHEM-US-00032\" num=\"00032\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00032.TIF\" he=\"29.55mm\" id=\"EMI-C00032\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0187\" num=\"0199\">Examples of a preferable embodiment of “carbocyclic group” or “carbocycle” include cycloalkyl, aryl and a non-aromatic condensed carbocyclic group, specifically examples include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, phenyl, naphthyl, and a group shown below:</p>\n",
       "<p id=\"p-0188\" num=\"0200\"><chemistry id=\"CHEM-US-00033\" num=\"00033\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00033.TIF\" he=\"29.55mm\" id=\"EMI-C00033\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0189\" num=\"0201\">A carbocyclic part of “carbocycle lower alkyl”, “carbocycle lower alkyloxy”, “carbocycleoxy lower alkyl”, “carbocyclecarbonyl”, “carbocycleoxy”, “carbocycleoxycarbonyl” and “carbocycle lower alkyloxy lower alkyl” is the same as the “carbocyclic group” or the “carbocycle” as described above.</p>\n",
       "<p id=\"p-0190\" num=\"0202\">“Heterocyclic group” or “heterocycle” includes heterocyclic group such as heteroaryl, a non-aromatic heterocyclic group, a bicyclic condensed heterocyclic group, a tricyclic condensed heterocyclic group, etc., having one or more same or different hetero atoms arbitrarily selected from O, S and N in a ring.</p>\n",
       "<p id=\"p-0191\" num=\"0203\">Specifically, “heteroaryl” includes a 5- to 6-membered aromatic cyclic group such as pyrrolyl, imidazolyl, pyrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazolyl, triazinyl, tetrazolyl, furyl, thienyl, isooxazolyl, oxazolyl, oxadiazolyl, isothiazolyl, thiazolyl, thiadiazolyl, etc.</p>\n",
       "<p id=\"p-0192\" num=\"0204\">Specifically, “non-aromatic heterocyclic group” includes a 4- to 8-membered non-aromatic heterocyclic group such as dioxanyl, thiiranyl, oxiranyl, oxetanyl, oxathiolanyl, azetidinyl, thianyl, thiazolidinyl, pyrrolidinyl, pyrrolinyl, imidazolidinyl, imidazolinyl, pyrazolidinyl, pyrazolinyl, piperidyl, piperazinyl, morpholinyl, morpholino, thiomorpholinyl, thiomorpholino, dihydropyridyl, tetrahydropyridyl, tetrahydrofuryl, tetrahydropyranyl, dihydrothiazolyl, tetrahydrothiazolyl, tetrahydroisothiazolyl, dihydrooxazinyl, hexahydroazepinyl, tetrahydrodiazepinyl, tetrahydropyridazinyl, hexahydropyrimidinyl, dioxolanyl, etc.</p>\n",
       "<p id=\"p-0193\" num=\"0205\">Specifically, “bicyclic condensed heterocyclic group” includes a cyclic group including at least one 4- to 8-membered aromatic or non-aromatic heterocyclic group such as indolyl, isoindolyl, indazolyl, indolizinyl, indolinyl, isoindolinyl, quinolyl, isoquinolyl, cinnolinyl, phthalazinyl, quinazolinyl, naphthyridinyl, quinoxalinyl, purinyl, pteridinyl, benzopyranyl, benzimidazolyl, benzotriazolyl, benzisooxazolyl, benzoxazolyl, benzoxadiazolyl, benzisothiazolyl, benzothiazolyl, benzothiadiazolyl, benzofuryl, isobenzofuryl, benzothienyl, benzotriazolyl, thienopyridyl, thienopyrrolyl, thienopyrazolyl, thienopyrazinyl, furopyrrolyl, thienothienyl, imidazopyridyl, pyrazolopyridyl, thiazolopyridyl, pyrazolopyrimidinyl, pyrazolotrianizyl, pyridazolopyridyl, triazolopyridyl, imidazothiazolyl, pyrazinopyridazinyl, quinazolinyl, quinolyl, isoquinolyl, naphthyridinyl, dihydrothiazolopyrimidinyl, tetrahydroquinolyl, tetrahydroisoquinolyl, dihydrobenzofuryl, dihydrobenzoxazinyl, dihydrobenzimidazolyl, tetrahydrobenzothienyl, tetrahydrobenzofuryl, benzodioxolyl, benzodioxonyl, chromanyl, chromenyl, octahydrochromenyl, dihydrobenzodioxynyl, dihydrobenzooxezinyl, dihydrobenzodioxepinyl, dihydrothienodioxynyl, etc.</p>\n",
       "<p id=\"p-0194\" num=\"0206\">Specifically, “tricyclic condensed heterocyclic group” includes a cyclic group including at least one 4- to 8-membered aromatic or non-aromatic heterocyclic group such as carbazolyl, acridinyl, xanthenyl, phenothiazinyl, phenoxathiinyl, phenoxazinyl, dibenzofuryl, imidazoquinolyl, tetrahydrocarbazolyl, and a group shown below:</p>\n",
       "<p id=\"p-0195\" num=\"0207\"><chemistry id=\"CHEM-US-00034\" num=\"00034\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00034.TIF\" he=\"75.27mm\" id=\"EMI-C00034\" img-content=\"chem\" img-format=\"tif\" wi=\"68.24mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0196\" num=\"0208\">Examples of a preferable embodiment of “heterocyclic group” include 5- to 6-membered heteroaryl, a non-aromatic heterocyclic group and a tricyclic condensed heterocyclic group.</p>\n",
       "<p id=\"p-0197\" num=\"0209\">A heterocyclic part of “heterocycle lower alkyl”, “heterocycle lower alkyloxy”, “carbocycleoxy lower alkyl”, “heterocyclecarbonyl”, “heterocycleoxy”, “heterocycleoxycarbonyl”, and “heterocycle lower alkyloxy lower alkyl” is the same as the “heterocyclic group” or the “heterocycle” as described above.</p>\n",
       "<p id=\"p-0198\" num=\"0210\">“Heterocyclic group substituted by oxo” means the “heterocyclic group” as described above, substituted by oxo as shown below. A group shown below:</p>\n",
       "<p id=\"p-0199\" num=\"0211\"><chemistry id=\"CHEM-US-00035\" num=\"00035\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00035.TIF\" he=\"19.39mm\" id=\"EMI-C00035\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "is exemplified.\n",
       "</p>\n",
       "<p id=\"p-0200\" num=\"0212\">“Straight or branched lower alkylene” is divalent “lower alkyl” as described above, and includes, for example, methylene, ethylene, propylene, butylene, isobutylene, pentylene, heptylene, dimethylmethylene, ethylmethylmethylene, 1,2-dimethylethylene, etc.</p>\n",
       "<p id=\"p-0201\" num=\"0213\">Examples of “lower alkyloxy” include methoxy, ethoxy, propyloxy, isopropyloxy, tert-butyloxy, isobutyloxy, sec-butyloxy, pentyloxy, isopentyloxy, hexyloxy, etc. Examples of a preferable embodiment include methoxy, ethoxy, propyloxy, isopropyloxy, and tert-butyloxy.</p>\n",
       "<p id=\"p-0202\" num=\"0214\">Examples of “lower alkylcarbonyl” include methylcarbonyl, ethylcarbonyl, propylcarbonyl, isopropylcarbonyl, tert-butylcarbonyl, isobutylcarbonyl, sec-butylcarbonyl, pentylcarbonyl, isopentylcarbonyl, hexylcarbonyl, etc. Examples of a preferable embodiment include methylcarbonyl, ethylcarbonyl, and propylcarbonyl.</p>\n",
       "<p id=\"p-0203\" num=\"0215\">Examples of “lower alkyloxycarbonyl” include methyloxycarbonyl, ethyloxycarbonyl, propyloxycarbonyl, isopropyloxycarbonyl, tert-butyloxycarbonyl, isobutyloxycarbonyl, sec-butyloxycarbonyl, pentyloxycarbonyl, isopentyloxycarbonyl, hexyloxycarbonyl, etc. Examples of a preferable embodiment include methyloxycarbonyl, ethyloxycarbonyl, and propyloxycarbonyl.</p>\n",
       "<p id=\"p-0204\" num=\"0216\">“Carbocycle lower alkyl” represents lower alkyl substituted by one, two or more carbocyclic groups, and examples of “carbocycle lower alkyl” include benzyl, phenethyl, phenylpropynyl, benzhydryl, trityl, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, naphthylmethyl, a group shown below:</p>\n",
       "<p id=\"p-0205\" num=\"0217\"><chemistry id=\"CHEM-US-00036\" num=\"00036\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00036.TIF\" he=\"22.94mm\" id=\"EMI-C00036\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc. Examples of a preferable embodiment include benzyl, phenethyl, and benzhydryl.\n",
       "</p>\n",
       "<p id=\"p-0206\" num=\"0218\">“Heterocycle lower alkyl” represents lower alkyl substituted by one, two or more heterocyclic groups, and also includes heterocycle lower alkyl in which an alkyl part is substituted by carbocyclic group. Examples of “heterocycle lower alkyl” include pyridylmethyl, tetrahydropyranylmethyl, furanylmethyl, morpholinylethyl, imidazolylmethyl, indolylmethyl, benzothiophenylmethyl, oxazolylmethyl, isooxazolylmethyl, thiazolylmethyl, isothiazolylmethyl, pyrazolylmethyl, isopyrazolylmethyl, pyrrolidinylmethyl, benzoxazolylmethyl, piperidinylmethyl, piperazinylmethyl, a group shown below:</p>\n",
       "<p id=\"p-0207\" num=\"0219\"><chemistry id=\"CHEM-US-00037\" num=\"00037\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00037.TIF\" he=\"77.55mm\" id=\"EMI-C00037\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc. Examples of a preferable embodiment include pyridylmethyl, tetrahydropyranylmethyl, furanylmethyl, and morpholinylethyl.\n",
       "</p>\n",
       "<p id=\"p-0208\" num=\"0220\">Examples of “carbocycleoxy lower alkyl” include phenyloxymethyl, phenyloxyethyl, cyclopropyloxymethyl, cyclopropyloxyethyl, cyclobutyloxymethyl, cyclobutyloxyethyl, cyclohexyloxymethyl, cyclohexyloxyethyl, etc. Examples of a preferable embodiment include phenyloxymethyl, and phenyloxyethyl.</p>\n",
       "<p id=\"p-0209\" num=\"0221\">Examples of “heterocycleoxy lower alkyl” include pyridyloxymethyl, pyridyloxyethyl, morpholinyloxymethyl, morpholinyloxyethyl, benzoxazolyloxymethyl, etc. Examples of a preferable embodiment include pyridyloxymethyl, morpholinyloxymethyl, etc.</p>\n",
       "<p id=\"p-0210\" num=\"0222\">“Carbocycle lower alkyloxy” represents lower alkyloxy in which an alkyl part is substituted by one, two or more carbocyclic groups, and examples of “carbocycle lower alkyloxy” include phenylmethyloxy, phenylethyloxy, cyclopropylmethyloxy, cyclobutylmethyloxy, cyclopentylmethyloxy, cyclohexylmethyloxy, etc. Examples of a preferable embodiment include phenylmethyloxy, cyclopropylmethyloxy, etc.</p>\n",
       "<p id=\"p-0211\" num=\"0223\">“Heterocycle lower alkyloxy” represents lower alkyloxy in which an alkyl part is substituted by one, two or more heterocyclic groups, and also includes heterocycle lower alkyloxy in which an alkyl part is substituted by carbocyclic group. Examples of “heterocycle lower alkyloxy” include pyridylmethyloxy, pyridylethyloxy, imidazolylmethyloxy, imidazolylethyloxy, benzoxazolylmethyloxy, benzoxazolylethyloxy, etc.</p>\n",
       "<p id=\"p-0212\" num=\"0224\">Examples of “lower alkyloxy lower alkyl” include methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, methoxypropyl, methoxybutyl, ethoxypropyl, ethoxybutyl, isopropyloxymethyl, tert-butyloxymethyl, etc. Examples of a preferable embodiment include methoxymethyl, methoxyethyl, ethoxymethyl, and ethoxyethyl.</p>\n",
       "<p id=\"p-0213\" num=\"0225\">Examples of “lower alkyloxy lower alkyloxy” include methoxymethoxy, methoxyethoxy, ethoxymethoxy, ethoxyethoxy, methoxypropyloxy, methoxybutyloxy, ethoxypropyloxy, ethoxybutyloxy, isopropyloxymethyloxy, tert-butyloxymethyloxy, etc. Examples of a preferable embodiment include methoxymethoxy, methoxyethoxy, ethoxymethoxy, and ethoxyethoxy.</p>\n",
       "<p id=\"p-0214\" num=\"0226\">Examples of “lower alkylamino” include methylamino, dimethylamino, ethylamino, diethylamino, isopropylamino, N,N-diisopropylamino, N-methyl-N-ethylamino, N-isopropyl-N-ethylamino, etc. Examples of a preferable embodiment include methylamino, dimethylamino, ethylamino, and diethylamino.</p>\n",
       "<p id=\"p-0215\" num=\"0227\">Examples of “lower alkylcarbonylamino” include methylcarbonylamino, ethylcarbonylamino, propylcarbonylamino, isopropylcarbonylamino, tert-butylcarbonylamino, isobutylcarbonylamino, sec-butylcarbonylamino, etc. Examples of a preferable embodiment include methylcarbonylamino, and ethylcarbonylamino.</p>\n",
       "<p id=\"p-0216\" num=\"0228\">Examples of “lower alkylaminocarbonyl” include methylaminocarbonyl, dimethylaminocarbonyl, ethylaminocarbonyl, diethylaminocarbonyl, isopropylaminocarbonyl, N,N-diisopropylaminocarbonyl, N-methyl-N-ethylaminocarbonyl, N-isopropyl-N-ethylaminocarbonyl, etc. Examples of a preferable embodiment include methylaminocarbonyl, dimethylaminocarbonyl, ethylaminocarbonyl, and diethylaminocarbonyl.</p>\n",
       "<p id=\"p-0217\" num=\"0229\">Examples of “lower alkylsulfonyl” include methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, tert-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl, etc. Examples of a preferable embodiment include methylsulfonyl, and ethylsulfonyl.</p>\n",
       "<p id=\"p-0218\" num=\"0230\">Examples of “lower alkylsulfonylamino” include methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino, isopropylsulfonylamino, tert-butylsulfonylamino, isobutylsulfonylamino, sec-butylsulfonylamino, etc. Examples of a preferable embodiment include methylsulfonylamino, and ethylsulfonylamino.</p>\n",
       "<p id=\"p-0219\" num=\"0231\">Examples of “lower alkenyloxy” include ethylenyloxy, 1-propylenyloxy, 2-propylenyloxy, 1-butylenyloxy, 2-butylenyloxy, 3-butylenyloxy, etc.</p>\n",
       "<p id=\"p-0220\" num=\"0232\">Examples of “halogeno lower alkyl” include monofluoromethyl, monofluoroethyl, monofluoropropyl, 2,2,3,3,3-pentafluoropropyl, monochloromethyl, trifluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2,2,2-trichloroethyl, 1,2-dibromoethyl, 1,1,1-trifluoropropan-2-yl, etc. Examples of a preferable embodiment include trifluoromethyl, trichloromethyl, 1,1,1-trifluoropropan-2-yl.</p>\n",
       "<p id=\"p-0221\" num=\"0233\">Examples of “halogeno lower alkyloxy” include monofluoromethoxy, monofluoroethoxy, trifluoromethoxy, trichloromethoxy, trifluoroethoxy, trichloroethoxy, etc. Examples of a preferable embodiment include trifluoromethoxy, and trichloromethoxy.</p>\n",
       "<p id=\"p-0222\" num=\"0234\">Examples of “lower alkylthio” include methylthio, ethylthio, propylthio, etc.</p>\n",
       "<p id=\"p-0223\" num=\"0235\">Examples of “hydroxy lower alkyl” include hydroxymethyl, hydroxyethyl, hydroxypropyl, etc.</p>\n",
       "<p id=\"p-0224\" num=\"0236\">Examples of “carbocycle lower alkyloxy lower alkyl” include benzyloxymethyl, benzyloxyethyl, benzhydryloxymethyl, etc.</p>\n",
       "<p id=\"p-0225\" num=\"0237\">Examples of “heterocycle lower alkyloxy lower alkyl” include pyridylmethyloxymethyl, pyridylmethyloxyethyl, etc.</p>\n",
       "<p id=\"p-0226\" num=\"0238\">Examples of “lower alkylcarbonyloxy” include methylcarbonyloxy, ethylcarbonyloxy, etc.</p>\n",
       "<p id=\"p-0227\" num=\"0239\">Examples of “halogeno lower alkylcarbonylamino” include trifluoromethylcarbonylamino, 2,2,3,3,3-pentafluoropropylcarbonylamino, etc.</p>\n",
       "<p id=\"p-0228\" num=\"0240\">Examples of “lower alkylsulfinyl” include methylsulfinyl, ethylsulfinyl, etc.</p>\n",
       "<p id=\"p-0229\" num=\"0241\">Examples of “carbocyclecarbonyl” include phenylcarbonyl, naphthylcarbonyl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, etc.</p>\n",
       "<p id=\"p-0230\" num=\"0242\">Examples of “carbocycleoxy” include phenyloxy, naphthyloxy, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, etc.</p>\n",
       "<p id=\"p-0231\" num=\"0243\">Examples of “carbocycleoxycarbonyl” include phenyloxycarbonyl, naphthyloxycarbonyl, cyclopropyloxycarbonyl, cyclobutyloxycarbonyl, cyclopentyloxycarbonyl, cyclohexyloxycarbonyl, etc.</p>\n",
       "<p id=\"p-0232\" num=\"0244\">Examples of “heterocyclecarbonyl” include pyridylcarbonyl, benzoxazolylcarbonyl, morpholinylcarbonyl, tetrahydropyranylcarbonyl, etc.</p>\n",
       "<p id=\"p-0233\" num=\"0245\">Examples of “heterocycleoxy” include pyridyloxy, benzoxazolyloxy, morpholinyloxy, tetrahydropyranyloxy, etc.</p>\n",
       "<p id=\"p-0234\" num=\"0246\">Examples of “heterocycleoxycarbonyl” include pyridyloxycarbonyl, benzoxazolyloxycarbonyl, morpholinyloxycarbonyl, tetrahydropyranyloxycarbonyl, etc.</p>\n",
       "<p id=\"h-0142\" num=\"0000\">“R<sup>X1 </sup>and R<sup>X2</sup>, R<sup>X9 </sup>and R<sup>X10</sup>, R<sup>X17 </sup>and R<sup>X18 </sup>as well as R<sup>X20 </sup>and R<sup>X21</sup>, each may be taken together with an adjacent atom to form a heterocycle”,</p>\n",
       "<p id=\"h-0143\" num=\"0000\">“R<sup>Y7 </sup>and R<sup>Y8</sup>, as well as R<sup>Y9 </sup>and R<sup>Y10</sup>, each may be taken together with an adjacent atom to form a heterocycle”,</p>\n",
       "<p id=\"h-0144\" num=\"0000\">“R<sup>Z7 </sup>and R<sup>Z8</sup>, as well as R<sup>Z9 </sup>and R<sup>Z10</sup>, each may be taken together with an adjacent atom to form a heterocycle”, and</p>\n",
       "<p id=\"h-0145\" num=\"0000\">“R<sup>V5 </sup>and R<sup>V6 </sup>may be taken together with an adjacent atom to form a heterocycle” in item 1′ and item 1; and</p>\n",
       "<p id=\"h-0146\" num=\"0000\">“R<sup>A1 </sup>and R<sup>A2</sup>, R<sup>A15 </sup>and R<sup>A16</sup>, as well as R<sup>A19 </sup>and R<sup>A20</sup>, each may be taken together with an adjacent atom to form a heterocycle”,</p>\n",
       "<p id=\"h-0147\" num=\"0000\">“R<sup>B7 </sup>and R<sup>B8</sup>, as well as R<sup>B9 </sup>and R<sup>B10</sup>, each may be taken together with an adjacent atom to form a heterocycle”,</p>\n",
       "<p id=\"h-0148\" num=\"0000\">“R<sup>C7 </sup>and R<sup>C8</sup>, as well as R<sup>C9 </sup>and R<sup>C10</sup>, each may be taken together with an adjacent atom to form a heterocycle”, and</p>\n",
       "<p id=\"h-0149\" num=\"0000\">“R<sup>D5 </sup>and R<sup>D6 </sup>may be taken together with an adjacent atom to form a heterocycle” in item 13′ and item 13 mean a heterocycle having N atom, and include, for example, a group shown below:</p>\n",
       "<p id=\"p-0235\" num=\"0247\"><chemistry id=\"CHEM-US-00038\" num=\"00038\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00038.TIF\" he=\"17.10mm\" id=\"EMI-C00038\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0236\" num=\"0248\">In the present description, (R<sup>E6</sup>)<sub>m </sub>in the formula shown below:</p>\n",
       "<p id=\"p-0237\" num=\"0249\"><chemistry id=\"CHEM-US-00039\" num=\"00039\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00039.TIF\" he=\"192.70mm\" id=\"EMI-C00039\" img-content=\"chem\" img-format=\"tif\" wi=\"53.17mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "means that an arbitrary carbon atom or nitrogen atom which can chemically have a substituent on a ring is substituted by m of R<sup>E6</sup>s which are same or different.\n",
       "</p>\n",
       "<p id=\"p-0238\" num=\"0250\">For example, in the formula below:</p>\n",
       "<p id=\"p-0239\" num=\"0251\"><chemistry id=\"CHEM-US-00040\" num=\"00040\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00040.TIF\" he=\"23.03mm\" id=\"EMI-C00040\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "as shown by a substituent below:\n",
       "</p>\n",
       "<p id=\"p-0240\" num=\"0252\"><chemistry id=\"CHEM-US-00041\" num=\"00041\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00041.TIF\" he=\"31.83mm\" id=\"EMI-C00041\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein ma+mb+mc=m, and R<sup>E6 </sup>is as defined above), it is meant that any hydrogen atom on two benzene rings and a 7-membered ring containing a sulfur atom may be substituted by R<sup>E6</sup>, and respective R<sup>E6</sup>s may be the same or different.\n",
       "</p>\n",
       "<p id=\"p-0241\" num=\"0253\">And, ma is preferably an integer of 0 to 3, mb is preferably an integer of 0 to 3, and mc is preferably an integer of 0 or 1. And, ma is more preferably an integer of 0 or 1, mb is more preferably an integer of 0 or 1, and mc is more preferably 0.</p>\n",
       "<p id=\"p-0242\" num=\"0254\">For example, in the formula below:</p>\n",
       "<p id=\"p-0243\" num=\"0255\"><chemistry id=\"CHEM-US-00042\" num=\"00042\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00042.TIF\" he=\"23.03mm\" id=\"EMI-C00042\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "substituents shown below:\n",
       "</p>\n",
       "<p id=\"p-0244\" num=\"0256\"><chemistry id=\"CHEM-US-00043\" num=\"00043\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00043.TIF\" he=\"208.96mm\" id=\"EMI-C00043\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6</sup>, and m are as defined in item 13′) etc. are included.\n",
       "</p>\n",
       "<p id=\"p-0245\" num=\"0257\">“When A<sup>1 </sup>is CR<sup>5</sup>R<sup>6</sup>, and A<sup>2 </sup>is NR<sup>7</sup>, R<sup>3 </sup>and R<sup>7 </sup>may be taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group B” in the formula (I) in item 1′ and item 1 represents the formula (I′) shown below:</p>\n",
       "<p id=\"p-0246\" num=\"0258\"><chemistry id=\"CHEM-US-00044\" num=\"00044\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00044.TIF\" he=\"36.41mm\" id=\"EMI-C00044\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>5 </sup>and R<sup>6 </sup>are as defined in item 1′ and item 1), and indicates that the “ring” may be substituted by one, two or more same or different substituents selected from substituent group B at an arbitrary position. The heterocycle is preferably a 5- to 7-membered ring. In addition, “the heterocycle may form a condensed ring” indicates that the ring in the formula (I′) may be further condensed with a ring, and indicates that substituent group B may be bound to any of the ring in the formula (I′) or the ring which is condensed with a ring. Examples of the formula (I′) include compounds shown by the following formulae:\n",
       "</p>\n",
       "<p id=\"p-0247\" num=\"0259\"><chemistry id=\"CHEM-US-00045\" num=\"00045\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00045.TIF\" he=\"58.00mm\" id=\"EMI-C00045\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>x</sup>, and R<sup>y </sup>are a substituent selected from substituent group B, and R<sup>1</sup>, R<sup>2</sup>, R<sup>5</sup>, and R<sup>6 </sup>are as defined in item 1′ and item 1) etc.\n",
       "</p>\n",
       "<p id=\"p-0248\" num=\"0260\">“When form a heterocycle” in “when A<sup>1 </sup>is NR<sup>7</sup>, and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>, R<sup>3 </sup>and R<sup>6 </sup>may be taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group B” in the formula (I) in item 1′ and item 1 represents the formula (I″) shown below:</p>\n",
       "<p id=\"p-0249\" num=\"0261\"><chemistry id=\"CHEM-US-00046\" num=\"00046\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00046.TIF\" he=\"33.44mm\" id=\"EMI-C00046\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>5</sup>, and R<sup>6 </sup>are as defined in item 1′ and item 1), and indicates that a part of a ring may be substituted by one, two or more same or different substituents selected from substituent group B at an arbitrary position. The heterocycle is preferably a 5- to 7-membered ring. In addition, “the heterocycle may form a condensed ring” indicates that the ring in the formula (I″) may be further condensed with a ring, and indicates that one, two or more of substituent group B may be bound to any of the ring in the formula (I″) or the ring which is condensed with a ring. Examples of the formula (I″) include compounds shown in the following formula:\n",
       "</p>\n",
       "<p id=\"p-0250\" num=\"0262\"><chemistry id=\"CHEM-US-00047\" num=\"00047\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00047.TIF\" he=\"58.00mm\" id=\"EMI-C00047\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>x </sup>an R<sup>y </sup>are a substituent selected from substituent group B, and R<sup>1</sup>, R<sup>2</sup>, R<sup>5 </sup>and R<sup>7 </sup>are as defined in item 1′ and item 1) etc.\n",
       "</p>\n",
       "<p id=\"p-0251\" num=\"0263\">“When form a bond” in “when A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>, R<sup>8 </sup>and R<sup>10 </sup>may be taken together with an adjacent atom to form a bond” in the formula (I) of item 1′ and item 1 represents the formula (I′″) shown below:</p>\n",
       "<p id=\"p-0252\" num=\"0264\"><chemistry id=\"CHEM-US-00048\" num=\"00048\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00048.TIF\" he=\"33.44mm\" id=\"EMI-C00048\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>9 </sup>and R<sup>11 </sup>are as defined in item 1′ and item 1).\n",
       "</p>\n",
       "<p id=\"p-0253\" num=\"0265\">In addition, “when form a bond” in “R<sup>8 </sup>and R<sup>10 </sup>may be taken together with an adjacent atom to form a carbocycle or a heterocycle optionally substituted by substituent group B” represents the formula (I″″) shown below:</p>\n",
       "<p id=\"p-0254\" num=\"0266\"><chemistry id=\"CHEM-US-00049\" num=\"00049\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00049.TIF\" he=\"33.44mm\" id=\"EMI-C00049\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>9 </sup>and R<sup>11 </sup>are as defined in item 1′ and item 1), and indicates that a part of a ring may be substituted by one, two or more same or different substituents selected from substituent group B at an arbitrary position. The carbocycle or the heterocycle is preferably a 5- to 7-membered ring. Examples of the formula (I″″) include a compound shown in the following formula:\n",
       "</p>\n",
       "<p id=\"p-0255\" num=\"0267\"><chemistry id=\"CHEM-US-00050\" num=\"00050\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00050.TIF\" he=\"27.77mm\" id=\"EMI-C00050\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>x </sup>and R<sup>y </sup>are a substituent selected from substituent group B, and R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>9 </sup>and R<sup>11 </sup>are as defined in item 1′ and item 1) etc.\n",
       "</p>\n",
       "<p id=\"p-0256\" num=\"0268\">Further, “R<sup>3 </sup>and R<sup>11 </sup>may be taken together with an adjacent atom to form a heterocyle optionally substituted by substituent group B, and the heterocycle may form a condensed ring” represents the formula (I) shown below:</p>\n",
       "<p id=\"p-0257\" num=\"0269\"><chemistry id=\"CHEM-US-00051\" num=\"00051\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00051.TIF\" he=\"33.44mm\" id=\"EMI-C00051\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>8</sup>, R<sup>9 </sup>and R<sup>10 </sup>are as defined in item 1′ and item 1), and indicates that a part of a ring may further form a condensed ring, and the same or different substituents selected from substituent group B may be bound to any of the ring in the formula (I′″″) or the ring which is condensed with a ring at an arbitrary position. The heterocycle is preferably a 5- to 7-membered ring. Examples of the formula (I′″″) include compounds shown by the following formula:\n",
       "</p>\n",
       "<p id=\"p-0258\" num=\"0270\"><chemistry id=\"CHEM-US-00052\" num=\"00052\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00052.TIF\" he=\"90.09mm\" id=\"EMI-C00052\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>x </sup>and R<sup>y </sup>are a substituent selected from substituent group B, and R<sup>1</sup>, R<sup>2</sup>, R<sup>8</sup>, R<sup>9 </sup>and R<sup>10 </sup>are as defined in item 1′ and item 1) etc.\n",
       "</p>\n",
       "<p id=\"p-0259\" num=\"0271\">“When form a heterocyle” in “when B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and B<sup>2 </sup>is NR<sup>7a</sup>, R<sup>3a </sup>and R<sup>7a </sup>may be taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group D” in the formula (II) in item 13 represents the formula (II′) shown below:</p>\n",
       "<p id=\"p-0260\" num=\"0272\"><chemistry id=\"CHEM-US-00053\" num=\"00053\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00053.TIF\" he=\"33.44mm\" id=\"EMI-C00053\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1a</sup>, R<sup>2a</sup>, R<sup>5a </sup>and R<sup>6a </sup>are as defined in item 13′ and item 13).\n",
       "</p>\n",
       "<p id=\"p-0261\" num=\"0273\">“When form a heterocycle” in “when B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, R<sup>3a </sup>and R<sup>6a </sup>may be taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group D” represents the formula (II″) shown below:</p>\n",
       "<p id=\"p-0262\" num=\"0274\"><chemistry id=\"CHEM-US-00054\" num=\"00054\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00054.TIF\" he=\"34.88mm\" id=\"EMI-C00054\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1a</sup>, R<sup>2a</sup>, R<sup>5a </sup>and R<sup>7a </sup>are as defined in item 13′ and item 13). The heterocycle is preferably a 5- to 7-membered ring.\n",
       "</p>\n",
       "<p id=\"p-0263\" num=\"0275\">“When form a heterocycle” in “when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>, R<sup>8a </sup>and R<sup>10a </sup>may be taken together with an adjacent atom to form a carbocycle or a heterocycle, optionally substituted by substituent group D” represents the formula (II′″) shown below:</p>\n",
       "<p id=\"p-0264\" num=\"0276\"><chemistry id=\"CHEM-US-00055\" num=\"00055\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00055.TIF\" he=\"33.44mm\" id=\"EMI-C00055\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1a</sup>, R<sup>2a</sup>, R<sup>3a</sup>, R<sup>9a </sup>and R<sup>11a </sup>are as defined in item 13′ and item 13). The carbocycle or the heterocycle is preferably a 5- to 7-membered ring.\n",
       "</p>\n",
       "<p id=\"p-0265\" num=\"0277\">“When form a heterocycle” in “when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>, R<sup>3a </sup>and R<sup>11a </sup>may be taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group D” represents the formula (II″″) shown below:</p>\n",
       "<p id=\"p-0266\" num=\"0278\"><chemistry id=\"CHEM-US-00056\" num=\"00056\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00056.TIF\" he=\"32.43mm\" id=\"EMI-C00056\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>1a</sup>, R<sup>2a</sup>, R<sup>3a</sup>, R<sup>9a </sup>and R<sup>10a </sup>are as defined in item 13′ and an item 13). The heterocycle is preferably a 5- to 7-membered ring.\n",
       "</p>\n",
       "<p id=\"p-0267\" num=\"0279\">“Solvate” includes, for example, a solvate with an organic solvent, a hydrate, etc. When a hydrate is formed, the compound may be coordinated with an arbitrary number of water molecules.</p>\n",
       "<p id=\"p-0268\" num=\"0280\">The compound of the present invention includes a pharmaceutically acceptable salt. Examples include salts with an alkali metal (lithium, sodium or potassium, etc.), an alkaline earth metal (magnesium or calcium, etc.), ammonium, an organic base and an amino acid, or salts with an inorganic acid (hydrochloric acid, sulfuric acid, nitric acid, hydrobromic acid, phosphoric acid or hydroiodic acid, etc.), and an organic acid (acetic acid, trifluoroacetic acid, citric acid, lactic acid, tartaric acid, oxalic acid, maleic acid, fumaric acid, mandelic acid, glutaric acid, malic acid, benzoic acid, phthalic acid, benzenesulfonic acid, p-toluenesulfonic acid, methanesulfonic acid or ethanesulfonic acid, etc.). These salts can be formed by the method which is usually performed.</p>\n",
       "<p id=\"p-0269\" num=\"0281\">In addition, the compound of the present invention is not limited to a particular isomer, but includes all possible isomers (keto-enol isomer, imine-enamine isomer, diastereoisomer, optical isomer and rotation isomer, etc.) and racemic bodies.</p>\n",
       "<p id=\"p-0270\" num=\"0282\">The formula (I) and the formula (II) in the present invention are not limited to a particular isomer, but include all possible isomers and racemic bodies. For example, they contain a tautomer and a steric isomer as follows.</p>\n",
       "<p id=\"p-0271\" num=\"0283\"><chemistry id=\"CHEM-US-00057\" num=\"00057\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00057.TIF\" he=\"210.23mm\" id=\"EMI-C00057\" img-content=\"chem\" img-format=\"tif\" wi=\"74.93mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0272\" num=\"0284\">Further in the formula (I) and the formula (II) of the present invention, one or more hydrogen atoms, carbon atoms or other atoms can be substituted by an isotope of a hydrogen atom, a carbon atom or other atoms, respectively.</p>\n",
       "<p id=\"p-0273\" num=\"0285\">In addition, the compounds of the formulae (I) and (II) include all radioactive labeled bodies thereof. Such the “radioactive labeling” and “radioactive labeled form” of the compounds of the formulae (I) and (II) are included in the present invention, respectively, and are useful as a study and/or diagnostic tool in metabolized drug dynamic state study and binding assay.</p>\n",
       "<p id=\"p-0274\" num=\"0286\">Examples of an isotope which can be incorporated into the compounds of the formulae (I) and (II) of the present invention include a hydrogen atom, a carbon atom, a nitrogen atom, an oxygen atom, a phosphorus atom, a sulfur atom, a fluorine atom and a chlorine atom, such as <sup>2</sup>H, <sup>3</sup>H, <sup>13</sup>C, <sup>14</sup>C, <sup>15</sup>N, <sup>18</sup>O, <sup>17</sup>O, <sup>31</sup>P, <sup>32</sup>P, <sup>35</sup>S, <sup>18</sup>F, and <sup>36</sup>Cl.</p>\n",
       "<p id=\"p-0275\" num=\"0287\">A particularly preferable example of an isotope which can be incorporated into the compounds of the formulae (I) and (II) of the present invention is <sup>2</sup>H (i.e. heavy hydrogen atom), and can be prepared by the method shown in Examples of the present description, or the method well-known in the art. In addition, a heavy hydrogen atom is expressed as “D” in Examples of the present description. Compounds of the formulae (I) and (II) of the present invention in which a hydrogen atom has been converted into a heavy hydrogen atom are excellent in respect of bioavailability, metabolism safety, drug efficacy, and toxicity as compared with unconverted forms, in some cases, and can be useful as medicaments.</p>\n",
       "<p id=\"p-0276\" num=\"0288\">“step B and step C are continuously performed” refers to execution of step C after reaction of step B without isolation operation and column chromatography purification of product generated in step B. A reaction container for step B and a reaction container for step C may be the same or different.</p>\n",
       "<p id=\"p-0277\" num=\"0289\">Examples of “lower alkyl optionally substituted by substituent group A” and “lower alkyl optionally substituted by substituent group C” include methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, sec-butyl, pentan-2-yl, hydroxymethyl, hydroxyethyl, carboxymethyl, carboxyethyl, carboxypropyl, ethoxycarbonylpropyl, cyanomethyl, cyanoethyl, fluoromethyl, fluoroethyl, fluoropropyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, ethyloxycarbonylethyl, methoxymethyl, dimethoxymethyl, methoxyethyl, methoxypropyl, ethoxyethyl, 1-methyl-1-methoxymethyl, propyloxymethyl, aminopropyl, dimethylaminomethyl, aminomethyl, aminoethyl, dimethylaminoethyl, diethylaminomethyl, diethylaminoethyl, dimethylaminopropyl, cyclopropylmethyloxymethyl, methylsulfonylaminomethyl, methylaminocarbonylethyl, 1,1,1-trifluoropropan-2-yl, 1,1-difluoroethyl, 1,1,1-trifluoroethyl, 1,1,1-trifluoropropyl, trifluoromethyloxyethyl, trifluoromethylcarbonylaminomethyl, methylsulfonylethyl, methylcarbonyloxyethyl, and groups shown below:</p>\n",
       "<p id=\"p-0278\" num=\"0290\"><chemistry id=\"CHEM-US-00058\" num=\"00058\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00058.TIF\" he=\"210.14mm\" id=\"EMI-C00058\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0279\" num=\"0291\">Examples of “lower alkenyl optionally substituted by substituent group A” and “lower alkenyl optionally substituted by substituent group C” include ethylenyl, 3-methylbuten-2-yl, carboxyethylenyl, hydroxyethylenyl, difluoroethylenyl, 1-propen-2-yl, etc.</p>\n",
       "<p id=\"p-0280\" num=\"0292\">Examples of “lower alkynyl optionally substituted by substituent group A” and “lower alkynyl optionally substituted by substituent group C” include 1-propynyl, 1-butynyl, 3,3,3-trifluoromethylpropynyl, 3-hydroxy-propynyl, etc.</p>\n",
       "<p id=\"p-0281\" num=\"0293\">Examples of “lower alkyloxy optionally substituted by substituent group A” and “lower alkyloxy optionally substituted by substituent group C” include methyloxy, ethyloxy, trifluoromethyloxy, trichloromethyloxy, hydroxymethyloxy, hydroxyethyloxy, carboxymethyloxy, carboxyethyloxy, etc.</p>\n",
       "<p id=\"p-0282\" num=\"0294\">Examples of “lower alkenyloxy optionally substituted by substituent group A” and “lower alkenyloxy optionally substituted by substituent group C” include 3-fluoro-1-propenyloxy, ethylenyl, carboxyethylenyl, hydroxyethylenyloxy, difluoroethylenyloxy, etc.</p>\n",
       "<p id=\"p-0283\" num=\"0295\">Examples of “lower alkylcarbonyl optionally substituted by substituent group A” and “lower alkylcarbonyl optionally substituted by substituent group C” include methylcarbonyl, ethylcarbonyl, propylcarbonyl, isopropylcarbonyl, hydroxymethylcarbonyl, hydroxyethylcarbonyl, trifluoromethylcarbonyl, 2,2,2-trifluoromethylcarbonyl, carboxymethylcarbonyl, etc.</p>\n",
       "<p id=\"p-0284\" num=\"0296\">Examples of “lower alkyloxycarbonyl optionally substituted by substituent group A” and “lower alkyloxycarbonyl optionally substituted by substituent group C” include methyloxycarbonyl, ethyloxycarbonyl, trifluoromethyl oxycarbonyl, trichloromethyloxycarbonyl, hydroxymethyloxycarbonyl, hydroxyethyloxycarbonyl, carboxymethyloxycarbonyl, etc.</p>\n",
       "<p id=\"p-0285\" num=\"0297\">Examples of “carbocyclic group optionally substituted by substituent group A” and “carbocyclic group optionally substituted by substituent group C” include phenyl, naphthyl, anthracenyl, phenanthracenyl, adamantyl, 1-hydroxyadamantyl, 2-hydroxyadamantyl, 3-methylphenyl, 4-methylphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 3-hydroxyphenyl, 4-hydroxyphenyl, 4-chlorophenyl, 4-fluorophenyl, 2-cyanophenyl, 3-cyanophenyl, 4-cyanophenyl, fluorocyclopropyl, difluorocyclobutanyl, difluorocyclohexyl, and groups shown below:</p>\n",
       "<p id=\"p-0286\" num=\"0298\"><chemistry id=\"CHEM-US-00059\" num=\"00059\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00059.TIF\" he=\"137.08mm\" id=\"EMI-C00059\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>represents a group selected from substituent group A or substituent group C, and m of R<sup>E6</sup>s may be the same or different) etc.\n",
       "</p>\n",
       "<p id=\"p-0287\" num=\"0299\">Examples of “carbocycle lower alkyl optionally substituted by substituent group A” and “carbocycle lower alkyl optionally substituted by substituent group C” include cyclopropylmethyl, 4-hydroxybenzyl, cyclopentylmethyl, benzyl, 2-aminobenzyl, 2-cyanobenzyl, 2-fluorobenzyl, 4-fluorobenzyl, 2-trifluoromethylbenzyl, 1,3,5-trifluorobenzyl, 3,4,5-trifluorobenzyl, 4-methoxybenzyl, 2,4-difluorobenzyl, 2-fluoro-3-chlorobenzyl, benzhydryl, 4-phenylbenzyl, phenethyl, phenylpropyl, 4-methylcarbonylaminobenzyl, 3,4-dichlorobenzyl, 4-chloro-2-fluorobenzyl, 3,5-dihydroxybenzyl, and groups shown below:</p>\n",
       "<p id=\"p-0288\" num=\"0300\"><chemistry id=\"CHEM-US-00060\" num=\"00060\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00060.TIF\" he=\"242.06mm\" id=\"EMI-C00060\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00061\" num=\"00061\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00061.TIF\" he=\"228.85mm\" id=\"EMI-C00061\" img-content=\"chem\" img-format=\"tif\" wi=\"72.31mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00062\" num=\"00062\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00062.TIF\" he=\"81.20mm\" id=\"EMI-C00062\" img-content=\"chem\" img-format=\"tif\" wi=\"59.86mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0289\" num=\"0301\">Examples of “carbocycric oxy lower alkyl optionally substituted by substituent group A” and “carbocycleoxy lower alkyl optionally substituted by substituent group C” include 4-hydroxyphenyloxymethyl, 4-hydroxyphenyloxyethyl, cyclopropyloxymethyl, cyclopentyloxymethyl, 4-fluorophenyloxymethyl, 4-fluorophenyloxyethyl, 4-trifluoromethylphenyloxymethyl, 4-trifluoromethylphenyloxyethyl, 4-methoxyphenyloxymethyl, 4-methoxyphenyloxyethyl, etc.</p>\n",
       "<p id=\"p-0290\" num=\"0302\">Examples of “carbocyclecarbonyl optionally substituted by substituent group A” and “carbocyclecarbonyl optionally substituted by substituent group C” include phenylcarbonyl, 4-fluorophenylcarbonyl, 4-trifluoromethylphenylcarbonyl, 4-methoxyphenylcarbonyl, cyclopropylcarbonyl, etc.</p>\n",
       "<p id=\"p-0291\" num=\"0303\">Examples of “carbocycleoxy optionally substituted by substituent group A” and “carbocycleoxy optionally substituted by substituent group C” include phenyloxy, cyclopropyloxy, cyclopentyloxy, 4-fluorophenyloxy, 4-trifluoromethylphenyloxy, 4-methoxyphenyloxy, etc.</p>\n",
       "<p id=\"p-0292\" num=\"0304\">Examples of “carbocycleoxycarbonyl optionally substituted by substituent group A” and “carbocycleoxycarbonyl optionally substituted by substituent group C” include phenyloxycarbonyl, cyclopropyloxycarbonyl, cyclopentyloxycarbonyl, 4-fluorophenyloxycarbonyl, 4-trifluoromethylphenyloxycarbonyl, 4-methoxyphenyloxycarbonyl, etc.</p>\n",
       "<p id=\"p-0293\" num=\"0305\">Examples of “heterocyclic group optionally substituted by substituent group A” and “heterocyclic group optionally substituted by substituent group C” include pyrimidinyl, pyridyl, benzoxazolyl, morpholinyl, tetrahydropyranyl, furyl, thiophenyl, oxazolyl, thiazolyl, pyrazolyl, methylpyrrolidinyl, isopropylpyrrolidinyl, methylsulfonylpyrrolidinyl, hydroxyethylpyrrolidinyl, methylpiperidinyl, methylpiperazinyl, tetrahydrofuryl, and groups shown below:</p>\n",
       "<p id=\"p-0294\" num=\"0306\"><chemistry id=\"CHEM-US-00063\" num=\"00063\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00063.TIF\" he=\"196.17mm\" id=\"EMI-C00063\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>represents a group selected from substituent group A or substituent group C, and m of R<sup>E6</sup>s may be the same or different) etc.\n",
       "</p>\n",
       "<p id=\"p-0295\" num=\"0307\">Examples of “heterocycle lower alkyl optionally substituted by substituent group A” and “heterocycle lower alkyl optionally substituted by substituent group C” include tetrahydropyranylmethyl, pyridylmethyl, isoxazolylmethyl, 5-methyl-isoxazolylmethyl, 3-methyl-oxadiazolylmethyl, indolylmethyl, benzothiophenylmethyl, 5-chlorobenzothiophenylmethyl, thiazolylmethyl, 2-methylthiazolylmethyl, pyrazolylmethyl, 2-methylpyrazolylmethyl, dithiophenylmethyl, tetrazolylmethyl, quinazolylmethyl, and groups shown below:</p>\n",
       "<p id=\"p-0296\" num=\"0308\"><chemistry id=\"CHEM-US-00064\" num=\"00064\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00064.TIF\" he=\"189.31mm\" id=\"EMI-C00064\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0297\" num=\"0309\">Examples of “heterocycleoxy lower alkyl optionally substituted by substituent group A” and “heterocycleoxy lower alkyl optionally substituted by a substituent group C” include tetrahydropyranyloxymethyl, pyridyloxymethyl, isoxazolyloxymethyl, 5-methyl-isoxazolyloxymethyl, indolyloxymethyl, benzothiophenyloxymethyl, 5-chlorobenzothiophenyloxymethyl, thiazolyloxymethyl, 2-methylthiazolyloxymethyl, pyrazolyloxymethyl, 2-methylpyrazolyloxymethyl, etc.</p>\n",
       "<p id=\"p-0298\" num=\"0310\">Examples of “heterocyclecarbonyl optionally substituted by substituent group A” and “heterocyclecarbonyl optionally substituted by substituent group C” include tetrahydropyranylcarbonyl, pyridylcarbonyl, isoxazolylcarbonyl, 5-methyl-isoxazolylcarbonyl, indolylcarbonyl, benzothiophenylcarbonyl, 5-chlorobenzothiophenylcarbonyl, thiazolylcarbonyl, 2-methylthiazolylcarbonyl, pyrazolylcarbonyl, 2-methylpyrazolylcarbonyl, etc.</p>\n",
       "<p id=\"p-0299\" num=\"0311\">Examples of “heterocycleoxy optionally substituted by substituent group A”, and “heterocycleoxy optionally substituted by substituent C” include tetrahydropyranyloxy, pyridyloxy, isoxazolyloxy, 5-methyl-isoxazolyloxy, indolyloxy, benzothiophenyloxy, 5-chlorobenzothiophenyloxy, thiazolyloxy, 2-methylthiazolyloxy, pyrazolyloxy, 2-methylpyrazolyloxy, etc.</p>\n",
       "<p id=\"p-0300\" num=\"0312\">Examples of “heterocycleoxycarbonyl optionally substituted by substituent group A”, and “heterocycleoxycarbonyl optionally substituted by substituent group C” include tetrahydropyranyloxycarbonyl, pyridyloxycarbonyl, isoxazolyloxycarbonyl, 5-methyl-isoxazolyloxycarbonyl, indolyloxycarbonyl, benzothiophenyloxycarbonyl, 5-chlorobenzothiophenyloxycarbonyl, thiazolyloxycarbonyl, 2-methylthiazolyloxycarbonyl, pyrazolyloxycarbonyl, 2-methylpyrazolyloxycarbonyl, etc.</p>\n",
       "<p id=\"p-0301\" num=\"0313\">Examples of a preferable substituent in R<sup>1 </sup>and R<sup>1a </sup>include hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0150\" num=\"0000\">—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),</p>\n",
       "<p id=\"h-0151\" num=\"0000\">—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>),</p>\n",
       "<p id=\"h-0152\" num=\"0000\">—Z—C(═O)—N(R<sup>A5</sup>)—SO<sub>2</sub>—(R<sup>A6</sup>),</p>\n",
       "<p id=\"h-0153\" num=\"0000\">—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,</p>\n",
       "<p id=\"h-0154\" num=\"0000\">—Z—S—R<sup>A9</sup>,</p>\n",
       "<p id=\"h-0155\" num=\"0000\">—Z—SO<sub>2</sub>—R<sup>A10</sup>,</p>\n",
       "<p id=\"h-0156\" num=\"0000\">—Z—S(═O)—R<sup>A11</sup>,</p>\n",
       "<p id=\"h-0157\" num=\"0000\">—C(═O)—O—R<sup>A13</sup>,</p>\n",
       "<p id=\"h-0158\" num=\"0000\">—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>,</p>\n",
       "<p id=\"h-0159\" num=\"0000\">—Z—N(R<sup>A14</sup>)—C(═O)—N(R<sup>A15</sup>)(R<sup>A16</sup>),</p>\n",
       "<p id=\"h-0160\" num=\"0000\">—Z—C(═O)—N(R<sup>A17</sup>)—C(═O)—N(R<sup>A18</sup>)(R<sup>A19</sup>), or</p>\n",
       "<p id=\"h-0161\" num=\"0000\">—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup></p>\n",
       "<p id=\"h-0162\" num=\"0000\">(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A3</sup>, R<sup>A5</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A9</sup>, R<sup>A10</sup>, R<sup>A11</sup>, R<sup>A12</sup>, R<sup>A13</sup>, R<sup>A14</sup>, R<sup>A15</sup>, R<sup>A16</sup>, R<sup>A17</sup>, R<sup>A18</sup>, R<sup>A19</sup>, R<sup>A20</sup>, R<sup>A21</sup>, and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0302\" num=\"0314\">Examples of a more preferable substituent in R<sup>1 </sup>and R<sup>1a </sup>include hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0163\" num=\"0000\">—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),</p>\n",
       "<p id=\"h-0164\" num=\"0000\">—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>, or</p>\n",
       "<p id=\"h-0165\" num=\"0000\">—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13 </sup></p>\n",
       "<p id=\"h-0166\" num=\"0000\">(Substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A12</sup>, R<sup>A13 </sup>and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0303\" num=\"0315\">Examples of a further preferable substituent in R<sup>1 </sup>and R<sup>1a </sup>include hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, or)</p>\n",
       "<p id=\"h-0167\" num=\"0000\">—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>)</p>\n",
       "<p id=\"h-0168\" num=\"0000\">(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0304\" num=\"0316\">Examples of another embodiment of a preferable substituent in R<sup>1 </sup>and R<sup>1a </sup>include hydrogen, carboxy, hydroxymethyl, methoxy, chlorine atom, bromine atom, ethoxymethyl, dimethylamino, hydroxy, —C(═O)—NH—S(═O)<sub>2</sub>-Me, amino, methylamino, methylaminomethyl, —NH—C(═O)—CF<sub>3</sub>, pyrazolyl, —NH—C(═O)-Me, —C(═O)N-Me<sub>2</sub>, tetrazolyl, —NH—C(═O)-Ph, —C(═O)NH-Me, —C(═O)NH-Et, —C(═O)NH-cyclopropyl, methoxycarbonyl, methyl, propenyl, propyl, isopropyl, fluoromethyl</p>\n",
       "<p id=\"h-0169\" num=\"0000\">(Me represents a methyl group, Ph represents a phenyl group, and Et represents an ethyl group) etc.</p>\n",
       "<p id=\"p-0305\" num=\"0317\">Examples of another embodiment of a more preferable substituent in R<sup>1 </sup>and R<sup>1a </sup>include hydrogen, carboxy, hydroxymethyl, methoxy, bromine atom, ethoxymethyl, dimethylamino, hydroxy, —C(═O)—NH—S(═O)<sub>2</sub>-Me, amino, methylamino, methyl, propenyl</p>\n",
       "<p id=\"h-0170\" num=\"0000\">(Me represents a methyl group) etc.</p>\n",
       "<p id=\"p-0306\" num=\"0318\">Examples of another embodiment of a further preferable substituent in R<sup>1 </sup>and R<sup>1a </sup>include hydrogen, and carboxy.</p>\n",
       "<p id=\"p-0307\" num=\"0319\">Examples of a preferable substituent in R<sup>2 </sup>and R<sup>2a </sup>include hydrogen, halogen, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0171\" num=\"0000\">—Z—N(R<sup>B1</sup>)—SO<sub>2</sub>—R<sup>B2</sup>,</p>\n",
       "<p id=\"h-0172\" num=\"0000\">—Z—N(R<sup>B9</sup>)—C(═O)—R<sup>B4</sup>,</p>\n",
       "<p id=\"h-0173\" num=\"0000\">—Z—N(R<sup>B5</sup>)—C(═O)—O—R<sup>B6</sup>,</p>\n",
       "<p id=\"h-0174\" num=\"0000\">—Z—C(═O)—N(R<sup>B7</sup>)(R<sup>B8</sup>),</p>\n",
       "<p id=\"h-0175\" num=\"0000\">—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>), or</p>\n",
       "<p id=\"h-0176\" num=\"0000\">—Z—SO<sub>2</sub>—R<sup>B11 </sup></p>\n",
       "<p id=\"h-0177\" num=\"0000\">(substituent group C, R<sup>B1</sup>, R<sup>B2</sup>, R<sup>B3</sup>, R<sup>B4</sup>, R<sup>B5</sup>, R<sup>B6</sup>, R<sup>B7</sup>, R<sup>B8</sup>, R<sup>B9</sup>, R<sup>B10</sup>, R<sup>B11 </sup>and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0308\" num=\"0320\">Examples of a more preferable substituent in R<sup>2 </sup>and R<sup>2a </sup>include hydrogen, lower alkyl optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, or</p>\n",
       "<p id=\"h-0178\" num=\"0000\">—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>)</p>\n",
       "<p id=\"h-0179\" num=\"0000\">(a substituent group C, R<sup>B9</sup>, R<sup>B10</sup>, and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0309\" num=\"0321\">Examples of a further preferable substituent in R<sup>2 </sup>and R<sup>2a </sup>include hydrogen, or lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C</p>\n",
       "<p id=\"h-0180\" num=\"0000\">(substituent group C is as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0310\" num=\"0322\">Examples of another embodiment of a preferable substituent in R<sup>2 </sup>and R<sup>2a </sup>include hydrogen, hydroxymethyl, amino, methoxymethyl, methoxymethylcyclopropylmethyloxymethyl, cyanomethyl, aminomethyl, propyloxymethyl, —CH<sub>2</sub>—NH—C(═O)-Me, methylaminomethyl, imidazolyl, dimethylaminomethyl, pyrrolidinyl, fluoromethyl, —CH<sub>2</sub>—NH—C(═O)H</p>\n",
       "<p id=\"h-0181\" num=\"0000\">(Me represents a methyl group) etc.</p>\n",
       "<p id=\"p-0311\" num=\"0323\">Examples of another embodiment of a more preferable substituent in R<sup>2 </sup>and R<sup>2a </sup>include hydrogen, hydroxymethyl, methoxymethylcyclopropylmethyloxymethyl, aminomethyl, propyloxymethyl, etc.</p>\n",
       "<p id=\"p-0312\" num=\"0324\">Examples of another embodiment of a further preferable substituent in R<sup>2 </sup>and R<sup>2a </sup>include hydrogen.</p>\n",
       "<p id=\"p-0313\" num=\"0325\">Examples of a preferable substituent in R<sup>3 </sup>and R<sup>3a </sup>include hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0182\" num=\"0000\">—Z—N(R<sup>C1</sup>)—SO<sub>2</sub>—R<sup>C2</sup>,</p>\n",
       "<p id=\"h-0183\" num=\"0000\">—Z—N(R<sup>C3</sup>)—C(═O)—R<sup>C4</sup>,</p>\n",
       "<p id=\"h-0184\" num=\"0000\">—Z—N(R<sup>C5</sup>)—C(═O)—O—R<sup>C6</sup>,</p>\n",
       "<p id=\"h-0185\" num=\"0000\">—Z—C(═O)—N(R<sup>C7</sup>)(R<sup>C8</sup>),</p>\n",
       "<p id=\"h-0186\" num=\"0000\">—Z—N(R<sup>C9</sup>)(R<sup>C10</sup>), or</p>\n",
       "<p id=\"h-0187\" num=\"0000\">—Z—SO<sub>2</sub>—R<sup>C11 </sup></p>\n",
       "<p id=\"h-0188\" num=\"0000\">(substituent group C, R<sup>C1</sup>, R<sup>C2</sup>, R<sup>C3</sup>, R<sup>C4</sup>, R<sup>C5</sup>, R<sup>C6</sup>, R<sup>C7</sup>, R<sup>C8</sup>, R<sup>C9</sup>, R<sup>C10</sup>, R<sup>C11</sup>, and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0314\" num=\"0326\">Examples of a more preferable substituent in R<sup>3 </sup>and R<sup>3a </sup>include hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0189\" num=\"0000\">—Z—N(R<sup>C1</sup>)—SO<sub>2</sub>—R<sup>C2</sup>,</p>\n",
       "<p id=\"h-0190\" num=\"0000\">—Z—N(R<sup>C3</sup>)—C(═O)—R<sup>C4</sup>,</p>\n",
       "<p id=\"h-0191\" num=\"0000\">—Z—N(R<sup>C5</sup>)—C(═O)—O—R<sup>C6</sup>,</p>\n",
       "<p id=\"h-0192\" num=\"0000\">—Z—C(═O)—N(R<sup>C7</sup>)(R<sup>C8</sup>), or</p>\n",
       "<p id=\"h-0193\" num=\"0000\">—Z—N(R<sup>C9</sup>)(R<sup>C10</sup>)</p>\n",
       "<p id=\"h-0194\" num=\"0000\">(substituent group C, R<sup>C1</sup>, R<sup>C2</sup>, R<sup>C3</sup>, R<sup>C4</sup>, R<sup>C5</sup>, R<sup>C6</sup>, R<sup>C7</sup>, R<sup>C8</sup>, R<sup>C9</sup>, R<sup>C10</sup>, and Z are as defined in item 13).</p>\n",
       "<p id=\"p-0315\" num=\"0327\">Examples of a further preferable substituent in R<sup>3 </sup>and R<sup>3a </sup>include hydrogen, lower alkyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, or carbocycle lower alkyl optionally substituted by substituent group C</p>\n",
       "<p id=\"h-0195\" num=\"0000\">(substituent group C is as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0316\" num=\"0328\">Examples of another embodiment of a preferable substituent in R<sup>3 </sup>and R<sup>3a </sup>include hydrogen, ethoxyethyl, methyl, ethyl, propyl, 2,4-difluorobenzyl, methoxyethyl, cyanomethyl, cyanoethyl, 3-chloro-2-fluorobenzyl, 1-methoxypropyl, pyridylmethyl, isopropyl, tetrahydropyranylmethyl, cyclopropylmethyl, benzyl, methylisoxazolylmethyl, methyloxadiazolyl, isopropyloxyethyl, hydroxyethyl, 4-fluorobenzyl, cyclopropyl, ethoxycarbonylethyl, —CH(Me)CH<sub>2</sub>OMe, carboxyethyl, —CH<sub>2</sub>CH<sub>2</sub>C(═O)—N(Me)<sub>2</sub>, —CH<sub>2</sub>CH<sub>2</sub>N(Me)—S(═O)<sub>2</sub>-Ph, —CH<sub>2</sub>CH<sub>2</sub>—N(Me)—S(═O)<sub>2</sub>-Me, —CH<sub>2</sub>CH<sub>2</sub>—NHC(═O)-Ph, —CH(Me)—CH<sub>2</sub>—OMe, —CH<sub>2</sub>CH<sub>2</sub>—NH—S(═O)<sub>2</sub>-Ph, —CH<sub>2</sub>CH<sub>2</sub>—NH—C(═O)—O—CH(Me)<sub>2</sub>, —CH<sub>2</sub>CH<sub>2</sub>—C(═O)—NH-Ph, —CH<sub>2</sub>CH<sub>2</sub>—N(Me)C(═O)-Ph, —CH<sub>2</sub>CH<sub>2</sub>—NH—C(═O)-Me, —CH<sub>2</sub>CH<sub>2</sub>—NH—S(═O)<sub>2</sub>-Me, aminoethyl, —CH<sub>2</sub>CH<sub>2</sub>—N(Me)—C(═O)-Me, —CH<sub>2</sub>CH<sub>2</sub>—C(═O)—N(Me)-Ph, —CH<sub>2</sub>CH<sub>2</sub>—NH—C(═O)—O-tBu, piperidinylcarbonylethyl, dimethylaminoethyl, cyclopropylmethyl, methylaminoethyl, furanylmethyl, morpholinylcarbonylethyl, sec-butyl, pentan-2-yl, carboxypropyl, ethoxycarbonylpropyl, phenylpropyl, propyloxyethyl, aminopropyl, dimethylaminomethyl, dimethylaminoethyl, diethylaminomethyl, diethylaminoethyl, dimethylaminopropyl, methylaminocarbonylethyl, 1,1,1-trifluoropropan-2-yl, 1,1-difluoroethyl, 1,1,1-trifluoroethyl, 1,1,1-trifluoropropyl, trifluoromethyloxyethyl, trifluoromethylcarbonylaminomethyl, methylsulfonylethyl, methylcarbonyloxyethyl, methylcarbonyloxypropyl, 1-fluoropropyl, fluorocyclopropyl, difluorocyclopropyl, 3,3-dimethylbutan-2-yl, 1-fluoroethyl, 1-methoxypropan-2-yl, amino, thiazolylmethyl, methylsulfonylethyl, 4-fluorophenyloxyethyl, pyridyl, pentan-2-yl, butan-2-yl, 3-methylbuten-2-yl, as well as groups shown below:</p>\n",
       "<p id=\"p-0317\" num=\"0329\"><chemistry id=\"CHEM-US-00065\" num=\"00065\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00065.TIF\" he=\"222.00mm\" id=\"EMI-C00065\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00066\" num=\"00066\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00066.TIF\" he=\"206.93mm\" id=\"EMI-C00066\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(Me represents a methyl group, Ph represents a phenyl group, and tBu represents a tert-butyl group) etc.\n",
       "</p>\n",
       "<p id=\"p-0318\" num=\"0330\">Examples of another embodiment of a more preferable substituent in R<sup>3 </sup>and R<sup>3a </sup>include ethoxyethyl, methyl, ethyl, 2,4-difluorobenzyl, methoxyethyl, cyanomethyl, 3-chloro-2-fluorobenzyl, methoxypropyl, pyridylmethyl, isopropyl, tetrahydropyranylmethyl, cyclopropylmethyl, benzyl, methylisoxazolylmethyl, 4-fluorobenzyl, cyclopropyl, ethoxycarbonylethyl, —CH(Me)CH<sub>2</sub>OMe, carboxyethyl, —CH<sub>2</sub>CH<sub>2</sub>C(═O)—N(Me)<sub>2</sub>, —CH<sub>2</sub>CH<sub>2</sub>N(Me)—S(═O)<sub>2</sub>-Ph, —CH<sub>2</sub>CH<sub>2</sub>—N(Me)—S(═O)<sub>2</sub>-Me, —CH<sub>2</sub>CH<sub>2</sub>—NHC(═O)-Ph, —CH(Me)—CH<sub>2</sub>—OMe, —CH<sub>2</sub>CH<sub>2</sub>—NH—S(═O)<sub>2</sub>-Ph, —CH<sub>2</sub>CH<sub>2</sub>—NH—C(═O)—O—CH(Me)<sub>2</sub>, —CH<sub>2</sub>CH<sub>2</sub>—C(═O)—NH-Ph, —CH<sub>2</sub>CH<sub>2</sub>—N(Me)C(═O)-Ph, —CH<sub>2</sub>CH<sub>2</sub>—NH—C(═O)-Me, —CH<sub>2</sub>CH<sub>2</sub>—NH—S(═O)<sub>2</sub>-Me, aminoethyl, 1,1,1-trifluoropropan-2-yl, propyl, methylthiomethyl, hydrogen, fluorocyclopropyl, trifluoromethoxyethyl, 1-fluoropropyl, 1-fluoroethyl, methylcarbonyloxymethyl, 1,1-difluoromethyl, and groups shown below:</p>\n",
       "<p id=\"p-0319\" num=\"0331\"><chemistry id=\"CHEM-US-00067\" num=\"00067\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00067.TIF\" he=\"48.18mm\" id=\"EMI-C00067\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(Me represents methyl group, and Ph represents phenyl group) etc.\n",
       "</p>\n",
       "<p id=\"p-0320\" num=\"0332\">Examples of another embodiment of a further preferable substituent in R<sup>3 </sup>and R<sup>3a </sup>include ethoxyethyl, methyl, ethyl, 2,4-difluorobenzyl, methoxyethyl, cyanomethyl, 3-chloro-2-fluorobenzyl, methoxypropyl, pyridylmethyl, isopropyl, tetrahydropyranylmethyl, cyclopropylmethyl, benzyl, 4-fluorobenzyl, cyclopropyl, ethoxycarbonylethyl, —CH(Me)CH<sub>2</sub>OMe, carboxyethyl, 1,1,1-trifluoropropan-2-yl, hydroxyethyl, 1-fluoroethyl</p>\n",
       "<p id=\"h-0196\" num=\"0000\">(Me represents methyl group) etc.</p>\n",
       "<p id=\"p-0321\" num=\"0333\">Examples of another embodiment of a most preferable substituent in R<sup>3 </sup>and R<sup>3a </sup>include 1,1,1-trifluoropropan-2-yl.</p>\n",
       "<p id=\"p-0322\" num=\"0334\">Examples of a preferable substituent in R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>8</sup>, R<sup>9</sup>, R<sup>10</sup>, and R<sup>11</sup>, as well as R<sup>5a</sup>, R<sup>6a</sup>, R<sup>7a</sup>, R<sup>8a</sup>, R<sup>9a</sup>, R<sup>10a</sup>, and R<sup>11a </sup>include hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0197\" num=\"0000\">—Y—S—R<sup>D1</sup>,</p>\n",
       "<p id=\"h-0198\" num=\"0000\">—Z—S(═O)—R<sup>D2</sup>,</p>\n",
       "<p id=\"h-0199\" num=\"0000\">—Z—SO<sub>2</sub>—R<sup>D3</sup>,</p>\n",
       "<p id=\"h-0200\" num=\"0000\">—C(═O)—C(═O)—R<sup>D4</sup>,</p>\n",
       "<p id=\"h-0201\" num=\"0000\">—C(═O)—N(R<sup>D5</sup>)(R<sup>D6</sup>),</p>\n",
       "<p id=\"h-0202\" num=\"0000\">—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>), or</p>\n",
       "<p id=\"h-0203\" num=\"0000\">—Z—CH<sub>2</sub>—R<sup>D10 </sup></p>\n",
       "<p id=\"h-0204\" num=\"0000\">(substituent group C, R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, R<sup>D4</sup>, R<sup>D5</sup>, R<sup>D6</sup>, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, R<sup>D10 </sup>and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0323\" num=\"0335\">Examples of a more preferable substituent in R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>8</sup>, R<sup>9</sup>, R<sup>10 </sup>and R<sup>11</sup>, as well as R<sup>5a</sup>, R<sup>6a</sup>, R<sup>7a</sup>, R<sup>8a</sup>, R<sup>9a </sup>R<sup>10a</sup>, and R<sup>11a </sup>include hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0205\" num=\"0000\">—Y—S—R<sup>D1</sup>, or</p>\n",
       "<p id=\"h-0206\" num=\"0000\">—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)</p>\n",
       "<p id=\"h-0207\" num=\"0000\">(substituent group C, R<sup>D1</sup>, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, Y, and Z are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0324\" num=\"0336\">Examples of another embodiment of a preferable substituent in R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>8</sup>, R<sup>9</sup>, R<sup>10</sup>, and R<sup>11</sup>, as well as R<sup>5a</sup>, R<sup>6a</sup>, R<sup>7a</sup>, R<sup>8a</sup>, R<sup>9a</sup>, R<sup>10a</sup>, and R<sup>11a </sup>include hydrogen, benzhydryl, benzyl, indolylmethyl, cyclohexylmethyl, phenethyl, benzylthiomethyl, 3,5-dimethylisoxazolyl, 5-chloro-3-ethylbenzothiophenyl, 4-fluorobenzyl, methylthiazolylmethyl, cyclopentylmethyl, 4-methoxybenzyl, 3-fluorobenzyl, naphthylmethyl, methyl, 3-trifluoromethylbenzyl, pyridylmethyl, 4-methylcarbonylaminobenzyl, pyrimidinyl, isobutyl, phenoxyethyl, methoxypropyl, phenylpropyl, as well as the following groups:</p>\n",
       "<p id=\"p-0325\" num=\"0337\"><chemistry id=\"CHEM-US-00068\" num=\"00068\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00068.TIF\" he=\"240.45mm\" id=\"EMI-C00068\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00069\" num=\"00069\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00069.TIF\" he=\"243.16mm\" id=\"EMI-C00069\" img-content=\"chem\" img-format=\"tif\" wi=\"72.31mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00070\" num=\"00070\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00070.TIF\" he=\"210.31mm\" id=\"EMI-C00070\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>represents a group selected from substituent group A or substituent group C, and m of R<sup>E6</sup>s may be the same or different) etc.\n",
       "</p>\n",
       "<p id=\"p-0326\" num=\"0338\">Examples of another embodiment of a more preferable substituent in R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>8</sup>, R<sup>9</sup>, R<sup>10</sup>, and R<sup>11</sup>, as well as R<sup>5a</sup>, R<sup>6a</sup>, R<sup>7a</sup>, R<sup>8a</sup>, R<sup>9a</sup>, R<sup>10a</sup>, and R<sup>11a </sup>include hydrogen, benzhydryl, benzyl, indolylmethyl, cyclohexylmethyl, phenethyl, 3,5-dimethylisoxazolyl, 5-chloro-3-ethylbenzothiophenyl, biphenylmethyl, 4-fluorobenzyl, methylthiazolylmethyl, cyclopentylmethyl, 4-methoxybenzyl, 3-fluorobenzyl, naphthylmethyl, methyl, 3-trifluoromethylbenzyl, pyridylmethyl, 4-methylcarbonylaminobenzyl, pyrimidinyl, and the following groups:</p>\n",
       "<p id=\"p-0327\" num=\"0339\"><chemistry id=\"CHEM-US-00071\" num=\"00071\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00071.TIF\" he=\"210.31mm\" id=\"EMI-C00071\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>represents a group selected from substituent group A or substituent group C, and m of R<sup>E6</sup>s may be the same or different).\n",
       "<br/>\n",
       "etc.\n",
       "<br/>\n",
       "1) Examples of a preferable embodiment when A<sup>1 </sup>is CR<sup>5</sup>R<sup>6</sup>, and A<sup>2 </sup>is NR<sup>7 </sup>include the case where R<sup>3 </sup>and R<sup>7 </sup>are taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group B.\n",
       "<br/>\n",
       "2) Examples of a preferable embodiment when A<sup>1 </sup>is NR<sup>7</sup>, and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6 </sup>include the case where R<sup>3 </sup>and R<sup>6 </sup>are taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group B.\n",
       "<br/>\n",
       "3) Examples of a preferable embodiment when A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11 </sup>include the case where R<sup>8 </sup>and R<sup>18 </sup>are taken together with an adjacent atom to form a carbocycle or a heterocycle optionally substituted by substituent group B.\n",
       "<br/>\n",
       "4) Examples of another preferable embodiment when A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11 </sup>include the case where R<sup>3 </sup>and R<sup>11 </sup>are taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group B.\n",
       "<br/>\n",
       "1) Examples of a preferable embodiment when B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and B<sup>2 </sup>is NR<sup>7a </sup>include the case where R<sup>3a </sup>and R<sup>7a </sup>are taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group D.\n",
       "<br/>\n",
       "2) Examples of a preferable embodiment when B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a </sup>include the case where R<sup>3a </sup>and R<sup>6a </sup>are taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group D.\n",
       "<br/>\n",
       "3) Examples of a preferable embodiment when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a </sup>include the case where R<sup>8a </sup>and R<sup>10a </sup>are taken together with an adjacent atom to form a carbocycle or a heterocycle optionally substituted by substituent group D.\n",
       "<br/>\n",
       "4) Examples of another preferable embodiment when B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a </sup>include the case where R<sup>3a </sup>and R<sup>11a </sup>are taken together with an adjacent atom to form a heterocycle optionally substituted by substituent group D.\n",
       "</p>\n",
       "<p id=\"p-0328\" num=\"0340\">When any one of A<sup>1 </sup>and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>, and the other is NR<sup>7</sup>, the case where A<sup>1 </sup>is NR<sup>7</sup>, and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6 </sup>is more preferable.</p>\n",
       "<p id=\"p-0329\" num=\"0341\">When any one of B<sup>1 </sup>and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and the other is NR<sup>7a</sup>, the case where B<sup>1 </sup>is NR<sup>7a</sup>, and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a </sup>is more preferable.</p>\n",
       "<p id=\"p-0330\" num=\"0342\">When any one of A<sup>1 </sup>and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>, and the other is NR<sup>7</sup>, it is preferable that at least any one of R<sup>5 </sup>or R<sup>6 </sup>is hydrogen. A more preferable embodiment is such that R<sup>5 </sup>is hydrogen, and R<sup>6 </sup>is hydrogen. In this case, R<sup>7 </sup>is not a hydrogen atom.</p>\n",
       "<p id=\"p-0331\" num=\"0343\">When any one of B<sup>1 </sup>and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and the other is NR<sup>7a</sup>, it is preferable that at least any one of R<sup>5a </sup>or R<sup>6a </sup>is hydrogen. A more preferable embodiment is such that R<sup>5a </sup>is hydrogen, and R<sup>6a </sup>is hydrogen. In this case, R<sup>7a </sup>is not a hydrogen atom.</p>\n",
       "<p id=\"p-0332\" num=\"0344\">A preferable embodiment of R<sup>7 </sup>and R<sup>7a </sup>is carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, and heterocyclic lower alkyl optionally substituted by substituent group A.</p>\n",
       "<p id=\"p-0333\" num=\"0345\">A more preferable embodiment of R<sup>7 </sup>and R<sup>7a </sup>is cycloalkyl, cycloalkenyl, aryl, non-aromatic condensed carbocyclic group, heteroaryl, non-aromatic heterocyclic group, bicyclic condensed heterocyclic group, tricyclic condensed heterocyclic group, lower alkyl substituted by one or two carbocyclic groups, and lower alkyl substituted by one or two heterocyclic groups.</p>\n",
       "<p id=\"p-0334\" num=\"0346\">A further preferable embodiment of R<sup>7 </sup>and R<sup>7a </sup>is benzyl, benzhydryl, 4-fluorobenzyl, p-methoxybenzyl, and the following groups:</p>\n",
       "<p id=\"p-0335\" num=\"0347\"><chemistry id=\"CHEM-US-00072\" num=\"00072\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00072.TIF\" he=\"195.66mm\" id=\"EMI-C00072\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6</sup>, and m are as defined in item 13′).\n",
       "</p>\n",
       "<p id=\"p-0336\" num=\"0348\">A most preferable embodiment of R<sup>7 </sup>and R<sup>7a </sup>is the following groups:</p>\n",
       "<p id=\"p-0337\" num=\"0349\"><chemistry id=\"CHEM-US-00073\" num=\"00073\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00073.TIF\" he=\"109.14mm\" id=\"EMI-C00073\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6</sup>, and m are as defined in item 13′).\n",
       "</p>\n",
       "<p id=\"p-0338\" num=\"0350\">When A<sup>1 </sup>is CR<sup>8</sup>R<sup>9</sup>, and A<sup>2 </sup>is CR<sup>10</sup>R<sup>11</sup>, it is preferable that R<sup>9 </sup>and R<sup>11 </sup>are hydrogen. A preferable embodiment of R<sup>8 </sup>and R<sup>11 </sup>is such that any one of them is hydrogen.</p>\n",
       "<p id=\"p-0339\" num=\"0351\">When R<sup>9 </sup>and R<sup>11 </sup>are hydrogen, and any one of R<sup>8 </sup>and R<sup>10 </sup>is hydrogen, a preferable embodiment of the other of R<sup>8 </sup>and R<sup>10 </sup>is carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A.</p>\n",
       "<p id=\"p-0340\" num=\"0352\">When B<sup>1 </sup>is CR<sup>8a</sup>R<sup>9a</sup>, and B<sup>2 </sup>is CR<sup>10a</sup>R<sup>11a</sup>, it is preferable that R<sup>9a </sup>and R<sup>11a </sup>are hydrogen. A preferable embodiment of R<sup>8a </sup>and R<sup>10a </sup>is such that any one of them is hydrogen.</p>\n",
       "<p id=\"p-0341\" num=\"0353\">When R<sup>9a </sup>and R<sup>11a </sup>are hydrogen, and any one of R<sup>8a </sup>and R<sup>10a </sup>is hydrogen, a preferable embodiment of the other of R<sup>8a </sup>and R<sup>10a </sup>is the following groups</p>\n",
       "<p id=\"h-0208\" num=\"0000\">—Z—C(R<sup>E1</sup>)(R<sup>E2</sup>)(R<sup>E3</sup>)</p>\n",
       "<p id=\"h-0209\" num=\"0000\">or</p>\n",
       "<p id=\"p-0342\" num=\"0354\"><chemistry id=\"CHEM-US-00074\" num=\"00074\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00074.TIF\" he=\"222.25mm\" id=\"EMI-C00074\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein Z, R<sup>E1</sup>, R<sup>E2</sup>, R<sup>E3</sup>, R<sup>E6</sup>, and m are as defined in item 13 or item 13′).\n",
       "</p>\n",
       "<p id=\"p-0343\" num=\"0355\">When R<sup>9a </sup>and R<sup>11a </sup>are hydrogen, and any one of R<sup>8a </sup>and R<sup>10a </sup>is hydrogen, a further preferable embodiment of the other of R<sup>8a </sup>and R<sup>10a </sup>is the following groups:</p>\n",
       "<p id=\"p-0344\" num=\"0356\"><chemistry id=\"CHEM-US-00075\" num=\"00075\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00075.TIF\" he=\"113.03mm\" id=\"EMI-C00075\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>and m are as defined in item 13 or item 13′).\n",
       "</p>\n",
       "<p id=\"p-0345\" num=\"0357\">Examples of a preferable substituent in substituent group B and substituent group D include carbocyclic group optionally substituted by substituent group A or substituent group C, heterocyclic group optionally substituted by substituent group A or substituent group C, carbocycle lower alkyl optionally substituted by substituent group A or substituent group C, and heterocycle lower alkyl optionally substituted by substituent group A or substituent group C.</p>\n",
       "<p id=\"p-0346\" num=\"0358\">Examples of another embodiment of a preferable substituent in substituent group B and substituent group D include benzyl, benzhydryl, 4-fluorobenzyl, p-methoxybenzyl,</p>\n",
       "<p id=\"p-0347\" num=\"0359\"><chemistry id=\"CHEM-US-00076\" num=\"00076\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00076.TIF\" he=\"193.12mm\" id=\"EMI-C00076\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>E6 </sup>represents a group selected from substituent group A or substituent group C, and m of R<sup>E6</sup>s may be the same or different) etc.\n",
       "</p>\n",
       "<p id=\"p-0348\" num=\"0360\">Examples of a preferable substituent of R<sup>E6 </sup>include halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, halogeno lower alkyloxy, etc.</p>\n",
       "<p id=\"p-0349\" num=\"0361\">Examples of a more preferable substituent of R<sup>E6 </sup>include fluorine atom, chlorine atom, bromine atom, cyano, methyl, hydroxymethyl, isopropyl, methoxy, trifluoromethyl, oxo, carboxy, etc.</p>\n",
       "<p id=\"p-0350\" num=\"0362\">A preferable embodiment of m is an integer of 0 to 6, further preferably an integer of 0 to 3, most preferably an integer of 0 to 2.</p>\n",
       "<p id=\"p-0351\" num=\"0363\">Examples of a preferable substituent of R<sup>1d </sup>include hydrogen, halogen, lower alkyloxy optionally substituted by substituent group E, carbocycle lower alkyloxy optionally substituted by substituent group E, and —OSi(R<sup>1e</sup>)<sub>3</sub>.</p>\n",
       "<p id=\"p-0352\" num=\"0364\">Examples of R<sup>1e</sup>s each include independently lower alkyl optionally substituted by substituent group E, and carbocyclic group optionally substituted by substituent group E.</p>\n",
       "<p id=\"p-0353\" num=\"0365\">Examples of a preferable substituent of R<sup>2d </sup>include lower alkyl optionally substituted by substituent group E.</p>\n",
       "<p id=\"p-0354\" num=\"0366\">Examples of a preferable embodiment of R<sup>3d </sup>include —N(R<sup>3e</sup>)<sub>2</sub>, or —OR<sup>3e</sup>.</p>\n",
       "<p id=\"p-0355\" num=\"0367\">R<sup>3e</sup>s are each independently lower alkyl optionally substituted by substituent group E.</p>\n",
       "<p id=\"p-0356\" num=\"0368\">Examples of a preferable substituent of R<sup>4d </sup>include lower alkyl optionally substituted by substituent group E, and carbocycle lower alkyl optionally substituted by substituent group E.</p>\n",
       "<p id=\"p-0357\" num=\"0369\">Examples of a preferable substituent of R<sup>5d </sup>include halogen, and lower alkyloxy optionally substituted by substituent group E.</p>\n",
       "<p id=\"p-0358\" num=\"0370\">Examples of a preferable substituent of R<sup>6d </sup>include lower alkyl optionally substituted by substituent group E, and lower alkenyl optionally substituted by substituent group E.</p>\n",
       "<p id=\"p-0359\" num=\"0371\">Examples of a preferable substituent of P<sup>d </sup>include lower alkyl optionally substituted by substituent group E.</p>\n",
       "<p id=\"p-0360\" num=\"0372\">Examples of another embodiment of a preferable substituent of R<sup>1d </sup>include hydrogen, chlorine atom, bromine atom, methoxy, ethoxy, tert-butyloxy, trifluoromethoxy, benzyloxy, p-methoxybenzyloxy, trimethylsilyloxy, triethylsilyloxy, tert-butyldimethylsilyloxy, diisopropylsilyloxy, triphenylsilyloxy, etc.</p>\n",
       "<p id=\"p-0361\" num=\"0373\">Examples of another embodiment of a preferable substituent of R<sup>2d </sup>include methyl, ethyl, isopropyl, tert-butyl, p-methoxybenzyl, and p-nitrobenzyl.</p>\n",
       "<p id=\"p-0362\" num=\"0374\">Examples of another embodiment of a preferable substituent of R<sup>3d </sup>include methoxy, ethoxy, isopropyloxy, benzyloxy, —N(Me)<sub>2</sub>, —N(Et)<sub>2</sub>, —N(<sup>i</sup>Pr)<sub>2 </sub>(Me represents methyl group, Et represents ethyl group, and <sup>i</sup>Pr represents isopropyl group) etc.</p>\n",
       "<p id=\"p-0363\" num=\"0375\">Examples of another embodiment of a preferable substituent of R<sup>4d </sup>include methyl, ethyl, isopropyl, tert-butyl, p-methoxybenzyl, and p-nitrobenzyl, etc.</p>\n",
       "<p id=\"p-0364\" num=\"0376\">Examples of another embodiment of a preferable substituent of R<sup>5d </sup>include hydrogen, chlorine atom, bromine atom, methoxy, ethoxy, tert-butyloxy, trifluoromethoxy, —O—SO<sub>2</sub>—CH<sub>3</sub>, —O—SO<sub>2</sub>-Ph-CH<sub>3 </sub>(Ph represents phenyl group) etc.</p>\n",
       "<p id=\"p-0365\" num=\"0377\">Examples of another embodiment of a preferable substituent of R<sup>6d </sup>include methyl, ethyl, isopropyl, allyl, —CH<sub>2</sub>—CH(OMe)<sub>2</sub>, —CH<sub>2</sub>—CH(OEt)<sub>2</sub>,</p>\n",
       "<p id=\"p-0366\" num=\"0378\"><chemistry id=\"CHEM-US-00077\" num=\"00077\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00077.TIF\" he=\"20.49mm\" id=\"EMI-C00077\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "etc.\n",
       "</p>\n",
       "<p id=\"p-0367\" num=\"0379\">Examples of another embodiment of a preferable substituent of P<sup>d </sup>include methyl, ethyl, isopropyl, etc.</p>\n",
       "<p id=\"p-0368\" num=\"0380\">One of characteristics of the compound in the present invention is in that a polycyclic carbamoylpyridone derivative, in which two or more rings are condensed, such as shown in the formula (I) in item 1′ and item 1 and/or the formula (II) in item 13′ and item 13 and/or a composition including them, has high inhibitory activity on cap-dependent endonuclease.</p>\n",
       "<p id=\"p-0369\" num=\"0381\">Another characteristic of the compound in the present invention is that cap-dependent endonuclease inhibitory activity was improved, by applying a functional group as shown below to R<sup>1 </sup>in the formula (I) and/or R<sup>1a </sup>in the formula (II).</p>\n",
       "<p id=\"p-0370\" num=\"0382\">Functional group: hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</p>\n",
       "<p id=\"h-0210\" num=\"0000\">—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),</p>\n",
       "<p id=\"h-0211\" num=\"0000\">—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>),</p>\n",
       "<p id=\"h-0212\" num=\"0000\">—Z—C(═O)—N(R<sup>A5</sup>)—SO<sub>2</sub>—(R<sup>A6</sup>),</p>\n",
       "<p id=\"h-0213\" num=\"0000\">—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,</p>\n",
       "<p id=\"h-0214\" num=\"0000\">—Z—S—R<sup>A9</sup>,</p>\n",
       "<p id=\"h-0215\" num=\"0000\">—Z—SO<sub>2</sub>—R<sup>A10</sup>, —Z—S(═O)—R<sup>A11</sup>,</p>\n",
       "<p id=\"h-0216\" num=\"0000\">—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>,</p>\n",
       "<p id=\"h-0217\" num=\"0000\">—Z—N(R<sup>A14</sup>)—C(═O)—N(R<sup>A15</sup>)(R<sup>A16</sup>),</p>\n",
       "<p id=\"h-0218\" num=\"0000\">—Z—C(═O)—N(R<sup>A17</sup>)—C(═O)—N(R<sup>A18</sup>)(R<sup>A19</sup>), or</p>\n",
       "<p id=\"h-0219\" num=\"0000\">—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup></p>\n",
       "<p id=\"h-0220\" num=\"0000\">(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A3</sup>, R<sup>A5</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A9</sup>, R<sup>A12 </sup>R<sup>A13</sup>, R<sup>A14</sup>, R<sup>A15</sup>, R<sup>A16</sup>, R<sup>A17</sup>, R<sup>A18</sup>, R<sup>A19</sup>, R<sup>A20</sup>, and R<sup>A21 </sup>are as defined in item 13′ or item 13).</p>\n",
       "<p id=\"p-0371\" num=\"0383\">The characteristic of a more preferable compound in the present invention is that cap-dependent endonuclease inhibitory activity is improved, by applying a functional group shown below to R<sup>1 </sup>in the formula (I) and/or R<sup>1a </sup>in the formula (II).</p>\n",
       "<p id=\"p-0372\" num=\"0384\">Functional group: hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group A,\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),\n",
       "<br/>\n",
       "—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13 </sup>\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A12</sup>, R<sup>A13</sup>, and Z are as defined in item 13′ or item 13).\n",
       "</p>\n",
       "<p id=\"p-0373\" num=\"0385\">The characteristic of a further preferable compound in the present invention is that cap-dependent endonuclease inhibitory activity is improved, by applying a functional group shown below to R<sup>1 </sup>in the formula (I) and/or R<sup>1a </sup>in the formula (II).</p>\n",
       "<p id=\"p-0374\" num=\"0386\">Functional group: hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group A, or\n",
       "<br/>\n",
       "—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>)\n",
       "<br/>\n",
       "(substituent group C, R<sup>A1</sup>, R<sup>A2 </sup>and Z are as defined in item 13′ or item 13).\n",
       "</p>\n",
       "<p id=\"p-0375\" num=\"0387\">The characteristic of a particularly preferable compound in the present invention is that cap-dependent endonuclease inhibitory activity is improved, by applying a functional group shown below to R<sup>1 </sup>in the formula (I) and/or R<sup>1a </sup>in the formula (II).</p>\n",
       "<p id=\"h-0221\" num=\"0000\">Functional group: hydrogen, or carboxy</p>\n",
       "<p id=\"p-0376\" num=\"0388\">Other characteristic of the compound in the present invention is that cap-dependent endonuclease inhibitory activity was improved, by introducing one, two or more of lipid-soluble functional groups shown below on carbon atom or on nitrogen atom of A<sup>1 </sup>and/or A<sup>2 </sup>in the formula (I), as well as of B<sup>1 </sup>and/or B<sup>2 </sup>in the formula (II).</p>\n",
       "<p id=\"p-0377\" num=\"0389\">Lipid-soluble functional group: carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C\n",
       "<br/>\n",
       "(substituent group C is as defined in item 13′ or item 13).\n",
       "</p>\n",
       "<p id=\"p-0378\" num=\"0390\">Other characteristic of a more preferable compound in the present invention is that cap-dependent endonuclease inhibitory activity is improved, by introducing one lipid-soluble functional group shown below on carbon atom or on nitrogen atom of A<sup>1 </sup>and/or A<sup>2 </sup>in the formula (I), as well as of B<sup>1 </sup>and/or B<sup>2 </sup>in the formula (II).</p>\n",
       "<p id=\"p-0379\" num=\"0391\">Lipid-soluble functional group: carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C\n",
       "<br/>\n",
       "(substituent group C is as defined in item 13′ or item 13).\n",
       "</p>\n",
       "<p id=\"p-0380\" num=\"0392\">Other characteristic of a particularly preferable compound in the present invention is that cap-dependent endonuclease inhibitory activity was improved, by introducing one lipid-soluble functional group shown below on carbon atom or on nitrogen atom of A<sup>1 </sup>and/or A<sup>2 </sup>in the formula (I), as well as of B<sup>1 </sup>and/or B<sup>2 </sup>in the formula (II).</p>\n",
       "<p id=\"p-0381\" num=\"0393\">Lipid-soluble functional group: carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<br/>\n",
       "(substituent group C is as defined in item 13′ or item 13).\n",
       "</p>\n",
       "<p id=\"p-0382\" num=\"0394\">A preferable embodiment of the present invention will be exemplified below.</p>\n",
       "<p id=\"h-0222\" num=\"0000\">In the formula (III), the formula (III′), the formula (III″), the formula (III′″), the formula (III″″), the formula (III′″″)</p>\n",
       "<p id=\"p-0383\" num=\"0395\"><chemistry id=\"CHEM-US-00078\" num=\"00078\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00078.TIF\" he=\"227.58mm\" id=\"EMI-C00078\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "1)\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is hydrogen (hereinafter, R<sup>1b </sup>is R1-1),\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is carboxy (hereinafter, R<sup>1b </sup>is R1-2)\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is halogen (hereinafter R<sup>1b </sup>is R1-3),\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is hydroxy (hereinafter, R<sup>1b </sup>is R1-4),\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is lower alkyl optionally substituted by substituent group C (hereinafter, R<sup>1b </sup>is R1-5),\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is lower alkylcarbonyl optionally substituted by substituent group C (hereinafter, R<sup>1b </sup>is R1-6),\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is lower alkyloxycarbonyl optionally substituted by substituent group C (hereinafter, R<sup>1b </sup>is R1-7),\n",
       "<br/>\n",
       "a compound in which R<sup>1b </sup>is amino (hereinafter, R<sup>1b </sup>is R1-8),\n",
       "<br/>\n",
       "2)\n",
       "<br/>\n",
       "a compound in which R<sup>2b </sup>is hydrogen (hereinafter, R<sup>2b </sup>is R2-1),\n",
       "<br/>\n",
       "a compound in which R<sup>2b </sup>is lower alkyl optionally substituted by substituent group C (hereinafter, R<sup>2b </sup>is R2-2),\n",
       "<br/>\n",
       "3)\n",
       "<br/>\n",
       "a compound in which R<sup>3b </sup>is lower alkyl optionally substituted by substituent group C (hereinafter, R<sup>3b </sup>is R3-1),\n",
       "<br/>\n",
       "a compound in which R<sup>3b </sup>is carbocycle lower alkyl optionally substituted by substituent group C (hereinafter, R<sup>3b </sup>is R3-2),\n",
       "<br/>\n",
       "a compound in which R<sup>3b </sup>is heterocycle lower alkyl optionally substituted by substituent group C (hereinafter, R<sup>3b </sup>is R3-3),\n",
       "<br/>\n",
       "a compound in which R<sup>3b </sup>is carbocyclic group optionally substituted by substituent group C (hereinafter, R<sup>3b </sup>is R3-4),\n",
       "<br/>\n",
       "a compound in which R<sup>3b </sup>is heterocyclic group optionally substituted by substituent group C (hereinafter, R<sup>3b </sup>is R3-5),\n",
       "<br/>\n",
       "in the formula (III′),\n",
       "<br/>\n",
       "1)\n",
       "<br/>\n",
       "a compound in which R<sup>7b </sup>is carbocyclic group optionally substituted by substituent group C, and R<sup>5b </sup>and R<sup>6b </sup>are hydrogen (hereinafter, R7-1),\n",
       "<br/>\n",
       "a compound in which R<sup>7b </sup>is heterocyclic group optionally substituted by substituent group C, and R<sup>5b </sup>and R<sup>6b </sup>are hydrogen (hereinafter, R7-2),\n",
       "<br/>\n",
       "a compound in which R<sup>7b </sup>is carbocycle lower alkyl optionally substituted by substituent group C, and R<sup>5b </sup>and R<sup>6b </sup>are hydrogen (hereinafter, R7-3),\n",
       "<br/>\n",
       "2)\n",
       "<br/>\n",
       "a compound in which R<sup>6b </sup>is carbocyclic group optionally substituted by substituent group C, and R<sup>5b </sup>and R<sup>7b </sup>are hydrogen (hereinafter, R6-1),\n",
       "<br/>\n",
       "a compound in which R<sup>6b </sup>is heterocyclic group optionally substituted by substituent group C, and R<sup>5b </sup>and R<sup>7b </sup>are hydrogen (hereinafter, R6-2),\n",
       "<br/>\n",
       "a compound in which R<sup>6b </sup>is carbocycle lower alkyl optionally substituted by substituent group C, and R<sup>5b </sup>and R<sup>7b </sup>are hydrogen (hereinafter, R6-3),\n",
       "<br/>\n",
       "in the formula (III),\n",
       "<br/>\n",
       "a compound in which R<sup>9b </sup>is carbocyclic group optionally substituted by substituent group C, and R<sup>8b</sup>, R<sup>10b </sup>and R<sup>11b </sup>are hydrogen (hereinafter, R9-1),\n",
       "<br/>\n",
       "a compound in which R<sup>9b </sup>is heterocyclic group optionally substituted by substituent group C, and R<sup>8b</sup>, R<sup>10b </sup>and R<sup>11b </sup>are hydrogen (hereinafter, R9-1),\n",
       "<br/>\n",
       "a compound in which R<sup>9b </sup>is carbocycle lower alkyl optionally substituted by substituent group C, and R<sup>8b</sup>, R<sup>10b</sup>, and R<sup>11b </sup>are hydrogen (hereinafter, R9-1).\n",
       "</p>\n",
       "<p id=\"p-0384\" num=\"0396\">Herein, the substituent group C is at least one selected from a substituent group consisting of halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclic group, heterocyclic group, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, and lower alkylsulfonylamino.</p>\n",
       "<p id=\"p-0385\" num=\"0397\">Compounds in which, in the formula (III′), a combination of R<sup>1b</sup>, R<sup>2b</sup>, R<sup>3b</sup>, well as (R<sup>5b</sup>, R<sup>6b</sup>, and R<sup>7b</sup>) is as follows.</p>\n",
       "<p id=\"p-0386\" num=\"0398\">(R1-1, R2-1, R3-1, R7-1), (R1-1, R<sup>2</sup>-1, R3-1, R7-2), (R1-1, R2-1, R3-1, R7-3), (R1-1, R2-1, R3-2, R7-1), (R1-1, R2-1, R3-2, R7-2), (R1-1, R2-1, R3-2, R7-3), (R1-1, R2-1, R3-3, R7-1), (R1-1, R2-1, R3-3, R7-2), (R1-1, R2-1, R3-3, R7-3), (R1-1, R2-1, R3-4, R7-1), (R1-1, R2-1, R3-4, R7-2), (R1-1, R2-1, R3-4, R7-3), (R1-1, R2-1, R3-5, R7-1), (R1-1, R2-1, R3-5, R7-2), (R1-1, R2-1, R3-5, R7-3), (R1-1, R2-2, R3-1, R7-1), (R1-1, R2-2, R3-1, R7-2), (R1-1, R2-2, R3-1, R7-3), (R1-1, R2-2, R3-2, R7-1), (R1-1, R2-2, R3-2, R7-2), (R1-1, R2-2, R3-2, R7-3), (R1-1, R2-2, R3-3, R7-1), (R1-1, R2-2, R3-3, R7-2), (R1-1, R2-2, R3-3, R7-3), (R1-1, R2-2, R3-4, R7-1), (R1-1, R2-2, R3-4, R7-2), (R1-1, R2-2, R3-4, R7-3), (R1-1, R2-2, R3-5, R7-1), (R1-1, R2-2, R3-5, R7-2), (R1-1, R2-2, R3-5, R7-3), (R1-2, R2-1, R3-1, R7-1), (R1-2, R2-1, R3-1, R7-2), (R1-2, R2-1, R3-1, R7-3), (R1-2, R2-1, R3-2, R7-1), (R1-2, R2-1, R3-2, R7-2), (R1-2, R2-1, R3-2, R7-3), (R1-2, R2-1, R3-3, R7-1), (R1-2, R2-1, R3-3, R7-2), (R1-2, R2-1, R3-3, R7-3), (R1-2, R2-1, R3-4, R7-1), (R1-2, R2-1, R3-4, R7-2), (R1-2, R2-1, R3-4, R7-3), (R1-2, R2-1, R3-5, R7-1), (R1-2, R2-1, R3-5, R7-2), (R1-2, R2-1, R3-5, R7-3), (R1-2, R2-2, R3-1, R7-1), (R1-2, R2-2, R3-1, R7-2), (R1-2, R2-2, R3-1, R7-3), (R1-2, R2-2, R3-2, R7-1), (R1-2, R2-2, R3-2, R7-2), (R1-2, R2-2, R3-2, R7-3), (R1-2, R2-2, R3-3, R7-1), (R1-2, R2-2, R3-3, R7-2), (R1-2, R2-2, R3-3, R7-3), (R1-2, R2-2, R3-4, R7-1), (R1-2, R2-2, R3-4, R7-2), (R1-2, R2-2, R3-4, R7-3), (R1-2, R2-2, R3-5, R7-1), (R1-2, R2-2, R3-5, R7-2), (R1-2, R2-2, R3-5, R7-3), (R1-3, R2-1, R3-1, R7-1), (R1-3, R2-1, R3-1, R7-2), (R1-3, R2-1, R3-1, R7-3), (R1-3, R2-1, R3-2, R7-1), (R1-3, R2-1, R3-2, R7-2), (R1-3, R2-1, R3-2, R7-3), (R1-3, R2-1, R3-3, R7-1), (R1-3, R2-1, R3-3, R7-2), (R1-3, R2-1, R3-3), R7-3), (R1-3, R2-1, R3-4, R7-1), (R1-3, R2-1, R3-4, R7-2), (R1-3, R2-1, R3-4, R7-3), (R1-3, R2-1, R3-5, R7-1), (R1-3, R2-1, R3-5, R7-2), (R1-3, R2-1, R3-5, R7-3), (R1-3, R2-2, R3-1, R7-1), (R1-3, R2-2, R3-1, R7-2), (R1-3, R2-2, R3-1, R7-3), (R1-3, R2-2, R3-2, R7-1), (R1-3, R2-2, R3-2, R7-2), (R1-3, R2-2, R3-2, R7-3), (R1-3, R2-2, R3-3, R7-1), (R1-3, R2-2, R3-3, R7-2), (R1-3, R2-2, R3-3, R7-3), (R1-3, R2-2, R3-4, R7-1), (R1-3, R2-2, R3-4, R7-2), (R1-3, R2-2, R3-4, R7-3), (R1-3, R2-2, R3-5, R7-1), (R1-3, R2-2, R3-5, R7-2), (R1-3, R2-2, R3-5, R7-3), (R1-4, R2-1, R3-1, R7-1), (R1-4, R2-1, R3-1, R7-2), (R1-4, R2-1, R3-1, R7-3), (R1-4, R2-1, R3-2, R7-1), (R1-4, R2-1, R3-2, R7-2), (R1-4, R2-1, R3-2, R7-3), (R1-4, R2-1, R3-3, R7-1), (R1-4, R2-1, R3-3, R7-2), (R1-4, R2-1, R3-3, R7-3), (R1-4, R2-1, R3-4, R7-1), (R1-4, R2-1, R3-4, R7-2), (R1-4, R2-1, R3-4, R7-3), (R1-4, R2-1, R3-5, R7-1), (R1-4, R2-1, R3-5, R7-2), (R1-4, R2-1, R3-5, R7-3), (R1-4, R2-2, R3-1, R7-1), (R1-4, R2-2, R3-1, R7-2), (R1-4, R2-2, R3-1, R7-3), (R1-4, R2-2, R3-2, R7-1), (R1-4, R2-2, R3-2, R7-2), (R1-4, R2-2, R3-2, R7-3), (R1-4, R2-2, R3-3, R7-1), (R1-4, R2-2, R3-3, R7-2), (R1-4, R2-2, R3-3, R7-3), (R1-4, R2-2, R3-4, R7-1), (R1-4, R2-2, R3-4, R7-2), (R1-4, R2-2, R3-4, R7-3), (R1-4, R2-2, R3-5, R7-1), (R1-4, R2-2, R3-5, R7-2), (R1-4, R2-2, R3-5, R7-3),\n",
       "<br/>\n",
       "(R1-5, R2-1, R3-1, R7-1), (R1-5, R2-1, R3-1, R7-2), (R1-5, R2-1, R3-1, R7-3), (R1-5, R2-1, R3-2, R7-1), (R1-5, R2-1, R3-2, R7-2), (R1-5, R2-1, R3-2, R7-3), (R1-5, R2-1, R3-3, R7-1), (R1-5, R2-1, R3-3, R7-2), (R1-5, R2-1, R3-3, R7-3), (R1-5, R2-1, R3-4, R7-1), (R1-5, R2-1, R3-4, R7-2), (R1-5, R2-1, R3-4, R7-3), (R1-5, R2-1, R3-5, R7-1), (R1-5, R2-1, R3-5, R7-2), (R1-5, R2-1, R3-5, R7-3), (R1-5, R2-2, R3-1, R7-1), (R1-5, R2-2, R3-1, R7-2), (R1-5, R2-2, R3-1, R7-3), (R1-5, R2-2, R3-2, R7-1), (R1-5, R2-2, R3-2, R7-2), (R1-5, R2-2, R3-2, R7-3), (R1-5, R2-2, R3-3, R7-1), (R1-5, R2-2, R3-3, R7-2), (R1-5, R2-2, R3-3, R7-3), (R1-5, R2-2, R3-4, R7-1), (R1-5, R2-2, R3-4, R7-2), (R1-5, R2-2, R3-4, R7-3), (R1-5, R2-2, R3-5, R7-1), (R1-5, R2-2, R3-5, R7-2), (R1-5, R2-2, R3-5, R7-3), (R1-6, R2-1, R3-1, R7-1), (R1-6, R2-1, R3-1, R7-2), (R1-6, R2-1, R3-1, R7-3), (R1-6, R2-1, R3-2, R7-1), (R1-6, R2-1, R3-2, R7-2), (R1-6, R2-1, R3-2, R7-3), (R1-6, R2-1, R3-3, R7-1), (R1-6, R2-1, R3-3, R7-2), (R1-6, R2-1, R3-3, R7-3), (R1-6, R2-1, R3-4, R7-1), (R1-6, R2-1, R3-4, R7-2), (R1-6, R2-1, R3-4, R7-3), (R1-6, R2-1, R3-5, R7-1), (R1-6, R2-1, R3-5, R7-2), (R1-6, R2-1, R3-5, R7-3), (R1-6, R2-2, R3-1, R7-1), (R1-6, R2-2, R3-1, R7-2), (R1-6, R2-2, R3-1, R7-3), (R1-6, R2-2, R3-2, R7-1), (R1-6, R2-2, R3-2, R7-2), (R1-6, R2-2, R3-2, R7-3), (R1-6, R2-2, R3-3, R7-1), (R1-6, R2-2, R3-3, R7-2), (R1-6, R2-2, R3-3, R7-3), (R1-6, R2-2, R3-4, R7-1), (R1-6, R2-2, R3-4, R7-2), (R1-6, R2-2, R3-4, R7-3), (R1-6, R2-2, R3-5, R7-1), (R1-6, R2-2, R3-5, R7-2), (R1-6, R2-2, R3-5, R7-3), (R1-7, R2-1, R3-1, R7-1), (R1-7, R2-1, R3-1, R7-2), (R1-7, R2-1, R3-1, R7-3), (R1-7, R2-1, R3-2, R7-1), (R1-7, R2-1, R3-2, R7-2), (R1-7, R2-1, R3-2, R7-3), (R1-7, R2-1, R3-3, R7-1), (R1-7, R2-1, R3-3, R7-2), (R1-7, R2-1, R3-3, R7-3), (R1-7, R2-1, R3-4, R7-1), (R1-7, R2-1, R3-4, R7-2), (R1-7, R2-1, R3-4, R7-3), (R1-7, R2-1, R3-5, R7-1), (R1-7, R2-1, R3-5, R7-2), (R1-7, R2-1, R3-5, R7-3), (R1-7, R2-2, R3-1, R7-1), (R1-7, R2-2, R3-1, R7-2), (R1-7, R2-2, R3-1, R7-3), (R1-7, R2-2, R3-2, R7-1), (R1-7, R2-2, R3-2, R7-2), (R1-7, R2-2, R3-2, R7-3), (R1-7, R2-2, R3-3, R7-1), (R1-7, R2-2, R3-3, R7-2), (R1-7, R2-2, R3-3, R7-3), (R1-7, R2-2, R3-4, R7-1), (R1-7, R2-2, R3-4, R7-2), (R1-7, R2-2, R3-4, R7-3), (R1-7, R2-2, R3-5, R7-1), (R1-7, R2-2, R3-5, R7-2), (R1-7, R2-2, R3-5, R7-3), (R1-8, R2-1, R3-1, R7-1), (R1-8, R2-1, R3-1, R7-2), (R1-8, R2-1, R3-1, R7-3), (R1-8, R2-1, R3-2, R7-1), (R1-8, R2-1, R3-2, R7-2), (R1-8, R2-1, R3-2, R7-3), (R1-8, R2-1, R3-3, R7-1), (R1-8, R2-1, R3-3, R7-2), (R1-8, R2-1, R3-3, R7-3), (R1-8, R2-1, R3-4, R7-1), (R1-8, R2-1, R3-4, R7-2), (R1-8, R2-1, R3-4, R7-3), (R1-8, R2-1, R3-5, R7-1), (R1-8, R2-1, R3-5, R7-2), (R1-8, R2-1, R3-5, R7-3), (R1-8, R2-2, R3-1, R7-1), (R1-8, R2-2, R3-1, R7-2), (R1-8, R2-2, R3-1, R7-3), (R1-8, R2-2, R3-2, R7-1), (R1-8, R2-2, R3-2, R7-2), (R1-8, R2-2, R3-2, R7-3), (R1-8, R2-2, R3-3, R7-1), (R1-8, R2-2, R3-3, R7-2), (R1-8, R2-2, R3-3, R7-3), (R1-8, R2-2, R3-4, R7-1), (R1-8, R2-2, R3-4, R7-2), (R1-8, R2-2, R3-4, R7-3), (R1-8, R2-2, R3-5, R7-1), (R1-8, R2-2, R3-5, R7-2), (R1-8, R2-2, R3-5, R7-3),\n",
       "<br/>\n",
       "(R1-1, R2-1, R3-1, R6-1), (R1-1, R2-1, R3-1, R6-2), (R1-1, R2-1, R3-1, R6-3), (R1-1, R2-1, R3-2, R6-1), (R1-1, R2-1, R3-2, R6-2), (R1-1, R2-1, R3-2, R6-3), (R1-1, R2-1, R3-3, R6-1), (R1-1, R2-1, R3-3, R6-2), (R1-1, R2-1, R3-3, R6-3), (R1-1, R2-1, R3-4, R6-1), (R1-1, R2-1, R3-4, R6-2), (R1-1, R2-1, R3-4, R6-3), (R1-1, R2-1, R3-5, R6-1), (R1-1, R2-1, R3-5, R6-2), (R1-1, R2-1, R3-5, R6-3), (R1-1, R2-2, R3-1, R6-1), (R1-1, R2-2, R3-1, R6-2), (R1-1, R2-2, R3-1, R6-3), (R1-1, R2-2, R3-2, R6-1), (R1-1, R2-2, R3-2, R6-2), (R1-1, R2-2, R3-2, R6-3), (R1-1, R2-2, R3-3, R6-1), (R1-1, R2-2, R3-3, R6-2), (R1-1, R2-2, R3-3, R6-3), (R1-1, R2-2, R3-4, R6-1), (R1-1, R2-2, R3-4, R6-2), (R1-1, R2-2, R3-4, R6-3), (R1-1, R2-2, R3-5, R6-1), (R1-1, R2-2, R3-5, R6-2), (R1-1, R2-2, R3-5, R6-3), (R1-2, R2-1, R3-1, R6-1), (R1-2, R2-1, R3-1, R6-2), (R1-2, R2-1, R3-1, R6-3), (R1-2, R2-1, R3-2, R6-1), (R1-2, R2-1, R3-2, R6-2), (R1-2, R2-1, R3-2, R6-3), (R1-2, R2-1, R3-3, R6-1), (R1-2, R2-1, R3-3, R6-2), (R1-2, R2-1, R3-3, R6-3), (R1-2, R2-1, R3-4, R6-1), (R1-2, R2-1, R3-4, R6-2), (R1-2, R2-1, R3-4, R6-3), (R1-2, R2-1, R3-5, R6-1), (R1-2, R2-1, R3-5, R6-2), (R1-2, R2-1, R3-5, R6-3), (R1-2, R2-2, R3-1, R6-1), (R1-2, R2-2, R3-1, R6-2), (R1-2, R2-2, R3-1, R6-3), (R1-2, R2-2, R3-2, R6-1), (R1-2, R2-2, R3-2, R6-2), (R1-2, R2-2, R3-2, R6-3), (R1-2, R2-2, R3-3, R6-1), (R1-2, R2-2, R3-3, R6-2), (R1-2, R2-2, R3-3, R6-3), (R1-2, R2-2, R3-4, R6-1), (R1-2, R2-2, R3-4, R6-2), (R1-2, R2-2, R3-4, R6-3), (R1-2, R2-2, R3-5, R6-1), (R1-2, R2-2, R3-5, R6-2), (R1-2, R2-2, R3-5, R6-3), (R1-3, R2-1, R3-1, R6-1), (R1-3, R2-1, R3-1, R6-2), (R1-3, R2-1, R3-1, R6-3), (R1-3, R2-1, R3-2, R6-1), (R1-3, R2-1, R3-2, R6-2), (R1-3, R2-1, R3-2, R6-3), (R1-3, R2-1, R3-3, R6-1), (R1-3, R2-1, R3-3, R6-2), (R1-3, R2-1, R3-3, R6-3), (R1-3, R2-1, R3-4, R6-1), (R1-3, R2-1, R3-4, R6-2), (R1-3, R2-1, R3-4, R6-3), (R1-3, R2-1, R3-5, R6-1), (R1-3, R2-1, R3-5, R6-2), (R1-3, R2-1, R3-5, R6-3), (R1-3, R2-2, R3-1, R6-1), (R1-3, R2-2, R3-1, R6-2), (R1-3, R2-2, R3-1, R6-3), (R1-3, R2-2, R3-2, R6-1), (R1-3, R2-2, R3-2, R6-2), (R1-3, R2-2, R3-2, R6-3), (R1-3, R2-2, R3-3, R6-1), (R1-3, R2-2, R3-3, R6-2), (R1-3, R2-2, R3-3, R6-3), (R1-3, R2-2, R3-4, R6-1), (R1-3, R2-2, R3-4, R6-2), (R1-3, R2-2, R3-4, R6-3), (R1-3, R2-2, R3-5, R6-1), (R1-3, R2-2, R3-5, R6-2), (R1-3, R2-2, R3-5, R6-3), (R1-4, R2-1, R3-1, R6-1), (R1-4, R2-1, R3-1, R6-2), (R1-4, R2-1, R3-1, R6-3), (R1-4, R2-1, R3-2, R6-1), (R1-4, R2-1, R3-2, R6-2), (R1-4, R2-1, R3-2, R6-3), (R1-4, R2-1, R3-3, R6-1), (R1-4, R2-1, R3-3, R6-2), (R1-4, R2-1, R3-3, R6-3), (R1-4, R2-1, R3-4, R6-1), (R1-4, R2-1, R3-4, R6-2), (R1-4, R2-1, R3-4, R6-3), (R1-4, R2-1, R3-5, R6-1), (R1-4, R2-1, R3-5, R6-2), (R1-4, R2-1, R3-5, R6-3), (R1-4, R2-2, R3-1, R6-1), (R1-4, R2-2, R3-1, R6-2), (R1-4, R2-2, R3-1, R6-3), (R1-4, R2-2, R3-2, R6-1), (R1-4, R2-2, R3-2, R6-2), (R1-4, R2-2, R3-2, R6-3), (R1-4, R2-2, R3-3, R6-1), (R1-4, R2-2, R3-3, R6-2), (R1-4, R2-2, R3-3, R6-3), (R1-4, R2-2, R3-4, R6-1), (R1-4, R2-2, R3-4, R6-2), (R1-4, R2-2, R3-4, R6-3), (R1-4, R2-2, R3-5, R6-1), (R1-4, R2-2, R3-5, R6-2), (R1-4, R2-2, R3-5, R6-3),\n",
       "<br/>\n",
       "(R1-5, R2-1, R3-1, R6-1), (R1-5, R2-1, R3-1, R6-2), (R1-5, R2-1, R3-1, R6-3), (R1-5, R2-1, R3-2, R6-1), (R1-5, R2-1, R3-2, R6-2), (R1-5, R2-1, R3-2, R6-3), (R1-5, R2-1, R3-3, R6-1), (R1-5, R2-1, R3-3, R6-2), (R1-5, R2-1, R3-3, R6-3), (R1-5, R2-1, R3-4, R6-1), (R1-5, R2-1, R3-4, R6-2), (R1-5, R2-1, R3-4, R6-3), (R1-5, R2-1, R3-5, R6-1), (R1-5, R2-1, R3-5, R6-2), (R1-5, R2-1, R3-5, R6-3), (R1-5, R2-2, R3-1, R6-1), (R1-5, R2-2, R3-1, R6-2), (R1-5, R2-2, R3-1, R6-3), (R1-5, R2-2, R3-2, R6-1), (R1-5, R2-2, R3-2, R6-2), (R1-5, R2-2, R3-2, R6-3), (R1-5, R2-2, R3-3, R6-1), (R1-5, R2-2, R3-3, R6-2), (R1-5, R2-2, R3-3, R6-3), (R1-5, R2-2, R3-4, R6-1), (R1-5, R2-2, R3-4, R6-2), (R1-5, R2-2, R3-4, R6-3), (R1-5, R2-2, R3-5, R6-1), (R1-5, R2-2, R3-5, R6-2), (R1-5, R2-2, R3-5, R6-3), (R1-6, R2-1, R3-1, R6-1), (R1-6, R2-1, R3-1, R6-2), (R1-6, R2-1, R3-1, R6-3), (R1-6, R2-1, R3-2, R6-1), (R1-6, R2-1, R3-2, R6-2), (R1-6, R2-1, R3-2, R6-3), (R1-6, R2-1, R3-3, R6-1), (R1-6, R2-1, R3-3, R6-2), (R1-6, R2-1, R3-3, R6-3), (R1-6, R2-1, R3-4, R6-1), (R1-6, R2-1, R3-4, R6-2), (R1-6, R2-1, R3-4, R6-3), (R1-6, R2-1, R3-5, R6-1), (R1-6, R2-1, R3-5, R6-2), (R1-6, R2-1, R3-5, R6-3), (R1-6, R2-2, R3-1, R6-1), (R1-6, R2-2, R3-1, R6-2), (R1-6, R2-2, R3-1, R6-3), (R1-6, R2-2, R3-2, R6-1), (R1-6, R2-2, R3-2, R6-2), (R1-6, R2-2, R3-2, R6-3), (R1-6, R2-2, R3-3, R6-1), (R1-6, R2-2, R3-3, R6-2), (R1-6, R2-2, R3-3, R6-3), (R1-6, R2-2, R3-4, R6-1), (R1-6, R2-2, R3-4, R6-2), (R1-6, R2-2, R3-4, R6-3), (R1-6, R2-2, R3-5, R6-1), (R1-6, R2-2, R3-5, R6-2), (R1-6, R2-2, R3-5, R6-3), (R1-7, R2-1, R3-1, R6-1), (R1-7, R2-1, R3-1, R6-2), (R1-7, R2-1, R3-1, R6-3), (R1-7, R2-1, R3-2, R6-1), (R1-7, R2-1, R3-2, R6-2), (R1-7, R2-1, R3-2, R6-3), (R1-7, R2-1, R3-3, R6-1), (R1-7, R2-1, R3-3, R6-2), (R1-7, R2-1, R3-3, R6-3), (R1-7, R2-1, R3-4, R6-1), (R1-7, R2-1, R3-4, R6-2), (R1-7, R2-1, R3-4, R6-3), (R1-7, R2-1, R3-5, R6-1), (R1-7, R2-1, R3-5, R6-2), (R1-7, R2-1, R3-5, R6-3), (R1-7, R2-2, R3-1, R6-1), (R1-7, R2-2, R3-1, R6-2), (R1-7, R2-2, R3-1, R6-3), (R1-7, R2-2, R3-2, R6-1), (R1-7, R2-2, R3-2, R6-2), (R1-7, R2-2, R3-2, R6-3), (R1-7, R2-2, R3-3, R6-1), (R1-7, R2-2, R3-3, R6-2), (R1-7, R2-2, R3-3, R6-3), (R1-7, R2-2, R3-4, R6-1), (R1-7, R2-2, R3-4, R6-2), (R1-7, R2-2, R3-4, R6-3), (R1-7, R2-2, R3-5, R6-1), (R1-7, R2-2, R3-5, R6-2), (R1-7, R2-2, R3-5, R6-3), (R1-8, R2-1, R3-1, R6-1), (R1-8, R2-1, R3-1, R6-2), (R1-8, R2-1, R3-1, R6-3), (R1-8, R2-1, R3-2, R6-1), (R1-8, R2-1, R3-2, R6-2), (R1-8, R2-1, R3-2, R6-3), (R1-8, R2-1, R3-3, R6-1), (R1-8, R2-1, R3-3, R6-2), (R1-8, R2-1, R3-3, R6-3), (R1-8, R2-1, R3-4, R6-1), (R1-8, R2-1, R3-4, R6-2), (R1-8, R2-1, R3-4, R6-3), (R1-8, R2-1, R3-5, R6-1), (R1-8, R2-1, R3-5, R6-2), (R1-8, R2-1, R3-5, R6-3), (R1-8, R2-2, R3-1, R6-1), (R1-8, R2-2, R3-1, R6-2), (R1-8, R2-2, R3-1, R6-3), (R1-8, R2-2, R3-2, R6-1), (R1-8, R2-2, R3-2, R6-2), (R1-8, R2-2, R3-2, R6-3), (R1-8, R2-2, R3-3, R6-1), (R1-8, R2-2, R3-3, R6-2), (R1-8, R2-2, R3-3, R6-3), (R1-8, R2-2, R3-4, R6-1), (R1-8, R2-2, R3-4, R6-2), (R1-8, R2-2, R3-4, R6-3), (R1-8, R2-2, R3-5, R6-1), (R1-8, R2-2, R3-5, R6-2), (R1-8, R2-2, R3-5, R6-3).\n",
       "<br/>\n",
       "Compounds in which, in the formula (III), a combination of R<sup>1b</sup>, R<sup>2b</sup>, R<sup>3b</sup>, as well as (R<sup>8b</sup>, R<sup>9b</sup>, R<sup>10b</sup>, and R<sup>11b</sup>) is as follows. (R1-1, R2-1, R3-1, R9-1), (R1-1, R2-1, R3-1, R9-2), (R1-1, R2-1, R<sup>3</sup>-1, R9-3), (R1-1, R2-1, R3-2, R9-1), (R1-1, R2-1, R3-2, R9-2), (R1-1, R<sup>2</sup>-1, R3-2, R9-3), (R1-1, R2-1, R3-3, R9-1), (R1-1, R2-1, R3-3, R9-2), (R1-1, R2-1, R3-3, R9-3), (R1-1, R2-1, R3-4, R9-1), (R1-1, R2-1, R3-4, R9-2), (R1-1, R2-1, R3-4, R9-3), (R1-1, R2-1, R3-5, R9-1), (R1-1, R2-1, R3-5, R9-2), (R1-1, R2-1, R3-5, R9-3), (R1-1, R2-2, R3-1, R9-1), (R1-1, R2-2, R3-1, R9-2), (R1-1, R2-2, R3-1, R9-3), (R1-1, R2-2, R3-2, R9-1), (R1-1, R2-2, R3-2, R9-2), (R1-1, R2-2, R3-2, R9-3), (R1-1, R2-2, R3-3, R9-1), (R1-1, R2-2, R3-3, R9-2), (R1-1, R2-2, R3-3, R9-3), (R1-1, R2-2, R3-4, R9-1), (R1-1, R2-2, R3-4, R9-2), (R1-1, R2-2, R3-4, R9-3), (R1-1, R2-2, R3-5, R9-1), (R1-1, R2-2, R3-5, R9-2), (R1-1, R2-2, R3-5, R9-3), (R1-2, R2-1, R3-1, R9-1), (R1-2, R2-1, R3-1, R9-2), (R1-2, R2-1, R3-1, R9-3), (R1-2, R2-1, R3-2, R9-1), (R1-2, R2-1, R3-2, R9-2), (R1-2, R2-1, R3-2, R9-3), (R1-2, R2-1, R3-3, R9-1), (R1-2, R2-1, R3-3, R9-2), (R1-2, R2-1, R3-3, R9-3), (R1-2, R2-1, R3-4, R9-1), (R1-2, R2-1, R3-4, R9-2), (R1-2, R2-1, R3-4, R9-3), (R1-2, R2-1, R3-5, R9-1), (R1-2, R2-1, R3-5, R9-2), (R1-2, R2-1, R3-5, R9-3), (R1-2, R2-2, R3-1, R9-1), (R1-2, R2-2, R3-1, R9-2), (R1-2, R2-2, R3-1, R9-3), (R1-2, R2-2, R3-2, R9-1), (R1-2, R2-2, R3-2, R9-2), (R1-2, R2-2, R3-2, R9-3), (R1-2, R2-2, R3-3, R9-1), (R1-2, R2-2, R3-3, R9-2), (R1-2, R2-2, R3-3, R9-3), (R1-2, R2-2, R3-4, R9-1), (R1-2, R2-2, R3-4, R9-2), (R1-2, R2-2, R3-4, R9-3), (R1-2, R2-2, R3-5, R9-1), (R1-2, R2-2, R3-5, R9-2), (R1-2, R2-2, R3-5, R9-3), (R1-3, R2-1, R3-1, R9-1), (R1-3, R2-1, R3-1, R9-2), (R1-3, R2-1, R3-1, R9-3), (R1-3, R2-1, R3-2, R9-1), (R1-3, R2-1, R3-2, R9-2), (R1-3, R2-1, R3-2, R9-3), (R1-3, R2-1, R3-3, R9-1), (R1-3, R2-1, R3-3, R9-2), (R1-3, R2-1, R3-3, R9-3), (R1-3, R2-1, R3-4, R9-1), (R1-3, R2-1, R3-4, R9-2), (R1-3, R2-1, R3-4, R9-3), (R1-3, R2-1, R3-5, R9-1), (R1-3, R2-1, R3-5, R9-2), (R1-3, R2-1, R3-5, R9-3), (R1-3, R2-2, R3-1, R9-1), (R1-3, R2-2, R3-1, R9-2), (R1-3, R2-2, R3-1, R9-3), (R1-3, R2-2, R3-2, R9-1), (R1-3, R2-2, R3-2, R9-2), (R1-3, R2-2, R3-2, R9-3), (R1-3, R2-2, R3-3, R9-1), (R1-3, R2-2, R3-3, R9-2), (R1-3, R2-2, R3-3, R9-3), (R1-3, R2-2, R3-4, R9-1), (R1-3, R2-2, R3-4, R9-2), (R1-3, R2-2, R3-4, R9-3), (R1-3, R2-2, R3-5, R9-1), (R1-3, R2-2, R3-5, R9-2), (R1-3, R2-2, R3-5, R9-3), (R1-4, R2-1, R3-1, R9-1), (R1-4, R2-1, R3-1, R9-2), (R1-4, R2-1, R3-1, R9-3), (R1-4, R2-1, R3-2, R9-1), (R1-4, R2-1, R3-2, R9-2), (R1-4, R2-1, R3-2, R9-3), (R1-4, R2-1, R3-3, R9-1), (R1-4, R2-1, R3-3, R9-2), (R1-4, R2-1, R3-3, R9-3), (R1-4, R2-1, R3-4, R9-1), (R1-4, R2-1, R3-4, R9-2), (R1-4, R2-1, R3-4, R9-3), (R1-4, R2-1, R3-5, R9-1), (R1-4, R2-1, R3-5, R9-2), (R1-4, R2-1, R3-5, R9-3), (R1-4, R2-2, R3-1, R9-1), (R1-4, R2-2, R3-1, R9-2), (R1-4, R2-2, R3-1, R9-3), (R1-4, R2-2, R3-2, R9-1), (R1-4, R2-2, R3-2, R9-2), (R1-4, R2-2, R3-2, R9-3), (R1-4, R2-2, R3-3, R9-1), (R1-4, R2-2, R3-3, R9-2), (R1-4, R2-2, R3-3, R9-3), (R1-4, R2-2, R3-4, R9-1), (R1-4, R2-2, R3-4, R9-2), (R1-4, R2-2, R3-4, R9-3), (R1-4, R2-2, R3-5, R9-1), (R1-4, R2-2, R3-5, R9-2), (R1-4, R2-2, R3-5, R9-3),\n",
       "<br/>\n",
       "(R1-5, R2-1, R3-1, R9-1), (R1-5, R2-1, R3-1, R9-2), (R1-5, R2-1, R3-1, R9-3), (R1-5, R2-1, R3-2, R9-1), (R1-5, R2-1, R3-2, R9-2), (R1-5, R2-1, R3-2, R9-3), (R1-5, R2-1, R3-3, R9-1), (R1-5, R2-1, R3-3, R9-2), (R1-5, R2-1, R3-3, R9-3), (R1-5, R2-1, R3-4, R9-1), (R1-5, R2-1, R3-4, R9-2), (R1-5, R2-1, R3-4, R9-3), (R1-5, R2-1, R3-5, R9-1), (R1-5, R2-1, R3-5, R9-2), (R1-5, R2-1, R3-5, R9-3), (R1-5, R2-2, R3-1, R9-1), (R1-5, R2-2, R3-1, R9-2), (R1-5, R2-2, R3-1, R9-3), (R1-5, R2-2, R3-2, R9-1), (R1-5, R2-2, R3-2, R9-2), (R1-5, R2-2, R3-2, R9-3), (R1-5, R2-2, R3-3, R9-1), (R1-5, R2-2, R3-3, R9-2), (R1-5, R2-2, R3-3, R9-3), (R1-5, R2-2, R3-4, R9-1), (R1-5, R2-2, R3-4, R9-2), (R1-5, R2-2, R3-4, R9-3), (R1-5, R2-2, R3-5, R9-1), (R1-5, R2-2, R3-5, R9-2), (R1-5, R2-2, R3-5, R9-3), (R1-6, R2-1, R3-1, R9-1), (R1-6, R2-1, R3-1, R9-2), (R1-6, R2-1, R3-1, R9-3), (R1-6, R2-1, R3-2, R9-1), (R1-6, R2-1, R3-2, R9-2), (R1-6, R2-1, R3-2, R9-3), (R1-6, R2-1, R3-3, R9-1), (R1-6, R2-1, R3-3, R9-2), (R1-6, R2-1, R3-3, R9-3), (R1-6, R2-1, R3-4, R9-1), (R1-6, R2-1, R3-4, R9-2), (R1-6, R2-1, R3-4, R9-3), (R1-6, R2-1, R3-5, R9-1), (R1-6, R2-1, R3-5, R9-2), (R1-6, R2-1, R3-5, R9-3), (R1-6, R2-2, R3-1, R9-1), (R1-6, R2-2, R3-1, R9-2), (R1-6, R2-2, R3-1, R9-3), (R1-6, R2-2, R3-2, R9-1), (R1-6, R2-2, R3-2, R9-2), (R1-6, R2-2, R3-2, R9-3), (R1-6, R2-2, R3-3, R9-1), (R1-6, R2-2, R3-3, R9-2), (R1-6, R2-2, R3-3, R9-3), (R1-6, R2-2, R3-4, R9-1), (R1-6, R2-2, R3-4, R9-2), (R1-6, R2-2, R3-4, R9-3), (R1-6, R2-2, R3-5, R9-1), (R1-6, R2-2, R3-5, R9-2), (R1-6, R2-2, R3-5, R9-3), (R1-7, R2-1, R3-1, R9-1), (R1-7, R2-1, R3-1, R9-2), (R1-7, R2-1, R3-1, R9-3), (R1-7, R2-1, R3-2, R9-1), (R1-7, R2-1, R3-2, R9-2), (R1-7, R2-1, R3-2, R9-3), (R1-7, R2-1, R3-3, R9-1), (R1-7, R2-1, R3-3, R9-2), (R1-7, R2-1, R3-3, R9-3), (R1-7, R2-1, R3-4, R9-1), (R1-7, R2-1, R3-4, R9-2), (R1-7, R2-1, R3-4, R9-3), (R1-7, R2-1, R3-5, R9-1), (R1-7, R2-1, R3-5, R9-2), (R1-7, R2-1, R3-5, R9-3), (R1-7, R2-2, R3-1, R9-1), (R1-7, R2-2, R3-1, R9-2), (R1-7, R2-2, R3-1, R9-3), (R1-7, R2-2, R3-2, R9-1), (R1-7, R2-2, R3-2, R9-2), (R1-7, R2-2, R3-2, R9-3), (R1-7, R2-2, R3-3, R9-1), (R1-7, R2-2, R3-3, R9-2), (R1-7, R2-2, R3-3, R9-3), (R1-7, R2-2, R3-4, R9-1), (R1-7, R2-2, R3-4, R9-2), (R1-7, R2-2, R3-4, R9-3), (R1-7, R2-2, R3-5, R9-1), (R1-7, R2-2, R3-5, R9-2), (R1-7, R2-2, R3-5, R9-3), (R1-8, R2-1, R3-1, R9-1), (R1-8, R2-1, R3-1, R9-2), (R1-8, R2-1, R3-1, R9-3), (R1-8, R2-1, R3-2, R9-1), (R1-8, R2-1, R3-2, R9-2), (R1-8, R2-1, R3-2, R9-3), (R1-8, R2-1, R3-3, R9-1), (R1-8, R2-1, R3-3, R9-2), (R1-8, R2-1, R3-3, R9-3), (R1-8, R2-1, R3-4, R9-1), (R1-8, R2-1, R3-4, R9-2), (R1-8, R2-1, R3-4, R9-3), (R1-8, R2-1, R3-5, R9-1), (R1-8, R2-1, R3-5, R9-2), (R1-8, R2-1, R3-5, R9-3), (R1-8, R2-2, R3-1, R9-1), (R1-8, R2-2, R3-1, R9-2), (R1-8, R2-2, R3-1, R9-3), (R1-8, R2-2, R3-2, R9-1), (R1-8, R2-2, R3-2, R9-2), (R1-8, R2-2, R3-2, R9-3), (R1-8, R2-2, R3-3, R9-1), (R1-8, R2-2, R3-3, R9-2), (R1-8, R2-2, R3-3, R9-3), (R1-8, R2-2, R3-4, R9-1), (R1-8, R2-2, R3-4, R9-2), (R1-8, R2-2, R3-4, R9-3), (R1-8, R2-2, R3-5, R9-1), (R1-8, R2-2, R3-5, R9-2), (R1-8, R2-2, R3-5, R9-3).\n",
       "<br/>\n",
       "(Method for Producing Compound of the Present Invention)\n",
       "</p>\n",
       "<p id=\"p-0387\" num=\"0399\">A general method for producing the compound of the present invention will be exemplified below. And, as extraction and purification, treatment which is performed in a normal experiment of organic chemistry may be conducted.</p>\n",
       "<p id=\"p-0388\" num=\"0400\">Synthesis of the compound of the present invention can be carried out referring to the procedures known in the art.</p>\n",
       "<p id=\"p-0389\" num=\"0401\">As a raw material compound, commercially available compounds, compounds described in the present description, compounds described in the references cited in the present description, and other known compounds can be utilized.</p>\n",
       "<p id=\"p-0390\" num=\"0402\">Among the compounds of the present invention, there are compounds in which a tautomer can be present, and the present invention includes all possible isomers and a mixture thereof, including them.</p>\n",
       "<p id=\"p-0391\" num=\"0403\">When one wants to obtain a salt of the compound of the present invention, in the case where the compound of the present invention is obtained in a form of a salt, it may be purified as it is and, in the case where the compound of the present invention is obtained in a free form, a salt may be formed by a normal method by dissolving or suspending the compound in a suitable organic solvent, and adding an acid or a base.</p>\n",
       "<p id=\"p-0392\" num=\"0404\">In addition, the compound of the present invention and a pharmaceutically acceptable salt thereof are present in a form of adducts with water or various solvents (hydrate or solvate) in some cases, and these adducts are included in the present invention.</p>\n",
       "<p id=\"p-0393\" num=\"0405\">In a general synthesis method as well as Examples and Reference Examples, the meaning of each abbreviation is as follows.</p>\n",
       "<p id=\"h-0223\" num=\"0000\">DMF: N,N-dimethylformamide</p>\n",
       "<p id=\"h-0224\" num=\"0000\">DMA: N,N-dimethylacetamide,</p>\n",
       "<p id=\"h-0225\" num=\"0000\">NMP: N-methylpyrrolidone</p>\n",
       "<p id=\"h-0226\" num=\"0000\">DMI: dimethylimidazolidinone</p>\n",
       "<p id=\"h-0227\" num=\"0000\">THF: tetrahydrofuran</p>\n",
       "<p id=\"h-0228\" num=\"0000\">Ms: methanesulfonyl</p>\n",
       "<p id=\"h-0229\" num=\"0000\">Ts: paratoluenesulfonyl</p>\n",
       "<p id=\"h-0230\" num=\"0000\">Boc: tert-butoxycarbonyl</p>\n",
       "<p id=\"h-0231\" num=\"0000\">DIBALH: diisobutylaluminum hydride</p>\n",
       "<p id=\"h-0232\" num=\"0000\">WSC or EDCI: N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide</p>\n",
       "<p id=\"h-0233\" num=\"0000\">HOBt: 1-hydroxybenzotriazole</p>\n",
       "<p id=\"h-0234\" num=\"0000\">HATU: O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate</p>\n",
       "<p id=\"h-0235\" num=\"0000\">NBS: N-bromosuccinimide</p>\n",
       "<p id=\"h-0236\" num=\"0000\">NCS: N-chlorosuccinimide</p>\n",
       "<p id=\"h-0237\" num=\"0000\">TEMPO: 2,2,6,6-tetramethylpiperidine-1-oxyl radical</p>\n",
       "<p id=\"h-0238\" num=\"0000\">PDC: pyridinium dichloromate</p>\n",
       "<p id=\"h-0239\" num=\"0000\">DEAD: diethyl azodicarboxylate</p>\n",
       "<p id=\"h-0240\" num=\"0000\">DIAD: diisopropyl azodicarboxylate</p>\n",
       "<p id=\"h-0241\" num=\"0000\">DMAP: 4-dimethylaminopyridine</p>\n",
       "<p id=\"h-0242\" num=\"0000\">mCPBA: m-chloroperbenzoic acid</p>\n",
       "<p id=\"h-0243\" num=\"0000\">DBU: 1,8-diazabicyclo[5.4.0]-7-undecene</p>\n",
       "<p id=\"h-0244\" num=\"0000\">DIPEA: diisopropylethylamine</p>\n",
       "<p id=\"h-0245\" num=\"0000\">TBAF: tetrabutylammonium fluoride</p>\n",
       "<p id=\"h-0246\" num=\"0000\">IBX: 2-iodoxybenzoic acid</p>\n",
       "<p id=\"h-0247\" num=\"0000\">DMSO: dimethyl sulfoxide</p>\n",
       "<p id=\"h-0248\" num=\"0000\">NaHMDS: sodium hexamethyldisilazide</p>\n",
       "<p id=\"h-0249\" num=\"0000\">TFA: trifluoroacetic acid</p>\n",
       "<heading id=\"h-0250\" level=\"1\">Synthesis of Objective Compound aj (See: Example 1)</heading>\n",
       "<p id=\"p-0394\" num=\"0406\"><chemistry id=\"CHEM-US-00079\" num=\"00079\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00079.TIF\" he=\"214.88mm\" id=\"EMI-C00079\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00080\" num=\"00080\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00080.TIF\" he=\"100.16mm\" id=\"EMI-C00080\" img-content=\"chem\" img-format=\"tif\" wi=\"65.28mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R is carboxy protective group, P<sup>1 </sup>is hydroxyl protective group, R<sup>2</sup>, R<sup>3</sup>, R<sup>5</sup>, R<sup>9</sup>, R<sup>10 </sup>and R<sup>11 </sup>are as defined in item 1′ or item 1, R and P<sup>1 </sup>may be a group which can be protected and/or deprotected by the method described in Protective Groups in Organic Synthesis, Theodora W Green (John Wiley &amp; Sons) etc. and, for example, R is lower alkyl etc., and P<sup>1 </sup>is arylalkyl etc.)\n",
       "</p>\n",
       "<heading id=\"h-0251\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0395\" num=\"0407\">A compound ab can be obtained by reacting a compound aa which is commercially available or can be prepared by the known method at −20° C. to 30° C., preferably 0° C. to 20° C. for 0.1 hour to 24 hours, preferably 0.5 hour to 12 hours in a solvent such as dichloromethane, toluene, THF etc. or a mixed solvent thereof, by adding dropwise tertiary amine such as pyridine, trimethylamine, N-methylmorpholine, 4-dimethylaminopyridine etc. and benzyloxyacetyl chloride.</p>\n",
       "<heading id=\"h-0252\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0396\" num=\"0408\">A compound ac can be obtained by adding an organometallic base such as lithium hexamethyldisilazane, lithium diisopropylamide, butyllithium, tert-butyllithium etc. to the compound ab in a solvent such as ether, dichloromethane, THF etc. or a mixed solvent thereof, in the presence of cinnamoyl chloride, and performing a reaction at −80° C. to 0° C., preferably −80° C. to −40° C. for 1 minute to 2 hours, preferably 10 minutes to 1 hour.</p>\n",
       "<heading id=\"h-0253\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0397\" num=\"0409\">A compound ad can be obtained by adding a catalytic amount of an oxidizing agent such as ruthenium chloride and sodium periodate, TEMPO, manganese dioxide, as well as PDC etc. to the compound ac in a solvent such as ether, dichloromethane, THF, acetonitrile etc. or a mixed solvent thereof, and performing a reaction at −40° C. to 80° C., preferably 0° C. to 40° C. for 0.1 hour to 24 hours, preferably 0.2 hour to 3 hours.</p>\n",
       "<heading id=\"h-0254\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0398\" num=\"0410\">Concentrated sulfuric acid and an aqeuous solution of amidosuluflic acid are added to the compound ad at 0° C. to 60° C., preferably 10° C. to 40° C. in the presence of a solvent such as ether, dichloromethane, THF, acetonitrile, acetone, water etc. or in a mixed solvent thereof. An aqueous sodium chlorite solution is added dropwise thereto at the same temperature to perform a reaction for 1 minute to 3 hours, preferably 5 minutes to 1 hour, thereby, a compound ae can be obtained.</p>\n",
       "<heading id=\"h-0255\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0399\" num=\"0411\">A compound af can be obtained by adding a compound R<sup>3</sup>—NH<sub>2 </sub>having a substituent corresponding to an objective compound to the compound ae in a solvent such as DMF, THF, dichloromethane, acetonitrile etc. in the presence of a dehydration-condensation agent such as dicyclohexylcarbodiimide, carbonyldiimidazole, dicyclohexylcarbodiimido-N-hydroxybenzotriazole, 4-(4,6-dimethoxy-1,3,5,-triazin-2-yl)-4-methylmorpholinium chloride, hexafluorophosphoric acid 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium, WSC.HCl, HATU etc., and performing a reaction at −20° C. to 60° C., preferably −10° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0256\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0400\" num=\"0412\">A compound ah can be obtained by adding a compound ag to the compound af in the presence of a solvent such as toluene, xylene, THF, dioxane etc. or in a mixed solvent thereof, and performing a reaction for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours under the heat-refluxing condition.</p>\n",
       "<heading id=\"h-0257\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0401\" num=\"0413\">A compound ai can be obtained by adding triphenylphosphine and a condensation agent such as DEAD, DIAD etc. to the compound ah in the presence of a solvent such as THF, dioxane, ethyl acetate, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours.</p>\n",
       "<heading id=\"h-0258\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0402\" num=\"0414\">By subjecting the compound ai to the known general deprotecting reaction of a carboxyl protective group and a hydroxyl protective group, a compound aj can be obtained.</p>\n",
       "<heading id=\"h-0259\" level=\"1\">Synthesis of Compound bk (See: Example 12)</heading>\n",
       "<p id=\"p-0403\" num=\"0415\"><chemistry id=\"CHEM-US-00081\" num=\"00081\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00081.TIF\" he=\"198.12mm\" id=\"EMI-C00081\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00082\" num=\"00082\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00082.TIF\" he=\"125.65mm\" id=\"EMI-C00082\" img-content=\"chem\" img-format=\"tif\" wi=\"62.91mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein P<sup>2 </sup>is amino protective group, P<sup>2 </sup>may be a group which can be protected and/or deprotected by the method described in Protective Groups in Organic Synthesis, Theodora W Green (John Wiley &amp; Sons) etc. and, for example, P<sup>2 </sup>is arylalkyloxycarbonyl, lower alkyloxycarbonyl, etc. Other each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0260\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0404\" num=\"0416\">A compound bb can be obtained by adding a base such as potassium carbonate, sodium carbonate, cesium carbonate etc. and a compound P<sup>2</sup>-L (wherein L is a leaving group such as halogen, OMs etc.) having a substituent corresponding to an objective compound to a compound ba in the presence of a solvent such as DMF, THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at −20° C. to 80° C., preferably 0° C. to 50° C. for 0.1 hour to 6 hours, preferably 0.2 hour to 6 hours.</p>\n",
       "<heading id=\"h-0261\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0405\" num=\"0417\">A compound bc can be obtained by adding triphenylphosphine and phthalimide to the compound bb in the presence of a solvent such as DMF, THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, adding a dehydration-condensation reagent such as DIAD, DEAD etc., and performing a reaction at −10° C. to 60° C., preferably 0° C. to 50° C. for 0.1 hour to 24 hours, preferably 0.2 hour to 12 hours.</p>\n",
       "<heading id=\"h-0262\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0406\" num=\"0418\">A compound bd can be obtained by adding hydrazine hydrate or methylhydrazine to the compound bc in the presence of a solvent such as methanol, THF, dioxane, acetonitrile, etc. or in a mixed solvent thereof, and performing a reaction at −10° C. to 80° C., preferably 10° C. to 60° C. for 0.5 hour to 24 hours, preferably 1 to 12 hours.</p>\n",
       "<heading id=\"h-0263\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0407\" num=\"0419\">A compound be can be obtained by adding Boc<sub>2</sub>O to the compound bd in the presence of a solvent such as THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at −10° C. to 80° C., preferably 10° C. to 60° C. for 0.5 hour to 24 hours, preferably 1 to 12 hours.</p>\n",
       "<heading id=\"h-0264\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0408\" num=\"0420\">A compound bf can be obtained by subjecting the compound be to the known general deprotecting reaction of an amino protective group.</p>\n",
       "<heading id=\"h-0265\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0409\" num=\"0421\">A compound bh can be obtained by adding a compound bg to the compound bf in the presence of a solvent such as toluene, THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at 20° C. to 110° C., preferably 40° C. to under heat-refluxing for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0266\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0410\" num=\"0422\">HCl-ethyl acetate, HCl-dioxane, formic acid etc. is added to the compound bh, and they are reacted at 0° C. or 40° C., preferably 0° C. to 20° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours. After the solvent is distilled off under reduced pressure, an aqueous saturated sodium bicarbonate solution is added, and the mixture is stirred, thereby, a compound bi can be obtained.</p>\n",
       "<heading id=\"h-0267\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0411\" num=\"0423\">A compound bj can be obtained by adding a base such as potassium carbonate, sodium carbonate, lithium carbonate, cesium carbonate etc. and a compound R<sup>3</sup>-L (L is a leaving group such as halogen, OMs etc.) to the compound bi in the presence of a solvent such as DMF, THF, DMA, NMP etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 30° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0268\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-0412\" num=\"0424\">A compound bk can be obtained by subjecting the compound bj to the known general deprotecting reaction of a carboxyl protective group and a hydroxyl protective group.</p>\n",
       "<p id=\"p-0413\" num=\"0425\">Synthesis of Compound cd (See: Examples 28 and 43)</p>\n",
       "<p id=\"p-0414\" num=\"0426\"><chemistry id=\"CHEM-US-00083\" num=\"00083\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00083.TIF\" he=\"91.86mm\" id=\"EMI-C00083\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0269\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0415\" num=\"0427\">A compound cb can be obtained by adding tertiary amine such as triethylamine, DMAP, morpholine etc. or a base such as sodium carbonate, sodium bicarbonate etc. to a compound ca in the presence of a solvent such as THF, dioxane, acetonitrile, water etc. or in a mixed solvent thereof, adding Boc<sub>2</sub>O, and performing a reaction at −10° C. to 80° C., preferably 10° C. to 60° C. for 0.5 hour to 24 hours, preferably 1 to 12 hours.</p>\n",
       "<heading id=\"h-0270\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0416\" num=\"0428\">A compound cc can be obtained by adding triphenylphosphine and phthalimide to the compound cb in the presence of a solvent such as DMF, THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, adding a dehydration-condensation reagent such as DIAD, DEAD etc., and performing a reaction at −10° C. to 60° C., preferably 0° C. to 50° C. for 0.1 hour to 24 hours, preferably 0.2 hour to 12 hours.</p>\n",
       "<heading id=\"h-0271\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0417\" num=\"0429\">A compound cd can be obtained by adding hydrazine hydrate to the compound cc in the presence of a solvent such as methanol, THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at −10° C. to 80° C., preferably 10° C. to 60° C. for 0.5 hour to 24 hours, preferably 1 to 12 hours.</p>\n",
       "<heading id=\"h-0272\" level=\"1\">Synthesis of Compound dg (See: Examples 36, 41 and 46)</heading>\n",
       "<p id=\"p-0418\" num=\"0430\"><chemistry id=\"CHEM-US-00084\" num=\"00084\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00084.TIF\" he=\"147.15mm\" id=\"EMI-C00084\" img-content=\"chem\" img-format=\"tif\" wi=\"158.75mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein B<sup>1 </sup>and B<sup>2 </sup>are as defined in item 13′ or item 13, and other each symbol is as defined above).\n",
       "</p>\n",
       "<heading id=\"h-0273\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0419\" num=\"0431\">A compound db can be obtained by subjecting the compound da obtained by the same method as the synthesis method of bi to the known general carboxyl deprotecting reaction.</p>\n",
       "<heading id=\"h-0274\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0420\" num=\"0432\">A decarbonized compound dc can be obtained by reacting the compound db for 1 minute to 2 hours under microwave irradiation in a solvent such as diphenyl ether etc. And, a decarbonized compound dc can be obtained by adding copper in a quinoline solvent, and performing a reaction at 180° C. for 2 to 48 hours.</p>\n",
       "<heading id=\"h-0275\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0421\" num=\"0433\">A compound dd can be obtained by adding a base such as potassium carbonate, sodium carbonate, lithium carbonate, cesium carbonate etc. and a compound R<sup>3</sup>-L (L is a leaving group such as halogen, OMs etc.) to the compound da obtained by the method described in Example 12 in the presence of a solvent such as DMF, THF, DMA, NMP etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 30° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0276\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0422\" num=\"0434\">A compound de can be obtained by the same method as that of the first step.</p>\n",
       "<heading id=\"h-0277\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0423\" num=\"0435\">A compound df can be obtained by the same method as that of the second step.</p>\n",
       "<heading id=\"h-0278\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0424\" num=\"0436\">A compound df can be obtained by the same method as that of the third step.</p>\n",
       "<heading id=\"h-0279\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0425\" num=\"0437\">A compound dg can be obtained by subjecting the compound df to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0280\" level=\"1\">Synthesis of Compound ec (See: Example 48)</heading>\n",
       "<p id=\"p-0426\" num=\"0438\"><chemistry id=\"CHEM-US-00085\" num=\"00085\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00085.TIF\" he=\"109.05mm\" id=\"EMI-C00085\" img-content=\"chem\" img-format=\"tif\" wi=\"75.86mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0281\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0427\" num=\"0439\">A base such as triethylamine, N-methylmorpholine, diisopropylethylamine etc. and ethyl chloroformate are added to a compound ea in the presence of a solvent such as THF, dioxane, dichloromethane, toluene etc. or in a mixed solvent thereof. A reducing agent having a low reducing power such as sodium borohydride etc. is added thereto, and a reaction is performed at −20° C. to 60° C., preferably −10° C. to 20° C. for 0.2 hour to 12 hours, preferably 0.5 hour to 6 hours, thereby, a compound eb can be obtained.</p>\n",
       "<heading id=\"h-0282\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0428\" num=\"0440\">A compound ec can be obtained by subjecting the compound eb to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0283\" level=\"1\">Synthesis of Compound fh (See: Example 50)</heading>\n",
       "<p id=\"p-0429\" num=\"0441\"><chemistry id=\"CHEM-US-00086\" num=\"00086\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00086.TIF\" he=\"219.12mm\" id=\"EMI-C00086\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0284\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0430\" num=\"0442\">A compound fb and triphenylphosphine are added to a compound fa in the presence of a solvent such as THF, dichloromethane, dioxane, acetonitrile etc. or in a mixed solvent thereof. DIAD is added thereto, and a reaction is performed at 0° C. to 60° C., preferably 10° C. to 30° C. for 0.5 hour to 12 hours, preferably 1 hour to 12 hours, thereby, a compound fc can be obtained.</p>\n",
       "<heading id=\"h-0285\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0431\" num=\"0443\">A compound fd can be obtained by adding a base such as potassium carbonate, sodium carbonate, lithium carbonate, cesium carbonate etc. and thiol such as benzenethiol etc. to the compound fc in the presence of a solvent such as THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 30° C. for 0.5 hour to 12 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0286\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0432\" num=\"0444\">A compound ff can be obtained by adding a compound fe having a substituent corresponding to an objective compound to the compound fd in a solvent such as DMF, THF, dichloromethane, acetonitrile etc. in the presence of a dehydration-condensation agent such as dicyclohexylcarbodiimide, carbonyldiimidazole, dicyclohexylcarbodiimido-N-hydroxybenzotriazole, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride, hexafluorophosphoric acid 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium, WSC.HCl etc., and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 1 hour to 48 hours, preferably 2 hours to 24 hours.</p>\n",
       "<heading id=\"h-0287\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0433\" num=\"0445\">A compound fg can be obtained by subjecting the compound ff to the known general deprotecting reaction concerning a P<sup>2 </sup>group on an amino group, subsequently, adding a base such as an aqueous sodium carbonate solution, an aqueous potassium carbonate solution etc. in a solvent such as water, ethanol, methanol, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at 20° C. to 80° C., preferably 20° C. to 70° C. for 0.5 hour to 24 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0288\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0434\" num=\"0446\">A compound fh can be obtained by subjecting the compound fd to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0289\" level=\"1\">Synthesis of Compound ga (See: Example 51)</heading>\n",
       "<p id=\"p-0435\" num=\"0447\"><chemistry id=\"CHEM-US-00087\" num=\"00087\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00087.TIF\" he=\"68.50mm\" id=\"EMI-C00087\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0290\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0436\" num=\"0448\">A compound ga can be obtained by subjecting a compound dd to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0291\" level=\"1\">Synthesis of Compound hh (See: Example 52)</heading>\n",
       "<p id=\"p-0437\" num=\"0449\"><chemistry id=\"CHEM-US-00088\" num=\"00088\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00088.TIF\" he=\"237.83mm\" id=\"EMI-C00088\" img-content=\"chem\" img-format=\"tif\" wi=\"76.28mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0292\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0438\" num=\"0450\">A compound hb can be obtained by adding O,N-dimethylhydroxylamine hydrochloride to a compound ha in a solvent such as DMF, THF, dichloromethane, acetonitrile etc. in the presence of a dehydration-condensation agent such as dicyclohexylcarbodiimide, carbonyldiimidazole, dicyclohexylcarbodiimido-N-hydroxybenzotriazole, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride, hexafluorophosphoric acid 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium, WSC.HCl, HATU etc., adding a tertiary base such as triethylamine, diisopropylethylamine, N-methylmorpholine etc., and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0293\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0439\" num=\"0451\">A compound hc can be obtained by adding a Grignard reagent (R—MgBr) to the compound hb at −80° C. to −40° C. in the presence of a solvent such as THF, ether, dichloromethane, dioxane etc. or in a mixed solvent thereof, and performing a reaction at −80° C. to 0° C., preferably −60° C. to −20° C. for 0.5 hour to 24 hours, preferably 0.5 hour to 6 hours.</p>\n",
       "<heading id=\"h-0294\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0440\" num=\"0452\">A compound hd can be obtained by adding mCPBA to the compound hc in the presence of a solvent such as chloroform and dichloromethane, and performing a reaction at −20° C. to 30° C., preferably 10° C. to 30° C. for 0.1 hour to 12 hours, preferably 0.5 hour to 6 hours.</p>\n",
       "<heading id=\"h-0295\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0441\" num=\"0453\">A compound he can be obtained by adding an aqueous sodium hydroxide solution to the compound hd in the presence of a solvent such as ethanol etc., and performing a reaction at 0° C. to 120° C., preferably 30° C. to 90° C. for 1 minute to 10 hours, preferably 30 minutes to 120 minutes.</p>\n",
       "<heading id=\"h-0296\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0442\" num=\"0454\">A compound hf can be obtained by subjecting the compound he to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0297\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0443\" num=\"0455\">A compound hg can be obtained by adding a compound R—Br etc. corresponding to an objective compound to a compound he in the presence of a solvent such as chloroform, dichloromethane, THF, toluene etc. or in a mixed solvent thereof, adding a metal base such as sodium hydride, sodium methylate, n-butyllithium etc., and performing a reaction at −20° C. to 120° C., preferably 0° C. to 30° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0298\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0444\" num=\"0456\">A compound hh can be obtained by subjecting the compound hg to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0299\" level=\"1\">Synthesis of Compound is (See: Example 53)</heading>\n",
       "<p id=\"p-0445\" num=\"0457\"><chemistry id=\"CHEM-US-00089\" num=\"00089\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00089.TIF\" he=\"109.05mm\" id=\"EMI-C00089\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0300\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0446\" num=\"0458\">Tertiary amine such as triethylamine, diisopropylethylamine, N-methylmorpholine etc., and a chlorinating reagent such as ethyl chlorocarbonate, and ethyl chloroformate are added to a compound is in the presence of a solvent such as DMF, DMA, NMP, THF etc. or in a mixed solvent thereof, and the mixture is stirred at 0° C. to 30° C. for 0.1 hour to 1 hour. A compound R—SO<sub>2</sub>—NH<sub>2 </sub>(e.g.: methanesulfonylamide) corresponding to an objective substance and DMAP are added thereto, and a reaction is performed at 40° C. to 100° C., preferably 40° C. to 80° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours, thereby, a compound ib can be obtained.</p>\n",
       "<heading id=\"h-0301\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0447\" num=\"0459\">A compound is can be obtained by subjecting the compound ib to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0302\" level=\"1\">Synthesis of Compound je (See: Example 54)</heading>\n",
       "<p id=\"p-0448\" num=\"0460\"><chemistry id=\"CHEM-US-00090\" num=\"00090\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00090.TIF\" he=\"193.04mm\" id=\"EMI-C00090\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0303\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0449\" num=\"0461\">Tertiary amine such as triethylamine, N-methylmorpholine, diisopropylethylamine etc. and ethyl chloroformate or ethyl chlorocarbonate are added to a compound ja in the presence of a solvent such as THF, dioxane, dichloromethane, toluene, DMF etc. or in a mixed solvent thereof. A reducing agent having low reactivity such as sodium borohydride etc. is added thereto, and a reaction is performed at −20° C. to 40° C., preferably −10° C. to 20° C. for 0.2 hour to 12 hours, preferably 0.5 hour to 6 hours to obtain an alcohol intermediate. This intermediate is dissolved in dichloromethane, chloroform, etc., an oxidizing agent such as TEMPO, manganese dioxide, PDC etc. is added, and a reaction is performed at −40° C. to 30° C., preferably 0° C. to 30° C. for 0.1 hour to 24 hours, preferably 0.5 hour to 12 hours, thereby, a compound jb can be obtained.</p>\n",
       "<heading id=\"h-0304\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0450\" num=\"0462\">A compound jc can be obtained by adding 28% aqueous ammonia and iodine to the compound jb in the presence of a solvent such as THF, dioxane, dichloromethane etc., and performing a reaction at 0° C. to 40° C., preferably 10° C. to 30° C. for 0.5 hour to 24 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0305\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0451\" num=\"0463\">A compound jd can be obtained by adding sodium azide, and tertiary amine such as triethylamine, diisopropylethylamine, N-methylmorpholine etc. to the compound jc in the presence of a solvent such as toluene, xylene, THF, dioxane etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0306\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0452\" num=\"0464\">A compound je can be obtained by subjecting the compound jd to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0307\" level=\"1\">Synthesis of Compounds kd and kf (See: Example 56 and Derivative Thereof)</heading>\n",
       "<p id=\"p-0453\" num=\"0465\"><chemistry id=\"CHEM-US-00091\" num=\"00091\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00091.TIF\" he=\"101.26mm\" id=\"EMI-C00091\" img-content=\"chem\" img-format=\"tif\" wi=\"151.47mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>m </sup>is lower alkyl, R is a substituent corresponding to an objective compound, W is —C(═O)— or —SO<sub>2</sub>—, and other each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0308\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0454\" num=\"0466\">Tertiary amine such as triethylamine, N-methylmorpholine, diisopropylethylamine etc. and ethyl chloroformate or ethyl chlorocarbonate are added to a compound ka in the presence of a solvent such as THF, dioxane, dichloromethane, toluene, DMF etc. or in a mixed solvent thereof. Sodium azide is added thereto to perform a reaction at 0° C. to 40° C., preferably 10° C. to 30° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours. Thereafter, an alcohol (R<sup>m</sup>—OH) is added, and a reaction is performed at 20° C. to 60° C., preferably 20° C. to 50° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours, thereby, a compound kb can be obtained.</p>\n",
       "<heading id=\"h-0309\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0455\" num=\"0467\">A compound kc can be obtained by adding a base such as an aqueous sodium hydroxide solution, an aqueous potassium hydroxide solution etc. to the compound kb in a solvent such as ethanol, methanol, water etc. or in a mixed solvent thereof, and performing a reaction at 20° C. to 80° C., preferably 40° C. to 60° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0310\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0456\" num=\"0468\">A compound kd can be obtained by subjecting the compound kc to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0311\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0457\" num=\"0469\">A compound ke can be obtained by adding acid chloride (R—CO—Cl) or sulfonyl chloride (R—SO<sub>2</sub>—Cl) corresponding to an objective substance to a compound kc in a solvent such as THF, dioxane, toluene, dichloromethane etc., adding tertiary amine such as pyridine, triethylamine, N-methylmorpholine etc. as necessary, and performing a reaction at −20° C. to 40° C., preferably 0° C. to 30° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours.</p>\n",
       "<heading id=\"h-0312\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0458\" num=\"0470\">A compound kf can be obtained by subjecting the compound ke to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0313\" level=\"1\">Synthesis of Compound lc (See: Example 60)</heading>\n",
       "<p id=\"p-0459\" num=\"0471\"><chemistry id=\"CHEM-US-00092\" num=\"00092\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00092.TIF\" he=\"109.05mm\" id=\"EMI-C00092\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R is a substituent corresponding to an objective compound, and other each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0314\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0460\" num=\"0472\">Sodium hydride is added to a compound la in a solvent such as THF, dichloromethane, DMF etc. R-L (L is a leaving group such as halogen, OMs etc.) corresponding to an objective substance is added thereto, and a reaction is performed at −20° C. to 40° C., preferably 0° C. to 30° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours, thereby, a compound lb can be obtained.</p>\n",
       "<p id=\"p-0461\" num=\"0473\">Alternatively, a compound lb can be obtained by adding formaldehyde to a compound la in a solvent of formic acid, and performing a reaction at 70° C. to 110° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0315\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0462\" num=\"0474\">A compound lc can be obtained by subjecting the compound lb to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0316\" level=\"1\">Synthesis of Compound md (See: Example 61)</heading>\n",
       "<p id=\"p-0463\" num=\"0475\"><chemistry id=\"CHEM-US-00093\" num=\"00093\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00093.TIF\" he=\"166.12mm\" id=\"EMI-C00093\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R is a substituent corresponding to an objective compound, and other each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0317\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0464\" num=\"0476\">An amino-protected body mb can be obtained by adding Boc<sub>2</sub>O etc. to a compound ma in a solvent such as THF, dioxane, acetonitrile, water etc. or in a mixed solvent thereof, and subjecting this to an amine protecting reaction.</p>\n",
       "<heading id=\"h-0318\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0465\" num=\"0477\">Sodium hydride is added to a compound mb in a solvent such as THF, dichloromethane, DMF etc. R-L (L is a leaving group such as halogen, OMs etc.) corresponding to an objective substance is added thereto, and a reaction is performed at −20° C. to 40° C., preferably 0° C. to 30° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours, thereby, a compound mc can be obtained.</p>\n",
       "<heading id=\"h-0319\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0466\" num=\"0478\">A compound and can be obtained by subjecting the compound mc to the known general amino group and hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0320\" level=\"1\">Synthesis of Compound nc and Compound ne (See: Examples 63 and 64)</heading>\n",
       "<p id=\"p-0467\" num=\"0479\"><chemistry id=\"CHEM-US-00094\" num=\"00094\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00094.TIF\" he=\"137.75mm\" id=\"EMI-C00094\" img-content=\"chem\" img-format=\"tif\" wi=\"75.35mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein X is halogen, M is boronic acid ester such as B(O-phenyl)<sub>3 </sub>etc., and other each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0321\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0468\" num=\"0480\">A compound nb can be obtained by adding a halogenating reagent (e.g. NBS, NCS, bromine etc.) to a compound na in a solvent such as dichloromethane, toluene, THF, dioxane etc., and performing a reaction for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours under the overheating refluxing condition.</p>\n",
       "<heading id=\"h-0322\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0469\" num=\"0481\">A compound nc can be obtained by subjecting the compound nb to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0323\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0470\" num=\"0482\">Boronic acid ester (R-M) corresponding to an objective substance is added to a compound nb in a solvent such as toluene, THF, DMF etc. or in a mixed solvent thereof, and a base such as potassium carbonate, sodium carbonate, sodium hydroxide etc. is added. A O-valent palladium catalyst (e.g.: Pd(PPh<sub>3</sub>)<sub>4</sub>) is added thereto under nitrogen stream, and a reaction is performed at 60° C. to 120° C., preferably 80° C. to 110° C. for 1 hour to 48 hours, preferably 2 hours to 24 hours, thereby, a compound nd can be obtained.</p>\n",
       "<heading id=\"h-0324\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0471\" num=\"0483\">A compound ne can be obtained by subjecting the compound nd to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0325\" level=\"1\">Synthesis of Compound oh (See: Example 65)</heading>\n",
       "<p id=\"p-0472\" num=\"0484\"><chemistry id=\"CHEM-US-00095\" num=\"00095\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00095.TIF\" he=\"219.71mm\" id=\"EMI-C00095\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00096\" num=\"00096\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00096.TIF\" he=\"84.41mm\" id=\"EMI-C00096\" img-content=\"chem\" img-format=\"tif\" wi=\"61.04mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R is a carboxyl protective group such as lower alkyl etc., R<sup>7 </sup>is as defined in item 1′ or item 1, L<sup>1 </sup>is a leaving group such as halogen, OMs, OTs etc., and other symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0326\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0473\" num=\"0485\">A compound ob can be obtained by adding sodium chlorite and amidosulfuric acid to a compound oa in the presence of a solvent such as THF, dioxane, dichloromethane, acetonitrile etc., and performing a reaction at 0° C. to 40° C., preferably 0° C. to 30° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0327\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0474\" num=\"0486\">A compound oc can be obtained by adding a condensation agent such as HATU, WSC.HCl etc. to the compound ob in the presence of a solvent such as DMF, DMA, NMP, THF etc., adding amine (R<sup>3</sup>—NH<sub>2</sub>) corresponding to an objective substance, and tertiary amine such as triethylamine, N-methylmorpholine, pyridine etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0328\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0475\" num=\"0487\">A compound od can be obtained by adding potassium carbonate, sodium carbonate, and O-(2,4-dinitrophenyl)hydroxylamine to the compound oc in the presence of a solvent such as DMF, DMA, NMP, THF etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0329\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0476\" num=\"0488\">A compound oe can be obtained by adding R<sup>5</sup>—C(═O)—R<sup>6 </sup>and acetic acid to the compound od in the presence of a solvent such as toluene, DMF, DMA, NMP, THF etc., and performing a reaction at 60° C. to 120° C., preferably 80° C. to 110° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0330\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0477\" num=\"0489\">A compound of can be obtained by adding a compound R<sup>7</sup>-L<sup>1 </sup>corresponding to an objective substance, and a base such as sodium carbonate, potassium carbonate, cesium carbonate etc. to the compound oe in the presence of a solvent such as DMF, DMA, NMP, THF etc., and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0331\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0478\" num=\"0490\">A compound og can be obtained by subjecting the compound of to the known general carboxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0332\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0479\" num=\"0491\">A compound oh can be obtained by subjecting the compound og to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0333\" level=\"1\">Synthesis of Compound pg (See: Example 95)</heading>\n",
       "<p id=\"p-0480\" num=\"0492\"><chemistry id=\"CHEM-US-00097\" num=\"00097\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00097.TIF\" he=\"224.71mm\" id=\"EMI-C00097\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0334\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0481\" num=\"0493\">A compound pb can be obtained by adding aqueous ammonia to a compound pa, and performing a reaction at 0° C. to 30° C., preferably 10° C. to 30° C. for 0.5 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0335\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0482\" num=\"0494\">A compound pc can be obtained by adding a condensation agent such as HATU, WSC.HCl etc. to the compound pb in the presence of a solvent such as DMF, DMA, NMP, THF etc. or in a mixed solvent thereof, adding amine (R<sup>3</sup>—NH<sub>2</sub>) corresponding to an objective substance and, if necessary, tertiary amine such as triethylamine, N-methylmorpholine etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0336\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0483\" num=\"0495\">A compound pd can be obtained by adding potassium carbonate, sodium carbonate, and O-(2,4-dinitrophenyl)hydroxylamine to the compound pc in the presence of a solvent such as DMF, DMA, NMP, THF etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0337\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0484\" num=\"0496\">A compound pe can be obtained by adding R<sup>5</sup>—C(═O)—R<sup>6 </sup>and acetic acid to the compound pd in the presence of a solvent such as toluene, DMF, DMA, NMP, THF etc., and performing a reaction at 60° C. to 120° C., preferably 80° C. to 110° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours.</p>\n",
       "<heading id=\"h-0338\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0485\" num=\"0497\">A compound pf can be obtained by adding a compound R<sup>7</sup>-L<sup>1 </sup>corresponding to an objective substance, and a base such as sodium carbonate, potassium carbonate, cesium carbonate etc. to the compound pe in the presence of a solvent such as DMF, DMA, NMP, THF etc., and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0339\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0486\" num=\"0498\">A compound pg can be obtained by subjecting the compound pf to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0340\" level=\"1\">Synthesis of Compound qg, Compound qi, and Compound qk (See: Example 128)</heading>\n",
       "<p id=\"p-0487\" num=\"0499\"><chemistry id=\"CHEM-US-00098\" num=\"00098\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00098.TIF\" he=\"224.87mm\" id=\"EMI-C00098\" img-content=\"chem\" img-format=\"tif\" wi=\"158.16mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R represents a carboxyl protective group, n represents an integer of 0 to 6, R<sup>Z7 </sup>and R<sup>Z8 </sup>are as defined in item 1′ or item 1, and other each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0341\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0488\" num=\"0500\">A compound qc can be obtained by adding a condensation agent such as HATU, WSC.HCl etc. to a compound qa in the presence of a solvent such as pyridine, DMF, DMA, NMP, THF etc. or in a mixed solvent thereof, adding a compound qb and, if necessary, tertiary amine such as triethylamine, N-methylmorpholine etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0342\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0489\" num=\"0501\">A compound qd can be obtained by adding potassium carbonate, sodium carbonate, and O-(2,4-dinitrophenyl)hydroxylamine to the compound qc in the presence of a solvent such as DMF, DMA, NMP, THF etc. or in a mixed solvent thereof, and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0343\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0490\" num=\"0502\">A compound pe can be obtained by adding R<sup>5</sup>—C(═O)—R<sup>6 </sup>and acetic acid to the compound qd in the presence of a solvent such as toluene, DMF, DMA, NMP, THF etc. or in a mixed solvent thereof, and performing a reaction at 60° C. to 120° C., preferably 80° C. to 110° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours.</p>\n",
       "<p id=\"p-0491\" num=\"0503\">Alternatively, a compound qe can be obtained by performing a reaction at 100° C. to 200° C. for 5 minutes to 1 hour under microwave irradiation condition in a solvent such as ethanol, isopropyl alcohol etc.</p>\n",
       "<heading id=\"h-0344\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0492\" num=\"0504\">A compound qf can be obtained by adding a compound R<sup>7</sup>-L<sup>1 </sup>corresponding to an objective substance, and a base such as sodium carbonate, potassium carbonate, cesium carbonate etc. to the compound qe in the presence of a solvent such as DMF, DMA, NMP etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0345\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0493\" num=\"0505\">A compound qg can be obtained by subjecting the compound qf to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0346\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0494\" num=\"0506\">A compound qh can be obtained by subjecting the compound qf to the known general carboxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0347\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0495\" num=\"0507\">A compound qi can be obtained by subjecting the compound qh to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0348\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0496\" num=\"0508\">A compound qj can be obtained by adding a condensation agent such as HATU, WSC.HCl etc. to a compound qh in the presence of a solvent such as pyridine, DMF, DMA, NMP, THF etc. or in a mixed solvent thereof, adding a compound HNR<sup>Z7</sup>R<sup>Z8 </sup>and, if necessary, tertiary amine such as triethylamine, diisopropylethylamine, N-methylmorpholine etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0349\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-0497\" num=\"0509\">A compound qk can be obtained by subjecting the compound qj to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0350\" level=\"1\">Synthesis of Compound qq, Compound qs, Compound qu, and Compound qw (See: Example 128)</heading>\n",
       "<p id=\"p-0498\" num=\"0510\"><chemistry id=\"CHEM-US-00099\" num=\"00099\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00099.TIF\" he=\"234.10mm\" id=\"EMI-C00099\" img-content=\"chem\" img-format=\"tif\" wi=\"155.36mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00100\" num=\"00100\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00100.TIF\" he=\"36.75mm\" id=\"EMI-C00100\" img-content=\"chem\" img-format=\"tif\" wi=\"109.30mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>Z2</sup>, R<sup>Z4</sup>, R<sup>Z9</sup>, R<sup>Z10</sup>, and R<sup>Z13 </sup>are as defined in item 1′ or item 1, and other each symbol is as defined above)\n",
       "<br/>\n",
       "Step 1\n",
       "</p>\n",
       "<p id=\"p-0499\" num=\"0511\">A compound qm can be obtained by adding a condensation agent such as HATU, WSC.HCl, etc. to a compound qa in the presence of a solvent such as pyridine, DMF, DMA, NMP etc. or in a mixed solvent thereof, adding a compound ql and, if necessary, tertiary amine such as triethylamine, diisopropylethylamine, N-methylmorpholine, etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0351\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0500\" num=\"0512\">A compound qn can be obtained by adding potassium carbonate, sodium carbonate, and O-(2,4-dinitrophenyl)hydroxylamine to the compound qm in the presence of a solvent such as DMF, DMA, NMP, THF etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0352\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0501\" num=\"0513\">A compound pe can be obtained by adding R<sup>5</sup>—C(═O)—R<sup>6 </sup>and acetic acid to the compound qn in the presence of a solvent such as toluene, DMF, DMA, NMP, THF etc. or in a mixed solvent thereof, and performing a reaction at 60° C. to 120° C., preferably 80° C. to 110° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours.</p>\n",
       "<p id=\"p-0502\" num=\"0514\">Alternatively, a compound qo can be obtained by performing a reaction at 100° C. to 200° C. for 5 minutes to 1 hour under microwave irradiation condition in a solvent such as ethanol etc.</p>\n",
       "<heading id=\"h-0353\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0503\" num=\"0515\">A compound qp can be obtained by adding a compound R<sup>7</sup>-L<sup>1 </sup>corresponding to an objective substance, and a base such as sodium carbonate, potassium carbonate, cesium carbonate, etc. to the compound qo in the presence of a solvent such as DMF, DMA, NMP, THF, etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0354\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0504\" num=\"0516\">A compound qq can be obtained by subjecting the compound qp to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0355\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0505\" num=\"0517\">A compound qr can be obtained by subjecting the compound qp to the known general amino group deprotecting reaction.</p>\n",
       "<heading id=\"h-0356\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0506\" num=\"0518\">A compound qs can be obtained by subjecting the compound qr to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0357\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0507\" num=\"0519\">A compound qt can be obtained by adding a compound R<sup>Z10</sup>-L<sup>1 </sup>corresponding to an objective substance, and a base such as sodium carbonate, potassium carbonate, cesium carbonate, etc. to the compound qr in the presence of a solvent such as DMF, DMA, NMP, THF, etc. or in a solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0358\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-0508\" num=\"0520\">A compound qu can be obtained by subjecting the compound qt to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0359\" level=\"1\">Tenth Step</heading>\n",
       "<p id=\"p-0509\" num=\"0521\">A base such as sodium carbonate, potassium carbonate, cesium carbonate etc. is added to the compound qr in the presence of a solvent such as THF, dioxane, dichloromethane, acetonitrile, etc. A compound (R<sup>Z4</sup>COCl, R<sup>Z2</sup>SO<sub>2</sub>Cl, or R<sup>Z13</sup>OCOCl) corresponding to an objective substance is added thereto, and a reaction is performed at −20° C. to 60° C., preferably 0° C. to 30° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours, thereby, a compound qv can be obtained.</p>\n",
       "<heading id=\"h-0360\" level=\"1\">Eleventh Step</heading>\n",
       "<p id=\"p-0510\" num=\"0522\">A compound qw can be obtained by subjecting the compound qv to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0361\" level=\"1\">Synthesis of Compound rb (See: Example 155)</heading>\n",
       "<p id=\"p-0511\" num=\"0523\"><chemistry id=\"CHEM-US-00101\" num=\"00101\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00101.TIF\" he=\"71.54mm\" id=\"EMI-C00101\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein each symbol is as defined above)\n",
       "</p>\n",
       "<p id=\"p-0512\" num=\"0524\">A compound rb can be obtained by adding a compound R<sup>3</sup>NH<sub>2 </sub>having a substituent corresponding to an objective compound to a compound ra in the presence of a dehydration-condensation agent such as dicyclohexylcarbodiimide, carbonyldiimidazole, dicyclohexylcarbodiimido-N-hydroxybenzotriazole, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride, hexafluorophosphoric acid 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium, WSC.HCl, HATU, etc. in a solvent such as DMF, THF, dichloromethane, acetonitrile, etc. or in a mixed solvent thereof, and performing a reaction at −20° C. to 60° C., preferably −10° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<p id=\"p-0513\" num=\"0525\">Alternatively, a compound rb can be obtained by adding an acylating reagent such as diphenylchlorophosphate, thionyl chloride, oxalyl chloride, etc. to a compound ra in the presence or absence of a base such as pyridine, triethylamine, diisopropylethylamine, 1-methylimidazole, etc. in the presence of a solvent such as THF, dioxane, dichloromethane, DMF, etc. to generate acid chloride, adding a compound R<sup>3</sup>—NH<sub>2 </sub>having a substituent corresponding to an objective compound, and performing a reaction at −20° C. to 60° C., preferably −10° C. to 40° C. for 0.1 hour to 24 hours, preferably 0.5 hour to 12 hours.</p>\n",
       "<heading id=\"h-0362\" level=\"1\">Synthesis of Compound sl (See: Example 49)</heading>\n",
       "<p id=\"p-0514\" num=\"0526\"><chemistry id=\"CHEM-US-00102\" num=\"00102\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00102.TIF\" he=\"242.99mm\" id=\"EMI-C00102\" img-content=\"chem\" img-format=\"tif\" wi=\"75.35mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00103\" num=\"00103\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00103.TIF\" he=\"34.29mm\" id=\"EMI-C00103\" img-content=\"chem\" img-format=\"tif\" wi=\"70.44mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein P<sup>3 </sup>is an amino protective group, and may be a group which can be protected and/or deprotected by the method described in Protective Groups in Organic Synthesis, Theodora W Green (John Wiley &amp; Sons) etc. and, for example, P<sup>3 </sup>is aryl lower alkyloxycarbonyl, lower alkylcarbonyl, etc. B is as defined in item 1′ or item 1, and other each symbol is as defined above.)\n",
       "</p>\n",
       "<heading id=\"h-0363\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0515\" num=\"0527\">A compound sb can be obtained by adding an oxidizing reagent such as Dess Martin Periodinane, manganese dioxide, PDC, etc, to a compound sa in the presence of a solvent such as dichloromethane, THF, dioxane, toluene etc., and performing a reaction at −20° C. to 60° C., preferably 0° C. to 40° C. for 0.1 hour to 24 hours, preferably 0.5 hour to 12 hours.</p>\n",
       "<heading id=\"h-0364\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0516\" num=\"0528\">A compound sd can be obtained by adding sodium sulfate and an aminoalcohol sc corresponding to an objective substance to the compound sb in the presence or absence of a solvent such as toluene, THF etc., and performing a reaction at 0° C. to 80° C., preferably 20° C. to 60° C. for 0.1 hour to 24 hours, preferably 0.5 hour to 12 hours.</p>\n",
       "<heading id=\"h-0365\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0517\" num=\"0529\">A compound se can be obtained by subjecting the compound sd to the known general amino group deprotecting reaction.</p>\n",
       "<heading id=\"h-0366\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0518\" num=\"0530\">A compound sg can be obtained by adding a compound sf to the compound se in the presence of a solvent such as toluene, THF, dioxane etc., and performing a reaction at 40° C. to 110° C., preferably 60° C. to 100° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0367\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0519\" num=\"0531\">A compound sh can be obtained by subjecting the compound sg to the known general amino group deprotecting reaction and, thereafter, performing a reaction at 40° C. to 110° C., preferably 60° C. to 100° C. for 0.1 hour to 12 hours, preferably 0.2 hour to 6 hours in the presence of a solvent such as toluene, THF, dioxane, etc.</p>\n",
       "<heading id=\"h-0368\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0520\" num=\"0532\">A compound si can be obtained by subjecting the compound sh to the known general carboxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0369\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0521\" num=\"0533\">A compound sj can be obtained by subjecting the compound si to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0370\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0522\" num=\"0534\">A decarbonized compound sk can be obtained by reacting the compound si for 1 minute to 2 hours under microwave irradiation in a solvent such as diphenyl ether etc.</p>\n",
       "<heading id=\"h-0371\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-0523\" num=\"0535\">A compound sl can be obtained by subjecting the compound sk to the known general hydroxyl group deprotecting reaction.</p>\n",
       "<heading id=\"h-0372\" level=\"1\">Synthesis of Compound un (See: Example 177)</heading>\n",
       "<p id=\"p-0524\" num=\"0536\"><chemistry id=\"CHEM-US-00104\" num=\"00104\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00104.TIF\" he=\"201.93mm\" id=\"EMI-C00104\" img-content=\"chem\" img-format=\"tif\" wi=\"137.33mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein L<sup>1 </sup>represents a leaving group such as halogen, OMs, OTs etc., and other each symbol is as defined above)\n",
       "</p>\n",
       "<heading id=\"h-0373\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0525\" num=\"0537\">A compound ub can be obtained by subjecting a compound ua to a secondary amino group protecting reaction.</p>\n",
       "<heading id=\"h-0374\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0526\" num=\"0538\">A compound uc can be obtained by subjecting the compound ub to a general amino group protecting reaction.</p>\n",
       "<heading id=\"h-0375\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0527\" num=\"0539\">A compound ue can be obtained by adding a compound R<sup>7</sup>-L<sup>1 </sup>corresponding to an objective compound to the compound uc in the presence of a solvent such as DMF, DMA, NMP, etc. and a base such as NaH etc., and performing a reaction at 0° C. to 80° C., preferably 20° C. to 60° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0376\" level=\"1\">Fourth Step, Fifth Step</heading>\n",
       "<p id=\"h-0377\" num=\"0000\">(wherein R<sup>3 </sup>and R<sup>7 </sup>may be bound adjacently and, in this case, a fourth step and a fifth step are performed simultaneously).</p>\n",
       "<p id=\"p-0528\" num=\"0540\">A compound ue can be obtained by reacting a compound ud sequentially with compounds corresponding to an objective compound, R<sup>3</sup>-L<sup>1 </sup>and R7-L<sup>1 </sup>in the presence of a solvent such as DMF, DMA, NMP etc. and a base such as NaH etc.</p>\n",
       "<heading id=\"h-0378\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0529\" num=\"0541\">A compound ug can be obtained by subjecting a compound of to a secondary amino group protecting reaction.</p>\n",
       "<heading id=\"h-0379\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0530\" num=\"0542\">A compound uh can be obtained by subjecting the compound ug to a secondary amino group protecting reaction.</p>\n",
       "<heading id=\"h-0380\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0531\" num=\"0543\">A compound ue can be obtained by adding a base such as NaH etc. to the compound uh in the presence of a solvent such as DMF, DMA, NMP, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction with a compound R3-L<sup>1 </sup>corresponding to an objective compound.</p>\n",
       "<heading id=\"h-0381\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-0532\" num=\"0544\">A compound uj can be obtained by subjecting the compound ue to a general secondary amine deprotecting reaction.</p>\n",
       "<heading id=\"h-0382\" level=\"1\">Tenth Step</heading>\n",
       "<p id=\"p-0533\" num=\"0545\">A compound ul can be obtained by adding a condensation agent such as HATU, WSC.HCl etc. to a compound uk in the presence of a solvent such as DMF, DMA, THF, etc., adding amine uj corresponding to an objective substance, and tertiary amine such as pyridine, triethylamine, N-methylmorpholine etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0383\" level=\"1\">Eleventh Step</heading>\n",
       "<p id=\"p-0534\" num=\"0546\">A compound um can be obtained by subjecting the compound ul to a general amino group protecting reaction.</p>\n",
       "<heading id=\"h-0384\" level=\"1\">Twelfth Step</heading>\n",
       "<p id=\"p-0535\" num=\"0547\">A compound un can be obtained by adding R<sup>5</sup>—C(═O)—R<sup>6</sup>, tertiary amine such as, triethylamine, diisopropylethylamine, N-methylmorpholine, etc. to the compound um in the presence of a solvent such as toluene, DMF, DMA, NMP etc., and performing a reaction at 60° C. to 120° C., preferably 80° C. to 100° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0385\" level=\"1\">Synthesis of Compound te</heading>\n",
       "<p id=\"p-0536\" num=\"0548\"><chemistry id=\"CHEM-US-00105\" num=\"00105\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00105.TIF\" he=\"131.91mm\" id=\"EMI-C00105\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R′ may be a group which can be protected and/or deprotected by the method described in Protective Groups in Organic Synthesis, Theodora W Green (John Wiley &amp; Sons) etc. and, for example, R′ is lower alkyl etc. X is halogen, and other each symbol is as defined above.)\n",
       "</p>\n",
       "<heading id=\"h-0386\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0537\" num=\"0549\">An alcohol (P<sup>1</sup>—OH) corresponding to an objective substance is added to an organometallic base such as sodium tert-pentoxide, n-butyllithium, tert-butyllithium etc. in a solvent such as THF, ether, dichloromethane, DMI, DMF, DMA, etc. or in a mixed solution thereof. A solution of a compound to is added dropwise thereto, and a reaction is performed at −20° C. to 40° C., preferably 0° C. to 30° C. for 0.1 hour to 12 hours, preferably 0.5 hour to 6 hours, thereby, a compound tb can be obtained.</p>\n",
       "<heading id=\"h-0387\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0538\" num=\"0550\">A compound tc can be obtained by adding N,N-dimethylformamidodimethylacetal to the compound tb in a solvent such as THF, dioxane, toluene, ethyl acetate etc. or in a mixed solvent thereof, or without a solvent, and performing a reaction at 0° C. to 80° C., preferably 20° C. to 40° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0388\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0539\" num=\"0551\">A compound td corresponding to an objective substance is added to an organometallic base such as sodium tert-pentoxide, n-butyllithium, tert-butyllithium, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium tert-butoxide etc. in a solvent such as THF, ether, DMI, methanol, ethanol, etc. or in a mixed solvent thereof. A solution of the compound tc is added dropwise thereto, a reaction is performed at −20° C. to 60° C., preferably 0° C. to 30° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours and, thereafter, an acid such as hydrochloric acid, sulfuric acid etc. is added to perform a reaction at −20° C. to 60° C., preferably 0° C. to 30° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours, thereby, a compound to can be obtained.</p>\n",
       "<heading id=\"h-0389\" level=\"1\">Synthesis of Compound tm and Compound tp (See: Examples 165, and 169)</heading>\n",
       "<p id=\"p-0540\" num=\"0552\"><chemistry id=\"CHEM-US-00106\" num=\"00106\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00106.TIF\" he=\"232.49mm\" id=\"EMI-C00106\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00107\" num=\"00107\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00107.TIF\" he=\"173.57mm\" id=\"EMI-C00107\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein R<sup>P </sup>may be an acetal protective group which can protect and/or can be deprotected by the method described in Protective Groups in Organic Synthesis, Theodora W Green (John Wiley &amp; Sons) etc. and, for example, R<sup>P </sup>is lower alkyl etc. Other each symbol is as defined above.)\n",
       "</p>\n",
       "<heading id=\"h-0390\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0541\" num=\"0553\">A compound th can be obtained by adding allylamine to a compound tf which can be synthesized by the same method as that of a compound to in the presence of a solvent such as ethanol, THF, dioxane, acetonitrile, etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 80° C., preferably 20° C. to 60° C. for 0.5 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0391\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0542\" num=\"0554\">A compound ti can be obtained by adding a compound tg to a compound tf in the presence of a solvent such as ethanol, THF, dioxane, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 80° C., preferably 20° C. to 60° C. for 0.5 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0392\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0543\" num=\"0555\">A compound tj can be obtained by adding potassium osmate dihydrate, sodium periodate, and water to the compound th in the presence of a solvent such as THF, ethyl acetate, dioxane, etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<p id=\"p-0544\" num=\"0556\">Alternatively, a compound tj can be obtained by introducing ozone into the compound th at −10° C. to 20° C. in the presence of a solvent such as THF, ethyl acetate, dioxane etc. or in a mixed solvent thereof and, subsequent to completion of the reaction, adding zinc-acetic acid, (EtO)<sub>3</sub>P, or dimethyl sulfide.</p>\n",
       "<heading id=\"h-0393\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0545\" num=\"0557\">A compound tk can be obtained by adding an acid such as formic acid, trifluoroacetic acid, paratoluenesulfonic acid, etc. to the compound ti in a solvent such as acetone, acetonitrile, ethanol, water, etc. or in a mixed solvent thereof, or adding sulfuric acid in a formic acid solvent, and performing a reaction at 0° C. to 90° C., preferably 20° C. to 80° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0394\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0546\" num=\"0558\">A compound tm can be obtained by adding a compound tl and acetic acid to the compound tj or the compound tk in the presence of a solvent such as chloroform, dichloromethane, THF, etc., and performing a reaction at 0° C. to 40° C., preferably 10° C. to 30° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0395\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0547\" num=\"0559\">A compound to can be obtained by adding a compound to and acetic acid to the compound tj or the compound tk in the presence of a solvent such as chloroform, dichloromethane, THF, etc., and performing a reaction at 0° C. to 40° C., preferably 10° C. to 30° C. for 0.5 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<heading id=\"h-0396\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0548\" num=\"0560\">A compound tp can be obtained by adding a compound B-L<sup>1 </sup>corresponding to an objective compound to the compound to in the presence of a solvent such as DMF, DMA, NMP, THF, etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 80° C., preferably 20° C. to 60° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0397\" level=\"1\">Synthesis of Compound vf (See: Examples 583 and 584)</heading>\n",
       "<p id=\"p-0549\" num=\"0561\"><chemistry id=\"CHEM-US-00108\" num=\"00108\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00108.TIF\" he=\"202.35mm\" id=\"EMI-C00108\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "(wherein Y1 is a substituent corresponding to R<sup>3 </sup>or R<sup>3a</sup>, and Y2 is a substituent corresponding to R<sup>11 </sup>or R<sup>11a</sup>. Other each symbol is as defined above.)\n",
       "</p>\n",
       "<heading id=\"h-0398\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0550\" num=\"0562\">A compound vc can be obtained by adding a compound vb having a substituent corresponding to an objective compound to a compound va in the presence of a dehydration-condensation agent such as dicyclohexylcarbodiimide, carbonyldiimidazole, dicyclohexylcarbodiimido-N-hydroxybenzotriazole, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride, hexafluorophosphoric acid 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium, WSC.HCl, HATU, etc. in a solvent such as DMF, THF, dichloromethane, acetonitrile etc. or in a mixed solvent thereof, and performing a reaction at −20° C. to 60° C., preferably −10° C. to 40° C. for 0.1 hour to 24 hours, preferably 1 hour to 12 hours.</p>\n",
       "<p id=\"p-0551\" num=\"0563\">Alternatively, a compound vc can be obtained by adding an acylating reagent such as diphenylchlorophosphate, thionyl chloride, oxalyl chloride etc. to a compound va in the presence or absence of a base such as pyridine, triethylamine, diisopropylethylamine, 1-methylimidazole, etc. in the presence of a solvent such as THF, dioxane, dichloromethane, DMF etc., thereby, generating acid chloride, and adding a compound vb having a substituent corresponding to an objective compound, and performing a reaction at −20° C. to 60° C., preferably −10° C. to 40° C. for 0.1 hour to 24 hours, preferably 0.5 hour to 12 hours.</p>\n",
       "<heading id=\"h-0399\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0552\" num=\"0564\">A compound vd can be obtained by adding potassium carbonate, sodium carbonate, and O-(2,4-dinitrophenyl)hydroxylamine to the compound vc in the presence of a solvent such as DMF, DMA, NMP, THF, etc., and performing a reaction at 10° C. to 60° C., preferably 20° C. to 40° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<heading id=\"h-0400\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0553\" num=\"0565\">A deprotecting reaction of an acetal protective group of the compound vd can be performed by the general method described in Protective Groups in Organic Synthesis, Theodora W Green (John Wiley &amp; Sons) etc. Thereafter, a generated aldehyde group is subjected to an intramolecular reaction, thereby, a compound ve can be obtained.</p>\n",
       "<p id=\"p-0554\" num=\"0566\">For example, a compound ve can be obtained by adding acetic acid and/or paratoluenesulfonic acid to the compound vd in the presence of a solvent such as DMF, toluene, THF, etc., and performing a reaction at 10° C. to 80° C., preferably 30° C. to 60° C. for 0.5 hour to 12 hours, preferably 1 hour to 6 hours.</p>\n",
       "<heading id=\"h-0401\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0555\" num=\"0567\">A compound of can be obtained by adding a compound R<sup>7</sup>-L<sup>1 </sup>corresponding to an objective substance, and a base such as sodium carbonate, potassium carbonate, cesium carbonate, etc. to the compound ve in the presence of a solvent such as DMF, DMA, NMP, THF, etc. or in a mixed solvent thereof, and performing a reaction at 0° C. to 60° C., preferably 10° C. to 40° C. for 0.1 hour to 48 hours, preferably 1 hour to 24 hours.</p>\n",
       "<p id=\"p-0556\" num=\"0568\">The present invention will be explained in more detail below by way of Examples and Reference Examples, as well as Test Examples of the present invention, but the present invention is not limited by them.</p>\n",
       "<heading id=\"h-0402\" level=\"1\">Example 1</heading>\n",
       "<p id=\"p-0557\" num=\"0569\"><chemistry id=\"CHEM-US-00109\" num=\"00109\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00109.TIF\" he=\"243.08mm\" id=\"EMI-C00109\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00110\" num=\"00110\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00110.TIF\" he=\"139.45mm\" id=\"EMI-C00110\" img-content=\"chem\" img-format=\"tif\" wi=\"71.88mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0403\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0558\" num=\"0570\">A dichloromethane (90 mL) solution of compound 1A (12.8 g, 89.4 mmol) and pyridine (8.50 g, 107 mmol) was cooled to 1 to 3° C., and a dichloromethane (90 mL) solution of benzyloxyacetyl chloride (19.8 g, 107 mmol) was added dropwise over 50 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, temperature was gradually raised to 15° C. over 60 minutes, and ice water was added. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane once. The combined extracts were washed with water three times, washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with n-hexane and, then, with n-hexane-ethyl acetate (1:1, v/v). Concentration of objective fraction afforded 22.2 g of compound 1B as an oil.</p>\n",
       "<p id=\"p-0559\" num=\"0571\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.25 (3H, t, J=7.2 Hz), 2.90 (3H, brs), 3.24 (3H, brs), 4.15 (2H, q, J=7.2 Hz), 4.45 (2H, s), 4.58 (2H, s), 7.25-7.38 (5H, m), 7.72 (1H, s).</p>\n",
       "<heading id=\"h-0404\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0560\" num=\"0572\">A 1N lithiumhexamethyldisilazane THF solution (4.29 ml, 4.29 mmol) was cooled to −78° C., and a THF solution (4 ml) of compound 1B (500 mg, 1.72 mmol) and cinnamoyl chloride (343.2 mg, 2.06 mmol) were added dropwise thereto over 3 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 25 minutes, 2N hydrochloric acid (10 ml) was added, and the mixture was further stirred at room temperature for 10 minutes. To the reaction solution was added ethyl acetate, the organic layer was separated, and the aqueous layer was extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. From fraction eluted with n-hexane-ethyl acetate (1:1, v/v), 364.3 mg (yield 56%) of compound 1C was obtained as a solid.</p>\n",
       "<p id=\"p-0561\" num=\"0573\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.40 (3H, t, J=7.2 Hz), 4.39 (2H, q, J=7.2 Hz), 5.27 (2H, s), 6.99 (1H, d, J=16.2 Hz), 7.23 (1H, d, J=16.2), 7.26-7.48 (10H, m), 8.45 (1H, s).</p>\n",
       "<heading id=\"h-0405\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0562\" num=\"0574\">To a MeCN (5 ml) solution of compound 1C and ruthenium chloride (2.76 mg, 0.0133 mmol) was added dropwise an aqueous solution (8 ml) of sodium periodate (625.8 mg, 2.93 mmol) and 96% sulfuric acid (287.4 mg, 2.93 mmol) over 10 minutes at room temperature under nitrogen stream. After the reaction solution was stirred at the same temperature for 5 minutes, ethyl acetate was added, the organic layer was separated, and the aqueous layer was extracted with ethyl acetate two times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. From fraction eluted with n-hexane-ethyl acetate (1:1, v/v), 303.2 mg (yield 75%) of compound 1D was obtained as an oil.</p>\n",
       "<p id=\"p-0563\" num=\"0575\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.39 (3H, t, J=6.9 Hz), 4.40 (2H, q, J=6.9 Hz), 5.54 (2H, s), 7.37 (5H, s), 8.48 (1H, s), 9.85 (1H, s).</p>\n",
       "<heading id=\"h-0406\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0564\" num=\"0576\">To a MeCN (15 ml) solution of compound 1D (1.00 g, 3.31 mmol) was added an aqueous solution (10 ml) of 96% sulfuric acid (421.7 mg, 4.30 mmol) and amidosululic acid (642.7 mg, 6.62 mmol) at room temperature, the mixture was stirred, and an aqueous solution (10 ml) of sodium chlorite (388.9 mg, 4.30 mmol) was added dropwise over 5 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 5 minutes, an aqueous saturated sodium chloride solution was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-MeOH (7:3, v/v). Concentration of objective fraction afforded 748.8 mg (yield 71%) of compound 1E as an oil.</p>\n",
       "<p id=\"p-0565\" num=\"0577\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.40 (3H, t, J=7.2 Hz), 3.93 (1H, br s), 4.40 (2H, q, J=7.2 Hz), 5.61 (2H, s), 7.38-7.44 (10H, m), 8.52 (1H, s).</p>\n",
       "<heading id=\"h-0407\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0566\" num=\"0578\">To a DMF (10 ml) solution of compound 1E (1.00 g, 3.14 mmol) were added WSC.HCl (1.20 g, 6.28 mmol) and HOBt (551.6 mg, 4.08 mmol) at room temperature, and the mixture was stirred at the same temperature for 90 minutes. The reaction solution was cooled to 0° C., and a DMF (2 ml) solution of 2-methoxyethanamine (236.0 mg, 3.14 mmol) was added dropwise over 3 minutes. The reaction solution was stirred at the same temperature for 1 hour, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (1:1, v/v) and, then, with n-hexane-ethyl acetate (1:9, v/v). Concentration of objective fraction afforded 928.5 mg (yield 79%) of compound 1F as an oil.</p>\n",
       "<p id=\"p-0567\" num=\"0579\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.39 (3H, t, J=7.2 Hz), 3.29 (3H, s), 3.41 (2H, t, J=5.4 Hz), 3.47-3.53 (2H, m), 4.39 (2H, q, J=7.2 Hz), 5.44 (2H, s), 7.36 (3H, m), 7.44-7.47 (2H, m), 8.07 (1H, br s), 8.54 (1H, s).</p>\n",
       "<heading id=\"h-0408\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0568\" num=\"0580\">A xylene (2 ml) solution of compound 1F (500 mg, 1.33 mmol) and (S)-2-amino-3-phenylpropan-1-ol (604.2 mg, 4.0 mmol) was heated to 120° C., and stirred for 30 minutes. After the reaction solution was cooled to room temperature, and the solvent was distilled off, the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-MeOH (9:1, v/v). Concentration of objective fraction afforded 487 mg (yield 72%) of compound 1G as an oil.</p>\n",
       "<p id=\"p-0569\" num=\"0581\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.41 (3H, t, J=6.9 Hz), 2.24-2.34 (1H, m), 2.24-3.00 (1H, m), 3.03-3.16 (1H, m), 3.05 (3H, m), 3.25-3.32 (2H, m), 4.13-4.19 (1H, m), 4.17-4.30 (1H, m), 4.36-4.47 (1H, m), 4.51-4.54 (1H, m), 4.55 (1H, d, J=10.5 Hz), 5.78 (1H, t, J=6.9 Hz), 7.17-7.26 (4H, m), 7.28-7.35 (5H, m), 7.49 (1H, t, J=5.4 Hz), 6.32 (1H, s).</p>\n",
       "<heading id=\"h-0409\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0570\" num=\"0582\">To a THF (6 ml) solution of compound 1G (2.86 g, 5.63 mmol) and triphenylphosphine (2.21 g, 8.45 mmol) was added dropwise a DEAD 40 wt % toluene solution (3.68 g, 8.45 mmol) at room temperature over 3 minutes. The reaction solution was stirred at the same temperature for 30 minutes, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (9:1, v/v), 1.37 g (yield 50%) of compound 1H was obtained as an oil.</p>\n",
       "<p id=\"p-0571\" num=\"0583\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.31 (3H, t, J=7.2 Hz), 3.07 (2H, d, J=6.9 Hz), 3.33 (3H, s), 3.57-3.80 (4H, m), 3.95 (1H, dd, J=3.0 Hz, 6.6 Hz), 4.01-4.14 (1H, m), 4.16-4.34 (2H, m), 5.24 (1H, d, J=9.9 Hz), 5.51 (1H, d, J=9.9 Hz), 7.01-7.03 (2H, m), 7.21-7.37 (5H, m), 7.41-7.58 (1H, m), 7.64-7.69 (2H, m).</p>\n",
       "<heading id=\"h-0410\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0572\" num=\"0584\">To an EtOH (6 ml) solution of compound 1H (1.0 g, 2.04 mmol) was added a 2N aqueous sodium hydroxide solution (6 ml), and the mixture was stirred at room temperature for 30 minutes. The reaction solution was neutralized with 2N hydrochloric acid, and the precipitated solid was filtered, and dried to obtain 754 mg (yield 80%) of compound 1I.</p>\n",
       "<p id=\"p-0573\" num=\"0585\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.10 (2H, d, J=7.8 Hz), 3.33 (3H, s), 3.57-3.69 (4H, m), 3.82-3.90 (1H, m), 3.95 (1H, dd, J=3.3 Hz, 13.8 Hz), 4.36 (1H, dd, J=6.3 Hz, 7.5 Hz), 5.36 (1H, d, J=10.2 Hz), 5.45 (1H, d, J=10.2 Hz), 6.98-7.01 (2H, m), 7.28-7.39 (6H, m), 7.59 (2H, dd, J=1.8 Hz, 8.1 Hz), 7.87 (1H, s).</p>\n",
       "<heading id=\"h-0411\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-0574\" num=\"0586\">Compound 1I (1.0 g, 2.16 mmol) was dissolved in THF (10 ml), 10% Pd—C (200 mg) was added, and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was washed with ether to obtain 512 mg (yield 64%) of compound 1.</p>\n",
       "<p id=\"p-0575\" num=\"0587\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 6.24 (2H, d, J=6.3 Hz), 3.36 (3H, s), 3.60-3.86 (5H, m), 4.14 (1H, d, J=12.9 Hz), 4.47 (1H, s), 7.03-7.05 (2H, m), 7.30-7.35 (3H, m), 7.88 (1H, s), 12.68 (1H, s), 14.83 (1H, s).</p>\n",
       "<heading id=\"h-0412\" level=\"1\">Example 2</heading>\n",
       "<p id=\"p-0576\" num=\"0588\"><chemistry id=\"CHEM-US-00111\" num=\"00111\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00111.TIF\" he=\"242.32mm\" id=\"EMI-C00111\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00112\" num=\"00112\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00112.TIF\" he=\"48.18mm\" id=\"EMI-C00112\" img-content=\"chem\" img-format=\"tif\" wi=\"40.22mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0413\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0577\" num=\"0589\">To (S)-tert-butyl 3-hydroxy-1,1-diphenylpropan-2-ylcarbamate (5.00 g, 15.3 mmol) was added trifluoroacetic acid (40 ml), and the mixture was stirred for 1 hour under ice-cooling. After trifluoroacetic acid was distilled off, toluene was added, and distilled off again under reduced pressure to obtain crude (S)-2-amino-3,3-diphenylpropan-1-ol. To the resulting (S)-2-amino-3,3-diphenylpropan-1-ol were added compound 1F (5.73 g, 15.3 mmol), toluene (50 ml), and triethylamine (6.4 ml, 45.8 mmol), the mixture was stirred at 90° C. for 1 hour, and cooled to room temperature and, thereafter, the solvent was distilled off. To the resulting residue was added dichloromethane, and the mixture was washed with 2N hydrochloric acid, an aqueous saturated sodium bicarbonate solution, and an aqueous saturated sodium chloride solution. After separation of the organic layer, after magnesium sulfate was added, the mixture was filtered with celite, and the filtrate was distilled off to obtain candy-like compound 2A (9.12 g).</p>\n",
       "<p id=\"p-0578\" num=\"0590\">MS: m/z=585.2 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0414\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0579\" num=\"0591\">The compound 2A (8.60 g, 14.7 mmol) and triphenylphosphine (7.72 g, 29.4 mmol) were dissolved in tetrahydrofuran (90 ml), and a 2.2M toluene solution of diethyl azodicarboxylate (10.0 ml, 22.0 mmol) was added dropwise under ice-cooling. After the mixture was stirred for 2 hours under ice-cooling, and for 18 hours under room temperature, the solvent was distilled off. The resulting residue was purified by silica gel column chromatography to obtain foamy compound 2B (3.88 g, 6.85 mmol).</p>\n",
       "<p id=\"p-0580\" num=\"0592\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.18 (3H, m), 3.11 (3H, s), 3.16 (1H, m), 3.28 (1H, m), 3.76 (1H, m), 3.97-4.13 (3H, m), 4.31 (1H, d, J=11.3 Hz), 5.08 (2H, s), 5.52 (1H, d, J=12.0 Hz), 7.18-7.25 (6H, m), 7.25-7.45 (6H, m), 7.55-7.66 (6H, m).</p>\n",
       "<p id=\"p-0581\" num=\"0593\">MS: m/z=567.7 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0415\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0582\" num=\"0594\">To compound 2B (3.4 g, 6.0 mmol) were added ethanol (36 ml), water (12 ml), and a 2N aqueous sodium hydroxide solution (4.5 ml, 9.0 mmol), and the mixture was stirred at room temperature for 40 minutes, thereafter, ethanol (10 ml) and water (10 ml) were added, and the mixture was further stirred for 30 minutes. Ethanol was distilled off, ethyl acetate and water were added, and the mixture was stirred vigorously and, thereafter, layers were separated. The ethyl acetate layer was washed with 2N sodium hydroxide three times, and the aqueous layers were combined into one aqueous layer. To the aqueous layer was added ethyl acetate, the mixture was neutralized using 2N hydrochloric acid, then the mixture was stirred vigorously and, thereafter, the ethyl acetate layer was separated. To the ethyl acetate layer was added magnesium sulfate, the mixture was filtered with celite, and the filtrate was distilled off. The resulting residue was dissolved in MeOH, and the solvent was distilled off to obtain a solid of compound 2C (3.0 g, 5.64 mmol).</p>\n",
       "<p id=\"p-0583\" num=\"0595\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.11 (3H, s), 3.16 (1H, m), 3.25 (1H, m), 3.75 (1H, m), 4.11 (1H, m), 4.36 (1H, d, J=11.6 Hz), 5.18 (2H, dd, J=15.7 Hz, 10.4 Hz), 5.71 (1H, d, J=11.6 Hz), 7.08-7.20 (5H, m), 7.29-7.45 (6H, m), 7.55 (2H, d, J=6.7 Hz), 7.61 (2H, d, J=7.5 Hz), 7.98 (1H, s).</p>\n",
       "<p id=\"p-0584\" num=\"0596\">MS: m/z=539.4 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0416\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0585\" num=\"0597\">To compound 2C (1.50 g, 2.79 mmol) were added methanol (22 ml), and 10% palladium carbon-50% wet (150 mg), and the mixture was stirred for 1 hour under hydrogen atmosphere. Ethyl acetate (44 ml) was added, the mixture was filtered with celite, and the filtrate was distilled off. The resulting residue was dissolved in methanol (20 ml), water (10 ml) was added, and methanol was distilled off. The precipitate was filtered, and dried to obtain compound 2 (1.15 g, 2.56 mmol).</p>\n",
       "<p id=\"p-0586\" num=\"0598\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.15 (3H, s), 3.50-3.70 (5H, m), 4.19 (1H, dd, J=13.8 Hz, 3.1 Hz), 4.49 (1H, d, J=11.6 Hz), 5.78 (1H, d, J=9.6 Hz), 7.10-7.27 (6H, m), 7.34 (1H, m), 7.46 (2H, t, J=7.5 Hz), 7.63 (2H, t, J=7.7 Hz), 7.94 (1H, s), 12.94 (1H, s), 15.08 (1H, s).</p>\n",
       "<p id=\"p-0587\" num=\"0599\">MS: m/z=449.4 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0417\" level=\"1\">Example 3</heading>\n",
       "<p id=\"p-0588\" num=\"0600\"><chemistry id=\"CHEM-US-00113\" num=\"00113\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00113.TIF\" he=\"64.85mm\" id=\"EMI-C00113\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0589\" num=\"0601\">According to Example 2, compound 3 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0590\" num=\"0602\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.15 (1H, m), 3.26 (3H, s), 3.52-3.70 (4H, m), 3.70-3.80 (2H, m), 4.10 (1H, d, J=12.9 Hz), 4.92 (1H, brs), 6.98 (1H, t, J=7.4 Hz), 7.03 (1H, brs), 7.08 (1H, t, 7.6 Hz), 7.34 (1H, d, J=7.8 Hz), 7.47 (1H, d, J=7.3 Hz), 7.80 (1H, s), 10.94 (1H, brs), 15.38 (1H, brs).</p>\n",
       "<p id=\"p-0591\" num=\"0603\">MS: m/z=412.4 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0418\" level=\"1\">Example 4</heading>\n",
       "<p id=\"p-0592\" num=\"0604\"><chemistry id=\"CHEM-US-00114\" num=\"00114\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00114.TIF\" he=\"63.25mm\" id=\"EMI-C00114\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0593\" num=\"0605\">According to Example 2, compound 4 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0594\" num=\"0606\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.13 (3H, s), 3.46-3.72 (5H, m), 4.16 (1H, d, J=12.6 Hz), 4.48 (1H, d, J=10.9 Hz), 5.77 (1H, d, J=11.6 Hz), 7.10-7.27 (6H, m), 7.32 (1H, m), 7.44 (2H, m), 7.61 (2H, m), 7.93 (1H, s), 15.04 (1H, s).</p>\n",
       "<p id=\"p-0595\" num=\"0607\">MS: m/z=449.3 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0419\" level=\"1\">Example 5</heading>\n",
       "<p id=\"p-0596\" num=\"0608\"><chemistry id=\"CHEM-US-00115\" num=\"00115\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00115.TIF\" he=\"71.71mm\" id=\"EMI-C00115\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0597\" num=\"0609\">According to Example 2, compound 5 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0598\" num=\"0610\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.28 (3H, s), 3.52-3.68 (4H, m), 4.06 (1H, m), 4.25 (2H, m), 4.41 (1H, brs), 4.56 (1H, d, J=13.6 Hz), 4.82 (1H, d, J=13.9 Hz), 6.74 (2H, d, J=7.6 Hz), 6.92 (1H, t, J=7.20 Hz), 7.25 (2H, t, J=7.8 Hz), 8.58 (1H, s), 12.48 (1H, brs), 15.55 (1H, brs).</p>\n",
       "<p id=\"p-0599\" num=\"0611\">MS: m/z=389.4 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0420\" level=\"1\">Example 6</heading>\n",
       "<p id=\"p-0600\" num=\"0612\"><chemistry id=\"CHEM-US-00116\" num=\"00116\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00116.TIF\" he=\"64.85mm\" id=\"EMI-C00116\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0601\" num=\"0613\">According to Example 2, compound 6 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0602\" num=\"0614\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.16 (1H, m), 3.26 (3H, s), 3.50-3.70 (4H, m), 3.70-3.80 (2H, m), 4.10 (1H, d, J=13.4 Hz), 4.92 (1H, brs), 6.98 (1H, t, J=7.1 Hz), 7.03 (1H, brs), 7.08 (1H, t, J=7.3 Hz), 7.34 (1H, d, J=7.8 Hz), 7.48 (1H, d, J=7.3 Hz), 7.81 (1H, s), 12.91 (1H, s), 15.36 (1H, s).</p>\n",
       "<p id=\"p-0603\" num=\"0615\">MS: m/z=412.4 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0421\" level=\"1\">Example 7</heading>\n",
       "<p id=\"p-0604\" num=\"0616\"><chemistry id=\"CHEM-US-00117\" num=\"00117\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00117.TIF\" he=\"63.25mm\" id=\"EMI-C00117\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0605\" num=\"0617\">According to Example 2, compound 7 was synthesized by the same method.</p>\n",
       "<p id=\"p-0606\" num=\"0618\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.85-0.95 (2H, m), 1.05-1.25 (5H, m), 1.45-1.80 (8H, m), 3.28 (3H, s), 3.46 (1H, m), 3.58 (1H, m), 3.72 (1H, d, J=13.9 Hz), 3.93 (1H, m), 4.04 (1H, d, J=13.1 Hz), 4.88 (1H, s), 8.56 (1H, s), 12.80 (1H, s), 15.51 (1H, s).</p>\n",
       "<p id=\"p-0607\" num=\"0619\">MS: m/z=379.3 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0422\" level=\"1\">Example 8</heading>\n",
       "<p id=\"p-0608\" num=\"0620\"><chemistry id=\"CHEM-US-00118\" num=\"00118\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00118.TIF\" he=\"63.25mm\" id=\"EMI-C00118\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0609\" num=\"0621\">According to Example 2, compound 8 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0610\" num=\"0622\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.07 (2H, m), 2.55 (1H, m), 2.74 (1H, m), 3.17 (1H, s), 3.23 (3H, s), 3.48-3.65 (4H, m), 3.79 (1H, d, J=13.6 Hz), 3.87 (1H, m), 4.09 (1H, d, J=13.6 Hz), 4.80 (1H, s), 7.10-7.29 (5H, m), 8.59 (1H, s), 12.77 (1H, s), 15.49 (1H, s).</p>\n",
       "<p id=\"p-0611\" num=\"0623\">MS: m/z=387.3 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0423\" level=\"1\">Example 9</heading>\n",
       "<p id=\"p-0612\" num=\"0624\"><chemistry id=\"CHEM-US-00119\" num=\"00119\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00119.TIF\" he=\"71.37mm\" id=\"EMI-C00119\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0613\" num=\"0625\">According to Example 2, compound 9 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0614\" num=\"0626\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.80 (1H, dd, J=14.5 Hz, J2=8.5 Hz), 2.93 (1H, dd, J=14.4 Hz, 5.6 Hz), 3.21 (3H, s), 3.40-3.55 (4H, m), 3.77 (2H, s), 3.82 (1H, d, J=13.1 Hz), 3.88 (1H, m), 4.13 (1H, d, J=13.6 Hz), 4.85 (1H, s), 7.20-7.35 (5H, m), 8.61 (1H, s), 12.79 (1H, s), 15.43 (1H, s).</p>\n",
       "<p id=\"p-0615\" num=\"0627\">MS: m/z=419.3 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0424\" level=\"1\">Example 10</heading>\n",
       "<p id=\"p-0616\" num=\"0628\"><chemistry id=\"CHEM-US-00120\" num=\"00120\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00120.TIF\" he=\"60.37mm\" id=\"EMI-C00120\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0617\" num=\"0629\">According to Example 2, compound 10 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0618\" num=\"0630\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.22 (3H, d, J=6.2 Hz), 3.29 (3H, s), 3.43 (1H, m), 3.58 (2H, m), 3.94 (1H, m), 4.12 (1H, brs), 4.41 (1H, d, J=13.6 Hz), 4.49 (1H, d, J=13.1 Hz), 8.59 (1H, s), 12.65 (1H, s), 15.53 (1H, s).</p>\n",
       "<p id=\"p-0619\" num=\"0631\">MS: m/z=297.2 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0425\" level=\"1\">Example 11</heading>\n",
       "<p id=\"p-0620\" num=\"0632\"><chemistry id=\"CHEM-US-00121\" num=\"00121\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00121.TIF\" he=\"60.37mm\" id=\"EMI-C00121\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0621\" num=\"0633\">According to Example 2, compound 11 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0622\" num=\"0634\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.46 (4H, brs), 1.76-1.90 (2H, m), 2.22 (1H, brs), 3.27 (3H, s), 3.57 (1H, d, J=5.3 Hz), 4.07 (1H, m), 4.69 (1H, m), 8.47 (1H, s), 13.04 (1H, s), 15.52 (1H, s).</p>\n",
       "<p id=\"p-0623\" num=\"0635\">MS: m/z=337.2 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0426\" level=\"1\">Example 12</heading>\n",
       "<p id=\"p-0624\" num=\"0636\"><chemistry id=\"CHEM-US-00122\" num=\"00122\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00122.TIF\" he=\"219.79mm\" id=\"EMI-C00122\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00123\" num=\"00123\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00123.TIF\" he=\"170.26mm\" id=\"EMI-C00123\" img-content=\"chem\" img-format=\"tif\" wi=\"63.25mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0427\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0625\" num=\"0637\">Compound 12A (1.53 g, 5.80 mmol) were dissolved in THF (6 ml) and water (6 ml), potassium carbonate (2.41 g, 17.4 mmol) was added, the mixture was stirred, and benzyl chloroformate (1.09 g, 6.38 mmol) was added dropwise at 0° C. After stirring at 0° C. for 10 minutes, the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into sodium bicarbonate water, and the mixture was extracted with ethyl acetate. The extract was washed with 1N hydrochloric acid and an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off to obtain 2.32 g of compound 12B as a colorless gummy solid.</p>\n",
       "<p id=\"p-0626\" num=\"0638\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.98 (1H, brs), 3.55 (1H, m), 3.75 (1H, m), 4.20 (1H, d, J=10.5 Hz), 4.58 (1H, m), 4.83 (1H, brs), 5.07 (2H, s), 7.16-7.39 (15H, m).</p>\n",
       "<heading id=\"h-0428\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0627\" num=\"0639\">The compound 12B (1.94 g, 5.37 mmol), triphenylphosphine (2.11 g, 8.05 mmol) and phthalimide (948 mg, 6.44 mmol) were added to THF (20 ml), and diisopropyl azodicarboxylate (2.2M in toluene, 3.66 ml, 8.05 mmol) was added dropwise at room temperature. After stirring at room temperature for 4 hours, the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 2.39 g of compound 12C as a colorless solid.</p>\n",
       "<p id=\"p-0628\" num=\"0640\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.73 (2H, m), 4.05 (1H, d, J=10.1 Hz), 4.70 (1H, d, J=9.6 Hz), 4.77 (2H, d, J=7.2 Hz) 5.02 (1H, m), 7.03-7.42 (15H, m), 7.68 (2H, dd, J=5.7, 2.1 Hz), 7.78 (2H, dd, J=5.7, 2.1 Hz).</p>\n",
       "<heading id=\"h-0429\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0629\" num=\"0641\">The compound 12C (2.39 g, 4.87 mmol) was added to THF (20 ml) and methanol (20 ml), hydrazine hydrate (4.88 g, 97.4 mmol) was added, and the mixture was stirred at 50° C. for 4 hours. The white precipitate was removed by filtration, and washed with methanol. After the filtrate was distilled off under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 1.41 g of compound 12D as a colorless solid.</p>\n",
       "<p id=\"p-0630\" num=\"0642\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.63 (1H, dd, J=13.2, 5.8 Hz), 2.86 (1H, d, J=9.9 Hz), 4.07 (1H, d, J=10.4 Hz), 4.53 (1H, m), 4.81 (1H, m), 5.00 (2H, d, 8.4 Hz), 7.20-7.36 (10H, m).</p>\n",
       "<heading id=\"h-0430\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0631\" num=\"0643\">Compound 12D (1.41 g, 3.91 mmol) was dissolved in THF (15 ml), and Boc<sub>2</sub>O (896 mg, 4.11 mmol) was added at room temperature. After stirring for 1.5 hours, the solvent was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 1.77 g of compound 12E as a colorless solid.</p>\n",
       "<p id=\"p-0632\" num=\"0644\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.41 (9H, s), 3.23 (2H, brm), 3.97 (1H, d, J=9.8 Hz), 4.58-4.80 (3H, m), 5.00 (2H, d, J=9.8 Hz), 7.15-7.29 (10H, m).</p>\n",
       "<heading id=\"h-0431\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0633\" num=\"0645\">Compound 12E (1.73 g, 3.76 mmol) and palladium-active carbon (10%, wet, 200 mg) were added to methanol (20 ml), and the mixture was stirred at room temperature for 1 hour under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 1.01 g of a colorless oily substance 12F.</p>\n",
       "<p id=\"p-0634\" num=\"0646\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.44 (9H, s), 2.82 (1H, m), 3.31 (1H, m), 3.73 (2H, d, J=6.9 Hz), 4.98 (1H, s), 7.18-7.39 (10H, m).</p>\n",
       "<heading id=\"h-0432\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0635\" num=\"0647\">Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (974 mg, 3.06 mmol) obtained by the method shown in Reference Example 1, and 12F (999 mg, 3.06 mmol) were added to toluene (10 ml), and the mixture was stirred at 110° C. for 5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain 1.51 g of compound 12G as a pale yellow solid.</p>\n",
       "<p id=\"p-0636\" num=\"0648\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.36 (9H, s), 3.40 (1H, m), 3.53 (1H, m), 3.82 (3H, s), 3.91 (3H, s), 4.29 (1H, d, J=11.3 Hz), 4.78 (1H, m), 4.82 (1H, m), 5.11 (1.9H, d, J=7.5 Hz), 7.10-7.38 (10H, m), 8.27 (1H, s).</p>\n",
       "<heading id=\"h-0433\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0637\" num=\"0649\">To compound 12G (1.45 g, 2.31 mmol) was added 4N HCl (ethyl acetate solution, 20 ml), and the mixture was stirred at room temperature for 1.5 hours. After the solvent was distilled off under reduced pressure, sodium bicarbonate water was added, and the mixture was stirred at room temperature for 1.5 hours. This was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 1.01 g of compound 12H as a colorless solid.</p>\n",
       "<p id=\"p-0638\" num=\"0650\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.40 (1H, dd, J=13.6, 6.6 Hz), 3.78 (3H, s), 3.80 (1H, m), 4.37 (1H, d, J=11.6 Hz), 4.59 (1H, d, J=11.0 Hz), 5.43 (2H, d, J=10.2 Hz), 5.93 (1H, d, J=5.8 Hz), 7.03-7.21 (5H, m), 7.37 (9H, m), 7.63 (2H, m).</p>\n",
       "<heading id=\"h-0434\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0639\" num=\"0651\">Compound 12H (50 mg, 0.10 mmol) was dissolved in DMF (1 ml), and cesium carbonate (165 mg, 0.50 mmol) was added. After stirring at room temperature for 30 minutes, iodomethane (0.032 ml, 0.50 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 49 mg of compound 121 as a colorless solid.</p>\n",
       "<heading id=\"h-0435\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-0640\" num=\"0652\">Compound 12I (49 mg, 0.096 mmol) was dissolved in THF (0.5 ml) and methanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.24 ml, 0.48 mmol) was added at room temperature, and the mixture was stirred for 1.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 54 mg of compound 12J was obtained as a colorless solid.</p>\n",
       "<p id=\"p-0641\" num=\"0653\">MS: m/z=481 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0436\" level=\"1\">Tenth Step</heading>\n",
       "<p id=\"p-0642\" num=\"0654\">To compound 12J obtained in the ninth step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 26 mg of compound 12 as a colorless solid.</p>\n",
       "<p id=\"p-0643\" num=\"0655\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.01 (3H, s), 3.26 (1H, t, J=14.4 Hz), 4.23 (1H, dd, J=13.5, 3.8 Hz), 4.57 (1H, d, J=11.6 Hz), 5.78 (1H, d, J=11.3 Hz), 7.16-7.70 (10H, m), 8.00 (1H, s), 13.00 (1H, s), 15.10 (1H, s).</p>\n",
       "<p id=\"p-0644\" num=\"0656\">MS: m/z=405 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0437\" level=\"1\">Example 13</heading>\n",
       "<p id=\"p-0645\" num=\"0657\"><chemistry id=\"CHEM-US-00124\" num=\"00124\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00124.TIF\" he=\"47.07mm\" id=\"EMI-C00124\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0646\" num=\"0658\">According to Example 12, compound 13 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0647\" num=\"0659\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.05 (3H, t, J=6.9 Hz), 3.43-3.65 (3H, m), 4.22 (1H, d, J=10.6 Hz), 4.55 (1H, d, J=11.6 Hz), 5.81 (1H, d, J=10.1 Hz), 7.15-7.68 (10H, m), 7.97 (1H, s), 12.96 (1H, s), 15.07 (1H, s).</p>\n",
       "<p id=\"p-0648\" num=\"0660\">MS: m/z=463 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0438\" level=\"1\">Example 14</heading>\n",
       "<p id=\"p-0649\" num=\"0661\"><chemistry id=\"CHEM-US-00125\" num=\"00125\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00125.TIF\" he=\"35.14mm\" id=\"EMI-C00125\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0650\" num=\"0662\">According to Example 12, compound 14 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0651\" num=\"0663\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.98 (3H, t, J=7.17 Hz), 3.44-3.64 (3H, m), 4.15 (1H, dd, J=13.7, 3.5 Hz), 4.45 (1H, d, J=11.6 Hz), 5.79 (1H, d, J=12.2 Hz), 7.08-7.63 (10H, m), 7.89 (1H, s), 13.01 (1H, s), 15.06 (1H, s).</p>\n",
       "<p id=\"p-0652\" num=\"0664\">MS: m/z=419 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0439\" level=\"1\">Example 15</heading>\n",
       "<p id=\"p-0653\" num=\"0665\"><chemistry id=\"CHEM-US-00126\" num=\"00126\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00126.TIF\" he=\"35.14mm\" id=\"EMI-C00126\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0654\" num=\"0666\">According to Example 12, compound 15 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0655\" num=\"0667\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.22 (1H, s), 3.47 (1H, d, J=13.3 Hz), 4.17 (2H, m), 4.44 (2H, dd, J=16.7, 3.0 Hz), 5.79 (1H, d, J 12.2 Hz), 7.10-7.64 (10H, m), 7.98 (1H, s), 12.56 (1H, s), 15.05 (1H, brs).</p>\n",
       "<heading id=\"h-0440\" level=\"1\">Example 16</heading>\n",
       "<p id=\"p-0656\" num=\"0668\"><chemistry id=\"CHEM-US-00127\" num=\"00127\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00127.TIF\" he=\"35.14mm\" id=\"EMI-C00127\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0657\" num=\"0669\">According to Example 12, compound 16 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0658\" num=\"0670\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.24 (1H, d, J=13.2 Hz), 4.23 (1H, m), 4.25 (1H, d, J=14.7 Hz), 4.40 (1H, d, J=14.8 Hz), 4.92 (1H, d, J=15.4 Hz), 5.79 (1H, m), 7.03-7.48 (10H, m), 7.93 (1H, s), 12.82 (1H, s), 15.06 (1H, s).</p>\n",
       "<heading id=\"h-0441\" level=\"1\">Example 17</heading>\n",
       "<p id=\"p-0659\" num=\"0671\"><chemistry id=\"CHEM-US-00128\" num=\"00128\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00128.TIF\" he=\"35.14mm\" id=\"EMI-C00128\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0660\" num=\"0672\">According to Example 12, compound 17 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0661\" num=\"0673\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.23 (1H, d, J=13.4 Hz), 4.22 (1H, m), 4.25 (1H, d, J=12.0 Hz), 4.45 (1H, d, J=14.9 Hz), 4.93 (1H, d, J=15.3 Hz), 5.77 (1H, d, J=11.6 Hz), 7.09-7.56 (10H, m), 7.92 (1H, s), 12.74 (1H, s), 15.06 (1H, s).</p>\n",
       "<heading id=\"h-0442\" level=\"1\">Example 18</heading>\n",
       "<p id=\"p-0662\" num=\"0674\"><chemistry id=\"CHEM-US-00129\" num=\"00129\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00129.TIF\" he=\"42.42mm\" id=\"EMI-C00129\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0663\" num=\"0675\">According to Example 12, compound 18 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0664\" num=\"0676\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.63 (2H, m), 3.20 (3H, s), 3.44 (5H, m), 4.19 (1H, d, J=10.2 Hz), 4.51 (1H, d, J=11.8 Hz), 5.80 (1H, d, J=11.0 Hz), 7.13-7.65 (10H, m), 7.93 (1H, s), 13.02 (1H, s).</p>\n",
       "<p id=\"p-0665\" num=\"0677\">MS: m/z=463 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0443\" level=\"1\">Example 19</heading>\n",
       "<p id=\"p-0666\" num=\"0678\"><chemistry id=\"CHEM-US-00130\" num=\"00130\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00130.TIF\" he=\"35.14mm\" id=\"EMI-C00130\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0667\" num=\"0679\">According to Example 12, compound 19 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0668\" num=\"0680\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.15 (1H, d, J=9.5 Hz), 3.95 (1H, dd, J=13.5, 3.4 Hz), 4.51 (1H, d, J=11.6 Hz), 5.74 (1H, d, J=11.1 Hz), 7.11-7.62 (10H, m), 7.93 (1H, s), 9.34 (1H, s), 12.97 (1H, s), 15.07 (1H, brs).</p>\n",
       "<p id=\"p-0669\" num=\"0681\">MS: m/z=391 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0444\" level=\"1\">Example 20</heading>\n",
       "<p id=\"p-0670\" num=\"0682\"><chemistry id=\"CHEM-US-00131\" num=\"00131\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00131.TIF\" he=\"42.42mm\" id=\"EMI-C00131\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0671\" num=\"0683\">According to Example 12, compound 20 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0672\" num=\"0684\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.26 (1H, m), 4.24 (1H, m), 4.27 (1H, d, J=12.0 Hz), 4.41 (1H, J=14.8 Hz), 4.87 (1H, d, J=14.9 Hz), 5.75 (1H, d, J=7.6 Hz), 7.09-7.77 (12H, m), 7.93 (1H, s), 8.52 (2H, m), 12.79 (1H, s), 15.07 (1H, brs).</p>\n",
       "<p id=\"p-0673\" num=\"0685\">MS: m/z=482 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0445\" level=\"1\">Example 21</heading>\n",
       "<p id=\"p-0674\" num=\"0686\"><chemistry id=\"CHEM-US-00132\" num=\"00132\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00132.TIF\" he=\"35.14mm\" id=\"EMI-C00132\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0675\" num=\"0687\">According to Example 12, compound 21 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0676\" num=\"0688\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.62 (3H, d, J=6.9 Hz), 0.82 (3H, d, J=6.6 Hz), 3.18 (1H, m), 3.75 (1H, d, J=10.2 Hz), 4.25 (1H, d, J=11.8 Hz), 4.58 (1H, m), 5.65 (1H, d, J=11.3 Hz), 6.89-7.43 (10H, m), 7.67 (1H, s), 12.94 (1H, s).</p>\n",
       "<p id=\"p-0677\" num=\"0689\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0446\" level=\"1\">Example 22</heading>\n",
       "<p id=\"p-0678\" num=\"0690\"><chemistry id=\"CHEM-US-00133\" num=\"00133\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00133.TIF\" he=\"42.42mm\" id=\"EMI-C00133\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0679\" num=\"0691\">According to Example 12, compound 22 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0680\" num=\"0692\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.07-1.70 (5H, m), 3.04-3.34 (5H, m), 3.82 (2H, dm), 4.18 (1H, d, J=10.2 Hz), 4.42 (1H, d, J=12.0 Hz), 5.81 (1H, d, J=11.7 Hz), 7.11-7.59 (10H, m), 7.86 (1H, s), 12.96 (1H, s), 15.07 (1H, brs).</p>\n",
       "<p id=\"p-0681\" num=\"0693\">MS: m/z=489 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0447\" level=\"1\">Example 23</heading>\n",
       "<p id=\"p-0682\" num=\"0694\"><chemistry id=\"CHEM-US-00134\" num=\"00134\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00134.TIF\" he=\"35.14mm\" id=\"EMI-C00134\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0683\" num=\"0695\">According to Example 12, compound 23 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0684\" num=\"0696\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.01-0.79 (5H, m), 3.05 (1H, dd, J=14.1, 7.5 Hz), 3.49-3.59 (2H, m), 4.16 (1H, dd, J=14.0, 3.3 Hz), 4.50 (1H, d, J=11.9 Hz), 5.82 (1H, d, J=11.1 Hz), 7.11-7.62 (10H, m), 7.89 (1H, s), 12.99 (1H, s), 15.07 (1H, brs).</p>\n",
       "<p id=\"p-0685\" num=\"0697\">MS: m/z=445 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0448\" level=\"1\">Example 24</heading>\n",
       "<p id=\"p-0686\" num=\"0698\"><chemistry id=\"CHEM-US-00135\" num=\"00135\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00135.TIF\" he=\"42.42mm\" id=\"EMI-C00135\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0687\" num=\"0699\">According to Example 12, compound 24 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0688\" num=\"0700\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.23 (1H, d, J=13.7 Hz), 4.16 (1H, dd, J=13.2, 3.3 Hz), 4.19 (2H, d, J=12.0 Hz), 4.38 (1H, d, J=14.6 Hz), 4.84 (1H, d, J=14.6 Hz), 5.72 (1H, d, J=11.4 Hz), 7.08-7.33 (15H, m), 7.98 (1H, s), 12.88 (1H, s), 15.07 (1H, s).</p>\n",
       "<p id=\"p-0689\" num=\"0701\">MS: m/z=481 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0449\" level=\"1\">Example 25</heading>\n",
       "<p id=\"p-0690\" num=\"0702\"><chemistry id=\"CHEM-US-00136\" num=\"00136\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00136.TIF\" he=\"35.14mm\" id=\"EMI-C00136\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0691\" num=\"0703\">According to Example 12, compound 25 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0692\" num=\"0704\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.39 (3H, s), 3.37 (1H, m), 4.21 (1H, dd, J=14.4, 3.9 Hz), 4.40 (1H, dd, J=11.7 Hz), 4.45 (1H, d, J=15.3 Hz), 4.81 (1H, d, J=15.4 Hz), 5.78 (1H, d, J=12.0 Hz), 6.30 (1H, s), 7.09-7.42 (10H, m), 7.95 (1H, s), 12.65 (1H, s), 15.07 (1H, s).</p>\n",
       "<p id=\"p-0693\" num=\"0705\">MS: m/z=486 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0450\" level=\"1\">Example 26</heading>\n",
       "<p id=\"p-0694\" num=\"0706\"><chemistry id=\"CHEM-US-00137\" num=\"00137\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00137.TIF\" he=\"42.42mm\" id=\"EMI-C00137\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0695\" num=\"0707\">According to Example 12, compound 26 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0696\" num=\"0708\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.20-1.77 (6H, m), 3.11-3.61 (6H, m), 4.21 (1H, d, J=9.9 Hz), 4.53 (1H, d, J=11.7 Hz), 5.80 (1H, d, J=11.8 Hz), 7.14-7.65 (10H, m), 7.95 (1H, s), 12.95 (1H, brs), 15.06 (1H, brs).</p>\n",
       "<p id=\"p-0697\" num=\"0709\">MS: m/z=489 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0451\" level=\"1\">Example 27</heading>\n",
       "<p id=\"p-0698\" num=\"0710\"><chemistry id=\"CHEM-US-00138\" num=\"00138\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00138.TIF\" he=\"35.14mm\" id=\"EMI-C00138\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0699\" num=\"0711\">According to Example 12, compound 27 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0700\" num=\"0712\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.36 (1H, m), 4.28 (1H, d, J=12.0 Hz), 4.54 (1H, d, J=11.4 Hz), 4.62 (1H, d, J=15.3 Hz), 4.79 (1H, d, J=15.4 Hz), 5.77 (1H, d, J=9.9 Hz), 7.09-7.79 (13H, m), 7.98 (1H, s), 8.46 (1H, d, J=4.6 Hz), 12.82 (1H, brs), 15.06 (1H, brs).</p>\n",
       "<p id=\"p-0701\" num=\"0713\">MS: m/z=482 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0452\" level=\"1\">Example 28</heading>\n",
       "<p id=\"p-0702\" num=\"0714\"><chemistry id=\"CHEM-US-00139\" num=\"00139\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00139.TIF\" he=\"220.73mm\" id=\"EMI-C00139\" img-content=\"chem\" img-format=\"tif\" wi=\"64.35mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00140\" num=\"00140\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00140.TIF\" he=\"112.35mm\" id=\"EMI-C00140\" img-content=\"chem\" img-format=\"tif\" wi=\"68.92mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0453\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0703\" num=\"0715\">Compound 28A (3.20 g, 17.1 mmol) was added to THF (20 ml), triethylamine (2.60 ml, 18.8 mmol) was added, and the mixture was stirred at room temperature for 10 minutes. After Boc<sub>2</sub>O (4.09 g, 18.8 mmol) was added at room temperature, the mixture was stirred for 2 hours. The solvent was distilled off under reduced pressure, water was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off under reduced pressure to obtain 5.17 g of compound 28B as a colorless solid.</p>\n",
       "<p id=\"p-0704\" num=\"0716\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.52 (9H, s), 2.77 (2H, m), 3.03-3.12 (1H, m), 3.38 (1H, m), 3.90-3.98 (1H, m), 4.93 (1H, brs), 7.20-7.35 (5H, m).</p>\n",
       "<heading id=\"h-0454\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0705\" num=\"0717\">Compound 28B (4.29 g, 17.1 mmol), triphenylphosphine (5.37 g, 20.5 mmol) and phthalimide (2.76 g, 18.8 mmol) were added to THF (60 ml), and diethyl azodicarboxylate (2.2M in toluene, 11.6 ml, 25.6 mmol) was added dropwise at room temperature. After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 2:1, v/v) to obtain 6.13 g of compound 28C as a colorless solid.</p>\n",
       "<p id=\"p-0706\" num=\"0718\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.30 (9H, s), 3.14 (1H, dd, J=13.8, 6.2 Hz), 3.39 (2H, m), 3.87 (1H, m), 4.67 (1H, m), 4.81 (1H, brs), 7.16-7.19 (5H, m), 7.66 (2H, dd, J=5.3, 3.1 Hz), 7.75 (2H, dd, J=5.7, 3.0 Hz).</p>\n",
       "<heading id=\"h-0455\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0707\" num=\"0719\">Compound 28C (1.00 g, 2.63 mmol) was added to THF (7 ml) and methanol (7 ml), hydrazine hydrate (2.63 g, 52.6 mmol) was added, and the mixture was stirred at 50° C. for 2 hours. The white precipitate was removed by filtration, and washed with methanol. After the filtrate was distilled off under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 249 mg of compound 28D as a colorless solid.</p>\n",
       "<p id=\"p-0708\" num=\"0720\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.44 (9H, s), 1.95 (2H, brs), 2.55-3.31 (5H, m), 5.06 (1H, brs), 7.18-7.33 (5H, m).</p>\n",
       "<heading id=\"h-0456\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0709\" num=\"0721\">Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (313 mg, 0.983 mmol) and 28D (246 mg, 0.983 mmol) were added to toluene (3 ml), and the mixture was stirred at 100° C. for 2.5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain 320 mg of compound 28E as a pale yellow gummy substance.</p>\n",
       "<p id=\"p-0710\" num=\"0722\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.42 (9H, s), 3.07 (2H, m), 3.56 (2H, m), 3.68 (3H, s), 3.95 (3H, s), 4.26 (1H, s), 4.86 (1H, s), 5.18 (1H, d, J=10.8 Hz), 5.22 (1H, d, J=10.8 Hz), 7.01 (2H, m), 7.24-7.38 (8H, m), 8.22 (1H, s).</p>\n",
       "<p id=\"p-0711\" num=\"0723\">MS: m/z=551 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0457\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0712\" num=\"0724\">To compound 28E (315 mg, 0.572 mmol) was added 4N HCl (ethyl acetate solution, 5 ml), and the mixture was stirred at room temperature for 30 minutes. After the solvent was distilled off under reduced pressure, aqueous sodium bicarbonate water was added, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 210 mg of compound 28F as a colorless solid.</p>\n",
       "<p id=\"p-0713\" num=\"0725\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.07-3.15 (2H, m), 3.34 (1H, dd, J=13.2, 6.0 Hz), 3.74 (2H, m), 3.86 (3H, s), 4.12 (1H, m), 5.27 (1H, d, J=10.1 Hz), 5.47 (1H, d, J=10.1 Hz), 6.76 (1H, d, J=6.4 Hz), 7.04 (2H, m), 7.32 (6H, m), 7.62 (2H, dd, J=7.7, 1.4 Hz), 7.70 (1H, s).</p>\n",
       "<p id=\"p-0714\" num=\"0726\">MS: m/z=419 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0458\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0715\" num=\"0727\">Compound 28F (50 mg, 0.12 mmol) was dissolved in DMF (1 ml), and cesium carbonate (195 mg, 0.597 mmol) was added. After the mixture was stirred at room temperature for 30 minutes, iodoethane (0.048 ml, 0.60 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 47 mg of compound 28G as a colorless solid.</p>\n",
       "<p id=\"p-0716\" num=\"0728\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.22 (3H, t, J=7.2 Hz), 3.00-3.15 (2H, m), 3.28 (1H, dd, J=13.6, 1.6 Hz), 3.48 (1H, m), 3.75 (1H, m), 3.85 (3H, s), 3.88 (1H, dd, J=13.3, 3.2 Hz), 4.15 (1H, m), 5.25 (1H, d, J=9.9 Hz), 5.50 (1H, d, J=9.9 Hz), 7.04 (2H, m), 7.29-7.38 (6H, m), 7.60 (1H, s), 7.68 (2H, m).</p>\n",
       "<p id=\"p-0717\" num=\"0729\">MS: m/z=447 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0459\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0718\" num=\"0730\">Compound 28G (47 mg, 0.11 mmol) was dissolved in THF (0.5 ml) and methanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.26 ml, 0.53 mmol) was added at room temperature, and the mixture was stirred for 1 hour. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 40 mg of compound 28H was obtained as a colorless solid.</p>\n",
       "<p id=\"p-0719\" num=\"0731\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0460\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-0720\" num=\"0732\">To compound 28H obtained in the seventh step was added trifluoroaceteic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 17 mg of compound 28 as a colorless solid.</p>\n",
       "<p id=\"p-0721\" num=\"0733\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.17 (3H, t, J=7.2 Hz), 3.08 (2H, m), 3.51-3.63 (3H, m), 4.08 (1H, dd, J=13.6, 3.9 Hz), 5.03 (1H, brs), 7.21 (5H, m), 8.07 (1H, s), 12.98 (1H, s), 15.07 (1H, brs).</p>\n",
       "<p id=\"p-0722\" num=\"0734\">MS: m/z=343 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0461\" level=\"1\">Example 29</heading>\n",
       "<p id=\"p-0723\" num=\"0735\"><chemistry id=\"CHEM-US-00141\" num=\"00141\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00141.TIF\" he=\"35.14mm\" id=\"EMI-C00141\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0724\" num=\"0736\">According to Example 28, compound 29 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0725\" num=\"0737\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.96 (2H, d, J=7.6 Hz), 3.46 (1H, d, J=13.3 Hz), 4.06 (1H, dd, J=13.6, 3.8 Hz), 4.64 (1H, d, J=14.9 Hz), 4.89 (1H, d, J=14.6 Hz), 4.98 (1H, m), 6.97 (2H, m), 7.10-7.37 (5H, m), 7.57 (1H, m), 8.12 (1H, s), 12.75 (1H, s), 15.07 (1H, brs).</p>\n",
       "<heading id=\"h-0462\" level=\"1\">Example 30</heading>\n",
       "<p id=\"p-0726\" num=\"0738\"><chemistry id=\"CHEM-US-00142\" num=\"00142\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00142.TIF\" he=\"35.14mm\" id=\"EMI-C00142\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0727\" num=\"0739\">According to Example 28, compound 30 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0728\" num=\"0740\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.99 (2H, dd, J=7.5, 3.6 Hz), 3.48 (1H, d, J=13.4 Hz), 4.09 (1H, dd, J=13.4, 4.0 Hz), 4.73 (1H, d, J=15.1 Hz), 4.92 (1H, d, J=15.1 Hz), 4.99 (1H, m), 6.97 (2H, m), 7.18-7.29 (4H, m), 7.49 (1H, m), 7.61 (1H, m), 8.15 (1H, s), 12.69 (1H, s), 15.06 (1H, brs).</p>\n",
       "<heading id=\"h-0463\" level=\"1\">Example 31</heading>\n",
       "<p id=\"p-0729\" num=\"0741\"><chemistry id=\"CHEM-US-00143\" num=\"00143\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00143.TIF\" he=\"35.14mm\" id=\"EMI-C00143\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0730\" num=\"0742\">According to Example 28, compound 31 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0731\" num=\"0743\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.91 (2H, m), 3.45 (1H, d, J=13.1 Hz), 4.02 (1H, dd, J=13.6, 4.0 Hz), 4.57 (1H, d, J=14.6 Hz), 4.91 (1H, d, J=14.6 Hz), 4.93 (1H, m), 6.89 (2H, m), 7.18 (3H, m), 7.40 (5H, m), 8.16 (1H, s), 12.86 (1H, brs), 15.06 (1H, brs).</p>\n",
       "<p id=\"p-0732\" num=\"0744\">MS: m/z=405 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0464\" level=\"1\">Example 32</heading>\n",
       "<p id=\"p-0733\" num=\"0745\"><chemistry id=\"CHEM-US-00144\" num=\"00144\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00144.TIF\" he=\"35.14mm\" id=\"EMI-C00144\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0734\" num=\"0746\">According to Example 28, compound 32 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0735\" num=\"0747\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.10 (2H, m), 3.39 (1H, d, J=13.6 Hz), 3.84 (1H, dd, J=13.6, 4.0 Hz), 4.94 (1H, m), 7.23 (5H, m), 8.19 (1H, s), 9.44 (1H, brs), 12.97 (1H, s), 15.06 (1H, brs).</p>\n",
       "<p id=\"p-0736\" num=\"0748\">MS: m/z=315 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0465\" level=\"1\">Example 33</heading>\n",
       "<p id=\"p-0737\" num=\"0749\"><chemistry id=\"CHEM-US-00145\" num=\"00145\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00145.TIF\" he=\"35.14mm\" id=\"EMI-C00145\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0738\" num=\"0750\">According to Example 28, compound 33 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0739\" num=\"0751\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.09 (3H, t, J=6.9 Hz), 3.10 (2H, m), 3.42-3.50 (2H, m), 3.71 (5H, m), 4.11 (1H, dd, J=13.6, 3.8 Hz), 4.99 (1H, brs), 7.11-7.29 (5H, m), 7.99 (1H, s), 12.88 (1H, s), 15.06 (1H, brs).</p>\n",
       "<p id=\"p-0740\" num=\"0752\">MS: m/z=387 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0466\" level=\"1\">Example 34</heading>\n",
       "<p id=\"p-0741\" num=\"0753\"><chemistry id=\"CHEM-US-00146\" num=\"00146\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00146.TIF\" he=\"42.42mm\" id=\"EMI-C00146\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0742\" num=\"0754\">According to Example 28, compound 34 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0743\" num=\"0755\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.16 (3H, d, J=6.9 Hz), 1.21 (3H, d, J=6.9 Hz), 2.98 (1H, dd, J=13.6, 9.8 Hz), 3.13 (1H, dd, J=13.7, 5.8 Hz), 3.68 (1H, d, J=12.8 Hz), 3.87 (1H, dd, J=13.6, 3.7 Hz), 4.83 (1H, quin, J=6.8 Hz), 5.07 (1H, brs), 7.19 (5H, m), 7.90 (1H, s), 13.09 (1H, s), 15.08 (1H, brs).</p>\n",
       "<p id=\"p-0744\" num=\"0756\">MS: m/z=357 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0467\" level=\"1\">Example 35</heading>\n",
       "<p id=\"p-0745\" num=\"0757\"><chemistry id=\"CHEM-US-00147\" num=\"00147\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00147.TIF\" he=\"35.14mm\" id=\"EMI-C00147\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0746\" num=\"0758\">According to Example 28, compound 35 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0747\" num=\"0759\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.07 (3H, s), 3.14 (2H, m), 3.49 (1H, d, J=13.3 Hz), 4.08 (1H, dd, J=13.7, 4.0 Hz), 4.99 (1H, m), 7.13-7.31 (5H, m), 8.18 (1H, s), 12.95 (1H, s), 15.06 (1H, brs).</p>\n",
       "<p id=\"p-0748\" num=\"0760\">MS: m/z=329 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0468\" level=\"1\">Example 36</heading>\n",
       "<p id=\"p-0749\" num=\"0761\"><chemistry id=\"CHEM-US-00148\" num=\"00148\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00148.TIF\" he=\"226.74mm\" id=\"EMI-C00148\" img-content=\"chem\" img-format=\"tif\" wi=\"75.86mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0469\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0750\" num=\"0762\">Compound 12H (460 mg, 0.930 mmol) was dissolved in THF (2.5 ml) and methanol (2.5 ml), a 2N aqueous sodium hydroxide solution (2.33 ml, 4.65 mmol) was added at room temperature, and the mixture was stirred for 1.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 405 mg of compound 36A was obtained as a colorless solid.</p>\n",
       "<p id=\"p-0751\" num=\"0763\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.45 (1H, ddd, J=13.8, 6.9, 1.3 Hz), 3.80 (1H, dd, J=13.5, 2.1 Hz), 4.35 (1H, d, J=11.6 Hz), 4.77 (1H, d, J=11.3 Hz), 5.46 (1H, d, J=10.5 Hz), 5.52 (1H, d, J=10.5 Hz), 6.11 (1H, d, J=5.8 Hz), 6.94-6.98 (2H, m), 7.17 (3H, m), 7.31-7.46 (8H, m), 7.58 (3H, m).</p>\n",
       "<heading id=\"h-0470\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0752\" num=\"0764\">Compound 36A (402 mg, 0.837 mmol) was added to diphenyl ether (5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 164 mg of compound 36B as a colorless solid.</p>\n",
       "<p id=\"p-0753\" num=\"0765\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.36 (1H, dd, J=13.0, 7.0 Hz), 3.72 (1H, d, J=11.1 Hz), 4.35 (1H, d, J=11.4 Hz), 4.49 (1H, d, J=10.2 Hz), 5.38 (1H, d, J=10.5 Hz), 5.43 (1H, d, J=10.4 Hz), 5.94 (1H, d, J=7.2 Hz), 6.29 (1H, d, J=6.6 Hz), 6.38 (1H, d, J=7.5 Hz), 6.99 (2H, m), 7.17 (3H, m), 7.36 (8H, m), 7.60 (2H, m).</p>\n",
       "<heading id=\"h-0471\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0754\" num=\"0766\">Compound 36B (40 mg, 0.092 mmol) was dissolved in DMF (1 ml), and cesium carbonate (179 mg, 0.55 mmol) was added. After stirring at room temperature for 30 minutes, iodomethane (0.029 ml, 0.46 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. After the reaction solution was poured into water, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 44 mg of compound 36C as a colorless gummy substance.</p>\n",
       "<heading id=\"h-0472\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0755\" num=\"0767\">To compound 36C obtained in the third step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 24 mg of compound 36 as a colorless solid.</p>\n",
       "<p id=\"p-0756\" num=\"0768\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.93 (3H, s), 3.17 (1H, d, J=13.0 Hz), 4.13 (1H, dd, J=13.6, 3.4 Hz), 4.47 (1H, d, J=11.4 Hz), 5.52 (1H, dd, J=9.3, 3.4 Hz), 5.99 (1H, d, J=7.3 Hz), 7.18 (4H, m), 7.30 (3H, m), 7.41 (2H, t, J=7.5 Hz), 7.60 (2H, d, J=7.2 Hz).</p>\n",
       "<p id=\"p-0757\" num=\"0769\">MS: m/z=361 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0473\" level=\"1\">Example 37</heading>\n",
       "<p id=\"p-0758\" num=\"0770\"><chemistry id=\"CHEM-US-00149\" num=\"00149\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00149.TIF\" he=\"39.88mm\" id=\"EMI-C00149\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0759\" num=\"0771\">According to Example 36, compound 37 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0760\" num=\"0772\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.16 (2H, d, J=13.3 Hz), 4.05 (1H, d, J=10.5 Hz), 4.15 (1H, d, J=11.7 Hz), 4.38 (1H, d, J=14.9 Hz), 4.74 (1H, d, J=14.5 Hz), 5.35 (1H, d, J=11.4 Hz), 5.65 (1H, d, J=7.3 Hz), 6.99 (1H, d, J=7.5 Hz), 7.21 (15H, m).</p>\n",
       "<p id=\"p-0761\" num=\"0773\">MS: m/z=437 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0474\" level=\"1\">Example 38</heading>\n",
       "<p id=\"p-0762\" num=\"0774\"><chemistry id=\"CHEM-US-00150\" num=\"00150\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00150.TIF\" he=\"39.88mm\" id=\"EMI-C00150\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0763\" num=\"0775\">According to Example 36, compound 38 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0764\" num=\"0776\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.57 (2H, m), 3.17 (3H, s), 3.21-3.31 (5H, m), 4.07 (1H, dd, J=13.5, 3.7 Hz), 4.36 (1H, d, J=11.6 Hz), 5.42 (1H, d, J=9.2 Hz), 5.61 (1H, d, J=7.3 Hz), 6.89 (1H, d, J=7.5 Hz), 7.13-7.31 (6H, m), 7.40 (2H, t, J=6.3 Hz), 7.57 (2H, d, J=7.3 Hz), 12.31 (1H, brs).</p>\n",
       "<p id=\"p-0765\" num=\"0777\">MS: m/z=419 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0475\" level=\"1\">Example 39</heading>\n",
       "<p id=\"p-0766\" num=\"0778\"><chemistry id=\"CHEM-US-00151\" num=\"00151\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00151.TIF\" he=\"39.88mm\" id=\"EMI-C00151\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0767\" num=\"0779\">According to Example 36, compound 39 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0768\" num=\"0780\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.12 (1H, dd, J=13.6, 5.5 Hz), 3.87 (1H, d, J=9.5 Hz), 4.44 (1H, d, J=11.7 Hz), 5.45 (1H, d, J=10.4 Hz), 5.83 (1H, d, J=7.5 Hz), 7.04 (1H, d, J=7.2 Hz), 7.14-7.31 (6H, m), 7.40 (2H, t, J=7.5 Hz), 7.58 (2H, d, J=7.5 Hz), 9.09 (1H, d, J=5.2 Hz).</p>\n",
       "<p id=\"p-0769\" num=\"0781\">MS: m/z=347 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0476\" level=\"1\">Example 40</heading>\n",
       "<p id=\"p-0770\" num=\"0782\"><chemistry id=\"CHEM-US-00152\" num=\"00152\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00152.TIF\" he=\"47.58mm\" id=\"EMI-C00152\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0771\" num=\"0783\">According to Example 36, compound 40 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0772\" num=\"0784\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.88-3.15 (2H, m), 3.27 (3H, s), 3.53-3.73 (5H, m), 3.99 (1H, dd, J=13.27, 3.97 Hz), 4.56-4.60 (1H, m), 5.89 (1H, d, J=7.32 Hz), 7.08-7.30 (6H, m).</p>\n",
       "<heading id=\"h-0477\" level=\"1\">Example 41</heading>\n",
       "<p id=\"p-0773\" num=\"0785\"><chemistry id=\"CHEM-US-00153\" num=\"00153\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00153.TIF\" he=\"134.45mm\" id=\"EMI-C00153\" img-content=\"chem\" img-format=\"tif\" wi=\"75.86mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0478\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0774\" num=\"0786\">Compound 41A (290 mg, 0.555 mmol) synthesized according to Example 12 was added to diphenyl ether (5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1→97:3, v/v) to obtain 86 mg of compound 41B as a colorless solid.</p>\n",
       "<p id=\"p-0775\" num=\"0787\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.76 (3H, d, J=6.7 Hz), 0.98 (3H, d, J=6.9 Hz), 3.43-3.52 (2H, m), 3.62 (1H, dd, J=13.6, 3.5 Hz), 4.22 (1H, d, J=11.6 Hz), 4.52 (1H, d, J=11.6 Hz), 4.86-4.95 (1H, m), 5.37 (1H, d, J=10.2 Hz), 5.45 (1H, d, J=10.2 Hz), 5.90 (1H, d, J=7.5 Hz), 6.22 (1H, d, J=7.5 Hz), 6.89 (2H, m), 7.15 (3H, m), 7.36 (8H, m), 7.67 (2H, m).</p>\n",
       "<heading id=\"h-0479\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0776\" num=\"0788\">To compound 41B obtained in the first step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 45 mg of compound 41 as a colorless solid.</p>\n",
       "<p id=\"p-0777\" num=\"0789\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.82 (3H, d, J=6.7 Hz), 1.05 (3H, d, J=6.7 Hz), 3.90 (1H, dd, J=13.6, 3.4 Hz), 4.39 (1H, d, J=11.9 Hz), 4.77-4.86 (1H, m), 5.50 (1H, d, J=8.6 Hz), 5.69 (1H, d, J=7.4 Hz), 6.92 (1H, d, J=7.4 Hz), 7.15-7.48 (8H, m), 7.63 (2H, d, J=7.7 Hz) 12.51 (1H, Brs).</p>\n",
       "<p id=\"p-0778\" num=\"0790\">MS: m/z=389 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0480\" level=\"1\">Example 42</heading>\n",
       "<p id=\"p-0779\" num=\"0791\"><chemistry id=\"CHEM-US-00154\" num=\"00154\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00154.TIF\" he=\"39.88mm\" id=\"EMI-C00154\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0780\" num=\"0792\">According to Example 41, compound 42 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0781\" num=\"0793\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.12 (3H, s), 3.51 (5H, m), 4.05 (1H, dd, J=13.9, 3.5 Hz), 4.37 (1H, d, J=11.4 Hz), 5.38 (1H, d, J=11.6 Hz), 5.60 (1H, d, J=7.3 Hz), 6.90 (1H, d, J=7.5 Hz), 7.22 (6H, m), 7.40 (2H, t, J=7.5 Hz), 7.56 (2H, d, J=7.2 Hz).</p>\n",
       "<p id=\"p-0782\" num=\"0794\">MS: m/z=405 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0481\" level=\"1\">Example 43</heading>\n",
       "<p id=\"p-0783\" num=\"0795\"><chemistry id=\"CHEM-US-00155\" num=\"00155\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00155.TIF\" he=\"189.57mm\" id=\"EMI-C00155\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00156\" num=\"00156\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00156.TIF\" he=\"139.28mm\" id=\"EMI-C00156\" img-content=\"chem\" img-format=\"tif\" wi=\"63.50mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0482\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0784\" num=\"0796\">Compound 43A (2.00 g, 6.11 mmol), triphenylphosphine (2.40 g, 9.16 mmol) and phthalimide (1.08 g, 7.33 mmol) were added to THF (20 ml), and diethyl azodicarboxylate (2.2M in toluene, 4.16 ml, 9.16 mmol) was added dropwise at room temperature. After stirring at room temperature for 3 hours, the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 2.39 g of compound 43B as a colorless solid.</p>\n",
       "<p id=\"p-0785\" num=\"0797\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.00 (9H, s), 3.30 (1H, m), 3.61 (1H, dd, J=13.4, 10.2 Hz), 4.15 (1H, d, J=12.2 Hz), 4.75 (1H, m), 6.79 (1H, d, J=9.5 Hz), 7.25 (15H, m), 7.76-7.89 (4H, m).</p>\n",
       "<heading id=\"h-0483\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0786\" num=\"0798\">Compound 43B (2.06 g, 4.51 mmol) was added to THF (20 ml) and methanol (20 ml), hydrazine hydrate (4.52 g, 90.2 mmol) was added, and the mixture was stirred at 60° C. for 5 hours. The white precipitate was removed by filtration, and washed with methanol. After the filtrate was distilled off under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v), n-hexane was added, and the precipitated solid was filtered to obtain 1.25 g of compound 43C as a colorless solid.</p>\n",
       "<p id=\"p-0787\" num=\"0799\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.32 (9H, s), 2.55 (1H, dd, J=13.3, 6.0 Hz), 2.80 (1H, dd, J=13.3, 3.5 Hz), 3.99 (1H, d, J=10.1 Hz), 4.47 (2H, m), 7.13-7.33 (10H, m).</p>\n",
       "<heading id=\"h-0484\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0788\" num=\"0800\">Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (488 mg, 1.53 mmol) and 43C (500 mg, 1.53 mmol) were added to toluene (8 ml), and the mixture was stirred at 110° C. for 1 hour. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→96:4→94:6, v/v) to obtain 667 mg of compound 43D as a pale yellow gummy substance.</p>\n",
       "<p id=\"p-0789\" num=\"0801\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.28 (9H, s), 3.63 (3H, s), 3.80 (1H, m), 3.87 (3H, s), 4.02 (1H, dd, J=14.5, 10.1 Hz), 4.21 (1H, d, J=10.4 Hz), 4.47 (2H, m), 5.20 (1H, d, J=10.8 Hz), 5.26 (1H, d, J=10.7 Hz), 7.30 (15H, m), 8.05 (1H, s).</p>\n",
       "<p id=\"p-0790\" num=\"0802\">MS: m/z=627 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0485\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0791\" num=\"0803\">To compound 43D (664 mg, 1.06 mmol) was added 4N HCl (ethyl acetate solution, 10 ml), and the mixture was stirred at room temperature for 1 hour. After the solvent was distilled off under reduced pressure, THF and saturated sodium bicarbonate water were added, and the mixture was stirred for 2.5 hours. This was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 458 mg of compound 43E as a colorless solid.</p>\n",
       "<p id=\"p-0792\" num=\"0804\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.86 (3H, m), 3.92 (3H, s), 4.41-4.48 (1H, m), 5.32 (1H, d, J=10.8 Hz), 5.42 (1H, d, J=10.1 Hz), 5.92 (1H, s), 7.21-7.39 (13H, m), 7.59 (2H, m), 7.89 (1H, s).</p>\n",
       "<p id=\"p-0793\" num=\"0805\">MS: m/z=495 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0486\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0794\" num=\"0806\">Compound 43E (50 mg, 0.10 mmol) was dissolved in DMF (1 ml), and cesium carbonate (165 mg, 0.51 mmol) was added. After the mixture was stirred at room temperature for 30 minutes, iodomethane (0.025 ml, 0.40 mmol) was added, and the mixture was stirred at room temperature for 1 hour. After the reaction solution was poured into water, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 60 mg of compound 43F as a colorless solid.</p>\n",
       "<p id=\"p-0795\" num=\"0807\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.57 (3H, s), 3.75 (2H, d, J=11.3 Hz), 3.93 (3H, s), 4.20-4.29 (2H, m), 5.25 (1H, d, J=9.9 Hz), 5.57 (1H, d, J=9.9 Hz), 7.15-7.41 (13H, m), 7.63 (1H, s), 7.72-7.76 (2H, m).</p>\n",
       "<heading id=\"h-0487\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0796\" num=\"0808\">Compound 43F obtained in the fifth step was dissolved in THF (0.5 ml) and methanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.25 ml, 0.50 mmol) was added at room temperature, and the mixture was stirred for 1 hour. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, a colorless gummy compound 43G was obtained.</p>\n",
       "<heading id=\"h-0488\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0797\" num=\"0809\">To compound 43G obtained in the sixth step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 27 mg of compound 43 as a colorless solid.</p>\n",
       "<p id=\"p-0798\" num=\"0810\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.53 (3H, s), 4.26 (1H, d, J=10.9 Hz), 4.35 (1H, d, J=13.3 Hz), 4.58 (1H, dd, J=13.8, 3.5 Hz), 5.06 (1H, d, J=10.9 Hz), 7.36 (10H, m), 8.36 (1H, s), 12.58 (1H, s), 15.62 (1H, s).</p>\n",
       "<p id=\"p-0799\" num=\"0811\">MS: m/z=405 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0489\" level=\"1\">Example 44</heading>\n",
       "<p id=\"p-0800\" num=\"0812\"><chemistry id=\"CHEM-US-00157\" num=\"00157\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00157.TIF\" he=\"39.62mm\" id=\"EMI-C00157\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0801\" num=\"0813\">According to Example 43, compound 44 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0802\" num=\"0814\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 4.19 (2H, m), 4.42 (1H, dd, J=13.3, 3.8 Hz), 4.90 (1H, d, J=9.2 Hz), 7.17-7.41 (10H, m), 8.40 (1H, s), 9.66 (1H, s), 12.70 (1H, s), 15.60 (1H, s).</p>\n",
       "<p id=\"p-0803\" num=\"0815\">MS: m/z=391 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0490\" level=\"1\">Example 45</heading>\n",
       "<p id=\"p-0804\" num=\"0816\"><chemistry id=\"CHEM-US-00158\" num=\"00158\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00158.TIF\" he=\"37.08mm\" id=\"EMI-C00158\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0805\" num=\"0817\">According to Example 43, compound 45 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0806\" num=\"0818\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.17-2.26 (1H, m), 3.22 (3H, s), 3.39 (2H, m), 3.58-3.67 (1H, m), 4.19 (1H, d, J=10.7 Hz), 4.38 (2H, m), 4.95 (1H, d, J=10.8 Hz), 7.20-7.44 (10H, m), 8.28 (1H, s), 12.40 (1H, s), 15.60 (1H, s).</p>\n",
       "<p id=\"p-0807\" num=\"0819\">MS: m/z=449 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0491\" level=\"1\">Example 46</heading>\n",
       "<p id=\"p-0808\" num=\"0820\"><chemistry id=\"CHEM-US-00159\" num=\"00159\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00159.TIF\" he=\"228.26mm\" id=\"EMI-C00159\" img-content=\"chem\" img-format=\"tif\" wi=\"75.86mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0492\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0809\" num=\"0821\">Compound 43E (289 mg, 0.584 mmol) obtained in Example 35 was dissolved in THF (3 ml) and methanol (3 ml), a 2N aqueous sodium hydroxide solution (1.46 ml, 2.92 mmol) was added at room temperature, and the mixture was stirred for 1.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off, 342 mg of compound 46A was obtained as a colorless solid.</p>\n",
       "<p id=\"p-0810\" num=\"0822\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.72-4.04 (3H, m), 4.46 (1H, m), 5.39 (1H, d, J=10.4 Hz), 5.44 (1H, d, J=10.4 Hz), 6.04 (1H, brs), 7.19-7.60 (15H, m), 8.10 (1H, s).</p>\n",
       "<heading id=\"h-0493\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0811\" num=\"0823\">Compound 46A (402 mg, 0.837 mmol) was added to diphenyl ether (5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→92:8, v/v) to obtain 85 mg of compound 46B as a colorless solid.</p>\n",
       "<p id=\"p-0812\" num=\"0824\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.86 (3H, m), 4.45 (1H, m), 5.35 (1H, d, J=10.5 Hz), 5.41 (1H, d, J=10.4 Hz), 5.94 (1H, brs), 6.48 (1H, d, J=7.4 Hz), 7.00 (1H, d, J=7.4 Hz), 7.25-7.44 (13H, m), 7.62 (2H, m).</p>\n",
       "<heading id=\"h-0494\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0813\" num=\"0825\">Compound 46B (39 mg, 0.089 mmol) was dissolved in DMF (1 ml), and cesium carbonate (145 mg, 0.445 mmol) was added. After stirring at room temperature for 30 minutes, 1-bromo-2-methoxyethane (0.033 ml, 0.36 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. After the reaction solution was poured into water, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→92:8, v/v) to obtain 66 mg of compound 46C as a colorless gummy substance.</p>\n",
       "<heading id=\"h-0495\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0814\" num=\"0826\">To compound 46C obtained in the third step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 21 mg of compound 46 as a colorless solid.</p>\n",
       "<p id=\"p-0815\" num=\"0827\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.12-2.21 (1H, m), 3.20 (3H, s), 3.55-3.64 (3H, m), 3.81 (1H, d, J=13.0 Hz), 3.99 (1H, d, J=11.0 Hz), 4.22 (1H, dd, J=13.3, 3.1 Hz), 4.86 (1H, d, J=11.0 Hz), 6.11 (1H, d, J=7.2 Hz), 7.18-7.45 (11H, m).</p>\n",
       "<p id=\"p-0816\" num=\"0828\">MS: m/z=405 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0496\" level=\"1\">Example 47</heading>\n",
       "<p id=\"p-0817\" num=\"0829\"><chemistry id=\"CHEM-US-00160\" num=\"00160\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00160.TIF\" he=\"39.54mm\" id=\"EMI-C00160\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0818\" num=\"0830\">According to Example 46, compound 47 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0819\" num=\"0831\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.70 (1H, d, J=12.2 Hz), 4.02 (1H, d, J=10.7 Hz), 4.17 (1H, dd, J=13.2, 3.6 Hz), 4.79 (1H, t, J=3.4 Hz), 6.11 (1H, d, J=7.3 Hz), 7.18-7.44 (11H, m), 9.23 (1H, d, J=4.3 Hz).</p>\n",
       "<p id=\"p-0820\" num=\"0832\">MS: m/z=347 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0497\" level=\"1\">Example 48</heading>\n",
       "<p id=\"p-0821\" num=\"0833\"><chemistry id=\"CHEM-US-00161\" num=\"00161\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00161.TIF\" he=\"115.74mm\" id=\"EMI-C00161\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0498\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0822\" num=\"0834\">Compound 41A (400 mg, 0.743 mmol) was dissolved in DMF (5 ml), triethylamine (0.21 ml, 1.5 mmol) and ethyl chloroformate (0.143 ml, 1.49 mmol) were added at 0° C., and the mixture was stirred for 20 minutes. Sodium borohydride (70.2 mg, 1.86 mmol) was added at 0° C., and the mixture was stirred at room temperature for 30 minutes. Sodium borohydride (70.2 mg, 1.86 mmol) was further added at 0° C., and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97.3, v/v) to obtain 160 mg of compound 48A as a colorless solid.</p>\n",
       "<p id=\"p-0823\" num=\"0835\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.19 (3H, s), 3.37-3.54 (3H, m), 3.65-3.73 (1H, m), 3.87 (1H, m), 4.06 (2H, d, J=13.9 Hz), 4.31 (1H, d, J=11.2 Hz), 4.39 (1H, d, J=13.8 Hz), 4.77 (1H, d, J=11.2 Hz), 5.36 (1H, d, J=10.1 Hz), 5.41 (1H, d, J=10.1 Hz), 6.65 (1H, brs), 7.00 (2H, m), 7.19 (3H, m), 7.33-7.49 (8H, m), 7.70 (2H, m).</p>\n",
       "<heading id=\"h-0499\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0824\" num=\"0836\">To compound 48A (50 mg, 0.095 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, chroloform-ethyl ether were added, and the precipitated solid was filtered to obtain 3.5 mg of compound 48 as a colorless solid.</p>\n",
       "<p id=\"p-0825\" num=\"0837\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.12 (3H, s), 3.51 (5H, m), 3.71 (1H, d, J=13.7 Hz), 4.02 (1H, d, J=9.9 Hz), 4.09 (1H, d, J=12.0 Hz), 4.36 (1H, d, J=11.6 Hz), 4.73 (1H, brs), 5.45 (1H, d, J=12.5 Hz), 7.00 (1H, s), 7.15 (5H, m), 7.28 (1H, t, J=7.2 Hz), 7.40 (2H, t, J=7.5 Hz), 7.59 (2H, d, J=7.6 Hz).</p>\n",
       "<p id=\"p-0826\" num=\"0838\">MS: m/z=435 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0500\" level=\"1\">Example 49</heading>\n",
       "<p id=\"p-0827\" num=\"0839\"><chemistry id=\"CHEM-US-00162\" num=\"00162\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00162.TIF\" he=\"243.42mm\" id=\"EMI-C00162\" img-content=\"chem\" img-format=\"tif\" wi=\"75.35mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00163\" num=\"00163\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00163.TIF\" he=\"95.42mm\" id=\"EMI-C00163\" img-content=\"chem\" img-format=\"tif\" wi=\"67.14mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0501\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0828\" num=\"0840\">To Dess-Martin Periodinane (0.3M, methylene chloride solution, 52.0 ml, 15.6 mmol) was added dropwise a methylene chloride solution (20 ml) of compound 49A (2.97 g, 10.4 mmol) at 0° C. After stirring at room temperature for 3 hours, the reaction mixture was poured into a 1N aqueous sodium hydroxide solution, and the mixture was extracted with ethyl ether. The organic layer was washed with a 1N aqueous sodium hydroxide solution and an aqueous saturated sodium chloride solution, and dried with magnesium sulfate. After the solvent was distilled off under reduced pressure, 2.08 g of compound 49B was obtained as a white solid.</p>\n",
       "<p id=\"p-0829\" num=\"0841\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.13 (2H, d, J=6.6 Hz), 4.53 (1H, q, J=6.7 Hz), 5.12 (2H, s), 5.28 (1H, brs), 7.26 (10H, m), 9.64 (1H, s).</p>\n",
       "<heading id=\"h-0502\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0830\" num=\"0842\">Compound 49B (700 mg, 2.47 mmol), 2-aminoethanol (166 mg, 2.72 mmol) and sodium sulfate (1.76 g, 12.4 mmol) were added to toluene (20 ml), and the mixture was stirred at room temperature for 1 hour. Boc<sub>2</sub>O (0.631 ml, 2.72 mmol) was added at room temperature, and the mixture was stirred for 18 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 893 mg of 49C as a colorless gummy substance.</p>\n",
       "<heading id=\"h-0503\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0831\" num=\"0843\">Compound 49C (890 mg, 2.09 mmol) and palladium-active carbon (10% wet, 200 mg) were added to ethanol (20 ml), and the mixture was stirred at room temperature for 2 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 656 mg of a colorless oily substance 49D.</p>\n",
       "<p id=\"p-0832\" num=\"0844\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.40 (9H, s), 2.65-2.86 (2H, m), 3.32 (2H, m), 3.80 (2H, m), 4.03-4.12 (1H, m), 4.86 (1H, brs), 7.22 (5H, m).</p>\n",
       "<heading id=\"h-0504\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0833\" num=\"0845\">Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (610 mg, 2.09 mmol) and 49D (664 mg, 2.09 mmol) were added to toluene (6 ml), and the mixture was stirred at 100° C. for 4 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 884 mg of compound 49E as a pale yellow gummy substance.</p>\n",
       "<p id=\"p-0834\" num=\"0846\">MS: m/z=593 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0505\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0835\" num=\"0847\">To compound 49E (860 mg, 1.45 mmol) was added 4N HCl (ethyl acetate solution, 10 ml). After stirring at room temperature for 30 minutes, the solvent was distilled off under reduced pressure. Subsequently, toluene (10 ml) and 2-aminoethanol (0.175 ml, 2.90 mmol) were added, and the mixture was stirred at 80° C. for 30 minutes. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 99:1→95:5→90:10, v/v) to obtain 157 mg of compound 49F as a colorless gummy substance and 217 mg of compound 49G as a yellow solid.</p>\n",
       "<p id=\"p-0836\" num=\"0848\">49F: <sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.48 (1H, dd, J=14.0, 11.4 Hz), 3.22 (1H, dd, J=14.1, 3.3 Hz), 3.69 (1H, m), 3.77 (3H, s), 3.83-3.95 (1H, m), 4.08 (1H, m), 4.29 (1H, m), 4.41 (1H, m), 5.34 (2H, m), 5.48 (1H, d, J=10.1 Hz), 6.86 (2H, m), 7.20-7.39 (7H, m), 7.64 (2H, m)</p>\n",
       "<p id=\"p-0837\" num=\"0849\">49G: <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.70 (2H, t, J=5.3 Hz), 3.73 (3H, s), 3.86 (2H, t, J=5.3 Hz), 4.14 (2H, s), 4.98 (1H, t, J=5.0 Hz), 5.06 (2H, s), 6.98 (1H, s), 7.35 (8H, m), 7.62 (2H, d, J=7.1 Hz), 8.34 (1H, d, J=0.8 Hz).</p>\n",
       "<heading id=\"h-0506\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0838\" num=\"0850\">The compound 49G (214 mg, 0.465 mmol) was dissolved in THF (4 ml), ethanol (2 ml) and methylene chloride (2 ml), a 2N aqueous sodium hydroxide solution (1.16 ml, 2.32 mmol) was added at room temperature, and the mixture was stirred for 2.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with chloroform, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 158 mg of compound 49H was obtained as a yellow solid.</p>\n",
       "<p id=\"p-0839\" num=\"0851\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.70 (2H, q, J=5.2 Hz), 3.89 (2H, t, J=5.3 Hz), 4.22 (2H, s), 4.97 (1H, t, J=5.6 Hz), 5.12 (2H, s), 7.23-7.41 (9H, m), 7.60 (2H, m), 8.54 (1H, s).</p>\n",
       "<heading id=\"h-0507\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-0840\" num=\"0852\">Compound 49H (50.0 mg, 0.112 mmol) and palladium-active carbon (10%, wet, 12 mg) were added to methanol (1 ml) and DMF (3 ml), and the mixture was stirred at room temperature for 5 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 9.0 mg of compound 49 as a colorless solid.</p>\n",
       "<p id=\"p-0841\" num=\"0853\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.10 (2H, m), 3.51-3.69 (4H, m), 4.10 (1H, d, J=10.7 Hz), 4.94 (2H, m), 7.11-7.26 (5H, m), 8.03 (1H, s), 12.94 (1H, brs), 15.30 (1H, brs).</p>\n",
       "<p id=\"p-0842\" num=\"0854\">MS: m/z=359 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0508\" level=\"1\">Example 50</heading>\n",
       "<p id=\"p-0843\" num=\"0855\"><chemistry id=\"CHEM-US-00164\" num=\"00164\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00164.TIF\" he=\"198.37mm\" id=\"EMI-C00164\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0509\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0844\" num=\"0856\">Compound 50A (1.00 g, 3.98 mmol), triphenylphosphine (1.15 g, 4.48 mmol) and N-methyl-2-nitrobenzenesulfonamide (860 mg, 3.98 mmol) were added to THF (10 ml), diethyl azodicarboxylate (2.2M in toluene, 1.99 ml, 4.38 mmol) was added dropwise at room temperature. After stirring at room temperature for 3 hours, and the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 710 mg of compound 50B as a colorless gummy substance.</p>\n",
       "<heading id=\"h-0510\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0845\" num=\"0857\">Compound 50B (458 mg, 1.02 mmol) was dissolved in acetonitrile, potassium carbonate (422 mg, 3.06 mmol) and benzenethiol (0.126 ml, 1.22 mmol) were added, and the mixture was stirred at room temperature for 5 hours. The reaction solution was poured into a 1N aqueous sodium hydroxide solution, the mixture was extracted with methylene chloride, and the extract was dried with sodium sulfate. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) to obtain 147 mg of compound 50C as a colorless oily substance.</p>\n",
       "<p id=\"p-0846\" num=\"0858\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.36 (9H, s), 2.40 (3H, s), 2.51-2.89 (4H, m), 3.90 (1H, s), 4.69 (1H, s), 7.17-7.31 (5H, m).</p>\n",
       "<heading id=\"h-0511\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0847\" num=\"0859\">Compound 50C (140 mg, 0.530 mmol) and 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (WO 2006/116764, 119 mg, 0.482 mmol) were added to THF (3 ml), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (111 mg, 0.578 mmol) and 1-hydroxybenzotriazole (65.1 mg, 0.482 mmol) were added, and the mixture was stirred at room temperature for 18 hours. The reaction solution was poured into sodium bicarbonate water, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3, v/v) to obtain 219 mg of compound 50D as a colorless solid.</p>\n",
       "<p id=\"p-0848\" num=\"0860\">MS: m/z=493 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0512\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0849\" num=\"0861\">To compound 50D (216 mg, 0.439 mmol) was added 4N HCl (ethyl acetate solution, 3 ml). After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Subsequently, ethanol (4 ml) and an aqueous saturated sodium carbonate solution (3 ml) were added, and the mixture was stirred at 60° C. for 2 hours. After water was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) to obtain 108 mg of compound 50E as a pale yellow gummy substance.</p>\n",
       "<p id=\"p-0850\" num=\"0862\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.00 (2H, m), 3.13 (3H, s), 3.18 (1H, m), 3.88 (1H, dd, J=13.5, 3.4 Hz), 4.00-4.07 (1H, m), 5.26 (1H, d, J=10.2 Hz), 5.46 (1H, d, J=10.1 Hz), 6.25 (1H, d, J=7.5 Hz), 6.73 (1H, d, J=7.5 Hz), 6.99-7.02 (2H, m), 7.28-7.37 (6H, m), 7.63-7.67 (2H, m).</p>\n",
       "<heading id=\"h-0513\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0851\" num=\"0863\">To compound 50E (105 mg, 0.280 mmol) was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 30 minutes. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 29 mg of compound 50 as a colorless solid.</p>\n",
       "<p id=\"p-0852\" num=\"0864\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.99 (3H, s), 3.26-3.47 (3H, m), 4.07 (1H, d, J=11.1 Hz), 4.80 (1H, m), 6.43 (1H, d, J=6.9 Hz), 7.11-7.29 (5H, m), 7.50 (1H, d, J=6.9 Hz).</p>\n",
       "<p id=\"p-0853\" num=\"0865\">MS: m/z=285 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0514\" level=\"1\">Example 51</heading>\n",
       "<p id=\"p-0854\" num=\"0866\"><chemistry id=\"CHEM-US-00165\" num=\"00165\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00165.TIF\" he=\"117.01mm\" id=\"EMI-C00165\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0515\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0855\" num=\"0867\">Compound 1D (60 mg, 0.11 mmol) was dissolved in trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. The reaction solution was distilled off, and the resulting residue was purified by LC/MS to obtain compound 51 (43 mg, 0.09 mmol).</p>\n",
       "<p id=\"p-0856\" num=\"0868\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.17 (3H, t, J=6.9 Hz), 3.11 (3H, s), 3.48-3.58 (2H, m), 3.95-4.12 (3H, m), 4.40 (1H, d, J=11.4 Hz), 5.59 (1H, d, J=11.4 Hz), 7.11 (1H, d, J=7.3 Hz), 7.17 (2H, t, J=7.2 Hz), 7.26 (2H, d, J=7.1 Hz), 7.30 (1H, t, J=7.3 Hz), 7.42 (2H, t, J=7.2 Hz), 7.60 (3H, m), 12.55 (1H, brs).</p>\n",
       "<p id=\"p-0857\" num=\"0869\">MS: m/z=477.2 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0516\" level=\"1\">Example 52</heading>\n",
       "<p id=\"p-0858\" num=\"0870\"><chemistry id=\"CHEM-US-00166\" num=\"00166\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00166.TIF\" he=\"218.36mm\" id=\"EMI-C00166\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0517\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0859\" num=\"0871\">To a DMF (10 ml) solution of compound 1I (2.0 g, 4.32 mmol) were added WSC.HCl (1.24 g, 6.49 mmol) and HOBt (876.9 mg, 6.49 mmol) at room temperature, and the mixture was stirred at the same temperature for 1 hour. To the reaction solution were added O,N-dimethylhydroxylamine hydrochloride (842.7 mg, 8.64 mmol) and triethylamine (2.19 g, 21.6 mmol), the mixture was stirred at the same temperature for 3 hours, thereafter, water was added, and the mixture was extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (7:3, v/v) and, then, with only ethyl acetate. Concentration of an objective fraction afforded 543 mg (yield 25%) of compound 52A as an oil.</p>\n",
       "<p id=\"p-0860\" num=\"0872\">MS: m/z=506 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0518\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0861\" num=\"0873\">A THF (5 ml) solution of compound 52A (543 mg, 1.07 mmol) was cooled to −78° C., a methylmagnesium bromide 0.97M THF solution (1.66 ml, 1.61 mmol) was added, and temperature was raised up to −20° C. over 2 hours. To the reaction solution was added 1N hydrochloric acid, and the mixture was extracted with ethyl acetate three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (7:3, v/v) and, then, with only ethyl acetate. Concentration of an objective fraction afforded 256.8 mg (yield 52%) of compound 52B as an oil.</p>\n",
       "<p id=\"p-0862\" num=\"0874\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.65 (3H, s), 3.08 (2H, d, J=7.5 Hz), 3.12 (3H, s), 3.53-3.68 (4H, m), 3.79-3.95 (1H, m), 3.92 (1H, dd, J=3.3 Hz, 13.5 Hz), 4.10-4.16 (1H, m), 5.30 (1H, d, J=10.2 Hz), 5.45 (1H, d, J=10.2 Hz), 6.99-7.02 (2H, m), 7.25-7.38 (6H, m), 7.49 (1H, s), 7.63-7.66 (2H, m).</p>\n",
       "<heading id=\"h-0519\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0863\" num=\"0875\">To a dichloromethane (4 ml) solution of compound 528 (256 mg, 0.558 mmol) was added mCPBA (144.3 mg, 0.836 mmol) under ice-cooling, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added an aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate three times. After the extract was washed with saturated sodium bicarbonate water two times, and dried with sodium sulfate, the solvent was distilled off, the resulting oil was dissolved in ethanol (4 ml), and a 2N-aqueous sodium hydroxide solution (1 ml) was added, followed by refluxing for 1 hour. After the solvent was distilled off, the precipitated solid was washed with diisopropyl ether to obtain 242 mg (yield 100%) of compound 52C.</p>\n",
       "<p id=\"p-0864\" num=\"0876\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.09 (2H, d, J=6.9 Hz), 3.32 (3H, s), 3.54 (1H, d, J=14.1 Hz), 3.59-3.71 (2H, m), 3.76-3.85 (1H, m), 3.92 (1H, dd, J=3.6 Hz, 13.5 Hz), 4.03 (1H, brt), 5.28 (1H, d, J=10.2 Hz), 5.47 (1H, d, J=10.2 Hz), 6.68 (1H, s), 7.00-7.04 (2H, m), 7.23-7.37 (6H, m), 7.64 (2H, d, J=6.3 Hz).</p>\n",
       "<heading id=\"h-0520\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0865\" num=\"0877\">To a THF (3 ml) solution of compound 52C (242 mg, 0.558 mmol) was added 10% Pd—C (50 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 60 mg (yield 31%) of compound 52.</p>\n",
       "<p id=\"p-0866\" num=\"0878\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.05 (2H, brs), 3.36 (3H, s), 3.58 (1H, d, J=12 Hz), 3.66-3.68 (2H, m), 3.74-3.75 (2H, m), 4.11-4.19 (2H, m), 6.80 (1H, brs), 6.90-7.04 (2H, m), 7.30 (3H, brs).</p>\n",
       "<heading id=\"h-0521\" level=\"1\">Example 53</heading>\n",
       "<p id=\"p-0867\" num=\"0879\"><chemistry id=\"CHEM-US-00167\" num=\"00167\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00167.TIF\" he=\"132.33mm\" id=\"EMI-C00167\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0522\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0868\" num=\"0880\">To a DMF (10 ml) solution of compound 1I (1.0 mg, 2.23 mmol) were added triethylamine (677 mg, 6.69 mmol) and ethyl chlorocarbonate (729 mg, 6.69 mmol) under ice-cooling, and the mixture was stirred at room temperature for 10 minutes. To the reaction solution were added methanesulfonamide (1.06 g, 11.15 mmol) and DMAP (272.4 mg, 2.23 mmol), and the mixture was heated to stir at 80° C. for 2 hours. To the reaction solution was added water, and the mixture was extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with only chloroform and, then, with chloroform-MeOH (9:1, v/v). Concentration of an objective fraction afforded 535 mg (yield 46%) of compound 53A as an oil.</p>\n",
       "<p id=\"p-0869\" num=\"0881\">MS: m/z=463 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0523\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0870\" num=\"0882\">To a THF (5 ml) solution of compound 53A (535 mg, 0.991 mmol) was added 10% Pd—C (218 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 235 mg (yield 53%) of compound 53.</p>\n",
       "<p id=\"p-0871\" num=\"0883\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.99-3.17 (2H, m), 3.27 (3H, s), 3.33 (3H, s), 3.53-3.76 (5H, m), 4.06 (1H, dd, J=3.6 Hz, 13.8 Hz), 4.98 (1H, brs), 7.14 (2H, d, J=6.6 Hz), 7.19-7.30 (3H, m), 8.07 (1H, s), 12.84 (1H, s), 13.24 (1H, s).</p>\n",
       "<heading id=\"h-0524\" level=\"1\">Example 54</heading>\n",
       "<p id=\"p-0872\" num=\"0884\"><chemistry id=\"CHEM-US-00168\" num=\"00168\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00168.TIF\" he=\"222.08mm\" id=\"EMI-C00168\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0525\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0873\" num=\"0885\">To a DMF (10 ml) solution of compound 1I (1.0 mg, 2.23 mmol) were added triethylamine (677 mg, 6.69 mmol) and ethyl chlorocarbonate (729 mg, 6.69 mmol) under ice-cooling, and the mixture was stirred at the same temperature for 10 minutes. The reaction solution was added dropwise to an ice-cooled solution of sodium borohydride (441 mg, 11.7 mmol) in water (5 ml), and the mixture was stirred at the same temperature for 2 hours. To the reaction solution was added 2N hydrochloric acid to stop the reaction, and the mixture was neutralized with a 2N aqueous sodium hydroxide solution, and extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting crude product was dissolved in dichloromethane (5 ml).</p>\n",
       "<p id=\"p-0874\" num=\"0886\">To the dichloromethane solution was added manganese dioxide (2.1 g, 24.15 mmol), and the mixture was stirred at room temperature for 6 hours. After the reaction solution was filtered, and the solvent was distilled off, the resulting oil was purified by silica gel chromatography. Elution with ethyl acetate-MeOH (9:1, v/v) and concentration of an objective fraction afforded 188 mg (yield 19%) of compound 54A.</p>\n",
       "<p id=\"p-0875\" num=\"0887\">MS: m/z=447 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0526\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0876\" num=\"0888\">Compound 54A (188 mg, 0.422 mmol) was dissolved in THF (6 ml), 28% aqueous ammonia and iodine (117.7 mg, 0.464 mmol) were added at room temperature, and the mixture was stirred at the same temperature for 2 hours. To the reaction solution was added an aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. Elution with ethyl acetate-MeOH (9:1, v/v) and concentration of an objective fraction afforded 54.7 mg (yield 29%) of compound 54B.</p>\n",
       "<p id=\"p-0877\" num=\"0889\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.05 (2H, d, J=7.5 Hz), 3.33 (3H, s), 3.56-3.79 (5H, m), 3.99 (1H, dd, J=3.6 Hz, 13.8 Hz), 4.08 (1H, brt), 5.33 (1H, d, J=10.2 Hz), 5.46 (1H, d, J=10.2 Hz), 6.83 (1H, s), 6.93-6.97 (2H, m), 7.25-7.37 (5H, m), 7.58-7.62 (2H, m).</p>\n",
       "<heading id=\"h-0527\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0878\" num=\"0890\">To a toluene (2 ml) solution of compound 54B (216 mg, 0.487 mmol) were added sodium azide (95 mg, 1.46 mmol) and triethylamine (201 mg, 1.46 mmol), and the mixture was stirred at room temperature for 6 hours. The reaction solution was extracted with a 2N aqueous sodium hydroxide solution two times, and the extract was neutralized with 2N hydrochloric acid, and extracted with ethyl acetate three times. After drying of the organic layer with sodium sulfate, the solvent was distilled off to obtain 65 mg (yield 27%) of compound 54C.</p>\n",
       "<p id=\"p-0879\" num=\"0891\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.08-3.21 (2H, m), 3.33 (3H, s), 3.55-3.70 (4H, m), 3.81-3.90 (1H, m), 3.96-4.01 (1H, m), 4.51 (1H, brt), 5.31 (1H, d, J=10.2 Hz), 5.42 (1H, d, J=10.2 Hz), 7.03-7.05 (2H, m), 7.18-7.37 (6H, m), 7.58-7.61 (2H, m), 8.33 (1H, s).</p>\n",
       "<heading id=\"h-0528\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0880\" num=\"0892\">To a THF (2 ml)-MeOH (2 ml) solution of compound 54C (500 mg, 1.03 mmol) was added 10% Pd—C (100 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was dissolved in dichloromethane (10 ml), and the solution was extracted with a 2N aqueous sodium hydroxide solution two times. After the extract was neutralized with 2N hydrochloric acid, the mixture was extracted with ethyl acetate three times. The organic layer was dried with sodium sulfate, the solvent was distilled off, and the resulting solid was washed with diisopropyl ether, and filtered to obtain 55 mg (yield 14%) of compound 54.</p>\n",
       "<p id=\"p-0881\" num=\"0893\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.01-3.19 (2H, m), 3.28 (3H, s), 3.51-3.79 (5H, m), 4.09 (1H, dd, J=3.9 Hz, 13.5 Hz), 4.95 (1H, brs), 7.13-7.26 (5H, m), 8.20 (1H, s), 12.23 (1H, s).</p>\n",
       "<heading id=\"h-0529\" level=\"1\">Example 55</heading>\n",
       "<p id=\"p-0882\" num=\"0894\"><chemistry id=\"CHEM-US-00169\" num=\"00169\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00169.TIF\" he=\"143.43mm\" id=\"EMI-C00169\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0530\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0883\" num=\"0895\">To a THF (5 ml) solution of compound 1I (500 mg, 1.08 mmol) was added a trimethylsilyldiazomethane 2M hexane solution (1 ml, 2.0 mmol) at room temperature, and the mixture was heated to 50° C., and stirred. After the solvent was distilled off, the resulting oil was purified by silica gel chromatography. Elution with n-hexane-ethyl acetate (1:1, v/v) and concentration of objective fraction afforded 115 mg (yield 22%) of compound 55A.</p>\n",
       "<p id=\"p-0884\" num=\"0896\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.06 (2H, d, J=7.5 Hz), 3.31 (3H, s), 3.51-3.72 (5H, m), 3.81 (3H, s), 3.98 (1H, dd, J=3.6 Hz), 13.5 Hz), 4.11 (1H, brt), 5.22 (1H, d, J=9.6 Hz), 5.46 (1H, d, J=9.6 Hz), 6.99-7.02 (2H, m), 7.26-7.37 (6H, m), 7.46 (1H, s), 7.65-7.69 (2H, m).</p>\n",
       "<heading id=\"h-0531\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0885\" num=\"0897\">Compound 55A (210 mg, 0.441 mmol) was dissolved in THF (2 ml), 10% Pd—C (85.7 mg) was added, and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was washed with diisopropyl ether to obtain 50 mg (yield 23%) of compound 55.</p>\n",
       "<p id=\"p-0886\" num=\"0898\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.55 (2H, d, J=7.5 Hz), 3.37 (3H, s), 3.59-3.84 (5H, m), 4.23-4.32 (2H, m), 7.00 (2H, dd, J=1.5 Hz, 6.9 Hz), 7.23-7.32 (3H, m), 7.39 (1H, s), 12.31 (1H, brs).</p>\n",
       "<heading id=\"h-0532\" level=\"1\">Example 56</heading>\n",
       "<p id=\"p-0887\" num=\"0899\"><chemistry id=\"CHEM-US-00170\" num=\"00170\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00170.TIF\" he=\"175.94mm\" id=\"EMI-C00170\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0533\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0888\" num=\"0900\">A DMF (5 ml) solution of compound 2D (424 mg, 0.787 mmol) was ice-cooled, and triethylamine (327 ul, 2.36 mmol) and, subsequently, ethyl chloroformate (150 ul, 1.57 mmol) were added. After the reaction solution was stirred at room temperature for 10 minutes, it was ice-cooled again, sodium azide (154 mg, 2.36 mmol) was added, and the mixture was stirred for 1 hour. To the reaction solution were added dichloromethane, water and a small amount of methanol, the dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane once. The combined extracts were concentrated, methanol (8 ml) was added to the resulting residue, the mixture was stirred at 50° C. for 3 hours, and the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (1:1, v/v) and, then, with only ethyl acetate. Concentration of objective fraction afforded 160 mg of compound 56A as a white solid.</p>\n",
       "<p id=\"p-0889\" num=\"0901\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.08-3.18 (4H, m), 3.35-3.49 (3H, m), 3.68 (3H, s), 3.98 (2H, dt, J=23.1, 5.6 Hz), 4.32 (1H, d, J=11.3 Hz), 4.59 (1H, d, J=11.3 Hz), 5.37 (2H, dd, J=12.0, 10.4 Hz), 6.98-7.70 (15H, m).</p>\n",
       "<p id=\"p-0890\" num=\"0902\">MS: m/z=568.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0534\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0891\" num=\"0903\">Compound 56A (160 mg, 0.102 mmol) was dissolved in EtOH (10 mL), a 2N aqueous sodium hydroxide solution (14 ml) was added, and the mixture was stirred at 60° C. for 2 hours. After the reaction solution was concentrated under reduced pressure, the residue was distributed between dichloromethane and water. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane three times. The solvent was distilled off to obtain compound 56B.</p>\n",
       "<p id=\"p-0892\" num=\"0904\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.97-3.06 (1H, m), 3.15 (3H, s), 3.38-3.44 (3H, m), 3.71 (2H, s), 3.93-3.99 (2H, m), 4.35 (2H, dd, J=19.3, 11.1 Hz), 5.37 (2H, dd, J=31.6, 10.1 Hz), 6.04 (1H, s), 6.98 (2H, dd, J=6.4, 2.9 Hz), 7.17 (4H, t, J=3.3 Hz), 7.28-7.69 (12H, m).</p>\n",
       "<p id=\"p-0893\" num=\"0905\">MS: m/z=509.23 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0535\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0894\" num=\"0906\">Compound 56B (56 mg, 0.11 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 1 hour. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionation device. The eluted solvent was distilled off, isopropyl ether was added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether and drying afforded 7 mg of compound 56.</p>\n",
       "<p id=\"p-0895\" num=\"0907\">MS: m/z=420.07 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0536\" level=\"1\">Example 57</heading>\n",
       "<p id=\"p-0896\" num=\"0908\"><chemistry id=\"CHEM-US-00171\" num=\"00171\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00171.TIF\" he=\"108.63mm\" id=\"EMI-C00171\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0537\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0897\" num=\"0909\">To a THF (1 mL) solution of compound 56B (25 mg, 0.049 mmol) were added triethylamine (20 ul, 0.015 mmol) and, subsequently, acetic acid anhydride (7.0 ul, 0.074 mmol) under ice-cooling, and the mixture was stirred at room temperature for 15 minutes. Then, 4-fluorobenzyl amine (330 mg, 1.75 mmol) was added, and the mixture was stirred for 7 hours. Further, triethylamine (20 uL, 0.15 mmol) and, subsequently, acetic acid anhydride (7.0 ul, 0.074 mmol) were added, and the mixture was stirred overnight. To the reaction solution were added water, ethyl acetate, and brine, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, and filtration and concentration afforded 18 mg of compound 57A as a white solid.</p>\n",
       "<p id=\"p-0898\" num=\"0910\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.05 (3H, s), 3.09-3.14 (4H, m), 3.41-3.45 (3H, m), 3.95-4.02 (2H, m), 4.31 (1H, d, J=11.4 Hz), 4.59 (1H, d, J=12.4 Hz), 5.36 (2H, s), 7.00 (2H, d, J=4.0 Hz), 7.11-7.16 (3H, m), 7.36 (7H, tt, J=14.5, 5.1 Hz), 7.62 (2H, t, J=7.3 Hz), 8.02 (1H, s), 8.18 (1H, s).</p>\n",
       "<p id=\"p-0899\" num=\"0911\">MS: m/z=552.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0538\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0900\" num=\"0912\">Compound 57A (21 mg, 0.038 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 3.5 hours. The reaction mixture was subjected to toluene azeotropy, isopropyl ether was added to the resulting residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 10 mg of compound 57.</p>\n",
       "<p id=\"p-0901\" num=\"0913\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.12 (3H, s), 3.20 (3H, s), 3.39-3.60 (4H, m), 3.76-3.86 (1H, m), 4.08 (1H, dd, J=13.7, 3.7 Hz), 4.31 (1H, d, J=11.5 Hz), 4.68 (1H, dd, J=8.5, 4.3 Hz), 6.96-7.19 (4H, m), 7.30-7.44 (6H, m), 8.11 (1H, s).</p>\n",
       "<p id=\"p-0902\" num=\"0914\">MS: m/z=462.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0539\" level=\"1\">Example 58</heading>\n",
       "<p id=\"p-0903\" num=\"0915\"><chemistry id=\"CHEM-US-00172\" num=\"00172\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00172.TIF\" he=\"44.20mm\" id=\"EMI-C00172\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0904\" num=\"0916\">According to Example 57, compound 58 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0905\" num=\"0917\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.20 (3H, s), 3.41-3.54 (3H, m), 3.60-3.68 (2H, m), 3.73-3.85 (1H, m), 4.12 (1H, dt, J=14.0, 3.5 Hz), 4.31 (1H, d, J=11.4 Hz), 4.68 (1H, dd, J=11.4, 2.6 Hz), 6.95-7.21 (5H, m), 7.39 (5H, dt, J=26.9, 7.6 Hz), 7.94 (1H, s), 8.88 (1H, s).</p>\n",
       "<p id=\"p-0906\" num=\"0918\">MS: m/z=516.10 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0540\" level=\"1\">Example 59</heading>\n",
       "<p id=\"p-0907\" num=\"0919\"><chemistry id=\"CHEM-US-00173\" num=\"00173\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00173.TIF\" he=\"49.87mm\" id=\"EMI-C00173\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0908\" num=\"0920\">According to Example 57, compound 59 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0909\" num=\"0921\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.21 (3H, s), 3.43-3.63 (4H, m), 3.82 (1H, d, J=14.0 Hz), 4.12 (1H, dd, J=8.3, 4.2 Hz), 4.35 (1H, d, J=11.2 Hz), 4.74 (1H, d, J=8.3 Hz), 6.90-7.18 (5H, m), 7.34-7.60 (8H, m), 7.82 (2H, d, J=6.8 Hz), 8.34 (1H, s), 8.89 (1H, s).</p>\n",
       "<p id=\"p-0910\" num=\"0922\">MS: m/z=523.21 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0541\" level=\"1\">Example 60</heading>\n",
       "<p id=\"p-0911\" num=\"0923\"><chemistry id=\"CHEM-US-00174\" num=\"00174\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00174.TIF\" he=\"79.93mm\" id=\"EMI-C00174\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0912\" num=\"0924\">To compound 56B (30 mg, 0.059 mmol) were added formic acid (1.0 mL, 26 mmol) and, subsequently, a 37% formaldehyde solution (0.5 mL, 6.7 mmol), and the mixture was stirred at 100° C. for 7 hours. The reaction solution was subjected to toluene azeotropy, DMSO was added, insolubles were filtered and, thereafter, purification was performed using a LCMS fractionating device. The eluted solvent was distilled off, isopropyl ether was added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 3 mg of compound 60.</p>\n",
       "<p id=\"p-0913\" num=\"0925\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.37 (6H, s), 3.18 (3H, s), 3.29-3.66 (4H, m), 3.82 (1H, d, J=12.5 Hz), 4.06-4.15 (1H, m), 4.31 (1H, d, J=11.7 Hz), 4.54 (1H, d, J=8.1 Hz), 5.97 (1H, s), 7.01 (2H, dd, J=6.4, 2.8 Hz), 7.17 (3H, t, J=2.9 Hz), 7.32-7.45 (6H, m).</p>\n",
       "<p id=\"p-0914\" num=\"0926\">MS: m/z=448.15 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0542\" level=\"1\">Example 61</heading>\n",
       "<p id=\"p-0915\" num=\"0927\"><chemistry id=\"CHEM-US-00175\" num=\"00175\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00175.TIF\" he=\"144.95mm\" id=\"EMI-C00175\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0543\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0916\" num=\"0928\">Compound 56B (50 mg, 0.098 mmol) was dissolved in THF (1 mL), Boc<sub>2</sub>O (0.068 mL, 0.29 mmol) and, subsequently, DMAP (6.0 mg, 0.049 mmol) were added, and the mixture was stirred at room temperature for 5 hours. To the reaction solution were added water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 20 mg of compound 61A as a colorless transparent oil.</p>\n",
       "<p id=\"p-0917\" num=\"0929\">MS: m/z=610.50 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0544\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0918\" num=\"0930\">Compound 61A (20 mg, 0.033 mmol) was dissolved in DMF (1 mL), sodium hydride (2.6 mg, 0.066 mmol) was added under ice-cooling, the mixture was stirred for 10 minutes, methyl iodide (4.1 uL, 0.066 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. Ice water, ethyl acetate and brine were added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 13 mg of compound 61B as a white solid.</p>\n",
       "<p id=\"p-0919\" num=\"0931\">MS: m/z=624.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0545\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0920\" num=\"0932\">Compound 61B (13 mg, 0.021 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 3 hours. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, isopropyl ether-hexane were added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 7.5 mg of compound 61.</p>\n",
       "<p id=\"p-0921\" num=\"0933\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.19 (3H, s), 3.26 (3H, s), 3.46-3.70 (4H, m), 4.23 (1H, d, J=11.0 Hz), 4.58-4.60 (1H, br m), 5.41-5.44 (1H, br m), 6.28 (1H, br s), 6.99 (2H, br s), 7.13 (3H, br s), 7.31-7.46 (6H, m).</p>\n",
       "<p id=\"p-0922\" num=\"0934\">MS: m/z=434.10 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0546\" level=\"1\">Example 62</heading>\n",
       "<p id=\"p-0923\" num=\"0935\"><chemistry id=\"CHEM-US-00176\" num=\"00176\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00176.TIF\" he=\"246.72mm\" id=\"EMI-C00176\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0547\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0924\" num=\"0936\">Compound 2D (112 mg, 0.208 mmol) was dissolved in DMF (2 mL), triethylamine (0.144 ml, 1.04 mmol) and, subsequently, ethyl chloroformate (0.040 mL, 0.42 mmol) were added under ice-cooling, the mixture was stirred at room temperature for 10 minutes, thereafter, N,O-dimethylhydroxyamine hydrochloride (41 mg, 0.42 mmol) and, subsequently, DMAP (3 mg, 0.02 mmol) were added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution were added water, and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 127 mg of crude purified product 62A as a yellow oil.</p>\n",
       "<p id=\"p-0925\" num=\"0937\">MS: m/z=582.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0548\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0926\" num=\"0938\">Compound 62A (137 mg, 0.236 mmol) was dissolved in THF (8 mL), a 2M THF solution of methylmagnesium bromide (0.444 ml, 0.471 mmol) was added at −78° C. under nitrogen stream, and the mixture was stirred for 30 minutes while temperature was raised to −50° C. To the reaction solution was added 1M hydrochloric acid (4 ml), the mixture was stirred at 0° C. for 20 minutes, ethyl acetate was added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined extracts were neutralized with an aqueous saturated sodium bicarbonate solution, sodium sulfate was added to the organic layer, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 67 mg of compound 62B as a yellow oil.</p>\n",
       "<p id=\"p-0927\" num=\"0939\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.55 (3H, s), 3.01-3.14 (1H, m), 3.16 (3H, s), 3.37-3.54 (3H, m), 3.91-4.07 (2H, m), 4.28 (1H, d, J=11.3 Hz), 4.50-4.60 (1H, m), 5.42 (2H, d, J=1.2 Hz), 6.97-6.99 (2H, m), 7.14-7.17 (4H, m), 7.31-7.45 (8H, m), 7.65 (2H, d, J=6.5 Hz).</p>\n",
       "<p id=\"p-0928\" num=\"0940\">MS: m/z=537.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0549\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0929\" num=\"0941\">Compound 62B (67 mg, 0.13 mmol) was dissolved in dichloromethane (4 mL), mCPBA (32 mg, 0.19 mmol) was added at 0° C. under nitrogen stream, and the mixture was stirred at room temperature for 3 hours. The reaction solution was ice-cooled, an aqueous sodium thiosulfate solution, and ethyl acetate were added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined extracts were neutralized with an aqueous saturated sodium bicarbonate solution, sodium sulfate was added to the organic layer, the mixture was filtered, and the solvent was distilled off to obtain 64 mg of compound 62C.</p>\n",
       "<p id=\"p-0930\" num=\"0942\">MS: m/z=553.23 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0550\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0931\" num=\"0943\">Compound 62C (64 mg, 0.12 mmol) was dissolved in ethanol (8 mL), and the solution was heated to reflux for 4 hours. The reaction solution was concentrated, and the resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 42 mg of compound 62D.</p>\n",
       "<p id=\"p-0932\" num=\"0944\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.93-3.09 (1H, m), 3.16 (3H, s), 3.33-3.53 (4H, m), 3.90-4.07 (2H, m), 4.29-4.47 (2H, m), 5.41 (2H, q, J=10.4 Hz), 6.34 (1H, s), 6.95-6.99 (2H, m), 7.12-7.21 (4H, m), 7.33-7.42 (8H, m), 7.64 (2H, d, J=6.9 Hz).</p>\n",
       "<p id=\"p-0933\" num=\"0945\">MS: m/z=511.21 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0551\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0934\" num=\"0946\">Compound 62D (41 mg, 0.080 mmol) was dissolved in DMF (1 mL), sodium hydride (6.4 mg, 0.16 mmol) was added under ice-cooling, the mixture was stirred for 10 minutes, methyl iodide (0.010 ml, 0.16 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. To the reaction solution were added ice water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 41 mg of compound 62E as a white solid.</p>\n",
       "<p id=\"p-0935\" num=\"0947\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.99-3.09 (1H, m), 3.16 (3H, s), 3.25 (3H, s), 3.32-3.38 (1H, m), 3.42-3.50 (2H, m), 3.94-4.03 (2H, m), 4.28 (1H, d, J=11.3 Hz), 4.43 (1H, br s), 5.40 (2H, dd, J=28.3, 10.2 Hz), 6.01 (1H, s), 6.90-7.19 (5H, m), 7.28-7.44 (8H, m), 7.66 (2H, d, J=6.4 Hz).</p>\n",
       "<p id=\"p-0936\" num=\"0948\">MS: m/z=525.21 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0552\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0937\" num=\"0949\">Compound 62E (40 mg, 0.076 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 30 minutes. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, ethyl acetate-isopropyl ether-hexane were added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 7.1 mg of compound 62 as a pink solid.</p>\n",
       "<p id=\"p-0938\" num=\"0950\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.17 (3H, s), 3.22 (3H, s), 3.40-3.53 (4H, m), 3.63-3.71 (1H, m), 4.24 (1H, d, J=11.5 Hz), 4.45 (1H, d, J=13.3 Hz), 4.60 (1H, d, J=11.2 Hz), 6.08 (1H, d, J=11.7 Hz), 6.96-6.99 (2H, br m), 7.13-7.17 (3H, m), 7.30-7.43 (5H, m).</p>\n",
       "<p id=\"p-0939\" num=\"0951\">MS: m/z=435.15 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0553\" level=\"1\">Example 63</heading>\n",
       "<p id=\"p-0940\" num=\"0952\"><chemistry id=\"CHEM-US-00177\" num=\"00177\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00177.TIF\" he=\"145.54mm\" id=\"EMI-C00177\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0554\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0941\" num=\"0953\">Compound 2D (164 mg, 0.304 mmol) was dissolved in diphenyl ether (1 mL), the mixture was stirred at 245° C. for 1 hour using a microwave apparatus and, thereafter, the reaction solution was purified by silica gel column chromatography. Concentration of an objective fraction afforded 72 mg of compound 63A as a brown solid.</p>\n",
       "<p id=\"p-0942\" num=\"0954\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.92-3.01 (1H, m), 3.16 (3H, s), 3.32-3.50 (3H, m), 3.90-4.46 (4H, m), 5.42 (2H, dd, J=26.1, 10.3 Hz), 5.94 (1H, d, J=7.4 Hz), 6.28 (1H, d, J=7.5 Hz), 6.96-6.99 (2H, m), 7.15-7.19 (3H, m), 7.28-7.44 (8H, m), 7.62-7.65 (2H, m).</p>\n",
       "<p id=\"p-0943\" num=\"0955\">MS: m/z=495.21 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0555\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0944\" num=\"0956\">To a dichloromethane (4 mL) solution of compound 63A (21 mg, 0.042 mmol) was added NBS (11 mg, 0.062 mmol), and the mixture was heated to reflux for 1 hour. The reaction solution was allowed to cool, and purified by silica gel column chromatography. Concentration of an objective fraction afforded 26 mg of compound 63B as a white solid.</p>\n",
       "<p id=\"p-0945\" num=\"0957\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.01-3.09 (1H, m), 3.16 (3H, s), 3.35-3.53 (3H, m), 3.92-4.47 (4H, m), 5.41 (2H, dd, J=32.6, 10.0 Hz), 6.72 (1H, s), 6.97-7.00 (2H, br m), 7.20-7.22 (3H, m), 7.30-7.46 (8H, m), 7.66-7.70 (2H, m).</p>\n",
       "<p id=\"p-0946\" num=\"0958\">MS: m/z=573.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0556\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0947\" num=\"0959\">Compound 63B (10 mg, 0.017 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 50 minutes. The reaction mixture was subjected to toluene azeotropy, isopropyl ether was added to the resulting residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 1.4 mg of compound 63 as an orange solid.</p>\n",
       "<p id=\"p-0948\" num=\"0960\">MS: m/z=483.15 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0557\" level=\"1\">Example 64</heading>\n",
       "<p id=\"p-0949\" num=\"0961\"><chemistry id=\"CHEM-US-00178\" num=\"00178\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00178.TIF\" he=\"125.90mm\" id=\"EMI-C00178\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0558\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0950\" num=\"0962\">To a DMF solution (2 mL) of compound 63B (20 mg, 0.035 mmol) were added pyrazole-4-boronic acid pinacol ester (36 mg, 0.19 mmol) and, subsequently, potassium carbonate (29 mg, 0.21 mmol) and, thereafter, tetrakistriphenylphosphinepalladium (24 mg, 0.021 mmol) was added under nitrogen atmosphere, and the mixture was stirred at 110° C. for 8.5 hours. After the reaction solution was concentrated, ethyl acetate and methanol were added, and insolubles were removed. The filtrate was concentrated, and the resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 18 mg of compound 64A as a white solid.</p>\n",
       "<p id=\"p-0951\" num=\"0963\">MS: m/z=561.30 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0559\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0952\" num=\"0964\">Compound 64A (14 mg, 0.025 mmol) was dissolved in TFA (2 mL), and the mixture was stirred at room temperature for 30 minutes. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, isopropyl ether was added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 1.1 mg of compound 64 as an orange solid.</p>\n",
       "<p id=\"p-0953\" num=\"0965\">MS: m/z=471.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0560\" level=\"1\">Example 65</heading>\n",
       "<p id=\"p-0954\" num=\"0966\"><chemistry id=\"CHEM-US-00179\" num=\"00179\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00179.TIF\" he=\"243.67mm\" id=\"EMI-C00179\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0561\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0955\" num=\"0967\">A THF (1.1 L) solution of compound 65A (WO 2006/088173, 20.0 g, 69.6 mmol) was retained at 25° C. on a water bath, an aqueous (378 mL) solution of sodium chlorite (25.2 g, 278 mmol) and amidosulfuric acid (27.0 g, 278 mmol) was added dropwise over 30 minutes. The reaction solution was stirred at the same temperature for 1 hour, and concentrated under reduced pressure. To the residue were added ice water (100 mL) and diethyl ether (100 mL), and the precipitated solid was filtered. The resulting crude purified product was washed with water and diethyl ether to obtain 20.3 g of compound 65B as a white solid.</p>\n",
       "<p id=\"p-0956\" num=\"0968\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.74 (3H, s), 5.11 (2H, s), 7.31-7.38 (3H, m), 7.48 (2H, d, J=7.2 Hz), 8.11 (1H, s), 12.07 (1H, brs).</p>\n",
       "<heading id=\"h-0562\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0957\" num=\"0969\">Compound 65B (2.0 g, 6.59 mmol) was dissolved in DMF (340 mL), HATU (2.76 g, 7.25 mmol), methylamine (2 mol/L, THF solution, 3.63 mL, 7.25 mmol) and triethylamine (9.89 mmol) were added, and the mixture was stirred at room temperature for 5 hours. The reaction solution was distributed between ethyl acetate and water, the ethyl acetate layer was separated. and the aqueous layer was extracted with ethyl acetate once. The combined extracts were washed with water and an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off to obtain 1.66 g of a crude purified product of compound 65C as a white solid.</p>\n",
       "<p id=\"p-0958\" num=\"0970\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.38 (3H, brs), 3.75 (3H, s), 5.37 (2H, s), 7.34-7.44 (5H, m), 8.10 (1H, s), 8.38 (1H, s), 11.84 (1H, brs).</p>\n",
       "<heading id=\"h-0563\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0959\" num=\"0971\">To a DMF (20 mL) solution of compound 65C (1.2 g, 3.79 mmol) were added potassium carbonate (1.04 g, 7.59 mmol) and O-(2,4-dinitrophenyl)hydroxylamine (831 mg, 4.17 mmol), and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added water, and the precipitated solid was filtered, and washed with water to obtain 1.0 g of a crude purified product of compound 65D.</p>\n",
       "<p id=\"p-0960\" num=\"0972\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.74 (3H, s), 3.83 (3H, brs), 5.05 (2H, s), 6.46 (2H, brs), 7.31-7.38 (5H, m), 8.20 (1H, s), 8.52 (1H, brs).</p>\n",
       "<heading id=\"h-0564\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0961\" num=\"0973\">To a DMF (10 mL) solution of compound 65D (1.0 g, 3.02 mmol) were added paraformaldehyde (109 mg, 3.62 mmol) and acetic acid (0.017 ml, 0.302 mmol) at room temperature, and the mixture was stirred at 105° C. for 2 hours. The reaction solution was cooled to 0° C., cesium carbonate (3.44 g, 10.6 mmol) was added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added water, and the mixture was distributed between ethyl acetate and water. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off to obtain 120 mg of compound 65E.</p>\n",
       "<p id=\"p-0962\" num=\"0974\">MS: m/z=344 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0565\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0963\" num=\"0975\">To a DMF (1 mL) solution of compound 65E (17.0 mg, 0.05 mmol) were added cesium carbonate (81.4 mg, 0.25 mmol) and methylamine (2 mol/L THF solution, 0.125 ml, 0.25 mmol), and the mixture was stirred at room temperature for 5 hours. The reaction solution was filtered, and the filtrate was fractionated and purified by LCMS to obtain compound 65F.</p>\n",
       "<p id=\"p-0964\" num=\"0976\">MS: m/z=358 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0566\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-0965\" num=\"0977\">To a DMF (0.5 mL) solution of compound 65F was added a 2N aqueous sodium hydroxide solution (0.2 mL), and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added ion-exchange resin DOWEX (50W-X8), and the mixture was filtered, and washed with DMF. After concentration of the filtrate, trifluoroacetic acid (0.5 mL) was added, and the mixture was stirred at 80° C. for 4 hours. After concentration of the reaction solution, water and chloroform were added, and the organic layer was separated. The organic layer was concentrated, and fractionation-purified by LCMS to obtain 6.47 mg of compound 65.</p>\n",
       "<p id=\"p-0966\" num=\"0978\">MS: m/z=254 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"p-0967\" num=\"0979\">According to Example 65, the following compounds were synthesized by the same procedure.</p>\n",
       "<p id=\"p-0968\" num=\"0980\">\n",
       "<tables id=\"TABLE-US-00001\" num=\"00001\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"161pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"14pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 1</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example</entry>\n",
       "<entry>Structure</entry>\n",
       "<entry>MS</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>Example 66</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00180\" num=\"00180\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00180.TIF\" he=\"26.42mm\" id=\"EMI-C00180\" img-content=\"table\" img-format=\"tif\" wi=\"52.41mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>348</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 67</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00181\" num=\"00181\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00181.TIF\" he=\"26.42mm\" id=\"EMI-C00181\" img-content=\"table\" img-format=\"tif\" wi=\"33.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>296</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 68</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00182\" num=\"00182\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00182.TIF\" he=\"27.26mm\" id=\"EMI-C00182\" img-content=\"table\" img-format=\"tif\" wi=\"46.82mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>340</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 69</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00183\" num=\"00183\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00183.TIF\" he=\"26.42mm\" id=\"EMI-C00183\" img-content=\"table\" img-format=\"tif\" wi=\"40.72mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>348</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 70</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00184\" num=\"00184\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00184.TIF\" he=\"23.20mm\" id=\"EMI-C00184\" img-content=\"table\" img-format=\"tif\" wi=\"52.75mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>442</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 71</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00185\" num=\"00185\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00185.TIF\" he=\"34.97mm\" id=\"EMI-C00185\" img-content=\"table\" img-format=\"tif\" wi=\"33.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>318</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-0969\" num=\"0981\">\n",
       "<tables id=\"TABLE-US-00002\" num=\"00002\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"161pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"14pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 2</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example</entry>\n",
       "<entry>Structure</entry>\n",
       "<entry>MS</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>Example 72</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00186\" num=\"00186\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00186.TIF\" he=\"34.88mm\" id=\"EMI-C00186\" img-content=\"table\" img-format=\"tif\" wi=\"46.82mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>362</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 73</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00187\" num=\"00187\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00187.TIF\" he=\"34.88mm\" id=\"EMI-C00187\" img-content=\"table\" img-format=\"tif\" wi=\"54.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>388</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 74</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00188\" num=\"00188\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00188.TIF\" he=\"30.65mm\" id=\"EMI-C00188\" img-content=\"table\" img-format=\"tif\" wi=\"52.24mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>438</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 75</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00189\" num=\"00189\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00189.TIF\" he=\"27.18mm\" id=\"EMI-C00189\" img-content=\"table\" img-format=\"tif\" wi=\"46.82mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>298</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 76</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00190\" num=\"00190\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00190.TIF\" he=\"24.89mm\" id=\"EMI-C00190\" img-content=\"table\" img-format=\"tif\" wi=\"51.22mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>430</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 77</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00191\" num=\"00191\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00191.TIF\" he=\"38.78mm\" id=\"EMI-C00191\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>442</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-0970\" num=\"0982\">\n",
       "<tables id=\"TABLE-US-00003\" num=\"00003\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"161pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"14pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 3</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example</entry>\n",
       "<entry>Structure</entry>\n",
       "<entry>MS</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>Example 78 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00192\" num=\"00192\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00192.TIF\" he=\"33.44mm\" id=\"EMI-C00192\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>442</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 79</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00193\" num=\"00193\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00193.TIF\" he=\"40.72mm\" id=\"EMI-C00193\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>454</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 80</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00194\" num=\"00194\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00194.TIF\" he=\"32.77mm\" id=\"EMI-C00194\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>438</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 81</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00195\" num=\"00195\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00195.TIF\" he=\"44.03mm\" id=\"EMI-C00195\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>492</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 82</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00196\" num=\"00196\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00196.TIF\" he=\"32.77mm\" id=\"EMI-C00196\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>443</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-0971\" num=\"0983\">\n",
       "<tables id=\"TABLE-US-00004\" num=\"00004\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"168pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"7pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 4</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example</entry>\n",
       "<entry>Structure</entry>\n",
       "<entry>MS</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>Example 83 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00197\" num=\"00197\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00197.TIF\" he=\"45.89mm\" id=\"EMI-C00197\" img-content=\"table\" img-format=\"tif\" wi=\"57.23mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>513</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 84</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00198\" num=\"00198\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00198.TIF\" he=\"40.72mm\" id=\"EMI-C00198\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>500</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 85</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00199\" num=\"00199\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00199.TIF\" he=\"38.02mm\" id=\"EMI-C00199\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>454</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 86</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00200\" num=\"00200\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00200.TIF\" he=\"40.72mm\" id=\"EMI-C00200\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>452</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 87</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00201\" num=\"00201\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00201.TIF\" he=\"33.27mm\" id=\"EMI-C00201\" img-content=\"table\" img-format=\"tif\" wi=\"53.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>480</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-0972\" num=\"0984\">\n",
       "<tables id=\"TABLE-US-00005\" num=\"00005\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"161pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"14pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 5</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example</entry>\n",
       "<entry>Structure</entry>\n",
       "<entry>MS</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>Example 88</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00202\" num=\"00202\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00202.TIF\" he=\"38.02mm\" id=\"EMI-C00202\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>406</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 89</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00203\" num=\"00203\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00203.TIF\" he=\"36.24mm\" id=\"EMI-C00203\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>445</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 90</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00204\" num=\"00204\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00204.TIF\" he=\"40.72mm\" id=\"EMI-C00204\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>500</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 91</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00205\" num=\"00205\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00205.TIF\" he=\"31.75mm\" id=\"EMI-C00205\" img-content=\"table\" img-format=\"tif\" wi=\"53.93mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>416</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example 92</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00206\" num=\"00206\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00206.TIF\" he=\"43.35mm\" id=\"EMI-C00206\" img-content=\"table\" img-format=\"tif\" wi=\"51.73mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "<entry>450</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<heading id=\"h-0567\" level=\"1\">Example 93</heading>\n",
       "<p id=\"p-0973\" num=\"0985\"><chemistry id=\"CHEM-US-00207\" num=\"00207\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00207.TIF\" he=\"45.47mm\" id=\"EMI-C00207\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0974\" num=\"0986\">According to Example 65, compound 93 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-0975\" num=\"0987\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.34 (3H, s), 3.57-3.68 (2H, m), 3.73 (2H, br s), 4.18 (2H, s), 4.75 (2H, br s), 7.06-7.12 (2H, m), 7.21-7.24 (2H, m), 8.10 (1H, s), 11.96 (1H, br s), 14.52 (1H, brs).</p>\n",
       "<heading id=\"h-0568\" level=\"1\">Example 94</heading>\n",
       "<p id=\"p-0976\" num=\"0988\"><chemistry id=\"CHEM-US-00208\" num=\"00208\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00208.TIF\" he=\"162.22mm\" id=\"EMI-C00208\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0569\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0977\" num=\"0989\">Using compound 94A (WO 2007/049675), and according to the same procedure as that of the fifth step of Example 65, compound 94B was synthesized.</p>\n",
       "<p id=\"p-0978\" num=\"0990\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.00-3.09 (1H, m), 3.18 (3H, s), 3.44 (2H, dd, J=7.55, 2.82 Hz), 4.02-4.08 (1H, m), 4.44-4.59 (3H, m), 4.86 (1H, d, J=13.57 Hz), 5.25 (1H, s), 5.36 (2H, dd, J=14.87, 9.99 Hz), 6.74-6.84 (2H, m), 7.09-7.60 (16H, m), 7.90 (1H, s), 10.07 (1H, t, J=5.87 Hz).</p>\n",
       "<heading id=\"h-0570\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0979\" num=\"0991\">To a MeCN (20 ml) solution of compound 94B (1.1 g, 1.655 mmol) were added DMAP (202 mg, 1.655 mmol) and Boc<sub>2</sub>O (20 ml, 86 mmol) at room temperature under nitrogen stream, and the mixture was heated to reflux for 5 hours. Further, Boc<sub>2</sub>O (20 ml, 86 mmol) was added, and the mixture was heated to reflux for 5 hours. After concentration under reduced pressure, to the residue were added ethanol (20.00 ml) and an aqueous sodium hydroxide solution (40%, 25 ml), and the mixture was stirred at room temperature for 5 hours. To the reaction mixture were added ethyl acetate-water to make the aqueous layer acidic. After extraction with ethyl acetate (2×200 mL), the organic layer was washed with an aqueous saturated sodium chloride solution. After drying with magnesium sulfate, the solvent was distilled off under reduced pressure. The crude product was purified by silica gel column chromatography (CHCl<sub>3</sub>/MeOH 20:1) to obtain compound 94C. (750 mg, 63%)</p>\n",
       "<p id=\"p-0980\" num=\"0992\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.13 (3H, s), 3.25-3.34 (3H, m), 3.79 (1H, d, J=13.73 Hz), 4.42 (1H, d, J=14.03 Hz), 5.11-5.27 (3H, m), 5.48 (1H, s), 7.18-7.21 (5H, m), 7.33-7.49 (6H, m), 7.56-7.58 (2H, m), 7.74 (2H, d, J=7.32 Hz), 8.01 (1H, s).</p>\n",
       "<heading id=\"h-0571\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0981\" num=\"0993\">Using compound 94C, and according to the same procedure as that of the tenth step of Example 12, compound 94 was synthesized.</p>\n",
       "<p id=\"p-0982\" num=\"0994\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.13 (3H, s), 3.41-3.56 (4H, m), 4.50 (1H, d, J=13.57 Hz), 5.21 (1H, d, J=13.42 Hz), 5.58 (1H, s), 7.16-7.50 (8H, m), 7.72 (2H, d, J=7.32 Hz), 7.93 (1H, s), 12.12 (1H, s).</p>\n",
       "<heading id=\"h-0572\" level=\"1\">Example 95</heading>\n",
       "<p id=\"p-0983\" num=\"0995\"><chemistry id=\"CHEM-US-00209\" num=\"00209\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00209.TIF\" he=\"219.96mm\" id=\"EMI-C00209\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0573\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-0984\" num=\"0996\">Compound 95A (WO 2006/116764, 1 g, 4.06 mmol) was dissolved in 28% aqueous ammonia, and the solution was stirred at room temperature for 12 hours. After concentration of the reaction solution, the resulting residue was neutralized with 2N hydrochloric acid, and the precipitated solid was suspended in ethyl acetate, filtered, and dried to obtain 1.14 g (yield 100%) of compound 95B.</p>\n",
       "<p id=\"p-0985\" num=\"0997\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 5.14 (2H, s), 7.31 (1H, d, J=6.6 Hz), 7.34-7.41 (3H, m), 7.45-7.51 (2H, m), 8.17 (1H, d, J=6.6 Hz).</p>\n",
       "<heading id=\"h-0574\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-0986\" num=\"0998\">To a DMF (10 ml) solution of compound 95B (3.00 g, 10.65 mmol) were added WSC.HCl (3.06 g, 15.98 mmol) and HOBt (1.58 g, 11.7 mmol) at room temperature, the mixture was stirred for 10 minutes, and a methylamine 33 wt % ethanol solution (1.50 g, 15.98 mmol) was added dropwise. After the reaction solution was stirred at the same temperature for 2 hours, water was added, and the mixture was extracted with chloroform five times. The extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (6:4, v/v), 2.62 g (yield 95%) of compound 95C was obtained as a solid.</p>\n",
       "<p id=\"p-0987\" num=\"0999\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.77 (3H, d, J=4.8 Hz), 5.49 (2H, s), 6.57 (1H, d, J=6.9 Hz), 7.25-7.43 (5H, m), 7.48 (1H, t, J=6.0 Hz), 8.23 (1H, brs), 9.77 (1H, brs).</p>\n",
       "<heading id=\"h-0575\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-0988\" num=\"1000\">Into a DMF (10 ml) solution of compound 95C (2.62 g, 10.14 mmol) was suspended potassium carbonate (4.20 g, 30.42 mmol) at room temperature, the suspension was stirred for 5 minutes, O-(2,4-dinitrophenyl)hydroxylamine (3.03 g, 15.21 mmol) was added, and the mixture was stirred at the same temperature for 3 hours. To the reaction solution was added water, the mixture was extracted with chloroform five times, and the extract was dried with sodium sulfate. After the solvent was distilled off, the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (6:4, v/v), 1.41 g (yield 51%) of compound 95D was obtained as a solid.</p>\n",
       "<p id=\"p-0989\" num=\"1001\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.62 (3H, d, J=5.1 Hz), 5.06 (2H, s), 5.22 (2H, s), 6.18 (1H, d, J=7.8 Hz), 7.25-7.36 (5H, m), 5.89 (1H, d, J=7.8 Hz), 7.57 (1H, q, J=5.1 Hz).</p>\n",
       "<heading id=\"h-0576\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-0990\" num=\"1002\">A toluene (10 ml) solution of compound 95D (1.0 g, 3.66 mmol) were added paraformaldehyde (109.9 mg, 3.66 mmol) and acetic acid (22 mg, 0.37 mmol), and the mixture was heated to stir at 100° C. for 40 minutes. After cooling, the solvent was distilled off, the residue was dissolved in DMF (10 ml) without purification, cesium carbonate (3.58 g, 10.98 mmol) was added under ice-cooling, and the mixture was stirred for 10 minutes. To the reaction solution was added benzohydryl bromide (1.36 g, 5.49 mmol), the mixture was stirred at room temperature for 3 hours, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (9:1, v/v), 1.26 g (yield 71%) of compound 95E was obtained as a solid.</p>\n",
       "<p id=\"p-0991\" num=\"1003\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.91 (3H, s), 4.26 (1H, d, J=13.2 Hz), 4.77 (1H, d, J=13.2 Hz), 5.12 (1H, s), 5.42 (1H, J=13.2 Hz), 5.45 (1H, d, J=13.2 Hz), 5.82 (1H, J=7.5 Hz), 6.71 (1H, d, J=7.5 Hz), 7.10-7.23 (5H, m), 7.27-7.46 (6H, m), 7.52 (2H, d, J=6.9 Hz), 7.60-7.64 (2H, m).</p>\n",
       "<heading id=\"h-0577\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-0992\" num=\"1004\">Compound 95E (100 mg, 0.221 mmol) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 50 mg (yield 63%) of compound 95.</p>\n",
       "<p id=\"p-0993\" num=\"1005\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.95 (3H, s), 4.36 (1H, d, J=13.2 Hz), 4.95 (1H, d, J=13.2 Hz), 5.22 (1H, s), 5.71 (1H, d, J=7.8 Hz), 6.75 (1H, d, J=7.8 Hz), 7.21 (5H, br s), 7.33-7.47 (4H, m), 7.55 (2H, d, J=6.6 Hz).</p>\n",
       "<p id=\"p-0994\" num=\"1006\">According to Example 95, the following compounds were synthesized by the same procedure.</p>\n",
       "<heading id=\"h-0578\" level=\"1\">Example 96</heading>\n",
       "<p id=\"p-0995\" num=\"1007\"><chemistry id=\"CHEM-US-00210\" num=\"00210\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00210.TIF\" he=\"49.87mm\" id=\"EMI-C00210\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0996\" num=\"1008\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.12-3.18 (1H, m), 3.21 (3H, s), 3.38-3.52 (2H, m), 3.81 (1H, ddd, J=3.3 Hz, 4.2 Hz, 14.1 Hz), 4.52 (1H, d, J=13.2 Hz), 5.00 (1H, d, J=13.2 Hz), 5.28 (1H, s), 5.71 (1H, d, J=7.8 Hz), 6.74 (1H, d, J=7.8 Hz), 7.14-7.21 (5H, m), 7.32-7.46 (3H, m), 7.53 (2H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-0579\" level=\"1\">Example 97</heading>\n",
       "<p id=\"p-0997\" num=\"1009\"><chemistry id=\"CHEM-US-00211\" num=\"00211\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00211.TIF\" he=\"49.87mm\" id=\"EMI-C00211\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-0998\" num=\"1010\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.99-3.06 (0.54H, m), 3.18-3.23 (3.9H, m), 3.42-3.54 (2.5H, m), 3.86-3.91 (0.42H, m), 4.03-4.08 (0.58H, m), 4.37 (0.58H, d, J=13.5 Hz), 4.54 (0.42H, d, J=13.8 Hz), 4.98 (0.58H, d, J=13.5 Hz), 5.08 (0.42H, d, J=13.8 Hz), 5.36 (0.58H, s), 5.43 (0.42H, s), 5.70-5.77 (1H, m), 6.77 (0.42H, d, J=7.5 Hz), 6.94 (0.58H, d, J=7.8 Hz), 7.08-7.53 (6H, m), 7.60-7.78 (2H, m), 8.55 (0.58H, d, J=4.2 Hz), 8.72 (0.42H, d, J=3.9 Hz).</p>\n",
       "<heading id=\"h-0580\" level=\"1\">Example 98</heading>\n",
       "<p id=\"p-0999\" num=\"1011\"><chemistry id=\"CHEM-US-00212\" num=\"00212\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00212.TIF\" he=\"49.87mm\" id=\"EMI-C00212\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1000\" num=\"1012\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.930 (3H, d, J=6.9 Hz), 1.09 (3H, d, J=6.9 Hz), 4.58 (1H, d, J=12.6 Hz), 4.79 (1H, d, J=12.6 Hz), 4.83-4.90 (1H, m), 5.20 (1H, s), 5.67 (1H, d, J=7.5 Hz), 6.66 (1H, d, J=7.5 Hz), 7.07-7.09 (2H, m), 7.13-7.19 (3H, m), 7.34-7.46 (3H, m), 7.52 (1H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-0581\" level=\"1\">Example 99</heading>\n",
       "<p id=\"p-1001\" num=\"1013\"><chemistry id=\"CHEM-US-00213\" num=\"00213\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00213.TIF\" he=\"58.34mm\" id=\"EMI-C00213\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1002\" num=\"1014\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.30 (3H, s), 3.49 (1H, brs), 3.54-3.56 (2H, m), 3.73 (1H, brs), 4.11 (2H, brs), 4.25 (1H, brs), 4.78 (1H, brs), 6.00 (1H, d, J=7.5 Hz), 8.33 (1H, d, J=7.5 Hz), 7.19-7.24 (3H, m), 7.34-7.37 (2H, m), 7.38-7.48 (4H, m).</p>\n",
       "<heading id=\"h-0582\" level=\"1\">Example 100</heading>\n",
       "<p id=\"p-1003\" num=\"1015\"><chemistry id=\"CHEM-US-00214\" num=\"00214\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00214.TIF\" he=\"49.87mm\" id=\"EMI-C00214\" img-content=\"chem\" img-format=\"tif\" wi=\"50.55mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1004\" num=\"1016\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.32 (1H, d, J=14.7 Hz), 4.41 (1H, d, J=12.9 Hz), 4.69 (1H, d, J=14.7 Hz), 4.88 (1H, d, J=12.9 Hz), 4.97 (1H, s), 5.68 (1H, d, J=7.5 Hz), 6.70 (1H, d, J=7.5 Hz), 6.91-6.98 (2H, m), 7.05-7.08 (2H, m), 7.12-7.20 (7H, m), 7.30-7.32 (4H, m).</p>\n",
       "<heading id=\"h-0583\" level=\"1\">Example 101</heading>\n",
       "<p id=\"p-1005\" num=\"1017\"><chemistry id=\"CHEM-US-00215\" num=\"00215\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00215.TIF\" he=\"55.12mm\" id=\"EMI-C00215\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1006\" num=\"1018\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.35 (3H, s), 3.66-3.69 (3H, m), 3.89 (1H, brs), 4.51 (1H, brs), 4.64 (2H, brs), 5.05 (1H, brs), 5.89 (1H, d, J=7.5 Hz), 6.58 (1H, d, J=7.5H), 7.11 (1H, d, J=7.2 Hz), 7.26-7.40 (1H, m), 7.54-7.62 (2H, m), 7.86-7.93 (2H, m), 8.13 (1H, d, J=8.4 Hz).</p>\n",
       "<heading id=\"h-0584\" level=\"1\">Example 102</heading>\n",
       "<p id=\"p-1007\" num=\"1019\"><chemistry id=\"CHEM-US-00216\" num=\"00216\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00216.TIF\" he=\"49.87mm\" id=\"EMI-C00216\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1008\" num=\"1020\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.54 (1H, d, J=12.9 Hz), 4.56 (2H, s), 4.94 (1H, d, J=12.9 Hz), 5.14 (1H, s), 5.68 (1H, d, J=7.8 Hz), 6.20 (1H, d, J=3.0 Hz), 6.25-6.27 (1H, m), 6.72 (1H, d, J=7.8 Hz), 7.10-7.37 (11H, m).</p>\n",
       "<heading id=\"h-0585\" level=\"1\">Example 103</heading>\n",
       "<p id=\"p-1009\" num=\"1021\"><chemistry id=\"CHEM-US-00217\" num=\"00217\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00217.TIF\" he=\"49.87mm\" id=\"EMI-C00217\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1010\" num=\"1022\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.33 (3H, s), 3.63-3.66 (2H, m), 3.75 (2H, brs), 4.27 (2H, brs), 4.67 (1H, brs), 5.00 (1H, brs), 6.09 (1H, d, J=7.8 Hz), 6.99 (1H, d, J=7.8 Hz), 7.18 (1H, d, J=7.8 Hz), 7.27-7.32 (1H, m), 7.66-7.71 (1H, m), 8.63-8.65 (1H, m).</p>\n",
       "<heading id=\"h-0586\" level=\"1\">Example 104</heading>\n",
       "<p id=\"p-1011\" num=\"1023\"><chemistry id=\"CHEM-US-00218\" num=\"00218\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00218.TIF\" he=\"49.87mm\" id=\"EMI-C00218\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1012\" num=\"1024\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.12-3.22 (1H, m), 3.21 (3H, m), 3.38-3.55 (3H, m), 3.74-3.80 (0.55H, m), 3.87-3.94 (0.44H, m), 4.46-4.54 (1H, m), 5.00-5.07 (1H, m), 5.30-5.39 (1H, m), 5.70 (0.55H, d, J=7.5 Hz), 5.77 (0.45H, d, J=7.5 Hz), 6.74 (0.55H, d, J=7.8 Hz), 6.81 (0.45H, d, J=7.8 Hz), 7.11-7.54 (7.45H, m), 7.90 (0.55H, d, J=7.8 Hz), 8.459-8.783 (2H, m).</p>\n",
       "<heading id=\"h-0587\" level=\"1\">Example 105</heading>\n",
       "<p id=\"p-1013\" num=\"1025\"><chemistry id=\"CHEM-US-00219\" num=\"00219\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00219.TIF\" he=\"49.36mm\" id=\"EMI-C00219\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1014\" num=\"1026\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.34 (3H, s), 3.65-3.70 (4H, m), 4.18 (1H, brs), 4.21 (1H, brs), 4.48 (1H, brs), 4.98 (1H, brs), 6.12 (1H, d, J=7.8 Hz), 6.97 (1H, d, J=7.8 Hz), 7.36 (1H, d, J 7.5 Hz), 7.49 (1H, t, J=7.8 Hz), 7.61-7.66 (2H, m).</p>\n",
       "<heading id=\"h-0588\" level=\"1\">Example 106</heading>\n",
       "<p id=\"p-1015\" num=\"1027\"><chemistry id=\"CHEM-US-00220\" num=\"00220\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00220.TIF\" he=\"52.24mm\" id=\"EMI-C00220\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1016\" num=\"1028\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.54 (2H, t, J=7.5 Hz), 3.01 (2H, t, J=7, 5 Hz), 4.38 (2H, brs), 4.77 (2H, brs), 6.27 (1H, d, J=7.5 Hz), 6.96-7.00 (2H, m), 7.04-7.09 (3H, m), 7.19-7.33 (5H, m).</p>\n",
       "<heading id=\"h-0589\" level=\"1\">Example 107</heading>\n",
       "<p id=\"p-1017\" num=\"1029\"><chemistry id=\"CHEM-US-00221\" num=\"00221\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00221.TIF\" he=\"96.44mm\" id=\"EMI-C00221\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0590\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1018\" num=\"1030\">To a DMF (30 ml) solution of compound 107A (3.0 g, 9.96 mmol) synthesized according to the method of synthesizing compound 95D were added paraformaldehyde (299 mg, 9.96 mmol) and acetic acid (1 ml), and the mixture was heated to stir at 120° C. for 4 hours. After the solvent was distilled off, to the residue were added ethyl acetate-diisopropyl ether, and the precipitated solid was filtered to obtain 2.85 g (yield 91%) of compound 107B.</p>\n",
       "<p id=\"p-1019\" num=\"1031\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.19 (6H, J=6.6 Hz), 4.34 (2H, J=7.5 Hz), 4.72-4.86 (1H, m), 5.30 (2H, s), 5.49 (1H, t, J=7.5 Hz), 6.36 (1H, d, J=7.8 Hz), 7.26-7.35 (4H, m), 7.37 (1H, d, J=7.8 Hz), 7.55-7.58 (2H, m).</p>\n",
       "<heading id=\"h-0591\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1020\" num=\"1032\">To an acetic acid (2 ml) solution of compound 107B (100 mg, 0.319 mmol) were added 96% sulfuric acid (0.5 ml) and bis(3-chlorophenyl)methanol (242.3 mg, 0.957 mmol) at room temperature, and the mixture was stirred at 80° C. for 2 hours. After the reaction solution was cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate three times. The organic layer was washed with water once, and dried with sodium sulfate. After the solvent was distilled off, to the residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 42 mg (yield 29%) of compound 107.</p>\n",
       "<p id=\"p-1021\" num=\"1033\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.953 (3H, d, J=3.9 Hz), 1.12 (3H, d, J=4.2 Hz), 4.51 (1H, 13.5 Hz), 4.83 (1H, d, J=13.5 Hz), 4.83-4.92 (1H, m), 5.18 (1H, s), 5.74 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.8 Hz), 6.90 (1H, d, J=7.5 Hz), 7.12 (2H, dd, J=7.2 Hz, 8.1 Hz), 7.19-7.22 (1H, m), 7.37-7.41 (3H, m), 7.55 (1H, s).</p>\n",
       "<p id=\"p-1022\" num=\"1034\">According to Example 107, the following compounds were synthesized by the same procedure.</p>\n",
       "<heading id=\"h-0592\" level=\"1\">Example 108</heading>\n",
       "<p id=\"p-1023\" num=\"1035\"><chemistry id=\"CHEM-US-00222\" num=\"00222\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00222.TIF\" he=\"44.79mm\" id=\"EMI-C00222\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1024\" num=\"1036\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.465-0.549 (1H, m), 0.642-0.738 (1H, m), 0.754-0.907 (2H, m), 2.71-2.79 (1H, m), 2.86 (1H, ddd, J=4.8 Hz, 5.7 Hz, 14.7 Hz), 3.01 (2H, ddd, J=4.2 Hz, 16.0 Hz, 16.8 Hz), 3.88 (1H, ddd, J=4.8 Hz, 5.1 Hz, 16.8 Hz), 4.08-4.14 (1H, m), 4.16 (1H, d, J=12.9 Hz), 4.70 (1H, d, J=12.9 Hz), 4.96 (1H, s), 5.75 (1H, d, J=7.8 Hz), 6.58 (1H, d, J=7.8 Hz), 6.61 (1H, d, J=7.5 Hz), 6.92 (1H, dd, J=6.0 Hz, 7.5 Hz), 7.11-7.80 (6H, m).</p>\n",
       "<heading id=\"h-0593\" level=\"1\">Example 109</heading>\n",
       "<p id=\"p-1025\" num=\"1037\"><chemistry id=\"CHEM-US-00223\" num=\"00223\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00223.TIF\" he=\"44.79mm\" id=\"EMI-C00223\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1026\" num=\"1038\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.14 (3H, d, J=6.9 Hz), 1.18 (3H, d, J=6.9 Hz), 2.82 (1H, ddd, J=4.5 Hz, 4.8 Hz, 14.1 Hz), 3.08 (1H, ddd, J=4.2 Hz, 13.2 Hz, 17.7 Hz), 3.53 (1H, ddd, J=4.2 Hz, 4.5 Hz, 17.7 Hz), 4.27 (1H, d, J=12.9 Hz), 4.26-4.37 (1H, m), 4.62-4.71 (1H, m), 4.68 (1H, d, J=12.9 Hz), 5.05 (1H, s), 5.71 (1H, d, J=7.5 Hz), 6.63 (2H, d, J=7.2 Hz), 6.90 (1H, t, J=7.5 Hz), 7.08-7.63 (6H, m).</p>\n",
       "<heading id=\"h-0594\" level=\"1\">Example 110</heading>\n",
       "<p id=\"p-1027\" num=\"1039\"><chemistry id=\"CHEM-US-00224\" num=\"00224\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00224.TIF\" he=\"44.45mm\" id=\"EMI-C00224\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1028\" num=\"1040\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.16-3.28 (1H, m), 3.22 (3H, s), 3.46-3.50 (2H, m), 3.86 (1H, ddd, J=3.6 Hz, 3.6 Hz, 14.4 Hz), 4.47 (1H, d, J=13.2 Hz), 5.01 (1H, d, J=13.2 Hz), 5.30 (1H, s), 5.76 (1H, d, J=7.5 Hz), 6.72 (1H, d, J=7.5 Hz), 6.90 (2H, t, J=8.4 Hz), 7.06-7.18 (4H, m), 7.51 (2H, dd, J=5.4 Hz, 8.7 Hz).</p>\n",
       "<heading id=\"h-0595\" level=\"1\">Example 111</heading>\n",
       "<p id=\"p-1029\" num=\"1041\"><chemistry id=\"CHEM-US-00225\" num=\"00225\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00225.TIF\" he=\"43.77mm\" id=\"EMI-C00225\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1030\" num=\"1042\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.903 (1.3H, d, J=6.9 Hz), 0.982 (1.5H, d, J=6.6 Hz), 1.08-1.14 (3.2H, m), 4.55 (1H, dd, J=13.2 Hz, 16.5 Hz), 4.78-4.93 (2H, m), 5, 20 (1H, s), 5.66 (0.58H, d, J=7.5 Hz), 5.75 (0.42H, d, J=7.5 Hz), 6.67 (0.55H, d, J=7.5 Hz), 6.73 (0.45H, d, J=7.5 Hz), 6.92 (0.45H, d, J=7.2 Hz), 7.04-7.59 (8.6H, m).</p>\n",
       "<heading id=\"h-0596\" level=\"1\">Example 112</heading>\n",
       "<p id=\"p-1031\" num=\"1043\"><chemistry id=\"CHEM-US-00226\" num=\"00226\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00226.TIF\" he=\"43.77mm\" id=\"EMI-C00226\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1032\" num=\"1044\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.22 (3H, s), 3.24-3.32 (1H, m), 3.47-3.50 (2H, m), 3.84 (1H, ddd, J=3.3 Hz, 3.9 Hz, 14.4 Hz), 4.51 (1H, d, J=13.5 Hz), 5.03 (1H, d, J=13.5 Hz), 5.32 (1H, s), 5.77 (1H, d, J=7.8 Hz), 6.80 (1H, d, J=7.8 Hz), 6.84 (1H, d, J=7.8 Hz), 6.93 (2H, t, J=8.4 Hz), 7.06-7.20 (2H, m), 7.25-7.29 (2H, m), 7.39-7.47 (1H, m).</p>\n",
       "<heading id=\"h-0597\" level=\"1\">Example 113</heading>\n",
       "<p id=\"p-1033\" num=\"1045\"><chemistry id=\"CHEM-US-00227\" num=\"00227\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00227.TIF\" he=\"46.65mm\" id=\"EMI-C00227\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1034\" num=\"1046\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.88 (3H, d, J=6.9 Hz), 1.10 (3H, d, J=6.6 Hz), 2.10 (3H, s), 4.62-4.69 (1H, m), 4.79-4.92 (2H, m), 5.32 (1H, s), 5.64 (0.74H, 7.5 Hz), 5.72 (0.26H, d, J=7.5 Hz), 6.61 (0.74H, d, J=7.8 Hz), 6.82 (0.26H, d, J=7.8 Hz), 6.96-7.52 (8.26H, m), 7.48 (0.74H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-0598\" level=\"1\">Example 114</heading>\n",
       "<p id=\"p-1035\" num=\"1047\"><chemistry id=\"CHEM-US-00228\" num=\"00228\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00228.TIF\" he=\"43.77mm\" id=\"EMI-C00228\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1036\" num=\"1048\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.976 (2H, d, J=6.9 Hz), 1.09-1.14 (3H, m), 5.63 (0.74H, d, J=7.8 Hz), 5.65 (0.74H, s), 5.73 (0.26H, d, J=7.8 Hz), 6.20 (0.26H, s), 6.65 (0.74H, d, J=7.8 Hz), 6.79 (0.26H, d, J=7.8 Hz), 7.05-7.24 (4.26H, m), 7.31-7.56 (4H, m), 8.02 (0.74H, d, J=6.3 Hz).</p>\n",
       "<heading id=\"h-0599\" level=\"1\">Example 115</heading>\n",
       "<p id=\"p-1037\" num=\"1049\"><chemistry id=\"CHEM-US-00229\" num=\"00229\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00229.TIF\" he=\"54.02mm\" id=\"EMI-C00229\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1038\" num=\"1050\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.893 (1.2H, d, J=6.6 Hz), 0.958 (1.8H, d, J=6.9 Hz), 1.09-1.13 (3H, m), 4.44 (0.56H, d, J=13.2 Hz), 4.63 (0.44H, d, J=13.5 Hz), 4.81-4.93 (2H, m), 5.35 (1H, m), 5.67 (0.56H, d, J=7.8 Hz), 5.72 (0.44H, d, J=7.8 Hz), 6.67-6.73 (1H, m), 7.03 (1H, d, J=6.6 Hz), 7.20-7.51 (5H, m), 7.75 (1H, d, 8.4 Hz), 8.06 (0.88H, d, J=8.7 Hz), 8.33 (1.1H, d, J=8.7 Hz).</p>\n",
       "<heading id=\"h-0600\" level=\"1\">Example 116</heading>\n",
       "<p id=\"p-1039\" num=\"1051\"><chemistry id=\"CHEM-US-00230\" num=\"00230\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00230.TIF\" he=\"43.77mm\" id=\"EMI-C00230\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1040\" num=\"1052\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.91-0.0.948 (3H, m), 1.10-1.14 (3H, m), 3.61-3.68 (1H, m), 4.44 (0.56H, d, J=12.9 Hz), 4.59 (0.44H, d, J=12.9 Hz), 4.79-4.91 (2H, m), 5.29 (1H, s), 5.67-5.69 (1H, m), 6.63-6.70 (2H, m), 6.90-7.81 (8H, m).</p>\n",
       "<heading id=\"h-0601\" level=\"1\">Example 117</heading>\n",
       "<p id=\"p-1041\" num=\"1053\"><chemistry id=\"CHEM-US-00231\" num=\"00231\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00231.TIF\" he=\"47.41mm\" id=\"EMI-C00231\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1042\" num=\"1054\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.19-3.28 (1H, m), 3.22 (3H, s), 3.46-3.50 (2H, m), 3.85 (1H, ddd, J=3 Hz, 4.2 Hz, 14.4 Hz), 4.47 (1H, d, J=13.2 Hz), 5.01 (1H, d, J=13.2 Hz), 5.28 (1H, s), 5.78 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.8 Hz), 7.04 (2H, d, J=8.4 Hz), 7.19 (2H, d, 8.4 Hz), 7.36-7.50 (4H, m).</p>\n",
       "<heading id=\"h-0602\" level=\"1\">Example 118</heading>\n",
       "<p id=\"p-1043\" num=\"1055\"><chemistry id=\"CHEM-US-00232\" num=\"00232\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00232.TIF\" he=\"43.77mm\" id=\"EMI-C00232\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1044\" num=\"1056\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.914-0.957 (3H, m), 1.08-1.14 (3H, m), 2.20 (1.4H, s). 2.39 (1.6H, s), 4.56 (0.48H, d, J=4.5 Hz), 4.60 (0.52H, d, J=4.2 Hz), 4.77-4.89 (2H, m), 5.16 (1H, s), 5.66-5.70 (1H, m), 6.65-6.69 (1H, m), 6.85-6.91 (1H, m), 6.98-7.10 (2H, m), 7.14-7.19 (2H, m), 7.30-7.39 (2H, m), 7.44 (1H, t, J=6.9 Hz), 7.51 (1H, d, J=6.9 Hz).</p>\n",
       "<heading id=\"h-0603\" level=\"1\">Example 119</heading>\n",
       "<p id=\"p-1045\" num=\"1057\"><chemistry id=\"CHEM-US-00233\" num=\"00233\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00233.TIF\" he=\"47.41mm\" id=\"EMI-C00233\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1046\" num=\"1058\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.893-0.982 (3H, m), 1.08-1.14 (3H, m), 4.49-4.60 (1H, m), 4.78-4.90 (2H, m), 5.20 (1H, s), 5.65 (0.57H, J=7.5 Hz), 5.76 (0.43H, d, J=7.8 Hz), 6.64-6.70 (1H, m), 7.03 (2H, d, J=8.1 Hz), 7.10-7.20 (3H, m), 7.28-7.51 (4H, m).</p>\n",
       "<heading id=\"h-0604\" level=\"1\">Example 120</heading>\n",
       "<p id=\"p-1047\" num=\"1059\"><chemistry id=\"CHEM-US-00234\" num=\"00234\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00234.TIF\" he=\"43.77mm\" id=\"EMI-C00234\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1048\" num=\"1060\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.526 (3H, d, J=6.9 Hz), 1.01 (3H, d, J=6.6 Hz), 4.69 (1H, d, J=13.8 Hz), 4.75-4, 83 (1H, m), 4.86 (1H, d, J=13.8 Hz), 5.69 (1H, d, J=7.8 Hz), 6.03 (1H, s), 6.70 (1H, d, J=7.8 Hz), 7.16 (5H, s), 7.40-7.48 (2H, m), 7.67 (1H, t, J=7.8 Hz), 7.81-7.91 (3H, m), 8.16 (1H, d, J=7.2 Hz).</p>\n",
       "<heading id=\"h-0605\" level=\"1\">Example 121</heading>\n",
       "<p id=\"p-1049\" num=\"1061\"><chemistry id=\"CHEM-US-00235\" num=\"00235\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00235.TIF\" he=\"44.28mm\" id=\"EMI-C00235\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1050\" num=\"1062\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.947 (3H, d, J=6.9 Hz), 1.09 (3H, d, J=7.2 Hz), 2.22 (3H, s), 2.37 (3H, s), 4.58 (1H, d, J=12.9 Ha), 4.76 (1H, d, J=12.9 Hz), 4.78-4.88 (1H, m), 5.13 (1H, s), 5.72 (1H, d, J=7.8 Hz), 6.67 (1H, d, J=7.8 Hz), 6.72 (1H, s), 6.90-6.98 (4H, m), 7.22 (2H, d, J=7.8 Hz), 7.38 (2H, d, J=7.8 Hz).</p>\n",
       "<heading id=\"h-0606\" level=\"1\">Example 122</heading>\n",
       "<p id=\"p-1051\" num=\"1063\"><chemistry id=\"CHEM-US-00236\" num=\"00236\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00236.TIF\" he=\"43.77mm\" id=\"EMI-C00236\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1052\" num=\"1064\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.932 (3H, d, J=6.6 Hz), 1.12 (3H, d, J=6.9 Hz), 4.44 (1H, d, J=13.2 Hz), 4.86 (1H, d, J=13.2 Hz), 4.87-4.93 (1H, m), 5.38 (1H, s), 5.67 (1H, d, J=7.8 Hz), 6.67 (1H, d, J=7.8 Hz), 7.21-7.24 (1H, m), 7.32-7.40 (2H, m), 7.52 (1H, d, J=7.5 Hz), 7.60-7.72 (2H, m), 7.77-7.79 (2H, m).</p>\n",
       "<heading id=\"h-0607\" level=\"1\">Example 123</heading>\n",
       "<p id=\"p-1053\" num=\"1065\"><chemistry id=\"CHEM-US-00237\" num=\"00237\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00237.TIF\" he=\"51.31mm\" id=\"EMI-C00237\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1054\" num=\"1066\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.08-3.17 (1H, m), 3.23 (3H, s), 3.40-3.54 (2H, m), 3.71 (3H, s), 3.82 (3H, s), 3.95 (1H, ddd, J=3.3 Hz, 3.9 Hz, 14.4 Hz), 4.48 (1H, d, J=13.5 Hz), 4.96 (1H, d, J=13.5 Hz), 5.16 (1H, s), 5.76 (1H, d, J=7.5 Hz), 6.70 (2H, d, J=9.0 Hz), 6.73 (1H, d, J=7.5 Hz), 6.94 (2H, d, J=8.7 Hz), 7.03 (2H, d, J=8.7 Hz), 7.42 (2H, d, J=8.7 Hz).</p>\n",
       "<heading id=\"h-0608\" level=\"1\">Example 124</heading>\n",
       "<p id=\"p-1055\" num=\"1067\"><chemistry id=\"CHEM-US-00238\" num=\"00238\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00238.TIF\" he=\"43.77mm\" id=\"EMI-C00238\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1056\" num=\"1068\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.966 (3H, d, J=6.9 Hz), 1.10 (3H, d, J=6.9 Hz), 3.67 (3H, s), 3.83 (3H, s), 4.60 (1H, d, J=12.9 Hz), 4.78 (1H, d, J=12.9 Hz), 4.80-4.90 (1H, m), 5.13 (1H, m), 5.23 (1H, d, J=7.8 Hz), 6.66 (2H, d, J=7.2 Hz), 6.72-6.87 (2H, m), 6.87-6.90 (1H, m), 7.06-7.11 (3H, m), 7.34 (1H, t, J=8.1 Hz).</p>\n",
       "<heading id=\"h-0609\" level=\"1\">Example 125</heading>\n",
       "<p id=\"p-1057\" num=\"1069\"><chemistry id=\"CHEM-US-00239\" num=\"00239\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00239.TIF\" he=\"45.30mm\" id=\"EMI-C00239\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1058\" num=\"1070\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.05 (2H, d, J=7.0 Hz), 1.15 (1H, d, J=7.5 Hz), 2.73-3.63 (8H, m), 4.20-4.93 (4H, m), 5.25 (0.4H, s), 5.30 (0.6H, s), 5.46 (1H, d, J=7.8 Hz), 6.68-7.46 (11H, m).</p>\n",
       "<p id=\"p-1059\" num=\"1071\">MS: m/z=446 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0610\" level=\"1\">Example 126</heading>\n",
       "<p id=\"p-1060\" num=\"1072\"><chemistry id=\"CHEM-US-00240\" num=\"00240\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00240.TIF\" he=\"176.28mm\" id=\"EMI-C00240\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0611\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1061\" num=\"1073\">Compound 95B (1.00 g, 3.55 mmol) and cyclopropanamine (0.492 ml, 7.10 mmol) were added to pyridine (20 ml), 1-hydroxybenzotriazole (544 mg, 3.55 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.36 g, 7.10 mmol) were sequentially added, and the mixture was stirred at room temperature for 18 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) and, subsequently, amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 1.19 g of compound 126A as a colorless solid.</p>\n",
       "<p id=\"p-1062\" num=\"1074\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.22 (1H, m), 0.70 (2H, m), 2.76-2.83 (1H, m), 5.50 (2H, s), 6.59 (1H, dd, J=7.0, 1.9 Hz), 7.44 (5H, d, J=0.7 Hz), 7.53 (1H, dd, J=6.9, 6.2 Hz), 8.30 (1H, brs), 9.71 (1H, brs).</p>\n",
       "<heading id=\"h-0612\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1063\" num=\"1075\">Compound 126A (1.19 g, 4.19 mmol) was dissolved in DMF (15 ml), potassium carbonate (2.90 g, 20.1 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. O-(2,4-dinitrophenyl)hydroxylamine (1.67 g, 8.38 mmol) was added, and the mixture was stirred at room temperature for 18 hours. To the reaction solution was added chloroform, the precipitated yellow precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 851 mg of compound 126B as a yellow solid.</p>\n",
       "<p id=\"p-1064\" num=\"1076\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.41-0.46 (2H, m), 0.76 (2H, m), 2.73-2.81 (1H, m), 5.19 (2H, s), 5.61 (2H, s), 6.26 (1H, d, J=7.2 Hz), 7.38 (5H, s), 7.44 (1H, d, J=7.8 Hz), 7.70 (1H, s).</p>\n",
       "<heading id=\"h-0613\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1065\" num=\"1077\">Compound 126B (847 mg, 2.83 mmol) and paraformaldehyde (255 mg, 8.49 mmol) were added to ethanol (12 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→90:10, v/v) and, subsequently, amino column chromatography (chloroform-methanol, 97:3, v/v), methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 665 mg of compound 126C as a colorless solid.</p>\n",
       "<p id=\"p-1066\" num=\"1078\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.61-0.66 (2H, m), 0.87 (2H, m), 2.68-2.76 (1H, m), 4.32 (2H, d, J=7.9 Hz), 5.28 (2H, s), 6.33 (1H, d, J=7.7 Hz), 6.45 (1H, t, J=7.7 Hz), 7.33 (3H, m), 7.38 (1H, d, J=7.7 Hz), 7.52 (2H, m).</p>\n",
       "<heading id=\"h-0614\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1067\" num=\"1079\">Compound 126C (100 mg, 0.321 mmol) was dissolved in DMF (0.5 ml), cesium carbonate (314 mg, 0.964 mmol) and (bromomethylene)dibenzene (119 mg, 0.482 mmol) were added at 0° C., and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 124 mg of compound 126D as a colorless gummy substance.</p>\n",
       "<p id=\"p-1068\" num=\"1080\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.37-0.47 (2H, m), 0.74 (2H, m), 2.63-2.68 (1H, m), 4.35 (1H, d, J=13.4 Hz), 4.65 (1H, d, J=13.4 Hz), 5.07 (1H, s), 5.40 (1H, d, J=10.7 Hz); 5.47 (1H, d, J=10.5 Hz), 5.79 (1H, d, J=7.6 Hz), 6.67 (1H, d, J=7.8 Hz), 7.04-7.62 (15H, m).</p>\n",
       "<heading id=\"h-0615\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1069\" num=\"1081\">To compound 126D obtained in the fourth step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1.5 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 52 mg of compound 126 as a colorless solid.</p>\n",
       "<p id=\"p-1070\" num=\"1082\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: −0.19-−0.06 (1H, m), 0.44-0.54 (1H, m), 0.82 (2H, m), 2.62-2.69 (1H, m), 4.21 (1H, d, J=13.3 Hz), 5.11 (1H, d, J=13.1 Hz), 5.32 (1H, s), 5.47 (1H, t, J=11.1 Hz), 7.13 (1H, d, J=7.6 Hz), 7.23 (3H, m), 7.28-7.47 (8H, m), 7.69 (2H, t, J=8.5 Hz).</p>\n",
       "<p id=\"p-1071\" num=\"1083\">MS: m/z=388 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0616\" level=\"1\">Example 127</heading>\n",
       "<p id=\"p-1072\" num=\"1084\"><chemistry id=\"CHEM-US-00241\" num=\"00241\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00241.TIF\" he=\"35.98mm\" id=\"EMI-C00241\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1073\" num=\"1085\">According to Example 126, compound 127 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1074\" num=\"1086\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.86 (1.5H, d, J=7.0 Hz), 1.04 (1.5H, d, J=7.2 Hz), 3.08 (1.5H, s), 3.16 (1.5H, s), 4.52-5.05 (3H, m), 5.48 (2H, m), 7.31-7.47 (9H, m), 7.66 (2H, t, J=8.4 Hz).</p>\n",
       "<p id=\"p-1075\" num=\"1087\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0617\" level=\"1\">Example 128</heading>\n",
       "<p id=\"p-1076\" num=\"1088\"><chemistry id=\"CHEM-US-00242\" num=\"00242\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00242.TIF\" he=\"178.39mm\" id=\"EMI-C00242\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0618\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1077\" num=\"1089\">Compound 95B (2.40 g, 8.52 mmol) and ethyl 3-aminopropanoate hydrochloride (2.62 g, 17.0 mmol) were added to pyridine (30 ml), 1-hydroxybenzotriazole (1.31 g, 8.52 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (3.27 g, 17.0 mmol) were sequentially added, and the mixture was stirred at room temperature for 2 hours. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) to obtain 1.90 g of compound 128A as a colorless solid.</p>\n",
       "<p id=\"p-1078\" num=\"1090\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (3H, t, J=7.1 Hz), 2.48 (2H, t, J=6.4 Hz), 3.58 (2H, q, J=6.3 Hz), 4.17 (2H, q, J=7.1 Hz), 5.59 (2H, s), 6.57 (1H, dd, J=7.1, 1.6 Hz), 7.37-7.52 (6H, m), 8.73 (1H, brs), 9.72 (1H, brs).</p>\n",
       "<heading id=\"h-0619\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1079\" num=\"1091\">Compound 128A (2.58 g, 7.49 mmol) was dissolved in DMF (30 ml), potassium carbonate (5.18 g, 37.5 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. O-(2,4-dinitrophenyl)hydroxylamine (2.98 g, 15.0 mmol) was added, and the mixture was stirred at room temperature for 20 hours. To the reaction solution was added chloroform, the precipitated yellow precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 97:3→95:5, v/v) and, subsequently, silica gel column chromatography (chloroform-methanol, 95:5→92:8, v/v) to obtain 1.67 g of compound 128B as a yellow solid.</p>\n",
       "<p id=\"p-1080\" num=\"1092\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.26 (3H, t, J=7.2 Hz), 2.42 (2H, t, J=6.6 Hz), 3.43 (2H, q, J=6.4 Hz), 4.12 (2H, q, J=7.1 Hz), 5.13 (2H, s), 5.53 (2H, s), 6.21 (1H, d, J=7.6 Hz), 7.33 (5H, s), 7.39 (1H, d, J=7.6 Hz), 7.85 (1H, t, J=5.6 Hz).</p>\n",
       "<heading id=\"h-0620\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1081\" num=\"1093\">Compound 128B (1.66 g, 4.62 mmol) and paraformaldehyde (416 mg, 13.9 mmol) were added to ethanol (20 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1→95:5, v/v) to obtain 1.57 g of compound 128C as a colorless solid.</p>\n",
       "<p id=\"p-1082\" num=\"1094\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.27 (3H, t, J=7.2 Hz), 2.70 (2H, t, J=5.7 Hz), 3.57 (2H, t, J=5.8 Hz), 4.13 (2H, q, J=7.1 Hz), 4.50 (2H, d, J=7.9 Hz), 5.27 (2H, s), 5.87 (1H, t, J=7.8 Hz), 6.32 (1H, d, J=7.6 Hz), 7.31 (4H, m), 7.54 (2H, m).</p>\n",
       "<heading id=\"h-0621\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1083\" num=\"1095\">Compound 128C (1.00 g, 2.69 mmol) was dissolved in DMF (10 ml), cesium carbonate (2.63 g, 8.08 mmol) and (bromomethylene)dibenzene (998 mg, 4.04 mmol) were added at 0° C., and the mixture was stirred at room temperature for 18 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform/methanol, 98:2, v/v) to obtain 500 mg of compound 128D as a colorless gummy substance.</p>\n",
       "<p id=\"p-1084\" num=\"1096\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.25 (3H, t, J=7.3 Hz), 2.46 (1H, m), 2.70-2.80 (1H, m), 2.87-2.96 (1H, m), 4.11 (2H, q, J=7.3 Hz), 4.12 (1H, m), 4.48 (1H, d, J=13.7 Hz), 4.85 (1H, d, J=13.7 Hz), 5.10 (1H, s), 5.47 (2H, s), 5.83 (1H, d, J=8.0 Hz), 6.73 (1H, d, J=8.0 Hz), 7.37 (15H, m).</p>\n",
       "<heading id=\"h-0622\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1085\" num=\"1097\">To compound 128D (40 mg, 0.074 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 20 mg of compound 128 as a colorless solid.</p>\n",
       "<p id=\"p-1086\" num=\"1098\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.16 (3H, t, J=7.1 Hz), 2.45-2.58 (3H, m), 3.70 (1H, m), 4.02 (2H, q, J=7.1 Hz), 4.39 (1H, d, J=13.4 Hz), 5.09 (1H, d, J=13.3 Hz), 5.48 (1H, d, J=3.2 Hz), 5.51 (1H, s), 7.19-7.38 (7H, m), 7.45 (2H, t, J=7.3 Hz), 7.69 (2H, d, J=7.2 Hz).</p>\n",
       "<p id=\"p-1087\" num=\"1099\">MS: m/z=448 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0623\" level=\"1\">Example 129</heading>\n",
       "<p id=\"p-1088\" num=\"1100\"><chemistry id=\"CHEM-US-00243\" num=\"00243\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00243.TIF\" he=\"110.74mm\" id=\"EMI-C00243\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0624\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1089\" num=\"1101\">Compound 128D (426 mg, 0.792 mmol) was dissolved in ethanol (3 ml) and THF (3 ml), a 2N aqueous sodium hydroxide solution (1.19 ml, 2.38 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. To the reaction solution was added 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. To the resulting crude product were added methylene chloride-ethyl ether, and the precipitated solid was filtered to obtain 359 mg of compound 129A as a colorless solid.</p>\n",
       "<heading id=\"h-0625\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1090\" num=\"1102\">To compound 129A (40 mg, 0.079 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 25 mg of compound 129 as a colorless solid.</p>\n",
       "<p id=\"p-1091\" num=\"1103\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.31-2.41 (1H, m), 2.57 (1H, m), 3.63-3.72 (1H, m), 4.37 (1H, d, J=13.3 Hz), 5.09 (1H, d, J=13.3 Hz), 5.47 (1H, s), 5.50 (1H, d, J=7.8 Hz), 7.28 (7H, m), 7.44 (2H, t, J=7.5 Hz), 7.69 (2H, d, J=7.2 Hz), 12.40 (1H, brs).</p>\n",
       "<p id=\"p-1092\" num=\"1104\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0626\" level=\"1\">Examples 130</heading>\n",
       "<p id=\"p-1093\" num=\"1105\"><chemistry id=\"CHEM-US-00244\" num=\"00244\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00244.TIF\" he=\"110.24mm\" id=\"EMI-C00244\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0627\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1094\" num=\"1106\">Compound 129A (50 mg, 0.098 mmol) was added to DMF (1 ml), 1-hydroxybenzotriazole (14 mg, 0.098 mmol), dimethylamine hydrochloride (24 mg, 0.29 mmol), triethylamine (0.048 ml, 0.34 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (28 mg, 0.15 mmol) were added, and the mixture was stirred at room temperature for 1.5 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, washed with sodium bicarbonate water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure to obtain compound 130A as a colorless gummy substance.</p>\n",
       "<heading id=\"h-0628\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1095\" num=\"1107\">To compound 130A obtained in the first step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 2 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, and the mixture was extracted with chloroform, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 25 mg of compound 130 as a colorless solid.</p>\n",
       "<p id=\"p-1096\" num=\"1108\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.33-2.43 (1H, m), 2.66 (1H, m), 2.78 (3H, s), 2.89 (3H, s), 3.56 (2H, m), 4.45 (1H, d, J=13.6 Hz), 5.05 (1H, d, J=13.6 Hz), 5.47 (s, 1H), 5.49 (1H, d, J=7.5 Hz), 7.27 (7H, m), 7.44 (2H, t, J=7.3 Hz), 7.69 (2H, d, J=7.3 Hz).</p>\n",
       "<heading id=\"h-0629\" level=\"1\">Example 131</heading>\n",
       "<p id=\"p-1097\" num=\"1109\"><chemistry id=\"CHEM-US-00245\" num=\"00245\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00245.TIF\" he=\"37.68mm\" id=\"EMI-C00245\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1098\" num=\"1110\">According to Example 130, compound 131 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1099\" num=\"1111\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.60-2.77 (3H, m), 3.94 (1H, m), 4.42 (1H, d, J=13.4 Hz), 5.15 (1H, d, J=13.4 Hz), 5.49 (1H, s), 5.55 (1H, d, J=7.2 Hz), 7.07 (1H, t, J=7.3 Hz), 7.12-7.49 (13H, m), 7.73 (2H, d, J=7.2 Hz), 10.01 (1H, s).</p>\n",
       "<p id=\"p-1100\" num=\"1112\">MS: m/z=495 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0630\" level=\"1\">Example 132</heading>\n",
       "<p id=\"p-1101\" num=\"1113\"><chemistry id=\"CHEM-US-00246\" num=\"00246\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00246.TIF\" he=\"36.32mm\" id=\"EMI-C00246\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1102\" num=\"1114\">According to Example 130, compound 132 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1103\" num=\"1115\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.14 (3H, s), 3.65 (4H, m), 4.34 (1H, d, J=13.6 Hz), 5.06 (1H, d, J=13.6 Hz), 5.42 (1H, s), 5.53 (1H, d, J=7.5 Hz), 7.42-7.58 (16H, m).</p>\n",
       "<p id=\"p-1104\" num=\"1116\">MS: m/z=509 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0631\" level=\"1\">Example 133</heading>\n",
       "<p id=\"p-1105\" num=\"1117\"><chemistry id=\"CHEM-US-00247\" num=\"00247\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00247.TIF\" he=\"35.39mm\" id=\"EMI-C00247\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1106\" num=\"1118\">According to Example 130, compound 133 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1107\" num=\"1119\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.08-1.55 (8H, m), 2.33 (1H, m), 2.68 (1H, m), 4.45 (1H, d, J=13.6 Hz), 5.05 (1H, d, J=13.6 Hz), 5.50 (2H, brs), 7.46-7.68 (11H, m).</p>\n",
       "<p id=\"p-1108\" num=\"1120\">MS: m/z=487 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0632\" level=\"1\">Example 134</heading>\n",
       "<p id=\"p-1109\" num=\"1121\"><chemistry id=\"CHEM-US-00248\" num=\"00248\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00248.TIF\" he=\"34.71mm\" id=\"EMI-C00248\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1110\" num=\"1122\">According to Example 130, compound 134 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1111\" num=\"1123\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.34-2.40 (1H, m), 2.61-2.77 (1H, m), 3.51-3.69 (10H, m), 4.44 (1H, d, J=13.4 Hz), 5.03-5.11 (1H, d, J=13.4 Hz), 5.51 (2H, s), 7.18-7.52 (9H, m), 7.69-7.75 (2H, m).</p>\n",
       "<heading id=\"h-0633\" level=\"1\">Example 135</heading>\n",
       "<p id=\"p-1112\" num=\"1124\"><chemistry id=\"CHEM-US-00249\" num=\"00249\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00249.TIF\" he=\"213.78mm\" id=\"EMI-C00249\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0634\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1113\" num=\"1125\">Compound 95B (1.50 g, 5.32 mmol) and tert-butyl 2-aminoethyl(methyl)carbamate (1.86 g, 10.7 mmol) were added to pyridine (20 ml), 1-hydroxybenzotriazole (815 mg, 5.32 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.04 g, 10.7 mmol) were sequentially added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into 1N hydrochloric acid, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) and, subsequently, silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 1.63 g of compound 135A as a colorless gummy substance.</p>\n",
       "<p id=\"p-1114\" num=\"1126\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.44 (9H, s), 2.82 (3H, s), 3.28 (4H, m), 5.59 (2H, s), 6.57 (1H, d, J=6.0 Hz), 7.46 (6H, m), 8.46 (1H, m), 9.68 (1H, brs).</p>\n",
       "<heading id=\"h-0635\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1115\" num=\"1127\">Compound 135A (1.05 g, 2.62 mmol) was dissolved in DMF (15 ml), potassium carbonate (1.81 g, 13.1 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. O-(2,4-dinitrophenyl)hydroxylamine (1.04 g, 5.23 mmol) was added, and the mixture was stirred at room temperature for 18 hours. To the reaction solution was added chloroform, the precipitated yellow precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 887 mg of compound 135B as a pale yellow solid.</p>\n",
       "<p id=\"p-1116\" num=\"1128\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.44 (9H, s), 2.84 (3H, s), 3.38 (4H, m), 5.33 (2H, s), 5.68 (1H, brs), 5.80 (1H, brs), 6.35 (1H, d, J=7.6 Hz), 6.74 (1H, brs), 7.39 (5H, brm), 7.52 (1H, t, J=9.5 Hz).</p>\n",
       "<heading id=\"h-0636\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1117\" num=\"1129\">Compound 135B (880 mg, 2.11 mmol) and paraformaldehyde (190 mg, 6.34 mmol) were added to ethanol (18 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→90:10 v/v) and, subsequently, amino column chromatography (chloroform-methanol, 97:3, v/v) to obtain 721 mg of compound 135C as a colorless solid.</p>\n",
       "<p id=\"p-1118\" num=\"1130\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (9H, s), 2.95 (3H, s), 4.38 (2H, brs), 5.33 (2H, brs), 6.36 (1H, d, J=7.6 Hz), 6.85 (1H, t, J=7.4 Hz), 7.33 (4H, m), 7.55 (2H, m).</p>\n",
       "<p id=\"p-1119\" num=\"1131\">MS: m/z=429 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0637\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1120\" num=\"1132\">Compound 135C (720 mg, 1.68 mmol) was dissolved in DMF (3.5 ml), cesium carbonate (1.64 g, 5.04 mmol) and (bromomethylene)dibenzene (623 mg, 2.52 mmol) were added at 0° C., and the mixture was stirred at room temperature for 18 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5 v/v) to obtain 732 mg of compound 135D.</p>\n",
       "<heading id=\"h-0638\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1121\" num=\"1133\">To compound 135D (727 mg, 1.22 mmol) was added 4N HCl (ethyl acetate solution, 10 ml). After stirring at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Saturated sodium bicarbonate water was added, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting crude product were added methylene chloride-ethyl ether, and the precipitated solid was filtered to obtain 575 mg of compound 135E as a colorless solid.</p>\n",
       "<heading id=\"h-0639\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-1122\" num=\"1134\">To compound 135E (50 mg, 0.10 mmol) was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1.5 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, ethylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 15 mg of compound 135 as a colorless solid.</p>\n",
       "<p id=\"p-1123\" num=\"1135\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.40 (3H, s), 2.80 (1H, s), 3.12 (3H, m), 3.87 (1H, m), 4.37 (1H, d, J=13.6 Hz), 5.10 (1H, d, J=13.4 Hz), 5.52 (1H, s), 5.53 (1H, d, J=5.5 Hz), 7.15-7.70 (11H, m).</p>\n",
       "<p id=\"p-1124\" num=\"1136\">MS: m/z=405 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0640\" level=\"1\">Example 136</heading>\n",
       "<p id=\"p-1125\" num=\"1137\"><chemistry id=\"CHEM-US-00250\" num=\"00250\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00250.TIF\" he=\"111.84mm\" id=\"EMI-C00250\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0641\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1126\" num=\"1138\">Compound 135E (50 mg, 0.10 mmol) was dissolved in methylene chloride (1 ml), triethylamine (0.042 ml, 0.30 mmol) and acetyl chloride (0.011 ml, 0.15 mmol) were added, and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) and, subsequently, amino column chromatography (chloroform-methanol, 97:3, v/v) to obtain 72 mg of compound 136A as a colorless solid.</p>\n",
       "<heading id=\"h-0642\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1127\" num=\"1139\">To compound 136A obtained in the first step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1.5 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 23 mg of compound 136 as a colorless solid.</p>\n",
       "<p id=\"p-1128\" num=\"1140\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.89 (2H, s), 1.92 (1H, s), 2.73 (1H, s), 2.95 (2H, s), 3.00-3.06 (1H, m), 3.43 (2H, m), 3.80 (1H, m), 4.34 (0.7H, d, J=13.3 Hz), 4.45 (0.3H, d, J=13.1 Hz), 5.11 (1H, m), 5.49 (2H, m), 7.20-7.73 (11H, m).</p>\n",
       "<heading id=\"h-0643\" level=\"1\">Example 137</heading>\n",
       "<p id=\"p-1129\" num=\"1141\"><chemistry id=\"CHEM-US-00251\" num=\"00251\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00251.TIF\" he=\"38.44mm\" id=\"EMI-C00251\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1130\" num=\"1142\">According to Example 136, compound 137 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1131\" num=\"1143\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.95 (3H, s), 3.13-4.07 (4H, m), 4.46 (1H, d, J=13.2 Hz), 5.16 (1H, d, J=13.0 Hz), 5.51 (1H, d, J=7.3 Hz), 5.62 (1H, s), 7.17-7.78 (16H, m).</p>\n",
       "<p id=\"p-1132\" num=\"1144\">MS: m/z=509 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0644\" level=\"1\">Example 138</heading>\n",
       "<p id=\"p-1133\" num=\"1145\"><chemistry id=\"CHEM-US-00252\" num=\"00252\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00252.TIF\" he=\"38.10mm\" id=\"EMI-C00252\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1134\" num=\"1146\">According to Example 136, compound 138 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1135\" num=\"1147\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.62 (3H, s), 3.03-3.22 (4H, m), 3.72 (2H, d, J=13.3 Hz), 4.39 (1H, d, J=13.3 Hz), 5.08 (1H, d, J=13.3 Hz), 5.53 (1H, d, J=7.8 Hz), 5.55 (1H, s), 7.19-7.79 (16H, m).</p>\n",
       "<p id=\"p-1136\" num=\"1148\">MS: m/z=545 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0645\" level=\"1\">Example 139</heading>\n",
       "<p id=\"p-1137\" num=\"1149\"><chemistry id=\"CHEM-US-00253\" num=\"00253\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00253.TIF\" he=\"35.22mm\" id=\"EMI-C00253\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1138\" num=\"1150\">According to Example 136, compound 139 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1139\" num=\"1151\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.72 (3H, s), 2.88 (3H, s), 3.12-3.24 (3H, m), 3.75-3.80 (1H, m), 4.37 (1H, d, J=13.0 Hz), 5.10 (1H, d, J=13.4 Hz), 5.51 (1H, d, J=7.6 Hz), 5.54 (1H, s), 7.19-7.46 (19H, m), 7.72 (2H, d, J=7.0 Hz).</p>\n",
       "<p id=\"p-1140\" num=\"1152\">MS: m/z=483 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0646\" level=\"1\">Example 140</heading>\n",
       "<p id=\"p-1141\" num=\"1153\"><chemistry id=\"CHEM-US-00254\" num=\"00254\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00254.TIF\" he=\"35.39mm\" id=\"EMI-C00254\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1142\" num=\"1154\">According to Example 136, compound 140 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1143\" num=\"1155\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.88 (3H, s), 2.98-3.12 (3H, m), 3.77 (1H, m), 4.31 (1H, d, J=13.3 Hz), 5.13 (1H, d, J=13.3 Hz), 5.51 (1H, s), 5.52 (1H, d, J=7.6 Hz), 7.13-7.46 (9H, m), 7.71 (2H, d, J=7.2 Hz).</p>\n",
       "<p id=\"p-1144\" num=\"1156\">MS: m/z=469 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0647\" level=\"1\">Example 141</heading>\n",
       "<p id=\"p-1145\" num=\"1157\"><chemistry id=\"CHEM-US-00255\" num=\"00255\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00255.TIF\" he=\"36.58mm\" id=\"EMI-C00255\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1146\" num=\"1158\">According to Example 136, compound 141 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1147\" num=\"1159\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.07 (9H, s), 2.84 (1H, m), 3.19 (2H, d, J=3.9 Hz), 3.96 (1H, d, m), 4.28 (1H, d, J=13.1 Hz), 5.21 (1H, d, J=13.1 Hz), 5.52 (1H, s), 5.56 (1H, t, J=4.2 Hz), 7.25-7.59 (10H, m), 7.75 (2H, d, J=7.7 Hz).</p>\n",
       "<p id=\"p-1148\" num=\"1160\">MS: m/z=475 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0648\" level=\"1\">Example 142</heading>\n",
       "<p id=\"p-1149\" num=\"1161\"><chemistry id=\"CHEM-US-00256\" num=\"00256\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00256.TIF\" he=\"38.18mm\" id=\"EMI-C00256\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1150\" num=\"1162\">According to Example 136, compound 142 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1151\" num=\"1163\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.10 (6H, m), 2.98 (3H, m), 3.78 (1H, m). 4.27 (1H, d, J=13.6 Hz), 4.68 (1H, m), 5.11 (1H, d, J=12.8 Hz), 5.51 (2H, m), 7.07-7.46 (10H, m), 7.70 (2H, d, J=7.2 Hz).</p>\n",
       "<p id=\"p-1152\" num=\"1164\">MS: m/z=477 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0649\" level=\"1\">Example 143</heading>\n",
       "<p id=\"p-1153\" num=\"1165\"><chemistry id=\"CHEM-US-00257\" num=\"00257\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00257.TIF\" he=\"38.02mm\" id=\"EMI-C00257\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1154\" num=\"1166\">According to Example 136, compound 143 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1155\" num=\"1167\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.89 (3H, m), 3.62 (1H, m), 4.17 (1H, d, J=13.1 Hz), 4.99 (1H, d, J=13.1 Hz), 5.45 (1H, s), 5.51 (1H, d, J=7.8 Hz), 7.18-7.77 (17H, m).</p>\n",
       "<p id=\"p-1156\" num=\"1168\">MS: m/z=531 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0650\" level=\"1\">Example 144</heading>\n",
       "<p id=\"p-1157\" num=\"1169\"><chemistry id=\"CHEM-US-00258\" num=\"00258\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00258.TIF\" he=\"110.91mm\" id=\"EMI-C00258\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0651\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1158\" num=\"1170\">To compound 144A synthesized according to the first to fifth steps of Example 135 were added formic acid and formalin, and the mixture was stirred at 80 degree for 1.5 hours. The solvent was distilled off under reduced pressure, saturated sodium bicarbonate water was added, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5→92:8, v/v) to obtain 26 mg of compound 144B.</p>\n",
       "<p id=\"p-1159\" num=\"1171\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.06 (6H, s), 2.18-2.26 (1H, m), 2.36-2.45 (1H, m), 2.89-2.98 (1H, m), 3.91 (1H, dt, J=14.1, 5.9 Hz), 4.43 (1H, d, J=13.6 Hz), 4.82 (1H, d, J=13.4 Hz), 5.20 (1H, s), 5.41 (1H, d, J=10.8 Hz), 5.46 (1H, d, J=10.7 Hz), 5.80 (1H, d, J=7.8 Hz), 6.69 (1H, d, J=7.8 Hz), 7.05-7.64 (15H, m).</p>\n",
       "<heading id=\"h-0652\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1160\" num=\"1172\">To compound 144B obtained in the first step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 13 mg of compound 144 as a colorless solid.</p>\n",
       "<p id=\"p-1161\" num=\"1173\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.17 (6H, s), 2.38-2.46 (3H, m), 3.59 (1H, m), 4.41 (1H, d, J=13.1 Hz), 5.09 (1H, d, J=13.3 Hz), 5.50 (1H, d, J=6.4 Hz), 5.51 (1H, s), 7.19-7.47 (9H, m), 7.66 (2H, d, J=7.3 Hz).</p>\n",
       "<p id=\"p-1162\" num=\"1174\">MS: m/z=419 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0653\" level=\"1\">Example 145</heading>\n",
       "<p id=\"p-1163\" num=\"1175\"><chemistry id=\"CHEM-US-00259\" num=\"00259\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00259.TIF\" he=\"174.75mm\" id=\"EMI-C00259\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0654\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1164\" num=\"1176\">To a dichloromethane (5 ml) solution of compound 95E (300 mg, 0.664 mmol) was added NBS (130 mg, 0.731 mmol) under ice-cooling, temperature was raised to room temperature and, thereafter, the mixture was refluxed for 1 hour. After the solvent was distilled off, the resulting residue was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (1:1, v/v) and, then, with ethyl acetate. Concentration of an objective fraction afforded 326.7 mg (yield 93%) of compound 145A as a solid.</p>\n",
       "<p id=\"p-1165\" num=\"1177\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.93 (3H, s), 4.27 (1H, d, J=13.5 Hz), 4.82 (1H, d, J=13.5 Hz), 5.13 (1H, s), 5.41 (2H, s), 5.41-7.12 (2H, m), 7.15 (1H, s), 7.17-7.28 (3H, m), 7.31-7.47 (6H, m), 7.52 (2H, d, J=6.6 Hz), 7.63-7.67 (2H, m).</p>\n",
       "<heading id=\"h-0655\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1166\" num=\"1178\">To a DMF (3 ml) solution of compound 145A (100 mg, 0.189 mmol) were added a solution of potassium carbonate (78.4 mg, 0.567 mmol) in water (0.5 ml), 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane (47.6 mg, 0.284 mmol) and tetakistriphenylphosphinepalladium (21.8 mg, 0.189 mmol), and the mixture was heated to stir at 80° C. for 4 hours. After the reaction solution was cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times, and dried with sodium sulfate and, thereafter, the resulting oil was purified by silica gel chromatography. Elution with only ethyl acetate, and concentration of an objective fraction afforded 42.0 mg (yield 45%) of compound 145B as an oil.</p>\n",
       "<p id=\"p-1167\" num=\"1179\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.73 (3H, s), 2.92 (3H, s), 4.29 (1H, d, J=13.5 Hz), 4.83 (1H, d, J=13.5 Hz), 4.96-4.97 (1H, m), 5.15 (1H, s), 5.21-5.21 (1H, m), 5.37 (1H, d, J=10.8 Hz), 5.40 (1H, d, J=10.8 Hz), 6.82 (1H, s), 7.15-7.21 (5H, m), 7.27-7.47 (6H, m), 7.54 (2H, d, J=6.9 Hz), 7.64-7.69 (2H, m).</p>\n",
       "<heading id=\"h-0656\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1168\" num=\"1180\">To a THF (2 ml) solution of compound 145B (40 mg, 0.081 mmol) was added 10% Pd—C (8 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was washed with ether to obtain 6.8 mg (yield 21%) of compound 145.</p>\n",
       "<p id=\"p-1169\" num=\"1181\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.629 (3H, d, J=6.9 Hz), 0.900 (3H, d, J=6.9 Hz), 2.87-3.00 (1H, m), 2.94 (3H, s), 4.37 (1H, d, J=13.2 Hz), 4.93 (1H, d, J=13.2 Hz), 5.21 (1H, s), 6.69 (1H, s), 7.21 (5H, s), 7.35-7.47 (3H, m), 7.57 (2H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-0657\" level=\"1\">Example 146</heading>\n",
       "<p id=\"p-1170\" num=\"1182\"><chemistry id=\"CHEM-US-00260\" num=\"00260\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00260.TIF\" he=\"42.67mm\" id=\"EMI-C00260\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1171\" num=\"1183\">According to Example 145, compound 146 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1172\" num=\"1184\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.738 (3H, t, J=7.2 Hz), 1.05-1.18 (2H, m), 2.01-2.18 (2H, m), 2.94 (3H, s), 4.35 (1H, d, J=13.2 Hz), 4.95 (1H, d, J=13.2 Hz), 5.22 (1H, s), 6.71 (1H, s), 7.20 (5H, s), 7.35-7.47 (3H, m), 7.55 (2H, d, J=6.9 Hz).</p>\n",
       "<heading id=\"h-0658\" level=\"1\">Example 147</heading>\n",
       "<p id=\"p-1173\" num=\"1185\"><chemistry id=\"CHEM-US-00261\" num=\"00261\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00261.TIF\" he=\"95.08mm\" id=\"EMI-C00261\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0659\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1174\" num=\"1186\">Compound 145A (60 mg, 0.113 mg) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 30 mg (yield 60%) of compound 147.</p>\n",
       "<p id=\"p-1175\" num=\"1187\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.97 (3H, s), 4.36 (1H, d, J=13.2 Hz), 5.01 (1H, d, J=13.2 Hz), 5.21 (1H, s), 7.14 (1H, s), 7.17-7.25 (5H, m), 7.36-7.48 (3H, m), 7.54 (2H, d, J=7.2 Hz).</p>\n",
       "<heading id=\"h-0660\" level=\"1\">Example 148</heading>\n",
       "<p id=\"p-1176\" num=\"1188\"><chemistry id=\"CHEM-US-00262\" num=\"00262\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00262.TIF\" he=\"87.12mm\" id=\"EMI-C00262\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1177\" num=\"1189\">Compound 145B (41 mg, 0.083 mg) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 12 mg (yield 36%) of compound 148.</p>\n",
       "<p id=\"p-1178\" num=\"1190\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.70 (3H, s), 2.95 (3H, s), 4.36 (1H, d, J=12.9 Hz), 4.95 (1H, d, J=12.9 Hz), 4.96-4.98 (1H, m), 5.23 (1H, s), 5.32-5.33 (1H, m), 6.86 (1H, s), 7.21 (5H, s), 7.35-7.48 (3H, m), 7.56 (2H, d, J=7.2 Hz).</p>\n",
       "<heading id=\"h-0661\" level=\"1\">Example 149</heading>\n",
       "<p id=\"p-1179\" num=\"1191\"><chemistry id=\"CHEM-US-00263\" num=\"00263\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00263.TIF\" he=\"95.08mm\" id=\"EMI-C00263\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1180\" num=\"1192\">To a THF (2 ml) solution of compound 145A (100 mg, 0.189 mg) were added a 2N methylzinc chloride THF solution (0.377 ml, 0.754 mmol) and tetrakistriphenylphosphinepalladium (10.9 mg, 0.0945 mmol) at room temperature, and the mixture was heated to stir at 60° C. for 4 hours. After the reaction solution was cooled to room temperature, water was added, and the mixture was extracted with chloroform three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by a MS trigger reverse layer column to obtain 9.6 mg (yield 14%) of compound 149.</p>\n",
       "<p id=\"p-1181\" num=\"1193\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.63 (3H, s), 2.95 (3H, s), 4.34 (1H, d, J=12.9 Hz), 4.68 (1H, d, J=12.9 Hz), 5.21 (1H, s), 6.70 (1H, s), 7.18 (5H, s), 7.37-7.47 (3H, m), 7.54 (2H, d, J=6.9 Hz).</p>\n",
       "<heading id=\"h-0662\" level=\"1\">Example 150</heading>\n",
       "<p id=\"p-1182\" num=\"1194\"><chemistry id=\"CHEM-US-00264\" num=\"00264\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00264.TIF\" he=\"144.36mm\" id=\"EMI-C00264\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0663\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1183\" num=\"1195\">Compound 150A (465 mg, 0.801 mmol) synthesized according to the first to fourth step of Example 135 was dissolved in a 4N hydrochloric acid dioxane solution (5 ml), and the mixture was stirred at room temperature for 2 hours. The reaction solution was neutralized with saturated sodium bicarbonate water, and was extracted with dichloromethane three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and 100 mg of the resulting oil was dissolved in dichloromethane (2 ml). To the dichloromethane solution were added triethylamine (63.2 mg, 0.624 mmol) and benzoyl chloride (31.9 mg, 0.312 mmol) under ice-cooling, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added water, and the mixture was extracted with dichloromethane three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting residue was washed with diethyl ether to obtain 68 mg (yield 56%) of compound 150B.</p>\n",
       "<p id=\"p-1184\" num=\"1196\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.05-3.12 (1H, m), 3.38-3.45 (1H, m), 3.64-3.70 (1H, m), 3.93-3.99 (1H, m), 4.22 (1H, d, J=13.2 Hz), 5.04 (1H, s), 5.07 (1H, d, J=13.2 Hz), 5.22 (1H, d, J=10.2 Hz), 5.31 (1H, d, J=10.2 Hz), 5.70 (1H, d, J=7.8 Hz), 6.55 (1H, d, J=7.8 Hz), 6.98 (2H, d, J=6.6 Hz), 7.08-7.19 (4H, m), 7.29-7.46 (5H, m), 7.49-7.53 (2H, m), 7.87 (2H, d, J=7.2 Hz), 8.06 (1H, brs).</p>\n",
       "<heading id=\"h-0664\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1185\" num=\"1197\">Compound 150B (30 mg, 0.051 mg) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 15 mg (yield 59%) of compound 150.</p>\n",
       "<p id=\"p-1186\" num=\"1198\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.91-2.98 (1H, m), 3.54-3.66 (1H, m), 3.76-3.84 (1H, m), 4.13-4.18 (1H, m), 4.28 (1H, d, J=12.9 Hz), 5.11 (1H, s), 5.43 (1H, d, J=12.9 Hz), 5.45 (1H, d, J=7.5 Hz), 6.68 (1H, d, J=7.5 Hz), 7.10-7.18 (4H, m), 7.35-7.47 (8H, m), 7.89 (2H, d, J=7.2 Hz), 8.41 (1H, s).</p>\n",
       "<heading id=\"h-0665\" level=\"1\">Example 151</heading>\n",
       "<p id=\"p-1187\" num=\"1199\"><chemistry id=\"CHEM-US-00265\" num=\"00265\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00265.TIF\" he=\"49.19mm\" id=\"EMI-C00265\" img-content=\"chem\" img-format=\"tif\" wi=\"49.95mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1188\" num=\"1200\">According to Example 150, compound 151 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1189\" num=\"1201\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.02 (3H, s), 2.69 (1H, br t, J=10.8 Hz), 3.40-3.49 (1H, m), 3.06-3.74 (1H, m), 4.12-4.22 (1H, m), 4.20 (1H, d, J=12.9 Hz), 5.08 (1H, s), 5.47 (1H, d, J=7.8 Hz), 5.50 (1H, d, J=12.9 Hz), 6.67 (1H, d, J=7.8 Hz), 7.12-7.21 (5H, m), 7.28-7.46 (5H, m), 8.31 (1H, brs).</p>\n",
       "<heading id=\"h-0666\" level=\"1\">Example 152</heading>\n",
       "<p id=\"p-1190\" num=\"1202\"><chemistry id=\"CHEM-US-00266\" num=\"00266\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00266.TIF\" he=\"92.88mm\" id=\"EMI-C00266\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0667\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1191\" num=\"1203\">Compound 150A (50 mg, 0.801 mmol) was dissolved in a 4N hydrochloric acid dioxane solution (5 ml), and the mixture was stirred at room temperature for 2 hours. The reaction solution was neutralized with saturated sodium bicarbonate water, and was extracted with dichloromethane three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and 50 mg of the resulting oil was dissolved in methanol (2 ml). To the methanol solution was added 10% Pd—C (10 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 10 mg (yield 25%) of compound 152.</p>\n",
       "<p id=\"p-1192\" num=\"1204\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.74-2.78 (2H, m), 3.00-3.07 (1H, m), 3.78-3.85 (1H, m), 4.34 (1H, d, J=13.5 Hz), 5.13 (1H, d, J=13.5 Hz), 5.48-5.54 (1H, m), 5.10 (1H, s), 7.20-7.47 (9H, m), 7.63-7.71 (2H, m).</p>\n",
       "<heading id=\"h-0668\" level=\"1\">Example 153</heading>\n",
       "<p id=\"p-1193\" num=\"1205\"><chemistry id=\"CHEM-US-00267\" num=\"00267\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00267.TIF\" he=\"93.30mm\" id=\"EMI-C00267\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0669\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1194\" num=\"1206\">To a THF (3 ml) solution of compound 150A (30 mg, 0.052 mmol) was added 10% Pd—C (10 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 20 mg (yield 79%) of compound 153.</p>\n",
       "<p id=\"p-1195\" num=\"1207\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.34 (9H, s), 2.84-2.91 (1H, m), 3.18-3.25 (2H, m), 4.03-4.11 (1H, m), 4.35 (1H, d, J=13.2 Hz), 5.20 (1H, s), 5.24 (1H, d, J=13.2 Hz), 5.49 (1H, brs), 5.70 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.8 Hz), 7.16-7.20 (5H, m), 7.32-7.46 (3H, m), 7.53 (2H, d, J=7.2 Hz).</p>\n",
       "<heading id=\"h-0670\" level=\"1\">Example 154</heading>\n",
       "<p id=\"p-1196\" num=\"1208\"><chemistry id=\"CHEM-US-00268\" num=\"00268\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00268.TIF\" he=\"216.41mm\" id=\"EMI-C00268\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0671\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1197\" num=\"1209\">To a DMF (10 ml) solution of compound 154A (539 mg, 1.01 mmol) synthesized according to the synthesis method of Example 65 were added triethylamine (615.7 mg, 6.08 mmol) and ethyl chlorocarbonate (328.8 mg, 3.03 mmol) under ice-cooling, and the mixture was stirred at room temperature for 10 minutes. To the reaction solution were added O,N-dimethylhydroxylamine hydrochloride (295.0 mg, 3.03 mmol) and DMAP (12.3 mg, 0.101 mmol), the mixture was stirred at the same temperature for 2 hours, water was added, and was extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (7:3, v/v) and, then, with only ethyl acetate. Concentration of an objective fraction afforded 445.4 mg (yield 76%) of compound 154B as an oil.</p>\n",
       "<p id=\"p-1198\" num=\"1210\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.09 (3H, s), 3.52 (3H, s), 3.94 (2H, s), 4.40 (1H, brs), 4.64 (2H, s), 4.96 (1H, brs), 5.15 (2H, s), 7.06-7.15 (4H, m), 7.21 (2H, t, J=8.7 Hz), 7.28-7.38 (3H, m), 7.43 (2H, dd, J=5.7 Hz, 8.4 Hz), 7.52-7.54 (2H, m), 7.66 (1H, s).</p>\n",
       "<heading id=\"h-0672\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1199\" num=\"1211\">A THF (5 ml) solution of compound 154B (250 mg, 0.435 mmol) was cooled to −78° C., a methylmagnesium bromide 0.97M THF solution (0.673 ml, 0.653 mmol) was added, and temperature was raised to −20° C. over 2 hours. To the reaction solution was added 1N hydrochloric acid, and the mixture was extracted with ethyl acetate three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with only chloroform and, then, with chloroform-methanol (7:3, v/v). Concentration of an objective fraction afforded 117.0 mg (yield 51%) of compound 154C as an oil.</p>\n",
       "<p id=\"p-1200\" num=\"1212\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.68 (3H, s), 3.80 (2H, brs), 4.29 (2H, brs), 4.71 (2H, brs), 5.45 (2H, brs), 6.83 (2H, m), 6.92-6.98 (2H, m), 7.03-7.10 (2H, m), 7.28-7.39 (5H, m), 7.90 (1H, s).</p>\n",
       "<heading id=\"h-0673\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1201\" num=\"1213\">To a dichloromethane (2 ml) solution of compound 154C (117 mg, 0.221 mmol) was added mCPBA (52.7 mg, 0.332 mmol) under ice-cooling, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added an aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate three times. After the extract was washed with saturated sodium bicarbonate water two times, and dried with sodium sulfate, the solvent was distilled off, the resulting oil was dissolved in ethanol (2 ml), and the solution was refluxed for 1 hour. After the solvent was distilled off, the precipitated solid was washed with diisopropyl ether to obtain 54 mg (yield 49%) of compound 154D.</p>\n",
       "<p id=\"p-1202\" num=\"1214\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.74 (1H, brs), 3.85 (1H, brs), 4.20 (2H, brs), 4.61 (1H, brs), 4.93 (1H, brs), 5, 41 (2H, brs), 6.79-6.86 (2H, m), 6.91-6.96 (2H, m), 7.02-7.09 (2H, m), 7.15-7.16 (1H, m), 7.26-7.34 (5H, m), 7.56-7.65 (2H, m).</p>\n",
       "<heading id=\"h-0674\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1203\" num=\"1215\">To a THF (3 ml) solution of compound 154D (54 mg, 0.107 mmol) was added 10% Pd—C (20 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 21 mg (yield 47%) of compound 154.</p>\n",
       "<p id=\"p-1204\" num=\"1216\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.90 (2H, brs), 3.95 (2H, s), 4, 66 (2H, brs), 7.07-7.12 (4H, m), 7.22 (2H, t, J=8.7 Hz), 7.29 (1H, s), 7.43-7.47 (2H, m).</p>\n",
       "<heading id=\"h-0675\" level=\"1\">Example 155</heading>\n",
       "<p id=\"p-1205\" num=\"1217\"><chemistry id=\"CHEM-US-00269\" num=\"00269\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00269.TIF\" he=\"238.59mm\" id=\"EMI-C00269\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00270\" num=\"00270\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00270.TIF\" he=\"153.16mm\" id=\"EMI-C00270\" img-content=\"chem\" img-format=\"tif\" wi=\"71.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0676\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1206\" num=\"1218\">To a toluene (150 ml) solution of compound 155A (WO 2006/066414, 15.0 g, 38.4 mmol) were sequentially added N,N-diisopropylethylamine (16.1 mL, 92.0 mmol), 1-methylimidazole (3.70 mL, 46.4 mmol) and 2-methoxyethylamine (4.05 mL, 46.4 mmol) under ice-cooling and, thereafter, diphenyl chlorophosphate (9.60 mL, 46.1 mmol) was further added dropwise over 10 minutes. After the reaction solution was stirred for 20 minutes under ice-cooling, acetonitrile (50 mL) was added, and the mixture was further stirred for 2 hours. To the reaction solution was added an aqueous acetic acid solution (10%, 100 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate. The extract was sequentially washed with water (100 mL), saturated sodium bicarbonate water (150 mL) and an aqueous saturated sodium chloride solution (100 ml) and, thereafter, dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=25%→50%) to obtain compound 155B (7.86 g, 46%) as a colorless oil.</p>\n",
       "<p id=\"p-1207\" num=\"1219\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.10 (6H, s), 0.93 (9H, s), 3.29 (3H, s), 3.39 (2H, m), 3.47 (2H, m), 4.56 (2H, d, J=1.2 Hz), 5.41 (2H, s), 6.60 (1H, s), 7.35-7.42 (5H, m), 8.11 (1H, brt).</p>\n",
       "<heading id=\"h-0677\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1208\" num=\"1220\">To an ethanol (80 mL) solution of compound 155B (7.70 g, 17.2 mmol) was added aqueous ammonia (40 mL) at room temperature, and the mixture was stirred for 18 hours. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=75%→100%) to obtain compound 155C (7.15 g, 93%) as a colorless oil.</p>\n",
       "<p id=\"p-1209\" num=\"1221\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.14 (6H, s), 0.97 (9H, s), 3.28 (3H, s), 3.38 (2H, m), 3.49 (2H, m), 4.64 (2H, s), 5.53 (2H, s), 6.31 (1H, s), 7.34-7.49 (5H, m), 8.61 (1H, brs), 9.94 (1H, brs).</p>\n",
       "<heading id=\"h-0678\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1210\" num=\"1222\">To a DMF (125 mL) solution of compound 155C (7.15 g, 16.0 mmol) and potassium carbonate (6.64 g, 48.0 mmol) was added O-(2,4-dinitrophenyl)hydroxylamine (7.97 g, 40.0 mmol) at room temperature, and the mixture was stirred for 2 days. To the reaction solution was added water (250 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate (300 mL×2). After the extract was sequentially washed with water (300 mL), saturated sodium bicarbonate water (300 mL×2) and an aqueous saturated sodium chloride solution (150 mL), the mixture was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=0%→10%) to obtain compound 155D (6.47 g, 88%) as a pale yellow solid.</p>\n",
       "<p id=\"p-1211\" num=\"1223\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.11 (6H, s), 0.94 (9H, s), 3.26 (3H, s), 3.35 (4H, m), 4.66 (2H, s), 5.16 (2H, s), 5.24 (2H, s), 6.43 (1H, s), 7.31-7.40 (5H, m), 7.59 (1H, brs).</p>\n",
       "<heading id=\"h-0679\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1212\" num=\"1224\">To a toluene (100 mL) solution of compound 155D (6.47 g, 14.0 mmol) and acetic acid (0.080 mL, 1.4 mmol) was added paraformaldehyde (0.422 g, 14.1 mmol) at room temperature, and the mixture was stirred at 80° C. for 2 hours. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 155E was utilized in a next step without purification.</p>\n",
       "<heading id=\"h-0680\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1213\" num=\"1225\">To a DMF (100 mL) solution of the crude product of compound 155E obtained in the fourth step was added cesium carbonate (22.7 g, 69.8 mmol) under ice-cooling, and the mixture was stirred for 1 hour. Under ice-cooling, bromodiphenylmethane (5.20 g, 21.0 mmol) was added, and the mixture was stirred at room temperature for 19 hours. To the reaction solution was added water (200 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate (200 mL×3). The extract was sequentially washed with water (200 mL×2) and an aqueous saturated sodium chloride solution (100 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 155F was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1214\" num=\"1226\">MS: m/z=640 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0681\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-1215\" num=\"1227\">To a methanol (100 mL) solution of the crude product of compound 155F obtained in the fifth step was added hydrogen chloride (4N ethyl acetate solution, 40 mL) at room temperature, and the mixture was stirred for 2.5 hours. To the reaction solution was added an aqueous sodium hydroxide solution (2N, 75 mL) to perform neutralization (pH=6) under ice-cooling, and the mixture was extracted with chloroform (200 mL×3). The extract was dried with sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=5%→40%) to obtain compound 155G (5.18 g, 3 step 70%) as an orange oil.</p>\n",
       "<p id=\"p-1216\" num=\"1228\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.16 (3H, s), 3.18-3.43 (3H, m), 3.60-3.74 (2H, m), 4.06 (1H, d, J=13.5 Hz), 4.19 (1H, brs), 4.58 (1H, d, J=14.7 Hz), 5.00 (1H, d, J=13.5 Hz), 5.24 (1H, s), 5.27 (2H, s), 5.96 (1H, s), 6.78 (2H, m), 6.98-7.10 (3H, m), 7.30-7.42 (8H, m), 7.72 (2H, m).</p>\n",
       "<heading id=\"h-0682\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-1217\" num=\"1229\">To a THF (2 mL) solution of compound 155G (100 mg, 0.190 mmol), (bromomethyl)cyclopropane (0.110 mL, 1.12 mmol) and sodium iodide (5.0 mg, 0.033 mmol) was added potassium tert-butoxide (78.0 mg, 0.695 mmol) at room temperature, the mixture was stirred at room temperature for 22 hours and, thereafter, the mixture was stirred at 100° C. for 10 minutes under microwave irradiation. To the reaction solution were added water and hydrochloric acid (2N) (pH=1), the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 155H was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1218\" num=\"1230\">MS: m/z=580 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0683\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-1219\" num=\"1231\">To a DMF (2 mL) solution of the crude product of compound 155H obtained in the seventh step was added lithium chloride (35.0 mg, 0.826 mmol) at room temperature, and the mixture was stirred at 150° C. for 15 minutes under microwave irradiation. The reaction solution was purified by preparative LCMS to obtain compound 155 (4.3 mg, 2 step 5%) as a white solid.</p>\n",
       "<p id=\"p-1220\" num=\"1232\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.16 (2H, m), 0.52 (2H, m), 0.98 (1H, m), 3.08 (3H, m), 3.20 (3H, s), 3.46 (2H, m), 3.68 (1H, dd, J=0.6, 14.1 Hz), 3.90 (1H, m), 4.52 (1H, d, J=13.2 Hz), 4.58 (1H, d, J=14.1 Hz), 4.93 (1H, d, J=13.2 Hz), 5.38 (1H, s), 6.01 (1H, s), 6.98 (2H, m), 7.11-7.48 (8H, m).</p>\n",
       "<p id=\"p-1221\" num=\"1233\">MS: m/z=490 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0684\" level=\"1\">Example 156</heading>\n",
       "<p id=\"p-1222\" num=\"1234\"><chemistry id=\"CHEM-US-00271\" num=\"00271\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00271.TIF\" he=\"48.94mm\" id=\"EMI-C00271\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1223\" num=\"1235\">According to Example 155, compound 156 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1224\" num=\"1236\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.88 (3H, t, J=7.4 Hz), 1.51 (2H, m), 3.15-3.23 (6H, m), 3.46 (2H, m), 3.69 (1H, dd, J=0.6, 14.1 Hz), 3.88 (1H, m), 4.54 (2H, d, J=14.1 Hz), 4.58 (1H, d, J=14.1 Hz), 4.93 (1H, d, J=13.5 Hz), 5.39 (1H, s), 6.12 (1H, s), 6.97 (2H, m), 7.12-7.47 (8H, m).</p>\n",
       "<p id=\"p-1225\" num=\"1237\">MS: m/z=478 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0685\" level=\"1\">Example 157</heading>\n",
       "<p id=\"p-1226\" num=\"1238\"><chemistry id=\"CHEM-US-00272\" num=\"00272\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00272.TIF\" he=\"54.44mm\" id=\"EMI-C00272\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1227\" num=\"1239\">According to Example 155, compound 157 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1228\" num=\"1240\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.13-3.22 (1H, m), 3.18 (3H, s), 3.20 (3H, s), 3.41-3.51 (2H, m), 3.60 (1H, d, J=13.8 Hz), 3.89 (1H, ddd, J=3.3 Hz, 4.2 Hz, 14.4 Hz), 4.52 (1H, d, J=13.2 Hz), 4.53 (1H, d, J=13.8 Hz), 4.92 (1H, d, J=13.2 Hz), 5.38 (1H, s), 5.98 (1H, s), 6.98 (2H, d, J=8.4 Hz), 7.11-7.22 (3H, m), 7.36-7.48 (5H, m).</p>\n",
       "<heading id=\"h-0686\" level=\"1\">Example 158</heading>\n",
       "<p id=\"p-1229\" num=\"1241\"><chemistry id=\"CHEM-US-00273\" num=\"00273\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00273.TIF\" he=\"210.48mm\" id=\"EMI-C00273\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0687\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1230\" num=\"1242\">To a THF (100 mL) solution of compound 155G (960 mg, 1.83 mmol) was added manganese dioxide (2.06 g, 92.0 mmol) at room temperature, and the mixture was stirred for 2 days. After the reaction solution was filtered, the filtrate was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=60%→100%) to obtain compound 158A (554 mg, 58%) as a pale yellow foam.</p>\n",
       "<p id=\"p-1231\" num=\"1243\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.96 (1H, m), 3.18 (3H, s), 3.44 (2H, m), 4.18 (1H, m), 4.56 (1H, d, J′=13.8 Hz), 4.98 (1H, d, J=13.8 Hz), 5.28 (1H, s), 5.54 (1H, d, J=10.5 Hz), 5.64 (1H, d, J=10.5 Hz), 6.35 (1H, s), 6.85 (2H, m), 7.03 (2H, m), 7.18 (1H, m), 7.26-7.48 (8H, m), 7.64 (2H, m), 10.10 (1H, s).</p>\n",
       "<heading id=\"h-0688\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1232\" num=\"1244\">To a methylene chloride (4 mL) solution of compound 158A (83.0 mg, 0.159 mmol), pyrrolidine (0.0400 mL, 0.484 mmol) and acetic acid (0.100 ml) was added sodium triacetoxyborohydride (136 mg, 0.642 mmol) at room temperature, and the mixture was stirred for 28 hours. To the reaction solution was added water, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 158B was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1233\" num=\"1245\">MS: m/z=579 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0689\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1234\" num=\"1246\">To a DMF (2 mL) solution of the crude product of compound 158B obtained in the second step was added lithium chloride (39.2 mg, 0.925 mmol) at room temperature, and the mixture was stirred at 150° C. for 15 minutes under microwave irradiation. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 158 (8.8 mg, 2 step 11%) as a yellow oil.</p>\n",
       "<p id=\"p-1235\" num=\"1247\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.84 (4H, m), 2.70-2.85 (5H, m), 3.19 (3H, s), 3.20-3.47 (3H, m), 3.80 (1H, m), 4.25 (1H, d, J=14.7 Hz), 4.57 (1H, d, J=13.5 Hz), 5.07 (1H, d, J=13.5 Hz), 5.39 (1H, s), 6.06 (1H, s), 6.97 (2H, m), 7.12-7.54 (8H, m), 8.29 (1H, s).</p>\n",
       "<p id=\"p-1236\" num=\"1248\">MS: m/z=489 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0690\" level=\"1\">Example 159</heading>\n",
       "<p id=\"p-1237\" num=\"1249\"><chemistry id=\"CHEM-US-00274\" num=\"00274\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00274.TIF\" he=\"210.48mm\" id=\"EMI-C00274\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0691\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1238\" num=\"1250\">To a methylene chloride (20 mL) solution of compound 155G (950 mg, 1.81 mmol) and N,N-diisopropylethylamine (0.380 mL, 2.18 mmol) was added dropwise methanesulfonyl chloride (0.148 mL, 1.90 mmol) under ice-cooling, and the mixture was stirred for 90 minutes. To the reaction solution was added water (20 mL), the mixture was extracted with chloroform (50 mL), and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product (1.06 g) of compound 159A was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1239\" num=\"1251\">MS: m/z=604 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0692\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1240\" num=\"1252\">To the crude product (161 mg) of compound 159A obtained in the first step was added dimethylamine (2M THF solution, 2.00 mL, 4.00 mmol) at room temperature, and the mixture was stirred for 3 days. To the reaction solution was added an aqueous saturated sodium chloride solution (2 mL), the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 159B was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1241\" num=\"1253\">MS: m/z=553 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0693\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1242\" num=\"1254\">To a DMF (2 mL) solution of the crude product of compound 159B obtained in the second step was added lithium chloride (56.0 mg, 1.32 mmol) at room temperature, and the mixture was stirred at 150° C. for 30 minutes under microwave irradiation. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 159 (33.6 mg, 3 step 27%) as a white solid.</p>\n",
       "<p id=\"p-1243\" num=\"1255\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.37 (6H, s), 2.69 (1H, d, J=14.4 Hz), 3.19 (3H, s), 3.30-3.46 (3H, m), 3.76 (1H, m), 4.00 (1H, d, J=14.4 Hz), 4.60 (1H, d, J=13.5 Hz), 5.20 (1H, d, J=13.5 Hz), 5.40 (1H, s), 6.01 (1H, s), 6.97 (2H, m), 7.11-7.42 (8H, m).</p>\n",
       "<p id=\"p-1244\" num=\"1256\">MS: m/z=463 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0694\" level=\"1\">Example 160</heading>\n",
       "<p id=\"p-1245\" num=\"1257\"><chemistry id=\"CHEM-US-00275\" num=\"00275\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00275.TIF\" he=\"156.89mm\" id=\"EMI-C00275\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0695\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1246\" num=\"1258\">To a crude product (95.8 mg) of compound 159A was added methylamine (2M THF solution, 2.00 mL, 4.00 mmol) at room temperature, and the mixture was stirred for 3 days. The reaction solution was filtered, the solvent was distilled off under reduced pressure, and the resulting crude product of compound 160A was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1247\" num=\"1259\">MS: m/z=539 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0696\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1248\" num=\"1260\">To an acetonitrile (3 mL) suspension of the crude product of compound 160A and sodium iodide (100 mg, 0.667 mmol) was added chlorotrimethylsilane (0.0850 mL, 0.665 mmol) at room temperature, and the mixture was stirred for 5 hours. To the reaction solution was added water (1 mL), the solvent was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 160 (59.8 mg, 3 step 84%) as a white solid.</p>\n",
       "<p id=\"p-1249\" num=\"1261\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.75 (3H, s), 3.08 (1H, d, J=13.5 Hz), 3.24 (3H, s), 3.30-3.40 (3H, m), 3.75 (1H, m), 4.32 (1H, d, J=13.8 Hz), 4.66 (1H, d, J=13.8 Hz), 5.33 (1H, s), 5.58 (1H, d, J=13.5 Hz), 6.40 (1H, s), 6.98 (2H, m), 7.12-7.25 (3H, m), 7.40-7.51 (2H, m), 7.60 (2H, m).</p>\n",
       "<p id=\"p-1250\" num=\"1262\">MS: m/z=449 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0697\" level=\"1\">Example 161</heading>\n",
       "<p id=\"p-1251\" num=\"1263\"><chemistry id=\"CHEM-US-00276\" num=\"00276\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00276.TIF\" he=\"156.80mm\" id=\"EMI-C00276\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0698\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1252\" num=\"1264\">After a DMF (2 mL) suspension of a crude product (156 mg) of compound 159A, imidazole (19.5 mg, 0.286 mmol) and potassium carbonate (37.7 mg, 0.273 mmol) was stirred at room temperature for 4 hours, sodium hydride (60%, 11.7 mg, 0.293 mmol) was added, and the mixture was stirred for 3 days. To the reaction solution was added an aqueous acetic acid solution (10%), the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 161A was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1253\" num=\"1265\">MS: m/z=576 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0699\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1254\" num=\"1266\">To the crude product of compound 161A was added trifluoroacetic acid (1 mL) at room temperature, and the mixture was stirred for 18 hours and, thereafter, the mixture was stirred at 60° C. for 3 hours. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 161 (19.8 mg, 3 step 16%) as a pale orange amorphous substance.</p>\n",
       "<p id=\"p-1255\" num=\"1267\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.17-3.25 (1H, m), 3.21 (3H, s), 3.38-3.47 (2H, m), 3.82 (1H, m), 4.40 (1H, d, J=16.5 Hz), 4.54 (1H, d, J=13.5 Hz), 5.02 (1H, d, J=13.5 Hz), 5.09 (1H, s), 5.32 (1H, d, J=16.5 Hz), 5.40 (1H, s), 6.65 (1H, brs), 7.03 (2H, m), 7.15-7.49 (8H, m), 8.08 (1H, brs).</p>\n",
       "<p id=\"p-1256\" num=\"1268\">MS: m/z=486 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0700\" level=\"1\">Example 162</heading>\n",
       "<p id=\"p-1257\" num=\"1269\"><chemistry id=\"CHEM-US-00277\" num=\"00277\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00277.TIF\" he=\"210.57mm\" id=\"EMI-C00277\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0701\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1258\" num=\"1270\">To a DMF (2 mL) solution of a crude product (192 mg) of compound 159A was added sodium azide (24.2 mg, 0.372 mmol) at room temperature, and the mixture was stirred at 60° C. for 2 hours. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 162A was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1259\" num=\"1271\">MS: m/z=551 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0702\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1260\" num=\"1272\">To a THF (4 mL) solution of the crude product of compound 162A were sequentially added water (0.200 mL) and triphenylphosphine (83.0 mg, 0.316 mmol) at room temperature, and the mixture was stirred at 60° C. for 1 hour. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 162B (110 mg, 3 step 66%) as a colorless oil.</p>\n",
       "<p id=\"p-1261\" num=\"1273\">MS: m/z=525 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0703\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1262\" num=\"1274\">To an acetonitrile (1 mL) suspension of compound 162B (50.0 mg, 0.0950 mmol) and sodium iodide (56.2 mg, 0.375 mmol) was added chlorotrimethylsilane (0.0490 mL, 0.381 mmol) at room temperature, and the mixture was stirred for 6 hours. To the reaction solution was added water (0.5 mL), the solvent was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 162 (25.9 mg, 63%) as a pale orange solid.</p>\n",
       "<p id=\"p-1263\" num=\"1275\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.12 (1H, d, J=14.7 Hz), 3.27 (3H, s), 3.35-3.48 (3H, m), 3.81 (1H, m), 4.65 (1H, d, J=13.5 Hz), 5.31 (1H, s), 5.59 (1H, d, J=13.5 Hz), 6.40 (1H, s), 6.98 (2H, m), 7.19 (3H, m), 7.40 (1H, m), 7.50 (2H, m), 7.62 (2H, m), 8.11 (1H, s).</p>\n",
       "<p id=\"p-1264\" num=\"1276\">MS: m/z=435 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0704\" level=\"1\">Example 163</heading>\n",
       "<p id=\"p-1265\" num=\"1277\"><chemistry id=\"CHEM-US-00278\" num=\"00278\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00278.TIF\" he=\"148.08mm\" id=\"EMI-C00278\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0705\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1266\" num=\"1278\">To an acetonitrile (3 mL) solution of compound 162B (50.0 mg, 0.0950 mmol) and N,N-diisopropylethylamine (0.0366 mL, 0.210 mmol) was added acetic anhydride (0.0100 mL, 0.106 mmol) at room temperature, and the mixture was stirred for 6 hours. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 163A was utilized in a next step without purification.</p>\n",
       "<p id=\"p-1267\" num=\"1279\">MS: m/z=567 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0706\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1268\" num=\"1280\">To an acetonitrile (5 mL) suspension of the crude product of compound 163A and sodium iodide (59.2 mg, 0.395 mmol) was added chlorotrimethylsilane (0.0487 mL, 0.381 mmol) at room temperature, and the mixture was stirred for 16 hours. To the reaction solution was added water (0.5 mL), the solvent was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 163 (28.1 mg, 2 step 62%) as a pale orange foam.</p>\n",
       "<p id=\"p-1269\" num=\"1281\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.07 (3H, s), 3.24 (3H, s), 3.27-3.52 (4H, m), 3.67 (1H, m), 4.54 (1H, d, J=13.5 Hz), 4.78 (1H, dd, J=6.5, 14.9 Hz), 5.17 (1H, d, J=13.5 Hz), 5.28 (1H, s), 5.61 (1H, s), 7.01 (2H, m), 7.01-7.58 (9H, m).</p>\n",
       "<p id=\"p-1270\" num=\"1282\">MS: m/z=477 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0707\" level=\"1\">Example 164</heading>\n",
       "<p id=\"p-1271\" num=\"1283\"><chemistry id=\"CHEM-US-00279\" num=\"00279\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00279.TIF\" he=\"88.98mm\" id=\"EMI-C00279\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0708\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1272\" num=\"1284\">Compound 155G (43.3 mg, 0.221 mmol) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 22 mg (yield 61%) of compound 164.</p>\n",
       "<p id=\"p-1273\" num=\"1285\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.13 (6H, d, J=6.0 Hz), 3.18-3.77 (7H, m), 3.26 (3H, s), 4.49 (1H, d, J=12.3 Hz), 4.76 (1H, d, J=12.3 Hz), 5.27 (2H, brs), 5.89 (1H, s), 6.90 (2H, d, J=7.2 Hz), 6.98-7.14 (3H, m), 7.315-7.50 (5H, m).</p>\n",
       "<heading id=\"h-0709\" level=\"1\">Example 165</heading>\n",
       "<p id=\"p-1274\" num=\"1286\"><chemistry id=\"CHEM-US-00280\" num=\"00280\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00280.TIF\" he=\"239.10mm\" id=\"EMI-C00280\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0710\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1275\" num=\"1287\">To a DMF (370 mL) solution of compound 165A (WO 2006/088173, 37.0 g, 108 mmol) were sequentially added potassium carbonate (17.9 mg, 129 mmol) and methyl iodide (8.03 mL, 129 mmol) at room temperature, and the mixture was stirred for 1.5 hours. The reaction solution was added to a solution of ammonium chloride (20.8 g, 390 mmol) in water (1110 mL) under ice-cooling, and the precipitated solid was filtered, and washed with water to obtain a crude product (33 g). In addition, the aqueous layer was salted out with sodium chloride, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and a crude product (9 g) was obtained from the resulting residue. The crude products were combined and purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%) to obtain compound 165B (36.5 g, 95%) as a white solid.</p>\n",
       "<heading id=\"h-0711\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1276\" num=\"1288\">To a 1,4-dioxane (548 mL) solution of compound 165B (36.5 g, 102 mmol) were sequentially added potassium osmate dihydrate (1.13 g, 3.06 mmol), sodium periodate (87.3 g, 408 mmol) and water (365 mmol) at room temperature, and the mixture was stirred for 6 hours. The reaction solution was extracted with methylene chloride, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%) to obtain compound 165C (33.0 g, 90%) as a bronzed foam.</p>\n",
       "<heading id=\"h-0712\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1277\" num=\"1289\">To a toluene (25 mL) suspension of compound 165C (1.38 g, 3.66 mmol) were sequentially added ethylenediamine (0.247 mL, 3.66 mmol) and acetic acid (0.0210 mL, 0.366 mmol) at room temperature and, thereafter, the mixture was stirred for 1 hour, and further stirred at 50° C. for 17 hours. The precipitated solid was filtered, and washed with ether to obtain compound 165D (1.11 g, 100%) as a pale yellow solid.</p>\n",
       "<p id=\"p-1278\" num=\"1290\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 3.05 (2H, m), 3.26 (1H, m), 3.63 (2H, m), 3.75 (3H, s), 3.87 (1H, m), 4.52 (1H, dd, J=3.3, 12.6 Hz), 4.69 (1H, m), 4.99 (1H, d, J=10.4 Hz), 5.15 (1H, d, J=10.4 Hz), 7.35 (3H, m), 7.54 (2H, m), 8.41 (1H, s).</p>\n",
       "<heading id=\"h-0713\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1279\" num=\"1291\">To an acetonitrile (30 mL) suspension of compound 165D (2.77 g, 7.50 mmol), potassium carbonate. (2.23 g, 16.1 mmol) and sodium iodide (102 mg, 0.680 mmol) was added bromodiphenylmethane (2.26 g, 9.14 mmol) at room temperature, and the mixture was stirred at 90° C. for 7 hours. The reaction solution was poured into hydrochloric acid (2N, 10 mL) and an ice (20 g), the mixture was extracted with chloroform (100 mL×2), and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (chloroform/methanol=0%→5%) to obtain compound 165E (2.72 g, 68%) as a pale yellow solid.</p>\n",
       "<heading id=\"h-0714\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1280\" num=\"1292\">To an ethanol (30 mL) solution of compound 165E (2.72 g, 5.08 mmol) was added an aqueous sodium hydroxide solution (2N, 10 mL) at room temperature, and the mixture was stirred for 3 days. To the reaction solution was added hydrochloric acid (1N, 20 mL) (pH=1) at room temperature, the mixture was extracted with chloroform (100 mL×2), and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (chloroform/methanol=0%→10%) to obtain compound 165F (1.77 g, 67%) as a pale yellow solid.</p>\n",
       "<p id=\"p-1281\" num=\"1293\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.63 (1H, m), 3.16 (1H, m), 3.49 (1H, m), 3.73 (1H, m), 4.12 (2H, m), 4.56 (1H, m), 5.04 (1H, s), 5.09 (1H, d, J=10.7 Hz), 5.19 (1H, d, J=10.7 Hz), 7.28-7.53 (15H, m), 8.32 (1H, s), 8.39 (1H, s).</p>\n",
       "<heading id=\"h-0715\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-1282\" num=\"1294\">A N,N′-dimethylimidazolidinone (20 mL) solution of compound 165F (1.77 g, 3.39 mmol) and lithium chloride (0.515 g, 12.2 mmol) was stirred at 90° C. for 1 hour. To the reaction solution were sequentially added water (10 mL), hydrochloric acid (2N, 10 mL) and water (10 mL) at room temperature. The precipitated solid was filtered, and washed with ether, DMF-water were added, and the precipitated solid was filtered to obtain compound 165 (599 mg, 41%) as a white solid.</p>\n",
       "<p id=\"p-1283\" num=\"1295\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.60 (1H, m), 3.20 (1H, m), 3.64 (2H, m), 4.00 (2H, m), 4.55 (1H, m), 5.01 (1H, s), 7.28-7.47 (10H, m), 8.16 (1H, s), 11.97 (1H, brs).</p>\n",
       "<p id=\"p-1284\" num=\"1296\">MS: m/z=432 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0716\" level=\"1\">Example 166</heading>\n",
       "<p id=\"p-1285\" num=\"1297\"><chemistry id=\"CHEM-US-00281\" num=\"00281\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00281.TIF\" he=\"45.30mm\" id=\"EMI-C00281\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1286\" num=\"1298\">According to Example 165, following compound 166 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1287\" num=\"1299\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 1.54 (1H, d, J=12.6H), 1.66-1.78 (1H, m), 2.60 (1H, t, J=9.9 Hz), 2.83 (1H, d, J=11.7 Hz), 3.01 (1H, t, J=11.7 Hz), 3.34-3.38 (1H, m), 3.94 (1H, d, J=13.8 Hz), 4.44-4.59 (3H, m), 4.82 (1H, d, J=14.7 Hz), 7.06 (2H, t, J=8.7 Hz), 7.18-7.23 (2H, m), 8.27 (1H, s), 12.84 (1H, brs).</p>\n",
       "<heading id=\"h-0717\" level=\"1\">Example 167</heading>\n",
       "<p id=\"p-1288\" num=\"1300\"><chemistry id=\"CHEM-US-00282\" num=\"00282\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00282.TIF\" he=\"162.39mm\" id=\"EMI-C00282\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0718\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1289\" num=\"1301\">To a xylene (30 ml) solution of compound 167A (WO 2006/11674, 3.58 g, 7.61 mmol) were added (S)—N1-benzyl-3-phenylpropane-1,2-diamine (Journal of the American Chemical Society; English; 127; 30; 2005; 10504, 1.83 g, 7.61 mmol) and acetic acid (0.5 ml), and the mixture was refluxed for 2 hours. After cooling to room temperature, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (9:1, v/v) and, then, with n-hexane-ethyl acetate (1:1, v/v). Concentration of an objective fraction afforded 349 mg (yield 7%) of compound 167B as an oil.</p>\n",
       "<p id=\"p-1290\" num=\"1302\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 2.54 (1H, t, J=9.6 Hz), 2.77 (1H, dd, J=9.0 Hz, 13.2 Hz), 3.31 (1H, dd, J=6.9 Hz, 9.6 Hz), 3.43-3.78 (5H, m), 4.04-4.15 (1H, m), 4.42-4.48 (1H, m), 4.62 (2H, d, J=6.0 Hz), 5.29 (1H, d, J=10.5 Hz), 5.43 (1H, d, J=10.5 Hz), 6.77-6.85 (2H, m), 7.19-7.39 (14H, m), 7.60 (2H, d, J=6.3 Hz), 8.05 (1H, s).</p>\n",
       "<heading id=\"h-0719\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1291\" num=\"1303\">To a MeCN (10 ml) solution of compound 167B (968 mg, 1.47 mmol) were added Boc<sub>2</sub>O (3 ml) and DMAP (180 mg, 1.47 mmol), and the mixture was heated to reflux for 5 hours. To the reaction solution was added a 2N aqueous sodium hydroxide solution to stop the reaction, the reaction solution was neutralized using 2N hydrochloric acid and, thereafter, the mixture was extracted with ethyl acetate three times. After the extract was washed with an aqueous saturated sodium chloride solution, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (6:4, v/v) and, then, only with ethyl acetate. Concentration of an objective fraction afforded 349 mg (yield 45%) of compound 167C.</p>\n",
       "<p id=\"p-1292\" num=\"1304\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 2.54 (1H, t=9.0 Hz), 2.76 (1H, dd, J=9.3 Hz, 16.5 Hz), 3.31 (1H, dd, J=6.9 Hz, 9.6 Hz), 3.45 (1H, dd, J=3.3 Hz, 12.6 Hz), 3.51-3.78 (4H, m), 4.04-4.13 (1H, m), 4.42-4.52 (1H, m), 4.61 (2H, d, J=6.0 Hz), 2.79 (1H, d, J=10.2 Hz), 5.29 (1H, d, J=10.2 Hz), 5.43 (1H, d, J=10.2 Hz), 6.76-7.39 (11H, m), 7.60 (2H, d, J=6.6 Hz), 8.05 (1H, s), 10.42 (1H, t, J=5.7 Hz).</p>\n",
       "<heading id=\"h-0720\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1293\" num=\"1305\">Compound 167C (150 mg, 0.280 mmol) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 71 mg (yield 57%) of compound 167.</p>\n",
       "<p id=\"p-1294\" num=\"1306\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 2.65 (1H, dd, J=8.4 Hz, 9.6 Hz), 2.97 (1H, dd, J=9 Hz, 13.5 Hz), 3.43 (1J, dd, J=7.2 Hz, 9.6 Hz), 3.55 (1H, dd, J=3.0 Hz, 13.2 Hz), 3.61-3.80 (4H, m), 4.15 (1H, dd, J=4.2 Hz, 9.9 Hz), 4.51-4.60 (1H, m), 7.15-7.18 (2H, m), 7.28-7.38 (8H, m), 8.02 (1H, s), 12.04 (1H, s).</p>\n",
       "<heading id=\"h-0721\" level=\"1\">Example 168</heading>\n",
       "<p id=\"p-1295\" num=\"1307\"><chemistry id=\"CHEM-US-00283\" num=\"00283\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00283.TIF\" he=\"166.37mm\" id=\"EMI-C00283\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0722\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1296\" num=\"1308\">To a DMF (3 mL) solution of compound 168A (WO 2006/116764, 400 mg, 0.840 mmol) were added cesium carbonate (821 mg, 2.52 mmol) and, subsequently, bromomethylenedibenzene (311 mg, 1.26 mmol), and the mixture was stirred at 100° C. for 5 hours. To the reaction solution were added 2N hydrochloric acid, water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate once. The combined extracts were washed with an aqueous saturated sodium bicarbonate solution and brine, dried with magnesium sulfate, filtered and concentrated. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 100 mg of compound 168B as a yellow oil.</p>\n",
       "<p id=\"p-1297\" num=\"1309\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.79-1.84 (2H, m), 2.67-2.77 (1H, m), 2.84-3.05 (2H, m), 4.03 (1H, dd, J=13.0, 4.2 Hz), 4.28 (1H, dd, J=13.6, 6.5 Hz), 4.49 (1H, dd, J=6.4, 3.8 Hz), 4.57 (2H, d, J=5.7 Hz), 4.78 (1H, dd, J=13.4, 5.7 Hz), 4.93 (1H, s), 5.27 (2H, s), 7.00 (2H, t, J=8.8 Hz), 7.15-7.37 (14H, m), 7.57-7.63 (2H, m), 7.76 (1H, s), 10.44 (1H, t, J=5.9 Hz).</p>\n",
       "<p id=\"p-1298\" num=\"1310\">MS: m/z=643.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0723\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1299\" num=\"1311\">Compound 168B (100 mg, 0.156 mmol) was dissolved in acetonitrile (3 mL), Boc<sub>2</sub>O (4.0 mL, 17.3 mmol) and, subsequently, DMAP (84 mg, 0.69 mmol) were added, and the mixture was stirred at 80° C. for 6 hours. The reaction solution was allowed to cool, a 2N aqueous sodium hydroxide solution (8 mL) and, subsequently, ethanol (3 mL) were added, and the mixture was stirred at 60° C. for 2 hours. To the reaction solution were added 2N hydrochloric acid and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The solvent was distilled off, and the resulting residue was purified by silica gel chromatography. Elution with ethyl acetate-methanol, and concentration of an objective fraction afforded 84 mg of compound 168C.</p>\n",
       "<p id=\"p-1300\" num=\"1312\">MS: m/z=536.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0724\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1301\" num=\"1313\">To a DMI (2 mL) solution of compound 168C (80 mg, 0.15 mmol) was added lithium chloride (19 mg, 0.45 mmol), and the mixture was stirred at 90° C. for 2 hours. To the reaction mixture were added water and 2N hydrochloric acid, the precipitated solid was filtered, and the resulting solid was purified using a LCMS fractionating device. The eluted solvent was distilled off, to the residue was added isopropyl ether, and the precipitated solid was filtered. Washing with isopropyl ether and drying afforded 12 mg of compound 168.</p>\n",
       "<p id=\"p-1302\" num=\"1314\">MS: m/z=446.05 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0725\" level=\"1\">Example 169</heading>\n",
       "<p id=\"p-1303\" num=\"1315\"><chemistry id=\"CHEM-US-00284\" num=\"00284\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00284.TIF\" he=\"185.67mm\" id=\"EMI-C00284\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0726\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1304\" num=\"1316\">To an ethanol (5 mL) solution of compound 95A (WO 2006/116764, 500 mg, 2.03 mmol) was added 2,2-dimethoxyethanamine (0.49 ml, 4.47 mmol), and the mixture was stirred at 80° C. for 3 hours. After the reaction solution was allowed to cool, acetic acid (0.27 ml, 4.69 mmol) was added at room temperature, and the mixture was concentrated under reduced pressure. The resulting residue was dissolved in DMF (5 mL), DBU (0.66 mL, 4.4 mmol) and, subsequently, methyl iodide (1.02 mL, 16.2 mmol) were added under nitrogen atmosphere, and the mixture was stirred at room temperature for 3 hours. To the reaction solution were added an aqueous saturated sodium bicarbonate solution and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered and concentrated, and the resulting residue was purified by silica gel chromatography. Elution with chloroform-methanol (9:1) and concentration of an objective fraction afforded 258 mg of compound 169A as a brown oil.</p>\n",
       "<p id=\"p-1305\" num=\"1317\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.37 (6H, s), 3.80 (3H, s), 3.87 (2H, d, J=4.8 Hz), 4.46 (1H, t, J=4.8 Hz), 5.30 (2H, s), 6.75 (1H, d, J=6.0 Hz), 7.30-7.41 (6H, m).</p>\n",
       "<heading id=\"h-0727\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1306\" num=\"1318\">To compound 169A (1.00 g, 2.88 mmol) were added formic acid (31 mL) and, subsequently, water (5 mL), and the mixture was stirred at 70° C. for 6.5 hours. To the reaction mixture were added water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. After the combined extracts were washed with an aqueous saturated sodium bicarbonate solution, and sodium sulfate was added, then the mixture was filtered and concentrated, and the resulting residue was purified by silica gel chromatography. Elution with ethyl acetate-methanol, and concentration of an objective fraction afforded a mixture of aldehyde hydride and methylacetal as a colorless transparent oil. The resulting oil was dissolved in dichloromethane (5 mL), 1,3-diaminopropane dihydrochloride (354 mg, 2.41 mmol) and, subsequently, acetic acid (0.069 ml, 1.2 mmol) were added, and the mixture was stirred at room temperature for 6 hours. The reaction solution was diluted with dichloromethane, insolubles were filtered and, thereafter, the mixture was concentrated under reduced pressure to obtain a crude purified product of compound 169B.</p>\n",
       "<p id=\"p-1307\" num=\"1319\">MS: m/z=326.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0728\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1308\" num=\"1320\">To an acetonitrile (4 mL) solution of compound 168B (391 mg, 1.20 mmol) were added potassium carbonate (498 mg, 3.61 mmol) and, subsequently, bromomethylenedibenzene (890 mg, 3.61 mmol). After the reaction solution was stirred at 90° C. for 2 hours, to the reaction solution were added water, ethyl acetate and brine, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate once. After the combined extracts were dried with magnesium sulfate, then the mixture was filtered and concentrated. The resulting residue was purified by silica gel column chromatography. Elution with ethyl acetate-methanol, and concentration of an objective fraction afforded 106 mg of compound 169C as an orange solid.</p>\n",
       "<p id=\"p-1309\" num=\"1321\">MS: m/z=492.15 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0729\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1310\" num=\"1322\">To a DMI (2 mL) solution of compound 169C (105 mg, 0.214 mmol) was added lithium chloride (27.2 mg, 0.641 mmol), and the mixture was stirred at 90° C. for 3 hours. Further, lithium chloride (27.2 mg, 0.641 mmol) was added, and the mixture was stirred at 90° C. for 1 hour. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, to the residue was added diethyl ether, and the precipitated solid was filtered. Washing with diethyl ether, and drying afforded 27 mg of compound 169.</p>\n",
       "<p id=\"p-1311\" num=\"1323\"><sup>1</sup>H-NMR (CD<sub>3</sub>OD) δ: 1.63 (1H, dd, J=13.4, 2.8 Hz), 1.84 (1H, br s), 2.55-2.64 (1H, m), 2.90-3.10 (2H, m), 4.30 (1H, dd, J=14.5, 4.0 Hz), 4.52 (4H, dd, J=14.5, 3.8 Hz), 4.63-4.75 (4H, m), 5.16 (1H, s), 6.16 (1H, d, J=7.2 Hz), 6.78 (1H, d, J=7.2 Hz), 7.16-7.32 (10H, m).</p>\n",
       "<p id=\"p-1312\" num=\"1324\">MS: m/z=402.10 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0730\" level=\"1\">Example 170</heading>\n",
       "<p id=\"p-1313\" num=\"1325\"><chemistry id=\"CHEM-US-00285\" num=\"00285\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00285.TIF\" he=\"129.29mm\" id=\"EMI-C00285\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0731\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1314\" num=\"1326\">Compound 49F (87 mg, 0.19 mmol) was dissolved in ethanol (1 ml) and THF (1 ml), a 2N aqueous sodium hydroxide solution (0.47 ml, 0.95 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. To the reaction solution was added 2N hydrochloric acid, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol 95:5→90:10, v/v) to obtain 60 mg of compound 170A.</p>\n",
       "<p id=\"p-1315\" num=\"1327\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.48 (1H, dd, J=13.8, 11.8 Hz), 3.27 (1H, dd, J=14.2, 3.4 Hz), 3.73-3.80 (1H, m), 3.92 (1H, m), 4.16 (1H, m), 4.45 (2H, m), 5.34 (1H, d, J=3.5 Hz), 5.47 (1H, d, J=10.4 Hz), 5.52 (1H, d, J=10.7 Hz), 6.73 (2H, d, J=6.9 Hz), 7.18-7.42 (7H, m), 7.60 (2H, d, J=6.9 Hz), 14.63 (1H, s).</p>\n",
       "<heading id=\"h-0732\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1316\" num=\"1328\">To compound 170A (57 mg, 0.13 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 19 mg of compound 170 as a colorless solid.</p>\n",
       "<p id=\"p-1317\" num=\"1329\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.74 (1H, t, J=12.1 Hz), 3.10-3.22 (1H, m), 3.76 (2H, m), 4.12 (1H, q, J=8.0 Hz), 4.44 (1H, m), 5.35 (1H, m), 5.49 (1H, d, J=3.4 Hz), 7.05 (5H, m), 7.77 (1H, s), 12.05 (1H, brs).</p>\n",
       "<heading id=\"h-0733\" level=\"1\">Example 171</heading>\n",
       "<p id=\"p-1318\" num=\"1330\"><chemistry id=\"CHEM-US-00286\" num=\"00286\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00286.TIF\" he=\"242.82mm\" id=\"EMI-C00286\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00287\" num=\"00287\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00287.TIF\" he=\"85.51mm\" id=\"EMI-C00287\" img-content=\"chem\" img-format=\"tif\" wi=\"63.16mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0734\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1319\" num=\"1331\">Compound 49B (950 mg, 3.35 mmol), 3-aminopropan-1-ol (277 mg, 3.69 mmol) and sodium sulfate (1.91 g, 13.4 mmol) were added to toluene (25 ml), and the mixture was stirred at room temperature for 1 hour. Boc<sub>2</sub>O (0.856 ml, 3.69 mmol) was added at room temperature, and the mixture was stirred for 18 hours. Further, Boc<sub>2</sub>O (0.400 ml, 1.72 mmol) was added at room temperature, and the mixture was stirred for 60 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 1.02 g of compound 171A as a colorless gummy substance.</p>\n",
       "<heading id=\"h-0735\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1320\" num=\"1332\">Compound 171A (1.01 g, 2.29 mmol) and palladium-active carbon (10%, wet, 200 mg) were added to ethanol (20 ml), and the mixture was stirred at room temperature for 1.5 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 755 mg of a colorless oily substance 171B.</p>\n",
       "<p id=\"p-1321\" num=\"1333\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.42 (5H, s), 1.49 (4H, s), 1.56-1.92 (2H, m), 2.49 (0.4H, dd, J=13.6, 9.8 Hz), 2.62 (0.6H, dd, J=13.6, 8.5 Hz), 2.81 (0.4H, dd, J=13.5, 3.6 Hz), 3.16 (1.6H, m), 3.60-4.14 (4H, m), 5.13 (0.6H, d, J=8.8 Hz), 5.19 (0.4H, d, J=8.5 Hz), 7.22-7.37 (5H, m).</p>\n",
       "<heading id=\"h-0736\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1322\" num=\"1334\">Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (660 mg, 1.99 mmol) and compound 171B (609 mg, 1.99 mmol) were added to toluene (8 ml), and the mixture was stirred at 100° C. for 1.5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 99:1, v/v) to obtain 1.02 g of compound 171C as a pale yellow gummy substance.</p>\n",
       "<heading id=\"h-0737\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1323\" num=\"1335\">To compound 171C (991 mg, 1.60 mmol) was added 4N HCl (ethyl acetate solution, 12 ml). After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Subsequently, toluene (12 ml) and 3-aminopropan-1-ol (0.244 ml, 3.19 mmol) were added, the mixture was stirred at 80° C. for 10 minutes. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 99:1→95:5→90:10, v/v) to obtain 341 mg of compound 171D as a yellow gummy substance and 338 mg of compound 171E as a colorless solid.</p>\n",
       "<p id=\"p-1324\" num=\"1336\">171D: <sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (3H, t, J=7.1 Hz), 1.51 (1H, d, J=13.7 Hz), 1.97 (1H, m), 2.91 (1H, dd, J=13.8, 9.8 Hz), 2.99-3.10 (2H, m), 3.90 (1H, td, J=12.1, 2.5 Hz), 4.12 (2H, m), 4.25 (2H, m), 4.83 (2H, m), 5.33 (1H, d, J=10.1 Hz), 5.51 (1H, d, J=10.1 Hz), 6.88 (2H, m), 7.23-7.40 (7H, m), 7.68 (2H, m)</p>\n",
       "<p id=\"p-1325\" num=\"1337\">171E: <sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.19 (3H, t, J=7.2 Hz), 1.82-1.99 (2H, m), 2.73 (1H, dd, J=14.0, 11.3 Hz), 3.13 (1H, m), 3.35 (1H, dd, J=14.0, 3.4 Hz), 3.63 (1H, m), 3.90-4.26 (4H, m), 4.43 (1H, d, J=13.6 Hz), 5.27 (1H, t, J=3.5 Hz), 5.31 (2H, s), 6.78 (2H, dd, J=6.3, 3.2 Hz), 7.01 (1H, d, J=7.0 Hz), 7.18 (3H, t, J=3.1 Hz), 7.28-7.39 (3H, m), 7.67 (2H, m).</p>\n",
       "<heading id=\"h-0738\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1326\" num=\"1338\">Compound 171D (329 mg, 0.673 mmol) was dissolved in ethanol (2 ml) and THF (4 ml), a 2N aqueous sodium hydroxide solution (1.69 ml, 3.38 mmol) was added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added 2N hydrochloric acid, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 215 mg of compound 171F as a colorless solid.</p>\n",
       "<p id=\"p-1327\" num=\"1339\">MS: m/z=461 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0739\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-1328\" num=\"1340\">To compound 171F (50 mg, 0.11 mmol) was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 24 mg of compound 171 as a colorless solid.</p>\n",
       "<p id=\"p-1329\" num=\"1341\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.63 (1H, d, J=12.6 Hz), 1.83 (1H, m), 2.96-3.29 (3H, m), 4.05 (2H, m), 4.55 (1H, dd, J=13.2, 4.4 Hz), 5.08 (1H, dd, J=9.2, 5.4 Hz), 5.30 (1H, s), 7.19 (5H, m), 8.09 (1H, s), 12.84 (1H, brs).</p>\n",
       "<p id=\"p-1330\" num=\"1342\">MS: m/z=371 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0740\" level=\"1\">Example 172</heading>\n",
       "<p id=\"p-1331\" num=\"1343\"><chemistry id=\"CHEM-US-00288\" num=\"00288\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00288.TIF\" he=\"44.96mm\" id=\"EMI-C00288\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1332\" num=\"1344\">According to Example 171, using compound 171E, compound 172 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1333\" num=\"1345\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.91 (2H, m), 2.94 (1H, dd, J=14.0, 10.8 Hz), 3.11-3.21 (3H, m), 3.71 (1H, m), 4.19 (1H, m), 4.29-4.35 (1H, m), 5.08-5.14 (1H, m), 5.47 (1H, d, J=4.0 Hz), 6.92-7.22 (5H, m), 7.71 (1H, s), 12.80 (1H, brs), 15.06 (1H, brs).</p>\n",
       "<p id=\"p-1334\" num=\"1346\">MS: m/z=371 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0741\" level=\"1\">Example 173</heading>\n",
       "<p id=\"p-1335\" num=\"1347\"><chemistry id=\"CHEM-US-00289\" num=\"00289\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00289.TIF\" he=\"91.19mm\" id=\"EMI-C00289\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0742\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1336\" num=\"1348\">Compound 171F (159 mg, 0.345 mmol) was added to diphenyl ether (2.5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5→90:10, v/v) to obtain compound 173A.</p>\n",
       "<heading id=\"h-0743\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1337\" num=\"1349\">To compound 173A obtained in the first step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 10 mg of compound 173 as a colorless solid.</p>\n",
       "<p id=\"p-1338\" num=\"1350\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.55-1.86 (2H, m), 2.84-3.26 (3H, m), 3.92-4.09 (2H, m), 4.55 (2H, m), 5.15 (1H, s), 5.89 (1H, d, J=7.5 Hz), 7.17 (6H, m), 12.11 (1H, brs)</p>\n",
       "<p id=\"p-1339\" num=\"1351\">MS: m/z=327 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0744\" level=\"1\">Example 174</heading>\n",
       "<p id=\"p-1340\" num=\"1352\"><chemistry id=\"CHEM-US-00290\" num=\"00290\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00290.TIF\" he=\"42.59mm\" id=\"EMI-C00290\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1341\" num=\"1353\">According to Example 173, compound 174 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1342\" num=\"1354\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.86 (2H, m), 2.87 (1H, t, J=12.3 Hz), 3.18 (2H, m), 3.68 (1H, t, J=10.4 Hz), 4.16 (1H, d, J=10.1 Hz), 4.29 (1H, d, J=12.4 Hz), 4.71 (1H, d, J=9.2 Hz), 5.37 (1H, d, J=3.5 Hz), 5.75 (1H, d, J=7.5 Hz), 7.00 (6H, m), 12.51 (1H, brs).</p>\n",
       "<p id=\"p-1343\" num=\"1355\">MS: m/z=327 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0745\" level=\"1\">Example 175</heading>\n",
       "<p id=\"p-1344\" num=\"1356\"><chemistry id=\"CHEM-US-00291\" num=\"00291\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00291.TIF\" he=\"228.60mm\" id=\"EMI-C00291\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00292\" num=\"00292\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00292.TIF\" he=\"138.85mm\" id=\"EMI-C00292\" img-content=\"chem\" img-format=\"tif\" wi=\"75.78mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0746\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1345\" num=\"1357\">To Dess-Martin Periodinane (0.3M, methylene chloride solution, 25.0 ml, 7.50 mmol) was added dropwise a methylene chloride solution (10 ml) of compound 2B (1.98 g, 5.48 mmol) at 0° C. After the mixture was stirred at room temperature for 3 hours, the mixture was poured into a 1N aqueous sodium hydroxide solution, and extracted with ethyl ether. The organic layer was washed with a 1N aqueous sodium hydroxide solution and an aqueous saturated sodium chloride solution, and dried with magnesium sulfate. After the solvent was distilled off under reduced pressure, purification was performed by silica gel column chromatography (n-hexane-ethyl acetate, 2:1, v/v) to obtain 1.73 g of compound 175A as a white solid.</p>\n",
       "<p id=\"p-1346\" num=\"1358\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.55 (1H, d, J=7.3 Hz), 5.09 (2H, s), 5.14 (2H, m), 7.22-7.35 (15H, m), 9.62 (1H, s).</p>\n",
       "<heading id=\"h-0747\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1347\" num=\"1359\">Compound 175A (1.30 g, 4.59 mmol), 3-aminopropan-1-ol (379 mg, 5.05 mmol) and sodium sulfate (3.26 g, 22.4 mmol) were added to toluene (40 ml), and the mixture was stirred at room temperature for 1 hour. Boc<sub>2</sub>O (1.17 ml, 5.05 mmol) was added at room temperature, and the mixture was stirred for 18 hours. Boc<sub>2</sub>O (1.17 ml, 5.05 mmol) and sodium sulfate (3.26 g, 22.4 mmol) were added, and the mixture was stirred for 60 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 635 mg of compound 175B as a colorless solid.</p>\n",
       "<heading id=\"h-0748\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1348\" num=\"1360\">Compound 175B (632 mg, 1.22 mmol) and palladium-active carbon (10%, wet, 100 mg) were added to ethanol (10 ml) and THF (5 ml), and the mixture was stirred at room temperature for 3 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 502 mg of a colorless oily substance 175C.</p>\n",
       "<p id=\"p-1349\" num=\"1361\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.45 (9H, s), 1.77 (2H, m), 3.18-3.27 (1H, m), 3.43-3.51 (1H, m), 4.04 (4H, m), 4.92 (1H, d, J=4.7 Hz), 7.28 (10H, m).</p>\n",
       "<heading id=\"h-0749\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1350\" num=\"1362\">Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (390 mg, 1.22 mmol) and compound 175C (468 mg, 1.22 mmol) were added to toluene (5 ml), and the mixture was stirred at 100° C. for 2 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 391 mg of compound 175D as a pale yellow gummy substance.</p>\n",
       "<heading id=\"h-0750\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1351\" num=\"1363\">To compound 175D (388 mg, 0.568 mmol) was added 4N HCl (ethyl acetate solution, 4 ml). After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Subsequently, toluene (4 ml) and 3-aminopropan-1-ol (0.0870 ml, 1.14 mmol) were added, and the mixture was stirred at 80° C. for 5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain 57 mg of compound 175E as a yellow gummy substance and 44 mg of compound 175F as a brown gummy substance.</p>\n",
       "<p id=\"p-1352\" num=\"1364\">175E: <sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.91-2.00 (2H, m), 2.87 (1H, m), 3.78 (3H, s), 3.87-4.15 (3H, m), 4.61 (1H, d, J=12.1 Hz), 4.78 (2H, m), 5.33 (1H, d, J=10.2 Hz), 5.63 (1H, d, J=10.2 Hz), 6.95 (2H, m), 7.13-7.53 (12H, m), 7.76 (2H, m)</p>\n",
       "<p id=\"p-1353\" num=\"1365\">175F: <sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.83-1.97 (2H, m), 3.12-3.22 (1H, m), 3.50 (1H, m), 3.85 (3H, s), 3.90 (1H, m), 4.34-4.40 (1H, m), 4.74 (1H, d, J=8.6 Hz), 4.84-4.89 (1H, m), 5.09 (1H, d, J=3.3 Hz), 5.15 (1H, d, J=9.9 Hz), 5.26 (1H, d, J=9.6 Hz), 7.08-7.50 (13H, m), 7.65-7.77 (3H, m).</p>\n",
       "<heading id=\"h-0751\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-1354\" num=\"1366\">Compound 175E (57 mg, 0.10 mmol) was dissolved in THF (0.5 ml) and ethanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.25 ml, 0.50 mmol) was added at room temperature, and the mixture was stirred for 1 hour. After 1N hydrochloric acid was added, and the mixture was extracted with chloroform, the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain compound 175G.</p>\n",
       "<heading id=\"h-0752\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-1355\" num=\"1367\">To compound 175G obtained in the sixth step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 11 mg of compound 175 as a colorless solid.</p>\n",
       "<p id=\"p-1356\" num=\"1368\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.50 (1H, d, J=13.1 Hz), 1.79 (1H, m), 3.17 (1H, m), 3.86 (1H, t, J=11.0 Hz), 4.03 (1H, dd, J=10.8, 4.1 Hz), 4.46 (1H, d, J=12.0 Hz), 4.53 (1H, dd, J=12.7, 4.2 Hz), 4.84 (1H, s), 5.85 (1H, d, J=11.7 Hz), 7.22 (7H, m), 7.44 (2H, t, J=7.6 Hz), 7.65 (2H, d, J=7.3 Hz), 8.14 (1H, s), 12.75 (1H, s), 15.33 (1H, brs).</p>\n",
       "<p id=\"p-1357\" num=\"1369\">MS: m/z=447 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0753\" level=\"1\">Example 176</heading>\n",
       "<p id=\"p-1358\" num=\"1370\"><chemistry id=\"CHEM-US-00293\" num=\"00293\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00293.TIF\" he=\"42.76mm\" id=\"EMI-C00293\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1359\" num=\"1371\">According to Example 175, using compound 175F, compound 176 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1360\" num=\"1372\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.75 (2H, m), 3.17 (2H, m), 3.43 (1H, m), 3.60 (1H, d, J=10.7 Hz), 4.31 (1H, d, J=12.7 Hz), 4.73 (1H, d, J=9.8 Hz), 5.52 (1H, d, J=3.4 Hz), 5.87 (1H, dd, J=9.9, 3.4 Hz), 7.10 (7H, m), 7.29 (2H, t, J=7.5 Hz), 7.58 (2H, d, J=7.3 Hz), 8.37 (1H, s), 12.65 (1H, brs).</p>\n",
       "<p id=\"p-1361\" num=\"1373\">MS: m/z=447 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0754\" level=\"1\">Example 177</heading>\n",
       "<p id=\"p-1362\" num=\"1374\"><chemistry id=\"CHEM-US-00294\" num=\"00294\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00294.TIF\" he=\"187.88mm\" id=\"EMI-C00294\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0755\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1363\" num=\"1375\">Tert-butyl pyrazolidine-1-carboxylate (275 mg, 1.60 mmol) synthesized according to the method of the reference (Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1975, p. 1712), and compound 95B (409 mg, 1.45 mmol) were dissolved in pyridine (5 ml), HATU (607 mg, 1.60 mmol) was added at room temperature, and the mixture was stirred for 18 hours. The reaction solution was poured into 1N hydrochloric acid, then the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 529 mg of compound 177A as a yellow solid.</p>\n",
       "<p id=\"p-1364\" num=\"1376\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.35 (9H, s), 1.88-2.10 (2H, m), 3.04 (1H, s), 3.31 (1H, s), 3.86 (2H, m), 4.96 (1H, d, J=9.3 Hz), 5.45 (1H, d, J=11.0 Hz), 6.56 (1H, d, J=6.7 Hz), 7.29-7.43 (6H, m).</p>\n",
       "<heading id=\"h-0756\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1365\" num=\"1377\">To compound 177A (525 mg, 1.31 mmol) was added 4N HCl (dioxane solution, 6 ml). After the mixture was stirred at room temperature for 1.5 hours, the solvent was distilled off under reduced pressure to obtain 413 mg of compound 177B as a colorless solid.</p>\n",
       "<p id=\"p-1366\" num=\"1378\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.95-2.05 (2H, m), 2.78 (2H, t, J=6.6 Hz), 3.41-3.54 (2H, m), 5.11 (2H, s), 7.38 (5H, m), 7.46 (1H, d, J=6.6 Hz), 8.36 (1H, d, J=6.7 Hz).</p>\n",
       "<heading id=\"h-0757\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1367\" num=\"1379\">Compound 177B (100 mg, 0.298 mmol) was added to ethanol (2 ml), 2,2-diphenylacetaldehyde (58 mg, 0.30 mmol), triethylamine (0.083 ml, 0.596 mmol) and acetic acid (0.051 ml, 0.89 mmol) were added, and the mixture was stirred at 80° C. for 3 hours. The reaction solution was poured into water, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→93:7→90:10, v/v) to obtain 106 mg of compound 177C as a yellow gummy substance.</p>\n",
       "<p id=\"p-1368\" num=\"1380\">MS: m/z=478 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0758\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1369\" num=\"1381\">To compound 177C obtained in the third step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 7 mg of compound 177 as a colorless solid.</p>\n",
       "<p id=\"p-1370\" num=\"1382\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.95 (2H, m), 2.76 (1H, m), 2.96-3.17 (2H, m), 4.04 (1H, m), 4.68 (1H, d, J=10.4 Hz), 5.66 (1H, d, J=7.3 Hz), 6.56 (1H, d, J=10.5 Hz), 7.03 (1H, d, J=7.2 Hz), 7.17 (6H, m), 7.34 (2H, t, J=7.3 Hz), 7.55 (2H, d, J=7.5 Hz).</p>\n",
       "<p id=\"p-1371\" num=\"1383\">MS: m/z=388 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0759\" level=\"1\">Example 178</heading>\n",
       "<p id=\"p-1372\" num=\"1384\"><chemistry id=\"CHEM-US-00295\" num=\"00295\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00295.TIF\" he=\"42.59mm\" id=\"EMI-C00295\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1373\" num=\"1385\">According to Example 177, compound 178 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1374\" num=\"1386\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.55 (4H, m), 2.35-7.49 (1H, m), 2.39 (1H, t, J=12.6 Hz), 2.77 (1H, t, J=10.0 Hz), 3.09 (1H, d, J=11.4 Hz), 4.34 (1H, d, J=12.8 Hz), 4.55 (1H, d, J=10.8 Hz), 5.71 (1H, d, J=7.0 Hz), 6.17 (1H, d, J=10.8 Hz), 6.82 (1H, d, J=7.3 Hz), 7.13-7.40 (8H, m), 7.48 (2H, d, J=7.3 Hz).</p>\n",
       "<p id=\"p-1375\" num=\"1387\">MS: m/z=402 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0760\" level=\"1\">Example 179</heading>\n",
       "<p id=\"p-1376\" num=\"1388\"><chemistry id=\"CHEM-US-00296\" num=\"00296\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00296.TIF\" he=\"43.26mm\" id=\"EMI-C00296\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1377\" num=\"1389\">According to Example 177, compound 179 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1378\" num=\"1390\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.31 (6H, m), 2.68 (2H, m), 3.21 (1H, m), 4.04 (1H, m), 4.40 (1H, d, J=10.8 Hz), 5.77 (1H, t, J=5.2 Hz), 6.26 (1H, d, J=10.8 Hz), 6.78 (1H, d, J=7.3 Hz), 7.27 (8H, m), 7.53 (2H, d, J=7.2 Hz).</p>\n",
       "<p id=\"p-1379\" num=\"1391\">MS: m/z=416 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0761\" level=\"1\">Example 180</heading>\n",
       "<p id=\"p-1380\" num=\"1392\"><chemistry id=\"CHEM-US-00297\" num=\"00297\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00297.TIF\" he=\"43.26mm\" id=\"EMI-C00297\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1381\" num=\"1393\">According to Example 177, compound 180 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1382\" num=\"1394\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.78-3.74 (7H, m), 4.17 (1H, m), 4.49 (1H, d, J=10.8 Hz), 5.79 (1H, d, J=7.2 Hz), 6.32 (1H, d, J=10.8 Hz), 6.79 (1H, d, J=7.2 Hz), 7.28 (8H, m), 7.55 (2H, d, J=7.6 Hz).</p>\n",
       "<p id=\"p-1383\" num=\"1395\">MS: m/z=418 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"p-1384\" num=\"1396\">Using amines which are commercially available or known in the references and halides which are commercially available or known in the references, and according to the method of Example 12, Examples 181 to 187 were synthesized.</p>\n",
       "<heading id=\"h-0762\" level=\"1\">Example 181</heading>\n",
       "<p id=\"p-1385\" num=\"1397\"><chemistry id=\"CHEM-US-00298\" num=\"00298\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00298.TIF\" he=\"50.72mm\" id=\"EMI-C00298\" img-content=\"chem\" img-format=\"tif\" wi=\"44.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1386\" num=\"1398\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0763\" level=\"1\">Example 182</heading>\n",
       "<p id=\"p-1387\" num=\"1399\"><chemistry id=\"CHEM-US-00299\" num=\"00299\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00299.TIF\" he=\"48.94mm\" id=\"EMI-C00299\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1388\" num=\"1400\">MS: m/z=459 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0764\" level=\"1\">Example 183</heading>\n",
       "<p id=\"p-1389\" num=\"1401\"><chemistry id=\"CHEM-US-00300\" num=\"00300\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00300.TIF\" he=\"50.72mm\" id=\"EMI-C00300\" img-content=\"chem\" img-format=\"tif\" wi=\"64.43mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1390\" num=\"1402\">MS: m/z=529 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0765\" level=\"1\">Example 184</heading>\n",
       "<p id=\"p-1391\" num=\"1403\"><chemistry id=\"CHEM-US-00301\" num=\"00301\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00301.TIF\" he=\"50.72mm\" id=\"EMI-C00301\" img-content=\"chem\" img-format=\"tif\" wi=\"54.02mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1392\" num=\"1404\">MS: m/z=477 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0766\" level=\"1\">Example 185</heading>\n",
       "<p id=\"p-1393\" num=\"1405\"><chemistry id=\"CHEM-US-00302\" num=\"00302\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00302.TIF\" he=\"50.72mm\" id=\"EMI-C00302\" img-content=\"chem\" img-format=\"tif\" wi=\"44.87mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1394\" num=\"1406\">MS: m/z=473 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0767\" level=\"1\">Example 186</heading>\n",
       "<p id=\"p-1395\" num=\"1407\"><chemistry id=\"CHEM-US-00303\" num=\"00303\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00303.TIF\" he=\"50.72mm\" id=\"EMI-C00303\" img-content=\"chem\" img-format=\"tif\" wi=\"44.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1396\" num=\"1408\">MS: m/z=447 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0768\" level=\"1\">Example 187</heading>\n",
       "<p id=\"p-1397\" num=\"1409\"><chemistry id=\"CHEM-US-00304\" num=\"00304\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00304.TIF\" he=\"50.72mm\" id=\"EMI-C00304\" img-content=\"chem\" img-format=\"tif\" wi=\"49.11mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1398\" num=\"1410\">MS: m/z=461 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0769\" level=\"1\">Example 188</heading>\n",
       "<p id=\"p-1399\" num=\"1411\"><chemistry id=\"CHEM-US-00305\" num=\"00305\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00305.TIF\" he=\"50.72mm\" id=\"EMI-C00305\" img-content=\"chem\" img-format=\"tif\" wi=\"46.82mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1400\" num=\"1412\">According to Example 12 and Example 129, compound 188 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1401\" num=\"1413\">MS: m/z=449 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"p-1402\" num=\"1414\">Using amines which are commercially available or known in the references and halides which are commercially available or known in the references, and according to the method of Example 95, Examples 189 to 229 were synthesized.</p>\n",
       "<heading id=\"h-0770\" level=\"1\">Example 189</heading>\n",
       "<p id=\"p-1403\" num=\"1415\"><chemistry id=\"CHEM-US-00306\" num=\"00306\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00306.TIF\" he=\"43.10mm\" id=\"EMI-C00306\" img-content=\"chem\" img-format=\"tif\" wi=\"50.63mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1404\" num=\"1416\">MS: m/z=399 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0771\" level=\"1\">Example 190</heading>\n",
       "<p id=\"p-1405\" num=\"1417\"><chemistry id=\"CHEM-US-00307\" num=\"00307\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00307.TIF\" he=\"41.15mm\" id=\"EMI-C00307\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1406\" num=\"1418\">MS: m/z=488 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0772\" level=\"1\">Example 191</heading>\n",
       "<p id=\"p-1407\" num=\"1419\"><chemistry id=\"CHEM-US-00308\" num=\"00308\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00308.TIF\" he=\"43.18mm\" id=\"EMI-C00308\" img-content=\"chem\" img-format=\"tif\" wi=\"50.63mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1408\" num=\"1420\">MS: m/z=470 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0773\" level=\"1\">Example 192</heading>\n",
       "<p id=\"p-1409\" num=\"1421\"><chemistry id=\"CHEM-US-00309\" num=\"00309\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00309.TIF\" he=\"42.16mm\" id=\"EMI-C00309\" img-content=\"chem\" img-format=\"tif\" wi=\"50.63mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1410\" num=\"1422\">MS: m/z=422 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0774\" level=\"1\">Example 193</heading>\n",
       "<p id=\"p-1411\" num=\"1423\"><chemistry id=\"CHEM-US-00310\" num=\"00310\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00310.TIF\" he=\"42.16mm\" id=\"EMI-C00310\" img-content=\"chem\" img-format=\"tif\" wi=\"50.63mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1412\" num=\"1424\">MS: m/z=422 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0775\" level=\"1\">Example 194</heading>\n",
       "<p id=\"p-1413\" num=\"1425\"><chemistry id=\"CHEM-US-00311\" num=\"00311\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00311.TIF\" he=\"50.63mm\" id=\"EMI-C00311\" img-content=\"chem\" img-format=\"tif\" wi=\"50.63mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1414\" num=\"1426\">MS: m/z=486 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0776\" level=\"1\">Example 195</heading>\n",
       "<p id=\"p-1415\" num=\"1427\"><chemistry id=\"CHEM-US-00312\" num=\"00312\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00312.TIF\" he=\"43.52mm\" id=\"EMI-C00312\" img-content=\"chem\" img-format=\"tif\" wi=\"50.63mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1416\" num=\"1428\">MS: m/z=365 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0777\" level=\"1\">Example 196</heading>\n",
       "<p id=\"p-1417\" num=\"1429\"><chemistry id=\"CHEM-US-00313\" num=\"00313\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00313.TIF\" he=\"42.16mm\" id=\"EMI-C00313\" img-content=\"chem\" img-format=\"tif\" wi=\"39.37mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1418\" num=\"1430\">MS: m/z=418 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0778\" level=\"1\">Example 197</heading>\n",
       "<p id=\"p-1419\" num=\"1431\"><chemistry id=\"CHEM-US-00314\" num=\"00314\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00314.TIF\" he=\"38.61mm\" id=\"EMI-C00314\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1420\" num=\"1432\">MS: m/z=339 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0779\" level=\"1\">Example 198</heading>\n",
       "<p id=\"p-1421\" num=\"1433\"><chemistry id=\"CHEM-US-00315\" num=\"00315\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00315.TIF\" he=\"49.53mm\" id=\"EMI-C00315\" img-content=\"chem\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1422\" num=\"1434\">MS: m/z=344 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0780\" level=\"1\">Example 199</heading>\n",
       "<p id=\"p-1423\" num=\"1435\"><chemistry id=\"CHEM-US-00316\" num=\"00316\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00316.TIF\" he=\"41.91mm\" id=\"EMI-C00316\" img-content=\"chem\" img-format=\"tif\" wi=\"41.57mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1424\" num=\"1436\">MS: m/z=383 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0781\" level=\"1\">Example 200</heading>\n",
       "<p id=\"p-1425\" num=\"1437\"><chemistry id=\"CHEM-US-00317\" num=\"00317\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00317.TIF\" he=\"40.56mm\" id=\"EMI-C00317\" img-content=\"chem\" img-format=\"tif\" wi=\"42.67mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1426\" num=\"1438\">MS: m/z=339 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0782\" level=\"1\">Example 201</heading>\n",
       "<p id=\"p-1427\" num=\"1439\"><chemistry id=\"CHEM-US-00318\" num=\"00318\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00318.TIF\" he=\"41.74mm\" id=\"EMI-C00318\" img-content=\"chem\" img-format=\"tif\" wi=\"40.56mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1428\" num=\"1440\">MS: m/z=440 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0783\" level=\"1\">Example 202</heading>\n",
       "<p id=\"p-1429\" num=\"1441\"><chemistry id=\"CHEM-US-00319\" num=\"00319\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00319.TIF\" he=\"48.51mm\" id=\"EMI-C00319\" img-content=\"chem\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1430\" num=\"1442\">MS: m/z=365 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0784\" level=\"1\">Example 203</heading>\n",
       "<p id=\"p-1431\" num=\"1443\"><chemistry id=\"CHEM-US-00320\" num=\"00320\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00320.TIF\" he=\"48.68mm\" id=\"EMI-C00320\" img-content=\"chem\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1432\" num=\"1444\">MS: m/z=396 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0785\" level=\"1\">Example 204</heading>\n",
       "<p id=\"p-1433\" num=\"1445\"><chemistry id=\"CHEM-US-00321\" num=\"00321\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00321.TIF\" he=\"37.85mm\" id=\"EMI-C00321\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1434\" num=\"1446\">MS: m/z=370 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0786\" level=\"1\">Example 205</heading>\n",
       "<p id=\"p-1435\" num=\"1447\"><chemistry id=\"CHEM-US-00322\" num=\"00322\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00322.TIF\" he=\"46.91mm\" id=\"EMI-C00322\" img-content=\"chem\" img-format=\"tif\" wi=\"40.98mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1436\" num=\"1448\">MS: m/z=390 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0787\" level=\"1\">Example 206</heading>\n",
       "<p id=\"p-1437\" num=\"1449\"><chemistry id=\"CHEM-US-00323\" num=\"00323\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00323.TIF\" he=\"48.94mm\" id=\"EMI-C00323\" img-content=\"chem\" img-format=\"tif\" wi=\"59.77mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1438\" num=\"1450\">MS: m/z=420 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0788\" level=\"1\">Example 207</heading>\n",
       "<p id=\"p-1439\" num=\"1451\"><chemistry id=\"CHEM-US-00324\" num=\"00324\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00324.TIF\" he=\"41.23mm\" id=\"EMI-C00324\" img-content=\"chem\" img-format=\"tif\" wi=\"40.81mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1440\" num=\"1452\">MS: m/z=350 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0789\" level=\"1\">Example 208</heading>\n",
       "<p id=\"p-1441\" num=\"1453\"><chemistry id=\"CHEM-US-00325\" num=\"00325\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00325.TIF\" he=\"49.53mm\" id=\"EMI-C00325\" img-content=\"chem\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1442\" num=\"1454\">MS: m/z=428 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0790\" level=\"1\">Example 209</heading>\n",
       "<p id=\"p-1443\" num=\"1455\"><chemistry id=\"CHEM-US-00326\" num=\"00326\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00326.TIF\" he=\"55.03mm\" id=\"EMI-C00326\" img-content=\"chem\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1444\" num=\"1456\">MS: m/z=386 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0791\" level=\"1\">Example 210</heading>\n",
       "<p id=\"p-1445\" num=\"1457\"><chemistry id=\"CHEM-US-00327\" num=\"00327\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00327.TIF\" he=\"40.72mm\" id=\"EMI-C00327\" img-content=\"chem\" img-format=\"tif\" wi=\"45.04mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1446\" num=\"1458\">MS: m/z=378 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0792\" level=\"1\">Example 211</heading>\n",
       "<p id=\"p-1447\" num=\"1459\"><chemistry id=\"CHEM-US-00328\" num=\"00328\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00328.TIF\" he=\"38.52mm\" id=\"EMI-C00328\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1448\" num=\"1460\">MS: m/z=366 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0793\" level=\"1\">Example 212</heading>\n",
       "<p id=\"p-1449\" num=\"1461\"><chemistry id=\"CHEM-US-00329\" num=\"00329\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00329.TIF\" he=\"47.33mm\" id=\"EMI-C00329\" img-content=\"chem\" img-format=\"tif\" wi=\"45.04mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1450\" num=\"1462\">MS: m/z=362 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0794\" level=\"1\">Example 213</heading>\n",
       "<p id=\"p-1451\" num=\"1463\"><chemistry id=\"CHEM-US-00330\" num=\"00330\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00330.TIF\" he=\"40.22mm\" id=\"EMI-C00330\" img-content=\"chem\" img-format=\"tif\" wi=\"44.03mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1452\" num=\"1464\">MS: m/z=358 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0795\" level=\"1\">Example 214</heading>\n",
       "<p id=\"p-1453\" num=\"1465\"><chemistry id=\"CHEM-US-00331\" num=\"00331\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00331.TIF\" he=\"46.82mm\" id=\"EMI-C00331\" img-content=\"chem\" img-format=\"tif\" wi=\"40.81mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1454\" num=\"1466\">MS: m/z=350 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0796\" level=\"1\">Example 215</heading>\n",
       "<p id=\"p-1455\" num=\"1467\"><chemistry id=\"CHEM-US-00332\" num=\"00332\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00332.TIF\" he=\"38.52mm\" id=\"EMI-C00332\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1456\" num=\"1468\">MS: m/z=350 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0797\" level=\"1\">Example 216</heading>\n",
       "<p id=\"p-1457\" num=\"1469\"><chemistry id=\"CHEM-US-00333\" num=\"00333\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00333.TIF\" he=\"38.52mm\" id=\"EMI-C00333\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1458\" num=\"1470\">MS: m/z=411 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0798\" level=\"1\">Example 217</heading>\n",
       "<p id=\"p-1459\" num=\"1471\"><chemistry id=\"CHEM-US-00334\" num=\"00334\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00334.TIF\" he=\"41.57mm\" id=\"EMI-C00334\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1460\" num=\"1472\">MS: m/z=445 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0799\" level=\"1\">Example 218</heading>\n",
       "<p id=\"p-1461\" num=\"1473\"><chemistry id=\"CHEM-US-00335\" num=\"00335\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00335.TIF\" he=\"38.61mm\" id=\"EMI-C00335\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1462\" num=\"1474\">MS: m/z=366 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0800\" level=\"1\">Example 219</heading>\n",
       "<p id=\"p-1463\" num=\"1475\"><chemistry id=\"CHEM-US-00336\" num=\"00336\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00336.TIF\" he=\"36.75mm\" id=\"EMI-C00336\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1464\" num=\"1476\">MS: m/z=354 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0801\" level=\"1\">Example 220</heading>\n",
       "<p id=\"p-1465\" num=\"1477\"><chemistry id=\"CHEM-US-00337\" num=\"00337\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00337.TIF\" he=\"44.20mm\" id=\"EMI-C00337\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1466\" num=\"1478\">MS: m/z=368 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0802\" level=\"1\">Example 221</heading>\n",
       "<p id=\"p-1467\" num=\"1479\"><chemistry id=\"CHEM-US-00338\" num=\"00338\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00338.TIF\" he=\"37.85mm\" id=\"EMI-C00338\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1468\" num=\"1480\">MS: m/z=314 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0803\" level=\"1\">Example 222</heading>\n",
       "<p id=\"p-1469\" num=\"1481\"><chemistry id=\"CHEM-US-00339\" num=\"00339\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00339.TIF\" he=\"38.61mm\" id=\"EMI-C00339\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1470\" num=\"1482\">MS: m/z=330 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0804\" level=\"1\">Example 223</heading>\n",
       "<p id=\"p-1471\" num=\"1483\"><chemistry id=\"CHEM-US-00340\" num=\"00340\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00340.TIF\" he=\"44.28mm\" id=\"EMI-C00340\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1472\" num=\"1484\">MS: m/z=346 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0805\" level=\"1\">Example 224</heading>\n",
       "<p id=\"p-1473\" num=\"1485\"><chemistry id=\"CHEM-US-00341\" num=\"00341\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00341.TIF\" he=\"48.94mm\" id=\"EMI-C00341\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1474\" num=\"1486\">MS: m/z=418 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0806\" level=\"1\">Example 225</heading>\n",
       "<p id=\"p-1475\" num=\"1487\"><chemistry id=\"CHEM-US-00342\" num=\"00342\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00342.TIF\" he=\"42.50mm\" id=\"EMI-C00342\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1476\" num=\"1488\">MS: m/z=445 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0807\" level=\"1\">Example 226</heading>\n",
       "<p id=\"p-1477\" num=\"1489\"><chemistry id=\"CHEM-US-00343\" num=\"00343\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00343.TIF\" he=\"48.94mm\" id=\"EMI-C00343\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1478\" num=\"1490\">MS: m/z=473 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0808\" level=\"1\">Example 227</heading>\n",
       "<p id=\"p-1479\" num=\"1491\"><chemistry id=\"CHEM-US-00344\" num=\"00344\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00344.TIF\" he=\"49.53mm\" id=\"EMI-C00344\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1480\" num=\"1492\">MS: m/z=444 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0809\" level=\"1\">Example 228</heading>\n",
       "<p id=\"p-1481\" num=\"1493\"><chemistry id=\"CHEM-US-00345\" num=\"00345\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00345.TIF\" he=\"42.50mm\" id=\"EMI-C00345\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1482\" num=\"1494\">MS: m/z=434 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0810\" level=\"1\">Example 229</heading>\n",
       "<p id=\"p-1483\" num=\"1495\"><chemistry id=\"CHEM-US-00346\" num=\"00346\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00346.TIF\" he=\"40.47mm\" id=\"EMI-C00346\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1484\" num=\"1496\">MS: m/z=443 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0811\" level=\"1\">Example 230</heading>\n",
       "<p id=\"p-1485\" num=\"1497\"><chemistry id=\"CHEM-US-00347\" num=\"00347\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00347.TIF\" he=\"54.44mm\" id=\"EMI-C00347\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1486\" num=\"1498\">According to Example 128, compound 230 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1487\" num=\"1499\">MS: m/z=461 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0812\" level=\"1\">Example 231</heading>\n",
       "<p id=\"p-1488\" num=\"1500\"><chemistry id=\"CHEM-US-00348\" num=\"00348\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00348.TIF\" he=\"46.23mm\" id=\"EMI-C00348\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1489\" num=\"1501\">According to Example 129, compound 231 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1490\" num=\"1502\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0813\" level=\"1\">Example 232</heading>\n",
       "<p id=\"p-1491\" num=\"1503\"><chemistry id=\"CHEM-US-00349\" num=\"00349\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00349.TIF\" he=\"48.94mm\" id=\"EMI-C00349\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1492\" num=\"1504\">According to Example 129, compound 232 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1493\" num=\"1505\">MS: m/z=434 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0814\" level=\"1\">Example 233</heading>\n",
       "<p id=\"p-1494\" num=\"1506\"><chemistry id=\"CHEM-US-00350\" num=\"00350\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00350.TIF\" he=\"46.31mm\" id=\"EMI-C00350\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1495\" num=\"1507\">According to Example 130, compound 233 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1496\" num=\"1508\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0815\" level=\"1\">Example 234</heading>\n",
       "<p id=\"p-1497\" num=\"1509\"><chemistry id=\"CHEM-US-00351\" num=\"00351\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00351.TIF\" he=\"48.94mm\" id=\"EMI-C00351\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1498\" num=\"1510\">According to Example 130, compound 234 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1499\" num=\"1511\">MS: m/z=447 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0816\" level=\"1\">Example 235</heading>\n",
       "<p id=\"p-1500\" num=\"1512\"><chemistry id=\"CHEM-US-00352\" num=\"00352\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00352.TIF\" he=\"48.94mm\" id=\"EMI-C00352\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1501\" num=\"1513\">According to Example 130, compound 235 was synthesized by the same procedure</p>\n",
       "<p id=\"p-1502\" num=\"1514\">MS: m/z=473 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0817\" level=\"1\">Example 236</heading>\n",
       "<p id=\"p-1503\" num=\"1515\"><chemistry id=\"CHEM-US-00353\" num=\"00353\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00353.TIF\" he=\"48.94mm\" id=\"EMI-C00353\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1504\" num=\"1516\">According to Example 130, compound 236 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1505\" num=\"1517\">MS: m/z=447 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0818\" level=\"1\">Example 237</heading>\n",
       "<p id=\"p-1506\" num=\"1518\"><chemistry id=\"CHEM-US-00354\" num=\"00354\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00354.TIF\" he=\"54.78mm\" id=\"EMI-C00354\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1507\" num=\"1519\">According to Example 130, compound 237 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1508\" num=\"1520\">MS: m/z=487 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0819\" level=\"1\">Example 238</heading>\n",
       "<p id=\"p-1509\" num=\"1521\"><chemistry id=\"CHEM-US-00355\" num=\"00355\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00355.TIF\" he=\"57.40mm\" id=\"EMI-C00355\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1510\" num=\"1522\">According to Example 130, compound 238 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1511\" num=\"1523\">MS: m/z=509 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0820\" level=\"1\">Example 239</heading>\n",
       "<p id=\"p-1512\" num=\"1524\"><chemistry id=\"CHEM-US-00356\" num=\"00356\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00356.TIF\" he=\"38.52mm\" id=\"EMI-C00356\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1513\" num=\"1525\">MS: m/z=376 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-1514\" num=\"1526\">According to Example 157, compound 239 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1515\" num=\"1527\">Using amines which are commercially available or known in the references and alcohols which are commercially available or known in the references, and according to the method of Example 107, Examples 240 to 245 were synthesized.</p>\n",
       "<heading id=\"h-0821\" level=\"1\">Example 240</heading>\n",
       "<p id=\"p-1516\" num=\"1528\"><chemistry id=\"CHEM-US-00357\" num=\"00357\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00357.TIF\" he=\"38.61mm\" id=\"EMI-C00357\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1517\" num=\"1529\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.05 (3H, d, J=6.9 Hz), 1.04-1.14 (4H, m), 4.49 (1H, d, J=13.2 Hz), 4.83 (1H, d, J=13.2 Hz), 4.91-4.99 (1H, m), 5.73 (1H, d, J=7.8 Hz), 6.50 (1H, s), 6.70 (1H, d, J=7.8 Hz), 7.12-7.30 (4H, m), 7.33-7.43 (2H, m), 7.46-7.54 (1H, m), 8.06 (1H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-0822\" level=\"1\">Example 241</heading>\n",
       "<p id=\"p-1518\" num=\"1530\"><chemistry id=\"CHEM-US-00358\" num=\"00358\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00358.TIF\" he=\"37.85mm\" id=\"EMI-C00358\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1519\" num=\"1531\">MS: m/z=478 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0823\" level=\"1\">Example 242</heading>\n",
       "<p id=\"p-1520\" num=\"1532\"><chemistry id=\"CHEM-US-00359\" num=\"00359\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00359.TIF\" he=\"37.85mm\" id=\"EMI-C00359\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1521\" num=\"1533\">MS: m/z=478 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0824\" level=\"1\">Example 243</heading>\n",
       "<p id=\"p-1522\" num=\"1534\"><chemistry id=\"CHEM-US-00360\" num=\"00360\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00360.TIF\" he=\"37.85mm\" id=\"EMI-C00360\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1523\" num=\"1535\">MS: m/z=478 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0825\" level=\"1\">Example 244</heading>\n",
       "<p id=\"p-1524\" num=\"1536\"><chemistry id=\"CHEM-US-00361\" num=\"00361\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00361.TIF\" he=\"36.75mm\" id=\"EMI-C00361\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1525\" num=\"1537\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.14 (6H, d, J=6.9 Hz), 4.59 (1H, d, J=12.6 Hz), 4.77 (1H, d, J=12.6 Hz), 4.81-4.91 (1H, m), 5.82 (1H, d, J=7.5 Hz), 5.82 (1H, s), 6.71 (1H, brs), 6.78 (1H, brs), 6.87 (1H, d, J=7.5 Hz), 7.05 (1H, brs), 7.16 (1H, brs), 7.25 (1H, brs), 7.41 (1H, brs).</p>\n",
       "<heading id=\"h-0826\" level=\"1\">Example 245</heading>\n",
       "<p id=\"p-1526\" num=\"1538\"><chemistry id=\"CHEM-US-00362\" num=\"00362\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00362.TIF\" he=\"44.53mm\" id=\"EMI-C00362\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1527\" num=\"1539\">MS: m/z=490 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0827\" level=\"1\">Example 246</heading>\n",
       "<p id=\"p-1528\" num=\"1540\"><chemistry id=\"CHEM-US-00363\" num=\"00363\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00363.TIF\" he=\"246.55mm\" id=\"EMI-C00363\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0828\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1529\" num=\"1541\">To a dimethylformamide (20 ml) solution of compound 246A (5.30 g, 18.76 mmol) and potassium carbonate (5.19 g, 27.53 mmol) was added benzyl bromide (3.21 g, 18.76 mmol), and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added ethyl acetate (80 ml), insolubles were filtered off, and 1N hydrochloric acid was added. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate two times. The combined organic layers were washed with water once and, further, washed with sodium bicarbonate water once, and with an aqueous saturated sodium chloride solution once. The resulting solution was dried with sodium sulfate, and the solvent was distilled off to obtain 6.98 g of compound 246B as an oil.</p>\n",
       "<p id=\"p-1530\" num=\"1542\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 5.36 (2H, s), 7.35-7.47 (6H, m), 7.78 (1H, d, J=8.4 Hz), 8.01 (1H, d, J=2.1 Hz).</p>\n",
       "<heading id=\"h-0829\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1531\" num=\"1543\">To a dimethylformamide (15 ml) solution of compound 246B (3 g, 8.05 mmol) and 1-chloro-3-ethynylbenzene (1.32 g, 9.66 mmol) and triethylamine (4.07 g, 40.25 mmol) were added copper chloride (76.6 mg, 0.403 mmol) and dichlorobis(triphenylphosphine)palladium (282.5 mg, 0.403 mmol) under nitrogen atmosphere, and the mixture was stirred at room temperature for 5 hours. The reaction solution was diluted with water, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water three times, and dried with sodium sulfate, then the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The material were eluted firstly with hexane and, then, with hexane-ethyl acetate (7:3, v/v). Concentration of an objective fraction afforded 3.10 g of compound 246C as an oil.</p>\n",
       "<p id=\"p-1532\" num=\"1544\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 5.39 (2H, s), 7.21-7.46 (9H, m), 7.62 (1H, d, J=2.1 Hz), 7.98 (1H, d, J=8.4 Hz).</p>\n",
       "<heading id=\"h-0830\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1533\" num=\"1545\">To a methanol (30 ml) solution of compound 246C (3.10 g, 8.05 mmol) was added 10% palladium carbon (620 mg, 20 wt %), and the mixture was stirred at room temperature under 1 atm hydrogen atmosphere. The reaction solution was filtered with celite, the solvent was distilled off, to the resulting crude product were added ethyl acetate-diisopropyl ether, and the precipitated residue was filtered to obtain 618 mg of compound 246D as a solid.</p>\n",
       "<p id=\"p-1534\" num=\"1546\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.90 (2H, dd, J=7.8 Hz, 10.8 Hz), 3.29 (2H, dd, J=7.5 Hz, 10.5 Hz), 7.06-7.09 (1H, m), 7.18-7.25 (4H, m), 7.31 (1H, dd, J=2.1 Hz, 8.7 Hz), 8.05 (1H, d, J=8.4 Hz).</p>\n",
       "<heading id=\"h-0831\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1535\" num=\"1547\">To compound 246D (2.20 g, 7.45 mmol) was added polyphosphoric acid (20 g), and the mixture was stirred at 200° C. for 1 hour. After cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with saturated sodium bicarbonate water, and dried with sodium sulfate and, thereafter, the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with hexane and, then, with hexane-ethyl acetate (7:3, v/v). Concentration of an objective fraction afforded 1.05 g of compound 246E as an oil.</p>\n",
       "<p id=\"p-1536\" num=\"1548\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.17 (4H, s), 7.24 (2H, d, J=2.1 Hz), 7.32 (2H, dd, J=2.1 Hz, 8.4 Hz, 8.00 (2H, d, J=8.4 Hz).</p>\n",
       "<heading id=\"h-0832\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1537\" num=\"1549\">A methanol (10 ml) suspension of sodium borohydride (409 mg, 10.82 mmol) was cooled to 1 to 3° C., and compound 246E (1.0 g, 3.61 mmol) was added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, water was added. The precipitated solid was filtered to obtain 968 mg of compound 246F.</p>\n",
       "<p id=\"p-1538\" num=\"1550\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.25 (1H, d, J=3.0 Hz), 3.05-3.16 (2H, m), 3.27-3.38 (2H, m), 5.95 (1H, d, J=3.0 Hz), 7.14-7.17 (4H, m), 7.39 (2H, d, J=8.1 Hz).</p>\n",
       "<heading id=\"h-0833\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-1539\" num=\"1551\">According to Example 107, compound 246 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1540\" num=\"1552\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.14 (3H, d, J=6.9 Hz), 1.20 (3H, d, J=6.9 Hz), 2.79 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.4 Hz), 2.99-3.11 (1H, m), 3.50 (1H, ddd, J=4.8 Hz, 4.8 Hz), 17.7 Hz), 4.21-4.33 (1H, m), 4.23 (1H, d, J=12.9 Hz), 4.62-4.74 (2H, m), 5.04 (1H, s), 5.84 (1H, d, J=7.8 Hz), 6.57 (1H, d, J=8.1 Hz), 6.65-6.72 (2H, m), 6.89-6.92 (1H, m), 7.11-7.30 (4H, m).</p>\n",
       "<p id=\"p-1541\" num=\"1553\">Using amines which are commercially available or known in the references and intermediates corresponding to compound 246A to compound 246F which are commercially available or known in the references, and according to the method of Example 246, compounds 247 to 284 were synthesized.</p>\n",
       "<heading id=\"h-0834\" level=\"1\">Example 247</heading>\n",
       "<p id=\"p-1542\" num=\"1554\"><chemistry id=\"CHEM-US-00364\" num=\"00364\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00364.TIF\" he=\"42.50mm\" id=\"EMI-C00364\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1543\" num=\"1555\">MS: m/z=457 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0835\" level=\"1\">Example 248</heading>\n",
       "<p id=\"p-1544\" num=\"1556\"><chemistry id=\"CHEM-US-00365\" num=\"00365\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00365.TIF\" he=\"41.91mm\" id=\"EMI-C00365\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1545\" num=\"1557\">MS: m/z=485 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0836\" level=\"1\">Example 249</heading>\n",
       "<p id=\"p-1546\" num=\"1558\"><chemistry id=\"CHEM-US-00366\" num=\"00366\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00366.TIF\" he=\"47.41mm\" id=\"EMI-C00366\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1547\" num=\"1559\">MS: m/z=471 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0837\" level=\"1\">Example 250</heading>\n",
       "<p id=\"p-1548\" num=\"1560\"><chemistry id=\"CHEM-US-00367\" num=\"00367\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00367.TIF\" he=\"41.49mm\" id=\"EMI-C00367\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1549\" num=\"1561\">MS: m/z=457 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0838\" level=\"1\">Example 251</heading>\n",
       "<p id=\"p-1550\" num=\"1562\"><chemistry id=\"CHEM-US-00368\" num=\"00368\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00368.TIF\" he=\"39.88mm\" id=\"EMI-C00368\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1551\" num=\"1563\">MS: m/z=521 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0839\" level=\"1\">Example 252</heading>\n",
       "<p id=\"p-1552\" num=\"1564\"><chemistry id=\"CHEM-US-00369\" num=\"00369\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00369.TIF\" he=\"42.59mm\" id=\"EMI-C00369\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1553\" num=\"1565\">MS: m/z=485 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0840\" level=\"1\">Example 253</heading>\n",
       "<p id=\"p-1554\" num=\"1566\"><chemistry id=\"CHEM-US-00370\" num=\"00370\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00370.TIF\" he=\"43.60mm\" id=\"EMI-C00370\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1555\" num=\"1567\">MS: m/z=471 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0841\" level=\"1\">Example 254</heading>\n",
       "<p id=\"p-1556\" num=\"1568\"><chemistry id=\"CHEM-US-00371\" num=\"00371\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00371.TIF\" he=\"42.59mm\" id=\"EMI-C00371\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1557\" num=\"1569\">MS: m/z=487 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0842\" level=\"1\">Example 255</heading>\n",
       "<p id=\"p-1558\" num=\"1570\"><chemistry id=\"CHEM-US-00372\" num=\"00372\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00372.TIF\" he=\"41.57mm\" id=\"EMI-C00372\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1559\" num=\"1571\">MS: m/z=469 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0843\" level=\"1\">Example 256</heading>\n",
       "<p id=\"p-1560\" num=\"1572\"><chemistry id=\"CHEM-US-00373\" num=\"00373\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00373.TIF\" he=\"41.57mm\" id=\"EMI-C00373\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1561\" num=\"1573\">MS: m/z=470 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0844\" level=\"1\">Example 257</heading>\n",
       "<p id=\"p-1562\" num=\"1574\"><chemistry id=\"CHEM-US-00374\" num=\"00374\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00374.TIF\" he=\"41.57mm\" id=\"EMI-C00374\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1563\" num=\"1575\">MS: m/z=434 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0845\" level=\"1\">Example 258</heading>\n",
       "<p id=\"p-1564\" num=\"1576\"><chemistry id=\"CHEM-US-00375\" num=\"00375\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00375.TIF\" he=\"41.57mm\" id=\"EMI-C00375\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1565\" num=\"1577\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.88 (3H, m), 3.43 (2H, m), 3.69 (1H, dt, J=16.9, 5.1 Hz), 4.01 (1H, d, J=13.4 Hz), 4.07-4.17 (2H, m), 4.97 (1H, d, J=13.4 Hz), 5.24 (1H, s), 5.50 (1H, d, J=7.6 Hz), 6.73 (1H, d, J=7.2 Hz), 6.85-6.94 (2H, m), 7.14-7.41 (6H, m), 11.73 (1H, s).</p>\n",
       "<p id=\"p-1566\" num=\"1578\">MS: m/z=432 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0846\" level=\"1\">Example 259</heading>\n",
       "<p id=\"p-1567\" num=\"1579\"><chemistry id=\"CHEM-US-00376\" num=\"00376\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00376.TIF\" he=\"38.86mm\" id=\"EMI-C00376\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1568\" num=\"1580\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.80 (1H, td, J=9.6, 4.5 Hz), 2.86-2.99 (1H, m), 3.00-3.18 (1H, m), 3.67 (1H, dt, J=17.1, 5.0 Hz), 4.03-4.19 (2H, m), 4.32-4.52 (1H, m), 5.05 (1H, d, J=13.3 Hz), 5.26 (1H, s), 5.53 (1H, d, J=7.6 Hz), 6.17 (1H, tt, J=55.0, 3.5 Hz), 6.72 (1H, d, J=7.5 Hz), 6.87-6.94 (2H, m), 7.12-7.27 (3H, m), 7.30-7.43 (3H, m).</p>\n",
       "<p id=\"p-1569\" num=\"1581\">MS: m/z=438 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0847\" level=\"1\">Example 260</heading>\n",
       "<p id=\"p-1570\" num=\"1582\"><chemistry id=\"CHEM-US-00377\" num=\"00377\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00377.TIF\" he=\"43.60mm\" id=\"EMI-C00377\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1571\" num=\"1583\">MS: m/z=460 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0848\" level=\"1\">Example 261</heading>\n",
       "<p id=\"p-1572\" num=\"1584\"><chemistry id=\"CHEM-US-00378\" num=\"00378\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00378.TIF\" he=\"41.57mm\" id=\"EMI-C00378\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1573\" num=\"1585\">MS: m/z=474 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0849\" level=\"1\">Example 262</heading>\n",
       "<p id=\"p-1574\" num=\"1586\"><chemistry id=\"CHEM-US-00379\" num=\"00379\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00379.TIF\" he=\"38.86mm\" id=\"EMI-C00379\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1575\" num=\"1587\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.80 (1H, dt, J=14.2, 5.1 Hz), 2.86-2.99 (1H, m), 3.00-3.18 (1H, m), 3.68 (1H, dt, J=16.9, 5.3 Hz), 4.05 (1H, d, J=13.3 Hz), 4.07-4.32 (2H, m), 4.37-4.52 (1H, m), 4.53-4.67 (1H, m), 5.02 (1H, d, J=13.0 Hz), 5.26 (1H, s), 5.50 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.6 Hz), 6.85-6.94 (2H, m), 7.12-7.27 (3H, m), 7.30-7.43 (3H, m).</p>\n",
       "<p id=\"p-1576\" num=\"1588\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0850\" level=\"1\">Example 263</heading>\n",
       "<p id=\"p-1577\" num=\"1589\"><chemistry id=\"CHEM-US-00380\" num=\"00380\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00380.TIF\" he=\"38.86mm\" id=\"EMI-C00380\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1578\" num=\"1590\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.76-3.00 (2H, m), 3.46-3.73 (2H, m), 4.06-4.22 (2H, m), 4.77-4.91 (1H, m), 5.15 (1H, d, J=12.9 Hz), 5.24 (1H, s), 5.56 (1H, d, J=7.7 Hz), 6.72 (1H, d, J=7.1 Hz), 6.88-6.95 (1H, m), 6.96 (1H, d, J=7.7 Hz), 7.09-7.41 (7H, m).</p>\n",
       "<p id=\"p-1579\" num=\"1591\">MS: m/z=456 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0851\" level=\"1\">Example 264</heading>\n",
       "<p id=\"p-1580\" num=\"1592\"><chemistry id=\"CHEM-US-00381\" num=\"00381\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00381.TIF\" he=\"41.57mm\" id=\"EMI-C00381\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1581\" num=\"1593\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.74-2.99 (2H, m), 3.62-3.73 (1H, m), 4.01-4.20 (3H, m), 5.12 (1H, d, J=13.2 Hz), 5.15 (1H, d, J=15.7 Hz), 5.34 (1H, s), 5.52 (1H, d, J=7.7 Hz), 6.78 (1H, d, J=8.0 Hz), 6.89-6.96 (2H, m), 7.10-7.23 (5H, m), 7.27-7.35 (3H, m), 7.43 (1H, d, J=7.7 Hz), 7.79 (1H, td, J=7.6, 1.8 Hz), 8.45-8.50 (1H, m).</p>\n",
       "<p id=\"p-1582\" num=\"1594\">MS: m/z=465 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0852\" level=\"1\">Example 265</heading>\n",
       "<p id=\"p-1583\" num=\"1595\"><chemistry id=\"CHEM-US-00382\" num=\"00382\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00382.TIF\" he=\"38.86mm\" id=\"EMI-C00382\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1584\" num=\"1596\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.32 (9H, s), 2.76-2.86 (1H, m), 2.87-3.01 (1H, m), 3.59-3.70 (1H, m), 4.12-4.25 (1H, m), 4.29 (1H, d, J=13.5 Hz), 4.90 (1H, d, J=13.2 Hz), 5.20 (1H, s), 5.49 (1H, d, J=7.4 Hz), 6.75 (1H, d, J=8.0 Hz), 6.81 (1H, d, J=7.4 Hz), 6.91 (1H, t, J=6.6 Hz), 7.12-7.21 (2H, m), 7.22-7.30 (1H, m), 7.33-7.38 (2H, m), 7.46 (1H, d, J=7.4 Hz).</p>\n",
       "<p id=\"p-1585\" num=\"1597\">MS: m/z=430 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0853\" level=\"1\">Example 266</heading>\n",
       "<p id=\"p-1586\" num=\"1598\"><chemistry id=\"CHEM-US-00383\" num=\"00383\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00383.TIF\" he=\"38.86mm\" id=\"EMI-C00383\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1587\" num=\"1599\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.05 (3H, t, J=7.2 Hz), 2.80 (1H, dt, J=14.4, 5.1 Hz), 2.85-2.99 (2H, m), 3.68 (1H, dt, J=16.8, 5.0 Hz), 3.74-3.87 (1H, m), 4.02 (1H, d, J=13.3 Hz), 4.06-4.19 (1H, m), 4.98 (1H, d, J=13.1 Hz), 5.22 (1H, s), 5.48 (1H, d, J=7.6 Hz), 6.73 (1H, d, J=7.5 Hz), 6.83-6.94 (2H, m), 7.12-7.40 (6H, m).</p>\n",
       "<p id=\"p-1588\" num=\"1600\">MS: m/z=402 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0854\" level=\"1\">Example 267</heading>\n",
       "<p id=\"p-1589\" num=\"1601\"><chemistry id=\"CHEM-US-00384\" num=\"00384\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00384.TIF\" he=\"41.57mm\" id=\"EMI-C00384\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1590\" num=\"1602\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.74-1.86 (2H, m), 2.71-2.82 (1H, m), 2.83-2.93 (1H, m), 2.98-3.11 (1H, m), 3.25 (3H, s), 3.39 (2H, t, J=5.4 Hz), 3.62-3.74 (1H, m), 4.02-4.14 (2H, m), 4.16-4.28 (1H, m), 4.82 (1H, d, J=13.2 Hz), 5.03 (1H, s), 5.76 (1H, d, J=7.7 Hz), 6.58 (1H, d, J=7.7 Hz), 6.64 (1H, d, J=7.4 Hz), 6.89-6.97 (1H, m), 7.12-7.39 (6H, m).</p>\n",
       "<p id=\"p-1591\" num=\"1603\">MS: m/z=446 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0855\" level=\"1\">Example 268</heading>\n",
       "<p id=\"p-1592\" num=\"1604\"><chemistry id=\"CHEM-US-00385\" num=\"00385\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00385.TIF\" he=\"41.57mm\" id=\"EMI-C00385\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1593\" num=\"1605\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.09 (3H, t, J=7.0 Hz), 2.65-2.77 (1H, m), 2.83-2.94 (1H, m), 2.97-3.10 (1H, m), 3.40 (2H, q, J=7.0 Hz), 3.45-3.52 (1H, m), 3.55-3.64 (1H, m), 3.65-3.76 (1H, m), 4.00-4.15 (2H, m), 4.36-4.45 (1H, m), 4.90 (1H, d, J=13.5 Hz), 5.02 (1H, s), 5.79 (1H, d, J=7.7 Hz), 6.59 (1H, d, J=7.7 Hz), 6.63 (1H, d, J=7.4 Hz), 6.90-6.97 (1H, m), 7.13-7.39 (6H, m).</p>\n",
       "<p id=\"p-1594\" num=\"1606\">MS: m/z=446 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0856\" level=\"1\">Example 269</heading>\n",
       "<p id=\"p-1595\" num=\"1607\"><chemistry id=\"CHEM-US-00386\" num=\"00386\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00386.TIF\" he=\"41.57mm\" id=\"EMI-C00386\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1596\" num=\"1608\">MS: m/z=480 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0857\" level=\"1\">Example 270</heading>\n",
       "<p id=\"p-1597\" num=\"1609\"><chemistry id=\"CHEM-US-00387\" num=\"00387\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00387.TIF\" he=\"41.57mm\" id=\"EMI-C00387\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1598\" num=\"1610\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.33 (3H, s), 2.85 (2H, m), 3.68 (1H, m), 4.16 (1H, m), 4.29 (1H, d, J=13.3 Hz), 4.45 (1H, d, J=17.1 Hz), 5.12 (1H, d, J=13.1 Hz), 5.26 (1H, d, J=17.4 Hz), 5.36 (1H, s), 5.55 (1H, d, J=7.6 Hz), 6.74 (1H, d, J=7.6 Hz), 6.89-7.38 (8H, m).</p>\n",
       "<p id=\"p-1599\" num=\"1611\">MS: m/z=470 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0858\" level=\"1\">Example 271</heading>\n",
       "<p id=\"p-1600\" num=\"1612\"><chemistry id=\"CHEM-US-00388\" num=\"00388\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00388.TIF\" he=\"41.57mm\" id=\"EMI-C00388\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1601\" num=\"1613\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.87 (2H, m), 3.61-3.69 (1H, m), 4.15 (1H, m), 4.18 (1H, d, J=13.2 Hz), 4.51 (1H, d, J=15.9 Hz), 5.08 (1H, d, J=13.1 Hz), 5.21 (1H, s), 5.22 (1H, d, J=15.6 Hz), 5.52 (1H, d, J=7.6 Hz), 6.72 (1H, d, J=7.5 Hz), 6.89-7.32 (8H, m), 7.76 (2H, s).</p>\n",
       "<p id=\"p-1602\" num=\"1614\">MS: m/z=471 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0859\" level=\"1\">Example 272</heading>\n",
       "<p id=\"p-1603\" num=\"1615\"><chemistry id=\"CHEM-US-00389\" num=\"00389\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00389.TIF\" he=\"49.19mm\" id=\"EMI-C00389\" img-content=\"chem\" img-format=\"tif\" wi=\"45.21mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1604\" num=\"1616\">MS: m/z=476 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0860\" level=\"1\">Example 273</heading>\n",
       "<p id=\"p-1605\" num=\"1617\"><chemistry id=\"CHEM-US-00390\" num=\"00390\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00390.TIF\" he=\"38.86mm\" id=\"EMI-C00390\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1606\" num=\"1618\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.84-2.93 (1H, m), 2.98 (3H, s), 2.98-3.09 (1H, m), 3.66-3.75 (1H, m), 3.99-4.15 (1H, m), 4.06 (1H, d, J=12.9 Hz), 4.80 (1H, d, J=13.2 Hz), 5.03 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.56 (1H, d, J=7.5 Hz), 6.63 (1H, d, J=6.6 Hz), 6.90-6.96 (1H, m), 7.14-7.37 (6H, m).</p>\n",
       "<heading id=\"h-0861\" level=\"1\">Example 274</heading>\n",
       "<p id=\"p-1607\" num=\"1619\"><chemistry id=\"CHEM-US-00391\" num=\"00391\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00391.TIF\" he=\"41.49mm\" id=\"EMI-C00391\" img-content=\"chem\" img-format=\"tif\" wi=\"40.98mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1608\" num=\"1620\">MS: m/z=470 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0862\" level=\"1\">Example 275</heading>\n",
       "<p id=\"p-1609\" num=\"1621\"><chemistry id=\"CHEM-US-00392\" num=\"00392\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00392.TIF\" he=\"38.86mm\" id=\"EMI-C00392\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1610\" num=\"1622\">MS: m/z=470 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0863\" level=\"1\">Example 276</heading>\n",
       "<p id=\"p-1611\" num=\"1623\"><chemistry id=\"CHEM-US-00393\" num=\"00393\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00393.TIF\" he=\"41.49mm\" id=\"EMI-C00393\" img-content=\"chem\" img-format=\"tif\" wi=\"50.12mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1612\" num=\"1624\">MS: m/z=460 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0864\" level=\"1\">Example 277</heading>\n",
       "<p id=\"p-1613\" num=\"1625\"><chemistry id=\"CHEM-US-00394\" num=\"00394\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00394.TIF\" he=\"41.49mm\" id=\"EMI-C00394\" img-content=\"chem\" img-format=\"tif\" wi=\"50.80mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1614\" num=\"1626\">MS: m/z=486 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0865\" level=\"1\">Example 278</heading>\n",
       "<p id=\"p-1615\" num=\"1627\"><chemistry id=\"CHEM-US-00395\" num=\"00395\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00395.TIF\" he=\"41.83mm\" id=\"EMI-C00395\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1616\" num=\"1628\">MS: m/z=446 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0866\" level=\"1\">Example 279</heading>\n",
       "<p id=\"p-1617\" num=\"1629\"><chemistry id=\"CHEM-US-00396\" num=\"00396\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00396.TIF\" he=\"41.49mm\" id=\"EMI-C00396\" img-content=\"chem\" img-format=\"tif\" wi=\"40.22mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1618\" num=\"1630\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.08-1.21 (6H, m), 2.84 (1H, ddd, J=4.8</p>\n",
       "<p id=\"p-1619\" num=\"1631\">Hz, 4.8 Hz, 14.4 Hz), 2.97-3.08 (1H, m), 3.54 (1H, ddd, J=4.8 Hz, 6.6 Hz, 17.1 Hz), 4.09-4.26 (1H, m), 4.24 (1H, d, J=13.2 Hz), 4.64-4.74 (m, 1H), 4.70 (1H, d, J=13.2 Hz), 4.94 (1H, s), 5.81 (1H, d, J=7.8 Hz), 6.42 (1H, dd, J=2.7 Hz, 9.0 Hz), 6.67 (1H, d, J=7.8 Hz), 6.89-7.12 (4H, m), 7.19-7.36 (1H, m).</p>\n",
       "<heading id=\"h-0867\" level=\"1\">Example 280</heading>\n",
       "<p id=\"p-1620\" num=\"1632\"><chemistry id=\"CHEM-US-00397\" num=\"00397\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00397.TIF\" he=\"38.86mm\" id=\"EMI-C00397\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1621\" num=\"1633\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.15 (3H, d, J=6.9 Hz), 1.20 (3H, d, J=6.9 Hz), 2.84 (1H, ddd, J=4.8 Hz, 5.1 Hz, 14.4 Hz), 2.96-3.07 (1H, m), 3.55 (1H, ddd, J=4.8 Hz, 5.1 Hz, 17.4 Hz), 4.11-4.23 (1H, m), 4.21 (1H, d, J=12.9 Hz), 4.65-4.74 (1H, m), 4.70 (1H, d, J=12.9 Hz), 4.95 (1H, s), 5.78 (1H, d, J=7.8 Hz), 6.63 (1H, d, J=7.8 Hz), 6.69 (1H, d, J=2.1 Hz), 7.06 (1H, d, J=8.4 Hz), 7.18 (1H, dd, J=2.1 Hz, 8.4 Hz), 7.23-7.26 (2H, m), 7.24 (1H, dd, J=2.1 Hz, 8.1 Hz).</p>\n",
       "<heading id=\"h-0868\" level=\"1\">Example 281</heading>\n",
       "<p id=\"p-1622\" num=\"1634\"><chemistry id=\"CHEM-US-00398\" num=\"00398\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00398.TIF\" he=\"44.96mm\" id=\"EMI-C00398\" img-content=\"chem\" img-format=\"tif\" wi=\"36.66mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1623\" num=\"1635\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.13 (3H, d, J=6.6 Hz), 1.20 (3H, d, J=6.9 Hz), 2.90-3.32 (1H, m), 3.36 (1H, ddd, J=4.5 Hz, 4.5 Hz, 9.6 Hz), 3.42-3.51 (1H, m), 3.95-4.02 (1H, m), 4.28 (1H, d, J=12.9 Hz), 4.64-4.75 (1H, m), 1.89 (1H, d, J=12.9 Hz), 5.15 (1H, s), 5.80 (1H, d, J=7.5 Hz), 6.46-6.49 (1H, m), 6.70 (1H, d, J=7.8 Hz), 6.88-7.00 (2H, m), 7.03-7.06 (1H, m), 7.11-7.22 (2H, m).</p>\n",
       "<heading id=\"h-0869\" level=\"1\">Example 282</heading>\n",
       "<p id=\"p-1624\" num=\"1636\"><chemistry id=\"CHEM-US-00399\" num=\"00399\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00399.TIF\" he=\"45.04mm\" id=\"EMI-C00399\" img-content=\"chem\" img-format=\"tif\" wi=\"36.66mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1625\" num=\"1637\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.09-1.19 (6H, m), 2.80-3.10 (2H, m), 3.40-3.60 (1H, m), 4.16-4.41 (2H, m), 4.61-4.47 (2H, m), 5.06-5.10 (1H, m), 5.71 (0.45H, d, J=7.5 Hz), 5.74 (0.55H, d, J=7.8 Hz), 6.60-6.72 (2H, m), 6.86-6.94 (1H, m), 7.10-7.46 (6H, m).</p>\n",
       "<heading id=\"h-0870\" level=\"1\">Example 283</heading>\n",
       "<p id=\"p-1626\" num=\"1638\"><chemistry id=\"CHEM-US-00400\" num=\"00400\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00400.TIF\" he=\"41.49mm\" id=\"EMI-C00400\" img-content=\"chem\" img-format=\"tif\" wi=\"43.52mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1627\" num=\"1639\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.10-1.21 (6H, m), 2.75-2, 86 (1H, m), 2.99-3.14 (1H, m), 4.23-4.37 (2H, m), 4.59-4.74 (2H, m), 5.04 (1H, s), 5.67-5.80 (1H, m), 6.58-6.67 (2H, m), 6.88-7.08 (1H, m), 7.11-7.38 (5H, m).</p>\n",
       "<heading id=\"h-0871\" level=\"1\">Example 284</heading>\n",
       "<p id=\"p-1628\" num=\"1640\"><chemistry id=\"CHEM-US-00401\" num=\"00401\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00401.TIF\" he=\"41.49mm\" id=\"EMI-C00401\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1629\" num=\"1641\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.15 (3H, d, J=6.9 Hz), 1.20 (3H, d, J=6.9 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz, 9.9 Hz), 3.07 (1H, t, J=3.9 Hz, 13.2 Hz, 13.2 Hz), 3.50 (1H, ddd, J=4.2 Hz, 4.2 Hz, 18.0 Hz), 4.24 (1H, 6.9 Hz), 4.34 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.63-4.74 (2H, m), 5.06 (1H, s), 5.81 (1H, d, J=7.8 Hz), 6.57-6.64 (2H, m), 6.65 (1H, d, J=7.5 Hz), 6.82 (1H, d, J=9.3 Hz), 6.90 (1H, ddd, J=2.7 Hz, 8.4 Hz, 8.4 Hz), 7.02 (1H, dd, J=2.7 Hz, 9.0 Hz), 7.19-7.26 (2H, m).</p>\n",
       "<heading id=\"h-0872\" level=\"1\">Example 285</heading>\n",
       "<p id=\"p-1630\" num=\"1642\"><chemistry id=\"CHEM-US-00402\" num=\"00402\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00402.TIF\" he=\"226.74mm\" id=\"EMI-C00402\" img-content=\"chem\" img-format=\"tif\" wi=\"63.84mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00403\" num=\"00403\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00403.TIF\" he=\"81.45mm\" id=\"EMI-C00403\" img-content=\"chem\" img-format=\"tif\" wi=\"63.50mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0873\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1631\" num=\"1643\">Compound 285A (5.00 g, 29.3 mmol) was dissolved in dimethylformamide (150 ml), potassium carbonate (14.2 mmol) and iodoethane (7.11 ml, 88.0 mmol) were added, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added hexane, and the mixture was washed with water and an aqueous saturated sodium chloride solution. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a colorless oily substance 285B.</p>\n",
       "<p id=\"p-1632\" num=\"1644\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.40 (3H, t, J=7.2 Hz), 2.60 (3H, s), 4.37 (2H, q, J=7.1 Hz), 7.17 (1H, td, J=7.9, 0.6 Hz), 7.49 (1H, ddd, J=8.0, 1.4, 0.4 Hz), 7.68 (1H, ddd, J=7.8, 1.4, 0.3 Hz).</p>\n",
       "<heading id=\"h-0874\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1633\" num=\"1645\">Compound 285B (5.63 g, 28.3 mmol) obtained in the first step was dissolved in carbon tetrachloride (150 ml), N-bromosuccinimide (5.55 g, 31.2 mmol) was added, and the mixture was stirred at 100° C. for 18 hours. The reaction solution was cooled to room temperature, and washed with water and an aqueous saturated sodium chloride solution. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 8.08 g of an orange oily substance 285C.</p>\n",
       "<p id=\"p-1634\" num=\"1646\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.43 (3H, t, J=7.6 Hz), 4.42 (2H, q, J=7.1 Hz), 5.10 (2H, s), 7.31 (1H, t, J=8.6 Hz), 7.57 (1H, d, J=8.1 Hz), 7.84 (1H, d, J=8.1 Hz).</p>\n",
       "<heading id=\"h-0875\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1635\" num=\"1647\">Compound 285C (2.17 g, 7.8 mmol) obtained in the second step was dissolved in acetone (25 ml), 4-fluorobenzenethiol (1.00 g, 7.80 mmol) and potassium carbonate (1.62 g, 11.7 mmol) were added, and the mixture was stirred at 80° C. for 18 hours. After cooled to room temperature, the reaction solution was poured into water, the mixture was extracted with ethyl acetate, the extract was washed with an aqueous saturated sodium chloride solution, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography and eluted with n-hexane-ethyl acetate (4:1, v/v) to obtain 2.20 g of a colorless oily substance 285D.</p>\n",
       "<p id=\"p-1636\" num=\"1648\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.35 (3H, t, J=7.2 Hz), 4.25 (2H, d, J=7.5 Hz), 4.65 (2H, s), 6.91 (2H, t, J=8.8 Hz), 7.19-7.31 (3H, m), 7.48 (1H, dd, J=8.2, 1.4 Hz), 7.70 (1H, dd, J=7.6, 1.5 Hz).</p>\n",
       "<heading id=\"h-0876\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1637\" num=\"1649\">Compound 285D (2.20 g, 6.77 mmol) obtained in the third step was dissolved in ethanol (20 ml), a 2N aqueous sodium hydroxide solution (16.9 ml, 33.8 mmol) was added, and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added water, the mixture was made acidic with dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 1.81 g of a white solid 285E.</p>\n",
       "<p id=\"p-1638\" num=\"1650\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.74 (2H, s), 6.95 (2H, t, J=8.8 Hz), 7.34 (3H, m), 7.59 (1H, dd, J=7.9, 1.5 Hz), 7.92 (1H, dd, J=7.9, 1.3 Hz).</p>\n",
       "<heading id=\"h-0877\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-1639\" num=\"1651\">To compound 285E (1.81 g, 6.10 mmol) obtained in the fourth step was added polyphosphoric acid (10.0 g), and the mixture was stirred at 120° C. for 5 hours. After cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried with sodium sulfate, the solvent was concentrated under reduced pressure, to the resulting compound were added n-hexane-ethyl acetate, and the precipitated residue was filtered to obtain 1.18 g of a white solid 285F.</p>\n",
       "<p id=\"p-1640\" num=\"1652\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.28 (2H, s), 7.18 (1H, ddd, J=9.3, 6.6, 2.3 Hz), 7.33 (2H, m), 7.46 (1H, dd, J=7.7, 1.5 Hz), 7.59 (1H, dd, J=7.9, 1.3 Hz), 7.91 (1H, dd, J=10.1, 2.9 Hz).</p>\n",
       "<heading id=\"h-0878\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-1641\" num=\"1653\">To compound 285F (1.17 g, 4.20 mmol) was added methanol (15 ml), sodium borohydride (191 mg, 5.04 mmol) was added at 0° C., and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 945 mg of a white solid 285G.</p>\n",
       "<p id=\"p-1642\" num=\"1654\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.58 (1H, d, J=3.2 Hz), 4.46 (1H, d, J=14.3 Hz), 4.58 (1H, d, J=14.6 Hz), 6.33 (1H, d, J=3.7 Hz), 6.82 (1H, td, J=8.3, 2.9 Hz), 7.07 (1H, dd, J=8.5, 5.4 Hz), 7.20 (1H, t, J=7.9 Hz), 7.33 (2H, m), 7.44 (1H, d, J=6.9 Hz).</p>\n",
       "<heading id=\"h-0879\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-1643\" num=\"1655\">According to the same procedure as that of Example 107, compound 285 was synthesized.</p>\n",
       "<p id=\"p-1644\" num=\"1656\">MS: m/z=486 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-1645\" num=\"1657\">Using amines which are commercially available or known in the references and intermediates corresponding to compound 285A to compound 285G which are commercially available or known in the references. Then according to the method of Example 285, compounds 286 to compound 359 were synthesized.</p>\n",
       "<heading id=\"h-0880\" level=\"1\">Example 286</heading>\n",
       "<p id=\"p-1646\" num=\"1658\"><chemistry id=\"CHEM-US-00404\" num=\"00404\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00404.TIF\" he=\"44.45mm\" id=\"EMI-C00404\" img-content=\"chem\" img-format=\"tif\" wi=\"57.07mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1647\" num=\"1659\">MS: m/z=595 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0881\" level=\"1\">Example 287</heading>\n",
       "<p id=\"p-1648\" num=\"1660\"><chemistry id=\"CHEM-US-00405\" num=\"00405\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00405.TIF\" he=\"43.35mm\" id=\"EMI-C00405\" img-content=\"chem\" img-format=\"tif\" wi=\"44.62mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1649\" num=\"1661\">MS: m/z=475 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0882\" level=\"1\">Example 288</heading>\n",
       "<p id=\"p-1650\" num=\"1662\"><chemistry id=\"CHEM-US-00406\" num=\"00406\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00406.TIF\" he=\"44.37mm\" id=\"EMI-C00406\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1651\" num=\"1663\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.57 (1H, brs), 1.84-1.99 (2H, m), 2.68 (3H, d, J=4.6 Hz), 3.08-3.17 (2H, m), 3.39 (3H, brs), 3.89 (1H, d, J=13.4 Hz), 4.16 (1H, d, J=13.3 Hz), 4.54 (1H, brs), 5.10 (1H, d, J=12.7 Hz), 5.50 (1H, s), 5.63 (1H, d, J=13.4 Hz), 5.73 (1H, d, J=7.8 Hz), 6.82-7.94 (9H, m).</p>\n",
       "<p id=\"p-1652\" num=\"1664\">MS: m/z=489 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0883\" level=\"1\">Example 289</heading>\n",
       "<p id=\"p-1653\" num=\"1665\"><chemistry id=\"CHEM-US-00407\" num=\"00407\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00407.TIF\" he=\"44.45mm\" id=\"EMI-C00407\" img-content=\"chem\" img-format=\"tif\" wi=\"48.34mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1654\" num=\"1666\">MS: m/z=503 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0884\" level=\"1\">Example 290</heading>\n",
       "<p id=\"p-1655\" num=\"1667\"><chemistry id=\"CHEM-US-00408\" num=\"00408\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00408.TIF\" he=\"44.45mm\" id=\"EMI-C00408\" img-content=\"chem\" img-format=\"tif\" wi=\"55.80mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1656\" num=\"1668\">MS: m/z=505 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0885\" level=\"1\">Example 291</heading>\n",
       "<p id=\"p-1657\" num=\"1669\"><chemistry id=\"CHEM-US-00409\" num=\"00409\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00409.TIF\" he=\"50.72mm\" id=\"EMI-C00409\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1658\" num=\"1670\">MS: m/z=517 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0886\" level=\"1\">Example 292</heading>\n",
       "<p id=\"p-1659\" num=\"1671\"><chemistry id=\"CHEM-US-00410\" num=\"00410\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00410.TIF\" he=\"42.33mm\" id=\"EMI-C00410\" img-content=\"chem\" img-format=\"tif\" wi=\"49.95mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1660\" num=\"1672\">MS: m/z=503 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0887\" level=\"1\">Example 293</heading>\n",
       "<p id=\"p-1661\" num=\"1673\"><chemistry id=\"CHEM-US-00411\" num=\"00411\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00411.TIF\" he=\"44.45mm\" id=\"EMI-C00411\" img-content=\"chem\" img-format=\"tif\" wi=\"45.04mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1662\" num=\"1674\">MS: m/z=489 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0888\" level=\"1\">Example 294</heading>\n",
       "<p id=\"p-1663\" num=\"1675\"><chemistry id=\"CHEM-US-00412\" num=\"00412\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00412.TIF\" he=\"39.62mm\" id=\"EMI-C00412\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1664\" num=\"1676\">MS: m/z=456 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0889\" level=\"1\">Example 295</heading>\n",
       "<p id=\"p-1665\" num=\"1677\"><chemistry id=\"CHEM-US-00413\" num=\"00413\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00413.TIF\" he=\"42.33mm\" id=\"EMI-C00413\" img-content=\"chem\" img-format=\"tif\" wi=\"45.04mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1666\" num=\"1678\">MS: m/z=488 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0890\" level=\"1\">Example 296</heading>\n",
       "<p id=\"p-1667\" num=\"1679\"><chemistry id=\"CHEM-US-00414\" num=\"00414\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00414.TIF\" he=\"45.13mm\" id=\"EMI-C00414\" img-content=\"chem\" img-format=\"tif\" wi=\"50.12mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1668\" num=\"1680\">MS: m/z=498 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0891\" level=\"1\">Example 297</heading>\n",
       "<p id=\"p-1669\" num=\"1681\"><chemistry id=\"CHEM-US-00415\" num=\"00415\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00415.TIF\" he=\"42.25mm\" id=\"EMI-C00415\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1670\" num=\"1682\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.21 (1H, m), 3.85 (1H, d, J=13.4 Hz), 4.08-4.18 (3H, m), 4.28 (1H, d, J=13.4 Hz), 5.10 (1H, d, J=13.7 Hz), 5.45 (1H, s), 5.57-5.64 (2H, m), 6.82-7.50 (10H, m).</p>\n",
       "<p id=\"p-1671\" num=\"1683\">MS: m/z=504 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0892\" level=\"1\">Example 298</heading>\n",
       "<p id=\"p-1672\" num=\"1684\"><chemistry id=\"CHEM-US-00416\" num=\"00416\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00416.TIF\" he=\"42.33mm\" id=\"EMI-C00416\" img-content=\"chem\" img-format=\"tif\" wi=\"45.89mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1673\" num=\"1685\">According to Example 107, compound 298 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1674\" num=\"1686\">MS: m/z=452 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0893\" level=\"1\">Example 299</heading>\n",
       "<p id=\"p-1675\" num=\"1687\"><chemistry id=\"CHEM-US-00417\" num=\"00417\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00417.TIF\" he=\"42.33mm\" id=\"EMI-C00417\" img-content=\"chem\" img-format=\"tif\" wi=\"45.21mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1676\" num=\"1688\">MS: m/z=450 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0894\" level=\"1\">Example 300</heading>\n",
       "<p id=\"p-1677\" num=\"1689\"><chemistry id=\"CHEM-US-00418\" num=\"00418\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00418.TIF\" he=\"42.33mm\" id=\"EMI-C00418\" img-content=\"chem\" img-format=\"tif\" wi=\"45.21mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1678\" num=\"1690\">MS: m/z=464 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0895\" level=\"1\">Example 301</heading>\n",
       "<p id=\"p-1679\" num=\"1691\"><chemistry id=\"CHEM-US-00419\" num=\"00419\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00419.TIF\" he=\"42.33mm\" id=\"EMI-C00419\" img-content=\"chem\" img-format=\"tif\" wi=\"36.66mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1680\" num=\"1692\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.00 (3H, d, J=6.9 Hz), 1.06 (3H, d, J=6.9 Hz), 3.88 (1H, d, J=13.4 Hz), 4.32 (1H, d, J=13.3 Hz), 4.67 (1H, m), 4.97 (1H, d, J=13.4 Hz), 5.43 (1H, s), 5.59 (2H, m), 6.84-7.45 (9H, m), 11.90 (1H, brs).</p>\n",
       "<p id=\"p-1681\" num=\"1693\">MS: m/z=434 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0896\" level=\"1\">Example 302</heading>\n",
       "<p id=\"p-1682\" num=\"1694\"><chemistry id=\"CHEM-US-00420\" num=\"00420\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00420.TIF\" he=\"39.62mm\" id=\"EMI-C00420\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1683\" num=\"1695\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.11 (1H, m), 0.54-0.92 (3H, m), 2.71 (1H, m), 3.85 (1H, d, J=13.7 Hz), 4.06 (1H, d, J=13.1 Hz), 5.06 (1H, d, J=13.1 Hz), 5.35 (1H, s), 5.57 (2H, m), 7.15 (9H, m), 11.66 (1H, brs).</p>\n",
       "<p id=\"p-1684\" num=\"1696\">MS: m/z=432 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0897\" level=\"1\">Example 303</heading>\n",
       "<p id=\"p-1685\" num=\"1697\"><chemistry id=\"CHEM-US-00421\" num=\"00421\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00421.TIF\" he=\"42.33mm\" id=\"EMI-C00421\" img-content=\"chem\" img-format=\"tif\" wi=\"38.02mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1686\" num=\"1698\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.14 (1H, m), 1.54 (2H, m), 1.67 (1H, m), 3.60 (1H, d, J=13.5 Hz), 4.39 (1H, d, J=12.6 Hz), 5.02 (1H, s), 5.07 (1H, d, J=12.6 Hz), 5.60 (1H, d. J=13.5 Hz), 5.77 (1H, d, J=7.7 Hz), 6.69 (1H, d, J=7.7 Hz), 7.07-7.13 (3H, m), 7.25-7.44 (4H, m).</p>\n",
       "<p id=\"p-1687\" num=\"1699\">MS: m/z=457.10 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0898\" level=\"1\">Example 304</heading>\n",
       "<p id=\"p-1688\" num=\"1700\"><chemistry id=\"CHEM-US-00422\" num=\"00422\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00422.TIF\" he=\"39.62mm\" id=\"EMI-C00422\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1689\" num=\"1701\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.33-3.42 (1H, m), 3.84 (1H, d, J=13.1 Hz), 3.90-4.10 (1H, m), 4.24 (1H, d, J=13.4 Hz), 4.35-4.66 (2H, m), 5.13 (1H, d, J=13.4 Hz), 5.43 (1H, s), 5.54-5.64 (2H, m), 6.80-6.95 (2H, m), 7.04-7.50 (8H, m).</p>\n",
       "<p id=\"p-1690\" num=\"1702\">MS: m/z=438 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0899\" level=\"1\">Example 305</heading>\n",
       "<p id=\"p-1691\" num=\"1703\"><chemistry id=\"CHEM-US-00423\" num=\"00423\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00423.TIF\" he=\"42.33mm\" id=\"EMI-C00423\" img-content=\"chem\" img-format=\"tif\" wi=\"49.70mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1692\" num=\"1704\">MS: m/z=487 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0900\" level=\"1\">Example 306</heading>\n",
       "<p id=\"p-1693\" num=\"1705\"><chemistry id=\"CHEM-US-00424\" num=\"00424\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00424.TIF\" he=\"42.33mm\" id=\"EMI-C00424\" img-content=\"chem\" img-format=\"tif\" wi=\"40.98mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1694\" num=\"1706\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.69-3.82 (1H, m), 3.89 (1H, d, J=13.6 Hz), 4.40 (1H, d, J=12.9 Hz), 4.60-4.77 (1H, m), 5.27 (1H, d, J=13.3 Hz), 5.43 (1H, s), 5.60 (1H, d, J=13.6 Hz), 5.70 (1H, d, J=7.7 Hz), 6.84-6.95 (1H, m), 7.08-7.55 (9H, m).</p>\n",
       "<p id=\"p-1695\" num=\"1707\">MS: m/z=474 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0901\" level=\"1\">Example 307</heading>\n",
       "<p id=\"p-1696\" num=\"1708\"><chemistry id=\"CHEM-US-00425\" num=\"00425\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00425.TIF\" he=\"42.33mm\" id=\"EMI-C00425\" img-content=\"chem\" img-format=\"tif\" wi=\"45.21mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1697\" num=\"1709\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.81 (1H, d, J=13.5 Hz), 4.29 (1H, d, J=13.5 Hz), 4.33 (1H, d, J=16.2 Hz), 4.96 (1H, d, J=16.2 Hz), 5.23 (1H, d, J=13.5 Hz), 5.49 (1H, s), 5.59 (1H, d, J=13.2 Hz), 5.64 (1H, d, J=7.7 Hz), 6.82-6.97 (2H, m), 7.05-7.41 (10H, m), 7.80 (1H, td, J=7.6, 1.7 Hz), 8.47 (1H, d, J=4.9 Hz).</p>\n",
       "<p id=\"p-1698\" num=\"1710\">MS: m/z=483 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0902\" level=\"1\">Example 308</heading>\n",
       "<p id=\"p-1699\" num=\"1711\"><chemistry id=\"CHEM-US-00426\" num=\"00426\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00426.TIF\" he=\"42.33mm\" id=\"EMI-C00426\" img-content=\"chem\" img-format=\"tif\" wi=\"36.66mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1700\" num=\"1712\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.28 (9H, s), 3.86 (1H, d, J=13.6 Hz), 4.42 (1H, d, J=13.3 Hz), 4.99 (1H, d, J=13.4 Hz), 5.32 (1H, s), 5.53 (1H, d, J=13.3 Hz), 5.60 (1H, d, J=7.6 Hz), 6.81-7.63 (10H, m).</p>\n",
       "<p id=\"p-1701\" num=\"1713\">MS: m/z=448 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0903\" level=\"1\">Example 309</heading>\n",
       "<p id=\"p-1702\" num=\"1714\"><chemistry id=\"CHEM-US-00427\" num=\"00427\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00427.TIF\" he=\"42.33mm\" id=\"EMI-C00427\" img-content=\"chem\" img-format=\"tif\" wi=\"36.66mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1703\" num=\"1715\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.03 (3H, t, J=7.4 Hz), 3.12-3.26 (1H, m), 3.43-3.58 (1H, m), 3.85 (1H, d, J=13.6 Hz), 4.21 (1H, d, J=13.4 Hz), 5.07 (1H, d, J=13.4 Hz), 5.40 (1H, s), 5.57 (1H, d, J=13.1 Hz), 5.59 (1H, d, J=7.3 Hz), 6.80-6.88 (1H, m), 6.91 (1H, d, J=7.9 Hz), 7.03-7.55 (8H, m).</p>\n",
       "<p id=\"p-1704\" num=\"1716\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0904\" level=\"1\">Example 310</heading>\n",
       "<p id=\"p-1705\" num=\"1717\"><chemistry id=\"CHEM-US-00428\" num=\"00428\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00428.TIF\" he=\"42.33mm\" id=\"EMI-C00428\" img-content=\"chem\" img-format=\"tif\" wi=\"45.21mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1706\" num=\"1718\">MS: m/z=498 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0905\" level=\"1\">Example 311</heading>\n",
       "<p id=\"p-1707\" num=\"1719\"><chemistry id=\"CHEM-US-00429\" num=\"00429\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00429.TIF\" he=\"42.25mm\" id=\"EMI-C00429\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1708\" num=\"1720\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.73-1.85 (2H, m), 2.96-3.07 (1H, m), 3.27 (3H, s), 3.42 (2H, t, J=5.6 Hz), 3.56 (1H, d, J=13.5 Hz), 3.93-4.04 (1H, m), 4.25 (1H, d, J=13.2 Hz), 4.95 (1H, d, J=12.9 Hz), 5.13 (1H, s), 5.65 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.7 Hz), 6.69 (1H, d, J=7.7 Hz), 6.78-6.86 (1H, m), 7.03-7.15 (3H, m), 7.17-7.47 (5H, m).</p>\n",
       "<p id=\"p-1709\" num=\"1721\">MS: m/z=464 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0906\" level=\"1\">Example 312</heading>\n",
       "<p id=\"p-1710\" num=\"1722\"><chemistry id=\"CHEM-US-00430\" num=\"00430\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00430.TIF\" he=\"42.33mm\" id=\"EMI-C00430\" img-content=\"chem\" img-format=\"tif\" wi=\"50.12mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1711\" num=\"1723\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.10 (3H, t, J=6.9 Hz), 2.79-2.91 (1H, m), 3.41 (2H, q, J=7.1 Hz), 3.46-3.69 (3H, m), 4.30 (1H, d, J=13.5 Hz), 5.01 (1H, d, J=13.5 Hz), 5.12 (1H, s), 5.65 (1H, d, J=13.5 Hz), 5.83 (1H, d, J=7.7 Hz), 6.68 (1H, d, J=7.7 Hz), 6.77-6.86 (1H, m), 7.03-7.12 (3H, m), 7.16-7.46 (5H, m).</p>\n",
       "<p id=\"p-1712\" num=\"1724\">MS: m/z=464 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0907\" level=\"1\">Example 313</heading>\n",
       "<p id=\"p-1713\" num=\"1725\"><chemistry id=\"CHEM-US-00431\" num=\"00431\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00431.TIF\" he=\"47.16mm\" id=\"EMI-C00431\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1714\" num=\"1726\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.30-1.47 (1H, m), 1.49-1.67 (1H, m), 1.73-2.02 (4H, m), 2.09-2.23 (2H, m), 3.60 (1H, d, J=13.5 Hz), 4.39 (1H, d, J=12.9 Hz), 4.45-4.64 (1H, m), 4.93 (1H, d, J=12.6 Hz), 5.10 (1H, s), 5.65 (1H, d, J=13.5 Hz), 5.87 (1H, d, J=7.4 Hz), 6.67 (1H, d, J=8.0 Hz), 6.76-6.85 (1H, m), 7.08 (2H, d, J=3.8 Hz), 7.16 (2H, d, J=7.7 Hz), 7.23-7.31 (1H, m), 7.34-7.48 (2H, m).</p>\n",
       "<p id=\"p-1715\" num=\"1727\">MS: m/z=510 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0908\" level=\"1\">Example 314</heading>\n",
       "<p id=\"p-1716\" num=\"1728\"><chemistry id=\"CHEM-US-00432\" num=\"00432\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00432.TIF\" he=\"42.33mm\" id=\"EMI-C00432\" img-content=\"chem\" img-format=\"tif\" wi=\"40.30mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1717\" num=\"1729\">MS: m/z=476 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0909\" level=\"1\">Example 315</heading>\n",
       "<p id=\"p-1718\" num=\"1730\"><chemistry id=\"CHEM-US-00433\" num=\"00433\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00433.TIF\" he=\"42.25mm\" id=\"EMI-C00433\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1719\" num=\"1731\">MS: m/z=488 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0910\" level=\"1\">Example 316</heading>\n",
       "<p id=\"p-1720\" num=\"1732\"><chemistry id=\"CHEM-US-00434\" num=\"00434\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00434.TIF\" he=\"42.33mm\" id=\"EMI-C00434\" img-content=\"chem\" img-format=\"tif\" wi=\"44.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1721\" num=\"1733\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.83 (1H, d, J=13.4 Hz), 4.34 (1H, d, J=13.1 Hz), 4.67 (1H, d, J=15.9 Hz), 5.05 (1H, d, J=15.9 Hz), 5.20 (1H, d, J=13.4 Hz), 5.33 (1H, s), 5.60 (1H, d, J=13.8 Hz), 5.64 (1H, d, J=7.8 Hz), 6.87 (3H, m), 7.05-7.19 (4H, m), 7.35-7.44 (2H, m), 7.74 (1H, d, 3.3 Hz), 7.77 (1H, d, 3.3 Hz).</p>\n",
       "<heading id=\"h-0911\" level=\"1\">Example 317</heading>\n",
       "<p id=\"p-1722\" num=\"1734\"><chemistry id=\"CHEM-US-00435\" num=\"00435\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00435.TIF\" he=\"42.25mm\" id=\"EMI-C00435\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1723\" num=\"1735\">MS: m/z=464 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0912\" level=\"1\">Example 318</heading>\n",
       "<p id=\"p-1724\" num=\"1736\"><chemistry id=\"CHEM-US-00436\" num=\"00436\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00436.TIF\" he=\"49.95mm\" id=\"EMI-C00436\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1725\" num=\"1737\">MS: m/z=494 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0913\" level=\"1\">Example 319</heading>\n",
       "<p id=\"p-1726\" num=\"1738\"><chemistry id=\"CHEM-US-00437\" num=\"00437\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00437.TIF\" he=\"42.33mm\" id=\"EMI-C00437\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1727\" num=\"1739\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.18-3.35 (1H, m), 3.60 (1H, d, J=13.7</p>\n",
       "<p id=\"p-1728\" num=\"1740\">Hz), 4.37 (1H, d, J=13.2 Hz), 4.75-4.95 (1H, m), 5.07-5.15 (2H, m), 5.60 (1H, d, J=13.7 Hz), 5.85 (1H, d, J=7.7 Hz), 6.68 (1H, d, J=7.7 Hz), 6.79-6.88 (1H, m), 7.09-7.14 (3H, m), 7.16 (1H, d, J=7.7 Hz), 7.29-7.36 (1H, m), 7.36-7.41 (1H, m), 7.42-7.50 (1H, m).</p>\n",
       "<p id=\"p-1729\" num=\"1741\">MS: m/z=524 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0914\" level=\"1\">Example 320</heading>\n",
       "<p id=\"p-1730\" num=\"1742\"><chemistry id=\"CHEM-US-00438\" num=\"00438\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00438.TIF\" he=\"39.71mm\" id=\"EMI-C00438\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1731\" num=\"1743\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.89 (9H, s), 0.97 (3H, d, J=7.1 Hz), 3.61 (1H, d, J=13.2 Hz), 4.43 (1H, d, J=13.2 Hz), 4.84-4.92 (2H, m), 5.11 (1H, s), 5.70 (1H, d, J=13.2 Hz), 5.83 (1H, d, J=7.7 Hz), 6.72 (1H, d, J=7.4 Hz), 6.79-6.85 (1H, m), 7.03-7.09 (2H, m), 7.16-7.24 (3H, m), 7.29-7.44 (2H, m).</p>\n",
       "<p id=\"p-1732\" num=\"1744\">MS: m/z=476 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0915\" level=\"1\">Example 321</heading>\n",
       "<p id=\"p-1733\" num=\"1745\"><chemistry id=\"CHEM-US-00439\" num=\"00439\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00439.TIF\" he=\"39.71mm\" id=\"EMI-C00439\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1734\" num=\"1746\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.87 (0.75H, s), 3.01 (2.25H, s), 3.55 (1.5H, d, J=10.2 Hz), 3.62 (0.5H, 13.5 Hz), 4.17 (0.5H, d, J=13.2 Hz), 4.22 (1.5 Hz, J=12.9 Hz), 4.97 (1H, d, J=12.9 Hz), 5.02 (0.25H, s), 5.11 (0.75H, s), 5.63 (0.75H, d, J=13.5 Hz), 5.77-5.83 (1.25H, m), 6.64-6.68 (1H, m), 6.76-6.85 (1H, m), 7.01 (1H, d, J=7.5 Hz), 7.05-7.13 (2H, m), 7.17-7.45 (3H, m).</p>\n",
       "<heading id=\"h-0916\" level=\"1\">Example 322</heading>\n",
       "<p id=\"p-1735\" num=\"1747\"><chemistry id=\"CHEM-US-00440\" num=\"00440\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00440.TIF\" he=\"42.50mm\" id=\"EMI-C00440\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1736\" num=\"1748\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.63 (1H, d, J=13.4 Hz), 4.51-4.59 (2H, m), 4.68-4.98 (4H, m), 5.13 (1H, d, J=12.9 Hz), 5.28 (1H, s), 5.71 (1H, d, J=13.3 Hz), 5.85 (1H, d, J=7.7 Hz), 6.77 (1H, d, J=7.4 Hz), 6.82-6.89 (1H, m), 7.12 (2H, d, J=3.5 Hz), 7.24 (1H, d, J=7.6 Hz), 7.33 (2H, d, J=4.4 Hz), 7.39 (1H, d, J=7.1 Hz), 7.42-7.50 (1H, m).</p>\n",
       "<p id=\"p-1737\" num=\"1749\">MS: m/z=470 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0917\" level=\"1\">Example 323</heading>\n",
       "<p id=\"p-1738\" num=\"1750\"><chemistry id=\"CHEM-US-00441\" num=\"00441\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00441.TIF\" he=\"39.71mm\" id=\"EMI-C00441\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1739\" num=\"1751\">MS: m/z=450 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0918\" level=\"1\">Example 324</heading>\n",
       "<p id=\"p-1740\" num=\"1752\"><chemistry id=\"CHEM-US-00442\" num=\"00442\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00442.TIF\" he=\"46.06mm\" id=\"EMI-C00442\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1741\" num=\"1753\">MS: m/z=482 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0919\" level=\"1\">Example 325</heading>\n",
       "<p id=\"p-1742\" num=\"1754\"><chemistry id=\"CHEM-US-00443\" num=\"00443\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00443.TIF\" he=\"42.33mm\" id=\"EMI-C00443\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1743\" num=\"1755\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.93 (3H, s), 3.13 (1H, m), 3.86 (1H, d, J=13.6 Hz), 4.06 (3H, m), 4.26 (1H, d, J=13.3 Hz), 5.14 (1H, d, J=13.6 Hz), 5.44 (1H, s), 5.60 (2H, m), 6.82-7.49 (10H, m).</p>\n",
       "<p id=\"p-1744\" num=\"1756\">MS: m/z=478 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0920\" level=\"1\">Example 326</heading>\n",
       "<p id=\"p-1745\" num=\"1757\"><chemistry id=\"CHEM-US-00444\" num=\"00444\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00444.TIF\" he=\"42.42mm\" id=\"EMI-C00444\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1746\" num=\"1758\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.07 (3H, d, J=6.6 Hz), 1.10 (3H, d, J=6.9 Hz), 3.70 (1H, d, J=13.5 Hz), 4.37 (1H, d, J=12.9 Hz), 4.75-4.85 (2H, m), 5.18 (1H, s), 5.76 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.8 Hz), 6.67 (1H, dd, J=1.2 Hz, 7.8 Hz), 6.77 (1H, t, J=7.8 Hz), 7.07 (1H, d, J=7.5 Hz), 7.18-7.30 (3H, m), 7.35-7.46 (2H, m).</p>\n",
       "<heading id=\"h-0921\" level=\"1\">Example 327</heading>\n",
       "<p id=\"p-1747\" num=\"1759\"><chemistry id=\"CHEM-US-00445\" num=\"00445\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00445.TIF\" he=\"42.33mm\" id=\"EMI-C00445\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1748\" num=\"1760\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.06 (3H, d, J=6.9 Hz), 1.15 (3H, d, J=7.2 Hz), 3.60 (H, d, J=13.5 Hz), 4.36 (1H, d, J=12.9 Hz), 4.75-4.83 (2H, m), 5.10 (1H, s), 5.67 (1H, d, J=13.2 Hz), 5.86 (1H, d, J=7.5 Hz), 6.65 (1H, d, J=8, 1 Hz), 6.78 (1H, dd, J=1.8 Hz, 8.1 Hz), 7.08-7.18 (2H, m), 7.13 (1H, d, J=8.1 Hz), 7.24-7.30 (1H, m), 7.33-7.36 (1H, m), 7.39-7.45 (1H, m).</p>\n",
       "<heading id=\"h-0922\" level=\"1\">Example 328</heading>\n",
       "<p id=\"p-1749\" num=\"1761\"><chemistry id=\"CHEM-US-00446\" num=\"00446\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00446.TIF\" he=\"39.71mm\" id=\"EMI-C00446\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1750\" num=\"1762\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.98 (0.4H, d, J=7.2 Hz), 1.07 (2.6H, d, J 6.6 Hz), 1.15 (2.6H, d, J=6.9 Hz), 1.27 (0.4H, d, J=0.6 Hz), 3.62 (0.9H, d, J=13.2 Hz), 3.73 (0.1H, d, J=13.8 Hz), 4.36 (1H, d, J=12.9 Hz), 4.77-4.88 (1H, m), 4.83 (1H, d, J=12.9 Hz), 5.07 (1H, s), 5.62 (1H, d, J=13.2 Hz), 5.77 (0.1H, d, J=7.5 Hz), 5.85 (0.9H, d, J=7.8 Hz), 6.69-6.83 (1H, m), 6.98-7.07 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.25-7.35 (2H, m), 7.40-7.45 (1H, m).</p>\n",
       "<heading id=\"h-0923\" level=\"1\">Example 329</heading>\n",
       "<p id=\"p-1751\" num=\"1763\"><chemistry id=\"CHEM-US-00447\" num=\"00447\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00447.TIF\" he=\"39.71mm\" id=\"EMI-C00447\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1752\" num=\"1764\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.07 (3H, d, J=6.6 Hz), 1.15 (3H, d, J=6.9 Hz), 3.63 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.9 Hz), 4.77-4.8 (1H, m), 4.82 (1H, d, J=12.6 Hz), 5.06 (1H, s), 5.60 (1H, d, J=12.9 Hz), 5.85 (1H, d, J=7.8 Hz), 6.53 (1H, dd, J=3.0 Hz, 9.0 Hz), 6.80-6.86 (1H, m), 7.03 (1H, dd, J=4.2 Hz, 9.0 Hz), 7.16-7.30 (3H, m), 7.35 (1H, d, J=6.3 Hz), 7.40-7.45 (1H, m).</p>\n",
       "<heading id=\"h-0924\" level=\"1\">Example 330</heading>\n",
       "<p id=\"p-1753\" num=\"1765\"><chemistry id=\"CHEM-US-00448\" num=\"00448\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00448.TIF\" he=\"42.42mm\" id=\"EMI-C00448\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1754\" num=\"1766\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.02 (3H, t, J=7.2 Hz), 3.07-3.22 (1H, m), 3.44-3.59 (1H, m), 4.00 (1H, d, J=13.4 Hz), 4.21 (1H, d, J=13.4 Hz), 5.06 (1H, d, J=13.3 Hz), 5.47-5.76 (3H, m), 6.84-6.92 (1H, m), 6.92-6.99 (1H, m), 7.04 (1H, d, J=7.6 Hz), 7.10-7.52 (6H, m).</p>\n",
       "<p id=\"p-1755\" num=\"1767\">MS: m/z=454 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0925\" level=\"1\">Example 331</heading>\n",
       "<p id=\"p-1756\" num=\"1768\"><chemistry id=\"CHEM-US-00449\" num=\"00449\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00449.TIF\" he=\"39.71mm\" id=\"EMI-C00449\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1757\" num=\"1769\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.96 (0.79H, s), 3.00 (2.2H, s), 3.59 (0.75H, d, J=13.2 Hz), 3.62 (0.25H, d, J=13.8 Hz), 4.15 (0.25H, d, J=13.2 Hz), 4.21 (0.75H, d, J=12.9 Hz), 4.95-5.01 (2H, m), 5.07 (1H, s), 5.56 (1H, d, J=13.5 Hz), 5.75-5.79 (1H, m), 5.88 (1H, d, J=7.8 Hz), 6.63 (0.36H, d, J=7.8 Hz), 6.73 (1H, d, J=1.8 Hz), 6.83 (0.39H, d, J=7.2 Hz), 7.01-7.46 (7.25H, m).</p>\n",
       "<heading id=\"h-0926\" level=\"1\">Example 332</heading>\n",
       "<p id=\"p-1758\" num=\"1770\"><chemistry id=\"CHEM-US-00450\" num=\"00450\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00450.TIF\" he=\"42.42mm\" id=\"EMI-C00450\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1759\" num=\"1771\">MS: m/z=484 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0927\" level=\"1\">Example 333</heading>\n",
       "<p id=\"p-1760\" num=\"1772\"><chemistry id=\"CHEM-US-00451\" num=\"00451\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00451.TIF\" he=\"42.33mm\" id=\"EMI-C00451\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1761\" num=\"1773\">MS: m/z=484 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0928\" level=\"1\">Example 334</heading>\n",
       "<p id=\"p-1762\" num=\"1774\"><chemistry id=\"CHEM-US-00452\" num=\"00452\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00452.TIF\" he=\"42.33mm\" id=\"EMI-C00452\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1763\" num=\"1775\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.01-3.10 (1H, m), 3.16 (3H, s), 3.40 (2H, m), 3.89 (2H, d, J=13.4 Hz), 4.19 (1H, d, J=13.4 Hz), 5.06 (1H, d, J=13.6 Hz), 5.49 (1H, s), 5.58 (1H, d, J=13.4 Hz), 5.70 (1H, d, J=7.8 Hz), 6.89-7.48 (8H, m), 11.36 (1H, s).</p>\n",
       "<heading id=\"h-0929\" level=\"1\">Example 335</heading>\n",
       "<p id=\"p-1764\" num=\"1776\"><chemistry id=\"CHEM-US-00453\" num=\"00453\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00453.TIF\" he=\"45.04mm\" id=\"EMI-C00453\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1765\" num=\"1777\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.00-3.09 (1H, m), 3.15 (3H, s), 3.39 (2H, m), 3.94 (1H, m), 4.00 (1H, d, J=13.2 Hz), 4.20 (1H, d, J=13.4 Hz), 5.06 (1H, d, J=13.4 Hz), 5.54 (1H, s), 5.65 (2H, m), 6.86-7.50 (8H, m), 11.54 (1H, brs).</p>\n",
       "<heading id=\"h-0930\" level=\"1\">Example 336</heading>\n",
       "<p id=\"p-1766\" num=\"1778\"><chemistry id=\"CHEM-US-00454\" num=\"00454\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00454.TIF\" he=\"44.96mm\" id=\"EMI-C00454\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1767\" num=\"1779\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.01-3.09 (1H, m), 3.15 (3H, s), 3.40 (2H, m), 3.87-3.94 (1H, m), 3.98 (1H, d, J=13.6 Hz), 4.20 (1H, d, J=13.6 Hz), 5.06 (1H, d, J=13.4 Hz), 5.54 (1H, s), 5.62 (1H, d, J=13.6 Hz), 5.67 (1H, d, J=7.6 Hz), 6.78-7.50 (8H, m).</p>\n",
       "<p id=\"p-1768\" num=\"1780\">MS: m/z=468 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0931\" level=\"1\">Example 337</heading>\n",
       "<p id=\"p-1769\" num=\"1781\"><chemistry id=\"CHEM-US-00455\" num=\"00455\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00455.TIF\" he=\"42.33mm\" id=\"EMI-C00455\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1770\" num=\"1782\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.07 (1H, m), 3.16 (3H, s), 3.41 (2H, s), 3.89 (1H, d, J=13.7 Hz), 3.91 (1H, m), 4.19 (1H, d, J=13.6 Hz), 5.06 (1H, d, J=13.6 Hz), 5.48 (1H, s), 5.61 (1H, d, J=13.3 Hz), 5.69 (1H, d, J=7.6 Hz), 6.70-7.48 (9H, m).</p>\n",
       "<p id=\"p-1771\" num=\"1783\">MS: m/z=468 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0932\" level=\"1\">Example 338</heading>\n",
       "<p id=\"p-1772\" num=\"1784\"><chemistry id=\"CHEM-US-00456\" num=\"00456\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00456.TIF\" he=\"42.33mm\" id=\"EMI-C00456\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1773\" num=\"1785\">MS: m/z=468 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0933\" level=\"1\">Example 339</heading>\n",
       "<p id=\"p-1774\" num=\"1786\"><chemistry id=\"CHEM-US-00457\" num=\"00457\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00457.TIF\" he=\"52.58mm\" id=\"EMI-C00457\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1775\" num=\"1787\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.14 (3H, s), 3.18 (s, 3H), 3.50 (4H, m), 4.00 (1H, d, J=13.1 Hz), 4.49 (1H, d, J=13.3 Hz), 4.77 (1H, m), 4.95 (1H, d, J=13.3 Hz), 5.56 (1H, s), 5.68 (2H, m), 7.14 (8H, m).</p>\n",
       "<p id=\"p-1776\" num=\"1788\">MS: m/z=512 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0934\" level=\"1\">Example 340</heading>\n",
       "<p id=\"p-1777\" num=\"1789\"><chemistry id=\"CHEM-US-00458\" num=\"00458\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00458.TIF\" he=\"49.95mm\" id=\"EMI-C00458\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1778\" num=\"1790\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.12 (3H, s), 3.20 (3H, s), 3.51 (4H, m), 3.96 (1H, d, J=13.3 Hz), 4.53 (1H, d, J=13.4 Hz), 4.75 (1H, m), 4.97 (1H, d, J=13.1 Hz), 5.50 (1H, d, J=13.3 Hz), 5.54 (1H, s), 5.67 (1H, d, J=7.8 Hz), 6.87-7.54 (8H, m).</p>\n",
       "<p id=\"p-1779\" num=\"1791\">MS: m/z=530 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0935\" level=\"1\">Example 341</heading>\n",
       "<p id=\"p-1780\" num=\"1792\"><chemistry id=\"CHEM-US-00459\" num=\"00459\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00459.TIF\" he=\"42.42mm\" id=\"EMI-C00459\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1781\" num=\"1793\">MS: m/z=466 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0936\" level=\"1\">Example 342</heading>\n",
       "<p id=\"p-1782\" num=\"1794\"><chemistry id=\"CHEM-US-00460\" num=\"00460\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00460.TIF\" he=\"42.25mm\" id=\"EMI-C00460\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1783\" num=\"1795\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0937\" level=\"1\">Example 343</heading>\n",
       "<p id=\"p-1784\" num=\"1796\"><chemistry id=\"CHEM-US-00461\" num=\"00461\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00461.TIF\" he=\"42.33mm\" id=\"EMI-C00461\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1785\" num=\"1797\">MS: m/z=522 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0938\" level=\"1\">Example 344</heading>\n",
       "<p id=\"p-1786\" num=\"1798\"><chemistry id=\"CHEM-US-00462\" num=\"00462\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00462.TIF\" he=\"39.62mm\" id=\"EMI-C00462\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1787\" num=\"1799\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0939\" level=\"1\">Example 345</heading>\n",
       "<p id=\"p-1788\" num=\"1800\"><chemistry id=\"CHEM-US-00463\" num=\"00463\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00463.TIF\" he=\"39.62mm\" id=\"EMI-C00463\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1789\" num=\"1801\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0940\" level=\"1\">Example 346</heading>\n",
       "<p id=\"p-1790\" num=\"1802\"><chemistry id=\"CHEM-US-00464\" num=\"00464\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00464.TIF\" he=\"39.62mm\" id=\"EMI-C00464\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1791\" num=\"1803\">MS: m/z=470 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0941\" level=\"1\">Example 347</heading>\n",
       "<p id=\"p-1792\" num=\"1804\"><chemistry id=\"CHEM-US-00465\" num=\"00465\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00465.TIF\" he=\"42.42mm\" id=\"EMI-C00465\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1793\" num=\"1805\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) E: 2.88 (0.60H, s), 2.99 (2.40H, s), 3.67 (0.80H, d, J=13.8 Hz), 3.73 (0.20H, d, J=14.1 Hz), 4.16 (0.20H, d, J=11.1 Hz), 4.20 (0.80H, d, J=12.9 Hz), 4.97 (0.80H, d, J=12.9 Hz), 4.99 (0.20H, d, J=15 Hz), 5.10 (0.20H, s), 5.18 (0.80H, s), 5.69 (0.80H, d, J=13.5 Hz), 5.79 (0.20H, d, J=7.8 Hz), 5.85 (0.80H, d, J=7.5 Hz), 5.88 (0.20H, J=13.5 Hz), 6.62-6.66 (1H, m), 6.75-6.85 (1H, m), 6.98 (1H, d, J=7.5 Hz), 7.03-7.16 (0.5H, m), 7.19 (1H, d, J=6.9 Hz), 7.24-7.39 (2.5H, m), 7.43-7.48 (1H, m).</p>\n",
       "<heading id=\"h-0942\" level=\"1\">Example 348</heading>\n",
       "<p id=\"p-1794\" num=\"1806\"><chemistry id=\"CHEM-US-00466\" num=\"00466\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00466.TIF\" he=\"42.25mm\" id=\"EMI-C00466\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1795\" num=\"1807\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.91 (0.75H, s), 2.99 (2.25H, s), 3.57 (0.75H, d, J=13.8 Hz), 3.63 (0.25H, d, 13.8 Hz), 4.17 (0.25H, d, J=12.9 Hz), 4.10 (0.75H, d, J=12.9 Hz), 4.99 (0.75H, d, J=12.9 Hz), 5.00 (0.25H, s), 5.01 (0.25H, d, J=12.3 Hz), 5.10 (0.75H, s), 5.61 (0.75H, d, J=13.5 Hz), 5.78 (0.25H, J=7.5 Hz), 5.80 (0.25H, J=15 Hz), 5.89 (0.75H, d, J=7.5 Hz), 6.60 (0.75H, d, J=8.4 Hz), 6.64 (0.25H, d, J=7.8 Hz), 6.78 (1H, dd, J=2.1 Hz, 8.1 Hz), 7.03 (1H, d, J=7.8 Hz), 7.04-7.21 (2H, m), 7.26-7.36 (2H, m), 7.41-7.47 (1H, m).</p>\n",
       "<heading id=\"h-0943\" level=\"1\">Example 349</heading>\n",
       "<p id=\"p-1796\" num=\"1808\"><chemistry id=\"CHEM-US-00467\" num=\"00467\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00467.TIF\" he=\"39.62mm\" id=\"EMI-C00467\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1797\" num=\"1809\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.94 (0.66H, s), 3.00 (2.34H, s), 3.60 (0.78H, d, J=13.5 Hz), 3.65 (0.22H, d, J=3.8 Hz), 4.22 (1H, d, J=12.9 Hz), 4.94-5.00 (1H, m), 5.06 (1H, s), 5.54 (0.78H, d, J=13.2 Hz), 5.71 (0.22H, d, J=13.8 Hz), 5.78 (0.22H, d, J=7.5 Hz), 5.88 (0.78H, d, J=7.8 Hz), 6.49 (1H, dd, J=3.0 Hz, 9.0 Hz), 6.66 (0.22H, d, J=7.8 Hz), 6.82-6.88 (1H, m), 6.97-7.13 (2H, m), 7.16-7.21 (1H, m), 7.29-7.36 (2H, m), 7.41-7.46 (1H, m).</p>\n",
       "<heading id=\"h-0944\" level=\"1\">Example 350</heading>\n",
       "<p id=\"p-1798\" num=\"1810\"><chemistry id=\"CHEM-US-00468\" num=\"00468\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00468.TIF\" he=\"42.33mm\" id=\"EMI-C00468\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1799\" num=\"1811\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.08 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 3.63 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.6 Hz), 4.78-4.87 (1H, m), 5.10 (1H, s), 5.67 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=2.1 Hz), 6.96-6.99 (1H, m), 7.08-7.12 (2H, m), 7.17 (1H, d, J=13.5 Hz), 7.25-7.32 (1H, m), 7.35-7.37 (1H, m), 7.42-7.47 (1H, m).</p>\n",
       "<heading id=\"h-0945\" level=\"1\">Example 351</heading>\n",
       "<p id=\"p-1800\" num=\"1812\"><chemistry id=\"CHEM-US-00469\" num=\"00469\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00469.TIF\" he=\"42.25mm\" id=\"EMI-C00469\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1801\" num=\"1813\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.08 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 3.68 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.9 Hz), 4.76-4.84 (2H, m), 5.18 (1H, s), 5.72 (1H, d, J=13.5 Hz), 5.81 (1H, dd, J=0.9 Hz, 7.5 Hz), 6.56 (1H, d, J=7.2 Hz), 6.76-6.83 (1H, m), 6.90 (1H, t, J=9.0 Hz), 7.07-7.11 (1H, m), 7.19 (1H, d, J=7.5 Hz), 7.25-7.30 (1H, m), 7.35-7.45 (2H, m).</p>\n",
       "<heading id=\"h-0946\" level=\"1\">Example 352</heading>\n",
       "<p id=\"p-1802\" num=\"1814\"><chemistry id=\"CHEM-US-00470\" num=\"00470\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00470.TIF\" he=\"39.62mm\" id=\"EMI-C00470\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1803\" num=\"1815\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.07 (3H, d, J=6.9 Hz), 1.15 (3H, d, J=7.1 Hz), 3.59 (1H, d, J=13.2 Hz), 4.36 (1H, d, J=9.9 Hz), 4.75-4.85 (2H, m), 5.11 (1H, s), 5.70 (1H, d, J=13.2 Hz), 5.84 (1H, d, J=7.8 Hz), 6.48-6.55 (1H, m), 6.71 (1H, dd, J=5.4 Hz, 8.4 Hz), 6.80 (1H, dd, J=2.4 Hz, 9.3 Hz), 7.11 (1H, d, J=7.8 Hz), 7.18 (1H, dd, J=0.9 Hz), 7.5 Hz), 7.25-7.30 (1H, m), 7.32-7.36 (1H, m), 7.39-7.45 (1H, m).</p>\n",
       "<heading id=\"h-0947\" level=\"1\">Example 353</heading>\n",
       "<p id=\"p-1804\" num=\"1816\"><chemistry id=\"CHEM-US-00471\" num=\"00471\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00471.TIF\" he=\"42.25mm\" id=\"EMI-C00471\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1805\" num=\"1817\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.92 (0.66H, s), 3.01 (2.34H, s), 3.59 (0.78H, d, J=13.5 Hz), 3.67 (0.22H, d, J=13.8 Hz), 4.18 (0.22H, d, J=13.2 Hz), 4.21 (0.78H, d, J=12.9 Hz), 5.03 (1H, J=12.9 Hz), 5.05 (0.22H, s), 5.10 (0.78H, s), 5.62 (0.78H, d, J=13.5 Hz), 5.76-5.82 (0.44H, m), 5.87 (0.78H, d, J=7.8 Hz), 6.62 (0.78H, brs), 6.68 (0.22H, d, J=8.1 Hz), 6.85 (0.22H, d, J=7.8 Hz), 6.98-7.04 (1.56H, m), 7.11-7.39 (3H, m), 7.44-7.49 (1H, m).</p>\n",
       "<heading id=\"h-0948\" level=\"1\">Example 354</heading>\n",
       "<p id=\"p-1806\" num=\"1818\"><chemistry id=\"CHEM-US-00472\" num=\"00472\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00472.TIF\" he=\"42.25mm\" id=\"EMI-C00472\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1807\" num=\"1819\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.89 (0.48H, s), 3.00 (2.52H, s), 3.64 (0.84H, d, J=13.5 Hz), 3.71 (0.16H, d, J=13.8 Hz), 4.21 (1H, d, J=12.9 Hz), 4.94 (0.84H, d, J=12.9 Hz), 4.98 (0.16H, d, J=12.9 Hz), 5.10 (0.16H, s), 5.19 (0.84H, s), 5.65 (0.84H, d, J=7.5 Hz), 5.77-5.85 (1.32H, m), 6.52 (0.84H, d, J=7.8 Hz), 6.64 (0.16H, d, J=7.8 Hz), 6.77-6.84 (1H, m), 6.89-6.95 (1H, m), 6.99 (1H, d, J=7.8 Hz), 7.07-7.25 (1H, m), 7.29-7.38 (2H, m), 7.42-7.47 (1H, m).</p>\n",
       "<heading id=\"h-0949\" level=\"1\">Example 355</heading>\n",
       "<p id=\"p-1808\" num=\"1820\"><chemistry id=\"CHEM-US-00473\" num=\"00473\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00473.TIF\" he=\"39.62mm\" id=\"EMI-C00473\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1809\" num=\"1821\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.91 (0.48H, s), 3.00 (2.52H, s), 3.56 (d, J=13.8 Hz), 3.62 (0.16H, d, J=13.8 Hz), 4.18 (0.16H, d, J=12.9 Hz), 4.20 (0.84H, d, J=12.9 Hz), 4.96 (0.84H, d, J=12.9 Hz), 4.98 (0.16H, d, J=13.8 Hz), 5.03 (0.16H, s), 5.12 (0.84H, s), 5.64 (0.84H, d, J=13.5 Hz), 5.78-5.87 (0.32H, m), 5.89 (0.84H, d, J=7.8 Hz), 6.50-6.56 (0.84H, m), 6.63-6.69 (1.16H, m), 6.84 (1H, dd, J=2.4 Hz, 9.3 Hz), 6.94-6.97 (0.16H, m), 7.02 (0.84H, d, J=7.5 Hz), 7.13-7.23 (1H, m), 7.33-7.38 (2H, m), 7.42-7.47 (1H, m).</p>\n",
       "<heading id=\"h-0950\" level=\"1\">Example 356</heading>\n",
       "<p id=\"p-1810\" num=\"1822\"><chemistry id=\"CHEM-US-00474\" num=\"00474\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00474.TIF\" he=\"41.49mm\" id=\"EMI-C00474\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1811\" num=\"1823\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.08 (3H, d, J=6.9 Hz), 1.15 (3H, d, J=6.9 Hz), 2.24 (3H, s), 3.68 (1H, d, J=13.2 Hz), 4.38 (1H, d, J=13.2 Hz), 4.76-4.85 (1H, m), 4.80 (1H, d, J=12.6 Hz), 5.14 (1H, s), 5.72 (1H, d, J=12.9 Hz), 5.76 (1H, d, J=7.8 Hz), 6.59 (1H, d, J=7.5 Hz), 6.72 (1H, t, J=7.5 Hz), 6.99 (1H, d, J=6.9 Hz), 7.07 (1H, d, J=7.8 Hz), 7.17-7.27 (2H, m), 7.33-7.42 (2H, m).</p>\n",
       "<heading id=\"h-0951\" level=\"1\">Example 357</heading>\n",
       "<p id=\"p-1812\" num=\"1824\"><chemistry id=\"CHEM-US-00475\" num=\"00475\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00475.TIF\" he=\"39.62mm\" id=\"EMI-C00475\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1813\" num=\"1825\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.10 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 3.58 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.9 Hz), 4.76-4.87 (1H, m), 4.85 (1H, d, J=12.6 Hz), 5.06 (1H, s), 5.65 (1H, d, J=13.2 Hz), 5.79 (1H, d, J=7.5 Hz), 6.54 (1H, s), 6.89 (1H, dd, J=1.5 Hz, 8.4 Hz), 6.95 (1H, d, J=7.8 Hz), 7.14-7.19 (1H, m), 7.22-7.28 (1H, m), 7.33-7.43 (2H, m).</p>\n",
       "<heading id=\"h-0952\" level=\"1\">Example 358</heading>\n",
       "<p id=\"p-1814\" num=\"1826\"><chemistry id=\"CHEM-US-00476\" num=\"00476\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00476.TIF\" he=\"41.49mm\" id=\"EMI-C00476\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1815\" num=\"1827\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.07 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 2.20 (3H, s), 2.23 (3H, s), 3.77 (1H, d, J=12.6 Hz), 4.47 (1H, d, J=12.9 Hz), 4.78-4.86 (1H, m), 4.88 (1H, 12.9 Hz), 5.49 (1H, d, J=12.9 Hz), 5.83 (1H, d, J=11.1 Hz), 5.85 (1H, d, J=9.0 Hz), 6.64 (1H, d, J=7.8 Hz), 6.86 (1H, J=7.8 Hz), 7.16-7.40 (5H, m).</p>\n",
       "<heading id=\"h-0953\" level=\"1\">Example 359</heading>\n",
       "<p id=\"p-1816\" num=\"1828\"><chemistry id=\"CHEM-US-00477\" num=\"00477\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00477.TIF\" he=\"45.04mm\" id=\"EMI-C00477\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1817\" num=\"1829\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.94 (3H, s), 3.07 (1H, m), 3.98-4.12 (4H, m), 4.25 (2H, d, J=13.4 Hz), 5.13 (2H, d, J=13.3 Hz), 5.56 (1H, s), 5.66 (1H, d, J=13.5 Hz), 5.68 (1H, t, J=7.8 Hz), 6.87-7.51 (8H, m).</p>\n",
       "<heading id=\"h-0954\" level=\"1\">Example 360</heading>\n",
       "<p id=\"p-1818\" num=\"1830\"><chemistry id=\"CHEM-US-00478\" num=\"00478\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00478.TIF\" he=\"95.59mm\" id=\"EMI-C00478\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1819\" num=\"1831\">Compound 325 (46.0 mg, 0.0960 mmol) was dissolved in methanol (0.5 ml) and tetrahydrofuran (0.5 ml), a 2N aqueous sodium hydroxide solution (0.241 ml, 0.482 mmol) was added, and the mixture was stirred for 30 minutes. To the reaction solution was added dilute hydrochloric acid to make the solution acidic, and the mixture was extracted with chloroform. The organic layer was dried with sodium sulfate, and the reaction solution was concentrated under reduced pressure. To the resulting compound 360 were added n-hexane-diethyl ether, and the precipitated residue was filtered to obtain 33 mg of a white solid.</p>\n",
       "<p id=\"p-1820\" num=\"1832\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.85-2.94 (1H, m), 3.52 (2H, m), 3.89 (1H, d, J=13.4 Hz), 3.98 (1H, td, J=9.1, 4.5 Hz), 4.24 (1H, d, J=13.6 Hz), 4.84 (1H, brs), 5.16 (1H, d, J=13.6 Hz), 5.48 (1H, s), 5.65 (2H, m), 6.86-7.55 (9H, m).</p>\n",
       "<p id=\"p-1821\" num=\"1833\">MS: m/z=436 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-1822\" num=\"1834\">Using ester bodies synthesized according to Examples 107, 246 and 285, and according to the method of Example 320, compounds 361 to 382 were synthesized.</p>\n",
       "<heading id=\"h-0955\" level=\"1\">Example 361</heading>\n",
       "<p id=\"p-1823\" num=\"1835\"><chemistry id=\"CHEM-US-00479\" num=\"00479\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00479.TIF\" he=\"38.86mm\" id=\"EMI-C00479\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1824\" num=\"1836\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.82 (3H, m), 3.49 (1H, brs), 3.71 (1H, dt, J=16.7, 5.0 Hz), 4.03 (1H, t, J=7.8 Hz), 4.08-4.15 (2H, m), 4.79 (1H, brs), 5.01 (1H, d, J=13.4 Hz), 5.25 (1H, s), 5.51 (1H, d, J=7.6 Hz), 6.72-7.41 (9H, m).</p>\n",
       "<heading id=\"h-0956\" level=\"1\">Example 362</heading>\n",
       "<p id=\"p-1825\" num=\"1837\"><chemistry id=\"CHEM-US-00480\" num=\"00480\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00480.TIF\" he=\"38.86mm\" id=\"EMI-C00480\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1826\" num=\"1838\">MS: m/z=432 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0957\" level=\"1\">Example 363</heading>\n",
       "<p id=\"p-1827\" num=\"1839\"><chemistry id=\"CHEM-US-00481\" num=\"00481\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00481.TIF\" he=\"39.71mm\" id=\"EMI-C00481\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1828\" num=\"1840\">MS: m/z=450 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0958\" level=\"1\">Example 364</heading>\n",
       "<p id=\"p-1829\" num=\"1841\"><chemistry id=\"CHEM-US-00482\" num=\"00482\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00482.TIF\" he=\"41.49mm\" id=\"EMI-C00482\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1830\" num=\"1842\">MS: m/z=448 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0959\" level=\"1\">Example 365</heading>\n",
       "<p id=\"p-1831\" num=\"1843\"><chemistry id=\"CHEM-US-00483\" num=\"00483\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00483.TIF\" he=\"42.33mm\" id=\"EMI-C00483\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1832\" num=\"1844\">MS: m/z=466 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0960\" level=\"1\">Example 366</heading>\n",
       "<p id=\"p-1833\" num=\"1845\"><chemistry id=\"CHEM-US-00484\" num=\"00484\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00484.TIF\" he=\"42.50mm\" id=\"EMI-C00484\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1834\" num=\"1846\">MS: m/z=466 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0961\" level=\"1\">Example 367</heading>\n",
       "<p id=\"p-1835\" num=\"1847\"><chemistry id=\"CHEM-US-00485\" num=\"00485\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00485.TIF\" he=\"50.21mm\" id=\"EMI-C00485\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1836\" num=\"1848\">MS: m/z=512 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0962\" level=\"1\">Example 368</heading>\n",
       "<p id=\"p-1837\" num=\"1849\"><chemistry id=\"CHEM-US-00486\" num=\"00486\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00486.TIF\" he=\"46.31mm\" id=\"EMI-C00486\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1838\" num=\"1850\">MS: m/z=406 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0963\" level=\"1\">Example 369</heading>\n",
       "<p id=\"p-1839\" num=\"1851\"><chemistry id=\"CHEM-US-00487\" num=\"00487\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00487.TIF\" he=\"40.47mm\" id=\"EMI-C00487\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1840\" num=\"1852\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0964\" level=\"1\">Example 370</heading>\n",
       "<p id=\"p-1841\" num=\"1853\"><chemistry id=\"CHEM-US-00488\" num=\"00488\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00488.TIF\" he=\"38.86mm\" id=\"EMI-C00488\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1842\" num=\"1854\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.23 (3H, s), 1.24 (3H, s), 2.43 (1H, d, J=13.7 Hz), 2.81-2.91 (1H, m), 2.96-3.10 (1H, m), 3.61-3.72 (1H, m), 4.02-4.14 (1H, m), 4.15 (1H, d, J=13.7 Hz), 4.42 (1H, d, J=14.0 Hz), 4.95 (1H, s), 5.15 (1H, d, J=13.5 Hz), 5.74 (1H, d, J=7.7 Hz), 6.54-6.61 (2H, m), 6.86-6.94 (1H, m), 7.11-7.39 (8H, m).</p>\n",
       "<p id=\"p-1843\" num=\"1855\">MS: m/z=446 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0965\" level=\"1\">Example 371</heading>\n",
       "<p id=\"p-1844\" num=\"1856\"><chemistry id=\"CHEM-US-00489\" num=\"00489\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00489.TIF\" he=\"39.62mm\" id=\"EMI-C00489\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1845\" num=\"1857\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.24 (3H, s), 1.26 (3H, s), 2.52 (1H, d, J=14.0 Hz), 3.56 (1H, d, J=13.7 Hz), 4.34 (1H, d, J=13.5 Hz), 4.36 (1H, d, J=13.5 Hz), 5.04 (1H, s), 5.23 (1H, d, J=13.7 Hz), 5.63 (1H, d, J=13.5 Hz), 5.84 (1H, d, J=7.7 Hz), 6.65 (1H, d, J=7.7 Hz), 6.76-6.84 (1H, m), 7.03-7.18 (5H, m), 7.27-7.47 (4H, m).</p>\n",
       "<p id=\"p-1846\" num=\"1858\">MS: m/z=464 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0966\" level=\"1\">Example 372</heading>\n",
       "<p id=\"p-1847\" num=\"1859\"><chemistry id=\"CHEM-US-00490\" num=\"00490\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00490.TIF\" he=\"39.62mm\" id=\"EMI-C00490\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1848\" num=\"1860\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.21-1.68 (10H, m), 2.47 (1H, d, J=13.7 Hz), 3.55 (1H, d, J=13.5 Hz), 4.34 (1H, d, J=13.6 Hz), 4.35 (1H, d, J=13.6 Hz), 5.03 (1H, s), 5.25 (1H, d, J=13.5 Hz), 5.63 (1H, d, J=13.5 Hz), 5.79 (1H, d, J=7.7 Hz), 6.64 (1H, d, J=7.4 Hz), 6.76-6.84 (1H, m), 7.03 (1H, d, J=7.7 Hz), 7.06-7.10 (2H, m), 7.15 (1H, d, J=7.1 Hz), 7.28-7.37 (2H, m), 7.37-7.46 (1H, m).</p>\n",
       "<p id=\"p-1849\" num=\"1861\">MS: m/z=504 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0967\" level=\"1\">Example 373</heading>\n",
       "<p id=\"p-1850\" num=\"1862\"><chemistry id=\"CHEM-US-00491\" num=\"00491\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00491.TIF\" he=\"39.62mm\" id=\"EMI-C00491\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1851\" num=\"1863\">MS: m/z=450 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0968\" level=\"1\">Example 374</heading>\n",
       "<p id=\"p-1852\" num=\"1864\"><chemistry id=\"CHEM-US-00492\" num=\"00492\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00492.TIF\" he=\"47.24mm\" id=\"EMI-C00492\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1853\" num=\"1865\">MS: m/z=492 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0969\" level=\"1\">Example 375</heading>\n",
       "<p id=\"p-1854\" num=\"1866\"><chemistry id=\"CHEM-US-00493\" num=\"00493\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00493.TIF\" he=\"39.71mm\" id=\"EMI-C00493\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1855\" num=\"1867\">MS: m/z=445 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0970\" level=\"1\">Example 376</heading>\n",
       "<p id=\"p-1856\" num=\"1868\"><chemistry id=\"CHEM-US-00494\" num=\"00494\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00494.TIF\" he=\"50.21mm\" id=\"EMI-C00494\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1857\" num=\"1869\">MS: m/z=512 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0971\" level=\"1\">Example 377</heading>\n",
       "<p id=\"p-1858\" num=\"1870\"><chemistry id=\"CHEM-US-00495\" num=\"00495\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00495.TIF\" he=\"1727.20mm\" id=\"EMI-C00495\" img-content=\"chem\" img-format=\"tif\" wi=\"2540.00mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1859\" num=\"1871\">MS: m/z=492 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0972\" level=\"1\">Example 378</heading>\n",
       "<p id=\"p-1860\" num=\"1872\"><chemistry id=\"CHEM-US-00496\" num=\"00496\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00496.TIF\" he=\"41.66mm\" id=\"EMI-C00496\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1861\" num=\"1873\">MS: m/z=478 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0973\" level=\"1\">Example 379</heading>\n",
       "<p id=\"p-1862\" num=\"1874\"><chemistry id=\"CHEM-US-00497\" num=\"00497\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00497.TIF\" he=\"41.66mm\" id=\"EMI-C00497\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1863\" num=\"1875\">MS: m/z=478 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0974\" level=\"1\">Example 380</heading>\n",
       "<p id=\"p-1864\" num=\"1876\"><chemistry id=\"CHEM-US-00498\" num=\"00498\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00498.TIF\" he=\"47.16mm\" id=\"EMI-C00498\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1865\" num=\"1877\">MS: m/z=492 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0975\" level=\"1\">Example 381</heading>\n",
       "<p id=\"p-1866\" num=\"1878\"><chemistry id=\"CHEM-US-00499\" num=\"00499\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00499.TIF\" he=\"44.45mm\" id=\"EMI-C00499\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1867\" num=\"1879\">MS: m/z=492 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0976\" level=\"1\">Example 382</heading>\n",
       "<p id=\"p-1868\" num=\"1880\"><chemistry id=\"CHEM-US-00500\" num=\"00500\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00500.TIF\" he=\"42.42mm\" id=\"EMI-C00500\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1869\" num=\"1881\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.76-2.85 (1H, m), 3.58 (2H, m), 3.92 (1H, m), 3.98 (1H, d, J=13.5 Hz), 4.18 (1H, d, J=13.6 Hz), 4.80 (1H, brs), 5.10 (1H, t, J=8.8 Hz), 5.50-5.68 (3H, m), 6.87-7.52 (8H, m).</p>\n",
       "<heading id=\"h-0977\" level=\"1\">Example 383</heading>\n",
       "<p id=\"p-1870\" num=\"1882\"><chemistry id=\"CHEM-US-00501\" num=\"00501\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00501.TIF\" he=\"154.94mm\" id=\"EMI-C00501\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0978\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1871\" num=\"1883\">Compound 383A (1.00 g, 4.42 mmol) was dissolved in dichloromethane (50 ml), mCPBA (2.67 g, 15.5 mmol) was added at 0° C., and the mixture was stirred at room temperature for 4 hours. To the reaction solution was added an aqueous sodium sulfite solution, and the mixture was extracted with dichloromethane. The organic layer was washed with an aqueous sodium bicarbonate solution, and dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 1.06 g of a white solid 383B.</p>\n",
       "<p id=\"p-1872\" num=\"1884\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.81 (2H, s), 7.29-8.12 (6H, m).</p>\n",
       "<heading id=\"h-0979\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1873\" num=\"1885\">To compound 383B (1.05 g, 4.07 mmol) was added methanol (11 ml), sodium borohydride (185 mg, 4.88 mmol) was added at 0° C., and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 1.01 g of a white solid 383C.</p>\n",
       "<p id=\"p-1874\" num=\"1886\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.84 (1H, d, J=3.7 Hz), 4.76 (1H, d, J=14.6 Hz), 5.25 (1H, d, J=14.6 Hz), 6.23 (1H, d, J=3.7 Hz), 7.28-7.96 (8H, m).</p>\n",
       "<heading id=\"h-0980\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1875\" num=\"1887\">According to Example 107, compound 383 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-1876\" num=\"1888\">MS: m/z=466 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"p-1877\" num=\"1889\">Using intermediates corresponding to 383A to 383C which are commercially available or known in the references, and according to the method of Example 383, compounds 384 to 389 were synthesized.</p>\n",
       "<heading id=\"h-0981\" level=\"1\">Example 384</heading>\n",
       "<p id=\"p-1878\" num=\"1890\"><chemistry id=\"CHEM-US-00502\" num=\"00502\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00502.TIF\" he=\"44.03mm\" id=\"EMI-C00502\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1879\" num=\"1891\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.12-1.25 (6H, m), 2.87-3.26 (3H, m), 3.42-3.67 (1H, m), 4.00-4.08 (1H, m), 4.28-4.35 (1H, m), 4.56-4.83 (3H, m), 5.10-5.30 (1H, m), 5.89-6.11 (1H, m), 6.55-6.63 (0.5H, m), 6.71-6.75 (0.5H, m), 6.84-6.94 (1H, m), 7.03-7.47 (4H, m), 8.18-8.20 (0.5H, m), 8.48-8.49 (0.5H, m).</p>\n",
       "<heading id=\"h-0982\" level=\"1\">Example 385</heading>\n",
       "<p id=\"p-1880\" num=\"1892\"><chemistry id=\"CHEM-US-00503\" num=\"00503\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00503.TIF\" he=\"41.23mm\" id=\"EMI-C00503\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1881\" num=\"1893\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.59 (3H, d, J=6.6 Hz), 1.07-1.14 (4H, m), 1.19-1.28 (1H, m), 2.22-2.32 (1H, m), 2.73-3.12 (3H, m), 4.71-4.81 (1H, m), 4.83 (1H, d, J=12.9 Hz), 4.96 (1H, d, J=12.9 Hz), 5.88 (1H, d, J=7.5 Hz), 5.89 (1H, s), 6.89 (1H, m), 7.00-7.04 (2H, m), 7.08-7.18 (2H, m), 7.22-7.27 (1H, m), 7.38 (1H, d, J=7.5 Hz), 7.58-7.61 (1H, m), 7.79 (1H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-0983\" level=\"1\">Example 386</heading>\n",
       "<p id=\"p-1882\" num=\"1894\"><chemistry id=\"CHEM-US-00504\" num=\"00504\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00504.TIF\" he=\"48.43mm\" id=\"EMI-C00504\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1883\" num=\"1895\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.95 (3H, d, J=6.9 Hz), 1.17 (3H, d, 6.9 Hz), 3.34 (2H, d, J=12.3 Hz), 4.39 (1H, d, J=12.9 Hz), 4.56-4.65 (1H, m), 4.85 (1H, d, J=12.9 Hz), 4.93 (1H, m), 5.77 (1H, d, J=7.5 Hz), 6.77-6.81 (1H, m), 6.79 (1H, d, J=7.5 Hz), 7.00-7.05 (1H, m), 7.21-7.29 (2H, m), 7.32-7.42 (3H, m).</p>\n",
       "<heading id=\"h-0984\" level=\"1\">Example 387</heading>\n",
       "<p id=\"p-1884\" num=\"1896\"><chemistry id=\"CHEM-US-00505\" num=\"00505\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00505.TIF\" he=\"44.70mm\" id=\"EMI-C00505\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1885\" num=\"1897\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.06-1.17 (6H, m), 4.02-4.17 (1H, m), 4.61-4.78 (2H, m), 5.16 (1H, d, J=5.1 Hz), 5.72 (1H, t, J=8.1 Hz), 6.54 (0.5H, d, J=7.8 Hz), 6.84 (0.5H, d, J=7.8 Hz), 6.91-7.08 (2H, m), 7.16-7.47 (4H, m), 7.56-7.59 (1H, m), 8.00 (0.5H, J=6.3 Hz), 8.09-8.12 (0.5H, m), 8.51 (0.5H, s), 8.68 (0.5H, s).</p>\n",
       "<heading id=\"h-0985\" level=\"1\">Example 388</heading>\n",
       "<p id=\"p-1886\" num=\"1898\"><chemistry id=\"CHEM-US-00506\" num=\"00506\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00506.TIF\" he=\"38.86mm\" id=\"EMI-C00506\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1887\" num=\"1899\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.19 (3H, d, J=6.9 Hz), 1.25 (3H, d, J=6.9 Hz), 2.76-2.91 (2H, m), 3.23-3.31 (1H, m), 4.17-4.33 (2H, m), 4.54-4.84 (2H, m), 5.18 (1H, s), 5.87 (1H, d, J=7.8 Hz), 6.70 (1H, d, J=5.1 Hz), 6.86 (1H, d, J=7.8 Hz), 7.04 (1H, d, J=5.1 Hz), 7.19-7.25 (2H, m), 7.32-7.38 (2H, m).</p>\n",
       "<heading id=\"h-0986\" level=\"1\">Example 389</heading>\n",
       "<p id=\"p-1888\" num=\"1900\"><chemistry id=\"CHEM-US-00507\" num=\"00507\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00507.TIF\" he=\"46.40mm\" id=\"EMI-C00507\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1889\" num=\"1901\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.04-1.20 (6H, m), 2.83-3.02 (1H, m), 3.46-3.57 (1H, m), 3.75-3.85 (1H, m), 4.13-4.26 (1H, m), 4.32-4.50 (1H, m), 4.56-4.62 (1H, m), 4.89 (1H, d, J=13.2 Hz), 5.36 (1H, s), 5.44-5.50 (1H, m), 6.73 (1H, d, J=7.8 Hz), 6.86 (1H, t, J=7.5 Hz), 6.95-6.98 (1H, m), 7.09-6.54 (5H, m).</p>\n",
       "<heading id=\"h-0987\" level=\"1\">Example 390</heading>\n",
       "<p id=\"p-1890\" num=\"1902\"><chemistry id=\"CHEM-US-00508\" num=\"00508\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00508.TIF\" he=\"186.52mm\" id=\"EMI-C00508\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-0988\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1891\" num=\"1903\">Compound 390A (14.8 g, 115 mmol) was added to methanol (200 ml), sodium methoxide (28% methanol solution, 22.2 g, 115 mmol) was added at room temperature, and the mixture was stirred for 1 hour. The solvent was distilled off under reduced pressure to obtain 17.3 g of a white solid. To 5.61 g of it was added phthalide (5.00 g, 37.3 mmol), and the mixture was stirred at 200° C. for 1 hour. The reaction solution was poured into water, the mixture was made acidic with hydrochloric acid, and the generated white precipitate was filtered. This was dissolved in chloroform, the solution was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-chloroform-diisopropyl ether, and the precipitated residue was filtered to obtain 2.44 g of a pale brown solid 390B.</p>\n",
       "<p id=\"p-1892\" num=\"1904\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 5.61 (2H, s), 6.92 (1H, td, J=7.6, 1.4 Hz), 7.01 (1H, dd, J=8.3, 1.3 Hz), 7.21 (1H, ddd, J=8.7, 7.0, 1.2 Hz), 7.32-7.54 (2H, m), 7.66 (1H, td, J=7.6, 1.4 Hz), 7.92-7.99 (1H, m), 8.17 (1H, dd, J=7.9, 1.3 Hz).</p>\n",
       "<heading id=\"h-0989\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1893\" num=\"1905\">Compound 390B (2.44 g, 9.29 mmol) was dissolved in dichloromethane (30 ml), trifluoroacetic acid anhydride (1.44 ml, 10.2 mmol) and boron trifluoride etherate (0.235 ml, 1.86 mmol) were added, and the mixture was stirred at room temperature for 3 hours. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was washed with 1N hydrochloric acid and an aqueous saturated sodium chloride solution, and the solvent was distilled off. The resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (4:1, v/v) to obtain 1.76 g of a pale yellow solid 390C.</p>\n",
       "<p id=\"p-1894\" num=\"1906\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 5.36 (2H, s), 7.11 (1H, t, J=8.0 Hz), 7.43-7.66 (4H, m), 7.93 (1H, d, J=6.5 Hz), 8.19 (1H, dd, J=8.1, 1.8 Hz).</p>\n",
       "<heading id=\"h-0990\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-1895\" num=\"1907\">To compound 390C (1.76 g, 7.19 mmol) was added methanol (20 ml), sodium borohydride (327 mg, 8.63 mmol) was added at 0° C., and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 1.44 g of a white solid 390D.</p>\n",
       "<p id=\"p-1896\" num=\"1908\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.75 (1H, d, J=5.0 Hz), 5.18 (1H, d, J=13.6 Hz), 5.69 (1H, d, J=5.0 Hz), 5.89 (1H, d, J=13.6 Hz), 6.93 (1H, t, J=7.9 Hz), 7.19-7.43 (6H, m).</p>\n",
       "<heading id=\"h-0991\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-1897\" num=\"1909\">Compound 390 was synthesized by the same procedure as that of Example 107.</p>\n",
       "<p id=\"p-1898\" num=\"1910\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-1899\" num=\"1911\">Using amines which are commercially available or known in the references and intermediates corresponding to 390A to 390D which are commercially available or known in the references, and according to the method of Example 390, compounds 391 to 412 were synthesized.</p>\n",
       "<heading id=\"h-0992\" level=\"1\">Example 391</heading>\n",
       "<p id=\"p-1900\" num=\"1912\"><chemistry id=\"CHEM-US-00509\" num=\"00509\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00509.TIF\" he=\"39.62mm\" id=\"EMI-C00509\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1901\" num=\"1913\">MS: m/z=418 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0993\" level=\"1\">Example 392</heading>\n",
       "<p id=\"p-1902\" num=\"1914\"><chemistry id=\"CHEM-US-00510\" num=\"00510\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00510.TIF\" he=\"39.71mm\" id=\"EMI-C00510\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1903\" num=\"1915\">MS: m/z=416 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0994\" level=\"1\">Example 393</heading>\n",
       "<p id=\"p-1904\" num=\"1916\"><chemistry id=\"CHEM-US-00511\" num=\"00511\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00511.TIF\" he=\"39.62mm\" id=\"EMI-C00511\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1905\" num=\"1917\">MS: m/z=458 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0995\" level=\"1\">Example 394</heading>\n",
       "<p id=\"p-1906\" num=\"1918\"><chemistry id=\"CHEM-US-00512\" num=\"00512\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00512.TIF\" he=\"42.33mm\" id=\"EMI-C00512\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1907\" num=\"1919\">MS: m/z=434 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0996\" level=\"1\">Example 395</heading>\n",
       "<p id=\"p-1908\" num=\"1920\"><chemistry id=\"CHEM-US-00513\" num=\"00513\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00513.TIF\" he=\"39.62mm\" id=\"EMI-C00513\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1909\" num=\"1921\">MS: m/z=390 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-0997\" level=\"1\">Example 396</heading>\n",
       "<p id=\"p-1910\" num=\"1922\"><chemistry id=\"CHEM-US-00514\" num=\"00514\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00514.TIF\" he=\"45.04mm\" id=\"EMI-C00514\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1911\" num=\"1923\">MS: m/z=468 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0998\" level=\"1\">Example 397</heading>\n",
       "<p id=\"p-1912\" num=\"1924\"><chemistry id=\"CHEM-US-00515\" num=\"00515\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00515.TIF\" he=\"42.33mm\" id=\"EMI-C00515\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1913\" num=\"1925\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-0999\" level=\"1\">Example 398</heading>\n",
       "<p id=\"p-1914\" num=\"1926\"><chemistry id=\"CHEM-US-00516\" num=\"00516\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00516.TIF\" he=\"39.62mm\" id=\"EMI-C00516\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1915\" num=\"1927\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.12-1.32 (6H, m), 4.25 (0.52H, d, J=12.9 Hz), 4.41 (0.48H, d, J=13.2 Hz), 4.58-4.79 (2H, m), 4.92-5.03 (2H, m), 5.73 (0.48H, d, J=7.8 Hz), 5.89 (0.52H, d, J=7.8 Hz), 6.12 (0.48H, d, J=12 Hz), 6.46-6.58 (1.52H, m), 6.74-6.78 (1H, m), 6.98 (1H, t, J=7.5 Hz), 7.10-7.14 (1H, m), 7.20-7.50 (4H, m).</p>\n",
       "<heading id=\"h-1000\" level=\"1\">Example 399</heading>\n",
       "<p id=\"p-1916\" num=\"1928\"><chemistry id=\"CHEM-US-00517\" num=\"00517\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00517.TIF\" he=\"39.62mm\" id=\"EMI-C00517\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1917\" num=\"1929\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.12-1.31 (6H, m), 4.25 (0.75H, d, J=12.9 Hz), 4.43 (0.25H, d, J=12.9 Hz), 4.53-4.60 (0.50H, m), 4.67-4.78 (1.5H, m), 4.90-5.05 (2H, m), 5.70 (0.25H, d, J=7.8 Hz, 5.86 (0.75H, d, J=7.5 Hz), 6.18 (0.25H, d, J=13.5 Hz), 6.36-6.42 (0.75H, m), 6.49-6.56 (2H, m), 6.69-6.80 (1H, m), 6.94 (1H, d, J=7.8 Hz), 7.10-7.19 (0.25H, m), 7.21-7.50 (3.75H, m).</p>\n",
       "<heading id=\"h-1001\" level=\"1\">Example 400</heading>\n",
       "<p id=\"p-1918\" num=\"1930\"><chemistry id=\"CHEM-US-00518\" num=\"00518\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00518.TIF\" he=\"44.96mm\" id=\"EMI-C00518\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1919\" num=\"1931\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1002\" level=\"1\">Example 401</heading>\n",
       "<p id=\"p-1920\" num=\"1932\"><chemistry id=\"CHEM-US-00519\" num=\"00519\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00519.TIF\" he=\"42.33mm\" id=\"EMI-C00519\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1921\" num=\"1933\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1003\" level=\"1\">Example 402</heading>\n",
       "<p id=\"p-1922\" num=\"1934\"><chemistry id=\"CHEM-US-00520\" num=\"00520\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00520.TIF\" he=\"42.33mm\" id=\"EMI-C00520\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1923\" num=\"1935\">MS: m/z=470 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1004\" level=\"1\">Example 403</heading>\n",
       "<p id=\"p-1924\" num=\"1936\"><chemistry id=\"CHEM-US-00521\" num=\"00521\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00521.TIF\" he=\"42.33mm\" id=\"EMI-C00521\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1925\" num=\"1937\">MS: m/z=436 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1005\" level=\"1\">Example 404</heading>\n",
       "<p id=\"p-1926\" num=\"1938\"><chemistry id=\"CHEM-US-00522\" num=\"00522\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00522.TIF\" he=\"42.33mm\" id=\"EMI-C00522\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1927\" num=\"1939\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1006\" level=\"1\">Example 405</heading>\n",
       "<p id=\"p-1928\" num=\"1940\"><chemistry id=\"CHEM-US-00523\" num=\"00523\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00523.TIF\" he=\"44.96mm\" id=\"EMI-C00523\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1929\" num=\"1941\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1007\" level=\"1\">Example 406</heading>\n",
       "<p id=\"p-1930\" num=\"1942\"><chemistry id=\"CHEM-US-00524\" num=\"00524\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00524.TIF\" he=\"42.33mm\" id=\"EMI-C00524\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1931\" num=\"1943\">MS: m/z=490 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1008\" level=\"1\">Example 407</heading>\n",
       "<p id=\"p-1932\" num=\"1944\"><chemistry id=\"CHEM-US-00525\" num=\"00525\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00525.TIF\" he=\"42.25mm\" id=\"EMI-C00525\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1933\" num=\"1945\">MS: m/z=436 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1009\" level=\"1\">Example 408</heading>\n",
       "<p id=\"p-1934\" num=\"1946\"><chemistry id=\"CHEM-US-00526\" num=\"00526\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00526.TIF\" he=\"39.62mm\" id=\"EMI-C00526\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1935\" num=\"1947\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1010\" level=\"1\">Example 409</heading>\n",
       "<p id=\"p-1936\" num=\"1948\"><chemistry id=\"CHEM-US-00527\" num=\"00527\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00527.TIF\" he=\"39.62mm\" id=\"EMI-C00527\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1937\" num=\"1949\">MS: m/z=452 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1011\" level=\"1\">Example 410</heading>\n",
       "<p id=\"p-1938\" num=\"1950\"><chemistry id=\"CHEM-US-00528\" num=\"00528\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00528.TIF\" he=\"39.62mm\" id=\"EMI-C00528\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1939\" num=\"1951\">MS: m/z=490 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1012\" level=\"1\">Example 411</heading>\n",
       "<p id=\"p-1940\" num=\"1952\"><chemistry id=\"CHEM-US-00529\" num=\"00529\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00529.TIF\" he=\"42.33mm\" id=\"EMI-C00529\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1941\" num=\"1953\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1013\" level=\"1\">Example 412</heading>\n",
       "<p id=\"p-1942\" num=\"1954\"><chemistry id=\"CHEM-US-00530\" num=\"00530\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00530.TIF\" he=\"45.47mm\" id=\"EMI-C00530\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1943\" num=\"1955\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.13-1.31 (12H, m), 3.28-3.37 (0.50H, m), 3.44-3.53 (0.50H, m), 4.29-4.36 (1H, m), 4.65-4.76 (2H, m), 4.98-5.05 (2H, m), 6.37 (0.5H, d, J=12.9 Hz), 6.45 (0.5H, d, J=7.5 Hz), 6.67 (0.5H, t, J=7.8 Hz), 6.81 (0.5H, 7.8 Hz), 6.98-7.08 (2H, m), 7.14 (0.5Hm d, J=7.8 Hz), 7.22-7.45 (2.5H, m).</p>\n",
       "<heading id=\"h-1014\" level=\"1\">Example 413, Example 414</heading>\n",
       "<p id=\"p-1944\" num=\"1956\"><chemistry id=\"CHEM-US-00531\" num=\"00531\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00531.TIF\" he=\"134.70mm\" id=\"EMI-C00531\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1015\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-1945\" num=\"1957\">Compound 413A (200 mg, 0.544 mmol) obtained by the same procedure as that of Example 95, and 6,11-dihydrodibenzo[b,e]thiepin-11-ol (124 mg 0.554 mmol) were dissolved in acetic acid (8 ml), and concentrated sulfuric acid (2 ml) was added dropwise under water-cooling. After the mixture was stirred at room temperature for 30 minutes, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a crude product of 413B.</p>\n",
       "<heading id=\"h-1016\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-1946\" num=\"1958\">Compound 413B obtained in the first step was dissolved in dichloromethane (2 ml), acetic acid anhydride (0.154 ml, 1.63 mmol), triethylamine (0.226 ml, 1.63 mmol) and 4-(dimethylamino)pyridine (cat.) were added, and the mixture was stirred at room temperature for 30 minutes. The solvent was distilled off, the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), and diastereomers were resolved. They were dissolved in methanol (1 ml) and tetrahydrofran (1 ml), respectively, a 2N aqueous sodium hydroxide solution (0.198 ml, 0.397 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into water, and the mixture was made acidic with hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound were added ethyl acetate-diethyl ether, and the fractionation-precipitated residue was filtered to obtain compound 413 (22 mg) and compound 414 (20 mg), respectively.</p>\n",
       "<heading id=\"h-1017\" level=\"1\">Example 413</heading>\n",
       "<p id=\"p-1947\" num=\"1959\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.20 (3H, d, J=7.4 Hz), 3.92 (1H, d, J=13.6 Hz), 4.45 (1H, d, J=13.4 Hz), 5.12 (1H, d, J=12.8 Hz), 5.60 (4H, m), 6.87-7.60 (9H, m).</p>\n",
       "<p id=\"p-1948\" num=\"1960\">MS: m/z=488 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1018\" level=\"1\">Example 414</heading>\n",
       "<p id=\"p-1949\" num=\"1961\">MS: m/z=488 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-1950\" num=\"1962\">According to Example 413, compounds 414 to 475 were synthesized using the same procedure.</p>\n",
       "<heading id=\"h-1019\" level=\"1\">Example 415</heading>\n",
       "<p id=\"p-1951\" num=\"1963\"><chemistry id=\"CHEM-US-00532\" num=\"00532\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00532.TIF\" he=\"39.62mm\" id=\"EMI-C00532\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1952\" num=\"1964\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.16 (3H, d, J=7.3 Hz), 3.88 (1H, d, J=13.3 Hz), 4.41 (1H, d, J=13.3 Hz), 5.07 (1H, d, J=13.0 Hz), 5.42-5.52 (1H, m), 5.62 (3H, m), 6.82-7.56 (9H, m).</p>\n",
       "<p id=\"p-1953\" num=\"1965\">MS: m/z=488 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1020\" level=\"1\">Example 416</heading>\n",
       "<p id=\"p-1954\" num=\"1966\"><chemistry id=\"CHEM-US-00533\" num=\"00533\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00533.TIF\" he=\"39.62mm\" id=\"EMI-C00533\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1955\" num=\"1967\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.35 (3H, d, J=7.3 Hz), 3.88 (1H, d, J=13.3 Hz), 4.44 (1H, d, J=12.7 Hz), 5.15 (1H, d, J=12.5 Hz), 5.16 (1H, m), 5.29 (1H, s), 5.57 (1H, d, J=13.4 Hz), 5.64 (1H, d, J=7.8 Hz), 6.81-7.45 (9H, m).</p>\n",
       "<p id=\"p-1956\" num=\"1968\">MS: m/z=488 [M+H]</p>\n",
       "<heading id=\"h-1021\" level=\"1\">Example 417</heading>\n",
       "<p id=\"p-1957\" num=\"1969\"><chemistry id=\"CHEM-US-00534\" num=\"00534\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00534.TIF\" he=\"42.33mm\" id=\"EMI-C00534\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1958\" num=\"1970\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.22 (3H, d, J=7.2 Hz), 4.32 (1H, d, J=13.9 Hz), 4.49 (1H, d, J=13.1 Hz), 4.90 (1H, d, J=13.3 Hz), 5.15 (1H, s), 5.47-5.65 (2H, m), 5.83 (1H, d, J=8.1 Hz), 6.69 (1H, d, J=6.5 Hz), 6.80-6.87 (1H, m), 7.07-7.24 (5H, m), 7.54 (1H, d, J=7.9 Hz).</p>\n",
       "<p id=\"p-1959\" num=\"1971\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1022\" level=\"1\">Example 418</heading>\n",
       "<p id=\"p-1960\" num=\"1972\"><chemistry id=\"CHEM-US-00535\" num=\"00535\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00535.TIF\" he=\"39.71mm\" id=\"EMI-C00535\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1961\" num=\"1973\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.48 (3H, d, J=7.1 Hz), 3.63 (1H, d, J=13.2 Hz), 4.49 (1H, d, J=12.6 Hz), 5.03 (1H, s), 5.28-5.45 (2H, m), 5.53 (1H, d, J=13.5 Hz), 5.73 (1H, d, J=7.7 Hz), 6.50 (1H, dd, J=8.7, 2.6 Hz), 6.79-6.86 (1H, m), 6.90 (1H, d, J=9.1 Hz), 7.02 (1H, dd, J=8.8, 5.2 Hz), 7.10 (1H, ddd, J=8.1, 2.5, 1.2 Hz), 7.25 (1H, d, J=7.7 Hz), 7.30 (1H, dd, J=8.5, 5.5 Hz).</p>\n",
       "<p id=\"p-1962\" num=\"1974\">MS: m/z=524 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1023\" level=\"1\">Example 419</heading>\n",
       "<p id=\"p-1963\" num=\"1975\"><chemistry id=\"CHEM-US-00536\" num=\"00536\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00536.TIF\" he=\"42.33mm\" id=\"EMI-C00536\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1964\" num=\"1976\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.50 (3H, d, J=7.1 Hz), 4.28 (1H, d, J=13.7 Hz), 4.50 (1H, d, J=12.4 Hz), 5.17 (1H, s), 5.26-5.44 (2H, m), 5.60-5.69 (2H, m), 6.65 (1H, d, J=7.4 Hz), 6.73-6.80 (1H, m), 7.01-7.21 (5H, m), 7.48 (1H, d, J=8.0 Hz).</p>\n",
       "<p id=\"p-1965\" num=\"1977\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1024\" level=\"1\">Example 420</heading>\n",
       "<p id=\"p-1966\" num=\"1978\"><chemistry id=\"CHEM-US-00537\" num=\"00537\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00537.TIF\" he=\"42.33mm\" id=\"EMI-C00537\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1967\" num=\"1979\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.49 (3H, d, J=7.4 Hz), 3.51 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=12.6 Hz), 5.12 (1H, s), 5.28-5.44 (2H, m), 5.60-5.70 (2H, m), 6.65 (1H, d, J=7.4 Hz), 6.73-6.80 (1H, m), 7.00-7.06 (2H, m), 7.10 (1H, d, J=8.5 Hz), 7.14 (1H, d, J=8.0 Hz), 7.23 (1H, dd, J=8.2, 2.2 Hz), 7.31 (1H, d, J=1.9 Hz).</p>\n",
       "<p id=\"p-1968\" num=\"1980\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1025\" level=\"1\">Example 421</heading>\n",
       "<p id=\"p-1969\" num=\"1981\"><chemistry id=\"CHEM-US-00538\" num=\"00538\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00538.TIF\" he=\"39.62mm\" id=\"EMI-C00538\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1970\" num=\"1982\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.53 (3H, d, J=7.4 Hz), 3.59 (1H, d, J=13.4 Hz), 4.51 (1H, d, J=12.6 Hz), 5.12 (1H, s), 5.30-5.48 (2H, m), 5.62-5.70 (2H, m), 6.71 (1H, d, J=7.7 Hz), 6.80-6.83 (1H, m), 7.07-7.11 (2H, m), 7.18 (1H, d, J=7.7 Hz), 7.22 (1H, s), 7.28 (1H, d, J=8.4 Hz), 7.39 (1H, d, J=8.1 Hz).</p>\n",
       "<p id=\"p-1971\" num=\"1983\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1026\" level=\"1\">Example 422</heading>\n",
       "<p id=\"p-1972\" num=\"1984\"><chemistry id=\"CHEM-US-00539\" num=\"00539\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00539.TIF\" he=\"42.33mm\" id=\"EMI-C00539\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1973\" num=\"1985\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.49 (3H, d, J=7.4 Hz), 3.59 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=12.4 Hz), 5.12 (1H, s), 5.29-5.39 (2H, m), 5.66 (1H, d, J=13.5 Hz), 5.73 (1H, d, J=7.7 Hz), 6.61 (1H, d, J=8.2 Hz), 6.73 (1H, dd, J=8.2, 2.2 Hz), 7.04 (1H, d, J=2.2 Hz), 7.12-7.20 (2H, m), 7.23-7.27 (1H, m), 7.31 (1H, d, J=6.3 Hz), 7.36-7.44 (1H, m).</p>\n",
       "<p id=\"p-1974\" num=\"1986\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1027\" level=\"1\">Example 423</heading>\n",
       "<p id=\"p-1975\" num=\"1987\"><chemistry id=\"CHEM-US-00540\" num=\"00540\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00540.TIF\" he=\"42.33mm\" id=\"EMI-C00540\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1976\" num=\"1988\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.47 (3H, d, J=7.1 Hz), 3.69 (1H, d, J=13.5 Hz), 4.49 (1H, d, J=12.6 Hz), 5.21 (1H, s), 5.27 (1H, d, J=12.6 Hz), 5.30-5.40 (1H, m), 5.70 (1H, d, J=7.7 Hz), 5.75 (1H, d, J=13.5 Hz), 6.65 (1H, dd, J=7.8, 1.5 Hz), 6.73 (1H, t, J=7.7 Hz), 7.13 (1H, d, J=7.7 Hz), 7.15-7.22 (2H, m), 7.25-7.29 (1H, m), 7.32 (1H, d, J=8.0 Hz), 7.37-7.45 (1H, m).</p>\n",
       "<p id=\"p-1977\" num=\"1989\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1028\" level=\"1\">Example 424</heading>\n",
       "<p id=\"p-1978\" num=\"1990\"><chemistry id=\"CHEM-US-00541\" num=\"00541\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00541.TIF\" he=\"42.25mm\" id=\"EMI-C00541\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1979\" num=\"1991\">MS: m/z=490 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1029\" level=\"1\">Example 425</heading>\n",
       "<p id=\"p-1980\" num=\"1992\"><chemistry id=\"CHEM-US-00542\" num=\"00542\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00542.TIF\" he=\"42.33mm\" id=\"EMI-C00542\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1981\" num=\"1993\">MS: m/z=490 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1030\" level=\"1\">Example 426</heading>\n",
       "<p id=\"p-1982\" num=\"1994\"><chemistry id=\"CHEM-US-00543\" num=\"00543\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00543.TIF\" he=\"42.25mm\" id=\"EMI-C00543\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1983\" num=\"1995\">MS: m/z=490 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1031\" level=\"1\">Example 427</heading>\n",
       "<p id=\"p-1984\" num=\"1996\"><chemistry id=\"CHEM-US-00544\" num=\"00544\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00544.TIF\" he=\"42.25mm\" id=\"EMI-C00544\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1985\" num=\"1997\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.14 (3H, d, J=6.9 Hz), 3.64 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=12.8 Hz), 4.88 (1H, d, J=12.8 Hz), 5.08 (1H, s), 5.51 (1H, m), 5.60 (1H, d, J=13.5 Hz), 5.93 (1H, d, J=8.1 Hz), 6.58 (1H, d, J=8.1 Hz), 6.95 (1H, dd, J=2.0, 8.1 Hz), 7.18 (2H, m), 7.29 (1H, m), 7.37-7.45 (2H, m).</p>\n",
       "<heading id=\"h-1032\" level=\"1\">Example 428</heading>\n",
       "<p id=\"p-1986\" num=\"1998\"><chemistry id=\"CHEM-US-00545\" num=\"00545\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00545.TIF\" he=\"42.33mm\" id=\"EMI-C00545\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1987\" num=\"1999\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.41 (3H, d, J=7.5 Hz), 3.61 (1H, d, J=13.4 Hz), 4.55 (1H, d, J=12.5 Hz), 5.06 (1H, d, J=12.5 Hz), 5.16 (1H, s), 5.34 (1H, m), 5.63 (1H, d, J=13.4 Hz), 5.87 (1H, d, J=8.1 Hz), 6.61 (1H, d, J=8.1 Hz), 6.93 (1H, dd, J=1.8, 8.1 Hz), 7.16-7.41 (5H, m).</p>\n",
       "<heading id=\"h-1033\" level=\"1\">Example 429</heading>\n",
       "<p id=\"p-1988\" num=\"2000\"><chemistry id=\"CHEM-US-00546\" num=\"00546\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00546.TIF\" he=\"43.18mm\" id=\"EMI-C00546\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1989\" num=\"2001\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.15 (3H, d, J=7.4 Hz), 3.64 (1H, d, J=13.5 Hz), 4.44 (1H, d, J=13.2 Hz), 4.87 (1H, d, J=13.2 Hz), 5.44-5.57 (1H, m), 5.68 (1H, d, J=13.2 Hz), 5.83 (1H, d, J=7.7 Hz), 5.94 (1H, s), 6.78-6.91 (2H, m), 7.08-7.18 (3H, m), 7.28-7.38 (3H, m).</p>\n",
       "<p id=\"p-1990\" num=\"2002\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1034\" level=\"1\">Example 430</heading>\n",
       "<p id=\"p-1991\" num=\"2003\"><chemistry id=\"CHEM-US-00547\" num=\"00547\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00547.TIF\" he=\"44.20mm\" id=\"EMI-C00547\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1992\" num=\"2004\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1035\" level=\"1\">Example 431</heading>\n",
       "<p id=\"p-1993\" num=\"2005\"><chemistry id=\"CHEM-US-00548\" num=\"00548\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00548.TIF\" he=\"43.18mm\" id=\"EMI-C00548\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1994\" num=\"2006\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1036\" level=\"1\">Example 432</heading>\n",
       "<p id=\"p-1995\" num=\"2007\"><chemistry id=\"CHEM-US-00549\" num=\"00549\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00549.TIF\" he=\"42.50mm\" id=\"EMI-C00549\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1996\" num=\"2008\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.21 (3H, d, J=7.4 Hz), 3.70 (1H, d, J=13.5 Hz), 4.43 (1H, d, J=13.2 Hz), 4.93 (1H, d, J=13.2 Hz), 5.21 (1H, s), 5.46-5.60 (1H, m), 5.70 (1H, d, J=13.5 Hz), 5.84 (1H, d, J=7.7 Hz), 6.73 (1H, d, J=7.1 Hz), 6.82-6.89 (1H, m), 7.08-7.17 (2H, m), 7.22 (1H, d, J=7.7 Hz), 7.35 (1H, d, J=8.0 Hz), 7.55 (1H, d, J=8.0 Hz), 7.67 (1H, s).</p>\n",
       "<p id=\"p-1997\" num=\"2009\">MS: m/z=071 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1037\" level=\"1\">Example 433</heading>\n",
       "<p id=\"p-1998\" num=\"2010\"><chemistry id=\"CHEM-US-00550\" num=\"00550\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00550.TIF\" he=\"42.25mm\" id=\"EMI-C00550\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-1999\" num=\"2011\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.22 (3H, d, J=7.1 Hz), 3.56 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=13.2 Hz), 4.90 (1H, d, J=13.2 Hz), 5.09 (1H, s), 5.46-5.60 (1H, m), 5.62 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.7 Hz), 6.69 (1H, d, J=7.4 Hz), 6.84 (1H, dt, J=10.0, 3.5 Hz), 7.04-7.14 (3H, m), 7.17 (1H, d, J=7.7 Hz), 7.42 (1H, dd, J=8.0, 1.6 Hz), 7.55 (1H, d, J=1.9 Hz).</p>\n",
       "<p id=\"p-2000\" num=\"2012\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1038\" level=\"1\">Example 434</heading>\n",
       "<p id=\"p-2001\" num=\"2013\"><chemistry id=\"CHEM-US-00551\" num=\"00551\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00551.TIF\" he=\"42.25mm\" id=\"EMI-C00551\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2002\" num=\"2014\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.44 (3H, d, J=7.3 Hz), 3.54 (1H, d, J=13.4 Hz), 4.54 (1H, d, J=12.5 Hz), 5.10 (1H, d, J=12.5 Hz), 5.16 (1H, s), 5.31-5.45 (1H, m), 5.65 (1H, d, J=13.3 Hz), 5.73 (1H, d, J=7.8 Hz), 6.71 (1H, d, J=7.8 Hz), 6.77-6.84 (1H, m), 7.03-7.11 (3H, m), 7.22 (1H, d, J=7.6 Hz), 7.40 (1H, dd, J=8.2, 2.0 Hz), 7.48 (1H, d, J=2.0 Hz).</p>\n",
       "<p id=\"p-2003\" num=\"2015\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1039\" level=\"1\">Example 435</heading>\n",
       "<p id=\"p-2004\" num=\"2016\"><chemistry id=\"CHEM-US-00552\" num=\"00552\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00552.TIF\" he=\"42.76mm\" id=\"EMI-C00552\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2005\" num=\"2017\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.14 (3H, d, J=7.3 Hz), 3.70 (1H, d, J=13.4 Hz), 4.51 (1H, d, J=13.1 Hz), 4.90 (1H, d, J=12.8 Hz), 5.19 (1H, s), 5.44-5.58 (1H, m), 5.62 (1H, d, J=13.3 Hz), 5.87 (1H, d, J=7.6 Hz), 6.86 (1H, d, J=7.9 Hz), 7.07 (1H, dd, J=8.2, 1.4 Hz), 7.15-7.22 (2H, m), 7.27-7.51 (4H, m).</p>\n",
       "<p id=\"p-2006\" num=\"2018\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1040\" level=\"1\">Example 436</heading>\n",
       "<p id=\"p-2007\" num=\"2019\"><chemistry id=\"CHEM-US-00553\" num=\"00553\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00553.TIF\" he=\"42.76mm\" id=\"EMI-C00553\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2008\" num=\"2020\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.48 (3H, d, J=7.4 Hz), 3.71 (1H, d, J=13.3 Hz), 4.60 (1H, d, J=12.6 Hz), 5.21 (1H, d, J=12.6 Hz), 5.29 (1H, s), 5.32-5.46 (1H, m), 5.70 (1H, d, J=13.3 Hz), 5.80 (1H, d, J=7.7 Hz), 6.91 (1H, d, J=7.9 Hz), 7.08 (1H, d, J=7.4 Hz), 7.20-7.29 (2H, m), 7.33-7.51 (4H, m).</p>\n",
       "<p id=\"p-2009\" num=\"2021\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1041\" level=\"1\">Example 437</heading>\n",
       "<p id=\"p-2010\" num=\"2022\"><chemistry id=\"CHEM-US-00554\" num=\"00554\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00554.TIF\" he=\"42.33mm\" id=\"EMI-C00554\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2011\" num=\"2023\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.21 (3H, d, J=7.3 Hz), 3.60 (1H, d, J=13.6 Hz), 4.46 (1H, d, J=13.1 Hz), 4.90 (1H, d, J=12.8 Hz), 5.15 (1H, s), 5.47-5.59 (1H, m), 5.68 (1H, d, J=13.4 Hz), 5.83 (1H, d, J=7.6 Hz), 6.70 (1H, d, J=7.3 Hz), 6.80-6.88 (1H, m), 7.07-7.26 (6H, m).</p>\n",
       "<p id=\"p-2012\" num=\"2024\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1042\" level=\"1\">Example 438</heading>\n",
       "<p id=\"p-2013\" num=\"2025\"><chemistry id=\"CHEM-US-00555\" num=\"00555\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00555.TIF\" he=\"42.33mm\" id=\"EMI-C00555\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2014\" num=\"2026\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.42 (3H, d, J=7.3 Hz), 3.57 (1H, d, J=13.3 Hz), 4.55 (1H, d, J=12.5 Hz), 5.05 (1H, d, J=12.5 Hz), 5.23 (1H, s), 5.32-5.47 (1H, m), 5.70 (1H, d, J=13.4 Hz), 5.77 (1H, d, J=7.6 Hz), 6.74 (1H, d, J=7.8 Hz), 6.79-6.87 (1H, m), 7.04-7.26 (6H, m).</p>\n",
       "<p id=\"p-2015\" num=\"2027\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1043\" level=\"1\">Example 439</heading>\n",
       "<p id=\"p-2016\" num=\"2028\"><chemistry id=\"CHEM-US-00556\" num=\"00556\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00556.TIF\" he=\"41.57mm\" id=\"EMI-C00556\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2017\" num=\"2029\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.20 (3H, d, J=7.2 Hz), 2.29 (3H, s), 3.76 (1H, d, J=13.3 Hz), 4.54 (1H, d, J=13.1 Hz), 4.92 (1H, d, J=13.1 Hz), 5.18 (1H, s), 5.50-5.62 (1H, m), 5.71 (1H, d, J=13.4 Hz), 5.84 (1H, d, J=7.7 Hz), 6.63 (1H, d, J=7.4 Hz), 6.78 (1H, t, J=7.6 Hz), 7.06 (1H, d, J=7.6 Hz), 7.17 (1H, d, J=7.7 Hz), 7.23 (1H, d, J=7.6 Hz), 7.28-7.34 (1H, m), 7.39-7.51 (2H, m).</p>\n",
       "<p id=\"p-2018\" num=\"2030\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1044\" level=\"1\">Example 440</heading>\n",
       "<p id=\"p-2019\" num=\"2031\"><chemistry id=\"CHEM-US-00557\" num=\"00557\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00557.TIF\" he=\"41.57mm\" id=\"EMI-C00557\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2020\" num=\"2032\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.45 (3H, d, J=7.2 Hz), 2.27 (3H, s), 3.74 (1H, d, J=13.3 Hz), 4.61 (1H, d, J=12.4 Hz), 5.07 (1H, d, J=12.4 Hz), 5.27 (1H, s), 5.31-5.44 (1H, m), 5.75 (1H, d, J 13.3 Hz), 5.80 (1H, d, J=7.7 Hz), 6.67 (1H, d, J=7.1 Hz), 6.77 (1H, t, J=7.6 Hz), 7.04 (1H, d, J=7.1 Hz), 7.21-7.47 (5H, m).</p>\n",
       "<p id=\"p-2021\" num=\"2033\">MS: m/z=433 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1045\" level=\"1\">Example 441</heading>\n",
       "<p id=\"p-2022\" num=\"2034\"><chemistry id=\"CHEM-US-00558\" num=\"00558\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00558.TIF\" he=\"39.62mm\" id=\"EMI-C00558\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2023\" num=\"2035\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.22 (3H, d, J=7.2 Hz), 3.94 (1H, d, J=13.3 Hz), 4.45 (1H, d, J=13.4 Hz), 5.08 (1H, d, J=12.8 Hz), 5.56 (4H, dm), 6.84-7.54 (8H, m).</p>\n",
       "<heading id=\"h-1046\" level=\"1\">Example 442</heading>\n",
       "<p id=\"p-2024\" num=\"2036\"><chemistry id=\"CHEM-US-00559\" num=\"00559\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00559.TIF\" he=\"39.62mm\" id=\"EMI-C00559\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2025\" num=\"2037\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.37 (3H, d, J=7.2 Hz), 3.98 (1H, d, J=13.4 Hz), 4.48 (1H, d, J=13.1 Hz), 5.21 (1H, d, J=12.9 Hz), 5.22 (1H, m), 5.38 (1H, s), 5.52 (1H, d, J=13.4 Hz), 5.67 (1H, d, J=7.6 Hz), 6.87-7.57 (8H, m).</p>\n",
       "<heading id=\"h-1047\" level=\"1\">Example 443</heading>\n",
       "<p id=\"p-2026\" num=\"2038\"><chemistry id=\"CHEM-US-00560\" num=\"00560\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00560.TIF\" he=\"39.62mm\" id=\"EMI-C00560\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2027\" num=\"2039\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.19 (3H, d, J=7.2 Hz), 3.92 (1H, d, J=13.4 Hz), 4.43 (1H, d, J=13.1 Hz), 5.05 (1H, d, J=13.0 Hz), 5.54 (4H, m), 7.29 (8H, m).</p>\n",
       "<p id=\"p-2028\" num=\"2040\">MS: m/z=522 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1048\" level=\"1\">Example 444</heading>\n",
       "<p id=\"p-2029\" num=\"2041\"><chemistry id=\"CHEM-US-00561\" num=\"00561\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00561.TIF\" he=\"42.33mm\" id=\"EMI-C00561\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2030\" num=\"2042\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.13 (3H, d, J=7.0 Hz), 4.00 (1H, d, J=14.2 Hz), 4.40 (1H, d, J=13.3 Hz), 5.05 (1H, d, J=13.3 Hz), 5.44 (1H, m), 5.62-5.71 (3H, m), 6.82-7.56 (8H, m).</p>\n",
       "<p id=\"p-2031\" num=\"2043\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1049\" level=\"1\">Example 445</heading>\n",
       "<p id=\"p-2032\" num=\"2044\"><chemistry id=\"CHEM-US-00562\" num=\"00562\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00562.TIF\" he=\"42.33mm\" id=\"EMI-C00562\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2033\" num=\"2045\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.23 (3H, d, J=7.2 Hz), 4.14 (1H, d, J=13.8 Hz), 4.60 (1H, d, J=13.6 Hz), 5.10 (1H, d, J=13.3 Hz), 5.48 (1H, d, J=15.6 Hz) 5.49 (1H, m), 5.69 (1H, d, J=7.9 Hz), 5.70 (1H, s), 6.89-7.47 (8H, m).</p>\n",
       "<p id=\"p-2034\" num=\"2046\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1050\" level=\"1\">Example 446</heading>\n",
       "<p id=\"p-2035\" num=\"2047\"><chemistry id=\"CHEM-US-00563\" num=\"00563\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00563.TIF\" he=\"42.33mm\" id=\"EMI-C00563\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2036\" num=\"2048\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.22 (3H, d, J=6.9 Hz), 3.93 (1H, d, J=13.1 Hz), 4.49 (1H, d, J=13.4 Hz), 5.05 (1H, d, J=13.7 Hz), 5.57 (4H, m), 6.87-7.61 (8H, m).</p>\n",
       "<p id=\"p-2037\" num=\"2049\">MS: m/z=522 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1051\" level=\"1\">Example 447</heading>\n",
       "<p id=\"p-2038\" num=\"2050\"><chemistry id=\"CHEM-US-00564\" num=\"00564\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00564.TIF\" he=\"39.62mm\" id=\"EMI-C00564\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2039\" num=\"2051\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.41 (3H, d, J=7.2 Hz), 3.98 (1H, d, J=13.3 Hz), 4.48 (1H, d, J=12.9 Hz), 5.21 (1H, d, J=14.4 Hz), 5.22 (1H, m), 5.39 (1H, s), 5.52 (1H, d, J=13.6 Hz), 5.67 (1H, d, J=7.6 Hz), 6.88-7.57 (8H, m).</p>\n",
       "<p id=\"p-2040\" num=\"2052\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1052\" level=\"1\">Example 448</heading>\n",
       "<p id=\"p-2041\" num=\"2053\"><chemistry id=\"CHEM-US-00565\" num=\"00565\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00565.TIF\" he=\"39.71mm\" id=\"EMI-C00565\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2042\" num=\"2054\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.19 (3H, d, J=7.2 Hz), 3.94 (1H, d, J=13.3 Hz), 4.44 (1H, d, J=13.3 Hz), 5.12 (1H, d, J=13.1 Hz), 5.46-5.68 (3H, m), 5.76 (1H, d, J=7.6 Hz), 7.27 (8H, m).</p>\n",
       "<p id=\"p-2043\" num=\"2055\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1053\" level=\"1\">Example 449</heading>\n",
       "<p id=\"p-2044\" num=\"2056\"><chemistry id=\"CHEM-US-00566\" num=\"00566\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00566.TIF\" he=\"42.25mm\" id=\"EMI-C00566\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2045\" num=\"2057\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.14 (3H, d, J=7.2 Hz), 3.93 (1H, d, J=13.3 Hz), 4.40 (1H, d, J=13.1 Hz), 5.07 (1H, d, J=13.0 Hz), 5.46 (1H, m), 5.62 (1H, d, J=15.6 Hz), 5.64 (1H, s), 5.75 (1H, d, J=7.6 Hz), 6.94-7.55 (8H, m).</p>\n",
       "<p id=\"p-2046\" num=\"2058\">MS: m/z=522 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1054\" level=\"1\">Example 450</heading>\n",
       "<p id=\"p-2047\" num=\"2059\"><chemistry id=\"CHEM-US-00567\" num=\"00567\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00567.TIF\" he=\"42.42mm\" id=\"EMI-C00567\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2048\" num=\"2060\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.14 (3H, d, J=7.2 Hz), 4.03 (1H, d, J=13.3 Hz), 4.41 (1H, d, J=13.3 Hz), 5.06 (1H, d, J=13.0 Hz), 5.46 (1H, m), 5.69 (3H, m), 6.88-7.57 (8H, m).</p>\n",
       "<p id=\"p-2049\" num=\"2061\">MS: m/z=522 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1055\" level=\"1\">Example 451</heading>\n",
       "<p id=\"p-2050\" num=\"2062\"><chemistry id=\"CHEM-US-00568\" num=\"00568\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00568.TIF\" he=\"42.42mm\" id=\"EMI-C00568\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2051\" num=\"2063\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.35 (3H, d, J=7.2 Hz), 4.03 (1H, d, J=13.3 Hz), 4.43 (1H, d, J=13.0 Hz), 5.14 (1H, t, J=12.6 Hz), 5.15 (1H, m), 5.42 (1H, s), 5.63 (1H, d, J=13.5 Hz), 5.65 (1H, d, J=7.8 Hz), 6.88-7.44 (8H, m).</p>\n",
       "<p id=\"p-2052\" num=\"2064\">MS: m/z=522 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1056\" level=\"1\">Example 452</heading>\n",
       "<p id=\"p-2053\" num=\"2065\"><chemistry id=\"CHEM-US-00569\" num=\"00569\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00569.TIF\" he=\"42.33mm\" id=\"EMI-C00569\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2054\" num=\"2066\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.42 (3H, d, J=7.2 Hz), 4.14 (1H, d, J=13.9 Hz), 4.57 (1H, d, J=13.1 Hz), 5.14 (1H, d, J=13.0 Hz), 5.15 (1H, m), 5.30 (1H, d, J=13.0 Hz), 5.40 (1H, s), 5.68 (1H, d, J=7.7 Hz), 6.89-7.38 (8H, m).</p>\n",
       "<p id=\"p-2055\" num=\"2067\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1057\" level=\"1\">Example 453</heading>\n",
       "<p id=\"p-2056\" num=\"2068\"><chemistry id=\"CHEM-US-00570\" num=\"00570\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00570.TIF\" he=\"42.25mm\" id=\"EMI-C00570\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2057\" num=\"2069\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.40 (3H, d, J=7.4 Hz), 4.05 (1H, d, J=13.4 Hz), 4.47 (1H, d, J=13.1 Hz), 5.18 (1H, m), 5.19 (1H, d, J=13.2 Hz), 5.46 (1H, s), 5.65 (1H, d, J=13.4 Hz), 5.74 (1H, d, J=7.6 Hz), 6.89-7.52 (8H, m).</p>\n",
       "<p id=\"p-2058\" num=\"2070\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1058\" level=\"1\">Example 454</heading>\n",
       "<p id=\"p-2059\" num=\"2071\"><chemistry id=\"CHEM-US-00571\" num=\"00571\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00571.TIF\" he=\"39.62mm\" id=\"EMI-C00571\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2060\" num=\"2072\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.20 (3H, d, J=7.2 Hz), 3.89 (1H, d, J=13.4 Hz), 4.46 (1H, d, J=13.4 Hz), 5.05 (1H, d, J=13.4 Hz), 5.44-5.66 (4H, m), 6.83-7.63 (8H, m).</p>\n",
       "<p id=\"p-2061\" num=\"2073\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1059\" level=\"1\">Example 455</heading>\n",
       "<p id=\"p-2062\" num=\"2074\"><chemistry id=\"CHEM-US-00572\" num=\"00572\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00572.TIF\" he=\"39.62mm\" id=\"EMI-C00572\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2063\" num=\"2075\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.16 (3H, d, J=7.3 Hz), 3.92 (1H, d, J=13.3 Hz), 4.39 (1H, d, J=13.1 Hz), 5.07 (1H, d, J=13.3 Hz), 5.47 (1H, m), 5.60 (1H, d, J=13.3 Hz), 5.68 (1H, s), 5.72 (1H, d, J=7.6 Hz), 7.07-7.54 (8H, m).</p>\n",
       "<p id=\"p-2064\" num=\"2076\">MS: m/z=522 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1060\" level=\"1\">Example 456</heading>\n",
       "<p id=\"p-2065\" num=\"2077\"><chemistry id=\"CHEM-US-00573\" num=\"00573\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00573.TIF\" he=\"39.62mm\" id=\"EMI-C00573\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2066\" num=\"2078\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.13 (5H, d, J=6.3 Hz), 4.00 (1H, d, J=13.4 Hz), 4.52 (1H, d, J=13.6 Hz), 5.09 (1H, d, J=13.3 Hz), 5.49-5.69 (4H, m), 6.84-7.51 (8H, m).</p>\n",
       "<p id=\"p-2067\" num=\"2079\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1061\" level=\"1\">Example 457</heading>\n",
       "<p id=\"p-2068\" num=\"2080\"><chemistry id=\"CHEM-US-00574\" num=\"00574\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00574.TIF\" he=\"39.71mm\" id=\"EMI-C00574\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2069\" num=\"2081\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.40 (3H, d, J=7.2 Hz), 4.02 (1H, d, J=13.1 Hz), 4.53 (1H, d, J=13.3 Hz), 5.20 (1H, d, J=12.9 Hz), 5.26 (1H, m), 5.67 (3H, m), 7.18 (8H, m).</p>\n",
       "<p id=\"p-2070\" num=\"2082\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1062\" level=\"1\">Example 458</heading>\n",
       "<p id=\"p-2071\" num=\"2083\"><chemistry id=\"CHEM-US-00575\" num=\"00575\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00575.TIF\" he=\"39.62mm\" id=\"EMI-C00575\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2072\" num=\"2084\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.15 (3H, d, J=7.3 Hz), 3.91 (1H, d, J=13.4 Hz), 4.39 (1H, d, J=13.3 Hz), 5.06 (1H, d, J=13.3 Hz), 5.45 (1H, m), 5.62 (1H, s), 5.63 (1H, t, J=13.5 Hz), 5.74 (1H, d, J=7.6 Hz), 6.71-7.55 (8H, m).</p>\n",
       "<p id=\"p-2073\" num=\"2085\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1063\" level=\"1\">Example 459</heading>\n",
       "<p id=\"p-2074\" num=\"2086\"><chemistry id=\"CHEM-US-00576\" num=\"00576\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00576.TIF\" he=\"39.62mm\" id=\"EMI-C00576\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2075\" num=\"2087\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.39 (3H, d, J=7.4 Hz), 3.95 (1H, d, J=13.4 Hz), 4.46 (1H, d, J=12.9 Hz), 5.19 (1H, d, J=13.1 Hz), 5.20 (1H, m), 5.41 (1H, s), 5.62 (1H, d, J=13.4 Hz), 5.76 (1H, d, J=7.7 Hz), 6.72-7.50 (8H, m).</p>\n",
       "<p id=\"p-2076\" num=\"2088\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1064\" level=\"1\">Example 460</heading>\n",
       "<p id=\"p-2077\" num=\"2089\"><chemistry id=\"CHEM-US-00577\" num=\"00577\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00577.TIF\" he=\"39.62mm\" id=\"EMI-C00577\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2078\" num=\"2090\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.42 (3H, d, J=7.2 Hz), 3.94 (1H, d, J=13.3 Hz), 4.50 (1H, d, J=13.1 Hz), 5.17 (1H, d, J=12.4 Hz), 5.18 (1H, m), 5.39 (1H, s), 5.60-5.69 (2H, m), 6.87-7.42 (8H, m).</p>\n",
       "<p id=\"p-2079\" num=\"2091\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1065\" level=\"1\">Example 461</heading>\n",
       "<p id=\"p-2080\" num=\"2092\"><chemistry id=\"CHEM-US-00578\" num=\"00578\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00578.TIF\" he=\"39.62mm\" id=\"EMI-C00578\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2081\" num=\"2093\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.35 (3H, d, J=7.2 Hz), 3.91 (1H, d, J=13.0 Hz), 4.43 (1H, d, J=13.1 Hz), 5.15 (1H, d, J=12.8 Hz), 5.16 (1H, m), 5.41 (1H, s), 5.47 (1H, d, J=13.0 Hz), 5.69 (1H, d, J=7.6 Hz), 7.00-7.45 (8H, m).</p>\n",
       "<p id=\"p-2082\" num=\"2094\">MS: m/z=506 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1066\" level=\"1\">Example 462</heading>\n",
       "<p id=\"p-2083\" num=\"2095\"><chemistry id=\"CHEM-US-00579\" num=\"00579\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00579.TIF\" he=\"39.62mm\" id=\"EMI-C00579\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2084\" num=\"2096\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.21 (3H, d, J=7.3 Hz), 3.97 (1H, d, J=13.3 Hz), 4.46 (1H, d, J=13.1 Hz), 5.09 (1H, d, J=13.6 Hz), 5.50 (1H, m), 5.51 (1H, d, J=12.8 Hz), 5.65 (1H, s), 5.72 (1H, d, J=7.6 Hz), 6.85-7.55 (7H, m).</p>\n",
       "<p id=\"p-2085\" num=\"2097\">MS: m/z=524 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1067\" level=\"1\">Example 463</heading>\n",
       "<p id=\"p-2086\" num=\"2098\"><chemistry id=\"CHEM-US-00580\" num=\"00580\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00580.TIF\" he=\"42.33mm\" id=\"EMI-C00580\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2087\" num=\"2099\">MS: m/z=568 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1068\" level=\"1\">Example 464</heading>\n",
       "<p id=\"p-2088\" num=\"2100\"><chemistry id=\"CHEM-US-00581\" num=\"00581\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00581.TIF\" he=\"41.57mm\" id=\"EMI-C00581\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2089\" num=\"2101\">MS: m/z=502 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1069\" level=\"1\">Example 465</heading>\n",
       "<p id=\"p-2090\" num=\"2102\"><chemistry id=\"CHEM-US-00582\" num=\"00582\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00582.TIF\" he=\"41.57mm\" id=\"EMI-C00582\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2091\" num=\"2103\">MS: m/z=502 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1070\" level=\"1\">Example 466</heading>\n",
       "<p id=\"p-2092\" num=\"2104\"><chemistry id=\"CHEM-US-00583\" num=\"00583\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00583.TIF\" he=\"42.42mm\" id=\"EMI-C00583\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2093\" num=\"2105\">MS: m/z=540 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1071\" level=\"1\">Example 467</heading>\n",
       "<p id=\"p-2094\" num=\"2106\"><chemistry id=\"CHEM-US-00584\" num=\"00584\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00584.TIF\" he=\"42.42mm\" id=\"EMI-C00584\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2095\" num=\"2107\">MS: m/z=540 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1072\" level=\"1\">Example 468</heading>\n",
       "<p id=\"p-2096\" num=\"2108\"><chemistry id=\"CHEM-US-00585\" num=\"00585\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00585.TIF\" he=\"42.33mm\" id=\"EMI-C00585\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2097\" num=\"2109\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.13 (3H, d, J=5.8 Hz), 4.20 (1H, d, J=13.6 Hz), 4.58 (1H, d, J=12.7 Hz), 4.99 (1H, d, J=12.7 Hz), 5.29-5.42 (3H, m), 5.84 (1H, d, J=7.8 Hz), 6.60 (1H, m), 6.79-7.01 (3H, m), 7.19-7.28 (4H, m).</p>\n",
       "<p id=\"p-2098\" num=\"2110\">MS: m/z=524 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1073\" level=\"1\">Example 469</heading>\n",
       "<p id=\"p-2099\" num=\"2111\"><chemistry id=\"CHEM-US-00586\" num=\"00586\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00586.TIF\" he=\"42.33mm\" id=\"EMI-C00586\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2100\" num=\"2112\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.19 (3H, d, J=7.6 Hz), 4.21 (1H, d, J=13.9 Hz), 4.48 (1H, d, J=13.3 Hz), 4.89 (1H, d, J=13.3 Hz), 5.22 (1H, s), 5.37 (1H, dd, J=2.1, 13.9 Hz), 5.52 (1H, m), 5.86 (1H, d, J=7.6), 6.55 (1H, m), 6.83 (1H, m), 6.96 (1H, m), 7.14 (1H, d, J=7.6 Hz), 7.19-7.30 (4H, m).</p>\n",
       "<p id=\"p-2101\" num=\"2113\">MS: m/z=524 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1074\" level=\"1\">Example 470</heading>\n",
       "<p id=\"p-2102\" num=\"2114\"><chemistry id=\"CHEM-US-00587\" num=\"00587\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00587.TIF\" he=\"42.33mm\" id=\"EMI-C00587\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2103\" num=\"2115\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.19 (3H, d, J=7.3 Hz), 3.65 (1H, d, J=13.5 Hz), 4.47 (1H, d, J=13.0 Hz), 4.87 (1H, d, J=13.0 Hz), 5.18 (1H, s), 5.50 (1H, m), 5.69 (1H, d, J=13.5 Hz), 5.85 (1H, d, J=7.8 Hz), 6.53 (1H, m), 6.83 (1H, m), 6.91-7.01 (2H, m), 7.11 (1H, d, J=7.6 Hz), 7.10-7.20 (3H, m).</p>\n",
       "<p id=\"p-2104\" num=\"2116\">MS: m/z=524 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1075\" level=\"1\">Example 471</heading>\n",
       "<p id=\"p-2105\" num=\"2117\"><chemistry id=\"CHEM-US-00588\" num=\"00588\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00588.TIF\" he=\"42.33mm\" id=\"EMI-C00588\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2106\" num=\"2118\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.13 (3H, d, J=6.1 Hz), 3.63 (1H, d, J=13.5 Hz), 4.56 (1H, d, J=12.5 Hz), 5.02 (1H, d, J=12.5 Hz), 5.26 (1H, s), 5.38 (1H, m), 5.71 (1H, d, J=13.5 Hz), 5.81 (1H, d, J=7.8 Hz), 6.57 (1H, m), 6.81 (1H, m), 6.91 (1H, m), 6.99 (1H, dd, J=2.6, 8.2 Hz), 7.05 (1H, dd, J=2.6, 8.7 Hz), 7.17 (2H, m), 7.19 (1H, d, J=7.6 Hz).</p>\n",
       "<p id=\"p-2107\" num=\"2119\">MS: m/z=524 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1076\" level=\"1\">Example 472</heading>\n",
       "<p id=\"p-2108\" num=\"2120\"><chemistry id=\"CHEM-US-00589\" num=\"00589\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00589.TIF\" he=\"42.33mm\" id=\"EMI-C00589\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2109\" num=\"2121\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.21 (3H, d, J=7.4 Hz), 3.66 (1H, d, J=13.5 Hz), 4.47 (1H, d, J=13.3 Hz), 4.88 (1H, d, J=13.3 Hz), 5.17 (1H, s), 5.52 (1H, m), 5.66 (1H, d, J=13.5 Hz), 5.85 (1H, d, J=7.7 Hz), 6.54 (1H, m), 6.83 (1H, m), 6.95 (1H, m), 7.11-7.14 (2H, m), 7.23-7.29 (2H, m), 7.41 (1H, d, J=2.0 Hz).</p>\n",
       "<p id=\"p-2110\" num=\"2122\">MS: m/z=540 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1077\" level=\"1\">Example 473</heading>\n",
       "<p id=\"p-2111\" num=\"2123\"><chemistry id=\"CHEM-US-00590\" num=\"00590\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00590.TIF\" he=\"42.33mm\" id=\"EMI-C00590\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2112\" num=\"2124\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.13 (3H, d, J=6.2 Hz), 3.63 (1H, d, J=13.5 Hz), 4.55 (1H, d, J=12.6 Hz), 5.04 (1H, d, J=12.6 Hz), 5.25 (1H, s), 5.38 (1H, m), 5.69 (1H, d, J=13.5 Hz), 5.80 (1H, d, J=7.7 Hz), 6.58 (1H, m), 6.82 (1H, m), 6.92 (1H, m), 7.13 (1H, m), 7.19 (1H, d, J=7.7 Hz), 7.24-7.29 (2H, m), 7.34 (1H, d, J=2.2 Hz).</p>\n",
       "<p id=\"p-2113\" num=\"2125\">MS: m/z=540 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1078\" level=\"1\">Example 474</heading>\n",
       "<p id=\"p-2114\" num=\"2126\"><chemistry id=\"CHEM-US-00591\" num=\"00591\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00591.TIF\" he=\"42.42mm\" id=\"EMI-C00591\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2115\" num=\"2127\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.19 (3H, d, J=7.3 Hz), 4.40 (1H, d, J=13.9 Hz), 4.59 (1H, d, J=13.0 Hz), 5.02 (1H, d, J=13.0 Hz), 5.31 (1H, s), 5.39 (1H, m), 5.66 (1H, d, J=13.9 Hz), 5.84 (1H, d, J=7.8 Hz), 6.58 (1H, m), 6.82 (1H, m), 6.92 (1H, m), 7.10 (1H, m), 7.19 (1H, dd, J=3.7, 7.9 Hz), 7.20-7.26 (2H, m), 7.51 (1H, m).</p>\n",
       "<p id=\"p-2116\" num=\"2128\">MS: m/z=540 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1079\" level=\"1\">Example 475</heading>\n",
       "<p id=\"p-2117\" num=\"2129\"><chemistry id=\"CHEM-US-00592\" num=\"00592\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00592.TIF\" he=\"39.62mm\" id=\"EMI-C00592\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2118\" num=\"2130\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1080\" level=\"1\">Example 476</heading>\n",
       "<p id=\"p-2119\" num=\"2131\"><chemistry id=\"CHEM-US-00593\" num=\"00593\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00593.TIF\" he=\"119.89mm\" id=\"EMI-C00593\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1081\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2120\" num=\"2132\">Compound 476A (3.00 g, 9.83 mmol) synthesized by the same procedure as that of Example was dissolved in dimethylformamide (30 ml), copper (I) cyanide (2.64 g, 29.5 mmol) was added, and the mixture was stirred at 150° C. for 7 hours. The reaction solution was cooled to room temperature, and filtered with celite. To the filtrate was added water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (1:1, v/v). To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 1.81 g of a white solid 476B.</p>\n",
       "<p id=\"p-2121\" num=\"2133\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.29 (2H, s), 7.28-7.48 (4H, m), 7.78 (2H, t, J=7.5 Hz), 8.20 (1H, dd, J=8.1, 1.5 Hz).</p>\n",
       "<heading id=\"h-1082\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2122\" num=\"2134\">Compound 476 was synthesized by the same procedure as that of Example 107.</p>\n",
       "<p id=\"p-2123\" num=\"2135\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.16 (3H, d, J=7.0 Hz), 4.01 (1H, d, J=14.0 Hz), 4.65 (1H, d, J=13.7 Hz), 5.04 (1H, d, J=13.3 Hz), 5.45 (1H, t, J=8.1 Hz), 5.66 (1H, d, J=7.6 Hz), 5.74 (1H, s), 5.84 (1H, d, J=14.0 Hz), 6.87-7.93 (7H, m).</p>\n",
       "<p id=\"p-2124\" num=\"2136\">MS: m/z=513 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1083\" level=\"1\">Example 477</heading>\n",
       "<p id=\"p-2125\" num=\"2137\"><chemistry id=\"CHEM-US-00594\" num=\"00594\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00594.TIF\" he=\"170.26mm\" id=\"EMI-C00594\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1084\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2126\" num=\"2138\">To compound 476B (859 mg, 3.42 mmol) was added concentrated sulfuric acid (13 ml), and the mixture was stirred at room temperature for 18 hours, and at 60° C. for 2 hours. The reaction solution was added to water, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 387 mg of a pale yellow solid. To the resulting compound was added methanol (10 ml), a 10N aqueous sodium hydroxide solution (6 ml) was added, and the mixture was stirred at 90° C. for 5 hours. The reaction solution was cooled to room temperature, water was added, and the mixture was washed with dichloromethane. To the aqueous layer was added dilute hydrochloric acid, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 296 mg of a yellow solid 477A.</p>\n",
       "<heading id=\"h-1085\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2127\" num=\"2139\">Compound 477A (179 mg, 0.662 mmol) obtained in the first step was dissolved in dichloromethane (4 ml), dimethylamine hydrochloride (108 mg, 1.32 mmol), EDCI (190 mg, 0.993 mmol), 1H-benzo[d][1,2,3]triazol-1-ol (89.0 mg, 0.662 mmol) and triethylamine (0.3 ml) were added, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous sodium bicarbonate solution, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (1:1, v/v), to obtain 170 mg of a colorless gummy substance 477B.</p>\n",
       "<p id=\"p-2128\" num=\"2140\">1H-NMR (CDCl3) δ: 2.99 (3H, s), 3.23 (3H, s), 4.08 (2H, s), 7.28-7.44 (5H, m), 7.58 (1H, t, J=4.4 Hz), 8.22 (1H, dd, J=8.1, 1.5 Hz).</p>\n",
       "<heading id=\"h-1086\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2129\" num=\"2141\">Compound 477 was synthesized by the same procedure as that of Example 107.</p>\n",
       "<p id=\"p-2130\" num=\"2142\">MS: m/z=559 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1087\" level=\"1\">Example 478</heading>\n",
       "<p id=\"p-2131\" num=\"2143\"><chemistry id=\"CHEM-US-00595\" num=\"00595\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00595.TIF\" he=\"245.70mm\" id=\"EMI-C00595\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00596\" num=\"00596\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00596.TIF\" he=\"110.24mm\" id=\"EMI-C00596\" img-content=\"chem\" img-format=\"tif\" wi=\"67.31mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1088\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2132\" num=\"2144\">Compound 277 (971 mg, 2.11 mmol) was dissolved in dimethylformamide (10 ml), cesium carbonate (2.75 g, 8.45 mmol) and benzyl bromide (0.753 ml, 6.34 mmol) were added, and the mixture was stirred at room temperature for 4 hours. The reaction solution was poured into water, then extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting compound were added dichloromethane-diethyl ether, and the precipitated residue was filtered to obtain 740 mg of a white solid 478A.</p>\n",
       "<heading id=\"h-1089\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2133\" num=\"2145\">Compound 478A (740 mg, 1.35 mmol) was dissolved in tetrahydrofuran (7 ml) and methanol (7 ml), a 2N aqueous sodium hydroxide solution (3.37 ml, 6.73 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. To the reaction solution was added dilute hydrochloric acid to make the solution acidic, the mixture was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 618 mg of a white solid 478B.</p>\n",
       "<p id=\"p-2134\" num=\"2146\">MS: m/z=508 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1090\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2135\" num=\"2147\">Compound 478B (505 mg, 0.995 mmol) was dissolved in tetrahydrofuran (10 ml), triphenylphosphine (391 mg, 1.49 mmol), phthalimide (220 mg, 1.49 mmol) and azodicarboxylic acid diisopropyl ester (0.290 ml, 1.49 mmol) were added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound were added dichloromethane-diethyl ether, and the precipitated residue was filtered to obtain 578 mg of a white solid 478C.</p>\n",
       "<p id=\"p-2136\" num=\"2148\">MS: m/z=637 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1091\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2137\" num=\"2149\">To compound 478C (667 mg, 1.05 mmol) was added ethanol (10 ml), hydrazine hydrate (0.254 ml, 5.24 mmol) was added, and the mixture was stirred at 90° C. for 2 hours. The reaction solution was cooled to room temperature, chloroform was added, insolubles were removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound were added dichloromethane-diethyl ether, and the precipitated residue was filtered to obtain 462 mg of a white soled 478D.</p>\n",
       "<p id=\"p-2138\" num=\"2150\">MS: m/z=507 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1092\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2139\" num=\"2151\">To compound 478D (100 mg, 0.197 mmol) were added formic acid (1.0 ml) and an aqueous formalin solution (1.0 ml), and the mixture was stirred at 80° C. for 1 hour. To the reaction solution was added a 1N aqueous sodium hydroxide solution, the mixture was extracted with dichloromethane, and the organic layer was dried with sodium sulfate. The resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 56 mg of a colorless oily substance. This compound was dissolved in acetic acid (2.0 ml), concentrated sulfuric acid (0.5 ml) was added dropwise, and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into an aqueous sodium bicarbonate solution, and was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting crude product were added dichloromethane-ethyl acetate-diethyl ether, and the precipitated residue was filtered to obtain 12 mg of a white solid 478.</p>\n",
       "<p id=\"p-2140\" num=\"2152\">MS: m/z=445 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1093\" level=\"1\">Example 479</heading>\n",
       "<p id=\"p-2141\" num=\"2153\"><chemistry id=\"CHEM-US-00597\" num=\"00597\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00597.TIF\" he=\"220.98mm\" id=\"EMI-C00597\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1094\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2142\" num=\"2154\">To a dichloromethane (50 ml) solution of compound 479A (5.25 g, 11.8 mmol) synthesized according to Example 95, DIPEA (6.20 mL, 35.5 mmol) and Boc<sub>2</sub>O (5.17 g, 23.7 mmol) was added DMAP (434 mg, 3.55 mmol), and the mixture was stirred at room temperature for 4 hours. After the reaction solution was concentrated under reduced pressure, the residue was dissolved in ethyl acetate. The solution was sequentially washed with 0.5N hydrochloric acid and an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-methanol (97:3, v/v). Concentration of an objective fraction afforded 5.22 g of compound 479B as an oil.</p>\n",
       "<p id=\"p-2143\" num=\"2155\">MS: m/z=544 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1095\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2144\" num=\"2156\">To a THF (340 mL) solution of compound 479B (29.7 g, 102 mmol) and acetic acid (29.7 g, 102 mmol) was added TBAF (1M THF solution, 23.6 g, 310 mmol) under ice-cooling, and the mixture was stirred at room temperature for 16 hours. To the reaction solution were added ethyl acetate and water, and the ethyl acetate layer was separated, washed with water, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was solidified by adding dichloromethane-ether, to obtain 2.76 g of compound 479C.</p>\n",
       "<p id=\"p-2145\" num=\"2157\">MS: m/z=430 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1096\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2146\" num=\"2158\">To an ethyl acetate (20 mL) suspension of compound 479C (500 mg, 1.16 mmol) was added IBX (652 mg, 2.33 mmol), and the mixture was heated to stir for 3 hours. After the reaction solution was diluted with ethyl acetate, insolubles were filtered, and the resulting filtrate was sequentially washed with a 1N aqueous sodium hydroxide solution and water, and dried with sodium sulfate. After the solvent was distilled off, and the resulting oil was dissolved in THF (5 mL), dimethylamine (2M THF solution, 0.873 mL, 1.75 mmol) and NaBH(OAc)<sub>3 </sub>(370 mg, 1.75 mmol) were added under ice-cooling, and the mixture was stirred at room temperature for 1.5 hours. After 2N hydrochloric acid was added to the reaction solution under ice-cooling, the mixture was made basic with an aqueous sodium bicarbonate solution. This was extracted with chloroform, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted first with chloroform and, then, with chloroform-methanol (93:7, v/v). Concentration of an objective fraction afforded 437 mg of compound 479D as an amorphous substance.</p>\n",
       "<p id=\"p-2147\" num=\"2159\">MS: m/z=457 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1097\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2148\" num=\"2160\">Compound 479D (430 mg, 0.942 mmol) was dissolved in acetic acid (10 mL), and the solution was heated to stir for 1 hour. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-methanol (95:5, v/v). Concentration of an objective fraction afforded 330 mg of compound 479E as an oil.</p>\n",
       "<p id=\"p-2149\" num=\"2161\">MS: m/z=357 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1098\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2150\" num=\"2162\">To an acetic acid (2 mL) solution of compound 479E (50 mg, 0.140 mmol) and dibenzosuberol (29.5 mg, 0.140 mmol) was added dropwise sulfuric acid (0.5 mL), and the mixture was stirred for 30 minutes. To the reaction solution were added ethyl acetate and water, thereafter, the aqueous layer was separated, and neutralized with an aqueous sodium bicarbonate solution. Extraction was performed using the ethyl acetate layer, and the extract was washed with water, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was solidified by adding ether, to obtain 17.0 mg of compound 479.</p>\n",
       "<p id=\"p-2151\" num=\"2163\">MS: m/z=354 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"p-2152\" num=\"2164\">According to Example 478 or Example 479, Examples 480 to 490 were synthesized using the same procedure.</p>\n",
       "<heading id=\"h-1099\" level=\"1\">Example 480</heading>\n",
       "<p id=\"p-2153\" num=\"2165\"><chemistry id=\"CHEM-US-00598\" num=\"00598\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00598.TIF\" he=\"42.33mm\" id=\"EMI-C00598\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2154\" num=\"2166\">MS: m/z=477 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1100\" level=\"1\">Example 481</heading>\n",
       "<p id=\"p-2155\" num=\"2167\"><chemistry id=\"CHEM-US-00599\" num=\"00599\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00599.TIF\" he=\"44.96mm\" id=\"EMI-C00599\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2156\" num=\"2168\">MS: m/z=512 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1101\" level=\"1\">Example 482</heading>\n",
       "<p id=\"p-2157\" num=\"2169\"><chemistry id=\"CHEM-US-00600\" num=\"00600\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00600.TIF\" he=\"43.60mm\" id=\"EMI-C00600\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2158\" num=\"2170\">MS: m/z=501 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1102\" level=\"1\">Example 483</heading>\n",
       "<p id=\"p-2159\" num=\"2171\"><chemistry id=\"CHEM-US-00601\" num=\"00601\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00601.TIF\" he=\"44.37mm\" id=\"EMI-C00601\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2160\" num=\"2172\">MS: m/z=519 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1103\" level=\"1\">Example 484</heading>\n",
       "<p id=\"p-2161\" num=\"2173\"><chemistry id=\"CHEM-US-00602\" num=\"00602\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00602.TIF\" he=\"43.60mm\" id=\"EMI-C00602\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2162\" num=\"2174\">MS: m/z=514 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1104\" level=\"1\">Example 485</heading>\n",
       "<p id=\"p-2163\" num=\"2175\"><chemistry id=\"CHEM-US-00603\" num=\"00603\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00603.TIF\" he=\"44.37mm\" id=\"EMI-C00603\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2164\" num=\"2176\">MS: m/z=532 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1105\" level=\"1\">Example 486</heading>\n",
       "<p id=\"p-2165\" num=\"2177\"><chemistry id=\"CHEM-US-00604\" num=\"00604\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00604.TIF\" he=\"43.60mm\" id=\"EMI-C00604\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2166\" num=\"2178\">MS: m/z=499 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1106\" level=\"1\">Example 487</heading>\n",
       "<p id=\"p-2167\" num=\"2179\"><chemistry id=\"CHEM-US-00605\" num=\"00605\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00605.TIF\" he=\"44.37mm\" id=\"EMI-C00605\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2168\" num=\"2180\">MS: m/z=517 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1107\" level=\"1\">Example 488</heading>\n",
       "<p id=\"p-2169\" num=\"2181\"><chemistry id=\"CHEM-US-00606\" num=\"00606\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00606.TIF\" he=\"43.60mm\" id=\"EMI-C00606\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2170\" num=\"2182\">MS: m/z=517 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1108\" level=\"1\">Example 489</heading>\n",
       "<p id=\"p-2171\" num=\"2183\"><chemistry id=\"CHEM-US-00607\" num=\"00607\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00607.TIF\" he=\"44.37mm\" id=\"EMI-C00607\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2172\" num=\"2184\">MS: m/z=535 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1109\" level=\"1\">Example 490</heading>\n",
       "<p id=\"p-2173\" num=\"2185\"><chemistry id=\"CHEM-US-00608\" num=\"00608\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00608.TIF\" he=\"43.60mm\" id=\"EMI-C00608\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2174\" num=\"2186\">MS: m/z=473 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1110\" level=\"1\">Example 491</heading>\n",
       "<p id=\"p-2175\" num=\"2187\"><chemistry id=\"CHEM-US-00609\" num=\"00609\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00609.TIF\" he=\"38.86mm\" id=\"EMI-C00609\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2176\" num=\"2188\">According to Example 65 and Example 107, compound 491 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-2177\" num=\"2189\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.10 (3H, d, J=4.0 Hz), 1.12 (3H, d, J=4.6 Hz), 2.82-3.06 (2H, m), 3.56 (1H, d, J=17.8 Hz), 4.26 (1H, d, J=13.2 Hz), 4.31 (1H, m), 4.51-4.60 (1H, m), 4.97 (1H, d, J=13.1 Hz), 5.39 (1H, s), 6.74-7.52 (8H, m).</p>\n",
       "<p id=\"p-2178\" num=\"2190\">MS: m/z=460 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1111\" level=\"1\">Example 492</heading>\n",
       "<p id=\"p-2179\" num=\"2191\"><chemistry id=\"CHEM-US-00610\" num=\"00610\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00610.TIF\" he=\"39.62mm\" id=\"EMI-C00610\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2180\" num=\"2192\">According to Example 65 and Example 107, compound 492 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-2181\" num=\"2193\">MS: m/z=478 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1112\" level=\"1\">Example 493</heading>\n",
       "<p id=\"p-2182\" num=\"2194\"><chemistry id=\"CHEM-US-00611\" num=\"00611\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00611.TIF\" he=\"99.99mm\" id=\"EMI-C00611\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1113\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2183\" num=\"2195\">A dichloromethane (5 mL) solution of compound 493A (258 mg, 1.30 mmol) was cooled to −50° C., and a toluene solution (1M, 1.96 mL) of DIBAL-H was added dropwise over 5 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 1 hour, temperature was raised to room temperature, and the mixture was stirred for 2.5 hours. To the reaction solution was added an aqueous saturated ammonium chloride solution, thereafter, the mixture was stirred at room temperature for 1 hour, and insolubles were removed by filtration. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane once. The combined extracts were washed with water three times, washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with n-hexane-ethyl acetate. Concentration of an objective fraction afforded 148 mg of compound 493B as an oil.</p>\n",
       "<p id=\"p-2184\" num=\"2196\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 1.03-1.44 (5H, m), 1.63-1.83 (5H, m), 2.05-2.13 (1H, m), 3.25 (1H, dd, J=9.5 Hz, 3.4 Hz), 7.16-7.19 (2H, ms), 7.27-7.38 (3H, m), 9.69 (1H, d, J=3.5 Hz).</p>\n",
       "<heading id=\"h-1114\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2185\" num=\"2197\">According to Example 177, compound 493 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-2186\" num=\"2198\">MS: m/z=410 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-2187\" num=\"2199\">Using aldehydes which are commercially available or known in the references and hydrazines which are commercially available or known in the references, and according to Example 493, compounds 494 to 505 were synthesized.</p>\n",
       "<heading id=\"h-1115\" level=\"1\">Example 494</heading>\n",
       "<p id=\"p-2188\" num=\"2200\"><chemistry id=\"CHEM-US-00612\" num=\"00612\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00612.TIF\" he=\"38.52mm\" id=\"EMI-C00612\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2189\" num=\"2201\">MS: m/z=428 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1116\" level=\"1\">Example 495</heading>\n",
       "<p id=\"p-2190\" num=\"2202\"><chemistry id=\"CHEM-US-00613\" num=\"00613\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00613.TIF\" he=\"40.47mm\" id=\"EMI-C00613\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2191\" num=\"2203\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1117\" level=\"1\">Example 496</heading>\n",
       "<p id=\"p-2192\" num=\"2204\"><chemistry id=\"CHEM-US-00614\" num=\"00614\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00614.TIF\" he=\"37.76mm\" id=\"EMI-C00614\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2193\" num=\"2205\">MS: m/z=376 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1118\" level=\"1\">Example 497</heading>\n",
       "<p id=\"p-2194\" num=\"2206\"><chemistry id=\"CHEM-US-00615\" num=\"00615\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00615.TIF\" he=\"40.47mm\" id=\"EMI-C00615\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2195\" num=\"2207\">MS: m/z=500 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1119\" level=\"1\">Example 498</heading>\n",
       "<p id=\"p-2196\" num=\"2208\"><chemistry id=\"CHEM-US-00616\" num=\"00616\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00616.TIF\" he=\"37.76mm\" id=\"EMI-C00616\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2197\" num=\"2209\">MS: m/z=404 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1120\" level=\"1\">Example 499</heading>\n",
       "<p id=\"p-2198\" num=\"2210\"><chemistry id=\"CHEM-US-00617\" num=\"00617\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00617.TIF\" he=\"37.76mm\" id=\"EMI-C00617\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2199\" num=\"2211\">MS: m/z=382 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1121\" level=\"1\">Example 500</heading>\n",
       "<p id=\"p-2200\" num=\"2212\"><chemistry id=\"CHEM-US-00618\" num=\"00618\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00618.TIF\" he=\"38.86mm\" id=\"EMI-C00618\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2201\" num=\"2213\">MS: m/z=382 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1122\" level=\"1\">Example 501</heading>\n",
       "<p id=\"p-2202\" num=\"2214\"><chemistry id=\"CHEM-US-00619\" num=\"00619\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00619.TIF\" he=\"37.76mm\" id=\"EMI-C00619\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2203\" num=\"2215\">MS: m/z=368 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1123\" level=\"1\">Example 502</heading>\n",
       "<p id=\"p-2204\" num=\"2216\"><chemistry id=\"CHEM-US-00620\" num=\"00620\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00620.TIF\" he=\"39.62mm\" id=\"EMI-C00620\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2205\" num=\"2217\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.94 (3H, t, J=7.2 Hz), 1.26 (3H, t, J=7.3 Hz), 2.87-2.94 (2H, m), 3.10-3.22 (1H, m), 3.79-3.89 (1H, m), 3.98 (1H, d, J=16.9 Hz), 4.17 (1H, d, J=16.8 Hz), 4.28 (1H, d, J=9.8 Hz), 6.04 (1H, d, J=7.2 Hz), 6.54 (2H, t, J=8.1 Hz), 6.73 (1H, d, J=9.8 Hz), 6.95-7.33 (6H, m), 7.66 (1H, dd, J=5.3, 3.6 Hz).</p>\n",
       "<p id=\"p-2206\" num=\"2218\">MS: m/z=448 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1124\" level=\"1\">Example 503</heading>\n",
       "<p id=\"p-2207\" num=\"2219\"><chemistry id=\"CHEM-US-00621\" num=\"00621\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00621.TIF\" he=\"37.76mm\" id=\"EMI-C00621\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2208\" num=\"2220\">MS: m/z=374 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1125\" level=\"1\">Example 504</heading>\n",
       "<p id=\"p-2209\" num=\"2221\"><chemistry id=\"CHEM-US-00622\" num=\"00622\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00622.TIF\" he=\"38.52mm\" id=\"EMI-C00622\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2210\" num=\"2222\">MS: m/z=374 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1126\" level=\"1\">Example 505</heading>\n",
       "<p id=\"p-2211\" num=\"2223\"><chemistry id=\"CHEM-US-00623\" num=\"00623\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00623.TIF\" he=\"37.76mm\" id=\"EMI-C00623\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2212\" num=\"2224\">MS: m/z=342 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1127\" level=\"1\">Example 506</heading>\n",
       "<p id=\"p-2213\" num=\"2225\"><chemistry id=\"CHEM-US-00624\" num=\"00624\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00624.TIF\" he=\"40.39mm\" id=\"EMI-C00624\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2214\" num=\"2226\">According to Example 177, using compound 65B, compound 506 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-2215\" num=\"2227\">MS: m/z=470 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1128\" level=\"1\">Example 507</heading>\n",
       "<p id=\"p-2216\" num=\"2228\"><chemistry id=\"CHEM-US-00625\" num=\"00625\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00625.TIF\" he=\"37.76mm\" id=\"EMI-C00625\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2217\" num=\"2229\">According to Example 65, using compound 506, compound 507 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-2218\" num=\"2230\">MS: m/z=446 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1129\" level=\"1\">Example 508</heading>\n",
       "<p id=\"p-2219\" num=\"2231\"><chemistry id=\"CHEM-US-00626\" num=\"00626\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00626.TIF\" he=\"209.89mm\" id=\"EMI-C00626\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00627\" num=\"00627\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00627.TIF\" he=\"41.15mm\" id=\"EMI-C00627\" img-content=\"chem\" img-format=\"tif\" wi=\"41.15mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1130\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2220\" num=\"2232\">Compound 508A (261 mg, 0.475 mmol) which is a synthetic intermediate of Example 491 was dissolved in dimethylformamide (3 ml), triethylamine (0.132 ml, 0.950 mmol) and ethyl chloroformate (0.0910 ml, 0.950 mmol) were added at 0° C., and the mixture was stirred at room temperature for 20 minutes. An aqueous solution (0.5 ml) of sodium borohydride (71.9 mg, 1.90 mmol) was added at 0° C., and the mixture was stirred for 30 minutes. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). Diethyl ether was added, and the precipitated residue was filtered to obtain 107 mg of a white solid 508B.</p>\n",
       "<p id=\"p-2221\" num=\"2233\">MS: m/z=536 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1131\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2222\" num=\"2234\">Compound 508B (100 mg, 0.187 mmol) obtained in the first step was dissolved in dichloromethane (1 ml), DAST (33.1 mg, 0.205 mmol) was added at 0° C., and the mixture was stirred for 30 minutes. The reaction solution was poured into water, the mixture was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 28 mg of a pale yellow gummy substance 508C.</p>\n",
       "<p id=\"p-2223\" num=\"2235\">MS: m/z=538 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1132\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2224\" num=\"2236\">To compound 508C obtained in the second step were added acetic acid (2 ml) and concentrated sulfuric acid (0.5 ml), and the mixture was stirred at room temperature for 20 minutes. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. Diethyl ether was added, and the precipitated residue was filtered to obtain 4.5 mg of a white solid 508.</p>\n",
       "<p id=\"p-2225\" num=\"2237\">MS: m/z=448 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1133\" level=\"1\">Example 509</heading>\n",
       "<p id=\"p-2226\" num=\"2238\"><chemistry id=\"CHEM-US-00628\" num=\"00628\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00628.TIF\" he=\"39.71mm\" id=\"EMI-C00628\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2227\" num=\"2239\">According to Example 508, compound 509 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-2228\" num=\"2240\">MS: m/z=466 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1134\" level=\"1\">Example 510</heading>\n",
       "<p id=\"p-2229\" num=\"2241\"><chemistry id=\"CHEM-US-00629\" num=\"00629\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00629.TIF\" he=\"244.01mm\" id=\"EMI-C00629\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00630\" num=\"00630\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00630.TIF\" he=\"205.06mm\" id=\"EMI-C00630\" img-content=\"chem\" img-format=\"tif\" wi=\"65.28mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1135\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2230\" num=\"2242\">Compound 510A (36.8 g, 259 mmol) was dissolved in dimethylformamide (380 ml), potassium carbonate (39.3 g, 285 mmol) and benzyl bromide (30.7 ml, 259 mmol) were added, and the mixture was stirred at 80° C. for 8 hours. The reaction was cooled to room temperature, insolubles were removed by filtration, and the solvent was distilled off under reduced pressure. Water was added, and the precipitated residue was filtered, and dried under reduced pressure to obtain 46.21 g of a pale brown solid 510B.</p>\n",
       "<heading id=\"h-1136\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2231\" num=\"2243\">To compound 510B (4.79 g, 20.6 mmol) obtained in the first step was added dichloromethane (70 ml), triethylamine (4.29 ml, 30.9 mmol) and methanesulfonyl chloride (1.93 ml, 24.8 mmol) were added at 0° C., and the mixture was stirred for 30 minutes. The reaction solution was poured into an aqueous saturated sodium chloride solution, the mixture was extracted with dichloromethane, the extract was dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 6.56 g of a white solid. This compound was dissolved in acetonitrile (40 ml), tetrabutylammonium fluoride (75% aqueous solution, 21.6 g, 61.9 mmol) was added, and the mixture was stirred at room temperature for 18 hours. The solvent was distilled off under reduced pressure, ethyl acetate was added, and the mixture was washed with an aqueous sodium bicarbonate solution. The organic layer was dried with sodium sulfate, and distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (1:1, v/v), to obtain 2.51 g of a white solid 510C.</p>\n",
       "<p id=\"p-2232\" num=\"2244\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 4.96 (3H, s), 5.30 (3H, d, J=46.4 Hz), 6.56 (1H, d, J=1.8 Hz), 7.39 (5H, m), 8.30 (1H, s).</p>\n",
       "<heading id=\"h-1137\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2233\" num=\"2245\">Compound 510C (2.40 g, 10.3 mmol) obtained in the second step was dissolved in dichloromethane (40 ml), boron tribromide (1M dichloromethane solution, 10.3 ml, 10.3 mmol) was added dropwise at 0° C., and the mixture was stirred for 30 minutes. Methanol was added, the solvent was distilled off under reduced pressure, ethyl acetate was added, and the mixture was washed with an aqueous saturated sodium chloride solution. The organic layer was dried with sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting solid was washed with diethyl ether to obtain 940 mg of 510D.</p>\n",
       "<p id=\"p-2234\" num=\"2246\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 5.20 (2H, d, J=46.3 Hz), 6.40 (1H, s), 6.62 (1H, s), 7.91 (1H, s).</p>\n",
       "<heading id=\"h-1138\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2235\" num=\"2247\">Compound 510D (940 mg, 6.52 mmol) obtained in the third step was dissolved in methanol (8 ml), a 2N aqueous sodium hydroxide solution (3.26 ml, 6.52 mmol) and a 37% aqueous formaldehyde solution (1.46 ml, 19.6 mmol) were added at 0° C., and the mixture was stirred at room temperature for 20 hours. To the reaction solution was added an aqueous saturated ammonium chloride solution, and the solvent was distilled off under reduced pressure. Hydrochloric acid was added, the mixture was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting compound were added n-hexane-dichloromethane-ethyl acetate, and the precipitated residue was filtered to obtain 858 mg of a pale yellow solid 510E.</p>\n",
       "<p id=\"p-2236\" num=\"2248\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.73 (2H, s), 5.19 (2H, d, J=46.1 Hz), 6.55 (1H, s).</p>\n",
       "<heading id=\"h-1139\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2237\" num=\"2249\">Compound 510E (855 mg, 4.91 mmol) obtained in the fourth step was dissolved in dimethylformamide (10 ml), potassium carbonate (746 mg, 5.40 mmol) and benzyl bromide (0.583 ml, 4.91 mmol) were added, and the mixture was stirred at 80° C. for 5 hours. Insolubles were removed by filtration, and the filtrate was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 887 mg of a pale orange solid 510F.</p>\n",
       "<p id=\"p-2238\" num=\"2250\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.39 (1H, t, J=7.1 Hz), 4.31 (2H, d, J=7.2 Hz), 5.12 (2H, dd, J=46.3, 0.7 Hz), 5.23 (2H, s), 6.50 (1H, s), 7.33-7.43 (5H, m).</p>\n",
       "<heading id=\"h-1140\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-2239\" num=\"2251\">Compound 510F (887 mg, 3.36 mmol) obtained in the fifth step was dissolved in chloroform, manganese dioxide (2.00 g, 23.0 mmol) was added, and the mixture was stirred at 80° C. for 2 hours. After cooled to room temperature, the mixture was filtered with celite, and the solvent was distilled off under reduced pressure to obtain 812 mg of a white solid 510G.</p>\n",
       "<p id=\"p-2240\" num=\"2252\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 5.18 (2H, dd, J=45.8, 0.8 Hz), 5.52 (2H, s), 6.60 (1H, d, J=0.8 Hz), 7.32-7.38 (5H, m), 9.86 (1H, s).</p>\n",
       "<heading id=\"h-1141\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-2241\" num=\"2253\">To compound 510G (884 mg, 3.37 mmol) obtained in the sixth step were added acetonitrile and water, monosodium dihydrogen phosphate (809 mg, 6.74 mmol) and sodium hypochlorite (1.01 g, 11.1 mmol) were added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated, pH was adjusted to 3 with hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure to obtain 404 mg of a white solid 510H.</p>\n",
       "<p id=\"p-2242\" num=\"2254\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 5.17 (2H, s), 5.38 (2H, d, J=46.2 Hz), 6.73 (1H, d, J=1.5 Hz), 7.34-7.51 (5H, m).</p>\n",
       "<heading id=\"h-1142\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-2243\" num=\"2255\">Compound 510H (402 mg, 1.45 mmol) obtained in the seventh step was dissolved in dimethylformamide, N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine hydrochloride (554 mg, 2.89 mmol) and 1H-benzo[d][1,2,3]triazol-1-ol (195 mg, 1.45 mmol) were added, and the mixture was stirred at room temperature for 5 minutes. After propan-2-amine (0.149 ml, 1.73 mmol) was added, the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, water was added, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous sodium bicarbonate solution, and dried with sodium sulfate. The reaction solution was distilled off under reduced pressure, to the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 3.56 g of a white solid 510I.</p>\n",
       "<p id=\"p-2244\" num=\"2256\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.98 (6H, d, J=6.6 Hz), 4.05 (1H, m), 5.24 (2H, dd, J=45.9, 0.9 Hz), 5.41 (2H, s), 6.59 (1H, q, J=0.9 Hz), 7.40 (5H, m), 7.56 (1H, brs).</p>\n",
       "<heading id=\"h-1143\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-2245\" num=\"2257\">Compound 5101 (392 mg, 1.23 mmol) obtained in the eighth step was dissolved in ethanol (6 ml), aqueous ammonia (4 ml) was added, and the mixture was stirred at room temperature for 15 hours. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 333 mg of a white solid 510J.</p>\n",
       "<p id=\"p-2246\" num=\"2258\">MS: m/z=319 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1144\" level=\"1\">Tenth Step</heading>\n",
       "<p id=\"p-2247\" num=\"2259\">Compound 510 was synthesized by the same procedure as that of Example 95.</p>\n",
       "<p id=\"p-2248\" num=\"2260\">MS: m/z=422 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1145\" level=\"1\">Example 511</heading>\n",
       "<p id=\"p-2249\" num=\"2261\"><chemistry id=\"CHEM-US-00631\" num=\"00631\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00631.TIF\" he=\"171.03mm\" id=\"EMI-C00631\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1146\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2250\" num=\"2262\">A dichloromethane (90 mL) solution of compound 511A (200 mg, 0.664 mmol) and 1,1,3-trimethoxypropane (178.2 mg, 1.33 mmol) was cooled to 1 to 3° C., and a boron trifluoride diethyl ether complex (113 mg, 0.797 mmol) was added dropwise while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, saturated sodium bicarbonate water was added. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane three times. After the combined extracts were dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with ethyl acetate and, then, with ethyl acetate-methanol (3:2, v/v). Concentration of an objective fraction afforded 179.2 mg of compound 511B as an oil.</p>\n",
       "<p id=\"p-2251\" num=\"2263\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.14 (6H, d, J=6.3 Hz), 2.71 (2H, dd, J=6.0 Hz), 3.34 (3H, s), 3.64 (2H, t, J=6.0 Hz), 4.06-4.17 (1H, m), 5.23 (2H, s), 6.34 (1H, brs), 6.37 (1H, d, J=7.8 Hz), 7.26-7.43 (6H, m), 7.90 (1H, t, J=5.4 Hz).</p>\n",
       "<heading id=\"h-1147\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2252\" num=\"2264\">A dimethylformamide (3 ml) solution of compound 511B (179.2 mg, 0.482 mmol) was cooled to 1 to 3° C., cesium carbonate (786 mg, 2.41 mmol) was added while the same temperature was retained, and the mixture was stirred at the same temperature for 15 minutes. The reaction solution was diluted with water, and extracted with chloroform three times. After the combined extracts were dried with sodium sulfate, the solvent was distilled off to obtain 130 mg of compound 511C as a solid.</p>\n",
       "<p id=\"p-2253\" num=\"2265\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.22 (3H, d, J=6.9 Hz), 1.28 (3H, d, J=6.9 Hz), 1.59 (2H, brs), 3.22-3.41 (2H, m), 3.12 (3H, s), 4.57-4.70 (2H, m), 5.19 (1H, d, J=10.5 Hz), 5.38 (1H, brs), 5.54 (1H, d, J=10.5 Hz), 6.34 (1H, d, J=7.8 Hz), 7.26-7.32 (4H, m), 7.49-7.52 (2H, m).</p>\n",
       "<heading id=\"h-1148\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2254\" num=\"2266\">To an acetic acid (2 ml) solution of compound 511C (130 mg, 0.350 mmol) and dibenzosuberol (368 mg, 1.75 mmol) was added dropwise sulfuric acid (0.4 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, thereafter, the solvent was distilled off, and the resulting solid was washed with diisopropyl ether to obtain 65 mg of compound 511 as a solid.</p>\n",
       "<p id=\"p-2255\" num=\"2267\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.27 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.6 Hz), 1.64-1.74 (1H, m), 1.88-1.99 (1H, m), 2.83 (1H, d, J=4.5 Hz, 4.5 Hz, 9.3 Hz), 3.06 (1H, ddd, J=5.6 Hz, 13.2 Hz, 13.2 Hz), 3.19 (3H, s), 3.30-3.44 (1H, m), 3.50-3.57 (1H, m), 3.78-3.92 (1H, m), 4.28 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.53 (1H, dd, J=3.3 Hz, 10.8 Hz), 4.96 (1H, s), 5.73 (1H, d, J=7.5 Hz), 6.61 (1H, d, J=7.5 Hz), 6.65 (1H, d, J=7.5 Hz), 6.89-6.93 (1H, m), 7.08-7.36 (6H, m).</p>\n",
       "<p id=\"p-2256\" num=\"2268\">Using amines which are commercially available or known in the references and acetals which are commercially available or known in the references, and according to Example 511, compounds 512 to 515 were synthesized.</p>\n",
       "<heading id=\"h-1149\" level=\"1\">Example 512</heading>\n",
       "<p id=\"p-2257\" num=\"2269\"><chemistry id=\"CHEM-US-00632\" num=\"00632\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00632.TIF\" he=\"41.49mm\" id=\"EMI-C00632\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2258\" num=\"2270\">MS: m/z=528 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1150\" level=\"1\">Example 513</heading>\n",
       "<p id=\"p-2259\" num=\"2271\"><chemistry id=\"CHEM-US-00633\" num=\"00633\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00633.TIF\" he=\"41.49mm\" id=\"EMI-C00633\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2260\" num=\"2272\">MS: m/z=528 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1151\" level=\"1\">Example 514</heading>\n",
       "<p id=\"p-2261\" num=\"2273\"><chemistry id=\"CHEM-US-00634\" num=\"00634\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00634.TIF\" he=\"38.86mm\" id=\"EMI-C00634\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2262\" num=\"2274\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.27 (1H, 3H, d, J=6.9 Hz), 1.48 (3H, d, J=6.6 Hz), 1.95 (3H, s), 2.63-2.68 (2H, m), 2.84 (1H, ddd, J=4.8 Hz, 9.3 Hz, 9.3 Hz), 3.05 (1H, ddd, J=4.2 Hz, 13.2 Hz, 13.2 Hz), 3.60 (1H, ddd, J=4.8 Hz, 4.8 Hz, 17.4 Hz), 3.87-3.98 (1H, m), 4.42 (1H, dd, J=6.6 Hz, 8.1 Hz), 4.59 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.93 (1H, s), 5.77 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=6.9 Hz), 6.69 (1H, d, J=7.8 Hz), 6.91 (1H, t, J=6.0 Hz), 7.09-7.38 (6H, m).</p>\n",
       "<heading id=\"h-1152\" level=\"1\">Example 515</heading>\n",
       "<p id=\"p-2263\" num=\"2275\"><chemistry id=\"CHEM-US-00635\" num=\"00635\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00635.TIF\" he=\"38.86mm\" id=\"EMI-C00635\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2264\" num=\"2276\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.20 (3H, d, J=6.9 Hz), 1.44 (3H, d, J=6.9 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz, 9.3 Hz), 3.07 (1H, ddd, J=4.5 Hz, 13.5 Hz, 13.5 Hz), 3.25 (3H, s), 3.22-3.43 (2H, m), 3.55 (1H, ddd, J=4.2 Hz, 4.2 Hz, 8.7 Hz), 3.85-3.94 (1H, m), 4.36 (1H, dd, J=5.1 Hz, 14.1 Hz), 4.42-4.48 (1H, m), 4.92 (1H, s), 5.78 (1H, d, J=7.5 Hz), 6.59 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=7.5 Hz), 6.91 (1H, t, J=6.9 Hz), 7.09-7.36 (6H, m).</p>\n",
       "<heading id=\"h-1153\" level=\"1\">Example 516</heading>\n",
       "<p id=\"p-2265\" num=\"2277\"><chemistry id=\"CHEM-US-00636\" num=\"00636\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00636.TIF\" he=\"108.71mm\" id=\"EMI-C00636\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1154\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2266\" num=\"2278\">To a toluene (3 ml) solution of compound 516A (100 mg, 0.332 mmol) and 3-(methylthio)propanal (52 mg, 0.498 mmol) was added acetic acid (30 mg, 0.500 mmol), and the mixture was refluxed for 30 minutes. After cooled to room temperature, the solvent was distilled off, and the resulting crude product was dissolved in dimethylformamide (3 ml). The solution was cooled to 1 to 3° C., cesium carbonate (541 mg, 1.66 mmol) was added while the same temperature was retained, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The combined extracts were washed with water three times, and dried with sodium sulfate, and the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with ethyl acetate and, then, with ethyl acetate-methanol (7:3, v/v). Concentration of an objective fraction afforded 84.7 mg of compound 516B as an oil.</p>\n",
       "<p id=\"p-2267\" num=\"2279\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.21 (3H, J=6.9 Hz), 1.28 (3H, d, J=6, 9 Hz), 1.31-1.56 (2H, m), 2.05 (3H, s), 2.46 (2H, dd, J=5.4 Hz, 7.8 Hz), 4.57-4.71 (2H, m), 5.18 (1H, d, J=10.5 Hz), 5.51 (1H, d, J=10.5 Hz), 5.66 (1H, brs), 6.33 (1H, d, J=7.8 Hz), 7.19-7.35 (4H, m), 7.46-7.49 (2H, m).</p>\n",
       "<heading id=\"h-1155\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2268\" num=\"2280\">Compound 516 was synthesized by the same procedure as that of Example 511.</p>\n",
       "<p id=\"p-2269\" num=\"2281\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.6 Hz), 1.82-1.89 (2H, m), 1.99 (3H, s), 2.41-2.58 (2H, m), 2.86 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 2.99-3.11 (1H, m), 3.53 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.7 Hz), 4.87-3.96 (1H, m), 4.21 (1H, ddd, J=3.9 Hz, 12.9 Hz, 12.9 Hz), 4.53 (1H, dd, J=5.1 Hz, 8.7 Hz), 4.96 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.62 (1H, d, J=7.5 Hz), 6.64 (1H, d, J=9.0 Hz), 6.89-6.94 (1H, m), 7.07-7.37 (6H, m).</p>\n",
       "<p id=\"p-2270\" num=\"2282\">Using amines which are commercially available or known in the references and aldehydes which are commercially available or known in the references, and according to Example 516, compounds 517 to 526 were synthesized.</p>\n",
       "<heading id=\"h-1156\" level=\"1\">Example 517</heading>\n",
       "<p id=\"p-2271\" num=\"2283\"><chemistry id=\"CHEM-US-00637\" num=\"00637\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00637.TIF\" he=\"44.53mm\" id=\"EMI-C00637\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2272\" num=\"2284\">MS: m/z=500 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1157\" level=\"1\">Example 518</heading>\n",
       "<p id=\"p-2273\" num=\"2285\"><chemistry id=\"CHEM-US-00638\" num=\"00638\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00638.TIF\" he=\"39.37mm\" id=\"EMI-C00638\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2274\" num=\"2286\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.78 (3H, t, J=6.9 Hz), 1.19-1.30 (1H, m), 1.29 (3H, d, J=6.9 Hz), 1.43-1.62 (3H, m), 1.50 (3H, d, J=6.9 Hz), 2.84 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 3.00-3.11 (1H, ddd, J=3.9 Hz, 12.9 Hz, 12.9 Hz), 3.52 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.4 Hz), 3.79-3.88 (1H, m), 4.23-4.35 (2H, m), 4.96 (1H, s), 5.74 (1H, d, J=7.8 Hz), 6.61 (1H, d, J=7.5 Hz), 6.65 (1H, dd, J=1.2 Hz, 7.8 Hz), 6.91 (1H, ddd, J=1.5 Hz, 7.5 Hz, 7.5 Hz), 7.08-7.37 (6H, m).</p>\n",
       "<heading id=\"h-1158\" level=\"1\">Example 519</heading>\n",
       "<p id=\"p-2275\" num=\"2287\"><chemistry id=\"CHEM-US-00639\" num=\"00639\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00639.TIF\" he=\"41.49mm\" id=\"EMI-C00639\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2276\" num=\"2288\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.44 (3H, d, J=6.9 Hz), 1.54 (3H, d, J=6.6 Hz), 1.88 (1H, ddd, J=3.9 Hz, 3.9 Hz, 14.4 Hz), 2.72 (1H, ddd, J=3.6 Hz, 14.1 Hz, 14.1 Hz), 3.15 (1H, ddd, J=4.2 Hz, 4.2 Hz, 16.5 Hz), 3.54 (1H, dd, J=3.0 Hz, 14.4 Hz), 3.66 (1H, ddd, J=3.9 Hz, 13.8 Hz, 13.8 Hz), 4.03 (1H, dd, J=10.5 Hz, 14.1 Hz), 4.27-4.26 (1H, m), 4.64 (1H, dd, J=2.7 Hz, 10.5 Hz), 4.92 (1H, s), 5.80 (1H, d, J=7.8 Hz), 6.62-6.70 (2H, m), 6.69 (1H, d, J=7.8 Hz), 6.89 (1H, t, J=7.5 Hz), 6.96 (1H, d, J=7.5 Hz), 7.09-7.25 (4H, m), 7.77-7.89 (4H, m).</p>\n",
       "<heading id=\"h-1159\" level=\"1\">Example 520</heading>\n",
       "<p id=\"p-2277\" num=\"2289\"><chemistry id=\"CHEM-US-00640\" num=\"00640\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00640.TIF\" he=\"41.99mm\" id=\"EMI-C00640\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2278\" num=\"2290\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.30 (3H, d, J=6.6 Hz), 1.54 (3H, d, J=6.6 Hz), 2.83 (1H, ddd, J=4.8 Hz, 4.8 Hz, 14.1 Hz), 3.03-3.14 (1H, m), 3.21 (3H, s), 3.30 (3H, s), 3.53 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.7 Hz), 3.61-3.70 (1H, m), 4.18 (1H, d, J=5.4 Hz), 4.26 (1H, d, J=5.4 Hz), 4.45 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.92 (1H, s), 5.72 (1H, d, J=7.8 Hz), 6.63 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=6.6 Hz), 6.91 (1H, t, J=6.0 Hz), 7.08-7.36 (6H, m).</p>\n",
       "<heading id=\"h-1160\" level=\"1\">Example 521</heading>\n",
       "<p id=\"p-2279\" num=\"2291\"><chemistry id=\"CHEM-US-00641\" num=\"00641\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00641.TIF\" he=\"41.49mm\" id=\"EMI-C00641\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2280\" num=\"2292\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.30 (2.52H, d, J=6.9 Hz), 1.36 (0.48H, d, J=6.9 Hz), 1.42 (0.48H, d, J=6.9 Hz), 1.50 (2.52H, d, J=6.9 Hz), 1.74-1.98 (1H, m), 2.00-2.12 (1H, m), 2.16-2.35 (1H, m), 2.89 (1H, ddd, J=5.1 Hz, 5.1 Hz, 13.5 Hz), 3.06 (1H, ddd, J=3.9 Hz, 12.9 Hz, 12.9H), 3.52 (1H, d, J=4.2 Hz, 4.2 Hz, 17.4 Hz), 3.86-3.96 (1H, m), 4.15 (1H, ddd, J=3.9 Hz, 13.5 Hz, 13.5 Hz), 4.32 (1H, dd, J=3.9 Hz, 10.8 Hz), 4.48-4.64 (1H, m), 4.97 (0.84H, s), 5.30 (0.16H, s), 5.73 (0.84H, d, J=7.8 Hz), 6.20 (0.16H, d, J=7.5 Hz), 6.45 (0.16H, brs), 6.61 (1H, d, J=7.5 Hz), 6.64 (0.84H, d, J=8.7 Hz), 6.92 (1H, t, J=6.3 Hz), 7.10 (1H, d, J=7.5 Hz), 7.15-7.39 (3H, m).</p>\n",
       "<heading id=\"h-1161\" level=\"1\">Example 522</heading>\n",
       "<p id=\"p-2281\" num=\"2293\"><chemistry id=\"CHEM-US-00642\" num=\"00642\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00642.TIF\" he=\"41.49mm\" id=\"EMI-C00642\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2282\" num=\"2294\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.28 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.9 Hz), 1.54-1.79 (4H, m), 2.84 (1H, ddd, J=4.8 Hz, 4.8 Hz, 14.1 Hz), 3.05 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 3.17 (3H, s), 3.17-3.21 (2H, m), 3.52 (1H, ddd, J=4.2 Hz, 4.2 Hz, 17.7 Hz), 3.83-3.92 (1H, m), 4.22-4.32 (2H, m), 4.96 (1H, s), 5.73 (1H, d, J=7.5 Hz), 6.62 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=8.1 Hz), 6.92 (1H, t, J=7.2 Hz), 7.07-7.37 (6H, m).</p>\n",
       "<heading id=\"h-1162\" level=\"1\">Example 523</heading>\n",
       "<p id=\"p-2283\" num=\"2295\"><chemistry id=\"CHEM-US-00643\" num=\"00643\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00643.TIF\" he=\"45.04mm\" id=\"EMI-C00643\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2284\" num=\"2296\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.19-1.28 (1H, m), 1.28 (3H, d, J=6.9 Hz), 1.40-1.82 (4H, m), 1.48 (3H, d, J=6.6 Hz), 2.89-3.00 z81H, m), 3.17 (3H, s), 3.20-3.27 (2H, m), 3.31-3.40 (1H, m), 3.44-3.53 (1H, m), 3.86-3.98 (2H, m), 4.38 (1H, dd, J=3.6 Hz, 10.5 Hz), 5.05 (1H, s), 5.84 (1H, d, 7.5 Hz), 6.48-6.50 (1H, m), 6.66-6.69 (1H, m), 6.89-7.00 (2H, m), 7.05 (1H, d, 7.2 Hz), 7.11-7.24 (2H, m).</p>\n",
       "<heading id=\"h-1163\" level=\"1\">Example 524</heading>\n",
       "<p id=\"p-2285\" num=\"2297\"><chemistry id=\"CHEM-US-00644\" num=\"00644\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00644.TIF\" he=\"41.49mm\" id=\"EMI-C00644\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2286\" num=\"2298\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (3H, d, J=6.9 Hz), 1.42-1.83 (4H, m), 1.48 (3H, d, J=6.6 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz), 14.4H), 2.94-3.11 (1H, m), 3.18 (3H, s), 3.21-3.26 (2H, m), 3.49 (1H, ddd, J=4.2 Hz, 4.2 Hz, 18.0 Hz), 3.82-3.91 (1H, m), 4.20-4.33 (2H, m), 5.83 (1H, s), 5.84 (1Hm d, J=7.8 Hz), 6.58-6.72 (2H, m), 6.91-6.94 (1H, m), 7.11-7.30 (4H, m).</p>\n",
       "<heading id=\"h-1164\" level=\"1\">Example 525</heading>\n",
       "<p id=\"p-2287\" num=\"2299\"><chemistry id=\"CHEM-US-00645\" num=\"00645\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00645.TIF\" he=\"41.49mm\" id=\"EMI-C00645\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2288\" num=\"2300\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (3H, d, J=6.9 Hz), 1.47 (3H, d, J=6.6 Hz), 2.10 (3H, s), 2.78 (1H, ddd, J=4.2 Hz, 4.2 Hz, 13.8 Hz), 2.97 (3H, s), 3.01-3.13 (2H, m), 3.47 (1H, ddd, J=4.2 Hz, 4.2 Hz, 17.7 Hz), 3.65 (1H, dd, J=3.3 Hz, 14.1 Hz), 3.99-4.23 (2H, m), 4.70 (1H, dd, J=3.3 Hz, 10.2 Hz), 4.95 (1H, s), 5.78 (1H, d, J=7.8 Hz), 6.61 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=7.5 Hz), 6.93 (1H, t, J=6.6 Hz), 7.09 (1H, d, J=7.5 Hz), 7.15-7.27 (4H, m), 7.30-7.37 (1H, m).</p>\n",
       "<heading id=\"h-1165\" level=\"1\">Example 526</heading>\n",
       "<p id=\"p-2289\" num=\"2301\"><chemistry id=\"CHEM-US-00646\" num=\"00646\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00646.TIF\" he=\"41.49mm\" id=\"EMI-C00646\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2290\" num=\"2302\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.57-1.34 (1H, m), 1.29 (3H, d, J=6.9 Hz), 1.41-1.52 (1H, m), 1.48 (3H, d, J=6.6 Hz), 1.59-1.81 (2H, m), 2.80 (1H, ddd, 4.5 Hz, 4.5 Hz, 14.4 Hz), 3.04 (1H, ddd, J=4.2 Hz, 13.2 Hz, 13.2 Hz), 3.14-3.26 (2H, m), 3.18 (3H, s), 3.49 (1H, ddd, J=4.8 Hz, 4.8 Hz, 17.7 Hz), 3.84-3.93 (1H, m), 4.23-4.34 (2H, m), 4.96 (1H, s), 5.81 (1H, d, J=7.5 Hz), 6.60-6.79 (3H, m), 6.81 (1Hm d, J=9.3 Hz), 6.92 (1H, ddd, J=2.7 Hz, 8.4 Hz, 8.4 Hz), 7.19-7.24 (1H, m).</p>\n",
       "<heading id=\"h-1166\" level=\"1\">Example 527</heading>\n",
       "<p id=\"p-2291\" num=\"2303\"><chemistry id=\"CHEM-US-00647\" num=\"00647\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00647.TIF\" he=\"156.46mm\" id=\"EMI-C00647\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1167\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2292\" num=\"2304\">A DMF (0.2 mL) solution of compound 527A (36 mg, 0.09 mmol) synthesized according to the method of synthesizing compound 516 was cooled to 1 to 3° C., 5-chlorodibenzosuberane (97 mg, 0.43 mmol) and cesium carbonate (138 mg, 0.43 mmol) were added, and the mixture was stirred at room temperature overnight. To the reaction solution was added water, and the mixture was distributed between ethyl acetate and water. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol. Concentration of an objective fraction afforded 19 mg of compound 527B as an oil.</p>\n",
       "<p id=\"p-2293\" num=\"2305\">MS: m/z=616 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1168\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2294\" num=\"2306\">Compound 527B (19 mg, 0.03 mmol) was dissolved in MeOH (0.6 mL), 10% Pd—C (3 mg) was added, and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting oil was subjected to diol silica gel column chromatography, and eluted with chloroform-methanol. Concentration of an objective fraction afforded 7 mg of compound 527 as an oil.</p>\n",
       "<p id=\"p-2295\" num=\"2307\">MS: m/z=526 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"p-2296\" num=\"2308\">Using halides which are commercially available or known in the references and aldehydes which are commercially available or known in the references, and according to the method of Example 527, compounds 528 to 531 were synthesized.</p>\n",
       "<heading id=\"h-1169\" level=\"1\">Example 528</heading>\n",
       "<p id=\"p-2297\" num=\"2309\"><chemistry id=\"CHEM-US-00648\" num=\"00648\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00648.TIF\" he=\"40.39mm\" id=\"EMI-C00648\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2298\" num=\"2310\">MS: m/z=418 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1170\" level=\"1\">Example 529</heading>\n",
       "<p id=\"p-2299\" num=\"2311\"><chemistry id=\"CHEM-US-00649\" num=\"00649\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00649.TIF\" he=\"40.39mm\" id=\"EMI-C00649\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2300\" num=\"2312\">MS: m/z=432 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1171\" level=\"1\">Example 530</heading>\n",
       "<p id=\"p-2301\" num=\"2313\"><chemistry id=\"CHEM-US-00650\" num=\"00650\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00650.TIF\" he=\"41.23mm\" id=\"EMI-C00650\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2302\" num=\"2314\">MS: m/z=459 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1172\" level=\"1\">Example 531</heading>\n",
       "<p id=\"p-2303\" num=\"2315\"><chemistry id=\"CHEM-US-00651\" num=\"00651\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00651.TIF\" he=\"43.60mm\" id=\"EMI-C00651\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2304\" num=\"2316\">MS: m/z=466 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1173\" level=\"1\">Example 532</heading>\n",
       "<p id=\"p-2305\" num=\"2317\"><chemistry id=\"CHEM-US-00652\" num=\"00652\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00652.TIF\" he=\"99.82mm\" id=\"EMI-C00652\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1174\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2306\" num=\"2318\">To a methanol (5 ml) solution of compound 519 (440 mg, 0.766 mmol) was added hydrazine hydrate (383 mg, 7.66 mmol), and the mixture was refluxed for 1 hour. After cooled to room temperature, the precipitated insolubles were filtered off. After the solvent was distilled off, the residue was suspended in ethyl acetate, the insolubles were filtered off, and the solvent was distilled off. The resulting crude product was suspended in chloroform, and insolubles were filtered off. The solvent was distilled off, and the resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 190 mg of compound 532 as a solid.</p>\n",
       "<p id=\"p-2307\" num=\"2319\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.24 (3H, d, J=6.9H), 1.46 (3H, d, J=6.6 Hz), 2.73-2.90 (3H, m), 3.08 (1H, ddd, J=4.2 Hz, 12.9 Hz, 12.9 Hz), 3.54 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.7 Hz), 3.85-3.94 (1H, m), 4.19 (1H, dd, J=7.2 Hz, 11.1 Hz), 4.35 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.97 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.60 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=7.2 Hz), 6.92 (1H, t, J=6.3 Hz), 7.09-7.45 (6H, m).</p>\n",
       "<heading id=\"h-1175\" level=\"1\">Example 533</heading>\n",
       "<p id=\"p-2308\" num=\"2320\"><chemistry id=\"CHEM-US-00653\" num=\"00653\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00653.TIF\" he=\"41.49mm\" id=\"EMI-C00653\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2309\" num=\"2321\">Compound 533 was synthesized by the same procedure as that of Example 532.</p>\n",
       "<p id=\"p-2310\" num=\"2322\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.22 (3H, d, J=6.6 Hz), 1.40 (3H, d, J=6.6 Hz), 1.45-1.58 (1H, m), 1.62-1.75 (1H, m), 2.61-2.69 (1H, m), 2.71-2.84 (1H, m), 2.88-2.95 (1H, m), 3.16-3.34 (1H, m), 3.60-3.64 (1H, m), 3.92-4.00 (1H, m), 4.24-4.33 (1H, m), 4.42-4.46 (1H, dd, J=3.3 Hz, 10.8 Hz), 5.10 (1H, s), 5.47 (1H, d, J=7.5 Hz), 6.70 (1H, d, J=7.5 Hz), 6.88 (1H, t, J=7.5 Hz), 7.02 (1H, d, J=10.8 Hz), 7.09-7.16 (2H, m), 7.19-7.25 (1H, m), 7.33 (2H, d, 4.2 Hz), 7.42 (1H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-1176\" level=\"1\">Example 534</heading>\n",
       "<p id=\"p-2311\" num=\"2323\"><chemistry id=\"CHEM-US-00654\" num=\"00654\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00654.TIF\" he=\"41.49mm\" id=\"EMI-C00654\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2312\" num=\"2324\">Compound 534 was synthesized by the same procedure as that of Example 532.</p>\n",
       "<p id=\"p-2313\" num=\"2325\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.25 (3H, d, J=6.9 Hz), 1.44 (3H, d, J=6.6 Hz), 1.32-1.58 (2H, m), 1.77-1.79 (2H, m), 2.64-2.73 (1H, m), 2.79-3.00 (2H, m), 3.88-3.97 (2H, m), 4.19-4.28 (2H, m), 5.15 (1H, s), 5.67 (1H, d, J=7.5 Hz), 5.73 (1H, d, J=7.5 Hz), 6.90 (1H, t, J=6.6 Hz), 7.03 (1H, d, J=7.5 Hz), 7.13-7.32 (3H, m), 7.36 (2H, d, J=4.2 Hz), 7.44 (1H, J=7.2 Hz), 7.75 (1H, brs).</p>\n",
       "<heading id=\"h-1177\" level=\"1\">Example 535</heading>\n",
       "<p id=\"p-2314\" num=\"2326\"><chemistry id=\"CHEM-US-00655\" num=\"00655\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00655.TIF\" he=\"41.49mm\" id=\"EMI-C00655\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2315\" num=\"2327\">Compound 535 was synthesized by the same procedure as that of Example 532.</p>\n",
       "<p id=\"p-2316\" num=\"2328\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.40-1.52 (1H, m), 1.61-1.72 (1H, m), 2.40-2.49 (1H, m), 2.58-2.62 (1H, m), 2.78-2.86 (1H, m), 2.89-2.95 (1H, m), 2.95 (3H, m), 3.66-3.74 (1H, m), 4.01-4.13 (1H, m), 4.28-4.32 (1H, m), 5.14 (1H, m), 5.51 (1H, d, J=7.8 Hz), 6.72 (1H, d, J=7.5 Hz), 6.91-6.94 (2H, m), 7.14-7.40 (6H, m).</p>\n",
       "<heading id=\"h-1178\" level=\"1\">Example 536</heading>\n",
       "<p id=\"p-2317\" num=\"2329\"><chemistry id=\"CHEM-US-00656\" num=\"00656\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00656.TIF\" he=\"99.23mm\" id=\"EMI-C00656\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1179\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2318\" num=\"2330\">A dichloromethane (1 ml) solution of compound 532 (30 mg, 0.0675 mmol) and a 38% aqueous formalin solution (53.5 mg, 0.675 mmol) was cooled to 1 to 3° C., sodium triacetoxyhydroborate (42.9 mg, 0.293 mmol) and acetic acid (10 mg, 0.166 mmol) were added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, saturated sodium bicarbonate water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 20 mg of compound 536 as a solid.</p>\n",
       "<p id=\"p-2319\" num=\"2331\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.22 (3H, d, J=6.6 Hz), 1.44 (3H, d, J=6.9 Hz), 2.06 (6H, s), 2.29 (1H, dd, J=4.5 Hz, 13.2 Hz), 4.23 (1H, dd, J=8.4 Hz, 13.2 Hz), 2.78 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz, 3.06 (1H, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 3.55 (1H, ddd, J=4.2 Hz, 4.2 Hz, 17.7 Hz), 3.83-3.92 (1H, m), 4.34 (1H, dd, J=4.5 Hz, 8.4 Hz), 4.54 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.91 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.63 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=7.8 Hz), 6.88-6.93 (1H, m), 7.08-7.45 (6H, m).</p>\n",
       "<heading id=\"h-1180\" level=\"1\">Example 537</heading>\n",
       "<p id=\"p-2320\" num=\"2332\"><chemistry id=\"CHEM-US-00657\" num=\"00657\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00657.TIF\" he=\"41.49mm\" id=\"EMI-C00657\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2321\" num=\"2333\">Compound 537 was synthesized by the same procedure as that of Example 536.</p>\n",
       "<p id=\"p-2322\" num=\"2334\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.25 (3H, d, J=6.6 Hz), 1.40 (3H, d, J=6.6 Hz), 1.46-1.57 (1H, m), 1.68-1.79 (1H, m), 1.98 (6H, s), 2.04-2.11 (1H, m), 2.27-2.41 (1H, m), 2.72-2.94 (2H, m), 3.55-3.64 (1H, m), 3.91-4.00 (1H, m), 4.29-4.44 (2H, m), 5.10 (1H, s), 5.48 (1H, d, J=7.8 Hz), 6.71 (1H, d, J=7.8 Hz), 6.86-6.90 (1H, m), 7.05-7.24 (4H, m), 7.33 (2H, d, J=4.2 Hz), 7.40 (1H, d, J=7.5 Hz).</p>\n",
       "<heading id=\"h-1181\" level=\"1\">Example 538</heading>\n",
       "<p id=\"p-2323\" num=\"2335\"><chemistry id=\"CHEM-US-00658\" num=\"00658\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00658.TIF\" he=\"41.49mm\" id=\"EMI-C00658\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2324\" num=\"2336\">Compound 538 was synthesized by the same procedure as that of Example 536.</p>\n",
       "<p id=\"p-2325\" num=\"2337\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.75 (6H, t, J=6.6 Hz), 1.28 (3H, d, J=6.6 Hz), 1.41 (3H, d, J=6.6 Hz), 1.45-1.56 (1H, m), 1.67-1.78 (1H, m), 2.22-2.49 (4H, m), 2.74-2.97 (2H, m), 3.94-4.03 (1H, m), 4.29-4.41 (2H, m), 5.11 (1H, s), 5.48 (1H, d, J=7.8 Hz), 6.71 (1H, d, J=6.9 Hz), 6.87 (1H, t, J=7.2 Hz), 7.06-7.25 (4H, m), 7.33 (2H, d, J=7.2 Hz), 7.35 (1H, m).</p>\n",
       "<heading id=\"h-1182\" level=\"1\">Example 539</heading>\n",
       "<p id=\"p-2326\" num=\"2338\"><chemistry id=\"CHEM-US-00659\" num=\"00659\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00659.TIF\" he=\"41.49mm\" id=\"EMI-C00659\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2327\" num=\"2339\">Compound 539 was synthesized by the same procedure as that of Example 536.</p>\n",
       "<p id=\"p-2328\" num=\"2340\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.25 (3H, d, J=6.6 Hz), 1.44 (3H, d, J=6.6 Hz), 1.42-1.51 (2H, m), 1.75-1.91 (2H, m), 2.62-2.67 (1H, m), 2.65 (6H, s), 2.74-2.97 (3H, m), 3.57-3.63 (1H, m), 3.91-3.26 (4H, m), 5.16 (1H, s), 5.73 (1H, d, J=7.5 Hz), 6.71 (1H, d, J=7.2 Hz), 6.89 (1H, t, J=6.9 Hz), 7.12-7.28 (4H, m), 7.33-7.45 (3H, m).</p>\n",
       "<heading id=\"h-1183\" level=\"1\">Example 540</heading>\n",
       "<p id=\"p-2329\" num=\"2341\"><chemistry id=\"CHEM-US-00660\" num=\"00660\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00660.TIF\" he=\"41.49mm\" id=\"EMI-C00660\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2330\" num=\"2342\">Compound 540 was synthesized by the same procedure as that of Example 536.</p>\n",
       "<p id=\"p-2331\" num=\"2343\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.58-1.78 (2H, m), 2.06 (6H, s), 2.15-2.35 (2H, m), 2.84-2.93 (1H, m), 2.96-3.11 (1H, m), 3.00 (3H, s), 3.65-3.74 (1H, m), 3.99-4.14 (1H, m), 4.28-4.33 (1H, m), 4.94 (1H, s), 5.78 (1H, d, J=7.5 Hz), 6.56 (1H, d, J=7.8 Hz), 8.66 (1H, d, J=7.2 Hz), 6.95 (t, J=7.2 Hz), 7.13-7.38 (6H, m).</p>\n",
       "<heading id=\"h-1184\" level=\"1\">Example 541</heading>\n",
       "<p id=\"p-2332\" num=\"2344\"><chemistry id=\"CHEM-US-00661\" num=\"00661\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00661.TIF\" he=\"41.49mm\" id=\"EMI-C00661\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2333\" num=\"2345\">Compound 541 was synthesized by the same procedure as that of Example 536.</p>\n",
       "<p id=\"p-2334\" num=\"2346\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.846 (6H, t, J=7.2 Hz), 1.49-1.75 (2H, m), 2.30-2.41 (5H, m), 2.43-2.53 (1H, m), 2.85-2.93 (1H, m), 2.98-3.08 (1H, m), 3.01 (3H, s), 3.63-3.74 (1H, m), 3.97-4.07 (1H, m), 4.30 (1H, dd, J=5.1 Hz, 8.1 Hz), 4.95 (1H, s), 5.77 (1H, d, J=6.0 Hz), 6.56 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=7.8 Hz), 6.95 (1H, t, J=6.3 Hz), 7.13-7.38 (6H, m).</p>\n",
       "<heading id=\"h-1185\" level=\"1\">Example 542</heading>\n",
       "<p id=\"p-2335\" num=\"2347\"><chemistry id=\"CHEM-US-00662\" num=\"00662\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00662.TIF\" he=\"98.98mm\" id=\"EMI-C00662\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1186\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2336\" num=\"2348\">A dichloromethane (1 ml) solution of compound 532 (30 mg, 0.0675 mmol) and triethylamine (20.5 mg, 0.202 mmol) was cooled to 1 to 3° C., and acetic acid anhydride (10.3 mg, 0.101 mmol) was added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 15 mg of compound 542 as a solid.</p>\n",
       "<p id=\"p-2337\" num=\"2349\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.30 (3H, d, J=6.9 Hz), 1.47 (3H, d, J=6.6 Hz), 2.00 (3H, s), 2.78-2.94 (2H, m), 3.04 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 3.48-3.60 (1H, m), 3.98-3.07 (1H, m), 4.36 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.64 (1H, dd, J=3.9 Hz, 9.3 Hz), 4.87 (1H, s), 5.43 (1H, d, J=7.5 Hz), 6.57 (1H, d, J=7.5 Hz), 6.68 (1H, d, J=7.5 Hz), 6.85 (1H, t, J=6.0 Hz), 7.09-7.36 (6H, m), 7.41 (1H, brs).</p>\n",
       "<heading id=\"h-1187\" level=\"1\">Example 543</heading>\n",
       "<p id=\"p-2338\" num=\"2350\"><chemistry id=\"CHEM-US-00663\" num=\"00663\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00663.TIF\" he=\"41.49mm\" id=\"EMI-C00663\" img-content=\"chem\" img-format=\"tif\" wi=\"50.80mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2339\" num=\"2351\">Compound 543 was synthesized by the same procedure as that of Example 542.</p>\n",
       "<p id=\"p-2340\" num=\"2352\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.32 (3H, d, J=6.9 Hz), 1.50 (3H, d, J=6.9 Hz), 2.79 (1H, ddd, J=4.2 Hz, 4.2 Hz, 14.4 Hz), 3.01 (1H, ddd, J=3.9 Hz, 13.5 Hz, 13.5 Hz), 3.18-3.28 (1H, m), 3.46-3.59 (2H, m), 4.04-4.18 (1H, m), 4.27 (1H, ddd, J=3.9 Hz, 13.5 Hz, 13.5 Hz), 4.69 (1H, dd, J=3.3 Hz, 9.9 Hz), 4.87 (0.9H, s), 5.17 (0.1H, s), 5.37 (0.9H, d, J=7.8 Hz), 4.50 (0.1H, d, J=7.8H), 6.32 (0.1H, d, J=7.8 Hz), 6.54 (1H, d, J=7.5 Hz), 6.78 (0.9H, d, J=7.5 Hz), 6.84 (1H, t, J=6.6 Hz), 6.91 (0.1H, d, J=6.0 Hz), 7.06-7.51 (6H, m), 9.29 (1H, brs).</p>\n",
       "<heading id=\"h-1188\" level=\"1\">Example 544</heading>\n",
       "<p id=\"p-2341\" num=\"2353\"><chemistry id=\"CHEM-US-00664\" num=\"00664\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00664.TIF\" he=\"41.49mm\" id=\"EMI-C00664\" img-content=\"chem\" img-format=\"tif\" wi=\"50.12mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2342\" num=\"2354\">Compound 544 was synthesized by the same procedure as that of Example 542.</p>\n",
       "<p id=\"p-2343\" num=\"2355\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (3H, d, J=6.9 Hz), 1.46 (3H, d, J=6.3 Hz), 2.78 (1H, ddd, J=4.5 Hz, 4.5 Hz, 15.9 Hz), 2.94-3.10 (2H, m), 3.19-3.54 (2H, m), 3.64 (3H, s), 3.96-3.11 (1H, m), 4.28 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.57 (1H, dd, J=3.3 Hz, 9.9 Hz), 4.91 (1H, s), 5.57 (1H, brs), 5.70 (1H, d, J=7.5 Hz), 6.60 (1H, d, J=7.5 Hz), 6.66 (1H, d, J=7.8 Hz), 6.89 (1H, t, J=7.2 Hz), 7.08-7.47 (6H, m).</p>\n",
       "<heading id=\"h-1189\" level=\"1\">Example 545</heading>\n",
       "<p id=\"p-2344\" num=\"2356\"><chemistry id=\"CHEM-US-00665\" num=\"00665\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00665.TIF\" he=\"97.20mm\" id=\"EMI-C00665\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1190\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2345\" num=\"2357\">A dichloromethane (1 ml) solution of compound 532 (30 mg, 0.0675 mmol) and pyridine (16 mg, 0.203 mmol) was cooled to 1 to 3° C., and 2-methoxyacetyl chloride (11 mg, 0.101 mmol) was added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 22 mg of compound 545 as a solid.</p>\n",
       "<p id=\"p-2346\" num=\"2358\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.31 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.9 Hz), 2.77 (1H, ddd, J=4.8 Hz, 4.8 Hz, 14.1 Hz), 2.99-3.11 (2H, m), 3.47 (3H, s), 3.47-3.55 (1H, m), 3.64-3.72 (1H, m), 3.77-3.88 (2H, m), 4.02-4.11 (1H, m), 4.23 (1H, ddd, J=4.2 Hz, 13.8 Hz, 13.8 Hz), 4.47 (1H, dd, J=3.3 Hz, 9.9 Hz), 4.94 (1H, s), 5.75 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=9.0 Hz), 6.67 (1H, 7.8 Hz), 6.80 (1H, brt), 6.91 (1H, t, J=7.5 Hz), 7.08-7.23 (5H, m), 7.29-7.36 (1H, m).</p>\n",
       "<heading id=\"h-1191\" level=\"1\">Example 546</heading>\n",
       "<p id=\"p-2347\" num=\"2359\"><chemistry id=\"CHEM-US-00666\" num=\"00666\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00666.TIF\" he=\"97.20mm\" id=\"EMI-C00666\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1192\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2348\" num=\"2360\">To a dimethylformamide (1 ml) solution of 2-(methylthio)acetic acid (15.7 mg, 0.148 mmol) were added EDCI (28.5 mg, 0.148 mmol) and 1-hydroxy benzotriazole (11.4 mg, 0.0742 mmol) at room temperature, the mixture was stirred at the same temperature for 5 minutes, and compound 532 was added. The reaction solution was stirred at room temperature for 1 hour, and diluted with methanol (3 ml). The solution was cooled to 1 to 3° C., a 2N aqueous sodium hydroxide solution (1 ml) was added, the mixture was stirred at the same temperature for 30 minutes, and the mixture was neutralized with 2N hydrochloric acid (1 ml). The reaction solution was extracted with ethyl acetate three times, the combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 15 mg of compound 546 as a solid.</p>\n",
       "<p id=\"p-2349\" num=\"2361\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.32 (3H, d, J=6.9 Hz), 1.50 (3H, J=6.6 Hz), 2.11 (3, s), 2.79 (1H, ddd, J=4.2 Hz, 4.2 Hz, 14.1 Hz), 2.99-3.16 (4H, m), 3.50 (1H, ddd, J=4.5 Hz, 4.5 Hz, 12.9 Hz), 3.68 (1H, d, J=10.2 Hz), 3.97-4.11 (1H, m), 4.26 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.94 (3H, s), 5.69 (1H, d, J=7.5 Hz), 6.63 (1H, d, J=7.5 Hz), 6.70 (1H, d, J=7.8 Hz), 6.90 (1H, t, J=6.0 Hz), 7.09 (1H, d, J=7.5 Hz), 7.20-7.25 (3H, m), 7.29-7.36 (1H, m), 7.36-7.49 (1H, m).</p>\n",
       "<heading id=\"h-1193\" level=\"1\">Example 547</heading>\n",
       "<p id=\"p-2350\" num=\"2362\"><chemistry id=\"CHEM-US-00667\" num=\"00667\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00667.TIF\" he=\"76.12mm\" id=\"EMI-C00667\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1194\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2351\" num=\"2363\">To an acetic acid (3 ml) solution of compound 547A (367 mg, 0.812 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (205 mg, 0.974 mmol) was added dropwise sulfuric acid (0.6 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (3 ml), a 2N aqueous sodium hydroxide solution (1 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with 2N hydrochloric acid (1 ml), and extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 75 mg of compound 547 as a solid.</p>\n",
       "<p id=\"p-2352\" num=\"2364\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.22 (3H, d, J=6.9 Hz), 1.45 (3H, d, J=6.3 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 2.99-3.11 (1H, m), 3.53 (1H, ddd, J=3.9 Hz, 3, 9 Hz, 17.7 Hz), 3.64 (1H, dd, J=6.9 Hz), 12.3 Hz), 3.82 (1H, dd, J=3.3 Hz, 12.3 Hz), 3.86-3.97 (1H, m), 4.34-4.44 (2H, m), 4.88 (1H, s), 5.35 (1H, d, J=7.5 Hz), 6.52-6.58 (2H, m), 6.82 (1H, dt, J=1.8 Hz, 7.2 Hz), 7.06-7.35 (6H, m).</p>\n",
       "<heading id=\"h-1195\" level=\"1\">Example 548</heading>\n",
       "<p id=\"p-2353\" num=\"2365\"><chemistry id=\"CHEM-US-00668\" num=\"00668\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00668.TIF\" he=\"41.49mm\" id=\"EMI-C00668\" img-content=\"chem\" img-format=\"tif\" wi=\"42.93mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2354\" num=\"2366\">Compound 548 was synthesized by the same procedure as that of Example 547.</p>\n",
       "<p id=\"p-2355\" num=\"2367\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.29 (3H, d, J=6.6 Hz), 1.50 (3H, d, J=6.6 Hz), 1.70-1.81 (1H, m), 1.88-2.00 (1H, m), 2.85 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 2.99-3.11 (1H, m), 3.48-3.57 (1H, m), 3.68-3.73 (2H, m), 3.83-3.92 (1H, m), 4.30 (1H, ddd, J=4.2 Hz, 13.8 Hz, 13.8 Hz), 4.54 (1H, dd, J=3.6 Hz, 11.1 Hz), 4.67 (1H, s), 5.69 (1H, d, J=7.8 Hz), 6.62 (1H, d, J=7.5 Hz), 6.64 (1H, d, J=5.7 Hz), 6.90 (1H, t, J=6.9 Hz), 7.07-7.36 (6H, m).</p>\n",
       "<heading id=\"h-1196\" level=\"1\">Example 549</heading>\n",
       "<p id=\"p-2356\" num=\"2368\"><chemistry id=\"CHEM-US-00669\" num=\"00669\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00669.TIF\" he=\"138.77mm\" id=\"EMI-C00669\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1197\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2357\" num=\"2369\">To an acetic acid (3 ml) solution of compound 549A (997 mg, 1.69 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (1.07 g, 5.08 mmol) was added dropwise sulfuric acid (0.6 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 513 mg of compound 549B.</p>\n",
       "<p id=\"p-2358\" num=\"2370\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.09 (3H, s), 2.71 (1H, ddd, J=3.6 Hz, 13.5 Hz, 13.5 Hz), 3.18-3.27 (1H, m), 3.42-3.56 (2H, m), 3.80 (1H, dd, J=2.7 Hz, 14.1 Hz), 4.03 (1H, dd, J=10.2 Hz, 14.1 Hz), 4.15 (1H, ddd, J=4.2 Hz, 4.2 Hz, 9.3 Hz), 4.32-4.40 (1H, m), 4.49-4.53 (2H, m), 4.94 (1H, s), 5/83 (1H, d, J=7.8 Hz), 6.63 (1H, d, J=7.5 Hz), 6.69 (1H, d, J=7.8 Hz), 6.76 (1H, d, J=6.6 Hz), 6.91 (1H, t, J=7.5 Hz), 7.00 (1H, d, J=8.1 Hz), 7.12-7.17 (2H, m), 7.20-7.32 (2H, m), 7.82-7.89 (4H, m).</p>\n",
       "<heading id=\"h-1198\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2359\" num=\"2371\">To a methanol (5 ml) solution of compound 549B (513 mg, 0.829 mmol) was added hydrazine hydrate (124.5 mg, 2.49 mmol), and the mixture was refluxed for 2 hours. After cooled to room temperature, to the reaction solution were added 2N hydrochloric acid (30 ml) and ethyl acetate (30 ml). After the layers were separated, the organic layer was extracted with 2N hydrochloric acid two times. The combined aqueous layers were neutralized with sodium bicarbonate water, and extracted with chloroform-methanol three times. The combined organic layers were dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 135 mg of compound 549.</p>\n",
       "<p id=\"p-2360\" num=\"2372\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.40-2.50 (1H, m), 2.72-2.80 (1H, m), 2.83-2.98 (2H, m), 3.03-3.66 (4H, m), 3.79-3.87 (1H, m), 4.11 (1H, 4.2 Hz), 4.32-4.44 (1H, m), 5.12 (1H, s), 5.51 (1H, 7.5 Hz), 6.69 (d, J=7.5 Hz), 6.84-6.90 (1H, m), 7.07-7.24 (4H, m), 7.30-7.34 (2H, m), 7.39-7.42 (1H, m).</p>\n",
       "<heading id=\"h-1199\" level=\"1\">Example 550</heading>\n",
       "<p id=\"p-2361\" num=\"2373\"><chemistry id=\"CHEM-US-00670\" num=\"00670\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00670.TIF\" he=\"44.28mm\" id=\"EMI-C00670\" img-content=\"chem\" img-format=\"tif\" wi=\"45.21mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2362\" num=\"2374\">According to Example 536, compound 550 was synthesized from compound 549 by the same procedure.</p>\n",
       "<p id=\"p-2363\" num=\"2375\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 0.77 (6H, t, 6.9 Hz), 1.99-2.36 (3H, m), 2.38-2.56 (1H, m), 2.64 (1H, dd, J=3.9 Hz, 14.1 Hz), 2.75 z81H, ddd, J=4.5 Hz, 4.5 Hz, 14.4 Hz), 2.89-3.00 (1H, m), 3.09-3.68 (4H, m), 3.74-3.82 (1H, m), 4.09 (1H, brs), 4.17 (1H, dd, J=3.6 Hz, 8.4 Hz), 5.03 (1H, brs), 5.17 (1H, s), 5.53 (1H, d, J=7.5 Hz), 6.73 (1H, d, J=7.5 Hz), 6.84 (1H, d, J=7.8 Hz), 6.91 (1H, t, J=7.2 Hz), 7.12-7.26 (4H, m), 7.31-7.44 (4H, m), 7.45 (1H, d, J=7.2 Hz).</p>\n",
       "<heading id=\"h-1200\" level=\"1\">Example 551</heading>\n",
       "<p id=\"p-2364\" num=\"2376\"><chemistry id=\"CHEM-US-00671\" num=\"00671\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00671.TIF\" he=\"44.28mm\" id=\"EMI-C00671\" img-content=\"chem\" img-format=\"tif\" wi=\"40.30mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2365\" num=\"2377\">According to Example 536, compound 551 was synthesized from compound 549 by the same procedure.</p>\n",
       "<p id=\"p-2366\" num=\"2378\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.99 (6H, s), 2.27 (1H, brs), 2.51-2.27 (3H, m), 3.56-3.70 (4H, m), 4.03 (2H, brs), 4.36 (1H, brs), 4.94 (2H, brs), 5.29 (1H, brs), 6.54-6.83 (3H, m), 7.11-7.33 (6H, m).</p>\n",
       "<heading id=\"h-1201\" level=\"1\">Example 552</heading>\n",
       "<p id=\"p-2367\" num=\"2379\"><chemistry id=\"CHEM-US-00672\" num=\"00672\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00672.TIF\" he=\"78.99mm\" id=\"EMI-C00672\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1202\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2368\" num=\"2380\">To an acetic acid (2 ml) solution of compound 552A (137 mg, 0.367 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (386 mg, 1.83 mmol) was added dropwise sulfuric acid (0.4 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (5 ml), a 2N aqueous sodium hydroxide solution (2 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with 2N hydrochloric acid (2 ml), and extracted with ethyl acetate two times. The combined extracts were dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate to obtain 62 mg of compound 552.</p>\n",
       "<p id=\"p-2369\" num=\"2381\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.71-1.82 (1H, m), 2.09-2.21 (1H, m), 2.82-2.90 (1H, m), 3.06 (1H, ddd, J=4.2 Hz, 13.2 Hz, 13.2 Hz), 3.19 (3H, s), 3.22-3.43 (3H, m), 3.60 (1H, ddd, J=10.5 Hz, 10.5 Hz, 17.4 Hz), 3.79-3.96 (3H, m), 4.12-4.21 (1H, m), 4.46 (1H, dd, J=3.3 Hz, 10.2 Hz), 4.98 (1H, s), 5.89 (1H, d, J=7.5 Hz), 6.62 (1H, d, J=6.9 Hz), 6.64 (1H, d, J=7.5 Hz), 6.88-6.93 (1H, m), 7.11-7.37 (6H, m).</p>\n",
       "<heading id=\"h-1203\" level=\"1\">Example 553</heading>\n",
       "<p id=\"p-2370\" num=\"2382\"><chemistry id=\"CHEM-US-00673\" num=\"00673\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00673.TIF\" he=\"43.86mm\" id=\"EMI-C00673\" img-content=\"chem\" img-format=\"tif\" wi=\"42.93mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2371\" num=\"2383\">Compound 553 was synthesized by the same procedure as that of Example 552.</p>\n",
       "<p id=\"p-2372\" num=\"2384\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.80 (3H, d, J=6.6 Hz), 0.94 (3H, d, J=6.9 Hz), 1.94-2.00 (1H, m), 2.82-2.90 (1H, m), 3.00-3.11 (1H, m), 5.31-3.59 (2H, m), 3.64-3.74 (1H, m), 3.94-4.04 (3H, m), 4.25-4.36 (1H, m), 5.04 (1H, s), 5.87 (1H, d, J=7.2 Hz), 6.65 (1H, d, J=7.2 Hz), 7.12 (1H, d, J=7.5 Hz), 6.92 (1H, t, J=8.1 Hz), 7.10 (1H, d, J=7.2 Hz), 7.15-7.38 (5H, m).</p>\n",
       "<heading id=\"h-1204\" level=\"1\">Example 554</heading>\n",
       "<p id=\"p-2373\" num=\"2385\"><chemistry id=\"CHEM-US-00674\" num=\"00674\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00674.TIF\" he=\"79.42mm\" id=\"EMI-C00674\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1205\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2374\" num=\"2386\">To an acetic acid (2 ml) solution of compound 554A (100 mg, 0.177 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (186 mg, 0.885 mmol) was added dropwise sulfuric acid (0.4 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (5 ml), a 2N aqueous sodium hydroxide solution (2 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with an aqueous citric acid solution, and extracted with ethyl acetate two times. The combined extracts were washed with sodium bicarbonate water, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate to obtain 24 mg of compound 554.</p>\n",
       "<p id=\"p-2375\" num=\"2387\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.81-2.91 (2H, m), 2.98-3.09 (1H, m), 3.60-3.75 (2H, m), 3.91-4.04 (2H, m), 4.08-4.17 (2H, m), 4.22-4.33 (2H, m), 4.80 (1H, s), 5.69 (1H, d, J=7.8 Hz), 6.48 (1H, d, J=7.5 Hz), 6.59 (1H, d, J=7.5 Hz), 6.80-6.85 (1H, m), 7.13-7.35 (6H, m).</p>\n",
       "<heading id=\"h-1206\" level=\"1\">Example 555</heading>\n",
       "<p id=\"p-2376\" num=\"2388\"><chemistry id=\"CHEM-US-00675\" num=\"00675\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00675.TIF\" he=\"76.12mm\" id=\"EMI-C00675\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2377\" num=\"2389\">To an acetic acid (4 ml) solution of compound 555A (380 mg, 1.11 mmol) synthesized according to Example 516 and dibenzosuberol (1.16 g, 5.52 mmol) was added dropwise sulfuric acid (0.8 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (5 ml), a 2N aqueous sodium hydroxide solution (2 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with an aqueous citric acid solution, and extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate, and the solvent was distilled off. To the resulting crude product were added ethyl acetate-diisopropyl ether, and the precipitated residue was filtered to obtain 22 mg of compound 555.</p>\n",
       "<p id=\"p-2378\" num=\"2390\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.62 (3H, d, J=6.9 Hz), 2.81 (1H, ddd, J=4.2 Hz, 4.2 Hz, 14.4 Hz), 3.09 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 3.37 (3H, s), 3.37-3.53 (2H, m), 3.70 (1H, d, J=5.4 Hz), 4.23-4.30 (2H, m), 4.33-4.44 (1H, m), 4.94 (1H, s), 5.70 (1H, d, J=7.8 Hz), 6.59 (1H, d, J=7.5 Hz), 6.64 (1H, d, J=7.8 Hz), 6.88-6.92 (1H, m), 7.08-7.37 (6H, m).</p>\n",
       "<heading id=\"h-1207\" level=\"1\">Example 556</heading>\n",
       "<p id=\"p-2379\" num=\"2391\"><chemistry id=\"CHEM-US-00676\" num=\"00676\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00676.TIF\" he=\"41.49mm\" id=\"EMI-C00676\" img-content=\"chem\" img-format=\"tif\" wi=\"51.73mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2380\" num=\"2392\">Compound 556 was synthesized by the same procedures as those of Example 65 and Example 516.</p>\n",
       "<p id=\"p-2381\" num=\"2393\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.66-1.78 (2H, m), 1.97 (3H, s), 2.19-2.31 (1H, m), 2.35-2.44 (1H, m), 2.49-2.57 (1H, m), 2.85-2.93 (1H, m), 3.06 (1H, J=3.9 Hz, 12.9 Hz, 12.9 Hz), 3.27-3.39 (2H, m), 3.34 (3H, s), 3.58-3.73 (3H, m), 3.96-4.04 (1H, m), 4.08-4.18 (1H, m), 4.60 (1H, dd, J=3.0 Hz, 11.1 Hz), 4.96 (1H, s), 6.52 (1H, d, J=7.5 Hz), 6.87-6.92 (1H, m), 7.18-7.28 (4H, m), 7.31-7.40 (2H, m), 7.65 (1H, s), 12.04 (1H, s), 14.33 (1H, s).</p>\n",
       "<heading id=\"h-1208\" level=\"1\">Example 557</heading>\n",
       "<p id=\"p-2382\" num=\"2394\"><chemistry id=\"CHEM-US-00677\" num=\"00677\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00677.TIF\" he=\"40.39mm\" id=\"EMI-C00677\" img-content=\"chem\" img-format=\"tif\" wi=\"45.04mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2383\" num=\"2395\">Compound 557 was synthesized by the same procedure as that of Example 149.</p>\n",
       "<p id=\"p-2384\" num=\"2396\">MS: m/z=419 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1209\" level=\"1\">Example 558</heading>\n",
       "<p id=\"p-2385\" num=\"2397\"><chemistry id=\"CHEM-US-00678\" num=\"00678\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00678.TIF\" he=\"100.16mm\" id=\"EMI-C00678\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2386\" num=\"2398\">To a DMSO (2 mL) solution of compound 63B (68.8 mg, 0.120 mmol) was added copper chloride (39.2 mg, 0.396 mmol), and the mixture was stirred at 110 degree for 2 hours and, further, at 120 degree for 1 hour. Thereafter, copper chloride (50.0 mg, 0.505 mmol) was added, and the mixture was stirred at 200 degree for 1 hour. The reaction solution was purified using a LCMS fractionating device, the eluted solvent was distilled off, to the concentrated residue was added diethyl ether, and the precipitated white solid was filtered. Washing with diethyl ether, and drying afforded 20.9 mg of compound 558.</p>\n",
       "<p id=\"p-2387\" num=\"2399\">MS: m/z=439 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1210\" level=\"1\">Example 559</heading>\n",
       "<p id=\"p-2388\" num=\"2400\"><chemistry id=\"CHEM-US-00679\" num=\"00679\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00679.TIF\" he=\"198.46mm\" id=\"EMI-C00679\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1211\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2389\" num=\"2401\">Compound 48A (43 mg, 0.083 mmol) was dissolved in dichloromethane (6.0 mL), manganese dioxide (120 mg, 1.38 mmol) was added, and the mixture was stirred at room temperature for 3 hours. After the reaction solution was filtered with celite, the filtrate was concentrated to obtain 22.3 mg of compound 559B as a pale yellow solid.</p>\n",
       "<p id=\"p-2390\" num=\"2402\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 3.17 (3H, s), 3.41-3.55 (4H, m), 3.95-4.07 (2H, m), 4.28 (1H, d, J=16.1 Hz), 4.53 (1H, d, J=11.8 Hz), 5.49 (2H, d, J=2.0 Hz), 6.97-7.66 (16H, m), 10.07 (1H, s).</p>\n",
       "<heading id=\"h-1212\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2391\" num=\"2403\">Compound 559B (22 mg, 0.043 mmol) was dissolved in THF (6.0 mL), a 40% methanamine methanol solution (6.5 ul, 0.064 mmol) and acetic acid (3.7 ul, 0.064 mmol) were added, and the mixture was stirred at room temperature for 5 minutes. The reaction solution was ice-cooled, NaBH(OAc)<sub>3 </sub>(14 mg, 0.064 mmol) was added, and the mixture was stirred at room temperature overnight. To the reaction solution were added water and chloroform, and the chloroform layer was separated. The aqueous layer was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off to obtain 24 mg of compound 559C as a pale yellow solid.</p>\n",
       "<p id=\"p-2392\" num=\"2404\">MS: m/z=538 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1213\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2393\" num=\"2405\">Compound 559 was synthesized by the same procedure as that of Example 1.</p>\n",
       "<p id=\"p-2394\" num=\"2406\">MS: m/z=448 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1214\" level=\"1\">Example 560</heading>\n",
       "<p id=\"p-2395\" num=\"2407\"><chemistry id=\"CHEM-US-00680\" num=\"00680\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00680.TIF\" he=\"243.50mm\" id=\"EMI-C00680\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00681\" num=\"00681\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00681.TIF\" he=\"235.03mm\" id=\"EMI-C00681\" img-content=\"chem\" img-format=\"tif\" wi=\"60.11mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00682\" num=\"00682\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00682.TIF\" he=\"41.99mm\" id=\"EMI-C00682\" img-content=\"chem\" img-format=\"tif\" wi=\"41.40mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1215\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2396\" num=\"2408\">A dioxane (20 mL) mixed solution of (methoxymethyl)triphenylphosphonium chloride (6.73 g, 19.0 mmol) was cooled to 0° C., and a 1.06M NaHMDS toluene solution (18.0 ml, 19.0 mmol) was added dropwise while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, compound 383A was added, and the mixture was refluxed for 1 hour and 30 minutes. The reaction solution was returned to room temperature, and water and ethyl acetate were added. The ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (95:5, v/v). Concentration of an objective fraction afforded 2.22 g of compound 560B as an oil.</p>\n",
       "<p id=\"p-2397\" num=\"2409\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.68 (3H, s), 3.73 (3H, s), 4.20 (4H, brs), 6.17 (1H, s), 6.39 (1H, s), 6.96-7.07 (6H, m), 7.18-7.32 (9H, m), 7.32-7.46 (1H, m).</p>\n",
       "<heading id=\"h-1216\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2398\" num=\"2410\">Compound 560B (1.98 g, 7.78 mmol) was dissolved in dichloromethane (30 mL), a 70% aqueous perchloric acid solution (8.0 ml, 93 mmol) was added, and the mixture was stirred at room temperature overnight. To the reaction solution was added an aqueous saturated sodium carbonate solution, and the dichloromethane layer was separated. The aqueous layer was extracted with dichloromethane, and magnesium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (90:10, v/v). Concentration of an objective fraction afforded 1.80 g of compound 560C as an oil.</p>\n",
       "<p id=\"p-2399\" num=\"2411\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.93 (1H, d, J=16.1 Hz), 4.06 (1H, d, J=16.1 Hz), 4.53 (1H, s), 7.11-7.50 (8H, m), 9.89 (1H, s).</p>\n",
       "<p id=\"p-2400\" num=\"2412\">MS: m/z=241 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1217\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2401\" num=\"2413\">To a dichloromethane (30 mL) solution of compound 560C (2.87 g, 11.9 mmol) were added tetraisopropoxytitanium (17.5 mL, 59.7 mmol) and (S)-4-methylbenzenesulfinamide (2.27 g, 14.3 mmol) at room temperature, then the mixture was refluxed for 3 hours and 30 minutes. The reaction solution was ice-cooled, ice water (30 ml) was added, the mixture was stirred for 1 hour while temperature was retained at the same temperature, and the precipitated solid was filtered using celite. The resulting filtrate was extracted with dichloromethane, and magnesium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (70:30, v/v). Concentration of an objective fraction afforded 3.16 g of compound 560D as a yellow solid.</p>\n",
       "<p id=\"p-2402\" num=\"2414\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.39 (6H, s), 3.60 (1H, d, J=15.2 Hz), 3.68 (1H, d, J=14.9 Hz), 3.97 (1H, d, J=15.0 Hz), 4.07 (1H, d, J=15.0 Hz), 4.90 (1H, d, J=2.7 Hz), 4.92 (1H, d, J=2.9 Hz), 7.08-7.26 (20H, m), 7.46-7.51 (4H, m), 8.62 (1H, d, J=2.8 Hz), 8.65 (1H, d, J=2.7 Hz).</p>\n",
       "<p id=\"p-2403\" num=\"2415\">MS: m/z=378 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1218\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2404\" num=\"2416\">A THF (30 mL) suspension of a 1M cyanodiethylaluminum toluene solution (16.7 mL, 16.7 mmol) was cooled to 0 degree, 2-propanol (1.29 mL, 16.7 mmol) was added and, thereafter, the mixture was stirred for 1 hour while temperature was retained at the same temperature. Thereafter, the reaction solution was cooled to −60 degree, a THF (12 mL) solution of compound 560D (3.16 g, 8.37 mmol) was added dropwise, the mixture was stirred for 15 minutes while temperature was retained at the same temperature, thereafter, temperature was raised to room temperature, and the mixture was stirred overnight. The reaction solution was ice-cooled, an aqueous saturated ammonium chloride solution was added, the mixture was stirred at room temperature for 1 hour and 30 minutes and, thereafter, the precipitated solid was filtered using celite, and washed with dichloromethane. The dichloromethane layer of the filtrate was separated, and the aqueous layer was extracted with dichloromethane and, thereafter, sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). Concentration of an objective fraction afforded 1.88 g of compound 560E.</p>\n",
       "<p id=\"p-2405\" num=\"2417\">MS: m/z=427 [M+Na]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1219\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2406\" num=\"2418\">A methanol (4 mL) solution of compound 560E (235 mg, 0.581 mmol) was cooled to 0 degree, cobalt (II) chloride hexahydrate (55.3 mg, 0.232 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. Thereafter, the reaction solution was ice-cooled, a DMF (4 mL) solution of sodium borohydride (88 mg, 2.3 mmol) was added dropwise, and the mixture was stirred at the same temperature for 5 minutes, and at room temperature for 1 hour. Then, Boc<sub>2</sub>O (0.674 mL, 2.90 mmol) was added, and the mixture was stirred for 30 minutes. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (98:2, v/v). Concentration of an objective fraction afforded a crude product (211 mg) of compound 560F.</p>\n",
       "<p id=\"p-2407\" num=\"2419\">MS: m/z=509 [M+Na]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1220\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-2408\" num=\"2420\">To a methanol (6 mL) solution of the crude product (211 mg) of compound 560F was added TFA (0.128 mL, 1.66 mmol), and the mixture was stirred at room temperature for 2.5 hours. To the reaction solution was added triethylamine (0.230 mL, 1.66 mmol), the solvent was distilled off, and the resulting crude product of compound 560G was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2409\" num=\"2421\">MS: m/z=371 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1221\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-2410\" num=\"2422\">To a toluene (4 mL) solution of the crude product of compound 560G was added dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (132 mg, 0.416 mmol), and the mixture was refluxed for 1 hour and 30 minutes. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→90:10, v/v). Concentration of an objective fraction afforded a crude product (287 mg) of compound 560H.</p>\n",
       "<p id=\"p-2411\" num=\"2423\">MS: m/z=671 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1222\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-2412\" num=\"2424\">To the crude product of compound 560H obtained in the seventh step was added a 4N hydrochloric acid ethyl acetate solution (3 mL), and the mixture was stirred at room temperature for 30 minutes. The solvent was distilled off, to the resulting concentrated residue were added THF (2 mL) and an aqueous saturated sodium bicarbonate solution (2 mL), and the mixture was stirred at room temperature for 45 minutes. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→0.94:6, v/v). Concentration of an objective fraction afforded 27 mg of compound 5601 as a yellow solid.</p>\n",
       "<p id=\"p-2413\" num=\"2425\">MS: m/z=539 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1223\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-2414\" num=\"2426\">Compound 5601 (27 mg, 0.050 mmol) was dissolved in DMF (2 mL), cesium carbonate (82 mg, 0.25 mmol) and methyl iodide (0.010 mL, 0.16 mmol) were added, and the mixture was stirred at room temperature for 1 hour and 30 minutes. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product of compound 560J.</p>\n",
       "<p id=\"p-2415\" num=\"2427\">MS: m/z=553 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1224\" level=\"1\">Tenth Step</heading>\n",
       "<p id=\"p-2416\" num=\"2428\">To an EtOH (2 mL) solution of the crude product of compound 560J obtained in the ninth step was added 2N NaOH (1 mL), and the mixture was stirred at room temperature for 40 minutes. To the reaction solution was added a 2N aqueous HCl solution, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off to obtain 17 mg of compound 560K as a white oil.</p>\n",
       "<p id=\"p-2417\" num=\"2429\">MS: m/z=539 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1225\" level=\"1\">Eleventh Step</heading>\n",
       "<p id=\"p-2418\" num=\"2430\">To compound 560K (17 mg, 0.032 mmol) was added TFA (2.0 mL), and the mixture was stirred at room temperature for 35 minutes. The reaction solution was subjected to toluene azeotropy, to the resulting concentrated residue was added isopropyl ether, and the precipitated solid was filtered and washed to obtain 7.1 mg of compound 560 as a pink solid.</p>\n",
       "<p id=\"p-2419\" num=\"2431\">MS: m/z=449 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1226\" level=\"1\">Example 561</heading>\n",
       "<p id=\"p-2420\" num=\"2432\"><chemistry id=\"CHEM-US-00683\" num=\"00683\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00683.TIF\" he=\"206.08mm\" id=\"EMI-C00683\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00684\" num=\"00684\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00684.TIF\" he=\"145.71mm\" id=\"EMI-C00684\" img-content=\"chem\" img-format=\"tif\" wi=\"70.61mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1227\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2421\" num=\"2433\">To a crude product (433 mg) of compound 560H was added a 4N hydrochloric acid ethyl acetate solution (3 mL), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, to a THF (2 mL) solution of the resulting residue was added acetone (2 mL), the mixture was stirred at room temperature for 20 minutes, NaBH(OAc)<sub>3 </sub>(70 mg, 0.32 mmol) was added, and the mixture was stirred at room temperature for 1 hour and 30 minutes. Thereafter, to the reaction solution was added an aqueous saturated sodium bicarbonate solution (3 mL), and the mixture was stirred at room temperature overnight. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product (79 mg) of compound 561A.</p>\n",
       "<p id=\"p-2422\" num=\"2434\">MS: m/z=581 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1228\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2423\" num=\"2435\">To an EtOH (4 mL) solution of the crude product (79 mg) of compound 561A was added 2N NaOH (2 mL), and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added a 2N aqueous HCl solution, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded compound 561B (53 mg).</p>\n",
       "<p id=\"p-2424\" num=\"2436\">MS: m/z=567 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1229\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2425\" num=\"2437\">A DMF (2 mL) solution of compound 561B (53 mg, 0.093 mmol) was cooled to 0 degree, triethylamine (0.039 mL, 0.28 mmol) and ethyl chloroformate (0.018 mL, 0.187 mmol) were added, and the mixture was stirred at room temperature for 10 minutes. Thereafter, the reaction solution was cooled to 0 degree, sodium azide (18 mg, 0.28 mmol) was added, and the mixture was stirred for 50 minutes while temperature was retained at the same temperature. To the reaction solution was added water, the mixture was extracted with dichloromethane, and the combined extracts were concentrated to obtain a crude product of compound 561C.</p>\n",
       "<p id=\"p-2426\" num=\"2438\">MS: m/z=592 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1230\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2427\" num=\"2439\">The crude product (55 mg) of compound 561C was dissolved in methanol (2 mL), and the mixture was stirred at 50° C. for 1 hour. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product (43 mg) of compound 561D.</p>\n",
       "<p id=\"p-2428\" num=\"2440\">MS: m/z=596 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1231\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2429\" num=\"2441\">To an EtOH (2 mL) solution of the crude product (43 mg) of compound 561D was added 2N NaOH (4 mL), and the mixture was stirred at 60 degree for 1 hour. The solvent was distilled off, water was added, the mixture was extracted with ethyl acetate and, thereafter, sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, the resulting oil was subjected to amino column chromatography, and eluted with chloroform-methanol (100:0→80:20, v/v). Concentration of an objective fraction afforded 16 mg of compound 561E as a pale yellow solid.</p>\n",
       "<p id=\"p-2430\" num=\"2442\">MS: m/z=538 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1232\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-2431\" num=\"2443\">Compound 561E (16 mg, 0.029 mmol) was dissolved in EtOH (1 mL) and a 48% aqueous tetrafluoroboric acid (1 mL), the reaction solution was cooled to 0 degree, sodium nitrite (15 mg, 0.22 mmol) was added, and the mixture was stirred for 1 hour and 30 minutes while temperature was retained at the same temperature and, further, at room temperature for 2 hours and 30 minutes. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, to the resulting concentrated residue were added ethyl acetate and isopropyl ether, and the precipitated solid was filtered and washed to obtain 5 mg of compound 561 as a white solid.</p>\n",
       "<p id=\"p-2432\" num=\"2444\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 0.96 (3H, d, J=6.9 Hz), 1.17 (3H, d, J=6.8 Hz), 3.37 (1H, d, J=13.3 Hz), 3.88 (1H, dd, J=13.4, 4.3 Hz), 3.99 (1H, d, J=14.9 Hz), 4.08 (1H, d, J=11.3 Hz), 4.52 (1H, d, J=14.9 Hz), 4.81-4.90 (1H, m), 5.67 (1H, dd, J=11.3, 3.1 Hz), 5.94 (1H, d, J=7.4 Hz), 6.59 (1H, d, J=6.4 Hz), 6.72 (1H, d, J=7.3 Hz), 6.86 (1H, t, J=7.1 Hz), 7.09 (1H, t, J=7.6 Hz), 7.16-7.31 (5H, m).</p>\n",
       "<heading id=\"h-1233\" level=\"1\">Example 562</heading>\n",
       "<p id=\"p-2433\" num=\"2445\"><chemistry id=\"CHEM-US-00685\" num=\"00685\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00685.TIF\" he=\"42.25mm\" id=\"EMI-C00685\" img-content=\"chem\" img-format=\"tif\" wi=\"36.49mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2434\" num=\"2446\">Compound 562 was synthesized by the same procedure as that of Example 561.</p>\n",
       "<p id=\"p-2435\" num=\"2447\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.07 (3H, s), 3.21 (1H, d, J=12.3 Hz), 4.00-4.31 (4H, m), 5.78 (1H, d, J=10.5 Hz), 5.94 (1H, d, J=7.4 Hz), 6.54 (1H, d, J=7.3 Hz), 6.69 (1H, d, J=7.5 Hz), 6.98 (1H, t, J=7.6 Hz), 7.14-7.41 (6H, m).</p>\n",
       "<p id=\"p-2436\" num=\"2448\">MS: m/z=405 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1234\" level=\"1\">Example 563</heading>\n",
       "<p id=\"p-2437\" num=\"2449\"><chemistry id=\"CHEM-US-00686\" num=\"00686\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00686.TIF\" he=\"226.74mm\" id=\"EMI-C00686\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00687\" num=\"00687\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00687.TIF\" he=\"202.18mm\" id=\"EMI-C00687\" img-content=\"chem\" img-format=\"tif\" wi=\"67.39mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1235\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2438\" num=\"2450\">Compound 563A (Tetrahedron Letters, 34, 953-956, 1993, 41.1 g, 154 mmol) was dissolved in THF (300 mL), 1M BH<sub>3</sub>-THF (770 mL) was slowly added at room temperature, and the mixture was stirred for 18 hours. 3N hydrochloric acid (513 mL) was slowly added, and the mixture was refluxed for 1 hour, and was progressed to a next step without purification.</p>\n",
       "<p id=\"p-2439\" num=\"2451\">LC-MS: m/z=254 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1236\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2440\" num=\"2452\">Using a solution containing compound 563B, according to Example 12, compound 563C was synthesized.</p>\n",
       "<p id=\"p-2441\" num=\"2453\">LC-MS: m/z=353 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"p-2442\" num=\"2454\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 1.40 (9H, s), 2.65-2.72 (1H, m), 2.86-2.92 (3H, m), 3.47-3.56 (3H, m), 3.56-3.69 (1H, m), 6.63 (1H, s), 7.11-7.26 (8H, m).</p>\n",
       "<heading id=\"h-1237\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2443\" num=\"2455\">A toluene (30 mL) solution of compound 563C (2.16 g, 6.79 mmol) and dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (2.38 g, 6.75 mmol) was stirred at 100° C. for 4 hours. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 563D was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2444\" num=\"2456\">MS: m/z=653.05 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1238\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2445\" num=\"2457\">To an ethyl acetate (20 mL) solution of the crude product of compound 563D was added hydrogen chloride (4N ethyl acetate solution, 20 mL) at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 563E was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2446\" num=\"2458\">MS: m/z=553.05 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1239\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2447\" num=\"2459\">To a tetrahydrofuran (40 mL) solution of the crude product of compound 563E was added saturated sodium bicarbonate water (5 mL) at room temperature, and the mixture was stirred for 16 hours. To the reaction solution was added water (50 mL), the mixture was extracted with chloroform three times, and the extracts were combined, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and diethyl ether and chloroform were added to the resulting residue to covert them into a powder, to obtain compound 563F (2.90 g, 70.2%) as a white solid.</p>\n",
       "<p id=\"p-2448\" num=\"2460\">MS: m/z=521.05 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1240\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-2449\" num=\"2461\">To a methanol (7.5 mL) suspension of compound 563F (523 mg, 1.01 mmol) was added an aqueous sodium hydroxide solution (2 M, 1.5 mL) at room temperature, and the mixture was stirred for 3 hours. To the reaction solution were added hydrochloric acid (2N, 1.5 mL) and water (3 mL) at room temperature and, thereafter, the mixture was stirred at 0° C. for 15 minutes. The precipitated solid was filtered, and washed with water and diethyl ether to obtain compound 563G (418 mg, 82.0%) as a white solid.</p>\n",
       "<p id=\"p-2450\" num=\"2462\">MS: m/z=507.00 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1241\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-2451\" num=\"2463\">A diphenyl ether (5 mL) suspension of compound 563G (107 mg, 0.211 mmol) was stirred at 240° C. for 1 hour under microwave irradiation. The reaction solution was purified by silica gel column chromatography (methanol/chloroform=0%→5%) to obtain compound 563H (64.4 mg, 65.9%) as a white solid.</p>\n",
       "<p id=\"p-2452\" num=\"2464\">MS: m/z=463.05 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1242\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-2453\" num=\"2465\">A methanol (30 mL) solution of compound 563H (64.4 mg, 0.139 mmol) was hydrogenated by passing through 10% Pd—C CatCart (H-cube, Full-H<sub>2 </sub>mode, 25° C.) for 3 hours. The reaction solution was distilled off under reduced pressure, and ethyl acetate and methanol were added to the resulting residue to convert it into a powder, to obtain compound 563 (31.1 mg, 60.0%) as a gray white solid.</p>\n",
       "<p id=\"p-2454\" num=\"2466\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.50-3.03 (3H, m), 3.50-3.72 (3H, m), 4.29 (1H, d, J=11.4 Hz), 5.12 (1H, m), 5.69 (1H, d, J=7.2 Hz), 6.50 (1H, d, J=7.7 Hz), 6.75 (1H, d, J=7.7 Hz), 6.84 (1H, m), 7.14-7.30 (6H, m), 9.16 (1H, d, J=4.8 Hz).</p>\n",
       "<p id=\"p-2455\" num=\"2467\">MS: m/z=372.90 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1243\" level=\"1\">Example 564</heading>\n",
       "<p id=\"p-2456\" num=\"2468\"><chemistry id=\"CHEM-US-00688\" num=\"00688\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00688.TIF\" he=\"149.01mm\" id=\"EMI-C00688\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1244\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2457\" num=\"2469\">To a dimethylformamide (2 mL) suspension of compound 563H (64.2 mg, 0.139 mmol) and cesium carbonate (220 mg, 0.675 mmol) was added methyl iodide (0.0430 mL, 0.688 mmol) at room temperature, and the mixture was stirred for 3 hours. To the reaction solution was added water (10 mL) at room temperature, and the mixture was extracted with ethyl acetate (30 mL). The organic layer was washed with water (10 mL) and an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (methanol/chloroform=2.5%→10%) to obtain compound 564A (56.0 mg, 85.0%) as a colorless gummy substance.</p>\n",
       "<p id=\"p-2458\" num=\"2470\">MS: m/z=477.00 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1245\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2459\" num=\"2471\">A solution of compound 564A (56.0 mg, 0.118 mmol) in methanol (10 mL), ethyl acetate (5 mL) and tetrahydrofran (5 mL) was hydrogenated by passing through 10% Pd—C CatCart (H-cube, Full-H<sub>2 </sub>mode, 25° C.) for 75 minutes. The reaction solution was distilled off under reduced pressure, and ethyl acetate and methanol were added to the resulting residue to convert it into a powder, to obtain compound 564 (22.0 mg, 48.4%) as a gray white solid.</p>\n",
       "<p id=\"p-2460\" num=\"2472\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.86-2.98 (6H, m), 3.51-3.58 (2H, m), 3.94 (1H, m), 4.30 (1H, d, J=11.1 Hz), 5.19 (1H, d, J=10.2 Hz), 5.79 (1H, d, J=6.9 Hz), 6.49 (1H, d, J=7.4 Hz), 6.74 (1H, d, J=7.4 Hz), 6.85 (1H, m), 7.14 (2H, m), 7.25 (4H, m), 12.50 (1H, brs).</p>\n",
       "<p id=\"p-2461\" num=\"2473\">MS: m/z=387.05 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1246\" level=\"1\">Example 565</heading>\n",
       "<p id=\"p-2462\" num=\"2474\"><chemistry id=\"CHEM-US-00689\" num=\"00689\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00689.TIF\" he=\"41.49mm\" id=\"EMI-C00689\" img-content=\"chem\" img-format=\"tif\" wi=\"45.21mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2463\" num=\"2475\">Compound 565 was synthesized by the same procedure as that of Example 564.</p>\n",
       "<p id=\"p-2464\" num=\"2476\">MS: m/z=443.95 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1247\" level=\"1\">Example 566</heading>\n",
       "<p id=\"p-2465\" num=\"2477\"><chemistry id=\"CHEM-US-00690\" num=\"00690\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00690.TIF\" he=\"145.54mm\" id=\"EMI-C00690\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1248\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2466\" num=\"2478\">A dimethylformamide (2 mL) suspension of compound 563H (75.4 mg, 0.163 mmol), 3-iodobenzonitrile (124 mg, 0.541 mmol), copper (I) iodide (33.2 mg, 0.174 mmol), potassium carbonate (74.7 mg, 0.540 mmol) and N,N′-dimethylethylenediamine (0.0200 ml, 0.186 mmol) was stirred at 140° C. for 2 hours under microwave irradiation. To the reaction solution were added water (10 mL) and hydrochloric acid (2M, 2 mL) at room temperature, and the mixture was extracted with ethyl acetate. The extract was filtered with celite, and the filtrate was washed with water (10 mL×2) and an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 566A was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2467\" num=\"2479\">MS: m/z=564.05 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1249\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2468\" num=\"2480\">To a methylene chloride (10 mL) solution of the crude product of compound 566A obtained in the first step was added trifluoroacetic acid (2 mL) at room temperature, and the mixture was stirred for 1 hour. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 566 (30.3 mg, 39.3%) as a yellow solid.</p>\n",
       "<p id=\"p-2469\" num=\"2481\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.81-2.94 (2H, m), 3.38-3.58 (2H, m), 4.54 (1H, d, J=10.5 Hz), 4.64 (1H, d, J=10.5 Hz), 5.35 (1H, d, J=10.5 Hz), 5.76 (1H, m), 6.66-6.71 (3H, m), 6.90 (1H, m), 7.06-7.15 (6H, m), 7.76 (2H, m), 7.90 (2H, m).</p>\n",
       "<p id=\"p-2470\" num=\"2482\">MS: m/z=473.90 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1250\" level=\"1\">Example 567</heading>\n",
       "<p id=\"p-2471\" num=\"2483\"><chemistry id=\"CHEM-US-00691\" num=\"00691\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00691.TIF\" he=\"47.24mm\" id=\"EMI-C00691\" img-content=\"chem\" img-format=\"tif\" wi=\"50.97mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2472\" num=\"2484\">Compound 567 was synthesized by the same procedure as that of Example 566.</p>\n",
       "<p id=\"p-2473\" num=\"2485\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.80-3.00 (2H, m), 3.40-3.70 (2H, m), 4.52 (1H, m), 4.64 (1H, m), 5.38 (1H, m), 5.76 (1H, m), 6.60-7.20 (10H, m), 7.60-7.90 (3H, m), 8.11 (1H, m).</p>\n",
       "<p id=\"p-2474\" num=\"2486\">MS: m/z=474.00 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1251\" level=\"1\">Example 568</heading>\n",
       "<p id=\"p-2475\" num=\"2487\"><chemistry id=\"CHEM-US-00692\" num=\"00692\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00692.TIF\" he=\"43.52mm\" id=\"EMI-C00692\" img-content=\"chem\" img-format=\"tif\" wi=\"40.39mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2476\" num=\"2488\">Compound 568 was synthesized by the same procedure as that of Example 566.</p>\n",
       "<p id=\"p-2477\" num=\"2489\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.87-2.96 (2H, m), 3.34-3.73 (2H, m), 4.64 (2H, m), 5.33 (1H, m), 5.71 (1H, d, J=7.2 Hz), 6.61 (1H, d, J=7.8 Hz), 6.87-6.95 (3H, m), 7.00-7.27 (6H, m), 7.62 (2H, m), 7.86 (1H, m), 8.07 (1H, m).</p>\n",
       "<p id=\"p-2478\" num=\"2490\">MS: m/z=474.00 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1252\" level=\"1\">Example 569</heading>\n",
       "<p id=\"p-2479\" num=\"2491\"><chemistry id=\"CHEM-US-00693\" num=\"00693\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00693.TIF\" he=\"43.52mm\" id=\"EMI-C00693\" img-content=\"chem\" img-format=\"tif\" wi=\"40.39mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2480\" num=\"2492\">Compound 569 was synthesized by the same procedure as that of Example 566.</p>\n",
       "<p id=\"p-2481\" num=\"2493\">MS: m/z=449.95 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1253\" level=\"1\">Example 570</heading>\n",
       "<p id=\"p-2482\" num=\"2494\"><chemistry id=\"CHEM-US-00694\" num=\"00694\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00694.TIF\" he=\"41.74mm\" id=\"EMI-C00694\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2483\" num=\"2495\">Compound 570 was synthesized by the same procedure as that of Example 566.</p>\n",
       "<p id=\"p-2484\" num=\"2496\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 2.83-2.97 (3H, m), 3.16-3.62 (2H, m), 3.56 (1H, m), 3.66 (1H, d, J=11.1 Hz), 5.35 (1H, d, J=11.1 Hz), 5.73 (1H, d, J=7.4 Hz), 6.68 (1H, d, J=7.4 Hz), 6.92 (1H, m), 7.06-7.21 (5H, m), 7.49 (1H, m), 7.97 (1H, d, J=8.4 Hz), 8.14 (1H, s), 8.50 (1H, d, J=3.6 Hz), 8.81 (1H, d, J=2.1 Hz).</p>\n",
       "<p id=\"p-2485\" num=\"2497\">MS: m/z=449.95 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1254\" level=\"1\">Example 571</heading>\n",
       "<p id=\"p-2486\" num=\"2498\"><chemistry id=\"CHEM-US-00695\" num=\"00695\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00695.TIF\" he=\"142.16mm\" id=\"EMI-C00695\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1255\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2487\" num=\"2499\">To a DMF (1 mL) solution of compound 563H (50.0 mg, 0.108 mmol) was added cesium carbonate (176 mg, 0.540 mmol), and the mixture was stirred at room temperature for 10 minutes. To the reaction solution was added O-(2,4-dinitrophenyl)hydroxylamine (64.6 mg, 0.324 mmol), and the mixture was stirred at room temperature for 9 hours. To the reaction solution was added chloroform, and the mixture was washed with water, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-methanol (98:2, v/v). Concentration of an objective fraction afforded 28.3 mg of compound 571A as an amorphous substance.</p>\n",
       "<p id=\"p-2488\" num=\"2500\">MS: m/z=478 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1256\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2489\" num=\"2501\">Compound 571A (27.0 g, 0.057 mmol) was dissolved in a THF-methanol (1 mL, 1:1, v/v) solution, 10% palladium carbon (15.0 mg) was added, and the mixture was stirred at room temperature for 2 hours under hydrogen atmosphere. After dilution with chloroform, insolubles were removed by celite filtration. After the filtrate was concentrated under reduced pressure, the residue was solidified with dichloromethane-ether to obtain 12.0 mg of compound 571.</p>\n",
       "<p id=\"p-2490\" num=\"2502\">MS: m/z=388 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1257\" level=\"1\">Example 572</heading>\n",
       "<p id=\"p-2491\" num=\"2503\"><chemistry id=\"CHEM-US-00696\" num=\"00696\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00696.TIF\" he=\"40.39mm\" id=\"EMI-C00696\" img-content=\"chem\" img-format=\"tif\" wi=\"44.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2492\" num=\"2504\">Using compound 12H, and according to Example 571, compound 572 was synthesized by the same procedure.</p>\n",
       "<p id=\"p-2493\" num=\"2505\">MS: m/z=420 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1258\" level=\"1\">Example 573</heading>\n",
       "<p id=\"p-2494\" num=\"2506\"><chemistry id=\"CHEM-US-00697\" num=\"00697\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00697.TIF\" he=\"141.56mm\" id=\"EMI-C00697\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1259\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2495\" num=\"2507\">To a dimethylformamide (1.5 mL) solution of compound 563H (83.2 mg, 0.160 mmol) was added sodium hydride (60%, 13.2 mg, 0.330 mmol) under ice-cooling, the mixture was stirred for 30 minutes, thereafter, bromoacetonitrile (0.0190 mL, 0.270 mmol) was added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added an aqueous ammonium chloride solution (10%, 3 mL), and the mixture was extracted with ethyl acetate. The organic layer was washed with water (10 mL) and an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 573A was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2496\" num=\"2508\">MS: m/z=502.00 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1260\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2497\" num=\"2509\">To an acetonitrile (4 mL) suspension of the crude product of compound 573A obtained in the first step and sodium iodide (111 mg, 0.741 mmol) was added chlorotrimethylsilane (0.0920 mL, 0.720 mmol) at room temperature, and the mixture was stirred for 24 hours. To the reaction solution was added an aqueous sodium hydrogen sulfite solution (10%, 10 mL) and, thereafter, the mixture was extracted with chloroform. After the extracts were combined, and dried with sodium sulfate, the solvent was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 573 (22.0 mg, 29.7%) as a gray white solid.</p>\n",
       "<p id=\"p-2498\" num=\"2510\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 2.86-2.95 (2H, m), 3.45-3.63 (2H, m), 4.01 (1H, m), 4.30 (1H, d, J=10.8 Hz), 4.35 (1H, d, J=17.4 Hz), 4.74 (1H, d, J=17.4 Hz), 5.20 (1H, m), 5.66 (1H, d, J=7.5 Hz), 6.52 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.5 Hz), 6.83 (1H, m), 7.11-7.28 (6H, m).</p>\n",
       "<p id=\"p-2499\" num=\"2511\">MS: m/z=502.00 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1261\" level=\"1\">Example 574</heading>\n",
       "<p id=\"p-2500\" num=\"2512\"><chemistry id=\"CHEM-US-00698\" num=\"00698\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00698.TIF\" he=\"40.39mm\" id=\"EMI-C00698\" img-content=\"chem\" img-format=\"tif\" wi=\"41.06mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2501\" num=\"2513\">Compound 574 was synthesized by the same procedure as that of Example 573.</p>\n",
       "<p id=\"p-2502\" num=\"2514\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 4.16 (1H, dd, J=13.26, 3.53 Hz), 4.36 (1H, d, J=11.58 Hz), 4.52 (2H, dd, J=20.73, 17.54 Hz), 5.44 (1H, d, J=11.41 Hz), 5.65 (1H, d, J=7.39 Hz), 6.99 (1H, d, J=7.55 Hz), 7.11-7.32 (6H, m), 7.36-7.45 (2H, m), 7.58 (2H, d, J=7.39 Hz).</p>\n",
       "<heading id=\"h-1262\" level=\"1\">Example 575</heading>\n",
       "<p id=\"p-2503\" num=\"2515\"><chemistry id=\"CHEM-US-00699\" num=\"00699\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00699.TIF\" he=\"38.86mm\" id=\"EMI-C00699\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2504\" num=\"2516\">Compound 575 was synthesized by the same procedure as that of Example 573.</p>\n",
       "<p id=\"p-2505\" num=\"2517\">MS: m/z=425.95 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1263\" level=\"1\">Example 576</heading>\n",
       "<p id=\"p-2506\" num=\"2518\"><chemistry id=\"CHEM-US-00700\" num=\"00700\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00700.TIF\" he=\"201.76mm\" id=\"EMI-C00700\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00701\" num=\"00701\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00701.TIF\" he=\"227.67mm\" id=\"EMI-C00701\" img-content=\"chem\" img-format=\"tif\" wi=\"67.23mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1264\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2507\" num=\"2519\">A dichloromethane (30 mL) solution of compound 576A (Bioorg. Med. Chem., 2003, 11, 197-206) (2.26 g, 10.2 mmol) were added tetraisopropoxytitanium (10.0 mL, 33.1 mmol) and (S)-4-methylbenzenesulfinamide (1.29 g, 8.13 mmol) at room temperature, and the mixture was refluxed for 2 hours. The reaction solution was ice-cooled, ice water (40 ml) was added, the mixture was stirred for 1 hour while temperature was retained at the same temperature, and the precipitated solid was filtered using celite. The resulting filtrate was extracted with dichloromethane, and magnesium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (100:0→70:30, v/v). Concentration of an objective fraction afforded 1.35 g of compound 576B as a yellow solid.</p>\n",
       "<p id=\"p-2508\" num=\"2520\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.32 (3H, s), 2.72-2.85 (2H, m), 3.03-3.16 (2H, m), 4.89 (1H, d, J=3.5 Hz), 7.09-7.25 (10H, m), 7.39-7.42 (2H, m), 8.49 (1H, d, J=3.6 Hz).</p>\n",
       "<p id=\"p-2509\" num=\"2521\">MS: m/z=360 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1265\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2510\" num=\"2522\">A THF (20 mL) solution of a 1M cyanodiethylaluminum toluene solution (7.51 mL, 7.51 mmol) was cooled to 0 degree, 2-propanol (0.579 mL, 7.51 mmol) was added and, thereafter, the mixture was stirred for 1 hour while temperature was retained at the same temperature. Thereafter, the reaction solution was cooled to −60 degree, a THF (14 mL) solution of compound 576B was added dropwise, the mixture was stirred for 15 minutes while temperature was retained at the same temperature, thereafter, temperature was raised to room temperature, and the mixture was stirred overnight. The reaction solution was ice-cooled, an aqueous saturated ammonium chloride solution was added, the mixture was stirred at room temperature for 1 hour and 30 minutes and, thereafter, the precipitated solid was filtered using celite, and washed with dichloromethane. The dichloromethane layer of the filtrate was separated, the aqueous layer was extracted with dichloromethane, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, to the resulting oil were added ethyl acetate and hexane, and the precipitated solid was filtered and washed to obtain 976 mg of compound 576C as a white solid.</p>\n",
       "<p id=\"p-2511\" num=\"2523\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.38 (3H, s), 2.92-3.055 (2H, m), 3.41-3.52 (2H, m), 4.25 (1H, d, J=10.8 Hz), 4.28 (1H, d, J=5.6 Hz), 4.94 (1H, dd, J=10.6, 5.7 Hz), 7.14-7.41 (12H, m).</p>\n",
       "<heading id=\"h-1266\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2512\" num=\"2524\">A methanol (8 mL) suspension of compound 576C (500 mg, 1.29 mmol) was cooled to 0 degree, cobalt (II) chloride hexahydrate (123 mg, 0.517 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. To the reaction solution was added chloroform (5 mL), thereafter, the mixture was ice-cooled, a DMF (4 mL) solution of sodium borohydride (196 mg, 5.17 mmol) was added dropwise, and the mixture was stirred at the same temperature for 5 minutes, and at room temperature for 2 hours. Then, Boc<sub>2</sub>O (1.0 mL, 4.3 mmol) was added, and the mixture was stirred at room temperature overnight. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→98:2, v/v). Concentration of an objective fraction afforded a crude product (200 mg) of compound 576D.</p>\n",
       "<p id=\"p-2513\" num=\"2525\">MS: m/z=491 [M+Na]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1267\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2514\" num=\"2526\">To a methanol (6 mL) solution of the crude product (200 mg) of compound 576D obtained in the third step was added TFA (0.188 mL, 2.45 mmol), and the mixture was stirred at room temperature for 2.5 hours. To the reaction solution was added triethylamine (0.399 mL, 2.45 mmol), the solvent was distilled off, and the resulting crude product of compound 576E was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2515\" num=\"2527\">MS: m/z=353 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1268\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2516\" num=\"2528\">To a toluene (4 mL) solution of the crude product of compound 576E obtained in the fourth step was added dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (130 mg, 0.409 mmol), and the mixture was refluxed for 2 hours. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→90:10, v/v). Concentration of an objective fraction afforded a crude product (268 mg) of compound 576F.</p>\n",
       "<p id=\"p-2517\" num=\"2529\">MS: m/z=653 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1269\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-2518\" num=\"2530\">To the crude product (263 mg) of compound 576F obtained in the fifth step was added a 4N hydrochloric acid ethyl acetate solution (3 mL), and the mixture was stirred at room temperature for 1 hour and 30 minutes. The solvent was distilled off, to a THF (4 mL) solution of the resulting concentrated residue was added acetone (1 mL), the mixture was stirred at room temperature for 25 minutes, thereafter, NaBH(OAc)<sub>3 </sub>(180 mg, 0.807 mmol) was added, and the mixture was stirred at room temperature for 1 hour and 15 minutes. Thereafter, to the reaction solution was added an aqueous saturated sodium bicarbonate solution (7 mL), and the mixture was stirred at room temperature overnight. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product (160 mg) of compound 576G.</p>\n",
       "<p id=\"p-2519\" num=\"2531\">MS: m/z=563 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1270\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-2520\" num=\"2532\">To an EtOH (4 mL) solution of the crude product (160 mg) of compound 576G obtained in the sixth step was added 2N NaOH (2 mL), and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added a 2N aqueous HCl solution, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded 78 mg of compound 576H as a yellow solid.</p>\n",
       "<p id=\"p-2521\" num=\"2533\">MS: m/z=549 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1271\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-2522\" num=\"2534\">To compound 576H (78 mg, 0.14 mmol) was added diphenyl ether (3 mL), and the mixture was stirred at 245 degree for 1 hour under microwave irradiation. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→90:10, v/v). Concentration of an objective fraction afforded 43 mg of compound 5761 as a bronzed oil.</p>\n",
       "<p id=\"p-2523\" num=\"2535\">MS: m/z=505 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1272\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-2524\" num=\"2536\">To compound 5761 (42 mg, 0.083 mmol) was added TFA (1.0 mL), and the mixture was stirred at room temperature for 35 minutes. The reaction solution was subjected to toluene azeotropy, to the resulting concentrated residue was added an aqueous saturated sodium bicarbonate solution, and the mixture was extracted with ethyl acetate. Sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, to the resulting oil were added ethyl acetate and isopropyl ether, and the precipitated solid was filtered and washed to obtain 14 mg of compound 576 as a pale brown solid.</p>\n",
       "<p id=\"p-2525\" num=\"2537\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.13 (3H, d, J=6.7 Hz), 1.20 (3H, d, J=6.7 Hz), 2.95-3.13 (2H, m), 3.28 (1H, d, J=13.1 Hz), 3.37-3.59 (2H, m), 3.75 (1H, d, J=10.3 Hz), 4.10 (1H, d, J=10.8 Hz), 4.80-4.87 (2H, m), 5.91 (1H, d, J=5.8 Hz), 6.41 (2H, t, J=6.5 Hz), 6.85 (1H, t, J=6.4 Hz), 7.05-7.35 (6H, m).</p>\n",
       "<p id=\"p-2526\" num=\"2538\">MS: m/z=415 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1273\" level=\"1\">Example 577</heading>\n",
       "<p id=\"p-2527\" num=\"2539\"><chemistry id=\"CHEM-US-00702\" num=\"00702\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00702.TIF\" he=\"154.60mm\" id=\"EMI-C00702\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1274\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2528\" num=\"2540\">To a dimethylformamide (3 mL) solution of a crude product (140 mg) of compound 159A was added potassium cyanide (21.0 mg, 0.323 mmol) at room temperature, and the mixture was stirred at 80° C. for 30 minutes, and at 100° C. for 30 minutes. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=80%→100%) to obtain compound 577B (41.5 mg, 33.5%) as a pale orange foam.</p>\n",
       "<p id=\"p-2529\" num=\"2541\">MS: m/z=535.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1275\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2530\" num=\"2542\">To an acetonitrile (4 mL) solution of compound 577B (41.5 mg, 0.078 mmol) and sodium iodide (45.5 mg, 0.304 mmol) was added chlorotrimethylsilane (0.0400 mL, 0.313 mmol) at room temperature, and the mixture was stirred for 2 hours. To the reaction solution was added water (1 mL), the reaction solution was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS. Diethyl ether was added to the resulting residue to convert it into a powder, to obtain compound 577 (20.7 mg, 60.0%) as a gray white solid.</p>\n",
       "<p id=\"p-2531\" num=\"2543\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 3.10 (3H, s), 3.51 (2H, m), 3.70 (1H, d, J=18.9 Hz), 4.03 (1H, d, J=18.9 Hz), 4.46 (1H, d, J=13.4 Hz), 5.04 (1H, d, J=13.4 Hz), 5.56 (1H, s), 5.69 (1H, s), 7.09-7.21 (5H, m), 7.39-7.63 (3H, m), 7.64 (2H, m).</p>\n",
       "<p id=\"p-2532\" num=\"2544\">MS: m/z=445.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1276\" level=\"1\">Example 578</heading>\n",
       "<p id=\"p-2533\" num=\"2545\"><chemistry id=\"CHEM-US-00703\" num=\"00703\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00703.TIF\" he=\"37.85mm\" id=\"EMI-C00703\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2534\" num=\"2546\">Compound 578 was synthesized by the same procedure as that of Example 157.</p>\n",
       "<p id=\"p-2535\" num=\"2547\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 0.97 (3H, d, J=6.6 Hz), 1.19 (3H, d, J=6.9 Hz), 3.29 (3H, s), 3.97 (1H, d, J=16.1 Hz), 4.56 (1H, d, J=13.7 Hz), 4.82 (1H, m), 4.96 (1H, d, J=16.1 Hz), 5.34 (1H, s), 5.97 (1H, d, J=13.7 Hz), 6.78 (2H, m), 7.12 (2H, m), 7.44-7.51 (6H, m).</p>\n",
       "<p id=\"p-2536\" num=\"2548\">MS: m/z=434.10 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1277\" level=\"1\">Example 579</heading>\n",
       "<p id=\"p-2537\" num=\"2549\"><chemistry id=\"CHEM-US-00704\" num=\"00704\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00704.TIF\" he=\"43.52mm\" id=\"EMI-C00704\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2538\" num=\"2550\">Compound 579 was synthesized by the same procedure as that of Example 163.</p>\n",
       "<p id=\"p-2539\" num=\"2551\">MS: m/z=477.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1278\" level=\"1\">Example 580</heading>\n",
       "<p id=\"p-2540\" num=\"2552\"><chemistry id=\"CHEM-US-00705\" num=\"00705\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00705.TIF\" he=\"233.00mm\" id=\"EMI-C00705\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00706\" num=\"00706\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00706.TIF\" he=\"235.71mm\" id=\"EMI-C00706\" img-content=\"chem\" img-format=\"tif\" wi=\"65.11mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1279\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2541\" num=\"2553\">To a solution of compound 155A (10.5 g, 26.9 mmol), diisopropylethylamine (11.0 mL, 63.0 mmol), 1-methylimidazole (2.60 mL, 32.6 mmol) and isopropylamine (2.80 mL, 32.7 mmol) in toluene (100 mL) and acetonitrile (20 mL) was added dropwise diphenylphosphoric acid chloride (6.80 mL, 32.7 mmol) over 5 minutes under ice-cooling, and the mixture was stirred under ice-cooling for 90 minutes, at room temperature for 90 minutes. To the reaction solution were added tert-butyldimethylsilyl chloride (4.05 g, 26.9 mmol) and triethylamine (4.10 mL, 29.6 mmol) under ice-cooling, the mixture was stirred at room temperature for 80 minutes, 4-dimethylaminopyridine (164 mg, 1.35 mmol) and methylene chloride (100 mL) were added at room temperature, and the mixture was stirred for 15.5 hours. To the reaction solution was added tert-butyldimethylsilyl chloride (2.04 g, 26.9 mmol) at room temperature, and the mixture was stirred for 24 hours. To the reaction solution was added a 10% aqueous acetic acid solution (100 mL) at room temperature, and the mixture was extracted with chloroform, the extracts were combined, washed with saturated sodium bicarbonate water (100 mL), and dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=15%→40%) to obtain compound 580B (6.96 g, 59.9%) as a pale yellow oil.</p>\n",
       "<p id=\"p-2542\" num=\"2554\">MS: m/z=432.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1280\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2543\" num=\"2555\">To an ethanol (50 mL) solution of compound 580B (6.96 g, 16.1 mmol) was added aqueous ammonia (35 mL) at room temperature, and the mixture was stirred for 4 days. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=75%→100%, methanol/chloroform=0%→15%) to obtain compound 580C (4.50 g, 64.8%) as a pale orange gummy substance.</p>\n",
       "<p id=\"p-2544\" num=\"2556\">MS: m/z=431.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1281\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2545\" num=\"2557\">To a dimethylformamide (90 mL) solution of compound 580C (4.50 g, 10.5 mmol) and potassium carbonate (7.27 g, 52.6 mmol) was added O-(2,4-dinitrophenyl)hydroxylamine (6.29 g, 31.6 mmol) at room temperature, and the mixture was stirred for 2 days. To the reaction solution was added chloroform (180 mL) at room temperature, the precipitated insolubles were filtered off, the filtrated was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=0%→10%) to obtain compound 580D (5.28 g, quant) as a yellow solid.</p>\n",
       "<p id=\"p-2546\" num=\"2558\">MS: m/z=446.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1282\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2547\" num=\"2559\">To an ethanol (15 ml) solution of compound 580D (1.29 g, 2.89 mmol) was added paraformaldehyde (261 mg, 8.68 mmol) at room temperature, and the mixture was stirred at 140° C. for 3 hours under microwave irradiation. The reaction solution was concentrated under reduce pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%) to obtain compound 580E (2.47 g, 93.0%) as a pale orange solid.</p>\n",
       "<p id=\"p-2548\" num=\"2560\">MS: m/z=458.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1283\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2549\" num=\"2561\">To a DMF (25 mL) solution of compound 580E (2.47 g, 5.40 mmol) were added cesium carbonate (5.28 g, 16.2 mmol) and bromodiphenylmethane (4.02 g, 16.3 mmol) under ice-cooling, and the mixture was stirred at room temperature for 2 days. To the reaction solution was added water (50 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate (150 mL×2). The extracts were combined, sequentially washed with water (50 mL×2) and an aqueous saturated sodium chloride solution (50 mL), and dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%, methanol/chloroform=10%→20%) to obtain compound 580F (1.60 g, 47.5%) as a yellow form.</p>\n",
       "<p id=\"p-2550\" num=\"2562\">MS: m/z=624.30 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1284\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-2551\" num=\"2563\">To a methanol (40 mL) solution of compound 580F (1.60 g, 2.56 mmol) was added hydrogen chloride (4N ethyl acetate solution, 20 mL) at room temperature, and the mixture was stirred for 2 hours. The reaction solution was concentrated under reduced pressure, to the resulting residue was added saturated sodium bicarbonate water (20 mL) at room temperature and, thereafter, the mixture was extracted with chloroform three times. The extracts were combined, and dried with sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate) to obtain compound 580G (920 mg, 70.4%) as a white foam.</p>\n",
       "<p id=\"p-2552\" num=\"2564\">MS: m/z=510.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1285\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-2553\" num=\"2565\">To a THF (80 mL) solution of compound 580G (816 mg, 1.60 mmol) was added manganese dioxide (2.39 g, 27.5 mmol) at room temperature, and the mixture was stirred for 19 hours. After the reaction solution was filtered, the filtrate was distilled off under reduced pressure, and the resulting crude product (785 mg) of compound 580H was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2554\" num=\"2566\">MS: m/z=508.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1286\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-2555\" num=\"2567\">To a solution of the crude product (635 mg, 1.25 mmol) of compound 580H obtained in the seventh step and amidosulfuric acid (425 mg, 4.38 mmol) in methanol (30 mL) and water (10 mL) was added dropwise a solution of sodium chlorite (396 mg, 4.38 mmol) in water (4 mL) over 10 minutes under ice-cooling, the mixture was stirred at room temperature for 30 minutes, and a 5% aqueous sodium hydrogen sulfite solution (10 mL) was added. Methanol was distilled off under reduced pressure, and the resulting residue was extracted with ethyl acetate two times. The extracts were combined, washed with an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The filtrated was distilled off under reduced pressure, and the resulting crude product of compound 5801 was used in a next reaction without purification.</p>\n",
       "<p id=\"p-2556\" num=\"2568\">MS: m/z=524.25 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1287\" level=\"1\">Ninth Step</heading>\n",
       "<p id=\"p-2557\" num=\"2569\">To a methylene chloride (20 mL) solution of the crude product (164 mg, 0.313 mmol) of compound 5801 obtained in the eighth step, diisopropylethylamine (0.131 mL, and 0.751 mmol), 1-methylimidazole (0.0300 mL, 0.376 mmol) and methylamine (2.0M tetrahydrofuran solution, 0.188 mL, 0.376 mmol) was added diphenylphosphoric acid chloride (0.0780 mL, 0.375 mmol) at room temperature, the mixture was stirred for 3.5 hours, methylamine hydrochloride (25.0 mg, 0.370 mmol) was added, and the mixture was stirred for 6 days. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=75%→100%) to obtain compound 580J (45.7 mg, 27.2%) as a white foam.</p>\n",
       "<p id=\"p-2558\" num=\"2570\">MS: m/z=537.30 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1288\" level=\"1\">Tenth Step</heading>\n",
       "<p id=\"p-2559\" num=\"2571\">To an acetonitrile (4 mL) solution of compound 580J (45.7 mg, 0.0850 mmol) and sodium iodide (103 mg, 0.687 mmol) was added chlorotrimethylsilane (0.0870 mL, 0.681 mmol) at room temperature, and the mixture was stirred for 20 hours. To the reaction solution was added a 5% aqueous sodium hydrogen sulfite solution (4 mL), and the mixture was extracted with chloroform two times. After the extracts were combined, and dried with sodium sulfate, the residue obtained by concentration under reduced pressure was purified by preparative LCMS. Diethyl ether and n-hexane were added to the resulting residue to convert it into a powder, to obtain compound 580 (17.1 mg, 45.0%) as a white solid.</p>\n",
       "<p id=\"p-2560\" num=\"2572\"><sup>1</sup>HNMR (CDCl<sub>3</sub>) δ: 0.93 (3H, d, J=6.9 Hz), 1.11 (3H, d, J=6.9 Hz), 2.83 (3H, d, J=4.8 Hz), 4.53 (1H, d, J=13.4 Hz), 4.85 (1H, m), 4.97 (1H, d, J=13.4 Hz), 5.07 (1H, brd), 5.25 (1H, s), 5.86 (1H, s), 6.97 (2H, m), 7.15-7.24 (2H, m), 7.38-7.46 (6H, m).</p>\n",
       "<p id=\"p-2561\" num=\"2573\">MS: m/z=447.20 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1289\" level=\"1\">Example 581</heading>\n",
       "<p id=\"p-2562\" num=\"2574\"><chemistry id=\"CHEM-US-00707\" num=\"00707\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00707.TIF\" he=\"134.03mm\" id=\"EMI-C00707\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1290\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2563\" num=\"2575\">To a tert-butanol (4 mL) solution of compound 580I (398 mg, 0.760 mmol) were added triethylamine (0.158 mL, 1.14 mmol) and diphenylphosphoric acid azide (0.196 mL, 0.912 mmol) at room temperature, and the mixture was heated to reflux for 20 hours. To the reaction solution was added water (20 mL) at room temperature, and the mixture was extracted with chloroform three times. The extracts were combined, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=0%→10%) to obtain compound 581A (167 mg, 36.9%) as a gray white solid.</p>\n",
       "<p id=\"p-2564\" num=\"2576\">MS: m/z=595.10 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1291\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2565\" num=\"2577\">To a methylene chloride (2 mL) solution of compound 581A (167 mg, 0.281 mmol) was added trifluoroacetic acid (2 mL) at room temperature, and the mixture was stirred for 1.5 hours. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS. Ethyl acetate, diethyl ether, and methanol were added to the resulting residue to convert it into a powder, to obtain compound 581 (29.4 mg, 25.9%) as a white solid.</p>\n",
       "<p id=\"p-2566\" num=\"2578\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 0.81 (3H, d, J=6.5 Hz), 0.98 (3H, d, J=6.5 Hz), 4.35 (1H, d, J=12.6 Hz), 4.63 (1H, m), 4.68 (1H, d, J=12.6 Hz), 4.80 (1H, s), 5.28 (1H, s), 6.34 (2H, s), 7.10-7.43 (8H, m), 7.81-7.83 (2H, m).</p>\n",
       "<p id=\"p-2567\" num=\"2579\">MS: m/z=404.95 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1292\" level=\"1\">Example 582</heading>\n",
       "<p id=\"p-2568\" num=\"2580\"><chemistry id=\"CHEM-US-00708\" num=\"00708\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00708.TIF\" he=\"145.03mm\" id=\"EMI-C00708\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1293\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2569\" num=\"2581\">To an ethanol (4 mL) solution of compound 582A (200 mg, 0.470 mmol) synthesized according to the synthesis method of Example 65 was added paraformaldehyde (14.8 mg, 0.493 mmol) at room temperature, and the mixture was stirred at 140° C. for 45 minutes under microwave irradiation. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=90%→100%) to obtain compound 582B (173 mg, 84.0%) as a white solid.</p>\n",
       "<p id=\"p-2570\" num=\"2582\">MS: m/z=438.15 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1294\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2571\" num=\"2583\">To a methylene chloride (4 mL) solution of compound 582B (173 mg, 0.396 mmol), 4-dimethylaminopyridine (5.6 mg, 0.046 mmol) and triethylamine (0.164 mL, 1.18 mmol) was added 2-fluorobenzenesulfonyl chloride (0.0790 mL, 0.597 mmol) at room temperature, and the mixture was stirred for 3 days. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=60%→80%) to obtain compound 582C (199 mg, 84.0%) as a white solid.</p>\n",
       "<p id=\"p-2572\" num=\"2584\">MS: m/z=596.15 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1295\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2573\" num=\"2585\">To an acetic acid (2 mL) solution of compound 582C (162 mg, 0.272 mmol) was added 48% aqueous hydrogen bromide (2 mL) at room temperature, and the mixture was stirred at 100° C. for 20 minutes under microwave irradiation. The solvent was distilled off under reduced pressure, and diethyl ether and methanol were added to the resulting residue to convert it into a powder, to obtain compound 582 (160 mg, quant) as a yellow solid.</p>\n",
       "<p id=\"p-2574\" num=\"2586\"><sup>1</sup>HNMR (DMSO-d<sub>6</sub>) δ: 4.34 (1H, d, J=14.7 Hz), 4.59 (1H, d, J=14.7 Hz), 5.50 (1H, d, J=14.3 Hz), 5.81 (1H, d, J=14.3 Hz), 7.15-7.21 (2H, m), 7.35-7.40 (2H, m), 7.45-7.61 (2H, m), 7.78 (1H, m), 7.93 (1H, m), 8.42 (1H, s).</p>\n",
       "<p id=\"p-2575\" num=\"2587\">MS: m/z=492.10 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1296\" level=\"1\">Example 583, Example 584</heading>\n",
       "<p id=\"p-2576\" num=\"2588\"><chemistry id=\"CHEM-US-00709\" num=\"00709\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00709.TIF\" he=\"219.46mm\" id=\"EMI-C00709\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1297\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2577\" num=\"2589\">Compound 583A (3.0 g, 0.99 mmol) synthesized according to Example 95 was added to toluene (300 ml) and acetic acid (30.0 ml) to dissolve, and TsOH H<sub>2</sub>O (0.1 g, 0.526 mmol) was added at room temperature. The reaction mixture was stirred for 3 hours under heat-refluxing. After concentration under reduced pressure, the residue was purified by amino silica gel column chromatography (CHCl<sub>3</sub>/MeOH 50:1) to obtain compound 583B (1.8 g, 72.4%).</p>\n",
       "<p id=\"p-2578\" num=\"2590\">MS: m/z=312 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1298\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2579\" num=\"2591\">Compound 583B (233 mg, 0.748 mmol) and compound 583C (197 mg, 0.8 mmol) were suspended in THF (7.5 ml), and NaHMDS (1.123 ml, 1.123 mmol, 1M-THF solution) was added at room temperature under nitrogen stream. After stirring at room temperature for 3 hours, water was added, and the mixture was extracted with ethyl acetate (2×30 mL). The ethyl acetate layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (CHCl<sub>3</sub>/MeOH 20:1) to obtain compound 583D (90 mg, 23.1%).</p>\n",
       "<p id=\"p-2580\" num=\"2592\">MS: m/z=522 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1299\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2581\" num=\"2593\">Compound 583D (90 mg, 0.173 mmol) was dissolved in a mixed solvent of MeOH (3 ml) and THF (3.00 ml), and 10% palladium-carbon (90 mg, 0.846 mmol) was added. The mixture was stirred for 24 hours under hydrogen (2 atm) stream, and insolubles were filtered. The residue was purified using HPLC (MeCN—H<sub>2</sub>O), and diastereomers were resolved.</p>\n",
       "<p id=\"h-1300\" num=\"0000\">First Fraction (Compound 583)</p>\n",
       "<p id=\"p-2582\" num=\"2594\">(15 mg, 20.1%)</p>\n",
       "<p id=\"p-2583\" num=\"2595\">MS: m/z=432 [M+H]<sup>+</sup>.</p>\n",
       "<p id=\"h-1301\" num=\"0000\">Second Fraction (Compound 584)</p>\n",
       "<p id=\"p-2584\" num=\"2596\">(45 mg, 60.4%)</p>\n",
       "<p id=\"p-2585\" num=\"2597\">MS: m/z=432 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1302\" level=\"1\">Example 585</heading>\n",
       "<p id=\"p-2586\" num=\"2598\"><chemistry id=\"CHEM-US-00710\" num=\"00710\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00710.TIF\" he=\"37.85mm\" id=\"EMI-C00710\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2587\" num=\"2599\">Compound 585 was synthesized by the same procedure as that of Example 403.</p>\n",
       "<p id=\"p-2588\" num=\"2600\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 1.87-2.28 (4H, m), 3.40-3.80 (3H, m), 4.32 (1H, d, J=12.96 Hz), 5.34 (1H, t, J=7.32 Hz), 5.65 (1H, d, J=7.63 Hz), 6.90 (1H, d, J=7.78 Hz), 7.10-7.35 (5H, m).</p>\n",
       "<p id=\"p-2589\" num=\"2601\">MS: m/z=312 [M+H]<sup>+</sup>.</p>\n",
       "<heading id=\"h-1303\" level=\"1\">Example 586</heading>\n",
       "<p id=\"p-2590\" num=\"2602\"><chemistry id=\"CHEM-US-00711\" num=\"00711\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00711.TIF\" he=\"223.44mm\" id=\"EMI-C00711\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00712\" num=\"00712\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00712.TIF\" he=\"226.31mm\" id=\"EMI-C00712\" img-content=\"chem\" img-format=\"tif\" wi=\"72.73mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1304\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2591\" num=\"2603\">Compound 95B (2.29 g, 8.12 mmol) was dissolved in pyridine (10 ml), iso-propyl-D<sub>7</sub>-amine hydrochloride (1.00 g, 9.75 mmol), 1H-benzo[d][1,2,3]triazol-1-ol (1.10 g, 8.12 mmol) and N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine hydrochloride (3.11 g, 16.2 mmol) were added, and the mixture was stirred at room temperature for 20 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound was added diethyl ether, and the precipitated residue was filtered to obtain 1.36 g of a white solid 586B.</p>\n",
       "<heading id=\"h-1305\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2592\" num=\"2604\">Compound 586B (1.36 g, 4.64 mmol) obtained in the first step was dissolved in dimethylformamide (20 ml), potassium carbonate (3.20 g, 23.2 mmol) was added, and the mixture was stirred at room temperature for 50 minutes. O-(2,4-dinitrophenyl)hydroxylamine (1.85 g, 9.27 mmol) was added, and the mixture was stirred at room temperature for 18 hours. To the reaction solution was added chloroform, the generated precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v) to obtain 835 mg of a colorless solid 586C.</p>\n",
       "<p id=\"p-2593\" num=\"2605\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 5.28 (2H, s), 5.63 (2H, s), 6.32 (1H, d, J=7.7 Hz), 7.10 (1H, brs), 7.42 (6H, m).</p>\n",
       "<heading id=\"h-1306\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2594\" num=\"2606\">Compound 586C (581 mg, 1.88 mmol) obtained in the second step and paraformaldehyde-D<sub>2 </sub>(181 mg, 5.65 mmol) were added to ethanol (12 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound was added diethyl ether, and the precipitated residue was filtered to obtain 140 mg of white solid 586D.</p>\n",
       "<p id=\"p-2595\" num=\"2607\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 4.39 (2H, d, J=8.1 Hz), 5.36 (2H, s), 5.42 (1H, t, J=8.0 Hz), 6.37 (1H, d, J=7.6 Hz), 7.48 (6H, m).</p>\n",
       "<heading id=\"h-1307\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2596\" num=\"2608\">Compound 586E (972 mg, 5.78 mmol) was dissolved in tetrahydrofuran (10 ml), sodium hydride (60%, 231 mg, 5.78 mmol) and benzyl bromide-D<sub>2 </sub>(1.00 g, 5.78 mmol) were added at 0° C., and the mixture was stirred at 60° C. for 30 minutes. The reaction solution was added to dilute hydrochloric acid, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous sodium bicarbonate solution. The solvent was distilled off under reduced pressure to obtain 1.48 g of a white solid 586F.</p>\n",
       "<p id=\"p-2597\" num=\"2609\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.95 (3H, s), 7.17-7.48 (8H, m), 8.00 (1H, dd, J=7.8, 1.3 Hz).</p>\n",
       "<heading id=\"h-1308\" level=\"1\">Fifth Step</heading>\n",
       "<p id=\"p-2598\" num=\"2610\">Compound 586F (1.50 g, 5.76 mmol) obtained in the fourth step was dissolved in methanol (20 ml) and tetrahydrofuran (20 ml), a 2N aqueous sodium hydroxide solution (14.4 ml, 28.8 mmol) was added, and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added dilute hydrochloric acid to make the solution acidic, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting compound were added n-hexane-ethyl acetate, and the precipitated residue was filtered to obtain 1.17 g of a white solid 586G.</p>\n",
       "<p id=\"p-2599\" num=\"2611\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 7.18-7.48 (8H, m), 8.11 (1H, dd, J=7.9, 1.6 Hz).</p>\n",
       "<heading id=\"h-1309\" level=\"1\">Sixth Step</heading>\n",
       "<p id=\"p-2600\" num=\"2612\">To compound 586G (1.15 g, 4.67 mmol) obtained in the fifth step was added toluene (10 ml), dimethylformamide (0.100 ml, 1.29 mmol) and thionyl chloride (0.410 ml, 5.60 mmol) were added, and the mixture was stirred at 130° C. for 1.5 hours. After cooled to room temperature, the reaction solution was concentrated under reduced pressure. To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 1.16 g of a white solid. To aluminum chloride (718 mg, 5.38 mmol) were added dichloromethane (10 ml) and nitromethane (0.5 ml), a dichloromethane solution (5 ml) of 500 mg of the compound obtained above was added at 0° C., and the mixture was stirred at room temperature for 5 hours. To the reaction solution was added an aqueous sodium hydroxide solution, and the mixture was extracted with methylene chloride, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (4:1, v/v). To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 155 mg of a pale yellow solid 586H.</p>\n",
       "<p id=\"p-2601\" num=\"2613\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 7.21-7.39 (6H, m), 7.46 (1H, td, J=7.5, 1.4 Hz), 7.59 (1H, dd, J=7.5, 1.4 Hz), 8.21 (1H, dd, J=8.0, 1.0 Hz).</p>\n",
       "<heading id=\"h-1310\" level=\"1\">Seventh Step</heading>\n",
       "<p id=\"p-2602\" num=\"2614\">Compound 586H (150 mg, 0.657 mmol) obtained in the sixth step was dissolved in tetrahydrofuran (3 ml), lithium aluminum hydride-D<sub>4 </sub>(13.8 mg, 0.329 mmol) was added at 0° C., and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added dilute hydrochloric acid, the mixture was extracted with ethyl acetate, and dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 114 mg of a white solid 5861.</p>\n",
       "<p id=\"p-2603\" num=\"2615\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 7.17 (6H, m), 7.40-7.52 (2H, m).</p>\n",
       "<heading id=\"h-1311\" level=\"1\">Eighth Step</heading>\n",
       "<p id=\"p-2604\" num=\"2616\">Compound 586D (76.0 mg, 0.236 mmol) and 5861 (54.5 mg, 0.235 mmol) were dissolved in acetic acid (3.2 ml), and concentrated sulfuric acid (0.8 ml) was added dropwise under water-cooling. After the mixture was stirred at room temperature for 30 minutes, the mixture was poured into water, and extracted with ethyl acetate. The organic layer was dried with sodium sulfate, the solvent was distilled off under reduced pressure, to the resulting crude product were added ethyl acetate-diethyl ether, and the precipitated residue was filtered to obtain 32 mg of a white solid 586.</p>\n",
       "<p id=\"p-2605\" num=\"2617\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 5.57 (1H, d, J=7.3 Hz), 6.82-7.44 (9H, m).</p>\n",
       "<p id=\"p-2606\" num=\"2618\">MS: m/z=446 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-2607\" num=\"2619\">Using a commercially available heavy hydrogen reagent, and according to Example 586, compounds 587 to 591 were synthesized.</p>\n",
       "<heading id=\"h-1312\" level=\"1\">Example 587</heading>\n",
       "<p id=\"p-2608\" num=\"2620\"><chemistry id=\"CHEM-US-00713\" num=\"00713\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00713.TIF\" he=\"44.45mm\" id=\"EMI-C00713\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1313\" level=\"1\">Example 588</heading>\n",
       "<p id=\"p-2609\" num=\"2621\">MS: m/z=436 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-2610\" num=\"2622\"><chemistry id=\"CHEM-US-00714\" num=\"00714\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00714.TIF\" he=\"45.21mm\" id=\"EMI-C00714\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2611\" num=\"2623\"><sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) δ: 3.87 (1H, d, J=13.4 Hz), 5.58 (1H, d, J=7.8 Hz), 5.60 (1H, d, J=12.6 Hz), 6.81-7.48 (9H, m).</p>\n",
       "<heading id=\"h-1314\" level=\"1\">Example 589</heading>\n",
       "<p id=\"p-2612\" num=\"2624\"><chemistry id=\"CHEM-US-00715\" num=\"00715\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00715.TIF\" he=\"45.21mm\" id=\"EMI-C00715\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2613\" num=\"2625\">MS: m/z=441 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1315\" level=\"1\">Example 590</heading>\n",
       "<p id=\"p-2614\" num=\"2626\"><chemistry id=\"CHEM-US-00716\" num=\"00716\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00716.TIF\" he=\"39.62mm\" id=\"EMI-C00716\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2615\" num=\"2627\">MS: m/z=435 [M+H]<sup>+</sup></p>\n",
       "<heading id=\"h-1316\" level=\"1\">Example 591</heading>\n",
       "<p id=\"p-2616\" num=\"2628\"><chemistry id=\"CHEM-US-00717\" num=\"00717\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00717.TIF\" he=\"39.71mm\" id=\"EMI-C00717\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2617\" num=\"2629\">MS: m/z=436 [M+H]<sup>+</sup></p>\n",
       "<p id=\"p-2618\" num=\"2630\">The following EX-1 to EX-29 can be also synthesized like the Examples, and are a preferable embodiment of the present invention.</p>\n",
       "<p id=\"p-2619\" num=\"2631\"><chemistry id=\"CHEM-US-00718\" num=\"00718\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00718.TIF\" he=\"238.25mm\" id=\"EMI-C00718\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00719\" num=\"00719\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00719.TIF\" he=\"231.14mm\" id=\"EMI-C00719\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00720\" num=\"00720\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00720.TIF\" he=\"206.08mm\" id=\"EMI-C00720\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00721\" num=\"00721\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00721.TIF\" he=\"207.77mm\" id=\"EMI-C00721\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00722\" num=\"00722\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00722.TIF\" he=\"209.80mm\" id=\"EMI-C00722\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00723\" num=\"00723\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00723.TIF\" he=\"217.76mm\" id=\"EMI-C00723\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<chemistry id=\"CHEM-US-00724\" num=\"00724\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00724.TIF\" he=\"38.86mm\" id=\"EMI-C00724\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<p id=\"p-2620\" num=\"2632\">Further, the following combinations of substituents can be also synthesized like the above Examples, and are a preferable embodiment of the present invention.</p>\n",
       "<p id=\"p-2621\" num=\"2633\">Compounds in which, in the following formula (I) or (II):</p>\n",
       "<p id=\"p-2622\" num=\"2634\"><chemistry id=\"CHEM-US-00725\" num=\"00725\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00725.TIF\" he=\"61.64mm\" id=\"EMI-C00725\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "combinations of R<sup>3 </sup>or R<sup>3a</sup>, as Well as R<sup>7 </sup>or R<sup>7a </sup>of the following formula (I′) or (II′):\n",
       "</p>\n",
       "<p id=\"p-2623\" num=\"2635\"><chemistry id=\"CHEM-US-00726\" num=\"00726\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00726.TIF\" he=\"63.92mm\" id=\"EMI-C00726\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<br/>\n",
       "are selected from the following Tables 6 to 10 and Table 11, respectively.\n",
       "<br/>\n",
       "Combinations of (R<sup>3</sup>, R<sup>7</sup>) or (R<sup>3a</sup>, R<sup>7a</sup>)=(R3-1, R7-1), (R3-1, R7-2), (R3-1, R7-3), (R3-1, R7-4), (R3-1, R7-5), (R3-1, R7-6), (R3-1, R7-7), (R3-1, R7-8), (R3-1, R7-9), (R3-1, R7-10), (R3-1, R7-11), (R3-1, R7-12), (R3-1, R7-13), (R3-1, R7-14), (R3-1, R7-15), (R3-1, R7-16), (R3-1, R7-17), (R3-1, R7-18), (R3-1, R7-19), (R3-1, R7-20), (R3-1, R7-21), (R3-1, R7-22), (R3-1, R7-23), (R3-1, R7-24), (R3-1, R7-25), (R3-1, R7-26), (R3-1, R7-27), (R3-1, R7-28), (R3-1, R7-29), (R3-1, R7-30), (R3-1, R7-31), (R3-1, R7-32), (R3-1, R7-33), (R3-1, R7-34), (R3-1, R7-35), (R3-1, R7-36), (R3-1, R7-37), (R3-1, R7-38), (R3-1, R7-39), (R3-1, R7-40), (R3-1, R7-41), (R3-1, R7-42), (R3-1, R7-43), (R3-1, R7-44), (R3-1, R7-45), (R3-1, R7-46), (R3-1, R7-47), (R3-1, R7-48), (R3-1, R7-49), (R3-1, R7-50), (R3-1, R7-51), (R3-1, R7-52), (R3-1, R7-53), (R3-1, R7-54), (R3-1, R7-55), (R3-1, R7-56), (R3-1, R7-57), (R3-1, R7-58), (R3-1, R7-59), (R3-1, R7-60), (R3-1, R7-61), (R3-1, R7-62), (R3-1, R7-63), (R3-1, R7-64), (R3-1, R7-65), (R3-1, R7-66), (R3-1, R7-67), (R3-1, R7-68), (R3-1, R7-69), (R3-1, R7-70), (R3-1, R7-71), (R3-1, R7-72), (R3-1, R7-73), (R3-1, R7-74), (R3-1, R7-75), (R3-1, R7-76), (R3-1, R7-77),\n",
       "<br/>\n",
       "(R3-2, R7-1), (R3-2, R7-2), (R3-2, R7-3), (R3-2, R7-4), (R3-2, R7-5), (R3-2, R7-6), (R3-2, R7-7), (R3-2, R7-8), (R3-2, R7-9), (R3-2, R7-10), (R3-2, R7-11), (R3-2, R7-12), (R3-2, R7-13), (R3-2, R7-14), (R3-2, R7-15), (R3-2, R7-16), (R3-2, R7-17), (R3-2, R7-18), (R3-2, R7-19), (R3-2, R7-20), (R3-2, R7-21), (R3-2, R7-22), (R3-2, R7-23), (R3-2, R7-24), (R3-2, R7-25), (R3-2, R7-26), (R3-2, R7-27), (R3-2, R7-28), (R3-2, R7-29), (R3-2, R7-30), (R3-2, R7-31), (R3-2, R7-32), (R3-2, R7-33), (R3-2, R7-34), (R3-2, R7-35), (R3-2, R7-36), (R3-2, R7-37), (R3-2, R7-38), (R3-2, R7-39), (R3-2, R7-40), (R3-2, R7-41), (R3-2, R7-42), (R3-2, R7-43), (R3-2, R7-44), (R3-2, R7-45), (R3-2, R7-46), (R3-2, R7-47), (R3-2, R7-48), (R3-2, R7-49), (R3-2, R7-50), (R3-2, R7-51), (R3-2, R7-52), (R3-2, R7-53), (R3-2, R7-54), (R3-2, R7-55), (R3-2, R7-56), (R3-2, R7-57), (R3-2, R7-58), (R3-2, R7-59), (R3-2, R7-60), (R3-2, R7-61), (R3-2, R7-62), (R3-2, R7-63), (R3-2, R7-64), (R3-2, R7-65),\n",
       "<br/>\n",
       "(R3-2, R7-66), (R3-2, R7-67), (R3-2, R7-68), (R3-2, R7-69), (R3-2, R7-70), (R3-2, R7-71), (R3-2, R7-72), (R3-2, R7-73), (R3-2, R7-74), (R3-2, R7-75), (R3-2, R7-76), (R3-2, R7-77), (R3-3, R7-1), (R3-3, R7-2), (R3-3, R7-3), (R3-3, R7-4), (R3-3, R7-5), (R3-3, R7-6), (R3-3, R7-7, (R3-3, R7-8), (R3-3, R7-9), (R3-3, R7-10), (R3-3, R7-11), (R3-3, R7-12), (R3-3, R7-13), (R3-3, R7-14), (R3-3, R7-15), (R3-3, R7-16), (R3-3, R7-17), (R3-3, R7-18), (R3-3, R7-19), (R3-3, R7-20), (R3-3, R7-21), (R3-3, R7-22), (R3-3, R7-23), (R3-3, R7-24), (R3-3, R7-25), (R3-3, R7-26), (R3-3, R7-27), (R3-3, R7-28), (R3-3, R7-29), (R3-3, R7-30), (R3-3, R7-31), (R3-3, R7-32), (R3-3, R7-33), (R3-3, R7-34), (R3-3, R7-35), (R3-3, R7-36), (R3-3, R7-37), (R3-3, R7-38), (R3-3, R7-39), (R3-3, R7-40), (R3-3, R7-41), (R3-3, R7-42), (R3-3, R7-43), (R3-3, R7-44), (R3-3, R7-45), (R3-3, R7-46), (R3-3, R7-47), (R3-3, R7-48), (R3-3, R7-49), (R3-3, R7-50), (R3-3, R7-51), (R3-3, R7-52), (R3-3, R7-53), (R3-3, R7-54), (R3-3, R7-55), (R3-3, R7-56), (R3-3, R7-57), (R3-3, R7-58), (R3-3, R7-59), (R3-3, R7-60), (R3-3, R7-61), (R3-3, R7-62), (R3-3, R7-63), (R3-3, R7-64), (R3-3, R7-65), (R3-3, R7-66), (R3-3, R7-67), (R3-3, R7-68), (R3-3, R7-69), (R3-3, R7-70), (R3-3, R7-71), (R3-3, R7-72), (R3-3, R7-73), (R3-3, R7-74), (R3-3, R7-75), (R3-3, R7-76), (R3-3, R7-77).\n",
       "</p>\n",
       "<p id=\"p-2624\" num=\"2636\">\n",
       "<tables id=\"TABLE-US-00006\" num=\"00006\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"154pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry nameend=\"2\" namest=\"offset\" rowsep=\"1\">TABLE 6</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>R<sup>3 </sup>or R3<sup>a</sup></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R3-1</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00727\" num=\"00727\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00727.TIF\" he=\"13.38mm\" id=\"EMI-C00727\" img-content=\"table\" img-format=\"tif\" wi=\"16.17mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R3-2</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00728\" num=\"00728\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00728.TIF\" he=\"17.27mm\" id=\"EMI-C00728\" img-content=\"table\" img-format=\"tif\" wi=\"16.17mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R3-3</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00729\" num=\"00729\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00729.TIF\" he=\"13.38mm\" id=\"EMI-C00729\" img-content=\"table\" img-format=\"tif\" wi=\"15.92mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2625\" num=\"2637\">\n",
       "<tables id=\"TABLE-US-00007\" num=\"00007\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"175pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry nameend=\"2\" namest=\"offset\" rowsep=\"1\">TABLE 7</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>R<sup>7 </sup>or R<sup>7a</sup></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-1 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00730\" num=\"00730\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00730.TIF\" he=\"19.47mm\" id=\"EMI-C00730\" img-content=\"table\" img-format=\"tif\" wi=\"39.29mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-2 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00731\" num=\"00731\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00731.TIF\" he=\"22.01mm\" id=\"EMI-C00731\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-3 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00732\" num=\"00732\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00732.TIF\" he=\"18.63mm\" id=\"EMI-C00732\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-4 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00733\" num=\"00733\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00733.TIF\" he=\"19.39mm\" id=\"EMI-C00733\" img-content=\"table\" img-format=\"tif\" wi=\"38.86mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-5 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00734\" num=\"00734\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00734.TIF\" he=\"22.10mm\" id=\"EMI-C00734\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-6 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00735\" num=\"00735\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00735.TIF\" he=\"22.10mm\" id=\"EMI-C00735\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-7 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00736\" num=\"00736\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00736.TIF\" he=\"19.39mm\" id=\"EMI-C00736\" img-content=\"table\" img-format=\"tif\" wi=\"38.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-8 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00737\" num=\"00737\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00737.TIF\" he=\"22.18mm\" id=\"EMI-C00737\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-9 </entry>\n",
       "<entry><chemistry id=\"CHEM-US-00738\" num=\"00738\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00738.TIF\" he=\"19.39mm\" id=\"EMI-C00738\" img-content=\"table\" img-format=\"tif\" wi=\"36.32mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-10</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00739\" num=\"00739\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00739.TIF\" he=\"19.39mm\" id=\"EMI-C00739\" img-content=\"table\" img-format=\"tif\" wi=\"35.56mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-11</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00740\" num=\"00740\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00740.TIF\" he=\"21.17mm\" id=\"EMI-C00740\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-12</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00741\" num=\"00741\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00741.TIF\" he=\"18.63mm\" id=\"EMI-C00741\" img-content=\"table\" img-format=\"tif\" wi=\"44.03mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-13</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00742\" num=\"00742\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00742.TIF\" he=\"22.10mm\" id=\"EMI-C00742\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-14</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00743\" num=\"00743\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00743.TIF\" he=\"19.47mm\" id=\"EMI-C00743\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-15</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00744\" num=\"00744\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00744.TIF\" he=\"22.10mm\" id=\"EMI-C00744\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-16</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00745\" num=\"00745\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00745.TIF\" he=\"22.18mm\" id=\"EMI-C00745\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-17</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00746\" num=\"00746\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00746.TIF\" he=\"19.39mm\" id=\"EMI-C00746\" img-content=\"table\" img-format=\"tif\" wi=\"36.15mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-18</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00747\" num=\"00747\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00747.TIF\" he=\"19.47mm\" id=\"EMI-C00747\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2626\" num=\"2638\">\n",
       "<tables id=\"TABLE-US-00008\" num=\"00008\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"175pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry nameend=\"2\" namest=\"offset\" rowsep=\"1\">TABLE 8</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>R<sup>7 </sup>or R<sup>7a</sup></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-19</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00748\" num=\"00748\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00748.TIF\" he=\"22.10mm\" id=\"EMI-C00748\" img-content=\"table\" img-format=\"tif\" wi=\"35.39mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-20</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00749\" num=\"00749\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00749.TIF\" he=\"22.18mm\" id=\"EMI-C00749\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-21</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00750\" num=\"00750\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00750.TIF\" he=\"21.25mm\" id=\"EMI-C00750\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-22</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00751\" num=\"00751\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00751.TIF\" he=\"19.47mm\" id=\"EMI-C00751\" img-content=\"table\" img-format=\"tif\" wi=\"38.69mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-23</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00752\" num=\"00752\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00752.TIF\" he=\"19.39mm\" id=\"EMI-C00752\" img-content=\"table\" img-format=\"tif\" wi=\"41.40mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-24</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00753\" num=\"00753\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00753.TIF\" he=\"19.39mm\" id=\"EMI-C00753\" img-content=\"table\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-25</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00754\" num=\"00754\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00754.TIF\" he=\"22.10mm\" id=\"EMI-C00754\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-26</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00755\" num=\"00755\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00755.TIF\" he=\"19.39mm\" id=\"EMI-C00755\" img-content=\"table\" img-format=\"tif\" wi=\"38.10mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-27</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00756\" num=\"00756\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00756.TIF\" he=\"22.01mm\" id=\"EMI-C00756\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-28</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00757\" num=\"00757\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00757.TIF\" he=\"29.13mm\" id=\"EMI-C00757\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-29</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00758\" num=\"00758\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00758.TIF\" he=\"19.39mm\" id=\"EMI-C00758\" img-content=\"table\" img-format=\"tif\" wi=\"35.39mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-30</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00759\" num=\"00759\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00759.TIF\" he=\"21.25mm\" id=\"EMI-C00759\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-31</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00760\" num=\"00760\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00760.TIF\" he=\"19.39mm\" id=\"EMI-C00760\" img-content=\"table\" img-format=\"tif\" wi=\"38.10mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-32</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00761\" num=\"00761\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00761.TIF\" he=\"18.63mm\" id=\"EMI-C00761\" img-content=\"table\" img-format=\"tif\" wi=\"38.69mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-33</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00762\" num=\"00762\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00762.TIF\" he=\"18.63mm\" id=\"EMI-C00762\" img-content=\"table\" img-format=\"tif\" wi=\"40.81mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-34</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00763\" num=\"00763\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00763.TIF\" he=\"19.39mm\" id=\"EMI-C00763\" img-content=\"table\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-35</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00764\" num=\"00764\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00764.TIF\" he=\"19.39mm\" id=\"EMI-C00764\" img-content=\"table\" img-format=\"tif\" wi=\"39.37mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-36</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00765\" num=\"00765\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00765.TIF\" he=\"19.39mm\" id=\"EMI-C00765\" img-content=\"table\" img-format=\"tif\" wi=\"30.40mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2627\" num=\"2639\">\n",
       "<tables id=\"TABLE-US-00009\" num=\"00009\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"175pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry nameend=\"2\" namest=\"offset\" rowsep=\"1\">TABLE 9</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>R<sup>7 </sup>or R<sup>7a</sup></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-37</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00766\" num=\"00766\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00766.TIF\" he=\"19.47mm\" id=\"EMI-C00766\" img-content=\"table\" img-format=\"tif\" wi=\"36.66mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-38</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00767\" num=\"00767\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00767.TIF\" he=\"19.39mm\" id=\"EMI-C00767\" img-content=\"table\" img-format=\"tif\" wi=\"40.47mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-39</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00768\" num=\"00768\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00768.TIF\" he=\"25.06mm\" id=\"EMI-C00768\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-40</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00769\" num=\"00769\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00769.TIF\" he=\"23.54mm\" id=\"EMI-C00769\" img-content=\"table\" img-format=\"tif\" wi=\"34.80mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-41</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00770\" num=\"00770\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00770.TIF\" he=\"19.47mm\" id=\"EMI-C00770\" img-content=\"table\" img-format=\"tif\" wi=\"40.05mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-42</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00771\" num=\"00771\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00771.TIF\" he=\"22.01mm\" id=\"EMI-C00771\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-43</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00772\" num=\"00772\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00772.TIF\" he=\"19.47mm\" id=\"EMI-C00772\" img-content=\"table\" img-format=\"tif\" wi=\"34.71mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-44</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00773\" num=\"00773\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00773.TIF\" he=\"18.88mm\" id=\"EMI-C00773\" img-content=\"table\" img-format=\"tif\" wi=\"38.95mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-45</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00774\" num=\"00774\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00774.TIF\" he=\"19.39mm\" id=\"EMI-C00774\" img-content=\"table\" img-format=\"tif\" wi=\"39.54mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-46</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00775\" num=\"00775\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00775.TIF\" he=\"25.06mm\" id=\"EMI-C00775\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-47</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00776\" num=\"00776\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00776.TIF\" he=\"22.01mm\" id=\"EMI-C00776\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-48</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00777\" num=\"00777\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00777.TIF\" he=\"22.10mm\" id=\"EMI-C00777\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-49</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00778\" num=\"00778\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00778.TIF\" he=\"26.08mm\" id=\"EMI-C00778\" img-content=\"table\" img-format=\"tif\" wi=\"35.31mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-50</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00779\" num=\"00779\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00779.TIF\" he=\"25.23mm\" id=\"EMI-C00779\" img-content=\"table\" img-format=\"tif\" wi=\"34.71mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-51</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00780\" num=\"00780\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00780.TIF\" he=\"24.30mm\" id=\"EMI-C00780\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-52</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00781\" num=\"00781\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00781.TIF\" he=\"22.10mm\" id=\"EMI-C00781\" img-content=\"table\" img-format=\"tif\" wi=\"35.48mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-53</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00782\" num=\"00782\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00782.TIF\" he=\"22.10mm\" id=\"EMI-C00782\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-54</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00783\" num=\"00783\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00783.TIF\" he=\"22.10mm\" id=\"EMI-C00783\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2628\" num=\"2640\">\n",
       "<tables id=\"TABLE-US-00010\" num=\"00010\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"175pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry nameend=\"2\" namest=\"offset\" rowsep=\"1\">TABLE 10</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>R<sup>7 </sup>or R<sup>7a</sup></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-55</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00784\" num=\"00784\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00784.TIF\" he=\"22.10mm\" id=\"EMI-C00784\" img-content=\"table\" img-format=\"tif\" wi=\"39.45mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-56</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00785\" num=\"00785\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00785.TIF\" he=\"22.01mm\" id=\"EMI-C00785\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-57</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00786\" num=\"00786\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00786.TIF\" he=\"22.01mm\" id=\"EMI-C00786\" img-content=\"table\" img-format=\"tif\" wi=\"39.45mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-58</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00787\" num=\"00787\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00787.TIF\" he=\"22.18mm\" id=\"EMI-C00787\" img-content=\"table\" img-format=\"tif\" wi=\"39.96mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-59</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00788\" num=\"00788\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00788.TIF\" he=\"22.10mm\" id=\"EMI-C00788\" img-content=\"table\" img-format=\"tif\" wi=\"38.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-60</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00789\" num=\"00789\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00789.TIF\" he=\"22.01mm\" id=\"EMI-C00789\" img-content=\"table\" img-format=\"tif\" wi=\"38.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-61</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00790\" num=\"00790\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00790.TIF\" he=\"22.10mm\" id=\"EMI-C00790\" img-content=\"table\" img-format=\"tif\" wi=\"39.96mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-62</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00791\" num=\"00791\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00791.TIF\" he=\"22.10mm\" id=\"EMI-C00791\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-63</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00792\" num=\"00792\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00792.TIF\" he=\"22.10mm\" id=\"EMI-C00792\" img-content=\"table\" img-format=\"tif\" wi=\"39.96mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-64</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00793\" num=\"00793\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00793.TIF\" he=\"22.10mm\" id=\"EMI-C00793\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-65</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00794\" num=\"00794\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00794.TIF\" he=\"22.10mm\" id=\"EMI-C00794\" img-content=\"table\" img-format=\"tif\" wi=\"38.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-66</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00795\" num=\"00795\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00795.TIF\" he=\"22.10mm\" id=\"EMI-C00795\" img-content=\"table\" img-format=\"tif\" wi=\"38.02mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-67</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00796\" num=\"00796\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00796.TIF\" he=\"22.10mm\" id=\"EMI-C00796\" img-content=\"table\" img-format=\"tif\" wi=\"39.45mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-68</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00797\" num=\"00797\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00797.TIF\" he=\"22.10mm\" id=\"EMI-C00797\" img-content=\"table\" img-format=\"tif\" wi=\"32.00mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-69</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00798\" num=\"00798\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00798.TIF\" he=\"22.10mm\" id=\"EMI-C00798\" img-content=\"table\" img-format=\"tif\" wi=\"39.45mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-70</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00799\" num=\"00799\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00799.TIF\" he=\"19.39mm\" id=\"EMI-C00799\" img-content=\"table\" img-format=\"tif\" wi=\"39.96mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-71</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00800\" num=\"00800\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00800.TIF\" he=\"22.10mm\" id=\"EMI-C00800\" img-content=\"table\" img-format=\"tif\" wi=\"39.37mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-72</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00801\" num=\"00801\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00801.TIF\" he=\"22.01mm\" id=\"EMI-C00801\" img-content=\"table\" img-format=\"tif\" wi=\"39.37mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2629\" num=\"2641\">\n",
       "<tables id=\"TABLE-US-00011\" num=\"00011\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"21pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"175pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry nameend=\"2\" namest=\"offset\" rowsep=\"1\">TABLE 11</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>R<sup>7 </sup>or R<sup>7a</sup></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-73</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00802\" num=\"00802\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00802.TIF\" he=\"22.10mm\" id=\"EMI-C00802\" img-content=\"table\" img-format=\"tif\" wi=\"39.37mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-74</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00803\" num=\"00803\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00803.TIF\" he=\"22.10mm\" id=\"EMI-C00803\" img-content=\"table\" img-format=\"tif\" wi=\"39.96mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-75</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00804\" num=\"00804\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00804.TIF\" he=\"22.10mm\" id=\"EMI-C00804\" img-content=\"table\" img-format=\"tif\" wi=\"39.37mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-76</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00805\" num=\"00805\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00805.TIF\" he=\"24.38mm\" id=\"EMI-C00805\" img-content=\"table\" img-format=\"tif\" wi=\"34.80mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry> </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>R7-77</entry>\n",
       "<entry><chemistry id=\"CHEM-US-00806\" num=\"00806\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00806.TIF\" he=\"22.10mm\" id=\"EMI-C00806\" img-content=\"table\" img-format=\"tif\" wi=\"39.37mm\"/>\n",
       "</chemistry>\n",
       "</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"2\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2630\" num=\"2642\">As Reference Examples, a method for synthesizing intermediates useful for carrying out the present application is shown below.</p>\n",
       "<heading id=\"h-1317\" level=\"1\">Reference Example 1</heading>\n",
       "<p id=\"p-2631\" num=\"2643\"><chemistry id=\"CHEM-US-00807\" num=\"00807\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00807.TIF\" he=\"92.71mm\" id=\"EMI-C00807\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1318\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2632\" num=\"2644\">A solution of benzyl alcohol (1.00 g, 9.25 mmol) in THF (3 ml) was added to a suspension of sodium tert-pentoxide (2.55 g, 23.2 mmol) in THF (4 ml) at room temperature under nitrogen atmosphere, and the mixture was stirred at 40° C. for 2 hours. This reaction solution was cooled in an ice bath, and a solution of compound 1a (1.53 g, 10.2 mmol) in THF (3 ml) was added dropwise at 0 to 10° C. After the reaction solution was stirred at room temperature for 2 hours, 2 N hydrochloric acid (15 ml) was added, followed by extraction with ethyl acetate two times. The combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography (n-hexane-ethyl acetate 4:1, v/v) to obtain 1.89 g (yield 92%) of compound 1b as an oil product.</p>\n",
       "<p id=\"p-2633\" num=\"2645\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.56 (2H, s), 3.71 (3H, s), 4.14 (2H, s), 4.59 (2H, s), 7.27-7.42 (5H, m).</p>\n",
       "<heading id=\"h-1319\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2634\" num=\"2646\">Compound 1b (1.80 g, 8.1 mmol) was dissolved in 1,4-dioxane (18 mL), N,N-dimethylformamide dimethyl acetal (1.45 g, 12.2 mmol) was added, and the mixture was stirred at room temperature for 6 hours. The reaction solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 1:4, v/v) to obtain 1.77 g (yield 79%) of compound 1c as an oil product.</p>\n",
       "<p id=\"p-2635\" num=\"2647\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 2.90 (3H, br), 3.25 (3H, br), 3.69 (3H, s), 4.45 (2H, s), 4.59 (2H, s), 7.24-7.40 (5H, m), 7.73 (s, 1H).</p>\n",
       "<heading id=\"h-1320\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2636\" num=\"2648\">Sodium tert-butoxide (2.55 g, 23.2 mmol), dimethyl oxalate (639 mg, 5.41 mmol) and DMI (3 ml) were added to a three-neck flask under nitrogen atmosphere, and a solution of compound 1c (0.50 g, 1.80 mmol) in DMI (2 ml) was added dropwise thereto at 25 to 30° C. After stirring at room temperature for 7 hours, 2N hydrochloric acid (10 ml) was added, and the mixture was stirred at room temperature for 15 hours. The reaction solution was extracted with ethyl acetate two times, and the combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 2:1 to 1:1, v/v) to obtain 488 mg (yield 85%) of compound 1d as a white crystal.</p>\n",
       "<p id=\"p-2637\" num=\"2649\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 3.89 (3H, s), 3.93 (3H, s), 5.34 (2H, s), 7.32-7.40 (3H, m), 7.45-7.49 (2H, m), 8.50 (1H, s).</p>\n",
       "<heading id=\"h-1321\" level=\"1\">Reference Example 2</heading>\n",
       "<p id=\"p-2638\" num=\"2650\"><chemistry id=\"CHEM-US-00808\" num=\"00808\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00808.TIF\" he=\"92.71mm\" id=\"EMI-C00808\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1322\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2639\" num=\"2651\">A solution of benzyl alcohol (0.66 g, 6.1 mmol) in DMI (3 ml) was added to a suspension of sodium tert-pentoxide (1.67 g, 15.2 mmol) in DMI (4 ml) at room temperature under nitrogen atmosphere, and the mixture was stirred at 40° C. for 2 hours. This reaction solution was cooled in an ice bath, and a solution of compound 2a (1.10 g, 6.68 mmol) in DMI (3 ml) was added dropwise at 0 to 10° C. The reaction solution was stirred at 0 to 5° C. for 2 hours, and at room temperature for 3 hours, and 2N hydrochloric acid (15 ml) was added, followed by extraction with ethyl acetate two times. The combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting oil product was purified by silica gel column chromatography (n-hexane-ethyl acetate 4:1, v/v) to obtain 1.29 g (yield 90%) of compound 2b as an oil product.</p>\n",
       "<p id=\"p-2640\" num=\"2652\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.25 (3H, t, J=7.2 Hz), 3.54 (2H, s), 4.14 (2H, s), 4.17 (2H, q, J=7.2 Hz), 4.59 (2H, s), 7.28-7.40 (5H, m).</p>\n",
       "<heading id=\"h-1323\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2641\" num=\"2653\">Compound 2b (9.73 g, 41.2 mmol) was dissolved in toluene (45 ml), N,N-dimethylformamide dimethyl acetal (7.36 g, 61.8 mmol) was added, and the mixture was stirred at room temperature for 5 hours. Water was added to the reaction solution, followed by extraction with ethyl acetate two times. The combined extracts were washed sequentially with water, and saturated sodium chloride water, and then dried with anhydrous magnesium sulfate. The solvent was distilled off, and the resulting oil product was purified by silica gel column chromatography (n-hexane-ethyl acetate 1:1 to 3:7, v/v) to obtain 7.90 g (yield 66%) of compound 2c as an oil product.</p>\n",
       "<p id=\"p-2642\" num=\"2654\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.25 (3H, t, J=7.2 Hz), 2.95 (3H, br), 3.22 (3H, br), 4.15 (2H, q, J=7.2 Hz), 4.45 (2H, s), 4.59 (2H, s), 7.22-7.40 (5H, m), 7.73 (1H, s).</p>\n",
       "<heading id=\"h-1324\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2643\" num=\"2655\">Sodium tert-butoxide (495 mg, 5.15 mmol) and DMI (2 ml) were added to a three-neck flask under nitrogen atmosphere, and dimethyl oxalate (608 mg, 5.15 mmol) and a solution of compound 2c (0.50 g, 1.72 mmol) in DMI (3 ml) was added dropwise at 25 to 30° C. After stirring at room temperature for 4 hours, 2N hydrochloric acid (10 ml) was added, and the mixture was stirred at room temperature for 15 hours. The reaction solution was extracted with toluene two times, and the combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 2:1, v/v) to obtain 420 mg (yield 74%) of compound 2d as a white crystal.</p>\n",
       "<p id=\"p-2644\" num=\"2656\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.39 (3H, t, J=7.2 Hz), 3.88 (3H, s), 4.39 (2H, q, J=7.2 Hz), 5.34 (2H, s), 7.30-7.41 (3H, m), 7.45-7.50 (2H, m), 8.48 (1H, s).</p>\n",
       "<heading id=\"h-1325\" level=\"1\">Reference Example 3</heading>\n",
       "<p id=\"p-2645\" num=\"2657\"><chemistry id=\"CHEM-US-00809\" num=\"00809\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00809.TIF\" he=\"114.64mm\" id=\"EMI-C00809\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1326\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2646\" num=\"2658\">N,N-dimethylformamide dimethyl acetal (4.9 ml, 36.5 mmol) was added dropwise to compound 3a (5.0 g, 30.4 mmol) at 0° C. under cooling. After stirring at 0° C. for 1 hour, 100 ml of ethyl acetate was added to the reaction solution, followed by washing with 0.5N hydrochloric acid (50 ml). The aqueous layer was separated, and extracted with ethyl acetate (50 ml). The organic layers were combined, washed sequentially with saturated sodium bicarbonate water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 1:1 (v/v)→ethyl acetate) to obtain 4.49 g (yield 67%) of compound 3b as an oil product.</p>\n",
       "<p id=\"p-2647\" num=\"2659\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.32 (3H, t, J=7.1 Hz), 2.90 (3H, br s), 3.29 (3H, br s), 4.23 (2H, q, J=7.1 Hz), 4.54 (2H, s), 7.81 (1H, s).</p>\n",
       "<heading id=\"h-1327\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2648\" num=\"2660\">Lithium hexamethyldisilazide (1.0 M toluene solution, 49 ml, 49.0 mmol) was diluted with tetrahydrofuran (44 ml), a solution of compound 3b (4.49 g, 20.4 mmol) in tetrahydrofuran (10 ml) was added dropwise thereto at −78° C. under cooling, and a solution of ethyl oxalyl chloride (3.35 g, 24.5 mmol) in tetrahydrofuran (10 ml) was added dropwise. After stirring at −78° C. for 2 hours, temperature was raised to 0° C. After 2N hydrochloric acid was added to the reaction solution, and the mixture was stirred for 20 minutes, the solution was extracted with ethyl acetate (200 ml×2), and the organic layer was washed with saturated sodium bicarbonate water and saturated sodium chloride water and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 7:3→5:5→0:10 (v/v)) to obtain 1.77 g (yield 31%) of compound 3c as a white solid.</p>\n",
       "<p id=\"p-2649\" num=\"2661\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.36-1.46 (6H, m), 4.35-4.52 (8H, m), 8.53 (1H, s).</p>\n",
       "<heading id=\"h-1328\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2650\" num=\"2662\">Aminoacetaldehyde dimethyl acetal (0.13 ml, 1.20 mmol) was added to a solution of compound 3c (300 mg, 1.09 mmol) in ethanol (6 ml) at 0° C., and the mixture was stirred at 0° C. for 1 hour and 30 minutes, at room temperature for 18 hours and, then, at 60° C. for 4 hours. After the solvent was distilled off from the reaction solvent under reduced pressure, the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 5:5→0:10 (v/v)) to obtain 252 mg (yield 64%) of compound 3d as an oil product.</p>\n",
       "<p id=\"p-2651\" num=\"2663\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.36-1.47 (6H, m), 3.42 (6H, s), 3.90 (2H, d, J=5.2 Hz), 4.37 (3H, q, J=7.2 Hz), 4.50 (2H, q, J=7.2 Hz), 8.16 (1H, s).</p>\n",
       "<heading id=\"h-1329\" level=\"1\">Reference Example 4</heading>\n",
       "<p id=\"p-2652\" num=\"2664\"><chemistry id=\"CHEM-US-00810\" num=\"00810\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00810.TIF\" he=\"164.25mm\" id=\"EMI-C00810\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1330\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2653\" num=\"2665\">N,N-dimethylformamide dimethyl acetal (12.2 ml, 92.2 mmol) was added dropwise to compound 4a (10.0 g, 76.8 mmol) at 0° C. under cooling. After stirring at 0° C. for 1 hour and 30 minutes and, then, at room temperature for 2 hours and 30 minutes, 100 ml of ethyl acetate was added to the reaction solution, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 5:5→0:10 (v/v)) to obtain 12.45 g (yield 88%) of compound 4b as an oil product.</p>\n",
       "<p id=\"p-2654\" num=\"2666\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.32 (3H, t, J=7.1 Hz), 2.33 (3H, s), 3.04 (6H, br s), 4.23 (2H, q, J=7.2 Hz), 7.68 (1H, s).</p>\n",
       "<heading id=\"h-1331\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2655\" num=\"2667\">Lithium hexamethyldisilazide (1.0M toluene solution, 24 ml, 24.0 mmol) was diluted with tetrahydrofuran (20 ml), a solution of compound 4b (1.85 g, 10.0 mmol) in tetrahydrofuran (5 ml) was added dropwise thereto at −78° C. under cooling, and a solution of ethyl oxalyl chloride (1.34 ml, 12.0 mmol) in tetrahydrofuran (5 ml) was added dropwise. After stirring at −78° C. for 2 hours, 2N-hydrochloric acid was added to the reaction solution, and the mixture was stirred at room temperature for 20 minutes. The solution was extracted with ethyl acetate, and the organic layer was washed sequentially with saturated sodium bicarbonate water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 75:25→455:5 (v/v)) to obtain 1.03 g (yield 43%) of compound 4c as a brown oil product.</p>\n",
       "<p id=\"p-2656\" num=\"2668\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.38 (3H, t, J=7.1 Hz), 1.42 (3H, t, J=7.4 Hz), 4.33-4.47 (4H, m), 7.19 (1H, s), 8.54 (1H, s).</p>\n",
       "<heading id=\"h-1332\" level=\"1\">Third Step</heading>\n",
       "<p id=\"p-2657\" num=\"2669\">Aminoacetaldehyde dimethyl acetal (0.34 ml, 3.11 mmol) was added to a solution of compound 4c (680 mg, 2.83 mmol) in ethanol (6.8 ml) at 0° C., and it was allowed to stand at room temperature for 16 hours. After the solvent was distilled off from the reaction solution under reduced pressure, the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 90:10 (v/v)) to obtain 875 mg (yield 94%) of compound 4d as an oil product.</p>\n",
       "<p id=\"p-2658\" num=\"2670\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.38 (3H, t, J=7.1 Hz), 1.39 (3H, t, J=7.1 Hz), 3.40 (6H, s), 4.33 (2H, d, J=4.7 Hz), 4.37 (4H, q, J=7.1 Hz), 4.49 (1H, t, J=4.7 Hz), 7.06 (1H, s), 8.17 (1H, s).</p>\n",
       "<heading id=\"h-1333\" level=\"1\">Fourth Step</heading>\n",
       "<p id=\"p-2659\" num=\"2671\">N-bromosuccinimide (1.46 g, 8.18 mmol) was added to a solution of compound 4d (2.68 g, 8.18 mmol) in N,N-dimethylformamide (10 ml), and the mixture was stirred at room temperature for 48 hours. After saturated sodium bicarbonate water was added to the reaction solution, the solution was extracted with ethyl acetate, and the organic layer was washed sequentially with water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 90:10 (v/v)) to obtain 2.83 g (yield 85%) of compound 4e as an oil product.</p>\n",
       "<p id=\"p-2660\" num=\"2672\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.41 (3H, t, J=7.1 Hz), 1.48 (3H, t, J=7.1 Hz), 3.42 (6H, s), 3.90 (2H, d, J=5.0 Hz), 4.39 (2H, q, J=7.1 Hz), 4.53 (3H, q, J=14.3 Hz), 4.54 (3H, s), 4.57 (3H, t, J=5.4 Hz), 8.19 (1H, s).</p>\n",
       "<heading id=\"h-1334\" level=\"1\">Reference Example 5</heading>\n",
       "<p id=\"p-2661\" num=\"2673\"><chemistry id=\"CHEM-US-00811\" num=\"00811\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00811.TIF\" he=\"78.91mm\" id=\"EMI-C00811\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1335\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2662\" num=\"2674\">Compound 5a (598 mg, 4.09 mmol) and N,N-dimethylformamide dimethyl acetal (488 mg, 4.09 mmol) were dissolved in toluene (1 ml), and the mixture was stirred at room temperature for 11 hours. The solvent was distilled off from the reaction solution under reduced pressure, and the resulting residue (containing compound 5b) was used in Second step without purification.</p>\n",
       "<heading id=\"h-1336\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2663\" num=\"2675\">Sodium tert-butoxide (400 mg, 4.16 mmol) was suspended in dimethyl imidazolidinone (5 ml), a solution of the crude product obtained in First step in dimethylimidazolidinone (5 ml) was added thereto, a solution of dimethyl oxalate (983 mg, 8.32 mmol) in THF (10 ml) was added dropwise, and the mixture was stirred at room temperature for 45 minutes. The reaction solution was poured into 2N hydrochloric acid-methanol (20 ml), and the mixture was stirred at 0° C. for 20 minutes. Water was added, the solution was extracted with ethyl acetate, and the organic layer was washed sequentially with water, saturated sodium bicarbonate water, and saturated sodium chloride water, and dried with anhydrous sodium sulfate. After the solvent was distilled off, the resulting residue was purified by silica gel column chromatography to obtain 222 mg (yield: 22% from 5a) of compound 5c.</p>\n",
       "<heading id=\"h-1337\" level=\"1\">Reference Example 6</heading>\n",
       "<p id=\"p-2664\" num=\"2676\"><chemistry id=\"CHEM-US-00812\" num=\"00812\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00812.TIF\" he=\"104.56mm\" id=\"EMI-C00812\" img-content=\"chem\" img-format=\"tif\" wi=\"76.20mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1338\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2665\" num=\"2677\">Lithium hexamethyldisilazide (1.0M toluene solution, 12 ml, 12.0 mmol) was diluted with tetrahydrofuran (11 ml), a solution of compound 6a (1.46 g, 5.0 mmol) in tetrahydrofuran (2 ml) was added dropwise thereto at −78° C. under cooling, and a solution of ethyl oxalyl chloride (0.67 ml, 6.0 mmol) in tetrahydrofuran (2 ml) was added dropwise. After stirring at −78° C. for 2 hours, ammonium acetate (500 mg) and acetic acid (10 ml) were added to the reaction solution, and the mixture was stirred at 65° C. for 1 hour and 30 minutes. Water was added to the reaction solution, the solvent was extracted with ethyl acetate, and the organic layer was washed sequentially with water, and saturated sodium bicarbonate water, and dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (N-hexane-ethyl acetate 55:45→45:55 (v/v)) to obtain 505.1 mg of compound 6B as a yellow solid. It was washed with isopropyl ether-hexane (1:2), and dried under reduced pressure to obtain 416.8 mg (yield 24%) of Compound 6b as a yellow crystal.</p>\n",
       "<p id=\"p-2666\" num=\"2678\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.35 (3H, t, J=7.1 Hz), 1.46 (3H, t, J=7.1 Hz), 4.40 (2H, q, J=7.2 Hz), 4.50 (2H, q, J=7.1 Hz), 5.20 (2H, s), 7.33-7.41 (3H, m), 7.49-7.52 (2H, m), 8.76 (1H, s), 11.61 (1H, br s).</p>\n",
       "<heading id=\"h-1339\" level=\"1\">Second Step</heading>\n",
       "<p id=\"p-2667\" num=\"2679\">Cesium carbonate (73.3 mg, 0.23 mmol) and bromoacetaldehyde dimethyl acetal (38.0 mg, 0.23 mmol) were added to a solution of compound 6b (51.8 mg, 0.15 mmol) in N,N-dimethylformamide (1 ml), and the mixture was stirred at room temperature overnight. Cesium carbonate (73.3 mg, 0.23 mmol) and bromoacetaldehyde dimethyl acetal (38.0 mg, 0.23 mmol) were further added, and the mixture was further stirred at 100° C. for 20 minutes. After water was added to the reaction solution, the solution was extracted with ethyl acetate, and the organic layer was washed sequentially with water and saturated sodium chloride water, and dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 50:50→30:70 (v/v)) to obtain 35.3 mg (yield 54%) of compound 6c as a colorless oil product.</p>\n",
       "<p id=\"p-2668\" num=\"2680\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 1.26 (3H, t, J=7.1 Hz), 1.40 (3H, t, J=7.1 Hz), 3.39 (6H, s), 3.91 (2H, d, J=5.0 Hz), 4.29 (2H, q, J=7.1 Hz), 4.40 (2H, q, J=7.2 Hz), 4.50 (1H, t, J=5.0 Hz), 5.30 (2H, s), 7.31-7.37 (3H, m), 7.43-7.46 (2H, m), 8.12 (1H, s).</p>\n",
       "<heading id=\"h-1340\" level=\"1\">Reference Example 7</heading>\n",
       "<p id=\"p-2669\" num=\"2681\"><chemistry id=\"CHEM-US-00813\" num=\"00813\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00813.TIF\" he=\"43.18mm\" id=\"EMI-C00813\" img-content=\"chem\" img-format=\"tif\" wi=\"75.01mm\"/>\n",
       "</chemistry>\n",
       "</p>\n",
       "<heading id=\"h-1341\" level=\"1\">First Step</heading>\n",
       "<p id=\"p-2670\" num=\"2682\">Aminoacetaldehyde dimethyl acetal (7.80 mmol) was added to a solution of compound 7a (900 mg, 2.60 mmol) in ethanol (5 ml), and the mixture was stirred at room temperature for 22 hours. Ethyl acetate (5 ml) and water (5 ml) were added to the reaction solution, followed by extraction with ethyl acetate (5 ml). After the organic layer was washed with water (10 ml), the solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 2:1) to obtain 0.37 g (yield 33%) of compound 7b as a colorless oil product.</p>\n",
       "<p id=\"p-2671\" num=\"2683\"><sup>1</sup>H-NMR (CDCl<sub>3</sub>) δ: 7.90 (1H, s), 7.45-7.43 (5H, m), 5.30 (2H, s), 4.51 (1H, t, J=5.1 Hz), 4.40 (2H, q, J=7.1 Hz), 4.30 (2H, q, J=7.1 Hz), 3.91 (2H, d, J=5.1 Hz), 3.46 (6H, s), 1.40 (3H, t, J=7.1 Hz), 1.26 (3H, t, J=7.1 Hz).</p>\n",
       "<p id=\"p-2672\" num=\"2684\">The compounds in connection with the present invention are useful for symptoms and/or diseases which are induced by influenza virus. For example, they are useful for treating and/or preventing, or improving symptoms of, cold-like symptoms accompanying fever, algor, headache, muscular pain, general malaise etc., airway inflammation symptoms such as pharyngalgia, nasal secretion, nasal congestion, cough, sputum etc., gastrointestinal symptoms such as abdominal pain, vomitus, diarrhea etc. and, further, complications accompanying secondary infection such as acute encephalopathy and pneumonia.</p>\n",
       "<p id=\"p-2673\" num=\"2685\">Since the compounds in connection with the present invention have the effects such as inhibitory activity on high cap structure-dependent endonuclease, and high selectivity due to a virus-specific enzyme, they can be medicaments having reduced side effects. Further, since the compounds in connection with the present invention have advantages that metabolism stability is high, solubility is high, oral absorbability is high, good bioavailability is exhibited, good clearance is exhibited, pulmonary transitivity is high, a half life is long, a non-protein binding rate is high, hERG channel inhibition is low, CYP inhibition is low, CPE (CytoPathic Effect) inhibiting effect is recognized, and/or negativity is exhibited in a phototoxicity test, an Ames test and a gene toxicity test, they can be excellent medicaments.</p>\n",
       "<p id=\"p-2674\" num=\"2686\">The compounds in connection with the present invention can be administered orally or parenterally. In the case of oral administration, the present compounds can be also used as a normal preparation, for example, as any dosage form of solid preparations such as tablets, powders, granules, capsules etc.; solutions; oleaginous suspensions; or liquid preparations such as syrups or elixirs etc. In the case of parenteral administration, the compounds in connection with the present invention can be used as aqueous or oleaginous suspension injectables, or nose drops. Upon preparation of them, conventional excipients, binders, lubricants, aqueous solvents, oleaginous solvents, emulsifiers, suspending agents, preservatives, stabilizers etc. can be arbitrarily used. The pharmaceutical composition of the present invention can be produced by combining (for example, mixing) a therapeutically effective amount of the present compound with pharmaceutically acceptable carriers or diluents.</p>\n",
       "<p id=\"p-2675\" num=\"2687\">A dose of the compounds in connection with the present invention is different depending on an administration method, an age, a weight and the state of a patient, and a kind of a disease and, usually, in the case of oral administration, about 0.05 mg to 3000 mg, preferably about 0.1 mg to 1000 mg per adult a day may be administered, if necessary, by division. In addition, in the case of parenteral administration, about 0.01 mg to 1000 mg, preferably about 0.05 mg to 500 mg per adult a day is administered.</p>\n",
       "<heading id=\"h-1342\" level=\"1\">Test Example 1</heading>\n",
       "<heading id=\"h-1343\" level=\"1\">Measurement of Cap-Dependant Endonuclease (CEN) Inhibitory Activity</heading>\n",
       "<p id=\"h-1344\" num=\"0000\">1) Preparation of Substrate</p>\n",
       "<p id=\"p-2676\" num=\"2688\">30merRNA(5′-pp-[m2′-O]GAA UAU(-Cy3) GCA UCA CUA GUA AGC UUU GCU CUA-BHQ2-3′: manufactured by Japan Bioservice) in which G at a 5′ end is diphosphate-modified, a hydroxy group at 2′ position is methoxylation-modified, U sixth from a 5′ end is labelled with Cy3, and a 3′ end is labelled with BHQ2 was purchased, and a cap structure was added using ScriptCap system manufactured by EPICENTRE (a product was m7G [5′]-ppp-[5′] [m2′-O]GAA UAU(-Cy3) GCA UCA CUA GUA AGC UUU GCU CUA(-BHQ2)-3′). This was separated and purified by denatured polyacrylamide gel electrophoresis, and used as a substrate.</p>\n",
       "<p id=\"h-1345\" num=\"0000\">2) Preparation of Enzyme</p>\n",
       "<p id=\"p-2677\" num=\"2689\">RNP was prepared from a virus particle using standard method (Reference Document: VIROLOGY (1976) 73, p 327-338 OLGA M. ROCHOVANSKY). Specifically, A/WSN/33 virus (1×10<sup>3 </sup>PFU/mL, 200 μL) was innoculated in a 10 days old embryonated chicken egg. After incubation at 37° C. for 2 days, the allantoic fluid of the chicken egg was recovered. A virus particle was purified by ultracentrifugation using 20% sucrose, solubilized using TritonX-100 and lysolecithin, and an RNP fraction (50-70% glycerol fraction) was collected by ultracentrifugation using a 30-70% glycerol density gradient, and was used as an enzyme solution (containing approximately 1 nM PB1•PB2•PA complex).</p>\n",
       "<p id=\"h-1346\" num=\"0000\">3) Enzymatic Reaction</p>\n",
       "<p id=\"p-2678\" num=\"2690\">An enzymatic reaction solution (2.5 μL) (composition: 53 mM Tris-hydrochloride (pH 7.8), 1 mM MgCl<sub>2</sub>, 1.25 mM dithiothreitol, 80 mM NaCl, 12.5% glycerol, enzyme solution 0.15 μL) was dispensed into a 384-well plate made of polypropylene. Then, 0.5 μL of a test substance solution which had been serially diluted with dimethyl sulfoxide (DMSO) was added to the plate. As a positive control (PC) or a negative control (NC), 0.5 μL of DMSO was added to the plate respectively. Each plate was mixed well. Then, 2 μL of a substrate solution (1.4 nM substrate RNA, 0.05% Tween20) was added to initiate a reaction. After room temperature incubation for 60 minutes, 1 μL of the reaction solution was collected and added to 10 μL of a Hi-Di formamide solution (containing GeneScan 120 Liz Size Standard as a sizing marker: manufactured by Applied Biosystem (ABI)) in order to stop the reaction. For NC, the reaction was stopped in advance by adding EDTA (4.5 mM) before initiation of the reaction (all concentrations described above are final concentrations).</p>\n",
       "<p id=\"h-1347\" num=\"0000\">3) Measurement of Inhibition Ratio (IC<sub>50 </sub>Value)</p>\n",
       "<p id=\"p-2679\" num=\"2691\">The solution for which the reaction was stopped was heated at 85° C. for 5 minutes, rapidly cooled on ice for 2 minutes, and analyzed with an ABI PRIZM 3730 genetic analyzer. A peak of the cap-dependent endonuclease product was quantitated by analysis software ABI Genemapper, a CEN reaction inhibition ratio (%) of a test compound was obtained by setting fluorescent intensities of PC and NC to be 0% inhibition and 100% inhibition, respectively, an IC<sub>50 </sub>value was obtained using curve fitting software (XLfit2.0: Model 205 (manufactured IDBS etc.)). The IC<sub>50 </sub>values of test substances are shown in Table 12-21.</p>\n",
       "<heading id=\"h-1348\" level=\"1\">Test Example 2</heading>\n",
       "<heading id=\"h-1349\" level=\"1\">CYP Inhibition Test</heading>\n",
       "<p id=\"p-2680\" num=\"2692\">Using commercially available pooled human hepatic microsome, and employing, as markers, 7-ethoxyresorufin O-deethylation (CYP1A2), tolbutamide methyl-hydroxylation (CYP2C9), mephenyloin 4′-hydroxylation (CYP2C19), dextromethorphan O-demethylation (CYP2D6), and terfenedine hydroxylation as typical substrate metabolism reactions of human main five CYP enzyme forms (CYP1A2, 2C9, 2C19, 2D6, 3A4), an inhibitory degree of each metabolite production amount by a test compound was assessed.</p>\n",
       "<p id=\"p-2681\" num=\"2693\">The reaction conditions were as follows: substrate, 0.5 μmol/L ethoxyresorufin (CYP1A2), 100 μmol/L tolbutamide (CYP2C9), 50 μmol/L S-mephenitoin (CYP2C19), 5 μmol/L dextromethorphan (CYP2D6), 1 μmol/L terfenedine (CYP3A4); reaction time, 15 minutes; reaction temperature, 37° C.; enzyme, pooled human hepatic microsome 0.2 mg protein/mL; test drug concentration, 1, 5, 10, 20 μmol/L (four points).</p>\n",
       "<p id=\"p-2682\" num=\"2694\">Each five kinds of substrates, human hepatic microsome, or a test drug in 50 mM Hepes buffer as a reaction solution was added to a 96-well plate at the composition as described above, NADPH, as a cofactor was added to initiate metabolism reactions as markers and, after the incubation at 37° C. for 15 minutes, a methanol/acetonitrile=1/1 (v/v) solution was added to stop the reaction. After the centrifugation at 3000 rpm for 15 minutes, resorufin (CYP1A2 metabolite) in the supernatant was quantified by a fluorescent multilabel counter and tributamide hydroxide (CYP2CP metabolite), mephenyloin 4′ hydroxide (CYP2C19 metabolite), dextromethorphan (CYP2D6 metabolite), and terfenadine alcohol (CYP3A4 metabolite) were quantified by LC/MS/MS.</p>\n",
       "<p id=\"p-2683\" num=\"2695\">Addition of only DMSO being a solvent dissolving a drug to a reaction system was adopted as a control (100%), remaining activity (%) was calculated at each concentration of a test drug added as the solution and IC<sub>50 </sub>was calculated by reverse presumption by a logistic model using a concentration and an inhibition rate.</p>\n",
       "<heading id=\"h-1350\" level=\"1\">Test Example 3</heading>\n",
       "<heading id=\"h-1351\" level=\"1\">Solubility Test</heading>\n",
       "<p id=\"p-2684\" num=\"2696\">The solubility of each compound is determined under 1% DMSO addition conditions. A 10 mM solution of the compound is prepared with DMSO, and 6 μL of the compound solution is added to 594 μL of an artificial intestinal juice (water and 118 mL of 0.2 mol/L NaOH reagent are added to 250 mL of 0.2 mol/L potassium dihydrogen phosphate reagent to reach 1000 mL) with pH of 6.8. The mixture is left standing for 16 hours at 25° C., and the mixture is vacuum-filtered. The filtrate is two-fold diluted with methanol/water=1/1, and the compound concentration in the filtrate is measured with HPLC or LC/MS/MS by the absolute calibration method.</p>\n",
       "<heading id=\"h-1352\" level=\"1\">Test Example 4</heading>\n",
       "<heading id=\"h-1353\" level=\"1\">Metabolism Stability Test</heading>\n",
       "<p id=\"p-2685\" num=\"2697\">Using a commercially available pooled human hepatic microsomes, a test compound was reacted for a constant time, a remaining rate was calculated by comparing a reacted sample and an unreacted sample, thereby, a degree of metabolism in liver was assessed.</p>\n",
       "<p id=\"p-2686\" num=\"2698\">A reaction was performed (oxidative reaction) at 37° C. for 0 minute or 30 minutes in the presence of 1 mmol/L NADPH in 0.2 mL of a buffer (50 mmol/L Tris-HCl pH 7.4, 150 mmol/L potassium chloride, 10 mmol/L magnesium chloride) containing 0.5 mg protein/mL of human liver microsomes. After the reaction, 50 μL of the reaction solution was added to 100 μL of a methanol/acetonitrile=1/1 (v/v), mixed and centrifuged at 3000 rpm for 15 minutes. The test compound in the supernatant was quantified by LC/MS/MS, and a remaining amount of the test compound after the reaction was calculated, letting a compound amount at 0 minute reaction time to be 100%. Hydrolysis reaction was performed in the absence of NADPH and glucuronidation reaction was in the presence of 5 mM UDP-glucuronic acid in place of NADPH, followed by similar operations.</p>\n",
       "<heading id=\"h-1354\" level=\"1\">Test Example 5</heading>\n",
       "<heading id=\"h-1355\" level=\"1\">hERG Test</heading>\n",
       "<p id=\"p-2687\" num=\"2699\">For the purpose of assessing risk of an electrocardiogram QT interval prolongation, effects on delayed rectifier K+ current (I<sub>Kr</sub>), which plays an important role in the ventricular repolarization process, was studied using HEK293 cells expressing human ether-a-go-go related gene (hERG) channel.</p>\n",
       "<p id=\"p-2688\" num=\"2700\">After a cell was retained at a membrane potential of −80 mV by whole cell patch clamp method using an automated patch clamp system (PatchXpress 7000A, Axon Instruments Inc.), I<sub>Kr </sub>induced by depolarization pulse stimulation at +40 mV for 2 seconds and, further, repolarization pulse stimulation at −50 mV for 2 seconds was recorded. After the generated current was stabilized, extracellular solution (NaCl: 135 mmol/L, KCl: 5.4 mmol/L, NaH<sub>2</sub>PO<sub>4</sub>: 0.3 mmol/L, CaCl<sub>2</sub>. 2H<sub>2</sub>O: 1.8 mmol/L, MgCl<sub>2</sub>.6H<sub>2</sub>O: 1 mmol/L, glucose: 10 mmol/L, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid): 10 mmol/L, pH=7.4) in which the test compound had been dissolved at an objective concentration was applied to the cell under the room temperature condition for 10 minutes. From the recording I<sub>Kr</sub>, an absolute value of the tail peak current was measured based on the current value at the resting membrane potential using an analysis software (DataXpress ver. 1, Molecular Devices Corporation). Further, the % inhibition relative to the tail peak current before application of the test substance was calculated, and compared with the vehicle-applied group (0.1% dimethyl sulfoxide solution) to assess influence of the test substance on I<sub>Kr</sub>.</p>\n",
       "<heading id=\"h-1356\" level=\"1\">Test Example 6</heading>\n",
       "<heading id=\"h-1357\" level=\"1\">CPE Inhibitory Effect Confirming Assay</heading>\n",
       "<p id=\"h-1358\" num=\"0000\">&lt;Material&gt;</p>\n",
       "<p id=\"h-1359\" num=\"0000\">2% FCS E-MEM (prepared by adding kanamycin and FCS to MEM (Minimum Essential Medium) (Invitrogen))</p>\n",
       "<p id=\"h-1360\" num=\"0000\">0.5% BSA E-MEM (prepared by adding kanamycin and BSA to MEM (Minimum Essential Medium) (Invitrogen))</p>\n",
       "<p id=\"h-1361\" num=\"0000\">HB (Hanks' Balanced Salt Solution)</p>\n",
       "<p id=\"h-1362\" num=\"0000\">MDBK Cell</p>\n",
       "<p id=\"p-2689\" num=\"2701\">Cells were adjusted to the appropriate cell number (3×10<sup>5</sup>/mL) with 2% FCS E-MEM.</p>\n",
       "<p id=\"h-1363\" num=\"0000\">MDCK Cell</p>\n",
       "<p id=\"p-2690\" num=\"2702\">After washing with HBSS two times, cells were adjusted to the appropriate cell number (5×10<sup>5</sup>/mL) with 0.5% BSA E-MEM.</p>\n",
       "<p id=\"h-1364\" num=\"0000\">Trypsin Solution</p>\n",
       "<p id=\"p-2691\" num=\"2703\">Trypsin from porcine pancreas (SIGMA) was dissolved in PBS(−), and filtrated with a 0.45 μm filter.</p>\n",
       "<p id=\"h-1365\" num=\"0000\">EnVision (Perkin Elmer)</p>\n",
       "<p id=\"h-1366\" num=\"0000\">WST-8 Kit (Kishida Chemical Co., Ltd.)</p>\n",
       "<p id=\"h-1367\" num=\"0000\">10% SDS solution</p>\n",
       "<p id=\"h-1368\" num=\"0000\">&lt;Operation Procedure&gt;</p>\n",
       "<p id=\"h-1369\" num=\"0000\">Dilution and Dispensation of Test Sample</p>\n",
       "<p id=\"p-2692\" num=\"2704\">As a culture medium, 2% FCS E-MEM was used at the use of MDBK cells, and 0.5% BSA E-MEM was used at the use of MDCK cells. Hereinafter, for diluting virus, cells and a test sample, the same culture medium was used.</p>\n",
       "<p id=\"p-2693\" num=\"2705\">A test sample was diluted with a culture medium to a appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (50 μL/well) was prepared. Two plate, one for measuring anti-Flu activity and the other for measuring cytotoxity, were prepared. Each assay was performed triplicate for each drug.</p>\n",
       "<p id=\"p-2694\" num=\"2706\">At the use of MDCK cells, trypsin was added to the cells to be a final concentration of 3 μg/mL only for measuring anti-Flu activity.</p>\n",
       "<p id=\"h-1370\" num=\"0000\">Dilution and Dispensation of Influenza Virus</p>\n",
       "<p id=\"p-2695\" num=\"2707\">An influenza virus was diluted with a culture medium to a appropriate concentration in advance, and each 50 μL/well was dispensed on a 96-well plate containing a test substance. Each 50 μL/well of a culture medium was dispensed on a plate containing a test substance for measuring cytotoxity.</p>\n",
       "<p id=\"h-1371\" num=\"0000\">Dilution and Dispensation of Cell</p>\n",
       "<p id=\"p-2696\" num=\"2708\">Each 100 μL/well of cells which had been adjusted to the appropriate cell number was dispensed on a 96 well plate containing a test substance. This was mixed with a plate mixer, and incubated in a CO<sub>2 </sub>incubator for 3 days for measuring anti-Flu activity and measuring cytotoxity.</p>\n",
       "<p id=\"h-1372\" num=\"0000\">Dispensation of WST 8</p>\n",
       "<p id=\"p-2697\" num=\"2709\">The cells in 96-well plate which had been incubated for 3 days was observed visually under a microscope, and appearance of the cells, the presence or absence of a crystal of test substance were checked. The supernatant was removed so that the cells were not absorbed from the plate.</p>\n",
       "<p id=\"p-2698\" num=\"2710\">WST-8 Kit was diluted 10-fold with a culture medium, and each 100 μL was dispensed into each well. After mixing with a plate mixer, cells were incubated in a CO<sub>2 </sub>incubator for 1 to 3 hours.</p>\n",
       "<p id=\"p-2699\" num=\"2711\">After incubation, regarding the plate for measuring anti-Flu activity, each 10 μL/well of a 10% SDS solution was dispensed in order to inactivate a virus.</p>\n",
       "<p id=\"h-1373\" num=\"0000\">Measurement of Absorbance</p>\n",
       "<p id=\"p-2700\" num=\"2712\">After the 96-well plate was mixed, absorbance was measured with EnVision at two wavelengths of 450 nm/620 nm.</p>\n",
       "<p id=\"h-1374\" num=\"0000\">&lt;Calculation of Each Measurement Item Value&gt;</p>\n",
       "<p id=\"p-2701\" num=\"2713\">The value was calculated using Microsoft Excel or a program having the equivalent calculation and processing ability, based on the following calculation equation. Calculation of effective concentration to achieve 50% CPE inhibition (EC50)\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?>EC50=10^Z<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "<br/>\n",
       "<?in-line-formulae description=\"In-line Formulae\" end=\"lead\"?><i>Z</i>=(50%−High %)/(High %−Low %)×{ log(High conc.)−log(Low conc.)}+log(High conc.)<?in-line-formulae description=\"In-line Formulae\" end=\"tail\"?>\n",
       "</p>\n",
       "<p id=\"p-2702\" num=\"2714\">IC<sub>50 </sub>values of test substances are shown in Table 12-21.</p>\n",
       "<p id=\"p-2703\" num=\"2715\">\n",
       "<tables id=\"TABLE-US-00012\" num=\"00012\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 12</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"char\" char=\".\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"char\" char=\".\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>2</entry>\n",
       "<entry>0.048</entry>\n",
       "<entry>0.293</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>14</entry>\n",
       "<entry>0.043</entry>\n",
       "<entry>0.313</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>16</entry>\n",
       "<entry>0.065</entry>\n",
       "<entry>0.632</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>26</entry>\n",
       "<entry>0.108</entry>\n",
       "<entry>0.547</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>37</entry>\n",
       "<entry>0.101</entry>\n",
       "<entry>0.318</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>43</entry>\n",
       "<entry>0.078</entry>\n",
       "<entry>1.410</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>48</entry>\n",
       "<entry>0.087</entry>\n",
       "<entry>10.90</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>56</entry>\n",
       "<entry>0.358</entry>\n",
       "<entry>3.860</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>62</entry>\n",
       "<entry>0.110</entry>\n",
       "<entry>1.680</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>63</entry>\n",
       "<entry>0.170</entry>\n",
       "<entry>2.000</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>94</entry>\n",
       "<entry>0.096</entry>\n",
       "<entry>1.470</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>99</entry>\n",
       "<entry>0.341</entry>\n",
       "<entry>2.000</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>108</entry>\n",
       "<entry>0.037</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>128</entry>\n",
       "<entry>0.063</entry>\n",
       "<entry>0.416</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>138</entry>\n",
       "<entry>0.166</entry>\n",
       "<entry>0.100</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>139</entry>\n",
       "<entry>0.189</entry>\n",
       "<entry>0.741</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>143</entry>\n",
       "<entry>0.224</entry>\n",
       "<entry>0.333</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>150</entry>\n",
       "<entry>0.193</entry>\n",
       "<entry>0.553</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>175</entry>\n",
       "<entry>0.132</entry>\n",
       "<entry>0.102</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>178</entry>\n",
       "<entry>0.061</entry>\n",
       "<entry>0.075</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2704\" num=\"2716\">\n",
       "<tables id=\"TABLE-US-00013\" num=\"00013\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 13</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>181</entry>\n",
       "<entry>0.049</entry>\n",
       "<entry>0.349</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>182</entry>\n",
       "<entry>0.099</entry>\n",
       "<entry>0.562</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>183</entry>\n",
       "<entry>0.074</entry>\n",
       "<entry>2.370</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>184</entry>\n",
       "<entry>0.055</entry>\n",
       "<entry>0.403</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>185</entry>\n",
       "<entry>0.132</entry>\n",
       "<entry>1.920</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>186</entry>\n",
       "<entry>0.085</entry>\n",
       "<entry>0.159</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>187</entry>\n",
       "<entry>0.085</entry>\n",
       "<entry>0.282</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>190</entry>\n",
       "<entry>0.143</entry>\n",
       "<entry>2.640</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>191</entry>\n",
       "<entry>0.238</entry>\n",
       "<entry>2.820</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>199</entry>\n",
       "<entry>0.236</entry>\n",
       "<entry>2.720</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>204</entry>\n",
       "<entry>0.299</entry>\n",
       "<entry>2.360</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>224</entry>\n",
       "<entry>0.276</entry>\n",
       "<entry>0.119</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>225</entry>\n",
       "<entry>0.283</entry>\n",
       "<entry>0.663</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>228</entry>\n",
       "<entry>0.243</entry>\n",
       "<entry>0.141</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>230</entry>\n",
       "<entry>0.282</entry>\n",
       "<entry>0.525</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>233</entry>\n",
       "<entry>0.228</entry>\n",
       "<entry>2.240</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>238</entry>\n",
       "<entry>0.101</entry>\n",
       "<entry>0.440</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>240</entry>\n",
       "<entry>0.037</entry>\n",
       "<entry>0.048</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>241</entry>\n",
       "<entry>0.197</entry>\n",
       "<entry>0.063</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>242</entry>\n",
       "<entry>0.114</entry>\n",
       "<entry>0.059</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>243</entry>\n",
       "<entry>0.076</entry>\n",
       "<entry>0.020</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>244</entry>\n",
       "<entry>0.249</entry>\n",
       "<entry>0.108</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>246</entry>\n",
       "<entry>0.082</entry>\n",
       "<entry>0.026</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>247</entry>\n",
       "<entry>0.282</entry>\n",
       "<entry>2.260</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>248</entry>\n",
       "<entry>0.103</entry>\n",
       "<entry>0.489</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>249</entry>\n",
       "<entry>0.151</entry>\n",
       "<entry>1.890</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>250</entry>\n",
       "<entry>0.113</entry>\n",
       "<entry>0.476</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>251</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.157</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>252</entry>\n",
       "<entry>0.107</entry>\n",
       "<entry>0.454</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>253</entry>\n",
       "<entry>0.235</entry>\n",
       "<entry>0.280</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>254</entry>\n",
       "<entry>0.135</entry>\n",
       "<entry>0.564</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>255</entry>\n",
       "<entry>0.052</entry>\n",
       "<entry>0.319</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>256</entry>\n",
       "<entry>0.038</entry>\n",
       "<entry>0.400</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2705\" num=\"2717\">\n",
       "<tables id=\"TABLE-US-00014\" num=\"00014\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 14</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>257</entry>\n",
       "<entry>0.041</entry>\n",
       "<entry>0.055</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>258</entry>\n",
       "<entry>0.042</entry>\n",
       "<entry>0.028</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>259</entry>\n",
       "<entry>0.066</entry>\n",
       "<entry>0.026</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>260</entry>\n",
       "<entry>0.091</entry>\n",
       "<entry>0.065</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>261</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.047</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>262</entry>\n",
       "<entry>0.032</entry>\n",
       "<entry>0.038</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>263</entry>\n",
       "<entry>0.085</entry>\n",
       "<entry>0.075</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>264</entry>\n",
       "<entry>0.064</entry>\n",
       "<entry>0.128</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>265</entry>\n",
       "<entry>0.172</entry>\n",
       "<entry>0.036</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>266</entry>\n",
       "<entry>0.043</entry>\n",
       "<entry>0.085</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>267</entry>\n",
       "<entry>0.029</entry>\n",
       "<entry>0.063</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>268</entry>\n",
       "<entry>0.018</entry>\n",
       "<entry>0.074</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>269</entry>\n",
       "<entry>0.073</entry>\n",
       "<entry>0.417</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>270</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.129</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>271</entry>\n",
       "<entry>0.073</entry>\n",
       "<entry>0.102</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>272</entry>\n",
       "<entry>0.082</entry>\n",
       "<entry>0.030</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>273</entry>\n",
       "<entry>0.016</entry>\n",
       "<entry>0.084</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>274</entry>\n",
       "<entry>0.038</entry>\n",
       "<entry>0.016</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>274</entry>\n",
       "<entry>0.157</entry>\n",
       "<entry>0.056</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>276</entry>\n",
       "<entry>0.053</entry>\n",
       "<entry>0.089</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>277</entry>\n",
       "<entry>0.039</entry>\n",
       "<entry>0.071</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>278</entry>\n",
       "<entry>0.205</entry>\n",
       "<entry>0.074</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>279</entry>\n",
       "<entry>0.056</entry>\n",
       "<entry>0.119</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>280</entry>\n",
       "<entry>0.068</entry>\n",
       "<entry>0.145</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>281</entry>\n",
       "<entry>0.026</entry>\n",
       "<entry>0.018</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>282</entry>\n",
       "<entry>0.036</entry>\n",
       "<entry>0.029</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>283</entry>\n",
       "<entry>0.028</entry>\n",
       "<entry>0.021</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>284</entry>\n",
       "<entry>0.042</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>285</entry>\n",
       "<entry>0.044</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>286</entry>\n",
       "<entry>0.161</entry>\n",
       "<entry>0.121</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>287</entry>\n",
       "<entry>0.154</entry>\n",
       "<entry>0.268</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>288</entry>\n",
       "<entry>0.299</entry>\n",
       "<entry>0.085</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>289</entry>\n",
       "<entry>0.031</entry>\n",
       "<entry>0.419</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2706\" num=\"2718\">\n",
       "<tables id=\"TABLE-US-00015\" num=\"00015\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 15</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>290</entry>\n",
       "<entry>0.067</entry>\n",
       "<entry>0.492</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>292</entry>\n",
       "<entry>0.155</entry>\n",
       "<entry>2.230</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>293</entry>\n",
       "<entry>0.290</entry>\n",
       "<entry>0.437</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>294</entry>\n",
       "<entry>0.035</entry>\n",
       "<entry>0.018</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>295</entry>\n",
       "<entry>0.052</entry>\n",
       "<entry>0.334</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>296</entry>\n",
       "<entry>0.130</entry>\n",
       "<entry>0.397</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>297</entry>\n",
       "<entry>0.045</entry>\n",
       "<entry>0.033</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>298</entry>\n",
       "<entry>0.044</entry>\n",
       "<entry>0.012</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>299</entry>\n",
       "<entry>0.050</entry>\n",
       "<entry>0.015</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>300</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.021</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>301</entry>\n",
       "<entry>0.062</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>302</entry>\n",
       "<entry>0.035</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>304</entry>\n",
       "<entry>0.018</entry>\n",
       "<entry>0.015</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>305</entry>\n",
       "<entry>0.059</entry>\n",
       "<entry>0.103</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>306</entry>\n",
       "<entry>0.076</entry>\n",
       "<entry>0.021</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>307</entry>\n",
       "<entry>0.052</entry>\n",
       "<entry>0.095</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>308</entry>\n",
       "<entry>0.072</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>309</entry>\n",
       "<entry>0.040</entry>\n",
       "<entry>0.013</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>310</entry>\n",
       "<entry>0.108</entry>\n",
       "<entry>0.522</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>311</entry>\n",
       "<entry>0.040</entry>\n",
       "<entry>0.026</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>312</entry>\n",
       "<entry>0.019</entry>\n",
       "<entry>0.029</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>313</entry>\n",
       "<entry>0.189</entry>\n",
       "<entry>0.050</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>314</entry>\n",
       "<entry>0.149</entry>\n",
       "<entry>0.026</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>315</entry>\n",
       "<entry>0.057</entry>\n",
       "<entry>0.115</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>316</entry>\n",
       "<entry>0.069</entry>\n",
       "<entry>0.083</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>317</entry>\n",
       "<entry>0.048</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>318</entry>\n",
       "<entry>0.130</entry>\n",
       "<entry>0.015</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>320</entry>\n",
       "<entry>0.045</entry>\n",
       "<entry>0.011</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>321</entry>\n",
       "<entry>0.019</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>322</entry>\n",
       "<entry>0.113</entry>\n",
       "<entry>0.028</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>323</entry>\n",
       "<entry>0.077</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>324</entry>\n",
       "<entry>0.107</entry>\n",
       "<entry>0.035</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>325</entry>\n",
       "<entry>0.032</entry>\n",
       "<entry>0.025</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2707\" num=\"2719\">\n",
       "<tables id=\"TABLE-US-00016\" num=\"00016\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 16</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>326</entry>\n",
       "<entry>0.043</entry>\n",
       "<entry>0.005</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>327</entry>\n",
       "<entry>0.092</entry>\n",
       "<entry>0.024</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>328</entry>\n",
       "<entry>0.029</entry>\n",
       "<entry>0.168</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>329</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.023</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>330</entry>\n",
       "<entry>0.026</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>331</entry>\n",
       "<entry>0.045</entry>\n",
       "<entry>0.335</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>332</entry>\n",
       "<entry>0.048</entry>\n",
       "<entry>0.020</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>333</entry>\n",
       "<entry>0.021</entry>\n",
       "<entry>0.425</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>334</entry>\n",
       "<entry>0.075</entry>\n",
       "<entry>0.032</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>335</entry>\n",
       "<entry>0.019</entry>\n",
       "<entry>0.016</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>336</entry>\n",
       "<entry>0.051</entry>\n",
       "<entry>0.070</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>337</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.028</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>338</entry>\n",
       "<entry>0.074</entry>\n",
       "<entry>0.085</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>339</entry>\n",
       "<entry>0.183</entry>\n",
       "<entry>0.040</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>340</entry>\n",
       "<entry>0.101</entry>\n",
       "<entry>0.027</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>341</entry>\n",
       "<entry>0.016</entry>\n",
       "<entry>0.027</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>342</entry>\n",
       "<entry>0.099</entry>\n",
       "<entry>0.026</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>343</entry>\n",
       "<entry>0.122</entry>\n",
       "<entry>0.018</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>344</entry>\n",
       "<entry>0.050</entry>\n",
       "<entry>0.009</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>345</entry>\n",
       "<entry>0.097</entry>\n",
       "<entry>0.008</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>346</entry>\n",
       "<entry>0.028</entry>\n",
       "<entry>0.018</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>347</entry>\n",
       "<entry>0.014</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>348</entry>\n",
       "<entry>0.054</entry>\n",
       "<entry>0.080</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>349</entry>\n",
       "<entry>0.053</entry>\n",
       "<entry>0.075</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>351</entry>\n",
       "<entry>0.091</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>352</entry>\n",
       "<entry>0.067</entry>\n",
       "<entry>0.020</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>354</entry>\n",
       "<entry>0.025</entry>\n",
       "<entry>0.083</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>355</entry>\n",
       "<entry>0.040</entry>\n",
       "<entry>0.075</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>356</entry>\n",
       "<entry>0.066</entry>\n",
       "<entry>0.020</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>357</entry>\n",
       "<entry>0.138</entry>\n",
       "<entry>0.386</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>358</entry>\n",
       "<entry>0.051</entry>\n",
       "<entry>0.069</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>359</entry>\n",
       "<entry>0.037</entry>\n",
       "<entry>0.080</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>360</entry>\n",
       "<entry>0.042</entry>\n",
       "<entry>0.087</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2708\" num=\"2720\">\n",
       "<tables id=\"TABLE-US-00017\" num=\"00017\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 17</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>361</entry>\n",
       "<entry>0.039</entry>\n",
       "<entry>0.145</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>362</entry>\n",
       "<entry>0.084</entry>\n",
       "<entry>0.067</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>363</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.067</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>364</entry>\n",
       "<entry>0.112</entry>\n",
       "<entry>0.515</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>365</entry>\n",
       "<entry>0.041</entry>\n",
       "<entry>2.250</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>366</entry>\n",
       "<entry>0.090</entry>\n",
       "<entry>0.838</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>368</entry>\n",
       "<entry>0.140</entry>\n",
       "<entry>0.470</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>369</entry>\n",
       "<entry>0.294</entry>\n",
       "<entry>0.434</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>370</entry>\n",
       "<entry>0.113</entry>\n",
       "<entry>0.061</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>371</entry>\n",
       "<entry>0.161</entry>\n",
       "<entry>0.074</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>372</entry>\n",
       "<entry>0.164</entry>\n",
       "<entry>0.146</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>373</entry>\n",
       "<entry>0.065</entry>\n",
       "<entry>0.050</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>374</entry>\n",
       "<entry>0.137</entry>\n",
       "<entry>0.154</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>375</entry>\n",
       "<entry>0.037</entry>\n",
       "<entry>0.073</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>376</entry>\n",
       "<entry>0.063</entry>\n",
       "<entry>0.092</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>377</entry>\n",
       "<entry>0.024</entry>\n",
       "<entry>0.022</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>378</entry>\n",
       "<entry>0.047</entry>\n",
       "<entry>0.022</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>380</entry>\n",
       "<entry>0.123</entry>\n",
       "<entry>0.018</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>381</entry>\n",
       "<entry>0.200</entry>\n",
       "<entry>0.034</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>382</entry>\n",
       "<entry>0.032</entry>\n",
       "<entry>0.094</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>384</entry>\n",
       "<entry>0.153</entry>\n",
       "<entry>0.293</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>386</entry>\n",
       "<entry>0.075</entry>\n",
       "<entry>0.096</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>387</entry>\n",
       "<entry>0.300</entry>\n",
       "<entry>1.150</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>388</entry>\n",
       "<entry>0.133</entry>\n",
       "<entry>0.063</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>390</entry>\n",
       "<entry>0.095</entry>\n",
       "<entry>0.029</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>391</entry>\n",
       "<entry>0.264</entry>\n",
       "<entry>0.071</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>392</entry>\n",
       "<entry>0.153</entry>\n",
       "<entry>0.025</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>394</entry>\n",
       "<entry>0.087</entry>\n",
       "<entry>0.064</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>395</entry>\n",
       "<entry>0.043</entry>\n",
       "<entry>0.089</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>396</entry>\n",
       "<entry>0.056</entry>\n",
       "<entry>0.060</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>397</entry>\n",
       "<entry>0.055</entry>\n",
       "<entry>0.077</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>398</entry>\n",
       "<entry>0.034</entry>\n",
       "<entry>0.118</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>399</entry>\n",
       "<entry>0.105</entry>\n",
       "<entry>0.061</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2709\" num=\"2721\">\n",
       "<tables id=\"TABLE-US-00018\" num=\"00018\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 18</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>400</entry>\n",
       "<entry>0.067</entry>\n",
       "<entry>0.079</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>401</entry>\n",
       "<entry>0.089</entry>\n",
       "<entry>0.133</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>402</entry>\n",
       "<entry>0.085</entry>\n",
       "<entry>0.081</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>403</entry>\n",
       "<entry>0.090</entry>\n",
       "<entry>0.070</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>404</entry>\n",
       "<entry>0.084</entry>\n",
       "<entry>0.063</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>405</entry>\n",
       "<entry>0.074</entry>\n",
       "<entry>0.051</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>406</entry>\n",
       "<entry>0.119</entry>\n",
       "<entry>0.022</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>407</entry>\n",
       "<entry>0.035</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>408</entry>\n",
       "<entry>0.135</entry>\n",
       "<entry>0.061</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>409</entry>\n",
       "<entry>0.093</entry>\n",
       "<entry>0.029</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>410</entry>\n",
       "<entry>0.265</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>411</entry>\n",
       "<entry>0.046</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>412</entry>\n",
       "<entry>0.292</entry>\n",
       "<entry>0.203</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>413</entry>\n",
       "<entry>0.050</entry>\n",
       "<entry>0.005</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>414</entry>\n",
       "<entry>1.890</entry>\n",
       "<entry>0.131</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>415</entry>\n",
       "<entry>0.285</entry>\n",
       "<entry>0.022</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>416</entry>\n",
       "<entry>0.112</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>417</entry>\n",
       "<entry>0.030</entry>\n",
       "<entry>0.003</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>418</entry>\n",
       "<entry>0.121</entry>\n",
       "<entry>0.072</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>419</entry>\n",
       "<entry>0.124</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>420</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.021</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>423</entry>\n",
       "<entry>0.280</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>425</entry>\n",
       "<entry>0.183</entry>\n",
       "<entry>0.047</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>429</entry>\n",
       "<entry>0.016</entry>\n",
       "<entry>0.004</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>430</entry>\n",
       "<entry>0.168</entry>\n",
       "<entry>0.029</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>431</entry>\n",
       "<entry>0.097</entry>\n",
       "<entry>0.011</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>432</entry>\n",
       "<entry>0.155</entry>\n",
       "<entry>0.062</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>433</entry>\n",
       "<entry>0.014</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>441</entry>\n",
       "<entry>0.044</entry>\n",
       "<entry>0.005</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>443</entry>\n",
       "<entry>0.166</entry>\n",
       "<entry>0.004</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>444</entry>\n",
       "<entry>0.066</entry>\n",
       "<entry>0.003</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>445</entry>\n",
       "<entry>0.013</entry>\n",
       "<entry>0.004</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>446</entry>\n",
       "<entry>0.007</entry>\n",
       "<entry>0.011</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2710\" num=\"2722\">\n",
       "<tables id=\"TABLE-US-00019\" num=\"00019\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 19</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>447</entry>\n",
       "<entry>0.096</entry>\n",
       "<entry>0.018</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>448</entry>\n",
       "<entry>0.039</entry>\n",
       "<entry>0.008</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>449</entry>\n",
       "<entry>0.062</entry>\n",
       "<entry>0.021</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>450</entry>\n",
       "<entry>0.023</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>452</entry>\n",
       "<entry>0.177</entry>\n",
       "<entry>0.016</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>453</entry>\n",
       "<entry>0.186</entry>\n",
       "<entry>0.049</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>454</entry>\n",
       "<entry>0.012</entry>\n",
       "<entry>0.004</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>455</entry>\n",
       "<entry>0.025</entry>\n",
       "<entry>0.071</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>456</entry>\n",
       "<entry>0.032</entry>\n",
       "<entry>0.004</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>457</entry>\n",
       "<entry>0.242</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>458</entry>\n",
       "<entry>0.048</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>459</entry>\n",
       "<entry>0.287</entry>\n",
       "<entry>0.048</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>460</entry>\n",
       "<entry>0.085</entry>\n",
       "<entry>0.009</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>461</entry>\n",
       "<entry>0.255</entry>\n",
       "<entry>0.074</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>462</entry>\n",
       "<entry>0.069</entry>\n",
       "<entry>0.011</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>463</entry>\n",
       "<entry>0.012</entry>\n",
       "<entry>0.005</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>464</entry>\n",
       "<entry>0.024</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>469</entry>\n",
       "<entry>0.016</entry>\n",
       "<entry>0.004</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>470</entry>\n",
       "<entry>0.008</entry>\n",
       "<entry>0.003</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>475</entry>\n",
       "<entry>0.164</entry>\n",
       "<entry>0.441</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>476</entry>\n",
       "<entry>0.031</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>478</entry>\n",
       "<entry>0.088</entry>\n",
       "<entry>0.129</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>479</entry>\n",
       "<entry>0.117</entry>\n",
       "<entry>0.064</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>480</entry>\n",
       "<entry>0.151</entry>\n",
       "<entry>0.084</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>481</entry>\n",
       "<entry>0.114</entry>\n",
       "<entry>0.086</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>482</entry>\n",
       "<entry>0.103</entry>\n",
       "<entry>0.031</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>483</entry>\n",
       "<entry>0.101</entry>\n",
       "<entry>0.027</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>485</entry>\n",
       "<entry>0.221</entry>\n",
       "<entry>0.424</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>486</entry>\n",
       "<entry>0.140</entry>\n",
       "<entry>0.072</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>487</entry>\n",
       "<entry>0.091</entry>\n",
       "<entry>0.026</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>488</entry>\n",
       "<entry>0.151</entry>\n",
       "<entry>0.027</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>489</entry>\n",
       "<entry>0.133</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>490</entry>\n",
       "<entry>0.212</entry>\n",
       "<entry>0.468</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2711\" num=\"2723\">\n",
       "<tables id=\"TABLE-US-00020\" num=\"00020\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 20</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>491</entry>\n",
       "<entry>0.069</entry>\n",
       "<entry>0.099</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>492</entry>\n",
       "<entry>0.121</entry>\n",
       "<entry>0.160</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>493</entry>\n",
       "<entry>0.112</entry>\n",
       "<entry>0.101</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>495</entry>\n",
       "<entry>0.277</entry>\n",
       "<entry>0.310</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>496</entry>\n",
       "<entry>0.170</entry>\n",
       "<entry>0.177</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>497</entry>\n",
       "<entry>0.215</entry>\n",
       "<entry>0.511</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>498</entry>\n",
       "<entry>0.161</entry>\n",
       "<entry>0.351</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>502</entry>\n",
       "<entry>0.042</entry>\n",
       "<entry>0.142</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>506</entry>\n",
       "<entry>0.247</entry>\n",
       "<entry>1.620</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>507</entry>\n",
       "<entry>0.063</entry>\n",
       "<entry>0.197</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>508</entry>\n",
       "<entry>0.036</entry>\n",
       "<entry>0.056</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>509</entry>\n",
       "<entry>0.015</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>511</entry>\n",
       "<entry>0.175</entry>\n",
       "<entry>0.015</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>514</entry>\n",
       "<entry>0.049</entry>\n",
       "<entry>0.018</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>515</entry>\n",
       "<entry>0.197</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>516</entry>\n",
       "<entry>0.039</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>518</entry>\n",
       "<entry>0.049</entry>\n",
       "<entry>0.024</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>520</entry>\n",
       "<entry>0.212</entry>\n",
       "<entry>0.017</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>521</entry>\n",
       "<entry>0.191</entry>\n",
       "<entry>0.015</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>522</entry>\n",
       "<entry>0.039</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>523</entry>\n",
       "<entry>0.035</entry>\n",
       "<entry>0.014</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>524</entry>\n",
       "<entry>0.057</entry>\n",
       "<entry>0.026</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>525</entry>\n",
       "<entry>0.141</entry>\n",
       "<entry>0.090</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>526</entry>\n",
       "<entry>0.044</entry>\n",
       "<entry>0.019</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>527</entry>\n",
       "<entry>0.127</entry>\n",
       "<entry>0.088</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>532</entry>\n",
       "<entry>0.098</entry>\n",
       "<entry>0.075</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>533</entry>\n",
       "<entry>0.065</entry>\n",
       "<entry>0.391</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>534</entry>\n",
       "<entry>0.165</entry>\n",
       "<entry>1.200</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>536</entry>\n",
       "<entry>0.071</entry>\n",
       "<entry>0.027</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>537</entry>\n",
       "<entry>0.152</entry>\n",
       "<entry>0.022</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>538</entry>\n",
       "<entry>0.196</entry>\n",
       "<entry>0.030</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>544</entry>\n",
       "<entry>0.168</entry>\n",
       "<entry>0.051</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>546</entry>\n",
       "<entry>0.202</entry>\n",
       "<entry>0.124</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2712\" num=\"2724\">\n",
       "<tables id=\"TABLE-US-00021\" num=\"00021\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"3\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"center\" colname=\"1\" colwidth=\"91pt\"/>\n",
       "<colspec align=\"center\" colname=\"2\" colwidth=\"35pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"91pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry nameend=\"3\" namest=\"1\" rowsep=\"1\">TABLE 21</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>CEN IC<sub>50</sub></entry>\n",
       "<entry>CPE EC<sub>50</sub></entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>Example No.</entry>\n",
       "<entry>(μM)</entry>\n",
       "<entry>(μM)</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry>547</entry>\n",
       "<entry>0.032</entry>\n",
       "<entry>0.027</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>548</entry>\n",
       "<entry>0.086</entry>\n",
       "<entry>0.038</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>549</entry>\n",
       "<entry>0.076</entry>\n",
       "<entry>2.100</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>550</entry>\n",
       "<entry>0.042</entry>\n",
       "<entry>0.042</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>551</entry>\n",
       "<entry>0.041</entry>\n",
       "<entry>0.107</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>552</entry>\n",
       "<entry>0.230</entry>\n",
       "<entry>0.085</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>553</entry>\n",
       "<entry>0.028</entry>\n",
       "<entry>0.030</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>554</entry>\n",
       "<entry>0.065</entry>\n",
       "<entry>0.465</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>555</entry>\n",
       "<entry>0.023</entry>\n",
       "<entry>0.012</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>556</entry>\n",
       "<entry>0.023</entry>\n",
       "<entry>0.412</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>557</entry>\n",
       "<entry>0.281</entry>\n",
       "<entry>2.470</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>558</entry>\n",
       "<entry>0.114</entry>\n",
       "<entry>0.541</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>560</entry>\n",
       "<entry>0.027</entry>\n",
       "<entry>0.173</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>561</entry>\n",
       "<entry>0.073</entry>\n",
       "<entry>0.008</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>562</entry>\n",
       "<entry>0.022</entry>\n",
       "<entry>0.062</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>563</entry>\n",
       "<entry>0.049</entry>\n",
       "<entry>0.464</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>564</entry>\n",
       "<entry>0.088</entry>\n",
       "<entry>0.136</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>565</entry>\n",
       "<entry>0.154</entry>\n",
       "<entry>0.726</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>568</entry>\n",
       "<entry>0.264</entry>\n",
       "<entry>2.810</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>569</entry>\n",
       "<entry>0.138</entry>\n",
       "<entry>1.010</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>570</entry>\n",
       "<entry>0.081</entry>\n",
       "<entry>2.050</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>571</entry>\n",
       "<entry>0.065</entry>\n",
       "<entry>0.320</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>573</entry>\n",
       "<entry>0.055</entry>\n",
       "<entry>0.158</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>574</entry>\n",
       "<entry>0.165</entry>\n",
       "<entry>0.442</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>575</entry>\n",
       "<entry>0.058</entry>\n",
       "<entry>0.087</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>576</entry>\n",
       "<entry>0.063</entry>\n",
       "<entry>0.027</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>577</entry>\n",
       "<entry>0.233</entry>\n",
       "<entry>0.337</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry>581</entry>\n",
       "<entry>0.083</entry>\n",
       "<entry>0.480</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"1\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<heading id=\"h-1375\" level=\"1\">Test Example 7</heading>\n",
       "<heading id=\"h-1376\" level=\"1\">Influenza Virus-Infected Mouse Lethality Inhibitory Test</heading>\n",
       "<p id=\"h-1377\" num=\"0000\">&lt;Mouse&gt;</p>\n",
       "<p id=\"p-2713\" num=\"2725\">BALB/cAnNCrlCrlj (female, 5-week-old; CHARLES RIVER LABORATORIES JAPAN, INC.) was purchased, and 6- to 7-week-old mice were used in the test.</p>\n",
       "<p id=\"h-1378\" num=\"0000\">&lt;Preparation of Virus Solution&gt;</p>\n",
       "<p id=\"p-2714\" num=\"2726\">A/Victoria/3/75 or B/Maryland/1/59(ATCC) was passaged in mouse lung to make a mouse-acclimatized virus. A freezing-stored mouse-acclimatized virus solution was rapidly thawed, and diluted with DPBS to an infectivity titer to be used (in the case of A/Victoria/3/75:750 TCID<sub>50</sub>/mouse, in the case of B/Maryland/1/59:100 TCID<sub>50</sub>/mouse).</p>\n",
       "<p id=\"h-1379\" num=\"0000\">&lt;Infection&gt;</p>\n",
       "<p id=\"p-2715\" num=\"2727\">Under anesthesia with ketamine.xylazine, 100 ul of the prepared virus solution was nasally inoculated to directly infect mouse lung.</p>\n",
       "<p id=\"h-1380\" num=\"0000\">&lt;Preparation of Test Sample&gt;</p>\n",
       "<p id=\"p-2716\" num=\"2728\">A test sample was dissolved in a 5% DMAA/20% HP-β-CD aqueous solution to a suitable concentration.</p>\n",
       "<p id=\"h-1381\" num=\"0000\">&lt;Administration of Test Sample to Infected Mouse&gt;</p>\n",
       "<p id=\"p-2717\" num=\"2729\">A suitably diluted test sample was intravenously administered at 200 ul to a mouse immediately after virus infection, by a single dose.</p>\n",
       "<p id=\"h-1382\" num=\"0000\">&lt;Drug Efficacy Assessment&gt;</p>\n",
       "<p id=\"p-2718\" num=\"2730\">The mouse was reared for 14 days after virus infection, and a necessary dose per day for 50% lethality inhibition, ED<sub>50 </sub>(mg/kg/day), a lethality inhibition rate at a maximum dose (% survival), or days during which the mouse survives 50% as compared with a control at a maximum dose (50% life extension days) was calculated.</p>\n",
       "<p id=\"h-1383\" num=\"0000\">&lt;Euthanasia&gt;</p>\n",
       "<p id=\"p-2719\" num=\"2731\">The mouse after completion of the test was euthanized by carbon dioxide or halothane excessive administration.</p>\n",
       "<p id=\"p-2720\" num=\"2732\">The present compound exhibits the effect of inhibiting lethality of an influenza virus-infected mouse in the above test. Therefore, the present compound is effective in treating and/or preventing an influenza infectious disease.</p>\n",
       "<heading id=\"h-1384\" level=\"1\">Formulation Example 1</heading>\n",
       "<p id=\"p-2721\" num=\"2733\">A granule containing the following ingredients is manufactured.</p>\n",
       "<p id=\"p-2722\" num=\"2734\">\n",
       "<tables id=\"TABLE-US-00022\" num=\"00022\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"4\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"14pt\"/>\n",
       "<colspec align=\"left\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"left\" colname=\"2\" colwidth=\"105pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"56pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>Ingredient</entry>\n",
       "<entry>A compound shown by formula (I)</entry>\n",
       "<entry> 10 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>lactose</entry>\n",
       "<entry>700 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>cornstarch</entry>\n",
       "<entry>274 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>HPC-L</entry>\n",
       "<entry> 16 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>1000 mg </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2723\" num=\"2735\">A compound shown by formula (I) and lactose are passed through a 60 mesh sieve. Corn starch is passed through a 120 mesh sieve. These are mixed with V-type blender. To the mixture, aqueous HPC-L (low viscosity of hydroxypropylcellulose) is added, then the mixture is kneaded together, granulated (extrusive granulation pore diameter 0.5˜1 mm), and dried. The obtained dried granule is passed through vibrating sieve (12/60 mesh) to obtain a granule.</p>\n",
       "<heading id=\"h-1385\" level=\"1\">Formulation Example 2</heading>\n",
       "<p id=\"p-2724\" num=\"2736\">A granule for encapsulation containing the following ingredients is manufactured.</p>\n",
       "<p id=\"p-2725\" num=\"2737\">\n",
       "<tables id=\"TABLE-US-00023\" num=\"00023\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"4\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"14pt\"/>\n",
       "<colspec align=\"left\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"left\" colname=\"2\" colwidth=\"105pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"56pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>Ingredient</entry>\n",
       "<entry>A compound shown by formula (I)</entry>\n",
       "<entry>15 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>lactose</entry>\n",
       "<entry>90 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>cornstarch</entry>\n",
       "<entry>42 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>HPC-L</entry>\n",
       "<entry> 3 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>150 mg </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2726\" num=\"2738\">A compound shown by formula (I) and lactose are passed through a 60 mesh sieve. Corn starch is passed through a 120 mesh sieve. These are mixed and aqueous HPC-L (low viscosity of hydroxypropylcellulose) is added thereto, then the mixture is kneaded together, granulated, and dried. The obtained dried granule is trimmed and 150 mg thereof is filled into a No. 4 hard gelatin capsule.</p>\n",
       "<heading id=\"h-1386\" level=\"1\">Formulation Example 3</heading>\n",
       "<p id=\"p-2727\" num=\"2739\">A tablet containing the following ingredients is manufactured.</p>\n",
       "<p id=\"p-2728\" num=\"2740\">\n",
       "<tables id=\"TABLE-US-00024\" num=\"00024\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"4\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"14pt\"/>\n",
       "<colspec align=\"left\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"left\" colname=\"2\" colwidth=\"105pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"56pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>Ingredient</entry>\n",
       "<entry>A compound shown by formula (I)</entry>\n",
       "<entry>10 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>lactose</entry>\n",
       "<entry>90 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>microcrystal cellulose</entry>\n",
       "<entry>30 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>CMC-Na</entry>\n",
       "<entry>15 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>Magnesium stearate</entry>\n",
       "<entry> 5 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>150 mg </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<p id=\"p-2729\" num=\"2741\">A compound shown by formula (I), lactose, and microcrystal cellulose, CMC-Na (carboxymethylcellulose sodium salt) are passed through a 60 mesh sieve and mixed. Magnesium stearate is added to the mixed powder to obtain a mixture for tablet. The mixture is tableted directly to obtain a 150 mg tablet.</p>\n",
       "<heading id=\"h-1387\" level=\"1\">Formulation Example 4</heading>\n",
       "<p id=\"p-2730\" num=\"2742\">An injectable solution is manufactured by mixing the following ingredients under warming, followed by sterilization.</p>\n",
       "<p id=\"p-2731\" num=\"2743\">\n",
       "<tables id=\"TABLE-US-00025\" num=\"00025\">\n",
       "<table colsep=\"0\" frame=\"none\" rowsep=\"0\">\n",
       "<tgroup align=\"left\" cols=\"4\" colsep=\"0\" rowsep=\"0\">\n",
       "<colspec align=\"left\" colname=\"offset\" colwidth=\"14pt\"/>\n",
       "<colspec align=\"left\" colname=\"1\" colwidth=\"42pt\"/>\n",
       "<colspec align=\"left\" colname=\"2\" colwidth=\"105pt\"/>\n",
       "<colspec align=\"center\" colname=\"3\" colwidth=\"56pt\"/>\n",
       "<thead>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</thead>\n",
       "<tbody valign=\"top\">\n",
       "<row>\n",
       "<entry/>\n",
       "<entry>Ingredient</entry>\n",
       "<entry>A compound shown by formula (I)</entry>\n",
       "<entry>3 mg</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>non-ion surfactant</entry>\n",
       "<entry>15 mg </entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry/>\n",
       "<entry>Water for injection</entry>\n",
       "<entry>1 ml</entry>\n",
       "</row>\n",
       "<row>\n",
       "<entry/>\n",
       "<entry align=\"center\" nameend=\"3\" namest=\"offset\" rowsep=\"1\"/>\n",
       "</row>\n",
       "</tbody>\n",
       "</tgroup>\n",
       "</table>\n",
       "</tables>\n",
       "</p>\n",
       "<heading id=\"h-1388\" level=\"1\">INDUSTRIAL APPLICABILITY</heading>\n",
       "<p id=\"p-2732\" num=\"2744\">The compound of the present invention has cap-dependent endonuclease (CEN) inhibitory activity. The compound of the present invention can be a useful agent for treatment and/or prevention of symptom and/or disease induced by infection with influenza virus.</p>\n",
       "<?DETDESC description=\"Detailed Description\" end=\"tail\"?>\n",
       "</description>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00001.CDX\" idref=\"CHEM-US-00001\" mol-file=\"US08927710-20150106-C00001.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00002.CDX\" idref=\"CHEM-US-00002\" mol-file=\"US08927710-20150106-C00002.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00003.CDX\" idref=\"CHEM-US-00003\" mol-file=\"US08927710-20150106-C00003.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00004.CDX\" idref=\"CHEM-US-00004\" mol-file=\"US08927710-20150106-C00004.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00005.CDX\" idref=\"CHEM-US-00005\" mol-file=\"US08927710-20150106-C00005.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00006.CDX\" idref=\"CHEM-US-00006\" mol-file=\"US08927710-20150106-C00006.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00007.CDX\" idref=\"CHEM-US-00007\" mol-file=\"US08927710-20150106-C00007.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00008.CDX\" idref=\"CHEM-US-00008\" mol-file=\"US08927710-20150106-C00008.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00009.CDX\" idref=\"CHEM-US-00009\" mol-file=\"US08927710-20150106-C00009.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00010.CDX\" idref=\"CHEM-US-00010\" mol-file=\"US08927710-20150106-C00010.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00011.CDX\" idref=\"CHEM-US-00011\" mol-file=\"US08927710-20150106-C00011.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00012.CDX\" idref=\"CHEM-US-00012\" mol-file=\"US08927710-20150106-C00012.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00013.CDX\" idref=\"CHEM-US-00013\" mol-file=\"US08927710-20150106-C00013.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00014.CDX\" idref=\"CHEM-US-00014\" mol-file=\"US08927710-20150106-C00014.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00015.CDX\" idref=\"CHEM-US-00015\" mol-file=\"US08927710-20150106-C00015.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00016.CDX\" idref=\"CHEM-US-00016\" mol-file=\"US08927710-20150106-C00016.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00017.CDX\" idref=\"CHEM-US-00017\" mol-file=\"US08927710-20150106-C00017.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00018.CDX\" idref=\"CHEM-US-00018\" mol-file=\"US08927710-20150106-C00018.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00019.CDX\" idref=\"CHEM-US-00019\" mol-file=\"US08927710-20150106-C00019.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00020.CDX\" idref=\"CHEM-US-00020\" mol-file=\"US08927710-20150106-C00020.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00021.CDX\" idref=\"CHEM-US-00021\" mol-file=\"US08927710-20150106-C00021.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00022.CDX\" idref=\"CHEM-US-00022\" mol-file=\"US08927710-20150106-C00022.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00023.CDX\" idref=\"CHEM-US-00023\" mol-file=\"US08927710-20150106-C00023.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00024.CDX\" idref=\"CHEM-US-00024\" mol-file=\"US08927710-20150106-C00024.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00025.CDX\" idref=\"CHEM-US-00025\" mol-file=\"US08927710-20150106-C00025.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00026.CDX\" idref=\"CHEM-US-00026\" mol-file=\"US08927710-20150106-C00026.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00027.CDX\" idref=\"CHEM-US-00027\" mol-file=\"US08927710-20150106-C00027.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00028.CDX\" idref=\"CHEM-US-00028\" mol-file=\"US08927710-20150106-C00028.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00029.CDX\" idref=\"CHEM-US-00029\" mol-file=\"US08927710-20150106-C00029.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00030.CDX\" idref=\"CHEM-US-00030\" mol-file=\"US08927710-20150106-C00030.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00031.CDX\" idref=\"CHEM-US-00031\" mol-file=\"US08927710-20150106-C00031.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00032.CDX\" idref=\"CHEM-US-00032\" mol-file=\"US08927710-20150106-C00032.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00033.CDX\" idref=\"CHEM-US-00033\" mol-file=\"US08927710-20150106-C00033.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00034.CDX\" idref=\"CHEM-US-00034\" mol-file=\"US08927710-20150106-C00034.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00035.CDX\" idref=\"CHEM-US-00035\" mol-file=\"US08927710-20150106-C00035.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00036.CDX\" idref=\"CHEM-US-00036\" mol-file=\"US08927710-20150106-C00036.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00037.CDX\" idref=\"CHEM-US-00037\" mol-file=\"US08927710-20150106-C00037.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00038.CDX\" idref=\"CHEM-US-00038\" mol-file=\"US08927710-20150106-C00038.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00039.CDX\" idref=\"CHEM-US-00039\" mol-file=\"US08927710-20150106-C00039.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00040.CDX\" idref=\"CHEM-US-00040\" mol-file=\"US08927710-20150106-C00040.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00041.CDX\" idref=\"CHEM-US-00041\" mol-file=\"US08927710-20150106-C00041.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00042.CDX\" idref=\"CHEM-US-00042\" mol-file=\"US08927710-20150106-C00042.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00043.CDX\" idref=\"CHEM-US-00043\" mol-file=\"US08927710-20150106-C00043.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00044.CDX\" idref=\"CHEM-US-00044\" mol-file=\"US08927710-20150106-C00044.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00045.CDX\" idref=\"CHEM-US-00045\" mol-file=\"US08927710-20150106-C00045.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00046.CDX\" idref=\"CHEM-US-00046\" mol-file=\"US08927710-20150106-C00046.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00047.CDX\" idref=\"CHEM-US-00047\" mol-file=\"US08927710-20150106-C00047.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00048.CDX\" idref=\"CHEM-US-00048\" mol-file=\"US08927710-20150106-C00048.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00049.CDX\" idref=\"CHEM-US-00049\" mol-file=\"US08927710-20150106-C00049.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00050.CDX\" idref=\"CHEM-US-00050\" mol-file=\"US08927710-20150106-C00050.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00051.CDX\" idref=\"CHEM-US-00051\" mol-file=\"US08927710-20150106-C00051.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00052.CDX\" idref=\"CHEM-US-00052\" mol-file=\"US08927710-20150106-C00052.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00053.CDX\" idref=\"CHEM-US-00053\" mol-file=\"US08927710-20150106-C00053.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00054.CDX\" idref=\"CHEM-US-00054\" mol-file=\"US08927710-20150106-C00054.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00055.CDX\" idref=\"CHEM-US-00055\" mol-file=\"US08927710-20150106-C00055.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00056.CDX\" idref=\"CHEM-US-00056\" mol-file=\"US08927710-20150106-C00056.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00057.CDX\" idref=\"CHEM-US-00057\" mol-file=\"US08927710-20150106-C00057.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00058.CDX\" idref=\"CHEM-US-00058\" mol-file=\"US08927710-20150106-C00058.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00059.CDX\" idref=\"CHEM-US-00059\" mol-file=\"US08927710-20150106-C00059.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00060.CDX\" idref=\"CHEM-US-00060\" mol-file=\"US08927710-20150106-C00060.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00061.CDX\" idref=\"CHEM-US-00061\" mol-file=\"US08927710-20150106-C00061.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00062.CDX\" idref=\"CHEM-US-00062\" mol-file=\"US08927710-20150106-C00062.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00063.CDX\" idref=\"CHEM-US-00063\" mol-file=\"US08927710-20150106-C00063.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00064.CDX\" idref=\"CHEM-US-00064\" mol-file=\"US08927710-20150106-C00064.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00065.CDX\" idref=\"CHEM-US-00065\" mol-file=\"US08927710-20150106-C00065.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00066.CDX\" idref=\"CHEM-US-00066\" mol-file=\"US08927710-20150106-C00066.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00067.CDX\" idref=\"CHEM-US-00067\" mol-file=\"US08927710-20150106-C00067.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00068.CDX\" idref=\"CHEM-US-00068\" mol-file=\"US08927710-20150106-C00068.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00069.CDX\" idref=\"CHEM-US-00069\" mol-file=\"US08927710-20150106-C00069.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00070.CDX\" idref=\"CHEM-US-00070\" mol-file=\"US08927710-20150106-C00070.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00071.CDX\" idref=\"CHEM-US-00071\" mol-file=\"US08927710-20150106-C00071.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00072.CDX\" idref=\"CHEM-US-00072\" mol-file=\"US08927710-20150106-C00072.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00073.CDX\" idref=\"CHEM-US-00073\" mol-file=\"US08927710-20150106-C00073.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00074.CDX\" idref=\"CHEM-US-00074\" mol-file=\"US08927710-20150106-C00074.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00075.CDX\" idref=\"CHEM-US-00075\" mol-file=\"US08927710-20150106-C00075.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00076.CDX\" idref=\"CHEM-US-00076\" mol-file=\"US08927710-20150106-C00076.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00077.CDX\" idref=\"CHEM-US-00077\" mol-file=\"US08927710-20150106-C00077.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00078.CDX\" idref=\"CHEM-US-00078\" mol-file=\"US08927710-20150106-C00078.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00079.CDX\" idref=\"CHEM-US-00079\" mol-file=\"US08927710-20150106-C00079.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00080.CDX\" idref=\"CHEM-US-00080\" mol-file=\"US08927710-20150106-C00080.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00081.CDX\" idref=\"CHEM-US-00081\" mol-file=\"US08927710-20150106-C00081.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00082.CDX\" idref=\"CHEM-US-00082\" mol-file=\"US08927710-20150106-C00082.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00083.CDX\" idref=\"CHEM-US-00083\" mol-file=\"US08927710-20150106-C00083.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00084.CDX\" idref=\"CHEM-US-00084\" mol-file=\"US08927710-20150106-C00084.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00085.CDX\" idref=\"CHEM-US-00085\" mol-file=\"US08927710-20150106-C00085.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00086.CDX\" idref=\"CHEM-US-00086\" mol-file=\"US08927710-20150106-C00086.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00087.CDX\" idref=\"CHEM-US-00087\" mol-file=\"US08927710-20150106-C00087.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00088.CDX\" idref=\"CHEM-US-00088\" mol-file=\"US08927710-20150106-C00088.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00089.CDX\" idref=\"CHEM-US-00089\" mol-file=\"US08927710-20150106-C00089.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00090.CDX\" idref=\"CHEM-US-00090\" mol-file=\"US08927710-20150106-C00090.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00091.CDX\" idref=\"CHEM-US-00091\" mol-file=\"US08927710-20150106-C00091.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00092.CDX\" idref=\"CHEM-US-00092\" mol-file=\"US08927710-20150106-C00092.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00093.CDX\" idref=\"CHEM-US-00093\" mol-file=\"US08927710-20150106-C00093.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00094.CDX\" idref=\"CHEM-US-00094\" mol-file=\"US08927710-20150106-C00094.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00095.CDX\" idref=\"CHEM-US-00095\" mol-file=\"US08927710-20150106-C00095.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00096.CDX\" idref=\"CHEM-US-00096\" mol-file=\"US08927710-20150106-C00096.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00097.CDX\" idref=\"CHEM-US-00097\" mol-file=\"US08927710-20150106-C00097.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00098.CDX\" idref=\"CHEM-US-00098\" mol-file=\"US08927710-20150106-C00098.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00099.CDX\" idref=\"CHEM-US-00099\" mol-file=\"US08927710-20150106-C00099.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00100.CDX\" idref=\"CHEM-US-00100\" mol-file=\"US08927710-20150106-C00100.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00101.CDX\" idref=\"CHEM-US-00101\" mol-file=\"US08927710-20150106-C00101.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00102.CDX\" idref=\"CHEM-US-00102\" mol-file=\"US08927710-20150106-C00102.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00103.CDX\" idref=\"CHEM-US-00103\" mol-file=\"US08927710-20150106-C00103.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00104.CDX\" idref=\"CHEM-US-00104\" mol-file=\"US08927710-20150106-C00104.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00105.CDX\" idref=\"CHEM-US-00105\" mol-file=\"US08927710-20150106-C00105.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00106.CDX\" idref=\"CHEM-US-00106\" mol-file=\"US08927710-20150106-C00106.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00107.CDX\" idref=\"CHEM-US-00107\" mol-file=\"US08927710-20150106-C00107.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00108.CDX\" idref=\"CHEM-US-00108\" mol-file=\"US08927710-20150106-C00108.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00109.CDX\" idref=\"CHEM-US-00109\" mol-file=\"US08927710-20150106-C00109.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00110.CDX\" idref=\"CHEM-US-00110\" mol-file=\"US08927710-20150106-C00110.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00111.CDX\" idref=\"CHEM-US-00111\" mol-file=\"US08927710-20150106-C00111.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00112.CDX\" idref=\"CHEM-US-00112\" mol-file=\"US08927710-20150106-C00112.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00113.CDX\" idref=\"CHEM-US-00113\" mol-file=\"US08927710-20150106-C00113.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00114.CDX\" idref=\"CHEM-US-00114\" mol-file=\"US08927710-20150106-C00114.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00115.CDX\" idref=\"CHEM-US-00115\" mol-file=\"US08927710-20150106-C00115.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00116.CDX\" idref=\"CHEM-US-00116\" mol-file=\"US08927710-20150106-C00116.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00117.CDX\" idref=\"CHEM-US-00117\" mol-file=\"US08927710-20150106-C00117.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00118.CDX\" idref=\"CHEM-US-00118\" mol-file=\"US08927710-20150106-C00118.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00119.CDX\" idref=\"CHEM-US-00119\" mol-file=\"US08927710-20150106-C00119.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00120.CDX\" idref=\"CHEM-US-00120\" mol-file=\"US08927710-20150106-C00120.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00121.CDX\" idref=\"CHEM-US-00121\" mol-file=\"US08927710-20150106-C00121.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00122.CDX\" idref=\"CHEM-US-00122\" mol-file=\"US08927710-20150106-C00122.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00123.CDX\" idref=\"CHEM-US-00123\" mol-file=\"US08927710-20150106-C00123.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00124.CDX\" idref=\"CHEM-US-00124\" mol-file=\"US08927710-20150106-C00124.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00125.CDX\" idref=\"CHEM-US-00125\" mol-file=\"US08927710-20150106-C00125.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00126.CDX\" idref=\"CHEM-US-00126\" mol-file=\"US08927710-20150106-C00126.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00127.CDX\" idref=\"CHEM-US-00127\" mol-file=\"US08927710-20150106-C00127.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00128.CDX\" idref=\"CHEM-US-00128\" mol-file=\"US08927710-20150106-C00128.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00129.CDX\" idref=\"CHEM-US-00129\" mol-file=\"US08927710-20150106-C00129.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00130.CDX\" idref=\"CHEM-US-00130\" mol-file=\"US08927710-20150106-C00130.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00131.CDX\" idref=\"CHEM-US-00131\" mol-file=\"US08927710-20150106-C00131.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00132.CDX\" idref=\"CHEM-US-00132\" mol-file=\"US08927710-20150106-C00132.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00133.CDX\" idref=\"CHEM-US-00133\" mol-file=\"US08927710-20150106-C00133.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00134.CDX\" idref=\"CHEM-US-00134\" mol-file=\"US08927710-20150106-C00134.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00135.CDX\" idref=\"CHEM-US-00135\" mol-file=\"US08927710-20150106-C00135.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00136.CDX\" idref=\"CHEM-US-00136\" mol-file=\"US08927710-20150106-C00136.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00137.CDX\" idref=\"CHEM-US-00137\" mol-file=\"US08927710-20150106-C00137.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00138.CDX\" idref=\"CHEM-US-00138\" mol-file=\"US08927710-20150106-C00138.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00139.CDX\" idref=\"CHEM-US-00139\" mol-file=\"US08927710-20150106-C00139.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00140.CDX\" idref=\"CHEM-US-00140\" mol-file=\"US08927710-20150106-C00140.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00141.CDX\" idref=\"CHEM-US-00141\" mol-file=\"US08927710-20150106-C00141.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00142.CDX\" idref=\"CHEM-US-00142\" mol-file=\"US08927710-20150106-C00142.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00143.CDX\" idref=\"CHEM-US-00143\" mol-file=\"US08927710-20150106-C00143.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00144.CDX\" idref=\"CHEM-US-00144\" mol-file=\"US08927710-20150106-C00144.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00145.CDX\" idref=\"CHEM-US-00145\" mol-file=\"US08927710-20150106-C00145.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00146.CDX\" idref=\"CHEM-US-00146\" mol-file=\"US08927710-20150106-C00146.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00147.CDX\" idref=\"CHEM-US-00147\" mol-file=\"US08927710-20150106-C00147.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00148.CDX\" idref=\"CHEM-US-00148\" mol-file=\"US08927710-20150106-C00148.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00149.CDX\" idref=\"CHEM-US-00149\" mol-file=\"US08927710-20150106-C00149.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00150.CDX\" idref=\"CHEM-US-00150\" mol-file=\"US08927710-20150106-C00150.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00151.CDX\" idref=\"CHEM-US-00151\" mol-file=\"US08927710-20150106-C00151.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00152.CDX\" idref=\"CHEM-US-00152\" mol-file=\"US08927710-20150106-C00152.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00153.CDX\" idref=\"CHEM-US-00153\" mol-file=\"US08927710-20150106-C00153.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00154.CDX\" idref=\"CHEM-US-00154\" mol-file=\"US08927710-20150106-C00154.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00155.CDX\" idref=\"CHEM-US-00155\" mol-file=\"US08927710-20150106-C00155.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00156.CDX\" idref=\"CHEM-US-00156\" mol-file=\"US08927710-20150106-C00156.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00157.CDX\" idref=\"CHEM-US-00157\" mol-file=\"US08927710-20150106-C00157.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00158.CDX\" idref=\"CHEM-US-00158\" mol-file=\"US08927710-20150106-C00158.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00159.CDX\" idref=\"CHEM-US-00159\" mol-file=\"US08927710-20150106-C00159.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00160.CDX\" idref=\"CHEM-US-00160\" mol-file=\"US08927710-20150106-C00160.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00161.CDX\" idref=\"CHEM-US-00161\" mol-file=\"US08927710-20150106-C00161.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00162.CDX\" idref=\"CHEM-US-00162\" mol-file=\"US08927710-20150106-C00162.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00163.CDX\" idref=\"CHEM-US-00163\" mol-file=\"US08927710-20150106-C00163.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00164.CDX\" idref=\"CHEM-US-00164\" mol-file=\"US08927710-20150106-C00164.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00165.CDX\" idref=\"CHEM-US-00165\" mol-file=\"US08927710-20150106-C00165.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00166.CDX\" idref=\"CHEM-US-00166\" mol-file=\"US08927710-20150106-C00166.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00167.CDX\" idref=\"CHEM-US-00167\" mol-file=\"US08927710-20150106-C00167.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00168.CDX\" idref=\"CHEM-US-00168\" mol-file=\"US08927710-20150106-C00168.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00169.CDX\" idref=\"CHEM-US-00169\" mol-file=\"US08927710-20150106-C00169.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00170.CDX\" idref=\"CHEM-US-00170\" mol-file=\"US08927710-20150106-C00170.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00171.CDX\" idref=\"CHEM-US-00171\" mol-file=\"US08927710-20150106-C00171.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00172.CDX\" idref=\"CHEM-US-00172\" mol-file=\"US08927710-20150106-C00172.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00173.CDX\" idref=\"CHEM-US-00173\" mol-file=\"US08927710-20150106-C00173.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00174.CDX\" idref=\"CHEM-US-00174\" mol-file=\"US08927710-20150106-C00174.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00175.CDX\" idref=\"CHEM-US-00175\" mol-file=\"US08927710-20150106-C00175.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00176.CDX\" idref=\"CHEM-US-00176\" mol-file=\"US08927710-20150106-C00176.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00177.CDX\" idref=\"CHEM-US-00177\" mol-file=\"US08927710-20150106-C00177.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00178.CDX\" idref=\"CHEM-US-00178\" mol-file=\"US08927710-20150106-C00178.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00179.CDX\" idref=\"CHEM-US-00179\" mol-file=\"US08927710-20150106-C00179.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00180.CDX\" idref=\"CHEM-US-00180\" mol-file=\"US08927710-20150106-C00180.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00181.CDX\" idref=\"CHEM-US-00181\" mol-file=\"US08927710-20150106-C00181.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00182.CDX\" idref=\"CHEM-US-00182\" mol-file=\"US08927710-20150106-C00182.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00183.CDX\" idref=\"CHEM-US-00183\" mol-file=\"US08927710-20150106-C00183.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00184.CDX\" idref=\"CHEM-US-00184\" mol-file=\"US08927710-20150106-C00184.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00185.CDX\" idref=\"CHEM-US-00185\" mol-file=\"US08927710-20150106-C00185.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00186.CDX\" idref=\"CHEM-US-00186\" mol-file=\"US08927710-20150106-C00186.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00187.CDX\" idref=\"CHEM-US-00187\" mol-file=\"US08927710-20150106-C00187.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00188.CDX\" idref=\"CHEM-US-00188\" mol-file=\"US08927710-20150106-C00188.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00189.CDX\" idref=\"CHEM-US-00189\" mol-file=\"US08927710-20150106-C00189.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00190.CDX\" idref=\"CHEM-US-00190\" mol-file=\"US08927710-20150106-C00190.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00191.CDX\" idref=\"CHEM-US-00191\" mol-file=\"US08927710-20150106-C00191.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00192.CDX\" idref=\"CHEM-US-00192\" mol-file=\"US08927710-20150106-C00192.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00193.CDX\" idref=\"CHEM-US-00193\" mol-file=\"US08927710-20150106-C00193.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00194.CDX\" idref=\"CHEM-US-00194\" mol-file=\"US08927710-20150106-C00194.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00195.CDX\" idref=\"CHEM-US-00195\" mol-file=\"US08927710-20150106-C00195.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00196.CDX\" idref=\"CHEM-US-00196\" mol-file=\"US08927710-20150106-C00196.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00197.CDX\" idref=\"CHEM-US-00197\" mol-file=\"US08927710-20150106-C00197.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00198.CDX\" idref=\"CHEM-US-00198\" mol-file=\"US08927710-20150106-C00198.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00199.CDX\" idref=\"CHEM-US-00199\" mol-file=\"US08927710-20150106-C00199.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00200.CDX\" idref=\"CHEM-US-00200\" mol-file=\"US08927710-20150106-C00200.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00201.CDX\" idref=\"CHEM-US-00201\" mol-file=\"US08927710-20150106-C00201.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00202.CDX\" idref=\"CHEM-US-00202\" mol-file=\"US08927710-20150106-C00202.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00203.CDX\" idref=\"CHEM-US-00203\" mol-file=\"US08927710-20150106-C00203.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00204.CDX\" idref=\"CHEM-US-00204\" mol-file=\"US08927710-20150106-C00204.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00205.CDX\" idref=\"CHEM-US-00205\" mol-file=\"US08927710-20150106-C00205.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00206.CDX\" idref=\"CHEM-US-00206\" mol-file=\"US08927710-20150106-C00206.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00207.CDX\" idref=\"CHEM-US-00207\" mol-file=\"US08927710-20150106-C00207.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00208.CDX\" idref=\"CHEM-US-00208\" mol-file=\"US08927710-20150106-C00208.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00209.CDX\" idref=\"CHEM-US-00209\" mol-file=\"US08927710-20150106-C00209.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00210.CDX\" idref=\"CHEM-US-00210\" mol-file=\"US08927710-20150106-C00210.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00211.CDX\" idref=\"CHEM-US-00211\" mol-file=\"US08927710-20150106-C00211.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00212.CDX\" idref=\"CHEM-US-00212\" mol-file=\"US08927710-20150106-C00212.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00213.CDX\" idref=\"CHEM-US-00213\" mol-file=\"US08927710-20150106-C00213.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00214.CDX\" idref=\"CHEM-US-00214\" mol-file=\"US08927710-20150106-C00214.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00215.CDX\" idref=\"CHEM-US-00215\" mol-file=\"US08927710-20150106-C00215.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00216.CDX\" idref=\"CHEM-US-00216\" mol-file=\"US08927710-20150106-C00216.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00217.CDX\" idref=\"CHEM-US-00217\" mol-file=\"US08927710-20150106-C00217.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00218.CDX\" idref=\"CHEM-US-00218\" mol-file=\"US08927710-20150106-C00218.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00219.CDX\" idref=\"CHEM-US-00219\" mol-file=\"US08927710-20150106-C00219.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00220.CDX\" idref=\"CHEM-US-00220\" mol-file=\"US08927710-20150106-C00220.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00221.CDX\" idref=\"CHEM-US-00221\" mol-file=\"US08927710-20150106-C00221.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00222.CDX\" idref=\"CHEM-US-00222\" mol-file=\"US08927710-20150106-C00222.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00223.CDX\" idref=\"CHEM-US-00223\" mol-file=\"US08927710-20150106-C00223.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00224.CDX\" idref=\"CHEM-US-00224\" mol-file=\"US08927710-20150106-C00224.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00225.CDX\" idref=\"CHEM-US-00225\" mol-file=\"US08927710-20150106-C00225.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00226.CDX\" idref=\"CHEM-US-00226\" mol-file=\"US08927710-20150106-C00226.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00227.CDX\" idref=\"CHEM-US-00227\" mol-file=\"US08927710-20150106-C00227.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00228.CDX\" idref=\"CHEM-US-00228\" mol-file=\"US08927710-20150106-C00228.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00229.CDX\" idref=\"CHEM-US-00229\" mol-file=\"US08927710-20150106-C00229.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00230.CDX\" idref=\"CHEM-US-00230\" mol-file=\"US08927710-20150106-C00230.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00231.CDX\" idref=\"CHEM-US-00231\" mol-file=\"US08927710-20150106-C00231.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00232.CDX\" idref=\"CHEM-US-00232\" mol-file=\"US08927710-20150106-C00232.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00233.CDX\" idref=\"CHEM-US-00233\" mol-file=\"US08927710-20150106-C00233.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00234.CDX\" idref=\"CHEM-US-00234\" mol-file=\"US08927710-20150106-C00234.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00235.CDX\" idref=\"CHEM-US-00235\" mol-file=\"US08927710-20150106-C00235.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00236.CDX\" idref=\"CHEM-US-00236\" mol-file=\"US08927710-20150106-C00236.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00237.CDX\" idref=\"CHEM-US-00237\" mol-file=\"US08927710-20150106-C00237.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00238.CDX\" idref=\"CHEM-US-00238\" mol-file=\"US08927710-20150106-C00238.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00239.CDX\" idref=\"CHEM-US-00239\" mol-file=\"US08927710-20150106-C00239.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00240.CDX\" idref=\"CHEM-US-00240\" mol-file=\"US08927710-20150106-C00240.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00241.CDX\" idref=\"CHEM-US-00241\" mol-file=\"US08927710-20150106-C00241.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00242.CDX\" idref=\"CHEM-US-00242\" mol-file=\"US08927710-20150106-C00242.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00243.CDX\" idref=\"CHEM-US-00243\" mol-file=\"US08927710-20150106-C00243.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00244.CDX\" idref=\"CHEM-US-00244\" mol-file=\"US08927710-20150106-C00244.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00245.CDX\" idref=\"CHEM-US-00245\" mol-file=\"US08927710-20150106-C00245.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00246.CDX\" idref=\"CHEM-US-00246\" mol-file=\"US08927710-20150106-C00246.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00247.CDX\" idref=\"CHEM-US-00247\" mol-file=\"US08927710-20150106-C00247.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00248.CDX\" idref=\"CHEM-US-00248\" mol-file=\"US08927710-20150106-C00248.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00249.CDX\" idref=\"CHEM-US-00249\" mol-file=\"US08927710-20150106-C00249.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00250.CDX\" idref=\"CHEM-US-00250\" mol-file=\"US08927710-20150106-C00250.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00251.CDX\" idref=\"CHEM-US-00251\" mol-file=\"US08927710-20150106-C00251.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00252.CDX\" idref=\"CHEM-US-00252\" mol-file=\"US08927710-20150106-C00252.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00253.CDX\" idref=\"CHEM-US-00253\" mol-file=\"US08927710-20150106-C00253.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00254.CDX\" idref=\"CHEM-US-00254\" mol-file=\"US08927710-20150106-C00254.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00255.CDX\" idref=\"CHEM-US-00255\" mol-file=\"US08927710-20150106-C00255.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00256.CDX\" idref=\"CHEM-US-00256\" mol-file=\"US08927710-20150106-C00256.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00257.CDX\" idref=\"CHEM-US-00257\" mol-file=\"US08927710-20150106-C00257.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00258.CDX\" idref=\"CHEM-US-00258\" mol-file=\"US08927710-20150106-C00258.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00259.CDX\" idref=\"CHEM-US-00259\" mol-file=\"US08927710-20150106-C00259.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00260.CDX\" idref=\"CHEM-US-00260\" mol-file=\"US08927710-20150106-C00260.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00261.CDX\" idref=\"CHEM-US-00261\" mol-file=\"US08927710-20150106-C00261.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00262.CDX\" idref=\"CHEM-US-00262\" mol-file=\"US08927710-20150106-C00262.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00263.CDX\" idref=\"CHEM-US-00263\" mol-file=\"US08927710-20150106-C00263.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00264.CDX\" idref=\"CHEM-US-00264\" mol-file=\"US08927710-20150106-C00264.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00265.CDX\" idref=\"CHEM-US-00265\" mol-file=\"US08927710-20150106-C00265.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00266.CDX\" idref=\"CHEM-US-00266\" mol-file=\"US08927710-20150106-C00266.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00267.CDX\" idref=\"CHEM-US-00267\" mol-file=\"US08927710-20150106-C00267.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00268.CDX\" idref=\"CHEM-US-00268\" mol-file=\"US08927710-20150106-C00268.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00269.CDX\" idref=\"CHEM-US-00269\" mol-file=\"US08927710-20150106-C00269.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00270.CDX\" idref=\"CHEM-US-00270\" mol-file=\"US08927710-20150106-C00270.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00271.CDX\" idref=\"CHEM-US-00271\" mol-file=\"US08927710-20150106-C00271.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00272.CDX\" idref=\"CHEM-US-00272\" mol-file=\"US08927710-20150106-C00272.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00273.CDX\" idref=\"CHEM-US-00273\" mol-file=\"US08927710-20150106-C00273.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00274.CDX\" idref=\"CHEM-US-00274\" mol-file=\"US08927710-20150106-C00274.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00275.CDX\" idref=\"CHEM-US-00275\" mol-file=\"US08927710-20150106-C00275.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00276.CDX\" idref=\"CHEM-US-00276\" mol-file=\"US08927710-20150106-C00276.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00277.CDX\" idref=\"CHEM-US-00277\" mol-file=\"US08927710-20150106-C00277.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00278.CDX\" idref=\"CHEM-US-00278\" mol-file=\"US08927710-20150106-C00278.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00279.CDX\" idref=\"CHEM-US-00279\" mol-file=\"US08927710-20150106-C00279.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00280.CDX\" idref=\"CHEM-US-00280\" mol-file=\"US08927710-20150106-C00280.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00281.CDX\" idref=\"CHEM-US-00281\" mol-file=\"US08927710-20150106-C00281.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00282.CDX\" idref=\"CHEM-US-00282\" mol-file=\"US08927710-20150106-C00282.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00283.CDX\" idref=\"CHEM-US-00283\" mol-file=\"US08927710-20150106-C00283.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00284.CDX\" idref=\"CHEM-US-00284\" mol-file=\"US08927710-20150106-C00284.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00285.CDX\" idref=\"CHEM-US-00285\" mol-file=\"US08927710-20150106-C00285.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00286.CDX\" idref=\"CHEM-US-00286\" mol-file=\"US08927710-20150106-C00286.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00287.CDX\" idref=\"CHEM-US-00287\" mol-file=\"US08927710-20150106-C00287.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00288.CDX\" idref=\"CHEM-US-00288\" mol-file=\"US08927710-20150106-C00288.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00289.CDX\" idref=\"CHEM-US-00289\" mol-file=\"US08927710-20150106-C00289.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00290.CDX\" idref=\"CHEM-US-00290\" mol-file=\"US08927710-20150106-C00290.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00291.CDX\" idref=\"CHEM-US-00291\" mol-file=\"US08927710-20150106-C00291.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00292.CDX\" idref=\"CHEM-US-00292\" mol-file=\"US08927710-20150106-C00292.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00293.CDX\" idref=\"CHEM-US-00293\" mol-file=\"US08927710-20150106-C00293.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00294.CDX\" idref=\"CHEM-US-00294\" mol-file=\"US08927710-20150106-C00294.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00295.CDX\" idref=\"CHEM-US-00295\" mol-file=\"US08927710-20150106-C00295.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00296.CDX\" idref=\"CHEM-US-00296\" mol-file=\"US08927710-20150106-C00296.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00297.CDX\" idref=\"CHEM-US-00297\" mol-file=\"US08927710-20150106-C00297.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00298.CDX\" idref=\"CHEM-US-00298\" mol-file=\"US08927710-20150106-C00298.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00299.CDX\" idref=\"CHEM-US-00299\" mol-file=\"US08927710-20150106-C00299.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00300.CDX\" idref=\"CHEM-US-00300\" mol-file=\"US08927710-20150106-C00300.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00301.CDX\" idref=\"CHEM-US-00301\" mol-file=\"US08927710-20150106-C00301.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00302.CDX\" idref=\"CHEM-US-00302\" mol-file=\"US08927710-20150106-C00302.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00303.CDX\" idref=\"CHEM-US-00303\" mol-file=\"US08927710-20150106-C00303.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00304.CDX\" idref=\"CHEM-US-00304\" mol-file=\"US08927710-20150106-C00304.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00305.CDX\" idref=\"CHEM-US-00305\" mol-file=\"US08927710-20150106-C00305.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00306.CDX\" idref=\"CHEM-US-00306\" mol-file=\"US08927710-20150106-C00306.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00307.CDX\" idref=\"CHEM-US-00307\" mol-file=\"US08927710-20150106-C00307.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00308.CDX\" idref=\"CHEM-US-00308\" mol-file=\"US08927710-20150106-C00308.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00309.CDX\" idref=\"CHEM-US-00309\" mol-file=\"US08927710-20150106-C00309.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00310.CDX\" idref=\"CHEM-US-00310\" mol-file=\"US08927710-20150106-C00310.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00311.CDX\" idref=\"CHEM-US-00311\" mol-file=\"US08927710-20150106-C00311.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00312.CDX\" idref=\"CHEM-US-00312\" mol-file=\"US08927710-20150106-C00312.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00313.CDX\" idref=\"CHEM-US-00313\" mol-file=\"US08927710-20150106-C00313.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00314.CDX\" idref=\"CHEM-US-00314\" mol-file=\"US08927710-20150106-C00314.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00315.CDX\" idref=\"CHEM-US-00315\" mol-file=\"US08927710-20150106-C00315.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00316.CDX\" idref=\"CHEM-US-00316\" mol-file=\"US08927710-20150106-C00316.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00317.CDX\" idref=\"CHEM-US-00317\" mol-file=\"US08927710-20150106-C00317.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00318.CDX\" idref=\"CHEM-US-00318\" mol-file=\"US08927710-20150106-C00318.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00319.CDX\" idref=\"CHEM-US-00319\" mol-file=\"US08927710-20150106-C00319.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00320.CDX\" idref=\"CHEM-US-00320\" mol-file=\"US08927710-20150106-C00320.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00321.CDX\" idref=\"CHEM-US-00321\" mol-file=\"US08927710-20150106-C00321.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00322.CDX\" idref=\"CHEM-US-00322\" mol-file=\"US08927710-20150106-C00322.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00323.CDX\" idref=\"CHEM-US-00323\" mol-file=\"US08927710-20150106-C00323.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00324.CDX\" idref=\"CHEM-US-00324\" mol-file=\"US08927710-20150106-C00324.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00325.CDX\" idref=\"CHEM-US-00325\" mol-file=\"US08927710-20150106-C00325.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00326.CDX\" idref=\"CHEM-US-00326\" mol-file=\"US08927710-20150106-C00326.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00327.CDX\" idref=\"CHEM-US-00327\" mol-file=\"US08927710-20150106-C00327.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00328.CDX\" idref=\"CHEM-US-00328\" mol-file=\"US08927710-20150106-C00328.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00329.CDX\" idref=\"CHEM-US-00329\" mol-file=\"US08927710-20150106-C00329.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00330.CDX\" idref=\"CHEM-US-00330\" mol-file=\"US08927710-20150106-C00330.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00331.CDX\" idref=\"CHEM-US-00331\" mol-file=\"US08927710-20150106-C00331.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00332.CDX\" idref=\"CHEM-US-00332\" mol-file=\"US08927710-20150106-C00332.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00333.CDX\" idref=\"CHEM-US-00333\" mol-file=\"US08927710-20150106-C00333.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00334.CDX\" idref=\"CHEM-US-00334\" mol-file=\"US08927710-20150106-C00334.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00335.CDX\" idref=\"CHEM-US-00335\" mol-file=\"US08927710-20150106-C00335.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00336.CDX\" idref=\"CHEM-US-00336\" mol-file=\"US08927710-20150106-C00336.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00337.CDX\" idref=\"CHEM-US-00337\" mol-file=\"US08927710-20150106-C00337.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00338.CDX\" idref=\"CHEM-US-00338\" mol-file=\"US08927710-20150106-C00338.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00339.CDX\" idref=\"CHEM-US-00339\" mol-file=\"US08927710-20150106-C00339.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00340.CDX\" idref=\"CHEM-US-00340\" mol-file=\"US08927710-20150106-C00340.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00341.CDX\" idref=\"CHEM-US-00341\" mol-file=\"US08927710-20150106-C00341.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00342.CDX\" idref=\"CHEM-US-00342\" mol-file=\"US08927710-20150106-C00342.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00343.CDX\" idref=\"CHEM-US-00343\" mol-file=\"US08927710-20150106-C00343.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00344.CDX\" idref=\"CHEM-US-00344\" mol-file=\"US08927710-20150106-C00344.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00345.CDX\" idref=\"CHEM-US-00345\" mol-file=\"US08927710-20150106-C00345.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00346.CDX\" idref=\"CHEM-US-00346\" mol-file=\"US08927710-20150106-C00346.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00347.CDX\" idref=\"CHEM-US-00347\" mol-file=\"US08927710-20150106-C00347.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00348.CDX\" idref=\"CHEM-US-00348\" mol-file=\"US08927710-20150106-C00348.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00349.CDX\" idref=\"CHEM-US-00349\" mol-file=\"US08927710-20150106-C00349.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00350.CDX\" idref=\"CHEM-US-00350\" mol-file=\"US08927710-20150106-C00350.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00351.CDX\" idref=\"CHEM-US-00351\" mol-file=\"US08927710-20150106-C00351.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00352.CDX\" idref=\"CHEM-US-00352\" mol-file=\"US08927710-20150106-C00352.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00353.CDX\" idref=\"CHEM-US-00353\" mol-file=\"US08927710-20150106-C00353.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00354.CDX\" idref=\"CHEM-US-00354\" mol-file=\"US08927710-20150106-C00354.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00355.CDX\" idref=\"CHEM-US-00355\" mol-file=\"US08927710-20150106-C00355.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00356.CDX\" idref=\"CHEM-US-00356\" mol-file=\"US08927710-20150106-C00356.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00357.CDX\" idref=\"CHEM-US-00357\" mol-file=\"US08927710-20150106-C00357.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00358.CDX\" idref=\"CHEM-US-00358\" mol-file=\"US08927710-20150106-C00358.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00359.CDX\" idref=\"CHEM-US-00359\" mol-file=\"US08927710-20150106-C00359.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00360.CDX\" idref=\"CHEM-US-00360\" mol-file=\"US08927710-20150106-C00360.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00361.CDX\" idref=\"CHEM-US-00361\" mol-file=\"US08927710-20150106-C00361.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00362.CDX\" idref=\"CHEM-US-00362\" mol-file=\"US08927710-20150106-C00362.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00363.CDX\" idref=\"CHEM-US-00363\" mol-file=\"US08927710-20150106-C00363.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00364.CDX\" idref=\"CHEM-US-00364\" mol-file=\"US08927710-20150106-C00364.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00365.CDX\" idref=\"CHEM-US-00365\" mol-file=\"US08927710-20150106-C00365.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00366.CDX\" idref=\"CHEM-US-00366\" mol-file=\"US08927710-20150106-C00366.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00367.CDX\" idref=\"CHEM-US-00367\" mol-file=\"US08927710-20150106-C00367.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00368.CDX\" idref=\"CHEM-US-00368\" mol-file=\"US08927710-20150106-C00368.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00369.CDX\" idref=\"CHEM-US-00369\" mol-file=\"US08927710-20150106-C00369.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00370.CDX\" idref=\"CHEM-US-00370\" mol-file=\"US08927710-20150106-C00370.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00371.CDX\" idref=\"CHEM-US-00371\" mol-file=\"US08927710-20150106-C00371.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00372.CDX\" idref=\"CHEM-US-00372\" mol-file=\"US08927710-20150106-C00372.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00373.CDX\" idref=\"CHEM-US-00373\" mol-file=\"US08927710-20150106-C00373.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00374.CDX\" idref=\"CHEM-US-00374\" mol-file=\"US08927710-20150106-C00374.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00375.CDX\" idref=\"CHEM-US-00375\" mol-file=\"US08927710-20150106-C00375.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00376.CDX\" idref=\"CHEM-US-00376\" mol-file=\"US08927710-20150106-C00376.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00377.CDX\" idref=\"CHEM-US-00377\" mol-file=\"US08927710-20150106-C00377.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00378.CDX\" idref=\"CHEM-US-00378\" mol-file=\"US08927710-20150106-C00378.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00379.CDX\" idref=\"CHEM-US-00379\" mol-file=\"US08927710-20150106-C00379.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00380.CDX\" idref=\"CHEM-US-00380\" mol-file=\"US08927710-20150106-C00380.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00381.CDX\" idref=\"CHEM-US-00381\" mol-file=\"US08927710-20150106-C00381.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00382.CDX\" idref=\"CHEM-US-00382\" mol-file=\"US08927710-20150106-C00382.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00383.CDX\" idref=\"CHEM-US-00383\" mol-file=\"US08927710-20150106-C00383.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00384.CDX\" idref=\"CHEM-US-00384\" mol-file=\"US08927710-20150106-C00384.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00385.CDX\" idref=\"CHEM-US-00385\" mol-file=\"US08927710-20150106-C00385.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00386.CDX\" idref=\"CHEM-US-00386\" mol-file=\"US08927710-20150106-C00386.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00387.CDX\" idref=\"CHEM-US-00387\" mol-file=\"US08927710-20150106-C00387.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00388.CDX\" idref=\"CHEM-US-00388\" mol-file=\"US08927710-20150106-C00388.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00389.CDX\" idref=\"CHEM-US-00389\" mol-file=\"US08927710-20150106-C00389.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00390.CDX\" idref=\"CHEM-US-00390\" mol-file=\"US08927710-20150106-C00390.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00391.CDX\" idref=\"CHEM-US-00391\" mol-file=\"US08927710-20150106-C00391.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00392.CDX\" idref=\"CHEM-US-00392\" mol-file=\"US08927710-20150106-C00392.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00393.CDX\" idref=\"CHEM-US-00393\" mol-file=\"US08927710-20150106-C00393.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00394.CDX\" idref=\"CHEM-US-00394\" mol-file=\"US08927710-20150106-C00394.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00395.CDX\" idref=\"CHEM-US-00395\" mol-file=\"US08927710-20150106-C00395.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00396.CDX\" idref=\"CHEM-US-00396\" mol-file=\"US08927710-20150106-C00396.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00397.CDX\" idref=\"CHEM-US-00397\" mol-file=\"US08927710-20150106-C00397.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00398.CDX\" idref=\"CHEM-US-00398\" mol-file=\"US08927710-20150106-C00398.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00399.CDX\" idref=\"CHEM-US-00399\" mol-file=\"US08927710-20150106-C00399.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00400.CDX\" idref=\"CHEM-US-00400\" mol-file=\"US08927710-20150106-C00400.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00401.CDX\" idref=\"CHEM-US-00401\" mol-file=\"US08927710-20150106-C00401.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00402.CDX\" idref=\"CHEM-US-00402\" mol-file=\"US08927710-20150106-C00402.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00403.CDX\" idref=\"CHEM-US-00403\" mol-file=\"US08927710-20150106-C00403.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00404.CDX\" idref=\"CHEM-US-00404\" mol-file=\"US08927710-20150106-C00404.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00405.CDX\" idref=\"CHEM-US-00405\" mol-file=\"US08927710-20150106-C00405.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00406.CDX\" idref=\"CHEM-US-00406\" mol-file=\"US08927710-20150106-C00406.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00407.CDX\" idref=\"CHEM-US-00407\" mol-file=\"US08927710-20150106-C00407.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00408.CDX\" idref=\"CHEM-US-00408\" mol-file=\"US08927710-20150106-C00408.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00409.CDX\" idref=\"CHEM-US-00409\" mol-file=\"US08927710-20150106-C00409.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00410.CDX\" idref=\"CHEM-US-00410\" mol-file=\"US08927710-20150106-C00410.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00411.CDX\" idref=\"CHEM-US-00411\" mol-file=\"US08927710-20150106-C00411.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00412.CDX\" idref=\"CHEM-US-00412\" mol-file=\"US08927710-20150106-C00412.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00413.CDX\" idref=\"CHEM-US-00413\" mol-file=\"US08927710-20150106-C00413.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00414.CDX\" idref=\"CHEM-US-00414\" mol-file=\"US08927710-20150106-C00414.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00415.CDX\" idref=\"CHEM-US-00415\" mol-file=\"US08927710-20150106-C00415.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00416.CDX\" idref=\"CHEM-US-00416\" mol-file=\"US08927710-20150106-C00416.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00417.CDX\" idref=\"CHEM-US-00417\" mol-file=\"US08927710-20150106-C00417.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00418.CDX\" idref=\"CHEM-US-00418\" mol-file=\"US08927710-20150106-C00418.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00419.CDX\" idref=\"CHEM-US-00419\" mol-file=\"US08927710-20150106-C00419.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00420.CDX\" idref=\"CHEM-US-00420\" mol-file=\"US08927710-20150106-C00420.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00421.CDX\" idref=\"CHEM-US-00421\" mol-file=\"US08927710-20150106-C00421.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00422.CDX\" idref=\"CHEM-US-00422\" mol-file=\"US08927710-20150106-C00422.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00423.CDX\" idref=\"CHEM-US-00423\" mol-file=\"US08927710-20150106-C00423.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00424.CDX\" idref=\"CHEM-US-00424\" mol-file=\"US08927710-20150106-C00424.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00425.CDX\" idref=\"CHEM-US-00425\" mol-file=\"US08927710-20150106-C00425.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00426.CDX\" idref=\"CHEM-US-00426\" mol-file=\"US08927710-20150106-C00426.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00427.CDX\" idref=\"CHEM-US-00427\" mol-file=\"US08927710-20150106-C00427.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00428.CDX\" idref=\"CHEM-US-00428\" mol-file=\"US08927710-20150106-C00428.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00429.CDX\" idref=\"CHEM-US-00429\" mol-file=\"US08927710-20150106-C00429.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00430.CDX\" idref=\"CHEM-US-00430\" mol-file=\"US08927710-20150106-C00430.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00431.CDX\" idref=\"CHEM-US-00431\" mol-file=\"US08927710-20150106-C00431.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00432.CDX\" idref=\"CHEM-US-00432\" mol-file=\"US08927710-20150106-C00432.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00433.CDX\" idref=\"CHEM-US-00433\" mol-file=\"US08927710-20150106-C00433.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00434.CDX\" idref=\"CHEM-US-00434\" mol-file=\"US08927710-20150106-C00434.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00435.CDX\" idref=\"CHEM-US-00435\" mol-file=\"US08927710-20150106-C00435.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00436.CDX\" idref=\"CHEM-US-00436\" mol-file=\"US08927710-20150106-C00436.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00437.CDX\" idref=\"CHEM-US-00437\" mol-file=\"US08927710-20150106-C00437.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00438.CDX\" idref=\"CHEM-US-00438\" mol-file=\"US08927710-20150106-C00438.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00439.CDX\" idref=\"CHEM-US-00439\" mol-file=\"US08927710-20150106-C00439.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00440.CDX\" idref=\"CHEM-US-00440\" mol-file=\"US08927710-20150106-C00440.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00441.CDX\" idref=\"CHEM-US-00441\" mol-file=\"US08927710-20150106-C00441.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00442.CDX\" idref=\"CHEM-US-00442\" mol-file=\"US08927710-20150106-C00442.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00443.CDX\" idref=\"CHEM-US-00443\" mol-file=\"US08927710-20150106-C00443.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00444.CDX\" idref=\"CHEM-US-00444\" mol-file=\"US08927710-20150106-C00444.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00445.CDX\" idref=\"CHEM-US-00445\" mol-file=\"US08927710-20150106-C00445.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00446.CDX\" idref=\"CHEM-US-00446\" mol-file=\"US08927710-20150106-C00446.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00447.CDX\" idref=\"CHEM-US-00447\" mol-file=\"US08927710-20150106-C00447.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00448.CDX\" idref=\"CHEM-US-00448\" mol-file=\"US08927710-20150106-C00448.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00449.CDX\" idref=\"CHEM-US-00449\" mol-file=\"US08927710-20150106-C00449.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00450.CDX\" idref=\"CHEM-US-00450\" mol-file=\"US08927710-20150106-C00450.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00451.CDX\" idref=\"CHEM-US-00451\" mol-file=\"US08927710-20150106-C00451.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00452.CDX\" idref=\"CHEM-US-00452\" mol-file=\"US08927710-20150106-C00452.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00453.CDX\" idref=\"CHEM-US-00453\" mol-file=\"US08927710-20150106-C00453.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00454.CDX\" idref=\"CHEM-US-00454\" mol-file=\"US08927710-20150106-C00454.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00455.CDX\" idref=\"CHEM-US-00455\" mol-file=\"US08927710-20150106-C00455.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00456.CDX\" idref=\"CHEM-US-00456\" mol-file=\"US08927710-20150106-C00456.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00457.CDX\" idref=\"CHEM-US-00457\" mol-file=\"US08927710-20150106-C00457.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00458.CDX\" idref=\"CHEM-US-00458\" mol-file=\"US08927710-20150106-C00458.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00459.CDX\" idref=\"CHEM-US-00459\" mol-file=\"US08927710-20150106-C00459.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00460.CDX\" idref=\"CHEM-US-00460\" mol-file=\"US08927710-20150106-C00460.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00461.CDX\" idref=\"CHEM-US-00461\" mol-file=\"US08927710-20150106-C00461.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00462.CDX\" idref=\"CHEM-US-00462\" mol-file=\"US08927710-20150106-C00462.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00463.CDX\" idref=\"CHEM-US-00463\" mol-file=\"US08927710-20150106-C00463.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00464.CDX\" idref=\"CHEM-US-00464\" mol-file=\"US08927710-20150106-C00464.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00465.CDX\" idref=\"CHEM-US-00465\" mol-file=\"US08927710-20150106-C00465.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00466.CDX\" idref=\"CHEM-US-00466\" mol-file=\"US08927710-20150106-C00466.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00467.CDX\" idref=\"CHEM-US-00467\" mol-file=\"US08927710-20150106-C00467.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00468.CDX\" idref=\"CHEM-US-00468\" mol-file=\"US08927710-20150106-C00468.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00469.CDX\" idref=\"CHEM-US-00469\" mol-file=\"US08927710-20150106-C00469.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00470.CDX\" idref=\"CHEM-US-00470\" mol-file=\"US08927710-20150106-C00470.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00471.CDX\" idref=\"CHEM-US-00471\" mol-file=\"US08927710-20150106-C00471.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00472.CDX\" idref=\"CHEM-US-00472\" mol-file=\"US08927710-20150106-C00472.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00473.CDX\" idref=\"CHEM-US-00473\" mol-file=\"US08927710-20150106-C00473.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00474.CDX\" idref=\"CHEM-US-00474\" mol-file=\"US08927710-20150106-C00474.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00475.CDX\" idref=\"CHEM-US-00475\" mol-file=\"US08927710-20150106-C00475.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00476.CDX\" idref=\"CHEM-US-00476\" mol-file=\"US08927710-20150106-C00476.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00477.CDX\" idref=\"CHEM-US-00477\" mol-file=\"US08927710-20150106-C00477.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00478.CDX\" idref=\"CHEM-US-00478\" mol-file=\"US08927710-20150106-C00478.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00479.CDX\" idref=\"CHEM-US-00479\" mol-file=\"US08927710-20150106-C00479.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00480.CDX\" idref=\"CHEM-US-00480\" mol-file=\"US08927710-20150106-C00480.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00481.CDX\" idref=\"CHEM-US-00481\" mol-file=\"US08927710-20150106-C00481.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00482.CDX\" idref=\"CHEM-US-00482\" mol-file=\"US08927710-20150106-C00482.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00483.CDX\" idref=\"CHEM-US-00483\" mol-file=\"US08927710-20150106-C00483.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00484.CDX\" idref=\"CHEM-US-00484\" mol-file=\"US08927710-20150106-C00484.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00485.CDX\" idref=\"CHEM-US-00485\" mol-file=\"US08927710-20150106-C00485.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00486.CDX\" idref=\"CHEM-US-00486\" mol-file=\"US08927710-20150106-C00486.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00487.CDX\" idref=\"CHEM-US-00487\" mol-file=\"US08927710-20150106-C00487.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00488.CDX\" idref=\"CHEM-US-00488\" mol-file=\"US08927710-20150106-C00488.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00489.CDX\" idref=\"CHEM-US-00489\" mol-file=\"US08927710-20150106-C00489.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00490.CDX\" idref=\"CHEM-US-00490\" mol-file=\"US08927710-20150106-C00490.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00491.CDX\" idref=\"CHEM-US-00491\" mol-file=\"US08927710-20150106-C00491.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00492.CDX\" idref=\"CHEM-US-00492\" mol-file=\"US08927710-20150106-C00492.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00493.CDX\" idref=\"CHEM-US-00493\" mol-file=\"US08927710-20150106-C00493.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00494.CDX\" idref=\"CHEM-US-00494\" mol-file=\"US08927710-20150106-C00494.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00495.CDX\" idref=\"CHEM-US-00495\" mol-file=\"US08927710-20150106-C00495.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00496.CDX\" idref=\"CHEM-US-00496\" mol-file=\"US08927710-20150106-C00496.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00497.CDX\" idref=\"CHEM-US-00497\" mol-file=\"US08927710-20150106-C00497.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00498.CDX\" idref=\"CHEM-US-00498\" mol-file=\"US08927710-20150106-C00498.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00499.CDX\" idref=\"CHEM-US-00499\" mol-file=\"US08927710-20150106-C00499.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00500.CDX\" idref=\"CHEM-US-00500\" mol-file=\"US08927710-20150106-C00500.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00501.CDX\" idref=\"CHEM-US-00501\" mol-file=\"US08927710-20150106-C00501.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00502.CDX\" idref=\"CHEM-US-00502\" mol-file=\"US08927710-20150106-C00502.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00503.CDX\" idref=\"CHEM-US-00503\" mol-file=\"US08927710-20150106-C00503.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00504.CDX\" idref=\"CHEM-US-00504\" mol-file=\"US08927710-20150106-C00504.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00505.CDX\" idref=\"CHEM-US-00505\" mol-file=\"US08927710-20150106-C00505.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00506.CDX\" idref=\"CHEM-US-00506\" mol-file=\"US08927710-20150106-C00506.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00507.CDX\" idref=\"CHEM-US-00507\" mol-file=\"US08927710-20150106-C00507.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00508.CDX\" idref=\"CHEM-US-00508\" mol-file=\"US08927710-20150106-C00508.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00509.CDX\" idref=\"CHEM-US-00509\" mol-file=\"US08927710-20150106-C00509.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00510.CDX\" idref=\"CHEM-US-00510\" mol-file=\"US08927710-20150106-C00510.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00511.CDX\" idref=\"CHEM-US-00511\" mol-file=\"US08927710-20150106-C00511.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00512.CDX\" idref=\"CHEM-US-00512\" mol-file=\"US08927710-20150106-C00512.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00513.CDX\" idref=\"CHEM-US-00513\" mol-file=\"US08927710-20150106-C00513.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00514.CDX\" idref=\"CHEM-US-00514\" mol-file=\"US08927710-20150106-C00514.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00515.CDX\" idref=\"CHEM-US-00515\" mol-file=\"US08927710-20150106-C00515.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00516.CDX\" idref=\"CHEM-US-00516\" mol-file=\"US08927710-20150106-C00516.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00517.CDX\" idref=\"CHEM-US-00517\" mol-file=\"US08927710-20150106-C00517.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00518.CDX\" idref=\"CHEM-US-00518\" mol-file=\"US08927710-20150106-C00518.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00519.CDX\" idref=\"CHEM-US-00519\" mol-file=\"US08927710-20150106-C00519.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00520.CDX\" idref=\"CHEM-US-00520\" mol-file=\"US08927710-20150106-C00520.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00521.CDX\" idref=\"CHEM-US-00521\" mol-file=\"US08927710-20150106-C00521.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00522.CDX\" idref=\"CHEM-US-00522\" mol-file=\"US08927710-20150106-C00522.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00523.CDX\" idref=\"CHEM-US-00523\" mol-file=\"US08927710-20150106-C00523.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00524.CDX\" idref=\"CHEM-US-00524\" mol-file=\"US08927710-20150106-C00524.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00525.CDX\" idref=\"CHEM-US-00525\" mol-file=\"US08927710-20150106-C00525.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00526.CDX\" idref=\"CHEM-US-00526\" mol-file=\"US08927710-20150106-C00526.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00527.CDX\" idref=\"CHEM-US-00527\" mol-file=\"US08927710-20150106-C00527.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00528.CDX\" idref=\"CHEM-US-00528\" mol-file=\"US08927710-20150106-C00528.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00529.CDX\" idref=\"CHEM-US-00529\" mol-file=\"US08927710-20150106-C00529.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00530.CDX\" idref=\"CHEM-US-00530\" mol-file=\"US08927710-20150106-C00530.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00531.CDX\" idref=\"CHEM-US-00531\" mol-file=\"US08927710-20150106-C00531.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00532.CDX\" idref=\"CHEM-US-00532\" mol-file=\"US08927710-20150106-C00532.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00533.CDX\" idref=\"CHEM-US-00533\" mol-file=\"US08927710-20150106-C00533.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00534.CDX\" idref=\"CHEM-US-00534\" mol-file=\"US08927710-20150106-C00534.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00535.CDX\" idref=\"CHEM-US-00535\" mol-file=\"US08927710-20150106-C00535.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00536.CDX\" idref=\"CHEM-US-00536\" mol-file=\"US08927710-20150106-C00536.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00537.CDX\" idref=\"CHEM-US-00537\" mol-file=\"US08927710-20150106-C00537.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00538.CDX\" idref=\"CHEM-US-00538\" mol-file=\"US08927710-20150106-C00538.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00539.CDX\" idref=\"CHEM-US-00539\" mol-file=\"US08927710-20150106-C00539.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00540.CDX\" idref=\"CHEM-US-00540\" mol-file=\"US08927710-20150106-C00540.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00541.CDX\" idref=\"CHEM-US-00541\" mol-file=\"US08927710-20150106-C00541.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00542.CDX\" idref=\"CHEM-US-00542\" mol-file=\"US08927710-20150106-C00542.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00543.CDX\" idref=\"CHEM-US-00543\" mol-file=\"US08927710-20150106-C00543.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00544.CDX\" idref=\"CHEM-US-00544\" mol-file=\"US08927710-20150106-C00544.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00545.CDX\" idref=\"CHEM-US-00545\" mol-file=\"US08927710-20150106-C00545.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00546.CDX\" idref=\"CHEM-US-00546\" mol-file=\"US08927710-20150106-C00546.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00547.CDX\" idref=\"CHEM-US-00547\" mol-file=\"US08927710-20150106-C00547.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00548.CDX\" idref=\"CHEM-US-00548\" mol-file=\"US08927710-20150106-C00548.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00549.CDX\" idref=\"CHEM-US-00549\" mol-file=\"US08927710-20150106-C00549.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00550.CDX\" idref=\"CHEM-US-00550\" mol-file=\"US08927710-20150106-C00550.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00551.CDX\" idref=\"CHEM-US-00551\" mol-file=\"US08927710-20150106-C00551.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00552.CDX\" idref=\"CHEM-US-00552\" mol-file=\"US08927710-20150106-C00552.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00553.CDX\" idref=\"CHEM-US-00553\" mol-file=\"US08927710-20150106-C00553.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00554.CDX\" idref=\"CHEM-US-00554\" mol-file=\"US08927710-20150106-C00554.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00555.CDX\" idref=\"CHEM-US-00555\" mol-file=\"US08927710-20150106-C00555.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00556.CDX\" idref=\"CHEM-US-00556\" mol-file=\"US08927710-20150106-C00556.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00557.CDX\" idref=\"CHEM-US-00557\" mol-file=\"US08927710-20150106-C00557.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00558.CDX\" idref=\"CHEM-US-00558\" mol-file=\"US08927710-20150106-C00558.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00559.CDX\" idref=\"CHEM-US-00559\" mol-file=\"US08927710-20150106-C00559.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00560.CDX\" idref=\"CHEM-US-00560\" mol-file=\"US08927710-20150106-C00560.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00561.CDX\" idref=\"CHEM-US-00561\" mol-file=\"US08927710-20150106-C00561.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00562.CDX\" idref=\"CHEM-US-00562\" mol-file=\"US08927710-20150106-C00562.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00563.CDX\" idref=\"CHEM-US-00563\" mol-file=\"US08927710-20150106-C00563.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00564.CDX\" idref=\"CHEM-US-00564\" mol-file=\"US08927710-20150106-C00564.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00565.CDX\" idref=\"CHEM-US-00565\" mol-file=\"US08927710-20150106-C00565.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00566.CDX\" idref=\"CHEM-US-00566\" mol-file=\"US08927710-20150106-C00566.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00567.CDX\" idref=\"CHEM-US-00567\" mol-file=\"US08927710-20150106-C00567.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00568.CDX\" idref=\"CHEM-US-00568\" mol-file=\"US08927710-20150106-C00568.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00569.CDX\" idref=\"CHEM-US-00569\" mol-file=\"US08927710-20150106-C00569.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00570.CDX\" idref=\"CHEM-US-00570\" mol-file=\"US08927710-20150106-C00570.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00571.CDX\" idref=\"CHEM-US-00571\" mol-file=\"US08927710-20150106-C00571.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00572.CDX\" idref=\"CHEM-US-00572\" mol-file=\"US08927710-20150106-C00572.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00573.CDX\" idref=\"CHEM-US-00573\" mol-file=\"US08927710-20150106-C00573.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00574.CDX\" idref=\"CHEM-US-00574\" mol-file=\"US08927710-20150106-C00574.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00575.CDX\" idref=\"CHEM-US-00575\" mol-file=\"US08927710-20150106-C00575.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00576.CDX\" idref=\"CHEM-US-00576\" mol-file=\"US08927710-20150106-C00576.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00577.CDX\" idref=\"CHEM-US-00577\" mol-file=\"US08927710-20150106-C00577.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00578.CDX\" idref=\"CHEM-US-00578\" mol-file=\"US08927710-20150106-C00578.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00579.CDX\" idref=\"CHEM-US-00579\" mol-file=\"US08927710-20150106-C00579.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00580.CDX\" idref=\"CHEM-US-00580\" mol-file=\"US08927710-20150106-C00580.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00581.CDX\" idref=\"CHEM-US-00581\" mol-file=\"US08927710-20150106-C00581.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00582.CDX\" idref=\"CHEM-US-00582\" mol-file=\"US08927710-20150106-C00582.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00583.CDX\" idref=\"CHEM-US-00583\" mol-file=\"US08927710-20150106-C00583.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00584.CDX\" idref=\"CHEM-US-00584\" mol-file=\"US08927710-20150106-C00584.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00585.CDX\" idref=\"CHEM-US-00585\" mol-file=\"US08927710-20150106-C00585.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00586.CDX\" idref=\"CHEM-US-00586\" mol-file=\"US08927710-20150106-C00586.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00587.CDX\" idref=\"CHEM-US-00587\" mol-file=\"US08927710-20150106-C00587.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00588.CDX\" idref=\"CHEM-US-00588\" mol-file=\"US08927710-20150106-C00588.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00589.CDX\" idref=\"CHEM-US-00589\" mol-file=\"US08927710-20150106-C00589.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00590.CDX\" idref=\"CHEM-US-00590\" mol-file=\"US08927710-20150106-C00590.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00591.CDX\" idref=\"CHEM-US-00591\" mol-file=\"US08927710-20150106-C00591.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00592.CDX\" idref=\"CHEM-US-00592\" mol-file=\"US08927710-20150106-C00592.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00593.CDX\" idref=\"CHEM-US-00593\" mol-file=\"US08927710-20150106-C00593.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00594.CDX\" idref=\"CHEM-US-00594\" mol-file=\"US08927710-20150106-C00594.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00595.CDX\" idref=\"CHEM-US-00595\" mol-file=\"US08927710-20150106-C00595.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00596.CDX\" idref=\"CHEM-US-00596\" mol-file=\"US08927710-20150106-C00596.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00597.CDX\" idref=\"CHEM-US-00597\" mol-file=\"US08927710-20150106-C00597.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00598.CDX\" idref=\"CHEM-US-00598\" mol-file=\"US08927710-20150106-C00598.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00599.CDX\" idref=\"CHEM-US-00599\" mol-file=\"US08927710-20150106-C00599.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00600.CDX\" idref=\"CHEM-US-00600\" mol-file=\"US08927710-20150106-C00600.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00601.CDX\" idref=\"CHEM-US-00601\" mol-file=\"US08927710-20150106-C00601.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00602.CDX\" idref=\"CHEM-US-00602\" mol-file=\"US08927710-20150106-C00602.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00603.CDX\" idref=\"CHEM-US-00603\" mol-file=\"US08927710-20150106-C00603.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00604.CDX\" idref=\"CHEM-US-00604\" mol-file=\"US08927710-20150106-C00604.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00605.CDX\" idref=\"CHEM-US-00605\" mol-file=\"US08927710-20150106-C00605.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00606.CDX\" idref=\"CHEM-US-00606\" mol-file=\"US08927710-20150106-C00606.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00607.CDX\" idref=\"CHEM-US-00607\" mol-file=\"US08927710-20150106-C00607.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00608.CDX\" idref=\"CHEM-US-00608\" mol-file=\"US08927710-20150106-C00608.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00609.CDX\" idref=\"CHEM-US-00609\" mol-file=\"US08927710-20150106-C00609.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00610.CDX\" idref=\"CHEM-US-00610\" mol-file=\"US08927710-20150106-C00610.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00611.CDX\" idref=\"CHEM-US-00611\" mol-file=\"US08927710-20150106-C00611.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00612.CDX\" idref=\"CHEM-US-00612\" mol-file=\"US08927710-20150106-C00612.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00613.CDX\" idref=\"CHEM-US-00613\" mol-file=\"US08927710-20150106-C00613.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00614.CDX\" idref=\"CHEM-US-00614\" mol-file=\"US08927710-20150106-C00614.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00615.CDX\" idref=\"CHEM-US-00615\" mol-file=\"US08927710-20150106-C00615.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00616.CDX\" idref=\"CHEM-US-00616\" mol-file=\"US08927710-20150106-C00616.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00617.CDX\" idref=\"CHEM-US-00617\" mol-file=\"US08927710-20150106-C00617.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00618.CDX\" idref=\"CHEM-US-00618\" mol-file=\"US08927710-20150106-C00618.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00619.CDX\" idref=\"CHEM-US-00619\" mol-file=\"US08927710-20150106-C00619.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00620.CDX\" idref=\"CHEM-US-00620\" mol-file=\"US08927710-20150106-C00620.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00621.CDX\" idref=\"CHEM-US-00621\" mol-file=\"US08927710-20150106-C00621.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00622.CDX\" idref=\"CHEM-US-00622\" mol-file=\"US08927710-20150106-C00622.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00623.CDX\" idref=\"CHEM-US-00623\" mol-file=\"US08927710-20150106-C00623.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00624.CDX\" idref=\"CHEM-US-00624\" mol-file=\"US08927710-20150106-C00624.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00625.CDX\" idref=\"CHEM-US-00625\" mol-file=\"US08927710-20150106-C00625.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00626.CDX\" idref=\"CHEM-US-00626\" mol-file=\"US08927710-20150106-C00626.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00627.CDX\" idref=\"CHEM-US-00627\" mol-file=\"US08927710-20150106-C00627.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00628.CDX\" idref=\"CHEM-US-00628\" mol-file=\"US08927710-20150106-C00628.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00629.CDX\" idref=\"CHEM-US-00629\" mol-file=\"US08927710-20150106-C00629.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00630.CDX\" idref=\"CHEM-US-00630\" mol-file=\"US08927710-20150106-C00630.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00631.CDX\" idref=\"CHEM-US-00631\" mol-file=\"US08927710-20150106-C00631.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00632.CDX\" idref=\"CHEM-US-00632\" mol-file=\"US08927710-20150106-C00632.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00633.CDX\" idref=\"CHEM-US-00633\" mol-file=\"US08927710-20150106-C00633.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00634.CDX\" idref=\"CHEM-US-00634\" mol-file=\"US08927710-20150106-C00634.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00635.CDX\" idref=\"CHEM-US-00635\" mol-file=\"US08927710-20150106-C00635.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00636.CDX\" idref=\"CHEM-US-00636\" mol-file=\"US08927710-20150106-C00636.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00637.CDX\" idref=\"CHEM-US-00637\" mol-file=\"US08927710-20150106-C00637.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00638.CDX\" idref=\"CHEM-US-00638\" mol-file=\"US08927710-20150106-C00638.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00639.CDX\" idref=\"CHEM-US-00639\" mol-file=\"US08927710-20150106-C00639.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00640.CDX\" idref=\"CHEM-US-00640\" mol-file=\"US08927710-20150106-C00640.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00641.CDX\" idref=\"CHEM-US-00641\" mol-file=\"US08927710-20150106-C00641.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00642.CDX\" idref=\"CHEM-US-00642\" mol-file=\"US08927710-20150106-C00642.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00643.CDX\" idref=\"CHEM-US-00643\" mol-file=\"US08927710-20150106-C00643.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00644.CDX\" idref=\"CHEM-US-00644\" mol-file=\"US08927710-20150106-C00644.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00645.CDX\" idref=\"CHEM-US-00645\" mol-file=\"US08927710-20150106-C00645.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00646.CDX\" idref=\"CHEM-US-00646\" mol-file=\"US08927710-20150106-C00646.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00647.CDX\" idref=\"CHEM-US-00647\" mol-file=\"US08927710-20150106-C00647.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00648.CDX\" idref=\"CHEM-US-00648\" mol-file=\"US08927710-20150106-C00648.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00649.CDX\" idref=\"CHEM-US-00649\" mol-file=\"US08927710-20150106-C00649.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00650.CDX\" idref=\"CHEM-US-00650\" mol-file=\"US08927710-20150106-C00650.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00651.CDX\" idref=\"CHEM-US-00651\" mol-file=\"US08927710-20150106-C00651.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00652.CDX\" idref=\"CHEM-US-00652\" mol-file=\"US08927710-20150106-C00652.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00653.CDX\" idref=\"CHEM-US-00653\" mol-file=\"US08927710-20150106-C00653.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00654.CDX\" idref=\"CHEM-US-00654\" mol-file=\"US08927710-20150106-C00654.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00655.CDX\" idref=\"CHEM-US-00655\" mol-file=\"US08927710-20150106-C00655.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00656.CDX\" idref=\"CHEM-US-00656\" mol-file=\"US08927710-20150106-C00656.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00657.CDX\" idref=\"CHEM-US-00657\" mol-file=\"US08927710-20150106-C00657.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00658.CDX\" idref=\"CHEM-US-00658\" mol-file=\"US08927710-20150106-C00658.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00659.CDX\" idref=\"CHEM-US-00659\" mol-file=\"US08927710-20150106-C00659.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00660.CDX\" idref=\"CHEM-US-00660\" mol-file=\"US08927710-20150106-C00660.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00661.CDX\" idref=\"CHEM-US-00661\" mol-file=\"US08927710-20150106-C00661.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00662.CDX\" idref=\"CHEM-US-00662\" mol-file=\"US08927710-20150106-C00662.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00663.CDX\" idref=\"CHEM-US-00663\" mol-file=\"US08927710-20150106-C00663.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00664.CDX\" idref=\"CHEM-US-00664\" mol-file=\"US08927710-20150106-C00664.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00665.CDX\" idref=\"CHEM-US-00665\" mol-file=\"US08927710-20150106-C00665.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00666.CDX\" idref=\"CHEM-US-00666\" mol-file=\"US08927710-20150106-C00666.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00667.CDX\" idref=\"CHEM-US-00667\" mol-file=\"US08927710-20150106-C00667.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00668.CDX\" idref=\"CHEM-US-00668\" mol-file=\"US08927710-20150106-C00668.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00669.CDX\" idref=\"CHEM-US-00669\" mol-file=\"US08927710-20150106-C00669.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00670.CDX\" idref=\"CHEM-US-00670\" mol-file=\"US08927710-20150106-C00670.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00671.CDX\" idref=\"CHEM-US-00671\" mol-file=\"US08927710-20150106-C00671.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00672.CDX\" idref=\"CHEM-US-00672\" mol-file=\"US08927710-20150106-C00672.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00673.CDX\" idref=\"CHEM-US-00673\" mol-file=\"US08927710-20150106-C00673.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00674.CDX\" idref=\"CHEM-US-00674\" mol-file=\"US08927710-20150106-C00674.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00675.CDX\" idref=\"CHEM-US-00675\" mol-file=\"US08927710-20150106-C00675.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00676.CDX\" idref=\"CHEM-US-00676\" mol-file=\"US08927710-20150106-C00676.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00677.CDX\" idref=\"CHEM-US-00677\" mol-file=\"US08927710-20150106-C00677.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00678.CDX\" idref=\"CHEM-US-00678\" mol-file=\"US08927710-20150106-C00678.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00679.CDX\" idref=\"CHEM-US-00679\" mol-file=\"US08927710-20150106-C00679.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00680.CDX\" idref=\"CHEM-US-00680\" mol-file=\"US08927710-20150106-C00680.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00681.CDX\" idref=\"CHEM-US-00681\" mol-file=\"US08927710-20150106-C00681.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00682.CDX\" idref=\"CHEM-US-00682\" mol-file=\"US08927710-20150106-C00682.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00683.CDX\" idref=\"CHEM-US-00683\" mol-file=\"US08927710-20150106-C00683.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00684.CDX\" idref=\"CHEM-US-00684\" mol-file=\"US08927710-20150106-C00684.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00685.CDX\" idref=\"CHEM-US-00685\" mol-file=\"US08927710-20150106-C00685.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00686.CDX\" idref=\"CHEM-US-00686\" mol-file=\"US08927710-20150106-C00686.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00687.CDX\" idref=\"CHEM-US-00687\" mol-file=\"US08927710-20150106-C00687.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00688.CDX\" idref=\"CHEM-US-00688\" mol-file=\"US08927710-20150106-C00688.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00689.CDX\" idref=\"CHEM-US-00689\" mol-file=\"US08927710-20150106-C00689.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00690.CDX\" idref=\"CHEM-US-00690\" mol-file=\"US08927710-20150106-C00690.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00691.CDX\" idref=\"CHEM-US-00691\" mol-file=\"US08927710-20150106-C00691.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00692.CDX\" idref=\"CHEM-US-00692\" mol-file=\"US08927710-20150106-C00692.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00693.CDX\" idref=\"CHEM-US-00693\" mol-file=\"US08927710-20150106-C00693.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00694.CDX\" idref=\"CHEM-US-00694\" mol-file=\"US08927710-20150106-C00694.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00695.CDX\" idref=\"CHEM-US-00695\" mol-file=\"US08927710-20150106-C00695.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00696.CDX\" idref=\"CHEM-US-00696\" mol-file=\"US08927710-20150106-C00696.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00697.CDX\" idref=\"CHEM-US-00697\" mol-file=\"US08927710-20150106-C00697.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00698.CDX\" idref=\"CHEM-US-00698\" mol-file=\"US08927710-20150106-C00698.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00699.CDX\" idref=\"CHEM-US-00699\" mol-file=\"US08927710-20150106-C00699.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00700.CDX\" idref=\"CHEM-US-00700\" mol-file=\"US08927710-20150106-C00700.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00701.CDX\" idref=\"CHEM-US-00701\" mol-file=\"US08927710-20150106-C00701.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00702.CDX\" idref=\"CHEM-US-00702\" mol-file=\"US08927710-20150106-C00702.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00703.CDX\" idref=\"CHEM-US-00703\" mol-file=\"US08927710-20150106-C00703.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00704.CDX\" idref=\"CHEM-US-00704\" mol-file=\"US08927710-20150106-C00704.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00705.CDX\" idref=\"CHEM-US-00705\" mol-file=\"US08927710-20150106-C00705.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00706.CDX\" idref=\"CHEM-US-00706\" mol-file=\"US08927710-20150106-C00706.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00707.CDX\" idref=\"CHEM-US-00707\" mol-file=\"US08927710-20150106-C00707.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00708.CDX\" idref=\"CHEM-US-00708\" mol-file=\"US08927710-20150106-C00708.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00709.CDX\" idref=\"CHEM-US-00709\" mol-file=\"US08927710-20150106-C00709.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00710.CDX\" idref=\"CHEM-US-00710\" mol-file=\"US08927710-20150106-C00710.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00711.CDX\" idref=\"CHEM-US-00711\" mol-file=\"US08927710-20150106-C00711.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00712.CDX\" idref=\"CHEM-US-00712\" mol-file=\"US08927710-20150106-C00712.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00713.CDX\" idref=\"CHEM-US-00713\" mol-file=\"US08927710-20150106-C00713.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00714.CDX\" idref=\"CHEM-US-00714\" mol-file=\"US08927710-20150106-C00714.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00715.CDX\" idref=\"CHEM-US-00715\" mol-file=\"US08927710-20150106-C00715.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00716.CDX\" idref=\"CHEM-US-00716\" mol-file=\"US08927710-20150106-C00716.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00717.CDX\" idref=\"CHEM-US-00717\" mol-file=\"US08927710-20150106-C00717.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00718.CDX\" idref=\"CHEM-US-00718\" mol-file=\"US08927710-20150106-C00718.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00719.CDX\" idref=\"CHEM-US-00719\" mol-file=\"US08927710-20150106-C00719.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00720.CDX\" idref=\"CHEM-US-00720\" mol-file=\"US08927710-20150106-C00720.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00721.CDX\" idref=\"CHEM-US-00721\" mol-file=\"US08927710-20150106-C00721.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00722.CDX\" idref=\"CHEM-US-00722\" mol-file=\"US08927710-20150106-C00722.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00723.CDX\" idref=\"CHEM-US-00723\" mol-file=\"US08927710-20150106-C00723.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00724.CDX\" idref=\"CHEM-US-00724\" mol-file=\"US08927710-20150106-C00724.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00725.CDX\" idref=\"CHEM-US-00725\" mol-file=\"US08927710-20150106-C00725.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00726.CDX\" idref=\"CHEM-US-00726\" mol-file=\"US08927710-20150106-C00726.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00727.CDX\" idref=\"CHEM-US-00727\" mol-file=\"US08927710-20150106-C00727.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00728.CDX\" idref=\"CHEM-US-00728\" mol-file=\"US08927710-20150106-C00728.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00729.CDX\" idref=\"CHEM-US-00729\" mol-file=\"US08927710-20150106-C00729.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00730.CDX\" idref=\"CHEM-US-00730\" mol-file=\"US08927710-20150106-C00730.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00731.CDX\" idref=\"CHEM-US-00731\" mol-file=\"US08927710-20150106-C00731.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00732.CDX\" idref=\"CHEM-US-00732\" mol-file=\"US08927710-20150106-C00732.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00733.CDX\" idref=\"CHEM-US-00733\" mol-file=\"US08927710-20150106-C00733.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00734.CDX\" idref=\"CHEM-US-00734\" mol-file=\"US08927710-20150106-C00734.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00735.CDX\" idref=\"CHEM-US-00735\" mol-file=\"US08927710-20150106-C00735.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00736.CDX\" idref=\"CHEM-US-00736\" mol-file=\"US08927710-20150106-C00736.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00737.CDX\" idref=\"CHEM-US-00737\" mol-file=\"US08927710-20150106-C00737.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00738.CDX\" idref=\"CHEM-US-00738\" mol-file=\"US08927710-20150106-C00738.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00739.CDX\" idref=\"CHEM-US-00739\" mol-file=\"US08927710-20150106-C00739.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00740.CDX\" idref=\"CHEM-US-00740\" mol-file=\"US08927710-20150106-C00740.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00741.CDX\" idref=\"CHEM-US-00741\" mol-file=\"US08927710-20150106-C00741.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00742.CDX\" idref=\"CHEM-US-00742\" mol-file=\"US08927710-20150106-C00742.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00743.CDX\" idref=\"CHEM-US-00743\" mol-file=\"US08927710-20150106-C00743.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00744.CDX\" idref=\"CHEM-US-00744\" mol-file=\"US08927710-20150106-C00744.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00745.CDX\" idref=\"CHEM-US-00745\" mol-file=\"US08927710-20150106-C00745.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00746.CDX\" idref=\"CHEM-US-00746\" mol-file=\"US08927710-20150106-C00746.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00747.CDX\" idref=\"CHEM-US-00747\" mol-file=\"US08927710-20150106-C00747.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00748.CDX\" idref=\"CHEM-US-00748\" mol-file=\"US08927710-20150106-C00748.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00749.CDX\" idref=\"CHEM-US-00749\" mol-file=\"US08927710-20150106-C00749.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00750.CDX\" idref=\"CHEM-US-00750\" mol-file=\"US08927710-20150106-C00750.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00751.CDX\" idref=\"CHEM-US-00751\" mol-file=\"US08927710-20150106-C00751.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00752.CDX\" idref=\"CHEM-US-00752\" mol-file=\"US08927710-20150106-C00752.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00753.CDX\" idref=\"CHEM-US-00753\" mol-file=\"US08927710-20150106-C00753.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00754.CDX\" idref=\"CHEM-US-00754\" mol-file=\"US08927710-20150106-C00754.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00755.CDX\" idref=\"CHEM-US-00755\" mol-file=\"US08927710-20150106-C00755.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00756.CDX\" idref=\"CHEM-US-00756\" mol-file=\"US08927710-20150106-C00756.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00757.CDX\" idref=\"CHEM-US-00757\" mol-file=\"US08927710-20150106-C00757.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00758.CDX\" idref=\"CHEM-US-00758\" mol-file=\"US08927710-20150106-C00758.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00759.CDX\" idref=\"CHEM-US-00759\" mol-file=\"US08927710-20150106-C00759.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00760.CDX\" idref=\"CHEM-US-00760\" mol-file=\"US08927710-20150106-C00760.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00761.CDX\" idref=\"CHEM-US-00761\" mol-file=\"US08927710-20150106-C00761.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00762.CDX\" idref=\"CHEM-US-00762\" mol-file=\"US08927710-20150106-C00762.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00763.CDX\" idref=\"CHEM-US-00763\" mol-file=\"US08927710-20150106-C00763.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00764.CDX\" idref=\"CHEM-US-00764\" mol-file=\"US08927710-20150106-C00764.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00765.CDX\" idref=\"CHEM-US-00765\" mol-file=\"US08927710-20150106-C00765.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00766.CDX\" idref=\"CHEM-US-00766\" mol-file=\"US08927710-20150106-C00766.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00767.CDX\" idref=\"CHEM-US-00767\" mol-file=\"US08927710-20150106-C00767.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00768.CDX\" idref=\"CHEM-US-00768\" mol-file=\"US08927710-20150106-C00768.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00769.CDX\" idref=\"CHEM-US-00769\" mol-file=\"US08927710-20150106-C00769.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00770.CDX\" idref=\"CHEM-US-00770\" mol-file=\"US08927710-20150106-C00770.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00771.CDX\" idref=\"CHEM-US-00771\" mol-file=\"US08927710-20150106-C00771.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00772.CDX\" idref=\"CHEM-US-00772\" mol-file=\"US08927710-20150106-C00772.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00773.CDX\" idref=\"CHEM-US-00773\" mol-file=\"US08927710-20150106-C00773.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00774.CDX\" idref=\"CHEM-US-00774\" mol-file=\"US08927710-20150106-C00774.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00775.CDX\" idref=\"CHEM-US-00775\" mol-file=\"US08927710-20150106-C00775.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00776.CDX\" idref=\"CHEM-US-00776\" mol-file=\"US08927710-20150106-C00776.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00777.CDX\" idref=\"CHEM-US-00777\" mol-file=\"US08927710-20150106-C00777.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00778.CDX\" idref=\"CHEM-US-00778\" mol-file=\"US08927710-20150106-C00778.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00779.CDX\" idref=\"CHEM-US-00779\" mol-file=\"US08927710-20150106-C00779.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00780.CDX\" idref=\"CHEM-US-00780\" mol-file=\"US08927710-20150106-C00780.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00781.CDX\" idref=\"CHEM-US-00781\" mol-file=\"US08927710-20150106-C00781.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00782.CDX\" idref=\"CHEM-US-00782\" mol-file=\"US08927710-20150106-C00782.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00783.CDX\" idref=\"CHEM-US-00783\" mol-file=\"US08927710-20150106-C00783.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00784.CDX\" idref=\"CHEM-US-00784\" mol-file=\"US08927710-20150106-C00784.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00785.CDX\" idref=\"CHEM-US-00785\" mol-file=\"US08927710-20150106-C00785.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00786.CDX\" idref=\"CHEM-US-00786\" mol-file=\"US08927710-20150106-C00786.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00787.CDX\" idref=\"CHEM-US-00787\" mol-file=\"US08927710-20150106-C00787.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00788.CDX\" idref=\"CHEM-US-00788\" mol-file=\"US08927710-20150106-C00788.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00789.CDX\" idref=\"CHEM-US-00789\" mol-file=\"US08927710-20150106-C00789.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00790.CDX\" idref=\"CHEM-US-00790\" mol-file=\"US08927710-20150106-C00790.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00791.CDX\" idref=\"CHEM-US-00791\" mol-file=\"US08927710-20150106-C00791.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00792.CDX\" idref=\"CHEM-US-00792\" mol-file=\"US08927710-20150106-C00792.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00793.CDX\" idref=\"CHEM-US-00793\" mol-file=\"US08927710-20150106-C00793.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00794.CDX\" idref=\"CHEM-US-00794\" mol-file=\"US08927710-20150106-C00794.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00795.CDX\" idref=\"CHEM-US-00795\" mol-file=\"US08927710-20150106-C00795.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00796.CDX\" idref=\"CHEM-US-00796\" mol-file=\"US08927710-20150106-C00796.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00797.CDX\" idref=\"CHEM-US-00797\" mol-file=\"US08927710-20150106-C00797.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00798.CDX\" idref=\"CHEM-US-00798\" mol-file=\"US08927710-20150106-C00798.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00799.CDX\" idref=\"CHEM-US-00799\" mol-file=\"US08927710-20150106-C00799.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00800.CDX\" idref=\"CHEM-US-00800\" mol-file=\"US08927710-20150106-C00800.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00801.CDX\" idref=\"CHEM-US-00801\" mol-file=\"US08927710-20150106-C00801.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00802.CDX\" idref=\"CHEM-US-00802\" mol-file=\"US08927710-20150106-C00802.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00803.CDX\" idref=\"CHEM-US-00803\" mol-file=\"US08927710-20150106-C00803.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00804.CDX\" idref=\"CHEM-US-00804\" mol-file=\"US08927710-20150106-C00804.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00805.CDX\" idref=\"CHEM-US-00805\" mol-file=\"US08927710-20150106-C00805.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00806.CDX\" idref=\"CHEM-US-00806\" mol-file=\"US08927710-20150106-C00806.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00807.CDX\" idref=\"CHEM-US-00807\" mol-file=\"US08927710-20150106-C00807.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00808.CDX\" idref=\"CHEM-US-00808\" mol-file=\"US08927710-20150106-C00808.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00809.CDX\" idref=\"CHEM-US-00809\" mol-file=\"US08927710-20150106-C00809.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00810.CDX\" idref=\"CHEM-US-00810\" mol-file=\"US08927710-20150106-C00810.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00811.CDX\" idref=\"CHEM-US-00811\" mol-file=\"US08927710-20150106-C00811.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00812.CDX\" idref=\"CHEM-US-00812\" mol-file=\"US08927710-20150106-C00812.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00813.CDX\" idref=\"CHEM-US-00813\" mol-file=\"US08927710-20150106-C00813.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00814.CDX\" idref=\"CHEM-US-00814\" mol-file=\"US08927710-20150106-C00814.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00815.CDX\" idref=\"CHEM-US-00815\" mol-file=\"US08927710-20150106-C00815.MOL\"/>\n",
       "<us-chemistry cdx-file=\"US08927710-20150106-C00816.CDX\" idref=\"CHEM-US-00816\" mol-file=\"US08927710-20150106-C00816.MOL\"/>\n",
       "<us-claim-statement>The invention claimed is:</us-claim-statement>\n",
       "<claims id=\"claims\">\n",
       "<claim id=\"CLM-00001\" num=\"00001\">\n",
       "<claim-text>1. A CAP dependent endonuclease inhibitor compound represented by formula (I), a pharmaceutically acceptable salt, or a solvate thereof:</claim-text>\n",
       "<claim-text><chemistry id=\"CHEM-US-00814\" num=\"00814\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00814.TIF\" he=\"31.33mm\" id=\"EMI-C00814\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>1 </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x1</sup>)(R<sup>x2</sup>),</claim-text>\n",
       "<claim-text>—Z—N(Rx<sup>3</sup>)-SO<sub>2</sub>—(R<sup>x4</sup>),</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>x5</sup>)—SO<sub>2</sub>—(R<sup>x6</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x7</sup>)—C(═O)—R<sup>x8</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>x9</sup>)(R<sup>x10</sup>),</claim-text>\n",
       "<claim-text>—Z—S—R<sup>x11</sup>,</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>x12</sup>,</claim-text>\n",
       "<claim-text>—Z—S(═O)—R<sup>x13</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x14</sup>)—C(═O)—O—R<sup>x15</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x16</sup>)—C(═O)—N(R<sup>x17</sup>)(R<sup>X18</sup>),</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>x19</sup>)—C(═O)—N(R<sup>x20</sup>)(R<sup>x21</sup>), and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x22</sup>)—C(═O)—C(═O)—R<sup>x23</sup>,\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>x1</sup>, R<sup>x2</sup>, R<sup>x3</sup>, R<sup>x5</sup>, R<sup>x7</sup>, R<sup>x8</sup>, R<sup>x9</sup>, R<sup>x10</sup>, R<sup>x11</sup>, R<sup>x14</sup>, R<sup>x15</sup>, R<sup>x16</sup>, R<sup>x17</sup>, R<sup>x18</sup>, R<sup>x19</sup>, R<sup>x20</sup>, R<sup>x21</sup>, R<sup>x22</sup>, and R<sup>x23 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>x4</sup>, R<sup>x6</sup>, R<sup>x12</sup>, and R<sup>x13 </sup>are each independently selected from a substituent group consisting of, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>x1 </sup>and R<sup>x2</sup>, R<sup>x9 </sup>and R<sup>x10</sup>, R<sup>x17 </sup>and R<sup>x18</sup>, and R<sup>x20 </sup>and R<sup>X21 </sup>each may be taken together with an adjacent atom to form heterocycle, and</claim-text>\n",
       "<claim-text>Z is a bond or straight or branched lower alkylene;</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>R<sup>2 </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>y1</sup>)—SO<sub>2</sub>—R<sup>y2</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>y3</sup>)—C(═O)—R<sup>y4</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>y5</sup>)—C(═O)—O—R<sup>y6</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>y7</sup>)(R<sup>y8</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>y9</sup>)(R<sup>y10</sup>), and</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>y11</sup>,\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>Y1</sup>, R<sup>Y3</sup>, R<sup>Y4</sup>, R<sup>Y5</sup>, R<sup>Y6</sup>, R<sup>Y7</sup>, R<sup>Y8</sup>, R<sup>Y9</sup>, and R<sup>Y10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>Y2 </sup>and R<sup>Y11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>Y7 </sup>and R<sup>Y8</sup>, and R<sup>Y9 </sup>and R<sup>Y10 </sup>may be taken together with an adjacent atom to form heterocycle, and</claim-text>\n",
       "<claim-text>a Z is a bond or straight or branched lower alkylene;</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>R<sup>3 </sup>is chosen from hydrogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z1</sup>)—SO<sub>2</sub>—R<sup>z2</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z3</sup>)—C(═O)—R<sup>z4</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z5</sup>)—C(═O)—O—R<sup>z6</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>z7</sup>)(R<sup>z8</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z9</sup>)(R<sup>z10</sup>),</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>z11</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z12</sup>)—O—C(═O)—R<sup>z13 </sup>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>z1</sup>, R<sup>z3</sup>, R<sup>z4</sup>, R<sup>z5</sup>, R<sup>z6</sup>, R<sup>z7</sup>, R<sup>z8</sup>, R<sup>z9</sup>, R<sup>z10</sup>, R<sup>z12</sup>, and R<sup>z13 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>z2 </sup>and R<sup>z11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>z7 </sup>and R<sup>z8</sup>, and R<sup>z9 </sup>and R<sup>z10 </sup>each may be taken together with an adjacent atom to form heterocycle, and</claim-text>\n",
       "<claim-text>Z is a bond or straight or branched lower alkylene, and;</claim-text>\n",
       "</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>wherein:</claim-text>\n",
       "<claim-text>a) either A<sup>1 </sup>or A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>, and the other is NR<sup>7</sup>,</claim-text>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>8</sup>, R<sup>9</sup>, R<sup>10</sup>, and R<sup>11 </sup>are each independently selected from a substituent group consisting of hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyl carbonyl optionally substituted by substituent group A, lower alkyl oxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, carbocyclecarbonyl optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocycleoxy lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—S—R<sup>v1</sup>,</claim-text>\n",
       "<claim-text>—Z—S(═O)—R<sup>v2</sup>,</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>v3</sup>,</claim-text>\n",
       "<claim-text>—C(═O)—C(═O)—R<sup>v4</sup>,</claim-text>\n",
       "<claim-text>—C(═O)—N(R<sup>v5</sup>)(R<sup>v6</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>v7</sup>)—C(═O)—O—R<sup>v8</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>v9</sup>)—C(═O)—R<sup>v10 </sup>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>v1</sup>, R<sup>v4</sup>, R<sup>v5</sup>, R<sup>v6</sup>, R<sup>v7</sup>, R<sup>v8</sup>, R<sup>v9 </sup>and R<sup>v10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>v2 </sup>and R<sup>v3 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "<claim-text>R<sup>v5 </sup>and R<sup>v6 </sup>may be taken together with an adjacent atom to form heterocycle, and</claim-text>\n",
       "<claim-text>Z is a bond or straight or branched lower alkylene, and</claim-text>\n",
       "<claim-text>R<sup>5 </sup>and R<sup>6 </sup>may be taken together with an adjacent atom to form carbocycle;</claim-text>\n",
       "</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>wherein:</claim-text>\n",
       "<claim-text>1) when A1 is CR<sup>5</sup>R<sup>6 </sup>and A<sup>2 </sup>is NR<sup>7</sup>,</claim-text>\n",
       "<claim-text>R<sup>3 </sup>and R<sup>7 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form a condensed ring,</claim-text>\n",
       "<claim-text>2) when A<sup>1 </sup>is NR<sup>7 </sup>and A<sup>2 </sup>is CR<sup>5</sup>R<sup>6</sup>,</claim-text>\n",
       "<claim-text>R<sup>3 </sup>and R<sup>6 </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group B or may form condensed ring,</claim-text>\n",
       "<claim-text>with a proviso that</claim-text>\n",
       "<claim-text>c) R<sup>5</sup>, R<sup>6</sup>, and R<sup>7 </sup>are not all hydrogens; and</claim-text>\n",
       "<claim-text>wherein\n",
       "<claim-text>Substituent group A is chosen from halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, lower alkylthio, hydroxy lower alkyl, carbocyclic group, heterocyclic group, heterocyclic group substituted by oxo, carbocycle lower alkyloxy, carbocycleoxy lower alkyl, carbocycle lower alkyloxy lower alkyl, heterocycle lower alkyloxy, heterocycleoxy lower alkyl, heterocycle lower alkyloxy lower alkyl, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkylcarbonyloxy, lower alkyloxycarbonyl, lower alkylamine, lower alkylcarbonylamino, halogeno lower alkyl carbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfinyl, and lower alkylsulfonylamino; and</claim-text>\n",
       "<claim-text>Substituent group B is chosen from halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamine, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfonylamino, carbocyclic group optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, and heterocycle lower alkyl optionally substituted by substituent group A.</claim-text>\n",
       "</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00002\" num=\"00002\">\n",
       "<claim-text>2. The CAP dependent endonuclease inhibitor according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, wherein\n",
       "<claim-text>R<sup>1 </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkenyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoarbonyl optionally substituted by substituent group A, carbocycleoxy optionally substituted by substituent group A, carbocycleoxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, heterocyclecarbonyl optionally substituted by substituent group A, heterocycleoxy optionally substituted by substituent group A, heterocycleoxycarbonyl optionally substituted by substituent group A,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x1</sup>)(R<sup>x2</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x3</sup>)—SO<sub>2</sub>—(R<sup>x4</sup>),</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>x5</sup>)—SO<sub>2</sub>—(R<sup>x6</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x7</sup>)—C(═O)—R<sup>x8</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>x9</sup>)(R<sup>x10</sup>),</claim-text>\n",
       "<claim-text>—Z—S<sub>2</sub>—R<sup>x11</sup>,</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>x12</sup>,</claim-text>\n",
       "<claim-text>—Z—S(═O)—R<sup>x13</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x14</sup>)—C(═O)—O—R<sup>x15</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x16</sup>)—C(═O)—N(R<sup>x17</sup>)(R<sup>X18</sup>), and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x22</sup>)—C(═O)—C(═O)—R<sup>x23</sup>,</claim-text>\n",
       "<claim-text>(Substituent group A, R<sup>x1</sup>, R<sup>x2</sup>, R<sup>x3</sup>, R<sup>x4</sup>, R<sup>x5</sup>, R<sup>x6</sup>, R<sup>x7</sup>, R<sup>x8</sup>, R<sup>x11</sup>, R<sup>x12</sup>, R<sup>x13</sup>, R<sup>x14</sup>, R<sup>x15</sup>, R<sup>x16</sup>, R<sup>x17</sup>, R<sup>x18</sup>, R<sup>x22</sup>, R<sup>x23</sup>, and</claim-text>\n",
       "<claim-text>z are same meaning as those of <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>).</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00003\" num=\"00003\">\n",
       "<claim-text>3. The CAP dependent endonuclease inhibitor according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, wherein\n",
       "<claim-text>R<sup>1 </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkylcarbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x1</sup>)(R<sup>x2</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x7</sup>)—C(═O)—R<sup>x8</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x14</sup>)—C{═O)—O—R<sup>x15 </sup></claim-text>\n",
       "<claim-text>(Substituent group A, R<sup>x1</sup>, R<sup>x2</sup>, R<sup>x7</sup>, R<sup>x8</sup>, R<sup>x14</sup>, R<sup>x15</sup>, and Z are same meaning as those of <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>).</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00004\" num=\"00004\">\n",
       "<claim-text>4. The CAP dependent endonuclease inhibitor according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, wherein\n",
       "<claim-text>R<sup>1 </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkyloxy optionally substituted by substituent group A, lower alkyl carbonyl optionally substituted by substituent group A, lower alkyloxycarbonyl optionally substituted by substituent group A, heterocyclic group optionally substituted by substituent group A, and</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>x1</sup>)(R<sup>x2</sup>)</claim-text>\n",
       "<claim-text>(Substituent group A, R<sup>x1</sup>, R<sup>x2</sup>, and Z are same meaning as those of <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>).</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00005\" num=\"00005\">\n",
       "<claim-text>5. The CAP dependent endonuclease inhibitor according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, wherein R<sup>1 </sup>is hydrogen or carboxy.</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00006\" num=\"00006\">\n",
       "<claim-text>6. The CAP dependent endonuclease inhibitor according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, wherein\n",
       "<claim-text>R<sup>2 </sup>is chosen from hydrogen, lower alkyl optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A, and</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>Y9</sup>)(R<sup>Y10</sup>)</claim-text>\n",
       "<claim-text>(Substituent group A, R<sup>Y9</sup>, R<sup>Y10</sup>, and z are same meaning as those of <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>).</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00007\" num=\"00007\">\n",
       "<claim-text>7. The CAP dependent endonuclease inhibitor according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, wherein R<sup>2 </sup>is chosen from hydrogen and lower alkyl optionally substituted by substituent group A\n",
       "<claim-text>(Substituent group A is same meaning as that of <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00008\" num=\"00008\">\n",
       "<claim-text>8. The CAP dependent endonuclease inhibitor according to <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>, wherein\n",
       "<claim-text>R<sup>3 </sup>is chosen from hydrogen, lower alkyl optionally substituted by substituent group A, lower alkenyl optionally substituted by substituent group A, lower alkynyl optionally substituted by substituent group A, carbocyclic group optionally substituted by substituent group A, carbocycle lower alkyl optionally substituted by substituent group A, carbocycleoxy lower alkyl optionally substituted by substituent group A, heterocycle lower alkyl optionally substituted by substituent group A,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z1</sup>)—SO<sub>2</sub>—R<sup>z2</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z3</sup>)—C(═O)—R<sup>z4</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z5</sup>)—C(═O)—O—R<sup>z6</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>z7</sup>)(R<sup>z8</sup>), and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>z9</sup>)(R<sup>z10</sup>)</claim-text>\n",
       "<claim-text>(Substituent group A, R<sup>z1</sup>, R<sup>z2</sup>, R<sup>z3</sup>, R<sup>z4</sup>, R<sup>z5</sup>, R<sup>z6</sup>, R<sup>z7</sup>, R<sup>z8</sup>, R<sup>z9</sup>, R<sup>z10</sup>, and Z are same meaning as those of <claim-ref idref=\"CLM-00001\">claim 1</claim-ref>).</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00009\" num=\"00009\">\n",
       "<claim-text>9. The compound represented by formula or a pharmaceutically acceptable salt thereof or a solvate thereof:</claim-text>\n",
       "<claim-text><chemistry id=\"CHEM-US-00815\" num=\"00815\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00815.TIF\" he=\"32.17mm\" id=\"EMI-C00815\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>1a </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>),</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>A5</sup>)—SO<sub>2</sub>—(R<sup>A6</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,</claim-text>\n",
       "<claim-text>—Z—S—R<sup>A9</sup>,</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>A10</sup>,</claim-text>\n",
       "<claim-text>—Z—S(═O)—R<sup>A11</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A14</sup>)—C(═O)—N(R<sup>A15</sup>)(R<sup>A16</sup>),</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>A17</sup>)—C(═O)—N(R<sup>A18</sup>)(R<sup>A19</sup>), and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A3</sup>, R<sup>A5</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A9</sup>, R<sup>A12</sup>, R<sup>A13</sup>, R<sup>A14</sup>, R<sup>A15</sup>, R<sup>A16</sup>, R<sup>A17</sup>, R<sup>A18</sup>, R<sup>A19</sup>, R<sup>A20</sup>, and R<sup>A21 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>A4</sup>, R<sup>A6</sup>, R<sup>A10</sup>, and R<sup>A11 </sup>are each independently selected from a substituent group consisting of, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group c, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>A1 </sup>and R<sup>A2</sup>, R<sup>A15 </sup>and R<sup>A16</sup>, and R<sup>A18 </sup>and R<sup>A19 </sup>each may be taken together with an adjacent atom to form heterocycle, and</claim-text>\n",
       "<claim-text>Z is a bond or straight or branched lower alkylene;</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>R<sup>2a </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>B1</sup>)—SO<sub>2</sub>—R<sup>B2</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>B3</sup>)—C(═O)—R<sup>B4</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>B5</sup>)—C(═O)—O—R<sup>B6</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>B7</sup>)(R<sup>B8</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>), and</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>B11 </sup>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>B1</sup>, R<sup>B6</sup>, R<sup>B7</sup>, R<sup>B8</sup>, and R<sup>B10 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally, substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>B2 </sup>and R<sup>B11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group c, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group c, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>B7 </sup>and R<sup>B8</sup>, and R<sup>B9 </sup>and R<sup>B10 </sup>each may be taken together with an adjacent atom to form heterocycle, and</claim-text>\n",
       "<claim-text>Z is a bond or straight or branched lower alkylene;</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>R<sup>3a </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—N(R<sup>c1</sup>)—SO<sub>2</sub>—R<sup>c2</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>c3</sup>)—C(═O)—R<sup>c4</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>c5</sup>)—C(═O)—O—R<sup>c6</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>c7</sup>)(R<sup>c8</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>c9</sup>)(R<sup>c10</sup>),</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>c11</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(Rc<sup>12</sup>)—O—C(═O)—Rc<sup>13 </sup>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>c1</sup>, and, R<sup>c13 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group c, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>c2 </sup>and R<sup>c11 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, ower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>c7 </sup>and R<sup>c8</sup>, and R<sup>c9 </sup>and R<sup>c10 </sup>each may be taken together with an adjacent atom to form heterocycle, and</claim-text>\n",
       "<claim-text>Z is a bond or straight or branched lower alkylene and;</claim-text>\n",
       "</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>wherein:</claim-text>\n",
       "<claim-text>a) either B<sup>1 </sup>or B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and the other is NR<sup>7a</sup>,</claim-text>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>5a</sup>, R<sup>6a</sup>, and R<sup>7a </sup>are each independently selected from a substituent group consisting of hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyl carbonyl optionally substituted by substituent group C, lower alkyl oxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Y—S—R<sup>D1</sup>,</claim-text>\n",
       "<claim-text>—Z—S(═O)—R<sup>D2</sup>,</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>D3</sup>,</claim-text>\n",
       "<claim-text>—C(═O)—C(═O)—R<sup>D4</sup>,</claim-text>\n",
       "<claim-text>—C(═O)—N(R<sup>D5</sup>)(R<sup>D6</sup>),</claim-text>\n",
       "<claim-text>—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>),</claim-text>\n",
       "<claim-text>—Z—CH<sub>2</sub>—R<sup>D10</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>D11</sup>)—C(═O)—O—R<sup>D12</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>D13</sup>)—C(═O)—R<sup>D14 </sup>\n",
       "<claim-text>wherein:\n",
       "<claim-text>R<sup>D1</sup>, R<sup>D4</sup>, R<sup>D5</sup>, R<sup>D6</sup>, R<sup>D9</sup>, R<sup>D11</sup>, R<sup>D12</sup>, R<sup>D13</sup>, and R<sup>D14 </sup>are each independently selected from a substituent group consisting of hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>D2</sup>, and R<sup>D3 </sup>are each independently selected from a substituent group consisting of lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group c, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>D7</sup>, R<sup>D8</sup>, and R<sup>D10 </sup>are each independently selected from a substituent group consisting of carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>R<sup>D5 </sup>and R<sup>D6 </sup>may be taken together with an adjacent atom to form heterocycle,</claim-text>\n",
       "<claim-text>Y is straight or branched lower alkylene, and</claim-text>\n",
       "<claim-text>Z is a bond or straight or branched lower alkylene; and</claim-text>\n",
       "<claim-text>R<sup>D5 </sup>and R<sup>D6 </sup>may be taken together with an adjacent atom to form carbocycie;</claim-text>\n",
       "</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>wherein:</claim-text>\n",
       "<claim-text>1) when B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a </sup>and B<sup>2 </sup>is NR<sup>7a</sup>,</claim-text>\n",
       "<claim-text>R<sup>3a </sup>and R<sup>7a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D,</claim-text>\n",
       "<claim-text>2) when B<sup>1 </sup>is NR<sup>7a </sup>and B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,</claim-text>\n",
       "<claim-text>R<sup>3a </sup>and R<sup>6a </sup>may be taken together with an adjacent atom to form heterocycle optionally substituted by substituent group D; and</claim-text>\n",
       "<claim-text>with a proviso that</claim-text>\n",
       "<claim-text>c) R<sup>5a</sup>, R<sup>6a</sup>, and R<sup>7a </sup>are not all hydrogens; and</claim-text>\n",
       "<claim-text>wherein;\n",
       "<claim-text>Substituent group C is chosen from halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, lower alkylthio, hydroxy lower alkyl, carbocyclic group, heterocyclic group, heterocyclic group substituted by oxo, carbocycle lower alkyloxy, carbocycleoxy lower alkyl, carbocycle lower alkyloxy lower alkyl, heterocycle lower alkyloxy, heterocycleoxy lower alkyl, heterocycle lower alkyloxy lower alkyl, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkylcarbonyloxy, lower alkyloxycarbonyl, lower alkylamine, lower alkylcarbonylamino, halogeno lower alkyl carbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfinyl, and lower alkylsulfonylamino;</claim-text>\n",
       "<claim-text>Substituent group D is chosen from halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocycle lower alkyloxy, heterocycle lower alkyloxy, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkylamine, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, lower alkylsulfonylamino, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, and heterocycle lower alkyl optionally substituted by substituent group C.</claim-text>\n",
       "</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00010\" num=\"00010\">\n",
       "<claim-text>10. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein R<sup>1a </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, cyano, formyl, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkenyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxy optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxy optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,\n",
       "<claim-text>—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A3</sup>)—SO<sub>2</sub>—(R<sup>A4</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>,</claim-text>\n",
       "<claim-text>—Z—S—R<sup>A9</sup>,</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>A10</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A20</sup>)—C(═O)—C(═O)—R<sup>A21 </sup></claim-text>\n",
       "<claim-text>(substituent group C, R<sup>A3</sup>, R<sup>A4</sup>, R<sup>A12</sup>, R<sup>A13</sup>, R<sup>A20</sup>, R<sup>A21</sup>, and Z are same meaning as those of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00011\" num=\"00011\">\n",
       "<claim-text>11. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein R<sup>1a </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkylcarbonyl optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C,\n",
       "<claim-text>—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>),</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A7</sup>)—C(═O)—R<sup>A8</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A12</sup>)—C(═O)—O—R<sup>A13 </sup></claim-text>\n",
       "<claim-text>(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, R<sup>A7</sup>, R<sup>A8</sup>, R<sup>A12</sup>, R<sup>A13</sup>, and Z are same as those of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00012\" num=\"00012\">\n",
       "<claim-text>12. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof,\n",
       "<claim-text>wherein R<sup>1a </sup>is chosen from hydrogen, halogen, hydroxy, carboxy, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkyloxy optionally substituted by substituent group C, lower alkyloxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>A1</sup>)(R<sup>A2</sup>)</claim-text>\n",
       "<claim-text>(substituent group C, R<sup>A1</sup>, R<sup>A2</sup>, and Z are same as those of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00013\" num=\"00013\">\n",
       "<claim-text>13. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof,\n",
       "<claim-text>wherein R<sup>1a </sup>is chosen from hydrogen and carboxy.</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00014\" num=\"00014\">\n",
       "<claim-text>14. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein R<sup>2a </sup>is chosen from hydrogen, lower alkyl optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, and\n",
       "<claim-text>—Z—N(R<sup>B9</sup>)(R<sup>B10</sup>)</claim-text>\n",
       "<claim-text>(substituent group C, R<sup>B9</sup>, R<sup>B10</sup>), and Z are same as those of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00015\" num=\"00015\">\n",
       "<claim-text>15. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein R<sup>2a </sup>is chosen from hydrogen and lower alkyl optionally substituted by substituent group C (substituent group C is same as that of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00016\" num=\"00016\">\n",
       "<claim-text>16. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref> or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein R<sup>3a </sup>is chosen from hydrogen, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C,\n",
       "<claim-text>—Z—N(R<sup>c1</sup>)—SO<sub>2</sub>—R<sup>c2</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>c3</sup>)—C(═O)—R<sup>c4</sup>,</claim-text>\n",
       "<claim-text>—Z—N(R<sup>c5</sup>)—C(═O)—O—R<sup>c6</sup>,</claim-text>\n",
       "<claim-text>—Z—C(═O)—N(R<sup>c7</sup>)(R<sup>c8</sup>), and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>c9</sup>)(R<sup>c10</sup>)</claim-text>\n",
       "<claim-text>(substituent group C, R<sup>c1</sup>, R<sup>c2</sup>, R<sup>c3</sup>, R<sup>c4</sup>, R<sup>c5</sup>, R<sup>c6</sup>, R<sup>c7</sup>, R<sup>c8</sup>, R<sup>c9</sup>, R<sup>c10 </sup>and Z are same as those of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00017\" num=\"00017\">\n",
       "<claim-text>17. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref> or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein R<sup>3a </sup>is chosen from hydrogen, lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, and carbocycle lower alkyl optionally substituted by substituent group C, (substituent group C is same as that of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00018\" num=\"00018\">\n",
       "<claim-text>18. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein:\n",
       "<claim-text>B<sup>1 </sup>is NR<sup>7a</sup>,</claim-text>\n",
       "<claim-text>B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>, and</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>R<sup>5a</sup>, R<sup>6a </sup>and R<sup>7a </sup>are each independently hydrogen, carboxy, cyano, lower alkyl optionally substituted by substituent group C, lower alkenyl optionally substituted by substituent group C, lower alkynyl optionally substituted by substituent group C, lower alkyl carbonyl optionally substituted by substituent group C, lower alkyl oxycarbonyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, carbocyclecarbonyl optionally substituted by substituent group C, carbocycleoxycarbonyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, heterocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclecarbonyl optionally substituted by substituent group C, heterocycleoxycarbonyl optionally substituted by substituent group C,</claim-text>\n",
       "<claim-text>—Y—S—R<sup>D1</sup>,\n",
       "<claim-text>Z—S(═O)—R<sup>D2</sup>,</claim-text>\n",
       "<claim-text>—Z—SO<sub>2</sub>—R<sup>D3</sup>,</claim-text>\n",
       "<claim-text>—C(═O)—C(═O)—R<sup>D4</sup>,</claim-text>\n",
       "<claim-text>—C(═O)—N(R<sup>D5</sup>)(R<sup>D6</sup>),</claim-text>\n",
       "<claim-text>—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)</claim-text>\n",
       "<claim-text>—Z—N(R<sup>D11</sup>)—C(═O)—O—R<sup>D12</sup>, and</claim-text>\n",
       "<claim-text>—Z—N(R<sup>D13</sup>)—C(═O)—R<sup>D14</sup>)</claim-text>\n",
       "<claim-text>(substituent group C, R<sup>D1</sup>, R<sup>D2</sup>, R<sup>D3</sup>, R<sup>D4</sup>, R<sup>D5</sup>, R<sup>D6</sup>, R<sup>D7</sup>, R<sup>D8</sup>, Y, and Z are same as those of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00019\" num=\"00019\">\n",
       "<claim-text>19. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein:\n",
       "<claim-text>B<sup>1 </sup>is NR<sup>7a</sup>,</claim-text>\n",
       "<claim-text>B<sup>2 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,</claim-text>\n",
       "<claim-text>R<sup>5a </sup>is hydrogen,</claim-text>\n",
       "<claim-text>R<sup>6a </sup>is chosen from hydrogen and lower alkyl optionally substituted by substituent group C, and</claim-text>\n",
       "<claim-text>R<sup>7a </sup>is chosen from lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, and</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)\n",
       "<claim-text>(substituent group C, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, and Z are same as <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00020\" num=\"00020\">\n",
       "<claim-text>20. The compound according to <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof, wherein:\n",
       "<claim-text>B<sup>1 </sup>is CR<sup>5a</sup>R<sup>6a</sup>,</claim-text>\n",
       "<claim-text>B<sup>2 </sup>is NR<sup>7a</sup>,</claim-text>\n",
       "<claim-text>R<sup>5a </sup>is hydrogen,</claim-text>\n",
       "<claim-text>R<sup>6a </sup>is chosen from hydrogen and lower alkyl optionally substituted by substituent group C, and</claim-text>\n",
       "<claim-text>R<sup>7a </sup>is chosen from lower alkyl optionally substituted by substituent group C, carbocyclic group optionally substituted by substituent group C, carbocycleoxy lower alkyl optionally substituted by substituent group C, heterocyclic group optionally substituted by substituent group C, carbocycle lower alkyl optionally substituted by substituent group C, heterocycle lower alkyl optionally substituted by substituent group C, and</claim-text>\n",
       "</claim-text>\n",
       "<claim-text>—Z—C(R<sup>D7</sup>)(R<sup>D8</sup>)(R<sup>D9</sup>)\n",
       "<claim-text>(Substituent group C, R<sup>D7</sup>, R<sup>D8</sup>, R<sup>D9</sup>, and Z are same as <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00021\" num=\"00021\">\n",
       "<claim-text>21. The compound according to <claim-ref idref=\"CLM-00019\">claim 19</claim-ref>, or the pharmaceutically acceptable salt thereof or the solvate thereof,\n",
       "<claim-text>wherein R<sup>7a </sup>is a group chosen from:</claim-text>\n",
       "</claim-text>\n",
       "<claim-text><chemistry id=\"CHEM-US-00816\" num=\"00816\">\n",
       "<img alt=\"embedded image\" file=\"US08927710-20150106-C00816.TIF\" he=\"221.32mm\" id=\"EMI-C00816\" img-content=\"chem\" img-format=\"tif\" wi=\"69.85mm\"/>\n",
       "</chemistry>\n",
       "<claim-text>(wherein R<sup>E6 </sup>and m are same as those of <claim-ref idref=\"CLM-00009\">claim 9</claim-ref>).</claim-text>\n",
       "</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00022\" num=\"00022\">\n",
       "<claim-text>22. A pharmaceutical composition comprising a compound according to any one of <claim-ref idref=\"CLM-00009\">claims 9</claim-ref>-<b>21</b>, or a pharmaceutically acceptable salt thereof or a solvate thereof, and a pharmaceutically acceptable carrier or diluent.</claim-text>\n",
       "</claim>\n",
       "<claim id=\"CLM-00023\" num=\"00023\">\n",
       "<claim-text>23. A method for treating influenza infectious disease characterized in administering a compound according to any of <claim-ref idref=\"CLM-00009\">claims 9</claim-ref>-<b>21</b>, or a pharmaceutically acceptable salt thereof or the solvate thereof.</claim-text>\n",
       "</claim>\n",
       "</claims>\n",
       "</us-patent-grant>"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "soup.find_all()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "metadata": {},
   "outputs": [],
   "source": [
    "from bs4 import BeautifulSoup\n",
    "xml = merged[merged.patentnumber == \"8933222\"].xml.values[0]\n",
    "soup = BeautifulSoup(xml, \"xml\")\n",
    "exammples = extract_examples_start_w_word_test(soup.find_all([\"heading\",\"p\"]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'present'"
      ]
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ex = \"(S)-3-(4′-Cyano-biphenyl-4-yl)-2-{[(S)-3-[4-(3,4-dichloro-benzyloxy)-phenyl]-2-oxo-6-((R)-tetrahydro-furan-2-carbonyl)-2,3,5,6,7,8-hexahydro-1H-4-oxa-1,6-diaza-anthracene-7-carbonyl]-amino}-propionic acid Title compound (62 mg) was prepared from Intermediate A (76 mg, 0.1 mmol) following general procedures F and B. LC-MS (m/z): 845.\"\n",
    "analyze_sentence_tense(ex)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [],
   "source": [
    "for example in exammples:\n",
    "    text = example[\"title\"] + \" \".join(example[\"content\"])\n",
    "    tense = analyze_sentence_tense(text)\n",
    "    if tense == \"present\":\n",
    "        print(text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'number': 'Example 1',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dichloromethane (90 mL) solution of compound 1A (12.8 g, 89.4 mmol) and pyridine (8.50 g, 107 mmol) was cooled to 1 to 3° C., and a dichloromethane (90 mL) solution of benzyloxyacetyl chloride (19.8 g, 107 mmol) was added dropwise over 50 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, temperature was gradually raised to 15° C. over 60 minutes, and ice water was added. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane once. The combined extracts were washed with water three times, washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with n-hexane and, then, with n-hexane-ethyl acetate (1:1, v/v). Concentration of objective fraction afforded 22.2 g of compound 1B as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.25 (3H, t, J=7.2 Hz), 2.90 (3H, brs), 3.24 (3H, brs), 4.15 (2H, q, J=7.2 Hz), 4.45 (2H, s), 4.58 (2H, s), 7.25-7.38 (5H, m), 7.72 (1H, s).',\n",
       "   'A 1N lithiumhexamethyldisilazane THF solution (4.29 ml, 4.29 mmol) was cooled to −78° C., and a THF solution (4 ml) of compound 1B (500 mg, 1.72 mmol) and cinnamoyl chloride (343.2 mg, 2.06 mmol) were added dropwise thereto over 3 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 25 minutes, 2N hydrochloric acid (10 ml) was added, and the mixture was further stirred at room temperature for 10 minutes. To the reaction solution was added ethyl acetate, the organic layer was separated, and the aqueous layer was extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. From fraction eluted with n-hexane-ethyl acetate (1:1, v/v), 364.3 mg (yield 56%) of compound 1C was obtained as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.40 (3H, t, J=7.2 Hz), 4.39 (2H, q, J=7.2 Hz), 5.27 (2H, s), 6.99 (1H, d, J=16.2 Hz), 7.23 (1H, d, J=16.2), 7.26-7.48 (10H, m), 8.45 (1H, s).',\n",
       "   'To a MeCN (5 ml) solution of compound 1C and ruthenium chloride (2.76 mg, 0.0133 mmol) was added dropwise an aqueous solution (8 ml) of sodium periodate (625.8 mg, 2.93 mmol) and 96% sulfuric acid (287.4 mg, 2.93 mmol) over 10 minutes at room temperature under nitrogen stream. After the reaction solution was stirred at the same temperature for 5 minutes, ethyl acetate was added, the organic layer was separated, and the aqueous layer was extracted with ethyl acetate two times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. From fraction eluted with n-hexane-ethyl acetate (1:1, v/v), 303.2 mg (yield 75%) of compound 1D was obtained as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.39 (3H, t, J=6.9 Hz), 4.40 (2H, q, J=6.9 Hz), 5.54 (2H, s), 7.37 (5H, s), 8.48 (1H, s), 9.85 (1H, s).',\n",
       "   'To a MeCN (15 ml) solution of compound 1D (1.00 g, 3.31 mmol) was added an aqueous solution (10 ml) of 96% sulfuric acid (421.7 mg, 4.30 mmol) and amidosululic acid (642.7 mg, 6.62 mmol) at room temperature, the mixture was stirred, and an aqueous solution (10 ml) of sodium chlorite (388.9 mg, 4.30 mmol) was added dropwise over 5 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 5 minutes, an aqueous saturated sodium chloride solution was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-MeOH (7:3, v/v). Concentration of objective fraction afforded 748.8 mg (yield 71%) of compound 1E as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.40 (3H, t, J=7.2 Hz), 3.93 (1H, br s), 4.40 (2H, q, J=7.2 Hz), 5.61 (2H, s), 7.38-7.44 (10H, m), 8.52 (1H, s).',\n",
       "   'To a DMF (10 ml) solution of compound 1E (1.00 g, 3.14 mmol) were added WSC.HCl (1.20 g, 6.28 mmol) and HOBt (551.6 mg, 4.08 mmol) at room temperature, and the mixture was stirred at the same temperature for 90 minutes. The reaction solution was cooled to 0° C., and a DMF (2 ml) solution of 2-methoxyethanamine (236.0 mg, 3.14 mmol) was added dropwise over 3 minutes. The reaction solution was stirred at the same temperature for 1 hour, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (1:1, v/v) and, then, with n-hexane-ethyl acetate (1:9, v/v). Concentration of objective fraction afforded 928.5 mg (yield 79%) of compound 1F as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.39 (3H, t, J=7.2 Hz), 3.29 (3H, s), 3.41 (2H, t, J=5.4 Hz), 3.47-3.53 (2H, m), 4.39 (2H, q, J=7.2 Hz), 5.44 (2H, s), 7.36 (3H, m), 7.44-7.47 (2H, m), 8.07 (1H, br s), 8.54 (1H, s).',\n",
       "   'A xylene (2 ml) solution of compound 1F (500 mg, 1.33 mmol) and (S)-2-amino-3-phenylpropan-1-ol (604.2 mg, 4.0 mmol) was heated to 120° C., and stirred for 30 minutes. After the reaction solution was cooled to room temperature, and the solvent was distilled off, the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-MeOH (9:1, v/v). Concentration of objective fraction afforded 487 mg (yield 72%) of compound 1G as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.41 (3H, t, J=6.9 Hz), 2.24-2.34 (1H, m), 2.24-3.00 (1H, m), 3.03-3.16 (1H, m), 3.05 (3H, m), 3.25-3.32 (2H, m), 4.13-4.19 (1H, m), 4.17-4.30 (1H, m), 4.36-4.47 (1H, m), 4.51-4.54 (1H, m), 4.55 (1H, d, J=10.5 Hz), 5.78 (1H, t, J=6.9 Hz), 7.17-7.26 (4H, m), 7.28-7.35 (5H, m), 7.49 (1H, t, J=5.4 Hz), 6.32 (1H, s).',\n",
       "   'To a THF (6 ml) solution of compound 1G (2.86 g, 5.63 mmol) and triphenylphosphine (2.21 g, 8.45 mmol) was added dropwise a DEAD 40 wt % toluene solution (3.68 g, 8.45 mmol) at room temperature over 3 minutes. The reaction solution was stirred at the same temperature for 30 minutes, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (9:1, v/v), 1.37 g (yield 50%) of compound 1H was obtained as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.31 (3H, t, J=7.2 Hz), 3.07 (2H, d, J=6.9 Hz), 3.33 (3H, s), 3.57-3.80 (4H, m), 3.95 (1H, dd, J=3.0 Hz, 6.6 Hz), 4.01-4.14 (1H, m), 4.16-4.34 (2H, m), 5.24 (1H, d, J=9.9 Hz), 5.51 (1H, d, J=9.9 Hz), 7.01-7.03 (2H, m), 7.21-7.37 (5H, m), 7.41-7.58 (1H, m), 7.64-7.69 (2H, m).',\n",
       "   'To an EtOH (6 ml) solution of compound 1H (1.0 g, 2.04 mmol) was added a 2N aqueous sodium hydroxide solution (6 ml), and the mixture was stirred at room temperature for 30 minutes. The reaction solution was neutralized with 2N hydrochloric acid, and the precipitated solid was filtered, and dried to obtain 754 mg (yield 80%) of compound 1I.',\n",
       "   '1H-NMR (CDCl3) δ: 3.10 (2H, d, J=7.8 Hz), 3.33 (3H, s), 3.57-3.69 (4H, m), 3.82-3.90 (1H, m), 3.95 (1H, dd, J=3.3 Hz, 13.8 Hz), 4.36 (1H, dd, J=6.3 Hz, 7.5 Hz), 5.36 (1H, d, J=10.2 Hz), 5.45 (1H, d, J=10.2 Hz), 6.98-7.01 (2H, m), 7.28-7.39 (6H, m), 7.59 (2H, dd, J=1.8 Hz, 8.1 Hz), 7.87 (1H, s).',\n",
       "   'Compound 1I (1.0 g, 2.16 mmol) was dissolved in THF (10 ml), 10% Pd—C (200 mg) was added, and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was washed with ether to obtain 512 mg (yield 64%) of compound 1.',\n",
       "   '1H-NMR (CDCl3) δ: 6.24 (2H, d, J=6.3 Hz), 3.36 (3H, s), 3.60-3.86 (5H, m), 4.14 (1H, d, J=12.9 Hz), 4.47 (1H, s), 7.03-7.05 (2H, m), 7.30-7.35 (3H, m), 7.88 (1H, s), 12.68 (1H, s), 14.83 (1H, s).']},\n",
       " {'number': 'Example 2',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To (S)-tert-butyl 3-hydroxy-1,1-diphenylpropan-2-ylcarbamate (5.00 g, 15.3 mmol) was added trifluoroacetic acid (40 ml), and the mixture was stirred for 1 hour under ice-cooling. After trifluoroacetic acid was distilled off, toluene was added, and distilled off again under reduced pressure to obtain crude (S)-2-amino-3,3-diphenylpropan-1-ol. To the resulting (S)-2-amino-3,3-diphenylpropan-1-ol were added compound 1F (5.73 g, 15.3 mmol), toluene (50 ml), and triethylamine (6.4 ml, 45.8 mmol), the mixture was stirred at 90° C. for 1 hour, and cooled to room temperature and, thereafter, the solvent was distilled off. To the resulting residue was added dichloromethane, and the mixture was washed with 2N hydrochloric acid, an aqueous saturated sodium bicarbonate solution, and an aqueous saturated sodium chloride solution. After separation of the organic layer, after magnesium sulfate was added, the mixture was filtered with celite, and the filtrate was distilled off to obtain candy-like compound 2A (9.12 g).',\n",
       "   'MS: m/z=585.2 [M+H]+.',\n",
       "   'The compound 2A (8.60 g, 14.7 mmol) and triphenylphosphine (7.72 g, 29.4 mmol) were dissolved in tetrahydrofuran (90 ml), and a 2.2M toluene solution of diethyl azodicarboxylate (10.0 ml, 22.0 mmol) was added dropwise under ice-cooling. After the mixture was stirred for 2 hours under ice-cooling, and for 18 hours under room temperature, the solvent was distilled off. The resulting residue was purified by silica gel column chromatography to obtain foamy compound 2B (3.88 g, 6.85 mmol).',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.18 (3H, m), 3.11 (3H, s), 3.16 (1H, m), 3.28 (1H, m), 3.76 (1H, m), 3.97-4.13 (3H, m), 4.31 (1H, d, J=11.3 Hz), 5.08 (2H, s), 5.52 (1H, d, J=12.0 Hz), 7.18-7.25 (6H, m), 7.25-7.45 (6H, m), 7.55-7.66 (6H, m).',\n",
       "   'MS: m/z=567.7 [M+H]+.',\n",
       "   'To compound 2B (3.4 g, 6.0 mmol) were added ethanol (36 ml), water (12 ml), and a 2N aqueous sodium hydroxide solution (4.5 ml, 9.0 mmol), and the mixture was stirred at room temperature for 40 minutes, thereafter, ethanol (10 ml) and water (10 ml) were added, and the mixture was further stirred for 30 minutes. Ethanol was distilled off, ethyl acetate and water were added, and the mixture was stirred vigorously and, thereafter, layers were separated. The ethyl acetate layer was washed with 2N sodium hydroxide three times, and the aqueous layers were combined into one aqueous layer. To the aqueous layer was added ethyl acetate, the mixture was neutralized using 2N hydrochloric acid, then the mixture was stirred vigorously and, thereafter, the ethyl acetate layer was separated. To the ethyl acetate layer was added magnesium sulfate, the mixture was filtered with celite, and the filtrate was distilled off. The resulting residue was dissolved in MeOH, and the solvent was distilled off to obtain a solid of compound 2C (3.0 g, 5.64 mmol).',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.11 (3H, s), 3.16 (1H, m), 3.25 (1H, m), 3.75 (1H, m), 4.11 (1H, m), 4.36 (1H, d, J=11.6 Hz), 5.18 (2H, dd, J=15.7 Hz, 10.4 Hz), 5.71 (1H, d, J=11.6 Hz), 7.08-7.20 (5H, m), 7.29-7.45 (6H, m), 7.55 (2H, d, J=6.7 Hz), 7.61 (2H, d, J=7.5 Hz), 7.98 (1H, s).',\n",
       "   'MS: m/z=539.4 [M+H]+.',\n",
       "   'To compound 2C (1.50 g, 2.79 mmol) were added methanol (22 ml), and 10% palladium carbon-50% wet (150 mg), and the mixture was stirred for 1 hour under hydrogen atmosphere. Ethyl acetate (44 ml) was added, the mixture was filtered with celite, and the filtrate was distilled off. The resulting residue was dissolved in methanol (20 ml), water (10 ml) was added, and methanol was distilled off. The precipitate was filtered, and dried to obtain compound 2 (1.15 g, 2.56 mmol).',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.15 (3H, s), 3.50-3.70 (5H, m), 4.19 (1H, dd, J=13.8 Hz, 3.1 Hz), 4.49 (1H, d, J=11.6 Hz), 5.78 (1H, d, J=9.6 Hz), 7.10-7.27 (6H, m), 7.34 (1H, m), 7.46 (2H, t, J=7.5 Hz), 7.63 (2H, t, J=7.7 Hz), 7.94 (1H, s), 12.94 (1H, s), 15.08 (1H, s).',\n",
       "   'MS: m/z=449.4 [M+H]+.']},\n",
       " {'number': 'Example 3',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 3 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.15 (1H, m), 3.26 (3H, s), 3.52-3.70 (4H, m), 3.70-3.80 (2H, m), 4.10 (1H, d, J=12.9 Hz), 4.92 (1H, brs), 6.98 (1H, t, J=7.4 Hz), 7.03 (1H, brs), 7.08 (1H, t, 7.6 Hz), 7.34 (1H, d, J=7.8 Hz), 7.47 (1H, d, J=7.3 Hz), 7.80 (1H, s), 10.94 (1H, brs), 15.38 (1H, brs).',\n",
       "   'MS: m/z=412.4 [M+H]+.']},\n",
       " {'number': 'Example 4',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 4 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.13 (3H, s), 3.46-3.72 (5H, m), 4.16 (1H, d, J=12.6 Hz), 4.48 (1H, d, J=10.9 Hz), 5.77 (1H, d, J=11.6 Hz), 7.10-7.27 (6H, m), 7.32 (1H, m), 7.44 (2H, m), 7.61 (2H, m), 7.93 (1H, s), 15.04 (1H, s).',\n",
       "   'MS: m/z=449.3 [M+H]+.']},\n",
       " {'number': 'Example 5',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 5 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.28 (3H, s), 3.52-3.68 (4H, m), 4.06 (1H, m), 4.25 (2H, m), 4.41 (1H, brs), 4.56 (1H, d, J=13.6 Hz), 4.82 (1H, d, J=13.9 Hz), 6.74 (2H, d, J=7.6 Hz), 6.92 (1H, t, J=7.20 Hz), 7.25 (2H, t, J=7.8 Hz), 8.58 (1H, s), 12.48 (1H, brs), 15.55 (1H, brs).',\n",
       "   'MS: m/z=389.4 [M+H]+.']},\n",
       " {'number': 'Example 6',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 6 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.16 (1H, m), 3.26 (3H, s), 3.50-3.70 (4H, m), 3.70-3.80 (2H, m), 4.10 (1H, d, J=13.4 Hz), 4.92 (1H, brs), 6.98 (1H, t, J=7.1 Hz), 7.03 (1H, brs), 7.08 (1H, t, J=7.3 Hz), 7.34 (1H, d, J=7.8 Hz), 7.48 (1H, d, J=7.3 Hz), 7.81 (1H, s), 12.91 (1H, s), 15.36 (1H, s).',\n",
       "   'MS: m/z=412.4 [M+H]+.']},\n",
       " {'number': 'Example 7',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 7 was synthesized by the same method.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.85-0.95 (2H, m), 1.05-1.25 (5H, m), 1.45-1.80 (8H, m), 3.28 (3H, s), 3.46 (1H, m), 3.58 (1H, m), 3.72 (1H, d, J=13.9 Hz), 3.93 (1H, m), 4.04 (1H, d, J=13.1 Hz), 4.88 (1H, s), 8.56 (1H, s), 12.80 (1H, s), 15.51 (1H, s).',\n",
       "   'MS: m/z=379.3 [M+H]+.']},\n",
       " {'number': 'Example 8',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 8 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.07 (2H, m), 2.55 (1H, m), 2.74 (1H, m), 3.17 (1H, s), 3.23 (3H, s), 3.48-3.65 (4H, m), 3.79 (1H, d, J=13.6 Hz), 3.87 (1H, m), 4.09 (1H, d, J=13.6 Hz), 4.80 (1H, s), 7.10-7.29 (5H, m), 8.59 (1H, s), 12.77 (1H, s), 15.49 (1H, s).',\n",
       "   'MS: m/z=387.3 [M+H]+.']},\n",
       " {'number': 'Example 9',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 9 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.80 (1H, dd, J=14.5 Hz, J2=8.5 Hz), 2.93 (1H, dd, J=14.4 Hz, 5.6 Hz), 3.21 (3H, s), 3.40-3.55 (4H, m), 3.77 (2H, s), 3.82 (1H, d, J=13.1 Hz), 3.88 (1H, m), 4.13 (1H, d, J=13.6 Hz), 4.85 (1H, s), 7.20-7.35 (5H, m), 8.61 (1H, s), 12.79 (1H, s), 15.43 (1H, s).',\n",
       "   'MS: m/z=419.3 [M+H]+.']},\n",
       " {'number': 'Example 10',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 10 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.22 (3H, d, J=6.2 Hz), 3.29 (3H, s), 3.43 (1H, m), 3.58 (2H, m), 3.94 (1H, m), 4.12 (1H, brs), 4.41 (1H, d, J=13.6 Hz), 4.49 (1H, d, J=13.1 Hz), 8.59 (1H, s), 12.65 (1H, s), 15.53 (1H, s).',\n",
       "   'MS: m/z=297.2 [M+H]+.']},\n",
       " {'number': 'Example 11',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 2, compound 11 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.46 (4H, brs), 1.76-1.90 (2H, m), 2.22 (1H, brs), 3.27 (3H, s), 3.57 (1H, d, J=5.3 Hz), 4.07 (1H, m), 4.69 (1H, m), 8.47 (1H, s), 13.04 (1H, s), 15.52 (1H, s).',\n",
       "   'MS: m/z=337.2 [M+H]+.']},\n",
       " {'number': 'Example 12',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 12A (1.53 g, 5.80 mmol) were dissolved in THF (6 ml) and water (6 ml), potassium carbonate (2.41 g, 17.4 mmol) was added, the mixture was stirred, and benzyl chloroformate (1.09 g, 6.38 mmol) was added dropwise at 0° C. After stirring at 0° C. for 10 minutes, the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into sodium bicarbonate water, and the mixture was extracted with ethyl acetate. The extract was washed with 1N hydrochloric acid and an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off to obtain 2.32 g of compound 12B as a colorless gummy solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.98 (1H, brs), 3.55 (1H, m), 3.75 (1H, m), 4.20 (1H, d, J=10.5 Hz), 4.58 (1H, m), 4.83 (1H, brs), 5.07 (2H, s), 7.16-7.39 (15H, m).',\n",
       "   'The compound 12B (1.94 g, 5.37 mmol), triphenylphosphine (2.11 g, 8.05 mmol) and phthalimide (948 mg, 6.44 mmol) were added to THF (20 ml), and diisopropyl azodicarboxylate (2.2M in toluene, 3.66 ml, 8.05 mmol) was added dropwise at room temperature. After stirring at room temperature for 4 hours, the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 2.39 g of compound 12C as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.73 (2H, m), 4.05 (1H, d, J=10.1 Hz), 4.70 (1H, d, J=9.6 Hz), 4.77 (2H, d, J=7.2 Hz) 5.02 (1H, m), 7.03-7.42 (15H, m), 7.68 (2H, dd, J=5.7, 2.1 Hz), 7.78 (2H, dd, J=5.7, 2.1 Hz).',\n",
       "   'The compound 12C (2.39 g, 4.87 mmol) was added to THF (20 ml) and methanol (20 ml), hydrazine hydrate (4.88 g, 97.4 mmol) was added, and the mixture was stirred at 50° C. for 4 hours. The white precipitate was removed by filtration, and washed with methanol. After the filtrate was distilled off under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 1.41 g of compound 12D as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.63 (1H, dd, J=13.2, 5.8 Hz), 2.86 (1H, d, J=9.9 Hz), 4.07 (1H, d, J=10.4 Hz), 4.53 (1H, m), 4.81 (1H, m), 5.00 (2H, d, 8.4 Hz), 7.20-7.36 (10H, m).',\n",
       "   'Compound 12D (1.41 g, 3.91 mmol) was dissolved in THF (15 ml), and Boc2O (896 mg, 4.11 mmol) was added at room temperature. After stirring for 1.5 hours, the solvent was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 1.77 g of compound 12E as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.41 (9H, s), 3.23 (2H, brm), 3.97 (1H, d, J=9.8 Hz), 4.58-4.80 (3H, m), 5.00 (2H, d, J=9.8 Hz), 7.15-7.29 (10H, m).',\n",
       "   'Compound 12E (1.73 g, 3.76 mmol) and palladium-active carbon (10%, wet, 200 mg) were added to methanol (20 ml), and the mixture was stirred at room temperature for 1 hour under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 1.01 g of a colorless oily substance 12F.',\n",
       "   '1H-NMR (CDCl3) δ: 1.44 (9H, s), 2.82 (1H, m), 3.31 (1H, m), 3.73 (2H, d, J=6.9 Hz), 4.98 (1H, s), 7.18-7.39 (10H, m).',\n",
       "   'Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (974 mg, 3.06 mmol) obtained by the method shown in Reference Example 1, and 12F (999 mg, 3.06 mmol) were added to toluene (10 ml), and the mixture was stirred at 110° C. for 5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain 1.51 g of compound 12G as a pale yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.36 (9H, s), 3.40 (1H, m), 3.53 (1H, m), 3.82 (3H, s), 3.91 (3H, s), 4.29 (1H, d, J=11.3 Hz), 4.78 (1H, m), 4.82 (1H, m), 5.11 (1.9H, d, J=7.5 Hz), 7.10-7.38 (10H, m), 8.27 (1H, s).',\n",
       "   'To compound 12G (1.45 g, 2.31 mmol) was added 4N HCl (ethyl acetate solution, 20 ml), and the mixture was stirred at room temperature for 1.5 hours. After the solvent was distilled off under reduced pressure, sodium bicarbonate water was added, and the mixture was stirred at room temperature for 1.5 hours. This was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 1.01 g of compound 12H as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.40 (1H, dd, J=13.6, 6.6 Hz), 3.78 (3H, s), 3.80 (1H, m), 4.37 (1H, d, J=11.6 Hz), 4.59 (1H, d, J=11.0 Hz), 5.43 (2H, d, J=10.2 Hz), 5.93 (1H, d, J=5.8 Hz), 7.03-7.21 (5H, m), 7.37 (9H, m), 7.63 (2H, m).',\n",
       "   'Compound 12H (50 mg, 0.10 mmol) was dissolved in DMF (1 ml), and cesium carbonate (165 mg, 0.50 mmol) was added. After stirring at room temperature for 30 minutes, iodomethane (0.032 ml, 0.50 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 49 mg of compound 121 as a colorless solid.',\n",
       "   'Compound 12I (49 mg, 0.096 mmol) was dissolved in THF (0.5 ml) and methanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.24 ml, 0.48 mmol) was added at room temperature, and the mixture was stirred for 1.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 54 mg of compound 12J was obtained as a colorless solid.',\n",
       "   'MS: m/z=481 [M+H]+.',\n",
       "   'To compound 12J obtained in the ninth step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 26 mg of compound 12 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.01 (3H, s), 3.26 (1H, t, J=14.4 Hz), 4.23 (1H, dd, J=13.5, 3.8 Hz), 4.57 (1H, d, J=11.6 Hz), 5.78 (1H, d, J=11.3 Hz), 7.16-7.70 (10H, m), 8.00 (1H, s), 13.00 (1H, s), 15.10 (1H, s).',\n",
       "   'MS: m/z=405 [M+H]+.']},\n",
       " {'number': 'Example 13',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 13 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.05 (3H, t, J=6.9 Hz), 3.43-3.65 (3H, m), 4.22 (1H, d, J=10.6 Hz), 4.55 (1H, d, J=11.6 Hz), 5.81 (1H, d, J=10.1 Hz), 7.15-7.68 (10H, m), 7.97 (1H, s), 12.96 (1H, s), 15.07 (1H, s).',\n",
       "   'MS: m/z=463 [M+H]+.']},\n",
       " {'number': 'Example 14',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 14 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.98 (3H, t, J=7.17 Hz), 3.44-3.64 (3H, m), 4.15 (1H, dd, J=13.7, 3.5 Hz), 4.45 (1H, d, J=11.6 Hz), 5.79 (1H, d, J=12.2 Hz), 7.08-7.63 (10H, m), 7.89 (1H, s), 13.01 (1H, s), 15.06 (1H, s).',\n",
       "   'MS: m/z=419 [M+H]+.']},\n",
       " {'number': 'Example 15',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 15 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.22 (1H, s), 3.47 (1H, d, J=13.3 Hz), 4.17 (2H, m), 4.44 (2H, dd, J=16.7, 3.0 Hz), 5.79 (1H, d, J 12.2 Hz), 7.10-7.64 (10H, m), 7.98 (1H, s), 12.56 (1H, s), 15.05 (1H, brs).']},\n",
       " {'number': 'Example 16',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 16 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.24 (1H, d, J=13.2 Hz), 4.23 (1H, m), 4.25 (1H, d, J=14.7 Hz), 4.40 (1H, d, J=14.8 Hz), 4.92 (1H, d, J=15.4 Hz), 5.79 (1H, m), 7.03-7.48 (10H, m), 7.93 (1H, s), 12.82 (1H, s), 15.06 (1H, s).']},\n",
       " {'number': 'Example 17',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 17 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.23 (1H, d, J=13.4 Hz), 4.22 (1H, m), 4.25 (1H, d, J=12.0 Hz), 4.45 (1H, d, J=14.9 Hz), 4.93 (1H, d, J=15.3 Hz), 5.77 (1H, d, J=11.6 Hz), 7.09-7.56 (10H, m), 7.92 (1H, s), 12.74 (1H, s), 15.06 (1H, s).']},\n",
       " {'number': 'Example 18',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 18 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.63 (2H, m), 3.20 (3H, s), 3.44 (5H, m), 4.19 (1H, d, J=10.2 Hz), 4.51 (1H, d, J=11.8 Hz), 5.80 (1H, d, J=11.0 Hz), 7.13-7.65 (10H, m), 7.93 (1H, s), 13.02 (1H, s).',\n",
       "   'MS: m/z=463 [M+H]+.']},\n",
       " {'number': 'Example 19',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 19 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.15 (1H, d, J=9.5 Hz), 3.95 (1H, dd, J=13.5, 3.4 Hz), 4.51 (1H, d, J=11.6 Hz), 5.74 (1H, d, J=11.1 Hz), 7.11-7.62 (10H, m), 7.93 (1H, s), 9.34 (1H, s), 12.97 (1H, s), 15.07 (1H, brs).',\n",
       "   'MS: m/z=391 [M+H]+.']},\n",
       " {'number': 'Example 20',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 20 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.26 (1H, m), 4.24 (1H, m), 4.27 (1H, d, J=12.0 Hz), 4.41 (1H, J=14.8 Hz), 4.87 (1H, d, J=14.9 Hz), 5.75 (1H, d, J=7.6 Hz), 7.09-7.77 (12H, m), 7.93 (1H, s), 8.52 (2H, m), 12.79 (1H, s), 15.07 (1H, brs).',\n",
       "   'MS: m/z=482 [M+H]+.']},\n",
       " {'number': 'Example 21',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 21 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.62 (3H, d, J=6.9 Hz), 0.82 (3H, d, J=6.6 Hz), 3.18 (1H, m), 3.75 (1H, d, J=10.2 Hz), 4.25 (1H, d, J=11.8 Hz), 4.58 (1H, m), 5.65 (1H, d, J=11.3 Hz), 6.89-7.43 (10H, m), 7.67 (1H, s), 12.94 (1H, s).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 22',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 22 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.07-1.70 (5H, m), 3.04-3.34 (5H, m), 3.82 (2H, dm), 4.18 (1H, d, J=10.2 Hz), 4.42 (1H, d, J=12.0 Hz), 5.81 (1H, d, J=11.7 Hz), 7.11-7.59 (10H, m), 7.86 (1H, s), 12.96 (1H, s), 15.07 (1H, brs).',\n",
       "   'MS: m/z=489 [M+H]+.']},\n",
       " {'number': 'Example 23',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 23 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.01-0.79 (5H, m), 3.05 (1H, dd, J=14.1, 7.5 Hz), 3.49-3.59 (2H, m), 4.16 (1H, dd, J=14.0, 3.3 Hz), 4.50 (1H, d, J=11.9 Hz), 5.82 (1H, d, J=11.1 Hz), 7.11-7.62 (10H, m), 7.89 (1H, s), 12.99 (1H, s), 15.07 (1H, brs).',\n",
       "   'MS: m/z=445 [M+H]+.']},\n",
       " {'number': 'Example 24',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 24 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.23 (1H, d, J=13.7 Hz), 4.16 (1H, dd, J=13.2, 3.3 Hz), 4.19 (2H, d, J=12.0 Hz), 4.38 (1H, d, J=14.6 Hz), 4.84 (1H, d, J=14.6 Hz), 5.72 (1H, d, J=11.4 Hz), 7.08-7.33 (15H, m), 7.98 (1H, s), 12.88 (1H, s), 15.07 (1H, s).',\n",
       "   'MS: m/z=481 [M+H]+.']},\n",
       " {'number': 'Example 25',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 25 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.39 (3H, s), 3.37 (1H, m), 4.21 (1H, dd, J=14.4, 3.9 Hz), 4.40 (1H, dd, J=11.7 Hz), 4.45 (1H, d, J=15.3 Hz), 4.81 (1H, d, J=15.4 Hz), 5.78 (1H, d, J=12.0 Hz), 6.30 (1H, s), 7.09-7.42 (10H, m), 7.95 (1H, s), 12.65 (1H, s), 15.07 (1H, s).',\n",
       "   'MS: m/z=486 [M+H]+.']},\n",
       " {'number': 'Example 26',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 26 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.20-1.77 (6H, m), 3.11-3.61 (6H, m), 4.21 (1H, d, J=9.9 Hz), 4.53 (1H, d, J=11.7 Hz), 5.80 (1H, d, J=11.8 Hz), 7.14-7.65 (10H, m), 7.95 (1H, s), 12.95 (1H, brs), 15.06 (1H, brs).',\n",
       "   'MS: m/z=489 [M+H]+.']},\n",
       " {'number': 'Example 27',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12, compound 27 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.36 (1H, m), 4.28 (1H, d, J=12.0 Hz), 4.54 (1H, d, J=11.4 Hz), 4.62 (1H, d, J=15.3 Hz), 4.79 (1H, d, J=15.4 Hz), 5.77 (1H, d, J=9.9 Hz), 7.09-7.79 (13H, m), 7.98 (1H, s), 8.46 (1H, d, J=4.6 Hz), 12.82 (1H, brs), 15.06 (1H, brs).',\n",
       "   'MS: m/z=482 [M+H]+.']},\n",
       " {'number': 'Example 28',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 28A (3.20 g, 17.1 mmol) was added to THF (20 ml), triethylamine (2.60 ml, 18.8 mmol) was added, and the mixture was stirred at room temperature for 10 minutes. After Boc2O (4.09 g, 18.8 mmol) was added at room temperature, the mixture was stirred for 2 hours. The solvent was distilled off under reduced pressure, water was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off under reduced pressure to obtain 5.17 g of compound 28B as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.52 (9H, s), 2.77 (2H, m), 3.03-3.12 (1H, m), 3.38 (1H, m), 3.90-3.98 (1H, m), 4.93 (1H, brs), 7.20-7.35 (5H, m).',\n",
       "   'Compound 28B (4.29 g, 17.1 mmol), triphenylphosphine (5.37 g, 20.5 mmol) and phthalimide (2.76 g, 18.8 mmol) were added to THF (60 ml), and diethyl azodicarboxylate (2.2M in toluene, 11.6 ml, 25.6 mmol) was added dropwise at room temperature. After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 2:1, v/v) to obtain 6.13 g of compound 28C as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.30 (9H, s), 3.14 (1H, dd, J=13.8, 6.2 Hz), 3.39 (2H, m), 3.87 (1H, m), 4.67 (1H, m), 4.81 (1H, brs), 7.16-7.19 (5H, m), 7.66 (2H, dd, J=5.3, 3.1 Hz), 7.75 (2H, dd, J=5.7, 3.0 Hz).',\n",
       "   'Compound 28C (1.00 g, 2.63 mmol) was added to THF (7 ml) and methanol (7 ml), hydrazine hydrate (2.63 g, 52.6 mmol) was added, and the mixture was stirred at 50° C. for 2 hours. The white precipitate was removed by filtration, and washed with methanol. After the filtrate was distilled off under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 249 mg of compound 28D as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.44 (9H, s), 1.95 (2H, brs), 2.55-3.31 (5H, m), 5.06 (1H, brs), 7.18-7.33 (5H, m).',\n",
       "   'Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (313 mg, 0.983 mmol) and 28D (246 mg, 0.983 mmol) were added to toluene (3 ml), and the mixture was stirred at 100° C. for 2.5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain 320 mg of compound 28E as a pale yellow gummy substance.',\n",
       "   '1H-NMR (CDCl3) δ: 1.42 (9H, s), 3.07 (2H, m), 3.56 (2H, m), 3.68 (3H, s), 3.95 (3H, s), 4.26 (1H, s), 4.86 (1H, s), 5.18 (1H, d, J=10.8 Hz), 5.22 (1H, d, J=10.8 Hz), 7.01 (2H, m), 7.24-7.38 (8H, m), 8.22 (1H, s).',\n",
       "   'MS: m/z=551 [M+H]+.',\n",
       "   'To compound 28E (315 mg, 0.572 mmol) was added 4N HCl (ethyl acetate solution, 5 ml), and the mixture was stirred at room temperature for 30 minutes. After the solvent was distilled off under reduced pressure, aqueous sodium bicarbonate water was added, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 210 mg of compound 28F as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.07-3.15 (2H, m), 3.34 (1H, dd, J=13.2, 6.0 Hz), 3.74 (2H, m), 3.86 (3H, s), 4.12 (1H, m), 5.27 (1H, d, J=10.1 Hz), 5.47 (1H, d, J=10.1 Hz), 6.76 (1H, d, J=6.4 Hz), 7.04 (2H, m), 7.32 (6H, m), 7.62 (2H, dd, J=7.7, 1.4 Hz), 7.70 (1H, s).',\n",
       "   'MS: m/z=419 [M+H]+.',\n",
       "   'Compound 28F (50 mg, 0.12 mmol) was dissolved in DMF (1 ml), and cesium carbonate (195 mg, 0.597 mmol) was added. After the mixture was stirred at room temperature for 30 minutes, iodoethane (0.048 ml, 0.60 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 47 mg of compound 28G as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.22 (3H, t, J=7.2 Hz), 3.00-3.15 (2H, m), 3.28 (1H, dd, J=13.6, 1.6 Hz), 3.48 (1H, m), 3.75 (1H, m), 3.85 (3H, s), 3.88 (1H, dd, J=13.3, 3.2 Hz), 4.15 (1H, m), 5.25 (1H, d, J=9.9 Hz), 5.50 (1H, d, J=9.9 Hz), 7.04 (2H, m), 7.29-7.38 (6H, m), 7.60 (1H, s), 7.68 (2H, m).',\n",
       "   'MS: m/z=447 [M+H]+.',\n",
       "   'Compound 28G (47 mg, 0.11 mmol) was dissolved in THF (0.5 ml) and methanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.26 ml, 0.53 mmol) was added at room temperature, and the mixture was stirred for 1 hour. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 40 mg of compound 28H was obtained as a colorless solid.',\n",
       "   'MS: m/z=433 [M+H]+.',\n",
       "   'To compound 28H obtained in the seventh step was added trifluoroaceteic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 17 mg of compound 28 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.17 (3H, t, J=7.2 Hz), 3.08 (2H, m), 3.51-3.63 (3H, m), 4.08 (1H, dd, J=13.6, 3.9 Hz), 5.03 (1H, brs), 7.21 (5H, m), 8.07 (1H, s), 12.98 (1H, s), 15.07 (1H, brs).',\n",
       "   'MS: m/z=343 [M+H]+.']},\n",
       " {'number': 'Example 29',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 28, compound 29 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.96 (2H, d, J=7.6 Hz), 3.46 (1H, d, J=13.3 Hz), 4.06 (1H, dd, J=13.6, 3.8 Hz), 4.64 (1H, d, J=14.9 Hz), 4.89 (1H, d, J=14.6 Hz), 4.98 (1H, m), 6.97 (2H, m), 7.10-7.37 (5H, m), 7.57 (1H, m), 8.12 (1H, s), 12.75 (1H, s), 15.07 (1H, brs).']},\n",
       " {'number': 'Example 30',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 28, compound 30 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.99 (2H, dd, J=7.5, 3.6 Hz), 3.48 (1H, d, J=13.4 Hz), 4.09 (1H, dd, J=13.4, 4.0 Hz), 4.73 (1H, d, J=15.1 Hz), 4.92 (1H, d, J=15.1 Hz), 4.99 (1H, m), 6.97 (2H, m), 7.18-7.29 (4H, m), 7.49 (1H, m), 7.61 (1H, m), 8.15 (1H, s), 12.69 (1H, s), 15.06 (1H, brs).']},\n",
       " {'number': 'Example 31',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 28, compound 31 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.91 (2H, m), 3.45 (1H, d, J=13.1 Hz), 4.02 (1H, dd, J=13.6, 4.0 Hz), 4.57 (1H, d, J=14.6 Hz), 4.91 (1H, d, J=14.6 Hz), 4.93 (1H, m), 6.89 (2H, m), 7.18 (3H, m), 7.40 (5H, m), 8.16 (1H, s), 12.86 (1H, brs), 15.06 (1H, brs).',\n",
       "   'MS: m/z=405 [M+H]+.']},\n",
       " {'number': 'Example 32',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 28, compound 32 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.10 (2H, m), 3.39 (1H, d, J=13.6 Hz), 3.84 (1H, dd, J=13.6, 4.0 Hz), 4.94 (1H, m), 7.23 (5H, m), 8.19 (1H, s), 9.44 (1H, brs), 12.97 (1H, s), 15.06 (1H, brs).',\n",
       "   'MS: m/z=315 [M+H]+.']},\n",
       " {'number': 'Example 33',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 28, compound 33 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.09 (3H, t, J=6.9 Hz), 3.10 (2H, m), 3.42-3.50 (2H, m), 3.71 (5H, m), 4.11 (1H, dd, J=13.6, 3.8 Hz), 4.99 (1H, brs), 7.11-7.29 (5H, m), 7.99 (1H, s), 12.88 (1H, s), 15.06 (1H, brs).',\n",
       "   'MS: m/z=387 [M+H]+.']},\n",
       " {'number': 'Example 34',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 28, compound 34 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.16 (3H, d, J=6.9 Hz), 1.21 (3H, d, J=6.9 Hz), 2.98 (1H, dd, J=13.6, 9.8 Hz), 3.13 (1H, dd, J=13.7, 5.8 Hz), 3.68 (1H, d, J=12.8 Hz), 3.87 (1H, dd, J=13.6, 3.7 Hz), 4.83 (1H, quin, J=6.8 Hz), 5.07 (1H, brs), 7.19 (5H, m), 7.90 (1H, s), 13.09 (1H, s), 15.08 (1H, brs).',\n",
       "   'MS: m/z=357 [M+H]+.']},\n",
       " {'number': 'Example 35',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 28, compound 35 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.07 (3H, s), 3.14 (2H, m), 3.49 (1H, d, J=13.3 Hz), 4.08 (1H, dd, J=13.7, 4.0 Hz), 4.99 (1H, m), 7.13-7.31 (5H, m), 8.18 (1H, s), 12.95 (1H, s), 15.06 (1H, brs).',\n",
       "   'MS: m/z=329 [M+H]+.']},\n",
       " {'number': 'Example 36',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 12H (460 mg, 0.930 mmol) was dissolved in THF (2.5 ml) and methanol (2.5 ml), a 2N aqueous sodium hydroxide solution (2.33 ml, 4.65 mmol) was added at room temperature, and the mixture was stirred for 1.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 405 mg of compound 36A was obtained as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.45 (1H, ddd, J=13.8, 6.9, 1.3 Hz), 3.80 (1H, dd, J=13.5, 2.1 Hz), 4.35 (1H, d, J=11.6 Hz), 4.77 (1H, d, J=11.3 Hz), 5.46 (1H, d, J=10.5 Hz), 5.52 (1H, d, J=10.5 Hz), 6.11 (1H, d, J=5.8 Hz), 6.94-6.98 (2H, m), 7.17 (3H, m), 7.31-7.46 (8H, m), 7.58 (3H, m).',\n",
       "   'Compound 36A (402 mg, 0.837 mmol) was added to diphenyl ether (5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 164 mg of compound 36B as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.36 (1H, dd, J=13.0, 7.0 Hz), 3.72 (1H, d, J=11.1 Hz), 4.35 (1H, d, J=11.4 Hz), 4.49 (1H, d, J=10.2 Hz), 5.38 (1H, d, J=10.5 Hz), 5.43 (1H, d, J=10.4 Hz), 5.94 (1H, d, J=7.2 Hz), 6.29 (1H, d, J=6.6 Hz), 6.38 (1H, d, J=7.5 Hz), 6.99 (2H, m), 7.17 (3H, m), 7.36 (8H, m), 7.60 (2H, m).',\n",
       "   'Compound 36B (40 mg, 0.092 mmol) was dissolved in DMF (1 ml), and cesium carbonate (179 mg, 0.55 mmol) was added. After stirring at room temperature for 30 minutes, iodomethane (0.029 ml, 0.46 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. After the reaction solution was poured into water, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 44 mg of compound 36C as a colorless gummy substance.',\n",
       "   'To compound 36C obtained in the third step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 24 mg of compound 36 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.93 (3H, s), 3.17 (1H, d, J=13.0 Hz), 4.13 (1H, dd, J=13.6, 3.4 Hz), 4.47 (1H, d, J=11.4 Hz), 5.52 (1H, dd, J=9.3, 3.4 Hz), 5.99 (1H, d, J=7.3 Hz), 7.18 (4H, m), 7.30 (3H, m), 7.41 (2H, t, J=7.5 Hz), 7.60 (2H, d, J=7.2 Hz).',\n",
       "   'MS: m/z=361 [M+H]+.']},\n",
       " {'number': 'Example 37',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 36, compound 37 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.16 (2H, d, J=13.3 Hz), 4.05 (1H, d, J=10.5 Hz), 4.15 (1H, d, J=11.7 Hz), 4.38 (1H, d, J=14.9 Hz), 4.74 (1H, d, J=14.5 Hz), 5.35 (1H, d, J=11.4 Hz), 5.65 (1H, d, J=7.3 Hz), 6.99 (1H, d, J=7.5 Hz), 7.21 (15H, m).',\n",
       "   'MS: m/z=437 [M+H]+.']},\n",
       " {'number': 'Example 38',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 36, compound 38 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.57 (2H, m), 3.17 (3H, s), 3.21-3.31 (5H, m), 4.07 (1H, dd, J=13.5, 3.7 Hz), 4.36 (1H, d, J=11.6 Hz), 5.42 (1H, d, J=9.2 Hz), 5.61 (1H, d, J=7.3 Hz), 6.89 (1H, d, J=7.5 Hz), 7.13-7.31 (6H, m), 7.40 (2H, t, J=6.3 Hz), 7.57 (2H, d, J=7.3 Hz), 12.31 (1H, brs).',\n",
       "   'MS: m/z=419 [M+H]+.']},\n",
       " {'number': 'Example 39',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 36, compound 39 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.12 (1H, dd, J=13.6, 5.5 Hz), 3.87 (1H, d, J=9.5 Hz), 4.44 (1H, d, J=11.7 Hz), 5.45 (1H, d, J=10.4 Hz), 5.83 (1H, d, J=7.5 Hz), 7.04 (1H, d, J=7.2 Hz), 7.14-7.31 (6H, m), 7.40 (2H, t, J=7.5 Hz), 7.58 (2H, d, J=7.5 Hz), 9.09 (1H, d, J=5.2 Hz).',\n",
       "   'MS: m/z=347 [M+H]+.']},\n",
       " {'number': 'Example 40',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 36, compound 40 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.88-3.15 (2H, m), 3.27 (3H, s), 3.53-3.73 (5H, m), 3.99 (1H, dd, J=13.27, 3.97 Hz), 4.56-4.60 (1H, m), 5.89 (1H, d, J=7.32 Hz), 7.08-7.30 (6H, m).']},\n",
       " {'number': 'Example 41',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 41A (290 mg, 0.555 mmol) synthesized according to Example 12 was added to diphenyl ether (5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1→97:3, v/v) to obtain 86 mg of compound 41B as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 0.76 (3H, d, J=6.7 Hz), 0.98 (3H, d, J=6.9 Hz), 3.43-3.52 (2H, m), 3.62 (1H, dd, J=13.6, 3.5 Hz), 4.22 (1H, d, J=11.6 Hz), 4.52 (1H, d, J=11.6 Hz), 4.86-4.95 (1H, m), 5.37 (1H, d, J=10.2 Hz), 5.45 (1H, d, J=10.2 Hz), 5.90 (1H, d, J=7.5 Hz), 6.22 (1H, d, J=7.5 Hz), 6.89 (2H, m), 7.15 (3H, m), 7.36 (8H, m), 7.67 (2H, m).',\n",
       "   'To compound 41B obtained in the first step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 45 mg of compound 41 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.82 (3H, d, J=6.7 Hz), 1.05 (3H, d, J=6.7 Hz), 3.90 (1H, dd, J=13.6, 3.4 Hz), 4.39 (1H, d, J=11.9 Hz), 4.77-4.86 (1H, m), 5.50 (1H, d, J=8.6 Hz), 5.69 (1H, d, J=7.4 Hz), 6.92 (1H, d, J=7.4 Hz), 7.15-7.48 (8H, m), 7.63 (2H, d, J=7.7 Hz) 12.51 (1H, Brs).',\n",
       "   'MS: m/z=389 [M+H]+.']},\n",
       " {'number': 'Example 42',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 41, compound 42 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.12 (3H, s), 3.51 (5H, m), 4.05 (1H, dd, J=13.9, 3.5 Hz), 4.37 (1H, d, J=11.4 Hz), 5.38 (1H, d, J=11.6 Hz), 5.60 (1H, d, J=7.3 Hz), 6.90 (1H, d, J=7.5 Hz), 7.22 (6H, m), 7.40 (2H, t, J=7.5 Hz), 7.56 (2H, d, J=7.2 Hz).',\n",
       "   'MS: m/z=405 [M+H]+.']},\n",
       " {'number': 'Example 43',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 43A (2.00 g, 6.11 mmol), triphenylphosphine (2.40 g, 9.16 mmol) and phthalimide (1.08 g, 7.33 mmol) were added to THF (20 ml), and diethyl azodicarboxylate (2.2M in toluene, 4.16 ml, 9.16 mmol) was added dropwise at room temperature. After stirring at room temperature for 3 hours, the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 2.39 g of compound 43B as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.00 (9H, s), 3.30 (1H, m), 3.61 (1H, dd, J=13.4, 10.2 Hz), 4.15 (1H, d, J=12.2 Hz), 4.75 (1H, m), 6.79 (1H, d, J=9.5 Hz), 7.25 (15H, m), 7.76-7.89 (4H, m).',\n",
       "   'Compound 43B (2.06 g, 4.51 mmol) was added to THF (20 ml) and methanol (20 ml), hydrazine hydrate (4.52 g, 90.2 mmol) was added, and the mixture was stirred at 60° C. for 5 hours. The white precipitate was removed by filtration, and washed with methanol. After the filtrate was distilled off under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1, v/v), n-hexane was added, and the precipitated solid was filtered to obtain 1.25 g of compound 43C as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.32 (9H, s), 2.55 (1H, dd, J=13.3, 6.0 Hz), 2.80 (1H, dd, J=13.3, 3.5 Hz), 3.99 (1H, d, J=10.1 Hz), 4.47 (2H, m), 7.13-7.33 (10H, m).',\n",
       "   'Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (488 mg, 1.53 mmol) and 43C (500 mg, 1.53 mmol) were added to toluene (8 ml), and the mixture was stirred at 110° C. for 1 hour. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→96:4→94:6, v/v) to obtain 667 mg of compound 43D as a pale yellow gummy substance.',\n",
       "   '1H-NMR (CDCl3) δ: 1.28 (9H, s), 3.63 (3H, s), 3.80 (1H, m), 3.87 (3H, s), 4.02 (1H, dd, J=14.5, 10.1 Hz), 4.21 (1H, d, J=10.4 Hz), 4.47 (2H, m), 5.20 (1H, d, J=10.8 Hz), 5.26 (1H, d, J=10.7 Hz), 7.30 (15H, m), 8.05 (1H, s).',\n",
       "   'MS: m/z=627 [M+H]+.',\n",
       "   'To compound 43D (664 mg, 1.06 mmol) was added 4N HCl (ethyl acetate solution, 10 ml), and the mixture was stirred at room temperature for 1 hour. After the solvent was distilled off under reduced pressure, THF and saturated sodium bicarbonate water were added, and the mixture was stirred for 2.5 hours. This was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 458 mg of compound 43E as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.86 (3H, m), 3.92 (3H, s), 4.41-4.48 (1H, m), 5.32 (1H, d, J=10.8 Hz), 5.42 (1H, d, J=10.1 Hz), 5.92 (1H, s), 7.21-7.39 (13H, m), 7.59 (2H, m), 7.89 (1H, s).',\n",
       "   'MS: m/z=495 [M+H]+.',\n",
       "   'Compound 43E (50 mg, 0.10 mmol) was dissolved in DMF (1 ml), and cesium carbonate (165 mg, 0.51 mmol) was added. After the mixture was stirred at room temperature for 30 minutes, iodomethane (0.025 ml, 0.40 mmol) was added, and the mixture was stirred at room temperature for 1 hour. After the reaction solution was poured into water, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 60 mg of compound 43F as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.57 (3H, s), 3.75 (2H, d, J=11.3 Hz), 3.93 (3H, s), 4.20-4.29 (2H, m), 5.25 (1H, d, J=9.9 Hz), 5.57 (1H, d, J=9.9 Hz), 7.15-7.41 (13H, m), 7.63 (1H, s), 7.72-7.76 (2H, m).',\n",
       "   'Compound 43F obtained in the fifth step was dissolved in THF (0.5 ml) and methanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.25 ml, 0.50 mmol) was added at room temperature, and the mixture was stirred for 1 hour. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, a colorless gummy compound 43G was obtained.',\n",
       "   'To compound 43G obtained in the sixth step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 27 mg of compound 43 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.53 (3H, s), 4.26 (1H, d, J=10.9 Hz), 4.35 (1H, d, J=13.3 Hz), 4.58 (1H, dd, J=13.8, 3.5 Hz), 5.06 (1H, d, J=10.9 Hz), 7.36 (10H, m), 8.36 (1H, s), 12.58 (1H, s), 15.62 (1H, s).',\n",
       "   'MS: m/z=405 [M+H]+.']},\n",
       " {'number': 'Example 44',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 43, compound 44 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 4.19 (2H, m), 4.42 (1H, dd, J=13.3, 3.8 Hz), 4.90 (1H, d, J=9.2 Hz), 7.17-7.41 (10H, m), 8.40 (1H, s), 9.66 (1H, s), 12.70 (1H, s), 15.60 (1H, s).',\n",
       "   'MS: m/z=391 [M+H]+.']},\n",
       " {'number': 'Example 45',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 43, compound 45 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.17-2.26 (1H, m), 3.22 (3H, s), 3.39 (2H, m), 3.58-3.67 (1H, m), 4.19 (1H, d, J=10.7 Hz), 4.38 (2H, m), 4.95 (1H, d, J=10.8 Hz), 7.20-7.44 (10H, m), 8.28 (1H, s), 12.40 (1H, s), 15.60 (1H, s).',\n",
       "   'MS: m/z=449 [M+H]+.']},\n",
       " {'number': 'Example 46',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 43E (289 mg, 0.584 mmol) obtained in Example 35 was dissolved in THF (3 ml) and methanol (3 ml), a 2N aqueous sodium hydroxide solution (1.46 ml, 2.92 mmol) was added at room temperature, and the mixture was stirred for 1.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off, 342 mg of compound 46A was obtained as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.72-4.04 (3H, m), 4.46 (1H, m), 5.39 (1H, d, J=10.4 Hz), 5.44 (1H, d, J=10.4 Hz), 6.04 (1H, brs), 7.19-7.60 (15H, m), 8.10 (1H, s).',\n",
       "   'Compound 46A (402 mg, 0.837 mmol) was added to diphenyl ether (5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→92:8, v/v) to obtain 85 mg of compound 46B as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.86 (3H, m), 4.45 (1H, m), 5.35 (1H, d, J=10.5 Hz), 5.41 (1H, d, J=10.4 Hz), 5.94 (1H, brs), 6.48 (1H, d, J=7.4 Hz), 7.00 (1H, d, J=7.4 Hz), 7.25-7.44 (13H, m), 7.62 (2H, m).',\n",
       "   'Compound 46B (39 mg, 0.089 mmol) was dissolved in DMF (1 ml), and cesium carbonate (145 mg, 0.445 mmol) was added. After stirring at room temperature for 30 minutes, 1-bromo-2-methoxyethane (0.033 ml, 0.36 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. After the reaction solution was poured into water, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→92:8, v/v) to obtain 66 mg of compound 46C as a colorless gummy substance.',\n",
       "   'To compound 46C obtained in the third step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 21 mg of compound 46 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.12-2.21 (1H, m), 3.20 (3H, s), 3.55-3.64 (3H, m), 3.81 (1H, d, J=13.0 Hz), 3.99 (1H, d, J=11.0 Hz), 4.22 (1H, dd, J=13.3, 3.1 Hz), 4.86 (1H, d, J=11.0 Hz), 6.11 (1H, d, J=7.2 Hz), 7.18-7.45 (11H, m).',\n",
       "   'MS: m/z=405 [M+H]+.']},\n",
       " {'number': 'Example 47',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 46, compound 47 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.70 (1H, d, J=12.2 Hz), 4.02 (1H, d, J=10.7 Hz), 4.17 (1H, dd, J=13.2, 3.6 Hz), 4.79 (1H, t, J=3.4 Hz), 6.11 (1H, d, J=7.3 Hz), 7.18-7.44 (11H, m), 9.23 (1H, d, J=4.3 Hz).',\n",
       "   'MS: m/z=347 [M+H]+.']},\n",
       " {'number': 'Example 48',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 41A (400 mg, 0.743 mmol) was dissolved in DMF (5 ml), triethylamine (0.21 ml, 1.5 mmol) and ethyl chloroformate (0.143 ml, 1.49 mmol) were added at 0° C., and the mixture was stirred for 20 minutes. Sodium borohydride (70.2 mg, 1.86 mmol) was added at 0° C., and the mixture was stirred at room temperature for 30 minutes. Sodium borohydride (70.2 mg, 1.86 mmol) was further added at 0° C., and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97.3, v/v) to obtain 160 mg of compound 48A as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.19 (3H, s), 3.37-3.54 (3H, m), 3.65-3.73 (1H, m), 3.87 (1H, m), 4.06 (2H, d, J=13.9 Hz), 4.31 (1H, d, J=11.2 Hz), 4.39 (1H, d, J=13.8 Hz), 4.77 (1H, d, J=11.2 Hz), 5.36 (1H, d, J=10.1 Hz), 5.41 (1H, d, J=10.1 Hz), 6.65 (1H, brs), 7.00 (2H, m), 7.19 (3H, m), 7.33-7.49 (8H, m), 7.70 (2H, m).',\n",
       "   'To compound 48A (50 mg, 0.095 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, chroloform-ethyl ether were added, and the precipitated solid was filtered to obtain 3.5 mg of compound 48 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.12 (3H, s), 3.51 (5H, m), 3.71 (1H, d, J=13.7 Hz), 4.02 (1H, d, J=9.9 Hz), 4.09 (1H, d, J=12.0 Hz), 4.36 (1H, d, J=11.6 Hz), 4.73 (1H, brs), 5.45 (1H, d, J=12.5 Hz), 7.00 (1H, s), 7.15 (5H, m), 7.28 (1H, t, J=7.2 Hz), 7.40 (2H, t, J=7.5 Hz), 7.59 (2H, d, J=7.6 Hz).',\n",
       "   'MS: m/z=435 [M+H]+.']},\n",
       " {'number': 'Example 49',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To Dess-Martin Periodinane (0.3M, methylene chloride solution, 52.0 ml, 15.6 mmol) was added dropwise a methylene chloride solution (20 ml) of compound 49A (2.97 g, 10.4 mmol) at 0° C. After stirring at room temperature for 3 hours, the reaction mixture was poured into a 1N aqueous sodium hydroxide solution, and the mixture was extracted with ethyl ether. The organic layer was washed with a 1N aqueous sodium hydroxide solution and an aqueous saturated sodium chloride solution, and dried with magnesium sulfate. After the solvent was distilled off under reduced pressure, 2.08 g of compound 49B was obtained as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.13 (2H, d, J=6.6 Hz), 4.53 (1H, q, J=6.7 Hz), 5.12 (2H, s), 5.28 (1H, brs), 7.26 (10H, m), 9.64 (1H, s).',\n",
       "   'Compound 49B (700 mg, 2.47 mmol), 2-aminoethanol (166 mg, 2.72 mmol) and sodium sulfate (1.76 g, 12.4 mmol) were added to toluene (20 ml), and the mixture was stirred at room temperature for 1 hour. Boc2O (0.631 ml, 2.72 mmol) was added at room temperature, and the mixture was stirred for 18 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 893 mg of 49C as a colorless gummy substance.',\n",
       "   'Compound 49C (890 mg, 2.09 mmol) and palladium-active carbon (10% wet, 200 mg) were added to ethanol (20 ml), and the mixture was stirred at room temperature for 2 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 656 mg of a colorless oily substance 49D.',\n",
       "   '1H-NMR (CDCl3) δ: 1.40 (9H, s), 2.65-2.86 (2H, m), 3.32 (2H, m), 3.80 (2H, m), 4.03-4.12 (1H, m), 4.86 (1H, brs), 7.22 (5H, m).',\n",
       "   'Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (610 mg, 2.09 mmol) and 49D (664 mg, 2.09 mmol) were added to toluene (6 ml), and the mixture was stirred at 100° C. for 4 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 884 mg of compound 49E as a pale yellow gummy substance.',\n",
       "   'MS: m/z=593 [M+H]+.',\n",
       "   'To compound 49E (860 mg, 1.45 mmol) was added 4N HCl (ethyl acetate solution, 10 ml). After stirring at room temperature for 30 minutes, the solvent was distilled off under reduced pressure. Subsequently, toluene (10 ml) and 2-aminoethanol (0.175 ml, 2.90 mmol) were added, and the mixture was stirred at 80° C. for 30 minutes. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 99:1→95:5→90:10, v/v) to obtain 157 mg of compound 49F as a colorless gummy substance and 217 mg of compound 49G as a yellow solid.',\n",
       "   '49F: 1H-NMR (CDCl3) δ: 2.48 (1H, dd, J=14.0, 11.4 Hz), 3.22 (1H, dd, J=14.1, 3.3 Hz), 3.69 (1H, m), 3.77 (3H, s), 3.83-3.95 (1H, m), 4.08 (1H, m), 4.29 (1H, m), 4.41 (1H, m), 5.34 (2H, m), 5.48 (1H, d, J=10.1 Hz), 6.86 (2H, m), 7.20-7.39 (7H, m), 7.64 (2H, m)',\n",
       "   '49G: 1H-NMR (DMSO-d6) δ: 3.70 (2H, t, J=5.3 Hz), 3.73 (3H, s), 3.86 (2H, t, J=5.3 Hz), 4.14 (2H, s), 4.98 (1H, t, J=5.0 Hz), 5.06 (2H, s), 6.98 (1H, s), 7.35 (8H, m), 7.62 (2H, d, J=7.1 Hz), 8.34 (1H, d, J=0.8 Hz).',\n",
       "   'The compound 49G (214 mg, 0.465 mmol) was dissolved in THF (4 ml), ethanol (2 ml) and methylene chloride (2 ml), a 2N aqueous sodium hydroxide solution (1.16 ml, 2.32 mmol) was added at room temperature, and the mixture was stirred for 2.5 hours. After 1N hydrochloric acid was added, and the mixture was extracted with chloroform, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 158 mg of compound 49H was obtained as a yellow solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.70 (2H, q, J=5.2 Hz), 3.89 (2H, t, J=5.3 Hz), 4.22 (2H, s), 4.97 (1H, t, J=5.6 Hz), 5.12 (2H, s), 7.23-7.41 (9H, m), 7.60 (2H, m), 8.54 (1H, s).',\n",
       "   'Compound 49H (50.0 mg, 0.112 mmol) and palladium-active carbon (10%, wet, 12 mg) were added to methanol (1 ml) and DMF (3 ml), and the mixture was stirred at room temperature for 5 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 9.0 mg of compound 49 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.10 (2H, m), 3.51-3.69 (4H, m), 4.10 (1H, d, J=10.7 Hz), 4.94 (2H, m), 7.11-7.26 (5H, m), 8.03 (1H, s), 12.94 (1H, brs), 15.30 (1H, brs).',\n",
       "   'MS: m/z=359 [M+H]+.']},\n",
       " {'number': 'Example 50',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 50A (1.00 g, 3.98 mmol), triphenylphosphine (1.15 g, 4.48 mmol) and N-methyl-2-nitrobenzenesulfonamide (860 mg, 3.98 mmol) were added to THF (10 ml), diethyl azodicarboxylate (2.2M in toluene, 1.99 ml, 4.38 mmol) was added dropwise at room temperature. After stirring at room temperature for 3 hours, and the solvent was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 710 mg of compound 50B as a colorless gummy substance.',\n",
       "   'Compound 50B (458 mg, 1.02 mmol) was dissolved in acetonitrile, potassium carbonate (422 mg, 3.06 mmol) and benzenethiol (0.126 ml, 1.22 mmol) were added, and the mixture was stirred at room temperature for 5 hours. The reaction solution was poured into a 1N aqueous sodium hydroxide solution, the mixture was extracted with methylene chloride, and the extract was dried with sodium sulfate. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) to obtain 147 mg of compound 50C as a colorless oily substance.',\n",
       "   '1H-NMR (CDCl3) δ: 1.36 (9H, s), 2.40 (3H, s), 2.51-2.89 (4H, m), 3.90 (1H, s), 4.69 (1H, s), 7.17-7.31 (5H, m).',\n",
       "   'Compound 50C (140 mg, 0.530 mmol) and 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (WO 2006/116764, 119 mg, 0.482 mmol) were added to THF (3 ml), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (111 mg, 0.578 mmol) and 1-hydroxybenzotriazole (65.1 mg, 0.482 mmol) were added, and the mixture was stirred at room temperature for 18 hours. The reaction solution was poured into sodium bicarbonate water, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3, v/v) to obtain 219 mg of compound 50D as a colorless solid.',\n",
       "   'MS: m/z=493 [M+H]+.',\n",
       "   'To compound 50D (216 mg, 0.439 mmol) was added 4N HCl (ethyl acetate solution, 3 ml). After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Subsequently, ethanol (4 ml) and an aqueous saturated sodium carbonate solution (3 ml) were added, and the mixture was stirred at 60° C. for 2 hours. After water was added, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) to obtain 108 mg of compound 50E as a pale yellow gummy substance.',\n",
       "   '1H-NMR (CDCl3) δ: 3.00 (2H, m), 3.13 (3H, s), 3.18 (1H, m), 3.88 (1H, dd, J=13.5, 3.4 Hz), 4.00-4.07 (1H, m), 5.26 (1H, d, J=10.2 Hz), 5.46 (1H, d, J=10.1 Hz), 6.25 (1H, d, J=7.5 Hz), 6.73 (1H, d, J=7.5 Hz), 6.99-7.02 (2H, m), 7.28-7.37 (6H, m), 7.63-7.67 (2H, m).',\n",
       "   'To compound 50E (105 mg, 0.280 mmol) was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 30 minutes. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 29 mg of compound 50 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.99 (3H, s), 3.26-3.47 (3H, m), 4.07 (1H, d, J=11.1 Hz), 4.80 (1H, m), 6.43 (1H, d, J=6.9 Hz), 7.11-7.29 (5H, m), 7.50 (1H, d, J=6.9 Hz).',\n",
       "   'MS: m/z=285 [M+H]+.']},\n",
       " {'number': 'Example 51',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 1D (60 mg, 0.11 mmol) was dissolved in trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. The reaction solution was distilled off, and the resulting residue was purified by LC/MS to obtain compound 51 (43 mg, 0.09 mmol).',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.17 (3H, t, J=6.9 Hz), 3.11 (3H, s), 3.48-3.58 (2H, m), 3.95-4.12 (3H, m), 4.40 (1H, d, J=11.4 Hz), 5.59 (1H, d, J=11.4 Hz), 7.11 (1H, d, J=7.3 Hz), 7.17 (2H, t, J=7.2 Hz), 7.26 (2H, d, J=7.1 Hz), 7.30 (1H, t, J=7.3 Hz), 7.42 (2H, t, J=7.2 Hz), 7.60 (3H, m), 12.55 (1H, brs).',\n",
       "   'MS: m/z=477.2 [M+H]+.']},\n",
       " {'number': 'Example 52',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (10 ml) solution of compound 1I (2.0 g, 4.32 mmol) were added WSC.HCl (1.24 g, 6.49 mmol) and HOBt (876.9 mg, 6.49 mmol) at room temperature, and the mixture was stirred at the same temperature for 1 hour. To the reaction solution were added O,N-dimethylhydroxylamine hydrochloride (842.7 mg, 8.64 mmol) and triethylamine (2.19 g, 21.6 mmol), the mixture was stirred at the same temperature for 3 hours, thereafter, water was added, and the mixture was extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (7:3, v/v) and, then, with only ethyl acetate. Concentration of an objective fraction afforded 543 mg (yield 25%) of compound 52A as an oil.',\n",
       "   'MS: m/z=506 [M+H]+.',\n",
       "   'A THF (5 ml) solution of compound 52A (543 mg, 1.07 mmol) was cooled to −78° C., a methylmagnesium bromide 0.97M THF solution (1.66 ml, 1.61 mmol) was added, and temperature was raised up to −20° C. over 2 hours. To the reaction solution was added 1N hydrochloric acid, and the mixture was extracted with ethyl acetate three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (7:3, v/v) and, then, with only ethyl acetate. Concentration of an objective fraction afforded 256.8 mg (yield 52%) of compound 52B as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 2.65 (3H, s), 3.08 (2H, d, J=7.5 Hz), 3.12 (3H, s), 3.53-3.68 (4H, m), 3.79-3.95 (1H, m), 3.92 (1H, dd, J=3.3 Hz, 13.5 Hz), 4.10-4.16 (1H, m), 5.30 (1H, d, J=10.2 Hz), 5.45 (1H, d, J=10.2 Hz), 6.99-7.02 (2H, m), 7.25-7.38 (6H, m), 7.49 (1H, s), 7.63-7.66 (2H, m).',\n",
       "   'To a dichloromethane (4 ml) solution of compound 528 (256 mg, 0.558 mmol) was added mCPBA (144.3 mg, 0.836 mmol) under ice-cooling, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added an aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate three times. After the extract was washed with saturated sodium bicarbonate water two times, and dried with sodium sulfate, the solvent was distilled off, the resulting oil was dissolved in ethanol (4 ml), and a 2N-aqueous sodium hydroxide solution (1 ml) was added, followed by refluxing for 1 hour. After the solvent was distilled off, the precipitated solid was washed with diisopropyl ether to obtain 242 mg (yield 100%) of compound 52C.',\n",
       "   '1H-NMR (CDCl3) δ: 3.09 (2H, d, J=6.9 Hz), 3.32 (3H, s), 3.54 (1H, d, J=14.1 Hz), 3.59-3.71 (2H, m), 3.76-3.85 (1H, m), 3.92 (1H, dd, J=3.6 Hz, 13.5 Hz), 4.03 (1H, brt), 5.28 (1H, d, J=10.2 Hz), 5.47 (1H, d, J=10.2 Hz), 6.68 (1H, s), 7.00-7.04 (2H, m), 7.23-7.37 (6H, m), 7.64 (2H, d, J=6.3 Hz).',\n",
       "   'To a THF (3 ml) solution of compound 52C (242 mg, 0.558 mmol) was added 10% Pd—C (50 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 60 mg (yield 31%) of compound 52.',\n",
       "   '1H-NMR (CDCl3) δ: 3.05 (2H, brs), 3.36 (3H, s), 3.58 (1H, d, J=12 Hz), 3.66-3.68 (2H, m), 3.74-3.75 (2H, m), 4.11-4.19 (2H, m), 6.80 (1H, brs), 6.90-7.04 (2H, m), 7.30 (3H, brs).']},\n",
       " {'number': 'Example 53',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (10 ml) solution of compound 1I (1.0 mg, 2.23 mmol) were added triethylamine (677 mg, 6.69 mmol) and ethyl chlorocarbonate (729 mg, 6.69 mmol) under ice-cooling, and the mixture was stirred at room temperature for 10 minutes. To the reaction solution were added methanesulfonamide (1.06 g, 11.15 mmol) and DMAP (272.4 mg, 2.23 mmol), and the mixture was heated to stir at 80° C. for 2 hours. To the reaction solution was added water, and the mixture was extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with only chloroform and, then, with chloroform-MeOH (9:1, v/v). Concentration of an objective fraction afforded 535 mg (yield 46%) of compound 53A as an oil.',\n",
       "   'MS: m/z=463 [M+H]+.',\n",
       "   'To a THF (5 ml) solution of compound 53A (535 mg, 0.991 mmol) was added 10% Pd—C (218 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 235 mg (yield 53%) of compound 53.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.99-3.17 (2H, m), 3.27 (3H, s), 3.33 (3H, s), 3.53-3.76 (5H, m), 4.06 (1H, dd, J=3.6 Hz, 13.8 Hz), 4.98 (1H, brs), 7.14 (2H, d, J=6.6 Hz), 7.19-7.30 (3H, m), 8.07 (1H, s), 12.84 (1H, s), 13.24 (1H, s).']},\n",
       " {'number': 'Example 54',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (10 ml) solution of compound 1I (1.0 mg, 2.23 mmol) were added triethylamine (677 mg, 6.69 mmol) and ethyl chlorocarbonate (729 mg, 6.69 mmol) under ice-cooling, and the mixture was stirred at the same temperature for 10 minutes. The reaction solution was added dropwise to an ice-cooled solution of sodium borohydride (441 mg, 11.7 mmol) in water (5 ml), and the mixture was stirred at the same temperature for 2 hours. To the reaction solution was added 2N hydrochloric acid to stop the reaction, and the mixture was neutralized with a 2N aqueous sodium hydroxide solution, and extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting crude product was dissolved in dichloromethane (5 ml).',\n",
       "   'To the dichloromethane solution was added manganese dioxide (2.1 g, 24.15 mmol), and the mixture was stirred at room temperature for 6 hours. After the reaction solution was filtered, and the solvent was distilled off, the resulting oil was purified by silica gel chromatography. Elution with ethyl acetate-MeOH (9:1, v/v) and concentration of an objective fraction afforded 188 mg (yield 19%) of compound 54A.',\n",
       "   'MS: m/z=447 [M+H]+.',\n",
       "   'Compound 54A (188 mg, 0.422 mmol) was dissolved in THF (6 ml), 28% aqueous ammonia and iodine (117.7 mg, 0.464 mmol) were added at room temperature, and the mixture was stirred at the same temperature for 2 hours. To the reaction solution was added an aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. Elution with ethyl acetate-MeOH (9:1, v/v) and concentration of an objective fraction afforded 54.7 mg (yield 29%) of compound 54B.',\n",
       "   '1H-NMR (CDCl3) δ: 3.05 (2H, d, J=7.5 Hz), 3.33 (3H, s), 3.56-3.79 (5H, m), 3.99 (1H, dd, J=3.6 Hz, 13.8 Hz), 4.08 (1H, brt), 5.33 (1H, d, J=10.2 Hz), 5.46 (1H, d, J=10.2 Hz), 6.83 (1H, s), 6.93-6.97 (2H, m), 7.25-7.37 (5H, m), 7.58-7.62 (2H, m).',\n",
       "   'To a toluene (2 ml) solution of compound 54B (216 mg, 0.487 mmol) were added sodium azide (95 mg, 1.46 mmol) and triethylamine (201 mg, 1.46 mmol), and the mixture was stirred at room temperature for 6 hours. The reaction solution was extracted with a 2N aqueous sodium hydroxide solution two times, and the extract was neutralized with 2N hydrochloric acid, and extracted with ethyl acetate three times. After drying of the organic layer with sodium sulfate, the solvent was distilled off to obtain 65 mg (yield 27%) of compound 54C.',\n",
       "   '1H-NMR (CDCl3) δ: 3.08-3.21 (2H, m), 3.33 (3H, s), 3.55-3.70 (4H, m), 3.81-3.90 (1H, m), 3.96-4.01 (1H, m), 4.51 (1H, brt), 5.31 (1H, d, J=10.2 Hz), 5.42 (1H, d, J=10.2 Hz), 7.03-7.05 (2H, m), 7.18-7.37 (6H, m), 7.58-7.61 (2H, m), 8.33 (1H, s).',\n",
       "   'To a THF (2 ml)-MeOH (2 ml) solution of compound 54C (500 mg, 1.03 mmol) was added 10% Pd—C (100 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was dissolved in dichloromethane (10 ml), and the solution was extracted with a 2N aqueous sodium hydroxide solution two times. After the extract was neutralized with 2N hydrochloric acid, the mixture was extracted with ethyl acetate three times. The organic layer was dried with sodium sulfate, the solvent was distilled off, and the resulting solid was washed with diisopropyl ether, and filtered to obtain 55 mg (yield 14%) of compound 54.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.01-3.19 (2H, m), 3.28 (3H, s), 3.51-3.79 (5H, m), 4.09 (1H, dd, J=3.9 Hz, 13.5 Hz), 4.95 (1H, brs), 7.13-7.26 (5H, m), 8.20 (1H, s), 12.23 (1H, s).']},\n",
       " {'number': 'Example 55',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a THF (5 ml) solution of compound 1I (500 mg, 1.08 mmol) was added a trimethylsilyldiazomethane 2M hexane solution (1 ml, 2.0 mmol) at room temperature, and the mixture was heated to 50° C., and stirred. After the solvent was distilled off, the resulting oil was purified by silica gel chromatography. Elution with n-hexane-ethyl acetate (1:1, v/v) and concentration of objective fraction afforded 115 mg (yield 22%) of compound 55A.',\n",
       "   '1H-NMR (CDCl3) δ: 3.06 (2H, d, J=7.5 Hz), 3.31 (3H, s), 3.51-3.72 (5H, m), 3.81 (3H, s), 3.98 (1H, dd, J=3.6 Hz), 13.5 Hz), 4.11 (1H, brt), 5.22 (1H, d, J=9.6 Hz), 5.46 (1H, d, J=9.6 Hz), 6.99-7.02 (2H, m), 7.26-7.37 (6H, m), 7.46 (1H, s), 7.65-7.69 (2H, m).',\n",
       "   'Compound 55A (210 mg, 0.441 mmol) was dissolved in THF (2 ml), 10% Pd—C (85.7 mg) was added, and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was washed with diisopropyl ether to obtain 50 mg (yield 23%) of compound 55.',\n",
       "   '1H-NMR (CDCl3) δ: 1.55 (2H, d, J=7.5 Hz), 3.37 (3H, s), 3.59-3.84 (5H, m), 4.23-4.32 (2H, m), 7.00 (2H, dd, J=1.5 Hz, 6.9 Hz), 7.23-7.32 (3H, m), 7.39 (1H, s), 12.31 (1H, brs).']},\n",
       " {'number': 'Example 56',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A DMF (5 ml) solution of compound 2D (424 mg, 0.787 mmol) was ice-cooled, and triethylamine (327 ul, 2.36 mmol) and, subsequently, ethyl chloroformate (150 ul, 1.57 mmol) were added. After the reaction solution was stirred at room temperature for 10 minutes, it was ice-cooled again, sodium azide (154 mg, 2.36 mmol) was added, and the mixture was stirred for 1 hour. To the reaction solution were added dichloromethane, water and a small amount of methanol, the dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane once. The combined extracts were concentrated, methanol (8 ml) was added to the resulting residue, the mixture was stirred at 50° C. for 3 hours, and the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (1:1, v/v) and, then, with only ethyl acetate. Concentration of objective fraction afforded 160 mg of compound 56A as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.08-3.18 (4H, m), 3.35-3.49 (3H, m), 3.68 (3H, s), 3.98 (2H, dt, J=23.1, 5.6 Hz), 4.32 (1H, d, J=11.3 Hz), 4.59 (1H, d, J=11.3 Hz), 5.37 (2H, dd, J=12.0, 10.4 Hz), 6.98-7.70 (15H, m).',\n",
       "   'MS: m/z=568.25 [M+H]+.',\n",
       "   'Compound 56A (160 mg, 0.102 mmol) was dissolved in EtOH (10 mL), a 2N aqueous sodium hydroxide solution (14 ml) was added, and the mixture was stirred at 60° C. for 2 hours. After the reaction solution was concentrated under reduced pressure, the residue was distributed between dichloromethane and water. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane three times. The solvent was distilled off to obtain compound 56B.',\n",
       "   '1H-NMR (CDCl3) δ: 2.97-3.06 (1H, m), 3.15 (3H, s), 3.38-3.44 (3H, m), 3.71 (2H, s), 3.93-3.99 (2H, m), 4.35 (2H, dd, J=19.3, 11.1 Hz), 5.37 (2H, dd, J=31.6, 10.1 Hz), 6.04 (1H, s), 6.98 (2H, dd, J=6.4, 2.9 Hz), 7.17 (4H, t, J=3.3 Hz), 7.28-7.69 (12H, m).',\n",
       "   'MS: m/z=509.23 [M+H]+.',\n",
       "   'Compound 56B (56 mg, 0.11 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 1 hour. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionation device. The eluted solvent was distilled off, isopropyl ether was added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether and drying afforded 7 mg of compound 56.',\n",
       "   'MS: m/z=420.07 [M+H]+.']},\n",
       " {'number': 'Example 57',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a THF (1 mL) solution of compound 56B (25 mg, 0.049 mmol) were added triethylamine (20 ul, 0.015 mmol) and, subsequently, acetic acid anhydride (7.0 ul, 0.074 mmol) under ice-cooling, and the mixture was stirred at room temperature for 15 minutes. Then, 4-fluorobenzyl amine (330 mg, 1.75 mmol) was added, and the mixture was stirred for 7 hours. Further, triethylamine (20 uL, 0.15 mmol) and, subsequently, acetic acid anhydride (7.0 ul, 0.074 mmol) were added, and the mixture was stirred overnight. To the reaction solution were added water, ethyl acetate, and brine, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, and filtration and concentration afforded 18 mg of compound 57A as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.05 (3H, s), 3.09-3.14 (4H, m), 3.41-3.45 (3H, m), 3.95-4.02 (2H, m), 4.31 (1H, d, J=11.4 Hz), 4.59 (1H, d, J=12.4 Hz), 5.36 (2H, s), 7.00 (2H, d, J=4.0 Hz), 7.11-7.16 (3H, m), 7.36 (7H, tt, J=14.5, 5.1 Hz), 7.62 (2H, t, J=7.3 Hz), 8.02 (1H, s), 8.18 (1H, s).',\n",
       "   'MS: m/z=552.20 [M+H]+.',\n",
       "   'Compound 57A (21 mg, 0.038 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 3.5 hours. The reaction mixture was subjected to toluene azeotropy, isopropyl ether was added to the resulting residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 10 mg of compound 57.',\n",
       "   '1H-NMR (CDCl3) δ: 2.12 (3H, s), 3.20 (3H, s), 3.39-3.60 (4H, m), 3.76-3.86 (1H, m), 4.08 (1H, dd, J=13.7, 3.7 Hz), 4.31 (1H, d, J=11.5 Hz), 4.68 (1H, dd, J=8.5, 4.3 Hz), 6.96-7.19 (4H, m), 7.30-7.44 (6H, m), 8.11 (1H, s).',\n",
       "   'MS: m/z=462.20 [M+H]+.']},\n",
       " {'number': 'Example 58',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 57, compound 58 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 3.20 (3H, s), 3.41-3.54 (3H, m), 3.60-3.68 (2H, m), 3.73-3.85 (1H, m), 4.12 (1H, dt, J=14.0, 3.5 Hz), 4.31 (1H, d, J=11.4 Hz), 4.68 (1H, dd, J=11.4, 2.6 Hz), 6.95-7.21 (5H, m), 7.39 (5H, dt, J=26.9, 7.6 Hz), 7.94 (1H, s), 8.88 (1H, s).',\n",
       "   'MS: m/z=516.10 [M+H]+.']},\n",
       " {'number': 'Example 59',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 57, compound 59 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 3.21 (3H, s), 3.43-3.63 (4H, m), 3.82 (1H, d, J=14.0 Hz), 4.12 (1H, dd, J=8.3, 4.2 Hz), 4.35 (1H, d, J=11.2 Hz), 4.74 (1H, d, J=8.3 Hz), 6.90-7.18 (5H, m), 7.34-7.60 (8H, m), 7.82 (2H, d, J=6.8 Hz), 8.34 (1H, s), 8.89 (1H, s).',\n",
       "   'MS: m/z=523.21 [M+H]+.']},\n",
       " {'number': 'Example 60',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To compound 56B (30 mg, 0.059 mmol) were added formic acid (1.0 mL, 26 mmol) and, subsequently, a 37% formaldehyde solution (0.5 mL, 6.7 mmol), and the mixture was stirred at 100° C. for 7 hours. The reaction solution was subjected to toluene azeotropy, DMSO was added, insolubles were filtered and, thereafter, purification was performed using a LCMS fractionating device. The eluted solvent was distilled off, isopropyl ether was added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 3 mg of compound 60.',\n",
       "   '1H-NMR (CDCl3) δ: 2.37 (6H, s), 3.18 (3H, s), 3.29-3.66 (4H, m), 3.82 (1H, d, J=12.5 Hz), 4.06-4.15 (1H, m), 4.31 (1H, d, J=11.7 Hz), 4.54 (1H, d, J=8.1 Hz), 5.97 (1H, s), 7.01 (2H, dd, J=6.4, 2.8 Hz), 7.17 (3H, t, J=2.9 Hz), 7.32-7.45 (6H, m).',\n",
       "   'MS: m/z=448.15 [M+H]+.']},\n",
       " {'number': 'Example 61',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 56B (50 mg, 0.098 mmol) was dissolved in THF (1 mL), Boc2O (0.068 mL, 0.29 mmol) and, subsequently, DMAP (6.0 mg, 0.049 mmol) were added, and the mixture was stirred at room temperature for 5 hours. To the reaction solution were added water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 20 mg of compound 61A as a colorless transparent oil.',\n",
       "   'MS: m/z=610.50 [M+H]+.',\n",
       "   'Compound 61A (20 mg, 0.033 mmol) was dissolved in DMF (1 mL), sodium hydride (2.6 mg, 0.066 mmol) was added under ice-cooling, the mixture was stirred for 10 minutes, methyl iodide (4.1 uL, 0.066 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. Ice water, ethyl acetate and brine were added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 13 mg of compound 61B as a white solid.',\n",
       "   'MS: m/z=624.25 [M+H]+.',\n",
       "   'Compound 61B (13 mg, 0.021 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 3 hours. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, isopropyl ether-hexane were added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 7.5 mg of compound 61.',\n",
       "   '1H-NMR (CDCl3) δ: 2.19 (3H, s), 3.26 (3H, s), 3.46-3.70 (4H, m), 4.23 (1H, d, J=11.0 Hz), 4.58-4.60 (1H, br m), 5.41-5.44 (1H, br m), 6.28 (1H, br s), 6.99 (2H, br s), 7.13 (3H, br s), 7.31-7.46 (6H, m).',\n",
       "   'MS: m/z=434.10 [M+H]+.']},\n",
       " {'number': 'Example 62',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 2D (112 mg, 0.208 mmol) was dissolved in DMF (2 mL), triethylamine (0.144 ml, 1.04 mmol) and, subsequently, ethyl chloroformate (0.040 mL, 0.42 mmol) were added under ice-cooling, the mixture was stirred at room temperature for 10 minutes, thereafter, N,O-dimethylhydroxyamine hydrochloride (41 mg, 0.42 mmol) and, subsequently, DMAP (3 mg, 0.02 mmol) were added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution were added water, and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 127 mg of crude purified product 62A as a yellow oil.',\n",
       "   'MS: m/z=582.20 [M+H]+.',\n",
       "   'Compound 62A (137 mg, 0.236 mmol) was dissolved in THF (8 mL), a 2M THF solution of methylmagnesium bromide (0.444 ml, 0.471 mmol) was added at −78° C. under nitrogen stream, and the mixture was stirred for 30 minutes while temperature was raised to −50° C. To the reaction solution was added 1M hydrochloric acid (4 ml), the mixture was stirred at 0° C. for 20 minutes, ethyl acetate was added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined extracts were neutralized with an aqueous saturated sodium bicarbonate solution, sodium sulfate was added to the organic layer, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 67 mg of compound 62B as a yellow oil.',\n",
       "   '1H-NMR (CDCl3) δ: 2.55 (3H, s), 3.01-3.14 (1H, m), 3.16 (3H, s), 3.37-3.54 (3H, m), 3.91-4.07 (2H, m), 4.28 (1H, d, J=11.3 Hz), 4.50-4.60 (1H, m), 5.42 (2H, d, J=1.2 Hz), 6.97-6.99 (2H, m), 7.14-7.17 (4H, m), 7.31-7.45 (8H, m), 7.65 (2H, d, J=6.5 Hz).',\n",
       "   'MS: m/z=537.20 [M+H]+.',\n",
       "   'Compound 62B (67 mg, 0.13 mmol) was dissolved in dichloromethane (4 mL), mCPBA (32 mg, 0.19 mmol) was added at 0° C. under nitrogen stream, and the mixture was stirred at room temperature for 3 hours. The reaction solution was ice-cooled, an aqueous sodium thiosulfate solution, and ethyl acetate were added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined extracts were neutralized with an aqueous saturated sodium bicarbonate solution, sodium sulfate was added to the organic layer, the mixture was filtered, and the solvent was distilled off to obtain 64 mg of compound 62C.',\n",
       "   'MS: m/z=553.23 [M+H]+.',\n",
       "   'Compound 62C (64 mg, 0.12 mmol) was dissolved in ethanol (8 mL), and the solution was heated to reflux for 4 hours. The reaction solution was concentrated, and the resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 42 mg of compound 62D.',\n",
       "   '1H-NMR (CDCl3) δ: 2.93-3.09 (1H, m), 3.16 (3H, s), 3.33-3.53 (4H, m), 3.90-4.07 (2H, m), 4.29-4.47 (2H, m), 5.41 (2H, q, J=10.4 Hz), 6.34 (1H, s), 6.95-6.99 (2H, m), 7.12-7.21 (4H, m), 7.33-7.42 (8H, m), 7.64 (2H, d, J=6.9 Hz).',\n",
       "   'MS: m/z=511.21 [M+H]+.',\n",
       "   'Compound 62D (41 mg, 0.080 mmol) was dissolved in DMF (1 mL), sodium hydride (6.4 mg, 0.16 mmol) was added under ice-cooling, the mixture was stirred for 10 minutes, methyl iodide (0.010 ml, 0.16 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. To the reaction solution were added ice water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 41 mg of compound 62E as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.99-3.09 (1H, m), 3.16 (3H, s), 3.25 (3H, s), 3.32-3.38 (1H, m), 3.42-3.50 (2H, m), 3.94-4.03 (2H, m), 4.28 (1H, d, J=11.3 Hz), 4.43 (1H, br s), 5.40 (2H, dd, J=28.3, 10.2 Hz), 6.01 (1H, s), 6.90-7.19 (5H, m), 7.28-7.44 (8H, m), 7.66 (2H, d, J=6.4 Hz).',\n",
       "   'MS: m/z=525.21 [M+H]+.',\n",
       "   'Compound 62E (40 mg, 0.076 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 30 minutes. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, ethyl acetate-isopropyl ether-hexane were added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 7.1 mg of compound 62 as a pink solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.17 (3H, s), 3.22 (3H, s), 3.40-3.53 (4H, m), 3.63-3.71 (1H, m), 4.24 (1H, d, J=11.5 Hz), 4.45 (1H, d, J=13.3 Hz), 4.60 (1H, d, J=11.2 Hz), 6.08 (1H, d, J=11.7 Hz), 6.96-6.99 (2H, br m), 7.13-7.17 (3H, m), 7.30-7.43 (5H, m).',\n",
       "   'MS: m/z=435.15 [M+H]+.']},\n",
       " {'number': 'Example 63',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 2D (164 mg, 0.304 mmol) was dissolved in diphenyl ether (1 mL), the mixture was stirred at 245° C. for 1 hour using a microwave apparatus and, thereafter, the reaction solution was purified by silica gel column chromatography. Concentration of an objective fraction afforded 72 mg of compound 63A as a brown solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.92-3.01 (1H, m), 3.16 (3H, s), 3.32-3.50 (3H, m), 3.90-4.46 (4H, m), 5.42 (2H, dd, J=26.1, 10.3 Hz), 5.94 (1H, d, J=7.4 Hz), 6.28 (1H, d, J=7.5 Hz), 6.96-6.99 (2H, m), 7.15-7.19 (3H, m), 7.28-7.44 (8H, m), 7.62-7.65 (2H, m).',\n",
       "   'MS: m/z=495.21 [M+H]+.',\n",
       "   'To a dichloromethane (4 mL) solution of compound 63A (21 mg, 0.042 mmol) was added NBS (11 mg, 0.062 mmol), and the mixture was heated to reflux for 1 hour. The reaction solution was allowed to cool, and purified by silica gel column chromatography. Concentration of an objective fraction afforded 26 mg of compound 63B as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.01-3.09 (1H, m), 3.16 (3H, s), 3.35-3.53 (3H, m), 3.92-4.47 (4H, m), 5.41 (2H, dd, J=32.6, 10.0 Hz), 6.72 (1H, s), 6.97-7.00 (2H, br m), 7.20-7.22 (3H, m), 7.30-7.46 (8H, m), 7.66-7.70 (2H, m).',\n",
       "   'MS: m/z=573.20 [M+H]+.',\n",
       "   'Compound 63B (10 mg, 0.017 mmol) was dissolved in TFA (3 mL), and the mixture was stirred at room temperature for 50 minutes. The reaction mixture was subjected to toluene azeotropy, isopropyl ether was added to the resulting residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 1.4 mg of compound 63 as an orange solid.',\n",
       "   'MS: m/z=483.15 [M+H]+.']},\n",
       " {'number': 'Example 64',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF solution (2 mL) of compound 63B (20 mg, 0.035 mmol) were added pyrazole-4-boronic acid pinacol ester (36 mg, 0.19 mmol) and, subsequently, potassium carbonate (29 mg, 0.21 mmol) and, thereafter, tetrakistriphenylphosphinepalladium (24 mg, 0.021 mmol) was added under nitrogen atmosphere, and the mixture was stirred at 110° C. for 8.5 hours. After the reaction solution was concentrated, ethyl acetate and methanol were added, and insolubles were removed. The filtrate was concentrated, and the resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 18 mg of compound 64A as a white solid.',\n",
       "   'MS: m/z=561.30 [M+H]+.',\n",
       "   'Compound 64A (14 mg, 0.025 mmol) was dissolved in TFA (2 mL), and the mixture was stirred at room temperature for 30 minutes. The reaction mixture was subjected to toluene azeotropy, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, isopropyl ether was added to the residue, and the precipitated solid was filtered. Washing with isopropyl ether, and drying afforded 1.1 mg of compound 64 as an orange solid.',\n",
       "   'MS: m/z=471.20 [M+H]+.']},\n",
       " {'number': 'Example 65',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A THF (1.1 L) solution of compound 65A (WO 2006/088173, 20.0 g, 69.6 mmol) was retained at 25° C. on a water bath, an aqueous (378 mL) solution of sodium chlorite (25.2 g, 278 mmol) and amidosulfuric acid (27.0 g, 278 mmol) was added dropwise over 30 minutes. The reaction solution was stirred at the same temperature for 1 hour, and concentrated under reduced pressure. To the residue were added ice water (100 mL) and diethyl ether (100 mL), and the precipitated solid was filtered. The resulting crude purified product was washed with water and diethyl ether to obtain 20.3 g of compound 65B as a white solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.74 (3H, s), 5.11 (2H, s), 7.31-7.38 (3H, m), 7.48 (2H, d, J=7.2 Hz), 8.11 (1H, s), 12.07 (1H, brs).',\n",
       "   'Compound 65B (2.0 g, 6.59 mmol) was dissolved in DMF (340 mL), HATU (2.76 g, 7.25 mmol), methylamine (2 mol/L, THF solution, 3.63 mL, 7.25 mmol) and triethylamine (9.89 mmol) were added, and the mixture was stirred at room temperature for 5 hours. The reaction solution was distributed between ethyl acetate and water, the ethyl acetate layer was separated. and the aqueous layer was extracted with ethyl acetate once. The combined extracts were washed with water and an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off to obtain 1.66 g of a crude purified product of compound 65C as a white solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.38 (3H, brs), 3.75 (3H, s), 5.37 (2H, s), 7.34-7.44 (5H, m), 8.10 (1H, s), 8.38 (1H, s), 11.84 (1H, brs).',\n",
       "   'To a DMF (20 mL) solution of compound 65C (1.2 g, 3.79 mmol) were added potassium carbonate (1.04 g, 7.59 mmol) and O-(2,4-dinitrophenyl)hydroxylamine (831 mg, 4.17 mmol), and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added water, and the precipitated solid was filtered, and washed with water to obtain 1.0 g of a crude purified product of compound 65D.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.74 (3H, s), 3.83 (3H, brs), 5.05 (2H, s), 6.46 (2H, brs), 7.31-7.38 (5H, m), 8.20 (1H, s), 8.52 (1H, brs).',\n",
       "   'To a DMF (10 mL) solution of compound 65D (1.0 g, 3.02 mmol) were added paraformaldehyde (109 mg, 3.62 mmol) and acetic acid (0.017 ml, 0.302 mmol) at room temperature, and the mixture was stirred at 105° C. for 2 hours. The reaction solution was cooled to 0° C., cesium carbonate (3.44 g, 10.6 mmol) was added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added water, and the mixture was distributed between ethyl acetate and water. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off to obtain 120 mg of compound 65E.',\n",
       "   'MS: m/z=344 [M+H]+.',\n",
       "   'To a DMF (1 mL) solution of compound 65E (17.0 mg, 0.05 mmol) were added cesium carbonate (81.4 mg, 0.25 mmol) and methylamine (2 mol/L THF solution, 0.125 ml, 0.25 mmol), and the mixture was stirred at room temperature for 5 hours. The reaction solution was filtered, and the filtrate was fractionated and purified by LCMS to obtain compound 65F.',\n",
       "   'MS: m/z=358 [M+H]+.',\n",
       "   'To a DMF (0.5 mL) solution of compound 65F was added a 2N aqueous sodium hydroxide solution (0.2 mL), and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added ion-exchange resin DOWEX (50W-X8), and the mixture was filtered, and washed with DMF. After concentration of the filtrate, trifluoroacetic acid (0.5 mL) was added, and the mixture was stirred at 80° C. for 4 hours. After concentration of the reaction solution, water and chloroform were added, and the organic layer was separated. The organic layer was concentrated, and fractionation-purified by LCMS to obtain 6.47 mg of compound 65.',\n",
       "   'MS: m/z=254 [M+H]+.',\n",
       "   'According to Example 65, the following compounds were synthesized by the same procedure.',\n",
       "   'TABLE 1\\n\\n\\n\\n\\n\\nExample\\nStructure\\nMS\\n\\n\\n\\n\\n\\n\\n\\nExample 66\\n\\n\\n\\n\\n348\\n\\n\\n \\n\\n\\nExample 67\\n\\n\\n\\n\\n296\\n\\n\\n \\n\\n\\nExample 68\\n\\n\\n\\n\\n340\\n\\n\\n \\n\\n\\nExample 69\\n\\n\\n\\n\\n348\\n\\n\\n \\n\\n\\nExample 70\\n\\n\\n\\n\\n442\\n\\n\\n \\n\\n\\nExample 71\\n\\n\\n\\n\\n318',\n",
       "   'TABLE 2\\n\\n\\n\\n\\n\\nExample\\nStructure\\nMS\\n\\n\\n\\n\\n\\n\\n\\nExample 72\\n\\n\\n\\n\\n362\\n\\n\\n \\n\\n\\nExample 73\\n\\n\\n\\n\\n388\\n\\n\\n \\n\\n\\nExample 74\\n\\n\\n\\n\\n438\\n\\n\\n \\n\\n\\nExample 75\\n\\n\\n\\n\\n298\\n\\n\\n \\n\\n\\nExample 76\\n\\n\\n\\n\\n430\\n\\n\\n \\n\\n\\nExample 77\\n\\n\\n\\n\\n442',\n",
       "   'TABLE 3\\n\\n\\n\\n\\n\\nExample\\nStructure\\nMS\\n\\n\\n\\n\\n\\n\\n\\nExample 78 \\n\\n\\n\\n\\n442\\n\\n\\n \\n\\n\\nExample 79\\n\\n\\n\\n\\n454\\n\\n\\n \\n\\n\\nExample 80\\n\\n\\n\\n\\n438\\n\\n\\n \\n\\n\\nExample 81\\n\\n\\n\\n\\n492\\n\\n\\n \\n\\n\\nExample 82\\n\\n\\n\\n\\n443',\n",
       "   'TABLE 4\\n\\n\\n\\n\\n\\nExample\\nStructure\\nMS\\n\\n\\n\\n\\n\\n\\n\\nExample 83 \\n\\n\\n\\n\\n513\\n\\n\\n \\n\\n\\nExample 84\\n\\n\\n\\n\\n500\\n\\n\\n \\n\\n\\nExample 85\\n\\n\\n\\n\\n454\\n\\n\\n \\n\\n\\nExample 86\\n\\n\\n\\n\\n452\\n\\n\\n \\n\\n\\nExample 87\\n\\n\\n\\n\\n480',\n",
       "   'TABLE 5\\n\\n\\n\\n\\n\\nExample\\nStructure\\nMS\\n\\n\\n\\n\\n\\n\\n\\nExample 88\\n\\n\\n\\n\\n406\\n\\n\\n \\n\\n\\nExample 89\\n\\n\\n\\n\\n445\\n\\n\\n \\n\\n\\nExample 90\\n\\n\\n\\n\\n500\\n\\n\\n \\n\\n\\nExample 91\\n\\n\\n\\n\\n416\\n\\n\\n \\n\\n\\nExample 92\\n\\n\\n\\n\\n450']},\n",
       " {'number': 'Example 93',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 65, compound 93 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 3.34 (3H, s), 3.57-3.68 (2H, m), 3.73 (2H, br s), 4.18 (2H, s), 4.75 (2H, br s), 7.06-7.12 (2H, m), 7.21-7.24 (2H, m), 8.10 (1H, s), 11.96 (1H, br s), 14.52 (1H, brs).']},\n",
       " {'number': 'Example 94',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Using compound 94A (WO 2007/049675), and according to the same procedure as that of the fifth step of Example 65, compound 94B was synthesized.',\n",
       "   '1H-NMR (CDCl3) δ: 3.00-3.09 (1H, m), 3.18 (3H, s), 3.44 (2H, dd, J=7.55, 2.82 Hz), 4.02-4.08 (1H, m), 4.44-4.59 (3H, m), 4.86 (1H, d, J=13.57 Hz), 5.25 (1H, s), 5.36 (2H, dd, J=14.87, 9.99 Hz), 6.74-6.84 (2H, m), 7.09-7.60 (16H, m), 7.90 (1H, s), 10.07 (1H, t, J=5.87 Hz).',\n",
       "   'To a MeCN (20 ml) solution of compound 94B (1.1 g, 1.655 mmol) were added DMAP (202 mg, 1.655 mmol) and Boc2O (20 ml, 86 mmol) at room temperature under nitrogen stream, and the mixture was heated to reflux for 5 hours. Further, Boc2O (20 ml, 86 mmol) was added, and the mixture was heated to reflux for 5 hours. After concentration under reduced pressure, to the residue were added ethanol (20.00 ml) and an aqueous sodium hydroxide solution (40%, 25 ml), and the mixture was stirred at room temperature for 5 hours. To the reaction mixture were added ethyl acetate-water to make the aqueous layer acidic. After extraction with ethyl acetate (2×200 mL), the organic layer was washed with an aqueous saturated sodium chloride solution. After drying with magnesium sulfate, the solvent was distilled off under reduced pressure. The crude product was purified by silica gel column chromatography (CHCl3/MeOH 20:1) to obtain compound 94C. (750 mg, 63%)',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.13 (3H, s), 3.25-3.34 (3H, m), 3.79 (1H, d, J=13.73 Hz), 4.42 (1H, d, J=14.03 Hz), 5.11-5.27 (3H, m), 5.48 (1H, s), 7.18-7.21 (5H, m), 7.33-7.49 (6H, m), 7.56-7.58 (2H, m), 7.74 (2H, d, J=7.32 Hz), 8.01 (1H, s).',\n",
       "   'Using compound 94C, and according to the same procedure as that of the tenth step of Example 12, compound 94 was synthesized.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.13 (3H, s), 3.41-3.56 (4H, m), 4.50 (1H, d, J=13.57 Hz), 5.21 (1H, d, J=13.42 Hz), 5.58 (1H, s), 7.16-7.50 (8H, m), 7.72 (2H, d, J=7.32 Hz), 7.93 (1H, s), 12.12 (1H, s).']},\n",
       " {'number': 'Example 95',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 95A (WO 2006/116764, 1 g, 4.06 mmol) was dissolved in 28% aqueous ammonia, and the solution was stirred at room temperature for 12 hours. After concentration of the reaction solution, the resulting residue was neutralized with 2N hydrochloric acid, and the precipitated solid was suspended in ethyl acetate, filtered, and dried to obtain 1.14 g (yield 100%) of compound 95B.',\n",
       "   '1H-NMR (DMSO-d6) δ: 5.14 (2H, s), 7.31 (1H, d, J=6.6 Hz), 7.34-7.41 (3H, m), 7.45-7.51 (2H, m), 8.17 (1H, d, J=6.6 Hz).',\n",
       "   'To a DMF (10 ml) solution of compound 95B (3.00 g, 10.65 mmol) were added WSC.HCl (3.06 g, 15.98 mmol) and HOBt (1.58 g, 11.7 mmol) at room temperature, the mixture was stirred for 10 minutes, and a methylamine 33 wt % ethanol solution (1.50 g, 15.98 mmol) was added dropwise. After the reaction solution was stirred at the same temperature for 2 hours, water was added, and the mixture was extracted with chloroform five times. The extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (6:4, v/v), 2.62 g (yield 95%) of compound 95C was obtained as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.77 (3H, d, J=4.8 Hz), 5.49 (2H, s), 6.57 (1H, d, J=6.9 Hz), 7.25-7.43 (5H, m), 7.48 (1H, t, J=6.0 Hz), 8.23 (1H, brs), 9.77 (1H, brs).',\n",
       "   'Into a DMF (10 ml) solution of compound 95C (2.62 g, 10.14 mmol) was suspended potassium carbonate (4.20 g, 30.42 mmol) at room temperature, the suspension was stirred for 5 minutes, O-(2,4-dinitrophenyl)hydroxylamine (3.03 g, 15.21 mmol) was added, and the mixture was stirred at the same temperature for 3 hours. To the reaction solution was added water, the mixture was extracted with chloroform five times, and the extract was dried with sodium sulfate. After the solvent was distilled off, the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (6:4, v/v), 1.41 g (yield 51%) of compound 95D was obtained as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.62 (3H, d, J=5.1 Hz), 5.06 (2H, s), 5.22 (2H, s), 6.18 (1H, d, J=7.8 Hz), 7.25-7.36 (5H, m), 5.89 (1H, d, J=7.8 Hz), 7.57 (1H, q, J=5.1 Hz).',\n",
       "   'A toluene (10 ml) solution of compound 95D (1.0 g, 3.66 mmol) were added paraformaldehyde (109.9 mg, 3.66 mmol) and acetic acid (22 mg, 0.37 mmol), and the mixture was heated to stir at 100° C. for 40 minutes. After cooling, the solvent was distilled off, the residue was dissolved in DMF (10 ml) without purification, cesium carbonate (3.58 g, 10.98 mmol) was added under ice-cooling, and the mixture was stirred for 10 minutes. To the reaction solution was added benzohydryl bromide (1.36 g, 5.49 mmol), the mixture was stirred at room temperature for 3 hours, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate-MeOH (9:1, v/v), 1.26 g (yield 71%) of compound 95E was obtained as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.91 (3H, s), 4.26 (1H, d, J=13.2 Hz), 4.77 (1H, d, J=13.2 Hz), 5.12 (1H, s), 5.42 (1H, J=13.2 Hz), 5.45 (1H, d, J=13.2 Hz), 5.82 (1H, J=7.5 Hz), 6.71 (1H, d, J=7.5 Hz), 7.10-7.23 (5H, m), 7.27-7.46 (6H, m), 7.52 (2H, d, J=6.9 Hz), 7.60-7.64 (2H, m).',\n",
       "   'Compound 95E (100 mg, 0.221 mmol) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 50 mg (yield 63%) of compound 95.',\n",
       "   '1H-NMR (CDCl3) δ: 2.95 (3H, s), 4.36 (1H, d, J=13.2 Hz), 4.95 (1H, d, J=13.2 Hz), 5.22 (1H, s), 5.71 (1H, d, J=7.8 Hz), 6.75 (1H, d, J=7.8 Hz), 7.21 (5H, br s), 7.33-7.47 (4H, m), 7.55 (2H, d, J=6.6 Hz).',\n",
       "   'According to Example 95, the following compounds were synthesized by the same procedure.']},\n",
       " {'number': 'Example 96',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.12-3.18 (1H, m), 3.21 (3H, s), 3.38-3.52 (2H, m), 3.81 (1H, ddd, J=3.3 Hz, 4.2 Hz, 14.1 Hz), 4.52 (1H, d, J=13.2 Hz), 5.00 (1H, d, J=13.2 Hz), 5.28 (1H, s), 5.71 (1H, d, J=7.8 Hz), 6.74 (1H, d, J=7.8 Hz), 7.14-7.21 (5H, m), 7.32-7.46 (3H, m), 7.53 (2H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 97',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.99-3.06 (0.54H, m), 3.18-3.23 (3.9H, m), 3.42-3.54 (2.5H, m), 3.86-3.91 (0.42H, m), 4.03-4.08 (0.58H, m), 4.37 (0.58H, d, J=13.5 Hz), 4.54 (0.42H, d, J=13.8 Hz), 4.98 (0.58H, d, J=13.5 Hz), 5.08 (0.42H, d, J=13.8 Hz), 5.36 (0.58H, s), 5.43 (0.42H, s), 5.70-5.77 (1H, m), 6.77 (0.42H, d, J=7.5 Hz), 6.94 (0.58H, d, J=7.8 Hz), 7.08-7.53 (6H, m), 7.60-7.78 (2H, m), 8.55 (0.58H, d, J=4.2 Hz), 8.72 (0.42H, d, J=3.9 Hz).']},\n",
       " {'number': 'Example 98',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.930 (3H, d, J=6.9 Hz), 1.09 (3H, d, J=6.9 Hz), 4.58 (1H, d, J=12.6 Hz), 4.79 (1H, d, J=12.6 Hz), 4.83-4.90 (1H, m), 5.20 (1H, s), 5.67 (1H, d, J=7.5 Hz), 6.66 (1H, d, J=7.5 Hz), 7.07-7.09 (2H, m), 7.13-7.19 (3H, m), 7.34-7.46 (3H, m), 7.52 (1H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 99',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.30 (3H, s), 3.49 (1H, brs), 3.54-3.56 (2H, m), 3.73 (1H, brs), 4.11 (2H, brs), 4.25 (1H, brs), 4.78 (1H, brs), 6.00 (1H, d, J=7.5 Hz), 8.33 (1H, d, J=7.5 Hz), 7.19-7.24 (3H, m), 7.34-7.37 (2H, m), 7.38-7.48 (4H, m).']},\n",
       " {'number': 'Example 100',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 4.32 (1H, d, J=14.7 Hz), 4.41 (1H, d, J=12.9 Hz), 4.69 (1H, d, J=14.7 Hz), 4.88 (1H, d, J=12.9 Hz), 4.97 (1H, s), 5.68 (1H, d, J=7.5 Hz), 6.70 (1H, d, J=7.5 Hz), 6.91-6.98 (2H, m), 7.05-7.08 (2H, m), 7.12-7.20 (7H, m), 7.30-7.32 (4H, m).']},\n",
       " {'number': 'Example 101',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.35 (3H, s), 3.66-3.69 (3H, m), 3.89 (1H, brs), 4.51 (1H, brs), 4.64 (2H, brs), 5.05 (1H, brs), 5.89 (1H, d, J=7.5 Hz), 6.58 (1H, d, J=7.5H), 7.11 (1H, d, J=7.2 Hz), 7.26-7.40 (1H, m), 7.54-7.62 (2H, m), 7.86-7.93 (2H, m), 8.13 (1H, d, J=8.4 Hz).']},\n",
       " {'number': 'Example 102',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 4.54 (1H, d, J=12.9 Hz), 4.56 (2H, s), 4.94 (1H, d, J=12.9 Hz), 5.14 (1H, s), 5.68 (1H, d, J=7.8 Hz), 6.20 (1H, d, J=3.0 Hz), 6.25-6.27 (1H, m), 6.72 (1H, d, J=7.8 Hz), 7.10-7.37 (11H, m).']},\n",
       " {'number': 'Example 103',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.33 (3H, s), 3.63-3.66 (2H, m), 3.75 (2H, brs), 4.27 (2H, brs), 4.67 (1H, brs), 5.00 (1H, brs), 6.09 (1H, d, J=7.8 Hz), 6.99 (1H, d, J=7.8 Hz), 7.18 (1H, d, J=7.8 Hz), 7.27-7.32 (1H, m), 7.66-7.71 (1H, m), 8.63-8.65 (1H, m).']},\n",
       " {'number': 'Example 104',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.12-3.22 (1H, m), 3.21 (3H, m), 3.38-3.55 (3H, m), 3.74-3.80 (0.55H, m), 3.87-3.94 (0.44H, m), 4.46-4.54 (1H, m), 5.00-5.07 (1H, m), 5.30-5.39 (1H, m), 5.70 (0.55H, d, J=7.5 Hz), 5.77 (0.45H, d, J=7.5 Hz), 6.74 (0.55H, d, J=7.8 Hz), 6.81 (0.45H, d, J=7.8 Hz), 7.11-7.54 (7.45H, m), 7.90 (0.55H, d, J=7.8 Hz), 8.459-8.783 (2H, m).']},\n",
       " {'number': 'Example 105',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.34 (3H, s), 3.65-3.70 (4H, m), 4.18 (1H, brs), 4.21 (1H, brs), 4.48 (1H, brs), 4.98 (1H, brs), 6.12 (1H, d, J=7.8 Hz), 6.97 (1H, d, J=7.8 Hz), 7.36 (1H, d, J 7.5 Hz), 7.49 (1H, t, J=7.8 Hz), 7.61-7.66 (2H, m).']},\n",
       " {'number': 'Example 106',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.54 (2H, t, J=7.5 Hz), 3.01 (2H, t, J=7, 5 Hz), 4.38 (2H, brs), 4.77 (2H, brs), 6.27 (1H, d, J=7.5 Hz), 6.96-7.00 (2H, m), 7.04-7.09 (3H, m), 7.19-7.33 (5H, m).']},\n",
       " {'number': 'Example 107',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (30 ml) solution of compound 107A (3.0 g, 9.96 mmol) synthesized according to the method of synthesizing compound 95D were added paraformaldehyde (299 mg, 9.96 mmol) and acetic acid (1 ml), and the mixture was heated to stir at 120° C. for 4 hours. After the solvent was distilled off, to the residue were added ethyl acetate-diisopropyl ether, and the precipitated solid was filtered to obtain 2.85 g (yield 91%) of compound 107B.',\n",
       "   '1H-NMR (CDCl3) δ: 1.19 (6H, J=6.6 Hz), 4.34 (2H, J=7.5 Hz), 4.72-4.86 (1H, m), 5.30 (2H, s), 5.49 (1H, t, J=7.5 Hz), 6.36 (1H, d, J=7.8 Hz), 7.26-7.35 (4H, m), 7.37 (1H, d, J=7.8 Hz), 7.55-7.58 (2H, m).',\n",
       "   'To an acetic acid (2 ml) solution of compound 107B (100 mg, 0.319 mmol) were added 96% sulfuric acid (0.5 ml) and bis(3-chlorophenyl)methanol (242.3 mg, 0.957 mmol) at room temperature, and the mixture was stirred at 80° C. for 2 hours. After the reaction solution was cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate three times. The organic layer was washed with water once, and dried with sodium sulfate. After the solvent was distilled off, to the residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 42 mg (yield 29%) of compound 107.',\n",
       "   '1H-NMR (CDCl3) δ: 0.953 (3H, d, J=3.9 Hz), 1.12 (3H, d, J=4.2 Hz), 4.51 (1H, 13.5 Hz), 4.83 (1H, d, J=13.5 Hz), 4.83-4.92 (1H, m), 5.18 (1H, s), 5.74 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.8 Hz), 6.90 (1H, d, J=7.5 Hz), 7.12 (2H, dd, J=7.2 Hz, 8.1 Hz), 7.19-7.22 (1H, m), 7.37-7.41 (3H, m), 7.55 (1H, s).',\n",
       "   'According to Example 107, the following compounds were synthesized by the same procedure.']},\n",
       " {'number': 'Example 108',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.465-0.549 (1H, m), 0.642-0.738 (1H, m), 0.754-0.907 (2H, m), 2.71-2.79 (1H, m), 2.86 (1H, ddd, J=4.8 Hz, 5.7 Hz, 14.7 Hz), 3.01 (2H, ddd, J=4.2 Hz, 16.0 Hz, 16.8 Hz), 3.88 (1H, ddd, J=4.8 Hz, 5.1 Hz, 16.8 Hz), 4.08-4.14 (1H, m), 4.16 (1H, d, J=12.9 Hz), 4.70 (1H, d, J=12.9 Hz), 4.96 (1H, s), 5.75 (1H, d, J=7.8 Hz), 6.58 (1H, d, J=7.8 Hz), 6.61 (1H, d, J=7.5 Hz), 6.92 (1H, dd, J=6.0 Hz, 7.5 Hz), 7.11-7.80 (6H, m).']},\n",
       " {'number': 'Example 109',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.14 (3H, d, J=6.9 Hz), 1.18 (3H, d, J=6.9 Hz), 2.82 (1H, ddd, J=4.5 Hz, 4.8 Hz, 14.1 Hz), 3.08 (1H, ddd, J=4.2 Hz, 13.2 Hz, 17.7 Hz), 3.53 (1H, ddd, J=4.2 Hz, 4.5 Hz, 17.7 Hz), 4.27 (1H, d, J=12.9 Hz), 4.26-4.37 (1H, m), 4.62-4.71 (1H, m), 4.68 (1H, d, J=12.9 Hz), 5.05 (1H, s), 5.71 (1H, d, J=7.5 Hz), 6.63 (2H, d, J=7.2 Hz), 6.90 (1H, t, J=7.5 Hz), 7.08-7.63 (6H, m).']},\n",
       " {'number': 'Example 110',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.16-3.28 (1H, m), 3.22 (3H, s), 3.46-3.50 (2H, m), 3.86 (1H, ddd, J=3.6 Hz, 3.6 Hz, 14.4 Hz), 4.47 (1H, d, J=13.2 Hz), 5.01 (1H, d, J=13.2 Hz), 5.30 (1H, s), 5.76 (1H, d, J=7.5 Hz), 6.72 (1H, d, J=7.5 Hz), 6.90 (2H, t, J=8.4 Hz), 7.06-7.18 (4H, m), 7.51 (2H, dd, J=5.4 Hz, 8.7 Hz).']},\n",
       " {'number': 'Example 111',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.903 (1.3H, d, J=6.9 Hz), 0.982 (1.5H, d, J=6.6 Hz), 1.08-1.14 (3.2H, m), 4.55 (1H, dd, J=13.2 Hz, 16.5 Hz), 4.78-4.93 (2H, m), 5, 20 (1H, s), 5.66 (0.58H, d, J=7.5 Hz), 5.75 (0.42H, d, J=7.5 Hz), 6.67 (0.55H, d, J=7.5 Hz), 6.73 (0.45H, d, J=7.5 Hz), 6.92 (0.45H, d, J=7.2 Hz), 7.04-7.59 (8.6H, m).']},\n",
       " {'number': 'Example 112',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.22 (3H, s), 3.24-3.32 (1H, m), 3.47-3.50 (2H, m), 3.84 (1H, ddd, J=3.3 Hz, 3.9 Hz, 14.4 Hz), 4.51 (1H, d, J=13.5 Hz), 5.03 (1H, d, J=13.5 Hz), 5.32 (1H, s), 5.77 (1H, d, J=7.8 Hz), 6.80 (1H, d, J=7.8 Hz), 6.84 (1H, d, J=7.8 Hz), 6.93 (2H, t, J=8.4 Hz), 7.06-7.20 (2H, m), 7.25-7.29 (2H, m), 7.39-7.47 (1H, m).']},\n",
       " {'number': 'Example 113',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.88 (3H, d, J=6.9 Hz), 1.10 (3H, d, J=6.6 Hz), 2.10 (3H, s), 4.62-4.69 (1H, m), 4.79-4.92 (2H, m), 5.32 (1H, s), 5.64 (0.74H, 7.5 Hz), 5.72 (0.26H, d, J=7.5 Hz), 6.61 (0.74H, d, J=7.8 Hz), 6.82 (0.26H, d, J=7.8 Hz), 6.96-7.52 (8.26H, m), 7.48 (0.74H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 114',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.976 (2H, d, J=6.9 Hz), 1.09-1.14 (3H, m), 5.63 (0.74H, d, J=7.8 Hz), 5.65 (0.74H, s), 5.73 (0.26H, d, J=7.8 Hz), 6.20 (0.26H, s), 6.65 (0.74H, d, J=7.8 Hz), 6.79 (0.26H, d, J=7.8 Hz), 7.05-7.24 (4.26H, m), 7.31-7.56 (4H, m), 8.02 (0.74H, d, J=6.3 Hz).']},\n",
       " {'number': 'Example 115',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.893 (1.2H, d, J=6.6 Hz), 0.958 (1.8H, d, J=6.9 Hz), 1.09-1.13 (3H, m), 4.44 (0.56H, d, J=13.2 Hz), 4.63 (0.44H, d, J=13.5 Hz), 4.81-4.93 (2H, m), 5.35 (1H, m), 5.67 (0.56H, d, J=7.8 Hz), 5.72 (0.44H, d, J=7.8 Hz), 6.67-6.73 (1H, m), 7.03 (1H, d, J=6.6 Hz), 7.20-7.51 (5H, m), 7.75 (1H, d, 8.4 Hz), 8.06 (0.88H, d, J=8.7 Hz), 8.33 (1.1H, d, J=8.7 Hz).']},\n",
       " {'number': 'Example 116',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.91-0.0.948 (3H, m), 1.10-1.14 (3H, m), 3.61-3.68 (1H, m), 4.44 (0.56H, d, J=12.9 Hz), 4.59 (0.44H, d, J=12.9 Hz), 4.79-4.91 (2H, m), 5.29 (1H, s), 5.67-5.69 (1H, m), 6.63-6.70 (2H, m), 6.90-7.81 (8H, m).']},\n",
       " {'number': 'Example 117',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.19-3.28 (1H, m), 3.22 (3H, s), 3.46-3.50 (2H, m), 3.85 (1H, ddd, J=3 Hz, 4.2 Hz, 14.4 Hz), 4.47 (1H, d, J=13.2 Hz), 5.01 (1H, d, J=13.2 Hz), 5.28 (1H, s), 5.78 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.8 Hz), 7.04 (2H, d, J=8.4 Hz), 7.19 (2H, d, 8.4 Hz), 7.36-7.50 (4H, m).']},\n",
       " {'number': 'Example 118',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.914-0.957 (3H, m), 1.08-1.14 (3H, m), 2.20 (1.4H, s). 2.39 (1.6H, s), 4.56 (0.48H, d, J=4.5 Hz), 4.60 (0.52H, d, J=4.2 Hz), 4.77-4.89 (2H, m), 5.16 (1H, s), 5.66-5.70 (1H, m), 6.65-6.69 (1H, m), 6.85-6.91 (1H, m), 6.98-7.10 (2H, m), 7.14-7.19 (2H, m), 7.30-7.39 (2H, m), 7.44 (1H, t, J=6.9 Hz), 7.51 (1H, d, J=6.9 Hz).']},\n",
       " {'number': 'Example 119',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.893-0.982 (3H, m), 1.08-1.14 (3H, m), 4.49-4.60 (1H, m), 4.78-4.90 (2H, m), 5.20 (1H, s), 5.65 (0.57H, J=7.5 Hz), 5.76 (0.43H, d, J=7.8 Hz), 6.64-6.70 (1H, m), 7.03 (2H, d, J=8.1 Hz), 7.10-7.20 (3H, m), 7.28-7.51 (4H, m).']},\n",
       " {'number': 'Example 120',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.526 (3H, d, J=6.9 Hz), 1.01 (3H, d, J=6.6 Hz), 4.69 (1H, d, J=13.8 Hz), 4.75-4, 83 (1H, m), 4.86 (1H, d, J=13.8 Hz), 5.69 (1H, d, J=7.8 Hz), 6.03 (1H, s), 6.70 (1H, d, J=7.8 Hz), 7.16 (5H, s), 7.40-7.48 (2H, m), 7.67 (1H, t, J=7.8 Hz), 7.81-7.91 (3H, m), 8.16 (1H, d, J=7.2 Hz).']},\n",
       " {'number': 'Example 121',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.947 (3H, d, J=6.9 Hz), 1.09 (3H, d, J=7.2 Hz), 2.22 (3H, s), 2.37 (3H, s), 4.58 (1H, d, J=12.9 Ha), 4.76 (1H, d, J=12.9 Hz), 4.78-4.88 (1H, m), 5.13 (1H, s), 5.72 (1H, d, J=7.8 Hz), 6.67 (1H, d, J=7.8 Hz), 6.72 (1H, s), 6.90-6.98 (4H, m), 7.22 (2H, d, J=7.8 Hz), 7.38 (2H, d, J=7.8 Hz).']},\n",
       " {'number': 'Example 122',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.932 (3H, d, J=6.6 Hz), 1.12 (3H, d, J=6.9 Hz), 4.44 (1H, d, J=13.2 Hz), 4.86 (1H, d, J=13.2 Hz), 4.87-4.93 (1H, m), 5.38 (1H, s), 5.67 (1H, d, J=7.8 Hz), 6.67 (1H, d, J=7.8 Hz), 7.21-7.24 (1H, m), 7.32-7.40 (2H, m), 7.52 (1H, d, J=7.5 Hz), 7.60-7.72 (2H, m), 7.77-7.79 (2H, m).']},\n",
       " {'number': 'Example 123',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.08-3.17 (1H, m), 3.23 (3H, s), 3.40-3.54 (2H, m), 3.71 (3H, s), 3.82 (3H, s), 3.95 (1H, ddd, J=3.3 Hz, 3.9 Hz, 14.4 Hz), 4.48 (1H, d, J=13.5 Hz), 4.96 (1H, d, J=13.5 Hz), 5.16 (1H, s), 5.76 (1H, d, J=7.5 Hz), 6.70 (2H, d, J=9.0 Hz), 6.73 (1H, d, J=7.5 Hz), 6.94 (2H, d, J=8.7 Hz), 7.03 (2H, d, J=8.7 Hz), 7.42 (2H, d, J=8.7 Hz).']},\n",
       " {'number': 'Example 124',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.966 (3H, d, J=6.9 Hz), 1.10 (3H, d, J=6.9 Hz), 3.67 (3H, s), 3.83 (3H, s), 4.60 (1H, d, J=12.9 Hz), 4.78 (1H, d, J=12.9 Hz), 4.80-4.90 (1H, m), 5.13 (1H, m), 5.23 (1H, d, J=7.8 Hz), 6.66 (2H, d, J=7.2 Hz), 6.72-6.87 (2H, m), 6.87-6.90 (1H, m), 7.06-7.11 (3H, m), 7.34 (1H, t, J=8.1 Hz).']},\n",
       " {'number': 'Example 125',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.05 (2H, d, J=7.0 Hz), 1.15 (1H, d, J=7.5 Hz), 2.73-3.63 (8H, m), 4.20-4.93 (4H, m), 5.25 (0.4H, s), 5.30 (0.6H, s), 5.46 (1H, d, J=7.8 Hz), 6.68-7.46 (11H, m).',\n",
       "   'MS: m/z=446 [M+H]+.']},\n",
       " {'number': 'Example 126',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 95B (1.00 g, 3.55 mmol) and cyclopropanamine (0.492 ml, 7.10 mmol) were added to pyridine (20 ml), 1-hydroxybenzotriazole (544 mg, 3.55 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.36 g, 7.10 mmol) were sequentially added, and the mixture was stirred at room temperature for 18 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5, v/v) and, subsequently, amino column chromatography (chloroform-methanol, 99:1, v/v) to obtain 1.19 g of compound 126A as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 0.22 (1H, m), 0.70 (2H, m), 2.76-2.83 (1H, m), 5.50 (2H, s), 6.59 (1H, dd, J=7.0, 1.9 Hz), 7.44 (5H, d, J=0.7 Hz), 7.53 (1H, dd, J=6.9, 6.2 Hz), 8.30 (1H, brs), 9.71 (1H, brs).',\n",
       "   'Compound 126A (1.19 g, 4.19 mmol) was dissolved in DMF (15 ml), potassium carbonate (2.90 g, 20.1 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. O-(2,4-dinitrophenyl)hydroxylamine (1.67 g, 8.38 mmol) was added, and the mixture was stirred at room temperature for 18 hours. To the reaction solution was added chloroform, the precipitated yellow precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 851 mg of compound 126B as a yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 0.41-0.46 (2H, m), 0.76 (2H, m), 2.73-2.81 (1H, m), 5.19 (2H, s), 5.61 (2H, s), 6.26 (1H, d, J=7.2 Hz), 7.38 (5H, s), 7.44 (1H, d, J=7.8 Hz), 7.70 (1H, s).',\n",
       "   'Compound 126B (847 mg, 2.83 mmol) and paraformaldehyde (255 mg, 8.49 mmol) were added to ethanol (12 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→90:10, v/v) and, subsequently, amino column chromatography (chloroform-methanol, 97:3, v/v), methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 665 mg of compound 126C as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 0.61-0.66 (2H, m), 0.87 (2H, m), 2.68-2.76 (1H, m), 4.32 (2H, d, J=7.9 Hz), 5.28 (2H, s), 6.33 (1H, d, J=7.7 Hz), 6.45 (1H, t, J=7.7 Hz), 7.33 (3H, m), 7.38 (1H, d, J=7.7 Hz), 7.52 (2H, m).',\n",
       "   'Compound 126C (100 mg, 0.321 mmol) was dissolved in DMF (0.5 ml), cesium carbonate (314 mg, 0.964 mmol) and (bromomethylene)dibenzene (119 mg, 0.482 mmol) were added at 0° C., and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 124 mg of compound 126D as a colorless gummy substance.',\n",
       "   '1H-NMR (CDCl3) δ: 0.37-0.47 (2H, m), 0.74 (2H, m), 2.63-2.68 (1H, m), 4.35 (1H, d, J=13.4 Hz), 4.65 (1H, d, J=13.4 Hz), 5.07 (1H, s), 5.40 (1H, d, J=10.7 Hz); 5.47 (1H, d, J=10.5 Hz), 5.79 (1H, d, J=7.6 Hz), 6.67 (1H, d, J=7.8 Hz), 7.04-7.62 (15H, m).',\n",
       "   'To compound 126D obtained in the fourth step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1.5 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 52 mg of compound 126 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: −0.19-−0.06 (1H, m), 0.44-0.54 (1H, m), 0.82 (2H, m), 2.62-2.69 (1H, m), 4.21 (1H, d, J=13.3 Hz), 5.11 (1H, d, J=13.1 Hz), 5.32 (1H, s), 5.47 (1H, t, J=11.1 Hz), 7.13 (1H, d, J=7.6 Hz), 7.23 (3H, m), 7.28-7.47 (8H, m), 7.69 (2H, t, J=8.5 Hz).',\n",
       "   'MS: m/z=388 [M+H]+.']},\n",
       " {'number': 'Example 127',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 126, compound 127 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.86 (1.5H, d, J=7.0 Hz), 1.04 (1.5H, d, J=7.2 Hz), 3.08 (1.5H, s), 3.16 (1.5H, s), 4.52-5.05 (3H, m), 5.48 (2H, m), 7.31-7.47 (9H, m), 7.66 (2H, t, J=8.4 Hz).',\n",
       "   'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Example 128',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 95B (2.40 g, 8.52 mmol) and ethyl 3-aminopropanoate hydrochloride (2.62 g, 17.0 mmol) were added to pyridine (30 ml), 1-hydroxybenzotriazole (1.31 g, 8.52 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (3.27 g, 17.0 mmol) were sequentially added, and the mixture was stirred at room temperature for 2 hours. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) to obtain 1.90 g of compound 128A as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.29 (3H, t, J=7.1 Hz), 2.48 (2H, t, J=6.4 Hz), 3.58 (2H, q, J=6.3 Hz), 4.17 (2H, q, J=7.1 Hz), 5.59 (2H, s), 6.57 (1H, dd, J=7.1, 1.6 Hz), 7.37-7.52 (6H, m), 8.73 (1H, brs), 9.72 (1H, brs).',\n",
       "   'Compound 128A (2.58 g, 7.49 mmol) was dissolved in DMF (30 ml), potassium carbonate (5.18 g, 37.5 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. O-(2,4-dinitrophenyl)hydroxylamine (2.98 g, 15.0 mmol) was added, and the mixture was stirred at room temperature for 20 hours. To the reaction solution was added chloroform, the precipitated yellow precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 97:3→95:5, v/v) and, subsequently, silica gel column chromatography (chloroform-methanol, 95:5→92:8, v/v) to obtain 1.67 g of compound 128B as a yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.26 (3H, t, J=7.2 Hz), 2.42 (2H, t, J=6.6 Hz), 3.43 (2H, q, J=6.4 Hz), 4.12 (2H, q, J=7.1 Hz), 5.13 (2H, s), 5.53 (2H, s), 6.21 (1H, d, J=7.6 Hz), 7.33 (5H, s), 7.39 (1H, d, J=7.6 Hz), 7.85 (1H, t, J=5.6 Hz).',\n",
       "   'Compound 128B (1.66 g, 4.62 mmol) and paraformaldehyde (416 mg, 13.9 mmol) were added to ethanol (20 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, the resulting crude product was purified by amino column chromatography (chloroform-methanol, 99:1→95:5, v/v) to obtain 1.57 g of compound 128C as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.27 (3H, t, J=7.2 Hz), 2.70 (2H, t, J=5.7 Hz), 3.57 (2H, t, J=5.8 Hz), 4.13 (2H, q, J=7.1 Hz), 4.50 (2H, d, J=7.9 Hz), 5.27 (2H, s), 5.87 (1H, t, J=7.8 Hz), 6.32 (1H, d, J=7.6 Hz), 7.31 (4H, m), 7.54 (2H, m).',\n",
       "   'Compound 128C (1.00 g, 2.69 mmol) was dissolved in DMF (10 ml), cesium carbonate (2.63 g, 8.08 mmol) and (bromomethylene)dibenzene (998 mg, 4.04 mmol) were added at 0° C., and the mixture was stirred at room temperature for 18 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform/methanol, 98:2, v/v) to obtain 500 mg of compound 128D as a colorless gummy substance.',\n",
       "   '1H-NMR (CDCl3) δ: 1.25 (3H, t, J=7.3 Hz), 2.46 (1H, m), 2.70-2.80 (1H, m), 2.87-2.96 (1H, m), 4.11 (2H, q, J=7.3 Hz), 4.12 (1H, m), 4.48 (1H, d, J=13.7 Hz), 4.85 (1H, d, J=13.7 Hz), 5.10 (1H, s), 5.47 (2H, s), 5.83 (1H, d, J=8.0 Hz), 6.73 (1H, d, J=8.0 Hz), 7.37 (15H, m).',\n",
       "   'To compound 128D (40 mg, 0.074 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 20 mg of compound 128 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.16 (3H, t, J=7.1 Hz), 2.45-2.58 (3H, m), 3.70 (1H, m), 4.02 (2H, q, J=7.1 Hz), 4.39 (1H, d, J=13.4 Hz), 5.09 (1H, d, J=13.3 Hz), 5.48 (1H, d, J=3.2 Hz), 5.51 (1H, s), 7.19-7.38 (7H, m), 7.45 (2H, t, J=7.3 Hz), 7.69 (2H, d, J=7.2 Hz).',\n",
       "   'MS: m/z=448 [M+H]+.']},\n",
       " {'number': 'Example 129',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 128D (426 mg, 0.792 mmol) was dissolved in ethanol (3 ml) and THF (3 ml), a 2N aqueous sodium hydroxide solution (1.19 ml, 2.38 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. To the reaction solution was added 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. To the resulting crude product were added methylene chloride-ethyl ether, and the precipitated solid was filtered to obtain 359 mg of compound 129A as a colorless solid.',\n",
       "   'To compound 129A (40 mg, 0.079 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, and the mixture was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 25 mg of compound 129 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.31-2.41 (1H, m), 2.57 (1H, m), 3.63-3.72 (1H, m), 4.37 (1H, d, J=13.3 Hz), 5.09 (1H, d, J=13.3 Hz), 5.47 (1H, s), 5.50 (1H, d, J=7.8 Hz), 7.28 (7H, m), 7.44 (2H, t, J=7.5 Hz), 7.69 (2H, d, J=7.2 Hz), 12.40 (1H, brs).',\n",
       "   'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Examples 130',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 129A (50 mg, 0.098 mmol) was added to DMF (1 ml), 1-hydroxybenzotriazole (14 mg, 0.098 mmol), dimethylamine hydrochloride (24 mg, 0.29 mmol), triethylamine (0.048 ml, 0.34 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (28 mg, 0.15 mmol) were added, and the mixture was stirred at room temperature for 1.5 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, washed with sodium bicarbonate water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure to obtain compound 130A as a colorless gummy substance.',\n",
       "   'To compound 130A obtained in the first step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 2 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, and the mixture was extracted with chloroform, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 25 mg of compound 130 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.33-2.43 (1H, m), 2.66 (1H, m), 2.78 (3H, s), 2.89 (3H, s), 3.56 (2H, m), 4.45 (1H, d, J=13.6 Hz), 5.05 (1H, d, J=13.6 Hz), 5.47 (s, 1H), 5.49 (1H, d, J=7.5 Hz), 7.27 (7H, m), 7.44 (2H, t, J=7.3 Hz), 7.69 (2H, d, J=7.3 Hz).']},\n",
       " {'number': 'Example 131',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 131 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.60-2.77 (3H, m), 3.94 (1H, m), 4.42 (1H, d, J=13.4 Hz), 5.15 (1H, d, J=13.4 Hz), 5.49 (1H, s), 5.55 (1H, d, J=7.2 Hz), 7.07 (1H, t, J=7.3 Hz), 7.12-7.49 (13H, m), 7.73 (2H, d, J=7.2 Hz), 10.01 (1H, s).',\n",
       "   'MS: m/z=495 [M+H]+.']},\n",
       " {'number': 'Example 132',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 132 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.14 (3H, s), 3.65 (4H, m), 4.34 (1H, d, J=13.6 Hz), 5.06 (1H, d, J=13.6 Hz), 5.42 (1H, s), 5.53 (1H, d, J=7.5 Hz), 7.42-7.58 (16H, m).',\n",
       "   'MS: m/z=509 [M+H]+.']},\n",
       " {'number': 'Example 133',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 133 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.08-1.55 (8H, m), 2.33 (1H, m), 2.68 (1H, m), 4.45 (1H, d, J=13.6 Hz), 5.05 (1H, d, J=13.6 Hz), 5.50 (2H, brs), 7.46-7.68 (11H, m).',\n",
       "   'MS: m/z=487 [M+H]+.']},\n",
       " {'number': 'Example 134',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 134 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.34-2.40 (1H, m), 2.61-2.77 (1H, m), 3.51-3.69 (10H, m), 4.44 (1H, d, J=13.4 Hz), 5.03-5.11 (1H, d, J=13.4 Hz), 5.51 (2H, s), 7.18-7.52 (9H, m), 7.69-7.75 (2H, m).']},\n",
       " {'number': 'Example 135',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 95B (1.50 g, 5.32 mmol) and tert-butyl 2-aminoethyl(methyl)carbamate (1.86 g, 10.7 mmol) were added to pyridine (20 ml), 1-hydroxybenzotriazole (815 mg, 5.32 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.04 g, 10.7 mmol) were sequentially added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into 1N hydrochloric acid, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by amino column chromatography (chloroform-methanol, 95:5, v/v) and, subsequently, silica gel column chromatography (chloroform-methanol, 95:5, v/v) to obtain 1.63 g of compound 135A as a colorless gummy substance.',\n",
       "   '1H-NMR (CDCl3) δ: 1.44 (9H, s), 2.82 (3H, s), 3.28 (4H, m), 5.59 (2H, s), 6.57 (1H, d, J=6.0 Hz), 7.46 (6H, m), 8.46 (1H, m), 9.68 (1H, brs).',\n",
       "   'Compound 135A (1.05 g, 2.62 mmol) was dissolved in DMF (15 ml), potassium carbonate (1.81 g, 13.1 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. O-(2,4-dinitrophenyl)hydroxylamine (1.04 g, 5.23 mmol) was added, and the mixture was stirred at room temperature for 18 hours. To the reaction solution was added chloroform, the precipitated yellow precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 887 mg of compound 135B as a pale yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.44 (9H, s), 2.84 (3H, s), 3.38 (4H, m), 5.33 (2H, s), 5.68 (1H, brs), 5.80 (1H, brs), 6.35 (1H, d, J=7.6 Hz), 6.74 (1H, brs), 7.39 (5H, brm), 7.52 (1H, t, J=9.5 Hz).',\n",
       "   'Compound 135B (880 mg, 2.11 mmol) and paraformaldehyde (190 mg, 6.34 mmol) were added to ethanol (18 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→90:10 v/v) and, subsequently, amino column chromatography (chloroform-methanol, 97:3, v/v) to obtain 721 mg of compound 135C as a colorless solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.29 (9H, s), 2.95 (3H, s), 4.38 (2H, brs), 5.33 (2H, brs), 6.36 (1H, d, J=7.6 Hz), 6.85 (1H, t, J=7.4 Hz), 7.33 (4H, m), 7.55 (2H, m).',\n",
       "   'MS: m/z=429 [M+H]+.',\n",
       "   'Compound 135C (720 mg, 1.68 mmol) was dissolved in DMF (3.5 ml), cesium carbonate (1.64 g, 5.04 mmol) and (bromomethylene)dibenzene (623 mg, 2.52 mmol) were added at 0° C., and the mixture was stirred at room temperature for 18 hours. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5 v/v) to obtain 732 mg of compound 135D.',\n",
       "   'To compound 135D (727 mg, 1.22 mmol) was added 4N HCl (ethyl acetate solution, 10 ml). After stirring at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Saturated sodium bicarbonate water was added, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting crude product were added methylene chloride-ethyl ether, and the precipitated solid was filtered to obtain 575 mg of compound 135E as a colorless solid.',\n",
       "   'To compound 135E (50 mg, 0.10 mmol) was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1.5 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, ethylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 15 mg of compound 135 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.40 (3H, s), 2.80 (1H, s), 3.12 (3H, m), 3.87 (1H, m), 4.37 (1H, d, J=13.6 Hz), 5.10 (1H, d, J=13.4 Hz), 5.52 (1H, s), 5.53 (1H, d, J=5.5 Hz), 7.15-7.70 (11H, m).',\n",
       "   'MS: m/z=405 [M+H]+.']},\n",
       " {'number': 'Example 136',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 135E (50 mg, 0.10 mmol) was dissolved in methylene chloride (1 ml), triethylamine (0.042 ml, 0.30 mmol) and acetyl chloride (0.011 ml, 0.15 mmol) were added, and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) and, subsequently, amino column chromatography (chloroform-methanol, 97:3, v/v) to obtain 72 mg of compound 136A as a colorless solid.',\n",
       "   'To compound 136A obtained in the first step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1.5 hours. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 23 mg of compound 136 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.89 (2H, s), 1.92 (1H, s), 2.73 (1H, s), 2.95 (2H, s), 3.00-3.06 (1H, m), 3.43 (2H, m), 3.80 (1H, m), 4.34 (0.7H, d, J=13.3 Hz), 4.45 (0.3H, d, J=13.1 Hz), 5.11 (1H, m), 5.49 (2H, m), 7.20-7.73 (11H, m).']},\n",
       " {'number': 'Example 137',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 136, compound 137 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.95 (3H, s), 3.13-4.07 (4H, m), 4.46 (1H, d, J=13.2 Hz), 5.16 (1H, d, J=13.0 Hz), 5.51 (1H, d, J=7.3 Hz), 5.62 (1H, s), 7.17-7.78 (16H, m).',\n",
       "   'MS: m/z=509 [M+H]+.']},\n",
       " {'number': 'Example 138',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 136, compound 138 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.62 (3H, s), 3.03-3.22 (4H, m), 3.72 (2H, d, J=13.3 Hz), 4.39 (1H, d, J=13.3 Hz), 5.08 (1H, d, J=13.3 Hz), 5.53 (1H, d, J=7.8 Hz), 5.55 (1H, s), 7.19-7.79 (16H, m).',\n",
       "   'MS: m/z=545 [M+H]+.']},\n",
       " {'number': 'Example 139',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 136, compound 139 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.72 (3H, s), 2.88 (3H, s), 3.12-3.24 (3H, m), 3.75-3.80 (1H, m), 4.37 (1H, d, J=13.0 Hz), 5.10 (1H, d, J=13.4 Hz), 5.51 (1H, d, J=7.6 Hz), 5.54 (1H, s), 7.19-7.46 (19H, m), 7.72 (2H, d, J=7.0 Hz).',\n",
       "   'MS: m/z=483 [M+H]+.']},\n",
       " {'number': 'Example 140',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 136, compound 140 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.88 (3H, s), 2.98-3.12 (3H, m), 3.77 (1H, m), 4.31 (1H, d, J=13.3 Hz), 5.13 (1H, d, J=13.3 Hz), 5.51 (1H, s), 5.52 (1H, d, J=7.6 Hz), 7.13-7.46 (9H, m), 7.71 (2H, d, J=7.2 Hz).',\n",
       "   'MS: m/z=469 [M+H]+.']},\n",
       " {'number': 'Example 141',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 136, compound 141 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.07 (9H, s), 2.84 (1H, m), 3.19 (2H, d, J=3.9 Hz), 3.96 (1H, d, m), 4.28 (1H, d, J=13.1 Hz), 5.21 (1H, d, J=13.1 Hz), 5.52 (1H, s), 5.56 (1H, t, J=4.2 Hz), 7.25-7.59 (10H, m), 7.75 (2H, d, J=7.7 Hz).',\n",
       "   'MS: m/z=475 [M+H]+.']},\n",
       " {'number': 'Example 142',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 136, compound 142 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.10 (6H, m), 2.98 (3H, m), 3.78 (1H, m). 4.27 (1H, d, J=13.6 Hz), 4.68 (1H, m), 5.11 (1H, d, J=12.8 Hz), 5.51 (2H, m), 7.07-7.46 (10H, m), 7.70 (2H, d, J=7.2 Hz).',\n",
       "   'MS: m/z=477 [M+H]+.']},\n",
       " {'number': 'Example 143',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 136, compound 143 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.89 (3H, m), 3.62 (1H, m), 4.17 (1H, d, J=13.1 Hz), 4.99 (1H, d, J=13.1 Hz), 5.45 (1H, s), 5.51 (1H, d, J=7.8 Hz), 7.18-7.77 (17H, m).',\n",
       "   'MS: m/z=531 [M+H]+.']},\n",
       " {'number': 'Example 144',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To compound 144A synthesized according to the first to fifth steps of Example 135 were added formic acid and formalin, and the mixture was stirred at 80 degree for 1.5 hours. The solvent was distilled off under reduced pressure, saturated sodium bicarbonate water was added, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5→92:8, v/v) to obtain 26 mg of compound 144B.',\n",
       "   '1H-NMR (CDCl3) δ: 2.06 (6H, s), 2.18-2.26 (1H, m), 2.36-2.45 (1H, m), 2.89-2.98 (1H, m), 3.91 (1H, dt, J=14.1, 5.9 Hz), 4.43 (1H, d, J=13.6 Hz), 4.82 (1H, d, J=13.4 Hz), 5.20 (1H, s), 5.41 (1H, d, J=10.8 Hz), 5.46 (1H, d, J=10.7 Hz), 5.80 (1H, d, J=7.8 Hz), 6.69 (1H, d, J=7.8 Hz), 7.05-7.64 (15H, m).',\n",
       "   'To compound 144B obtained in the first step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and an aqueous ammonium chloride solution, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 13 mg of compound 144 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.17 (6H, s), 2.38-2.46 (3H, m), 3.59 (1H, m), 4.41 (1H, d, J=13.1 Hz), 5.09 (1H, d, J=13.3 Hz), 5.50 (1H, d, J=6.4 Hz), 5.51 (1H, s), 7.19-7.47 (9H, m), 7.66 (2H, d, J=7.3 Hz).',\n",
       "   'MS: m/z=419 [M+H]+.']},\n",
       " {'number': 'Example 145',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a dichloromethane (5 ml) solution of compound 95E (300 mg, 0.664 mmol) was added NBS (130 mg, 0.731 mmol) under ice-cooling, temperature was raised to room temperature and, thereafter, the mixture was refluxed for 1 hour. After the solvent was distilled off, the resulting residue was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (1:1, v/v) and, then, with ethyl acetate. Concentration of an objective fraction afforded 326.7 mg (yield 93%) of compound 145A as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.93 (3H, s), 4.27 (1H, d, J=13.5 Hz), 4.82 (1H, d, J=13.5 Hz), 5.13 (1H, s), 5.41 (2H, s), 5.41-7.12 (2H, m), 7.15 (1H, s), 7.17-7.28 (3H, m), 7.31-7.47 (6H, m), 7.52 (2H, d, J=6.6 Hz), 7.63-7.67 (2H, m).',\n",
       "   'To a DMF (3 ml) solution of compound 145A (100 mg, 0.189 mmol) were added a solution of potassium carbonate (78.4 mg, 0.567 mmol) in water (0.5 ml), 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane (47.6 mg, 0.284 mmol) and tetakistriphenylphosphinepalladium (21.8 mg, 0.189 mmol), and the mixture was heated to stir at 80° C. for 4 hours. After the reaction solution was cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times, and dried with sodium sulfate and, thereafter, the resulting oil was purified by silica gel chromatography. Elution with only ethyl acetate, and concentration of an objective fraction afforded 42.0 mg (yield 45%) of compound 145B as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.73 (3H, s), 2.92 (3H, s), 4.29 (1H, d, J=13.5 Hz), 4.83 (1H, d, J=13.5 Hz), 4.96-4.97 (1H, m), 5.15 (1H, s), 5.21-5.21 (1H, m), 5.37 (1H, d, J=10.8 Hz), 5.40 (1H, d, J=10.8 Hz), 6.82 (1H, s), 7.15-7.21 (5H, m), 7.27-7.47 (6H, m), 7.54 (2H, d, J=6.9 Hz), 7.64-7.69 (2H, m).',\n",
       "   'To a THF (2 ml) solution of compound 145B (40 mg, 0.081 mmol) was added 10% Pd—C (8 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting residue was washed with ether to obtain 6.8 mg (yield 21%) of compound 145.',\n",
       "   '1H-NMR (CDCl3) δ: 0.629 (3H, d, J=6.9 Hz), 0.900 (3H, d, J=6.9 Hz), 2.87-3.00 (1H, m), 2.94 (3H, s), 4.37 (1H, d, J=13.2 Hz), 4.93 (1H, d, J=13.2 Hz), 5.21 (1H, s), 6.69 (1H, s), 7.21 (5H, s), 7.35-7.47 (3H, m), 7.57 (2H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 146',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 145, compound 146 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 0.738 (3H, t, J=7.2 Hz), 1.05-1.18 (2H, m), 2.01-2.18 (2H, m), 2.94 (3H, s), 4.35 (1H, d, J=13.2 Hz), 4.95 (1H, d, J=13.2 Hz), 5.22 (1H, s), 6.71 (1H, s), 7.20 (5H, s), 7.35-7.47 (3H, m), 7.55 (2H, d, J=6.9 Hz).']},\n",
       " {'number': 'Example 147',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 145A (60 mg, 0.113 mg) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 30 mg (yield 60%) of compound 147.',\n",
       "   '1H-NMR (CDCl3) δ: 2.97 (3H, s), 4.36 (1H, d, J=13.2 Hz), 5.01 (1H, d, J=13.2 Hz), 5.21 (1H, s), 7.14 (1H, s), 7.17-7.25 (5H, m), 7.36-7.48 (3H, m), 7.54 (2H, d, J=7.2 Hz).']},\n",
       " {'number': 'Example 148',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 145B (41 mg, 0.083 mg) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 12 mg (yield 36%) of compound 148.',\n",
       "   '1H-NMR (CDCl3) δ: 1.70 (3H, s), 2.95 (3H, s), 4.36 (1H, d, J=12.9 Hz), 4.95 (1H, d, J=12.9 Hz), 4.96-4.98 (1H, m), 5.23 (1H, s), 5.32-5.33 (1H, m), 6.86 (1H, s), 7.21 (5H, s), 7.35-7.48 (3H, m), 7.56 (2H, d, J=7.2 Hz).']},\n",
       " {'number': 'Example 149',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a THF (2 ml) solution of compound 145A (100 mg, 0.189 mg) were added a 2N methylzinc chloride THF solution (0.377 ml, 0.754 mmol) and tetrakistriphenylphosphinepalladium (10.9 mg, 0.0945 mmol) at room temperature, and the mixture was heated to stir at 60° C. for 4 hours. After the reaction solution was cooled to room temperature, water was added, and the mixture was extracted with chloroform three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by a MS trigger reverse layer column to obtain 9.6 mg (yield 14%) of compound 149.',\n",
       "   '1H-NMR (CDCl3) δ: 1.63 (3H, s), 2.95 (3H, s), 4.34 (1H, d, J=12.9 Hz), 4.68 (1H, d, J=12.9 Hz), 5.21 (1H, s), 6.70 (1H, s), 7.18 (5H, s), 7.37-7.47 (3H, m), 7.54 (2H, d, J=6.9 Hz).']},\n",
       " {'number': 'Example 150',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 150A (465 mg, 0.801 mmol) synthesized according to the first to fourth step of Example 135 was dissolved in a 4N hydrochloric acid dioxane solution (5 ml), and the mixture was stirred at room temperature for 2 hours. The reaction solution was neutralized with saturated sodium bicarbonate water, and was extracted with dichloromethane three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and 100 mg of the resulting oil was dissolved in dichloromethane (2 ml). To the dichloromethane solution were added triethylamine (63.2 mg, 0.624 mmol) and benzoyl chloride (31.9 mg, 0.312 mmol) under ice-cooling, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added water, and the mixture was extracted with dichloromethane three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting residue was washed with diethyl ether to obtain 68 mg (yield 56%) of compound 150B.',\n",
       "   '1H-NMR (CDCl3) δ: 3.05-3.12 (1H, m), 3.38-3.45 (1H, m), 3.64-3.70 (1H, m), 3.93-3.99 (1H, m), 4.22 (1H, d, J=13.2 Hz), 5.04 (1H, s), 5.07 (1H, d, J=13.2 Hz), 5.22 (1H, d, J=10.2 Hz), 5.31 (1H, d, J=10.2 Hz), 5.70 (1H, d, J=7.8 Hz), 6.55 (1H, d, J=7.8 Hz), 6.98 (2H, d, J=6.6 Hz), 7.08-7.19 (4H, m), 7.29-7.46 (5H, m), 7.49-7.53 (2H, m), 7.87 (2H, d, J=7.2 Hz), 8.06 (1H, brs).',\n",
       "   'Compound 150B (30 mg, 0.051 mg) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 15 mg (yield 59%) of compound 150.',\n",
       "   '1H-NMR (CDCl3) δ: 2.91-2.98 (1H, m), 3.54-3.66 (1H, m), 3.76-3.84 (1H, m), 4.13-4.18 (1H, m), 4.28 (1H, d, J=12.9 Hz), 5.11 (1H, s), 5.43 (1H, d, J=12.9 Hz), 5.45 (1H, d, J=7.5 Hz), 6.68 (1H, d, J=7.5 Hz), 7.10-7.18 (4H, m), 7.35-7.47 (8H, m), 7.89 (2H, d, J=7.2 Hz), 8.41 (1H, s).']},\n",
       " {'number': 'Example 151',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 150, compound 151 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 2.02 (3H, s), 2.69 (1H, br t, J=10.8 Hz), 3.40-3.49 (1H, m), 3.06-3.74 (1H, m), 4.12-4.22 (1H, m), 4.20 (1H, d, J=12.9 Hz), 5.08 (1H, s), 5.47 (1H, d, J=7.8 Hz), 5.50 (1H, d, J=12.9 Hz), 6.67 (1H, d, J=7.8 Hz), 7.12-7.21 (5H, m), 7.28-7.46 (5H, m), 8.31 (1H, brs).']},\n",
       " {'number': 'Example 152',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 150A (50 mg, 0.801 mmol) was dissolved in a 4N hydrochloric acid dioxane solution (5 ml), and the mixture was stirred at room temperature for 2 hours. The reaction solution was neutralized with saturated sodium bicarbonate water, and was extracted with dichloromethane three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and 50 mg of the resulting oil was dissolved in methanol (2 ml). To the methanol solution was added 10% Pd—C (10 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 10 mg (yield 25%) of compound 152.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.74-2.78 (2H, m), 3.00-3.07 (1H, m), 3.78-3.85 (1H, m), 4.34 (1H, d, J=13.5 Hz), 5.13 (1H, d, J=13.5 Hz), 5.48-5.54 (1H, m), 5.10 (1H, s), 7.20-7.47 (9H, m), 7.63-7.71 (2H, m).']},\n",
       " {'number': 'Example 153',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a THF (3 ml) solution of compound 150A (30 mg, 0.052 mmol) was added 10% Pd—C (10 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 20 mg (yield 79%) of compound 153.',\n",
       "   '1H-NMR (CDCl3) δ: 1.34 (9H, s), 2.84-2.91 (1H, m), 3.18-3.25 (2H, m), 4.03-4.11 (1H, m), 4.35 (1H, d, J=13.2 Hz), 5.20 (1H, s), 5.24 (1H, d, J=13.2 Hz), 5.49 (1H, brs), 5.70 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.8 Hz), 7.16-7.20 (5H, m), 7.32-7.46 (3H, m), 7.53 (2H, d, J=7.2 Hz).']},\n",
       " {'number': 'Example 154',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (10 ml) solution of compound 154A (539 mg, 1.01 mmol) synthesized according to the synthesis method of Example 65 were added triethylamine (615.7 mg, 6.08 mmol) and ethyl chlorocarbonate (328.8 mg, 3.03 mmol) under ice-cooling, and the mixture was stirred at room temperature for 10 minutes. To the reaction solution were added O,N-dimethylhydroxylamine hydrochloride (295.0 mg, 3.03 mmol) and DMAP (12.3 mg, 0.101 mmol), the mixture was stirred at the same temperature for 2 hours, water was added, and was extracted with ethyl acetate three times. After the extract was washed with water three times, and dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (7:3, v/v) and, then, with only ethyl acetate. Concentration of an objective fraction afforded 445.4 mg (yield 76%) of compound 154B as an oil.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.09 (3H, s), 3.52 (3H, s), 3.94 (2H, s), 4.40 (1H, brs), 4.64 (2H, s), 4.96 (1H, brs), 5.15 (2H, s), 7.06-7.15 (4H, m), 7.21 (2H, t, J=8.7 Hz), 7.28-7.38 (3H, m), 7.43 (2H, dd, J=5.7 Hz, 8.4 Hz), 7.52-7.54 (2H, m), 7.66 (1H, s).',\n",
       "   'A THF (5 ml) solution of compound 154B (250 mg, 0.435 mmol) was cooled to −78° C., a methylmagnesium bromide 0.97M THF solution (0.673 ml, 0.653 mmol) was added, and temperature was raised to −20° C. over 2 hours. To the reaction solution was added 1N hydrochloric acid, and the mixture was extracted with ethyl acetate three times. After the extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with only chloroform and, then, with chloroform-methanol (7:3, v/v). Concentration of an objective fraction afforded 117.0 mg (yield 51%) of compound 154C as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 2.68 (3H, s), 3.80 (2H, brs), 4.29 (2H, brs), 4.71 (2H, brs), 5.45 (2H, brs), 6.83 (2H, m), 6.92-6.98 (2H, m), 7.03-7.10 (2H, m), 7.28-7.39 (5H, m), 7.90 (1H, s).',\n",
       "   'To a dichloromethane (2 ml) solution of compound 154C (117 mg, 0.221 mmol) was added mCPBA (52.7 mg, 0.332 mmol) under ice-cooling, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added an aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate three times. After the extract was washed with saturated sodium bicarbonate water two times, and dried with sodium sulfate, the solvent was distilled off, the resulting oil was dissolved in ethanol (2 ml), and the solution was refluxed for 1 hour. After the solvent was distilled off, the precipitated solid was washed with diisopropyl ether to obtain 54 mg (yield 49%) of compound 154D.',\n",
       "   '1H-NMR (CDCl3) δ: 3.74 (1H, brs), 3.85 (1H, brs), 4.20 (2H, brs), 4.61 (1H, brs), 4.93 (1H, brs), 5, 41 (2H, brs), 6.79-6.86 (2H, m), 6.91-6.96 (2H, m), 7.02-7.09 (2H, m), 7.15-7.16 (1H, m), 7.26-7.34 (5H, m), 7.56-7.65 (2H, m).',\n",
       "   'To a THF (3 ml) solution of compound 154D (54 mg, 0.107 mmol) was added 10% Pd—C (20 mg), and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. To the resulting residue was added diisopropyl ether, and the precipitated solid was filtered to obtain 21 mg (yield 47%) of compound 154.',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.90 (2H, brs), 3.95 (2H, s), 4, 66 (2H, brs), 7.07-7.12 (4H, m), 7.22 (2H, t, J=8.7 Hz), 7.29 (1H, s), 7.43-7.47 (2H, m).']},\n",
       " {'number': 'Example 155',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a toluene (150 ml) solution of compound 155A (WO 2006/066414, 15.0 g, 38.4 mmol) were sequentially added N,N-diisopropylethylamine (16.1 mL, 92.0 mmol), 1-methylimidazole (3.70 mL, 46.4 mmol) and 2-methoxyethylamine (4.05 mL, 46.4 mmol) under ice-cooling and, thereafter, diphenyl chlorophosphate (9.60 mL, 46.1 mmol) was further added dropwise over 10 minutes. After the reaction solution was stirred for 20 minutes under ice-cooling, acetonitrile (50 mL) was added, and the mixture was further stirred for 2 hours. To the reaction solution was added an aqueous acetic acid solution (10%, 100 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate. The extract was sequentially washed with water (100 mL), saturated sodium bicarbonate water (150 mL) and an aqueous saturated sodium chloride solution (100 ml) and, thereafter, dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=25%→50%) to obtain compound 155B (7.86 g, 46%) as a colorless oil.',\n",
       "   '1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.93 (9H, s), 3.29 (3H, s), 3.39 (2H, m), 3.47 (2H, m), 4.56 (2H, d, J=1.2 Hz), 5.41 (2H, s), 6.60 (1H, s), 7.35-7.42 (5H, m), 8.11 (1H, brt).',\n",
       "   'To an ethanol (80 mL) solution of compound 155B (7.70 g, 17.2 mmol) was added aqueous ammonia (40 mL) at room temperature, and the mixture was stirred for 18 hours. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=75%→100%) to obtain compound 155C (7.15 g, 93%) as a colorless oil.',\n",
       "   '1H-NMR (CDCl3) δ: 0.14 (6H, s), 0.97 (9H, s), 3.28 (3H, s), 3.38 (2H, m), 3.49 (2H, m), 4.64 (2H, s), 5.53 (2H, s), 6.31 (1H, s), 7.34-7.49 (5H, m), 8.61 (1H, brs), 9.94 (1H, brs).',\n",
       "   'To a DMF (125 mL) solution of compound 155C (7.15 g, 16.0 mmol) and potassium carbonate (6.64 g, 48.0 mmol) was added O-(2,4-dinitrophenyl)hydroxylamine (7.97 g, 40.0 mmol) at room temperature, and the mixture was stirred for 2 days. To the reaction solution was added water (250 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate (300 mL×2). After the extract was sequentially washed with water (300 mL), saturated sodium bicarbonate water (300 mL×2) and an aqueous saturated sodium chloride solution (150 mL), the mixture was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=0%→10%) to obtain compound 155D (6.47 g, 88%) as a pale yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 0.11 (6H, s), 0.94 (9H, s), 3.26 (3H, s), 3.35 (4H, m), 4.66 (2H, s), 5.16 (2H, s), 5.24 (2H, s), 6.43 (1H, s), 7.31-7.40 (5H, m), 7.59 (1H, brs).',\n",
       "   'To a toluene (100 mL) solution of compound 155D (6.47 g, 14.0 mmol) and acetic acid (0.080 mL, 1.4 mmol) was added paraformaldehyde (0.422 g, 14.1 mmol) at room temperature, and the mixture was stirred at 80° C. for 2 hours. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 155E was utilized in a next step without purification.',\n",
       "   'To a DMF (100 mL) solution of the crude product of compound 155E obtained in the fourth step was added cesium carbonate (22.7 g, 69.8 mmol) under ice-cooling, and the mixture was stirred for 1 hour. Under ice-cooling, bromodiphenylmethane (5.20 g, 21.0 mmol) was added, and the mixture was stirred at room temperature for 19 hours. To the reaction solution was added water (200 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate (200 mL×3). The extract was sequentially washed with water (200 mL×2) and an aqueous saturated sodium chloride solution (100 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 155F was utilized in a next step without purification.',\n",
       "   'MS: m/z=640 [M+H]+.',\n",
       "   'To a methanol (100 mL) solution of the crude product of compound 155F obtained in the fifth step was added hydrogen chloride (4N ethyl acetate solution, 40 mL) at room temperature, and the mixture was stirred for 2.5 hours. To the reaction solution was added an aqueous sodium hydroxide solution (2N, 75 mL) to perform neutralization (pH=6) under ice-cooling, and the mixture was extracted with chloroform (200 mL×3). The extract was dried with sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=5%→40%) to obtain compound 155G (5.18 g, 3 step 70%) as an orange oil.',\n",
       "   '1H-NMR (CDCl3) δ: 3.16 (3H, s), 3.18-3.43 (3H, m), 3.60-3.74 (2H, m), 4.06 (1H, d, J=13.5 Hz), 4.19 (1H, brs), 4.58 (1H, d, J=14.7 Hz), 5.00 (1H, d, J=13.5 Hz), 5.24 (1H, s), 5.27 (2H, s), 5.96 (1H, s), 6.78 (2H, m), 6.98-7.10 (3H, m), 7.30-7.42 (8H, m), 7.72 (2H, m).',\n",
       "   'To a THF (2 mL) solution of compound 155G (100 mg, 0.190 mmol), (bromomethyl)cyclopropane (0.110 mL, 1.12 mmol) and sodium iodide (5.0 mg, 0.033 mmol) was added potassium tert-butoxide (78.0 mg, 0.695 mmol) at room temperature, the mixture was stirred at room temperature for 22 hours and, thereafter, the mixture was stirred at 100° C. for 10 minutes under microwave irradiation. To the reaction solution were added water and hydrochloric acid (2N) (pH=1), the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 155H was utilized in a next step without purification.',\n",
       "   'MS: m/z=580 [M+H]+.',\n",
       "   'To a DMF (2 mL) solution of the crude product of compound 155H obtained in the seventh step was added lithium chloride (35.0 mg, 0.826 mmol) at room temperature, and the mixture was stirred at 150° C. for 15 minutes under microwave irradiation. The reaction solution was purified by preparative LCMS to obtain compound 155 (4.3 mg, 2 step 5%) as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 0.16 (2H, m), 0.52 (2H, m), 0.98 (1H, m), 3.08 (3H, m), 3.20 (3H, s), 3.46 (2H, m), 3.68 (1H, dd, J=0.6, 14.1 Hz), 3.90 (1H, m), 4.52 (1H, d, J=13.2 Hz), 4.58 (1H, d, J=14.1 Hz), 4.93 (1H, d, J=13.2 Hz), 5.38 (1H, s), 6.01 (1H, s), 6.98 (2H, m), 7.11-7.48 (8H, m).',\n",
       "   'MS: m/z=490 [M+H]+.']},\n",
       " {'number': 'Example 156',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 155, compound 156 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 0.88 (3H, t, J=7.4 Hz), 1.51 (2H, m), 3.15-3.23 (6H, m), 3.46 (2H, m), 3.69 (1H, dd, J=0.6, 14.1 Hz), 3.88 (1H, m), 4.54 (2H, d, J=14.1 Hz), 4.58 (1H, d, J=14.1 Hz), 4.93 (1H, d, J=13.5 Hz), 5.39 (1H, s), 6.12 (1H, s), 6.97 (2H, m), 7.12-7.47 (8H, m).',\n",
       "   'MS: m/z=478 [M+H]+.']},\n",
       " {'number': 'Example 157',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 155, compound 157 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 3.13-3.22 (1H, m), 3.18 (3H, s), 3.20 (3H, s), 3.41-3.51 (2H, m), 3.60 (1H, d, J=13.8 Hz), 3.89 (1H, ddd, J=3.3 Hz, 4.2 Hz, 14.4 Hz), 4.52 (1H, d, J=13.2 Hz), 4.53 (1H, d, J=13.8 Hz), 4.92 (1H, d, J=13.2 Hz), 5.38 (1H, s), 5.98 (1H, s), 6.98 (2H, d, J=8.4 Hz), 7.11-7.22 (3H, m), 7.36-7.48 (5H, m).']},\n",
       " {'number': 'Example 158',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a THF (100 mL) solution of compound 155G (960 mg, 1.83 mmol) was added manganese dioxide (2.06 g, 92.0 mmol) at room temperature, and the mixture was stirred for 2 days. After the reaction solution was filtered, the filtrate was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=60%→100%) to obtain compound 158A (554 mg, 58%) as a pale yellow foam.',\n",
       "   '1H-NMR (CDCl3) δ: 2.96 (1H, m), 3.18 (3H, s), 3.44 (2H, m), 4.18 (1H, m), 4.56 (1H, d, J′=13.8 Hz), 4.98 (1H, d, J=13.8 Hz), 5.28 (1H, s), 5.54 (1H, d, J=10.5 Hz), 5.64 (1H, d, J=10.5 Hz), 6.35 (1H, s), 6.85 (2H, m), 7.03 (2H, m), 7.18 (1H, m), 7.26-7.48 (8H, m), 7.64 (2H, m), 10.10 (1H, s).',\n",
       "   'To a methylene chloride (4 mL) solution of compound 158A (83.0 mg, 0.159 mmol), pyrrolidine (0.0400 mL, 0.484 mmol) and acetic acid (0.100 ml) was added sodium triacetoxyborohydride (136 mg, 0.642 mmol) at room temperature, and the mixture was stirred for 28 hours. To the reaction solution was added water, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 158B was utilized in a next step without purification.',\n",
       "   'MS: m/z=579 [M+H]+.',\n",
       "   'To a DMF (2 mL) solution of the crude product of compound 158B obtained in the second step was added lithium chloride (39.2 mg, 0.925 mmol) at room temperature, and the mixture was stirred at 150° C. for 15 minutes under microwave irradiation. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 158 (8.8 mg, 2 step 11%) as a yellow oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.84 (4H, m), 2.70-2.85 (5H, m), 3.19 (3H, s), 3.20-3.47 (3H, m), 3.80 (1H, m), 4.25 (1H, d, J=14.7 Hz), 4.57 (1H, d, J=13.5 Hz), 5.07 (1H, d, J=13.5 Hz), 5.39 (1H, s), 6.06 (1H, s), 6.97 (2H, m), 7.12-7.54 (8H, m), 8.29 (1H, s).',\n",
       "   'MS: m/z=489 [M+H]+.']},\n",
       " {'number': 'Example 159',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a methylene chloride (20 mL) solution of compound 155G (950 mg, 1.81 mmol) and N,N-diisopropylethylamine (0.380 mL, 2.18 mmol) was added dropwise methanesulfonyl chloride (0.148 mL, 1.90 mmol) under ice-cooling, and the mixture was stirred for 90 minutes. To the reaction solution was added water (20 mL), the mixture was extracted with chloroform (50 mL), and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product (1.06 g) of compound 159A was utilized in a next step without purification.',\n",
       "   'MS: m/z=604 [M+H]+.',\n",
       "   'To the crude product (161 mg) of compound 159A obtained in the first step was added dimethylamine (2M THF solution, 2.00 mL, 4.00 mmol) at room temperature, and the mixture was stirred for 3 days. To the reaction solution was added an aqueous saturated sodium chloride solution (2 mL), the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 159B was utilized in a next step without purification.',\n",
       "   'MS: m/z=553 [M+H]+.',\n",
       "   'To a DMF (2 mL) solution of the crude product of compound 159B obtained in the second step was added lithium chloride (56.0 mg, 1.32 mmol) at room temperature, and the mixture was stirred at 150° C. for 30 minutes under microwave irradiation. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 159 (33.6 mg, 3 step 27%) as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.37 (6H, s), 2.69 (1H, d, J=14.4 Hz), 3.19 (3H, s), 3.30-3.46 (3H, m), 3.76 (1H, m), 4.00 (1H, d, J=14.4 Hz), 4.60 (1H, d, J=13.5 Hz), 5.20 (1H, d, J=13.5 Hz), 5.40 (1H, s), 6.01 (1H, s), 6.97 (2H, m), 7.11-7.42 (8H, m).',\n",
       "   'MS: m/z=463 [M+H]+.']},\n",
       " {'number': 'Example 160',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a crude product (95.8 mg) of compound 159A was added methylamine (2M THF solution, 2.00 mL, 4.00 mmol) at room temperature, and the mixture was stirred for 3 days. The reaction solution was filtered, the solvent was distilled off under reduced pressure, and the resulting crude product of compound 160A was utilized in a next step without purification.',\n",
       "   'MS: m/z=539 [M+H]+.',\n",
       "   'To an acetonitrile (3 mL) suspension of the crude product of compound 160A and sodium iodide (100 mg, 0.667 mmol) was added chlorotrimethylsilane (0.0850 mL, 0.665 mmol) at room temperature, and the mixture was stirred for 5 hours. To the reaction solution was added water (1 mL), the solvent was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 160 (59.8 mg, 3 step 84%) as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.75 (3H, s), 3.08 (1H, d, J=13.5 Hz), 3.24 (3H, s), 3.30-3.40 (3H, m), 3.75 (1H, m), 4.32 (1H, d, J=13.8 Hz), 4.66 (1H, d, J=13.8 Hz), 5.33 (1H, s), 5.58 (1H, d, J=13.5 Hz), 6.40 (1H, s), 6.98 (2H, m), 7.12-7.25 (3H, m), 7.40-7.51 (2H, m), 7.60 (2H, m).',\n",
       "   'MS: m/z=449 [M+H]+.']},\n",
       " {'number': 'Example 161',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'After a DMF (2 mL) suspension of a crude product (156 mg) of compound 159A, imidazole (19.5 mg, 0.286 mmol) and potassium carbonate (37.7 mg, 0.273 mmol) was stirred at room temperature for 4 hours, sodium hydride (60%, 11.7 mg, 0.293 mmol) was added, and the mixture was stirred for 3 days. To the reaction solution was added an aqueous acetic acid solution (10%), the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 161A was utilized in a next step without purification.',\n",
       "   'MS: m/z=576 [M+H]+.',\n",
       "   'To the crude product of compound 161A was added trifluoroacetic acid (1 mL) at room temperature, and the mixture was stirred for 18 hours and, thereafter, the mixture was stirred at 60° C. for 3 hours. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 161 (19.8 mg, 3 step 16%) as a pale orange amorphous substance.',\n",
       "   '1H-NMR (CDCl3) δ: 3.17-3.25 (1H, m), 3.21 (3H, s), 3.38-3.47 (2H, m), 3.82 (1H, m), 4.40 (1H, d, J=16.5 Hz), 4.54 (1H, d, J=13.5 Hz), 5.02 (1H, d, J=13.5 Hz), 5.09 (1H, s), 5.32 (1H, d, J=16.5 Hz), 5.40 (1H, s), 6.65 (1H, brs), 7.03 (2H, m), 7.15-7.49 (8H, m), 8.08 (1H, brs).',\n",
       "   'MS: m/z=486 [M+H]+.']},\n",
       " {'number': 'Example 162',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (2 mL) solution of a crude product (192 mg) of compound 159A was added sodium azide (24.2 mg, 0.372 mmol) at room temperature, and the mixture was stirred at 60° C. for 2 hours. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 162A was utilized in a next step without purification.',\n",
       "   'MS: m/z=551 [M+H]+.',\n",
       "   'To a THF (4 mL) solution of the crude product of compound 162A were sequentially added water (0.200 mL) and triphenylphosphine (83.0 mg, 0.316 mmol) at room temperature, and the mixture was stirred at 60° C. for 1 hour. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 162B (110 mg, 3 step 66%) as a colorless oil.',\n",
       "   'MS: m/z=525 [M+H]+.',\n",
       "   'To an acetonitrile (1 mL) suspension of compound 162B (50.0 mg, 0.0950 mmol) and sodium iodide (56.2 mg, 0.375 mmol) was added chlorotrimethylsilane (0.0490 mL, 0.381 mmol) at room temperature, and the mixture was stirred for 6 hours. To the reaction solution was added water (0.5 mL), the solvent was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 162 (25.9 mg, 63%) as a pale orange solid.',\n",
       "   '1H-NMR (CDCl3) δ: 3.12 (1H, d, J=14.7 Hz), 3.27 (3H, s), 3.35-3.48 (3H, m), 3.81 (1H, m), 4.65 (1H, d, J=13.5 Hz), 5.31 (1H, s), 5.59 (1H, d, J=13.5 Hz), 6.40 (1H, s), 6.98 (2H, m), 7.19 (3H, m), 7.40 (1H, m), 7.50 (2H, m), 7.62 (2H, m), 8.11 (1H, s).',\n",
       "   'MS: m/z=435 [M+H]+.']},\n",
       " {'number': 'Example 163',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an acetonitrile (3 mL) solution of compound 162B (50.0 mg, 0.0950 mmol) and N,N-diisopropylethylamine (0.0366 mL, 0.210 mmol) was added acetic anhydride (0.0100 mL, 0.106 mmol) at room temperature, and the mixture was stirred for 6 hours. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 163A was utilized in a next step without purification.',\n",
       "   'MS: m/z=567 [M+H]+.',\n",
       "   'To an acetonitrile (5 mL) suspension of the crude product of compound 163A and sodium iodide (59.2 mg, 0.395 mmol) was added chlorotrimethylsilane (0.0487 mL, 0.381 mmol) at room temperature, and the mixture was stirred for 16 hours. To the reaction solution was added water (0.5 mL), the solvent was distilled off under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 163 (28.1 mg, 2 step 62%) as a pale orange foam.',\n",
       "   '1H-NMR (CDCl3) δ: 2.07 (3H, s), 3.24 (3H, s), 3.27-3.52 (4H, m), 3.67 (1H, m), 4.54 (1H, d, J=13.5 Hz), 4.78 (1H, dd, J=6.5, 14.9 Hz), 5.17 (1H, d, J=13.5 Hz), 5.28 (1H, s), 5.61 (1H, s), 7.01 (2H, m), 7.01-7.58 (9H, m).',\n",
       "   'MS: m/z=477 [M+H]+.']},\n",
       " {'number': 'Example 164',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 155G (43.3 mg, 0.221 mmol) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 22 mg (yield 61%) of compound 164.',\n",
       "   '1H-NMR (CDCl3) δ: 1.13 (6H, d, J=6.0 Hz), 3.18-3.77 (7H, m), 3.26 (3H, s), 4.49 (1H, d, J=12.3 Hz), 4.76 (1H, d, J=12.3 Hz), 5.27 (2H, brs), 5.89 (1H, s), 6.90 (2H, d, J=7.2 Hz), 6.98-7.14 (3H, m), 7.315-7.50 (5H, m).']},\n",
       " {'number': 'Example 165',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (370 mL) solution of compound 165A (WO 2006/088173, 37.0 g, 108 mmol) were sequentially added potassium carbonate (17.9 mg, 129 mmol) and methyl iodide (8.03 mL, 129 mmol) at room temperature, and the mixture was stirred for 1.5 hours. The reaction solution was added to a solution of ammonium chloride (20.8 g, 390 mmol) in water (1110 mL) under ice-cooling, and the precipitated solid was filtered, and washed with water to obtain a crude product (33 g). In addition, the aqueous layer was salted out with sodium chloride, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and a crude product (9 g) was obtained from the resulting residue. The crude products were combined and purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%) to obtain compound 165B (36.5 g, 95%) as a white solid.',\n",
       "   'To a 1,4-dioxane (548 mL) solution of compound 165B (36.5 g, 102 mmol) were sequentially added potassium osmate dihydrate (1.13 g, 3.06 mmol), sodium periodate (87.3 g, 408 mmol) and water (365 mmol) at room temperature, and the mixture was stirred for 6 hours. The reaction solution was extracted with methylene chloride, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%) to obtain compound 165C (33.0 g, 90%) as a bronzed foam.',\n",
       "   'To a toluene (25 mL) suspension of compound 165C (1.38 g, 3.66 mmol) were sequentially added ethylenediamine (0.247 mL, 3.66 mmol) and acetic acid (0.0210 mL, 0.366 mmol) at room temperature and, thereafter, the mixture was stirred for 1 hour, and further stirred at 50° C. for 17 hours. The precipitated solid was filtered, and washed with ether to obtain compound 165D (1.11 g, 100%) as a pale yellow solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 3.05 (2H, m), 3.26 (1H, m), 3.63 (2H, m), 3.75 (3H, s), 3.87 (1H, m), 4.52 (1H, dd, J=3.3, 12.6 Hz), 4.69 (1H, m), 4.99 (1H, d, J=10.4 Hz), 5.15 (1H, d, J=10.4 Hz), 7.35 (3H, m), 7.54 (2H, m), 8.41 (1H, s).',\n",
       "   'To an acetonitrile (30 mL) suspension of compound 165D (2.77 g, 7.50 mmol), potassium carbonate. (2.23 g, 16.1 mmol) and sodium iodide (102 mg, 0.680 mmol) was added bromodiphenylmethane (2.26 g, 9.14 mmol) at room temperature, and the mixture was stirred at 90° C. for 7 hours. The reaction solution was poured into hydrochloric acid (2N, 10 mL) and an ice (20 g), the mixture was extracted with chloroform (100 mL×2), and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (chloroform/methanol=0%→5%) to obtain compound 165E (2.72 g, 68%) as a pale yellow solid.',\n",
       "   'To an ethanol (30 mL) solution of compound 165E (2.72 g, 5.08 mmol) was added an aqueous sodium hydroxide solution (2N, 10 mL) at room temperature, and the mixture was stirred for 3 days. To the reaction solution was added hydrochloric acid (1N, 20 mL) (pH=1) at room temperature, the mixture was extracted with chloroform (100 mL×2), and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (chloroform/methanol=0%→10%) to obtain compound 165F (1.77 g, 67%) as a pale yellow solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.63 (1H, m), 3.16 (1H, m), 3.49 (1H, m), 3.73 (1H, m), 4.12 (2H, m), 4.56 (1H, m), 5.04 (1H, s), 5.09 (1H, d, J=10.7 Hz), 5.19 (1H, d, J=10.7 Hz), 7.28-7.53 (15H, m), 8.32 (1H, s), 8.39 (1H, s).',\n",
       "   'A N,N′-dimethylimidazolidinone (20 mL) solution of compound 165F (1.77 g, 3.39 mmol) and lithium chloride (0.515 g, 12.2 mmol) was stirred at 90° C. for 1 hour. To the reaction solution were sequentially added water (10 mL), hydrochloric acid (2N, 10 mL) and water (10 mL) at room temperature. The precipitated solid was filtered, and washed with ether, DMF-water were added, and the precipitated solid was filtered to obtain compound 165 (599 mg, 41%) as a white solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.60 (1H, m), 3.20 (1H, m), 3.64 (2H, m), 4.00 (2H, m), 4.55 (1H, m), 5.01 (1H, s), 7.28-7.47 (10H, m), 8.16 (1H, s), 11.97 (1H, brs).',\n",
       "   'MS: m/z=432 [M+H]+.']},\n",
       " {'number': 'Example 166',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 165, following compound 166 was synthesized by the same procedure.',\n",
       "   '1HNMR (DMSO-d6) δ: 1.54 (1H, d, J=12.6H), 1.66-1.78 (1H, m), 2.60 (1H, t, J=9.9 Hz), 2.83 (1H, d, J=11.7 Hz), 3.01 (1H, t, J=11.7 Hz), 3.34-3.38 (1H, m), 3.94 (1H, d, J=13.8 Hz), 4.44-4.59 (3H, m), 4.82 (1H, d, J=14.7 Hz), 7.06 (2H, t, J=8.7 Hz), 7.18-7.23 (2H, m), 8.27 (1H, s), 12.84 (1H, brs).']},\n",
       " {'number': 'Example 167',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a xylene (30 ml) solution of compound 167A (WO 2006/11674, 3.58 g, 7.61 mmol) were added (S)—N1-benzyl-3-phenylpropane-1,2-diamine (Journal of the American Chemical Society; English; 127; 30; 2005; 10504, 1.83 g, 7.61 mmol) and acetic acid (0.5 ml), and the mixture was refluxed for 2 hours. After cooling to room temperature, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (9:1, v/v) and, then, with n-hexane-ethyl acetate (1:1, v/v). Concentration of an objective fraction afforded 349 mg (yield 7%) of compound 167B as an oil.',\n",
       "   '1HNMR (CDCl3) δ: 2.54 (1H, t, J=9.6 Hz), 2.77 (1H, dd, J=9.0 Hz, 13.2 Hz), 3.31 (1H, dd, J=6.9 Hz, 9.6 Hz), 3.43-3.78 (5H, m), 4.04-4.15 (1H, m), 4.42-4.48 (1H, m), 4.62 (2H, d, J=6.0 Hz), 5.29 (1H, d, J=10.5 Hz), 5.43 (1H, d, J=10.5 Hz), 6.77-6.85 (2H, m), 7.19-7.39 (14H, m), 7.60 (2H, d, J=6.3 Hz), 8.05 (1H, s).',\n",
       "   'To a MeCN (10 ml) solution of compound 167B (968 mg, 1.47 mmol) were added Boc2O (3 ml) and DMAP (180 mg, 1.47 mmol), and the mixture was heated to reflux for 5 hours. To the reaction solution was added a 2N aqueous sodium hydroxide solution to stop the reaction, the reaction solution was neutralized using 2N hydrochloric acid and, thereafter, the mixture was extracted with ethyl acetate three times. After the extract was washed with an aqueous saturated sodium chloride solution, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with n-hexane-ethyl acetate (6:4, v/v) and, then, only with ethyl acetate. Concentration of an objective fraction afforded 349 mg (yield 45%) of compound 167C.',\n",
       "   '1HNMR (CDCl3) δ: 2.54 (1H, t=9.0 Hz), 2.76 (1H, dd, J=9.3 Hz, 16.5 Hz), 3.31 (1H, dd, J=6.9 Hz, 9.6 Hz), 3.45 (1H, dd, J=3.3 Hz, 12.6 Hz), 3.51-3.78 (4H, m), 4.04-4.13 (1H, m), 4.42-4.52 (1H, m), 4.61 (2H, d, J=6.0 Hz), 2.79 (1H, d, J=10.2 Hz), 5.29 (1H, d, J=10.2 Hz), 5.43 (1H, d, J=10.2 Hz), 6.76-7.39 (11H, m), 7.60 (2H, d, J=6.6 Hz), 8.05 (1H, s), 10.42 (1H, t, J=5.7 Hz).',\n",
       "   'Compound 167C (150 mg, 0.280 mmol) was dissolved in trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, the residue was dissolved in dichloromethane (2 ml), and the solution was neutralized with saturated sodium bicarbonate water. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane once, and the combined organic layers were washed with water, and dried with sodium sulfate. After the solvent was distilled off, the resulting solid was washed with diisopropyl ether to obtain 71 mg (yield 57%) of compound 167.',\n",
       "   '1HNMR (CDCl3) δ: 2.65 (1H, dd, J=8.4 Hz, 9.6 Hz), 2.97 (1H, dd, J=9 Hz, 13.5 Hz), 3.43 (1J, dd, J=7.2 Hz, 9.6 Hz), 3.55 (1H, dd, J=3.0 Hz, 13.2 Hz), 3.61-3.80 (4H, m), 4.15 (1H, dd, J=4.2 Hz, 9.9 Hz), 4.51-4.60 (1H, m), 7.15-7.18 (2H, m), 7.28-7.38 (8H, m), 8.02 (1H, s), 12.04 (1H, s).']},\n",
       " {'number': 'Example 168',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (3 mL) solution of compound 168A (WO 2006/116764, 400 mg, 0.840 mmol) were added cesium carbonate (821 mg, 2.52 mmol) and, subsequently, bromomethylenedibenzene (311 mg, 1.26 mmol), and the mixture was stirred at 100° C. for 5 hours. To the reaction solution were added 2N hydrochloric acid, water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate once. The combined extracts were washed with an aqueous saturated sodium bicarbonate solution and brine, dried with magnesium sulfate, filtered and concentrated. The resulting residue was purified by silica gel column chromatography. Concentration of an objective fraction afforded 100 mg of compound 168B as a yellow oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.79-1.84 (2H, m), 2.67-2.77 (1H, m), 2.84-3.05 (2H, m), 4.03 (1H, dd, J=13.0, 4.2 Hz), 4.28 (1H, dd, J=13.6, 6.5 Hz), 4.49 (1H, dd, J=6.4, 3.8 Hz), 4.57 (2H, d, J=5.7 Hz), 4.78 (1H, dd, J=13.4, 5.7 Hz), 4.93 (1H, s), 5.27 (2H, s), 7.00 (2H, t, J=8.8 Hz), 7.15-7.37 (14H, m), 7.57-7.63 (2H, m), 7.76 (1H, s), 10.44 (1H, t, J=5.9 Hz).',\n",
       "   'MS: m/z=643.20 [M+H]+.',\n",
       "   'Compound 168B (100 mg, 0.156 mmol) was dissolved in acetonitrile (3 mL), Boc2O (4.0 mL, 17.3 mmol) and, subsequently, DMAP (84 mg, 0.69 mmol) were added, and the mixture was stirred at 80° C. for 6 hours. The reaction solution was allowed to cool, a 2N aqueous sodium hydroxide solution (8 mL) and, subsequently, ethanol (3 mL) were added, and the mixture was stirred at 60° C. for 2 hours. To the reaction solution were added 2N hydrochloric acid and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The solvent was distilled off, and the resulting residue was purified by silica gel chromatography. Elution with ethyl acetate-methanol, and concentration of an objective fraction afforded 84 mg of compound 168C.',\n",
       "   'MS: m/z=536.25 [M+H]+.',\n",
       "   'To a DMI (2 mL) solution of compound 168C (80 mg, 0.15 mmol) was added lithium chloride (19 mg, 0.45 mmol), and the mixture was stirred at 90° C. for 2 hours. To the reaction mixture were added water and 2N hydrochloric acid, the precipitated solid was filtered, and the resulting solid was purified using a LCMS fractionating device. The eluted solvent was distilled off, to the residue was added isopropyl ether, and the precipitated solid was filtered. Washing with isopropyl ether and drying afforded 12 mg of compound 168.',\n",
       "   'MS: m/z=446.05 [M+H]+.']},\n",
       " {'number': 'Example 169',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an ethanol (5 mL) solution of compound 95A (WO 2006/116764, 500 mg, 2.03 mmol) was added 2,2-dimethoxyethanamine (0.49 ml, 4.47 mmol), and the mixture was stirred at 80° C. for 3 hours. After the reaction solution was allowed to cool, acetic acid (0.27 ml, 4.69 mmol) was added at room temperature, and the mixture was concentrated under reduced pressure. The resulting residue was dissolved in DMF (5 mL), DBU (0.66 mL, 4.4 mmol) and, subsequently, methyl iodide (1.02 mL, 16.2 mmol) were added under nitrogen atmosphere, and the mixture was stirred at room temperature for 3 hours. To the reaction solution were added an aqueous saturated sodium bicarbonate solution and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered and concentrated, and the resulting residue was purified by silica gel chromatography. Elution with chloroform-methanol (9:1) and concentration of an objective fraction afforded 258 mg of compound 169A as a brown oil.',\n",
       "   '1H-NMR (CDCl3) δ: 3.37 (6H, s), 3.80 (3H, s), 3.87 (2H, d, J=4.8 Hz), 4.46 (1H, t, J=4.8 Hz), 5.30 (2H, s), 6.75 (1H, d, J=6.0 Hz), 7.30-7.41 (6H, m).',\n",
       "   'To compound 169A (1.00 g, 2.88 mmol) were added formic acid (31 mL) and, subsequently, water (5 mL), and the mixture was stirred at 70° C. for 6.5 hours. To the reaction mixture were added water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. After the combined extracts were washed with an aqueous saturated sodium bicarbonate solution, and sodium sulfate was added, then the mixture was filtered and concentrated, and the resulting residue was purified by silica gel chromatography. Elution with ethyl acetate-methanol, and concentration of an objective fraction afforded a mixture of aldehyde hydride and methylacetal as a colorless transparent oil. The resulting oil was dissolved in dichloromethane (5 mL), 1,3-diaminopropane dihydrochloride (354 mg, 2.41 mmol) and, subsequently, acetic acid (0.069 ml, 1.2 mmol) were added, and the mixture was stirred at room temperature for 6 hours. The reaction solution was diluted with dichloromethane, insolubles were filtered and, thereafter, the mixture was concentrated under reduced pressure to obtain a crude purified product of compound 169B.',\n",
       "   'MS: m/z=326.20 [M+H]+.',\n",
       "   'To an acetonitrile (4 mL) solution of compound 168B (391 mg, 1.20 mmol) were added potassium carbonate (498 mg, 3.61 mmol) and, subsequently, bromomethylenedibenzene (890 mg, 3.61 mmol). After the reaction solution was stirred at 90° C. for 2 hours, to the reaction solution were added water, ethyl acetate and brine, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate once. After the combined extracts were dried with magnesium sulfate, then the mixture was filtered and concentrated. The resulting residue was purified by silica gel column chromatography. Elution with ethyl acetate-methanol, and concentration of an objective fraction afforded 106 mg of compound 169C as an orange solid.',\n",
       "   'MS: m/z=492.15 [M+H]+.',\n",
       "   'To a DMI (2 mL) solution of compound 169C (105 mg, 0.214 mmol) was added lithium chloride (27.2 mg, 0.641 mmol), and the mixture was stirred at 90° C. for 3 hours. Further, lithium chloride (27.2 mg, 0.641 mmol) was added, and the mixture was stirred at 90° C. for 1 hour. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified using a LCMS fractionating device. The eluted solvent was distilled off, to the residue was added diethyl ether, and the precipitated solid was filtered. Washing with diethyl ether, and drying afforded 27 mg of compound 169.',\n",
       "   '1H-NMR (CD3OD) δ: 1.63 (1H, dd, J=13.4, 2.8 Hz), 1.84 (1H, br s), 2.55-2.64 (1H, m), 2.90-3.10 (2H, m), 4.30 (1H, dd, J=14.5, 4.0 Hz), 4.52 (4H, dd, J=14.5, 3.8 Hz), 4.63-4.75 (4H, m), 5.16 (1H, s), 6.16 (1H, d, J=7.2 Hz), 6.78 (1H, d, J=7.2 Hz), 7.16-7.32 (10H, m).',\n",
       "   'MS: m/z=402.10 [M+H]+.']},\n",
       " {'number': 'Example 170',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 49F (87 mg, 0.19 mmol) was dissolved in ethanol (1 ml) and THF (1 ml), a 2N aqueous sodium hydroxide solution (0.47 ml, 0.95 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. To the reaction solution was added 2N hydrochloric acid, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol 95:5→90:10, v/v) to obtain 60 mg of compound 170A.',\n",
       "   '1H-NMR (CDCl3) δ: 2.48 (1H, dd, J=13.8, 11.8 Hz), 3.27 (1H, dd, J=14.2, 3.4 Hz), 3.73-3.80 (1H, m), 3.92 (1H, m), 4.16 (1H, m), 4.45 (2H, m), 5.34 (1H, d, J=3.5 Hz), 5.47 (1H, d, J=10.4 Hz), 5.52 (1H, d, J=10.7 Hz), 6.73 (2H, d, J=6.9 Hz), 7.18-7.42 (7H, m), 7.60 (2H, d, J=6.9 Hz), 14.63 (1H, s).',\n",
       "   'To compound 170A (57 mg, 0.13 mmol) was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-ethyl ether were added, and the precipitated solid was filtered to obtain 19 mg of compound 170 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.74 (1H, t, J=12.1 Hz), 3.10-3.22 (1H, m), 3.76 (2H, m), 4.12 (1H, q, J=8.0 Hz), 4.44 (1H, m), 5.35 (1H, m), 5.49 (1H, d, J=3.4 Hz), 7.05 (5H, m), 7.77 (1H, s), 12.05 (1H, brs).']},\n",
       " {'number': 'Example 171',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 49B (950 mg, 3.35 mmol), 3-aminopropan-1-ol (277 mg, 3.69 mmol) and sodium sulfate (1.91 g, 13.4 mmol) were added to toluene (25 ml), and the mixture was stirred at room temperature for 1 hour. Boc2O (0.856 ml, 3.69 mmol) was added at room temperature, and the mixture was stirred for 18 hours. Further, Boc2O (0.400 ml, 1.72 mmol) was added at room temperature, and the mixture was stirred for 60 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 1.02 g of compound 171A as a colorless gummy substance.',\n",
       "   'Compound 171A (1.01 g, 2.29 mmol) and palladium-active carbon (10%, wet, 200 mg) were added to ethanol (20 ml), and the mixture was stirred at room temperature for 1.5 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 755 mg of a colorless oily substance 171B.',\n",
       "   '1H-NMR (CDCl3) δ: 1.42 (5H, s), 1.49 (4H, s), 1.56-1.92 (2H, m), 2.49 (0.4H, dd, J=13.6, 9.8 Hz), 2.62 (0.6H, dd, J=13.6, 8.5 Hz), 2.81 (0.4H, dd, J=13.5, 3.6 Hz), 3.16 (1.6H, m), 3.60-4.14 (4H, m), 5.13 (0.6H, d, J=8.8 Hz), 5.19 (0.4H, d, J=8.5 Hz), 7.22-7.37 (5H, m).',\n",
       "   'Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (660 mg, 1.99 mmol) and compound 171B (609 mg, 1.99 mmol) were added to toluene (8 ml), and the mixture was stirred at 100° C. for 1.5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 99:1, v/v) to obtain 1.02 g of compound 171C as a pale yellow gummy substance.',\n",
       "   'To compound 171C (991 mg, 1.60 mmol) was added 4N HCl (ethyl acetate solution, 12 ml). After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Subsequently, toluene (12 ml) and 3-aminopropan-1-ol (0.244 ml, 3.19 mmol) were added, the mixture was stirred at 80° C. for 10 minutes. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 99:1→95:5→90:10, v/v) to obtain 341 mg of compound 171D as a yellow gummy substance and 338 mg of compound 171E as a colorless solid.',\n",
       "   '171D: 1H-NMR (CDCl3) δ: 1.29 (3H, t, J=7.1 Hz), 1.51 (1H, d, J=13.7 Hz), 1.97 (1H, m), 2.91 (1H, dd, J=13.8, 9.8 Hz), 2.99-3.10 (2H, m), 3.90 (1H, td, J=12.1, 2.5 Hz), 4.12 (2H, m), 4.25 (2H, m), 4.83 (2H, m), 5.33 (1H, d, J=10.1 Hz), 5.51 (1H, d, J=10.1 Hz), 6.88 (2H, m), 7.23-7.40 (7H, m), 7.68 (2H, m)',\n",
       "   '171E: 1H-NMR (CDCl3) δ: 1.19 (3H, t, J=7.2 Hz), 1.82-1.99 (2H, m), 2.73 (1H, dd, J=14.0, 11.3 Hz), 3.13 (1H, m), 3.35 (1H, dd, J=14.0, 3.4 Hz), 3.63 (1H, m), 3.90-4.26 (4H, m), 4.43 (1H, d, J=13.6 Hz), 5.27 (1H, t, J=3.5 Hz), 5.31 (2H, s), 6.78 (2H, dd, J=6.3, 3.2 Hz), 7.01 (1H, d, J=7.0 Hz), 7.18 (3H, t, J=3.1 Hz), 7.28-7.39 (3H, m), 7.67 (2H, m).',\n",
       "   'Compound 171D (329 mg, 0.673 mmol) was dissolved in ethanol (2 ml) and THF (4 ml), a 2N aqueous sodium hydroxide solution (1.69 ml, 3.38 mmol) was added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added 2N hydrochloric acid, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 215 mg of compound 171F as a colorless solid.',\n",
       "   'MS: m/z=461 [M+H]+.',\n",
       "   'To compound 171F (50 mg, 0.11 mmol) was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 24 mg of compound 171 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.63 (1H, d, J=12.6 Hz), 1.83 (1H, m), 2.96-3.29 (3H, m), 4.05 (2H, m), 4.55 (1H, dd, J=13.2, 4.4 Hz), 5.08 (1H, dd, J=9.2, 5.4 Hz), 5.30 (1H, s), 7.19 (5H, m), 8.09 (1H, s), 12.84 (1H, brs).',\n",
       "   'MS: m/z=371 [M+H]+.']},\n",
       " {'number': 'Example 172',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 171, using compound 171E, compound 172 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.91 (2H, m), 2.94 (1H, dd, J=14.0, 10.8 Hz), 3.11-3.21 (3H, m), 3.71 (1H, m), 4.19 (1H, m), 4.29-4.35 (1H, m), 5.08-5.14 (1H, m), 5.47 (1H, d, J=4.0 Hz), 6.92-7.22 (5H, m), 7.71 (1H, s), 12.80 (1H, brs), 15.06 (1H, brs).',\n",
       "   'MS: m/z=371 [M+H]+.']},\n",
       " {'number': 'Example 173',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 171F (159 mg, 0.345 mmol) was added to diphenyl ether (2.5 ml), and the mixture was stirred at 245° C. for 1 hour under microwave irradiation. The reaction solution was poured into n-hexane, and the precipitated solid was filtered. The resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 95:5→90:10, v/v) to obtain compound 173A.',\n",
       "   'To compound 173A obtained in the first step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 10 mg of compound 173 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.55-1.86 (2H, m), 2.84-3.26 (3H, m), 3.92-4.09 (2H, m), 4.55 (2H, m), 5.15 (1H, s), 5.89 (1H, d, J=7.5 Hz), 7.17 (6H, m), 12.11 (1H, brs)',\n",
       "   'MS: m/z=327 [M+H]+.']},\n",
       " {'number': 'Example 174',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 173, compound 174 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.86 (2H, m), 2.87 (1H, t, J=12.3 Hz), 3.18 (2H, m), 3.68 (1H, t, J=10.4 Hz), 4.16 (1H, d, J=10.1 Hz), 4.29 (1H, d, J=12.4 Hz), 4.71 (1H, d, J=9.2 Hz), 5.37 (1H, d, J=3.5 Hz), 5.75 (1H, d, J=7.5 Hz), 7.00 (6H, m), 12.51 (1H, brs).',\n",
       "   'MS: m/z=327 [M+H]+.']},\n",
       " {'number': 'Example 175',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To Dess-Martin Periodinane (0.3M, methylene chloride solution, 25.0 ml, 7.50 mmol) was added dropwise a methylene chloride solution (10 ml) of compound 2B (1.98 g, 5.48 mmol) at 0° C. After the mixture was stirred at room temperature for 3 hours, the mixture was poured into a 1N aqueous sodium hydroxide solution, and extracted with ethyl ether. The organic layer was washed with a 1N aqueous sodium hydroxide solution and an aqueous saturated sodium chloride solution, and dried with magnesium sulfate. After the solvent was distilled off under reduced pressure, purification was performed by silica gel column chromatography (n-hexane-ethyl acetate, 2:1, v/v) to obtain 1.73 g of compound 175A as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 4.55 (1H, d, J=7.3 Hz), 5.09 (2H, s), 5.14 (2H, m), 7.22-7.35 (15H, m), 9.62 (1H, s).',\n",
       "   'Compound 175A (1.30 g, 4.59 mmol), 3-aminopropan-1-ol (379 mg, 5.05 mmol) and sodium sulfate (3.26 g, 22.4 mmol) were added to toluene (40 ml), and the mixture was stirred at room temperature for 1 hour. Boc2O (1.17 ml, 5.05 mmol) was added at room temperature, and the mixture was stirred for 18 hours. Boc2O (1.17 ml, 5.05 mmol) and sodium sulfate (3.26 g, 22.4 mmol) were added, and the mixture was stirred for 60 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 635 mg of compound 175B as a colorless solid.',\n",
       "   'Compound 175B (632 mg, 1.22 mmol) and palladium-active carbon (10%, wet, 100 mg) were added to ethanol (10 ml) and THF (5 ml), and the mixture was stirred at room temperature for 3 hours under hydrogen atmosphere. After filtration with celite, the solvent was concentrated under reduced pressure to obtain 502 mg of a colorless oily substance 175C.',\n",
       "   '1H-NMR (CDCl3) δ: 1.45 (9H, s), 1.77 (2H, m), 3.18-3.27 (1H, m), 3.43-3.51 (1H, m), 4.04 (4H, m), 4.92 (1H, d, J=4.7 Hz), 7.28 (10H, m).',\n",
       "   'Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (390 mg, 1.22 mmol) and compound 175C (468 mg, 1.22 mmol) were added to toluene (5 ml), and the mixture was stirred at 100° C. for 2 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (n-hexane-ethyl acetate, 1:1, v/v) to obtain 391 mg of compound 175D as a pale yellow gummy substance.',\n",
       "   'To compound 175D (388 mg, 0.568 mmol) was added 4N HCl (ethyl acetate solution, 4 ml). After the mixture was stirred at room temperature for 1 hour, the solvent was distilled off under reduced pressure. Subsequently, toluene (4 ml) and 3-aminopropan-1-ol (0.0870 ml, 1.14 mmol) were added, and the mixture was stirred at 80° C. for 5 hours. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain 57 mg of compound 175E as a yellow gummy substance and 44 mg of compound 175F as a brown gummy substance.',\n",
       "   '175E: 1H-NMR (CDCl3) δ: 1.91-2.00 (2H, m), 2.87 (1H, m), 3.78 (3H, s), 3.87-4.15 (3H, m), 4.61 (1H, d, J=12.1 Hz), 4.78 (2H, m), 5.33 (1H, d, J=10.2 Hz), 5.63 (1H, d, J=10.2 Hz), 6.95 (2H, m), 7.13-7.53 (12H, m), 7.76 (2H, m)',\n",
       "   '175F: 1H-NMR (CDCl3) δ: 1.83-1.97 (2H, m), 3.12-3.22 (1H, m), 3.50 (1H, m), 3.85 (3H, s), 3.90 (1H, m), 4.34-4.40 (1H, m), 4.74 (1H, d, J=8.6 Hz), 4.84-4.89 (1H, m), 5.09 (1H, d, J=3.3 Hz), 5.15 (1H, d, J=9.9 Hz), 5.26 (1H, d, J=9.6 Hz), 7.08-7.50 (13H, m), 7.65-7.77 (3H, m).',\n",
       "   'Compound 175E (57 mg, 0.10 mmol) was dissolved in THF (0.5 ml) and ethanol (0.5 ml), a 2N aqueous sodium hydroxide solution (0.25 ml, 0.50 mmol) was added at room temperature, and the mixture was stirred for 1 hour. After 1N hydrochloric acid was added, and the mixture was extracted with chloroform, the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 98:2, v/v) to obtain compound 175G.',\n",
       "   'To compound 175G obtained in the sixth step was added trifluoroacetic acid (1 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 3 with sodium bicarbonate water and 2N hydrochloric acid, then the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, chloroform-methanol-ethyl ether were added, and the precipitated solid was filtered to obtain 11 mg of compound 175 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.50 (1H, d, J=13.1 Hz), 1.79 (1H, m), 3.17 (1H, m), 3.86 (1H, t, J=11.0 Hz), 4.03 (1H, dd, J=10.8, 4.1 Hz), 4.46 (1H, d, J=12.0 Hz), 4.53 (1H, dd, J=12.7, 4.2 Hz), 4.84 (1H, s), 5.85 (1H, d, J=11.7 Hz), 7.22 (7H, m), 7.44 (2H, t, J=7.6 Hz), 7.65 (2H, d, J=7.3 Hz), 8.14 (1H, s), 12.75 (1H, s), 15.33 (1H, brs).',\n",
       "   'MS: m/z=447 [M+H]+.']},\n",
       " {'number': 'Example 176',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 175, using compound 175F, compound 176 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.75 (2H, m), 3.17 (2H, m), 3.43 (1H, m), 3.60 (1H, d, J=10.7 Hz), 4.31 (1H, d, J=12.7 Hz), 4.73 (1H, d, J=9.8 Hz), 5.52 (1H, d, J=3.4 Hz), 5.87 (1H, dd, J=9.9, 3.4 Hz), 7.10 (7H, m), 7.29 (2H, t, J=7.5 Hz), 7.58 (2H, d, J=7.3 Hz), 8.37 (1H, s), 12.65 (1H, brs).',\n",
       "   'MS: m/z=447 [M+H]+.']},\n",
       " {'number': 'Example 177',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Tert-butyl pyrazolidine-1-carboxylate (275 mg, 1.60 mmol) synthesized according to the method of the reference (Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1975, p. 1712), and compound 95B (409 mg, 1.45 mmol) were dissolved in pyridine (5 ml), HATU (607 mg, 1.60 mmol) was added at room temperature, and the mixture was stirred for 18 hours. The reaction solution was poured into 1N hydrochloric acid, then the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5, v/v) to obtain 529 mg of compound 177A as a yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.35 (9H, s), 1.88-2.10 (2H, m), 3.04 (1H, s), 3.31 (1H, s), 3.86 (2H, m), 4.96 (1H, d, J=9.3 Hz), 5.45 (1H, d, J=11.0 Hz), 6.56 (1H, d, J=6.7 Hz), 7.29-7.43 (6H, m).',\n",
       "   'To compound 177A (525 mg, 1.31 mmol) was added 4N HCl (dioxane solution, 6 ml). After the mixture was stirred at room temperature for 1.5 hours, the solvent was distilled off under reduced pressure to obtain 413 mg of compound 177B as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.95-2.05 (2H, m), 2.78 (2H, t, J=6.6 Hz), 3.41-3.54 (2H, m), 5.11 (2H, s), 7.38 (5H, m), 7.46 (1H, d, J=6.6 Hz), 8.36 (1H, d, J=6.7 Hz).',\n",
       "   'Compound 177B (100 mg, 0.298 mmol) was added to ethanol (2 ml), 2,2-diphenylacetaldehyde (58 mg, 0.30 mmol), triethylamine (0.083 ml, 0.596 mmol) and acetic acid (0.051 ml, 0.89 mmol) were added, and the mixture was stirred at 80° C. for 3 hours. The reaction solution was poured into water, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (chloroform-methanol, 97:3→95:5→93:7→90:10, v/v) to obtain 106 mg of compound 177C as a yellow gummy substance.',\n",
       "   'MS: m/z=478 [M+H]+.',\n",
       "   'To compound 177C obtained in the third step was added trifluoroacetic acid (2 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, pH was adjusted to 6 with sodium bicarbonate water and 2N hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, methylene chloride-ethyl ether were added, and the precipitated solid was filtered to obtain 7 mg of compound 177 as a colorless solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.95 (2H, m), 2.76 (1H, m), 2.96-3.17 (2H, m), 4.04 (1H, m), 4.68 (1H, d, J=10.4 Hz), 5.66 (1H, d, J=7.3 Hz), 6.56 (1H, d, J=10.5 Hz), 7.03 (1H, d, J=7.2 Hz), 7.17 (6H, m), 7.34 (2H, t, J=7.3 Hz), 7.55 (2H, d, J=7.5 Hz).',\n",
       "   'MS: m/z=388 [M+H]+.']},\n",
       " {'number': 'Example 178',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 177, compound 178 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.55 (4H, m), 2.35-7.49 (1H, m), 2.39 (1H, t, J=12.6 Hz), 2.77 (1H, t, J=10.0 Hz), 3.09 (1H, d, J=11.4 Hz), 4.34 (1H, d, J=12.8 Hz), 4.55 (1H, d, J=10.8 Hz), 5.71 (1H, d, J=7.0 Hz), 6.17 (1H, d, J=10.8 Hz), 6.82 (1H, d, J=7.3 Hz), 7.13-7.40 (8H, m), 7.48 (2H, d, J=7.3 Hz).',\n",
       "   'MS: m/z=402 [M+H]+.']},\n",
       " {'number': 'Example 179',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 177, compound 179 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.31 (6H, m), 2.68 (2H, m), 3.21 (1H, m), 4.04 (1H, m), 4.40 (1H, d, J=10.8 Hz), 5.77 (1H, t, J=5.2 Hz), 6.26 (1H, d, J=10.8 Hz), 6.78 (1H, d, J=7.3 Hz), 7.27 (8H, m), 7.53 (2H, d, J=7.2 Hz).',\n",
       "   'MS: m/z=416 [M+H]+.']},\n",
       " {'number': 'Example 180',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 177, compound 180 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.78-3.74 (7H, m), 4.17 (1H, m), 4.49 (1H, d, J=10.8 Hz), 5.79 (1H, d, J=7.2 Hz), 6.32 (1H, d, J=10.8 Hz), 6.79 (1H, d, J=7.2 Hz), 7.28 (8H, m), 7.55 (2H, d, J=7.6 Hz).',\n",
       "   'MS: m/z=418 [M+H]+.',\n",
       "   'Using amines which are commercially available or known in the references and halides which are commercially available or known in the references, and according to the method of Example 12, Examples 181 to 187 were synthesized.']},\n",
       " {'number': 'Example 181',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 182',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=459 [M+H]+.']},\n",
       " {'number': 'Example 183',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=529 [M+H]+.']},\n",
       " {'number': 'Example 184',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=477 [M+H]+.']},\n",
       " {'number': 'Example 185',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=473 [M+H]+.']},\n",
       " {'number': 'Example 186',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=447 [M+H]+.']},\n",
       " {'number': 'Example 187', 'title': '', 'content': ['', 'MS: m/z=461 [M+H]+']},\n",
       " {'number': 'Example 188',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 12 and Example 129, compound 188 was synthesized by the same procedure.',\n",
       "   'MS: m/z=449 [M+H]+.',\n",
       "   'Using amines which are commercially available or known in the references and halides which are commercially available or known in the references, and according to the method of Example 95, Examples 189 to 229 were synthesized.']},\n",
       " {'number': 'Example 189', 'title': '', 'content': ['', 'MS: m/z=399 [M+H]+']},\n",
       " {'number': 'Example 190', 'title': '', 'content': ['', 'MS: m/z=488 [M+H]+']},\n",
       " {'number': 'Example 191', 'title': '', 'content': ['', 'MS: m/z=470 [M+H]+']},\n",
       " {'number': 'Example 192',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=422 [M+H]+.']},\n",
       " {'number': 'Example 193', 'title': '', 'content': ['', 'MS: m/z=422 [M+H]+']},\n",
       " {'number': 'Example 194', 'title': '', 'content': ['', 'MS: m/z=486 [M+H]+']},\n",
       " {'number': 'Example 195', 'title': '', 'content': ['', 'MS: m/z=365 [M+H]+']},\n",
       " {'number': 'Example 196', 'title': '', 'content': ['', 'MS: m/z=418 [M+H]+']},\n",
       " {'number': 'Example 197', 'title': '', 'content': ['', 'MS: m/z=339 [M+H]+']},\n",
       " {'number': 'Example 198', 'title': '', 'content': ['', 'MS: m/z=344 [M+H]+']},\n",
       " {'number': 'Example 199', 'title': '', 'content': ['', 'MS: m/z=383 [M+H]+']},\n",
       " {'number': 'Example 200', 'title': '', 'content': ['', 'MS: m/z=339 [M+H]+']},\n",
       " {'number': 'Example 201', 'title': '', 'content': ['', 'MS: m/z=440 [M+H]+']},\n",
       " {'number': 'Example 202', 'title': '', 'content': ['', 'MS: m/z=365 [M+H]+']},\n",
       " {'number': 'Example 203', 'title': '', 'content': ['', 'MS: m/z=396 [M+H]+']},\n",
       " {'number': 'Example 204', 'title': '', 'content': ['', 'MS: m/z=370 [M+H]+']},\n",
       " {'number': 'Example 205', 'title': '', 'content': ['', 'MS: m/z=390 [M+H]+']},\n",
       " {'number': 'Example 206', 'title': '', 'content': ['', 'MS: m/z=420 [M+H]+']},\n",
       " {'number': 'Example 207', 'title': '', 'content': ['', 'MS: m/z=350 [M+H]+']},\n",
       " {'number': 'Example 208', 'title': '', 'content': ['', 'MS: m/z=428 [M+H]+']},\n",
       " {'number': 'Example 209', 'title': '', 'content': ['', 'MS: m/z=386 [M+H]+']},\n",
       " {'number': 'Example 210', 'title': '', 'content': ['', 'MS: m/z=378 [M+H]+']},\n",
       " {'number': 'Example 211', 'title': '', 'content': ['', 'MS: m/z=366 [M+H]+']},\n",
       " {'number': 'Example 212', 'title': '', 'content': ['', 'MS: m/z=362 [M+H]+']},\n",
       " {'number': 'Example 213', 'title': '', 'content': ['', 'MS: m/z=358 [M+H]+']},\n",
       " {'number': 'Example 214', 'title': '', 'content': ['', 'MS: m/z=350 [M+H]+']},\n",
       " {'number': 'Example 215', 'title': '', 'content': ['', 'MS: m/z=350 [M+H]+']},\n",
       " {'number': 'Example 216', 'title': '', 'content': ['', 'MS: m/z=411 [M+H]+']},\n",
       " {'number': 'Example 217', 'title': '', 'content': ['', 'MS: m/z=445 [M+H]+']},\n",
       " {'number': 'Example 218', 'title': '', 'content': ['', 'MS: m/z=366 [M+H]+']},\n",
       " {'number': 'Example 219', 'title': '', 'content': ['', 'MS: m/z=354 [M+H]+']},\n",
       " {'number': 'Example 220', 'title': '', 'content': ['', 'MS: m/z=368 [M+H]+']},\n",
       " {'number': 'Example 221', 'title': '', 'content': ['', 'MS: m/z=314 [M+H]+']},\n",
       " {'number': 'Example 222', 'title': '', 'content': ['', 'MS: m/z=330 [M+H]+']},\n",
       " {'number': 'Example 223', 'title': '', 'content': ['', 'MS: m/z=346 [M+H]+']},\n",
       " {'number': 'Example 224',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=418 [M+H]+.']},\n",
       " {'number': 'Example 225',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=445 [M+H]+.']},\n",
       " {'number': 'Example 226',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=473 [M+H]+.']},\n",
       " {'number': 'Example 227',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=444 [M+H]+.']},\n",
       " {'number': 'Example 228',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=434 [M+H]+.']},\n",
       " {'number': 'Example 229',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=443 [M+H]+.']},\n",
       " {'number': 'Example 230',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 128, compound 230 was synthesized by the same procedure.',\n",
       "   'MS: m/z=461 [M+H]+.']},\n",
       " {'number': 'Example 231',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 129, compound 231 was synthesized by the same procedure.',\n",
       "   'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Example 232',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 129, compound 232 was synthesized by the same procedure.',\n",
       "   'MS: m/z=434 [M+H]+.']},\n",
       " {'number': 'Example 233',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 233 was synthesized by the same procedure.',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 234',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 234 was synthesized by the same procedure.',\n",
       "   'MS: m/z=447 [M+H]+.']},\n",
       " {'number': 'Example 235',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 235 was synthesized by the same procedure',\n",
       "   'MS: m/z=473 [M+H]+.']},\n",
       " {'number': 'Example 236',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 236 was synthesized by the same procedure.',\n",
       "   'MS: m/z=447 [M+H]+.']},\n",
       " {'number': 'Example 237',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 237 was synthesized by the same procedure.',\n",
       "   'MS: m/z=487 [M+H]+.']},\n",
       " {'number': 'Example 238',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 130, compound 238 was synthesized by the same procedure.',\n",
       "   'MS: m/z=509 [M+H]+.']},\n",
       " {'number': 'Example 239',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'MS: m/z=376 [M+H]+',\n",
       "   'According to Example 157, compound 239 was synthesized by the same procedure.',\n",
       "   'Using amines which are commercially available or known in the references and alcohols which are commercially available or known in the references, and according to the method of Example 107, Examples 240 to 245 were synthesized.']},\n",
       " {'number': 'Example 240',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.05 (3H, d, J=6.9 Hz), 1.04-1.14 (4H, m), 4.49 (1H, d, J=13.2 Hz), 4.83 (1H, d, J=13.2 Hz), 4.91-4.99 (1H, m), 5.73 (1H, d, J=7.8 Hz), 6.50 (1H, s), 6.70 (1H, d, J=7.8 Hz), 7.12-7.30 (4H, m), 7.33-7.43 (2H, m), 7.46-7.54 (1H, m), 8.06 (1H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 241', 'title': '', 'content': ['', 'MS: m/z=478 [M+H]+']},\n",
       " {'number': 'Example 242', 'title': '', 'content': ['', 'MS: m/z=478 [M+H]+']},\n",
       " {'number': 'Example 243', 'title': '', 'content': ['', 'MS: m/z=478 [M+H]+']},\n",
       " {'number': 'Example 244',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.14 (6H, d, J=6.9 Hz), 4.59 (1H, d, J=12.6 Hz), 4.77 (1H, d, J=12.6 Hz), 4.81-4.91 (1H, m), 5.82 (1H, d, J=7.5 Hz), 5.82 (1H, s), 6.71 (1H, brs), 6.78 (1H, brs), 6.87 (1H, d, J=7.5 Hz), 7.05 (1H, brs), 7.16 (1H, brs), 7.25 (1H, brs), 7.41 (1H, brs).']},\n",
       " {'number': 'Example 245',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=490 [M+H]+.']},\n",
       " {'number': 'Example 246',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a dimethylformamide (20 ml) solution of compound 246A (5.30 g, 18.76 mmol) and potassium carbonate (5.19 g, 27.53 mmol) was added benzyl bromide (3.21 g, 18.76 mmol), and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added ethyl acetate (80 ml), insolubles were filtered off, and 1N hydrochloric acid was added. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate two times. The combined organic layers were washed with water once and, further, washed with sodium bicarbonate water once, and with an aqueous saturated sodium chloride solution once. The resulting solution was dried with sodium sulfate, and the solvent was distilled off to obtain 6.98 g of compound 246B as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 5.36 (2H, s), 7.35-7.47 (6H, m), 7.78 (1H, d, J=8.4 Hz), 8.01 (1H, d, J=2.1 Hz).',\n",
       "   'To a dimethylformamide (15 ml) solution of compound 246B (3 g, 8.05 mmol) and 1-chloro-3-ethynylbenzene (1.32 g, 9.66 mmol) and triethylamine (4.07 g, 40.25 mmol) were added copper chloride (76.6 mg, 0.403 mmol) and dichlorobis(triphenylphosphine)palladium (282.5 mg, 0.403 mmol) under nitrogen atmosphere, and the mixture was stirred at room temperature for 5 hours. The reaction solution was diluted with water, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water three times, and dried with sodium sulfate, then the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The material were eluted firstly with hexane and, then, with hexane-ethyl acetate (7:3, v/v). Concentration of an objective fraction afforded 3.10 g of compound 246C as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 5.39 (2H, s), 7.21-7.46 (9H, m), 7.62 (1H, d, J=2.1 Hz), 7.98 (1H, d, J=8.4 Hz).',\n",
       "   'To a methanol (30 ml) solution of compound 246C (3.10 g, 8.05 mmol) was added 10% palladium carbon (620 mg, 20 wt %), and the mixture was stirred at room temperature under 1 atm hydrogen atmosphere. The reaction solution was filtered with celite, the solvent was distilled off, to the resulting crude product were added ethyl acetate-diisopropyl ether, and the precipitated residue was filtered to obtain 618 mg of compound 246D as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.90 (2H, dd, J=7.8 Hz, 10.8 Hz), 3.29 (2H, dd, J=7.5 Hz, 10.5 Hz), 7.06-7.09 (1H, m), 7.18-7.25 (4H, m), 7.31 (1H, dd, J=2.1 Hz, 8.7 Hz), 8.05 (1H, d, J=8.4 Hz).',\n",
       "   'To compound 246D (2.20 g, 7.45 mmol) was added polyphosphoric acid (20 g), and the mixture was stirred at 200° C. for 1 hour. After cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with saturated sodium bicarbonate water, and dried with sodium sulfate and, thereafter, the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with hexane and, then, with hexane-ethyl acetate (7:3, v/v). Concentration of an objective fraction afforded 1.05 g of compound 246E as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 3.17 (4H, s), 7.24 (2H, d, J=2.1 Hz), 7.32 (2H, dd, J=2.1 Hz, 8.4 Hz, 8.00 (2H, d, J=8.4 Hz).',\n",
       "   'A methanol (10 ml) suspension of sodium borohydride (409 mg, 10.82 mmol) was cooled to 1 to 3° C., and compound 246E (1.0 g, 3.61 mmol) was added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, water was added. The precipitated solid was filtered to obtain 968 mg of compound 246F.',\n",
       "   '1H-NMR (CDCl3) δ: 2.25 (1H, d, J=3.0 Hz), 3.05-3.16 (2H, m), 3.27-3.38 (2H, m), 5.95 (1H, d, J=3.0 Hz), 7.14-7.17 (4H, m), 7.39 (2H, d, J=8.1 Hz).',\n",
       "   'According to Example 107, compound 246 was synthesized by the same procedure.',\n",
       "   '1H-NMR (CDCl3) δ: 1.14 (3H, d, J=6.9 Hz), 1.20 (3H, d, J=6.9 Hz), 2.79 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.4 Hz), 2.99-3.11 (1H, m), 3.50 (1H, ddd, J=4.8 Hz, 4.8 Hz), 17.7 Hz), 4.21-4.33 (1H, m), 4.23 (1H, d, J=12.9 Hz), 4.62-4.74 (2H, m), 5.04 (1H, s), 5.84 (1H, d, J=7.8 Hz), 6.57 (1H, d, J=8.1 Hz), 6.65-6.72 (2H, m), 6.89-6.92 (1H, m), 7.11-7.30 (4H, m).',\n",
       "   'Using amines which are commercially available or known in the references and intermediates corresponding to compound 246A to compound 246F which are commercially available or known in the references, and according to the method of Example 246, compounds 247 to 284 were synthesized.']},\n",
       " {'number': 'Example 247',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=457 [M+H]+.']},\n",
       " {'number': 'Example 248',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=485 [M+H]+.']},\n",
       " {'number': 'Example 249',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=471 [M+H]+.']},\n",
       " {'number': 'Example 250',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=457 [M+H]+.']},\n",
       " {'number': 'Example 251',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=521 [M+H]+.']},\n",
       " {'number': 'Example 252',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=485 [M+H]+.']},\n",
       " {'number': 'Example 253',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=471 [M+H]+.']},\n",
       " {'number': 'Example 254',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=487 [M+H]+.']},\n",
       " {'number': 'Example 255',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=469 [M+H]+.']},\n",
       " {'number': 'Example 256',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=470 [M+H]+.']},\n",
       " {'number': 'Example 257',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=434 [M+H]+.']},\n",
       " {'number': 'Example 258',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.88 (3H, m), 3.43 (2H, m), 3.69 (1H, dt, J=16.9, 5.1 Hz), 4.01 (1H, d, J=13.4 Hz), 4.07-4.17 (2H, m), 4.97 (1H, d, J=13.4 Hz), 5.24 (1H, s), 5.50 (1H, d, J=7.6 Hz), 6.73 (1H, d, J=7.2 Hz), 6.85-6.94 (2H, m), 7.14-7.41 (6H, m), 11.73 (1H, s).',\n",
       "   'MS: m/z=432 [M+H]+.']},\n",
       " {'number': 'Example 259',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.80 (1H, td, J=9.6, 4.5 Hz), 2.86-2.99 (1H, m), 3.00-3.18 (1H, m), 3.67 (1H, dt, J=17.1, 5.0 Hz), 4.03-4.19 (2H, m), 4.32-4.52 (1H, m), 5.05 (1H, d, J=13.3 Hz), 5.26 (1H, s), 5.53 (1H, d, J=7.6 Hz), 6.17 (1H, tt, J=55.0, 3.5 Hz), 6.72 (1H, d, J=7.5 Hz), 6.87-6.94 (2H, m), 7.12-7.27 (3H, m), 7.30-7.43 (3H, m).',\n",
       "   'MS: m/z=438 [M+H]+.']},\n",
       " {'number': 'Example 260',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=460 [M+H]+.']},\n",
       " {'number': 'Example 261',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=474 [M+H]+.']},\n",
       " {'number': 'Example 262',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.80 (1H, dt, J=14.2, 5.1 Hz), 2.86-2.99 (1H, m), 3.00-3.18 (1H, m), 3.68 (1H, dt, J=16.9, 5.3 Hz), 4.05 (1H, d, J=13.3 Hz), 4.07-4.32 (2H, m), 4.37-4.52 (1H, m), 4.53-4.67 (1H, m), 5.02 (1H, d, J=13.0 Hz), 5.26 (1H, s), 5.50 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.6 Hz), 6.85-6.94 (2H, m), 7.12-7.27 (3H, m), 7.30-7.43 (3H, m).',\n",
       "   'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Example 263',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.76-3.00 (2H, m), 3.46-3.73 (2H, m), 4.06-4.22 (2H, m), 4.77-4.91 (1H, m), 5.15 (1H, d, J=12.9 Hz), 5.24 (1H, s), 5.56 (1H, d, J=7.7 Hz), 6.72 (1H, d, J=7.1 Hz), 6.88-6.95 (1H, m), 6.96 (1H, d, J=7.7 Hz), 7.09-7.41 (7H, m).',\n",
       "   'MS: m/z=456 [M+H]+']},\n",
       " {'number': 'Example 264',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.74-2.99 (2H, m), 3.62-3.73 (1H, m), 4.01-4.20 (3H, m), 5.12 (1H, d, J=13.2 Hz), 5.15 (1H, d, J=15.7 Hz), 5.34 (1H, s), 5.52 (1H, d, J=7.7 Hz), 6.78 (1H, d, J=8.0 Hz), 6.89-6.96 (2H, m), 7.10-7.23 (5H, m), 7.27-7.35 (3H, m), 7.43 (1H, d, J=7.7 Hz), 7.79 (1H, td, J=7.6, 1.8 Hz), 8.45-8.50 (1H, m).',\n",
       "   'MS: m/z=465 [M+H]+.']},\n",
       " {'number': 'Example 265',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.32 (9H, s), 2.76-2.86 (1H, m), 2.87-3.01 (1H, m), 3.59-3.70 (1H, m), 4.12-4.25 (1H, m), 4.29 (1H, d, J=13.5 Hz), 4.90 (1H, d, J=13.2 Hz), 5.20 (1H, s), 5.49 (1H, d, J=7.4 Hz), 6.75 (1H, d, J=8.0 Hz), 6.81 (1H, d, J=7.4 Hz), 6.91 (1H, t, J=6.6 Hz), 7.12-7.21 (2H, m), 7.22-7.30 (1H, m), 7.33-7.38 (2H, m), 7.46 (1H, d, J=7.4 Hz).',\n",
       "   'MS: m/z=430 [M+H]+.']},\n",
       " {'number': 'Example 266',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.05 (3H, t, J=7.2 Hz), 2.80 (1H, dt, J=14.4, 5.1 Hz), 2.85-2.99 (2H, m), 3.68 (1H, dt, J=16.8, 5.0 Hz), 3.74-3.87 (1H, m), 4.02 (1H, d, J=13.3 Hz), 4.06-4.19 (1H, m), 4.98 (1H, d, J=13.1 Hz), 5.22 (1H, s), 5.48 (1H, d, J=7.6 Hz), 6.73 (1H, d, J=7.5 Hz), 6.83-6.94 (2H, m), 7.12-7.40 (6H, m).',\n",
       "   'MS: m/z=402 [M+H]+.']},\n",
       " {'number': 'Example 267',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.74-1.86 (2H, m), 2.71-2.82 (1H, m), 2.83-2.93 (1H, m), 2.98-3.11 (1H, m), 3.25 (3H, s), 3.39 (2H, t, J=5.4 Hz), 3.62-3.74 (1H, m), 4.02-4.14 (2H, m), 4.16-4.28 (1H, m), 4.82 (1H, d, J=13.2 Hz), 5.03 (1H, s), 5.76 (1H, d, J=7.7 Hz), 6.58 (1H, d, J=7.7 Hz), 6.64 (1H, d, J=7.4 Hz), 6.89-6.97 (1H, m), 7.12-7.39 (6H, m).',\n",
       "   'MS: m/z=446 [M+H]+.']},\n",
       " {'number': 'Example 268',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.09 (3H, t, J=7.0 Hz), 2.65-2.77 (1H, m), 2.83-2.94 (1H, m), 2.97-3.10 (1H, m), 3.40 (2H, q, J=7.0 Hz), 3.45-3.52 (1H, m), 3.55-3.64 (1H, m), 3.65-3.76 (1H, m), 4.00-4.15 (2H, m), 4.36-4.45 (1H, m), 4.90 (1H, d, J=13.5 Hz), 5.02 (1H, s), 5.79 (1H, d, J=7.7 Hz), 6.59 (1H, d, J=7.7 Hz), 6.63 (1H, d, J=7.4 Hz), 6.90-6.97 (1H, m), 7.13-7.39 (6H, m).',\n",
       "   'MS: m/z=446 [M+H]+.']},\n",
       " {'number': 'Example 269',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=480 [M+H]+.']},\n",
       " {'number': 'Example 270',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.33 (3H, s), 2.85 (2H, m), 3.68 (1H, m), 4.16 (1H, m), 4.29 (1H, d, J=13.3 Hz), 4.45 (1H, d, J=17.1 Hz), 5.12 (1H, d, J=13.1 Hz), 5.26 (1H, d, J=17.4 Hz), 5.36 (1H, s), 5.55 (1H, d, J=7.6 Hz), 6.74 (1H, d, J=7.6 Hz), 6.89-7.38 (8H, m).',\n",
       "   'MS: m/z=470 [M+H]+.']},\n",
       " {'number': 'Example 271',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.87 (2H, m), 3.61-3.69 (1H, m), 4.15 (1H, m), 4.18 (1H, d, J=13.2 Hz), 4.51 (1H, d, J=15.9 Hz), 5.08 (1H, d, J=13.1 Hz), 5.21 (1H, s), 5.22 (1H, d, J=15.6 Hz), 5.52 (1H, d, J=7.6 Hz), 6.72 (1H, d, J=7.5 Hz), 6.89-7.32 (8H, m), 7.76 (2H, s).',\n",
       "   'MS: m/z=471 [M+H]+.']},\n",
       " {'number': 'Example 272', 'title': '', 'content': ['', 'MS: m/z=476 [M+H]+']},\n",
       " {'number': 'Example 273',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.84-2.93 (1H, m), 2.98 (3H, s), 2.98-3.09 (1H, m), 3.66-3.75 (1H, m), 3.99-4.15 (1H, m), 4.06 (1H, d, J=12.9 Hz), 4.80 (1H, d, J=13.2 Hz), 5.03 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.56 (1H, d, J=7.5 Hz), 6.63 (1H, d, J=6.6 Hz), 6.90-6.96 (1H, m), 7.14-7.37 (6H, m).']},\n",
       " {'number': 'Example 274',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=470 [M+H]+.']},\n",
       " {'number': 'Example 275', 'title': '', 'content': ['', 'MS: m/z=470 [M+H]+']},\n",
       " {'number': 'Example 276', 'title': '', 'content': ['', 'MS: m/z=460 [M+H]+']},\n",
       " {'number': 'Example 277',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=486 [M+H]+.']},\n",
       " {'number': 'Example 278', 'title': '', 'content': ['', 'MS: m/z=446 [M+H]+']},\n",
       " {'number': 'Example 279',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.08-1.21 (6H, m), 2.84 (1H, ddd, J=4.8',\n",
       "   'Hz, 4.8 Hz, 14.4 Hz), 2.97-3.08 (1H, m), 3.54 (1H, ddd, J=4.8 Hz, 6.6 Hz, 17.1 Hz), 4.09-4.26 (1H, m), 4.24 (1H, d, J=13.2 Hz), 4.64-4.74 (m, 1H), 4.70 (1H, d, J=13.2 Hz), 4.94 (1H, s), 5.81 (1H, d, J=7.8 Hz), 6.42 (1H, dd, J=2.7 Hz, 9.0 Hz), 6.67 (1H, d, J=7.8 Hz), 6.89-7.12 (4H, m), 7.19-7.36 (1H, m).']},\n",
       " {'number': 'Example 280',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.15 (3H, d, J=6.9 Hz), 1.20 (3H, d, J=6.9 Hz), 2.84 (1H, ddd, J=4.8 Hz, 5.1 Hz, 14.4 Hz), 2.96-3.07 (1H, m), 3.55 (1H, ddd, J=4.8 Hz, 5.1 Hz, 17.4 Hz), 4.11-4.23 (1H, m), 4.21 (1H, d, J=12.9 Hz), 4.65-4.74 (1H, m), 4.70 (1H, d, J=12.9 Hz), 4.95 (1H, s), 5.78 (1H, d, J=7.8 Hz), 6.63 (1H, d, J=7.8 Hz), 6.69 (1H, d, J=2.1 Hz), 7.06 (1H, d, J=8.4 Hz), 7.18 (1H, dd, J=2.1 Hz, 8.4 Hz), 7.23-7.26 (2H, m), 7.24 (1H, dd, J=2.1 Hz, 8.1 Hz).']},\n",
       " {'number': 'Example 281',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.13 (3H, d, J=6.6 Hz), 1.20 (3H, d, J=6.9 Hz), 2.90-3.32 (1H, m), 3.36 (1H, ddd, J=4.5 Hz, 4.5 Hz, 9.6 Hz), 3.42-3.51 (1H, m), 3.95-4.02 (1H, m), 4.28 (1H, d, J=12.9 Hz), 4.64-4.75 (1H, m), 1.89 (1H, d, J=12.9 Hz), 5.15 (1H, s), 5.80 (1H, d, J=7.5 Hz), 6.46-6.49 (1H, m), 6.70 (1H, d, J=7.8 Hz), 6.88-7.00 (2H, m), 7.03-7.06 (1H, m), 7.11-7.22 (2H, m).']},\n",
       " {'number': 'Example 282',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.09-1.19 (6H, m), 2.80-3.10 (2H, m), 3.40-3.60 (1H, m), 4.16-4.41 (2H, m), 4.61-4.47 (2H, m), 5.06-5.10 (1H, m), 5.71 (0.45H, d, J=7.5 Hz), 5.74 (0.55H, d, J=7.8 Hz), 6.60-6.72 (2H, m), 6.86-6.94 (1H, m), 7.10-7.46 (6H, m).']},\n",
       " {'number': 'Example 283',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.10-1.21 (6H, m), 2.75-2, 86 (1H, m), 2.99-3.14 (1H, m), 4.23-4.37 (2H, m), 4.59-4.74 (2H, m), 5.04 (1H, s), 5.67-5.80 (1H, m), 6.58-6.67 (2H, m), 6.88-7.08 (1H, m), 7.11-7.38 (5H, m).']},\n",
       " {'number': 'Example 284',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.15 (3H, d, J=6.9 Hz), 1.20 (3H, d, J=6.9 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz, 9.9 Hz), 3.07 (1H, t, J=3.9 Hz, 13.2 Hz, 13.2 Hz), 3.50 (1H, ddd, J=4.2 Hz, 4.2 Hz, 18.0 Hz), 4.24 (1H, 6.9 Hz), 4.34 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.63-4.74 (2H, m), 5.06 (1H, s), 5.81 (1H, d, J=7.8 Hz), 6.57-6.64 (2H, m), 6.65 (1H, d, J=7.5 Hz), 6.82 (1H, d, J=9.3 Hz), 6.90 (1H, ddd, J=2.7 Hz, 8.4 Hz, 8.4 Hz), 7.02 (1H, dd, J=2.7 Hz, 9.0 Hz), 7.19-7.26 (2H, m).']},\n",
       " {'number': 'Example 285',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 285A (5.00 g, 29.3 mmol) was dissolved in dimethylformamide (150 ml), potassium carbonate (14.2 mmol) and iodoethane (7.11 ml, 88.0 mmol) were added, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added hexane, and the mixture was washed with water and an aqueous saturated sodium chloride solution. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a colorless oily substance 285B.',\n",
       "   '1H-NMR (CDCl3) δ: 1.40 (3H, t, J=7.2 Hz), 2.60 (3H, s), 4.37 (2H, q, J=7.1 Hz), 7.17 (1H, td, J=7.9, 0.6 Hz), 7.49 (1H, ddd, J=8.0, 1.4, 0.4 Hz), 7.68 (1H, ddd, J=7.8, 1.4, 0.3 Hz).',\n",
       "   'Compound 285B (5.63 g, 28.3 mmol) obtained in the first step was dissolved in carbon tetrachloride (150 ml), N-bromosuccinimide (5.55 g, 31.2 mmol) was added, and the mixture was stirred at 100° C. for 18 hours. The reaction solution was cooled to room temperature, and washed with water and an aqueous saturated sodium chloride solution. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 8.08 g of an orange oily substance 285C.',\n",
       "   '1H-NMR (CDCl3) δ: 1.43 (3H, t, J=7.6 Hz), 4.42 (2H, q, J=7.1 Hz), 5.10 (2H, s), 7.31 (1H, t, J=8.6 Hz), 7.57 (1H, d, J=8.1 Hz), 7.84 (1H, d, J=8.1 Hz).',\n",
       "   'Compound 285C (2.17 g, 7.8 mmol) obtained in the second step was dissolved in acetone (25 ml), 4-fluorobenzenethiol (1.00 g, 7.80 mmol) and potassium carbonate (1.62 g, 11.7 mmol) were added, and the mixture was stirred at 80° C. for 18 hours. After cooled to room temperature, the reaction solution was poured into water, the mixture was extracted with ethyl acetate, the extract was washed with an aqueous saturated sodium chloride solution, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography and eluted with n-hexane-ethyl acetate (4:1, v/v) to obtain 2.20 g of a colorless oily substance 285D.',\n",
       "   '1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.2 Hz), 4.25 (2H, d, J=7.5 Hz), 4.65 (2H, s), 6.91 (2H, t, J=8.8 Hz), 7.19-7.31 (3H, m), 7.48 (1H, dd, J=8.2, 1.4 Hz), 7.70 (1H, dd, J=7.6, 1.5 Hz).',\n",
       "   'Compound 285D (2.20 g, 6.77 mmol) obtained in the third step was dissolved in ethanol (20 ml), a 2N aqueous sodium hydroxide solution (16.9 ml, 33.8 mmol) was added, and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added water, the mixture was made acidic with dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 1.81 g of a white solid 285E.',\n",
       "   '1H-NMR (CDCl3) δ: 4.74 (2H, s), 6.95 (2H, t, J=8.8 Hz), 7.34 (3H, m), 7.59 (1H, dd, J=7.9, 1.5 Hz), 7.92 (1H, dd, J=7.9, 1.3 Hz).',\n",
       "   'To compound 285E (1.81 g, 6.10 mmol) obtained in the fourth step was added polyphosphoric acid (10.0 g), and the mixture was stirred at 120° C. for 5 hours. After cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried with sodium sulfate, the solvent was concentrated under reduced pressure, to the resulting compound were added n-hexane-ethyl acetate, and the precipitated residue was filtered to obtain 1.18 g of a white solid 285F.',\n",
       "   '1H-NMR (CDCl3) δ: 4.28 (2H, s), 7.18 (1H, ddd, J=9.3, 6.6, 2.3 Hz), 7.33 (2H, m), 7.46 (1H, dd, J=7.7, 1.5 Hz), 7.59 (1H, dd, J=7.9, 1.3 Hz), 7.91 (1H, dd, J=10.1, 2.9 Hz).',\n",
       "   'To compound 285F (1.17 g, 4.20 mmol) was added methanol (15 ml), sodium borohydride (191 mg, 5.04 mmol) was added at 0° C., and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 945 mg of a white solid 285G.',\n",
       "   '1H-NMR (CDCl3) δ: 2.58 (1H, d, J=3.2 Hz), 4.46 (1H, d, J=14.3 Hz), 4.58 (1H, d, J=14.6 Hz), 6.33 (1H, d, J=3.7 Hz), 6.82 (1H, td, J=8.3, 2.9 Hz), 7.07 (1H, dd, J=8.5, 5.4 Hz), 7.20 (1H, t, J=7.9 Hz), 7.33 (2H, m), 7.44 (1H, d, J=6.9 Hz).',\n",
       "   'According to the same procedure as that of Example 107, compound 285 was synthesized.',\n",
       "   'MS: m/z=486 [M+H]+',\n",
       "   'Using amines which are commercially available or known in the references and intermediates corresponding to compound 285A to compound 285G which are commercially available or known in the references. Then according to the method of Example 285, compounds 286 to compound 359 were synthesized.']},\n",
       " {'number': 'Example 286',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=595 [M+H]+.']},\n",
       " {'number': 'Example 287',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=475 [M+H]+.']},\n",
       " {'number': 'Example 288',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.57 (1H, brs), 1.84-1.99 (2H, m), 2.68 (3H, d, J=4.6 Hz), 3.08-3.17 (2H, m), 3.39 (3H, brs), 3.89 (1H, d, J=13.4 Hz), 4.16 (1H, d, J=13.3 Hz), 4.54 (1H, brs), 5.10 (1H, d, J=12.7 Hz), 5.50 (1H, s), 5.63 (1H, d, J=13.4 Hz), 5.73 (1H, d, J=7.8 Hz), 6.82-7.94 (9H, m).',\n",
       "   'MS: m/z=489 [M+H]+.']},\n",
       " {'number': 'Example 289',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=503 [M+H]+.']},\n",
       " {'number': 'Example 290',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=505 [M+H]+.']},\n",
       " {'number': 'Example 291',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=517 [M+H]+.']},\n",
       " {'number': 'Example 292',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=503 [M+H]+.']},\n",
       " {'number': 'Example 293',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=489 [M+H]+.']},\n",
       " {'number': 'Example 294',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=456 [M+H]+.']},\n",
       " {'number': 'Example 295',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=488 [M+H]+.']},\n",
       " {'number': 'Example 296', 'title': '', 'content': ['', 'MS: m/z=498 [M+H]+']},\n",
       " {'number': 'Example 297',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.21 (1H, m), 3.85 (1H, d, J=13.4 Hz), 4.08-4.18 (3H, m), 4.28 (1H, d, J=13.4 Hz), 5.10 (1H, d, J=13.7 Hz), 5.45 (1H, s), 5.57-5.64 (2H, m), 6.82-7.50 (10H, m).',\n",
       "   'MS: m/z=504 [M+H]+.']},\n",
       " {'number': 'Example 298',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 107, compound 298 was synthesized by the same procedure.',\n",
       "   'MS: m/z=452 [M+H]+.']},\n",
       " {'number': 'Example 299',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=450 [M+H]+.']},\n",
       " {'number': 'Example 300',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=464 [M+H]+.']},\n",
       " {'number': 'Example 301',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.00 (3H, d, J=6.9 Hz), 1.06 (3H, d, J=6.9 Hz), 3.88 (1H, d, J=13.4 Hz), 4.32 (1H, d, J=13.3 Hz), 4.67 (1H, m), 4.97 (1H, d, J=13.4 Hz), 5.43 (1H, s), 5.59 (2H, m), 6.84-7.45 (9H, m), 11.90 (1H, brs).',\n",
       "   'MS: m/z=434 [M+H]+.']},\n",
       " {'number': 'Example 302',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.11 (1H, m), 0.54-0.92 (3H, m), 2.71 (1H, m), 3.85 (1H, d, J=13.7 Hz), 4.06 (1H, d, J=13.1 Hz), 5.06 (1H, d, J=13.1 Hz), 5.35 (1H, s), 5.57 (2H, m), 7.15 (9H, m), 11.66 (1H, brs).',\n",
       "   'MS: m/z=432 [M+H]+.']},\n",
       " {'number': 'Example 303',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.14 (1H, m), 1.54 (2H, m), 1.67 (1H, m), 3.60 (1H, d, J=13.5 Hz), 4.39 (1H, d, J=12.6 Hz), 5.02 (1H, s), 5.07 (1H, d, J=12.6 Hz), 5.60 (1H, d. J=13.5 Hz), 5.77 (1H, d, J=7.7 Hz), 6.69 (1H, d, J=7.7 Hz), 7.07-7.13 (3H, m), 7.25-7.44 (4H, m).',\n",
       "   'MS: m/z=457.10 [M+H]+.']},\n",
       " {'number': 'Example 304',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.33-3.42 (1H, m), 3.84 (1H, d, J=13.1 Hz), 3.90-4.10 (1H, m), 4.24 (1H, d, J=13.4 Hz), 4.35-4.66 (2H, m), 5.13 (1H, d, J=13.4 Hz), 5.43 (1H, s), 5.54-5.64 (2H, m), 6.80-6.95 (2H, m), 7.04-7.50 (8H, m).',\n",
       "   'MS: m/z=438 [M+H]+.']},\n",
       " {'number': 'Example 305',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=487 [M+H]+.']},\n",
       " {'number': 'Example 306',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.69-3.82 (1H, m), 3.89 (1H, d, J=13.6 Hz), 4.40 (1H, d, J=12.9 Hz), 4.60-4.77 (1H, m), 5.27 (1H, d, J=13.3 Hz), 5.43 (1H, s), 5.60 (1H, d, J=13.6 Hz), 5.70 (1H, d, J=7.7 Hz), 6.84-6.95 (1H, m), 7.08-7.55 (9H, m).',\n",
       "   'MS: m/z=474 [M+H]+.']},\n",
       " {'number': 'Example 307',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.81 (1H, d, J=13.5 Hz), 4.29 (1H, d, J=13.5 Hz), 4.33 (1H, d, J=16.2 Hz), 4.96 (1H, d, J=16.2 Hz), 5.23 (1H, d, J=13.5 Hz), 5.49 (1H, s), 5.59 (1H, d, J=13.2 Hz), 5.64 (1H, d, J=7.7 Hz), 6.82-6.97 (2H, m), 7.05-7.41 (10H, m), 7.80 (1H, td, J=7.6, 1.7 Hz), 8.47 (1H, d, J=4.9 Hz).',\n",
       "   'MS: m/z=483 [M+H]+.']},\n",
       " {'number': 'Example 308',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.28 (9H, s), 3.86 (1H, d, J=13.6 Hz), 4.42 (1H, d, J=13.3 Hz), 4.99 (1H, d, J=13.4 Hz), 5.32 (1H, s), 5.53 (1H, d, J=13.3 Hz), 5.60 (1H, d, J=7.6 Hz), 6.81-7.63 (10H, m).',\n",
       "   'MS: m/z=448 [M+H]+.']},\n",
       " {'number': 'Example 309',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.03 (3H, t, J=7.4 Hz), 3.12-3.26 (1H, m), 3.43-3.58 (1H, m), 3.85 (1H, d, J=13.6 Hz), 4.21 (1H, d, J=13.4 Hz), 5.07 (1H, d, J=13.4 Hz), 5.40 (1H, s), 5.57 (1H, d, J=13.1 Hz), 5.59 (1H, d, J=7.3 Hz), 6.80-6.88 (1H, m), 6.91 (1H, d, J=7.9 Hz), 7.03-7.55 (8H, m).',\n",
       "   'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Example 310',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=498 [M+H]+.']},\n",
       " {'number': 'Example 311',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.73-1.85 (2H, m), 2.96-3.07 (1H, m), 3.27 (3H, s), 3.42 (2H, t, J=5.6 Hz), 3.56 (1H, d, J=13.5 Hz), 3.93-4.04 (1H, m), 4.25 (1H, d, J=13.2 Hz), 4.95 (1H, d, J=12.9 Hz), 5.13 (1H, s), 5.65 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.7 Hz), 6.69 (1H, d, J=7.7 Hz), 6.78-6.86 (1H, m), 7.03-7.15 (3H, m), 7.17-7.47 (5H, m).',\n",
       "   'MS: m/z=464 [M+H]+.']},\n",
       " {'number': 'Example 312',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.10 (3H, t, J=6.9 Hz), 2.79-2.91 (1H, m), 3.41 (2H, q, J=7.1 Hz), 3.46-3.69 (3H, m), 4.30 (1H, d, J=13.5 Hz), 5.01 (1H, d, J=13.5 Hz), 5.12 (1H, s), 5.65 (1H, d, J=13.5 Hz), 5.83 (1H, d, J=7.7 Hz), 6.68 (1H, d, J=7.7 Hz), 6.77-6.86 (1H, m), 7.03-7.12 (3H, m), 7.16-7.46 (5H, m).',\n",
       "   'MS: m/z=464 [M+H]+.']},\n",
       " {'number': 'Example 313',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.30-1.47 (1H, m), 1.49-1.67 (1H, m), 1.73-2.02 (4H, m), 2.09-2.23 (2H, m), 3.60 (1H, d, J=13.5 Hz), 4.39 (1H, d, J=12.9 Hz), 4.45-4.64 (1H, m), 4.93 (1H, d, J=12.6 Hz), 5.10 (1H, s), 5.65 (1H, d, J=13.5 Hz), 5.87 (1H, d, J=7.4 Hz), 6.67 (1H, d, J=8.0 Hz), 6.76-6.85 (1H, m), 7.08 (2H, d, J=3.8 Hz), 7.16 (2H, d, J=7.7 Hz), 7.23-7.31 (1H, m), 7.34-7.48 (2H, m).',\n",
       "   'MS: m/z=510 [M+H]+.']},\n",
       " {'number': 'Example 314',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=476 [M+H]+.']},\n",
       " {'number': 'Example 315',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=488 [M+H]+.']},\n",
       " {'number': 'Example 316',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.83 (1H, d, J=13.4 Hz), 4.34 (1H, d, J=13.1 Hz), 4.67 (1H, d, J=15.9 Hz), 5.05 (1H, d, J=15.9 Hz), 5.20 (1H, d, J=13.4 Hz), 5.33 (1H, s), 5.60 (1H, d, J=13.8 Hz), 5.64 (1H, d, J=7.8 Hz), 6.87 (3H, m), 7.05-7.19 (4H, m), 7.35-7.44 (2H, m), 7.74 (1H, d, 3.3 Hz), 7.77 (1H, d, 3.3 Hz).']},\n",
       " {'number': 'Example 317', 'title': '', 'content': ['', 'MS: m/z=464 [M+H]+']},\n",
       " {'number': 'Example 318', 'title': '', 'content': ['', 'MS: m/z=494 [M+H]+']},\n",
       " {'number': 'Example 319',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.18-3.35 (1H, m), 3.60 (1H, d, J=13.7',\n",
       "   'Hz), 4.37 (1H, d, J=13.2 Hz), 4.75-4.95 (1H, m), 5.07-5.15 (2H, m), 5.60 (1H, d, J=13.7 Hz), 5.85 (1H, d, J=7.7 Hz), 6.68 (1H, d, J=7.7 Hz), 6.79-6.88 (1H, m), 7.09-7.14 (3H, m), 7.16 (1H, d, J=7.7 Hz), 7.29-7.36 (1H, m), 7.36-7.41 (1H, m), 7.42-7.50 (1H, m).',\n",
       "   'MS: m/z=524 [M+H]+.']},\n",
       " {'number': 'Example 320',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.89 (9H, s), 0.97 (3H, d, J=7.1 Hz), 3.61 (1H, d, J=13.2 Hz), 4.43 (1H, d, J=13.2 Hz), 4.84-4.92 (2H, m), 5.11 (1H, s), 5.70 (1H, d, J=13.2 Hz), 5.83 (1H, d, J=7.7 Hz), 6.72 (1H, d, J=7.4 Hz), 6.79-6.85 (1H, m), 7.03-7.09 (2H, m), 7.16-7.24 (3H, m), 7.29-7.44 (2H, m).',\n",
       "   'MS: m/z=476 [M+H]+.']},\n",
       " {'number': 'Example 321',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.87 (0.75H, s), 3.01 (2.25H, s), 3.55 (1.5H, d, J=10.2 Hz), 3.62 (0.5H, 13.5 Hz), 4.17 (0.5H, d, J=13.2 Hz), 4.22 (1.5 Hz, J=12.9 Hz), 4.97 (1H, d, J=12.9 Hz), 5.02 (0.25H, s), 5.11 (0.75H, s), 5.63 (0.75H, d, J=13.5 Hz), 5.77-5.83 (1.25H, m), 6.64-6.68 (1H, m), 6.76-6.85 (1H, m), 7.01 (1H, d, J=7.5 Hz), 7.05-7.13 (2H, m), 7.17-7.45 (3H, m).']},\n",
       " {'number': 'Example 322',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 3.63 (1H, d, J=13.4 Hz), 4.51-4.59 (2H, m), 4.68-4.98 (4H, m), 5.13 (1H, d, J=12.9 Hz), 5.28 (1H, s), 5.71 (1H, d, J=13.3 Hz), 5.85 (1H, d, J=7.7 Hz), 6.77 (1H, d, J=7.4 Hz), 6.82-6.89 (1H, m), 7.12 (2H, d, J=3.5 Hz), 7.24 (1H, d, J=7.6 Hz), 7.33 (2H, d, J=4.4 Hz), 7.39 (1H, d, J=7.1 Hz), 7.42-7.50 (1H, m).',\n",
       "   'MS: m/z=470 [M+H]+.']},\n",
       " {'number': 'Example 323', 'title': '', 'content': ['', 'MS: m/z=450 [M+H]+']},\n",
       " {'number': 'Example 324', 'title': '', 'content': ['', 'MS: m/z=482 [M+H]+']},\n",
       " {'number': 'Example 325',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.93 (3H, s), 3.13 (1H, m), 3.86 (1H, d, J=13.6 Hz), 4.06 (3H, m), 4.26 (1H, d, J=13.3 Hz), 5.14 (1H, d, J=13.6 Hz), 5.44 (1H, s), 5.60 (2H, m), 6.82-7.49 (10H, m).',\n",
       "   'MS: m/z=478 [M+H]+.']},\n",
       " {'number': 'Example 326',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.07 (3H, d, J=6.6 Hz), 1.10 (3H, d, J=6.9 Hz), 3.70 (1H, d, J=13.5 Hz), 4.37 (1H, d, J=12.9 Hz), 4.75-4.85 (2H, m), 5.18 (1H, s), 5.76 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.8 Hz), 6.67 (1H, dd, J=1.2 Hz, 7.8 Hz), 6.77 (1H, t, J=7.8 Hz), 7.07 (1H, d, J=7.5 Hz), 7.18-7.30 (3H, m), 7.35-7.46 (2H, m).']},\n",
       " {'number': 'Example 327',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.06 (3H, d, J=6.9 Hz), 1.15 (3H, d, J=7.2 Hz), 3.60 (H, d, J=13.5 Hz), 4.36 (1H, d, J=12.9 Hz), 4.75-4.83 (2H, m), 5.10 (1H, s), 5.67 (1H, d, J=13.2 Hz), 5.86 (1H, d, J=7.5 Hz), 6.65 (1H, d, J=8, 1 Hz), 6.78 (1H, dd, J=1.8 Hz, 8.1 Hz), 7.08-7.18 (2H, m), 7.13 (1H, d, J=8.1 Hz), 7.24-7.30 (1H, m), 7.33-7.36 (1H, m), 7.39-7.45 (1H, m).']},\n",
       " {'number': 'Example 328',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.98 (0.4H, d, J=7.2 Hz), 1.07 (2.6H, d, J 6.6 Hz), 1.15 (2.6H, d, J=6.9 Hz), 1.27 (0.4H, d, J=0.6 Hz), 3.62 (0.9H, d, J=13.2 Hz), 3.73 (0.1H, d, J=13.8 Hz), 4.36 (1H, d, J=12.9 Hz), 4.77-4.88 (1H, m), 4.83 (1H, d, J=12.9 Hz), 5.07 (1H, s), 5.62 (1H, d, J=13.2 Hz), 5.77 (0.1H, d, J=7.5 Hz), 5.85 (0.9H, d, J=7.8 Hz), 6.69-6.83 (1H, m), 6.98-7.07 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.25-7.35 (2H, m), 7.40-7.45 (1H, m).']},\n",
       " {'number': 'Example 329',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.07 (3H, d, J=6.6 Hz), 1.15 (3H, d, J=6.9 Hz), 3.63 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.9 Hz), 4.77-4.8 (1H, m), 4.82 (1H, d, J=12.6 Hz), 5.06 (1H, s), 5.60 (1H, d, J=12.9 Hz), 5.85 (1H, d, J=7.8 Hz), 6.53 (1H, dd, J=3.0 Hz, 9.0 Hz), 6.80-6.86 (1H, m), 7.03 (1H, dd, J=4.2 Hz, 9.0 Hz), 7.16-7.30 (3H, m), 7.35 (1H, d, J=6.3 Hz), 7.40-7.45 (1H, m).']},\n",
       " {'number': 'Example 330',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.02 (3H, t, J=7.2 Hz), 3.07-3.22 (1H, m), 3.44-3.59 (1H, m), 4.00 (1H, d, J=13.4 Hz), 4.21 (1H, d, J=13.4 Hz), 5.06 (1H, d, J=13.3 Hz), 5.47-5.76 (3H, m), 6.84-6.92 (1H, m), 6.92-6.99 (1H, m), 7.04 (1H, d, J=7.6 Hz), 7.10-7.52 (6H, m).',\n",
       "   'MS: m/z=454 [M+H]+.']},\n",
       " {'number': 'Example 331',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.96 (0.79H, s), 3.00 (2.2H, s), 3.59 (0.75H, d, J=13.2 Hz), 3.62 (0.25H, d, J=13.8 Hz), 4.15 (0.25H, d, J=13.2 Hz), 4.21 (0.75H, d, J=12.9 Hz), 4.95-5.01 (2H, m), 5.07 (1H, s), 5.56 (1H, d, J=13.5 Hz), 5.75-5.79 (1H, m), 5.88 (1H, d, J=7.8 Hz), 6.63 (0.36H, d, J=7.8 Hz), 6.73 (1H, d, J=1.8 Hz), 6.83 (0.39H, d, J=7.2 Hz), 7.01-7.46 (7.25H, m).']},\n",
       " {'number': 'Example 332', 'title': '', 'content': ['', 'MS: m/z=484 [M+H]+']},\n",
       " {'number': 'Example 333',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=484 [M+H]+.']},\n",
       " {'number': 'Example 334',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.01-3.10 (1H, m), 3.16 (3H, s), 3.40 (2H, m), 3.89 (2H, d, J=13.4 Hz), 4.19 (1H, d, J=13.4 Hz), 5.06 (1H, d, J=13.6 Hz), 5.49 (1H, s), 5.58 (1H, d, J=13.4 Hz), 5.70 (1H, d, J=7.8 Hz), 6.89-7.48 (8H, m), 11.36 (1H, s).']},\n",
       " {'number': 'Example 335',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.00-3.09 (1H, m), 3.15 (3H, s), 3.39 (2H, m), 3.94 (1H, m), 4.00 (1H, d, J=13.2 Hz), 4.20 (1H, d, J=13.4 Hz), 5.06 (1H, d, J=13.4 Hz), 5.54 (1H, s), 5.65 (2H, m), 6.86-7.50 (8H, m), 11.54 (1H, brs).']},\n",
       " {'number': 'Example 336',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.01-3.09 (1H, m), 3.15 (3H, s), 3.40 (2H, m), 3.87-3.94 (1H, m), 3.98 (1H, d, J=13.6 Hz), 4.20 (1H, d, J=13.6 Hz), 5.06 (1H, d, J=13.4 Hz), 5.54 (1H, s), 5.62 (1H, d, J=13.6 Hz), 5.67 (1H, d, J=7.6 Hz), 6.78-7.50 (8H, m).',\n",
       "   'MS: m/z=468 [M+H]+']},\n",
       " {'number': 'Example 337',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.07 (1H, m), 3.16 (3H, s), 3.41 (2H, s), 3.89 (1H, d, J=13.7 Hz), 3.91 (1H, m), 4.19 (1H, d, J=13.6 Hz), 5.06 (1H, d, J=13.6 Hz), 5.48 (1H, s), 5.61 (1H, d, J=13.3 Hz), 5.69 (1H, d, J=7.6 Hz), 6.70-7.48 (9H, m).',\n",
       "   'MS: m/z=468 [M+H]+']},\n",
       " {'number': 'Example 338', 'title': '', 'content': ['', 'MS: m/z=468 [M+H]+']},\n",
       " {'number': 'Example 339',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.14 (3H, s), 3.18 (s, 3H), 3.50 (4H, m), 4.00 (1H, d, J=13.1 Hz), 4.49 (1H, d, J=13.3 Hz), 4.77 (1H, m), 4.95 (1H, d, J=13.3 Hz), 5.56 (1H, s), 5.68 (2H, m), 7.14 (8H, m).',\n",
       "   'MS: m/z=512 [M+H]+']},\n",
       " {'number': 'Example 340',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.12 (3H, s), 3.20 (3H, s), 3.51 (4H, m), 3.96 (1H, d, J=13.3 Hz), 4.53 (1H, d, J=13.4 Hz), 4.75 (1H, m), 4.97 (1H, d, J=13.1 Hz), 5.50 (1H, d, J=13.3 Hz), 5.54 (1H, s), 5.67 (1H, d, J=7.8 Hz), 6.87-7.54 (8H, m).',\n",
       "   'MS: m/z=530 [M+H]+']},\n",
       " {'number': 'Example 341', 'title': '', 'content': ['', 'MS: m/z=466 [M+H]+']},\n",
       " {'number': 'Example 342', 'title': '', 'content': ['', 'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 343', 'title': '', 'content': ['', 'MS: m/z=522 [M+H]+']},\n",
       " {'number': 'Example 344', 'title': '', 'content': ['', 'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 345', 'title': '', 'content': ['', 'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 346', 'title': '', 'content': ['', 'MS: m/z=470 [M+H]+']},\n",
       " {'number': 'Example 347',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) E: 2.88 (0.60H, s), 2.99 (2.40H, s), 3.67 (0.80H, d, J=13.8 Hz), 3.73 (0.20H, d, J=14.1 Hz), 4.16 (0.20H, d, J=11.1 Hz), 4.20 (0.80H, d, J=12.9 Hz), 4.97 (0.80H, d, J=12.9 Hz), 4.99 (0.20H, d, J=15 Hz), 5.10 (0.20H, s), 5.18 (0.80H, s), 5.69 (0.80H, d, J=13.5 Hz), 5.79 (0.20H, d, J=7.8 Hz), 5.85 (0.80H, d, J=7.5 Hz), 5.88 (0.20H, J=13.5 Hz), 6.62-6.66 (1H, m), 6.75-6.85 (1H, m), 6.98 (1H, d, J=7.5 Hz), 7.03-7.16 (0.5H, m), 7.19 (1H, d, J=6.9 Hz), 7.24-7.39 (2.5H, m), 7.43-7.48 (1H, m).']},\n",
       " {'number': 'Example 348',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.91 (0.75H, s), 2.99 (2.25H, s), 3.57 (0.75H, d, J=13.8 Hz), 3.63 (0.25H, d, 13.8 Hz), 4.17 (0.25H, d, J=12.9 Hz), 4.10 (0.75H, d, J=12.9 Hz), 4.99 (0.75H, d, J=12.9 Hz), 5.00 (0.25H, s), 5.01 (0.25H, d, J=12.3 Hz), 5.10 (0.75H, s), 5.61 (0.75H, d, J=13.5 Hz), 5.78 (0.25H, J=7.5 Hz), 5.80 (0.25H, J=15 Hz), 5.89 (0.75H, d, J=7.5 Hz), 6.60 (0.75H, d, J=8.4 Hz), 6.64 (0.25H, d, J=7.8 Hz), 6.78 (1H, dd, J=2.1 Hz, 8.1 Hz), 7.03 (1H, d, J=7.8 Hz), 7.04-7.21 (2H, m), 7.26-7.36 (2H, m), 7.41-7.47 (1H, m).']},\n",
       " {'number': 'Example 349',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.94 (0.66H, s), 3.00 (2.34H, s), 3.60 (0.78H, d, J=13.5 Hz), 3.65 (0.22H, d, J=3.8 Hz), 4.22 (1H, d, J=12.9 Hz), 4.94-5.00 (1H, m), 5.06 (1H, s), 5.54 (0.78H, d, J=13.2 Hz), 5.71 (0.22H, d, J=13.8 Hz), 5.78 (0.22H, d, J=7.5 Hz), 5.88 (0.78H, d, J=7.8 Hz), 6.49 (1H, dd, J=3.0 Hz, 9.0 Hz), 6.66 (0.22H, d, J=7.8 Hz), 6.82-6.88 (1H, m), 6.97-7.13 (2H, m), 7.16-7.21 (1H, m), 7.29-7.36 (2H, m), 7.41-7.46 (1H, m).']},\n",
       " {'number': 'Example 350',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.08 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 3.63 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.6 Hz), 4.78-4.87 (1H, m), 5.10 (1H, s), 5.67 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=2.1 Hz), 6.96-6.99 (1H, m), 7.08-7.12 (2H, m), 7.17 (1H, d, J=13.5 Hz), 7.25-7.32 (1H, m), 7.35-7.37 (1H, m), 7.42-7.47 (1H, m).']},\n",
       " {'number': 'Example 351',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.08 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 3.68 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.9 Hz), 4.76-4.84 (2H, m), 5.18 (1H, s), 5.72 (1H, d, J=13.5 Hz), 5.81 (1H, dd, J=0.9 Hz, 7.5 Hz), 6.56 (1H, d, J=7.2 Hz), 6.76-6.83 (1H, m), 6.90 (1H, t, J=9.0 Hz), 7.07-7.11 (1H, m), 7.19 (1H, d, J=7.5 Hz), 7.25-7.30 (1H, m), 7.35-7.45 (2H, m).']},\n",
       " {'number': 'Example 352',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.07 (3H, d, J=6.9 Hz), 1.15 (3H, d, J=7.1 Hz), 3.59 (1H, d, J=13.2 Hz), 4.36 (1H, d, J=9.9 Hz), 4.75-4.85 (2H, m), 5.11 (1H, s), 5.70 (1H, d, J=13.2 Hz), 5.84 (1H, d, J=7.8 Hz), 6.48-6.55 (1H, m), 6.71 (1H, dd, J=5.4 Hz, 8.4 Hz), 6.80 (1H, dd, J=2.4 Hz, 9.3 Hz), 7.11 (1H, d, J=7.8 Hz), 7.18 (1H, dd, J=0.9 Hz), 7.5 Hz), 7.25-7.30 (1H, m), 7.32-7.36 (1H, m), 7.39-7.45 (1H, m).']},\n",
       " {'number': 'Example 353',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.92 (0.66H, s), 3.01 (2.34H, s), 3.59 (0.78H, d, J=13.5 Hz), 3.67 (0.22H, d, J=13.8 Hz), 4.18 (0.22H, d, J=13.2 Hz), 4.21 (0.78H, d, J=12.9 Hz), 5.03 (1H, J=12.9 Hz), 5.05 (0.22H, s), 5.10 (0.78H, s), 5.62 (0.78H, d, J=13.5 Hz), 5.76-5.82 (0.44H, m), 5.87 (0.78H, d, J=7.8 Hz), 6.62 (0.78H, brs), 6.68 (0.22H, d, J=8.1 Hz), 6.85 (0.22H, d, J=7.8 Hz), 6.98-7.04 (1.56H, m), 7.11-7.39 (3H, m), 7.44-7.49 (1H, m).']},\n",
       " {'number': 'Example 354',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.89 (0.48H, s), 3.00 (2.52H, s), 3.64 (0.84H, d, J=13.5 Hz), 3.71 (0.16H, d, J=13.8 Hz), 4.21 (1H, d, J=12.9 Hz), 4.94 (0.84H, d, J=12.9 Hz), 4.98 (0.16H, d, J=12.9 Hz), 5.10 (0.16H, s), 5.19 (0.84H, s), 5.65 (0.84H, d, J=7.5 Hz), 5.77-5.85 (1.32H, m), 6.52 (0.84H, d, J=7.8 Hz), 6.64 (0.16H, d, J=7.8 Hz), 6.77-6.84 (1H, m), 6.89-6.95 (1H, m), 6.99 (1H, d, J=7.8 Hz), 7.07-7.25 (1H, m), 7.29-7.38 (2H, m), 7.42-7.47 (1H, m).']},\n",
       " {'number': 'Example 355',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 2.91 (0.48H, s), 3.00 (2.52H, s), 3.56 (d, J=13.8 Hz), 3.62 (0.16H, d, J=13.8 Hz), 4.18 (0.16H, d, J=12.9 Hz), 4.20 (0.84H, d, J=12.9 Hz), 4.96 (0.84H, d, J=12.9 Hz), 4.98 (0.16H, d, J=13.8 Hz), 5.03 (0.16H, s), 5.12 (0.84H, s), 5.64 (0.84H, d, J=13.5 Hz), 5.78-5.87 (0.32H, m), 5.89 (0.84H, d, J=7.8 Hz), 6.50-6.56 (0.84H, m), 6.63-6.69 (1.16H, m), 6.84 (1H, dd, J=2.4 Hz, 9.3 Hz), 6.94-6.97 (0.16H, m), 7.02 (0.84H, d, J=7.5 Hz), 7.13-7.23 (1H, m), 7.33-7.38 (2H, m), 7.42-7.47 (1H, m).']},\n",
       " {'number': 'Example 356',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.08 (3H, d, J=6.9 Hz), 1.15 (3H, d, J=6.9 Hz), 2.24 (3H, s), 3.68 (1H, d, J=13.2 Hz), 4.38 (1H, d, J=13.2 Hz), 4.76-4.85 (1H, m), 4.80 (1H, d, J=12.6 Hz), 5.14 (1H, s), 5.72 (1H, d, J=12.9 Hz), 5.76 (1H, d, J=7.8 Hz), 6.59 (1H, d, J=7.5 Hz), 6.72 (1H, t, J=7.5 Hz), 6.99 (1H, d, J=6.9 Hz), 7.07 (1H, d, J=7.8 Hz), 7.17-7.27 (2H, m), 7.33-7.42 (2H, m).']},\n",
       " {'number': 'Example 357',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.10 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 3.58 (1H, d, J=13.2 Hz), 4.37 (1H, d, J=12.9 Hz), 4.76-4.87 (1H, m), 4.85 (1H, d, J=12.6 Hz), 5.06 (1H, s), 5.65 (1H, d, J=13.2 Hz), 5.79 (1H, d, J=7.5 Hz), 6.54 (1H, s), 6.89 (1H, dd, J=1.5 Hz, 8.4 Hz), 6.95 (1H, d, J=7.8 Hz), 7.14-7.19 (1H, m), 7.22-7.28 (1H, m), 7.33-7.43 (2H, m).']},\n",
       " {'number': 'Example 358',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.07 (3H, d, J=6.9 Hz), 1.16 (3H, d, J=6.9 Hz), 2.20 (3H, s), 2.23 (3H, s), 3.77 (1H, d, J=12.6 Hz), 4.47 (1H, d, J=12.9 Hz), 4.78-4.86 (1H, m), 4.88 (1H, 12.9 Hz), 5.49 (1H, d, J=12.9 Hz), 5.83 (1H, d, J=11.1 Hz), 5.85 (1H, d, J=9.0 Hz), 6.64 (1H, d, J=7.8 Hz), 6.86 (1H, J=7.8 Hz), 7.16-7.40 (5H, m).']},\n",
       " {'number': 'Example 359',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.94 (3H, s), 3.07 (1H, m), 3.98-4.12 (4H, m), 4.25 (2H, d, J=13.4 Hz), 5.13 (2H, d, J=13.3 Hz), 5.56 (1H, s), 5.66 (1H, d, J=13.5 Hz), 5.68 (1H, t, J=7.8 Hz), 6.87-7.51 (8H, m).']},\n",
       " {'number': 'Example 360',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 325 (46.0 mg, 0.0960 mmol) was dissolved in methanol (0.5 ml) and tetrahydrofuran (0.5 ml), a 2N aqueous sodium hydroxide solution (0.241 ml, 0.482 mmol) was added, and the mixture was stirred for 30 minutes. To the reaction solution was added dilute hydrochloric acid to make the solution acidic, and the mixture was extracted with chloroform. The organic layer was dried with sodium sulfate, and the reaction solution was concentrated under reduced pressure. To the resulting compound 360 were added n-hexane-diethyl ether, and the precipitated residue was filtered to obtain 33 mg of a white solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.85-2.94 (1H, m), 3.52 (2H, m), 3.89 (1H, d, J=13.4 Hz), 3.98 (1H, td, J=9.1, 4.5 Hz), 4.24 (1H, d, J=13.6 Hz), 4.84 (1H, brs), 5.16 (1H, d, J=13.6 Hz), 5.48 (1H, s), 5.65 (2H, m), 6.86-7.55 (9H, m).',\n",
       "   'MS: m/z=436 [M+H]+',\n",
       "   'Using ester bodies synthesized according to Examples 107, 246 and 285, and according to the method of Example 320, compounds 361 to 382 were synthesized.']},\n",
       " {'number': 'Example 361',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.82 (3H, m), 3.49 (1H, brs), 3.71 (1H, dt, J=16.7, 5.0 Hz), 4.03 (1H, t, J=7.8 Hz), 4.08-4.15 (2H, m), 4.79 (1H, brs), 5.01 (1H, d, J=13.4 Hz), 5.25 (1H, s), 5.51 (1H, d, J=7.6 Hz), 6.72-7.41 (9H, m).']},\n",
       " {'number': 'Example 362',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=432 [M+H]+.']},\n",
       " {'number': 'Example 363',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=450 [M+H]+.']},\n",
       " {'number': 'Example 364',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=448 [M+H]+.']},\n",
       " {'number': 'Example 365',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=466 [M+H]+.']},\n",
       " {'number': 'Example 366',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=466 [M+H]+.']},\n",
       " {'number': 'Example 367',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=512 [M+H]+.']},\n",
       " {'number': 'Example 368',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=406 [M+H]+.']},\n",
       " {'number': 'Example 369',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Example 370',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.23 (3H, s), 1.24 (3H, s), 2.43 (1H, d, J=13.7 Hz), 2.81-2.91 (1H, m), 2.96-3.10 (1H, m), 3.61-3.72 (1H, m), 4.02-4.14 (1H, m), 4.15 (1H, d, J=13.7 Hz), 4.42 (1H, d, J=14.0 Hz), 4.95 (1H, s), 5.15 (1H, d, J=13.5 Hz), 5.74 (1H, d, J=7.7 Hz), 6.54-6.61 (2H, m), 6.86-6.94 (1H, m), 7.11-7.39 (8H, m).',\n",
       "   'MS: m/z=446 [M+H]+.']},\n",
       " {'number': 'Example 371',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.24 (3H, s), 1.26 (3H, s), 2.52 (1H, d, J=14.0 Hz), 3.56 (1H, d, J=13.7 Hz), 4.34 (1H, d, J=13.5 Hz), 4.36 (1H, d, J=13.5 Hz), 5.04 (1H, s), 5.23 (1H, d, J=13.7 Hz), 5.63 (1H, d, J=13.5 Hz), 5.84 (1H, d, J=7.7 Hz), 6.65 (1H, d, J=7.7 Hz), 6.76-6.84 (1H, m), 7.03-7.18 (5H, m), 7.27-7.47 (4H, m).',\n",
       "   'MS: m/z=464 [M+H]+.']},\n",
       " {'number': 'Example 372',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.21-1.68 (10H, m), 2.47 (1H, d, J=13.7 Hz), 3.55 (1H, d, J=13.5 Hz), 4.34 (1H, d, J=13.6 Hz), 4.35 (1H, d, J=13.6 Hz), 5.03 (1H, s), 5.25 (1H, d, J=13.5 Hz), 5.63 (1H, d, J=13.5 Hz), 5.79 (1H, d, J=7.7 Hz), 6.64 (1H, d, J=7.4 Hz), 6.76-6.84 (1H, m), 7.03 (1H, d, J=7.7 Hz), 7.06-7.10 (2H, m), 7.15 (1H, d, J=7.1 Hz), 7.28-7.37 (2H, m), 7.37-7.46 (1H, m).',\n",
       "   'MS: m/z=504 [M+H]+.']},\n",
       " {'number': 'Example 373',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=450 [M+H]+.']},\n",
       " {'number': 'Example 374',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=492 [M+H]+.']},\n",
       " {'number': 'Example 375',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=445 [M+H]+.']},\n",
       " {'number': 'Example 376',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=512 [M+H]+.']},\n",
       " {'number': 'Example 377',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=492 [M+H]+.']},\n",
       " {'number': 'Example 378', 'title': '', 'content': ['', 'MS: m/z=478 [M+H]+']},\n",
       " {'number': 'Example 379', 'title': '', 'content': ['', 'MS: m/z=478 [M+H]+']},\n",
       " {'number': 'Example 380', 'title': '', 'content': ['', 'MS: m/z=492 [M+H]+']},\n",
       " {'number': 'Example 381', 'title': '', 'content': ['', 'MS: m/z=492 [M+H]+']},\n",
       " {'number': 'Example 382',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.76-2.85 (1H, m), 3.58 (2H, m), 3.92 (1H, m), 3.98 (1H, d, J=13.5 Hz), 4.18 (1H, d, J=13.6 Hz), 4.80 (1H, brs), 5.10 (1H, t, J=8.8 Hz), 5.50-5.68 (3H, m), 6.87-7.52 (8H, m).']},\n",
       " {'number': 'Example 383',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 383A (1.00 g, 4.42 mmol) was dissolved in dichloromethane (50 ml), mCPBA (2.67 g, 15.5 mmol) was added at 0° C., and the mixture was stirred at room temperature for 4 hours. To the reaction solution was added an aqueous sodium sulfite solution, and the mixture was extracted with dichloromethane. The organic layer was washed with an aqueous sodium bicarbonate solution, and dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 1.06 g of a white solid 383B.',\n",
       "   '1H-NMR (CDCl3) δ: 4.81 (2H, s), 7.29-8.12 (6H, m).',\n",
       "   'To compound 383B (1.05 g, 4.07 mmol) was added methanol (11 ml), sodium borohydride (185 mg, 4.88 mmol) was added at 0° C., and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 1.01 g of a white solid 383C.',\n",
       "   '1H-NMR (CDCl3) δ: 2.84 (1H, d, J=3.7 Hz), 4.76 (1H, d, J=14.6 Hz), 5.25 (1H, d, J=14.6 Hz), 6.23 (1H, d, J=3.7 Hz), 7.28-7.96 (8H, m).',\n",
       "   'According to Example 107, compound 383 was synthesized by the same procedure.',\n",
       "   'MS: m/z=466 [M+H]+.',\n",
       "   'Using intermediates corresponding to 383A to 383C which are commercially available or known in the references, and according to the method of Example 383, compounds 384 to 389 were synthesized.']},\n",
       " {'number': 'Example 384',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.12-1.25 (6H, m), 2.87-3.26 (3H, m), 3.42-3.67 (1H, m), 4.00-4.08 (1H, m), 4.28-4.35 (1H, m), 4.56-4.83 (3H, m), 5.10-5.30 (1H, m), 5.89-6.11 (1H, m), 6.55-6.63 (0.5H, m), 6.71-6.75 (0.5H, m), 6.84-6.94 (1H, m), 7.03-7.47 (4H, m), 8.18-8.20 (0.5H, m), 8.48-8.49 (0.5H, m).']},\n",
       " {'number': 'Example 385',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.59 (3H, d, J=6.6 Hz), 1.07-1.14 (4H, m), 1.19-1.28 (1H, m), 2.22-2.32 (1H, m), 2.73-3.12 (3H, m), 4.71-4.81 (1H, m), 4.83 (1H, d, J=12.9 Hz), 4.96 (1H, d, J=12.9 Hz), 5.88 (1H, d, J=7.5 Hz), 5.89 (1H, s), 6.89 (1H, m), 7.00-7.04 (2H, m), 7.08-7.18 (2H, m), 7.22-7.27 (1H, m), 7.38 (1H, d, J=7.5 Hz), 7.58-7.61 (1H, m), 7.79 (1H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 386',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.95 (3H, d, J=6.9 Hz), 1.17 (3H, d, 6.9 Hz), 3.34 (2H, d, J=12.3 Hz), 4.39 (1H, d, J=12.9 Hz), 4.56-4.65 (1H, m), 4.85 (1H, d, J=12.9 Hz), 4.93 (1H, m), 5.77 (1H, d, J=7.5 Hz), 6.77-6.81 (1H, m), 6.79 (1H, d, J=7.5 Hz), 7.00-7.05 (1H, m), 7.21-7.29 (2H, m), 7.32-7.42 (3H, m).']},\n",
       " {'number': 'Example 387',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.06-1.17 (6H, m), 4.02-4.17 (1H, m), 4.61-4.78 (2H, m), 5.16 (1H, d, J=5.1 Hz), 5.72 (1H, t, J=8.1 Hz), 6.54 (0.5H, d, J=7.8 Hz), 6.84 (0.5H, d, J=7.8 Hz), 6.91-7.08 (2H, m), 7.16-7.47 (4H, m), 7.56-7.59 (1H, m), 8.00 (0.5H, J=6.3 Hz), 8.09-8.12 (0.5H, m), 8.51 (0.5H, s), 8.68 (0.5H, s).']},\n",
       " {'number': 'Example 388',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.19 (3H, d, J=6.9 Hz), 1.25 (3H, d, J=6.9 Hz), 2.76-2.91 (2H, m), 3.23-3.31 (1H, m), 4.17-4.33 (2H, m), 4.54-4.84 (2H, m), 5.18 (1H, s), 5.87 (1H, d, J=7.8 Hz), 6.70 (1H, d, J=5.1 Hz), 6.86 (1H, d, J=7.8 Hz), 7.04 (1H, d, J=5.1 Hz), 7.19-7.25 (2H, m), 7.32-7.38 (2H, m).']},\n",
       " {'number': 'Example 389',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.04-1.20 (6H, m), 2.83-3.02 (1H, m), 3.46-3.57 (1H, m), 3.75-3.85 (1H, m), 4.13-4.26 (1H, m), 4.32-4.50 (1H, m), 4.56-4.62 (1H, m), 4.89 (1H, d, J=13.2 Hz), 5.36 (1H, s), 5.44-5.50 (1H, m), 6.73 (1H, d, J=7.8 Hz), 6.86 (1H, t, J=7.5 Hz), 6.95-6.98 (1H, m), 7.09-6.54 (5H, m).']},\n",
       " {'number': 'Example 390',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 390A (14.8 g, 115 mmol) was added to methanol (200 ml), sodium methoxide (28% methanol solution, 22.2 g, 115 mmol) was added at room temperature, and the mixture was stirred for 1 hour. The solvent was distilled off under reduced pressure to obtain 17.3 g of a white solid. To 5.61 g of it was added phthalide (5.00 g, 37.3 mmol), and the mixture was stirred at 200° C. for 1 hour. The reaction solution was poured into water, the mixture was made acidic with hydrochloric acid, and the generated white precipitate was filtered. This was dissolved in chloroform, the solution was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-chloroform-diisopropyl ether, and the precipitated residue was filtered to obtain 2.44 g of a pale brown solid 390B.',\n",
       "   '1H-NMR (CDCl3) δ: 5.61 (2H, s), 6.92 (1H, td, J=7.6, 1.4 Hz), 7.01 (1H, dd, J=8.3, 1.3 Hz), 7.21 (1H, ddd, J=8.7, 7.0, 1.2 Hz), 7.32-7.54 (2H, m), 7.66 (1H, td, J=7.6, 1.4 Hz), 7.92-7.99 (1H, m), 8.17 (1H, dd, J=7.9, 1.3 Hz).',\n",
       "   'Compound 390B (2.44 g, 9.29 mmol) was dissolved in dichloromethane (30 ml), trifluoroacetic acid anhydride (1.44 ml, 10.2 mmol) and boron trifluoride etherate (0.235 ml, 1.86 mmol) were added, and the mixture was stirred at room temperature for 3 hours. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was washed with 1N hydrochloric acid and an aqueous saturated sodium chloride solution, and the solvent was distilled off. The resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (4:1, v/v) to obtain 1.76 g of a pale yellow solid 390C.',\n",
       "   '1H-NMR (CDCl3) δ: 5.36 (2H, s), 7.11 (1H, t, J=8.0 Hz), 7.43-7.66 (4H, m), 7.93 (1H, d, J=6.5 Hz), 8.19 (1H, dd, J=8.1, 1.8 Hz).',\n",
       "   'To compound 390C (1.76 g, 7.19 mmol) was added methanol (20 ml), sodium borohydride (327 mg, 8.63 mmol) was added at 0° C., and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into water, the mixture was extracted with dichloromethane, the organic layer was dried with sodium sulfate, and the solvent was distilled off. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 1.44 g of a white solid 390D.',\n",
       "   '1H-NMR (CDCl3) δ: 2.75 (1H, d, J=5.0 Hz), 5.18 (1H, d, J=13.6 Hz), 5.69 (1H, d, J=5.0 Hz), 5.89 (1H, d, J=13.6 Hz), 6.93 (1H, t, J=7.9 Hz), 7.19-7.43 (6H, m).',\n",
       "   'Compound 390 was synthesized by the same procedure as that of Example 107.',\n",
       "   'MS: m/z=452 [M+H]+',\n",
       "   'Using amines which are commercially available or known in the references and intermediates corresponding to 390A to 390D which are commercially available or known in the references, and according to the method of Example 390, compounds 391 to 412 were synthesized.']},\n",
       " {'number': 'Example 391',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=418 [M+H]+.']},\n",
       " {'number': 'Example 392',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=416 [M+H]+.']},\n",
       " {'number': 'Example 393',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=458 [M+H]+.']},\n",
       " {'number': 'Example 394',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=434 [M+H]+.']},\n",
       " {'number': 'Example 395',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=390 [M+H]+.']},\n",
       " {'number': 'Example 396', 'title': '', 'content': ['', 'MS: m/z=468 [M+H]+']},\n",
       " {'number': 'Example 397', 'title': '', 'content': ['', 'MS: m/z=452 [M+H]+']},\n",
       " {'number': 'Example 398',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.12-1.32 (6H, m), 4.25 (0.52H, d, J=12.9 Hz), 4.41 (0.48H, d, J=13.2 Hz), 4.58-4.79 (2H, m), 4.92-5.03 (2H, m), 5.73 (0.48H, d, J=7.8 Hz), 5.89 (0.52H, d, J=7.8 Hz), 6.12 (0.48H, d, J=12 Hz), 6.46-6.58 (1.52H, m), 6.74-6.78 (1H, m), 6.98 (1H, t, J=7.5 Hz), 7.10-7.14 (1H, m), 7.20-7.50 (4H, m).']},\n",
       " {'number': 'Example 399',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.12-1.31 (6H, m), 4.25 (0.75H, d, J=12.9 Hz), 4.43 (0.25H, d, J=12.9 Hz), 4.53-4.60 (0.50H, m), 4.67-4.78 (1.5H, m), 4.90-5.05 (2H, m), 5.70 (0.25H, d, J=7.8 Hz, 5.86 (0.75H, d, J=7.5 Hz), 6.18 (0.25H, d, J=13.5 Hz), 6.36-6.42 (0.75H, m), 6.49-6.56 (2H, m), 6.69-6.80 (1H, m), 6.94 (1H, d, J=7.8 Hz), 7.10-7.19 (0.25H, m), 7.21-7.50 (3.75H, m).']},\n",
       " {'number': 'Example 400', 'title': '', 'content': ['', 'MS: m/z=452 [M+H]+']},\n",
       " {'number': 'Example 401', 'title': '', 'content': ['', 'MS: m/z=452 [M+H]+']},\n",
       " {'number': 'Example 402', 'title': '', 'content': ['', 'MS: m/z=470 [M+H]+']},\n",
       " {'number': 'Example 403', 'title': '', 'content': ['', 'MS: m/z=436 [M+H]+']},\n",
       " {'number': 'Example 404', 'title': '', 'content': ['', 'MS: m/z=452 [M+H]+']},\n",
       " {'number': 'Example 405', 'title': '', 'content': ['', 'MS: m/z=452 [M+H]+']},\n",
       " {'number': 'Example 406', 'title': '', 'content': ['', 'MS: m/z=490 [M+H]+']},\n",
       " {'number': 'Example 407', 'title': '', 'content': ['', 'MS: m/z=436 [M+H]+']},\n",
       " {'number': 'Example 408', 'title': '', 'content': ['', 'MS: m/z=452 [M+H]+']},\n",
       " {'number': 'Example 409', 'title': '', 'content': ['', 'MS: m/z=452 [M+H]+']},\n",
       " {'number': 'Example 410', 'title': '', 'content': ['', 'MS: m/z=490 [M+H]+']},\n",
       " {'number': 'Example 411', 'title': '', 'content': ['', 'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 412',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.13-1.31 (12H, m), 3.28-3.37 (0.50H, m), 3.44-3.53 (0.50H, m), 4.29-4.36 (1H, m), 4.65-4.76 (2H, m), 4.98-5.05 (2H, m), 6.37 (0.5H, d, J=12.9 Hz), 6.45 (0.5H, d, J=7.5 Hz), 6.67 (0.5H, t, J=7.8 Hz), 6.81 (0.5H, 7.8 Hz), 6.98-7.08 (2H, m), 7.14 (0.5Hm d, J=7.8 Hz), 7.22-7.45 (2.5H, m).']},\n",
       " {'number': 'Example 413, Example 414',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 413A (200 mg, 0.544 mmol) obtained by the same procedure as that of Example 95, and 6,11-dihydrodibenzo[b,e]thiepin-11-ol (124 mg 0.554 mmol) were dissolved in acetic acid (8 ml), and concentrated sulfuric acid (2 ml) was added dropwise under water-cooling. After the mixture was stirred at room temperature for 30 minutes, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a crude product of 413B.',\n",
       "   'Compound 413B obtained in the first step was dissolved in dichloromethane (2 ml), acetic acid anhydride (0.154 ml, 1.63 mmol), triethylamine (0.226 ml, 1.63 mmol) and 4-(dimethylamino)pyridine (cat.) were added, and the mixture was stirred at room temperature for 30 minutes. The solvent was distilled off, the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), and diastereomers were resolved. They were dissolved in methanol (1 ml) and tetrahydrofran (1 ml), respectively, a 2N aqueous sodium hydroxide solution (0.198 ml, 0.397 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into water, and the mixture was made acidic with hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound were added ethyl acetate-diethyl ether, and the fractionation-precipitated residue was filtered to obtain compound 413 (22 mg) and compound 414 (20 mg), respectively.']},\n",
       " {'number': 'Example 413',\n",
       "  'title': '1H-NMR (DMSO-d6) δ: 1.20 (3H, d, J=7.4 Hz), 3.92 (1H, d, J=13.6 Hz), 4.45 (1H, d, J=13.4 Hz), 5.12 (1H, d, J=12.8 Hz), 5.60 (4H, m), 6.87-7.60 (9H, m).',\n",
       "  'content': ['1H-NMR (DMSO-d6) δ: 1.20 (3H, d, J=7.4 Hz), 3.92 (1H, d, J=13.6 Hz), 4.45 (1H, d, J=13.4 Hz), 5.12 (1H, d, J=12.8 Hz), 5.60 (4H, m), 6.87-7.60 (9H, m).',\n",
       "   'MS: m/z=488 [M+H]+']},\n",
       " {'number': 'Example 414',\n",
       "  'title': 'MS: m/z=488 [M+H]+',\n",
       "  'content': ['MS: m/z=488 [M+H]+',\n",
       "   'According to Example 413, compounds 414 to 475 were synthesized using the same procedure.']},\n",
       " {'number': 'Example 415',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.16 (3H, d, J=7.3 Hz), 3.88 (1H, d, J=13.3 Hz), 4.41 (1H, d, J=13.3 Hz), 5.07 (1H, d, J=13.0 Hz), 5.42-5.52 (1H, m), 5.62 (3H, m), 6.82-7.56 (9H, m).',\n",
       "   'MS: m/z=488 [M+H]+']},\n",
       " {'number': 'Example 416',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.35 (3H, d, J=7.3 Hz), 3.88 (1H, d, J=13.3 Hz), 4.44 (1H, d, J=12.7 Hz), 5.15 (1H, d, J=12.5 Hz), 5.16 (1H, m), 5.29 (1H, s), 5.57 (1H, d, J=13.4 Hz), 5.64 (1H, d, J=7.8 Hz), 6.81-7.45 (9H, m).',\n",
       "   'MS: m/z=488 [M+H]']},\n",
       " {'number': 'Example 417',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.22 (3H, d, J=7.2 Hz), 4.32 (1H, d, J=13.9 Hz), 4.49 (1H, d, J=13.1 Hz), 4.90 (1H, d, J=13.3 Hz), 5.15 (1H, s), 5.47-5.65 (2H, m), 5.83 (1H, d, J=8.1 Hz), 6.69 (1H, d, J=6.5 Hz), 6.80-6.87 (1H, m), 7.07-7.24 (5H, m), 7.54 (1H, d, J=7.9 Hz).',\n",
       "   'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 418',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.48 (3H, d, J=7.1 Hz), 3.63 (1H, d, J=13.2 Hz), 4.49 (1H, d, J=12.6 Hz), 5.03 (1H, s), 5.28-5.45 (2H, m), 5.53 (1H, d, J=13.5 Hz), 5.73 (1H, d, J=7.7 Hz), 6.50 (1H, dd, J=8.7, 2.6 Hz), 6.79-6.86 (1H, m), 6.90 (1H, d, J=9.1 Hz), 7.02 (1H, dd, J=8.8, 5.2 Hz), 7.10 (1H, ddd, J=8.1, 2.5, 1.2 Hz), 7.25 (1H, d, J=7.7 Hz), 7.30 (1H, dd, J=8.5, 5.5 Hz).',\n",
       "   'MS: m/z=524 [M+H]+.']},\n",
       " {'number': 'Example 419',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.50 (3H, d, J=7.1 Hz), 4.28 (1H, d, J=13.7 Hz), 4.50 (1H, d, J=12.4 Hz), 5.17 (1H, s), 5.26-5.44 (2H, m), 5.60-5.69 (2H, m), 6.65 (1H, d, J=7.4 Hz), 6.73-6.80 (1H, m), 7.01-7.21 (5H, m), 7.48 (1H, d, J=8.0 Hz).',\n",
       "   'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 420',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.49 (3H, d, J=7.4 Hz), 3.51 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=12.6 Hz), 5.12 (1H, s), 5.28-5.44 (2H, m), 5.60-5.70 (2H, m), 6.65 (1H, d, J=7.4 Hz), 6.73-6.80 (1H, m), 7.00-7.06 (2H, m), 7.10 (1H, d, J=8.5 Hz), 7.14 (1H, d, J=8.0 Hz), 7.23 (1H, dd, J=8.2, 2.2 Hz), 7.31 (1H, d, J=1.9 Hz).',\n",
       "   'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 421',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.53 (3H, d, J=7.4 Hz), 3.59 (1H, d, J=13.4 Hz), 4.51 (1H, d, J=12.6 Hz), 5.12 (1H, s), 5.30-5.48 (2H, m), 5.62-5.70 (2H, m), 6.71 (1H, d, J=7.7 Hz), 6.80-6.83 (1H, m), 7.07-7.11 (2H, m), 7.18 (1H, d, J=7.7 Hz), 7.22 (1H, s), 7.28 (1H, d, J=8.4 Hz), 7.39 (1H, d, J=8.1 Hz).',\n",
       "   'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 422',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.49 (3H, d, J=7.4 Hz), 3.59 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=12.4 Hz), 5.12 (1H, s), 5.29-5.39 (2H, m), 5.66 (1H, d, J=13.5 Hz), 5.73 (1H, d, J=7.7 Hz), 6.61 (1H, d, J=8.2 Hz), 6.73 (1H, dd, J=8.2, 2.2 Hz), 7.04 (1H, d, J=2.2 Hz), 7.12-7.20 (2H, m), 7.23-7.27 (1H, m), 7.31 (1H, d, J=6.3 Hz), 7.36-7.44 (1H, m).',\n",
       "   'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 423',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.47 (3H, d, J=7.1 Hz), 3.69 (1H, d, J=13.5 Hz), 4.49 (1H, d, J=12.6 Hz), 5.21 (1H, s), 5.27 (1H, d, J=12.6 Hz), 5.30-5.40 (1H, m), 5.70 (1H, d, J=7.7 Hz), 5.75 (1H, d, J=13.5 Hz), 6.65 (1H, dd, J=7.8, 1.5 Hz), 6.73 (1H, t, J=7.7 Hz), 7.13 (1H, d, J=7.7 Hz), 7.15-7.22 (2H, m), 7.25-7.29 (1H, m), 7.32 (1H, d, J=8.0 Hz), 7.37-7.45 (1H, m).',\n",
       "   'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 424',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=490 [M+H]+.']},\n",
       " {'number': 'Example 425',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=490 [M+H]+.']},\n",
       " {'number': 'Example 426',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=490 [M+H]+.']},\n",
       " {'number': 'Example 427',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.14 (3H, d, J=6.9 Hz), 3.64 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=12.8 Hz), 4.88 (1H, d, J=12.8 Hz), 5.08 (1H, s), 5.51 (1H, m), 5.60 (1H, d, J=13.5 Hz), 5.93 (1H, d, J=8.1 Hz), 6.58 (1H, d, J=8.1 Hz), 6.95 (1H, dd, J=2.0, 8.1 Hz), 7.18 (2H, m), 7.29 (1H, m), 7.37-7.45 (2H, m).']},\n",
       " {'number': 'Example 428',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.41 (3H, d, J=7.5 Hz), 3.61 (1H, d, J=13.4 Hz), 4.55 (1H, d, J=12.5 Hz), 5.06 (1H, d, J=12.5 Hz), 5.16 (1H, s), 5.34 (1H, m), 5.63 (1H, d, J=13.4 Hz), 5.87 (1H, d, J=8.1 Hz), 6.61 (1H, d, J=8.1 Hz), 6.93 (1H, dd, J=1.8, 8.1 Hz), 7.16-7.41 (5H, m).']},\n",
       " {'number': 'Example 429',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.15 (3H, d, J=7.4 Hz), 3.64 (1H, d, J=13.5 Hz), 4.44 (1H, d, J=13.2 Hz), 4.87 (1H, d, J=13.2 Hz), 5.44-5.57 (1H, m), 5.68 (1H, d, J=13.2 Hz), 5.83 (1H, d, J=7.7 Hz), 5.94 (1H, s), 6.78-6.91 (2H, m), 7.08-7.18 (3H, m), 7.28-7.38 (3H, m).',\n",
       "   'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 430',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 431',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 432',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.21 (3H, d, J=7.4 Hz), 3.70 (1H, d, J=13.5 Hz), 4.43 (1H, d, J=13.2 Hz), 4.93 (1H, d, J=13.2 Hz), 5.21 (1H, s), 5.46-5.60 (1H, m), 5.70 (1H, d, J=13.5 Hz), 5.84 (1H, d, J=7.7 Hz), 6.73 (1H, d, J=7.1 Hz), 6.82-6.89 (1H, m), 7.08-7.17 (2H, m), 7.22 (1H, d, J=7.7 Hz), 7.35 (1H, d, J=8.0 Hz), 7.55 (1H, d, J=8.0 Hz), 7.67 (1H, s).',\n",
       "   'MS: m/z=071 [M+H]+.']},\n",
       " {'number': 'Example 433',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.22 (3H, d, J=7.1 Hz), 3.56 (1H, d, J=13.5 Hz), 4.48 (1H, d, J=13.2 Hz), 4.90 (1H, d, J=13.2 Hz), 5.09 (1H, s), 5.46-5.60 (1H, m), 5.62 (1H, d, J=13.2 Hz), 5.82 (1H, d, J=7.7 Hz), 6.69 (1H, d, J=7.4 Hz), 6.84 (1H, dt, J=10.0, 3.5 Hz), 7.04-7.14 (3H, m), 7.17 (1H, d, J=7.7 Hz), 7.42 (1H, dd, J=8.0, 1.6 Hz), 7.55 (1H, d, J=1.9 Hz).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 434',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.44 (3H, d, J=7.3 Hz), 3.54 (1H, d, J=13.4 Hz), 4.54 (1H, d, J=12.5 Hz), 5.10 (1H, d, J=12.5 Hz), 5.16 (1H, s), 5.31-5.45 (1H, m), 5.65 (1H, d, J=13.3 Hz), 5.73 (1H, d, J=7.8 Hz), 6.71 (1H, d, J=7.8 Hz), 6.77-6.84 (1H, m), 7.03-7.11 (3H, m), 7.22 (1H, d, J=7.6 Hz), 7.40 (1H, dd, J=8.2, 2.0 Hz), 7.48 (1H, d, J=2.0 Hz).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 435',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.14 (3H, d, J=7.3 Hz), 3.70 (1H, d, J=13.4 Hz), 4.51 (1H, d, J=13.1 Hz), 4.90 (1H, d, J=12.8 Hz), 5.19 (1H, s), 5.44-5.58 (1H, m), 5.62 (1H, d, J=13.3 Hz), 5.87 (1H, d, J=7.6 Hz), 6.86 (1H, d, J=7.9 Hz), 7.07 (1H, dd, J=8.2, 1.4 Hz), 7.15-7.22 (2H, m), 7.27-7.51 (4H, m).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 436',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.48 (3H, d, J=7.4 Hz), 3.71 (1H, d, J=13.3 Hz), 4.60 (1H, d, J=12.6 Hz), 5.21 (1H, d, J=12.6 Hz), 5.29 (1H, s), 5.32-5.46 (1H, m), 5.70 (1H, d, J=13.3 Hz), 5.80 (1H, d, J=7.7 Hz), 6.91 (1H, d, J=7.9 Hz), 7.08 (1H, d, J=7.4 Hz), 7.20-7.29 (2H, m), 7.33-7.51 (4H, m).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 437',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.21 (3H, d, J=7.3 Hz), 3.60 (1H, d, J=13.6 Hz), 4.46 (1H, d, J=13.1 Hz), 4.90 (1H, d, J=12.8 Hz), 5.15 (1H, s), 5.47-5.59 (1H, m), 5.68 (1H, d, J=13.4 Hz), 5.83 (1H, d, J=7.6 Hz), 6.70 (1H, d, J=7.3 Hz), 6.80-6.88 (1H, m), 7.07-7.26 (6H, m).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 438',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.42 (3H, d, J=7.3 Hz), 3.57 (1H, d, J=13.3 Hz), 4.55 (1H, d, J=12.5 Hz), 5.05 (1H, d, J=12.5 Hz), 5.23 (1H, s), 5.32-5.47 (1H, m), 5.70 (1H, d, J=13.4 Hz), 5.77 (1H, d, J=7.6 Hz), 6.74 (1H, d, J=7.8 Hz), 6.79-6.87 (1H, m), 7.04-7.26 (6H, m).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 439',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.20 (3H, d, J=7.2 Hz), 2.29 (3H, s), 3.76 (1H, d, J=13.3 Hz), 4.54 (1H, d, J=13.1 Hz), 4.92 (1H, d, J=13.1 Hz), 5.18 (1H, s), 5.50-5.62 (1H, m), 5.71 (1H, d, J=13.4 Hz), 5.84 (1H, d, J=7.7 Hz), 6.63 (1H, d, J=7.4 Hz), 6.78 (1H, t, J=7.6 Hz), 7.06 (1H, d, J=7.6 Hz), 7.17 (1H, d, J=7.7 Hz), 7.23 (1H, d, J=7.6 Hz), 7.28-7.34 (1H, m), 7.39-7.51 (2H, m).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 440',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.45 (3H, d, J=7.2 Hz), 2.27 (3H, s), 3.74 (1H, d, J=13.3 Hz), 4.61 (1H, d, J=12.4 Hz), 5.07 (1H, d, J=12.4 Hz), 5.27 (1H, s), 5.31-5.44 (1H, m), 5.75 (1H, d, J 13.3 Hz), 5.80 (1H, d, J=7.7 Hz), 6.67 (1H, d, J=7.1 Hz), 6.77 (1H, t, J=7.6 Hz), 7.04 (1H, d, J=7.1 Hz), 7.21-7.47 (5H, m).',\n",
       "   'MS: m/z=433 [M+H]+.']},\n",
       " {'number': 'Example 441',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.22 (3H, d, J=7.2 Hz), 3.94 (1H, d, J=13.3 Hz), 4.45 (1H, d, J=13.4 Hz), 5.08 (1H, d, J=12.8 Hz), 5.56 (4H, dm), 6.84-7.54 (8H, m).']},\n",
       " {'number': 'Example 442',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.37 (3H, d, J=7.2 Hz), 3.98 (1H, d, J=13.4 Hz), 4.48 (1H, d, J=13.1 Hz), 5.21 (1H, d, J=12.9 Hz), 5.22 (1H, m), 5.38 (1H, s), 5.52 (1H, d, J=13.4 Hz), 5.67 (1H, d, J=7.6 Hz), 6.87-7.57 (8H, m).']},\n",
       " {'number': 'Example 443',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.19 (3H, d, J=7.2 Hz), 3.92 (1H, d, J=13.4 Hz), 4.43 (1H, d, J=13.1 Hz), 5.05 (1H, d, J=13.0 Hz), 5.54 (4H, m), 7.29 (8H, m).',\n",
       "   'MS: m/z=522 [M+H]+']},\n",
       " {'number': 'Example 444',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.13 (3H, d, J=7.0 Hz), 4.00 (1H, d, J=14.2 Hz), 4.40 (1H, d, J=13.3 Hz), 5.05 (1H, d, J=13.3 Hz), 5.44 (1H, m), 5.62-5.71 (3H, m), 6.82-7.56 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 445',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.23 (3H, d, J=7.2 Hz), 4.14 (1H, d, J=13.8 Hz), 4.60 (1H, d, J=13.6 Hz), 5.10 (1H, d, J=13.3 Hz), 5.48 (1H, d, J=15.6 Hz) 5.49 (1H, m), 5.69 (1H, d, J=7.9 Hz), 5.70 (1H, s), 6.89-7.47 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 446',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.22 (3H, d, J=6.9 Hz), 3.93 (1H, d, J=13.1 Hz), 4.49 (1H, d, J=13.4 Hz), 5.05 (1H, d, J=13.7 Hz), 5.57 (4H, m), 6.87-7.61 (8H, m).',\n",
       "   'MS: m/z=522 [M+H]+']},\n",
       " {'number': 'Example 447',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.41 (3H, d, J=7.2 Hz), 3.98 (1H, d, J=13.3 Hz), 4.48 (1H, d, J=12.9 Hz), 5.21 (1H, d, J=14.4 Hz), 5.22 (1H, m), 5.39 (1H, s), 5.52 (1H, d, J=13.6 Hz), 5.67 (1H, d, J=7.6 Hz), 6.88-7.57 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 448',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.19 (3H, d, J=7.2 Hz), 3.94 (1H, d, J=13.3 Hz), 4.44 (1H, d, J=13.3 Hz), 5.12 (1H, d, J=13.1 Hz), 5.46-5.68 (3H, m), 5.76 (1H, d, J=7.6 Hz), 7.27 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 449',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.14 (3H, d, J=7.2 Hz), 3.93 (1H, d, J=13.3 Hz), 4.40 (1H, d, J=13.1 Hz), 5.07 (1H, d, J=13.0 Hz), 5.46 (1H, m), 5.62 (1H, d, J=15.6 Hz), 5.64 (1H, s), 5.75 (1H, d, J=7.6 Hz), 6.94-7.55 (8H, m).',\n",
       "   'MS: m/z=522 [M+H]+']},\n",
       " {'number': 'Example 450',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.14 (3H, d, J=7.2 Hz), 4.03 (1H, d, J=13.3 Hz), 4.41 (1H, d, J=13.3 Hz), 5.06 (1H, d, J=13.0 Hz), 5.46 (1H, m), 5.69 (3H, m), 6.88-7.57 (8H, m).',\n",
       "   'MS: m/z=522 [M+H]+']},\n",
       " {'number': 'Example 451',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.35 (3H, d, J=7.2 Hz), 4.03 (1H, d, J=13.3 Hz), 4.43 (1H, d, J=13.0 Hz), 5.14 (1H, t, J=12.6 Hz), 5.15 (1H, m), 5.42 (1H, s), 5.63 (1H, d, J=13.5 Hz), 5.65 (1H, d, J=7.8 Hz), 6.88-7.44 (8H, m).',\n",
       "   'MS: m/z=522 [M+H]+']},\n",
       " {'number': 'Example 452',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.42 (3H, d, J=7.2 Hz), 4.14 (1H, d, J=13.9 Hz), 4.57 (1H, d, J=13.1 Hz), 5.14 (1H, d, J=13.0 Hz), 5.15 (1H, m), 5.30 (1H, d, J=13.0 Hz), 5.40 (1H, s), 5.68 (1H, d, J=7.7 Hz), 6.89-7.38 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 453',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.40 (3H, d, J=7.4 Hz), 4.05 (1H, d, J=13.4 Hz), 4.47 (1H, d, J=13.1 Hz), 5.18 (1H, m), 5.19 (1H, d, J=13.2 Hz), 5.46 (1H, s), 5.65 (1H, d, J=13.4 Hz), 5.74 (1H, d, J=7.6 Hz), 6.89-7.52 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 454',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.20 (3H, d, J=7.2 Hz), 3.89 (1H, d, J=13.4 Hz), 4.46 (1H, d, J=13.4 Hz), 5.05 (1H, d, J=13.4 Hz), 5.44-5.66 (4H, m), 6.83-7.63 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 455',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.16 (3H, d, J=7.3 Hz), 3.92 (1H, d, J=13.3 Hz), 4.39 (1H, d, J=13.1 Hz), 5.07 (1H, d, J=13.3 Hz), 5.47 (1H, m), 5.60 (1H, d, J=13.3 Hz), 5.68 (1H, s), 5.72 (1H, d, J=7.6 Hz), 7.07-7.54 (8H, m).',\n",
       "   'MS: m/z=522 [M+H]+']},\n",
       " {'number': 'Example 456',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.13 (5H, d, J=6.3 Hz), 4.00 (1H, d, J=13.4 Hz), 4.52 (1H, d, J=13.6 Hz), 5.09 (1H, d, J=13.3 Hz), 5.49-5.69 (4H, m), 6.84-7.51 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 457',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.40 (3H, d, J=7.2 Hz), 4.02 (1H, d, J=13.1 Hz), 4.53 (1H, d, J=13.3 Hz), 5.20 (1H, d, J=12.9 Hz), 5.26 (1H, m), 5.67 (3H, m), 7.18 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 458',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.15 (3H, d, J=7.3 Hz), 3.91 (1H, d, J=13.4 Hz), 4.39 (1H, d, J=13.3 Hz), 5.06 (1H, d, J=13.3 Hz), 5.45 (1H, m), 5.62 (1H, s), 5.63 (1H, t, J=13.5 Hz), 5.74 (1H, d, J=7.6 Hz), 6.71-7.55 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 459',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.39 (3H, d, J=7.4 Hz), 3.95 (1H, d, J=13.4 Hz), 4.46 (1H, d, J=12.9 Hz), 5.19 (1H, d, J=13.1 Hz), 5.20 (1H, m), 5.41 (1H, s), 5.62 (1H, d, J=13.4 Hz), 5.76 (1H, d, J=7.7 Hz), 6.72-7.50 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 460',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.42 (3H, d, J=7.2 Hz), 3.94 (1H, d, J=13.3 Hz), 4.50 (1H, d, J=13.1 Hz), 5.17 (1H, d, J=12.4 Hz), 5.18 (1H, m), 5.39 (1H, s), 5.60-5.69 (2H, m), 6.87-7.42 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 461',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.35 (3H, d, J=7.2 Hz), 3.91 (1H, d, J=13.0 Hz), 4.43 (1H, d, J=13.1 Hz), 5.15 (1H, d, J=12.8 Hz), 5.16 (1H, m), 5.41 (1H, s), 5.47 (1H, d, J=13.0 Hz), 5.69 (1H, d, J=7.6 Hz), 7.00-7.45 (8H, m).',\n",
       "   'MS: m/z=506 [M+H]+']},\n",
       " {'number': 'Example 462',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.21 (3H, d, J=7.3 Hz), 3.97 (1H, d, J=13.3 Hz), 4.46 (1H, d, J=13.1 Hz), 5.09 (1H, d, J=13.6 Hz), 5.50 (1H, m), 5.51 (1H, d, J=12.8 Hz), 5.65 (1H, s), 5.72 (1H, d, J=7.6 Hz), 6.85-7.55 (7H, m).',\n",
       "   'MS: m/z=524 [M+H]+']},\n",
       " {'number': 'Example 463', 'title': '', 'content': ['', 'MS: m/z=568 [M+H]+']},\n",
       " {'number': 'Example 464', 'title': '', 'content': ['', 'MS: m/z=502 [M+H]+']},\n",
       " {'number': 'Example 465', 'title': '', 'content': ['', 'MS: m/z=502 [M+H]+']},\n",
       " {'number': 'Example 466', 'title': '', 'content': ['', 'MS: m/z=540 [M+H]+']},\n",
       " {'number': 'Example 467', 'title': '', 'content': ['', 'MS: m/z=540 [M+H]+']},\n",
       " {'number': 'Example 468',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.13 (3H, d, J=5.8 Hz), 4.20 (1H, d, J=13.6 Hz), 4.58 (1H, d, J=12.7 Hz), 4.99 (1H, d, J=12.7 Hz), 5.29-5.42 (3H, m), 5.84 (1H, d, J=7.8 Hz), 6.60 (1H, m), 6.79-7.01 (3H, m), 7.19-7.28 (4H, m).',\n",
       "   'MS: m/z=524 [M+H]+.']},\n",
       " {'number': 'Example 469',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.19 (3H, d, J=7.6 Hz), 4.21 (1H, d, J=13.9 Hz), 4.48 (1H, d, J=13.3 Hz), 4.89 (1H, d, J=13.3 Hz), 5.22 (1H, s), 5.37 (1H, dd, J=2.1, 13.9 Hz), 5.52 (1H, m), 5.86 (1H, d, J=7.6), 6.55 (1H, m), 6.83 (1H, m), 6.96 (1H, m), 7.14 (1H, d, J=7.6 Hz), 7.19-7.30 (4H, m).',\n",
       "   'MS: m/z=524 [M+H]+.']},\n",
       " {'number': 'Example 470',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.19 (3H, d, J=7.3 Hz), 3.65 (1H, d, J=13.5 Hz), 4.47 (1H, d, J=13.0 Hz), 4.87 (1H, d, J=13.0 Hz), 5.18 (1H, s), 5.50 (1H, m), 5.69 (1H, d, J=13.5 Hz), 5.85 (1H, d, J=7.8 Hz), 6.53 (1H, m), 6.83 (1H, m), 6.91-7.01 (2H, m), 7.11 (1H, d, J=7.6 Hz), 7.10-7.20 (3H, m).',\n",
       "   'MS: m/z=524 [M+H]+.']},\n",
       " {'number': 'Example 471',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.13 (3H, d, J=6.1 Hz), 3.63 (1H, d, J=13.5 Hz), 4.56 (1H, d, J=12.5 Hz), 5.02 (1H, d, J=12.5 Hz), 5.26 (1H, s), 5.38 (1H, m), 5.71 (1H, d, J=13.5 Hz), 5.81 (1H, d, J=7.8 Hz), 6.57 (1H, m), 6.81 (1H, m), 6.91 (1H, m), 6.99 (1H, dd, J=2.6, 8.2 Hz), 7.05 (1H, dd, J=2.6, 8.7 Hz), 7.17 (2H, m), 7.19 (1H, d, J=7.6 Hz).',\n",
       "   'MS: m/z=524 [M+H]+.']},\n",
       " {'number': 'Example 472',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.21 (3H, d, J=7.4 Hz), 3.66 (1H, d, J=13.5 Hz), 4.47 (1H, d, J=13.3 Hz), 4.88 (1H, d, J=13.3 Hz), 5.17 (1H, s), 5.52 (1H, m), 5.66 (1H, d, J=13.5 Hz), 5.85 (1H, d, J=7.7 Hz), 6.54 (1H, m), 6.83 (1H, m), 6.95 (1H, m), 7.11-7.14 (2H, m), 7.23-7.29 (2H, m), 7.41 (1H, d, J=2.0 Hz).',\n",
       "   'MS: m/z=540 [M+H]+.']},\n",
       " {'number': 'Example 473',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.13 (3H, d, J=6.2 Hz), 3.63 (1H, d, J=13.5 Hz), 4.55 (1H, d, J=12.6 Hz), 5.04 (1H, d, J=12.6 Hz), 5.25 (1H, s), 5.38 (1H, m), 5.69 (1H, d, J=13.5 Hz), 5.80 (1H, d, J=7.7 Hz), 6.58 (1H, m), 6.82 (1H, m), 6.92 (1H, m), 7.13 (1H, m), 7.19 (1H, d, J=7.7 Hz), 7.24-7.29 (2H, m), 7.34 (1H, d, J=2.2 Hz).',\n",
       "   'MS: m/z=540 [M+H]+.']},\n",
       " {'number': 'Example 474',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1HNMR (CDCl3) δ: 1.19 (3H, d, J=7.3 Hz), 4.40 (1H, d, J=13.9 Hz), 4.59 (1H, d, J=13.0 Hz), 5.02 (1H, d, J=13.0 Hz), 5.31 (1H, s), 5.39 (1H, m), 5.66 (1H, d, J=13.9 Hz), 5.84 (1H, d, J=7.8 Hz), 6.58 (1H, m), 6.82 (1H, m), 6.92 (1H, m), 7.10 (1H, m), 7.19 (1H, dd, J=3.7, 7.9 Hz), 7.20-7.26 (2H, m), 7.51 (1H, m).',\n",
       "   'MS: m/z=540 [M+H]+.']},\n",
       " {'number': 'Example 475',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=522 [M+H]+.']},\n",
       " {'number': 'Example 476',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 476A (3.00 g, 9.83 mmol) synthesized by the same procedure as that of Example was dissolved in dimethylformamide (30 ml), copper (I) cyanide (2.64 g, 29.5 mmol) was added, and the mixture was stirred at 150° C. for 7 hours. The reaction solution was cooled to room temperature, and filtered with celite. To the filtrate was added water, the mixture was extracted with ethyl acetate, and the organic layer was washed with water. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (1:1, v/v). To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 1.81 g of a white solid 476B.',\n",
       "   '1H-NMR (CDCl3) δ: 4.29 (2H, s), 7.28-7.48 (4H, m), 7.78 (2H, t, J=7.5 Hz), 8.20 (1H, dd, J=8.1, 1.5 Hz).',\n",
       "   'Compound 476 was synthesized by the same procedure as that of Example 107.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.16 (3H, d, J=7.0 Hz), 4.01 (1H, d, J=14.0 Hz), 4.65 (1H, d, J=13.7 Hz), 5.04 (1H, d, J=13.3 Hz), 5.45 (1H, t, J=8.1 Hz), 5.66 (1H, d, J=7.6 Hz), 5.74 (1H, s), 5.84 (1H, d, J=14.0 Hz), 6.87-7.93 (7H, m).',\n",
       "   'MS: m/z=513 [M+H]+']},\n",
       " {'number': 'Example 477',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To compound 476B (859 mg, 3.42 mmol) was added concentrated sulfuric acid (13 ml), and the mixture was stirred at room temperature for 18 hours, and at 60° C. for 2 hours. The reaction solution was added to water, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 387 mg of a pale yellow solid. To the resulting compound was added methanol (10 ml), a 10N aqueous sodium hydroxide solution (6 ml) was added, and the mixture was stirred at 90° C. for 5 hours. The reaction solution was cooled to room temperature, water was added, and the mixture was washed with dichloromethane. To the aqueous layer was added dilute hydrochloric acid, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 296 mg of a yellow solid 477A.',\n",
       "   'Compound 477A (179 mg, 0.662 mmol) obtained in the first step was dissolved in dichloromethane (4 ml), dimethylamine hydrochloride (108 mg, 1.32 mmol), EDCI (190 mg, 0.993 mmol), 1H-benzo[d][1,2,3]triazol-1-ol (89.0 mg, 0.662 mmol) and triethylamine (0.3 ml) were added, and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous sodium bicarbonate solution, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (1:1, v/v), to obtain 170 mg of a colorless gummy substance 477B.',\n",
       "   '1H-NMR (CDCl3) δ: 2.99 (3H, s), 3.23 (3H, s), 4.08 (2H, s), 7.28-7.44 (5H, m), 7.58 (1H, t, J=4.4 Hz), 8.22 (1H, dd, J=8.1, 1.5 Hz).',\n",
       "   'Compound 477 was synthesized by the same procedure as that of Example 107.',\n",
       "   'MS: m/z=559 [M+H]+']},\n",
       " {'number': 'Example 478',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 277 (971 mg, 2.11 mmol) was dissolved in dimethylformamide (10 ml), cesium carbonate (2.75 g, 8.45 mmol) and benzyl bromide (0.753 ml, 6.34 mmol) were added, and the mixture was stirred at room temperature for 4 hours. The reaction solution was poured into water, then extracted with ethyl acetate, and the organic layer was washed with water, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting compound were added dichloromethane-diethyl ether, and the precipitated residue was filtered to obtain 740 mg of a white solid 478A.',\n",
       "   'Compound 478A (740 mg, 1.35 mmol) was dissolved in tetrahydrofuran (7 ml) and methanol (7 ml), a 2N aqueous sodium hydroxide solution (3.37 ml, 6.73 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. To the reaction solution was added dilute hydrochloric acid to make the solution acidic, the mixture was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure to obtain 618 mg of a white solid 478B.',\n",
       "   'MS: m/z=508 [M+H]+',\n",
       "   'Compound 478B (505 mg, 0.995 mmol) was dissolved in tetrahydrofuran (10 ml), triphenylphosphine (391 mg, 1.49 mmol), phthalimide (220 mg, 1.49 mmol) and azodicarboxylic acid diisopropyl ester (0.290 ml, 1.49 mmol) were added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound were added dichloromethane-diethyl ether, and the precipitated residue was filtered to obtain 578 mg of a white solid 478C.',\n",
       "   'MS: m/z=637 [M+H]+',\n",
       "   'To compound 478C (667 mg, 1.05 mmol) was added ethanol (10 ml), hydrazine hydrate (0.254 ml, 5.24 mmol) was added, and the mixture was stirred at 90° C. for 2 hours. The reaction solution was cooled to room temperature, chloroform was added, insolubles were removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound were added dichloromethane-diethyl ether, and the precipitated residue was filtered to obtain 462 mg of a white soled 478D.',\n",
       "   'MS: m/z=507 [M+H]+',\n",
       "   'To compound 478D (100 mg, 0.197 mmol) were added formic acid (1.0 ml) and an aqueous formalin solution (1.0 ml), and the mixture was stirred at 80° C. for 1 hour. To the reaction solution was added a 1N aqueous sodium hydroxide solution, the mixture was extracted with dichloromethane, and the organic layer was dried with sodium sulfate. The resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 56 mg of a colorless oily substance. This compound was dissolved in acetic acid (2.0 ml), concentrated sulfuric acid (0.5 ml) was added dropwise, and the mixture was stirred at room temperature for 30 minutes. The reaction solution was poured into an aqueous sodium bicarbonate solution, and was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting crude product were added dichloromethane-ethyl acetate-diethyl ether, and the precipitated residue was filtered to obtain 12 mg of a white solid 478.',\n",
       "   'MS: m/z=445 [M+H]+']},\n",
       " {'number': 'Example 479',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a dichloromethane (50 ml) solution of compound 479A (5.25 g, 11.8 mmol) synthesized according to Example 95, DIPEA (6.20 mL, 35.5 mmol) and Boc2O (5.17 g, 23.7 mmol) was added DMAP (434 mg, 3.55 mmol), and the mixture was stirred at room temperature for 4 hours. After the reaction solution was concentrated under reduced pressure, the residue was dissolved in ethyl acetate. The solution was sequentially washed with 0.5N hydrochloric acid and an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-methanol (97:3, v/v). Concentration of an objective fraction afforded 5.22 g of compound 479B as an oil.',\n",
       "   'MS: m/z=544 [M+H]+.',\n",
       "   'To a THF (340 mL) solution of compound 479B (29.7 g, 102 mmol) and acetic acid (29.7 g, 102 mmol) was added TBAF (1M THF solution, 23.6 g, 310 mmol) under ice-cooling, and the mixture was stirred at room temperature for 16 hours. To the reaction solution were added ethyl acetate and water, and the ethyl acetate layer was separated, washed with water, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was solidified by adding dichloromethane-ether, to obtain 2.76 g of compound 479C.',\n",
       "   'MS: m/z=430 [M+H]+.',\n",
       "   'To an ethyl acetate (20 mL) suspension of compound 479C (500 mg, 1.16 mmol) was added IBX (652 mg, 2.33 mmol), and the mixture was heated to stir for 3 hours. After the reaction solution was diluted with ethyl acetate, insolubles were filtered, and the resulting filtrate was sequentially washed with a 1N aqueous sodium hydroxide solution and water, and dried with sodium sulfate. After the solvent was distilled off, and the resulting oil was dissolved in THF (5 mL), dimethylamine (2M THF solution, 0.873 mL, 1.75 mmol) and NaBH(OAc)3 (370 mg, 1.75 mmol) were added under ice-cooling, and the mixture was stirred at room temperature for 1.5 hours. After 2N hydrochloric acid was added to the reaction solution under ice-cooling, the mixture was made basic with an aqueous sodium bicarbonate solution. This was extracted with chloroform, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted first with chloroform and, then, with chloroform-methanol (93:7, v/v). Concentration of an objective fraction afforded 437 mg of compound 479D as an amorphous substance.',\n",
       "   'MS: m/z=457 [M+H]+.',\n",
       "   'Compound 479D (430 mg, 0.942 mmol) was dissolved in acetic acid (10 mL), and the solution was heated to stir for 1 hour. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-methanol (95:5, v/v). Concentration of an objective fraction afforded 330 mg of compound 479E as an oil.',\n",
       "   'MS: m/z=357 [M+H]+.',\n",
       "   'To an acetic acid (2 mL) solution of compound 479E (50 mg, 0.140 mmol) and dibenzosuberol (29.5 mg, 0.140 mmol) was added dropwise sulfuric acid (0.5 mL), and the mixture was stirred for 30 minutes. To the reaction solution were added ethyl acetate and water, thereafter, the aqueous layer was separated, and neutralized with an aqueous sodium bicarbonate solution. Extraction was performed using the ethyl acetate layer, and the extract was washed with water, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was solidified by adding ether, to obtain 17.0 mg of compound 479.',\n",
       "   'MS: m/z=354 [M+H]+.',\n",
       "   'According to Example 478 or Example 479, Examples 480 to 490 were synthesized using the same procedure.']},\n",
       " {'number': 'Example 480',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=477 [M+H]+.']},\n",
       " {'number': 'Example 481',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=512 [M+H]+.']},\n",
       " {'number': 'Example 482',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=501 [M+H]+.']},\n",
       " {'number': 'Example 483',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=519 [M+H]+.']},\n",
       " {'number': 'Example 484',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=514 [M+H]+.']},\n",
       " {'number': 'Example 485', 'title': '', 'content': ['', 'MS: m/z=532 [M+H]+']},\n",
       " {'number': 'Example 486',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=499 [M+H]+.']},\n",
       " {'number': 'Example 487',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=517 [M+H]+.']},\n",
       " {'number': 'Example 488',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=517 [M+H]+.']},\n",
       " {'number': 'Example 489',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=535 [M+H]+.']},\n",
       " {'number': 'Example 490', 'title': '', 'content': ['', 'MS: m/z=473 [M+H]+']},\n",
       " {'number': 'Example 491',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 65 and Example 107, compound 491 was synthesized by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.10 (3H, d, J=4.0 Hz), 1.12 (3H, d, J=4.6 Hz), 2.82-3.06 (2H, m), 3.56 (1H, d, J=17.8 Hz), 4.26 (1H, d, J=13.2 Hz), 4.31 (1H, m), 4.51-4.60 (1H, m), 4.97 (1H, d, J=13.1 Hz), 5.39 (1H, s), 6.74-7.52 (8H, m).',\n",
       "   'MS: m/z=460 [M+H]+']},\n",
       " {'number': 'Example 492',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 65 and Example 107, compound 492 was synthesized by the same procedure.',\n",
       "   'MS: m/z=478 [M+H]+']},\n",
       " {'number': 'Example 493',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dichloromethane (5 mL) solution of compound 493A (258 mg, 1.30 mmol) was cooled to −50° C., and a toluene solution (1M, 1.96 mL) of DIBAL-H was added dropwise over 5 minutes while the same temperature was retained. After the reaction solution was stirred at the same temperature for 1 hour, temperature was raised to room temperature, and the mixture was stirred for 2.5 hours. To the reaction solution was added an aqueous saturated ammonium chloride solution, thereafter, the mixture was stirred at room temperature for 1 hour, and insolubles were removed by filtration. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane once. The combined extracts were washed with water three times, washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with n-hexane-ethyl acetate. Concentration of an objective fraction afforded 148 mg of compound 493B as an oil.',\n",
       "   '1HNMR (CDCl3) δ: 1.03-1.44 (5H, m), 1.63-1.83 (5H, m), 2.05-2.13 (1H, m), 3.25 (1H, dd, J=9.5 Hz, 3.4 Hz), 7.16-7.19 (2H, ms), 7.27-7.38 (3H, m), 9.69 (1H, d, J=3.5 Hz).',\n",
       "   'According to Example 177, compound 493 was synthesized by the same procedure.',\n",
       "   'MS: m/z=410 [M+H]+',\n",
       "   'Using aldehydes which are commercially available or known in the references and hydrazines which are commercially available or known in the references, and according to Example 493, compounds 494 to 505 were synthesized.']},\n",
       " {'number': 'Example 494', 'title': '', 'content': ['', 'MS: m/z=428 [M+H]+']},\n",
       " {'number': 'Example 495',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Example 496',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=376 [M+H]+.']},\n",
       " {'number': 'Example 497',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=500 [M+H]+.']},\n",
       " {'number': 'Example 498',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=404 [M+H]+.']},\n",
       " {'number': 'Example 499',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=382 [M+H]+.']},\n",
       " {'number': 'Example 500',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=382 [M+H]+.']},\n",
       " {'number': 'Example 501',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=368 [M+H]+.']},\n",
       " {'number': 'Example 502',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 0.94 (3H, t, J=7.2 Hz), 1.26 (3H, t, J=7.3 Hz), 2.87-2.94 (2H, m), 3.10-3.22 (1H, m), 3.79-3.89 (1H, m), 3.98 (1H, d, J=16.9 Hz), 4.17 (1H, d, J=16.8 Hz), 4.28 (1H, d, J=9.8 Hz), 6.04 (1H, d, J=7.2 Hz), 6.54 (2H, t, J=8.1 Hz), 6.73 (1H, d, J=9.8 Hz), 6.95-7.33 (6H, m), 7.66 (1H, dd, J=5.3, 3.6 Hz).',\n",
       "   'MS: m/z=448 [M+H]+.']},\n",
       " {'number': 'Example 503',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=374 [M+H]+.']},\n",
       " {'number': 'Example 504',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=374 [M+H]+.']},\n",
       " {'number': 'Example 505',\n",
       "  'title': '',\n",
       "  'content': ['', 'MS: m/z=342 [M+H]+.']},\n",
       " {'number': 'Example 506',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 177, using compound 65B, compound 506 was synthesized by the same procedure.',\n",
       "   'MS: m/z=470 [M+H]+.']},\n",
       " {'number': 'Example 507',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 65, using compound 506, compound 507 was synthesized by the same procedure.',\n",
       "   'MS: m/z=446 [M+H]+.']},\n",
       " {'number': 'Example 508',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 508A (261 mg, 0.475 mmol) which is a synthetic intermediate of Example 491 was dissolved in dimethylformamide (3 ml), triethylamine (0.132 ml, 0.950 mmol) and ethyl chloroformate (0.0910 ml, 0.950 mmol) were added at 0° C., and the mixture was stirred at room temperature for 20 minutes. An aqueous solution (0.5 ml) of sodium borohydride (71.9 mg, 1.90 mmol) was added at 0° C., and the mixture was stirred for 30 minutes. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). Diethyl ether was added, and the precipitated residue was filtered to obtain 107 mg of a white solid 508B.',\n",
       "   'MS: m/z=536 [M+H]+',\n",
       "   'Compound 508B (100 mg, 0.187 mmol) obtained in the first step was dissolved in dichloromethane (1 ml), DAST (33.1 mg, 0.205 mmol) was added at 0° C., and the mixture was stirred for 30 minutes. The reaction solution was poured into water, the mixture was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 28 mg of a pale yellow gummy substance 508C.',\n",
       "   'MS: m/z=538 [M+H]+',\n",
       "   'To compound 508C obtained in the second step were added acetic acid (2 ml) and concentrated sulfuric acid (0.5 ml), and the mixture was stirred at room temperature for 20 minutes. The reaction solution was poured into water, the mixture was extracted with ethyl acetate, and the organic layer was dried with sodium sulfate. Diethyl ether was added, and the precipitated residue was filtered to obtain 4.5 mg of a white solid 508.',\n",
       "   'MS: m/z=448 [M+H]+']},\n",
       " {'number': 'Example 509',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 508, compound 509 was synthesized by the same procedure.',\n",
       "   'MS: m/z=466 [M+H]+']},\n",
       " {'number': 'Example 510',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 510A (36.8 g, 259 mmol) was dissolved in dimethylformamide (380 ml), potassium carbonate (39.3 g, 285 mmol) and benzyl bromide (30.7 ml, 259 mmol) were added, and the mixture was stirred at 80° C. for 8 hours. The reaction was cooled to room temperature, insolubles were removed by filtration, and the solvent was distilled off under reduced pressure. Water was added, and the precipitated residue was filtered, and dried under reduced pressure to obtain 46.21 g of a pale brown solid 510B.',\n",
       "   'To compound 510B (4.79 g, 20.6 mmol) obtained in the first step was added dichloromethane (70 ml), triethylamine (4.29 ml, 30.9 mmol) and methanesulfonyl chloride (1.93 ml, 24.8 mmol) were added at 0° C., and the mixture was stirred for 30 minutes. The reaction solution was poured into an aqueous saturated sodium chloride solution, the mixture was extracted with dichloromethane, the extract was dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 6.56 g of a white solid. This compound was dissolved in acetonitrile (40 ml), tetrabutylammonium fluoride (75% aqueous solution, 21.6 g, 61.9 mmol) was added, and the mixture was stirred at room temperature for 18 hours. The solvent was distilled off under reduced pressure, ethyl acetate was added, and the mixture was washed with an aqueous sodium bicarbonate solution. The organic layer was dried with sodium sulfate, and distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (1:1, v/v), to obtain 2.51 g of a white solid 510C.',\n",
       "   '1H-NMR (DMSO-d6) δ: 4.96 (3H, s), 5.30 (3H, d, J=46.4 Hz), 6.56 (1H, d, J=1.8 Hz), 7.39 (5H, m), 8.30 (1H, s).',\n",
       "   'Compound 510C (2.40 g, 10.3 mmol) obtained in the second step was dissolved in dichloromethane (40 ml), boron tribromide (1M dichloromethane solution, 10.3 ml, 10.3 mmol) was added dropwise at 0° C., and the mixture was stirred for 30 minutes. Methanol was added, the solvent was distilled off under reduced pressure, ethyl acetate was added, and the mixture was washed with an aqueous saturated sodium chloride solution. The organic layer was dried with sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting solid was washed with diethyl ether to obtain 940 mg of 510D.',\n",
       "   '1H-NMR (CDCl3) δ: 5.20 (2H, d, J=46.3 Hz), 6.40 (1H, s), 6.62 (1H, s), 7.91 (1H, s).',\n",
       "   'Compound 510D (940 mg, 6.52 mmol) obtained in the third step was dissolved in methanol (8 ml), a 2N aqueous sodium hydroxide solution (3.26 ml, 6.52 mmol) and a 37% aqueous formaldehyde solution (1.46 ml, 19.6 mmol) were added at 0° C., and the mixture was stirred at room temperature for 20 hours. To the reaction solution was added an aqueous saturated ammonium chloride solution, and the solvent was distilled off under reduced pressure. Hydrochloric acid was added, the mixture was extracted with chloroform, and the organic layer was dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting compound were added n-hexane-dichloromethane-ethyl acetate, and the precipitated residue was filtered to obtain 858 mg of a pale yellow solid 510E.',\n",
       "   '1H-NMR (CDCl3) δ: 4.73 (2H, s), 5.19 (2H, d, J=46.1 Hz), 6.55 (1H, s).',\n",
       "   'Compound 510E (855 mg, 4.91 mmol) obtained in the fourth step was dissolved in dimethylformamide (10 ml), potassium carbonate (746 mg, 5.40 mmol) and benzyl bromide (0.583 ml, 4.91 mmol) were added, and the mixture was stirred at 80° C. for 5 hours. Insolubles were removed by filtration, and the filtrate was distilled off under reduced pressure. The resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 887 mg of a pale orange solid 510F.',\n",
       "   '1H-NMR (CDCl3) δ: 1.39 (1H, t, J=7.1 Hz), 4.31 (2H, d, J=7.2 Hz), 5.12 (2H, dd, J=46.3, 0.7 Hz), 5.23 (2H, s), 6.50 (1H, s), 7.33-7.43 (5H, m).',\n",
       "   'Compound 510F (887 mg, 3.36 mmol) obtained in the fifth step was dissolved in chloroform, manganese dioxide (2.00 g, 23.0 mmol) was added, and the mixture was stirred at 80° C. for 2 hours. After cooled to room temperature, the mixture was filtered with celite, and the solvent was distilled off under reduced pressure to obtain 812 mg of a white solid 510G.',\n",
       "   '1H-NMR (CDCl3) δ: 5.18 (2H, dd, J=45.8, 0.8 Hz), 5.52 (2H, s), 6.60 (1H, d, J=0.8 Hz), 7.32-7.38 (5H, m), 9.86 (1H, s).',\n",
       "   'To compound 510G (884 mg, 3.37 mmol) obtained in the sixth step were added acetonitrile and water, monosodium dihydrogen phosphate (809 mg, 6.74 mmol) and sodium hypochlorite (1.01 g, 11.1 mmol) were added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated, pH was adjusted to 3 with hydrochloric acid, the mixture was extracted with chloroform, and the extract was dried with sodium sulfate. The solvent was distilled off under reduced pressure to obtain 404 mg of a white solid 510H.',\n",
       "   '1H-NMR (DMSO-d6) δ: 5.17 (2H, s), 5.38 (2H, d, J=46.2 Hz), 6.73 (1H, d, J=1.5 Hz), 7.34-7.51 (5H, m).',\n",
       "   'Compound 510H (402 mg, 1.45 mmol) obtained in the seventh step was dissolved in dimethylformamide, N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine hydrochloride (554 mg, 2.89 mmol) and 1H-benzo[d][1,2,3]triazol-1-ol (195 mg, 1.45 mmol) were added, and the mixture was stirred at room temperature for 5 minutes. After propan-2-amine (0.149 ml, 1.73 mmol) was added, the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, water was added, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous sodium bicarbonate solution, and dried with sodium sulfate. The reaction solution was distilled off under reduced pressure, to the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 3.56 g of a white solid 510I.',\n",
       "   '1H-NMR (CDCl3) δ: 0.98 (6H, d, J=6.6 Hz), 4.05 (1H, m), 5.24 (2H, dd, J=45.9, 0.9 Hz), 5.41 (2H, s), 6.59 (1H, q, J=0.9 Hz), 7.40 (5H, m), 7.56 (1H, brs).',\n",
       "   'Compound 5101 (392 mg, 1.23 mmol) obtained in the eighth step was dissolved in ethanol (6 ml), aqueous ammonia (4 ml) was added, and the mixture was stirred at room temperature for 15 hours. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v), to obtain 333 mg of a white solid 510J.',\n",
       "   'MS: m/z=319 [M+H]+',\n",
       "   'Compound 510 was synthesized by the same procedure as that of Example 95.',\n",
       "   'MS: m/z=422 [M+H]+']},\n",
       " {'number': 'Example 511',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dichloromethane (90 mL) solution of compound 511A (200 mg, 0.664 mmol) and 1,1,3-trimethoxypropane (178.2 mg, 1.33 mmol) was cooled to 1 to 3° C., and a boron trifluoride diethyl ether complex (113 mg, 0.797 mmol) was added dropwise while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, saturated sodium bicarbonate water was added. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane three times. After the combined extracts were dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with ethyl acetate and, then, with ethyl acetate-methanol (3:2, v/v). Concentration of an objective fraction afforded 179.2 mg of compound 511B as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.14 (6H, d, J=6.3 Hz), 2.71 (2H, dd, J=6.0 Hz), 3.34 (3H, s), 3.64 (2H, t, J=6.0 Hz), 4.06-4.17 (1H, m), 5.23 (2H, s), 6.34 (1H, brs), 6.37 (1H, d, J=7.8 Hz), 7.26-7.43 (6H, m), 7.90 (1H, t, J=5.4 Hz).',\n",
       "   'A dimethylformamide (3 ml) solution of compound 511B (179.2 mg, 0.482 mmol) was cooled to 1 to 3° C., cesium carbonate (786 mg, 2.41 mmol) was added while the same temperature was retained, and the mixture was stirred at the same temperature for 15 minutes. The reaction solution was diluted with water, and extracted with chloroform three times. After the combined extracts were dried with sodium sulfate, the solvent was distilled off to obtain 130 mg of compound 511C as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.22 (3H, d, J=6.9 Hz), 1.28 (3H, d, J=6.9 Hz), 1.59 (2H, brs), 3.22-3.41 (2H, m), 3.12 (3H, s), 4.57-4.70 (2H, m), 5.19 (1H, d, J=10.5 Hz), 5.38 (1H, brs), 5.54 (1H, d, J=10.5 Hz), 6.34 (1H, d, J=7.8 Hz), 7.26-7.32 (4H, m), 7.49-7.52 (2H, m).',\n",
       "   'To an acetic acid (2 ml) solution of compound 511C (130 mg, 0.350 mmol) and dibenzosuberol (368 mg, 1.75 mmol) was added dropwise sulfuric acid (0.4 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, thereafter, the solvent was distilled off, and the resulting solid was washed with diisopropyl ether to obtain 65 mg of compound 511 as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.27 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.6 Hz), 1.64-1.74 (1H, m), 1.88-1.99 (1H, m), 2.83 (1H, d, J=4.5 Hz, 4.5 Hz, 9.3 Hz), 3.06 (1H, ddd, J=5.6 Hz, 13.2 Hz, 13.2 Hz), 3.19 (3H, s), 3.30-3.44 (1H, m), 3.50-3.57 (1H, m), 3.78-3.92 (1H, m), 4.28 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.53 (1H, dd, J=3.3 Hz, 10.8 Hz), 4.96 (1H, s), 5.73 (1H, d, J=7.5 Hz), 6.61 (1H, d, J=7.5 Hz), 6.65 (1H, d, J=7.5 Hz), 6.89-6.93 (1H, m), 7.08-7.36 (6H, m).',\n",
       "   'Using amines which are commercially available or known in the references and acetals which are commercially available or known in the references, and according to Example 511, compounds 512 to 515 were synthesized.']},\n",
       " {'number': 'Example 512', 'title': '', 'content': ['', 'MS: m/z=528 [M+H]+']},\n",
       " {'number': 'Example 513', 'title': '', 'content': ['', 'MS: m/z=528 [M+H]+']},\n",
       " {'number': 'Example 514',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.27 (1H, 3H, d, J=6.9 Hz), 1.48 (3H, d, J=6.6 Hz), 1.95 (3H, s), 2.63-2.68 (2H, m), 2.84 (1H, ddd, J=4.8 Hz, 9.3 Hz, 9.3 Hz), 3.05 (1H, ddd, J=4.2 Hz, 13.2 Hz, 13.2 Hz), 3.60 (1H, ddd, J=4.8 Hz, 4.8 Hz, 17.4 Hz), 3.87-3.98 (1H, m), 4.42 (1H, dd, J=6.6 Hz, 8.1 Hz), 4.59 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.93 (1H, s), 5.77 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=6.9 Hz), 6.69 (1H, d, J=7.8 Hz), 6.91 (1H, t, J=6.0 Hz), 7.09-7.38 (6H, m).']},\n",
       " {'number': 'Example 515',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.20 (3H, d, J=6.9 Hz), 1.44 (3H, d, J=6.9 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz, 9.3 Hz), 3.07 (1H, ddd, J=4.5 Hz, 13.5 Hz, 13.5 Hz), 3.25 (3H, s), 3.22-3.43 (2H, m), 3.55 (1H, ddd, J=4.2 Hz, 4.2 Hz, 8.7 Hz), 3.85-3.94 (1H, m), 4.36 (1H, dd, J=5.1 Hz, 14.1 Hz), 4.42-4.48 (1H, m), 4.92 (1H, s), 5.78 (1H, d, J=7.5 Hz), 6.59 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=7.5 Hz), 6.91 (1H, t, J=6.9 Hz), 7.09-7.36 (6H, m).']},\n",
       " {'number': 'Example 516',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a toluene (3 ml) solution of compound 516A (100 mg, 0.332 mmol) and 3-(methylthio)propanal (52 mg, 0.498 mmol) was added acetic acid (30 mg, 0.500 mmol), and the mixture was refluxed for 30 minutes. After cooled to room temperature, the solvent was distilled off, and the resulting crude product was dissolved in dimethylformamide (3 ml). The solution was cooled to 1 to 3° C., cesium carbonate (541 mg, 1.66 mmol) was added while the same temperature was retained, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The combined extracts were washed with water three times, and dried with sodium sulfate, and the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with ethyl acetate and, then, with ethyl acetate-methanol (7:3, v/v). Concentration of an objective fraction afforded 84.7 mg of compound 516B as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 1.21 (3H, J=6.9 Hz), 1.28 (3H, d, J=6, 9 Hz), 1.31-1.56 (2H, m), 2.05 (3H, s), 2.46 (2H, dd, J=5.4 Hz, 7.8 Hz), 4.57-4.71 (2H, m), 5.18 (1H, d, J=10.5 Hz), 5.51 (1H, d, J=10.5 Hz), 5.66 (1H, brs), 6.33 (1H, d, J=7.8 Hz), 7.19-7.35 (4H, m), 7.46-7.49 (2H, m).',\n",
       "   'Compound 516 was synthesized by the same procedure as that of Example 511.',\n",
       "   '1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.6 Hz), 1.82-1.89 (2H, m), 1.99 (3H, s), 2.41-2.58 (2H, m), 2.86 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 2.99-3.11 (1H, m), 3.53 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.7 Hz), 4.87-3.96 (1H, m), 4.21 (1H, ddd, J=3.9 Hz, 12.9 Hz, 12.9 Hz), 4.53 (1H, dd, J=5.1 Hz, 8.7 Hz), 4.96 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.62 (1H, d, J=7.5 Hz), 6.64 (1H, d, J=9.0 Hz), 6.89-6.94 (1H, m), 7.07-7.37 (6H, m).',\n",
       "   'Using amines which are commercially available or known in the references and aldehydes which are commercially available or known in the references, and according to Example 516, compounds 517 to 526 were synthesized.']},\n",
       " {'number': 'Example 517', 'title': '', 'content': ['', 'MS: m/z=500 [M+H]+']},\n",
       " {'number': 'Example 518',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.78 (3H, t, J=6.9 Hz), 1.19-1.30 (1H, m), 1.29 (3H, d, J=6.9 Hz), 1.43-1.62 (3H, m), 1.50 (3H, d, J=6.9 Hz), 2.84 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 3.00-3.11 (1H, ddd, J=3.9 Hz, 12.9 Hz, 12.9 Hz), 3.52 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.4 Hz), 3.79-3.88 (1H, m), 4.23-4.35 (2H, m), 4.96 (1H, s), 5.74 (1H, d, J=7.8 Hz), 6.61 (1H, d, J=7.5 Hz), 6.65 (1H, dd, J=1.2 Hz, 7.8 Hz), 6.91 (1H, ddd, J=1.5 Hz, 7.5 Hz, 7.5 Hz), 7.08-7.37 (6H, m).']},\n",
       " {'number': 'Example 519',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.44 (3H, d, J=6.9 Hz), 1.54 (3H, d, J=6.6 Hz), 1.88 (1H, ddd, J=3.9 Hz, 3.9 Hz, 14.4 Hz), 2.72 (1H, ddd, J=3.6 Hz, 14.1 Hz, 14.1 Hz), 3.15 (1H, ddd, J=4.2 Hz, 4.2 Hz, 16.5 Hz), 3.54 (1H, dd, J=3.0 Hz, 14.4 Hz), 3.66 (1H, ddd, J=3.9 Hz, 13.8 Hz, 13.8 Hz), 4.03 (1H, dd, J=10.5 Hz, 14.1 Hz), 4.27-4.26 (1H, m), 4.64 (1H, dd, J=2.7 Hz, 10.5 Hz), 4.92 (1H, s), 5.80 (1H, d, J=7.8 Hz), 6.62-6.70 (2H, m), 6.69 (1H, d, J=7.8 Hz), 6.89 (1H, t, J=7.5 Hz), 6.96 (1H, d, J=7.5 Hz), 7.09-7.25 (4H, m), 7.77-7.89 (4H, m).']},\n",
       " {'number': 'Example 520',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.30 (3H, d, J=6.6 Hz), 1.54 (3H, d, J=6.6 Hz), 2.83 (1H, ddd, J=4.8 Hz, 4.8 Hz, 14.1 Hz), 3.03-3.14 (1H, m), 3.21 (3H, s), 3.30 (3H, s), 3.53 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.7 Hz), 3.61-3.70 (1H, m), 4.18 (1H, d, J=5.4 Hz), 4.26 (1H, d, J=5.4 Hz), 4.45 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.92 (1H, s), 5.72 (1H, d, J=7.8 Hz), 6.63 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=6.6 Hz), 6.91 (1H, t, J=6.0 Hz), 7.08-7.36 (6H, m).']},\n",
       " {'number': 'Example 521',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.30 (2.52H, d, J=6.9 Hz), 1.36 (0.48H, d, J=6.9 Hz), 1.42 (0.48H, d, J=6.9 Hz), 1.50 (2.52H, d, J=6.9 Hz), 1.74-1.98 (1H, m), 2.00-2.12 (1H, m), 2.16-2.35 (1H, m), 2.89 (1H, ddd, J=5.1 Hz, 5.1 Hz, 13.5 Hz), 3.06 (1H, ddd, J=3.9 Hz, 12.9 Hz, 12.9H), 3.52 (1H, d, J=4.2 Hz, 4.2 Hz, 17.4 Hz), 3.86-3.96 (1H, m), 4.15 (1H, ddd, J=3.9 Hz, 13.5 Hz, 13.5 Hz), 4.32 (1H, dd, J=3.9 Hz, 10.8 Hz), 4.48-4.64 (1H, m), 4.97 (0.84H, s), 5.30 (0.16H, s), 5.73 (0.84H, d, J=7.8 Hz), 6.20 (0.16H, d, J=7.5 Hz), 6.45 (0.16H, brs), 6.61 (1H, d, J=7.5 Hz), 6.64 (0.84H, d, J=8.7 Hz), 6.92 (1H, t, J=6.3 Hz), 7.10 (1H, d, J=7.5 Hz), 7.15-7.39 (3H, m).']},\n",
       " {'number': 'Example 522',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.9 Hz), 1.54-1.79 (4H, m), 2.84 (1H, ddd, J=4.8 Hz, 4.8 Hz, 14.1 Hz), 3.05 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 3.17 (3H, s), 3.17-3.21 (2H, m), 3.52 (1H, ddd, J=4.2 Hz, 4.2 Hz, 17.7 Hz), 3.83-3.92 (1H, m), 4.22-4.32 (2H, m), 4.96 (1H, s), 5.73 (1H, d, J=7.5 Hz), 6.62 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=8.1 Hz), 6.92 (1H, t, J=7.2 Hz), 7.07-7.37 (6H, m).']},\n",
       " {'number': 'Example 523',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.19-1.28 (1H, m), 1.28 (3H, d, J=6.9 Hz), 1.40-1.82 (4H, m), 1.48 (3H, d, J=6.6 Hz), 2.89-3.00 z81H, m), 3.17 (3H, s), 3.20-3.27 (2H, m), 3.31-3.40 (1H, m), 3.44-3.53 (1H, m), 3.86-3.98 (2H, m), 4.38 (1H, dd, J=3.6 Hz, 10.5 Hz), 5.05 (1H, s), 5.84 (1H, d, 7.5 Hz), 6.48-6.50 (1H, m), 6.66-6.69 (1H, m), 6.89-7.00 (2H, m), 7.05 (1H, d, 7.2 Hz), 7.11-7.24 (2H, m).']},\n",
       " {'number': 'Example 524',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.9 Hz), 1.42-1.83 (4H, m), 1.48 (3H, d, J=6.6 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz), 14.4H), 2.94-3.11 (1H, m), 3.18 (3H, s), 3.21-3.26 (2H, m), 3.49 (1H, ddd, J=4.2 Hz, 4.2 Hz, 18.0 Hz), 3.82-3.91 (1H, m), 4.20-4.33 (2H, m), 5.83 (1H, s), 5.84 (1Hm d, J=7.8 Hz), 6.58-6.72 (2H, m), 6.91-6.94 (1H, m), 7.11-7.30 (4H, m).']},\n",
       " {'number': 'Example 525',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.9 Hz), 1.47 (3H, d, J=6.6 Hz), 2.10 (3H, s), 2.78 (1H, ddd, J=4.2 Hz, 4.2 Hz, 13.8 Hz), 2.97 (3H, s), 3.01-3.13 (2H, m), 3.47 (1H, ddd, J=4.2 Hz, 4.2 Hz, 17.7 Hz), 3.65 (1H, dd, J=3.3 Hz, 14.1 Hz), 3.99-4.23 (2H, m), 4.70 (1H, dd, J=3.3 Hz, 10.2 Hz), 4.95 (1H, s), 5.78 (1H, d, J=7.8 Hz), 6.61 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=7.5 Hz), 6.93 (1H, t, J=6.6 Hz), 7.09 (1H, d, J=7.5 Hz), 7.15-7.27 (4H, m), 7.30-7.37 (1H, m).']},\n",
       " {'number': 'Example 526',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   '1H-NMR (CDCl3) δ: 1.57-1.34 (1H, m), 1.29 (3H, d, J=6.9 Hz), 1.41-1.52 (1H, m), 1.48 (3H, d, J=6.6 Hz), 1.59-1.81 (2H, m), 2.80 (1H, ddd, 4.5 Hz, 4.5 Hz, 14.4 Hz), 3.04 (1H, ddd, J=4.2 Hz, 13.2 Hz, 13.2 Hz), 3.14-3.26 (2H, m), 3.18 (3H, s), 3.49 (1H, ddd, J=4.8 Hz, 4.8 Hz, 17.7 Hz), 3.84-3.93 (1H, m), 4.23-4.34 (2H, m), 4.96 (1H, s), 5.81 (1H, d, J=7.5 Hz), 6.60-6.79 (3H, m), 6.81 (1Hm d, J=9.3 Hz), 6.92 (1H, ddd, J=2.7 Hz, 8.4 Hz, 8.4 Hz), 7.19-7.24 (1H, m).']},\n",
       " {'number': 'Example 527',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A DMF (0.2 mL) solution of compound 527A (36 mg, 0.09 mmol) synthesized according to the method of synthesizing compound 516 was cooled to 1 to 3° C., 5-chlorodibenzosuberane (97 mg, 0.43 mmol) and cesium carbonate (138 mg, 0.43 mmol) were added, and the mixture was stirred at room temperature overnight. To the reaction solution was added water, and the mixture was distributed between ethyl acetate and water. The organic layer was washed with an aqueous saturated sodium chloride solution, and dried. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol. Concentration of an objective fraction afforded 19 mg of compound 527B as an oil.',\n",
       "   'MS: m/z=616 [M+H]+.',\n",
       "   'Compound 527B (19 mg, 0.03 mmol) was dissolved in MeOH (0.6 mL), 10% Pd—C (3 mg) was added, and the mixture was subjected to a catalytic reduction under hydrogen stream. The catalyst was removed by filtration, and the filtrate was concentrated. The resulting oil was subjected to diol silica gel column chromatography, and eluted with chloroform-methanol. Concentration of an objective fraction afforded 7 mg of compound 527 as an oil.',\n",
       "   'MS: m/z=526 [M+H]+.',\n",
       "   'Using halides which are commercially available or known in the references and aldehydes which are commercially available or known in the references, and according to the method of Example 527, compounds 528 to 531 were synthesized.']},\n",
       " {'number': 'Example 528', 'title': '', 'content': ['', 'MS: m/z=418 [M+H]+']},\n",
       " {'number': 'Example 529', 'title': '', 'content': ['', 'MS: m/z=432 [M+H]+']},\n",
       " {'number': 'Example 530', 'title': '', 'content': ['', 'MS: m/z=459 [M+H]+']},\n",
       " {'number': 'Example 531', 'title': '', 'content': ['', 'MS: m/z=466 [M+H]+']},\n",
       " {'number': 'Example 532',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a methanol (5 ml) solution of compound 519 (440 mg, 0.766 mmol) was added hydrazine hydrate (383 mg, 7.66 mmol), and the mixture was refluxed for 1 hour. After cooled to room temperature, the precipitated insolubles were filtered off. After the solvent was distilled off, the residue was suspended in ethyl acetate, the insolubles were filtered off, and the solvent was distilled off. The resulting crude product was suspended in chloroform, and insolubles were filtered off. The solvent was distilled off, and the resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 190 mg of compound 532 as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.24 (3H, d, J=6.9H), 1.46 (3H, d, J=6.6 Hz), 2.73-2.90 (3H, m), 3.08 (1H, ddd, J=4.2 Hz, 12.9 Hz, 12.9 Hz), 3.54 (1H, ddd, J=4.5 Hz, 4.5 Hz, 17.7 Hz), 3.85-3.94 (1H, m), 4.19 (1H, dd, J=7.2 Hz, 11.1 Hz), 4.35 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.97 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.60 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=7.2 Hz), 6.92 (1H, t, J=6.3 Hz), 7.09-7.45 (6H, m).']},\n",
       " {'number': 'Example 533',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 533 was synthesized by the same procedure as that of Example 532.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.22 (3H, d, J=6.6 Hz), 1.40 (3H, d, J=6.6 Hz), 1.45-1.58 (1H, m), 1.62-1.75 (1H, m), 2.61-2.69 (1H, m), 2.71-2.84 (1H, m), 2.88-2.95 (1H, m), 3.16-3.34 (1H, m), 3.60-3.64 (1H, m), 3.92-4.00 (1H, m), 4.24-4.33 (1H, m), 4.42-4.46 (1H, dd, J=3.3 Hz, 10.8 Hz), 5.10 (1H, s), 5.47 (1H, d, J=7.5 Hz), 6.70 (1H, d, J=7.5 Hz), 6.88 (1H, t, J=7.5 Hz), 7.02 (1H, d, J=10.8 Hz), 7.09-7.16 (2H, m), 7.19-7.25 (1H, m), 7.33 (2H, d, 4.2 Hz), 7.42 (1H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 534',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 534 was synthesized by the same procedure as that of Example 532.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.25 (3H, d, J=6.9 Hz), 1.44 (3H, d, J=6.6 Hz), 1.32-1.58 (2H, m), 1.77-1.79 (2H, m), 2.64-2.73 (1H, m), 2.79-3.00 (2H, m), 3.88-3.97 (2H, m), 4.19-4.28 (2H, m), 5.15 (1H, s), 5.67 (1H, d, J=7.5 Hz), 5.73 (1H, d, J=7.5 Hz), 6.90 (1H, t, J=6.6 Hz), 7.03 (1H, d, J=7.5 Hz), 7.13-7.32 (3H, m), 7.36 (2H, d, J=4.2 Hz), 7.44 (1H, J=7.2 Hz), 7.75 (1H, brs).']},\n",
       " {'number': 'Example 535',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 535 was synthesized by the same procedure as that of Example 532.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.40-1.52 (1H, m), 1.61-1.72 (1H, m), 2.40-2.49 (1H, m), 2.58-2.62 (1H, m), 2.78-2.86 (1H, m), 2.89-2.95 (1H, m), 2.95 (3H, m), 3.66-3.74 (1H, m), 4.01-4.13 (1H, m), 4.28-4.32 (1H, m), 5.14 (1H, m), 5.51 (1H, d, J=7.8 Hz), 6.72 (1H, d, J=7.5 Hz), 6.91-6.94 (2H, m), 7.14-7.40 (6H, m).']},\n",
       " {'number': 'Example 536',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dichloromethane (1 ml) solution of compound 532 (30 mg, 0.0675 mmol) and a 38% aqueous formalin solution (53.5 mg, 0.675 mmol) was cooled to 1 to 3° C., sodium triacetoxyhydroborate (42.9 mg, 0.293 mmol) and acetic acid (10 mg, 0.166 mmol) were added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, saturated sodium bicarbonate water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 20 mg of compound 536 as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.22 (3H, d, J=6.6 Hz), 1.44 (3H, d, J=6.9 Hz), 2.06 (6H, s), 2.29 (1H, dd, J=4.5 Hz, 13.2 Hz), 4.23 (1H, dd, J=8.4 Hz, 13.2 Hz), 2.78 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz, 3.06 (1H, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 3.55 (1H, ddd, J=4.2 Hz, 4.2 Hz, 17.7 Hz), 3.83-3.92 (1H, m), 4.34 (1H, dd, J=4.5 Hz, 8.4 Hz), 4.54 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.91 (1H, s), 5.74 (1H, d, J=7.5 Hz), 6.63 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=7.8 Hz), 6.88-6.93 (1H, m), 7.08-7.45 (6H, m).']},\n",
       " {'number': 'Example 537',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 537 was synthesized by the same procedure as that of Example 536.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.25 (3H, d, J=6.6 Hz), 1.40 (3H, d, J=6.6 Hz), 1.46-1.57 (1H, m), 1.68-1.79 (1H, m), 1.98 (6H, s), 2.04-2.11 (1H, m), 2.27-2.41 (1H, m), 2.72-2.94 (2H, m), 3.55-3.64 (1H, m), 3.91-4.00 (1H, m), 4.29-4.44 (2H, m), 5.10 (1H, s), 5.48 (1H, d, J=7.8 Hz), 6.71 (1H, d, J=7.8 Hz), 6.86-6.90 (1H, m), 7.05-7.24 (4H, m), 7.33 (2H, d, J=4.2 Hz), 7.40 (1H, d, J=7.5 Hz).']},\n",
       " {'number': 'Example 538',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 538 was synthesized by the same procedure as that of Example 536.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.75 (6H, t, J=6.6 Hz), 1.28 (3H, d, J=6.6 Hz), 1.41 (3H, d, J=6.6 Hz), 1.45-1.56 (1H, m), 1.67-1.78 (1H, m), 2.22-2.49 (4H, m), 2.74-2.97 (2H, m), 3.94-4.03 (1H, m), 4.29-4.41 (2H, m), 5.11 (1H, s), 5.48 (1H, d, J=7.8 Hz), 6.71 (1H, d, J=6.9 Hz), 6.87 (1H, t, J=7.2 Hz), 7.06-7.25 (4H, m), 7.33 (2H, d, J=7.2 Hz), 7.35 (1H, m).']},\n",
       " {'number': 'Example 539',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 539 was synthesized by the same procedure as that of Example 536.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.25 (3H, d, J=6.6 Hz), 1.44 (3H, d, J=6.6 Hz), 1.42-1.51 (2H, m), 1.75-1.91 (2H, m), 2.62-2.67 (1H, m), 2.65 (6H, s), 2.74-2.97 (3H, m), 3.57-3.63 (1H, m), 3.91-3.26 (4H, m), 5.16 (1H, s), 5.73 (1H, d, J=7.5 Hz), 6.71 (1H, d, J=7.2 Hz), 6.89 (1H, t, J=6.9 Hz), 7.12-7.28 (4H, m), 7.33-7.45 (3H, m).']},\n",
       " {'number': 'Example 540',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 540 was synthesized by the same procedure as that of Example 536.',\n",
       "   '1H-NMR (CDCl3) δ: 1.58-1.78 (2H, m), 2.06 (6H, s), 2.15-2.35 (2H, m), 2.84-2.93 (1H, m), 2.96-3.11 (1H, m), 3.00 (3H, s), 3.65-3.74 (1H, m), 3.99-4.14 (1H, m), 4.28-4.33 (1H, m), 4.94 (1H, s), 5.78 (1H, d, J=7.5 Hz), 6.56 (1H, d, J=7.8 Hz), 8.66 (1H, d, J=7.2 Hz), 6.95 (t, J=7.2 Hz), 7.13-7.38 (6H, m).']},\n",
       " {'number': 'Example 541',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 541 was synthesized by the same procedure as that of Example 536.',\n",
       "   '1H-NMR (CDCl3) δ: 0.846 (6H, t, J=7.2 Hz), 1.49-1.75 (2H, m), 2.30-2.41 (5H, m), 2.43-2.53 (1H, m), 2.85-2.93 (1H, m), 2.98-3.08 (1H, m), 3.01 (3H, s), 3.63-3.74 (1H, m), 3.97-4.07 (1H, m), 4.30 (1H, dd, J=5.1 Hz, 8.1 Hz), 4.95 (1H, s), 5.77 (1H, d, J=6.0 Hz), 6.56 (1H, d, J=7.8 Hz), 6.65 (1H, d, J=7.8 Hz), 6.95 (1H, t, J=6.3 Hz), 7.13-7.38 (6H, m).']},\n",
       " {'number': 'Example 542',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dichloromethane (1 ml) solution of compound 532 (30 mg, 0.0675 mmol) and triethylamine (20.5 mg, 0.202 mmol) was cooled to 1 to 3° C., and acetic acid anhydride (10.3 mg, 0.101 mmol) was added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 15 mg of compound 542 as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.30 (3H, d, J=6.9 Hz), 1.47 (3H, d, J=6.6 Hz), 2.00 (3H, s), 2.78-2.94 (2H, m), 3.04 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 3.48-3.60 (1H, m), 3.98-3.07 (1H, m), 4.36 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.64 (1H, dd, J=3.9 Hz, 9.3 Hz), 4.87 (1H, s), 5.43 (1H, d, J=7.5 Hz), 6.57 (1H, d, J=7.5 Hz), 6.68 (1H, d, J=7.5 Hz), 6.85 (1H, t, J=6.0 Hz), 7.09-7.36 (6H, m), 7.41 (1H, brs).']},\n",
       " {'number': 'Example 543',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 543 was synthesized by the same procedure as that of Example 542.',\n",
       "   '1H-NMR (CDCl3) δ: 1.32 (3H, d, J=6.9 Hz), 1.50 (3H, d, J=6.9 Hz), 2.79 (1H, ddd, J=4.2 Hz, 4.2 Hz, 14.4 Hz), 3.01 (1H, ddd, J=3.9 Hz, 13.5 Hz, 13.5 Hz), 3.18-3.28 (1H, m), 3.46-3.59 (2H, m), 4.04-4.18 (1H, m), 4.27 (1H, ddd, J=3.9 Hz, 13.5 Hz, 13.5 Hz), 4.69 (1H, dd, J=3.3 Hz, 9.9 Hz), 4.87 (0.9H, s), 5.17 (0.1H, s), 5.37 (0.9H, d, J=7.8 Hz), 4.50 (0.1H, d, J=7.8H), 6.32 (0.1H, d, J=7.8 Hz), 6.54 (1H, d, J=7.5 Hz), 6.78 (0.9H, d, J=7.5 Hz), 6.84 (1H, t, J=6.6 Hz), 6.91 (0.1H, d, J=6.0 Hz), 7.06-7.51 (6H, m), 9.29 (1H, brs).']},\n",
       " {'number': 'Example 544',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 544 was synthesized by the same procedure as that of Example 542.',\n",
       "   '1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.9 Hz), 1.46 (3H, d, J=6.3 Hz), 2.78 (1H, ddd, J=4.5 Hz, 4.5 Hz, 15.9 Hz), 2.94-3.10 (2H, m), 3.19-3.54 (2H, m), 3.64 (3H, s), 3.96-3.11 (1H, m), 4.28 (1H, ddd, J=4.2 Hz, 13.5 Hz, 13.5 Hz), 4.57 (1H, dd, J=3.3 Hz, 9.9 Hz), 4.91 (1H, s), 5.57 (1H, brs), 5.70 (1H, d, J=7.5 Hz), 6.60 (1H, d, J=7.5 Hz), 6.66 (1H, d, J=7.8 Hz), 6.89 (1H, t, J=7.2 Hz), 7.08-7.47 (6H, m).']},\n",
       " {'number': 'Example 545',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dichloromethane (1 ml) solution of compound 532 (30 mg, 0.0675 mmol) and pyridine (16 mg, 0.203 mmol) was cooled to 1 to 3° C., and 2-methoxyacetyl chloride (11 mg, 0.101 mmol) was added while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, water was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 22 mg of compound 545 as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.31 (3H, d, J=6.9 Hz), 1.49 (3H, d, J=6.9 Hz), 2.77 (1H, ddd, J=4.8 Hz, 4.8 Hz, 14.1 Hz), 2.99-3.11 (2H, m), 3.47 (3H, s), 3.47-3.55 (1H, m), 3.64-3.72 (1H, m), 3.77-3.88 (2H, m), 4.02-4.11 (1H, m), 4.23 (1H, ddd, J=4.2 Hz, 13.8 Hz, 13.8 Hz), 4.47 (1H, dd, J=3.3 Hz, 9.9 Hz), 4.94 (1H, s), 5.75 (1H, d, J=7.8 Hz), 6.64 (1H, d, J=9.0 Hz), 6.67 (1H, 7.8 Hz), 6.80 (1H, brt), 6.91 (1H, t, J=7.5 Hz), 7.08-7.23 (5H, m), 7.29-7.36 (1H, m).']},\n",
       " {'number': 'Example 546',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a dimethylformamide (1 ml) solution of 2-(methylthio)acetic acid (15.7 mg, 0.148 mmol) were added EDCI (28.5 mg, 0.148 mmol) and 1-hydroxy benzotriazole (11.4 mg, 0.0742 mmol) at room temperature, the mixture was stirred at the same temperature for 5 minutes, and compound 532 was added. The reaction solution was stirred at room temperature for 1 hour, and diluted with methanol (3 ml). The solution was cooled to 1 to 3° C., a 2N aqueous sodium hydroxide solution (1 ml) was added, the mixture was stirred at the same temperature for 30 minutes, and the mixture was neutralized with 2N hydrochloric acid (1 ml). The reaction solution was extracted with ethyl acetate three times, the combined extracts were washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 15 mg of compound 546 as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.32 (3H, d, J=6.9 Hz), 1.50 (3H, J=6.6 Hz), 2.11 (3, s), 2.79 (1H, ddd, J=4.2 Hz, 4.2 Hz, 14.1 Hz), 2.99-3.16 (4H, m), 3.50 (1H, ddd, J=4.5 Hz, 4.5 Hz, 12.9 Hz), 3.68 (1H, d, J=10.2 Hz), 3.97-4.11 (1H, m), 4.26 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 4.94 (3H, s), 5.69 (1H, d, J=7.5 Hz), 6.63 (1H, d, J=7.5 Hz), 6.70 (1H, d, J=7.8 Hz), 6.90 (1H, t, J=6.0 Hz), 7.09 (1H, d, J=7.5 Hz), 7.20-7.25 (3H, m), 7.29-7.36 (1H, m), 7.36-7.49 (1H, m).']},\n",
       " {'number': 'Example 547',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an acetic acid (3 ml) solution of compound 547A (367 mg, 0.812 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (205 mg, 0.974 mmol) was added dropwise sulfuric acid (0.6 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (3 ml), a 2N aqueous sodium hydroxide solution (1 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with 2N hydrochloric acid (1 ml), and extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 75 mg of compound 547 as a solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.22 (3H, d, J=6.9 Hz), 1.45 (3H, d, J=6.3 Hz), 2.80 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 2.99-3.11 (1H, m), 3.53 (1H, ddd, J=3.9 Hz, 3, 9 Hz, 17.7 Hz), 3.64 (1H, dd, J=6.9 Hz), 12.3 Hz), 3.82 (1H, dd, J=3.3 Hz, 12.3 Hz), 3.86-3.97 (1H, m), 4.34-4.44 (2H, m), 4.88 (1H, s), 5.35 (1H, d, J=7.5 Hz), 6.52-6.58 (2H, m), 6.82 (1H, dt, J=1.8 Hz, 7.2 Hz), 7.06-7.35 (6H, m).']},\n",
       " {'number': 'Example 548',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 548 was synthesized by the same procedure as that of Example 547.',\n",
       "   '1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.6 Hz), 1.50 (3H, d, J=6.6 Hz), 1.70-1.81 (1H, m), 1.88-2.00 (1H, m), 2.85 (1H, ddd, J=4.5 Hz, 4.5 Hz, 14.1 Hz), 2.99-3.11 (1H, m), 3.48-3.57 (1H, m), 3.68-3.73 (2H, m), 3.83-3.92 (1H, m), 4.30 (1H, ddd, J=4.2 Hz, 13.8 Hz, 13.8 Hz), 4.54 (1H, dd, J=3.6 Hz, 11.1 Hz), 4.67 (1H, s), 5.69 (1H, d, J=7.8 Hz), 6.62 (1H, d, J=7.5 Hz), 6.64 (1H, d, J=5.7 Hz), 6.90 (1H, t, J=6.9 Hz), 7.07-7.36 (6H, m).']},\n",
       " {'number': 'Example 549',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an acetic acid (3 ml) solution of compound 549A (997 mg, 1.69 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (1.07 g, 5.08 mmol) was added dropwise sulfuric acid (0.6 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 513 mg of compound 549B.',\n",
       "   '1H-NMR (CDCl3) δ: 2.09 (3H, s), 2.71 (1H, ddd, J=3.6 Hz, 13.5 Hz, 13.5 Hz), 3.18-3.27 (1H, m), 3.42-3.56 (2H, m), 3.80 (1H, dd, J=2.7 Hz, 14.1 Hz), 4.03 (1H, dd, J=10.2 Hz, 14.1 Hz), 4.15 (1H, ddd, J=4.2 Hz, 4.2 Hz, 9.3 Hz), 4.32-4.40 (1H, m), 4.49-4.53 (2H, m), 4.94 (1H, s), 5/83 (1H, d, J=7.8 Hz), 6.63 (1H, d, J=7.5 Hz), 6.69 (1H, d, J=7.8 Hz), 6.76 (1H, d, J=6.6 Hz), 6.91 (1H, t, J=7.5 Hz), 7.00 (1H, d, J=8.1 Hz), 7.12-7.17 (2H, m), 7.20-7.32 (2H, m), 7.82-7.89 (4H, m).',\n",
       "   'To a methanol (5 ml) solution of compound 549B (513 mg, 0.829 mmol) was added hydrazine hydrate (124.5 mg, 2.49 mmol), and the mixture was refluxed for 2 hours. After cooled to room temperature, to the reaction solution were added 2N hydrochloric acid (30 ml) and ethyl acetate (30 ml). After the layers were separated, the organic layer was extracted with 2N hydrochloric acid two times. The combined aqueous layers were neutralized with sodium bicarbonate water, and extracted with chloroform-methanol three times. The combined organic layers were dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate-diisopropyl ether to obtain 135 mg of compound 549.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.40-2.50 (1H, m), 2.72-2.80 (1H, m), 2.83-2.98 (2H, m), 3.03-3.66 (4H, m), 3.79-3.87 (1H, m), 4.11 (1H, 4.2 Hz), 4.32-4.44 (1H, m), 5.12 (1H, s), 5.51 (1H, 7.5 Hz), 6.69 (d, J=7.5 Hz), 6.84-6.90 (1H, m), 7.07-7.24 (4H, m), 7.30-7.34 (2H, m), 7.39-7.42 (1H, m).']},\n",
       " {'number': 'Example 550',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 536, compound 550 was synthesized from compound 549 by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 0.77 (6H, t, 6.9 Hz), 1.99-2.36 (3H, m), 2.38-2.56 (1H, m), 2.64 (1H, dd, J=3.9 Hz, 14.1 Hz), 2.75 z81H, ddd, J=4.5 Hz, 4.5 Hz, 14.4 Hz), 2.89-3.00 (1H, m), 3.09-3.68 (4H, m), 3.74-3.82 (1H, m), 4.09 (1H, brs), 4.17 (1H, dd, J=3.6 Hz, 8.4 Hz), 5.03 (1H, brs), 5.17 (1H, s), 5.53 (1H, d, J=7.5 Hz), 6.73 (1H, d, J=7.5 Hz), 6.84 (1H, d, J=7.8 Hz), 6.91 (1H, t, J=7.2 Hz), 7.12-7.26 (4H, m), 7.31-7.44 (4H, m), 7.45 (1H, d, J=7.2 Hz).']},\n",
       " {'number': 'Example 551',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'According to Example 536, compound 551 was synthesized from compound 549 by the same procedure.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.99 (6H, s), 2.27 (1H, brs), 2.51-2.27 (3H, m), 3.56-3.70 (4H, m), 4.03 (2H, brs), 4.36 (1H, brs), 4.94 (2H, brs), 5.29 (1H, brs), 6.54-6.83 (3H, m), 7.11-7.33 (6H, m).']},\n",
       " {'number': 'Example 552',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an acetic acid (2 ml) solution of compound 552A (137 mg, 0.367 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (386 mg, 1.83 mmol) was added dropwise sulfuric acid (0.4 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (5 ml), a 2N aqueous sodium hydroxide solution (2 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with 2N hydrochloric acid (2 ml), and extracted with ethyl acetate two times. The combined extracts were dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate to obtain 62 mg of compound 552.',\n",
       "   '1H-NMR (CDCl3) δ: 1.71-1.82 (1H, m), 2.09-2.21 (1H, m), 2.82-2.90 (1H, m), 3.06 (1H, ddd, J=4.2 Hz, 13.2 Hz, 13.2 Hz), 3.19 (3H, s), 3.22-3.43 (3H, m), 3.60 (1H, ddd, J=10.5 Hz, 10.5 Hz, 17.4 Hz), 3.79-3.96 (3H, m), 4.12-4.21 (1H, m), 4.46 (1H, dd, J=3.3 Hz, 10.2 Hz), 4.98 (1H, s), 5.89 (1H, d, J=7.5 Hz), 6.62 (1H, d, J=6.9 Hz), 6.64 (1H, d, J=7.5 Hz), 6.88-6.93 (1H, m), 7.11-7.37 (6H, m).']},\n",
       " {'number': 'Example 553',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 553 was synthesized by the same procedure as that of Example 552.',\n",
       "   '1H-NMR (CDCl3) δ: 0.80 (3H, d, J=6.6 Hz), 0.94 (3H, d, J=6.9 Hz), 1.94-2.00 (1H, m), 2.82-2.90 (1H, m), 3.00-3.11 (1H, m), 5.31-3.59 (2H, m), 3.64-3.74 (1H, m), 3.94-4.04 (3H, m), 4.25-4.36 (1H, m), 5.04 (1H, s), 5.87 (1H, d, J=7.2 Hz), 6.65 (1H, d, J=7.2 Hz), 7.12 (1H, d, J=7.5 Hz), 6.92 (1H, t, J=8.1 Hz), 7.10 (1H, d, J=7.2 Hz), 7.15-7.38 (5H, m).']},\n",
       " {'number': 'Example 554',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an acetic acid (2 ml) solution of compound 554A (100 mg, 0.177 mmol) synthesized by the same procedure as that of Example 516 and dibenzosuberol (186 mg, 0.885 mmol) was added dropwise sulfuric acid (0.4 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (5 ml), a 2N aqueous sodium hydroxide solution (2 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with an aqueous citric acid solution, and extracted with ethyl acetate two times. The combined extracts were washed with sodium bicarbonate water, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was washed with ethyl acetate to obtain 24 mg of compound 554.',\n",
       "   '1H-NMR (CDCl3) δ: 2.81-2.91 (2H, m), 2.98-3.09 (1H, m), 3.60-3.75 (2H, m), 3.91-4.04 (2H, m), 4.08-4.17 (2H, m), 4.22-4.33 (2H, m), 4.80 (1H, s), 5.69 (1H, d, J=7.8 Hz), 6.48 (1H, d, J=7.5 Hz), 6.59 (1H, d, J=7.5 Hz), 6.80-6.85 (1H, m), 7.13-7.35 (6H, m).']},\n",
       " {'number': 'Example 555',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an acetic acid (4 ml) solution of compound 555A (380 mg, 1.11 mmol) synthesized according to Example 516 and dibenzosuberol (1.16 g, 5.52 mmol) was added dropwise sulfuric acid (0.8 ml) at room temperature, and the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with water, and extracted with ethyl acetate three times. The extract was washed with water once, and dried with sodium sulfate, and the solvent was distilled off. The resulting crude product was dissolved in methanol (5 ml), a 2N aqueous sodium hydroxide solution (2 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was neutralized with an aqueous citric acid solution, and extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate, and the solvent was distilled off. To the resulting crude product were added ethyl acetate-diisopropyl ether, and the precipitated residue was filtered to obtain 22 mg of compound 555.',\n",
       "   '1H-NMR (CDCl3) δ: 1.62 (3H, d, J=6.9 Hz), 2.81 (1H, ddd, J=4.2 Hz, 4.2 Hz, 14.4 Hz), 3.09 (1H, ddd, J=4.5 Hz, 13.8 Hz, 13.8 Hz), 3.37 (3H, s), 3.37-3.53 (2H, m), 3.70 (1H, d, J=5.4 Hz), 4.23-4.30 (2H, m), 4.33-4.44 (1H, m), 4.94 (1H, s), 5.70 (1H, d, J=7.8 Hz), 6.59 (1H, d, J=7.5 Hz), 6.64 (1H, d, J=7.8 Hz), 6.88-6.92 (1H, m), 7.08-7.37 (6H, m).']},\n",
       " {'number': 'Example 556',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 556 was synthesized by the same procedures as those of Example 65 and Example 516.',\n",
       "   '1H-NMR (CDCl3) δ: 1.66-1.78 (2H, m), 1.97 (3H, s), 2.19-2.31 (1H, m), 2.35-2.44 (1H, m), 2.49-2.57 (1H, m), 2.85-2.93 (1H, m), 3.06 (1H, J=3.9 Hz, 12.9 Hz, 12.9 Hz), 3.27-3.39 (2H, m), 3.34 (3H, s), 3.58-3.73 (3H, m), 3.96-4.04 (1H, m), 4.08-4.18 (1H, m), 4.60 (1H, dd, J=3.0 Hz, 11.1 Hz), 4.96 (1H, s), 6.52 (1H, d, J=7.5 Hz), 6.87-6.92 (1H, m), 7.18-7.28 (4H, m), 7.31-7.40 (2H, m), 7.65 (1H, s), 12.04 (1H, s), 14.33 (1H, s).']},\n",
       " {'number': 'Example 557',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 557 was synthesized by the same procedure as that of Example 149.',\n",
       "   'MS: m/z=419 [M+H]+.']},\n",
       " {'number': 'Example 558',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMSO (2 mL) solution of compound 63B (68.8 mg, 0.120 mmol) was added copper chloride (39.2 mg, 0.396 mmol), and the mixture was stirred at 110 degree for 2 hours and, further, at 120 degree for 1 hour. Thereafter, copper chloride (50.0 mg, 0.505 mmol) was added, and the mixture was stirred at 200 degree for 1 hour. The reaction solution was purified using a LCMS fractionating device, the eluted solvent was distilled off, to the concentrated residue was added diethyl ether, and the precipitated white solid was filtered. Washing with diethyl ether, and drying afforded 20.9 mg of compound 558.',\n",
       "   'MS: m/z=439 [M+H]+.']},\n",
       " {'number': 'Example 559',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 48A (43 mg, 0.083 mmol) was dissolved in dichloromethane (6.0 mL), manganese dioxide (120 mg, 1.38 mmol) was added, and the mixture was stirred at room temperature for 3 hours. After the reaction solution was filtered with celite, the filtrate was concentrated to obtain 22.3 mg of compound 559B as a pale yellow solid.',\n",
       "   '1HNMR (CDCl3) δ: 3.17 (3H, s), 3.41-3.55 (4H, m), 3.95-4.07 (2H, m), 4.28 (1H, d, J=16.1 Hz), 4.53 (1H, d, J=11.8 Hz), 5.49 (2H, d, J=2.0 Hz), 6.97-7.66 (16H, m), 10.07 (1H, s).',\n",
       "   'Compound 559B (22 mg, 0.043 mmol) was dissolved in THF (6.0 mL), a 40% methanamine methanol solution (6.5 ul, 0.064 mmol) and acetic acid (3.7 ul, 0.064 mmol) were added, and the mixture was stirred at room temperature for 5 minutes. The reaction solution was ice-cooled, NaBH(OAc)3 (14 mg, 0.064 mmol) was added, and the mixture was stirred at room temperature overnight. To the reaction solution were added water and chloroform, and the chloroform layer was separated. The aqueous layer was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off to obtain 24 mg of compound 559C as a pale yellow solid.',\n",
       "   'MS: m/z=538 [M+H]+.',\n",
       "   'Compound 559 was synthesized by the same procedure as that of Example 1.',\n",
       "   'MS: m/z=448 [M+H]+.']},\n",
       " {'number': 'Example 560',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dioxane (20 mL) mixed solution of (methoxymethyl)triphenylphosphonium chloride (6.73 g, 19.0 mmol) was cooled to 0° C., and a 1.06M NaHMDS toluene solution (18.0 ml, 19.0 mmol) was added dropwise while the same temperature was retained. After the reaction solution was stirred at the same temperature for 30 minutes, compound 383A was added, and the mixture was refluxed for 1 hour and 30 minutes. The reaction solution was returned to room temperature, and water and ethyl acetate were added. The ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (95:5, v/v). Concentration of an objective fraction afforded 2.22 g of compound 560B as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 3.68 (3H, s), 3.73 (3H, s), 4.20 (4H, brs), 6.17 (1H, s), 6.39 (1H, s), 6.96-7.07 (6H, m), 7.18-7.32 (9H, m), 7.32-7.46 (1H, m).',\n",
       "   'Compound 560B (1.98 g, 7.78 mmol) was dissolved in dichloromethane (30 mL), a 70% aqueous perchloric acid solution (8.0 ml, 93 mmol) was added, and the mixture was stirred at room temperature overnight. To the reaction solution was added an aqueous saturated sodium carbonate solution, and the dichloromethane layer was separated. The aqueous layer was extracted with dichloromethane, and magnesium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (90:10, v/v). Concentration of an objective fraction afforded 1.80 g of compound 560C as an oil.',\n",
       "   '1H-NMR (CDCl3) δ: 3.93 (1H, d, J=16.1 Hz), 4.06 (1H, d, J=16.1 Hz), 4.53 (1H, s), 7.11-7.50 (8H, m), 9.89 (1H, s).',\n",
       "   'MS: m/z=241 [M+H]+.',\n",
       "   'To a dichloromethane (30 mL) solution of compound 560C (2.87 g, 11.9 mmol) were added tetraisopropoxytitanium (17.5 mL, 59.7 mmol) and (S)-4-methylbenzenesulfinamide (2.27 g, 14.3 mmol) at room temperature, then the mixture was refluxed for 3 hours and 30 minutes. The reaction solution was ice-cooled, ice water (30 ml) was added, the mixture was stirred for 1 hour while temperature was retained at the same temperature, and the precipitated solid was filtered using celite. The resulting filtrate was extracted with dichloromethane, and magnesium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (70:30, v/v). Concentration of an objective fraction afforded 3.16 g of compound 560D as a yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.39 (6H, s), 3.60 (1H, d, J=15.2 Hz), 3.68 (1H, d, J=14.9 Hz), 3.97 (1H, d, J=15.0 Hz), 4.07 (1H, d, J=15.0 Hz), 4.90 (1H, d, J=2.7 Hz), 4.92 (1H, d, J=2.9 Hz), 7.08-7.26 (20H, m), 7.46-7.51 (4H, m), 8.62 (1H, d, J=2.8 Hz), 8.65 (1H, d, J=2.7 Hz).',\n",
       "   'MS: m/z=378 [M+H]+.',\n",
       "   'A THF (30 mL) suspension of a 1M cyanodiethylaluminum toluene solution (16.7 mL, 16.7 mmol) was cooled to 0 degree, 2-propanol (1.29 mL, 16.7 mmol) was added and, thereafter, the mixture was stirred for 1 hour while temperature was retained at the same temperature. Thereafter, the reaction solution was cooled to −60 degree, a THF (12 mL) solution of compound 560D (3.16 g, 8.37 mmol) was added dropwise, the mixture was stirred for 15 minutes while temperature was retained at the same temperature, thereafter, temperature was raised to room temperature, and the mixture was stirred overnight. The reaction solution was ice-cooled, an aqueous saturated ammonium chloride solution was added, the mixture was stirred at room temperature for 1 hour and 30 minutes and, thereafter, the precipitated solid was filtered using celite, and washed with dichloromethane. The dichloromethane layer of the filtrate was separated, and the aqueous layer was extracted with dichloromethane and, thereafter, sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). Concentration of an objective fraction afforded 1.88 g of compound 560E.',\n",
       "   'MS: m/z=427 [M+Na]+.',\n",
       "   'A methanol (4 mL) solution of compound 560E (235 mg, 0.581 mmol) was cooled to 0 degree, cobalt (II) chloride hexahydrate (55.3 mg, 0.232 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. Thereafter, the reaction solution was ice-cooled, a DMF (4 mL) solution of sodium borohydride (88 mg, 2.3 mmol) was added dropwise, and the mixture was stirred at the same temperature for 5 minutes, and at room temperature for 1 hour. Then, Boc2O (0.674 mL, 2.90 mmol) was added, and the mixture was stirred for 30 minutes. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (98:2, v/v). Concentration of an objective fraction afforded a crude product (211 mg) of compound 560F.',\n",
       "   'MS: m/z=509 [M+Na]+.',\n",
       "   'To a methanol (6 mL) solution of the crude product (211 mg) of compound 560F was added TFA (0.128 mL, 1.66 mmol), and the mixture was stirred at room temperature for 2.5 hours. To the reaction solution was added triethylamine (0.230 mL, 1.66 mmol), the solvent was distilled off, and the resulting crude product of compound 560G was used in a next reaction without purification.',\n",
       "   'MS: m/z=371 [M+H]+.',\n",
       "   'To a toluene (4 mL) solution of the crude product of compound 560G was added dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (132 mg, 0.416 mmol), and the mixture was refluxed for 1 hour and 30 minutes. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→90:10, v/v). Concentration of an objective fraction afforded a crude product (287 mg) of compound 560H.',\n",
       "   'MS: m/z=671 [M+H]+.',\n",
       "   'To the crude product of compound 560H obtained in the seventh step was added a 4N hydrochloric acid ethyl acetate solution (3 mL), and the mixture was stirred at room temperature for 30 minutes. The solvent was distilled off, to the resulting concentrated residue were added THF (2 mL) and an aqueous saturated sodium bicarbonate solution (2 mL), and the mixture was stirred at room temperature for 45 minutes. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→0.94:6, v/v). Concentration of an objective fraction afforded 27 mg of compound 5601 as a yellow solid.',\n",
       "   'MS: m/z=539 [M+H]+.',\n",
       "   'Compound 5601 (27 mg, 0.050 mmol) was dissolved in DMF (2 mL), cesium carbonate (82 mg, 0.25 mmol) and methyl iodide (0.010 mL, 0.16 mmol) were added, and the mixture was stirred at room temperature for 1 hour and 30 minutes. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product of compound 560J.',\n",
       "   'MS: m/z=553 [M+H]+.',\n",
       "   'To an EtOH (2 mL) solution of the crude product of compound 560J obtained in the ninth step was added 2N NaOH (1 mL), and the mixture was stirred at room temperature for 40 minutes. To the reaction solution was added a 2N aqueous HCl solution, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off to obtain 17 mg of compound 560K as a white oil.',\n",
       "   'MS: m/z=539 [M+H]+.',\n",
       "   'To compound 560K (17 mg, 0.032 mmol) was added TFA (2.0 mL), and the mixture was stirred at room temperature for 35 minutes. The reaction solution was subjected to toluene azeotropy, to the resulting concentrated residue was added isopropyl ether, and the precipitated solid was filtered and washed to obtain 7.1 mg of compound 560 as a pink solid.',\n",
       "   'MS: m/z=449 [M+H]+.']},\n",
       " {'number': 'Example 561',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a crude product (433 mg) of compound 560H was added a 4N hydrochloric acid ethyl acetate solution (3 mL), and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off, to a THF (2 mL) solution of the resulting residue was added acetone (2 mL), the mixture was stirred at room temperature for 20 minutes, NaBH(OAc)3 (70 mg, 0.32 mmol) was added, and the mixture was stirred at room temperature for 1 hour and 30 minutes. Thereafter, to the reaction solution was added an aqueous saturated sodium bicarbonate solution (3 mL), and the mixture was stirred at room temperature overnight. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product (79 mg) of compound 561A.',\n",
       "   'MS: m/z=581 [M+H]+.',\n",
       "   'To an EtOH (4 mL) solution of the crude product (79 mg) of compound 561A was added 2N NaOH (2 mL), and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added a 2N aqueous HCl solution, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded compound 561B (53 mg).',\n",
       "   'MS: m/z=567 [M+H]+.',\n",
       "   'A DMF (2 mL) solution of compound 561B (53 mg, 0.093 mmol) was cooled to 0 degree, triethylamine (0.039 mL, 0.28 mmol) and ethyl chloroformate (0.018 mL, 0.187 mmol) were added, and the mixture was stirred at room temperature for 10 minutes. Thereafter, the reaction solution was cooled to 0 degree, sodium azide (18 mg, 0.28 mmol) was added, and the mixture was stirred for 50 minutes while temperature was retained at the same temperature. To the reaction solution was added water, the mixture was extracted with dichloromethane, and the combined extracts were concentrated to obtain a crude product of compound 561C.',\n",
       "   'MS: m/z=592 [M+H]+.',\n",
       "   'The crude product (55 mg) of compound 561C was dissolved in methanol (2 mL), and the mixture was stirred at 50° C. for 1 hour. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product (43 mg) of compound 561D.',\n",
       "   'MS: m/z=596 [M+H]+.',\n",
       "   'To an EtOH (2 mL) solution of the crude product (43 mg) of compound 561D was added 2N NaOH (4 mL), and the mixture was stirred at 60 degree for 1 hour. The solvent was distilled off, water was added, the mixture was extracted with ethyl acetate and, thereafter, sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, the resulting oil was subjected to amino column chromatography, and eluted with chloroform-methanol (100:0→80:20, v/v). Concentration of an objective fraction afforded 16 mg of compound 561E as a pale yellow solid.',\n",
       "   'MS: m/z=538 [M+H]+.',\n",
       "   'Compound 561E (16 mg, 0.029 mmol) was dissolved in EtOH (1 mL) and a 48% aqueous tetrafluoroboric acid (1 mL), the reaction solution was cooled to 0 degree, sodium nitrite (15 mg, 0.22 mmol) was added, and the mixture was stirred for 1 hour and 30 minutes while temperature was retained at the same temperature and, further, at room temperature for 2 hours and 30 minutes. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, to the resulting concentrated residue were added ethyl acetate and isopropyl ether, and the precipitated solid was filtered and washed to obtain 5 mg of compound 561 as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 0.96 (3H, d, J=6.9 Hz), 1.17 (3H, d, J=6.8 Hz), 3.37 (1H, d, J=13.3 Hz), 3.88 (1H, dd, J=13.4, 4.3 Hz), 3.99 (1H, d, J=14.9 Hz), 4.08 (1H, d, J=11.3 Hz), 4.52 (1H, d, J=14.9 Hz), 4.81-4.90 (1H, m), 5.67 (1H, dd, J=11.3, 3.1 Hz), 5.94 (1H, d, J=7.4 Hz), 6.59 (1H, d, J=6.4 Hz), 6.72 (1H, d, J=7.3 Hz), 6.86 (1H, t, J=7.1 Hz), 7.09 (1H, t, J=7.6 Hz), 7.16-7.31 (5H, m).']},\n",
       " {'number': 'Example 562',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 562 was synthesized by the same procedure as that of Example 561.',\n",
       "   '1H-NMR (CDCl3) δ: 3.07 (3H, s), 3.21 (1H, d, J=12.3 Hz), 4.00-4.31 (4H, m), 5.78 (1H, d, J=10.5 Hz), 5.94 (1H, d, J=7.4 Hz), 6.54 (1H, d, J=7.3 Hz), 6.69 (1H, d, J=7.5 Hz), 6.98 (1H, t, J=7.6 Hz), 7.14-7.41 (6H, m).',\n",
       "   'MS: m/z=405 [M+H]+.']},\n",
       " {'number': 'Example 563',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 563A (Tetrahedron Letters, 34, 953-956, 1993, 41.1 g, 154 mmol) was dissolved in THF (300 mL), 1M BH3-THF (770 mL) was slowly added at room temperature, and the mixture was stirred for 18 hours. 3N hydrochloric acid (513 mL) was slowly added, and the mixture was refluxed for 1 hour, and was progressed to a next step without purification.',\n",
       "   'LC-MS: m/z=254 [M+H]+.',\n",
       "   'Using a solution containing compound 563B, according to Example 12, compound 563C was synthesized.',\n",
       "   'LC-MS: m/z=353 [M+H]+.',\n",
       "   '1H-NMR (DMSO-d6): 1.40 (9H, s), 2.65-2.72 (1H, m), 2.86-2.92 (3H, m), 3.47-3.56 (3H, m), 3.56-3.69 (1H, m), 6.63 (1H, s), 7.11-7.26 (8H, m).',\n",
       "   'A toluene (30 mL) solution of compound 563C (2.16 g, 6.79 mmol) and dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (2.38 g, 6.75 mmol) was stirred at 100° C. for 4 hours. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 563D was used in a next reaction without purification.',\n",
       "   'MS: m/z=653.05 [M+H]+.',\n",
       "   'To an ethyl acetate (20 mL) solution of the crude product of compound 563D was added hydrogen chloride (4N ethyl acetate solution, 20 mL) at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was distilled off under reduced pressure, and the resulting crude product of compound 563E was used in a next reaction without purification.',\n",
       "   'MS: m/z=553.05 [M+H]+.',\n",
       "   'To a tetrahydrofuran (40 mL) solution of the crude product of compound 563E was added saturated sodium bicarbonate water (5 mL) at room temperature, and the mixture was stirred for 16 hours. To the reaction solution was added water (50 mL), the mixture was extracted with chloroform three times, and the extracts were combined, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and diethyl ether and chloroform were added to the resulting residue to covert them into a powder, to obtain compound 563F (2.90 g, 70.2%) as a white solid.',\n",
       "   'MS: m/z=521.05 [M+H]+.',\n",
       "   'To a methanol (7.5 mL) suspension of compound 563F (523 mg, 1.01 mmol) was added an aqueous sodium hydroxide solution (2 M, 1.5 mL) at room temperature, and the mixture was stirred for 3 hours. To the reaction solution were added hydrochloric acid (2N, 1.5 mL) and water (3 mL) at room temperature and, thereafter, the mixture was stirred at 0° C. for 15 minutes. The precipitated solid was filtered, and washed with water and diethyl ether to obtain compound 563G (418 mg, 82.0%) as a white solid.',\n",
       "   'MS: m/z=507.00 [M+H]+.',\n",
       "   'A diphenyl ether (5 mL) suspension of compound 563G (107 mg, 0.211 mmol) was stirred at 240° C. for 1 hour under microwave irradiation. The reaction solution was purified by silica gel column chromatography (methanol/chloroform=0%→5%) to obtain compound 563H (64.4 mg, 65.9%) as a white solid.',\n",
       "   'MS: m/z=463.05 [M+H]+.',\n",
       "   'A methanol (30 mL) solution of compound 563H (64.4 mg, 0.139 mmol) was hydrogenated by passing through 10% Pd—C CatCart (H-cube, Full-H2 mode, 25° C.) for 3 hours. The reaction solution was distilled off under reduced pressure, and ethyl acetate and methanol were added to the resulting residue to convert it into a powder, to obtain compound 563 (31.1 mg, 60.0%) as a gray white solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.50-3.03 (3H, m), 3.50-3.72 (3H, m), 4.29 (1H, d, J=11.4 Hz), 5.12 (1H, m), 5.69 (1H, d, J=7.2 Hz), 6.50 (1H, d, J=7.7 Hz), 6.75 (1H, d, J=7.7 Hz), 6.84 (1H, m), 7.14-7.30 (6H, m), 9.16 (1H, d, J=4.8 Hz).',\n",
       "   'MS: m/z=372.90 [M+H]+.']},\n",
       " {'number': 'Example 564',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a dimethylformamide (2 mL) suspension of compound 563H (64.2 mg, 0.139 mmol) and cesium carbonate (220 mg, 0.675 mmol) was added methyl iodide (0.0430 mL, 0.688 mmol) at room temperature, and the mixture was stirred for 3 hours. To the reaction solution was added water (10 mL) at room temperature, and the mixture was extracted with ethyl acetate (30 mL). The organic layer was washed with water (10 mL) and an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (methanol/chloroform=2.5%→10%) to obtain compound 564A (56.0 mg, 85.0%) as a colorless gummy substance.',\n",
       "   'MS: m/z=477.00 [M+H]+.',\n",
       "   'A solution of compound 564A (56.0 mg, 0.118 mmol) in methanol (10 mL), ethyl acetate (5 mL) and tetrahydrofran (5 mL) was hydrogenated by passing through 10% Pd—C CatCart (H-cube, Full-H2 mode, 25° C.) for 75 minutes. The reaction solution was distilled off under reduced pressure, and ethyl acetate and methanol were added to the resulting residue to convert it into a powder, to obtain compound 564 (22.0 mg, 48.4%) as a gray white solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.86-2.98 (6H, m), 3.51-3.58 (2H, m), 3.94 (1H, m), 4.30 (1H, d, J=11.1 Hz), 5.19 (1H, d, J=10.2 Hz), 5.79 (1H, d, J=6.9 Hz), 6.49 (1H, d, J=7.4 Hz), 6.74 (1H, d, J=7.4 Hz), 6.85 (1H, m), 7.14 (2H, m), 7.25 (4H, m), 12.50 (1H, brs).',\n",
       "   'MS: m/z=387.05 [M+H]+.']},\n",
       " {'number': 'Example 565',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 565 was synthesized by the same procedure as that of Example 564.',\n",
       "   'MS: m/z=443.95 [M+H]+.']},\n",
       " {'number': 'Example 566',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dimethylformamide (2 mL) suspension of compound 563H (75.4 mg, 0.163 mmol), 3-iodobenzonitrile (124 mg, 0.541 mmol), copper (I) iodide (33.2 mg, 0.174 mmol), potassium carbonate (74.7 mg, 0.540 mmol) and N,N′-dimethylethylenediamine (0.0200 ml, 0.186 mmol) was stirred at 140° C. for 2 hours under microwave irradiation. To the reaction solution were added water (10 mL) and hydrochloric acid (2M, 2 mL) at room temperature, and the mixture was extracted with ethyl acetate. The extract was filtered with celite, and the filtrate was washed with water (10 mL×2) and an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 566A was used in a next reaction without purification.',\n",
       "   'MS: m/z=564.05 [M+H]+.',\n",
       "   'To a methylene chloride (10 mL) solution of the crude product of compound 566A obtained in the first step was added trifluoroacetic acid (2 mL) at room temperature, and the mixture was stirred for 1 hour. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 566 (30.3 mg, 39.3%) as a yellow solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.81-2.94 (2H, m), 3.38-3.58 (2H, m), 4.54 (1H, d, J=10.5 Hz), 4.64 (1H, d, J=10.5 Hz), 5.35 (1H, d, J=10.5 Hz), 5.76 (1H, m), 6.66-6.71 (3H, m), 6.90 (1H, m), 7.06-7.15 (6H, m), 7.76 (2H, m), 7.90 (2H, m).',\n",
       "   'MS: m/z=473.90 [M+H]+.']},\n",
       " {'number': 'Example 567',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 567 was synthesized by the same procedure as that of Example 566.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.80-3.00 (2H, m), 3.40-3.70 (2H, m), 4.52 (1H, m), 4.64 (1H, m), 5.38 (1H, m), 5.76 (1H, m), 6.60-7.20 (10H, m), 7.60-7.90 (3H, m), 8.11 (1H, m).',\n",
       "   'MS: m/z=474.00 [M+H]+.']},\n",
       " {'number': 'Example 568',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 568 was synthesized by the same procedure as that of Example 566.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.87-2.96 (2H, m), 3.34-3.73 (2H, m), 4.64 (2H, m), 5.33 (1H, m), 5.71 (1H, d, J=7.2 Hz), 6.61 (1H, d, J=7.8 Hz), 6.87-6.95 (3H, m), 7.00-7.27 (6H, m), 7.62 (2H, m), 7.86 (1H, m), 8.07 (1H, m).',\n",
       "   'MS: m/z=474.00 [M+H]+.']},\n",
       " {'number': 'Example 569',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 569 was synthesized by the same procedure as that of Example 566.',\n",
       "   'MS: m/z=449.95 [M+H]+.']},\n",
       " {'number': 'Example 570',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 570 was synthesized by the same procedure as that of Example 566.',\n",
       "   '1HNMR (DMSO-d6) δ: 2.83-2.97 (3H, m), 3.16-3.62 (2H, m), 3.56 (1H, m), 3.66 (1H, d, J=11.1 Hz), 5.35 (1H, d, J=11.1 Hz), 5.73 (1H, d, J=7.4 Hz), 6.68 (1H, d, J=7.4 Hz), 6.92 (1H, m), 7.06-7.21 (5H, m), 7.49 (1H, m), 7.97 (1H, d, J=8.4 Hz), 8.14 (1H, s), 8.50 (1H, d, J=3.6 Hz), 8.81 (1H, d, J=2.1 Hz).',\n",
       "   'MS: m/z=449.95 [M+H]+.']},\n",
       " {'number': 'Example 571',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a DMF (1 mL) solution of compound 563H (50.0 mg, 0.108 mmol) was added cesium carbonate (176 mg, 0.540 mmol), and the mixture was stirred at room temperature for 10 minutes. To the reaction solution was added O-(2,4-dinitrophenyl)hydroxylamine (64.6 mg, 0.324 mmol), and the mixture was stirred at room temperature for 9 hours. To the reaction solution was added chloroform, and the mixture was washed with water, and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted firstly with chloroform and, then, with chloroform-methanol (98:2, v/v). Concentration of an objective fraction afforded 28.3 mg of compound 571A as an amorphous substance.',\n",
       "   'MS: m/z=478 [M+H]+.',\n",
       "   'Compound 571A (27.0 g, 0.057 mmol) was dissolved in a THF-methanol (1 mL, 1:1, v/v) solution, 10% palladium carbon (15.0 mg) was added, and the mixture was stirred at room temperature for 2 hours under hydrogen atmosphere. After dilution with chloroform, insolubles were removed by celite filtration. After the filtrate was concentrated under reduced pressure, the residue was solidified with dichloromethane-ether to obtain 12.0 mg of compound 571.',\n",
       "   'MS: m/z=388 [M+H]+.']},\n",
       " {'number': 'Example 572',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Using compound 12H, and according to Example 571, compound 572 was synthesized by the same procedure.',\n",
       "   'MS: m/z=420 [M+H]+.']},\n",
       " {'number': 'Example 573',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a dimethylformamide (1.5 mL) solution of compound 563H (83.2 mg, 0.160 mmol) was added sodium hydride (60%, 13.2 mg, 0.330 mmol) under ice-cooling, the mixture was stirred for 30 minutes, thereafter, bromoacetonitrile (0.0190 mL, 0.270 mmol) was added, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added an aqueous ammonium chloride solution (10%, 3 mL), and the mixture was extracted with ethyl acetate. The organic layer was washed with water (10 mL) and an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product of compound 573A was used in a next reaction without purification.',\n",
       "   'MS: m/z=502.00 [M+H]+.',\n",
       "   'To an acetonitrile (4 mL) suspension of the crude product of compound 573A obtained in the first step and sodium iodide (111 mg, 0.741 mmol) was added chlorotrimethylsilane (0.0920 mL, 0.720 mmol) at room temperature, and the mixture was stirred for 24 hours. To the reaction solution was added an aqueous sodium hydrogen sulfite solution (10%, 10 mL) and, thereafter, the mixture was extracted with chloroform. After the extracts were combined, and dried with sodium sulfate, the solvent was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS to obtain compound 573 (22.0 mg, 29.7%) as a gray white solid.',\n",
       "   '1H-NMR (DMSO-d6) δ: 2.86-2.95 (2H, m), 3.45-3.63 (2H, m), 4.01 (1H, m), 4.30 (1H, d, J=10.8 Hz), 4.35 (1H, d, J=17.4 Hz), 4.74 (1H, d, J=17.4 Hz), 5.20 (1H, m), 5.66 (1H, d, J=7.5 Hz), 6.52 (1H, d, J=7.8 Hz), 6.73 (1H, d, J=7.5 Hz), 6.83 (1H, m), 7.11-7.28 (6H, m).',\n",
       "   'MS: m/z=502.00 [M+H]+.']},\n",
       " {'number': 'Example 574',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 574 was synthesized by the same procedure as that of Example 573.',\n",
       "   '1H-NMR (DMSO-d6) δ: 4.16 (1H, dd, J=13.26, 3.53 Hz), 4.36 (1H, d, J=11.58 Hz), 4.52 (2H, dd, J=20.73, 17.54 Hz), 5.44 (1H, d, J=11.41 Hz), 5.65 (1H, d, J=7.39 Hz), 6.99 (1H, d, J=7.55 Hz), 7.11-7.32 (6H, m), 7.36-7.45 (2H, m), 7.58 (2H, d, J=7.39 Hz).']},\n",
       " {'number': 'Example 575',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 575 was synthesized by the same procedure as that of Example 573.',\n",
       "   'MS: m/z=425.95 [M+H]+.']},\n",
       " {'number': 'Example 576',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'A dichloromethane (30 mL) solution of compound 576A (Bioorg. Med. Chem., 2003, 11, 197-206) (2.26 g, 10.2 mmol) were added tetraisopropoxytitanium (10.0 mL, 33.1 mmol) and (S)-4-methylbenzenesulfinamide (1.29 g, 8.13 mmol) at room temperature, and the mixture was refluxed for 2 hours. The reaction solution was ice-cooled, ice water (40 ml) was added, the mixture was stirred for 1 hour while temperature was retained at the same temperature, and the precipitated solid was filtered using celite. The resulting filtrate was extracted with dichloromethane, and magnesium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (100:0→70:30, v/v). Concentration of an objective fraction afforded 1.35 g of compound 576B as a yellow solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.32 (3H, s), 2.72-2.85 (2H, m), 3.03-3.16 (2H, m), 4.89 (1H, d, J=3.5 Hz), 7.09-7.25 (10H, m), 7.39-7.42 (2H, m), 8.49 (1H, d, J=3.6 Hz).',\n",
       "   'MS: m/z=360 [M+H]+.',\n",
       "   'A THF (20 mL) solution of a 1M cyanodiethylaluminum toluene solution (7.51 mL, 7.51 mmol) was cooled to 0 degree, 2-propanol (0.579 mL, 7.51 mmol) was added and, thereafter, the mixture was stirred for 1 hour while temperature was retained at the same temperature. Thereafter, the reaction solution was cooled to −60 degree, a THF (14 mL) solution of compound 576B was added dropwise, the mixture was stirred for 15 minutes while temperature was retained at the same temperature, thereafter, temperature was raised to room temperature, and the mixture was stirred overnight. The reaction solution was ice-cooled, an aqueous saturated ammonium chloride solution was added, the mixture was stirred at room temperature for 1 hour and 30 minutes and, thereafter, the precipitated solid was filtered using celite, and washed with dichloromethane. The dichloromethane layer of the filtrate was separated, the aqueous layer was extracted with dichloromethane, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, to the resulting oil were added ethyl acetate and hexane, and the precipitated solid was filtered and washed to obtain 976 mg of compound 576C as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 2.38 (3H, s), 2.92-3.055 (2H, m), 3.41-3.52 (2H, m), 4.25 (1H, d, J=10.8 Hz), 4.28 (1H, d, J=5.6 Hz), 4.94 (1H, dd, J=10.6, 5.7 Hz), 7.14-7.41 (12H, m).',\n",
       "   'A methanol (8 mL) suspension of compound 576C (500 mg, 1.29 mmol) was cooled to 0 degree, cobalt (II) chloride hexahydrate (123 mg, 0.517 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. To the reaction solution was added chloroform (5 mL), thereafter, the mixture was ice-cooled, a DMF (4 mL) solution of sodium borohydride (196 mg, 5.17 mmol) was added dropwise, and the mixture was stirred at the same temperature for 5 minutes, and at room temperature for 2 hours. Then, Boc2O (1.0 mL, 4.3 mmol) was added, and the mixture was stirred at room temperature overnight. To the reaction solution was added water, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→98:2, v/v). Concentration of an objective fraction afforded a crude product (200 mg) of compound 576D.',\n",
       "   'MS: m/z=491 [M+Na]+.',\n",
       "   'To a methanol (6 mL) solution of the crude product (200 mg) of compound 576D obtained in the third step was added TFA (0.188 mL, 2.45 mmol), and the mixture was stirred at room temperature for 2.5 hours. To the reaction solution was added triethylamine (0.399 mL, 2.45 mmol), the solvent was distilled off, and the resulting crude product of compound 576E was used in a next reaction without purification.',\n",
       "   'MS: m/z=353 [M+H]+.',\n",
       "   'To a toluene (4 mL) solution of the crude product of compound 576E obtained in the fourth step was added dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (130 mg, 0.409 mmol), and the mixture was refluxed for 2 hours. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→90:10, v/v). Concentration of an objective fraction afforded a crude product (268 mg) of compound 576F.',\n",
       "   'MS: m/z=653 [M+H]+.',\n",
       "   'To the crude product (263 mg) of compound 576F obtained in the fifth step was added a 4N hydrochloric acid ethyl acetate solution (3 mL), and the mixture was stirred at room temperature for 1 hour and 30 minutes. The solvent was distilled off, to a THF (4 mL) solution of the resulting concentrated residue was added acetone (1 mL), the mixture was stirred at room temperature for 25 minutes, thereafter, NaBH(OAc)3 (180 mg, 0.807 mmol) was added, and the mixture was stirred at room temperature for 1 hour and 15 minutes. Thereafter, to the reaction solution was added an aqueous saturated sodium bicarbonate solution (7 mL), and the mixture was stirred at room temperature overnight. To the reaction solution was added water, the mixture was extracted with chloroform, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded a crude product (160 mg) of compound 576G.',\n",
       "   'MS: m/z=563 [M+H]+.',\n",
       "   'To an EtOH (4 mL) solution of the crude product (160 mg) of compound 576G obtained in the sixth step was added 2N NaOH (2 mL), and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added a 2N aqueous HCl solution, the mixture was extracted with ethyl acetate, and sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, and the resulting oil was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→94:6, v/v). Concentration of an objective fraction afforded 78 mg of compound 576H as a yellow solid.',\n",
       "   'MS: m/z=549 [M+H]+.',\n",
       "   'To compound 576H (78 mg, 0.14 mmol) was added diphenyl ether (3 mL), and the mixture was stirred at 245 degree for 1 hour under microwave irradiation. The reaction solution was subjected to silica gel column chromatography, and eluted with chloroform-methanol (100:0→90:10, v/v). Concentration of an objective fraction afforded 43 mg of compound 5761 as a bronzed oil.',\n",
       "   'MS: m/z=505 [M+H]+.',\n",
       "   'To compound 5761 (42 mg, 0.083 mmol) was added TFA (1.0 mL), and the mixture was stirred at room temperature for 35 minutes. The reaction solution was subjected to toluene azeotropy, to the resulting concentrated residue was added an aqueous saturated sodium bicarbonate solution, and the mixture was extracted with ethyl acetate. Sodium sulfate was added to the combined extracts to dry them. The solvent was distilled off, to the resulting oil were added ethyl acetate and isopropyl ether, and the precipitated solid was filtered and washed to obtain 14 mg of compound 576 as a pale brown solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.13 (3H, d, J=6.7 Hz), 1.20 (3H, d, J=6.7 Hz), 2.95-3.13 (2H, m), 3.28 (1H, d, J=13.1 Hz), 3.37-3.59 (2H, m), 3.75 (1H, d, J=10.3 Hz), 4.10 (1H, d, J=10.8 Hz), 4.80-4.87 (2H, m), 5.91 (1H, d, J=5.8 Hz), 6.41 (2H, t, J=6.5 Hz), 6.85 (1H, t, J=6.4 Hz), 7.05-7.35 (6H, m).',\n",
       "   'MS: m/z=415 [M+H]+.']},\n",
       " {'number': 'Example 577',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a dimethylformamide (3 mL) solution of a crude product (140 mg) of compound 159A was added potassium cyanide (21.0 mg, 0.323 mmol) at room temperature, and the mixture was stirred at 80° C. for 30 minutes, and at 100° C. for 30 minutes. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=80%→100%) to obtain compound 577B (41.5 mg, 33.5%) as a pale orange foam.',\n",
       "   'MS: m/z=535.25 [M+H]+.',\n",
       "   'To an acetonitrile (4 mL) solution of compound 577B (41.5 mg, 0.078 mmol) and sodium iodide (45.5 mg, 0.304 mmol) was added chlorotrimethylsilane (0.0400 mL, 0.313 mmol) at room temperature, and the mixture was stirred for 2 hours. To the reaction solution was added water (1 mL), the reaction solution was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS. Diethyl ether was added to the resulting residue to convert it into a powder, to obtain compound 577 (20.7 mg, 60.0%) as a gray white solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 3.10 (3H, s), 3.51 (2H, m), 3.70 (1H, d, J=18.9 Hz), 4.03 (1H, d, J=18.9 Hz), 4.46 (1H, d, J=13.4 Hz), 5.04 (1H, d, J=13.4 Hz), 5.56 (1H, s), 5.69 (1H, s), 7.09-7.21 (5H, m), 7.39-7.63 (3H, m), 7.64 (2H, m).',\n",
       "   'MS: m/z=445.20 [M+H]+.']},\n",
       " {'number': 'Example 578',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 578 was synthesized by the same procedure as that of Example 157.',\n",
       "   '1HNMR (CDCl3) δ: 0.97 (3H, d, J=6.6 Hz), 1.19 (3H, d, J=6.9 Hz), 3.29 (3H, s), 3.97 (1H, d, J=16.1 Hz), 4.56 (1H, d, J=13.7 Hz), 4.82 (1H, m), 4.96 (1H, d, J=16.1 Hz), 5.34 (1H, s), 5.97 (1H, d, J=13.7 Hz), 6.78 (2H, m), 7.12 (2H, m), 7.44-7.51 (6H, m).',\n",
       "   'MS: m/z=434.10 [M+H]+.']},\n",
       " {'number': 'Example 579',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 579 was synthesized by the same procedure as that of Example 163.',\n",
       "   'MS: m/z=477.25 [M+H]+.']},\n",
       " {'number': 'Example 580',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a solution of compound 155A (10.5 g, 26.9 mmol), diisopropylethylamine (11.0 mL, 63.0 mmol), 1-methylimidazole (2.60 mL, 32.6 mmol) and isopropylamine (2.80 mL, 32.7 mmol) in toluene (100 mL) and acetonitrile (20 mL) was added dropwise diphenylphosphoric acid chloride (6.80 mL, 32.7 mmol) over 5 minutes under ice-cooling, and the mixture was stirred under ice-cooling for 90 minutes, at room temperature for 90 minutes. To the reaction solution were added tert-butyldimethylsilyl chloride (4.05 g, 26.9 mmol) and triethylamine (4.10 mL, 29.6 mmol) under ice-cooling, the mixture was stirred at room temperature for 80 minutes, 4-dimethylaminopyridine (164 mg, 1.35 mmol) and methylene chloride (100 mL) were added at room temperature, and the mixture was stirred for 15.5 hours. To the reaction solution was added tert-butyldimethylsilyl chloride (2.04 g, 26.9 mmol) at room temperature, and the mixture was stirred for 24 hours. To the reaction solution was added a 10% aqueous acetic acid solution (100 mL) at room temperature, and the mixture was extracted with chloroform, the extracts were combined, washed with saturated sodium bicarbonate water (100 mL), and dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=15%→40%) to obtain compound 580B (6.96 g, 59.9%) as a pale yellow oil.',\n",
       "   'MS: m/z=432.25 [M+H]+.',\n",
       "   'To an ethanol (50 mL) solution of compound 580B (6.96 g, 16.1 mmol) was added aqueous ammonia (35 mL) at room temperature, and the mixture was stirred for 4 days. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=75%→100%, methanol/chloroform=0%→15%) to obtain compound 580C (4.50 g, 64.8%) as a pale orange gummy substance.',\n",
       "   'MS: m/z=431.25 [M+H]+.',\n",
       "   'To a dimethylformamide (90 mL) solution of compound 580C (4.50 g, 10.5 mmol) and potassium carbonate (7.27 g, 52.6 mmol) was added O-(2,4-dinitrophenyl)hydroxylamine (6.29 g, 31.6 mmol) at room temperature, and the mixture was stirred for 2 days. To the reaction solution was added chloroform (180 mL) at room temperature, the precipitated insolubles were filtered off, the filtrated was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=0%→10%) to obtain compound 580D (5.28 g, quant) as a yellow solid.',\n",
       "   'MS: m/z=446.25 [M+H]+.',\n",
       "   'To an ethanol (15 ml) solution of compound 580D (1.29 g, 2.89 mmol) was added paraformaldehyde (261 mg, 8.68 mmol) at room temperature, and the mixture was stirred at 140° C. for 3 hours under microwave irradiation. The reaction solution was concentrated under reduce pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%) to obtain compound 580E (2.47 g, 93.0%) as a pale orange solid.',\n",
       "   'MS: m/z=458.20 [M+H]+.',\n",
       "   'To a DMF (25 mL) solution of compound 580E (2.47 g, 5.40 mmol) were added cesium carbonate (5.28 g, 16.2 mmol) and bromodiphenylmethane (4.02 g, 16.3 mmol) under ice-cooling, and the mixture was stirred at room temperature for 2 days. To the reaction solution was added water (50 mL) under ice-cooling and, thereafter, the mixture was extracted with ethyl acetate (150 mL×2). The extracts were combined, sequentially washed with water (50 mL×2) and an aqueous saturated sodium chloride solution (50 mL), and dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=50%→100%, methanol/chloroform=10%→20%) to obtain compound 580F (1.60 g, 47.5%) as a yellow form.',\n",
       "   'MS: m/z=624.30 [M+H]+.',\n",
       "   'To a methanol (40 mL) solution of compound 580F (1.60 g, 2.56 mmol) was added hydrogen chloride (4N ethyl acetate solution, 20 mL) at room temperature, and the mixture was stirred for 2 hours. The reaction solution was concentrated under reduced pressure, to the resulting residue was added saturated sodium bicarbonate water (20 mL) at room temperature and, thereafter, the mixture was extracted with chloroform three times. The extracts were combined, and dried with sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate) to obtain compound 580G (920 mg, 70.4%) as a white foam.',\n",
       "   'MS: m/z=510.25 [M+H]+.',\n",
       "   'To a THF (80 mL) solution of compound 580G (816 mg, 1.60 mmol) was added manganese dioxide (2.39 g, 27.5 mmol) at room temperature, and the mixture was stirred for 19 hours. After the reaction solution was filtered, the filtrate was distilled off under reduced pressure, and the resulting crude product (785 mg) of compound 580H was used in a next reaction without purification.',\n",
       "   'MS: m/z=508.20 [M+H]+.',\n",
       "   'To a solution of the crude product (635 mg, 1.25 mmol) of compound 580H obtained in the seventh step and amidosulfuric acid (425 mg, 4.38 mmol) in methanol (30 mL) and water (10 mL) was added dropwise a solution of sodium chlorite (396 mg, 4.38 mmol) in water (4 mL) over 10 minutes under ice-cooling, the mixture was stirred at room temperature for 30 minutes, and a 5% aqueous sodium hydrogen sulfite solution (10 mL) was added. Methanol was distilled off under reduced pressure, and the resulting residue was extracted with ethyl acetate two times. The extracts were combined, washed with an aqueous saturated sodium chloride solution (10 mL), and dried with sodium sulfate. The filtrated was distilled off under reduced pressure, and the resulting crude product of compound 5801 was used in a next reaction without purification.',\n",
       "   'MS: m/z=524.25 [M+H]+.',\n",
       "   'To a methylene chloride (20 mL) solution of the crude product (164 mg, 0.313 mmol) of compound 5801 obtained in the eighth step, diisopropylethylamine (0.131 mL, and 0.751 mmol), 1-methylimidazole (0.0300 mL, 0.376 mmol) and methylamine (2.0M tetrahydrofuran solution, 0.188 mL, 0.376 mmol) was added diphenylphosphoric acid chloride (0.0780 mL, 0.375 mmol) at room temperature, the mixture was stirred for 3.5 hours, methylamine hydrochloride (25.0 mg, 0.370 mmol) was added, and the mixture was stirred for 6 days. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=75%→100%) to obtain compound 580J (45.7 mg, 27.2%) as a white foam.',\n",
       "   'MS: m/z=537.30 [M+H]+.',\n",
       "   'To an acetonitrile (4 mL) solution of compound 580J (45.7 mg, 0.0850 mmol) and sodium iodide (103 mg, 0.687 mmol) was added chlorotrimethylsilane (0.0870 mL, 0.681 mmol) at room temperature, and the mixture was stirred for 20 hours. To the reaction solution was added a 5% aqueous sodium hydrogen sulfite solution (4 mL), and the mixture was extracted with chloroform two times. After the extracts were combined, and dried with sodium sulfate, the residue obtained by concentration under reduced pressure was purified by preparative LCMS. Diethyl ether and n-hexane were added to the resulting residue to convert it into a powder, to obtain compound 580 (17.1 mg, 45.0%) as a white solid.',\n",
       "   '1HNMR (CDCl3) δ: 0.93 (3H, d, J=6.9 Hz), 1.11 (3H, d, J=6.9 Hz), 2.83 (3H, d, J=4.8 Hz), 4.53 (1H, d, J=13.4 Hz), 4.85 (1H, m), 4.97 (1H, d, J=13.4 Hz), 5.07 (1H, brd), 5.25 (1H, s), 5.86 (1H, s), 6.97 (2H, m), 7.15-7.24 (2H, m), 7.38-7.46 (6H, m).',\n",
       "   'MS: m/z=447.20 [M+H]+.']},\n",
       " {'number': 'Example 581',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To a tert-butanol (4 mL) solution of compound 580I (398 mg, 0.760 mmol) were added triethylamine (0.158 mL, 1.14 mmol) and diphenylphosphoric acid azide (0.196 mL, 0.912 mmol) at room temperature, and the mixture was heated to reflux for 20 hours. To the reaction solution was added water (20 mL) at room temperature, and the mixture was extracted with chloroform three times. The extracts were combined, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (methanol/chloroform=0%→10%) to obtain compound 581A (167 mg, 36.9%) as a gray white solid.',\n",
       "   'MS: m/z=595.10 [M+H]+.',\n",
       "   'To a methylene chloride (2 mL) solution of compound 581A (167 mg, 0.281 mmol) was added trifluoroacetic acid (2 mL) at room temperature, and the mixture was stirred for 1.5 hours. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by preparative LCMS. Ethyl acetate, diethyl ether, and methanol were added to the resulting residue to convert it into a powder, to obtain compound 581 (29.4 mg, 25.9%) as a white solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 0.81 (3H, d, J=6.5 Hz), 0.98 (3H, d, J=6.5 Hz), 4.35 (1H, d, J=12.6 Hz), 4.63 (1H, m), 4.68 (1H, d, J=12.6 Hz), 4.80 (1H, s), 5.28 (1H, s), 6.34 (2H, s), 7.10-7.43 (8H, m), 7.81-7.83 (2H, m).',\n",
       "   'MS: m/z=404.95 [M+H]+.']},\n",
       " {'number': 'Example 582',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'To an ethanol (4 mL) solution of compound 582A (200 mg, 0.470 mmol) synthesized according to the synthesis method of Example 65 was added paraformaldehyde (14.8 mg, 0.493 mmol) at room temperature, and the mixture was stirred at 140° C. for 45 minutes under microwave irradiation. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=90%→100%) to obtain compound 582B (173 mg, 84.0%) as a white solid.',\n",
       "   'MS: m/z=438.15 [M+H]+.',\n",
       "   'To a methylene chloride (4 mL) solution of compound 582B (173 mg, 0.396 mmol), 4-dimethylaminopyridine (5.6 mg, 0.046 mmol) and triethylamine (0.164 mL, 1.18 mmol) was added 2-fluorobenzenesulfonyl chloride (0.0790 mL, 0.597 mmol) at room temperature, and the mixture was stirred for 3 days. The reaction solution was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=60%→80%) to obtain compound 582C (199 mg, 84.0%) as a white solid.',\n",
       "   'MS: m/z=596.15 [M+H]+.',\n",
       "   'To an acetic acid (2 mL) solution of compound 582C (162 mg, 0.272 mmol) was added 48% aqueous hydrogen bromide (2 mL) at room temperature, and the mixture was stirred at 100° C. for 20 minutes under microwave irradiation. The solvent was distilled off under reduced pressure, and diethyl ether and methanol were added to the resulting residue to convert it into a powder, to obtain compound 582 (160 mg, quant) as a yellow solid.',\n",
       "   '1HNMR (DMSO-d6) δ: 4.34 (1H, d, J=14.7 Hz), 4.59 (1H, d, J=14.7 Hz), 5.50 (1H, d, J=14.3 Hz), 5.81 (1H, d, J=14.3 Hz), 7.15-7.21 (2H, m), 7.35-7.40 (2H, m), 7.45-7.61 (2H, m), 7.78 (1H, m), 7.93 (1H, m), 8.42 (1H, s).',\n",
       "   'MS: m/z=492.10 [M+H]+.']},\n",
       " {'number': 'Example 583, Example 584',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 583A (3.0 g, 0.99 mmol) synthesized according to Example 95 was added to toluene (300 ml) and acetic acid (30.0 ml) to dissolve, and TsOH H2O (0.1 g, 0.526 mmol) was added at room temperature. The reaction mixture was stirred for 3 hours under heat-refluxing. After concentration under reduced pressure, the residue was purified by amino silica gel column chromatography (CHCl3/MeOH 50:1) to obtain compound 583B (1.8 g, 72.4%).',\n",
       "   'MS: m/z=312 [M+H]+.',\n",
       "   'Compound 583B (233 mg, 0.748 mmol) and compound 583C (197 mg, 0.8 mmol) were suspended in THF (7.5 ml), and NaHMDS (1.123 ml, 1.123 mmol, 1M-THF solution) was added at room temperature under nitrogen stream. After stirring at room temperature for 3 hours, water was added, and the mixture was extracted with ethyl acetate (2×30 mL). The ethyl acetate layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (CHCl3/MeOH 20:1) to obtain compound 583D (90 mg, 23.1%).',\n",
       "   'MS: m/z=522 [M+H]+.',\n",
       "   'Compound 583D (90 mg, 0.173 mmol) was dissolved in a mixed solvent of MeOH (3 ml) and THF (3.00 ml), and 10% palladium-carbon (90 mg, 0.846 mmol) was added. The mixture was stirred for 24 hours under hydrogen (2 atm) stream, and insolubles were filtered. The residue was purified using HPLC (MeCN—H2O), and diastereomers were resolved.',\n",
       "   'First Fraction (Compound 583)',\n",
       "   '(15 mg, 20.1%)',\n",
       "   'MS: m/z=432 [M+H]+.',\n",
       "   'Second Fraction (Compound 584)',\n",
       "   '(45 mg, 60.4%)',\n",
       "   'MS: m/z=432 [M+H]+.']},\n",
       " {'number': 'Example 585',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 585 was synthesized by the same procedure as that of Example 403.',\n",
       "   '1H-NMR (DMSO-d6) δ: 1.87-2.28 (4H, m), 3.40-3.80 (3H, m), 4.32 (1H, d, J=12.96 Hz), 5.34 (1H, t, J=7.32 Hz), 5.65 (1H, d, J=7.63 Hz), 6.90 (1H, d, J=7.78 Hz), 7.10-7.35 (5H, m).',\n",
       "   'MS: m/z=312 [M+H]+.']},\n",
       " {'number': 'Example 586',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'Compound 95B (2.29 g, 8.12 mmol) was dissolved in pyridine (10 ml), iso-propyl-D7-amine hydrochloride (1.00 g, 9.75 mmol), 1H-benzo[d][1,2,3]triazol-1-ol (1.10 g, 8.12 mmol) and N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine hydrochloride (3.11 g, 16.2 mmol) were added, and the mixture was stirred at room temperature for 20 hours. The reaction solution was poured into water, and the mixture was extracted with ethyl acetate, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound was added diethyl ether, and the precipitated residue was filtered to obtain 1.36 g of a white solid 586B.',\n",
       "   'Compound 586B (1.36 g, 4.64 mmol) obtained in the first step was dissolved in dimethylformamide (20 ml), potassium carbonate (3.20 g, 23.2 mmol) was added, and the mixture was stirred at room temperature for 50 minutes. O-(2,4-dinitrophenyl)hydroxylamine (1.85 g, 9.27 mmol) was added, and the mixture was stirred at room temperature for 18 hours. To the reaction solution was added chloroform, the generated precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v) to obtain 835 mg of a colorless solid 586C.',\n",
       "   '1H-NMR (CDCl3) δ: 5.28 (2H, s), 5.63 (2H, s), 6.32 (1H, d, J=7.7 Hz), 7.10 (1H, brs), 7.42 (6H, m).',\n",
       "   'Compound 586C (581 mg, 1.88 mmol) obtained in the second step and paraformaldehyde-D2 (181 mg, 5.65 mmol) were added to ethanol (12 ml), and the mixture was stirred at 140° C. for 30 minutes under microwave irradiation. The reaction solution was concentrated under reduced pressure, and the resulting crude product was purified by amino column chromatography, and eluted with chloroform-methanol (97:3, v/v). To the resulting compound was added diethyl ether, and the precipitated residue was filtered to obtain 140 mg of white solid 586D.',\n",
       "   '1H-NMR (CDCl3) δ: 4.39 (2H, d, J=8.1 Hz), 5.36 (2H, s), 5.42 (1H, t, J=8.0 Hz), 6.37 (1H, d, J=7.6 Hz), 7.48 (6H, m).',\n",
       "   'Compound 586E (972 mg, 5.78 mmol) was dissolved in tetrahydrofuran (10 ml), sodium hydride (60%, 231 mg, 5.78 mmol) and benzyl bromide-D2 (1.00 g, 5.78 mmol) were added at 0° C., and the mixture was stirred at 60° C. for 30 minutes. The reaction solution was added to dilute hydrochloric acid, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous sodium bicarbonate solution. The solvent was distilled off under reduced pressure to obtain 1.48 g of a white solid 586F.',\n",
       "   '1H-NMR (CDCl3) δ: 3.95 (3H, s), 7.17-7.48 (8H, m), 8.00 (1H, dd, J=7.8, 1.3 Hz).',\n",
       "   'Compound 586F (1.50 g, 5.76 mmol) obtained in the fourth step was dissolved in methanol (20 ml) and tetrahydrofuran (20 ml), a 2N aqueous sodium hydroxide solution (14.4 ml, 28.8 mmol) was added, and the mixture was stirred at room temperature for 3 hours. To the reaction solution was added dilute hydrochloric acid to make the solution acidic, the mixture was extracted with ethyl acetate, and the organic layer was washed with an aqueous saturated sodium chloride solution, and dried with sodium sulfate. The solvent was distilled off under reduced pressure, to the resulting compound were added n-hexane-ethyl acetate, and the precipitated residue was filtered to obtain 1.17 g of a white solid 586G.',\n",
       "   '1H-NMR (CDCl3) δ: 7.18-7.48 (8H, m), 8.11 (1H, dd, J=7.9, 1.6 Hz).',\n",
       "   'To compound 586G (1.15 g, 4.67 mmol) obtained in the fifth step was added toluene (10 ml), dimethylformamide (0.100 ml, 1.29 mmol) and thionyl chloride (0.410 ml, 5.60 mmol) were added, and the mixture was stirred at 130° C. for 1.5 hours. After cooled to room temperature, the reaction solution was concentrated under reduced pressure. To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 1.16 g of a white solid. To aluminum chloride (718 mg, 5.38 mmol) were added dichloromethane (10 ml) and nitromethane (0.5 ml), a dichloromethane solution (5 ml) of 500 mg of the compound obtained above was added at 0° C., and the mixture was stirred at room temperature for 5 hours. To the reaction solution was added an aqueous sodium hydroxide solution, and the mixture was extracted with methylene chloride, and the organic layer was dried with sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography, and eluted with n-hexane-ethyl acetate (4:1, v/v). To the resulting compound was added n-hexane, and the precipitated residue was filtered to obtain 155 mg of a pale yellow solid 586H.',\n",
       "   '1H-NMR (CDCl3) δ: 7.21-7.39 (6H, m), 7.46 (1H, td, J=7.5, 1.4 Hz), 7.59 (1H, dd, J=7.5, 1.4 Hz), 8.21 (1H, dd, J=8.0, 1.0 Hz).',\n",
       "   'Compound 586H (150 mg, 0.657 mmol) obtained in the sixth step was dissolved in tetrahydrofuran (3 ml), lithium aluminum hydride-D4 (13.8 mg, 0.329 mmol) was added at 0° C., and the mixture was stirred at room temperature for 2 hours. To the reaction solution was added dilute hydrochloric acid, the mixture was extracted with ethyl acetate, and dried with sodium sulfate, and the solvent was distilled off under reduced pressure. To the resulting compound were added n-hexane-dichloromethane, and the precipitated residue was filtered to obtain 114 mg of a white solid 5861.',\n",
       "   '1H-NMR (CDCl3) δ: 7.17 (6H, m), 7.40-7.52 (2H, m).',\n",
       "   'Compound 586D (76.0 mg, 0.236 mmol) and 5861 (54.5 mg, 0.235 mmol) were dissolved in acetic acid (3.2 ml), and concentrated sulfuric acid (0.8 ml) was added dropwise under water-cooling. After the mixture was stirred at room temperature for 30 minutes, the mixture was poured into water, and extracted with ethyl acetate. The organic layer was dried with sodium sulfate, the solvent was distilled off under reduced pressure, to the resulting crude product were added ethyl acetate-diethyl ether, and the precipitated residue was filtered to obtain 32 mg of a white solid 586.',\n",
       "   '1H-NMR (DMSO-d6) δ: 5.57 (1H, d, J=7.3 Hz), 6.82-7.44 (9H, m).',\n",
       "   'MS: m/z=446 [M+H]+',\n",
       "   'Using a commercially available heavy hydrogen reagent, and according to Example 586, compounds 587 to 591 were synthesized.']},\n",
       " {'number': 'Example 587', 'title': '', 'content': ['']},\n",
       " {'number': 'Example 588',\n",
       "  'title': 'MS: m/z=436 [M+H]+',\n",
       "  'content': ['MS: m/z=436 [M+H]+',\n",
       "   '',\n",
       "   '1H-NMR (DMSO-d6) δ: 3.87 (1H, d, J=13.4 Hz), 5.58 (1H, d, J=7.8 Hz), 5.60 (1H, d, J=12.6 Hz), 6.81-7.48 (9H, m).']},\n",
       " {'number': 'Example 589', 'title': '', 'content': ['', 'MS: m/z=441 [M+H]+']},\n",
       " {'number': 'Example 590', 'title': '', 'content': ['', 'MS: m/z=435 [M+H]+']},\n",
       " {'number': 'Example 591',\n",
       "  'title': '',\n",
       "  'content': ['',\n",
       "   'MS: m/z=436 [M+H]+',\n",
       "   'The following EX-1 to EX-29 can be also synthesized like the Examples, and are a preferable embodiment of the present invention.',\n",
       "   '',\n",
       "   'Further, the following combinations of substituents can be also synthesized like the above Examples, and are a preferable embodiment of the present invention.',\n",
       "   'Compounds in which, in the following formula (I) or (II):',\n",
       "   'combinations of R3 or R3a, as Well as R7 or R7a of the following formula (I′) or (II′):',\n",
       "   'are selected from the following Tables 6 to 10 and Table 11, respectively.\\n\\nCombinations of (R3, R7) or (R3a, R7a)=(R3-1, R7-1), (R3-1, R7-2), (R3-1, R7-3), (R3-1, R7-4), (R3-1, R7-5), (R3-1, R7-6), (R3-1, R7-7), (R3-1, R7-8), (R3-1, R7-9), (R3-1, R7-10), (R3-1, R7-11), (R3-1, R7-12), (R3-1, R7-13), (R3-1, R7-14), (R3-1, R7-15), (R3-1, R7-16), (R3-1, R7-17), (R3-1, R7-18), (R3-1, R7-19), (R3-1, R7-20), (R3-1, R7-21), (R3-1, R7-22), (R3-1, R7-23), (R3-1, R7-24), (R3-1, R7-25), (R3-1, R7-26), (R3-1, R7-27), (R3-1, R7-28), (R3-1, R7-29), (R3-1, R7-30), (R3-1, R7-31), (R3-1, R7-32), (R3-1, R7-33), (R3-1, R7-34), (R3-1, R7-35), (R3-1, R7-36), (R3-1, R7-37), (R3-1, R7-38), (R3-1, R7-39), (R3-1, R7-40), (R3-1, R7-41), (R3-1, R7-42), (R3-1, R7-43), (R3-1, R7-44), (R3-1, R7-45), (R3-1, R7-46), (R3-1, R7-47), (R3-1, R7-48), (R3-1, R7-49), (R3-1, R7-50), (R3-1, R7-51), (R3-1, R7-52), (R3-1, R7-53), (R3-1, R7-54), (R3-1, R7-55), (R3-1, R7-56), (R3-1, R7-57), (R3-1, R7-58), (R3-1, R7-59), (R3-1, R7-60), (R3-1, R7-61), (R3-1, R7-62), (R3-1, R7-63), (R3-1, R7-64), (R3-1, R7-65), (R3-1, R7-66), (R3-1, R7-67), (R3-1, R7-68), (R3-1, R7-69), (R3-1, R7-70), (R3-1, R7-71), (R3-1, R7-72), (R3-1, R7-73), (R3-1, R7-74), (R3-1, R7-75), (R3-1, R7-76), (R3-1, R7-77),\\n\\n(R3-2, R7-1), (R3-2, R7-2), (R3-2, R7-3), (R3-2, R7-4), (R3-2, R7-5), (R3-2, R7-6), (R3-2, R7-7), (R3-2, R7-8), (R3-2, R7-9), (R3-2, R7-10), (R3-2, R7-11), (R3-2, R7-12), (R3-2, R7-13), (R3-2, R7-14), (R3-2, R7-15), (R3-2, R7-16), (R3-2, R7-17), (R3-2, R7-18), (R3-2, R7-19), (R3-2, R7-20), (R3-2, R7-21), (R3-2, R7-22), (R3-2, R7-23), (R3-2, R7-24), (R3-2, R7-25), (R3-2, R7-26), (R3-2, R7-27), (R3-2, R7-28), (R3-2, R7-29), (R3-2, R7-30), (R3-2, R7-31), (R3-2, R7-32), (R3-2, R7-33), (R3-2, R7-34), (R3-2, R7-35), (R3-2, R7-36), (R3-2, R7-37), (R3-2, R7-38), (R3-2, R7-39), (R3-2, R7-40), (R3-2, R7-41), (R3-2, R7-42), (R3-2, R7-43), (R3-2, R7-44), (R3-2, R7-45), (R3-2, R7-46), (R3-2, R7-47), (R3-2, R7-48), (R3-2, R7-49), (R3-2, R7-50), (R3-2, R7-51), (R3-2, R7-52), (R3-2, R7-53), (R3-2, R7-54), (R3-2, R7-55), (R3-2, R7-56), (R3-2, R7-57), (R3-2, R7-58), (R3-2, R7-59), (R3-2, R7-60), (R3-2, R7-61), (R3-2, R7-62), (R3-2, R7-63), (R3-2, R7-64), (R3-2, R7-65),\\n\\n(R3-2, R7-66), (R3-2, R7-67), (R3-2, R7-68), (R3-2, R7-69), (R3-2, R7-70), (R3-2, R7-71), (R3-2, R7-72), (R3-2, R7-73), (R3-2, R7-74), (R3-2, R7-75), (R3-2, R7-76), (R3-2, R7-77), (R3-3, R7-1), (R3-3, R7-2), (R3-3, R7-3), (R3-3, R7-4), (R3-3, R7-5), (R3-3, R7-6), (R3-3, R7-7, (R3-3, R7-8), (R3-3, R7-9), (R3-3, R7-10), (R3-3, R7-11), (R3-3, R7-12), (R3-3, R7-13), (R3-3, R7-14), (R3-3, R7-15), (R3-3, R7-16), (R3-3, R7-17), (R3-3, R7-18), (R3-3, R7-19), (R3-3, R7-20), (R3-3, R7-21), (R3-3, R7-22), (R3-3, R7-23), (R3-3, R7-24), (R3-3, R7-25), (R3-3, R7-26), (R3-3, R7-27), (R3-3, R7-28), (R3-3, R7-29), (R3-3, R7-30), (R3-3, R7-31), (R3-3, R7-32), (R3-3, R7-33), (R3-3, R7-34), (R3-3, R7-35), (R3-3, R7-36), (R3-3, R7-37), (R3-3, R7-38), (R3-3, R7-39), (R3-3, R7-40), (R3-3, R7-41), (R3-3, R7-42), (R3-3, R7-43), (R3-3, R7-44), (R3-3, R7-45), (R3-3, R7-46), (R3-3, R7-47), (R3-3, R7-48), (R3-3, R7-49), (R3-3, R7-50), (R3-3, R7-51), (R3-3, R7-52), (R3-3, R7-53), (R3-3, R7-54), (R3-3, R7-55), (R3-3, R7-56), (R3-3, R7-57), (R3-3, R7-58), (R3-3, R7-59), (R3-3, R7-60), (R3-3, R7-61), (R3-3, R7-62), (R3-3, R7-63), (R3-3, R7-64), (R3-3, R7-65), (R3-3, R7-66), (R3-3, R7-67), (R3-3, R7-68), (R3-3, R7-69), (R3-3, R7-70), (R3-3, R7-71), (R3-3, R7-72), (R3-3, R7-73), (R3-3, R7-74), (R3-3, R7-75), (R3-3, R7-76), (R3-3, R7-77).',\n",
       "   'TABLE 6\\n\\n\\n\\n\\n\\n\\n\\n\\nR3 or R3a\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nR3-1\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR3-2\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR3-3',\n",
       "   'TABLE 7\\n\\n\\n\\n\\n\\n\\n\\n\\nR7 or R7a\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nR7-1\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-2\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-3\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-4\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-5\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-6\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-7\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-8\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-9\\u2002\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-10\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-11\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-12\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-13\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-14\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-15\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-16\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-17\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-18',\n",
       "   'TABLE 8\\n\\n\\n\\n\\n\\n\\n\\n\\nR7 or R7a\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nR7-19\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-20\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-21\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-22\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-23\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-24\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-25\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-26\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-27\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-28\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-29\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-30\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-31\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-32\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-33\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-34\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-35\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-36',\n",
       "   'TABLE 9\\n\\n\\n\\n\\n\\n\\n\\n\\nR7 or R7a\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nR7-37\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-38\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-39\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-40\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-41\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-42\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-43\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-44\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-45\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-46\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-47\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-48\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-49\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-50\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-51\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-52\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-53\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-54',\n",
       "   'TABLE 10\\n\\n\\n\\n\\n\\n\\n\\n\\nR7 or R7a\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nR7-55\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-56\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-57\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-58\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-59\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-60\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-61\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-62\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-63\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-64\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-65\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-66\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-67\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-68\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-69\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-70\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-71\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-72',\n",
       "   'TABLE 11\\n\\n\\n\\n\\n\\n\\n\\n\\nR7 or R7a\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nR7-73\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-74\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-75\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-76\\n\\n\\n\\n\\n\\n\\n\\n \\n\\n\\n\\nR7-77',\n",
       "   'As Reference Examples, a method for synthesizing intermediates useful for carrying out the present application is shown below.',\n",
       "   '',\n",
       "   'A solution of benzyl alcohol (1.00 g, 9.25 mmol) in THF (3 ml) was added to a suspension of sodium tert-pentoxide (2.55 g, 23.2 mmol) in THF (4 ml) at room temperature under nitrogen atmosphere, and the mixture was stirred at 40° C. for 2 hours. This reaction solution was cooled in an ice bath, and a solution of compound 1a (1.53 g, 10.2 mmol) in THF (3 ml) was added dropwise at 0 to 10° C. After the reaction solution was stirred at room temperature for 2 hours, 2 N hydrochloric acid (15 ml) was added, followed by extraction with ethyl acetate two times. The combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography (n-hexane-ethyl acetate 4:1, v/v) to obtain 1.89 g (yield 92%) of compound 1b as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 3.56 (2H, s), 3.71 (3H, s), 4.14 (2H, s), 4.59 (2H, s), 7.27-7.42 (5H, m).',\n",
       "   'Compound 1b (1.80 g, 8.1 mmol) was dissolved in 1,4-dioxane (18 mL), N,N-dimethylformamide dimethyl acetal (1.45 g, 12.2 mmol) was added, and the mixture was stirred at room temperature for 6 hours. The reaction solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 1:4, v/v) to obtain 1.77 g (yield 79%) of compound 1c as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 2.90 (3H, br), 3.25 (3H, br), 3.69 (3H, s), 4.45 (2H, s), 4.59 (2H, s), 7.24-7.40 (5H, m), 7.73 (s, 1H).',\n",
       "   'Sodium tert-butoxide (2.55 g, 23.2 mmol), dimethyl oxalate (639 mg, 5.41 mmol) and DMI (3 ml) were added to a three-neck flask under nitrogen atmosphere, and a solution of compound 1c (0.50 g, 1.80 mmol) in DMI (2 ml) was added dropwise thereto at 25 to 30° C. After stirring at room temperature for 7 hours, 2N hydrochloric acid (10 ml) was added, and the mixture was stirred at room temperature for 15 hours. The reaction solution was extracted with ethyl acetate two times, and the combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 2:1 to 1:1, v/v) to obtain 488 mg (yield 85%) of compound 1d as a white crystal.',\n",
       "   '1H-NMR (CDCl3) δ: 3.89 (3H, s), 3.93 (3H, s), 5.34 (2H, s), 7.32-7.40 (3H, m), 7.45-7.49 (2H, m), 8.50 (1H, s).',\n",
       "   '',\n",
       "   'A solution of benzyl alcohol (0.66 g, 6.1 mmol) in DMI (3 ml) was added to a suspension of sodium tert-pentoxide (1.67 g, 15.2 mmol) in DMI (4 ml) at room temperature under nitrogen atmosphere, and the mixture was stirred at 40° C. for 2 hours. This reaction solution was cooled in an ice bath, and a solution of compound 2a (1.10 g, 6.68 mmol) in DMI (3 ml) was added dropwise at 0 to 10° C. The reaction solution was stirred at 0 to 5° C. for 2 hours, and at room temperature for 3 hours, and 2N hydrochloric acid (15 ml) was added, followed by extraction with ethyl acetate two times. The combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting oil product was purified by silica gel column chromatography (n-hexane-ethyl acetate 4:1, v/v) to obtain 1.29 g (yield 90%) of compound 2b as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.25 (3H, t, J=7.2 Hz), 3.54 (2H, s), 4.14 (2H, s), 4.17 (2H, q, J=7.2 Hz), 4.59 (2H, s), 7.28-7.40 (5H, m).',\n",
       "   'Compound 2b (9.73 g, 41.2 mmol) was dissolved in toluene (45 ml), N,N-dimethylformamide dimethyl acetal (7.36 g, 61.8 mmol) was added, and the mixture was stirred at room temperature for 5 hours. Water was added to the reaction solution, followed by extraction with ethyl acetate two times. The combined extracts were washed sequentially with water, and saturated sodium chloride water, and then dried with anhydrous magnesium sulfate. The solvent was distilled off, and the resulting oil product was purified by silica gel column chromatography (n-hexane-ethyl acetate 1:1 to 3:7, v/v) to obtain 7.90 g (yield 66%) of compound 2c as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.25 (3H, t, J=7.2 Hz), 2.95 (3H, br), 3.22 (3H, br), 4.15 (2H, q, J=7.2 Hz), 4.45 (2H, s), 4.59 (2H, s), 7.22-7.40 (5H, m), 7.73 (1H, s).',\n",
       "   'Sodium tert-butoxide (495 mg, 5.15 mmol) and DMI (2 ml) were added to a three-neck flask under nitrogen atmosphere, and dimethyl oxalate (608 mg, 5.15 mmol) and a solution of compound 2c (0.50 g, 1.72 mmol) in DMI (3 ml) was added dropwise at 25 to 30° C. After stirring at room temperature for 4 hours, 2N hydrochloric acid (10 ml) was added, and the mixture was stirred at room temperature for 15 hours. The reaction solution was extracted with toluene two times, and the combined extracts were washed sequentially with water, saturated sodium bicarbonate water, water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 2:1, v/v) to obtain 420 mg (yield 74%) of compound 2d as a white crystal.',\n",
       "   '1H-NMR (CDCl3) δ: 1.39 (3H, t, J=7.2 Hz), 3.88 (3H, s), 4.39 (2H, q, J=7.2 Hz), 5.34 (2H, s), 7.30-7.41 (3H, m), 7.45-7.50 (2H, m), 8.48 (1H, s).',\n",
       "   '',\n",
       "   'N,N-dimethylformamide dimethyl acetal (4.9 ml, 36.5 mmol) was added dropwise to compound 3a (5.0 g, 30.4 mmol) at 0° C. under cooling. After stirring at 0° C. for 1 hour, 100 ml of ethyl acetate was added to the reaction solution, followed by washing with 0.5N hydrochloric acid (50 ml). The aqueous layer was separated, and extracted with ethyl acetate (50 ml). The organic layers were combined, washed sequentially with saturated sodium bicarbonate water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 1:1 (v/v)→ethyl acetate) to obtain 4.49 g (yield 67%) of compound 3b as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.32 (3H, t, J=7.1 Hz), 2.90 (3H, br s), 3.29 (3H, br s), 4.23 (2H, q, J=7.1 Hz), 4.54 (2H, s), 7.81 (1H, s).',\n",
       "   'Lithium hexamethyldisilazide (1.0 M toluene solution, 49 ml, 49.0 mmol) was diluted with tetrahydrofuran (44 ml), a solution of compound 3b (4.49 g, 20.4 mmol) in tetrahydrofuran (10 ml) was added dropwise thereto at −78° C. under cooling, and a solution of ethyl oxalyl chloride (3.35 g, 24.5 mmol) in tetrahydrofuran (10 ml) was added dropwise. After stirring at −78° C. for 2 hours, temperature was raised to 0° C. After 2N hydrochloric acid was added to the reaction solution, and the mixture was stirred for 20 minutes, the solution was extracted with ethyl acetate (200 ml×2), and the organic layer was washed with saturated sodium bicarbonate water and saturated sodium chloride water and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 7:3→5:5→0:10 (v/v)) to obtain 1.77 g (yield 31%) of compound 3c as a white solid.',\n",
       "   '1H-NMR (CDCl3) δ: 1.36-1.46 (6H, m), 4.35-4.52 (8H, m), 8.53 (1H, s).',\n",
       "   'Aminoacetaldehyde dimethyl acetal (0.13 ml, 1.20 mmol) was added to a solution of compound 3c (300 mg, 1.09 mmol) in ethanol (6 ml) at 0° C., and the mixture was stirred at 0° C. for 1 hour and 30 minutes, at room temperature for 18 hours and, then, at 60° C. for 4 hours. After the solvent was distilled off from the reaction solvent under reduced pressure, the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 5:5→0:10 (v/v)) to obtain 252 mg (yield 64%) of compound 3d as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.36-1.47 (6H, m), 3.42 (6H, s), 3.90 (2H, d, J=5.2 Hz), 4.37 (3H, q, J=7.2 Hz), 4.50 (2H, q, J=7.2 Hz), 8.16 (1H, s).',\n",
       "   '',\n",
       "   'N,N-dimethylformamide dimethyl acetal (12.2 ml, 92.2 mmol) was added dropwise to compound 4a (10.0 g, 76.8 mmol) at 0° C. under cooling. After stirring at 0° C. for 1 hour and 30 minutes and, then, at room temperature for 2 hours and 30 minutes, 100 ml of ethyl acetate was added to the reaction solution, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 5:5→0:10 (v/v)) to obtain 12.45 g (yield 88%) of compound 4b as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.32 (3H, t, J=7.1 Hz), 2.33 (3H, s), 3.04 (6H, br s), 4.23 (2H, q, J=7.2 Hz), 7.68 (1H, s).',\n",
       "   'Lithium hexamethyldisilazide (1.0M toluene solution, 24 ml, 24.0 mmol) was diluted with tetrahydrofuran (20 ml), a solution of compound 4b (1.85 g, 10.0 mmol) in tetrahydrofuran (5 ml) was added dropwise thereto at −78° C. under cooling, and a solution of ethyl oxalyl chloride (1.34 ml, 12.0 mmol) in tetrahydrofuran (5 ml) was added dropwise. After stirring at −78° C. for 2 hours, 2N-hydrochloric acid was added to the reaction solution, and the mixture was stirred at room temperature for 20 minutes. The solution was extracted with ethyl acetate, and the organic layer was washed sequentially with saturated sodium bicarbonate water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 75:25→455:5 (v/v)) to obtain 1.03 g (yield 43%) of compound 4c as a brown oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.38 (3H, t, J=7.1 Hz), 1.42 (3H, t, J=7.4 Hz), 4.33-4.47 (4H, m), 7.19 (1H, s), 8.54 (1H, s).',\n",
       "   'Aminoacetaldehyde dimethyl acetal (0.34 ml, 3.11 mmol) was added to a solution of compound 4c (680 mg, 2.83 mmol) in ethanol (6.8 ml) at 0° C., and it was allowed to stand at room temperature for 16 hours. After the solvent was distilled off from the reaction solution under reduced pressure, the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 90:10 (v/v)) to obtain 875 mg (yield 94%) of compound 4d as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.38 (3H, t, J=7.1 Hz), 1.39 (3H, t, J=7.1 Hz), 3.40 (6H, s), 4.33 (2H, d, J=4.7 Hz), 4.37 (4H, q, J=7.1 Hz), 4.49 (1H, t, J=4.7 Hz), 7.06 (1H, s), 8.17 (1H, s).',\n",
       "   'N-bromosuccinimide (1.46 g, 8.18 mmol) was added to a solution of compound 4d (2.68 g, 8.18 mmol) in N,N-dimethylformamide (10 ml), and the mixture was stirred at room temperature for 48 hours. After saturated sodium bicarbonate water was added to the reaction solution, the solution was extracted with ethyl acetate, and the organic layer was washed sequentially with water and saturated sodium chloride water, and then dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 90:10 (v/v)) to obtain 2.83 g (yield 85%) of compound 4e as an oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.41 (3H, t, J=7.1 Hz), 1.48 (3H, t, J=7.1 Hz), 3.42 (6H, s), 3.90 (2H, d, J=5.0 Hz), 4.39 (2H, q, J=7.1 Hz), 4.53 (3H, q, J=14.3 Hz), 4.54 (3H, s), 4.57 (3H, t, J=5.4 Hz), 8.19 (1H, s).',\n",
       "   '',\n",
       "   'Compound 5a (598 mg, 4.09 mmol) and N,N-dimethylformamide dimethyl acetal (488 mg, 4.09 mmol) were dissolved in toluene (1 ml), and the mixture was stirred at room temperature for 11 hours. The solvent was distilled off from the reaction solution under reduced pressure, and the resulting residue (containing compound 5b) was used in Second step without purification.',\n",
       "   'Sodium tert-butoxide (400 mg, 4.16 mmol) was suspended in dimethyl imidazolidinone (5 ml), a solution of the crude product obtained in First step in dimethylimidazolidinone (5 ml) was added thereto, a solution of dimethyl oxalate (983 mg, 8.32 mmol) in THF (10 ml) was added dropwise, and the mixture was stirred at room temperature for 45 minutes. The reaction solution was poured into 2N hydrochloric acid-methanol (20 ml), and the mixture was stirred at 0° C. for 20 minutes. Water was added, the solution was extracted with ethyl acetate, and the organic layer was washed sequentially with water, saturated sodium bicarbonate water, and saturated sodium chloride water, and dried with anhydrous sodium sulfate. After the solvent was distilled off, the resulting residue was purified by silica gel column chromatography to obtain 222 mg (yield: 22% from 5a) of compound 5c.',\n",
       "   '',\n",
       "   'Lithium hexamethyldisilazide (1.0M toluene solution, 12 ml, 12.0 mmol) was diluted with tetrahydrofuran (11 ml), a solution of compound 6a (1.46 g, 5.0 mmol) in tetrahydrofuran (2 ml) was added dropwise thereto at −78° C. under cooling, and a solution of ethyl oxalyl chloride (0.67 ml, 6.0 mmol) in tetrahydrofuran (2 ml) was added dropwise. After stirring at −78° C. for 2 hours, ammonium acetate (500 mg) and acetic acid (10 ml) were added to the reaction solution, and the mixture was stirred at 65° C. for 1 hour and 30 minutes. Water was added to the reaction solution, the solvent was extracted with ethyl acetate, and the organic layer was washed sequentially with water, and saturated sodium bicarbonate water, and dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (N-hexane-ethyl acetate 55:45→45:55 (v/v)) to obtain 505.1 mg of compound 6B as a yellow solid. It was washed with isopropyl ether-hexane (1:2), and dried under reduced pressure to obtain 416.8 mg (yield 24%) of Compound 6b as a yellow crystal.',\n",
       "   '1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 1.46 (3H, t, J=7.1 Hz), 4.40 (2H, q, J=7.2 Hz), 4.50 (2H, q, J=7.1 Hz), 5.20 (2H, s), 7.33-7.41 (3H, m), 7.49-7.52 (2H, m), 8.76 (1H, s), 11.61 (1H, br s).',\n",
       "   'Cesium carbonate (73.3 mg, 0.23 mmol) and bromoacetaldehyde dimethyl acetal (38.0 mg, 0.23 mmol) were added to a solution of compound 6b (51.8 mg, 0.15 mmol) in N,N-dimethylformamide (1 ml), and the mixture was stirred at room temperature overnight. Cesium carbonate (73.3 mg, 0.23 mmol) and bromoacetaldehyde dimethyl acetal (38.0 mg, 0.23 mmol) were further added, and the mixture was further stirred at 100° C. for 20 minutes. After water was added to the reaction solution, the solution was extracted with ethyl acetate, and the organic layer was washed sequentially with water and saturated sodium chloride water, and dried with anhydrous sodium sulfate. The solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 50:50→30:70 (v/v)) to obtain 35.3 mg (yield 54%) of compound 6c as a colorless oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 1.26 (3H, t, J=7.1 Hz), 1.40 (3H, t, J=7.1 Hz), 3.39 (6H, s), 3.91 (2H, d, J=5.0 Hz), 4.29 (2H, q, J=7.1 Hz), 4.40 (2H, q, J=7.2 Hz), 4.50 (1H, t, J=5.0 Hz), 5.30 (2H, s), 7.31-7.37 (3H, m), 7.43-7.46 (2H, m), 8.12 (1H, s).',\n",
       "   '',\n",
       "   'Aminoacetaldehyde dimethyl acetal (7.80 mmol) was added to a solution of compound 7a (900 mg, 2.60 mmol) in ethanol (5 ml), and the mixture was stirred at room temperature for 22 hours. Ethyl acetate (5 ml) and water (5 ml) were added to the reaction solution, followed by extraction with ethyl acetate (5 ml). After the organic layer was washed with water (10 ml), the solvent was distilled off, and the resulting residue was purified by silica gel column chromatography (n-hexane-ethyl acetate 2:1) to obtain 0.37 g (yield 33%) of compound 7b as a colorless oil product.',\n",
       "   '1H-NMR (CDCl3) δ: 7.90 (1H, s), 7.45-7.43 (5H, m), 5.30 (2H, s), 4.51 (1H, t, J=5.1 Hz), 4.40 (2H, q, J=7.1 Hz), 4.30 (2H, q, J=7.1 Hz), 3.91 (2H, d, J=5.1 Hz), 3.46 (6H, s), 1.40 (3H, t, J=7.1 Hz), 1.26 (3H, t, J=7.1 Hz).',\n",
       "   'The compounds in connection with the present invention are useful for symptoms and/or diseases which are induced by influenza virus. For example, they are useful for treating and/or preventing, or improving symptoms of, cold-like symptoms accompanying fever, algor, headache, muscular pain, general malaise etc., airway inflammation symptoms such as pharyngalgia, nasal secretion, nasal congestion, cough, sputum etc., gastrointestinal symptoms such as abdominal pain, vomitus, diarrhea etc. and, further, complications accompanying secondary infection such as acute encephalopathy and pneumonia.',\n",
       "   'Since the compounds in connection with the present invention have the effects such as inhibitory activity on high cap structure-dependent endonuclease, and high selectivity due to a virus-specific enzyme, they can be medicaments having reduced side effects. Further, since the compounds in connection with the present invention have advantages that metabolism stability is high, solubility is high, oral absorbability is high, good bioavailability is exhibited, good clearance is exhibited, pulmonary transitivity is high, a half life is long, a non-protein binding rate is high, hERG channel inhibition is low, CYP inhibition is low, CPE (CytoPathic Effect) inhibiting effect is recognized, and/or negativity is exhibited in a phototoxicity test, an Ames test and a gene toxicity test, they can be excellent medicaments.',\n",
       "   'The compounds in connection with the present invention can be administered orally or parenterally. In the case of oral administration, the present compounds can be also used as a normal preparation, for example, as any dosage form of solid preparations such as tablets, powders, granules, capsules etc.; solutions; oleaginous suspensions; or liquid preparations such as syrups or elixirs etc. In the case of parenteral administration, the compounds in connection with the present invention can be used as aqueous or oleaginous suspension injectables, or nose drops. Upon preparation of them, conventional excipients, binders, lubricants, aqueous solvents, oleaginous solvents, emulsifiers, suspending agents, preservatives, stabilizers etc. can be arbitrarily used. The pharmaceutical composition of the present invention can be produced by combining (for example, mixing) a therapeutically effective amount of the present compound with pharmaceutically acceptable carriers or diluents.',\n",
       "   'A dose of the compounds in connection with the present invention is different depending on an administration method, an age, a weight and the state of a patient, and a kind of a disease and, usually, in the case of oral administration, about 0.05 mg to 3000 mg, preferably about 0.1 mg to 1000 mg per adult a day may be administered, if necessary, by division. In addition, in the case of parenteral administration, about 0.01 mg to 1000 mg, preferably about 0.05 mg to 500 mg per adult a day is administered.']},\n",
       " {'number': 'Test Example 1',\n",
       "  'title': 'Measurement of Cap-Dependant Endonuclease (CEN) Inhibitory Activity',\n",
       "  'content': ['1) Preparation of Substrate',\n",
       "   '30merRNA(5′-pp-[m2′-O]GAA UAU(-Cy3) GCA UCA CUA GUA AGC UUU GCU CUA-BHQ2-3′: manufactured by Japan Bioservice) in which G at a 5′ end is diphosphate-modified, a hydroxy group at 2′ position is methoxylation-modified, U sixth from a 5′ end is labelled with Cy3, and a 3′ end is labelled with BHQ2 was purchased, and a cap structure was added using ScriptCap system manufactured by EPICENTRE (a product was m7G [5′]-ppp-[5′] [m2′-O]GAA UAU(-Cy3) GCA UCA CUA GUA AGC UUU GCU CUA(-BHQ2)-3′). This was separated and purified by denatured polyacrylamide gel electrophoresis, and used as a substrate.',\n",
       "   '2) Preparation of Enzyme',\n",
       "   'RNP was prepared from a virus particle using standard method (Reference Document: VIROLOGY (1976) 73, p 327-338 OLGA M. ROCHOVANSKY). Specifically, A/WSN/33 virus (1×103 PFU/mL, 200 μL) was innoculated in a 10 days old embryonated chicken egg. After incubation at 37° C. for 2 days, the allantoic fluid of the chicken egg was recovered. A virus particle was purified by ultracentrifugation using 20% sucrose, solubilized using TritonX-100 and lysolecithin, and an RNP fraction (50-70% glycerol fraction) was collected by ultracentrifugation using a 30-70% glycerol density gradient, and was used as an enzyme solution (containing approximately 1 nM PB1•PB2•PA complex).',\n",
       "   '3) Enzymatic Reaction',\n",
       "   'An enzymatic reaction solution (2.5 μL) (composition: 53 mM Tris-hydrochloride (pH 7.8), 1 mM MgCl2, 1.25 mM dithiothreitol, 80 mM NaCl, 12.5% glycerol, enzyme solution 0.15 μL) was dispensed into a 384-well plate made of polypropylene. Then, 0.5 μL of a test substance solution which had been serially diluted with dimethyl sulfoxide (DMSO) was added to the plate. As a positive control (PC) or a negative control (NC), 0.5 μL of DMSO was added to the plate respectively. Each plate was mixed well. Then, 2 μL of a substrate solution (1.4 nM substrate RNA, 0.05% Tween20) was added to initiate a reaction. After room temperature incubation for 60 minutes, 1 μL of the reaction solution was collected and added to 10 μL of a Hi-Di formamide solution (containing GeneScan 120 Liz Size Standard as a sizing marker: manufactured by Applied Biosystem (ABI)) in order to stop the reaction. For NC, the reaction was stopped in advance by adding EDTA (4.5 mM) before initiation of the reaction (all concentrations described above are final concentrations).',\n",
       "   '3) Measurement of Inhibition Ratio (IC50 Value)',\n",
       "   'The solution for which the reaction was stopped was heated at 85° C. for 5 minutes, rapidly cooled on ice for 2 minutes, and analyzed with an ABI PRIZM 3730 genetic analyzer. A peak of the cap-dependent endonuclease product was quantitated by analysis software ABI Genemapper, a CEN reaction inhibition ratio (%) of a test compound was obtained by setting fluorescent intensities of PC and NC to be 0% inhibition and 100% inhibition, respectively, an IC50 value was obtained using curve fitting software (XLfit2.0: Model 205 (manufactured IDBS etc.)). The IC50 values of test substances are shown in Table 12-21.']},\n",
       " {'number': 'Test Example 2',\n",
       "  'title': 'CYP Inhibition Test',\n",
       "  'content': ['Using commercially available pooled human hepatic microsome, and employing, as markers, 7-ethoxyresorufin O-deethylation (CYP1A2), tolbutamide methyl-hydroxylation (CYP2C9), mephenyloin 4′-hydroxylation (CYP2C19), dextromethorphan O-demethylation (CYP2D6), and terfenedine hydroxylation as typical substrate metabolism reactions of human main five CYP enzyme forms (CYP1A2, 2C9, 2C19, 2D6, 3A4), an inhibitory degree of each metabolite production amount by a test compound was assessed.',\n",
       "   'The reaction conditions were as follows: substrate, 0.5 μmol/L ethoxyresorufin (CYP1A2), 100 μmol/L tolbutamide (CYP2C9), 50 μmol/L S-mephenitoin (CYP2C19), 5 μmol/L dextromethorphan (CYP2D6), 1 μmol/L terfenedine (CYP3A4); reaction time, 15 minutes; reaction temperature, 37° C.; enzyme, pooled human hepatic microsome 0.2 mg protein/mL; test drug concentration, 1, 5, 10, 20 μmol/L (four points).',\n",
       "   'Each five kinds of substrates, human hepatic microsome, or a test drug in 50 mM Hepes buffer as a reaction solution was added to a 96-well plate at the composition as described above, NADPH, as a cofactor was added to initiate metabolism reactions as markers and, after the incubation at 37° C. for 15 minutes, a methanol/acetonitrile=1/1 (v/v) solution was added to stop the reaction. After the centrifugation at 3000 rpm for 15 minutes, resorufin (CYP1A2 metabolite) in the supernatant was quantified by a fluorescent multilabel counter and tributamide hydroxide (CYP2CP metabolite), mephenyloin 4′ hydroxide (CYP2C19 metabolite), dextromethorphan (CYP2D6 metabolite), and terfenadine alcohol (CYP3A4 metabolite) were quantified by LC/MS/MS.',\n",
       "   'Addition of only DMSO being a solvent dissolving a drug to a reaction system was adopted as a control (100%), remaining activity (%) was calculated at each concentration of a test drug added as the solution and IC50 was calculated by reverse presumption by a logistic model using a concentration and an inhibition rate.']},\n",
       " {'number': 'Test Example 3',\n",
       "  'title': 'Solubility Test',\n",
       "  'content': ['The solubility of each compound is determined under 1% DMSO addition conditions. A 10 mM solution of the compound is prepared with DMSO, and 6 μL of the compound solution is added to 594 μL of an artificial intestinal juice (water and 118 mL of 0.2 mol/L NaOH reagent are added to 250 mL of 0.2 mol/L potassium dihydrogen phosphate reagent to reach 1000 mL) with pH of 6.8. The mixture is left standing for 16 hours at 25° C., and the mixture is vacuum-filtered. The filtrate is two-fold diluted with methanol/water=1/1, and the compound concentration in the filtrate is measured with HPLC or LC/MS/MS by the absolute calibration method.']},\n",
       " {'number': 'Test Example 4',\n",
       "  'title': 'Metabolism Stability Test',\n",
       "  'content': ['Using a commercially available pooled human hepatic microsomes, a test compound was reacted for a constant time, a remaining rate was calculated by comparing a reacted sample and an unreacted sample, thereby, a degree of metabolism in liver was assessed.',\n",
       "   'A reaction was performed (oxidative reaction) at 37° C. for 0 minute or 30 minutes in the presence of 1 mmol/L NADPH in 0.2 mL of a buffer (50 mmol/L Tris-HCl pH 7.4, 150 mmol/L potassium chloride, 10 mmol/L magnesium chloride) containing 0.5 mg protein/mL of human liver microsomes. After the reaction, 50 μL of the reaction solution was added to 100 μL of a methanol/acetonitrile=1/1 (v/v), mixed and centrifuged at 3000 rpm for 15 minutes. The test compound in the supernatant was quantified by LC/MS/MS, and a remaining amount of the test compound after the reaction was calculated, letting a compound amount at 0 minute reaction time to be 100%. Hydrolysis reaction was performed in the absence of NADPH and glucuronidation reaction was in the presence of 5 mM UDP-glucuronic acid in place of NADPH, followed by similar operations.']},\n",
       " {'number': 'Test Example 5',\n",
       "  'title': 'hERG Test',\n",
       "  'content': ['For the purpose of assessing risk of an electrocardiogram QT interval prolongation, effects on delayed rectifier K+ current (IKr), which plays an important role in the ventricular repolarization process, was studied using HEK293 cells expressing human ether-a-go-go related gene (hERG) channel.',\n",
       "   'After a cell was retained at a membrane potential of −80 mV by whole cell patch clamp method using an automated patch clamp system (PatchXpress 7000A, Axon Instruments Inc.), IKr induced by depolarization pulse stimulation at +40 mV for 2 seconds and, further, repolarization pulse stimulation at −50 mV for 2 seconds was recorded. After the generated current was stabilized, extracellular solution (NaCl: 135 mmol/L, KCl: 5.4 mmol/L, NaH2PO4: 0.3 mmol/L, CaCl2. 2H2O: 1.8 mmol/L, MgCl2.6H2O: 1 mmol/L, glucose: 10 mmol/L, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid): 10 mmol/L, pH=7.4) in which the test compound had been dissolved at an objective concentration was applied to the cell under the room temperature condition for 10 minutes. From the recording IKr, an absolute value of the tail peak current was measured based on the current value at the resting membrane potential using an analysis software (DataXpress ver. 1, Molecular Devices Corporation). Further, the % inhibition relative to the tail peak current before application of the test substance was calculated, and compared with the vehicle-applied group (0.1% dimethyl sulfoxide solution) to assess influence of the test substance on IKr.']},\n",
       " {'number': 'Test Example 6',\n",
       "  'title': 'CPE Inhibitory Effect Confirming Assay',\n",
       "  'content': ['<Material>',\n",
       "   '2% FCS E-MEM (prepared by adding kanamycin and FCS to MEM (Minimum Essential Medium) (Invitrogen))',\n",
       "   '0.5% BSA E-MEM (prepared by adding kanamycin and BSA to MEM (Minimum Essential Medium) (Invitrogen))',\n",
       "   \"HB (Hanks' Balanced Salt Solution)\",\n",
       "   'MDBK Cell',\n",
       "   'Cells were adjusted to the appropriate cell number (3×105/mL) with 2% FCS E-MEM.',\n",
       "   'MDCK Cell',\n",
       "   'After washing with HBSS two times, cells were adjusted to the appropriate cell number (5×105/mL) with 0.5% BSA E-MEM.',\n",
       "   'Trypsin Solution',\n",
       "   'Trypsin from porcine pancreas (SIGMA) was dissolved in PBS(−), and filtrated with a 0.45 μm filter.',\n",
       "   'EnVision (Perkin Elmer)',\n",
       "   'WST-8 Kit (Kishida Chemical Co., Ltd.)',\n",
       "   '10% SDS solution',\n",
       "   '<Operation Procedure>',\n",
       "   'Dilution and Dispensation of Test Sample',\n",
       "   'As a culture medium, 2% FCS E-MEM was used at the use of MDBK cells, and 0.5% BSA E-MEM was used at the use of MDCK cells. Hereinafter, for diluting virus, cells and a test sample, the same culture medium was used.',\n",
       "   'A test sample was diluted with a culture medium to a appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (50 μL/well) was prepared. Two plate, one for measuring anti-Flu activity and the other for measuring cytotoxity, were prepared. Each assay was performed triplicate for each drug.',\n",
       "   'At the use of MDCK cells, trypsin was added to the cells to be a final concentration of 3 μg/mL only for measuring anti-Flu activity.',\n",
       "   'Dilution and Dispensation of Influenza Virus',\n",
       "   'An influenza virus was diluted with a culture medium to a appropriate concentration in advance, and each 50 μL/well was dispensed on a 96-well plate containing a test substance. Each 50 μL/well of a culture medium was dispensed on a plate containing a test substance for measuring cytotoxity.',\n",
       "   'Dilution and Dispensation of Cell',\n",
       "   'Each 100 μL/well of cells which had been adjusted to the appropriate cell number was dispensed on a 96 well plate containing a test substance. This was mixed with a plate mixer, and incubated in a CO2 incubator for 3 days for measuring anti-Flu activity and measuring cytotoxity.',\n",
       "   'Dispensation of WST 8',\n",
       "   'The cells in 96-well plate which had been incubated for 3 days was observed visually under a microscope, and appearance of the cells, the presence or absence of a crystal of test substance were checked. The supernatant was removed so that the cells were not absorbed from the plate.',\n",
       "   'WST-8 Kit was diluted 10-fold with a culture medium, and each 100 μL was dispensed into each well. After mixing with a plate mixer, cells were incubated in a CO2 incubator for 1 to 3 hours.',\n",
       "   'After incubation, regarding the plate for measuring anti-Flu activity, each 10 μL/well of a 10% SDS solution was dispensed in order to inactivate a virus.',\n",
       "   'Measurement of Absorbance',\n",
       "   'After the 96-well plate was mixed, absorbance was measured with EnVision at two wavelengths of 450 nm/620 nm.',\n",
       "   '<Calculation of Each Measurement Item Value>',\n",
       "   'The value was calculated using Microsoft Excel or a program having the equivalent calculation and processing ability, based on the following calculation equation. Calculation of effective concentration to achieve 50% CPE inhibition (EC50)\\n\\nEC50=10^Z\\n\\nZ=(50%−High %)/(High %−Low %)×{ log(High conc.)−log(Low conc.)}+log(High conc.)',\n",
       "   'IC50 values of test substances are shown in Table 12-21.',\n",
       "   'TABLE 12\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n2\\n0.048\\n0.293\\n\\n\\n14\\n0.043\\n0.313\\n\\n\\n16\\n0.065\\n0.632\\n\\n\\n26\\n0.108\\n0.547\\n\\n\\n37\\n0.101\\n0.318\\n\\n\\n43\\n0.078\\n1.410\\n\\n\\n48\\n0.087\\n10.90\\n\\n\\n56\\n0.358\\n3.860\\n\\n\\n62\\n0.110\\n1.680\\n\\n\\n63\\n0.170\\n2.000\\n\\n\\n94\\n0.096\\n1.470\\n\\n\\n99\\n0.341\\n2.000\\n\\n\\n108\\n0.037\\n0.019\\n\\n\\n128\\n0.063\\n0.416\\n\\n\\n138\\n0.166\\n0.100\\n\\n\\n139\\n0.189\\n0.741\\n\\n\\n143\\n0.224\\n0.333\\n\\n\\n150\\n0.193\\n0.553\\n\\n\\n175\\n0.132\\n0.102\\n\\n\\n178\\n0.061\\n0.075',\n",
       "   'TABLE 13\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n181\\n0.049\\n0.349\\n\\n\\n182\\n0.099\\n0.562\\n\\n\\n183\\n0.074\\n2.370\\n\\n\\n184\\n0.055\\n0.403\\n\\n\\n185\\n0.132\\n1.920\\n\\n\\n186\\n0.085\\n0.159\\n\\n\\n187\\n0.085\\n0.282\\n\\n\\n190\\n0.143\\n2.640\\n\\n\\n191\\n0.238\\n2.820\\n\\n\\n199\\n0.236\\n2.720\\n\\n\\n204\\n0.299\\n2.360\\n\\n\\n224\\n0.276\\n0.119\\n\\n\\n225\\n0.283\\n0.663\\n\\n\\n228\\n0.243\\n0.141\\n\\n\\n230\\n0.282\\n0.525\\n\\n\\n233\\n0.228\\n2.240\\n\\n\\n238\\n0.101\\n0.440\\n\\n\\n240\\n0.037\\n0.048\\n\\n\\n241\\n0.197\\n0.063\\n\\n\\n242\\n0.114\\n0.059\\n\\n\\n243\\n0.076\\n0.020\\n\\n\\n244\\n0.249\\n0.108\\n\\n\\n246\\n0.082\\n0.026\\n\\n\\n247\\n0.282\\n2.260\\n\\n\\n248\\n0.103\\n0.489\\n\\n\\n249\\n0.151\\n1.890\\n\\n\\n250\\n0.113\\n0.476\\n\\n\\n251\\n0.058\\n0.157\\n\\n\\n252\\n0.107\\n0.454\\n\\n\\n253\\n0.235\\n0.280\\n\\n\\n254\\n0.135\\n0.564\\n\\n\\n255\\n0.052\\n0.319\\n\\n\\n256\\n0.038\\n0.400',\n",
       "   'TABLE 14\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n257\\n0.041\\n0.055\\n\\n\\n258\\n0.042\\n0.028\\n\\n\\n259\\n0.066\\n0.026\\n\\n\\n260\\n0.091\\n0.065\\n\\n\\n261\\n0.058\\n0.047\\n\\n\\n262\\n0.032\\n0.038\\n\\n\\n263\\n0.085\\n0.075\\n\\n\\n264\\n0.064\\n0.128\\n\\n\\n265\\n0.172\\n0.036\\n\\n\\n266\\n0.043\\n0.085\\n\\n\\n267\\n0.029\\n0.063\\n\\n\\n268\\n0.018\\n0.074\\n\\n\\n269\\n0.073\\n0.417\\n\\n\\n270\\n0.058\\n0.129\\n\\n\\n271\\n0.073\\n0.102\\n\\n\\n272\\n0.082\\n0.030\\n\\n\\n273\\n0.016\\n0.084\\n\\n\\n274\\n0.038\\n0.016\\n\\n\\n274\\n0.157\\n0.056\\n\\n\\n276\\n0.053\\n0.089\\n\\n\\n277\\n0.039\\n0.071\\n\\n\\n278\\n0.205\\n0.074\\n\\n\\n279\\n0.056\\n0.119\\n\\n\\n280\\n0.068\\n0.145\\n\\n\\n281\\n0.026\\n0.018\\n\\n\\n282\\n0.036\\n0.029\\n\\n\\n283\\n0.028\\n0.021\\n\\n\\n284\\n0.042\\n0.019\\n\\n\\n285\\n0.044\\n0.017\\n\\n\\n286\\n0.161\\n0.121\\n\\n\\n287\\n0.154\\n0.268\\n\\n\\n288\\n0.299\\n0.085\\n\\n\\n289\\n0.031\\n0.419',\n",
       "   'TABLE 15\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n290\\n0.067\\n0.492\\n\\n\\n292\\n0.155\\n2.230\\n\\n\\n293\\n0.290\\n0.437\\n\\n\\n294\\n0.035\\n0.018\\n\\n\\n295\\n0.052\\n0.334\\n\\n\\n296\\n0.130\\n0.397\\n\\n\\n297\\n0.045\\n0.033\\n\\n\\n298\\n0.044\\n0.012\\n\\n\\n299\\n0.050\\n0.015\\n\\n\\n300\\n0.058\\n0.021\\n\\n\\n301\\n0.062\\n0.017\\n\\n\\n302\\n0.035\\n0.014\\n\\n\\n304\\n0.018\\n0.015\\n\\n\\n305\\n0.059\\n0.103\\n\\n\\n306\\n0.076\\n0.021\\n\\n\\n307\\n0.052\\n0.095\\n\\n\\n308\\n0.072\\n0.019\\n\\n\\n309\\n0.040\\n0.013\\n\\n\\n310\\n0.108\\n0.522\\n\\n\\n311\\n0.040\\n0.026\\n\\n\\n312\\n0.019\\n0.029\\n\\n\\n313\\n0.189\\n0.050\\n\\n\\n314\\n0.149\\n0.026\\n\\n\\n315\\n0.057\\n0.115\\n\\n\\n316\\n0.069\\n0.083\\n\\n\\n317\\n0.048\\n0.017\\n\\n\\n318\\n0.130\\n0.015\\n\\n\\n320\\n0.045\\n0.011\\n\\n\\n321\\n0.019\\n0.019\\n\\n\\n322\\n0.113\\n0.028\\n\\n\\n323\\n0.077\\n0.019\\n\\n\\n324\\n0.107\\n0.035\\n\\n\\n325\\n0.032\\n0.025',\n",
       "   'TABLE 16\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n326\\n0.043\\n0.005\\n\\n\\n327\\n0.092\\n0.024\\n\\n\\n328\\n0.029\\n0.168\\n\\n\\n329\\n0.058\\n0.023\\n\\n\\n330\\n0.026\\n0.019\\n\\n\\n331\\n0.045\\n0.335\\n\\n\\n332\\n0.048\\n0.020\\n\\n\\n333\\n0.021\\n0.425\\n\\n\\n334\\n0.075\\n0.032\\n\\n\\n335\\n0.019\\n0.016\\n\\n\\n336\\n0.051\\n0.070\\n\\n\\n337\\n0.058\\n0.028\\n\\n\\n338\\n0.074\\n0.085\\n\\n\\n339\\n0.183\\n0.040\\n\\n\\n340\\n0.101\\n0.027\\n\\n\\n341\\n0.016\\n0.027\\n\\n\\n342\\n0.099\\n0.026\\n\\n\\n343\\n0.122\\n0.018\\n\\n\\n344\\n0.050\\n0.009\\n\\n\\n345\\n0.097\\n0.008\\n\\n\\n346\\n0.028\\n0.018\\n\\n\\n347\\n0.014\\n0.017\\n\\n\\n348\\n0.054\\n0.080\\n\\n\\n349\\n0.053\\n0.075\\n\\n\\n351\\n0.091\\n0.019\\n\\n\\n352\\n0.067\\n0.020\\n\\n\\n354\\n0.025\\n0.083\\n\\n\\n355\\n0.040\\n0.075\\n\\n\\n356\\n0.066\\n0.020\\n\\n\\n357\\n0.138\\n0.386\\n\\n\\n358\\n0.051\\n0.069\\n\\n\\n359\\n0.037\\n0.080\\n\\n\\n360\\n0.042\\n0.087',\n",
       "   'TABLE 17\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n361\\n0.039\\n0.145\\n\\n\\n362\\n0.084\\n0.067\\n\\n\\n363\\n0.058\\n0.067\\n\\n\\n364\\n0.112\\n0.515\\n\\n\\n365\\n0.041\\n2.250\\n\\n\\n366\\n0.090\\n0.838\\n\\n\\n368\\n0.140\\n0.470\\n\\n\\n369\\n0.294\\n0.434\\n\\n\\n370\\n0.113\\n0.061\\n\\n\\n371\\n0.161\\n0.074\\n\\n\\n372\\n0.164\\n0.146\\n\\n\\n373\\n0.065\\n0.050\\n\\n\\n374\\n0.137\\n0.154\\n\\n\\n375\\n0.037\\n0.073\\n\\n\\n376\\n0.063\\n0.092\\n\\n\\n377\\n0.024\\n0.022\\n\\n\\n378\\n0.047\\n0.022\\n\\n\\n380\\n0.123\\n0.018\\n\\n\\n381\\n0.200\\n0.034\\n\\n\\n382\\n0.032\\n0.094\\n\\n\\n384\\n0.153\\n0.293\\n\\n\\n386\\n0.075\\n0.096\\n\\n\\n387\\n0.300\\n1.150\\n\\n\\n388\\n0.133\\n0.063\\n\\n\\n390\\n0.095\\n0.029\\n\\n\\n391\\n0.264\\n0.071\\n\\n\\n392\\n0.153\\n0.025\\n\\n\\n394\\n0.087\\n0.064\\n\\n\\n395\\n0.043\\n0.089\\n\\n\\n396\\n0.056\\n0.060\\n\\n\\n397\\n0.055\\n0.077\\n\\n\\n398\\n0.034\\n0.118\\n\\n\\n399\\n0.105\\n0.061',\n",
       "   'TABLE 18\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n400\\n0.067\\n0.079\\n\\n\\n401\\n0.089\\n0.133\\n\\n\\n402\\n0.085\\n0.081\\n\\n\\n403\\n0.090\\n0.070\\n\\n\\n404\\n0.084\\n0.063\\n\\n\\n405\\n0.074\\n0.051\\n\\n\\n406\\n0.119\\n0.022\\n\\n\\n407\\n0.035\\n0.017\\n\\n\\n408\\n0.135\\n0.061\\n\\n\\n409\\n0.093\\n0.029\\n\\n\\n410\\n0.265\\n0.014\\n\\n\\n411\\n0.046\\n0.014\\n\\n\\n412\\n0.292\\n0.203\\n\\n\\n413\\n0.050\\n0.005\\n\\n\\n414\\n1.890\\n0.131\\n\\n\\n415\\n0.285\\n0.022\\n\\n\\n416\\n0.112\\n0.019\\n\\n\\n417\\n0.030\\n0.003\\n\\n\\n418\\n0.121\\n0.072\\n\\n\\n419\\n0.124\\n0.019\\n\\n\\n420\\n0.058\\n0.021\\n\\n\\n423\\n0.280\\n0.019\\n\\n\\n425\\n0.183\\n0.047\\n\\n\\n429\\n0.016\\n0.004\\n\\n\\n430\\n0.168\\n0.029\\n\\n\\n431\\n0.097\\n0.011\\n\\n\\n432\\n0.155\\n0.062\\n\\n\\n433\\n0.014\\n0.017\\n\\n\\n441\\n0.044\\n0.005\\n\\n\\n443\\n0.166\\n0.004\\n\\n\\n444\\n0.066\\n0.003\\n\\n\\n445\\n0.013\\n0.004\\n\\n\\n446\\n0.007\\n0.011',\n",
       "   'TABLE 19\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n447\\n0.096\\n0.018\\n\\n\\n448\\n0.039\\n0.008\\n\\n\\n449\\n0.062\\n0.021\\n\\n\\n450\\n0.023\\n0.014\\n\\n\\n452\\n0.177\\n0.016\\n\\n\\n453\\n0.186\\n0.049\\n\\n\\n454\\n0.012\\n0.004\\n\\n\\n455\\n0.025\\n0.071\\n\\n\\n456\\n0.032\\n0.004\\n\\n\\n457\\n0.242\\n0.014\\n\\n\\n458\\n0.048\\n0.014\\n\\n\\n459\\n0.287\\n0.048\\n\\n\\n460\\n0.085\\n0.009\\n\\n\\n461\\n0.255\\n0.074\\n\\n\\n462\\n0.069\\n0.011\\n\\n\\n463\\n0.012\\n0.005\\n\\n\\n464\\n0.024\\n0.014\\n\\n\\n469\\n0.016\\n0.004\\n\\n\\n470\\n0.008\\n0.003\\n\\n\\n475\\n0.164\\n0.441\\n\\n\\n476\\n0.031\\n0.014\\n\\n\\n478\\n0.088\\n0.129\\n\\n\\n479\\n0.117\\n0.064\\n\\n\\n480\\n0.151\\n0.084\\n\\n\\n481\\n0.114\\n0.086\\n\\n\\n482\\n0.103\\n0.031\\n\\n\\n483\\n0.101\\n0.027\\n\\n\\n485\\n0.221\\n0.424\\n\\n\\n486\\n0.140\\n0.072\\n\\n\\n487\\n0.091\\n0.026\\n\\n\\n488\\n0.151\\n0.027\\n\\n\\n489\\n0.133\\n0.014\\n\\n\\n490\\n0.212\\n0.468',\n",
       "   'TABLE 20\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n491\\n0.069\\n0.099\\n\\n\\n492\\n0.121\\n0.160\\n\\n\\n493\\n0.112\\n0.101\\n\\n\\n495\\n0.277\\n0.310\\n\\n\\n496\\n0.170\\n0.177\\n\\n\\n497\\n0.215\\n0.511\\n\\n\\n498\\n0.161\\n0.351\\n\\n\\n502\\n0.042\\n0.142\\n\\n\\n506\\n0.247\\n1.620\\n\\n\\n507\\n0.063\\n0.197\\n\\n\\n508\\n0.036\\n0.056\\n\\n\\n509\\n0.015\\n0.014\\n\\n\\n511\\n0.175\\n0.015\\n\\n\\n514\\n0.049\\n0.018\\n\\n\\n515\\n0.197\\n0.019\\n\\n\\n516\\n0.039\\n0.017\\n\\n\\n518\\n0.049\\n0.024\\n\\n\\n520\\n0.212\\n0.017\\n\\n\\n521\\n0.191\\n0.015\\n\\n\\n522\\n0.039\\n0.014\\n\\n\\n523\\n0.035\\n0.014\\n\\n\\n524\\n0.057\\n0.026\\n\\n\\n525\\n0.141\\n0.090\\n\\n\\n526\\n0.044\\n0.019\\n\\n\\n527\\n0.127\\n0.088\\n\\n\\n532\\n0.098\\n0.075\\n\\n\\n533\\n0.065\\n0.391\\n\\n\\n534\\n0.165\\n1.200\\n\\n\\n536\\n0.071\\n0.027\\n\\n\\n537\\n0.152\\n0.022\\n\\n\\n538\\n0.196\\n0.030\\n\\n\\n544\\n0.168\\n0.051\\n\\n\\n546\\n0.202\\n0.124',\n",
       "   'TABLE 21\\n\\n\\n\\n\\n\\n\\nCEN IC50\\nCPE EC50\\n\\n\\nExample No.\\n(μM)\\n(μM)\\n\\n\\n\\n\\n\\n\\n\\n547\\n0.032\\n0.027\\n\\n\\n548\\n0.086\\n0.038\\n\\n\\n549\\n0.076\\n2.100\\n\\n\\n550\\n0.042\\n0.042\\n\\n\\n551\\n0.041\\n0.107\\n\\n\\n552\\n0.230\\n0.085\\n\\n\\n553\\n0.028\\n0.030\\n\\n\\n554\\n0.065\\n0.465\\n\\n\\n555\\n0.023\\n0.012\\n\\n\\n556\\n0.023\\n0.412\\n\\n\\n557\\n0.281\\n2.470\\n\\n\\n558\\n0.114\\n0.541\\n\\n\\n560\\n0.027\\n0.173\\n\\n\\n561\\n0.073\\n0.008\\n\\n\\n562\\n0.022\\n0.062\\n\\n\\n563\\n0.049\\n0.464\\n\\n\\n564\\n0.088\\n0.136\\n\\n\\n565\\n0.154\\n0.726\\n\\n\\n568\\n0.264\\n2.810\\n\\n\\n569\\n0.138\\n1.010\\n\\n\\n570\\n0.081\\n2.050\\n\\n\\n571\\n0.065\\n0.320\\n\\n\\n573\\n0.055\\n0.158\\n\\n\\n574\\n0.165\\n0.442\\n\\n\\n575\\n0.058\\n0.087\\n\\n\\n576\\n0.063\\n0.027\\n\\n\\n577\\n0.233\\n0.337\\n\\n\\n581\\n0.083\\n0.480']},\n",
       " {'number': 'Test Example 7',\n",
       "  'title': 'Influenza Virus-Infected Mouse Lethality Inhibitory Test',\n",
       "  'content': ['<Mouse>',\n",
       "   'BALB/cAnNCrlCrlj (female, 5-week-old; CHARLES RIVER LABORATORIES JAPAN, INC.) was purchased, and 6- to 7-week-old mice were used in the test.',\n",
       "   '<Preparation of Virus Solution>',\n",
       "   'A/Victoria/3/75 or B/Maryland/1/59(ATCC) was passaged in mouse lung to make a mouse-acclimatized virus. A freezing-stored mouse-acclimatized virus solution was rapidly thawed, and diluted with DPBS to an infectivity titer to be used (in the case of A/Victoria/3/75:750 TCID50/mouse, in the case of B/Maryland/1/59:100 TCID50/mouse).',\n",
       "   '<Infection>',\n",
       "   'Under anesthesia with ketamine.xylazine, 100 ul of the prepared virus solution was nasally inoculated to directly infect mouse lung.',\n",
       "   '<Preparation of Test Sample>',\n",
       "   'A test sample was dissolved in a 5% DMAA/20% HP-β-CD aqueous solution to a suitable concentration.',\n",
       "   '<Administration of Test Sample to Infected Mouse>',\n",
       "   'A suitably diluted test sample was intravenously administered at 200 ul to a mouse immediately after virus infection, by a single dose.',\n",
       "   '<Drug Efficacy Assessment>',\n",
       "   'The mouse was reared for 14 days after virus infection, and a necessary dose per day for 50% lethality inhibition, ED50 (mg/kg/day), a lethality inhibition rate at a maximum dose (% survival), or days during which the mouse survives 50% as compared with a control at a maximum dose (50% life extension days) was calculated.',\n",
       "   '<Euthanasia>',\n",
       "   'The mouse after completion of the test was euthanized by carbon dioxide or halothane excessive administration.',\n",
       "   'The present compound exhibits the effect of inhibiting lethality of an influenza virus-infected mouse in the above test. Therefore, the present compound is effective in treating and/or preventing an influenza infectious disease.',\n",
       "   'A granule containing the following ingredients is manufactured.',\n",
       "   'Ingredient\\nA compound shown by formula (I)\\n\\u200210 mg\\n\\n\\n\\n\\nlactose\\n700 mg\\n\\n\\n\\n\\ncornstarch\\n274 mg\\n\\n\\n\\n\\nHPC-L\\n\\u200216 mg\\n\\n\\n\\n\\n\\n1000 mg',\n",
       "   'A compound shown by formula (I) and lactose are passed through a 60 mesh sieve. Corn starch is passed through a 120 mesh sieve. These are mixed with V-type blender. To the mixture, aqueous HPC-L (low viscosity of hydroxypropylcellulose) is added, then the mixture is kneaded together, granulated (extrusive granulation pore diameter 0.5˜1 mm), and dried. The obtained dried granule is passed through vibrating sieve (12/60 mesh) to obtain a granule.',\n",
       "   'A granule for encapsulation containing the following ingredients is manufactured.',\n",
       "   'Ingredient\\nA compound shown by formula (I)\\n15 mg\\n\\n\\n\\n\\nlactose\\n90 mg\\n\\n\\n\\n\\ncornstarch\\n42 mg\\n\\n\\n\\n\\nHPC-L\\n\\u20023 mg\\n\\n\\n\\n\\n\\n150 mg',\n",
       "   'A compound shown by formula (I) and lactose are passed through a 60 mesh sieve. Corn starch is passed through a 120 mesh sieve. These are mixed and aqueous HPC-L (low viscosity of hydroxypropylcellulose) is added thereto, then the mixture is kneaded together, granulated, and dried. The obtained dried granule is trimmed and 150 mg thereof is filled into a No. 4 hard gelatin capsule.',\n",
       "   'A tablet containing the following ingredients is manufactured.',\n",
       "   'Ingredient\\nA compound shown by formula (I)\\n10 mg\\n\\n\\n\\n\\nlactose\\n90 mg\\n\\n\\n\\n\\nmicrocrystal cellulose\\n30 mg\\n\\n\\n\\n\\nCMC-Na\\n15 mg\\n\\n\\n\\n\\nMagnesium stearate\\n\\u20025 mg\\n\\n\\n\\n\\n\\n150 mg',\n",
       "   'A compound shown by formula (I), lactose, and microcrystal cellulose, CMC-Na (carboxymethylcellulose sodium salt) are passed through a 60 mesh sieve and mixed. Magnesium stearate is added to the mixed powder to obtain a mixture for tablet. The mixture is tableted directly to obtain a 150 mg tablet.',\n",
       "   'An injectable solution is manufactured by mixing the following ingredients under warming, followed by sterilization.',\n",
       "   'Ingredient\\nA compound shown by formula (I)\\n3 mg\\n\\n\\n\\n\\nnon-ion surfactant\\n15 mg\\u2002\\n\\n\\n\\n\\nWater for injection\\n1 ml',\n",
       "   'The compound of the present invention has cap-dependent endonuclease (CEN) inhibitory activity. The compound of the present invention can be a useful agent for treatment and/or prevention of symptom and/or disease induced by infection with influenza virus.']}]"
      ]
     },
     "execution_count": 122,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stats[\"documents_with_examples\"][\"8927710\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "metadata": {},
   "outputs": [],
   "source": [
    "from utilities.database_utils import *"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "metadata": {},
   "outputs": [],
   "source": [
    "store_patent_examples(stats[\"documents_with_examples\"])\n",
    "store_patent_statistics(final)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "we extract more than janets: 97, total difference: 256.0\n",
      "we extract less than janets: 3, total difference: 3.0\n",
      "we extract equal to janets: 699\n"
     ]
    }
   ],
   "source": [
    "print(f\"we extract more than janets: {len(df_check[df_check.Total_Extracted > df_check.Total_Freilich])}, total difference: {df_check[df_check.Total_Extracted > df_check.Total_Freilich].Total_Extracted.sum() - df_check[df_check.Total_Extracted > df_check.Total_Freilich].Total_Freilich.sum()}\")\n",
    "print(f\"we extract less than janets: {len(df_check[df_check.Total_Extracted < df_check.Total_Freilich])}, total difference: {df_check[df_check.Total_Extracted < df_check.Total_Freilich].Total_Freilich.sum() - df_check[df_check.Total_Extracted < df_check.Total_Freilich].Total_Extracted.sum()}\")\n",
    "print(f\"we extract equal to janets: {len(df_check[df_check.Total_Extracted == df_check.Total_Freilich])}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 178,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patentnumber</th>\n",
       "      <th>present</th>\n",
       "      <th>past</th>\n",
       "      <th>unknown</th>\n",
       "      <th>prophetic</th>\n",
       "      <th>nonprophetic</th>\n",
       "      <th>allprophetic</th>\n",
       "      <th>someprophetic</th>\n",
       "      <th>Total_Extracted</th>\n",
       "      <th>Total_Freilich</th>\n",
       "      <th>prophetic_error</th>\n",
       "      <th>nonprophetic_error</th>\n",
       "      <th>Total_Mean_error</th>\n",
       "      <th>Sum_error</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>8927015</td>\n",
       "      <td>0</td>\n",
       "      <td>24</td>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>24.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>24</td>\n",
       "      <td>25.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>8927541</td>\n",
       "      <td>3</td>\n",
       "      <td>17</td>\n",
       "      <td>0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>20</td>\n",
       "      <td>21.0</td>\n",
       "      <td>17.0</td>\n",
       "      <td>16.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>34.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>444</th>\n",
       "      <td>8932615</td>\n",
       "      <td>2</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2</td>\n",
       "      <td>3.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patentnumber  present  past  unknown  prophetic  nonprophetic  \\\n",
       "87       8927015        0    24        0        1.0          24.0   \n",
       "199      8927541        3    17        0       20.0           1.0   \n",
       "444      8932615        2     0        0        1.0           2.0   \n",
       "\n",
       "     allprophetic  someprophetic  Total_Extracted  Total_Freilich  \\\n",
       "87            0.0            1.0               24            25.0   \n",
       "199           0.0            1.0               20            21.0   \n",
       "444           0.0            1.0                2             3.0   \n",
       "\n",
       "     prophetic_error  nonprophetic_error  Total_Mean_error  Sum_error  \n",
       "87               1.0                 0.0               1.0        2.0  \n",
       "199             17.0                16.0               1.0       34.0  \n",
       "444              1.0                 2.0               1.0        4.0  "
      ]
     },
     "execution_count": 178,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_check[df_check.Total_Extracted < df_check.Total_Freilich]"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "cuda",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
